25847295	Nonylphenol diethoxylate	C1254354
25847295	inhibits	C3463820
25847295	apoptosis	C0162638
25847295	induced	C0205263
25847295	PC12 cells	C0085262
25847295	Nonylphenol	C1254354
25847295	short-chain nonylphenol ethoxylates	C1254354
25847295	NP2 EO	C1254354
25847295	present	C0150312
25847295	aquatic environment	C0563034
25847295	wastewater	C3494254
25847295	contaminants	C2827365
25847295	toxic effects	C0600688
25847295	aquatic species	C0596121
25847295	Apoptosis	C0162638
25847295	induced	C0205263
25847295	serum	C0229671
25847295	deprivation	C0871712
25847295	copper	C0009968
25847295	treatment	C1522326
25847295	toxicity	C0040539
25847295	nonylphenol diethoxylate	C1254354
25847295	effects of	C1704420
25847295	NP2 EO	C1254354
25847295	apoptosis	C0162638
25847295	induced	C0205263
25847295	serum	C0229671
25847295	deprivation	C0871712
25847295	copper	C0009968
25847295	PC12 cell system	C0085262
25847295	Nonylphenol diethoxylate	C1254354
25847295	cell viability	C0007620
25847295	apoptosis	C0162638
25847295	nonylphenol diethoxylate	C1254354
25847295	decreased	C0205216
25847295	DNA fragmentation	C0376669
25847295	apoptosis	C0162638
25847295	PC12 cells	C0085262
25847295	phenomenon	C1882365
25847295	treating	C1522326
25847295	apoptotic	C1516044
25847295	PC12 cells	C0085262
25847295	nonylphenol diethoxylate	C1254354
25847295	cytochrome c	C0010749
25847295	cytosol	C1383501
25847295	decreased	C0205216
25847295	apoptotic cells	C0007634
25847295	treated	C1522326
25847295	nonylphenol diethoxylate	C1254354
25847295	Bax	C0219474
25847295	contents	C0456205
25847295	apoptotic cells	C0007634
25847295	reduced	C0392756
25847295	exposure to	C0332157
25847295	nonylphenol diethoxylate	C1254354
25847295	nonylphenol diethoxylate	C1254354
25847295	opposite effect	C1280500
25847295	apoptosis	C0162638
25847295	PC12 cells	C0085262
25847295	nonylphenol	C1254354
25847295	enhances	C2349975
25847295	apoptosis	C0162638
25847295	induced	C0205263
25847295	serum	C0229671
25847295	deprivation	C0871712
25847295	difference	C1705242
25847295	structure	C0678594
25847295	compounds	C0220806
25847295	hypothesized	C1512571
25847295	phenomenon	C1882365
25847295	results	C2825142
25847295	nonylphenol diethoxylate	C1254354
25847295	capability	C2698977
25847295	cell differentiation	C0007589
25847295	development	C0243107
25847295	potentially	C3245505
25847295	harmful effect	C0600688
25847295	organisms	C0029235
25847295	impact	C4049986
25847295	apoptosis	C0162638
26876532	EZH2	C1333368
26876532	ZFX	C1421578
26876532	oncogenes	C0029016
26876532	malignant behaviour	C0205282
26876532	parathyroid neoplasms	C0030521
26876532	studies	C0008972
26876532	somatic mutations	C0544886
26876532	genes	C0017337
26876532	MEN1	C0694884
26876532	CTNNB1	C1332803
26876532	CDKIs	C0919539
26876532	parathyroid adenoma	C0262587
26876532	different	C1705242
26876532	prevalence	C0220900
26876532	activating	C1879547
26876532	mutations	C0026882
26876532	EZH2	C1333368
26876532	ZFX	C1421578
26876532	oncogenes	C0029016
26876532	benign	C0205183
26876532	parathyroid adenoma	C0262587
26876532	whole exome sequencing	C3640077
26876532	mutations	C0026882
26876532	blood	C0005767
26876532	ovary	C0029939
26876532	malignant tumours	C0006826
26876532	hypothesis	C1512571
26876532	oncogenes	C0029016
26876532	onset	C0332162
26876532	parathyroid tumour	C0030521
26876532	malignant	C0205282
26876532	benign	C0205183
26876532	parathyroid neoplasm	C0030521
26876532	aim	C1947946
26876532	occurrence	C2745955
26876532	mutations	C0026882
26876532	EZH2	C1333368
26876532	ZFX genes	C1421578
26876532	Italian	C0337810
26876532	cohort	C0599755
26876532	sporadic	C0205422
26876532	parathyroid carcinomas	C0687150
26876532	atypical	C0205182
26876532	typical	C3538928
26876532	adenomas	C0001430
26876532	DNA	C0012854
26876532	extracted	C0185115
26876532	paraffin-embedded tissues	C1519524
26876532	PCR	C0032520
26876532	amplified	C1521871
26876532	sequenced	C1561491
26876532	No	C0205160
26876532	mutations	C0026882
26876532	detected	C0442726
26876532	coding sequence	C0015295
26876532	boundaries	C1136191
26876532	genes	C0017337
26876532	samples	C0370003
26876532	polymorphisms	C0678951
26876532	EZH2 gene	C1333368
26876532	identified	C0205396
26876532	different	C1705242
26876532	prevalence	C0033105
26876532	rs2072407 variant	C0678941
26876532	present	C0150312
26876532	samples	C0370003
26876532	overall	C1561607
26876532	frequency	C0439603
26876532	larger	C0549177
26876532	populations	C0032659
26876532	rs78589034 variant	C0678941
26876532	5' end	C1254348
26876532	exon 16	C0015295
26876532	detected	C0442726
26876532	proband	C1948021
26876532	familial	C0241888
26876532	isolated	C0205409
26876532	hyperparathyroidism	C0020502
26876532	investigated	C1292732
26876532	outcome	C1274040
26876532	splicing process	C0035687
26876532	EZH2	C1333368
26876532	ZFX genes	C1421578
26876532	impact	C4049986
26876532	onset	C0332162
26876532	parathyroid tumours	C0030521
26876532	benign	C0205183
26876532	malignant	C0205282
26876532	larger	C0549177
26876532	cohorts	C0599755
26876532	different	C1705242
26876532	ethnicity	C0243103
27059693	Patient	C0030705
27059693	Physician	C0031831
27059693	Discordance	C1705242
27059693	Global Assessment	C0281858
27059693	Rheumatoid Arthritis	C0003873
27059693	Systematic	C0220922
27059693	Literature Review	C0282441
27059693	Meta-Analysis	C0920317
27059693	patient	C0030705
27059693	therapeutic	C0302350
27059693	decision-making	C0011109
27059693	management	C0376636
27059693	rheumatoid arthritis	C0003873
27059693	RA	C0003873
27059693	patient	C0030705
27059693	opinion	C0871010
27059693	disease	C0012634
27059693	status	C0449438
27059693	physician's	C0031831
27059693	opinion	C0871010
27059693	study	C2603343
27059693	assess	C1516048
27059693	published literature	C0023866
27059693	frequency	C0376249
27059693	patient	C0030705
27059693	physician	C0031831
27059693	discordance	C1705242
27059693	global assessment	C0281858
27059693	RA	C0003873
27059693	systematic	C0220922
27059693	literature review	C0282441
27059693	articles	C1706852
27059693	published	C0034037
27059693	Medline	C0025141
27059693	Embase	C0282574
27059693	discordance	C1705242
27059693	RA	C0003873
27059693	investigators	C0035173
27059693	Discordance	C1705242
27059693	absolute difference	C1705242
27059693	patient global	C4054229
27059693	PGA	C4054229
27059693	physician global assessments	C0281858
27059693	PhGA	C0281858
27059693	frequency	C0376249
27059693	discordance	C1705242
27059693	predictors	C0035648
27059693	study	C2603343
27059693	Frequencies	C0376249
27059693	discordance	C1705242
27059693	pooled	C2349200
27059693	meta-analysis	C0920317
27059693	random	C0439605
27059693	effect	C1280500
27059693	studies	C2603343
27059693	patients	C0030705
27059693	weighted mean	C0444504
27059693	age	C0001779
27059693	years	C0439234
27059693	weighted mean	C0444504
27059693	disease duration	C0872146
27059693	years	C0439234
27059693	women	C0043210
27059693	value	C1522609
27059693	difference	C1705241
27059693	PGA	C4054229
27059693	PhGA	C0281858
27059693	discordance	C1705242
27059693	weighted mean value	C0444504
27059693	pooled	C2349200
27059693	percentage	C0439165
27059693	patients	C0030705
27059693	discordance	C1705242
27059693	confidence interval	C0009667
27059693	range	C1514721
27059693	PGA	C4054229
27059693	higher	C0205250
27059693	PhGA	C0281858
27059693	PGA	C4054229
27059693	pain	C0030193
27059693	functional	C0205245
27059693	incapacity	C3176592
27059693	PhGA	C0281858
27059693	joint counts	C0282574
27059693	acute-phase reactants	C0001347
27059693	Discordance	C1705242
27059693	global assessment	C0281858
27059693	frequently	C0332183
27059693	difference	C1705242
27059693	half	C2825407
27059693	patients	C0030705
27059693	discordant	C1705242
27059693	long-term	C0443252
27059693	consequences	C0686907
27059693	discordance	C1705242
27117874	Randomized Controlled Noninferiority Trial	C0206035
27117874	Single Dose	C0178602
27117874	Oral Dexamethasone	C0360528
27117874	Days	C0439228
27117874	Oral Prednisone	C3216040
27117874	Adult	C0001675
27117874	Asthma	C0004096
27117874	Oral dexamethasone	C0360528
27117874	demonstrates	C3687625
27117874	bioavailability	C0005508
27117874	similar	C2348205
27117874	oral prednisone	C3216040
27117874	half-life	C0018517
27117874	single dose	C0178602
27117874	oral dexamethasone	C0360528
27117874	plus	C0332287
27117874	days	C0439228
27117874	placebo	C1696465
27117874	inferior	C0542339
27117874	days	C0439228
27117874	oral prednisone	C3216040
27117874	treatment	C1522326
27117874	adults	C0001675
27117874	mild	C0581124
27117874	moderate	C0581125
27117874	asthma exacerbations	C0349790
27117874	prevent	C1292733
27117874	relapse	C0035020
27117874	unscheduled	C3854240
27117874	additional treatment	C1706712
27117874	persistent	C3266628
27117874	worsening	C0332271
27117874	asthma	C0004096
27117874	days	C0439228
27117874	Adult	C0001675
27117874	emergency department	C3840745
27117874	patients	C0030705
27117874	aged	C0001779
27117874	years	C0439234
27117874	randomized	C0034656
27117874	receive	C1514756
27117874	single dose	C0178602
27117874	oral dexamethasone	C0360528
27117874	days	C0439228
27117874	placebo	C1696465
27117874	day	C0439228
27117874	course	C0750729
27117874	oral prednisone	C3216040
27117874	day	C0439228
27117874	Outcomes	C1274040
27117874	including	C0332257
27117874	relapse	C0035020
27117874	assessed	C1516048
27117874	follow-up telephone interview	C0178941
27117874	weeks	C0439230
27117874	hundred seventy-three	C0392762
27117874	dexamethasone	C0011777
27117874	prednisone	C0032952
27117874	subjects	C0681850
27117874	completed	C0205197
27117874	telephone follow-up	C0178941
27117874	dexamethasone	C0011777
27117874	group	C0681860
27117874	difference	C1705242
27117874	groups	C0681860
27117874	noninferiority	C0205556
27117874	relapse	C0035020
27117874	rates	C1521828
27117874	days	C0439228
27117874	difference	C1705242
27117874	confidence interval	C0009667
27117874	Subjects	C0681850
27117874	groups	C0681860
27117874	rates	C1521828
27117874	hospitalization	C0019993
27117874	relapse	C0035020
27117874	visit	C1512346
27117874	dexamethasone	C0011777
27117874	prednisone	C0032952
27117874	difference	C1705242
27117874	confidence interval	C0009667
27117874	Adverse effect	C1280500
27117874	rates	C1521828
27117874	groups	C0681860
27117874	single dose	C0178602
27117874	oral dexamethasone	C0360528
27117874	demonstrate	C3687625
27117874	noninferiority	C0205556
27117874	prednisone	C0032952
27117874	days	C0439228
27117874	treatment	C1522326
27117874	adults	C0001675
27117874	mild	C0581124
27117874	moderate	C0581125
27117874	asthma exacerbations	C0349790
27117874	Enhanced	C2349975
27117874	compliance	C3714738
27117874	convenience	C3831015
27117874	use	C0457083
27117874	dexamethasone	C0011777
27172917	Malignancy	C4282132
27172917	associated with	C0332281
27172917	microcalcification	C0521174
27172917	higher AP/T ratio	C0456603
27172917	ultrasonography	C0041618
27172917	Hashimoto's thyroiditis	C0677607
27172917	histopathology	C0430445
27172917	patients	C0030705
27172917	thyroid nodules	C0040137
27172917	Bethesda Category III	C0040137
27172917	AUS	C0522580
27172917	FLUS	C1272585
27172917	cytology	C1305671
27172917	predictors	C0683956
27172917	malignancy	C4282132
27172917	management	C0376636
27172917	nodules	C0040137
27172917	atypia of undetermined significance	C0522580
27172917	follicular lesion of undetermined significance	C1272585
27172917	AUS	C0522580
27172917	FLUS	C1272585
27172917	ultrasonographical	C0683956
27172917	clinical	C0683956
27172917	biochemical predictors	C0683956
27172917	malignancy	C4282132
27172917	patients	C0030705
27172917	patients	C0030705
27172917	cytologically Bethesda Category III	C0040137
27172917	AUS	C0522580
27172917	FLUS	C1272585
27172917	thyroid nodules	C0040137
27172917	retrospective study	C0035363
27172917	nodules	C0040137
27172917	subgroups	C1257890
27172917	histopathology	C0430445
27172917	benign	C0205183
27172917	malignant	C0205282
27172917	preoperative	C0445204
27172917	ultrasonographical	C1720195
27172917	clinical	C3854293
27172917	biochemical findings	C0243095
27172917	patients	C0030705
27172917	AUS	C0522580
27172917	FLUS	C1272585
27172917	nodules	C0040137
27172917	surgery	C0543467
27172917	malignancy	C4282132
27172917	malignancy	C4282132
27172917	nodules	C0040137
27172917	AUS	C0522580
27172917	nodules	C0040137
27172917	FLUS	C1272585
27172917	malignant specimens	C2347026
27172917	histopathology	C0430445
27172917	papillary thyroid carcinoma	C0238463
27172917	PTC	C0238463
27172917	Preoperative	C0445204
27172917	ultrasonographic features	C1720195
27172917	malignant nodules	C0040137
27172917	histopathology	C0430445
27172917	benign nodules	C0749467
27172917	histopathology	C0430445
27172917	Anteroposterior/Transverse (AP/T) ratio	C0456603
27172917	malignant group	C1257890
27172917	benign group	C1257890
27172917	multiple logistic analysis	C0936012
27172917	higher AP/T ratio	C0456603
27172917	microcalcification	C0521174
27172917	associated with	C0332281
27172917	malignancy	C4282132
27172917	malignancy	C4282132
27172917	AP/T ratio	C0456603
27172917	sensitivity and specificity	C0036668
27172917	correlation	C1707520
27172917	malignancy	C4282132
27172917	Hashimoto's thyroiditis	C0677607
27172917	histopathology	C0430445
27172917	multivariate analysis	C0026777
27172917	Bethesda Category III nodules	C0040137
27172917	higher AP/T ratio	C0456603
27172917	microcalcification	C0521174
27172917	surgery	C0543467
27172917	fine-needle aspiration biopsy	C1510483
27172917	observation	C0302523
27233131	Impact	C4049986
27233131	cofactor	C0178555
27233131	binding loop	C0682969
27233131	mutations	C0026882
27233131	thermotolerance	C3544386
27233131	activity	C0243102
27233131	E. coli	C0014834
27233131	transketolase	C0040709
27233131	Improvement	C2986411
27233131	thermostability	C0597571
27233131	engineered enzymes	C0014442
27233131	biocatalysis	C2350294
27233131	substrates	C3891814
27233131	aqueous	C0599956
27233131	solubility	C0037628
27233131	Denaturation	C0033627
27233131	cofactor	C0178555
27233131	binding loops	C0682969
27233131	Escherichia coli	C0014834
27233131	transketolase	C0040709
27233131	TK	C0040709
27233131	loss	C1517945
27233131	enzyme activity	C0243102
27233131	conditions	C0348080
27233131	high	C0205250
27233131	pH	C0020283
27233131	urea	C0041942
27233131	Incubation	C0022885
27233131	temperatures	C0039476
27233131	thermal melting transition	C1254365
27233131	protein	C0033684
27233131	aggregates	C0332621
27233131	anneal	C0205245
27233131	enzyme	C0014442
27233131	increased	C0205217
27233131	activity	C0243102
27233131	role	C1705810
27233131	cofactor	C0178555
27233131	binding loop	C0682969
27233131	instability	C1444783
27233131	cofactor	C0178555
27233131	binding loops	C0682969
27233131	residues 185-192	C0002518
27233131	382-392	C0002518
27233131	sequence	C0004793
27233131	thermostable	C0205556
27233131	Thermus thermophilus	C0085475
27233131	TK	C0040709
27233131	variants	C0678941
27233131	assessed	C1516048
27233131	impact	C4049986
27233131	thermostability	C0597571
27233131	activity	C0441655
27233131	Cofactor-binding loop 2	C0004793
27233131	variants	C0678941
27233131	detrimental effects	C1280500
27233131	activity	C0441655
27233131	elevated	C3163633
27233131	temperatures	C0039476
27233131	H192P mutation	C0026882
27233131	cofactor-binding loop 1	C0004793
27233131	stability	C0597571
27233131	inactivation	C0544461
27233131	elevated	C3163633
27233131	temperatures	C0039476
27233131	increased	C0205217
27233131	critical onset temperature	C0039476
27233131	aggregation	C0332621
27233131	activity	C0441655
27233131	H192P	C0026882
27233131	higher	C0205250
27233131	wild-type	C1883559
27233131	higher	C0205250
27233131	re-cooling	C0678568
27233131	pre-incubations	C0022885
27233131	H192P	C0026882
27233131	active	C0205177
27233131	wild-type	C1883559
27233131	TK	C0040709
27233131	Optimal	C2698651
27233131	activity	C0441655
27233131	H192P	C0026882
27233131	wild type	C1883559
27233131	cofactor-binding loop 1	C0004793
27233131	role	C1705810
27233131	partial	C0728938
27233131	denaturation	C0033627
27233131	aggregation	C0332621
27233131	elevated	C3163633
27233131	temperatures	C0039476
27233131	single rigidifying mutation	C0026882
27233131	loop	C0004793
27233131	enzyme specific activity	C0243102
27233131	stability	C0597571
27233131	thermal	C0018837
27233131	denaturation	C0033627
27233131	aggregation	C0332621
27233131	increased	C0205217
27233131	temperature	C0039476
27233131	optimum	C2698651
27233131	activity	C0243102
27234220	Safety	C1705187
27234220	transradial diagnostic cardiac catheterization	C2041518
27234220	patients	C0030705
27234220	oral	C0442027
27234220	anticoagulant therapy	C0150457
27234220	Cardiac catheterization	C0018795
27234220	anticoagulated	C0741134
27234220	patients	C0030705
27234220	performed	C0884358
27234220	anticoagulation	C0003281
27234220	withdrawn	C1707825
27234220	bridging therapy with heparin	C3873426
27234220	observational study	C1518527
27234220	patients	C0030705
27234220	transradial catheterization	C0018795
27234220	patients	C0030705
27234220	acenocoumarol	C0000956
27234220	group A	C0441835
27234220	compared	C1707455
27234220	remainder	C1527428
27234220	group B	C0441836
27234220	complications	C0009566
27234220	procedure	C0018795
27234220	bleeding	C0019080
27234220	vascular access complications	C0920165
27234220	Patients	C0030705
27234220	group A	C0441835
27234220	older	C1518563
27234220	indication	C3146298
27234220	anticoagulation	C0003281
27234220	atrial fibrillation	C0004238
27234220	No	C1513916
27234220	complications	C0009566
27234220	procedures	C0018795
27234220	no	C1513916
27234220	acute bleedings	C0333276
27234220	after	C0687676
27234220	bandage	C0004726
27234220	removal	C1883720
27234220	radial occlusions	C1110554
27234220	group A	C0441835
27234220	group B	C0441836
27234220	recorded	C2355580
27234220	Hematomas	C0018944
27234220	group A	C0441835
27234220	group B	C0441836
27234220	1-month	C1442451
27234220	follow-up	C1522577
27234220	period	C1948053
27234220	radial occlusion	C1110554
27234220	group	C0441833
27234220	recorded	C2355580
27234220	mild	C2945599
27234220	hematomas	C0018944
27234220	group B	C0441836
27234220	group A	C0441835
27234220	Performing	C0884358
27234220	transradial diagnostic cardiac catheterization	C2041518
27234220	without	C0332288
27234220	removal	C1883720
27234220	oral	C0442027
27234220	chronic anticoagulation	C0694554
27234220	safe	C3266157
27234220	patients	C0030705
27234220	acenocumarol	C0000956
27234220	therapy	C0087111
27235559	infrared	C0181645
27235559	visualization	C0234621
27235559	selection	C1707391
27235559	venipuncture	C0600406
27235559	sites	C0205145
27235559	indwelling	C0439848
27235559	needle	C0027551
27235559	forearm	C0016536
27235559	nursing students	C0038496
27235559	effectiveness	C1280519
27235559	vein visualization display system	C0025080
27235559	near-infrared light	C1289901
27235559	Vein Display	C0025080
27235559	selection	C1707391
27235559	venipuncture	C0600406
27235559	sites	C0205145
27235559	indwelling	C0439848
27235559	needle	C0027551
27235559	forearm	C0016536
27235559	nursing students	C0038496
27235559	indwelling	C0439848
27235559	needle	C0027551
27235559	Vein	C0042449
27235559	Display	C0870432
27235559	participants	C0679646
27235559	faculty	C0015535
27235559	patients	C0030705
27235559	venipuncture procedure	C0600406
27235559	sites	C0205145
27235559	scale	C0349674
27235559	authors	C3812881
27235559	Time	C0040223
27235559	scores	C0449820
27235559	patterns	C0332307
27235559	puncture	C0600406
27235559	site	C0205145
27235559	selection	C1707391
27235559	tourniquet	C0040519
27235559	Vein Display	C0025080
27235559	effectiveness	C1280519
27235559	Vein	C0042449
27235559	Display	C0870432
27235559	venipuncture	C0600406
27235559	site	C0205145
27235559	selection	C1707391
27235559	Vein Display	C0025080
27235559	administer	C1621583
27235559	venipuncture	C0600406
27235559	sites	C0205145
27235559	venipuncture	C0600406
27235559	quality	C0332306
27235559	scale	C0349674
27235559	Vein Display	C0025080
27235559	practical skills	C0008973
27235559	venipuncture	C0600406
27235559	elderly	C0001792
27235559	patients	C0030705
27235789	Elective	C0206058
27235789	Nephron Sparing Surgery	C0194086
27235789	Decreases	C0205216
27235789	Other Cause Mortality	C0476465
27235789	Relative	C0205345
27235789	Radical Nephrectomy	C0401181
27235789	Specific	C0205369
27235789	Subgroups	C1515021
27235789	Patients	C0030705
27235789	Renal Cell Carcinoma	C0007134
27235789	consensus	C0376298
27235789	protective effect	C1545588
27235789	mortality	C0205848
27235789	cancer	C0006826
27235789	patients	C0030705
27235789	treated with	C0332293
27235789	elective	C0206058
27235789	nephron sparing surgery	C0194086
27235789	relative	C0205345
27235789	radical nephrectomy	C0401181
27235789	test	C0039593
27235789	protective effect	C1545588
27235789	nephron sparing surgery	C0194086
27235789	relative	C0205345
27235789	radical nephrectomy	C0401181
27235789	universal	C0175671
27235789	specific	C0205369
27235789	subgroups	C1515021
27235789	patients	C0030705
27235789	collaborative	C0392762
27235789	database	C0242356
27235789	institutions	C1272753
27235789	queried	C1522634
27235789	evaluate	C0220825
27235789	patients	C0030705
27235789	chronic kidney disease	C1561643
27235789	diagnosed	C0011900
27235789	clinical	C0205210
27235789	T1 renal mass	C2217020
27235789	treated with	C0332293
27235789	nephron sparing surgery	C0194086
27235789	radical nephrectomy	C0401181
27235789	Multivariable Cox regression analysis	C0034980
27235789	assess	C0184514
27235789	impact	C4049986
27235789	surgery	C0543467
27235789	nephron sparing surgery	C0194086
27235789	radical nephrectomy	C0401181
27235789	other cause mortality	C0476465
27235789	patient	C0030705
27235789	cancer	C0006826
27235789	characteristics	C1521970
27235789	Interaction	C1704675
27235789	test	C0039593
27235789	impact	C4049986
27235789	surgery	C0543467
27235789	specific	C0205369
27235789	subcohorts	C0599755
27235789	patients	C0030705
27235789	Ten-year	C1254367
27235789	other cause mortality	C0476465
27235789	survival rates	C0038954
27235789	nephron sparing surgery	C0194086
27235789	radical nephrectomy	C0401181
27235789	overall	C1561607
27235789	population	C1257890
27235789	radical nephrectomy	C0401181
27235789	associated with	C0332281
27235789	increased	C0205217
27235789	risk	C0035647
27235789	other cause mortality	C0476465
27235789	multivariable analysis	C0026777
27235789	nephron sparing surgery	C0194086
27235789	HR	C2985465
27235789	CI	C0009667
27235789	radical nephrectomy	C0401181
27235789	increased	C0205217
27235789	risk	C0035647
27235789	other cause mortality	C0476465
27235789	increasing	C0205217
27235789	baseline	C1442488
27235789	Charlson comorbidity index	C3714916
27235789	interaction	C1704675
27235789	test	C0039593
27235789	patient	C0030705
27235789	Charlson comorbidity index	C3714916
27235789	probability	C0033204
27235789	10-year	C1254367
27235789	other cause mortality	C0476465
27235789	survival	C0038952
27235789	nephron sparing surgery	C0194086
27235789	radical nephrectomy	C0401181
27235789	Elective	C0206058
27235789	nephron sparing surgery	C0194086
27235789	improve	C0184511
27235789	survival	C0038952
27235789	relative	C0205345
27235789	radical nephrectomy	C0401181
27235789	patients	C0030705
27235789	kidney cancer	C0740457
27235789	Patients	C0030705
27235789	ill	C0221423
27235789	relevant	C2347946
27235789	comorbidities	C0009488
27235789	benefit	C0814225
27235789	nephron sparing surgery	C0194086
27235789	other cause mortality	C0476465
27237609	dietary	C0012155
27237609	Non Enzymatic Antioxidant Capacity	C4049177
27237609	risk	C0035647
27237609	hip fracture	C0019557
27237609	elderly	C0001792
27237609	Dietary antioxidants	C0729311
27237609	bone loss	C0029453
27237609	fractures	C0016658
27237609	oxidative stress	C0242606
27237609	dietary	C0012155
27237609	Non Enzymatic Antioxidant Capacity	C4049177
27237609	NEAC	C4049177
27237609	risk	C0035647
27237609	hip fracture	C0019557
27237609	smoking	C0037369
27237609	Swedish National March Cohort	C0599755
27237609	men	C0025266
27237609	women	C0043210
27237609	cancer	C0006826
27237609	cardiovascular disease	C0007222
27237609	hip fracture	C0019557
27237609	record-linkages	C0025101
27237609	NEAC	C4049177
27237609	food frequency questionnaire	C2986698
27237609	baseline	C1442488
27237609	NEAC	C4049177
27237609	sex	C0079399
27237609	specific	C0205369
27237609	quartiles	C2828255
27237609	multivariable adjusted Cox proportional hazards regression models	C0033489
27237609	hazard ratios	C2985465
27237609	HRs	C2985465
27237609	confidence intervals	C0009667
27237609	CI	C0009667
27237609	follow-up	C1522577
27237609	time	C0040223
27237609	hip fracture	C0019557
27237609	quartile	C2828255
27237609	dietary	C0012155
27237609	NEAC	C4049177
27237609	lower risk	C3843763
27237609	hip fracture	C0019557
27237609	quartile	C2828255
27237609	HR	C2985465
27237609	CI	C0009667
27237609	quartile	C2828255
27237609	risk reduction	C1137094
27237609	dietary	C0012155
27237609	NEAC	C4049177
27237609	dietary	C0012155
27237609	NEAC	C4049177
27237609	smoking	C0037369
27237609	multiplicative	C2911648
27237609	additive scale	C0392762
27237609	NEAC	C4049177
27237609	risk	C0035647
27237609	hip fracture	C0019557
27239541	Function	C0563143
27239541	clinical	C0205210
27239541	meaningfulness	C1280519
27239541	treatments	C0087111
27239541	mild	C2945599
27239541	Alzheimer's disease	C0002395
27239541	Effectiveness	C1280519
27239541	Alzheimer's disease	C0002395
27239541	AD	C0002395
27239541	treatments	C0087111
27239541	coprimary outcomes	C1274040
27239541	cognition	C0009240
27239541	function	C0563143
27239541	clinical	C0205210
27239541	meaningfulness	C1280519
27239541	cognitive	C0009240
27239541	effect	C1280500
27239541	reviewed	C1709940
27239541	literature	C0023866
27239541	functional	C0563143
27239541	outcomes	C1274040
27239541	mild	C2945599
27239541	AD	C0002395
27239541	mild cognitive impairment	C1270972
27239541	MCI	C1270972
27239541	patients	C0030705
27239541	mild-moderate	C1299392
27239541	severe	C0205082
27239541	AD	C0002395
27239541	treated with	C0332293
27239541	AD	C0002395
27239541	drugs	C0013227
27239541	Cognitive	C0009244
27239541	functional	C0563143
27239541	treatment	C0087111
27239541	mild	C2945599
27239541	AD	C0002395
27239541	patients	C0030705
27239541	solanezumab	C2935150
27239541	EXPEDITION	C0015315
27239541	EXPEDITION2	C0015315
27239541	studies	C2603343
27239541	compared	C1707455
27239541	time	C0040223
27239541	publications	C0034036
27239541	MCI	C1270972
27239541	mild	C2945599
27239541	AD	C0002395
27239541	functional	C0563143
27239541	outcomes	C1274040
27239541	functional	C0563143
27239541	treatment effect	C1518681
27239541	Secondary analyses	C0683944
27239541	EXPEDITION	C0015315
27239541	studies	C2603343
27239541	functional	C0563143
27239541	effect	C1280500
27239541	solanezumab	C2935150
27239541	cognition	C0009240
27239541	increasing	C0442808
27239541	effect	C1280500
27239541	solanezumab	C2935150
27239541	months	C0439231
27239541	cognition	C0009240
27239541	function	C0563143
27239541	Function	C0563143
27239541	measure	C0079809
27239541	clinical	C0205210
27239541	meaningfulness	C1280519
27239541	cognitive	C0009240
27239541	effects	C1280500
27239541	mild	C2945599
27239541	AD	C0002395
27239541	limitations	C0449295
27239541	disease	C0012634
27239541	modifying	C0392747
27239541	treatments	C0087111
27239541	cognitive	C0009240
27239541	functional	C0563143
27239541	scales	C0349674
27239541	duration of treatment	C0444921
27241291	E. coli	C0014834
27241291	Compounds	C0574031
27241291	Antibiotic	C0003232
27241291	Production	C0205245
27241291	Streptomyces coelicolor	C0995741
27241291	Inter-species Interaction	C0870742
27241291	investigate	C1292732
27241291	interaction	C1704675
27241291	E.coli	C0014834
27241291	Streptomyces coelicolor A3 (2)	C1449847
27241291	increased	C0205217
27241291	production	C0205245
27241291	undecylprodigiosin	C0077826
27241291	E. coli	C0014834
27241291	actives	C0205177
27241291	mediating	C0086597
27241291	inter-species interaction	C0870742
27241291	antibiotics	C0003232
27241291	red-pigmented undecylprodigiosin	C0526040
27241291	blue-pigmented	C0333610
27241291	actinorhodin	C0050663
27241291	cultures	C0430402
27241291	S. coelicolor	C0995741
27241291	medium	C0010454
27241291	concentrations	C1264643
27241291	actinorhodin	C0050663
27241291	compared	C1707455
27241291	undecylprodigiosin	C0077826
27241291	immunosuppressive	C0021080
27241291	antitumor properties	C1516031
27241291	increase	C0442805
27241291	undecylprodigiosin	C0077826
27241291	production	C0205245
27241291	live cells	C1441322
27241291	heat-killed	C1522240
27241291	cells	C0007634
27241291	E. coli C600	C0014834
27241291	cell-free supernatant	C1550101
27241291	E. coli	C0014834
27241291	culture	C0430402
27241291	S. coelicolor	C0995741
27241291	cultures in shake flasks	C3179108
27241291	interaction	C1704675
27241291	live cells	C1441322
27241291	E. coli	C0014834
27241291	antibiotic	C0003232
27241291	production	C0205245
27241291	undecylprodigiosin	C0077826
27241291	production	C0205245
27241291	enhanced	C2349975
27241291	pure cultures	C0430402
27241291	S. coelicolor	C0995741
27241291	actinorhodin	C0050663
27241291	decreased	C0205216
27241291	heat-killed	C1522240
27241291	cells	C0007634
27241291	E. coli	C0014834
27241291	no effect	C1301751
27241291	antibiotic	C0003232
27241291	production	C0205245
27241291	growth	C0178747
27241291	glucose consumption	C0556133
27241291	S. coelicolor	C0995741
27241291	same	C0445247
27241291	observed	C1441672
27241291	pure culture	C0430402
27241291	changes	C0392747
27241291	antibiotic	C0003232
27241291	production	C0205245
27241291	nutritional	C1442959
27241291	stress	C0038435
27241291	Results	C1274040
27241291	cell-free supernatant	C1550101
27241291	E. coli	C0014834
27241291	culture	C0430402
27241291	interaction	C1704675
27241291	S. coelicolor	C0995741
27241291	E. coli	C0014834
27241291	mediated	C0086597
27241291	diffusible molecule(s)	C0574031
27241291	extraction procedures	C0684295
27241291	agar-well diffusion bioassays	C0005507
27241291	isolated	C0205409
27241291	identified	C0205396
27241291	class of compounds	C0574031
27241291	verification	C1711411
27241291	compound	C0574031
27241291	chemical structural moiety	C1254350
27241291	class of compounds	C0574031
27241291	S. coelicolor	C0995741
27241291	cultures	C1331092
27241291	effects	C1280500
27241291	antibiotic	C0003232
27241291	production	C0205245
27241291	E. coli	C0014834
27241291	cells	C0007634
27241291	supernatant	C1550101
27241291	class of compounds	C0574031
27241291	secreted	C1327616
27241291	E. coli	C0014834
27241291	actives	C0205177
27241291	interspecies interaction	C0870742
27241291	increase	C0442805
27241291	production	C0205245
27241291	undecylprodigiosin	C0077826
27241818	Group III/IV muscle	C0026845
27241818	afferents	C0027883
27241818	limit	C0439801
27241818	intramuscular	C0442117
27241818	metabolic	C0311400
27241818	perturbation	C0332453
27241818	whole body	C0444584
27241818	exercise	C0015259
27241818	humans	C0086418
27241818	purpose	C1285529
27241818	study	C2603343
27241818	determine	C1148554
27241818	role	C1705810
27241818	group III/IV muscle	C0026845
27241818	afferents	C0027883
27241818	limiting	C0439801
27241818	endurance	C0518031
27241818	exercise	C0015259
27241818	induced	C0205263
27241818	metabolic	C0311400
27241818	perturbation	C0332453
27241818	assayed	C1510438
27241818	muscle	C0026845
27241818	biopsy samples	C0677862
27241818	locomotor	C0023946
27241818	muscle	C0026845
27241818	Lumbar	C0024090
27241818	intrathecal	C1370196
27241818	fentanyl	C0015846
27241818	attenuate	C0599946
27241818	central	C0205099
27241818	projection	C0348018
27241818	μ-opioid receptor	C0066908
27241818	sensitive	C0332324
27241818	locomotor	C0023946
27241818	muscle	C0026845
27241818	afferents	C0027883
27241818	cycling	C1511572
27241818	time	C0040223
27241818	trial	C0008976
27241818	findings	C0243095
27241818	central	C0205099
27241818	projection	C0348018
27241818	group III/IV muscle	C0026845
27241818	afferent	C0027883
27241818	feedback	C0678663
27241818	constrains	C1707494
27241818	voluntary	C0439656
27241818	neural	C3714606
27241818	drive	C0013126
27241818	working	C0205177
27241818	locomotor	C0023946
27241818	muscle	C0026845
27241818	limits	C0439801
27241818	exercise	C0015259
27241818	induced	C0205263
27241818	intramuscular	C0442117
27241818	metabolic	C0311400
27241818	perturbation	C0332453
27241818	CNS	C3714787
27241818	regulate	C1327622
27241818	degree	C0449286
27241818	metabolic	C0311400
27241818	perturbation	C0332453
27241818	locomotor	C0023946
27241818	muscle	C0026845
27241818	limit	C0439801
27241818	peripheral	C0205100
27241818	fatigue	C0015672
27241818	appears	C0700364
27241818	group III/IV muscle	C0026845
27241818	afferents	C0027883
27241818	important	C3898777
27241818	neural	C3714606
27241818	link	C0178718
27241818	regulatory	C1327622
27241818	mechanism	C0441712
27241818	probably	C0750492
27241818	protect	C1545588
27241818	locomotor	C0023946
27241818	muscle	C0026845
27241818	potentially	C3245505
27241818	severe	C0205082
27241818	functional impairment	C4062321
27241818	consequence	C0686907
27241818	severe	C0205082
27241818	intramuscular	C0442117
27241818	metabolic	C0311400
27241818	disturbance	C2699787
27241818	investigate	C1292732
27241818	role	C1705810
27241818	metabo	C0025519
27241818	mechanosensitive	C1522640
27241818	group III/IV muscle	C0026845
27241818	afferents	C0027883
27241818	limiting	C0439801
27241818	intramuscular	C0442117
27241818	metabolic	C0311400
27241818	perturbation	C0332453
27241818	whole body	C0444584
27241818	endurance	C0518031
27241818	exercise	C0015259
27241818	subjects	C0681850
27241818	performed	C0884358
27241818	cycling	C1511572
27241818	time	C0040223
27241818	trials	C0008976
27241818	under control conditions	C2911690
27241818	CTRL	C2911690
27241818	lumbar	C0024090
27241818	intrathecal	C1370196
27241818	fentanyl	C0015846
27241818	impairing	C0221099
27241818	lower limb	C0023216
27241818	muscle	C0026845
27241818	afferent	C0027883
27241818	feedback	C0678663
27241818	FENT	C0678663
27241818	Vastus lateralis	C0224444
27241818	muscle	C0026845
27241818	biopsies	C0677862
27241818	obtained	C1301820
27241818	before	C0332152
27241818	immediately	C0205253
27241818	after	C0687676
27241818	exercise	C0015259
27241818	Motoneuronal	C0026609
27241818	output was estimated	C0204709
27241818	vastus lateralis surface	C0224444
27241818	electromyography	C0013839
27241818	EMG	C0013839
27241818	Exercise	C0015259
27241818	induced	C0205263
27241818	changes	C0392747
27241818	intramuscular	C0442117
27241818	metabolites	C0870883
27241818	determine	C1148554
27241818	liquid	C0302908
27241818	gas chromatography-mass spectrometry	C1720784
27241818	Quadriceps	C0224440
27241818	fatigue	C0015672
27241818	quantified	C1709793
27241818	pre	C0332152
27241818	post	C0687676
27241818	exercise	C0015259
27241818	changes	C0392747
27241818	potentiated quadriceps twitch torque	C0376590
27241818	ΔQTsingle	C0376590
27241818	evoked	C1444748
27241818	electrical	C0442828
27241818	femoral nerve	C0015808
27241818	stimulation	C1292856
27241818	motoneuronal	C0026609
27241818	output	C0441655
27241818	higher	C0205250
27241818	FENT	C0678663
27241818	compared	C1707455
27241818	CTRL	C2911690
27241818	time	C0040223
27241818	complete	C0205197
27241818	time	C0040223
27241818	trial	C0008976
27241818	similar	C2348205
27241818	Compared	C1707455
27241818	CTRL	C2911690
27241818	power output	C0445194
27241818	FENT	C0678663
27241818	higher	C0205250
27241818	first half	C3843058
27241818	time	C0040223
27241818	trial	C0008976
27241818	lower	C0205251
27241818	second half	C3843057
27241818	exercise	C0015259
27241818	induced	C0205263
27241818	increase	C0442805
27241818	intramuscular	C0442117
27241818	inorganic phosphate	C0031603
27241818	H(+)	C0033727
27241818	adenosine diphosphate	C0001459
27241818	lactate	C0022924
27241818	phosphocreatine	C0031634
27241818	depletion	C0333668
27241818	greater	C1704243
27241818	FENT	C0678663
27241818	CTRL	C2911690
27241818	ΔQTsingle	C0376590
27241818	greater	C1704243
27241818	FENT	C0678663
27241818	CTRL	C2911690
27241818	difference	C1705241
27241818	positively	C1446409
27241818	correlated	C1707520
27241818	difference	C1705241
27241818	inorganic phosphate	C0031603
27241818	conclusion	C1707478
27241818	whole body	C0444584
27241818	exercise	C0015259
27241818	group III/IV muscle	C0026845
27241818	afferents	C0027883
27241818	provide	C1999230
27241818	feedback	C0678663
27241818	CNS	C3714787
27241818	constrains	C1707494
27241818	motoneuronal	C0026609
27241818	output	C0441655
27241818	active	C0205177
27241818	skeletal muscle	C0242692
27241818	regulatory	C1327622
27241818	mechanism	C0441712
27241818	limits	C0439801
27241818	exercise	C0015259
27241818	induced	C0205263
27241818	intramuscular	C0442117
27241818	metabolic	C0311400
27241818	perturbation	C0332453
27241818	abnormal homeostatic	C4022950
27241818	challenge	C0805586
27241818	excessive	C0442802
27241818	peripheral	C0205100
27241818	fatigue	C0015672
27242550	Mitochondrial	C0026237
27242550	Ultrastructure	C3825563
27242550	Glucose Signaling Pathways	C1622453
27242550	Kv1.3 Ion Channel	C0290730
27242550	Gene-targeted	C0242613
27242550	deletion	C0017260
27242550	potassium channel Kv1.3	C0290730
27242550	Kv1.3(-∕-)) results i	C0456984
27242550	uper-smeller" mice	C0025929
27242550	nsory p	C0445254
27242550	enotype t	C0031437
27242550	increased	C0205217
27242550	olfactory	C0439826
27242550	ability	C0085732
27242550	olfactory	C0439826
27242550	circuitry	C0260041
27242550	increased	C0205217
27242550	abundance	C2346714
27242550	olfactory cilia	C0230758
27242550	increased	C0205217
27242550	expression	C0597360
27242550	odorant receptors	C0164313
27242550	G-protein, Golf	C0033684
27242550	Kv1.3(-∕-) mice a	C0025929
27242550	metabolic p	C0311400
27242550	enotype i	C0031437
27242550	wer b	C1611820
27242550	dy weight a	C0005910
27242550	creased a	C0205216
27242550	iposity,	C1563743
27242550	creased total energy expenditure	C0429629
27242550	TEE	C0429629
27242550	increased	C0205217
27242550	locomotor activity	C0023946
27242550	resistance	C0237834
27242550	diet	C0012155
27242550	genetic-induced	C0017391
27242550	obesity	C0028754
27242550	cellular aspects	C0935919
27242550	mechanism	C0441712
27242550	loss	C1517945
27242550	Kv1.3 channel	C0290730
27242550	olfactory bulb	C0028936
27242550	OB	C0028936
27242550	glucose utilization	C1148560
27242550	metabolic rate	C0870882
27242550	in situ hybridization	C0162788
27242550	Kv1.3	C0290730
27242550	insulin	C0021641
27242550	dependent	C1701901
27242550	glucose transporter type 4	C0166441
27242550	GLUT4	C0166441
27242550	mitral	C0026264
27242550	cell layer	C0007634
27242550	OB	C0028936
27242550	Disruption	C0332453
27242550	Kv1.3	C0290730
27242550	conduction	C0457405
27242550	pore mutation	C0026882
27242550	W386F Kv1.3	C0026882
27242550	translocate	C0599893
27242550	GLUT4	C0166441
27242550	plasma membrane	C0007603
27242550	HEK 293 cells	C2936239
27242550	olfactory sensory perception	C0037361
27242550	maintenance	C0024501
27242550	action potential (AP)	C0001272
27242550	mitral	C0026264
27242550	cells	C0007634
27242550	OB	C0028936
27242550	Kv1.3	C0290730
27242550	mitochondria	C0026237
27242550	organelle	C0029219
27242550	mitral	C0026264
27242550	cells	C0007634
27242550	wildtype	C1520150
27242550	WT	C1520150
27242550	Kv1.3(-∕-) male mice	C0025929
27242550	oderately high-fat diet (	C0521974
27242550	HF,	C0521974
27242550	months	C0439231
27242550	OB	C0028936
27242550	ultrastructure	C3825563
27242550	transmission electron microscopy	C0678118
27242550	WT mice	C1520150
27242550	mitochondria	C0026237
27242550	enlarged	C0442800
27242550	diet-induced obesity	C0028754
27242550	DIO	C0028754
27242550	mitochondria	C0026237
27242550	mitophagy	C1820119
27242550	mitochondria	C0026237
27242550	smaller	C0547044
27242550	Kv1.3(-∕-) mice c	C0025929
27242550	T mice.	C1520150
27242550	etabolic r	C0311400
27242550	IO,	C0028754
27242550	v1.3(-∕-) mice ha	C0025929
27242550	ochondria in	C0026237
27242550	s sectional	C0552389
27242550	area	C0205146
27242550	abundance	C2346714
27242550	modified diet	C0521974
27242550	disruption	C0332453
27242550	Kv1.3 channel	C0290730
27242550	OB	C0028936
27242550	TEE	C0429629
27242550	Kv1.3	C0290730
27242550	mitochondrial structure	C0026237
27242550	glucose utilization	C1148560
27242550	metabolic	C0311400
27242550	metabolism	C0025519
27242550	OB	C0028936
27245335	effects of	C1704420
27245335	paternal	C0337493
27245335	high-fat diet	C0012155
27245335	exposure	C0332157
27245335	offspring	C0680063
27245335	metabolism	C0025519
27245335	epigenetic changes	C1516924
27245335	adiponectin	C1540187
27245335	leptin	C1416825
27245335	gene promoters	C0314621
27245335	studies	C2603343
27245335	epigenetic changes	C1516924
27245335	malnutrition	C0162429
27245335	roles	C1705810
27245335	transgenerational links	C0871541
27245335	metabolic diseases	C0025517
27245335	observed	C1441672
27245335	exposure	C0332157
27245335	high-fat diet	C0012155
27245335	HFD	C0012155
27245335	in utero	C1708480
27245335	caused	C0015127
27245335	metabolic	C0311400
27245335	syndrome	C0039082
27245335	phenomenon	C1882365
27245335	through	C0332273
27245335	epigenetic modifications	C1516924
27245335	adiponectin	C1540187
27245335	leptin genes	C1416825
27245335	multiple	C0439064
27245335	generations	C0079411
27245335	etiological	C0015127
27245335	studies	C2603343
27245335	indicated	C1444656
27245335	paternal	C0337493
27245335	BMI	C1305855
27245335	effects	C1280500
27245335	offspring	C0680063
27245335	BMI	C1305855
27245335	independent of	C0332291
27245335	additive	C0442796
27245335	maternal	C1858460
27245335	BMI	C1305855
27245335	effects	C1280500
27245335	paternal	C0337493
27245335	HFD	C0012155
27245335	induced	C0205263
27245335	obesity	C0028754
27245335	affected	C1280500
27245335	metabolic	C0311400
27245335	status	C0449438
27245335	offspring	C0680063
27245335	through	C0332273
27245335	epigenetic changes	C1516924
27245335	adiponectin	C1540187
27245335	leptin genes	C1416825
27245335	investigated	C1292732
27245335	normal diet	C0184625
27245335	during	C0347984
27245335	subsequent generations	C1136186
27245335	abolished	C1947925
27245335	epigenetic changes	C1516924
27245335	associated with	C0332281
27245335	paternal	C0337493
27245335	HFD	C0012155
27245335	exposure	C0332157
27245335	before	C0332152
27245335	conception	C0009637
27245335	observed	C1441672
27245335	effects of	C1704420
27245335	paternal	C0337493
27245335	HFD	C0012155
27245335	exposure	C0332157
27245335	before	C0332152
27245335	conception	C0009637
27245335	multiple	C0439064
27245335	generations	C0079411
27245335	offspring	C0680063
27245335	metabolic	C0311400
27245335	traits	C0599883
27245335	including	C0332257
27245335	weight	C0043094
27245335	fat	C0015677
27245335	gain	C1517378
27245335	glucose intolerance	C0271650
27245335	hypertriglyceridemia	C0020557
27245335	abnormal adipocytokine	C1955907
27245335	levels	C0441889
27245335	hypertension	C0020538
27245335	adiponectin	C1540187
27245335	leptin gene	C1416825
27245335	expression	C0017262
27245335	epigenetic changes	C1516924
27245335	Normal diet	C0184625
27245335	offspring	C0680063
27245335	paternal	C0337493
27245335	HFD	C0012155
27245335	exposure	C0332157
27245335	diminished	C0205216
27245335	consumption	C2983605
27245335	generations	C0079411
27245335	abolished	C1947925
27245335	effect	C1280500
27245335	paternal	C0337493
27245335	HFD	C0012155
27245335	exposure	C0332157
27245335	metabolic	C0311400
27245335	traits	C0599883
27245335	adipocytokine	C1955907
27245335	epigenetic changes	C1516924
27245335	offspring	C0680063
27245335	effects of	C1704420
27245335	paternal	C0337493
27245335	HFD	C0012155
27245335	exposure	C0332157
27245335	offspring	C0680063
27245335	weaker	C1762617
27245335	following	C0332282
27245335	HFD	C0012155
27245335	exposure	C0332157
27245335	in utero	C1708480
27245335	paternal	C0337493
27245335	HFD	C0012155
27245335	exposure	C0332157
27245335	additive	C0442796
27245335	metabolic	C0311400
27245335	effect	C1280500
27245335	generations	C0079411
27245335	paternal	C0337493
27245335	maternal	C1858460
27245335	nutrition	C1442959
27245335	affect	C1280500
27245335	offspring	C0680063
27245335	metabolism	C0025519
27245335	through	C0332273
27245335	epigenetic modifications	C1516924
27245335	adipocytokine genes	C0017337
27245335	multiple	C0439064
27245335	generations	C0079411
27249559	Study	C0947630
27249559	Microfocus	C0205234
27249559	X-Ray Tube	C0184486
27249559	Point-Like Target	C1521840
27249559	Micro-Computed Tomography	C2350281
27249559	micro-Computed Tomography (Micro-CT) system	C2350281
27249559	microfocus	C0205234
27249559	X-ray tube	C0184486
27249559	essential	C0205224
27249559	spatial	C1254362
27249559	resolution	C1706463
27249559	CT	C0040405
27249559	images	C1704254
27249559	theory	C0871935
27249559	size	C0456389
27249559	stability	C0205360
27249559	X-ray	C0043299
27249559	focal spot	C0205146
27249559	microfocus	C0205234
27249559	X-ray tube	C0184486
27249559	factors	C1521761
27249559	voltage	C0598352
27249559	fluctuations	C0231241
27249559	mechanical	C0376706
27249559	vibrations	C0459800
27249559	temperature changes	C0450031
27249559	cause	C0085978
27249559	size	C0456389
27249559	stability	C0205360
27249559	X-ray	C0043299
27249559	focal spot	C0205146
27249559	degrade	C1254366
27249559	microfocus	C0205234
27249559	X-ray tube	C0184486
27249559	point-like micro-target	C1521840
27249559	X-ray	C0043299
27249559	target	C1521840
27249559	irradiated	C1254366
27249559	electron beam	C0013840
27249559	investigated	C1292732
27249559	EGS4 Monte Carlo simulation code	C0026507
27249559	calculation	C1441506
27249559	X-ray	C0043299
27249559	intensity	C0596836
27249559	point-like micro-target	C1521840
27249559	substrate	C3891814
27249559	effects of	C1704420
27249559	target	C1521840
27249559	material	C0520510
27249559	target	C1521840
27249559	beam	C0013840
27249559	size	C0456389
27249559	studied	C0947630
27249559	simulation	C0679083
27249559	results	C1274040
27249559	intensity	C0596836
27249559	X-rays	C0043299
27249559	generated	C2346631
27249559	point-like target	C1521840
27249559	greater than	C0439093
27249559	X-ray	C0043299
27249559	intensity	C0596836
27249559	substrate	C3891814
27249559	X-ray	C0043299
27249559	focal spot	C0205146
27249559	point-like target	C1521840
27249559	electron beam	C0013840
27249559	conventional	C0439858
27249559	X-ray tube	C0184486
27249559	theory	C0871935
27249559	reduce	C0392756
27249559	effects	C1280500
27249559	electron beam trajectory swinging	C0243095
27249559	beam	C0013840
27249559	size	C0456389
27249559	changing	C0392747
27249559	microfocus	C0205234
27249559	X-ray tube	C0184486
27249559	alleviate	C0392756
27249559	CT	C0040405
27249559	image	C1704254
27249559	artifacts	C0085089
27249559	caused	C0085978
27249559	X-ray	C0043299
27249559	focal spot	C0205146
27249559	shift	C3845720
27249559	size change	C0541591
27251800	Early	C1279919
27251800	assessment	C0220825
27251800	bilateral inguinal hernia repair	C0198737
27251800	comparison	C1707455
27251800	laparoscopic total extraperitoneal	C0087111
27251800	Stoppa approaches	C0087111
27251800	present	C0521116
27251800	clinical trial	C0008976
27251800	compare	C1707455
27251800	results	C1274040
27251800	bilateral inguinal hernia repair	C0198737
27251800	patients	C0030705
27251800	conventional	C0443177
27251800	Stoppa technique	C0087111
27251800	laparoscopic total extraperitoneal repair	C0521293
27251800	LTE	C0521293
27251800	mesh	C0181805
27251800	staple fixation	C1293125
27251800	randomised	C0034656
27251800	clinical trial	C0008976
27251800	General Surgery and Trauma of the Clinics Hospital	C1708333
27251800	Medical School	C1708333
27251800	University of Sγo Paulo	C1708333
27251800	male	C0086582
27251800	patients	C0030705
27251800	bilateral inguinal hernia	C0267672
27251800	years	C0439234
27251800	eligible	C1548635
27251800	study	C2603343
27251800	parameters	C0549193
27251800	analysed	C0936012
27251800	early	C1279919
27251800	post-operative period	C0032790
27251800	intensity	C0522510
27251800	surgical trauma	C4060629
27251800	operation time	C3494201
27251800	C-reactive protein	C0006560
27251800	CRP	C0006560
27251800	levels	C0441889
27251800	white blood cell count	C0023508
27251800	bleeding	C0019080
27251800	pain intensity	C1320357
27251800	quality of life	C0034380
27251800	assessment	C0220825
27251800	post-operative complications	C0032787
27251800	LTE procedure	C0521293
27251800	longer	C0205166
27251800	Stoppa procedure	C0087111
27251800	levels	C0441889
27251800	CRP	C0006560
27251800	higher	C0205250
27251800	Stoppa	C0087111
27251800	group	C0441833
27251800	leucocytes	C0023516
27251800	haematocrit	C0518014
27251800	haemoglobin	C0019046
27251800	similar	C2348205
27251800	groups	C0441833
27251800	no difference	C3842396
27251800	pain	C0030193
27251800	post-operative	C0241311
27251800	physical functioning	C0516981
27251800	physical limitation	C0449295
27251800	impact	C4049986
27251800	pain	C0030193
27251800	daily activities	C0871707
27251800	Carolinas Comfort Scale	C0349674
27251800	post-operative	C0241311
27251800	Complications	C0009566
27251800	Stoppa	C0087111
27251800	group	C0441833
27251800	patients	C0030705
27251800	LTE	C0521293
27251800	group	C0441833
27251800	patients	C0030705
27251800	comparative study	C1579762
27251800	Stoppa	C0087111
27251800	LTE	C0521293
27251800	bilateral inguinal hernia repair	C0198737
27251800	LTE	C0521293
27251800	surgical trauma	C4060629
27251800	longer	C0205166
27251800	operation time	C3494201
27251800	Quality of life	C0034380
27251800	early	C1279919
27251800	post-operative period	C0032790
27251800	similar	C2348205
27251800	Complication	C0009566
27251800	rates	C1521828
27251800	higher	C0205250
27251800	Stoppa	C0087111
27251800	group	C0441833
27252199	Morphological	C0543482
27252199	characteristics	C1521970
27252199	phallic glans	C0227948
27252199	engorgement	C0020452
27252199	American alligator	C0327167
27252199	distal part	C0205108
27252199	crocodilian	C0327160
27252199	phallus	C0030851
27252199	bulbous glans	C0227948
27252199	vascular tissues	C1511228
27252199	sexual activity	C0036864
27252199	enlarging	C0442800
27252199	glans	C1550261
27252199	complex	C0439855
27252199	functionally	C0205245
27252199	undefined	C0750600
27252199	copulatory	C1325873
27252199	enlarged	C0442800
27252199	glans	C1550261
27252199	interacts	C1704675
27252199	female	C0086287
27252199	cloaca	C0008987
27252199	change	C0392747
27252199	shape	C0332479
27252199	her reproductive tract	C0700038
27252199	insemination	C0021586
27252199	increase	C0442805
27252199	probability	C0033204
27252199	fertilization	C0015914
27252199	cellular-level properties	C0007613
27252199	glans	C1550261
27252199	inflatable phallic tissues	C0040300
27252199	sperm	C0037868
27252199	sulcus	C1184482
27252199	spermaticus	C0037855
27252199	American alligator	C0327167
27252199	Alligator mississippiensis	C0327167
27252199	histochemical staining	C0200825
27252199	collagen	C0009325
27252199	elastin fiber	C0230899
27252199	densities	C0178587
27252199	orientations	C1704322
27252199	tissues	C0040300
27252199	Extracellular matrix	C0015350
27252199	phallic glans	C0227948
27252199	affect	C0392760
27252199	tissue	C0040300
27252199	strength	C0237897
27252199	flexibility	C0242808
27252199	copulatory	C1325873
27252199	forces	C0441722
27252199	potential	C3245505
27252199	fluids	C0302908
27252199	induce	C0205263
27252199	alligator	C0002123
27252199	phalli	C0030851
27252199	serial sectioning	C0022885
27252199	three-dimensional reconstruction	C0022885
27252199	supracrucal plexus vascular	C0501402
27252199	bodies	C1995017
27252199	alligator	C0002123
27252199	phallus	C0030851
27252199	distally adjacent	C1254362
27252199	ventro-medial sulcus tissues	C0040300
27252199	gross	C0439806
27252199	histological examination	C0449575
27252199	American alligator	C0327167
27252199	phallic glans	C0227948
27252199	tissues	C0040300
27252199	vascular	C0005847
27252199	glans	C1550261
27252199	shape	C0332479
27252199	potentially	C3245505
27252199	secretory products	C0243092
27252199	female reproductive tract	C0700038
27252199	postcopulatory	C1325873
27252199	sexual selection	C1720879
27252199	mechanically	C0443254
27252199	affecting female reproductive physiology	C1517151
27257056	role	C1705810
27257056	poly(C) binding proteins	C0242210
27257056	programmed ribosomal frameshifting	C0282572
27257056	Translational	C1519614
27257056	control	C0243148
27257056	programmed ribosomal frameshifting	C0282572
27257056	PRF	C0282572
27257056	viruses	C0042776
27257056	cellular	C0007634
27257056	genes	C0017337
27257056	Frameshifting	C0282572
27257056	induced	C0205263
27257056	mRNA secondary structures	C0035696
27257056	ribosome	C0035553
27257056	fidelity	C0007613
27257056	decoding	C0205245
27257056	heptanucleotide 'slippery' sequence	C0004793
27257056	nsp2	C0033684
27257056	PRF	C0282572
27257056	signal	C0037080
27257056	porcine reproductive and respiratory syndrome virus	C0376536
27257056	-2	C0282572
27257056	-1 PRF	C0282572
27257056	requirement	C1514873
27257056	trans-acting protein factor	C0033684
27257056	viral	C0042776
27257056	replicase subunit nsp1β	C0033684
27257056	trans-activation	C0040624
27257056	frameshifting	C0282572
27257056	protein complex	C1180347
27257056	nsp1β	C0033684
27257056	cellular	C0007634
27257056	poly(C) binding protein	C0242210
27257056	PCBP	C0242210
27257056	in vitro	C1533691
27257056	translation	C1519614
27257056	electrophoretic mobility shift assays	C0949632
27257056	PCBP	C0242210
27257056	nsp1β	C0033684
27257056	complex	C1180347
27257056	C-rich sequence	C0004793
27257056	downstream	C0522506
27257056	slippery sequence	C0004793
27257056	activity	C0441655
27257056	mRNA	C0035696
27257056	stimulator	C0574031
27257056	PRF	C0282572
27257056	role	C1705810
27257056	trans-acting cellular protein	C0033684
27257056	PRF	C0282572
27257056	activities	C0441655
27257056	associated with	C0332281
27257056	poly(C) binding proteins	C0242210
27257056	prototypes	C0205556
27257056	virus	C0042776
27257056	host	C1167395
27257056	interactions	C1704675
27259647	bioactive	C3714412
27259647	conjugated linoleic acid	C1257880
27259647	multifunctional	C3658346
27259647	enolase	C0031691
27259647	Lactobacillus plantarum	C0317608
27259647	Lactobacillus plantarum	C0317608
27259647	α-enolase	C2364020
27259647	multifunctional	C3658346
27259647	surface protein	C0025252
27259647	enolases	C0031691
27259647	glycolytic	C0017952
27259647	metabolism	C0025519
27259647	characterized	C1880022
27259647	intricate metabolism	C0025519
27259647	biohydrogenation	C0020286
27259647	linoleic acid	C0023749
27259647	catalyzing	C0007382
27259647	formation	C1522492
27259647	bioactive	C3714412
27259647	9-cis-11-trans-CLA	C1609806
27259647	dehydration	C0598133
27259647	isomerization	C0596342
27259647	10-hydroxy-12-cis-octadecenoic acid	C0620518
27259647	enolase	C0031691
27259647	mass spectrometric analysis	C0037813
27259647	amino acid sequence	C0002518
27259647	molecular mass	C3152252
27259647	kDa	C1532717
27259647	enolase	C0031691
27259647	linoleic acid	C0023749
27259647	substrate	C3891814
27259647	hydroxyl	C0700307
27259647	derivative	C1527240
27259647	10-hydroxi-12-cis-octadecenoic acid	C0620518
27259647	bioactive	C3714412
27259647	conjugated linoleic acid	C0050156
27259647	Biochemical	C0205474
27259647	optimization	C2698650
27259647	studies	C2603343
27259647	9-cis-11-trans-CLA	C1609806
27259647	stability	C0014439
27259647	α-enolase	C2364020
27259647	catalyzing	C0007382
27259647	reaction	C0596319
27259647	structural analysis	C0204514
27259647	protein	C0033684
27259647	binding sites	C0005456
27259647	substrate	C3891814
27259647	product	C1514468
27259647	molecules	C0567416
27259647	characterized	C1880022
27259647	hydrophobic	C0598629
27259647	enolase	C0031691
27259647	channel	C0022009
27259647	catalysis	C0007382
27259647	dehydration	C0598133
27259647	isomerization	C0596342
27259647	multifunctional	C3658346
27259647	α-enolase	C2364020
27259647	cell detoxification	C4235382
27259647	polyunsaturated fatty acids	C0032615
27259647	linoleic acid	C0023749
27259647	linoleate isomerase	C0312354
27259647	complex	C1704241
27260627	Associations	C0439849
27260627	Body Mass Index	C1305855
27260627	Physical Activity	C0026606
27260627	Sexual Dysfunction	C0549622
27260627	Breast Cancer	C0678222
27260627	Survivors	C0206194
27260627	Sexual dysfunction	C0549622
27260627	distressing	C0231303
27260627	consequence of	C0686907
27260627	breast cancer	C0678222
27260627	BC	C0678222
27260627	treatment	C0087111
27260627	study	C2603343
27260627	sexual functioning	C0278092
27260627	BC	C0678222
27260627	patients	C0030705
27260627	association	C0004083
27260627	women's	C0043210
27260627	personal	C1519021
27260627	characteristics	C1521970
27260627	cancer treatments	C0920425
27260627	cross-sectional study	C0010362
27260627	sexual function	C0278092
27260627	Female Sexual Function Index	C4289276
27260627	FSFI	C4289276
27260627	health-related quality of life	C4279947
27260627	HRQOL	C4279947
27260627	European Organization for Research and Treatment of Cancer	C1516985
27260627	EORTC	C1516985
27260627	QLQ-C30	C3641780
27260627	breast module BR-23	C0282574
27260627	participants	C0679646
27260627	participants	C0679646
27260627	patients	C0030705
27260627	no sexual activity	C3840693
27260627	month	C0439231
27260627	sexual desire	C0023618
27260627	domain	C1880389
27260627	FSFI	C4289276
27260627	patients	C0030705
27260627	hypoactive sexual desire disorder	C0020594
27260627	HSDD	C0020594
27260627	patients	C0030705
27260627	sexual activity	C0036864
27260627	month	C0439231
27260627	sexual dysfunction	C0549622
27260627	hierarchical logistic regression	C0206031
27260627	body mass index	C1305855
27260627	BMI	C1305855
27260627	physical activity	C0026606
27260627	prediction	C0681842
27260627	models	C3161035
27260627	sexual dysfunction	C0549622
27260627	HSDD	C0020594
27260627	Age	C0001779
27260627	BMI	C1305855
27260627	physical activity	C0026606
27260627	sexual dysfunction	C0549622
27260627	HSDD	C0020594
27260627	BC	C0678222
27260627	patients	C0030705
27260627	sexual dysfunction	C0549622
27260627	lower	C1611820
27260627	scores	C0449820
27260627	HRQOL	C4279947
27260627	functioning	C0205245
27260627	fatigue	C0015672
27260627	findings	C0243095
27260627	BC	C0678222
27260627	survivors	C0206194
27260627	practice	C0032893
27260627	physical activity	C0026606
27260627	lose weight	C0418839
27260627	sexual dysfunction	C0549622
27260627	clinical trials	C0008976
27260627	findings	C0243095
27261587	Combination	C0013162
27261587	telmisartan	C0248719
27261587	sildenafil	C0529793
27261587	ameliorate	C0205556
27261587	progression	C0242656
27261587	diabetic nephropathy	C0011881
27261587	streptozotocin	C0038432
27261587	induced	C0205263
27261587	diabetic	C0241863
27261587	Diabetic nephropathy	C0011881
27261587	DN	C0011881
27261587	end-stage renal disease	C0022661
27261587	signaling pathways	C0037080
27261587	pathogenesis	C0699748
27261587	DN	C0011881
27261587	elevation	C0702240
27261587	angiotensin II	C0003009
27261587	formation	C1522492
27261587	advanced glycation end products	C0162574
27261587	AGE	C0162574
27261587	activation	C1819041
27261587	protein kinase c	C0033634
27261587	PKC	C0033634
27261587	lipid accumulation	C0333574
27261587	pathways	C0037080
27261587	activate	C1879547
27261587	oxidative stress	C0242606
27261587	expression	C1171362
27261587	transforming growth factor beta-1	C1704256
27261587	TGF-β 1	C1704256
27261587	release	C1283071
27261587	interleukins	C0021764
27261587	adhesion molecules	C0007578
27261587	pathogenic	C3816499
27261587	pathway	C1705987
27261587	ameliorate	C0205556
27261587	progression	C0242656
27261587	DN	C0011881
27261587	study	C0008972
27261587	white male rats	C0684072
27261587	rats	C0684072
27261587	normal control	C0009932
27261587	control vehicle group	C0009932
27261587	diabetic	C0241863
27261587	intraperitoneal injection	C0021493
27261587	Streptozotocin	C0038432
27261587	STZ	C0038432
27261587	DN	C0011881
27261587	rats	C0684072
27261587	DN	C0011881
27261587	DN	C0011881
27261587	Telmisartan	C0248719
27261587	Sildenafil	C0529793
27261587	Telmisartan	C0248719
27261587	Sildenafil	C0529793
27261587	combination	C0013162
27261587	specified	C0205369
27261587	treatment	C0039798
27261587	period	C1948053
27261587	urine samples	C1610733
27261587	collected	C1516695
27261587	metabolic cages	C3273359
27261587	proteinuria	C0033687
27261587	animals	C0003062
27261587	euthanized	C0162665
27261587	blood	C0178913
27261587	tissue samples	C1292533
27261587	collected	C1516695
27261587	measurement of Blood glucose	C0392201
27261587	BUN	C0005845
27261587	S.Cr	C0201976
27261587	LDL	C0202117
27261587	NO	C3810607
27261587	TGF-β1	C3889969
27261587	IL-1β	C3815172
27261587	AGEPs	C0022885
27261587	SOD	C0022885
27261587	combination therapy	C0013218
27261587	BUN	C0600137
27261587	S.Cr	C0010294
27261587	LDL	C0023823
27261587	TGF-β1	C1704256
27261587	IL-1β	C0021753
27261587	Proteinuria	C0033687
27261587	AGEPs	C0162574
27261587	SOD	C0038838
27261587	NO	C0028128
27261587	combination therapy	C0013218
27261587	ameliorate	C0205556
27261587	DN	C0011881
27261587	superior	C0205556
27261587	drugs	C0013227
27261783	Analysis	C0936012
27261783	Low-Biomass	C0005535
27261783	Microbial Communities	C0445623
27261783	Deep Biosphere	C0681784
27261783	few decades	C2981279
27261783	subseafloor biosphere	C0681784
27261783	scientific ocean drilling	C0205245
27261783	depths	C0205125
27261783	seafloor	C0681784
27261783	organic-rich anaerobic sedimentary habitats	C0871648
27261783	ocean margins harbor	C1254362
27261783	microbial cells	C0445623
27261783	microbial populations	C0445623
27261783	ultraoligotrophic aerobic sedimentary habitats	C0871648
27261783	ocean gyres	C0205245
27261783	magnitude	C1704240
27261783	abundant	C2346714
27261783	cultivation-independent molecular ecological techniques	C0449851
27261783	low-biomass	C0005535
27261783	environment	C0014406
27261783	technologically challenging	C0332218
27261783	deep subseafloor biosphere	C0681784
27261783	Reviewing	C1704362
27261783	historical background	C1552723
27261783	deep-biosphere	C0681784
27261783	analytical methods	C0178476
27261783	importance	C3898777
27261783	clean samples	C0370003
27261783	tracing	C0243095
27261783	contamination	C2349974
27261783	methods	C0025663
27261783	detecting	C0243095
27261783	microbial	C0599840
27261783	life	C0376558
27261783	technological aspects	C0681539
27261783	molecular microbiology	C0025952
27261783	detecting	C0243095
27261783	subseafloor	C0681784
27261783	metabolic activity	C0025519
27266283	sensitivity and specifity	C0036668
27266283	DR-70	C0041365
27266283	immunoassay	C0020980
27266283	tumor marker	C0041365
27266283	non-small cell lung cancer	C0007131
27266283	Lung cancer	C0242379
27266283	cancer related mortality	C1516192
27266283	Patients	C0030705
27266283	lung cancer	C0242379
27266283	diagnosed	C0430022
27266283	advanced	C0005898
27266283	locally advanced stage	C0005898
27266283	early diagnosis	C0596473
27266283	lung cancer	C0242379
27266283	early detection	C0596473
27266283	lung cancer	C0242379
27266283	low-dose computed tomography	C0040405
27266283	tumor biomarkers	C0041366
27266283	evaluate	C0220825
27266283	DR-70	C0041365
27266283	sensitivity and specificity	C0036668
27266283	tumor marker	C0041365
27266283	detection	C1511790
27266283	non-small cell lung cancers	C0007131
27266283	May	C3812381
27266283	April	C3715024
27266283	serum samples	C1550100
27266283	non lung cancer	C0006826
27266283	patients	C0030705
27266283	patients	C0030705
27266283	chronic obstructive pulmonary disesase	C0024117
27266283	Blood samples	C0178913
27266283	participant	C0679646
27266283	analyzed	C0936012
27266283	DR-70	C0041365
27266283	level	C0441889
27266283	patients	C0030705
27266283	study	C2603343
27266283	male	C0025266
27266283	female	C0043210
27266283	Histopathologically	C0243140
27266283	patients	C0030705
27266283	diagnosed	C0430022
27266283	squamous cell lung cancer	C0149782
27266283	adenocarcinoma	C0001418
27266283	non-small cell lung cancer	C0007131
27266283	mean serum DR-70	C0041365
27266283	levels	C0441889
27266283	lung cancer	C0242379
27266283	patients	C0030705
27266283	significantly higher	C0243095
27266283	compared	C1707455
27266283	non-cancerous	C0243095
27266283	subjects	C2349001
27266283	DR-70	C0041365
27266283	clinical	C0205210
27266283	sensitivity and specificity	C0036668
27266283	optimal	C2698651
27266283	cut off	C1442160
27266283	disease	C0012634
27266283	DR-70	C0041365
27266283	level	C0441889
27266283	DR-70	C0041365
27266283	marker	C0041365
27266283	measure	C0079809
27266283	fibrin degradation products	C0163275
27266283	cancers	C0006826
27266283	high risk	C0332167
27266283	lung cancer	C0242379
27266283	patients	C0030705
27266878	Catastrophic expenditure	C0015318
27266878	impoverishment	C0392762
27266878	patients	C0030705
27266878	rare diseases	C0678236
27266878	China	C0008115
27266878	China	C0008115
27266878	promoting	C0033414
27266878	rare diseases	C0678236
27266878	rare disease	C0678236
27266878	orphan drugs	C0013232
27266878	national planning	C0679910
27266878	studies	C2603343
27266878	affordability	C0814630
27266878	rare disease	C0678236
27266878	patients	C0030705
27266878	China	C0008115
27266878	policy	C0242456
27266878	recommendations	C0034866
27266878	establishment	C0443211
27266878	social security mechanism	C0282574
27266878	rare diseases	C0678236
27266878	China	C0008115
27266878	poverty	C0032854
27266878	diseases	C0012634
27266878	rare diseases	C0678236
27266878	Delphi method	C0011216
27266878	Affordability	C0814630
27266878	treatment	C0087111
27266878	rare diseases	C0678236
27266878	assessed	C1516048
27266878	annual per capital income	C0021162
27266878	catastrophic expenditure	C0015318
27266878	impoverishment	C0392762
27266878	expenditure	C0015316
27266878	urban	C1257890
27266878	rural residents	C1257890
27266878	China	C0008115
27266878	Assessed	C1516048
27266878	annual per capital income	C0021162
27266878	health expenditure	C0015318
27266878	rare diseases	C0678236
27266878	health expenditure	C0015318
27266878	income	C0021162
27266878	years	C0439234
27266878	urban resident	C1257890
27266878	rural residents	C1257890
27266878	catastrophic expenditure	C0015318
27266878	assessment	C1516048
27266878	proportions	C1709707
27266878	population	C1257890
27266878	catastrophic expenditure	C0015318
27266878	rare diseases	C0678236
27266878	ill	C0221423
27266878	medications	C4284232
27266878	catastrophic health expenditure	C0015318
27266878	impoverishment	C0392762
27266878	expenditure	C0015316
27266878	assessment	C1516048
27266878	proportions	C1709707
27266878	impoverishment	C0392762
27266878	payment	C0680264
27266878	urban	C1257890
27266878	rural residents	C1257890
27266878	rare diseases	C0678236
27266878	people	C1257890
27266878	poverty	C0032854
27266878	affordability	C0814630
27266878	treatment	C0087111
27266878	rare disease	C0678236
27266878	orphan drugs	C0013232
27266878	poor	C0542537
27266878	Residents	C2347958
27266878	income levels	C0870689
27266878	treatment	C0087111
27266878	rare diseases	C0678236
27266878	poverty	C0032854
27266878	rare diseases	C0678236
27266878	widespread	C0205391
27266878	social security mechanism	C0282574
27266878	rare disease	C0678236
27266878	patients	C0030705
27266878	payment	C0680264
27266878	orphan drugs	C0013232
27273231	Experimental study	C0681814
27273231	pulmonary artery	C0034052
27273231	sealing	C1963784
27273231	vessel-sealing device	C0025080
27273231	vessel-sealing devices	C0025080
27273231	safety	C0036043
27273231	video-assisted thoracoscopic surgery	C0752151
27273231	feasibility	C0205556
27273231	safety	C0036043
27273231	sealing	C1963784
27273231	pulmonary arteries	C0034052
27273231	Enseal tissue-sealing device	C0025080
27273231	Pulmonary arteries	C0034052
27273231	beagle dogs	C1296765
27273231	groups	C1642385
27273231	in-vivo	C1515655
27273231	sealing method	C0449371
27273231	Enseal	C0025080
27273231	ligation	C0189722
27273231	proximal	C0205107
27273231	ligation	C0189722
27273231	distal	C0205108
27273231	Enseal	C0025080
27273231	pressure	C0033095
27273231	tolerance	C1704410
27273231	sealed	C0587267
27273231	end	C0444930
27273231	lobectomy	C0023928
27273231	chronic-phase	C0457343
27273231	sealed stumps	C0025080
27273231	survival model	C0599779
27273231	pulmonary arteries	C0034052
27273231	dog	C0012984
27273231	groups	C1642385
27273231	survival	C0038952
27273231	period	C1948053
27273231	pulmonary arteries	C0034052
27273231	Pressure	C0033095
27273231	tolerance	C1704410
27273231	sealed	C0587267
27273231	end	C0444930
27273231	pulmonary artery	C0034052
27273231	sealed	C0587267
27273231	ends	C0444930
27273231	pressure	C0033095
27273231	tolerance	C1704410
27273231	lobectomy	C0023928
27273231	dogs	C0012984
27273231	pulmonary artery	C0034052
27273231	groups	C1642385
27273231	No	C1513916
27273231	sealing	C1963784
27273231	failure	C0231174
27273231	pathological	C1521733
27273231	findings	C0243095
27273231	healing	C0043240
27273231	persistent	C0205322
27273231	hemostasis	C0019116
27273231	sealed	C0587267
27273231	ends	C0444930
27273231	pulmonary arteries	C0034052
27273231	weeks	C0439230
27273231	survival	C0038952
27273231	period	C1948053
27273231	Pulmonary arteries	C0034052
27273231	sealed	C0587267
27273231	in vivo	C1515655
27273231	Enseal device	C0025080
27273231	pressure	C0033095
27273231	tolerance	C1704410
27273231	acute phase	C0439557
27273231	persistent	C0205322
27273231	hemostasis	C0019116
27273231	weeks	C0439230
27273231	Pulmonary artery	C0034052
27273231	sealing	C1963784
27273231	Enseal device	C0025080
27273231	feasible	C0205556
27273231	safe	C0036043
27273231	thoracic surgery	C0524832
27273307	Pathophysiology	C0031847
27273307	treatment	C0087111
27273307	prevention	C0199176
27273307	ovarian hyperstimulation syndrome	C0085083
27273307	Severe	C0205082
27273307	ovarian hyperstimulation syndrome	C0085083
27273307	OHSS	C0085083
27273307	iatrogenic	C0439669
27273307	condition	C0348080
27273307	affects	C4054723
27273307	women	C0043210
27273307	treatment	C0087111
27273307	assisted reproductive technology	C0872104
27273307	review	C0282443
27273307	aims	C1947946
27273307	summarize	C1706244
27273307	recent	C0332185
27273307	evidence	C3887511
27273307	pathophysiology	C0031847
27273307	treatment	C0087111
27273307	prevention	C0199176
27273307	OHSS	C0085083
27273307	pathophysiology	C0031847
27273307	completely	C0205197
27273307	understood	C0162340
27273307	vascular endothelial growth factor	C0078058
27273307	important	C3898777
27273307	Human chorionic gonadotropin	C1141639
27273307	thought	C0039869
27273307	OHSS	C0085083
27273307	occur	C1709305
27273307	recent case reports	C0007320
27273307	proven	C0456369
27273307	contribution	C1880177
27273307	attenuated	C0599946
27273307	anti-Mullerian hormone	C0066928
27273307	signalling pathway	C0037083
27273307	CD11c	C0023395
27273307	HLA-DR	C0019764
27273307	dendritic cells	C0011306
27273307	associated	C0332281
27273307	interleukins	C0021764
27273307	recently	C0332185
27273307	contributors	C1880177
27273307	pathogenesis	C0699748
27273307	Treatment	C0087111
27273307	supportive	C0344211
27273307	based	C1705938
27273307	consensus	C0376298
27273307	statements	C1710187
27273307	evidence	C3887511
27273307	important	C3898777
27273307	prevent	C1292733
27273307	condition	C0348080
27273307	identifying	C1269815
27273307	women	C0043210
27273307	at risk	C1444641
27273307	allowing	C0683607
27273307	clinician	C0871685
27273307	implement	C1708476
27273307	preventive strategies	C0679716
27273307	including	C0332257
27273307	GnRH antagonist	C1268855
27273307	cycles	C0001289
27273307	agonist	C2987634
27273307	research	C0035168
27273307	required	C1514873
27273307	pathophysiology	C0031847
27273307	condition	C0348080
27273307	Clinicians	C0871685
27273307	employ	C0457083
27273307	strategies	C0679199
27273307	prevent	C0679698
27273307	OHSS	C0085083
27274524	Eosinophilic Gastroenteritis	C1262481
27274524	Rare	C0522498
27274524	Cause	C0015127
27274524	Recurrent Epigastric Pain	C0743544
27274524	Eosinophilic gastroenteritis	C1262481
27274524	EGE	C1262481
27274524	inflammatory disorder	C1290884
27274524	gastrointestinal tract	C0017189
27274524	characterized	C1880022
27274524	eosinophilic infiltration	C0333390
27274524	bowel wall	C0021853
27274524	gastrointestinal disorders	C0017178
27274524	wide spectrum of presentations	C0243095
27274524	Diagnose	C0011900
27274524	excluding	C0332196
27274524	other	C0205394
27274524	disorders	C0012634
27274524	high	C0205250
27274524	suspicion	C0242114
27274524	report a case	C0007320
27274524	year	C0439234
27274524	old	C0580836
27274524	man	C0025266
27274524	history	C0262926
27274524	sever epigastric pain	C0232493
27274524	nausea	C0027497
27274524	vomiting	C0042963
27274524	few	C0205388
27274524	days	C0439228
27274524	before	C0332152
27274524	admission	C0030673
27274524	diagnosis	C0011900
27274524	EGE	C1262481
27274893	sonoelastography	C1955929
27274893	sonourethrography	C0581495
27274893	retrograde urethrography	C0845989
27274893	evaluation	C0220825
27274893	male	C0086582
27274893	anterior urethral strictures	C1720814
27274893	Retrograde urethrography	C0845989
27274893	RUG	C0845989
27274893	imaging modality	C1275506
27274893	imaging	C0011923
27274893	anterior urethral strictures	C1720814
27274893	limitations	C0449295
27274893	Sonourethrography	C0581495
27274893	SUG	C0581495
27274893	overcome	C2983310
27274893	limitations	C0449295
27274893	RUG	C0845989
27274893	accurate results	C0598285
27274893	imaging modality	C1275506
27274893	planning the treatment	C0599880
27274893	recurrence	C0034897
27274893	stricture disease	C0041974
27274893	spongiofibrosis	C0016059
27274893	Sonoelastography	C1955929
27274893	SE	C1955929
27274893	newer technique	C1519842
27274893	pathologies	C0030664
27274893	efficacy	C2348251
27274893	anterior urethral stricture disease	C1720814
27274893	RUG	C0845989
27274893	SUG	C0581495
27274893	patients	C0030705
27274893	anterior urethral stricture disease	C1720814
27274893	RUG	C0845989
27274893	SUG	C0581495
27274893	SE	C1955929
27274893	stricture	C1389955
27274893	location	C0450429
27274893	length	C1444754
27274893	depth	C1827571
27274893	spongiofibrosis	C0016059
27274893	periurethral	C3828581
27274893	pathologies	C0030664
27274893	histopathological findings	C0243140
27274893	diagnostic accuracy	C0598285
27274893	SE	C1955929
27274893	SUG	C0581495
27274893	RGU	C0845989
27274893	stricture	C1389955
27274893	location	C0450429
27274893	length	C1444754
27274893	depth	C1827571
27274893	spongiofibrosis	C0016059
27274893	SE	C1955929
27274893	SUG	C0581495
27274893	accuracy rates	C0443131
27274893	SE	C1955929
27274893	intra-operative	C0456904
27274893	stricture	C1389955
27274893	length	C1444754
27274893	SE	C1955929
27274893	colour of bladder mucosa	C0475705
27274893	cystoscopic examination	C0401483
27274893	incision	C0184898
27274893	SUG	C0581495
27274893	colour of the bladder mucosa	C0475705
27274893	incision	C0184898
27274893	cystoscopy	C0010702
27274893	SE	C1955929
27274893	histopathology findings	C0243140
27274893	degree of fibrosis	C4285457
27274893	Sonoelastography	C1955929
27274893	stricture site and length	C1254362
27274893	RUG	C0845989
27274893	SUG	C0581495
27274893	spongiofibrosis	C0016059
27274893	prognostic factor	C1514474
27274893	stricture recurrence	C0034897
27274893	accurately	C0443131
27274893	SUG	C0581495
27280034	Changes	C0392747
27280034	risk factors	C0035648
27280034	young	C0332239
27280034	male	C0086582
27280034	suicide	C0038661
27280034	Newcastle upon Tyne	C0017446
27280034	Aims	C1947946
27280034	method	C0025663
27280034	differences	C1705242
27280034	patterns of suicide	C0038661
27280034	young	C0332239
27280034	men	C0025266
27280034	decades	C2981279
27280034	implications	C0205556
27280034	suicide	C0038661
27280034	prevention	C2700409
27280034	Data	C1511726
27280034	suicides	C0038661
27280034	open verdicts	C0680738
27280034	men	C0025266
27280034	coroner's records	C0282574
27280034	Newcastle upon Tyne	C0017446
27280034	analysed	C0936012
27280034	SPSS software	C0037585
27280034	Results	C1274040
27280034	increase	C0442805
27280034	suicide rates	C1822575
27280034	decade	C2981279
27280034	decade	C2981279
27280034	associated with	C0332281
27280034	increasing	C0442808
27280034	proportion	C1709707
27280034	single	C0205171
27280034	men	C0025266
27280034	living alone	C0260794
27280034	unemployment	C0041674
27280034	consumption of alcohol	C0001948
27280034	hanging	C0544691
27280034	previous	C0205156
27280034	suicide attempt	C0038663
27280034	history of treatment	C0814462
27280034	mental illness	C0004936
27280034	Clinical	C0205210
27280034	implications	C0205556
27280034	study	C2603343
27280034	interventions	C0184661
27280034	focus	C0589098
27280034	young	C0332239
27280034	males	C0086582
27280034	suicide	C0038661
27280034	prevention area	C2700409
27280034	field of public health	C3244304
27280034	reducing	C0392756
27280034	access	C0444454
27280034	means	C1704970
27280034	suicide	C0038661
27280034	reducing	C0392756
27280034	alcohol use	C0001948
27280034	support	C1521721
27280034	relationship	C0439849
27280034	difficulties	C0332218
27280034	engagement	C3508152
27280034	mental health services	C0025355
27280034	management	C0376636
27280034	chronic illness	C0008679
27280525	Social cognition	C0871381
27280525	schizophrenia	C0036341
27280525	Factor structure	C0870541
27280525	emotion	C0013987
27280525	processing	C0025361
27280525	theory of mind	C0935573
27280525	Factor analytic studies	C0085801
27280525	social cognition	C0871381
27280525	schizophrenia	C0036341
27280525	results	C1274040
27280525	quality of measures	C3242457
27280525	Phase 3	C0439561
27280525	Social Cognition	C0871381
27280525	Psychometric Evaluation (SCOPE) Study	C0033920
27280525	psychometrically	C0033920
27280525	sound measures	C0430022
27280525	social cognition	C0871381
27280525	study	C2603343
27280525	examine	C0332128
27280525	factor structure	C0870541
27280525	social cognition	C0871381
27280525	schizophrenia	C0036341
27280525	psychometrically	C0033920
27280525	sound measures	C0430022
27280525	examine	C0332128
27280525	stability	C0205360
27280525	factor structure	C0870541
27280525	study	C2603343
27280525	factor structure	C0870541
27280525	social cognition	C0871381
27280525	schizophrenia	C0036341
27280525	healthy controls	C2986479
27280525	examine	C0332128
27280525	factors	C0870541
27280525	outcome measures	C0086749
27280525	social functioning	C0037395
27280525	symptoms	C1457887
27280525	Results	C1274040
27280525	one-factor model	C0282574
27280525	patient	C0030705
27280525	healthy control	C2986479
27280525	visits	C1512346
27280525	visits	C1512346
27280525	associated with	C0332281
27280525	negative symptoms	C1457887
27280525	schizophrenia	C0036341
27280525	sample	C0370003
27280525	social functioning	C0037395
27280525	groups	C1257890
27280525	study	C2603343
27280525	visits	C1512346
27282845	Assessment	C0220825
27282845	Residual Disease	C0543478
27282845	Molecular Breast Imaging	C2985547
27282845	Patients	C0030705
27282845	Neoadjuvant Therapy	C0600558
27282845	Molecular	C1521991
27282845	Subtypes	C0449560
27282845	Assessment	C0220825
27282845	residual disease	C0543478
27282845	neoadjuvant therapy	C0600558
27282845	breast cancer	C0006142
27282845	breast	C0006141
27282845	imaging	C0011923
27282845	study	C2603343
27282845	evaluates	C0220825
27282845	accuracy	C0443131
27282845	molecular breast imaging	C2985547
27282845	MBI	C2985547
27282845	cadmium zinc telluride	C1258740
27282845	detectors	C0180392
27282845	residual disease	C0543478
27282845	neoadjuvant therapy	C0600558
27282845	patients	C0030705
27282845	breast cancer	C0006142
27282845	Clinical data	C1516606
27282845	imaging	C0011923
27282845	surgical	C0038895
27282845	pathological	C1521733
27282845	findings	C0243095
27282845	women	C0043210
27282845	breast cancer	C0006142
27282845	neoadjuvant therapy	C0600558
27282845	MBI	C2985547
27282845	findings	C0243095
27282845	correlated	C1707520
27282845	surgical pathology results	C1710255
27282845	Accuracy	C0443131
27282845	MBI	C2985547
27282845	complete pathological response	C4050242
27282845	size	C0456389
27282845	residual disease	C0543478
27282845	molecular	C1521991
27282845	subtypes	C0449560
27282845	size	C0456389
27282845	MBI	C2985547
27282845	correlated	C1707520
27282845	pathology	C0205469
27282845	correlation	C1707520
27282845	triple negative	C3539878
27282845	HER2/neu positive	C2348909
27282845	subtypes	C0449560
27282845	patients	C0030705
27282845	complete pathological response	C4050242
27282845	sensitivity	C1511883
27282845	specificity	C0037791
27282845	MBI	C2985547
27282845	residual disease	C0543478
27282845	confidence interval	C0009667
27282845	CI	C0009667
27282845	CI	C0009667
27282845	triple negative	C3539878
27282845	HER2/neu positive	C2348909
27282845	sensitivity	C1511883
27282845	specificity	C0037791
27282845	CI	C0009667
27282845	CI	C0009667
27282845	accuracy	C0443131
27282845	MBI	C2985547
27282845	residual disease	C0543478
27282845	neoadjuvant treatment	C0600558
27282845	molecular	C1521991
27282845	subtype	C0449560
27282845	Accuracy	C0443131
27282845	triple negative	C3539878
27282845	HER2/neu positive	C2348909
27282845	subtypes	C0449560
27286118	relationship	C0439849
27286118	histological	C0205462
27286118	prostatitis	C0033581
27286118	lower urinary tract symptoms	C0574785
27286118	sexual function	C0278092
27286118	prospective analysis	C0033522
27286118	assessed	C1516048
27286118	effect	C1280500
27286118	histological	C0205462
27286118	prostatitis	C0033581
27286118	lower urinary tract	C0729866
27286118	functions	C0542341
27286118	sexual function	C0278092
27286118	patients	C0030705
27286118	separated	C0443299
27286118	groups	C0441833
27286118	histologically	C0205462
27286118	observed	C1441672
27286118	prostatitis	C0033581
27286118	Group A	C0441833
27286118	no prostatitis	C0243095
27286118	Group B	C0441833
27286118	biopsy	C0005558
27286118	outcomes	C1274040
27286118	International prostate symptom score	C1998280
27286118	international index of erectile function-5 scores	C2959364
27286118	maximal	C0429784
27286118	average flow rate	C0429785
27286118	residual urine volumes	C0429774
27286118	compared	C1707455
27286118	groups	C0441833
27286118	significant	C0237881
27286118	difference	C1705242
27286118	baseline	C1442488
27286118	age	C0001779
27286118	body mass index value	C1305855
27286118	prostate volume	C1441416
27286118	prostate-specific antigen levels	C0201544
27286118	maximal	C0429784
27286118	average flow rate	C0429785
27286118	post-void	C1439885
27286118	residual urine volume	C0429774
27286118	Mean	C0444504
27286118	international prostate symptom score	C1998280
27286118	patients	C0030705
27286118	prostatitis	C0033581
27286118	numerically	C0243174
27286118	significantly higher	C4055637
27286118	without	C0332288
27286118	prostatitis	C0033581
27286118	Mean	C0444504
27286118	international index of erectile function-5 score	C2959364
27286118	prostatitis	C0033581
27286118	group	C0441833
27286118	significantly lower	C4055638
27286118	without	C0332288
27286118	prostatitis	C0033581
27286118	Histological	C0205462
27286118	prostatitis	C0033581
27286118	affected	C0392760
27286118	sexual function	C0278092
27286118	patients	C0030705
27286118	major	C0205164
27286118	risk factor	C0035648
27286118	sexual dysfunction	C0549622
27286118	effect	C1280500
27286118	lower urinary tract symptoms	C0574785
27286174	Median	C0876920
27286174	Waiting Time	C0814636
27286174	Development	C1527148
27286174	Validation	C1519941
27286174	Risk Model	C0679713
27286174	Predict	C0681842
27286174	Outcomes	C1274040
27286174	Kidney	C0022646
27286174	Transplant Waiting List	C3272315
27286174	Median	C0876920
27286174	historical	C0019659
27286174	time	C0040223
27286174	kidney transplant	C0022671
27286174	risks	C0035647
27286174	death	C0011065
27286174	removal from the waiting list	C0420299
27286174	risk model	C0679713
27286174	calculate	C1441506
27286174	outcomes	C0085415
27286174	kidney transplant	C0022671
27286174	candidates	C0524355
27286174	information	C1533716
27286174	differs	C1705242
27286174	median	C0876920
27286174	time	C0814636
27286174	transplant	C0022671
27286174	Data	C1511726
27286174	obtained	C1301820
27286174	US Scientific Registry	C0034975
27286174	Transplant Recipients	C0376387
27286174	retrospective cohort	C2985505
27286174	adults	C0001675
27286174	kidney transplant	C0022671
27286174	Predictors	C0035648
27286174	age	C0001779
27286174	sex	C0079399
27286174	blood type	C1383165
27286174	calculated	C1443182
27286174	panel-reactive antibodies	C1141951
27286174	donation	C0411257
27286174	service area	C0007403
27286174	dialysis	C0011946
27286174	duration	C0449238
27286174	comorbid conditions	C1275743
27286174	body mass index	C1305855
27286174	Outcomes	C0085415
27286174	living donor	C0348050
27286174	transplant	C0022671
27286174	death	C0011065
27286174	removal from the list	C0420299
27286174	due to	C0678226
27286174	deteriorating	C0332271
27286174	medical	C0205476
27286174	condition	C0348080
27286174	removal	C0420299
27286174	due to	C0678226
27286174	other reasons	C3840932
27286174	calculated	C0444686
27286174	hazards	C0598697
27286174	possible	C0332149
27286174	outcomes	C0085415
27286174	cumulative	C1511559
27286174	incidence	C0021149
27286174	function	C0031843
27286174	candidate	C0524355
27286174	risk	C0035647
27286174	methodology	C3266812
27286174	Discrimination	C0012632
27286174	calibration	C0006751
27286174	assessed	C1516048
27286174	through	C0332273
27286174	C statistics	C0681933
27286174	calibration	C0006751
27286174	plots	C1301732
27286174	each	C1457900
27286174	cause	C0015127
27286174	specific	C0205369
27286174	Cox proportional hazard model	C0018623
27286174	C statistics	C0681933
27286174	Calibration	C0006751
27286174	plots	C1301732
27286174	good	C0205170
27286174	calibration	C0006751
27286174	risk model	C0679713
27286174	probability	C0033204
27286174	possible	C0332149
27286174	outcomes	C0085415
27286174	12 years	C0439234
27286174	candidate's	C0524355
27286174	characteristics	C1521970
27286174	median	C0876920
27286174	waiting time	C0814636
27286174	candidate's	C0524355
27286174	donation	C0411257
27286174	service area	C0007403
27286174	risk model	C0679713
27286174	relevant	C2347946
27286174	information	C1533716
27286174	median	C0876920
27286174	waiting time	C0814636
27286174	given	C1442162
27286174	transplant center	C1708333
27286174	model	C0033204
27286174	updated	C1519814
27286174	create	C1706214
27286174	recent	C0332185
27286174	outcomes	C0085415
27286174	changes	C0392747
27286174	allocation	C1706778
27286174	policy	C0242456
27286174	conversations	C0871703
27286174	initiated	C1704686
27286174	transplant	C0022671
27286174	candidates	C0524355
27288457	Tead1	C1420679
27288457	expression	C0017262
27288457	Peripheral Myelin Protein 22	C1418677
27288457	Schwann cell development	C1817645
27288457	Schwann cells	C0036387
27288457	myelinating glia	C0027836
27288457	peripheral nervous system	C0206417
27288457	myelin sheath	C0026973
27288457	peripheral neuropathy	C0031117
27288457	copy number variant	C1511518
27288457	Peripheral Myelin Protein 22 (PMP22) gene	C1418677
27288457	duplication	C0017261
27288457	chromosome 17	C0008659
27288457	Charcot-Marie-Tooth Disease	C0007959
27288457	CMT1A	C0007959
27288457	Rodent models	C1519106
27288457	CMT1A	C0007959
27288457	Pmp22	C1418677
27288457	overexpression	C0017262
27288457	CMT1A	C0007959
27288457	phenotype	C0031437
27288457	Mechanistic	C0441712
27288457	studies	C2603343
27288457	Pmp22	C1418677
27288457	regulation	C0017263
27288457	enhancers	C0014290
27288457	Sox10	C1571654
27288457	SRY sex determining region Y-box 10	C1571654
27288457	Egr2	C0064419
27288457	Krox20	C0064419
27288457	Early growth response protein 2	C0064419
27288457	transcription factors	C0040648
27288457	myelinated nerves	C0027750
27288457	transcription factors	C0040648
27288457	induce	C0205263
27288457	Pmp22	C1418677
27288457	expression	C0017262
27288457	Schwann cell development	C1817645
27288457	myelination	C0596991
27288457	Pmp22	C1418677
27288457	enhancers	C0014290
27288457	cell type-specificity	C1148560
27288457	nerve injury	C0161479
27288457	development	C1527148
27288457	Pmp22	C1418677
27288457	enhancers	C0014290
27288457	active	C0205177
27288457	histone modifications	C1156199
27288457	lost	C0745777
27288457	injury	C3263723
27288457	enhancers	C0014290
27288457	development	C1527148
27288457	Pmp22	C1418677
27288457	upregulation	C0041904
27288457	Pmp22	C1418677
27288457	enhancers	C0014290
27288457	binding motifs	C1956035
27288457	TEA domain	C0220134
27288457	Tead	C0220134
27288457	transcription factors	C0040648
27288457	Hippo signaling pathway	C3158583
27288457	Tead1	C1420679
27288457	Yap	C1424135
27288457	Taz	C1336578
27288457	Pmp22	C1418677
27288457	expression	C0017262
27288457	expression	C0017262
27288457	Egr2	C1414315
27288457	Tead1	C1420679
27288457	Pmp22	C1418677
27288457	Egr2	C1414315
27288457	enhancers	C0014290
27288457	development	C1527148
27288457	Tead1	C1420679
27288457	binding	C1167622
27288457	induced	C0205263
27288457	myelination	C0596991
27288457	Pmp22	C1418677
27288457	expression	C0017262
27288457	data	C1511726
27288457	Tead1	C1420679
27288457	regulator	C0017362
27288457	Pmp22	C1418677
27288457	expression	C0017262
27288457	development	C1527148
27288457	Sox10	C1420317
27288457	Egr2	C1414315
27291966	Neutrophil gelatinase-associated lipocalin	C1870887
27291966	triphasic	C0205185
27291966	rat model	C0599779
27291966	adenine	C0001407
27291966	induced	C0205263
27291966	kidney injury	C0160420
27291966	NGAL	C1870887
27291966	biomarkers	C0005516
27291966	renal tubulointerstitial insult	C0041349
27291966	adenine	C0001407
27291966	NGAL	C1870887
27291966	biomarker	C0005516
27291966	acute kidney injury	C2609414
27291966	chronic interstitial disease	C0238304
27291966	NGAL	C1870887
27291966	levels	C0441889
27291966	stable	C0205360
27291966	through	C0332273
27291966	chronic phase	C0457343
27291966	adenine model	C0599779
27291966	Study group	C2348561
27291966	rats	C0034693
27291966	adenine	C0001407
27291966	diet	C0012155
27291966	control group	C0009932
27291966	rats	C0034693
27291966	regular diet	C0184625
27291966	Blood	C0178913
27291966	urine samples	C1610733
27291966	urea	C0041942
27291966	creatinine	C0010294
27291966	NGAL	C1870887
27291966	rat	C0034693
27291966	beginning	C0439659
27291966	study	C0008972
27291966	Kidney	C0022646
27291966	slices	C1519355
27291966	rats	C0034693
27291966	stained	C0487602
27291966	Hematoxylin-eosin	C0523207
27291966	HE	C0523207
27291966	β-actin	C0005186
27291966	stainings	C0487602
27291966	Serum urea	C2945624
27291966	creatinine	C0201975
27291966	NGAL	C1870887
27291966	levels	C0441889
27291966	urinary NGAL/creatinine ratio	C1316828
27291966	baseline	C1442488
27291966	control group	C0009932
27291966	statistically significant	C0237881
27291966	intervals	C1272706
27291966	Tubulointerstitial	C0041349
27291966	adenine	C0001407
27291966	rats	C0034693
27291966	rats	C0034693
27291966	adenine	C0001407
27291966	serum urea	C2945624
27291966	creatinine	C1318439
27291966	NGAL	C1870887
27291966	levels	C0441889
27291966	urinary NGAL/creatinine ratio	C1316828
27291966	triphasic pattern	C1336825
27291966	kidney injury	C0160420
27291966	acute phase	C0439557
27291966	adenine	C0001407
27291966	diet	C0012155
27291966	partial	C0728938
27291966	recovery	C2004454
27291966	phase	C0205390
27291966	regular diet	C0184625
27291966	chronic kidney disease	C1561643
27291966	phase	C0205390
27291966	renal function	C0232804
27291966	NGAL	C1870887
27291966	biomarker	C0005516
27291966	acute kidney injury	C2609414
27291966	chronic kidney disease	C1561643
27291966	tubulointerstitial	C0041349
27291966	rat model	C0599779
27292374	Talking	C0234856
27292374	Keeping Silent	C0443304
27292374	Parental	C0030551
27292374	Mental Health Problems	C1446377
27292374	Grounded Theory	C1510611
27292374	Parents	C0030551
27292374	Decision Making	C0011109
27292374	Experiences	C0596545
27292374	Children	C0008059
27292374	grounded theory	C1510611
27292374	study	C2603343
27292374	parents	C0030551
27292374	experiences	C0596545
27292374	children's	C0008059
27292374	parental	C0030551
27292374	mental health	C0025353
27292374	concerns	C2699424
27292374	parents	C0030551
27292374	severe	C0205082
27292374	mental health difficulties	C1446377
27292374	study	C2603343
27292374	findings	C0243095
27292374	social processes	C0871384
27292374	parents	C0030551
27292374	talk	C0234856
27292374	children	C0008059
27292374	parental	C0030551
27292374	mental health issues	C1446377
27292374	Protecting	C3146231
27292374	being protected	C3146231
27292374	Responding	C0871261
27292374	children's	C0008059
27292374	search	C1706202
27292374	understanding	C0162340
27292374	Prioritizing	C0549179
27292374	family life	C0015608
27292374	Relating to others	C0004927
27292374	findings	C0243095
27292374	clinical practice	C1254363
27292374	research	C0035168
27292374	family-orientated services	C1254363
27292374	parents	C0030551
27292374	experience	C0596545
27292374	parental	C0030551
27292374	mental health problems	C1446377
27297523	case	C1706256
27297523	bilateral	C0238767
27297523	pneumothoraces	C0032326
27297523	tracheostomy	C0040590
27297523	advanced	C0679246
27297523	laryngeal cancer	C0007107
27297523	Pneumothorax	C0032326
27297523	complication	C0009566
27297523	tracheostomy	C0040590
27297523	report	C0700287
27297523	bilateral	C0238767
27297523	pneumothoraces	C0032326
27297523	tracheostomy	C0040590
27297523	advanced	C0679246
27297523	laryngeal cancer	C0007107
27297523	patient	C0030705
27297523	man	C0086582
27297523	clinic	C0442592
27297523	evaluation	C0220825
27297523	treatment	C0087111
27297523	laryngeal tumor	C0023055
27297523	Laryngeal endoscopy	C0023072
27297523	limited movement	C0243095
27297523	bilateral vocal cords	C0459363
27297523	computed tomography	C0040405
27297523	tumor	C0027651
27297523	lesion	C0221198
27297523	vocal cords	C0042930
27297523	subglottic area	C0456475
27297523	days	C0439228
27297523	first visit	C4287881
27297523	patient	C0030705
27297523	respiratory difficulty	C0013404
27297523	emergency tracheostomy	C0498305
27297523	airway management	C0150126
27297523	procedure	C0543467
27297523	hyperventilating	C0020578
27297523	respiratory discomfort	C4062414
27297523	chest pain	C0008031
27297523	mediastinal	C0025066
27297523	air leak	C2242512
27297523	suspected	C0332147
27297523	pneumothorax	C0032326
27297523	tracheostomy	C0040590
27297523	Chest X-ray	C0039985
27297523	bilateral	C0238767
27297523	pneumothoraces	C0032326
27297523	inserted	C0441587
27297523	bilateral	C0238767
27297523	chest	C0817096
27297523	drainage tubes	C0184114
27297523	stabilized	C0184512
27297523	respiratory condition	C4062804
27297523	pathogenesis	C0699748
27297523	bilateral	C0238767
27297523	pneumothoraces	C0032326
27297523	weakened	C1762617
27297523	alveolar walls	C0225695
27297523	long-term	C0443252
27297523	smoking	C0037369
27297523	rise	C0442805
27297523	airway pressure	C0428719
27297523	airway constriction	C0231818
27297523	neck-extended position	C0577754
27297523	hyperventilation	C0020578
27297523	tracheostomy	C0040590
27297967	Arsenic Triglutathione	C0596621
27297967	As(GS)3	C0596621
27297967	Transport	C0005528
27297967	Multidrug Resistance Protein 1	C1451297
27297967	MRP1	C1451297
27297967	ABCC1	C1451297
27297967	Modified	C0392747
27297967	Phosphorylation	C1158886
27297967	Tyr920/Ser921	C0002518
27297967	Glycosylation	C0376322
27297967	Asn19/Asn23	C0002518
27297967	ATP-binding cassette (ABC) transporter	C0242738
27297967	multidrug resistance protein 1	C1451297
27297967	MRP1	C1451297
27297967	ABCC1	C1451297
27297967	cellular	C0007634
27297967	export	C0699789
27297967	diverse	C1880371
27297967	array	C1510941
27297967	xenobiotics	C0043335
27297967	endogenous	C0205227
27297967	compounds	C0439861
27297967	Arsenic	C0003818
27297967	human	C0086418
27297967	carcinogen	C0007090
27297967	high-affinity	C0205556
27297967	MRP1	C1451297
27297967	substrate	C3891814
27297967	arsenic triglutathione	C0596621
27297967	As(GS)3	C0596621
27297967	As(GS)3	C0596621
27297967	transport	C0005528
27297967	kinetics	C2825046
27297967	MRP1	C1451297
27297967	membrane	C0596901
27297967	vesicles	C1622418
27297967	prepared	C1521827
27297967	human	C0086418
27297967	embryonic	C0013935
27297967	kidney	C0022646
27297967	293 (HEK)	C2936239
27297967	Km	C1706312
27297967	Vmax	C1710637
27297967	HeLa	C0018873
27297967	Km	C1706312
27297967	Vmax	C1710637
27297967	cells	C0007634
27297967	Mutant	C1564139
27297967	MRP1	C1451297
27297967	glycosylation	C0376322
27297967	Asn19/23/1006Gln	C0002518
27297967	(SF)-MRP1	C1451297
27297967	expressed	C1171362
27297967	HEK293	C2936239
27297967	HeLa cells	C0018873
27297967	Km	C1706312
27297967	Vmax	C1710637
27297967	As(GS)3	C0596621
27297967	similar	C2348205
27297967	HeLa wild-type	C0018873
27297967	MRP1	C1451297
27297967	prepared	C1521827
27297967	presence	C0150312
27297967	phosphatase inhibitors	C0597217
27297967	WT-	C1451297
27297967	SF-MRP1	C1451297
27297967	membrane	C0596901
27297967	vesicles	C1622418
27297967	Km	C1706312
27297967	As(GS)3	C0596621
27297967	cell line	C0682523
27297967	Kinetic parameters	C0449381
27297967	As(GS)3	C0596621
27297967	HEK	C2936239
27297967	Asn19/23Gln-MRP1	C1451297
27297967	similar	C2348205
27297967	HeLa	C0018873
27297967	HEK	C2936239
27297967	SF-MRP1	C1451297
27297967	HeLa-WT	C0018873
27297967	MRP1	C1451297
27297967	single	C0205171
27297967	glycosylation	C0376322
27297967	mutants	C1564139
27297967	HEK-WT	C2936239
27297967	Mutation	C0026882
27297967	potential	C3245505
27297967	phosphorylation	C1158886
27297967	sites	C0205145
27297967	HEK	C2936239
27297967	Tyr920Phe/Ser921Ala-MRP1	C1451297
27297967	transported	C0005528
27297967	As(GS)3	C0596621
27297967	HeLa-WT	C0018873
27297967	MRP1	C1451297
27297967	HEK	C2936239
27297967	Tyr920Phe-	C1451297
27297967	Ser921Ala-MRP1	C1451297
27297967	mutants	C1564139
27297967	similar	C2348205
27297967	HEK-WT	C2936239
27297967	MRP1	C1451297
27297967	results	C0683954
27297967	Asn19/Asn23	C0002518
27297967	glycosylation	C0376322
27297967	Tyr920/Ser921	C0002518
27297967	phosphorylation	C1158886
27297967	altering	C0392747
27297967	kinetics	C2825046
27297967	MRP1	C1451297
27297967	As(GS)3	C0596621
27297967	transport	C0005528
27297967	kinetics	C2825046
27297967	As(GS)3	C0596621
27297967	transport	C0005528
27297967	HEK	C2936239
27297967	Asn19/23Gln/Tyr920Glu/Ser921Glu	C0002518
27297967	similar	C2348205
27297967	HEK-WT	C2936239
27297967	MRP1	C1451297
27297967	phosphorylation	C1158886
27297967	influence	C4054723
27297967	Asn19/23Gln	C0002518
27297967	glycosylation	C0376322
27297967	MRP1	C1451297
27297967	glycosylation	C0376322
27297967	phosphorylation	C1158886
27297967	phosphorylation	C1158886
27297967	Tyr920	C0002518
27297967	Ser921	C0002518
27297967	MRP1	C1451297
27297967	lower-affinity	C0205556
27297967	higher-capacity	C0205556
27297967	As(GS)3	C0596621
27297967	transporter	C0596902
27297967	arsenic	C0003818
27297967	detoxification	C4235382
27297967	broad	C0332464
27297967	concentration	C1446561
27297967	range	C1514721
27298278	Naphthohydroquinones	C1254351
27298278	naphthoquinones	C0027388
27298278	anthraquinones	C0003174
27298278	naphthohydroquinone	C1254351
27298278	dimer	C0596448
27298278	isolated	C0205409
27298278	aerial parts	C1136056
27298278	Morinda parvifolia	C1474894
27298278	cytotoxic effects	C0596402
27298278	up-regulation	C0162493
27298278	p53	C0079419
27298278	unknown	C0439673
27298278	compounds	C1254351
27298278	morindaparvins C-G	C1254351
27298278	naphthohydroquinones	C1254351
27298278	naphthoquinone	C0027388
27298278	anthraquinone	C0003174
27298278	naphthohydroquinone	C1254351
27298278	dimer	C0596448
27298278	quinones	C0034435
27298278	compounds	C1254351
27298278	isolated	C0205409
27298278	aerial parts	C1136056
27298278	Morinda parvifolia	C1474894
27298278	morindaparvins C	C1254351
27298278	D	C1254351
27298278	E	C1254351
27298278	F	C1254351
27298278	G	C1254351
27298278	spectroscopic	C0037812
27298278	X-ray diffraction analysis	C0599643
27298278	methyl 4-hydroxy-1,6-dimethoxy-naphthalene-2-carboxylate	C1254351
27298278	methyl 4,8-dihydroxy-1-methoxy-naphthalene-2-carboxylate	C1254351
27298278	3-amino-6-methoxy-2-methoxycarbonyl-1,4-naphthoquinone	C1254351
27298278	1,4-dihydroxy-7-hydroxymethyl-anthraquinone	C1254351
27298278	dimethyl 1,1'-dihydroxy-4,4',7,7'-tetramethoxy-2,2'-binaphthalene-3,3'-dicarboxylate	C1254351
27298278	Naphthoquinones	C0027388
27298278	naphthohydroquinone	C1254351
27298278	dimers	C0596448
27298278	unknown	C0439673
27298278	genus	C1708235
27298278	Morinda	C1010821
27298278	compounds	C1254351
27298278	tested	C0039593
27298278	cytotoxicity	C0596402
27298278	human	C0086418
27298278	cancer cell lines	C0085983
27298278	HeLa	C0018873
27298278	A2780	C0085983
27298278	Ketr3	C0085983
27298278	MCF-7	C0596890
27298278	effects	C1280500
27298278	p53	C0079419
27298278	activated	C1879547
27298278	transcription	C0040649
27298278	naphthoquinones	C0027388
27298278	moderate	C1881878
27298278	cytotoxic effects	C0596402
27298278	IC50	C0600495
27298278	ranging	C1514721
27298278	up-regulation	C0162493
27298278	p53	C0079419
27298278	transcriptional activity	C0162493
27299916	Identification	C0020792
27299916	SAR	C0038477
27299916	Evaluation	C0220825
27299916	Hemozoin	C0062496
27299916	Inhibiting	C3463820
27299916	Benzamides	C0005029
27299916	Active	C0205177
27299916	Plasmodium falciparum	C0032150
27299916	Quinoline	C0034423
27299916	antimalarials	C0003374
27299916	target	C1521840
27299916	hemozoin	C0062496
27299916	formation	C1522492
27299916	cytotoxic	C1511636
27299916	accumulation	C4055506
27299916	ferriprotoporphyrin IX	C0015877
27299916	Fe(III)PPIX	C0015877
27299916	SAR	C0038477
27299916	models	C3161035
27299916	β-hematin	C0062496
27299916	inhibition	C3463820
27299916	parasite	C0030498
27299916	activity	C0441655
27299916	cellular mechanisms	C1148560
27299916	compound class	C0456387
27299916	investigations	C0243095
27299916	hemozoin	C0062496
27299916	inhibiting	C3463820
27299916	chemotypes	C1254351
27299916	benzamide	C0053139
27299916	analogues	C0002776
27299916	HTS	C2718003
27299916	purchased	C0870238
27299916	synthesized	C1883254
27299916	derivatives containing an electron deficient aromatic ring	C0243072
27299916	flat conformations	C0026377
27299916	π-π interactions	C1704675
27299916	Fe(III)PPIX	C0015877
27299916	inhibited	C0311403
27299916	β-hematin	C0062496
27299916	formation	C1522492
27299916	analogues	C0002776
27299916	nanomolar	C0439282
27299916	parasite	C0030498
27299916	activity	C0441655
27299916	CQ	C0008269
27299916	cross-resistance	C2363980
27299916	cytotoxicity	C0596402
27299916	in vitro	C1533691
27299916	microsomal	C1979928
27299916	stability	C0205360
27299916	analogues	C0002776
27299916	inhibited	C0311403
27299916	hemozoin	C0062496
27299916	formation	C1522492
27299916	Plasmodium falciparum	C0032150
27299916	levels	C0441889
27299916	heme	C0018966
27299916	quinolines	C0034424
27299916	introduction	C0579004
27299916	amine side chains	C1254350
27299916	benzamide	C0053139
27299916	accumulation	C4055506
27299916	parasite	C0030498
27299916	data	C1511726
27299916	relationships	C0439849
27299916	heme binding	C1148616
27299916	heme	C0018966
27299916	levels	C0441889
27299916	cellular accumulation	C0007613
27299916	in vitro	C1533691
27299916	activity	C0441655
27299916	novel	C0205314
27299916	antimalarials	C0003374
27300947	Shear modulus	C0392762
27300947	structured	C0678594
27300947	electrorheological fluid	C1704353
27300947	mixtures	C0439962
27300947	immiscible blends	C0439861
27300947	electric field	C0337037
27300947	periodic	C0332182
27300947	structures	C0678594
27300947	electrodes	C0013812
27300947	shear	C3825679
27300947	structures	C0678594
27300947	tilt	C1711426
27300947	elastic	C0681018
27300947	electric energy	C0013790
27300947	two-dimensional	C0439534
27300947	stripe structure	C0678594
27300947	Maxwell stress	C0038442
27300947	expression	C2911684
27300947	shear modulus	C0392762
27300947	electric field	C0337037
27300947	composition	C1882370
27300947	dielectric properties	C0596437
27300947	blend	C0439861
27300947	interfacial tension	C2713544
27300947	effect of	C1704420
27300947	electric field	C0337037
27300947	derivation	C1441547
27300947	scaling law	C1947938
27300947	wavelength	C0449819
27300947	structure	C0678594
27300947	electric field	C0337037
27301681	Sequence-specific DNA binding	C1624609
27301681	long hairpin	C1254350
27301681	pyrrole-imidazole polyamides	C0029224
27301681	8-amino-3,6-dioxaoctanoic acid	C0029224
27301681	aqueous solubility	C0597682
27301681	designed	C1707689
27301681	synthesized	C1883254
27301681	N-methylpyrrole (Py)-N-methylimidazole (Im) polyamides	C0029224
27301681	9-bp sequences	C0004793
27301681	DNA-binding	C1148673
27301681	affinities	C1510827
27301681	sequence	C0004793
27301681	specificities	C0037791
27301681	SPR	C0597731
27301681	Bind-n-Seq analyses	C0936012
27301681	design	C1707689
27301681	polyamide 1	C0029224
27301681	model	C3161035
27301681	Py	C0383659
27301681	Im	C0044472
27301681	β-alanine	C0000392
27301681	twist	C0231467
27301681	DNA	C0012854
27301681	helices	C1254362
27301681	Polyamides 2 and 3	C0029224
27301681	8-amino-3,6-dioxaoctanoic acid	C0029224
27301681	AO	C0029224
27301681	linker	C0029224
27301681	Py-Im polyamides	C0029224
27301681	Py	C0383659
27301681	Py - Im hairpin motifs	C1254350
27301681	Im	C0044472
27301681	tandem hairpin	C1254350
27301681	AO	C0029224
27301681	linker element	C0029224
27301681	2-bp	C0004793
27301681	hairpin motifs	C1254350
27301681	AO	C0029224
27301681	fail	C0231175
27301681	bind	C1145667
27301681	sequence	C0004793
27301681	polyamide 4	C0029224
27301681	AO	C0029224
27301681	hairpin form	C1254362
27301681	motif	C1254362
27301681	KD value	C0392762
27301681	Polyamide 5	C0029224
27301681	β-alanine-β-alanine	C0000392
27301681	AO	C0029224
27301681	polyamide 2	C0029224
27301681	synthesized	C1883254
27301681	comparison	C1707455
27301681	aqueous solubilities	C0597682
27301681	nuclear localization	C1659087
27301681	polyamides	C0029224
27301681	results	C1274040
27301681	AO	C0029224
27301681	core	C0444669
27301681	Py-Im polyamide compounds	C0029224
27304832	Causes of Death	C0007465
27304832	Children	C0008059
27304832	Aged	C0001779
27304832	Years	C1510829
27304832	Old	C0580836
27304832	Ethiopia	C0015024
27304832	mortality among children	C0008083
27304832	trend	C1521798
27304832	improvements	C2986411
27304832	living standard	C0080190
27304832	challenges	C0805586
27304832	children	C0008059
27304832	African countries	C0454695
27304832	Sub-Saharan Africa	C0001738
27304832	global	C2348867
27304832	child mortality	C0008083
27304832	objective	C0018017
27304832	magnitude	C1704240
27304832	distribution	C1704711
27304832	causes of death	C0007465
27304832	children	C0008059
27304832	aged	C0001779
27304832	population	C1257890
27304832	verbal	C0439824
27304832	autopsy	C0004398
27304832	period	C1948053
27304832	September	C3828193
27304832	rural	C0178837
27304832	urban	C0178876
27304832	kebeles	C1257890
27304832	kebeles	C1257890
27304832	district	C0001567
27304832	data	C1511726
27304832	Kersa HDSS database	C0282574
27304832	study	C2603343
27304832	population	C1257890
27304832	children	C0008059
27304832	aged	C0001779
27304832	period	C1948053
27304832	age	C0001779
27304832	questionnaires	C0034394
27304832	Data	C1511726
27304832	SPSS database	C0282574
27304832	STATA	C0282574
27304832	deaths	C1306577
27304832	period	C1948053
27304832	death rate	C0205848
27304832	population	C1257890
27304832	age group	C0027362
27304832	study	C2603343
27304832	period	C1948053
27304832	death rate	C0205848
27304832	populations	C1257890
27304832	females	C0086287
27304832	males	C0086582
27304832	deaths	C1306577
27304832	study	C2603343
27304832	malnutrition	C0162429
27304832	intestinal infectious diseases	C0178238
27304832	acute lower respiratory infections	C0238990
27304832	causes of death	C0007465
27304832	causes of death	C0007465
27304832	classification	C0008902
27304832	injuries	C0043251
27304832	cause of death	C0007465
27304832	communicable diseases	C0009450
27304832	deaths	C1306577
27304832	causes of death	C0007465
27304832	classification	C0008902
27304832	malnutrition	C0162429
27304832	intestinal infectious diseases	C0178238
27304832	acute lower respiratory infections	C0238990
27304832	causes of death	C0007465
27304832	causes of death	C0007465
27304832	communicable diseases	C0009450
27304832	injuries	C0043251
27304832	causes of death	C0007465
27304832	mortality	C0008083
27304832	causes of death	C0007465
27304832	inferential analysis	C0936012
27304832	prevention	C0033144
27304832	management	C0376636
27304832	infectious diseases	C0009450
27306834	Naïve	C3641721
27306834	CD8(+) T cell	C0242629
27306834	tumor	C0027651
27306834	specific	C0205369
27306834	cytotoxic effectors	C3641722
27306834	remedy	C1880198
27306834	TGF-β	C0040690
27306834	immunosuppression	C4048329
27306834	tumor microenvironment	C2936626
27306834	cancer immunotherapy	C0278348
27306834	conventional	C0439858
27306834	approaches	C1292724
27306834	in vitro	C1533691
27306834	expanded	C0205229
27306834	CD8(+) T cells	C0242629
27306834	suboptimal	C2984009
27306834	outcomes	C0085415
27306834	loss	C1517945
27306834	functionality	C0542341
27306834	cellular	C0007634
27306834	exhaustion	C0678684
27306834	phenotypic	C0031437
27306834	functional	C0205245
27306834	differences	C1705242
27306834	in vitro	C1533691
27306834	activated	C1879547
27306834	CD8(+) T cells	C0242629
27306834	sources	C0449416
27306834	naïve	C3641721
27306834	NTeff	C3641721
27306834	memory	C0682639
27306834	MTeff	C0682639
27306834	tumor-infiltrating lymphocytes	C0079722
27306834	TILeff	C0079722
27306834	human	C0086418
27306834	mice	C0025929
27306834	mechanisms	C0441712
27306834	effector	C3641722
27306834	functions	C0542341
27306834	limitations	C0449295
27306834	proliferation	C0596873
27306834	activity	C0441655
27306834	telomere	C0085187
27306834	lengths	C1444754
27306834	NTeff populations	C3641721
27306834	cells	C0007634
27306834	naïve origin	C0439659
27306834	T cell	C0039194
27306834	exhaustion	C0678684
27306834	markers	C0005516
27306834	MTeff	C0682639
27306834	TILeff	C0079722
27306834	expression patterns	C1171362
27306834	memory-promoting transcription factors	C0040648
27306834	T-bet	C0913648
27306834	Eomes	C1454790
27306834	induced	C0205263
27306834	rapid	C0456962
27306834	sustainable	C0443318
27306834	manner	C0205245
27306834	NTeff cells	C3641721
27306834	expression	C1171362
27306834	Foxp1	C3273485
27306834	apoptosis	C0162638
27306834	TGF-β	C0040690
27306834	conditioning	C0205245
27306834	survival	C0007620
27306834	potential	C3245505
27306834	resistance	C4281815
27306834	tumor	C0027651
27306834	induced	C0205263
27306834	immune suppression	C4048329
27306834	CD8(+) T cell	C0242629
27306834	activated	C1879547
27306834	tumor	C0027651
27306834	specific	C0205369
27306834	CTLs	C0039195
27306834	naïve cell	C3641721
27306834	generated	C3146294
27306834	effectors	C3641722
27306834	cytotoxic activity	C0243095
27306834	design	C1707689
27306834	adoptive immunotherapy	C0079613
27309274	Antiadipogenic Activity	C0243095
27309274	γ-Oryzanol	C0061081
27309274	Stability	C0205360
27309274	Pigmented	C0333610
27309274	Rice	C0035567
27309274	γ-Oryzanol	C0061081
27309274	pigmented	C0333610
27309274	rice	C0035567
27309274	varieties	C0332307
27309274	obesity-associated metabolic disorders	C1285391
27309274	Antiadipogenic activities	C0243095
27309274	γ-oryzanol	C0061081
27309274	human	C0086418
27309274	adipose	C0001527
27309274	derived	C1550535
27309274	mesenchymal stem cells	C1257975
27309274	mouse	C1522424
27309274	derived	C1550535
27309274	3T3-L1 cells	C1257743
27309274	γ-Oryzanol	C0061081
27309274	decreased	C0205216
27309274	lipid accumulation	C3810056
27309274	reduced	C0392756
27309274	glycerol-3-phosphate dehydrogenase activities	C1151278
27309274	adipocytes	C0206131
27309274	γ-oryzanol	C0061081
27309274	pigmented	C0333610
27309274	rice	C0035567
27309274	varieties	C0332307
27309274	black with giant embryo	C0035567
27309274	brown	C0452710
27309274	sugary brown	C0035567
27309274	red	C0452711
27309274	stable	C0205360
27309274	stored	C1698986
27309274	room temperature	C2348236
27309274	bioactives	C3714412
27309274	lutein	C0043328
27309274	β-carotene	C0053396
27309274	stable	C0205360
27309274	yield	C1265611
27309274	γ-oryzanol	C0061081
27309274	rice	C0035567
27309274	varieties	C0332307
27309274	steaming	C1522240
27309274	roasting processes	C1522240
27309274	γ-oryzanol	C0061081
27309274	antiadipogenic activity	C0243095
27309274	suppressing	C1260953
27309274	adipocyte differentiations	C1159884
27309274	stable	C0205360
27309274	pigmented	C0333610
27309274	rice	C0035567
27309274	extended	C0231448
27309274	period of time	C1948053
27309274	storage	C1698986
27309274	after	C0687676
27309274	cooking	C0335326
27309274	intake	C1512806
27309274	pigmented	C0333610
27309274	rice	C0035567
27309274	preventing	C1292733
27309274	obesity	C0028754
27310615	Impact	C4049986
27310615	Chemotherapy	C3665472
27310615	Diet	C0012155
27310615	Nutritional Status	C0392209
27310615	Women	C0043210
27310615	Breast Cancer	C0006142
27310615	Prospective Study	C0033522
27310615	food groups	C0016452
27310615	rejected	C1548437
27310615	chemotherapy	C3665472
27310615	CT	C3665472
27310615	side effects of treatment	C0879626
27310615	interfere with	C0521102
27310615	adequate diet	C0547809
27310615	nutritional status	C0392209
27310615	study	C2603343
27310615	evaluate	C0220825
27310615	treatment	C0039798
27310615	impact	C4049986
27310615	diet	C0012155
27310615	nutritional status	C0392209
27310615	women	C0043210
27310615	breast cancer	C0006142
27310615	BC	C0006142
27310615	prospective longitudinal study	C0033522
27310615	women	C0043210
27310615	BC	C0006142
27310615	age	C0001779
27310615	years	C0439234
27310615	data	C1511726
27310615	Anthropometric	C0815129
27310615	dietary assessments	C0814244
27310615	dietary recall	C0566508
27310615	Brazilian Healthy Eating Index Revised	C0282574
27310615	BHEI-R	C0282574
27310615	calculating	C1441506
27310615	prevalence	C0220900
27310615	inadequacy	C0205412
27310615	EAR cut-off point method	C0282574
27310615	BHEI-R	C0282574
27310615	analysis	C0936012
27310615	women	C0043210
27310615	diet	C0012155
27310615	modification	C3840684
27310615	beginning	C0439659
27310615	during treatment	C2709058
27310615	CT	C3665472
27310615	greater percentage	C0439165
27310615	patients	C0030705
27310615	inadequate diet	C0522060
27310615	Total	C0439810
27310615	Fruit	C0016767
27310615	consumption	C0441655
27310615	Dark Green	C2348898
27310615	Orange Vegetable	C0016452
27310615	Legume	C0023263
27310615	consumption	C0441655
27310615	decreased significantly	C0205216
27310615	during treatment	C2709058
27310615	significant reduction	C0392756
27310615	intake	C1512806
27310615	macro	C2346926
27310615	micronutrients	C0282575
27310615	prevalence	C0220900
27310615	inadequacy	C0205412
27310615	calcium	C0006726
27310615	iron	C0376520
27310615	phosphorus	C0080014
27310615	magnesium	C2348270
27310615	niacin	C0027996
27310615	riboflavin	C0035527
27310615	thiamin	C0039840
27310615	vitamin B6	C0087162
27310615	vitamin C	C0003968
27310615	zinc	C2348288
27310615	Assessment	C0028708
27310615	nutritional status	C0392209
27310615	patients	C0030705
27310615	overweight	C0497406
27310615	Weight	C0005910
27310615	BMI	C1305855
27310615	Waist Circumference	C0455829
27310615	increased significantly	C0205217
27310615	worse	C1457868
27310615	nutritional status	C0392209
27310615	correlation	C1707520
27310615	poor diet quality	C0332306
27310615	higher values	C0042295
27310615	BMI	C1305855
27310615	Waist-Hip Ratio	C0205682
27310615	Waist-to-Height Ratio	C1821269
27310615	Chemotherapy	C3665472
27310615	interferes	C0521102
27310615	patients	C0030705
27310615	diet	C0012155
27310615	negative impact	C4049986
27310615	quality	C0332306
27310615	intake	C1512806
27310615	micro	C0282575
27310615	macronutrients	C2346926
27310615	impact	C4049986
27310615	nutritional status	C0392209
27310615	anthropometric measurements	C0815129
27311447	risk	C0035649
27311447	total hip arthroplasty	C0040508
27311447	direct anterior approach	C0205511
27311447	dual mobility cup	C0025080
27311447	risks	C0035649
27311447	dual mobility cup	C0025080
27311447	DMC	C0025080
27311447	THA	C0040508
27311447	direct anterior approach	C0205511
27311447	DAA	C0205511
27311447	study	C2603343
27311447	safety	C1705187
27311447	postoperative complication	C0032787
27311447	DAA	C0205511
27311447	DMC	C0025080
27311447	THA	C0040508
27311447	DAA	C0205511
27311447	single standard cup	C0025080
27311447	DMC	C0025080
27311447	intra	C0456904
27311447	perioperative	C1518988
27311447	outcomes	C1274040
27311447	hips	C0019552
27311447	treated	C0087111
27311447	DAA	C0205511
27311447	group	C0441833
27311447	hips	C0019552
27311447	treated	C0087111
27311447	DAA	C0205511
27311447	group	C0441833
27311447	primary	C0205225
27311447	secondary	C0205436
27311447	outcome	C1274040
27311447	intra	C0021890
27311447	perioperative	C1518988
27311447	complication	C0009566
27311447	months	C0439231
27311447	operative time	C3494201
27311447	months	C0439231
27311447	postoperatively	C0032790
27311447	DMC	C0025080
27311447	intra	C0456904
27311447	perioperative	C1518988
27311447	outcomes	C1274040
27311447	No	C1513916
27311447	intraoperative complications	C0021890
27311447	group	C0441833
27311447	anterior dislocation	C1265658
27311447	periprosthetic hip fracture	C4040051
27311447	DAA	C0205511
27311447	group	C0441833
27311447	surgical times	C3494201
27311447	DAA	C0205511
27311447	DAA	C0205511
27311447	groups	C0441833
27311447	month	C0439231
27311447	postoperative	C0032790
27311447	hip function scores	C0449820
27311447	groups	C0441833
27311447	DMC	C0025080
27311447	intra	C0456904
27311447	perioperative	C1518988
27311447	outcomes	C1274040
27311447	safety	C1705187
27311447	DMC	C0025080
27311447	DAA	C0205511
27311447	standard single mobility cup	C0025080
27317610	Diffuse traumatic brain injury	C2832047
27317610	chronic	C0205191
27317610	corticosterone	C0010124
27317610	function	C0542341
27317610	rat	C0034721
27317610	patients	C0030705
27317610	history	C0332119
27317610	traumatic brain injury	C0876926
27317610	TBI	C0876926
27317610	chronic	C0205191
27317610	endocrine dysfunction	C1397856
27317610	impaired quality of life	C4049260
27317610	impaired	C0221099
27317610	rehabilitation	C0034992
27317610	efforts	C1516084
27317610	lowered life expectancy	C1504437
27317610	Endocrine dysfunction	C1397856
27317610	TBI	C0876926
27317610	result	C1274040
27317610	acceleration	C0000894
27317610	deceleration	C0011100
27317610	forces	C0441722
27317610	brain	C0006104
27317610	skull	C2951888
27317610	hypothalamic	C0020663
27317610	pituitary	C0032005
27317610	neuropathology	C1540677
27317610	hypothalamic	C0020663
27317610	hypothalamic -pituitary endocrine	C0014136
27317610	HPE	C0014136
27317610	dysfunction	C0277785
27317610	experiments	C0681814
27317610	hypothesis	C1512571
27317610	diffuse TBI	C2832047
27317610	results	C1274040
27317610	chronic	C0205191
27317610	dysfunction	C0277785
27317610	corticosterone	C0010124
27317610	CORT	C0010124
27317610	glucocorticoid	C0017710
27317610	released	C0391871
27317610	stress	C0449430
27317610	testosterone	C0039601
27317610	rodent model	C1519106
27317610	diffuse TBI	C2832047
27317610	midline fluid percussion injury	C3714660
27317610	mFPI	C3714660
27317610	months	C0439231
27317610	postinjury	C1254367
27317610	compared	C1707455
27317610	uninjured control animals	C1511501
27317610	circulating	C0175630
27317610	levels	C0441889
27317610	CORT	C0010124
27317610	at rest	C0443144
27317610	restraint stress	C0449430
27317610	dexamethasone	C0011777
27317610	synthetic glucocorticoid	C0017711
27317610	HPE	C0014136
27317610	axis	C1522496
27317610	regulation	C1327622
27317610	Testosterone	C0039601
27317610	evaluated	C1292732
27317610	at rest	C0443144
27317610	changes	C0392747
27317610	injury	C3714660
27317610	induced	C0205263
27317610	neuron	C0027882
27317610	morphology	C0332437
27317610	Golgi stain	C0487602
27317610	neuropathology	C1540677
27317610	silver stain	C0487602
27317610	activated	C1326120
27317610	astrocytes	C0004112
27317610	GFAP	C0487602
27317610	paraventricular nucleus	C0030532
27317610	PVN	C0030532
27317610	hypothalamus	C0020663
27317610	plasma	C0032105
27317610	CORT	C0010124
27317610	levels	C0441889
27317610	decreased	C0205216
27317610	months	C0439231
27317610	postinjury	C1254367
27317610	CORT	C0010124
27317610	increase	C0205217
27317610	restraint induced stress	C0449430
27317610	No changes	C0442739
27317610	testosterone	C0039601
27317610	measured	C0444706
27317610	changes	C0392747
27317610	CORT	C0010124
27317610	concomitantly	C0521115
27317610	altered	C0392747
27317610	complexity	C0439855
27317610	neuron	C0027882
27317610	processes	C0007613
27317610	PVN	C0030532
27317610	time	C0040223
27317610	neuropathology	C1540677
27317610	astrocytosis	C3887640
27317610	Results	C1274040
27317610	diffuse TBI	C2832047
27317610	changes	C0392747
27317610	CORT	C0010124
27317610	function	C0542341
27317610	persistence of symptoms	C0518691
27317610	endocrine dysfunction	C1397856
27317610	experiments	C0681814
27317610	evaluate	C1292732
27317610	HP-related hormones	C0019932
27317610	endocrine	C0014136
27317610	circuit pathology	C0205469
27317610	diffuse TBI	C2832047
27320055	Methamphetamine	C0025611
27320055	3,4-methylenedioxymethamphetamine	C0115471
27320055	MDMA	C0115471
27320055	3,4-methylenedioxypyrovalerone	C2974592
27320055	MDPV	C2974592
27320055	induce	C0205263
27320055	differential	C0443199
27320055	cytotoxic effects	C0596402
27320055	bovine	C0007452
27320055	brain	C0006104
27320055	microvessel	C2350570
27320055	endothelial cells	C0225336
27320055	Designer drugs	C0011684
27320055	synthetic psychostimulants	C0304403
27320055	problem	C0033213
27320055	drug abuse	C0013146
27320055	addiction	C1510472
27320055	methamphetamine	C0025611
27320055	METH	C0025611
27320055	drugs	C0011684
27320055	3,4-methylenedioxy-methamphetamine	C0115471
27320055	MDMA	C0115471
27320055	commercial	C0680536
27320055	preparations	C1521827
27320055	synthetic cathinones	C0054876
27320055	3,4-methylenedioxypyrovalerone	C2974592
27320055	MDPV	C2974592
27320055	bath salts	C0771243
27320055	psychostimulants	C0304403
27320055	neurotoxic effects	C0235032
27320055	altering	C1515926
27320055	monoamine systems	C0815020
27320055	brain	C0006104
27320055	METH	C0025611
27320055	MDMA	C0115471
27320055	adversely affect	C0879626
27320055	integrity	C1947912
27320055	blood-brain barrier	C0005854
27320055	BBB	C0005854
27320055	reports	C0684224
27320055	effects of	C1704420
27320055	MDPV	C2974592
27320055	BBB	C0005854
27320055	study	C2603343
27320055	compare	C1707455
27320055	effects of	C1704420
27320055	METH	C0025611
27320055	MDMA	C0115471
27320055	MDPV	C2974592
27320055	bovine	C0007452
27320055	brain	C0006104
27320055	microvessel	C2350570
27320055	endothelial cells	C0225336
27320055	bBMVECs	C0225336
27320055	in vitro model	C1515654
27320055	BBB	C0005854
27320055	Confluent	C0205200
27320055	bBMVEC	C0225336
27320055	monolayers	C0934502
27320055	treated	C1522326
27320055	METH	C0025611
27320055	MDMA	C0115471
27320055	MDPV	C2974592
27320055	METH	C0025611
27320055	MDMA	C0115471
27320055	increased	C0205217
27320055	lactate dehydrogenase	C0022917
27320055	release	C1283071
27320055	highest	C1522410
27320055	concentration	C1446561
27320055	MDPV	C2974592
27320055	induced	C0205263
27320055	cytotoxicity	C0596402
27320055	concentration	C1446561
27320055	MDMA	C0115471
27320055	METH	C0025611
27320055	decreased	C0205216
27320055	cellular proliferation	C0596290
27320055	effects	C1280500
27320055	MDPV	C2974592
27320055	exposures	C0332157
27320055	MDPV	C2974592
27320055	increased	C0205217
27320055	reactive oxygen species	C0162772
27320055	production	C1883254
27320055	concentrations	C1446561
27320055	tested	C0039593
27320055	drugs	C0011684
27320055	increased	C0205217
27320055	nitric oxide	C0028128
27320055	production	C1883254
27320055	Morphological analysis	C0936012
27320055	different	C1705242
27320055	compound	C1706082
27320055	induced	C0205263
27320055	cell damage	C0599732
27320055	METH	C0025611
27320055	induced	C0205263
27320055	vacuole	C0042219
27320055	formatio	C1522492
27320055	disruption	C0332453
27320055	monolayer	C0934502
27320055	MDMA	C0115471
27320055	induced	C0205263
27320055	disruption	C0332453
27320055	endothelial	C0225336
27320055	monolayer	C0934502
27320055	vacuolization	C0010840
27320055	MDPV	C2974592
27320055	induced	C0205263
27320055	monolayer	C0934502
27320055	disruption	C0332453
27320055	doses	C0178602
27320055	vacuole	C0042219
27320055	formation	C1522492
27320055	cells	C0007634
27320055	endothelial morphology	C0332437
27320055	data	C1511726
27320055	synthetic psychostimulants	C0304403
27320055	monoaminergic systems	C0815020
27320055	induce	C0205263
27320055	BBB	C0005854
27320055	toxicity	C0013221
27320055	different	C1705242
27320055	mechanisms	C0441712
27320055	MDPV	C2974592
27320055	toxic	C1407029
27320863	Alleviation	C0392756
27320863	hepatic	C0205054
27320863	fat accumulation	C0333574
27320863	betaine	C0005304
27320863	reduction	C0392756
27320863	homocysteine	C0019878
27320863	up-regulation	C0041904
27320863	betaine-homocysteine methyltransferase	C0053518
27320863	BHMT	C0053518
27320863	investigated	C1292732
27320863	anti-lipogenic effect	C0205245
27320863	betaine	C0005304
27320863	rats	C0086893
27320863	methionine	C0025646
27320863	choline	C0008405
27320863	deficient	C0332268
27320863	diet	C0012155
27320863	MCD	C0012155
27320863	MCD	C0012155
27320863	significant	C0750502
27320863	accumulation	C0333574
27320863	hepatic	C0205054
27320863	lipids	C0023779
27320863	prevented	C2700409
27320863	betaine	C0005304
27320863	supplementation	C0242297
27320863	drinking water	C0599638
27320863	Phosphorylation	C1158886
27320863	AMP-activated protein kinase	C2350345
27320863	AMPK	C2350345
27320863	acetyl-CoA carboxylase	C0001022
27320863	ACC	C0001022
27320863	sterol regulatory element-binding protein 1c	C0537474
27320863	SREBP-1c	C0537474
27320863	liver kinase B1	C1431123
27320863	LKB1	C1431123
27320863	inhibited	C0311403
27320863	MCD	C0012155
27320863	intake	C1512806
27320863	inhibited	C0311403
27320863	betaine	C0005304
27320863	feeding	C3714845
27320863	betaine	C0005304
27320863	supplementation	C0242297
27320863	reversed	C1555029
27320863	reduction	C0392756
27320863	methionine and S-adenosylmethionine	C1325080
27320863	SAM	C1325080
27320863	elevation	C3163633
27320863	homocysteine levels	C2242817
27320863	liver,	C0023884
27320863	induction	C0014431
27320863	betaine-homocysteine methyltransfease	C0053518
27320863	BHMT	C0053518
27320863	methionine adenosyltransferase	C0025647
27320863	MAT	C0025647
27320863	Different	C1705242
27320863	cell lines	C0007634
27320863	homocysteine	C0019878
27320863	activation	C0014429
27320863	AMPK	C2350345
27320863	pathway	C0598390
27320863	Homocysteine	C0019878
27320863	treatment	C1522326
27320863	decreased	C0205216
27320863	pAMPK	C2350345
27320863	pACC	C0001022
27320863	pSREBP-1c	C0537474
27320863	pLKB1	C1431123
27320863	HepG2 cells	C2717940
27320863	Metformin	C0025598
27320863	induced	C0205263
27320863	activation	C0014429
27320863	AMPK	C2350345
27320863	inhibited	C0311403
27320863	homocysteine	C0019878
27320863	Treatment	C1522326
27320863	hydroxylamine	C0020362
27320863	cystathionine β-synthase	C0010641
27320863	inhibitor	C0014432
27320863	reduction	C0392756
27320863	pAMPK	C2350345
27320863	pACC	C0001022
27320863	pSREBP-1c	C0537474
27320863	elevation	C3163633
27320863	intracellular	C0178719
27320863	homocysteine	C0019878
27320863	Betaine	C0005304
27320863	treatment	C0087111
27320863	prevented	C2700409
27320863	homocysteine	C0019878
27320863	induced	C0205263
27320863	reduction	C0392756
27320863	pAMPK	C2350345
27320863	pACC	C0001022
27320863	pSREBP-1c	C0537474
27320863	pLKB1	C1431123
27320863	H4IIE cells	C0007634
27320863	HepG2 cells	C2717940
27320863	elevation	C3163633
27320863	homocysteine	C0019878
27320863	inhibition	C3463820
27320863	protein expression	C1171362
27320863	BHMT	C0053518
27320863	prevented	C2700409
27320863	betaine	C0005304
27320863	H4IIE cells	C0007634
27320863	express	C1171362
27320863	BHMT	C0053518
27320863	betaine	C0005304
27320863	hepatic	C0205054
27320863	lipid	C0023779
27320863	accumulation	C0333574
27320863	attributed	C0449234
27320863	depletion	C0333668
27320863	homocysteine	C0019878
27320863	up-regulation	C0041904
27320863	BHMT	C0053518
27320863	hepatocytes	C0227525
27321892	Dual-color STED microscopy	C0026018
27321892	sandwich structure	C0678594
27321892	Bassoon	C1454967
27321892	Piccolo	C1452991
27321892	active zones	C3541837
27321892	adult	C0001675
27321892	aged	C0001779
27321892	mice	C0025929
27321892	Presynaptic active zones	C3541837
27321892	synaptic vesicle	C0039065
27321892	release sites	C0005898
27321892	synaptic transmission	C0027793
27321892	molecular architecture	C1254362
27321892	active zones	C3541837
27321892	mammalian	C0024660
27321892	neuromuscular junctions	C0027869
27321892	NMJs	C0027869
27321892	sub-diffraction limited resolution	C2699488
27321892	Bassoon	C1454967
27321892	Piccolo	C1452991
27321892	active zone	C3541837
27321892	cytosolic	C1383501
27321892	proteins	C0033684
27321892	active zone assembly	C3896009
27321892	NMJs	C0027869
27321892	ribbon synapses	C1179874
27321892	brain	C0006104
27321892	synapses	C0039062
27321892	proteins	C0033684
27321892	colocalize	C0392752
27321892	active zones	C3541837
27321892	non-overlapping localization	C0597704
27321892	proteins	C0033684
27321892	mouse	C0025929
27321892	NMJs	C0027869
27321892	dual-color stimulated emission depletion	C1254365
27321892	STED	C1254365
27321892	super resolution microscopy	C0026018
27321892	Piccolo	C1452991
27321892	puncta	C0243095
27321892	Bassoon	C1454967
27321892	puncta	C0243095
27321892	aligned	C1706765
27321892	Piccolo	C1452991
27321892	Bassoon	C1454967
27321892	Piccolo	C1452991
27321892	structure	C0678594
27321892	adult	C0001675
27321892	NMJs	C0027869
27321892	P/Q-type voltage-gated calcium channel	C0814022
27321892	VGCC	C0814022
27321892	puncta	C0243095
27321892	colocalized	C0392752
27321892	Bassoon	C1454967
27321892	puncta	C0243095
27321892	P/Q-type VGCC	C0814022
27321892	Bassoon	C1454967
27321892	protein levels	C0428479
27321892	decreased	C0205216
27321892	NMJs	C0027869
27321892	aged	C0001779
27321892	mouse	C0025929
27321892	Piccolo	C1452991
27321892	levels	C0428479
27321892	NMJs	C0027869
27321892	aged	C0001779
27321892	mice	C0025929
27321892	levels	C0428479
27321892	adult	C0001675
27321892	mice	C0025929
27321892	molecular architecture	C1254362
27321892	active zones	C3541837
27321892	mouse	C0025929
27321892	NMJs	C0027869
27321892	sub-diffraction limited resolution	C2699488
27321892	selective degeneration mechanism	C0007613
27321892	active zone	C3541837
27321892	proteins	C0033684
27321892	NMJs	C0027869
27321892	aged	C0001779
27321892	mice	C0025929
27321892	localization pattern	C0597704
27321892	active zone	C3541837
27321892	proteins	C0033684
27321892	active zone	C3541837
27321892	structures	C0678594
27321892	electron microscope tomography	C2350255
27325393	Molecular	C1521991
27325393	serum	C0229671
27325393	signature	C0005516
27325393	treatment resistant depression	C2063866
27325393	major depressive disorder	C1269683
27325393	MDD	C1269683
27325393	multiple	C0439064
27325393	trials	C0008976
27325393	anti-depressants	C0003289
27325393	chronic	C0205191
27325393	course of disease	C0242656
27325393	treatment	C0087111
27325393	resistant	C1514892
27325393	molecular	C1521991
27325393	changes	C0392747
27325393	treatment-resistant depression	C2063866
27325393	TRD	C2063866
27325393	genes	C0017337
27325393	biomarkers	C0005516
27325393	TRD	C2063866
27325393	high-throughput proteomic platforms	C0872252
27325393	peripheral	C0205100
27325393	biomarkers	C0005516
27325393	TRD	C2063866
27325393	staging models	C0449394
27325393	Thase and Rush staging model	C0449394
27325393	TRM	C0449394
27325393	Maudsley Staging Model	C0449394
27325393	MSM	C0449394
27325393	Serum	C0229671
27325393	inpatient	C0021562
27325393	individuals	C0027361
27325393	MDD	C1269683
27325393	mass spectrometric-based platforms	C0037813
27325393	label-free liquid chromatography mass spectrometry	C0872318
27325393	LC-MS(E)	C0872318
27325393	selective reaction monitoring	C2826902
27325393	SRM	C2826902
27325393	multiplex bead based assay	C0020980
27325393	LC-MS(E) analysis	C0872318
27325393	proteins	C0033684
27325393	acute phase response	C0001349
27325393	complement activation	C0009528
27325393	coagulation	C1328723
27325393	staging groups	C0449394
27325393	models	C0449394
27325393	multiplex bead-based assay	C0020980
27325393	TNF-α levels	C1168005
27325393	log(odds)	C0023956
27325393	significantly	C0237881
27325393	different	C1705242
27325393	TRM	C0449394
27325393	comparison	C1707455
27325393	SRM	C2826902
27325393	significant	C0237881
27325393	changes	C0392747
27325393	apolipoproteins A-I	C0085201
27325393	M	C1438565
27325393	F	C0052208
27325393	TRM	C0449394
27325393	MSM	C0449394
27325393	findings	C0243095
27325393	proteins	C0033684
27325393	immune	C1155000
27325393	complement activation	C0009528
27325393	biomarkers	C0005516
27325393	clinicians	C0871685
27325393	high-risk	C0332167
27325393	patients	C0030705
27325393	molecular	C1521991
27325393	changes	C0392747
27325393	staging groups	C0449394
27325393	interpreted	C1285553
27325547	study	C2603343
27325547	fine-mode aerosol	C0001712
27325547	big urban area	C0814837
27325547	relevant doses	C0178602
27325547	deposited	C0333562
27325547	human	C0086418
27325547	respiratory tract	C0282335
27325547	health	C0018684
27325547	effects	C1280500
27325547	PM	C1510837
27325547	particle size	C0030608
27325547	UltraFine Particles	C0597177
27325547	UFPs	C0597177
27325547	fraction of	C1264633
27325547	atmospheric	C0004178
27325547	aerosol	C0001712
27325547	Rome	C0035831
27325547	levels	C0441889
27325547	PM2.5	C1510837
27325547	PM10	C1510837
27325547	PM2.5	C1510837
27325547	submicron particles	C0597177
27325547	great urban area	C0814837
27325547	daytime	C0332169
27325547	nighttime	C3844540
27325547	work-	C0680192
27325547	weekdays	C0680189
27325547	cold	C0009264
27325547	hot	C2350229
27325547	seasonal trends	C0036497
27325547	submicron particles	C0597177
27325547	NOx	C0028167
27325547	PAH	C0032458
27325547	UFPs	C0597177
27325547	combustion processes	C1522240
27325547	dose	C0178602
27325547	submicron particles	C0597177
27325547	deposited	C0333562
27325547	respiratory system	C0035237
27325547	head	C0018670
27325547	tracheobronchial	C0458580
27325547	alveolar regions	C1440080
27325547	lung lobes	C0225752
27325547	Dosimeter	C0180488
27325547	estimates	C0750572
27325547	Multiple-Path Particle Dosimetry model	C3161035
27325547	MPPD v.2.1	C3161035
27325547	aerosol	C0001712
27325547	doses	C0178602
27325547	deposited	C0333562
27325547	respiratory system	C0035237
27325547	individuals	C0237401
27325547	exposed	C0332157
27325547	traffic	C3840880
27325547	traffic	C3840880
27325547	hours	C0439227
27325547	particles	C0597177
27325547	deposited	C0333562
27325547	respiratory system	C0035237
27325547	dose	C0178602
27325547	UFPs	C0597177
27325547	dose	C0178602
27325547	estimated	C0750572
27325547	right lung lobes	C0446959
27325547	susceptible	C0231204
27325547	respiratory	C0521346
27325547	pathologies	C0677042
27325547	left lobes	C0446960
27326810	International Liver Transplant Society Practice Guidelines	C0162791
27326810	Diagnosis	C0011900
27326810	Management	C0376636
27326810	Hepatopulmonary Syndrome	C0600452
27326810	Portopulmonary Hypertension	C1868851
27326810	pulmonary vascular disorders	C0854416
27326810	hepatopulmonary syndrome	C0600452
27326810	HPS	C0600452
27326810	portopulmonary hypertension	C1868851
27326810	POPH	C1868851
27326810	consequence of	C0686907
27326810	hepatic parenchymal	C0736268
27326810	vascular abnormalities	C0241657
27326810	HPS	C0600452
27326810	POPH	C1868851
27326810	clinical	C0205210
27326810	implications	C0243095
27326810	liver transplantation	C0023911
27326810	European Respiratory Society Task Force	C0162458
27326810	Pulmonary-Hepatic Disorders	C0012634
27326810	diagnosis	C0011900
27326810	guide management	C0162791
27326810	disorders	C0012634
27326810	International Liver Transplant Society diagnostic and management guidelines	C0162791
27326810	task force	C0162458
27326810	clinical	C0205210
27326810	HPS	C0600452
27326810	POPH	C1868851
27326810	MEDLINE search	C0242356
27326810	clinical guidelines	C0282451
27326810	selected single care reports	C0700287
27326810	small series	C0205549
27326810	registries	C0034975
27326810	databases	C0242356
27326810	expert opinion	C0600219
27326810	randomized, controlled trials	C0206035
27326810	disorders	C0012634
27326810	Guidelines	C0282451
27326810	Definitions	C0679227
27326810	Diagnostic criteria	C0679228
27326810	Hepatopulmonary syndrome	C0600452
27326810	Portopulmonary hypertension	C1868851
27326810	Implications	C0243095
27326810	liver transplantation	C0023911
27326810	Suggestions	C1705535
27326810	clinical research	C0008972
27328333	Uveitis	C0042164
27328333	children	C0008059
27328333	novel	C0205314
27328333	risk markers	C1519104
27328333	development	C1527148
27328333	pediatric	C1521725
27328333	inflammatory uveitis	C0042164
27328333	severe disease course	C0242656
27328333	treatment	C0087111
27328333	refractory disease	C1514815
27328333	measurement	C0242485
27328333	visual outcomes	C1274040
27328333	genetic markers	C0017393
27328333	biomarkers	C0005516
27328333	clinical	C0205210
27328333	factors	C1521761
27328333	child's	C0008059
27328333	uveitis	C0042164
27328333	disease course	C0242656
27328333	children	C0008059
27328333	risk	C0035647
27328333	poor visual outcomes	C1274040
27328333	refractory	C0332325
27328333	traditional therapy	C3650840
27328333	Racial disparities	C0243095
27328333	reported	C0684224
27328333	agents	C0450442
27328333	potential benefit	C0814225
27328333	patient reported outcomes	C2987124
27328333	population	C0030705
27328333	Uveitis	C0042164
27328333	vision-threatening complications	C0009566
27328333	Timely and aggressive treatment	C0087111
27328333	children	C0008059
27328333	risk	C0035647
27328333	severe uveitis course	C0242656
27328333	improved outcomes	C1274040
27329050	Utility	C0457083
27329050	mHealth App	C3658310
27329050	Self-Management	C0086969
27329050	Education	C0013621
27329050	Cardiac Diseases	C0018799
27329050	Spanish	C0037747
27329050	Urban and Rural Areas	C0017446
27329050	Analyze	C0936012
27329050	utility	C0457083
27329050	mobile health app	C3658310
27329050	HeartKeeper	C3827995
27329050	several groups of population	C1257890
27329050	obtain	C1301820
27329050	conclusions	C1707703
27329050	applied	C4048755
27329050	other similar apps	C3658310
27329050	questionnaire	C0034394
27329050	designed	C1707689
27329050	usage	C0457083
27329050	utility	C0457083
27329050	HeartKeeper app	C3658310
27329050	questionnaire	C0034394
27329050	information	C1533716
27329050	collected	C1516698
27329050	cardiologists	C0175906
27329050	patients	C0030705
27329050	before and after	C0150091
27329050	used	C0457083
27329050	app	C3658310
27329050	Patients	C0030705
27329050	randomly selected	C0150105
27329050	quotas	C2347740
27329050	interest groups	C1705429
27329050	men	C0025266
27329050	women	C0043210
27329050	patients	C0030705
27329050	older	C0001792
27329050	younger	C0332239
27329050	years old	C0439234
27329050	patients	C0030705
27329050	urban or rural areas	C0017446
27329050	equally represented	C1882932
27329050	statistical techniques	C1710191
27329050	HeartKeeper app	C3658310
27329050	patients	C0030705
27329050	qualify	C1548635
27329050	overall opinion	C3272903
27329050	app	C3658310
27329050	remember	C0034770
27329050	pills	C0994475
27329050	improvement	C2986411
27329050	global improvement	C2986411
27329050	observe	C1441672
27329050	improvements	C2986411
27329050	area (urban or rural)	C0017446
27329050	patient	C0030705
27329050	sex	C0079399
27329050	older patients	C1518563
27329050	needed	C0027552
27329050	use	C0457083
27329050	app	C3658310
27329050	used	C0457083
27329050	less frequently	C0205213
27329050	improvements	C2986411
27329050	several measures	C0079809
27329050	remembering	C0034770
27329050	pills	C0994475
27329050	breathing problems	C0497337
27329050	trouble developing activities	C0858854
27329050	older patients	C1518563
27329050	higher	C0205250
27329050	improvements	C2986411
27329050	younger ones	C0238598
27329050	results	C1274040
27329050	sample	C0079809
27329050	patients	C0030705
27329050	research	C0035168
27329050	utility	C0457083
27329050	HeartKeeper app	C3658310
27329050	utility	C0457083
27329050	urban and rural areas	C0017446
27329050	patients	C0030705
27329050	both sexes	C0079399
27329050	to some extent	C1555600
27329050	age	C0027362
27329050	patient	C0030705
27329050	older patients	C1518563
27329050	slightly lower frequency	C0205213
27329050	use	C0457083
27329050	higher	C0205250
27329050	health improvements	C2986411
27329050	younger ones	C0238598
27333847	holistic approach	C0683249
27333847	age	C0001779
27333847	estimation	C0680844
27333847	refugee	C0034961
27333847	children	C0008059
27333847	refugee	C0034961
27333847	children	C0008059
27333847	Australia	C0004340
27333847	inaccurately	C0443236
27333847	documented	C1301725
27333847	date of birth	C2348576
27333847	DOB	C2348576
27333847	medical assessment	C0582103
27333847	child's age	C0001779
27333847	concern	C2699424
27333847	documented	C1301725
27333847	DOB	C2348576
27333847	incorrect	C3827420
27333847	assess	C0184514
27333847	accuracy	C0443131
27333847	holistic age assessment tool	C0037589
27333847	AAT	C0037589
27333847	estimating	C0680844
27333847	age	C0001779
27333847	refugee	C0034961
27333847	children	C0008059
27333847	Australia	C0004340
27333847	holistic AAT	C0037589
27333847	medical	C0679624
27333847	non-medical approaches	C1254370
27333847	estimate	C0680844
27333847	ages	C0001779
27333847	refugee	C0034961
27333847	children	C0008059
27333847	DOB	C2348576
27333847	tool	C0037589
27333847	components	C1705248
27333847	assess	C0184514
27333847	age	C0001779
27333847	oral	C0442027
27333847	narrative	C1135957
27333847	developmental	C0458003
27333847	assessment	C0220825
27333847	anthropometric measures	C2598146
27333847	pubertal	C1627769
27333847	assessment	C0220825
27333847	Assessors	C0401803
27333847	blinded	C0150108
27333847	true	C0205238
27333847	age	C0001779
27333847	child	C0008059
27333847	Correlation coefficients	C0392762
27333847	actual	C0237400
27333847	estimated	C0680844
27333847	age	C0001779
27333847	calculated	C1441506
27333847	tool	C0037589
27333847	overall and individual components	C1705248
27333847	correlation coefficient	C0392762
27333847	actual	C0237400
27333847	estimated	C0680844
27333847	age	C0001779
27333847	AAT	C0037589
27333847	boys	C0870221
27333847	girls	C0870604
27333847	oral	C0442027
27333847	narrative	C1135957
27333847	component	C1705248
27333847	tool	C0037589
27333847	age	C0001779
27333847	estimates	C0680844
27333847	year	C0439234
27333847	true	C0205238
27333847	age	C0001779
27333847	years	C0439234
27333847	standard deviation	C0871420
27333847	years	C0439234
27333847	months	C0439231
27333847	AAT	C0037589
27333847	holistic	C1254370
27333847	simple	C0205352
27333847	safe	C0814103
27333847	estimate	C0680844
27333847	age	C0001779
27333847	refugee	C0034961
27333847	children	C0008059
27333847	radiological methods	C0039431
27334471	CAGEd-oPOSSUM	C0037589
27334471	motif enrichment analysis	C0936012
27334471	CAGE	C0150098
27334471	TSSs	C0949639
27334471	large-scale Cap Analysis of Gene Expression (CAGE) datasets	C0150098
27334471	individual labs	C0022877
27334471	FANTOM consortium	C1709701
27334471	cis-regulatory regions	C0034987
27334471	gene transcription	C0040649
27334471	unprecedented level of refinement	C0205556
27334471	transcription factor binding site	C3158211
27334471	TFBS	C3158211
27334471	enrichment analysis	C0936012
27334471	CAGE	C0150098
27334471	genomic regions	C0598659
27334471	CAGEd-oPOSSUM	C0037589
27334471	identify	C0205396
27334471	TFs	C0040648
27334471	key	C1706198
27334471	regulators	C1704735
27334471	genes	C0017337
27334471	specific	C0205369
27334471	mammalian cell	C1512977
27334471	tissue types	C2713035
27334471	webtool	C0037589
27334471	analysis	C0936012
27334471	CAGE	C0150098
27334471	transcription start sites	C0949639
27334471	TSSs	C0949639
27334471	user	C1706077
27334471	mammalian	C0024660
27334471	samples	C0370003
27334471	FANTOM5 project	C1709701
27334471	pre-computed	C1880157
27334471	TFBS	C3158211
27334471	JASPAR TF binding profiles	C0242356
27334471	tool	C0242356
27334471	insights	C0233820
27334471	regulation of genes	C0017263
27334471	study	C2603343
27334471	specific	C0205369
27334471	usage	C0457083
27334471	TSSs	C0949639
27334471	specific	C0205369
27334471	cell types	C0449475
27334471	specific conditions	C0348080
27334471	CAGEd-oPOSUM web tool	C0037589
27334471	Perl	C0037589
27334471	MySQL	C1710218
27334471	Apache	C0243030
27334471	http://cagedop.cmmt.ubc.ca/CAGEd_oPOSSUM	C2349146
27334471	anthony.mathelier@ncmm.uio.no	C1705961
27334471	wyeth@cmmt.ubc.ca	C1705961
27334471	Supplementary information	C2936424
27334471	Supplementary data	C2936424
27334471	Bioinformatics	C0282420
27334471	online	C0029038
27334669	Self-assembled	C0872376
27334669	polymeric	C0032521
27334669	vectors	C0085104
27334669	mixtures	C0439962
27334669	characterization	C1880022
27334669	polymorphism	C1882417
27334669	synergistic	C2986495
27334669	effects	C1280500
27334669	photodynamic therapy	C0031740
27334669	purity	C1882508
27334669	polymeric	C0032521
27334669	self-assemblies	C0872376
27334669	vectors	C0085104
27334669	solution	C0037633
27334669	photodynamic therapeutic	C0031740
27334669	efficiency	C0013682
27334669	amphiphilic	C0002671
27334669	block copolymers	C0596383
27334669	poly(ethyleneoxide-b-ε-caprolactone)	C1258138
27334669	self-assemblies	C0872376
27334669	morphologies	C0332437
27334669	micelles	C0025938
27334669	worm-like micelles	C0025938
27334669	vesicles	C0332437
27334669	controlled mixtures	C0439962
27334669	micelles	C0025938
27334669	vesicles	C0332437
27334669	dynamic light scattering	C1882368
27334669	asymmetrical flow field flow fractionation	C1135847
27334669	AsFlFFF	C1135847
27334669	custom-made	C1880202
27334669	program	C0037585
27334669	STORMS	C0037585
27334669	DLS	C1882368
27334669	data	C1511726
27334669	parameters	C0549193
27334669	DLS	C1882368
27334669	larger	C0549177
27334669	vesicles	C0332437
27334669	micelles	C0025938
27334669	vesicles	C0332437
27334669	ratio	C0456603
27334669	AsFlFFF	C1135847
27334669	detection	C0442726
27334669	micelles	C0025938
27334669	ratio	C0456603
27334669	photodynamic therapy	C0031740
27334669	efficiency	C0013682
27334669	controlled mixtures	C0439962
27334669	spheroids	C1844596
27334669	photosensitizer	C0162713
27334669	pheophorbide a	C0070716
27334669	encapsulated	C0205223
27334669	polymer	C0032521
27334669	self-assemblies	C0872376
27334669	efficient	C0442799
27334669	monomorphous systems	C0700329
27334669	mixtures	C0439962
27334669	PDT	C0031740
27334669	efficiency	C0013682
27334669	nano	C1553036
27334669	objects	C0347997
27334669	synergistic	C2986495
27334669	effect	C1280500
27334669	delivery	C3850077
27334669	photosensitizer	C0162713
27334669	Polymorphous	C1882417
27334669	vectors	C0085104
27334669	therapeutic applications	C0039798
27335087	Fuzheng Qingjie Granules	C0574031
27335087	Inhibit	C3463820
27335087	Growth	C0220844
27335087	Hepatoma Cells	C0677626
27335087	Inducing	C0205263
27335087	Mitochondria	C0026237
27335087	Apoptosis	C0162638
27335087	Enhancing	C2349975
27335087	Immune Function	C1817756
27335087	Fuzheng Qingjie	C0574031
27335087	(FZQJ) granules	C0574031
27335087	compound	C1706082
27335087	Chinese medicine	C0025123
27335087	adjuvant therapy	C0677850
27335087	alimentary tract	C0017189
27335087	cancers	C0006826
27335087	anticancer	C0243095
27335087	mechanisms	C0441712
27335087	present	C0521116
27335087	study	C2603343
27335087	HepG2 cells	C2717940
27335087	treated	C1522326
27335087	FZQJ	C0574031
27335087	containing	C2700400
27335087	serum	C0229671
27335087	Cell proliferation	C0596290
27335087	evaluated	C0220825
27335087	MTT assay	C2986858
27335087	Apoptosis	C0162638
27335087	analyzed	C0936012
27335087	flow cytometer	C0180279
27335087	Cell ultrastructure	C3825563
27335087	observed	C1441672
27335087	transmission electron microscope	C0262880
27335087	mitochondrial membrane potential	C1720920
27335087	Δψ	C1720920
27335087	examined	C0332128
27335087	JC-1 dye	C0013343
27335087	H22 tumor-bearing mice	C1512411
27335087	CD4(+) T cells	C0039215
27335087	CD8(+) T cells	C0242629
27335087	CD3(+) T cells	C1267816
27335087	natural killer cells	C0022688
27335087	NK	C0022688
27335087	peripheral blood	C0229664
27335087	cytometrically	C0180279
27335087	Interleukin (IL)-2	C0021756
27335087	tumor necrosis factor	C0041368
27335087	(TNF)-α	C0041368
27335087	levels	C0441889
27335087	measured	C0444706
27335087	radioimmunoassay	C0034580
27335087	mRNA	C0035696
27335087	levels	C0441889
27335087	Bax	C0812198
27335087	Bcl-2	C0376515
27335087	examined	C0332128
27335087	reverse transcription-polymerase chain reaction	C0599161
27335087	protein	C0033684
27335087	levels	C0441889
27335087	Bax	C0219474
27335087	Bcl-2	C0210955
27335087	cytochrome C	C0010749
27335087	caspase 3	C0291573
27335087	9	C0910167
27335087	PARP	C0032405
27335087	CD69	C0108800
27335087	examined	C0332128
27335087	Western blotting	C0005863
27335087	apoptotic	C1516044
27335087	cells	C0007634
27335087	tissues	C0040300
27335087	observed	C1441672
27335087	TUNEL method	C0872284
27335087	Alanine transaminase	C0001899
27335087	ALT	C0001899
27335087	aspartate transaminase	C0004002
27335087	AST	C0004002
27335087	blood urea nitrogen	C0600137
27335087	BUN	C0600137
27335087	creatinine	C0010294
27335087	CRE	C0010294
27335087	detected	C0442726
27335087	automatic	C0205554
27335087	biochemical	C0205474
27335087	analyzer	C0179038
27335087	results	C1274040
27335087	FZQJ	C0574031
27335087	containing	C2700400
27335087	serum	C0229671
27335087	inhibited	C3463820
27335087	proliferation	C0596290
27335087	HepG2 cells	C2717940
27335087	dose	C1512045
27335087	time	C0040223
27335087	dependent	C0851827
27335087	induced	C0205263
27335087	HepG2 cell	C2717940
27335087	apoptosis	C0162638
27335087	decrease	C0547047
27335087	Δψ	C1720920
27335087	Analysis	C0936012
27335087	tumor tissue	C0475358
27335087	FZQJ	C0574031
27335087	induced	C0205263
27335087	apoptosis	C0162638
27335087	downregulation	C0013081
27335087	Bcl-2	C0210955
27335087	upregulation	C0041904
27335087	Bax	C0219474
27335087	release	C1283071
27335087	cytochrome c	C0010749
27335087	activation	C0014429
27335087	caspase 3	C0291573
27335087	9	C0910167
27335087	cleavage	C0597304
27335087	PARP	C0032405
27335087	FZQJ	C0574031
27335087	increased	C0205217
27335087	percentages	C0439165
27335087	CD4(+) T	C0039215
27335087	NK cells	C0022688
27335087	ratio	C0456603
27335087	CD4(+)	C0039215
27335087	CD8(+) T cells	C0242629
27335087	levels	C0441889
27335087	serum	C0229671
27335087	TNF-α	C0041368
27335087	FZQJ	C0574031
27335087	increased	C0205217
27335087	CD69	C0108800
27335087	expression	C1171362
27335087	tumor tissue	C0475358
27335087	No hepatorenal toxicity	C0243095
27335087	observed	C1441672
27335087	H22 tumor-bearing mice	C1512411
27335087	results	C1274040
27335087	indicated	C1444656
27335087	FZQJ	C0574031
27335087	inhibit	C3463820
27335087	growth	C0220844
27335087	hepatoma cells	C0677626
27335087	immune function	C1817756
27335087	inducing	C0205263
27335087	mitochondria	C0026237
27335087	apoptosis	C0162638
27336239	Professional reinventions	C0282574
27336239	Swedish	C1710263
27336239	psychologists	C0033908
27336239	20th century	C0681748
27336239	Swedish	C1710263
27336239	psychology profession	C0033909
27336239	changes	C0392747
27336239	essential tasks	C0441655
27336239	epistemological foundations	C0376553
27336239	social roles	C0035820
27336239	changes	C0392747
27336239	occurred	C1709305
27336239	Swedish	C1710263
27336239	society	C0037455
27336239	profession	C0028811
27336239	society's	C0037455
27336239	concerns	C2699424
27336239	problems	C0033213
27336239	profession's	C0028811
27336239	goals	C0018017
27336239	aims	C1947946
27336239	history	C0019665
27336239	profession	C0028811
27336239	changing	C0392747
27336239	definitions	C1704788
27336239	contours	C0876954
27336239	psychology profession	C0033909
27336239	organization	C1300196
27336239	society	C0037455
27336239	article	C1706852
27336239	history	C0019665
27336239	Swedish	C1710263
27336239	psychology profession	C0033909
27336239	analysis	C0936012
27336239	discussions	C2584313
27336239	debates	C0870392
27336239	Swedish	C1710263
27336239	Psychological Association's journal	C0162443
27336239	analytical framework	C1254372
27336239	actor-network theory	C0683613
27336239	science studies	C0242481
27336239	profession's	C0028811
27336239	institutional connections	C0439849
27336239	tasks	C0441655
27336239	epistemological	C0376553
27336239	underpinnings	C1254370
27336239	social position	C0680375
27336239	changed	C0392747
27336239	decades	C2981279
27336239	insecurity	C0233497
27336239	profession	C0028811
27336239	legitimize	C1552821
27336239	politicians	C0682232
27336239	media	C0009458
27336239	patients	C0030705
27336239	customers	C2981734
27336239	economized	C0013557
27336239	vocabulary	C0042926
27336239	novel	C0205314
27336239	empirical research	C0376367
27336239	changes	C0392747
27336239	socialized	C2371613
27336239	profession	C0028811
27336239	actors	C0335083
27336239	Swedish	C1710263
27336239	society	C0037455
27336239	conflicts	C1705242
27336239	profession	C0028811
27336239	control	C0243148
27336239	loss of autonomy	C4061233
27336239	PsycINFO Database Record	C0242356
27337055	Personally Meaningful Rituals	C2945764
27337055	Increase	C0442805
27337055	Compassion	C0242270
27337055	Decrease	C0547047
27337055	Burnout	C0476644
27337055	Hospice	C0085555
27337055	Staff	C0851286
27337055	Volunteers	C3661466
27337055	Rituals	C2945764
27337055	increase	C0442805
27337055	sense of connectedness	C0814552
27337055	meaning	C0876919
27337055	support	C0037438
27337055	death	C0011065
27337055	Hospice	C0085555
27337055	staff	C1547600
27337055	personal rituals	C2945764
27337055	cope with	C0009967
27337055	frequent deaths	C0205848
27337055	patients	C0030705
27337055	compassionate care	C1947933
27337055	burnout	C0476644
27337055	personally meaningful rituals	C2945764
27337055	increasing	C0442805
27337055	compassion	C0242270
27337055	decreasing	C0392756
27337055	burnout	C0476644
27337055	hospice	C0085555
27337055	staff	C1547600
27337055	volunteers	C3661466
27337055	online survey	C0038951
27337055	National Hospice and Palliative Care Organization	C4035207
27337055	Hospice	C0085555
27337055	NHPCO	C4035207
27337055	personal ritual	C2945764
27337055	Professional Quality of Life (ProQOL) scale	C0451401
27337055	ProQOL	C0451401
27337055	Compassion	C0242270
27337055	Satisfaction	C0242428
27337055	Burnout	C0476644
27337055	Secondary Traumatic Stress	C4042834
27337055	hospice	C0085555
27337055	staff	C1547600
27337055	volunteers	C3661466
27337055	states	C1301808
27337055	online survey	C0038951
27337055	participants	C0679646
27337055	Caucasian	C0043157
27337055	female	C0086287
27337055	hospice	C0085555
27337055	hospice and palliative care	C4035207
27337055	hospice	C0085555
27337055	staff	C1547600
27337055	volunteers	C3661466
27337055	rituals	C2945764
27337055	death	C0011065
27337055	patients	C0030705
27337055	cope	C0009967
27337055	rituals	C2945764
27337055	Compassion	C0242270
27337055	Satisfaction	C0242428
27337055	Burnout	C0476644
27337055	ProQOL	C0451401
27337055	professional support	C1822039
27337055	social support	C0037438
27337055	age	C0001779
27337055	significant roles	C0243095
27337055	Rituals	C2945764
27337055	increase	C0442805
27337055	compassion	C0242270
27337055	decrease	C0547047
27337055	burnout	C0476644
27337055	hospice	C0085555
27337055	staff	C1547600
27337055	volunteers	C3661466
27337055	Organizations	C4035207
27337055	training and support	C0040607
27337055	personalized rituals	C2945764
27337055	new staff	C1547600
27337055	at greater risk	C1444641
27337055	burnout	C0476644
27340777	Activation	C1879547
27340777	orphan receptor GPR55	C2002138
27340777	lysophosphatidylinositol	C0065391
27340777	promotes	C0033414
27340777	metastasis	C0027627
27340777	triple-negative breast cancer	C3539878
27340777	orphan G protein-coupled receptor	C0682972
27340777	GPR55	C2002138
27340777	directly	C1947931
27340777	indirectly	C0439852
27340777	related	C0439849
27340777	alterations	C1515926
27340777	malignant	C0205282
27340777	growth	C0018270
27340777	uncontrolled	C0205318
27340777	cell proliferation	C0596290
27340777	sustained angiogenesis	C0302600
27340777	cell adhesion	C0007577
27340777	migration	C1254366
27340777	little	C0700321
27340777	known	C0205309
27340777	involvement	C1314939
27340777	receptor	C0597357
27340777	metastasis	C0027627
27340777	elevated	C3163633
27340777	GPR55 expression	C0597360
27340777	human	C0086418
27340777	tumors	C0027651
27340777	associated with	C0332281
27340777	aggressive basal	C0027671
27340777	triple-negative breast cancer	C3539878
27340777	population	C1257890
27340777	higher probability	C0033204
27340777	metastases	C0027627
27340777	poor	C2700379
27340777	patient	C0030705
27340777	prognosis	C0033325
27340777	Activation	C1879547
27340777	GPR55	C2002138
27340777	endogenous	C0205227
27340777	ligand	C0023688
27340777	lysophosphatidylinositol	C0065391
27340777	pro-invasive	C0205281
27340777	features	C2348519
27340777	breast cancer cells	C1512505
27340777	in vitro	C1533691
27340777	in vivo	C1515655
27340777	effect	C1280500
27340777	elicited by	C0449265
27340777	coupling	C1948027
27340777	Gq/11 heterotrimeric proteins	C2975447
27340777	subsequent	C0332282
27340777	activation	C1879547
27340777	ERK	C0600388
27340777	transcription factor ETV4	C1333479
27340777	PEA3	C0084827
27340777	Together	C1883357
27340777	data	C1511726
27340777	GPR55	C2002138
27340777	promotes	C0033414
27340777	breast cancer	C0678222
27340777	metastasis	C0027627
27340777	supports	C1521721
27340777	orphan receptor	C0597357
27340777	new	C0205314
27340777	therapeutic	C0302350
27340777	target	C1521840
27340777	potential	C3245505
27340777	biomarker	C0005516
27340777	aggressive triple-negative subtype	C1519691
27342634	Effect	C1280500
27342634	ultrasonic	C0220934
27342634	processing	C1709694
27342634	activity	C1537044
27342634	aggregation	C0332621
27342634	secondary	C0162807
27342634	tertiary structure	C0162808
27342634	polyphenol oxidase	C0012524
27342634	oriental	C0017446
27342634	sweet melon	C0440285
27342634	Cucumis melo var. makuwa Makino	C0947370
27342634	Polyphenol oxidase	C0012524
27342634	PPO	C0012524
27342634	contributes	C1880177
27342634	browning reaction	C0085927
27342634	fruits	C0016767
27342634	vegetables	C0042440
27342634	serious	C0205404
27342634	damage	C1883709
27342634	quality	C0332306
27342634	sweet melon	C0440285
27342634	products	C1514468
27342634	traditional	C0443324
27342634	methods	C0449851
27342634	inactivate	C0544461
27342634	browning	C0085927
27342634	induce	C0205263
27342634	unexpected	C4055646
27342634	risks	C0035647
27342634	ultrasonic	C0220934
27342634	processing	C1709694
27342634	reports	C0684224
27342634	effect	C1280500
27342634	ultrasound	C1456803
27342634	PPO	C0012524
27342634	purified	C1998793
27342634	sweet melon	C0440285
27342634	PPO	C0012524
27342634	original	C0205313
27342634	juice	C1268568
27342634	inactivated	C0544461
27342634	purified	C1998793
27342634	treated with	C0332293
27342634	ultrasound	C1456803
27342634	purified	C1998793
27342634	PPO	C0012524
27342634	thermal treatment	C0454527
27342634	heat	C0018837
27342634	inactivate	C0544461
27342634	PPO	C0012524
27342634	ultrasonic	C0220934
27342634	treatment	C0087111
27342634	intensity lower	C2173560
27342634	ultrasound	C1456803
27342634	significantly	C0750502
27342634	structure	C0678594
27342634	activity	C1561536
27342634	PPO	C0012524
27342634	latent	C0205275
27342634	PPO	C0012524
27342634	activated	C1879547
27342634	intensity higher	C2173560
27342634	ultrasound	C1456803
27342634	inactivated	C0544461
27342634	PPO	C0012524
27342634	induced	C0205263
27342634	aggregation	C0332621
27342634	dissociation	C0301643
27342634	PPO	C0012524
27342634	particles	C0597177
27342634	significantly decreased	C4055638
27342634	α-helix structure	C0162805
27342634	Low-frequency	C0205213
27342634	high-intensity	C4081854
27342634	ultrasound	C1456803
27342634	inactivation	C0544461
27342634	effect	C1280500
27342634	conformational changes	C0301641
27342634	purified	C1998793
27342634	PPO	C0012524
27342634	oriental	C0017446
27342634	sweet melons	C0440285
27342634	Changes	C0392747
27342634	PPO	C0012524
27342634	structure	C0678594
27342634	induced	C0205263
27342634	ultrasound	C1456803
27342634	inactivated	C0544461
27342634	enzyme	C0014442
27342634	Ultrasound	C1456803
27342634	potential	C3245505
27342634	method	C0449851
27342634	inactivate	C0544461
27342634	PPO	C0012524
27342634	oriental	C0017446
27342634	sweet melons	C0440285
27342978	Phylogeography	C2936603
27342978	Spanish	C0086409
27342978	Moon Moth	C0026593
27342978	Graellsia isabellae	C1024524
27342978	Lepidoptera	C0023338
27342978	Saturniidae	C3102349
27342978	Geographic	C0017444
27342978	demographic factors	C0011292
27342978	specialisation	C0037776
27342978	host-plant	C0868970
27342978	host	C0868970
27342978	associated	C0332281
27342978	differentiation	C2945687
27342978	plant	C0032098
27342978	insects	C0021585
27342978	phylogeography	C2936603
27342978	protected	C0205245
27342978	moth	C0026593
27342978	Graellsia isabellae	C1024524
27342978	host-plant	C0868970
27342978	species	C1705920
27342978	Pinus sylvestris	C0996613
27342978	P. nigra	C1670069
27342978	evolutionary history	C0019665
27342978	lepidopteran	C0023338
27342978	DNA	C0012854
27342978	variation	C0042333
27342978	mitochondrial	C0026237
27342978	marker	C0012872
27342978	nuclear	C0007610
27342978	microsatellite loci	C0678933
27342978	phylogeographic pattern	C0243095
27342978	G. isabellae	C1024524
27342978	Spain	C0037747
27342978	France	C0016674
27342978	groups	C0441833
27342978	distributed	C1704711
27342978	different	C1705242
27342978	mountain ranges	C0442533
27342978	Reanalysis	C0936012
27342978	chloroplast	C0008266
27342978	microsatellite dataset	C0150098
27342978	revealed	C0443289
27342978	group structure	C0018266
27342978	Spanish	C0086409
27342978	P. sylvestris	C0996613
27342978	P. nigra	C1670069
27342978	protected	C0205245
27342978	moth	C0026593
27342978	match	C1708943
27342978	P. sylvestris	C0996613
27342978	P. nigra	C1670069
27342978	no evidence of	C0332125
27342978	host	C0868970
27342978	associated	C0332281
27342978	differentiation	C2945687
27342978	P. sylvestris	C0996613
27342978	inhabiting	C0205245
27342978	P. nigra	C1670069
27342978	major	C0205164
27342978	mitochondrial	C0026237
27342978	clades	C0441833
27342978	G. isabellae	C1024524
27342978	Last Glacial Maximum	C1254367
27342978	geographically	C1517526
27342978	separated	C0443299
27342978	species	C1705920
27342978	southern	C1710133
27342978	Central and Southern Iberian clusters	C1704332
27342978	northern	C1709269
27342978	lineage	C1881379
27342978	Eastern Iberian	C1704332
27342978	Pyrenean	C1704332
27342978	French Alpine clusters	C1704332
27342978	Eastern Iberian System	C1704332
27342978	insect	C0021585
27342978	host-plants	C0868970
27342978	highest	C1522410
27342978	level	C0441889
27342978	genetic	C0314603
27342978	diversity	C1880371
27342978	group	C0441833
27342978	colonised	C4289767
27342978	West	C1705493
27342978	East parts	C1707877
27342978	Pyrenees	C0681784
27342978	native	C0302891
27342978	origin	C0439659
27342978	French populations	C0032659
27342978	occurring	C2745955
27342978	Alps	C0442533
27342978	genetically	C0314603
27342978	Eastern Iberian	C0681784
27342978	Pyrenean sites	C0681784
27342978	Central Iberian group	C0441833
27342978	Southern Iberian	C0681784
27342978	ancestors	C0870134
27342978	Secondary	C0205436
27342978	contacts	C0205556
27342978	Southern/Central Iberian populations	C0032659
27342978	Eastern Iberian cluster	C1704332
27342978	Pyrenean ones	C1704332
27342978	mito-nuclear discordance	C0392762
27342978	Eastern Iberian cluster	C1704332
27342978	congruent	C0439853
27342978	secondary	C0205436
27342978	contact	C0205556
27342978	evolution	C0015219
27342978	mito-nuclear incompatibilities	C0205556
27342978	geographically isolated areas	C0681784
27343229	Prevalence	C0220900
27343229	Physical Activity	C0026606
27343229	Sitting	C2584297
27343229	Time	C0040223
27343229	South Korean	C1556095
27343229	Adolescents	C0205653
27343229	Results	C0683954
27343229	Korean	C1556095
27343229	National Health and Nutrition Examination Survey	C0376344
27343229	physical activity	C0026606
27343229	PA	C0026606
27343229	sitting	C2584297
27343229	time	C0040223
27343229	associations	C0439849
27343229	sociodemographic factors	C0011292
27343229	weight	C0005910
27343229	status	C0449438
27343229	PA	C0026606
27343229	sitting	C2584297
27343229	time	C0040223
27343229	South Korean	C1556095
27343229	adolescents	C0205653
27343229	years	C1510829
27343229	Findings	C2607943
27343229	self-report data	C2700446
27343229	participants	C0679646
27343229	Korea	C0022771
27343229	National Health and Nutrition Examination Survey	C0376344
27343229	adolescents	C0205653
27343229	minutes	C0439232
27343229	moderate-to-vigorous PA	C0026606
27343229	daily	C0332173
27343229	Adolescents	C0205653
27343229	mins/d	C0556973
27343229	sitting	C2584297
27343229	age	C0001779
27343229	sex	C0079399
27343229	individuals	C0027361
27343229	higher income groups	C0019532
27343229	compared	C1707455
27343229	lowest income group	C0024045
27343229	living	C2982691
27343229	nonmetro	C1254362
27343229	Seoul	C3850150
27343229	compared	C1707455
27343229	metro	C0599587
27343229	Seoul	C3850150
27343229	overweight	C0497406
27343229	compared	C1707455
27343229	nonoverweight	C0005910
27343229	PA	C0026606
27343229	guidelines	C0162791
27343229	Participants	C0679646
27343229	highest income group	C0019532
27343229	compared	C1707455
27343229	lowest income group	C0024045
27343229	residing	C2982691
27343229	nonmetro	C1254362
27343229	Seoul	C3850150
27343229	compared	C1707455
27343229	metro	C0599587
27343229	Seoul	C3850150
27343229	sitting	C2584297
27343229	time	C0040223
27343229	group	C0441833
27343229	min/d	C0556973
27343229	Increasing	C0442808
27343229	PA	C0026606
27343229	reducing	C0392756
27343229	sitting	C2584297
27343229	public health	C3244304
27343229	priority	C0549179
27343229	South Korea	C0022773
27343573	Graphene	C2936695
27343573	Nafion	C0068361
27343573	composite film	C1561572
27343573	glassy	C0522500
27343573	carbon electrode	C3874229
27343573	simultaneous	C0521115
27343573	determination	C1148554
27343573	paracetamol	C0000970
27343573	aspirin	C0004057
27343573	caffeine	C0006644
27343573	pharmaceutical formulations	C1705957
27343573	graphene	C2936695
27343573	Nafion	C0068361
27343573	composite film	C1561572
27343573	fabricated	C0870840
27343573	glassy	C0522500
27343573	carbon electrode	C3874229
27343573	GR-NF/GCE	C3874229
27343573	simultaneous	C0521115
27343573	determination	C1148554
27343573	paracetamol	C0000970
27343573	PAR	C0000970
27343573	aspirin	C0004057
27343573	ASA	C0004057
27343573	caffeine	C0006644
27343573	CAF	C0006644
27343573	electrochemical behaviors	C0205556
27343573	PAR	C0000970
27343573	ASA	C0004057
27343573	CAF	C0006644
27343573	investigated	C1292732
27343573	cyclic voltammetry	C0683134
27343573	square-wave adsorptive anodic stripping voltammetry	C0201748
27343573	stripping	C0201748
27343573	simultaneous	C0521115
27343573	determination	C1148554
27343573	PAR	C0000970
27343573	ASA	C0004057
27343573	CAF	C0006644
27343573	electrochemical oxidation peaks	C0444505
27343573	appeared	C0700364
27343573	good	C0205170
27343573	linear current responses	C0205556
27343573	obtained	C1301820
27343573	detection limits	C2718050
27343573	proposed	C1705535
27343573	electrochemical sensor	C0183210
27343573	successfully	C1272703
27343573	applied	C4048755
27343573	quantifying	C1709793
27343573	PAR	C0000970
27343573	ASA	C0004057
27343573	CAF	C0006644
27343573	commercial	C0680536
27343573	tablet formulations	C1705957
27346839	Long-term	C0443252
27346839	antibiofilm activity	C0441655
27346839	carboxymethyl chitosan	C1744331
27346839	mixed biofilm	C0081786
27346839	silicone	C0037114
27346839	Silicone	C0037114
27346839	voice prostheses	C0087165
27346839	frequently	C0332183
27346839	voice rehabilitation	C0199531
27346839	laryngectomized	C0023065
27346839	patients	C0030705
27346839	functional device	C1385354
27346839	lifetimes	C4071830
27346839	limited	C0439801
27346839	due to	C0678226
27346839	formation	C1522492
27346839	mixed biofilms	C0081786
27346839	in vitro models	C1515654
27346839	biofilm formation	C1325881
27346839	restricted	C0443288
27346839	short-term	C0443303
27346839	periods	C1948053
27346839	goal	C0018017
27346839	study	C2603343
27346839	effect	C1280500
27346839	carboxymethyl chitosan	C1744331
27346839	mixed biofilm formation	C1325881
27346839	fungi	C0016832
27346839	bacteria	C0004611
27346839	silicone	C0037114
27346839	long-term	C0443252
27346839	period	C1948053
27346839	species	C1705920
27346839	biofilms	C0081786
27346839	Candida albicans	C0006837
27346839	Candida tropicalis	C0319882
27346839	Lactobacillus gasseri	C0317620
27346839	Streptococcus salivarius	C0318179
27346839	Rothia dentocariosa	C0318071
27346839	Staphylococcus epidermidis	C0038174
27346839	cultivated	C1254366
27346839	surfaces	C0205148
27346839	medical-grade silicone	C0037114
27346839	carboxymethyl chitosan	C1744331
27346839	Biofilm kinetics	C0022702
27346839	designed image analysis software	C3203922
27346839	calculate	C1441506
27346839	percentual surface covering	C0205245
27346839	platelet	C0005821
27346839	Biofilm architecture	C1254362
27346839	investigated	C1292732
27346839	scanning electron microscopy	C0026020
27346839	cover	C1999244
27346839	living	C0376558
27346839	mixed biofilm	C0081786
27346839	days	C0439228
27346839	silicone	C0037114
27346839	maximum	C0806909
27346839	biofilm	C0081786
27346839	surface covering	C0205245
27346839	day	C0439228
27346839	less than	C0439092
27346839	surface coverage	C1999244
27346839	observed	C1441672
27346839	carboxymethyl chitosan	C1744331
27346839	treated	C1522326
27346839	testing	C0039593
27346839	period	C1948053
27346839	Scanning electron microscopy	C0026020
27346839	confirms	C0750484
27346839	surfaces	C0205148
27346839	treated	C1522326
27346839	carboxymethyl chitosan	C1744331
27346839	biofilm	C0081786
27346839	less	C0547044
27346839	dense	C0439794
27346839	fewer	C0205388
27346839	cells	C0007634
27346839	profuse cellular debris	C4055264
27346839	together	C1883357
27346839	morphologically altered	C1260954
27346839	yeast	C0043393
27346839	yeast cells	C0007634
27346839	Carboxymethyl chitosan	C1744331
27346839	possible	C0332149
27346839	antibiofilm agent	C0439861
27346839	biofilm formation	C1325881
27346839	voice prostheses	C0087165
27346839	Laryngoscope	C0180453
27347668	Spectral fingerprints	C0037812
27347668	cortical	C0007776
27347668	dynamics	C3826426
27347668	during	C0347984
27347668	ambiguous	C0237467
27347668	motion perception	C0026598
27347668	Ambiguous	C1274012
27347668	stimuli	C0234402
27347668	neuronal	C0027882
27347668	correlates	C1707520
27347668	consciousness	C0234421
27347668	conscious	C0234421
27347668	perception	C0030971
27347668	dynamic	C0729333
27347668	cortical areas	C0007776
27347668	phase coupling	C4042905
27347668	correlate	C1707520
27347668	cortical	C0007776
27347668	coupling modes	C4042905
27347668	cortical functions	C0234393
27347668	coupling modes	C4042905
27347668	phase and envelope coupling	C4042905
27347668	dynamics	C3826426
27347668	EEG	C0013819
27347668	participants	C0679646
27347668	bistable motion task	C0025365
27347668	connectivity	C1707489
27347668	analysis	C0936012
27347668	techniques	C0449851
27347668	functional relevance	C2700217
27347668	coupling modes	C4042905
27347668	cortical	C0007776
27347668	gamma-band phase coupling	C4042905
27347668	extrastriate	C3498366
27347668	visual cortex	C0042817
27347668	visual tokens	C0031734
27347668	moving	C0560560
27347668	stimulus	C0234402
27347668	ambiguous	C0237467
27347668	visual stimulation	C0031734
27347668	envelope coupling	C4042905
27347668	ambiguous	C0237467
27347668	motion perception	C0026598
27347668	local parieto-occipital	C1518897
27347668	alpha-band phase coupling	C4042905
27347668	hemispheric	C0205139
27347668	information transfer	C0205245
27347668	correlative	C1707520
27347668	evidence	C3887511
27347668	synchronized	C0439580
27347668	brain activity	C0443158
27347668	processing of sensory	C1327511
27347668	information integration	C0679019
27347668	spatiotemporal scales	C3494293
27347668	distinct coupling modes	C0392762
27347668	cortical	C0007776
27347668	computations	C1880157
27347668	spatiotemporal correlation	C3494293
27347668	structure of the brain	C0006104
27347668	functional	C0205245
27347668	cortical	C0007776
27349182	Beneficial effects	C0683156
27349182	voglibose	C0532578
27349182	administration	C1533734
27349182	body weight	C0005910
27349182	lipid metabolism	C0598783
27349182	gastrointestinal	C0012240
27349182	bile acid	C0005390
27349182	modification	C0579005
27349182	study	C0008972
27349182	goal	C0018017
27349182	effects	C0728866
27349182	voglibose	C0532578
27349182	administration	C1533734
27349182	body weight	C0005910
27349182	lipid metabolism	C0598783
27349182	mechanism	C0441712
27349182	high fat diet	C0521974
27349182	obese mice	C0025933
27349182	Male	C0086582
27349182	C57BL/6 mice	C1521751
27349182	groups	C1642385
27349182	control diet	C0009932
27349182	CTL	C0009932
27349182	high-fat diet	C1642385
27349182	HF	C1642385
27349182	high-fat diet supplemented with voglibose	C1642385
27349182	VO	C1642385
27349182	high fat diet pair-fed group	C1642385
27349182	PF	C1642385
27349182	weeks	C0439230
27349182	characteristics	C1521970
27349182	serum lipid	C0428462
27349182	glucose levels	C0583332
27349182	expression levels	C3244092
27349182	genes	C0017337
27349182	lipid	C0598783
27349182	bile acid metabolism	C0678714
27349182	pyrosequencing	C2732543
27349182	composition	C0486616
27349182	gut microbiota	C2985398
27349182	feces	C0015733
27349182	Total body weight gain	C0043094
27349182	significantly lower	C4055638
27349182	VO group	C1642385
27349182	CTL	C0009932
27349182	HF	C1642385
27349182	PF groups	C1642385
27349182	VO group	C1642385
27349182	metabolic profiles	C3853758
27349182	blood glucose	C0392201
27349182	triglyceride	C0428475
27349182	total cholesterol levels	C0428466
27349182	week	C0439230
27349182	voglibose	C0532578
27349182	administration	C1533734
27349182	Firmicutes	C1254144
27349182	Bacteroidetes	C0995456
27349182	feces	C0015733
27349182	levels	C0441889
27349182	taurocholic	C0039358
27349182	cholic acid	C0055568
27349182	significantly higher	C4055637
27349182	VO group	C1642385
27349182	HF	C1642385
27349182	CTL groups	C0009932
27349182	Deoxycholic acid	C0011479
27349182	levels	C0441889
27349182	VO group	C1642385
27349182	HF group	C1642385
27349182	Voglibose	C0532578
27349182	administration	C1533734
27349182	downregulated	C0013081
27349182	expression levels	C3244092
27349182	CYP8B1	C1413895
27349182	HNF4α genes	C1415629
27349182	upregulated	C0041904
27349182	PGC1α	C1418779
27349182	FXRα	C1417825
27349182	Voglibose	C0532578
27349182	administration	C1533734
27349182	composition	C0486616
27349182	intestinal microbiota	C2985398
27349182	circulating metabolites	C0870883
27349182	systemic effects	C0678788
27349182	body weight	C0005910
27349182	lipid metabolism	C0598783
27349182	mice	C0025929
27349365	Supramolecular Recognition	C0599844
27349365	Amino Acids	C0002520
27349365	Twisted Cucurbit[14]uril	C1737934
27349365	Binding	C1167622
27349365	interactions	C1704675
27349365	between	C0205103
27349365	twisted cucurbit[14]uril	C1737934
27349365	(tQ[14])	C1737934
27349365	standard	C1442989
27349365	amino acids	C0002520
27349365	(AAs)	C0002520
27349365	investigated	C1292732
27349365	NMR spectroscopy	C0877853
27349365	isothermal titration calorimetry	C0006779
27349365	(ITC)	C0006779
27349365	aqueous	C0043047
27349365	HCl solutions	C0020259
27349365	DMSO	C0012403
27349365	results	C1274040
27349365	tQ[14]	C1737934
27349365	displays	C0870432
27349365	binding	C1167622
27349365	affinity	C1510827
27349365	AAs	C0002520
27349365	positively charged side chain	C1254350
27349365	containing	C0332256
27349365	aromatic ring	C0020245
27349365	weaker	C1762617
27349365	binding	C1167622
27349365	affinity	C1510827
27349365	AAs	C0002520
27349365	hydrophobic	C1254355
27349365	polar side chains	C1254355
27349365	binding	C1167622
27349365	mode	C1513371
27349365	side chain	C1254350
27349365	AAs	C0002520
27350860	Comparison	C1707455
27350860	alkaline phosphatase activity	C1149888
27350860	MC3T3-E1 cells	C0007600
27350860	Ti	C0040302
27350860	surfaces	C0205148
27350860	sandblasted	C1254366
27350860	grit	C0440273
27350860	acid-etched	C1254366
27350860	MSLA	C0040302
27350860	laser-treated	C1254366
27350860	laser and acid-treated	C1254366
27350860	Ti	C0040302
27350860	surfaces	C0205148
27350860	study	C2603343
27350860	study	C2603343
27350860	evaluate	C0220825
27350860	surface	C0205148
27350860	cell differentiation	C0007589
27350860	osteoblast cells	C0029418
27350860	surfaces	C0205148
27350860	grit	C0440273
27350860	NaCl	C0037494
27350860	laser treatment	C1254366
27350860	LT	C1254366
27350860	laser treatment	C1254366
27350860	titanium	C0040302
27350860	surface	C0205148
27350860	laser and acid-treated	C1254366
27350860	laser treatment, acid-etched	C1254366
27350860	titanium	C0040302
27350860	surface	C0205148
27350860	MSLA	C0040302
27350860	surfaces	C0205148
27350860	control group	C0009932
27350860	LT	C0040302
27350860	LAT	C0040302
27350860	surfaces	C0205148
27350860	test groups	C0441833
27350860	Alkaline phosphatase	C0002059
27350860	expression	C1171362
27350860	ALP	C0002059
27350860	osteoblastic differentiation	C1159974
27350860	MC3T3-E1 cell	C0007600
27350860	Surface	C0205148
27350860	roughness	C0205556
27350860	evaluated	C0220825
27350860	contact profilometer	C0025080
27350860	Japan	C0022341
27350860	mean roughness	C0205556
27350860	Ra	C0205556
27350860	maximum peak-to-valley height	C0392762
27350860	Rt	C0392762
27350860	Scanning electron microscope	C0262878
27350860	control group	C0009932
27350860	surface	C0205148
27350860	rough	C0205556
27350860	LT	C0040302
27350860	LAT	C0040302
27350860	surface	C0205148
27350860	test groups	C0441833
27350860	Alkaline phosphatase	C0002059
27350860	expression	C1171362
27350860	osteoblastic differentiation	C1159974
27350860	ALP	C0002059
27350860	expression	C1171362
27350860	surface-adherent cells	C0007634
27350860	days	C0439228
27350860	surfaces	C0205148
27350860	ALP	C0002059
27350860	expression	C1171362
27350860	levels	C0441889
27350860	MSLA	C0040302
27350860	LAT	C0040302
27350860	surfaces	C0205148
27350860	expression	C1171362
27350860	levels	C0441889
27350860	LT	C0040302
27350860	surface-adherent cells	C0007634
27350860	days	C0439228
27350860	ALP	C0002059
27350860	expression	C1171362
27350860	levels	C0441889
27350860	MSLA	C0040302
27350860	LAT	C0040302
27350860	surface	C0205148
27350860	days	C0439228
27350860	study	C2603343
27350860	MSLA	C0040302
27350860	LAT	C0040302
27350860	surfaces	C0205148
27350860	favorable	C3640814
27350860	environment	C0014406
27350860	osteoblast differentiation	C1159974
27350860	LT	C0040302
27350860	surface	C0205148
27350860	implant	C0021102
27350860	surface	C0205148
27350860	modification	C0392747
27350860	studies	C2603343
27352476	Overcoming	C2983310
27352476	structural	C0678594
27352476	inequalities	C0242503
27352476	oral health	C0029162
27352476	dental	C0011365
27352476	curricula	C0010478
27352476	health professional schools	C0036376
27352476	oral health	C0029162
27352476	inequalities	C0242503
27352476	attempts	C1516084
27352476	focused	C1285542
27352476	systemic	C0205373
27352476	reform	C0870472
27352476	societal obligations	C0028761
27352476	Professionalism	C4046065
27352476	competency	C0086035
27352476	dental schools	C0036376
27352476	range	C1514721
27352476	Professionalism	C4046065
27352476	competency	C0086035
27352476	debate	C0870392
27352476	shifting phenomenon	C0392747
27352476	professionalism	C4046065
27352476	dental	C0011365
27352476	curricula	C0010478
27352476	social accountability	C0037394
27352476	Social accountability	C0037394
27352476	oral health	C0029162
27352476	professional curricula	C0010478
27352476	education	C0013622
27352476	research	C0035168
27352476	service activities	C1254363
27352476	priority	C0549179
27352476	health	C0018684
27352476	concerns	C2699424
27352476	community	C0009462
27352476	oral health	C0029162
27352476	inequalities	C0242503
27352476	dental schools	C0036376
27352476	socially accountable	C0037394
27352476	address	C0376649
27352476	oral health	C0029162
27352476	inequalities	C0242503
27352476	dental	C0011365
27352476	curricula	C0010478
27352476	political	C0032380
27352476	structural	C0678594
27352476	social	C0337460
27352476	ethical	C0026531
27352476	factors	C1521761
27352476	influence	C4054723
27352476	institutions	C2607850
27352476	graduates	C0588053
27354201	Function	C0542341
27354201	analysis	C0936012
27354201	Mef2c	C1417102
27354201	promoter	C0086860
27354201	muscle differentiation	C1326080
27354201	Regeneration of adult skeletal muscle	C2752380
27354201	injury	C3263722
27354201	activation	C1326120
27354201	satellite cells	C0599856
27354201	proliferates	C0596290
27354201	differentiates	C0007589
27354201	fuses	C1261468
27354201	injured	C0332664
27354201	myofibers	C3899956
27354201	Myocyte enhancer factor 2 (MEF2) proteins	C3658245
27354201	adult	C0001675
27354201	muscle regeneration	C1850849
27354201	Mef2c gene	C1417102
27354201	promoter	C0086860
27354201	pig	C0039005
27354201	Mef2c gene	C1417102
27354201	Quantitative real-time PCR	C3179034
27354201	qRT-PCR	C3179034
27354201	expression	C0017262
27354201	Mef2c gene	C1417102
27354201	muscle	C0026845
27354201	tissues	C0040300
27354201	Mef2c	C1417102
27354201	promoter	C0086860
27354201	transcriptional activity	C0040649
27354201	differentiated	C0007589
27354201	C2C12 cells	C0007634
27354201	proliferating	C0596290
27354201	C2C12 cells	C0007634
27354201	up-regulation	C0162493
27354201	mRNA expression	C1515670
27354201	Mef2c gene	C1417102
27354201	Function	C0542341
27354201	deletion	C0017260
27354201	mutation	C0026882
27354201	analyses	C0936012
27354201	MyoD	C0165230
27354201	MEF2	C3658245
27354201	binding sites	C1514535
27354201	Mef2c	C1417102
27354201	promoter	C0086860
27354201	regulation	C1158770
27354201	Mef2c	C1417102
27354201	transcription	C0040649
27354201	MEF2C	C1417102
27354201	up-regulate the transcriptional activities	C0162493
27354201	Mef2c	C1417102
27354201	promoter constructs	C0086860
27354201	3'-end nucleotide sequence	C0314659
27354201	p300	C1530358
27354201	binding site	C0004793
27354201	Electrophoretic mobility shift assays	C0949632
27354201	EMSA	C0949632
27354201	chromatin immunoprecipitation (ChIP) assays	C1328856
27354201	MyoD	C0165230
27354201	binding site	C1514535
27354201	Mef2c	C1417102
27354201	promoter	C0086860
27354201	promoter	C0086860
27354201	pig	C0039005
27354201	Mef2c gene	C1417102
27354201	Mef2c	C1417102
27354201	promoter	C0086860
27354201	regulation mechanisms	C1158770
27354201	Mef2c	C1417102
27354201	muscle differentiation	C1326080
27354201	muscle repair	C0185414
27354201	regeneration	C1850849
27354236	diabetic	C0241863
27354236	bladder disorder	C0005686
27354236	metabolomic analysis	C1328813
27354236	rat	C0034721
27354236	diabetic	C0241863
27354236	detrusor	C1180419
27354236	urothelial layer	C0227692
27354236	changes	C0392747
27354236	bladder	C0005682
27354236	metabolism	C0025519
27354236	diabetes	C0011847
27354236	diabetic	C0241863
27354236	bladder disorder (DBD)	C0005686
27354236	metabolome	C2350399
27354236	detrusor	C1180419
27354236	urothelial layer	C0227692
27354236	streptozotocin	C0038432
27354236	rat	C0034721
27354236	model	C0012644
27354236	type 1 diabetes	C0011854
27354236	nondiabetic controls	C0009932
27354236	diabetes	C0011847
27354236	changes	C0392747
27354236	detrusor	C1180419
27354236	urothelial layer's	C0227692
27354236	metabolome	C2350399
27354236	Diabetes	C0011847
27354236	changes	C0392747
27354236	diabetic	C0011847
27354236	markers	C0005516
27354236	tissues	C0040300
27354236	glucose	C0017725
27354236	lactate	C0064582
27354236	2-hydroxybutyrate	C0046188
27354236	branched-chain amino acid degradation products	C3494275
27354236	bile acids	C0005390
27354236	1,5-anhydroglucitol	C0044029
27354236	markers	C0005516
27354236	oxidative stress	C0242606
27354236	detrusor	C1180419
27354236	urothelial layer	C0227692
27354236	diabetes	C0011847
27354236	pentose-phosphate	C0030893
27354236	polyol	C0071629
27354236	pathways	C1704259
27354236	TCA cycle	C1516586
27354236	β-oxidation	C1158368
27354236	Changes	C0392747
27354236	detrusor	C1180419
27354236	energy-generating pathways	C1158271
27354236	sorbitol	C0037688
27354236	advanced glycation end products	C0162574
27354236	DBD	C0005686
27354236	diabetic	C0241863
27354236	urothelial layer	C0227692
27354236	flux	C2348693
27354236	glucose	C0017725
27354236	glycolysis	C0017952
27354236	changes	C0392747
27354236	changes	C0392747
27354236	lipid metabolism	C0598783
27354236	prostaglandin	C0033554
27354236	synthesis	C1883254
27354236	detrusor	C1180419
27354236	dysfunction	C0277785
27355340	Proximal Soil Sensing	C0022885
27355340	Contribution	C1880177
27355340	Species	C1705920
27355340	Habitat	C0871648
27355340	Distribution	C1704711
27355340	Modelling	C0870071
27355340	Earthworms	C0086194
27355340	Agricultural	C0562975
27355340	Soils	C0037592
27355340	Earthworms	C0086194
27355340	soil	C0037592
27355340	ecosystem	C0162358
27355340	functioning	C0542341
27355340	indicators	C0021212
27355340	soil	C0037592
27355340	fertility	C0205556
27355340	earthworms	C0086194
27355340	time-consuming	C3827829
27355340	assessment	C1516048
27355340	earthworm	C0086194
27355340	abundances	C2346714
27355340	sampling	C0870078
27355340	density	C0178587
27355340	fields	C0562975
27355340	mobile terrestrial sensor platforms	C0183210
27355340	proximal soil sensing	C0022885
27355340	PSS	C0022885
27355340	tools	C0336791
27355340	information	C1533716
27355340	soils	C0037592
27355340	sensing principles	C0282574
27355340	PSS	C0022885
27355340	assessing	C1516048
27355340	earthworm	C0086194
27355340	habitats	C0871648
27355340	study	C2603343
27355340	investigates	C1292732
27355340	PSS	C0022885
27355340	data	C1511726
27355340	prediction	C0681842
27355340	earthworm	C0086194
27355340	abundances	C2346714
27355340	species	C1705920
27355340	distribution	C1704711
27355340	models	C3161035
27355340	agricultural	C0562975
27355340	soils	C0037592
27355340	Proximal soil sensing	C0022885
27355340	data	C1511726
27355340	soil	C0037592
27355340	electrical conductivity	C0013777
27355340	EC	C0013777
27355340	pH	C0020283
27355340	near infrared absorbance	C0376519
27355340	NIR	C0376519
27355340	collected	C1516695
27355340	real-time	C1550177
27355340	field	C0562975
27355340	management strategies	C0680830
27355340	reduced	C0392756
27355340	tillage	C1254366
27355340	tillage	C1254366
27355340	sandy	C0037592
27355340	loam soils	C0037592
27355340	PSS	C0022885
27355340	observations	C0302523
27355340	long-term	C0443252
27355340	years	C0439234
27355340	earthworm	C0086194
27355340	observation study	C0552617
27355340	plots	C0562975
27355340	Earthworms	C0086194
27355340	sampled	C0870078
27355340	soil	C0037592
27355340	identified	C0205396
27355340	species	C1705920
27355340	level	C0441889
27355340	Sensor	C0600364
27355340	data	C1511726
27355340	earthworm	C0086194
27355340	abundances	C2346714
27355340	observed	C1441672
27355340	reduced	C0392756
27355340	tillage	C1254366
27355340	correlated	C1707520
27355340	earthworm	C0086194
27355340	abundances	C2346714
27355340	observed	C1441672
27355340	conventional tillage	C1254366
27355340	management	C1273870
27355340	influences	C4054723
27355340	sensor	C0600364
27355340	earthworm	C0086194
27355340	models	C3161035
27355340	state-space models	C3161035
27355340	modelling	C0870071
27355340	data	C1511726
27355340	EC	C0013777
27355340	pH	C0020283
27355340	NIR	C0376519
27355340	sensors	C0600364
27355340	results	C0683954
27355340	modelling	C0870071
27355340	sensor	C0600364
27355340	data	C1511726
27355340	data	C1511726
27355340	sensor	C0600364
27355340	earthworm	C0086194
27355340	species	C1705920
27355340	sensor	C0600364
27355340	habitat	C0871648
27355340	requirements	C1514873
27355340	earthworms	C0086194
27355340	Earthworm	C0086194
27355340	species	C1705920
27355340	soil	C0037592
27355340	habitat	C0871648
27355340	preferences	C0558295
27355340	accuracy	C0443131
27355340	PSS	C0022885
27355340	ubiquitous	C2348867
27355340	species	C1705920
27355340	findings	C0243095
27355340	PSS	C0022885
27355340	modelling	C0870071
27355340	earthworm	C0086194
27355340	abundances	C2346714
27355340	field scale	C0814860
27355340	species	C1705920
27355340	distribution	C1704711
27355340	modelling	C0870071
27355340	soil	C0037592
27355340	earthworm	C0086194
27355340	agroecosystems	C0162358
27355434	Size	C0870226
27355434	Brain volume	C1113695
27355434	correlates	C1707520
27355434	intrinsic	C0205102
27355434	brain activity	C0443158
27355434	healthy	C3898900
27355434	individuals	C0027361
27355434	neuroscience	C0027910
27355434	structural	C0678594
27355434	substrates	C1521761
27355434	Intrinsic	C0205102
27355434	brain activity	C0443158
27355434	cognitive functions	C0392335
27355434	cognitive functions	C0392335
27355434	brain volume	C1113695
27355434	size	C0870226
27355434	association	C0439849
27355434	intrinsic	C0205102
27355434	brain activities	C0443158
27355434	brain volume	C1113695
27355434	size	C0870226
27355434	brain volume	C1113695
27355434	size	C0870226
27355434	impact	C4049986
27355434	intrinsic	C0205102
27355434	brain activity	C0443158
27355434	human	C0086418
27355434	brains	C0006104
27355434	study	C2603343
27355434	investigate	C1292732
27355434	brain structure	C0006104
27355434	function	C0031843
27355434	relationship	C0439849
27355434	cohorts	C0599755
27355434	young adults	C0238598
27355434	Structural	C0678594
27355434	MRI	C0024485
27355434	performed	C0884358
27355434	estimate	C0750572
27355434	brain volume	C1113695
27355434	resting-state functional-MRI	C4288291
27355434	amplitude of low-frequency fluctuations	C0392762
27355434	ALFF	C0392762
27355434	intrinsic	C0205102
27355434	brain activity	C0443158
27355434	linear	C0205132
27355434	correlation	C1707520
27355434	whole-brain size	C0870226
27355434	ALFF	C0392762
27355434	specific	C0205369
27355434	brain lobes	C0228179
27355434	regions	C1273723
27355434	frontal lobe	C0016733
27355434	left middle frontal gyrus	C2338540
27355434	anterior cingulate gyrus	C0175190
27355434	Rolandic operculum	C0228265
27355434	insula	C0021640
27355434	reliable	C0205556
27355434	positive	C1446409
27355434	volume	C1113695
27355434	ALFF	C0392762
27355434	correlation	C1707520
27355434	cohorts	C0599755
27355434	direct	C1947931
27355434	empirical	C1880496
27355434	evidence of	C0332120
27355434	strong	C0442821
27355434	association	C0439849
27355434	brain size	C0870226
27355434	volume	C1113695
27355434	intrinsic	C0205102
27355434	brain activity	C0443158
27355434	structural	C0678594
27355434	substrates	C1521761
27355434	intrinsic	C0205102
27355434	brain activity	C0443158
27355434	human	C0086418
27355434	brain	C0006104
27356521	Control	C2587213
27356521	Social	C0728831
27356521	Approach-Avoidance Behavior	C0562433
27356521	Neural	C3714606
27356521	Endocrine	C0521425
27356521	Mechanisms	C0441712
27356521	ability	C0085732
27356521	control	C2587213
27356521	automatic	C0205554
27356521	action	C3266814
27356521	tendencies	C0750492
27356521	crucial	C1511545
27356521	adequate	C0205411
27356521	social interactions	C0037420
27356521	Emotional	C0849912
27356521	events	C0441471
27356521	trigger	C1444748
27356521	automatic	C0205554
27356521	approach and avoidance	C0562433
27356521	tendencies	C0750492
27356521	actions	C3266814
27356521	adaptive	C0231193
27356521	capacity	C1516240
27356521	override	C1547671
27356521	emotional reactions	C0221736
27356521	key	C1706198
27356521	flexible	C0443220
27356521	behavior	C0004927
27356521	social interaction	C0037420
27356521	present	C0521116
27356521	chapter	C1552857
27356521	provides	C1999230
27356521	review	C1552617
27356521	neuroendocrine	C0027912
27356521	mechanisms	C0441712
27356521	ability	C0085732
27356521	relation	C0439849
27356521	social	C0728831
27356521	psychopathologies	C0033927
27356521	Aberrant	C0443127
27356521	social behavior	C0037397
27356521	observed	C1441672
27356521	social anxiety	C4237417
27356521	psychopathy	C0031212
27356521	marked	C1706089
27356521	abnormalities	C1704258
27356521	approach-avoidance	C0562433
27356521	tendencies	C0750492
27356521	ability	C0085732
27356521	control	C2587213
27356521	Key	C1706198
27356521	neural	C3714606
27356521	regions	C0205147
27356521	involved	C1314939
27356521	regulation	C1327622
27356521	approach-avoidance behavior	C0562433
27356521	amygdala	C0002708
27356521	implicated	C4049986
27356521	automatic	C0205554
27356521	emotional	C0849912
27356521	processing	C0025361
27356521	anterior	C0205094
27356521	prefrontal cortex	C0162783
27356521	exerts	C0015264
27356521	control	C2587213
27356521	amygdala	C0002708
27356521	Hormones	C0019932
27356521	testosterone	C0039601
27356521	cortisol	C0020268
27356521	affect	C0001721
27356521	approach-avoidance behavior	C0562433
27356521	associated	C0332281
27356521	neural	C3714606
27356521	mechanisms	C0441712
27356521	present	C0521116
27356521	chapter	C1552857
27356521	directly	C1947931
27356521	influence	C4054723
27356521	social	C0728831
27356521	approach and avoidance behavior	C0562433
27356521	research	C0035168
27356521	agenda	C0681473
27356521	advance	C1527148
27356521	important	C3898777
27356521	research field	C0035168
27356521	Control	C2587213
27356521	approach-avoidance	C0562433
27356521	tendencies	C0750492
27356521	exemplar	C3161035
27356521	emotional	C0849912
27356521	action	C3266814
27356521	regulation	C1327622
27356521	great	C1704243
27356521	value	C3827682
27356521	understanding	C0162340
27356521	mechanisms	C0441712
27356521	development	C1527148
27356521	affective disorders	C0001723
27356693	Non-Clear Cell Renal Cell Carcinoma	C0007134
27356693	Oman	C0028971
27356693	renal cell carcinoma	C0007134
27356693	RCC	C0007134
27356693	older patients	C0030705
27356693	clear cell type	C0279702
27356693	histology	C0019638
27356693	ethnic variations	C0205419
27356693	study	C2603343
27356693	epidemiological pattern	C0681682
27356693	RCC	C0007134
27356693	Oman	C0028971
27356693	RCC	C0007134
27356693	patients	C0030705
27356693	presented	C0449450
27356693	tertiary care center	C0587437
27356693	Sultanate of Oman	C0017446
27356693	studied	C2603343
27356693	main findings	C0243095
27356693	median age	C0001779
27356693	presentation	C0449450
27356693	low	C0205251
27356693	patients	C0030705
27356693	presented	C0449450
27356693	localized	C0392752
27356693	stage	C1306673
27356693	non-clear	C0007134
27356693	papillary	C1306837
27356693	histology	C0019638
27356693	Data	C1511726
27356693	Gulf countries	C0454664
27357394	Patient Mobility	C2094221
27357394	Elective	C0814500
27357394	Secondary Health Care Services	C0018747
27357394	Response	C2911692
27357394	Patient Choice Policies	C0600591
27357394	Systematic Review	C1955832
27357394	empirical	C1880496
27357394	evidence	C3887511
27357394	patient mobility	C2094221
27357394	elective secondary care services	C3494402
27357394	countries	C0454664
27357394	patients	C0030705
27357394	health care provider	C1999121
27357394	PubMed	C1138432
27357394	Embase	C0282574
27357394	articles	C1706852
27357394	titles	C1705823
27357394	abstracts	C0600678
27357394	reviewed	C1709940
27357394	studies	C0008972
27357394	studies	C0008972
27357394	methodological	C0025662
27357394	models	C3161035
27357394	mobility	C0425245
27357394	Variation	C0205419
27357394	patient mobility	C2094221
27357394	Mobility	C0425245
27357394	associated with	C0332281
27357394	lower waiting times	C0814636
27357394	indicators	C1522602
27357394	better service quality	C0034379
27357394	advanced technology	C1510819
27357394	advanced age	C0001792
27357394	socioeconomic	C0748878
27357394	policy	C0242456
27357394	perspective	C0032670
27357394	proportion	C1709707
27357394	patients	C0030705
27357394	travel	C0040802
27357394	provider	C1999121
27357394	elective services	C0814500
27357394	providers	C1999121
27357394	winners	C0511302
27357394	losers	C0243095
27357394	decreased	C0205216
27357394	provider	C1999121
27357394	capacity	C1516240
27357394	inefficient	C0231185
27357394	services	C0018747
27357394	Equity	C4042901
27358525	New	C0205314
27358525	Breast Pain	C0024902
27358525	Chart	C0007963
27358525	Objective Record	C0034869
27358525	Mastalgia	C0024902
27358525	Mastalgia	C0024902
27358525	commonest	C0205214
27358525	affliction	C0018235
27358525	mammary gland	C0929301
27358525	ladies	C0043210
27358525	reproductive	C0035156
27358525	age group	C0027362
27358525	etiopathogenesis	C1510540
27358525	therapy	C0087111
27358525	different	C1705242
27358525	cyclical	C0405472
27358525	noncyclical pain	C0405473
27358525	breast clinics	C3810844
27358525	patient	C0030705
27358525	pain diary	C0451366
27358525	period	C1948053
27358525	months	C0439231
27358525	menstrual cycles	C0025329
27358525	Cardiff pain chart records	C0007963
27358525	severity	C0439793
27358525	pain	C0030193
27358525	triangle	C0205119
27358525	mild	C2945599
27358525	moderate pain	C0278139
27358525	square	C0205120
27358525	severe pain	C0278140
27358525	Cardiff pain chart	C0007963
27358525	patient	C0030705
27358525	record	C2355580
27358525	severity	C0439793
27358525	pain	C0030193
27358525	days	C0439228
27358525	menses	C0025344
27358525	problems	C0033213
27358525	resolved	C2699488
27358525	new	C0205314
27358525	breast pain	C0024902
27358525	chart	C0007963
27358525	new	C0205314
27358525	pain chart	C0007963
27358525	lady	C0043210
27358525	records	C2355580
27358525	pain	C0030193
27358525	severity	C0439793
27358525	visual linear analogue scale score	C2960751
27358525	every day	C0332173
27358525	menstrual cycle	C0025329
27358525	menstrual	C0025329
27358525	experience	C0596545
27358525	chart	C0007963
27358525	visualize	C0449911
27358525	month's	C0439231
27358525	pain	C0030193
27358525	severity	C0439793
27358905	Cigarettes	C0677453
27358905	Tanzania	C0039298
27358905	Implications	C0814846
27358905	Tobacco	C0040329
27358905	Taxation Policy	C0681007
27358905	study	C2603343
27358905	cigarettes	C0677453
27358905	Tanzania	C0039298
27358905	simulation	C0679083
27358905	results	C1274040
27358905	effect	C1280500
27358905	cigarette	C0677453
27358905	excise tax	C0681045
27358905	smoking	C0037369
27358905	participation	C0679823
27358905	government revenue	C0681043
27358905	magnitude	C1704240
27358905	cigarette consumption	C0459840
27358905	country	C0454664
27358905	African	C0454695
27358905	countries	C0454664
27358905	Tanzanian	C0039298
27358905	household budget	C0006347
27358905	survey	C0038951
27358905	cigarettes	C0677453
27358905	Tanzania	C0039298
27358905	smoking	C0037369
27358905	Tanzania	C0039298
27358905	expenditure (income) groups	C0681860
27358905	Smoking	C0037369
27358905	per capita consumption	C0681013
27358905	cigarettes	C0677453
27358905	cigarettes	C0677453
27358905	two-part demand equation model	C3161035
27358905	elasticities	C0680960
27358905	equation	C0552449
27358905	price elasticities	C0814751
27358905	smoking	C0037369
27358905	participation	C0679823
27358905	smoking	C0037369
27358905	elasticity	C0680960
27358905	developing countries	C0011750
27358905	expenditure (income) groups	C0681860
27358905	magnitude	C1704240
27358905	elasticity	C0680960
27358905	high expenditure groups	C0681860
27358905	low expenditure groups	C0681860
27358905	simulation	C0679083
27358905	effect	C1280500
27358905	excise	C0681045
27358905	rates	C1521828
27358905	smoking	C0037369
27358905	participation rate	C1521828
27358905	cigarette consumption	C0459840
27358905	tax revenue	C0681043
27358905	effect	C1280500
27358905	increase	C0442805
27358905	cigarette	C0677453
27358905	excise tax	C0681045
27358905	expenditure groups	C0681860
27358905	results	C1274040
27358905	increase	C0442805
27358905	excise tax	C0681045
27358905	cigarettes	C0677453
27358905	Tanzania	C0039298
27358905	cigarette consumption	C0459840
27358905	increase	C0442805
27358905	government tax revenue	C0681043
27364111	Physicians'	C0031831
27364111	work-related	C0871617
27364111	chronic obstructive pulmonary disease	C0024117
27364111	Chronic obstructive pulmonary disease	C0024117
27364111	COPD	C0024117
27364111	work environment	C0162579
27364111	conditions	C0348080
27364111	estimates	C0750572
27364111	COPD	C0024117
27364111	cases	C0868928
27364111	associated with	C0332281
27364111	occupational exposure	C0028798
27364111	dusts	C0013330
27364111	irritant	C0022108
27364111	gases	C0017110
27364111	cases	C0868928
27364111	work-related	C0871617
27364111	COPD	C0024117
27364111	Poland	C0032356
27364111	study	C2603343
27364111	analyze	C0936012
27364111	low	C0205251
27364111	incidence	C0021149
27364111	work-related	C0871617
27364111	COPD	C0024117
27364111	context	C0449255
27364111	pulmonologists	C0586859
27364111	occupational	C0521127
27364111	risk factors	C0035648
27364111	procedures	C2700391
27364111	reporting	C0700287
27364111	suspected	C0277540
27364111	occupational diseases	C0028797
27364111	survey	C0038951
27364111	pulmonologists	C0586859
27364111	randomly	C0439605
27364111	specialists	C0920580
27364111	Local Physicians Chamber	C1708333
27364111	Łódź	C0681784
27364111	study	C2603343
27364111	performed	C0884358
27364111	anonymously	C2346787
27364111	questionnaire	C0034394
27364111	surveyed	C0038951
27364111	pulmonologists	C0586859
27364111	identified	C0205396
27364111	environmental	C0014406
27364111	risk factors	C0035648
27364111	COPD	C0024117
27364111	identified	C0205396
27364111	occupational	C0521127
27364111	risk factors	C0035648
27364111	cause	C0085978
27364111	COPD	C0024117
27364111	pulmonologists	C0586859
27364111	patients	C0030705
27364111	suffering	C0231303
27364111	COPD	C0024117
27364111	job	C0028811
27364111	profession	C0028811
27364111	procedures	C2700391
27364111	reporting	C0700287
27364111	suspected	C0277540
27364111	occupational diseases	C0028797
27364111	physicians	C0031831
27364111	rarely	C0522498
27364111	patients	C0030705
27364111	suffering	C0231303
27364111	COPD	C0024117
27364111	job	C0028811
27364111	profession	C0028811
27364111	relationship	C0439849
27364111	ailments	C0221423
27364111	occupational exposure	C0028798
27364111	legal regulations	C0680575
27364111	referral of a patient	C0034927
27364111	suspected	C0277540
27364111	case	C0868928
27364111	occupational disease	C0028797
27364111	results	C1274040
27364111	study	C2603343
27364111	indicate	C3146298
27364111	increasing	C0442808
27364111	pulmonologists	C0586859
27364111	work-related	C0871617
27364111	COPD	C0024117
27366176	Case Report	C0085973
27366176	Necrotizing Fasciitis	C0238124
27366176	Associated with	C0332281
27366176	Streptococcus pneumoniae	C0038410
27366176	Necrotizing fasciitis	C0238124
27366176	Streptococcus pneumoniae	C0038410
27366176	extremely rare	C0522498
27366176	life-threatening	C2826244
27366176	bacterial	C0004611
27366176	soft tissue infection	C0149778
27366176	report	C0700287
27366176	case	C0868928
27366176	necrotizing fasciitis	C0238124
27366176	associated with	C0332281
27366176	Streptococcus pneumoniae	C0038410
27366176	infection	C3714514
27366176	year	C0439234
27366176	man	C0025266
27366176	immunocompromised	C0085393
27366176	mixed connective tissue disease	C0026272
27366176	patient	C0030705
27366176	acute	C0205178
27366176	painful	C0030193
27366176	erythematous	C0332476
27366176	edematous skin	C0521464
27366176	lesions	C0221198
27366176	right lower back	C0817923
27366176	progressed	C1280477
27366176	right knee	C0230431
27366176	patient	C0030705
27366176	surgical exploration	C0184899
27366176	diagnosis	C0011900
27366176	necrotizing fasciitis	C0238124
27366176	pathological	C1521733
27366176	evidence	C3887511
27366176	necrosis	C0027540
27366176	fascia	C0015641
27366176	neutrophil infiltration	C0751982
27366176	tissue biopsies	C3864006
27366176	Cultures	C3826495
27366176	fascial	C0015450
27366176	tissue biopsies	C3864006
27366176	blood samples	C0178913
27366176	positive	C1446409
27366176	Streptococcus pneumoniae	C0038410
27366176	report	C0700287
27366176	necrotizing fasciitis	C0238124
27366176	Streptococcus pneumoniae	C0038410
27366176	diagnosed	C0011900
27366176	phase	C0205390
27366176	patient recovered	C1115804
27366176	surgical debridement	C0455097
27366491	Comparative Study	C1579762
27366491	Efficacy	C1280519
27366491	IV	C0348016
27366491	Dexketoprofen	C0772505
27366491	Lornoxicam	C0055477
27366491	Diclophenac Sodium	C1254351
27366491	Postoperative Analgesia	C0853389
27366491	Tramadol	C0040610
27366491	Consumption	C0678263
27366491	Patients	C0030705
27366491	Patient-Controlled	C0078944
27366491	Tramadol	C0040610
27366491	study	C2603343
27366491	designed	C1707689
27366491	compare	C1707455
27366491	effects of	C1704420
27366491	dexketoprofen	C0772505
27366491	lornoxicam	C0055477
27366491	diclophenac sodium	C1254351
27366491	postoperative analgesia	C0853389
27366491	tramadol	C0040610
27366491	consumption	C0678263
27366491	patients	C0030705
27366491	postoperative	C0032790
27366491	patient-controlled	C0078944
27366491	tramadol	C0040610
27366491	major	C0205164
27366491	abdominal surgery	C0198482
27366491	patients	C0030705
27366491	randomized	C3815594
27366491	study	C2603343
27366491	drugs	C1254351
27366491	Patients	C0030705
27366491	group	C0441833
27366491	dexketoprofen	C0772505
27366491	DT	C0772505
27366491	IV	C0348016
27366491	dexketoprofen	C0772505
27366491	group	C0441833
27366491	lornoxicam	C0055477
27366491	LR	C0055477
27366491	IV	C0348016
27366491	lornoxicam	C0055477
27366491	group	C0441833
27366491	diclophenac sodium	C1254351
27366491	DS	C1254351
27366491	IV	C0348016
27366491	diclophenac sodium	C1254351
27366491	group	C0441833
27366491	saline	C0036082
27366491	S	C0036082
27366491	saline	C0036082
27366491	syringes	C0039142
27366491	min	C0439232
27366491	anaesthesia	C0002903
27366491	standardized	C1442989
27366491	dose	C0178602
27366491	tramadol	C0040610
27366491	routinely	C0205547
27366491	administered	C1621583
27366491	patients	C0030705
27366491	loading dose	C3714444
27366491	surgery	C0543467
27366491	Postoperatively	C0032790
27366491	patients	C0030705
27366491	tramadol	C0040610
27366491	patient-controlled analgesia device	C3266095
27366491	bolus dose	C1511237
27366491	tramadol	C0040610
27366491	Pain	C0030193
27366491	discomfort	C0231218
27366491	sedation	C0235195
27366491	scores	C0449820
27366491	cumulative	C1511559
27366491	tramadol	C0040610
27366491	consumption	C0678263
27366491	supplemental	C2348609
27366491	meperidine	C0025376
27366491	requirement	C1514873
27366491	side effects	C0879626
27366491	Visual rating scale	C0681889
27366491	patient	C0030705
27366491	discomfort	C0231218
27366491	scores	C0449820
27366491	significantly	C0750502
27366491	lower	C2003888
27366491	DT	C0772505
27366491	LR	C0055477
27366491	DS	C1254351
27366491	groups	C0441833
27366491	group	C0441833
27366491	S	C0036082
27366491	Cumulative	C1511559
27366491	tramadol	C0040610
27366491	consumption	C0678263
27366491	significantly	C0750502
27366491	lower	C2003888
27366491	non-steroidal anti-inflammatory drug	C3536840
27366491	NSAID	C3536840
27366491	treated	C1522326
27366491	groups	C0441833
27366491	study period	C2347804
27366491	postoperative	C0032790
27366491	hour	C0439227
27366491	group	C0441833
27366491	S	C0036082
27366491	Supplemental	C2348609
27366491	meperidine	C0025376
27366491	requirement	C1514873
27366491	significantly	C0750502
27366491	group	C0441833
27366491	S	C0036082
27366491	study period	C2347804
27366491	postoperative	C0032790
27366491	min	C0439232
27366491	NSAID	C3536840
27366491	treated	C1522326
27366491	groups	C0441833
27366491	major	C0205164
27366491	abdominal surgery	C0198482
27366491	IV	C0348016
27366491	diclophenac	C0012091
27366491	lornoxicam	C0055477
27366491	dexketoprofen	C0772505
27366491	patient-controlled	C0078944
27366491	tramadol	C0040610
27366491	lower	C2003888
27366491	pain	C0030193
27366491	scores	C0449820
27366491	smaller	C0547044
27366491	tramadol	C0040610
27366491	consumption	C0678263
27366491	supplemental	C2348609
27366491	analgesic	C0002771
27366491	requirement	C1514873
27366491	side effects	C0879626
27366491	tramadol	C0040610
27366491	group	C0441833
27366556	Perioperative Management	C0150706
27366556	Severe Hypertension	C4013784
27366556	Laparoscopic Surgery	C0751429
27366556	Pheochromocytoma	C0031511
27366556	Phaeochromocytoma	C0031511
27366556	catecholamine-secreting	C1325901
27366556	vascular tumour	C0282607
27366556	chromaffin cell	C0376604
27366556	Lethal	C3151529
27366556	cardiovascular complications	C0161816
27366556	hypertension	C0020538
27366556	myocardial infarction	C0027051
27366556	aortic dissection	C0340643
27366556	uncontrolled catecholamine release	C0271748
27366556	stage	C0205390
27366556	anaesthesia management	C1300200
27366556	destructive catecholamine secretion	C0271748
27366556	induction	C0857127
27366556	perioperative stage	C1518988
27366556	surgical manipulation	C0185111
27366556	preoperative preparation	C0150706
27366556	severe, persistent hypertension attack management	C1254363
27366556	α-adrenergic blockade	C3536752
27366556	β-adrenergic blockade	C3536830
27366556	sodium nitroprusside	C0037533
27366556	remifentanil	C0246631
27366556	patient	C0030705
27366556	laparoscopic surgery	C0751429
27366556	phaeochromocytoma	C0031511
27370179	case	C0868928
27370179	reflection	C0243095
27370179	communicating end	C0205196
27370179	life	C0376558
27370179	information	C1533716
27370179	non-English speaking	C1546417
27370179	patients	C0030705
27370179	year old	C1510829
27370179	Chinese	C0152035
27370179	man	C0025266
27370179	non-English speaking	C1546417
27370179	emergency department	C0562508
27370179	non-specific	C0205370
27370179	symptoms	C1457887
27370179	diagnosed	C0011900
27370179	advanced cancer of the pancreas	C0235974
27370179	aggressive	C2945759
27370179	treatment resistant cancer	C0871547
27370179	poor prognosis	C0278252
27370179	diagnosis	C0011900
27370179	family	C0015576
27370179	team	C0086390
27370179	medical	C0205476
27370179	issues	C0033213
27370179	diagnosis	C0011900
27370179	support	C1521721
27370179	family	C0015576
27370179	diagnosis	C0011900
27370179	collective will	C0680341
27370179	information	C1533716
27370179	medical	C0205476
27370179	discussion	C0557061
27370179	doctor in charge	C0031831
27370179	diagnosis	C0011900
27370179	interpreter	C0150646
27370179	family	C0015576
27370179	bed	C0004916
27370179	case	C0868928
27370179	respecting patients' and families' preferences	C1279750
27370179	medical treatment and care	C0237726
27371369	Difference-in-Differences Method	C1710191
27371369	Comparative Effectiveness Research	C2718022
27371369	Unbalanced Groups	C0681860
27371369	Comparative effectiveness research	C2718022
27371369	CER	C2718022
27371369	observational studies	C3658316
27371369	administrative data	C1320722
27371369	CER	C2718022
27371369	group	C0681860
27371369	differences	C1705242
27371369	difference-in-differences (DiD) estimation	C1710191
27371369	DiD	C1710191
27371369	method	C0025663
27371369	treatment outcomes	C0085415
27371369	CER	C2718022
27371369	MarketScan® Databases	C0242356
27371369	multiple sclerosis	C0026769
27371369	MS	C0026769
27371369	patients	C0030705
27371369	therapies	C0087111
27371369	patients	C0030705
27371369	Test Cohort	C2348484
27371369	glatiramer acetate	C0289884
27371369	GA	C0289884
27371369	switched	C2936279
27371369	fingolimod	C1699926
27371369	FTY	C1699926
27371369	Control Cohort	C0009932
27371369	GA	C0289884
27371369	no switch	C0243095
27371369	US administrative claims database	C0242356
27371369	trend analysis	C0681702
27371369	regression	C0034980
27371369	mean	C0444504
27371369	relapse	C0035020
27371369	treatment cohorts	C2348484
27371369	DiD analysis	C1710191
27371369	comparisons	C1707455
27371369	Test	C2348484
27371369	Control Cohorts	C0009932
27371369	Logistic regression	C0206031
27371369	probability	C0033204
27371369	relapse	C0035020
27371369	switching	C2936279
27371369	GA	C0289884
27371369	FTY	C1699926
27371369	compare	C1707455
27371369	group	C0681860
27371369	differences	C1705242
27371369	pre	C0332152
27371369	post	C0687676
27371369	index periods	C1948053
27371369	DiD analysis	C1710191
27371369	pre	C0332152
27371369	index period	C1948053
27371369	patients	C0030705
27371369	Test Cohort	C2348484
27371369	MS	C0026769
27371369	relapse	C0035020
27371369	mean number	C0444504
27371369	relapses	C0035020
27371369	Control Cohort	C0009932
27371369	pre	C0332152
27371369	index period	C1948053
27371369	numeric	C1704455
27371369	MS	C0026769
27371369	relapses	C0035020
27371369	patients	C0030705
27371369	Test Cohort	C2348484
27371369	Control Cohort	C0009932
27371369	no significant	C1273937
27371369	group	C0681860
27371369	differences	C1705242
27371369	post	C0687676
27371369	index period	C1948053
27371369	linear modeling	C0023732
27371369	DiD	C1710191
27371369	regression estimation	C0681925
27371369	MS	C0026769
27371369	relapses	C0035020
27371369	post	C0687676
27371369	index period	C1948053
27371369	patients	C0030705
27371369	Test Cohort	C2348484
27371369	patients	C0030705
27371369	Control Cohort	C0009932
27371369	MS	C0026769
27371369	population	C1257890
27371369	DiD	C1710191
27371369	treatment effects	C1518681
27371369	heterogeneous	C0019409
27371369	population	C1257890
27371369	Test	C2348484
27371369	Control Cohorts	C0009932
27371369	DiD	C1710191
27371369	comparing	C1707455
27371369	diverse	C1880371
27371369	cohorts	C0599755
27371369	risk-adjustment methods	C0600568
27371817	Metabolomic	C1328813
27371817	analysis	C1524024
27371817	glycerophospholipid	C0162448
27371817	inflammation	C0021368
27371817	treated with	C0332293
27371817	non-steroidal anti-inflammatory drugs	C0003211
27371817	RAW264.7 cells	C0024432
27371817	(1)H NMR	C0877853
27371817	U-HPLC	C0008562
27371817	Q-TOF-MS	C0599827
27371817	Non-destructive proton nuclear magnetic resonance ((1)H NMR) spectroscopy	C0877853
27371817	highly sensitive	C0439822
27371817	ultra-performance liquid chromatography	C0008562
27371817	quadrupole time-of-flight mass spectrometry	C0599827
27371817	U-HPLC	C0008562
27371817	Q-TOF-MS	C0599827
27371817	data processing	C0868941
27371817	methods	C0025663
27371817	metabolic profiling	C1328813
27371817	glycerophospholipids	C0162448
27371817	GPLs	C0162448
27371817	RAW264.7 cells	C0024432
27371817	inflammation	C0021368
27371817	prognosis	C0033325
27371817	Analysis	C0936012
27371817	(1)H NMR	C0877853
27371817	models	C3161035
27371817	grouped	C1522242
27371817	differences	C1705242
27371817	highly simple	C0205352
27371817	accurate	C0443131
27371817	(1)H NMR	C0877853
27371817	anti-inflammatory drugs	C0003209
27371817	metabolic profiling	C1328813
27371817	GPLs	C0162448
27371817	GPLs	C0162448
27371817	identified	C0205396
27371817	U-HPLC	C0008562
27371817	Q-TOF-MS	C0599827
27371817	identified	C0205396
27371817	study	C2603343
27371817	potential	C3245505
27371817	biomarkers	C0005516
27371817	phosphatidylcholine	C1959616
27371817	PC	C1959616
27371817	changed	C0443172
27371817	drug-induced	C0458082
27371817	groups	C0441833
27371817	biomarkers	C0005516
27371817	(1)H NMR	C0877853
27371817	U-HPLC	C0008562
27371817	Q-TOF-MS	C0599827
27371817	higher	C0205250
27371817	sensitivity and specificity	C0036668
27371817	determination	C1148554
27371817	biomarkers	C0005516
27371817	deficiency	C2987487
27371817	time-consuming	C3827829
27371817	sample preparation steps	C1720914
27371817	metabolite	C0870883
27371817	identification	C0205396
27371817	changes	C1705241
27371817	GPLs	C0162448
27371817	inflammation	C0021368
27371817	(1)H NMR spectroscopy	C0877853
27371817	U-HPLC	C0008562
27371817	Q-TOF-MS	C0599827
27371817	metabolic profiling	C1328813
27371817	GPLs	C0162448
27371817	evidence	C3887511
27371817	inflammation	C0021368
27371817	diagnosis	C0011900
27371817	prognosis	C0033325
27371817	mechanisms	C0441712
27371817	inflammation	C0021368
27371817	progression	C0242656
27372076	Characterization	C1880022
27372076	novel	C0205314
27372076	DeoR-family	C0035147
27372076	member	C1551024
27372076	Streptomyces ahygroscopicus	C1937901
27372076	strain CK-15	C1518614
27372076	repressor	C1336789
27372076	morphological	C0543482
27372076	development	C1527148
27372076	Wuyiencin	C0031253
27372076	produced	C0441655
27372076	Streptomyces ahygroscopicus var. wuyiensis	C1937901
27372076	China	C0008115
27372076	industrially	C0007983
27372076	produced	C0033268
27372076	biopesticide	C0031253
27372076	control	C0243148
27372076	fungal diseases	C0026946
27372076	mechanism	C0441712
27372076	action	C3266814
27372076	breeding	C0006159
27372076	fermentation	C0015852
27372076	characterized	C1880022
27372076	regulatory functions	C1817179
27372076	biosynthesis	C0005572
27372076	morphological	C0543482
27372076	development	C1527148
27372076	wysR3 gene	C0017337
27372076	S. ahygroscopicus	C1937901
27372076	strain CK-15	C1518614
27372076	novel	C0205314
27372076	member	C1551024
27372076	DeoR family	C0035147
27372076	regulatory genes	C0017362
27372076	assessed	C1516048
27372076	function	C0542341
27372076	gene knockdown	C2350567
27372076	DeoR family proteins	C0035147
27372076	source	C0449416
27372076	single	C0205171
27372076	branch	C1253959
27372076	phylogenetic tree	C0205556
27372076	wysR3	C0017337
27372076	repressor	C1336789
27372076	morphological	C0543482
27372076	development	C1527148
27372076	wuyiencin	C0031253
27372076	production	C0441655
27372076	ΔwysR3	C0017337
27372076	strain	C1518614
27372076	plateau	C2964353
27372076	stage	C1306673
27372076	biomass	C0005535
27372076	faster	C0456962
27372076	wild-type	C1883559
27372076	strain	C1518614
27372076	industrial	C0007983
27372076	fermentation	C0015852
27372076	production	C0033268
27372076	process	C1522240
27372076	ΔwysR3	C0017337
27372076	strain	C1518614
27372076	reduce	C0392756
27372076	consumption	C0009830
27372076	time	C0040223
27372076	money	C0870909
27372861	Targeting	C1521840
27372861	ecology	C0013546
27372861	role	C1705810
27372861	gut-brain axis	C1522496
27372861	human	C0086418
27372861	microbiota	C3887843
27372861	drug addiction	C1510472
27372861	major advances	C3854260
27372861	understanding	C0162340
27372861	brain	C0006104
27372861	using	C1524063
27372861	traditional neuroscience	C0027910
27372861	reliable	C3858758
27372861	efficacious	C1704419
27372861	treatments	C0087111
27372861	drug addiction	C1510472
27372861	remained elusive	C0243095
27372861	time	C0040223
27372861	utilize	C0042153
27372861	novel	C0205314
27372861	approaches	C0449445
27372861	drawing	C0205556
27372861	contemporary	C1254367
27372861	advances	C3854260
27372861	fields	C1521738
27372861	established	C0443211
27372861	neuroscienc	C0027910
27372861	psychiatry	C0033873
27372861	time	C0040223
27372861	paradigm shift	C0681797
27372861	addiction	C0085281
27372861	sciences	C0036397
27372861	Apropos	C1548787
27372861	revolution	C0205245
27372861	area	C0205146
27372861	human	C0086418
27372861	health	C0018684
27372861	underway	C1272688
27372861	occurring	C1709305
27372861	nexus	C0205556
27372861	enteric	C1304890
27372861	microbiology	C0025952
27372861	neuroscience	C0027910
27372861	increasingly	C0442805
27372861	clear	C2963144
27372861	human	C0086418
27372861	microbiota	C3887843
27372861	ecology	C0013546
27372861	bacteria	C0004611
27372861	residing	C2982691
27372861	human	C0086418
27372861	organism	C0029235
27372861	important	C3898777
27372861	role	C1705810
27372861	health	C0018684
27372861	disease	C0012634
27372861	estimated	C0750572
27372861	bacteria	C0004611
27372861	living	C2982691
27372861	human body	C0242821
27372861	approximately	C0332232
27372861	mass	C1306372
27372861	equivalent	C0205163
27372861	human	C0086418
27372861	brain	C0006104
27372861	human cells	C0427861
27372861	understanding	C0162340
27372861	role	C1705810
27372861	microbiota	C3887843
27372861	areas	C0205146
27372861	human	C0086418
27372861	health	C0018684
27372861	yielded	C0392762
27372861	intriguing	C0205556
27372861	results	C1274040
27372861	Clostridium difficile	C1411966
27372861	irritable bowel syndrome	C0022104
27372861	autism	C0004352
27372861	date	C0011008
27372861	systematic	C0220922
27372861	programs	C3484370
27372861	research	C0035168
27372861	examined	C0332128
27372861	role	C1705810
27372861	microbiota	C3887843
27372861	drug addiction	C1510472
27372861	current	C0521116
27372861	hypothesis	C1512571
27372861	gut dysbiosis	C4287543
27372861	role	C1705810
27372861	addictive	C0085281
27372861	disorders	C0012634
27372861	context	C0449255
27372861	hypothesis	C1512571
27372861	paper	C0282420
27372861	provides	C1999230
27372861	rationale	C2699007
27372861	future	C0016884
27372861	research	C0035168
27372861	target	C1521840
27372861	gut	C0699819
27372861	brain	C0006104
27372861	axis	C1522496
27372861	addiction	C0085281
27372861	background	C1706907
27372861	gut	C0699819
27372861	brain	C0006104
27372861	axis	C1522496
27372861	provided	C1999230
27372861	series	C0205549
27372861	hypothesis-driven	C1512571
27372861	ideas	C1947946
27372861	potential	C3245505
27372861	treatments	C0087111
27372861	addiction	C0085281
27372861	manipulations	C0243095
27372861	ecology	C0013546
27373429	Homogeneous	C1881065
27373429	synthesis	C1883254
27373429	Ag nanoparticles	C1721060
27373429	water-soluble cellulose acetate	C0050505
27373429	versatile	C0205556
27373429	applications	C4048755
27373429	report	C0684224
27373429	facile	C0205352
27373429	efficient	C0442799
27373429	approach	C0449445
27373429	synthesis	C1883254
27373429	well-dispersed	C0332624
27373429	stable	C0205360
27373429	silver nanoparticles	C1721060
27373429	Ag NPs	C1721060
27373429	water-soluble cellulose acetate	C0050505
27373429	CA	C0050505
27373429	reductant	C0376446
27373429	stabilizer	C1550603
27373429	Partially	C0728938
27373429	CA	C0050505
27373429	highly	C0205250
27373429	active	C0205177
27373429	hydroxyl groups	C0700307
27373429	excellent	C1961136
27373429	water-solubility	C0597682
27373429	able	C1299581
27373429	reduce	C0301630
27373429	silver ions	C0022023
27373429	homogeneous	C1881065
27373429	aqueous	C0599956
27373429	medium	C1705217
27373429	effectively	C1704419
27373429	synthesized	C1883254
27373429	Ag NPs	C1721060
27373429	characterized	C1880022
27373429	UV-vis spectroscopy	C0037812
27373429	X-ray diffraction	C0043301
27373429	X-ray photoelectron spectroscopy	C2700282
27373429	transmission electron microscopy	C0678118
27373429	energy dispersive X-ray spectroscope	C2699997
27373429	analysis	C0002778
27373429	prepared	C4082130
27373429	Ag NPs	C1721060
27373429	well-dispersed	C0332624
27373429	surface plasmon resonance	C0597731
27373429	peak	C0444505
27373429	nm	C0439202
27373429	Ag NPs	C1721060
27373429	CA	C0050505
27373429	nanohybrids	C1721059
27373429	high	C0205250
27373429	catalytic activity	C1264638
27373429	reduction	C0301630
27373429	4-nitrophenol	C0048581
27373429	4-aminophenol	C0048047
27373429	NaBH4	C0074728
27373429	nanohybrids	C1721059
27373429	effective	C1704419
27373429	inhibiting	C3463820
27373429	growth	C0018270
27373429	bacterial	C0004611
27373429	environmentally friendly method	C2350566
27373429	promotes	C0033414
27373429	use of	C1524063
27373429	renewable natural resources	C0027492
27373429	prepare	C1521827
27373429	variety	C2346866
27373429	inorganic-organic materials	C0520510
27373429	catalysis	C0007382
27373429	antibacterial	C0279516
27373429	sensors	C0183210
27373429	applications	C4048755
27373772	ISX-9	C0022266
27373772	cell proliferation	C0596290
27373772	neuronal	C0027882
27373772	commitment	C1160036
27373772	rat	C0086893
27373772	dentate gyrus	C0152314
27373772	Adult	C0001675
27373772	hippocampal	C0019564
27373772	neurogenesis	C0814002
27373772	modulated	C0443264
27373772	physiological	C1254359
27373772	pathological conditions	C0752135
27373772	stress	C0038435
27373772	affective disorders	C0525045
27373772	neurological	C0205494
27373772	conditions	C0348080
27373772	structural plasticity	C1254358
27373772	functioning	C0031843
27373772	hippocampus	C0019564
27373772	learning	C0023185
27373772	memory	C0025260
27373772	affective	C0243150
27373772	behaviors	C0004927
27373772	alterations	C1515926
27373772	hippocampal	C0019564
27373772	neurogenesis	C0814002
27373772	behavioral	C0004927
27373772	deficits	C2987487
27373772	associated with	C0332281
27373772	psychiatric	C0205487
27373772	neurological	C0205494
27373772	conditions	C0348080
27373772	search	C1706202
27373772	compounds	C1254351
27373772	reverse	C1555029
27373772	deficits	C2987487
27373772	minimal	C0547040
27373772	side effects	C0879626
27373772	study	C0008972
27373772	tested	C0039593
27373772	pro-neurogenic	C0205494
27373772	effects	C1280500
27373772	isoxazole 9	C0022266
27373772	Isx-9	C0022266
27373772	synthetic	C1883254
27373772	molecule	C0567416
27373772	identified	C0205396
27373772	screening of chemical libraries	C0373483
27373772	stem cell-based assays	C0009385
27373772	administration	C1533734
27373772	Isx-9	C0022266
27373772	cell proliferation	C0596290
27373772	increase	C0442805
27373772	number	C0237753
27373772	immature	C0205252
27373772	neurons	C0027882
27373772	hippocampal	C0019564
27373772	DG	C0152314
27373772	adult	C0001675
27373772	rats	C0086893
27373772	In addition	C0332287
27373772	Isx-9	C0022266
27373772	treatment	C0087111
27373772	completely	C0205197
27373772	reverse	C1555029
27373772	marked	C1706089
27373772	reduction	C0392756
27373772	initial	C0205265
27373772	stages	C0205390
27373772	neurogenic process	C1518289
27373772	observed	C1441672
27373772	vehicle	C0042444
27373772	treated	C1522326
27373772	animals	C0003062
27373772	repeated	C0205341
27373772	handling	C0037793
27373772	exposure to	C0332157
27373772	daily	C0332173
27373772	intraperitoneal injections	C0021493
27373772	results	C1254595
27373772	neurogenesis	C0814002
27373772	studies	C0008972
27373772	repeated	C0205341
27373772	handling	C0037793
27373772	manipulation	C0947647
27373772	animals	C0003062
27373772	control	C0243148
27373772	baseline	C1442488
27373772	levels	C0441889
27373772	hippocampal	C0019564
27373772	cell proliferation	C0596290
27373772	neuronal	C0027882
27373772	differentiation	C0007589
27373772	findings	C2825141
27373772	Isx-9	C0022266
27373772	synthetic	C1883254
27373772	compound	C1254351
27373772	mitigation	C1553901
27373772	stress	C0038435
27373772	induced	C0205263
27373772	deficits	C2987487
27373772	adult	C0001675
27373772	hippocampal	C0019564
27373772	neurogenesis	C0814002
27373772	studies	C0008972
27373772	evaluate	C0220825
27373772	pro-neurogenic	C0205494
27373772	properties	C0871161
27373772	Isx-9	C0022266
27373772	animal models	C0599779
27373772	affective	C0525045
27373772	neurological disorders	C0027765
27373772	associated with	C0332281
27373772	impaired	C0221099
27373772	hippocampal	C0019564
27373772	structural plasticity	C1254358
27375774	Changes	C0392747
27375774	parenting	C0085092
27375774	strategies	C0679199
27375774	young	C0332239
27375774	person's	C0027361
27375774	self-harm	C0424366
27375774	qualitative study	C0949415
27375774	discovery	C1880355
27375774	child's	C0008059
27375774	self-harm	C0424366
27375774	mothers	C0026591
27375774	fathers	C0015671
27375774	re-evaluate	C0220825
27375774	parenting	C0085092
27375774	strategies	C0679199
27375774	changes	C0392747
27375774	support	C0037438
27375774	child	C0008059
27375774	changes	C0392747
27375774	degree	C0449286
27375774	control	C0243148
27375774	monitor	C0441655
27375774	child	C0008059
27375774	in-depth qualitative study	C0949415
27375774	parents	C0030551
27375774	young	C0332239
27375774	people	C0027361
27375774	self-harmed	C0424366
27375774	parenting	C0085092
27375774	changed	C0392747
27375774	discovery	C1880355
27375774	self-harm	C0424366
27375774	Early	C1279919
27375774	parents	C0030551
27375774	upset	C3887804
27375774	child	C0008059
27375774	control	C0243148
27375774	Parents	C0030551
27375774	reactions	C0443286
27375774	self-harm	C0424366
27375774	adolescence	C0001578
27375774	mental health issue	C4061796
27375774	naughty behaviour	C0004927
27375774	Parenting	C0085092
27375774	children	C0008059
27375774	family	C0015576
27375774	parents	C0030551
27375774	time	C0040223
27375774	siblings	C0037047
27375774	parents	C0030551
27375774	strategies	C0679199
27375774	parents	C0030551
27375774	learning	C0023185
27375774	blaming	C0870209
27375774	child	C0008059
27375774	self-harm	C0424366
27375774	communicate	C0566001
27375774	child	C0008059
27375774	Parents	C0030551
27375774	knowledge	C0376554
27375774	people	C0027361
27375774	situation	C0868928
27375774	Parents	C0030551
27375774	changes	C0392747
27375774	parenting	C0085092
27375774	behaviours	C0004927
27375774	discovery	C1880355
27375774	child	C0008059
27375774	self-harm	C0424366
27375774	Professionals	C0679924
27375774	care	C1947933
27375774	young	C0332239
27375774	people	C0027361
27375774	self-harm	C0424366
27375774	information	C1533716
27375774	supporting	C1521721
27375774	advising	C1828381
27375774	parents	C0030551
27378175	Optimizing	C2698650
27378175	Survival	C0220921
27378175	Patients	C0030705
27378175	Marginally Operable	C0205188
27378175	Stage IIIA Non-Small-Cell Lung Cancer	C0278983
27378175	Chemoradiotherapy	C0436307
27378175	With	C0038895
27378175	Without	C0332288
27378175	Surgery	C0038895
27378175	marginally operable	C0205188
27378175	stage IIIA non-small-cell lung cancer	C0278983
27378175	NSCLC	C0278983
27378175	surgery	C0038895
27378175	neoadjuvant	C0600558
27378175	concurrent chemoradiotherapy	C3178775
27378175	CCRT	C3178775
27378175	unresectable	C1519810
27378175	medically inoperable	C0205187
27378175	conditions	C0348080
27378175	patient refusal	C0040809
27378175	study	C2603343
27378175	investigate	C1292732
27378175	outcomes	C1274040
27378175	phased CCRT protocol	C0040808
27378175	operability	C0205245
27378175	marginally operable	C0205188
27378175	stage IIIA NSCLC	C0278983
27378175	reassessed	C1516048
27378175	inoperable patients	C0030705
27378175	continuous-course definitive CCRT	C3178775
27378175	patients	C0030705
27378175	marginally operable	C0205188
27378175	stage IIIA NSCLC	C0278983
27378175	CCRT	C3178775
27378175	patients	C0030705
27378175	treated	C1522326
27378175	phased CCRT protocol	C0040808
27378175	neoadjuvant	C0600558
27378175	CCRT	C3178775
27378175	surgery	C0038895
27378175	group A	C0441833
27378175	reassessed	C1516048
27378175	inoperable patients	C0030705
27378175	patients	C0030705
27378175	maintenance chemotherapy	C0481504
27378175	split-course CCRT	C3178775
27378175	boost	C1511253
27378175	group B	C0441833
27378175	treated	C1522326
27378175	continuous-course definitive CCRT	C3178775
27378175	group C	C0441833
27378175	Overall survival	C4086681
27378175	OS	C4086681
27378175	progression-free survival	C0242792
27378175	PFS	C0242792
27378175	analyzed	C0936012
27378175	median	C0876920
27378175	OS	C4086681
27378175	PFS	C0242792
27378175	months	C0439231
27378175	median	C0876920
27378175	follow-up	C1522577
27378175	months	C0439231
27378175	median	C0876920
27378175	OS	C4086681
27378175	group A	C0441833
27378175	group B	C0441833
27378175	months	C0439231
27378175	group C	C0441833
27378175	months	C0439231
27378175	multivariate analysis	C0026777
27378175	performance status	C1518965
27378175	hazard ratio	C2985465
27378175	HR	C2985465
27378175	adenocarcinoma	C0001418
27378175	HR	C2985465
27378175	group A	C0441833
27378175	HR	C2985465
27378175	independent prognostic factors	C1514474
27378175	OS	C4086681
27378175	group B	C0441833
27378175	HR	C2985465
27378175	confidence interval	C0009667
27378175	statistically different	C1705242
27378175	group C	C0441833
27378175	marginally operable	C0205188
27378175	stage IIIA NSCLC	C0278983
27378175	phased CCRT strategy	C0040808
27378175	optimize	C2698650
27378175	survival	C0220921
27378175	operability	C0205245
27378175	survival	C0220921
27378175	reassessed	C1516048
27378175	inoperable patients	C0030705
27378175	split-course CCRT	C3178775
27378175	boost	C1511253
27378175	maintenance chemotherapy	C0481504
27379139	Three	C0205449
27379139	Protein-Extraction Methods	C3827821
27379139	Proteome	C0751973
27379139	Analysis	C0002778
27379139	Maize	C0010028
27379139	Leaf	C0242724
27379139	Midrib	C2698828
27379139	Compound Tissue	C1514137
27379139	Sclerenchyma Cells	C1514137
27379139	Leaf	C0242724
27379139	morphology	C0332437
27379139	growth and development	C0018271
27379139	maize (Zea mays L.) plants	C0010028
27379139	kernel	C0043137
27379139	maize	C0010028
27379139	leaf	C0242724
27379139	midrib	C2698828
27379139	leaf	C0242724
27379139	aerial position	C1136056
27379139	sunlight	C0038817
27379139	Leaf	C0242724
27379139	midrib	C2698828
27379139	adult	C0205286
27379139	plants	C0010028
27379139	sclerenchyma cells	C1514137
27379139	heavily thickened	C1280412
27379139	lignified	C0023705
27379139	secondary walls	C0918262
27379139	phenolics	C0359916
27379139	protein extraction	C3827821
27379139	proteome	C0751973
27379139	analysis	C0002778
27379139	leaf	C0242724
27379139	midrib	C2698828
27379139	protein-extraction methods	C3827821
27379139	plant	C0032098
27379139	proteomics	C0872252
27379139	phenol	C0070570
27379139	extraction	C0684295
27379139	TCA	C0040900
27379139	acetone	C0001002
27379139	extraction	C0684295
27379139	TCA	C0040900
27379139	acetone	C0001002
27379139	phenol	C0070570
27379139	extraction	C0684295
27379139	qualitatively	C0034375
27379139	quantitatively evaluated	C0034384
27379139	MS/MS analysis	C0037813
27379139	midribs	C2698828
27379139	leaves	C0242724
27379139	maize plants	C0010028
27379139	Microscopy	C0026018
27379139	sclerenchyma	C1514137
27379139	maize	C0010028
27379139	midrib	C2698828
27379139	epidermises	C0376608
27379139	abaxial	C1254362
27379139	epidermises	C0376608
27379139	2DE mapping	C0013860
27379139	phenol	C0070570
27379139	extraction	C0684295
27379139	TCA	C0040900
27379139	acetone	C0001002
27379139	extraction	C0684295
27379139	TCA	C0040900
27379139	acetone	C0001002
27379139	phenol	C0070570
27379139	extraction	C0684295
27379139	MS/MS analysis	C0037813
27379139	spots	C1705203
27379139	three	C0205449
27379139	phenol	C0070570
27379139	extraction	C0684295
27379139	control	C0009932
27379139	proteins	C0032089
27379139	hydrophilic	C0475370
27379139	GRAVY values	C0392762
27379139	three	C0205449
27379139	protein	C0032089
27379139	2DE maps	C0013860
27379139	maize	C0010028
27379139	leaf	C0242724
27379139	midrib	C2698828
27379139	phenol	C0070570
27379139	extraction	C0684295
27379139	2DE map	C0013860
27379139	resolution	C2699488
27379139	spots	C1705203
27379139	TCA	C0040900
27379139	acetone	C0001002
27379139	extraction	C0684295
27379139	protein	C0032089
27379139	yields	C0392762
27379139	differential	C0443199
27379139	protein extraction	C3827821
27379139	three	C0205449
27379139	protein extraction	C3827821
27379139	proteome	C0751973
27379139	analysis	C0002778
27379139	plant tissues	C1514137
27379139	sclerenchyma cells	C1514137
27383174	Dominant	C0429283
27383174	Dominant	C0429283
27383174	Frequency	C0376249
27383174	Evoked	C1444748
27383174	Ventricular Fibrillation	C0042510
27383174	Dogs	C0012984
27383174	Myocardial Ischemia	C0151744
27383174	electrically provoked	C3517066
27383174	ventricular fibrillation	C0042510
27383174	dogs	C0012984
27383174	ischemic heart disease	C0151744
27383174	characterized	C1880022
27383174	organized	C1300196
27383174	myocardial activity	C1254358
27383174	dominant ECG frequency	C0429283
27383174	ventricular fibrillation	C0042510
27383174	low-frequency oscillations	C0205556
27383174	fibrillation	C0042510
27383174	dominant frequencies	C0429283
27383174	low	C0205251
27383174	medium	C0439536
27383174	fibrillation	C0042510
27383174	oscillations	C0695434
27383174	dominant	C0429283
27383174	ischemic myocardium	C2919051
27383174	maintains	C0024501
27383174	organized structure	C0449236
27383174	ventricular fibrillation	C0042510
27383174	development	C1527148
27383174	automatic diagnostics	C0011905
27383174	abnormal cardiac activity	C4062482
27383174	humans	C0086418
27383326	Adverse events	C0877248
27383326	risk	C0035647
27383326	associated with	C0332281
27383326	angiogenesis inhibitors	C0596087
27383326	therapy	C0087111
27383326	ovarian cancer	C0029925
27383326	meta-analysis	C0920317
27383326	randomized controlled trials	C0206035
27383326	Inhibition of angiogenesis	C1510884
27383326	treatment strategy	C0087111
27383326	advanced	C0029925
27383326	recurrent ovarian cancer	C0278689
27383326	meta-analysis	C0920317
27383326	investigate	C1292732
27383326	risk	C0035647
27383326	adverse events	C0877248
27383326	angiogenesis inhibitors	C0596087
27383326	AIs	C0596087
27383326	ovarian cancer	C0029925
27383326	Databases	C0242356
27383326	PubMed	C1138432
27383326	Web of Science	C0282574
27383326	Cochrane library	C0023621
27383326	relevant	C2347946
27383326	studies	C2603343
27383326	studies	C2603343
27383326	prospective randomized controlled phase II/III clinical trials	C0206035
27383326	evaluating	C0557980
27383326	therapy	C0087111
27383326	AIs	C0596087
27383326	ovarian cancer	C0029925
27383326	relative risk	C0242492
27383326	RR	C0242492
27383326	confidence intervals	C0009667
27383326	CIs	C0009667
27383326	calculated	C1441506
27383326	random-effects	C0205556
27383326	fixed-effects	C0205556
27383326	heterogeneity	C0019409
27383326	trials	C0008976
27383326	patients	C0030705
27383326	clinical trials	C0008976
27383326	meta-analysis	C0920317
27383326	Pooled	C2349200
27383326	RR	C0242492
27383326	use of	C1524063
27383326	AIs	C0596087
27383326	associated with	C0332281
27383326	increased	C0205217
27383326	risk	C0035647
27383326	adverse	C0001688
27383326	outcomes	C0085415
27383326	arterial thromboembolic	C3544094
27383326	events	C0441471
27383326	RR	C0242492
27383326	gastrointestinal (GI) perforation	C0151664
27383326	RR	C0242492
27383326	proteinuria	C0033687
27383326	RR	C0242492
27383326	hypertension	C0020538
27383326	RR	C0242492
27383326	No statistically significant	C3694175
27383326	differences	C1705242
27383326	hemorrhagic	C0019080
27383326	events	C0441471
27383326	venous thromboembolic	C1861172
27383326	events	C0441471
27383326	fatal	C1302234
27383326	adverse events	C0877248
27383326	AIs	C0596087
27383326	therapy	C0087111
27383326	ovarian cancer	C0029925
27383326	increase	C0442805
27383326	risk	C0035647
27383326	arterial thromboembolic	C3544094
27383326	events	C0441471
27383326	GI perforation	C0151664
27383326	proteinuria	C0033687
27383326	hypertension	C0020538
27383326	venous thromboembolic	C1861172
27383326	events	C0441471
27383326	hemorrhagic	C0019080
27383326	events	C0441471
27383326	fatal	C1302234
27383326	adverse events	C0877248
27384489	Relationship	C0439849
27384489	LRRK2	C1425650
27384489	R1628P polymorphism	C0752046
27384489	Parkinson's disease	C0030567
27384489	Asian populations	C0078988
27384489	leucine-rich repeat kinase 2	C1425650
27384489	LRRK2	C1425650
27384489	R1628P polymorphism	C0752046
27384489	associated with	C0332281
27384489	risk	C0035647
27384489	Parkinson's disease	C0030567
27384489	PD	C0030567
27384489	Taiwan	C0039260
27384489	China	C0008115
27384489	Singapore	C0037173
27384489	relationship	C0439849
27384489	meta-analysis	C0920317
27384489	associations	C0439849
27384489	LRRK2	C1425650
27384489	R1628P polymorphism	C0752046
27384489	rs33949390	C0752046
27384489	PD	C0030567
27384489	Asian populations	C0078988
27384489	studies	C2603343
27384489	PubMed	C1138432
27384489	Embase	C0079198
27384489	SinoMed	C0079198
27384489	China Knowledge Resource Integrated Database	C0242356
27384489	confidence intervals	C0009667
27384489	association	C0439849
27384489	R1628P polymorphism	C0752046
27384489	PD	C0030567
27384489	meta-analysis	C0920317
27384489	studies	C2603343
27384489	PD	C0030567
27384489	patients	C0030705
27384489	controls	C0009932
27384489	R1628P polymorphism	C0752046
27384489	associated with	C0332281
27384489	risk	C0035647
27384489	PD	C0030567
27384489	Asian populations	C0078988
27384489	stratification analyses	C1514983
27384489	R1628P polymorphism	C0752046
27384489	associated with	C0332281
27384489	risk	C0035647
27384489	PD	C0030567
27384489	Chinese	C0152035
27384489	non-Chinese Asian populations	C0078988
27384489	risk	C0035647
27384489	PD	C0030567
27384489	Chinese patients	C0030705
27384489	China	C0008115
27384489	Taiwan	C0039260
27384489	Singapore	C0037173
27384489	stratified analysis	C1514983
27384489	age	C0001779
27384489	associations	C0439849
27384489	PD	C0030567
27384489	PD	C0030567
27384489	R1628P polymorphism	C0752046
27384489	LRRK2 gene	C1425650
27384489	PD	C0030567
27384489	susceptibility	C0012655
27384489	Asian	C0078988
27384489	Chinese	C0152035
27384489	populations	C1257890
27384676	Efficacy	C1280519
27384676	safety	C0678800
27384676	cisplatin	C0008838
27384676	dexamethasone	C0011777
27384676	gemcitabine	C0045093
27384676	pegaspargase	C0071568
27384676	DDGP	C1254351
27384676	regimen	C0040808
27384676	newly diagnosed	C1518321
27384676	advanced-stage	C0205179
27384676	extranodal natural killer/T-cell lymphoma	C1955906
27384676	interim	C2827738
27384676	analysis	C0936012
27384676	phase 4	C0439562
27384676	study	C2603343
27384676	effective	C1704419
27384676	treatment	C0039798
27384676	newly diagnosed	C1518321
27384676	advanced-stage	C0205179
27384676	extranodal natural killer/T-cell lymphoma, nasal type	C0392788
27384676	ENKTL	C0392788
27384676	phase 4	C0439562
27384676	study	C2603343
27384676	cisplatin	C0008838
27384676	dexamethasone	C0011777
27384676	gemcitabine	C0045093
27384676	pegaspargase	C0071568
27384676	DDGP	C1254351
27384676	regimen	C0040808
27384676	end point	C2349179
27384676	progression-free survival	C0242792
27384676	PFS	C0242792
27384676	protocol treatment	C0040808
27384676	endpoints	C2349179
27384676	response rate	C0237629
27384676	RR	C0237629
27384676	overall survival	C4086681
27384676	OS	C4086681
27384676	median survival time	C2986586
27384676	MST	C2986586
27384676	interim	C2827738
27384676	analysis	C0936012
27384676	data	C1511726
27384676	received	C1514756
27384676	DDGP	C1254351
27384676	chemotherapy	C3665472
27384676	eligible	C1548635
27384676	patients	C0030705
27384676	patients	C0030705
27384676	complete response	C1275810
27384676	CR	C1275810
27384676	partial response	C1521726
27384676	PR	C1521726
27384676	progressive disease	C1335499
27384676	PD	C1335499
27384676	RR	C0237629
27384676	treatment	C0039798
27384676	median	C0876920
27384676	follow-up	C1522577
27384676	duration	C0449238
27384676	months	C0439231
27384676	months	C0439231
27384676	PFS	C0242792
27384676	OS rate	C0038954
27384676	CI	C0009667
27384676	CI	C0009667
27384676	MST	C2986586
27384676	months	C0439231
27384676	CI	C0009667
27384676	months	C0439231
27384676	months	C0439231
27384676	Grade	C0441800
27384676	leukopenia	C0023530
27384676	occurred	C2745955
27384676	patients	C0030705
27384676	grade	C0441800
27384676	thrombocytopenia	C0040034
27384676	occurred	C2745955
27384676	patients	C0030705
27384676	patients	C0030705
27384676	Activated Partial Phromboplastin Ptime	C0030605
27384676	APTT	C0030605
27384676	elongation	C0240671
27384676	patients	C0030705
27384676	hypofibrinogenemia	C0553681
27384676	DDGP	C1254351
27384676	regimen	C0040808
27384676	effective	C1704419
27384676	tolerated	C0013220
27384676	treatment	C0039798
27384676	newly diagnosed	C1518321
27384676	advanced-stage	C0205179
27384676	ENKTL	C0392788
27384676	trial	C0008976
27384676	registered	C1514821
27384676	www.ClinicalTrials.gov	C2349146
27388630	Effect	C1280500
27388630	Hepatitis C Virus Coinfection	C1698259
27388630	CD4(+) and CD8(+)	C0483191
27388630	T Cell	C0039194
27388630	Subpopulations	C0079720
27388630	HIV	C0019682
27388630	Infected	C0439663
27388630	Patients	C0030705
27388630	Receiving	C1514756
27388630	Antiretroviral Therapy	C1963724
27388630	effect	C1280500
27388630	hepatitis C virus coinfection	C1698259
27388630	T cell	C0039194
27388630	subpopulations	C0079720
27388630	HIV	C0019682
27388630	infected	C0439663
27388630	patients	C0030705
27388630	antiretroviral therapy	C1963724
27388630	Coinfection	C0275524
27388630	hepatitis C virus	C0220847
27388630	decrease	C0547047
27388630	naive CD4(+) T cells	C3273372
27388630	increase	C0442805
27388630	count	C0750480
27388630	CD8(+) memory T cells	C0242629
27388630	patients	C0030705
27388630	Hepatitis C virus	C0220847
27388630	no effect	C1301751
27388630	CD4(+) memory T cells	C3273371
27388630	HIV	C0019682
27388630	negative	C0205160
27388630	effect	C1280500
27388630	hepatitis C virus	C0220847
27388630	course	C0750729
27388630	HIV	C0019682
27388630	infection	C3714514
27388786	Examining	C1292732
27388786	contribution	C1880177
27388786	motor movement	C1513492
27388786	language	C0023008
27388786	dominance	C0870441
27388786	increased	C0205217
27388786	left	C0205091
27388786	lateralization	C0013010
27388786	sign	C0037078
27388786	generation	C3146294
27388786	native	C0302891
27388786	signers	C1257890
27388786	neural systems	C0027763
27388786	speech	C0037817
27388786	sign	C1547188
27388786	processing	C0025361
27388786	similar	C2348205
27388786	fTCD study	C2603343
27388786	hearing	C0025361
27388786	native	C0302891
27388786	signers	C1257890
27388786	left	C0205091
27388786	lateralization	C0013010
27388786	sign	C1547188
27388786	speech	C0037817
27388786	increased	C0205217
27388786	lateralization	C0013010
27388786	hand	C0018563
27388786	movement	C0026649
27388786	motor movement	C1513492
27388786	linguistic	C0023008
27388786	processes	C0025361
27388786	strength	C0808080
27388786	hemispheric	C0205139
27388786	lateralization	C0013010
27388786	sign	C1547188
27388786	production	C0025361
27388786	contrast	C1979874
27388786	lateralization	C0013010
27388786	strength	C0808080
27388786	covert	C0871315
27388786	overt	C2963144
27388786	signing	C1547188
27388786	phonological	C0542341
27388786	semantic	C0036612
27388786	fluency	C0870569
27388786	tasks	C0542341
27388786	hearing	C0025361
27388786	native	C0302891
27388786	signers	C1257890
27388786	elevated	C3163633
27388786	lateralization indices	C0392762
27388786	LIs	C0392762
27388786	task	C0542341
27388786	dominant	C1527180
27388786	language	C0023008
27388786	deaf	C0525064
27388786	native	C0302891
27388786	signers	C1257890
27388786	dominant	C1527180
27388786	language	C0023008
27388786	British Sign Language	C3874914
27388786	BSL	C3874914
27388786	Signers	C1257890
27388786	left	C0205091
27388786	lateralized	C0013010
27388786	overt	C2963144
27388786	covert	C0871315
27388786	sign	C1547188
27388786	strength	C0808080
27388786	lateralization	C0013010
27388786	correlated	C1707520
27388786	movements	C0026649
27388786	right hand	C0230370
27388786	Comparisons	C1707455
27388786	data	C1511726
27388786	hearing	C0025361
27388786	native	C0302891
27388786	English	C0376245
27388786	speakers	C1257890
27388786	laterality indices	C0392762
27388786	sign	C1547188
27388786	speech	C0037817
27388786	covert	C0871315
27388786	overt	C2963144
27388786	tasks	C0542341
27388786	increased	C0205217
27388786	left	C0205091
27388786	lateralization	C0013010
27388786	properties	C0871161
27388786	sign	C1547188
27388786	production	C0025361
27388786	increased	C0205217
27388786	use	C0457083
27388786	self-monitoring	C0237864
27388786	mechanisms	C0441712
27388786	nature	C0349590
27388786	phonological encoding	C0679058
27388786	signs	C1547188
27392740	Hard ticks	C0598741
27392740	Acari: Ixodidae	C0598741
27392740	livestock	C2936506
27392740	Nicaragua	C0028002
27392740	notes	C1317574
27392740	distribution	C1704711
27392740	document	C0920316
27392740	species	C1705920
27392740	ticks	C0040203
27392740	parasitize	C1384353
27392740	livestock	C2936506
27392740	Nicaragua	C0028002
27392740	study	C2603343
27392740	tick	C0040203
27392740	collection	C1516698
27392740	cattle	C0007452
27392740	horses	C0019944
27392740	farms	C0557759
27392740	departments	C1704729
27392740	animals	C0003062
27392740	cows	C0007452
27392740	horses	C0019944
27392740	parasitized	C1384353
27392740	bovines	C3667982
27392740	equines	C0019944
27392740	study	C2603343
27392740	cows	C0007452
27392740	horses	C0019944
27392740	parasitized	C1384353
27392740	species	C1705920
27392740	specimens	C0370003
27392740	entomological	C0014386
27392740	museum	C0026863
27392740	León	C3814077
27392740	ticks	C0040203
27392740	cattle	C0007452
27392740	Rhipicephalus microplus	C0323515
27392740	ticks	C0040203
27392740	collected	C1516698
27392740	Amblyomma mixtum	C3989620
27392740	A. parvum	C1667898
27392740	A. tenellum	C1690769
27392740	A. maculatum	C0323501
27392740	ticks	C0040203
27392740	collected	C1516698
27392740	horses	C0019944
27392740	Dermacentor nitens	C0323524
27392740	A. mixtum	C3989620
27392740	R. microplus	C0323515
27392740	A. parvum	C1667898
27392740	A. tenellum	C1690769
27392740	D. dissimilis	C0011595
27392740	A. maculatum	C0323501
27394918	Assessment	C0220825
27394918	Exposure	C0332157
27394918	Level	C0441889
27394918	Rare Earth Elements	C0025556
27394918	Workers	C1527116
27394918	Producing	C0033268
27394918	Cerium	C0007828
27394918	Lanthanum Oxide	C0534702
27394918	Ultrafine	C0077801
27394918	Nanoparticles	C1450054
27394918	assess	C0184514
27394918	occupational	C0521127
27394918	exposure	C0332157
27394918	level	C0441889
27394918	rare earth elements	C0025556
27394918	REEs	C0025556
27394918	identify	C0205396
27394918	associated	C0332281
27394918	influence	C4054723
27394918	inductively coupled plasma mass spectrometry	C1553183
27394918	ICP-MS	C1553183
27394918	based	C1527178
27394918	closed	C0587267
27394918	vessel	C3273359
27394918	microwave	C0026051
27394918	assisted	C1269765
27394918	wet digestion procedure	C2700391
27394918	determinate	C1148554
27394918	concentration	C1446561
27394918	Y	C0043432
27394918	La	C0534702
27394918	Ce	C0007828
27394918	Pr	C0032904
27394918	Nd	C0027599
27394918	Sm	C0036147
27394918	Eu	C0015180
27394918	Gd	C0016911
27394918	Tb	C0039541
27394918	Dy	C0013407
27394918	Ho	C0019846
27394918	Er	C0014688
27394918	Tm	C0040066
27394918	Yb	C0043431
27394918	Lu	C0024170
27394918	urinary samples	C1610733
27394918	obtained	C1301820
27394918	workers	C1527116
27394918	producing	C0033268
27394918	ultrafine	C0077801
27394918	nanoparticles	C1450054
27394918	cerium	C0007828
27394918	lanthanum oxide	C0534702
27394918	results	C1254595
27394918	suggest	C1705535
27394918	La	C0534702
27394918	Ce	C0007828
27394918	primary	C0205225
27394918	component	C1705248
27394918	accounting	C0680857
27394918	REEs	C0025556
27394918	workers	C1527116
27394918	urinary	C1610733
27394918	levels	C0441889
27394918	La	C0534702
27394918	Ce	C0007828
27394918	workers	C1527116
27394918	creatinine	C0010294
27394918	significantly	C0750502
27394918	enriched	C0205556
27394918	compared	C1707455
27394918	levels	C0441889
27394918	measured	C0444706
27394918	control	C0009932
27394918	subjects	C0681850
27394918	creatinine	C0010294
27394918	study	C2603343
27394918	simultaneously	C0521115
27394918	identified	C0205396
27394918	associated	C0332281
27394918	individual	C0237401
27394918	factors	C1521761
27394918	results	C1254595
27394918	indicate	C3146298
27394918	concentrations	C1446561
27394918	group	C0441833
27394918	La	C0534702
27394918	Ce	C0007828
27394918	significantly	C0750502
27394918	elevated	C3163633
27394918	compared	C1707455
27394918	group	C0441833
27394918	La	C0534702
27394918	Ce	C0007828
27394918	Compared	C1707455
27394918	urinary	C1610733
27394918	levels	C0441889
27394918	La	C0534702
27394918	Ce	C0007828
27394918	separation	C0445406
27394918	packaging	C0030176
27394918	locations	C0450429
27394918	La	C0534702
27394918	Ce	C0007828
27394918	locations	C0450429
27394918	La	C0534702
27394918	Ce	C0007828
27394918	results	C1254595
27394918	urinary	C1610733
27394918	concentrations	C1446561
27394918	significantly	C0750502
27394918	higher	C0205250
27394918	workers	C1527116
27394918	separation	C0445406
27394918	packaging	C0030176
27394918	locations	C0450429
27394918	Inter	C1548610
27394918	individual	C0237401
27394918	variation	C0205419
27394918	levels	C0441889
27394918	La	C0534702
27394918	Ce	C0007828
27394918	urine	C0042036
27394918	result	C1274040
27394918	multi-factorial	C0015483
27394918	comprehensive	C1880156
27394918	action	C3266814
27394918	researches	C0035173
27394918	focus	C1285542
27394918	multiple	C0439064
27394918	factors	C1521761
27394918	contributing	C1880177
27394918	REEs	C0025556
27394918	levels	C0441889
27394918	occupationally	C0521127
27394918	exposed	C0332157
27394918	workers	C1527116
27395231	known	C0205309
27395231	new	C0205314
27395231	species	C1705920
27395231	Draconematidae	C2992016
27395231	Epsilonematida	C2287919
27395231	Nematoda	C0027581
27395231	Desmodorida	C1030325
27395231	White Sea	C0036493
27395231	North Russia	C0035970
27395231	Morphological	C0543482
27395231	descriptions	C0678257
27395231	walking nematode	C1704319
27395231	species	C1705920
27395231	White Sea	C0036493
27395231	Draconema ophicephalum	C4111696
27395231	Claparède	C0805191
27395231	Draconematidae	C2992016
27395231	Epsilonema steineri	C4093458
27395231	Chitwood	C0805191
27395231	Epsilonematidae	C2287919
27395231	insufficient	C0231180
27395231	females	C0086287
27395231	problems	C0033213
27395231	taxonomic	C0008903
27395231	identification	C0205396
27395231	species	C1705920
27395231	compositions	C0486616
27395231	genera	C1708235
27395231	new	C0205314
27395231	species	C1705920
27395231	Prochaetosoma marisalbi sp	C2992020
27395231	Draconematidae	C2992016
27395231	Prochaetosoma species	C2992020
27395231	P. longicapitatum	C2992020
27395231	Allgén	C0805191
27395231	pharyngeal	C0031354
27395231	bulb	C1947952
27395231	lumen	C0524461
27395231	not cuticularised	C0243095
27395231	P. longicapitatum	C2992020
27395231	shape of body	C1268086
27395231	rostrum	C0243092
27395231	greater	C1704243
27395231	cephalic	C0205096
27395231	adhesive tubes	C0243092
27395231	P. maertensi	C2992020
27395231	Decraemer	C0805191
27395231	longer	C0205166
27395231	tail	C0039259
27395231	anterior	C0205094
27395231	adhesive tubes	C0243092
27395231	longer	C0205166
27395231	spicules	C2826618
27395231	cuticular thickening	C1160234
27395231	pharyngeal	C0031354
27395231	bulb	C1947952
27395231	Draconema hoonsooi	C2992018
27395231	D. youngeouni	C2992018
27395231	P.rochaetosoma beomseomense	C2992020
27395231	P. brevicaudatum	C2992020
27395231	P. byungilli	C2992020
27395231	P. cracense	C2992020
27395231	P. saheungi	C2992020
27395231	P. sujungi	C2992020
27395231	P. supseomense	C2992020
27395231	erected	C0443211
27395231	Rho	C0805191
27395231	Min	C0805191
27395231	invalid	C3245471
27395231	species	C1705920
27395231	Prochaetosoma arcticum	C2992020
27395231	P. lugubre	C2992020
27395231	Epsilonema cygnoides	C2287919
27395231	species inquirenda	C1705920
27395231	phylogenetic tree	C1519068
27395231	18S rRNA gene	C0035899
27395231	White Sea	C0036493
27395231	species	C1705920
27395231	adjoin	C0205107
27395231	unidentified	C0205427
27395231	species	C1705920
27395231	genera	C1708235
27395442	Differential	C0443199
27395442	effects of	C1704420
27395442	crude oil	C0031264
27395442	denitrification	C0598972
27395442	anammox	C1158281
27395442	impact	C4049986
27395442	N2O	C0028215
27395442	production	C1254365
27395442	Denitrification	C0598972
27395442	anammox	C1158281
27395442	processes	C1522240
27395442	reducing	C0392756
27395442	external	C0205101
27395442	nitrogen	C0028158
27395442	delivered	C1705822
27395442	coastal	C0557760
27395442	ecosystems	C0162358
27395442	processes	C1522240
27395442	affected	C0392760
27395442	pollutants	C0599786
27395442	study	C2603343
27395442	investigated	C1292732
27395442	effect of	C1704420
27395442	crude oil	C0031264
27395442	denitrification	C0598972
27395442	anammox	C1158281
27395442	Controlled laboratory experiments	C0681814
27395442	sediment	C1550099
27395442	slurries	C1550099
27395442	Lima	C0017446
27395442	Estuary	C3494468
27395442	NW	C1254362
27395442	Portugal	C0032729
27395442	Anammox	C1158281
27395442	denitrification	C0598972
27395442	rates	C0392762
27395442	(15)N-labeled	C0028162
27395442	NO3(-)	C0699857
27395442	production	C1254365
27395442	(29)N2	C0028158
27395442	(30)N2	C0028158
27395442	membrane inlet mass spectrometry	C0037813
27395442	denitrification	C0598972
27395442	rates	C0392762
27395442	crude oil	C0031264
27395442	amendment	C0680532
27395442	anammox	C1158281
27395442	activity	C0441655
27395442	completely	C0205197
27395442	inhibited	C0311403
27395442	addition	C1883712
27395442	crude oil	C0031264
27395442	rates	C0392762
27395442	unamended controls	C1882979
27395442	estuarine	C1254362
27395442	sediment	C1550099
27395442	types	C0332307
27395442	physical-chemical characteristics	C1521970
27395442	N2O	C0028215
27395442	production	C1254365
27395442	reduced	C0392756
27395442	crude oil	C0031264
27395442	addition	C1883712
27395442	mechanism(s)	C0441712
27395442	observed	C1441672
27395442	reduction	C0392756
27395442	N2O	C0028215
27395442	production	C1254365
27395442	study	C2603343
27395442	contributions	C1880177
27395442	impact	C4049986
27395442	crude oil	C0031264
27395442	pollution	C0392355
27395442	denitrification	C0598972
27395442	anammox	C1158281
27395442	management	C1273870
27395442	aquatic	C0563034
27395442	ecosystems	C0162358
27395442	eutrophication	C0015191
27395442	N-removal	C1883720
27397752	medical	C0205476
27397752	leadership	C0023181
27397752	qualitative study	C0949415
27397752	Australia	C0004340
27397752	aims	C1947946
27397752	beliefs	C0004951
27397752	doctors	C0031831
27397752	leadership	C0023181
27397752	concept	C0178566
27397752	data	C1511726
27397752	interviews	C0021822
27397752	doctors	C0031831
27397752	medical	C0205476
27397752	leadership	C0023181
27397752	Australia	C0004340
27397752	beliefs	C0004951
27397752	perspectives	C1254370
27397752	doctors	C0031831
27397752	leadership	C0023181
27397752	barriers	C4063003
27397752	doctors	C0031831
27397752	leadership	C0023181
27397752	Australian	C0238711
27397752	health system	C1456613
27397752	research	C0035168
27397752	beliefs	C0004951
27397752	medical	C0205476
27397752	leaders	C0557558
27397752	themes	C0869035
27397752	dimensions	C0439534
27397752	data	C1511726
27397752	qualitative studies	C0949415
27397752	medical	C0205476
27397752	leadership	C0023181
27397752	Australia	C0004340
27397752	collaboration	C0282116
27397752	researchers	C0035173
27397752	semi-structured interviews	C0681913
27397752	medical	C0205476
27397752	leaders	C0557558
27397752	leadership	C0023181
27397752	Australia	C0004340
27397752	health services	C0018747
27397752	private	C0033173
27397752	public hospitals	C0020022
27397752	professional associations	C0680403
27397752	health departments	C1514958
27397752	data	C1511726
27397752	approaches	C0449445
27397752	coding	C0009219
27397752	interview	C0021822
27397752	data	C1511726
27397752	literature review	C0282441
27397752	coded	C0009219
27397752	data	C1511726
27397752	grouped	C0441833
27397752	themes	C0869035
27397752	Medical	C0205476
27397752	leaders	C0557558
27397752	beliefs	C0004951
27397752	eyes	C0015392
27397752	clinical experience	C0008973
27397752	clinical	C0205210
27397752	colleagues	C0681088
27397752	beliefs	C0004951
27397752	dimensions	C0439534
27397752	belief	C0004951
27397752	managerial	C0402281
27397752	clinical	C0205210
27397752	credibility	C0870373
27397752	conflict	C0079152
27397752	clinicians	C0871685
27397752	clinical	C0205210
27397752	colleagues	C0681088
27397752	medical	C0205476
27397752	leadership	C0023181
27397752	doctors	C0031831
27397752	clinical practice	C0008973
27397752	medical	C0205476
27397752	leadership	C0023181
27397752	research	C0035168
27397752	Western	C1705493
27397752	developed-nation	C0282613
27397752	Australia	C0004340
27397752	interviews	C0021822
27397752	doctors	C0031831
27397752	medical	C0205476
27397752	leadership	C0023181
27397752	doctors	C0031831
27397752	beliefs	C0004951
27397752	research	C0035168
27397752	doctors	C0031831
27397752	transition	C2700061
27397752	leadership	C0023181
27397752	health practitioners	C1552267
27397752	perspective	C1254370
27397752	research	C0035168
27397752	descriptive	C0437940
27397752	qualitative methods	C0681940
27397752	quantitative research	C1510569
27397752	research	C0035168
27397752	statistical generalisation	C0871424
27397752	health organisations	C0018720
27397752	medical	C0205476
27397752	employers	C1274022
27397752	health departments	C1514958
27397752	study	C2603343
27397752	concept	C0178566
27397752	medical	C0205476
27397752	leadership	C0023181
27397752	evidence	C3887511
27397752	researched	C0035168
27397752	data	C1511726
27397752	studies	C2603343
27397752	analysis	C0936012
27397752	coding	C0009219
27397752	concept	C0178566
27400734	Erlotinib	C1135135
27400734	gemcitabine	C0045093
27400734	gemcitabine	C0045093
27400734	pancreatic cancer	C0235974
27400734	real	C0237400
27400734	world	C2700280
27400734	analysis	C0936012
27400734	Korean	C0022771
27400734	national	C0015737
27400734	database	C0242356
27400734	randomized clinical trial	C0206034
27400734	addition	C0596304
27400734	erlotinib	C1135135
27400734	gemcitabine	C0045093
27400734	GEM	C0045093
27400734	E	C1135135
27400734	pancreatic cancer	C0235974
27400734	modest	C0205081
27400734	increase	C0442805
27400734	survival	C0038952
27400734	aim	C1947946
27400734	national	C0681788
27400734	population	C1257890
27400734	based	C1527178
27400734	retrospective study	C0035363
27400734	compare	C1707455
27400734	effectiveness	C1280519
27400734	GEM	C0045093
27400734	E	C1135135
27400734	GEM	C0045093
27400734	pancreatic cancer	C0235974
27400734	patients	C0030705
27400734	real clinical practice	C0205897
27400734	Patients	C0030705
27400734	pancreatic cancer	C0235974
27400734	(ICD-10	C1137110
27400734	prescription	C1521941
27400734	gemcitabine	C0045093
27400734	erlotinib	C1135135
27400734	retrospectively	C1514923
27400734	identified	C0205396
27400734	Korean	C0022771
27400734	Health Insurance	C0027452
27400734	database	C0242356
27400734	study	C2603343
27400734	population	C1257890
27400734	patients	C0030705
27400734	required	C1514873
27400734	histological	C0679557
27400734	cytological diagnosis	C1298647
27400734	chemotherapy	C3665472
27400734	Patients	C0030705
27400734	treated with	C0332154
27400734	radiotherapy	C1522449
27400734	surgery	C2081627
27400734	chemotherapy	C3665472
27400734	excluded	C1554077
27400734	reduce	C0441610
27400734	heterogeneity	C0019409
27400734	survival	C0038952
27400734	initiation	C1704686
27400734	therapy	C0087111
27400734	medical costs	C0086600
27400734	GEM	C0045093
27400734	E	C1135135
27400734	GEM	C0045093
27400734	compared	C1707455
27400734	patients	C0030705
27400734	analysis	C0936012
27400734	survival	C0038952
27400734	significantly	C0750502
27400734	longer	C0205166
27400734	patients	C0030705
27400734	treated	C0332154
27400734	GEM	C0045093
27400734	E	C1135135
27400734	median	C0876920
27400734	GEM	C0045093
27400734	E	C1135135
27400734	GEM	C0045093
27400734	no significant	C3694175
27400734	difference	C1705241
27400734	survival rates	C0038954
27400734	Multivariate analysis	C0026777
27400734	age	C0001779
27400734	gender	C0079399
27400734	comorbidities	C0009488
27400734	covariates	C0814913
27400734	reveal	C0443289
27400734	significant	C0750502
27400734	differences	C1705241
27400734	survival	C0038952
27400734	Based	C1527178
27400734	relative effectiveness	C0035023
27400734	incremental	C1705117
27400734	cost	C0010186
27400734	life	C0376558
27400734	year	C0439234
27400734	gained	C1517378
27400734	GEM	C0045093
27400734	estimated	C0750572
27400734	USD	C1555442
27400734	GEM	C0045093
27400734	E	C1135135
27400734	GEM	C0045093
27400734	E	C1135135
27400734	pancreatic cancer	C0235974
27400734	effective	C1704419
27400734	GEM	C0045093
27400734	real	C0237400
27400734	world	C2700280
27400734	setting	C1552652
27400734	provide	C1999230
27400734	reasonable	C0566251
27400734	cost-effectiveness	C0010181
27400734	GEM	C0045093
27401409	Quantitative Structure-Activity Relationship	C0887819
27401409	Model	C3161035
27401409	Pulmonary Absorption	C3852990
27401409	Isolated	C0205409
27401409	Perfused	C1549542
27401409	Respiring	C0035203
27401409	Rat Lung	C1882727
27401409	Model	C3161035
27401409	Quantitative Structure-Activity Relationship	C0887819
27401409	QSAR	C0887819
27401409	model	C3161035
27401409	physicochemical	C2350461
27401409	pulmonary absorption	C3852990
27401409	compound design	C0013171
27401409	prediction	C0681842
27401409	absorption	C2347023
27401409	model	C3161035
27401409	compounds	C0013227
27401409	Pulmonary absorption	C3852990
27401409	isolated	C0205409
27401409	perfused	C1549542
27401409	respiring	C0035203
27401409	rat lung	C1882727
27401409	IPRLu	C1882727
27401409	model	C3161035
27401409	drug discovery	C0920472
27401409	compounds	C0013227
27401409	marketed drugs	C1254351
27401409	QSAR	C0887819
27401409	model	C3161035
27401409	physicochemical properties	C2350461
27401409	compounds	C0013227
27401409	model's	C3161035
27401409	capability	C2698977
27401409	QSAR	C0887819
27401409	model	C3161035
27401409	compounds	C0013227
27401409	Test set	C0150098
27401409	correlation	C0010100
27401409	compounds	C0013227
27401409	permeability	C0031164
27401409	hydrophobicity	C0598629
27401409	pulmonary absorption	C3852990
27401409	charge	C0205556
27401409	ionisation	C0596801
27401409	size	C0456389
27401409	QSAR	C0887819
27401409	model	C3161035
27401409	IPRLu	C1882727
27401409	model	C3161035
27401409	ranking	C0699794
27401409	classifying	C0008902
27401409	compounds	C0013227
27401409	synthesis	C1883254
27401409	inhaled drug discovery	C0920472
27401409	physicochemical	C2350461
27401409	pulmonary absorption	C3852990
27401409	compound	C0013227
27401409	dataset	C0150098
27402480	EpiDerm™	C0282574
27402480	3D human reconstructed skin micronucleus (RSMN) assay	C1511123
27402480	Historical control	C3850080
27402480	data	C1511726
27402480	proof	C0565962
27402480	principle studies	C2603343
27402480	mechanistic assay	C1510438
27402480	in vitro human reconstructed skin micronucleus (RSMN) assay	C1511123
27402480	EpiDerm™	C0282574
27402480	animal alternative	C0003059
27402480	genotoxicity	C0598309
27402480	topically applied	C0683174
27402480	chemicals	C0220806
27402480	assessing	C0184514
27402480	cosmetic ingredients	C0456611
27402480	tested	C0039593
27402480	in vivo	C1515655
27402480	assays	C1510438
27402480	test	C0392366
27402480	regulatory	C0220905
27402480	decision-making	C0011109
27402480	RSMN assay	C1511123
27402480	laboratory	C0022877
27402480	Good Laboratory Practice	C2983608
27402480	OECD	C3850013
27402480	test guideline 487	C0162791
27402480	in vitro	C1533691
27402480	mammalian cell	C1512977
27402480	micronucleus test	C0026006
27402480	assay	C1510438
27402480	direct-acting genotoxins	C0026879
27402480	genotoxins	C0026879
27402480	metabolism	C0025519
27402480	non-genotoxic	C0243095
27402480	non-carcinogenic	C0243095
27402480	chemicals	C0220806
27402480	report	C0684224
27402480	analysis	C0936012
27402480	historical control	C3850080
27402480	data	C1511726
27402480	positive control	C1883676
27402480	values	C0392762
27402480	micronuclei	C4048301
27402480	binucleated cells	C0333909
27402480	Technical issues	C1710348
27402480	solvents	C0037638
27402480	treatment regimens	C0040808
27402480	investigated	C1292732
27402480	mechanistic studies	C2698671
27402480	CREST analysis	C0242481
27402480	RSMN assay	C1510438
27402480	aneugens	C0949641
27402480	clastogens	C0008904
27402480	assay	C1510438
27402480	cytokines	C0079189
27402480	markers	C0162489
27402480	proliferative	C0334094
27402480	toxic effects	C0600688
27402480	chemicals	C0220806
27402827	Wnt-5a	C4255015
27402827	Frizzled9	C1438694
27402827	receptor signaling	C1514762
27402827	Gαo	C3884317
27402827	Gβγ complex	C0596637
27402827	regulates	C1327622
27402827	dendritic spine	C0872341
27402827	formation	C0007613
27402827	Wnt ligands	C0033684
27402827	development	C1254358
27402827	regulation of synapse structure and function	C1325905
27402827	Wnt-5a	C4255015
27402827	secreted growth factor	C0018284
27402827	regulates	C1327622
27402827	dendritic spine	C0872341
27402827	formation	C0007613
27402827	rodent	C0035804
27402827	hippocampal	C0019564
27402827	neurons	C0027882
27402827	postsynaptic	C1167384
27402827	development	C1254358
27402827	clustering of the postsynaptic density protein-95 (PSD-95)	C3269066
27402827	early	C1279919
27402827	events	C0441471
27402827	interaction	C0872079
27402827	Wnt-5a	C4255015
27402827	Frizzled receptor	C1564903
27402827	neuronal	C0027882
27402827	cell surface	C0699040
27402827	role	C1705810
27402827	heterotrimeric G proteins	C0752348
27402827	Wnt-5a	C4255015
27402827	synaptic	C0039063
27402827	development	C1254358
27402827	Frizzled9	C1438694
27402827	FZD9	C1438694
27402827	Wnt	C4255015
27402827	receptor	C1564903
27402827	Williams' syndrome	C0175702
27402827	postsynaptic region	C0682686
27402827	interacts	C0872079
27402827	Wnt-5a	C4255015
27402827	FZD9	C1438694
27402827	Wnt-5a	C4255015
27402827	increase	C0442805
27402827	dendritic spine density	C0872341
27402827	FZD9	C1438694
27402827	pre-coupled complex	C3893600
27402827	Gαo	C3884317
27402827	basal conditions	C1254365
27402827	dissociates	C0301643
27402827	Wnt-5a	C4255015
27402827	stimulation	C1148560
27402827	G-protein inhibition abrogates	C0007613
27402827	Wnt-5a	C4255015
27402827	pathway	C1704259
27402827	hippocampal	C0019564
27402827	neurons	C0027882
27402827	activation	C1879547
27402827	Gαo	C3884317
27402827	controlling	C2239193
27402827	Wnt-5a	C4255015
27402827	induced	C0205263
27402827	dendritic spine density	C0872341
27402827	Gβγ	C0596637
27402827	Wnt-5a	C4255015
27402827	increase	C0442805
27402827	cytosolic	C1383501
27402827	calcium	C0006675
27402827	levels	C0441889
27402827	spinogenesis	C0007613
27402827	findings	C2607943
27402827	FZD9	C1438694
27402827	heterotrimeric G proteins	C0752348
27402827	regulate	C1327622
27402827	Wnt-5a	C4255015
27402827	signaling	C0037080
27402827	dendritic spines	C0872341
27402827	cultured	C0007635
27402827	hippocampal	C0019564
27402827	neurons	C0027882
27403105	Delayed	C0205421
27403105	Diagnosis	C0011900
27403105	Chronic Mesenteric Ischaemia	C0311262
27403105	Clinicians	C0871685
27403105	Cognitive	C1516691
27403105	Errors	C0743559
27403105	Chronic	C0205191
27403105	diarrhoeal illnesses	C1290807
27403105	nausea	C0027497
27403105	weight loss	C1262477
27403105	common	C0205214
27403105	indication	C3146298
27403105	gastroenterology	C0017163
27403105	review	C1552617
27403105	intra-luminal	C0442115
27403105	aetiologies	C1314792
27403105	inflammatory bowel disease	C0021390
27403105	coeliac disease	C0007570
27403105	malabsorptive conditions	C3280502
27403105	functional	C0205245
27403105	gut	C0699819
27403105	disorders	C0012634
27403105	systemic	C0205373
27403105	malignancy	C4282132
27403105	clinicians	C0871685
27403105	vascular disorders	C0042373
27403105	patient	C0030705
27403105	delayed	C0205421
27403105	diagnosis	C0011900
27403105	chronic mesenteric ischaemia	C0311262
27403105	months	C0439231
27403105	gastrointestinal symptoms	C0426576
27403105	alternative	C1523987
27403105	diagnosis	C0011900
27403105	inflammatory bowel disease	C0021390
27403105	atypical	C0205182
27403105	predominance	C1527180
27403105	nausea	C0027497
27403105	diarrhoea	C0011991
27403105	pain	C0030193
27403105	review	C1552617
27403105	literature	C0023866
27403105	treatment	C1522326
27403105	condition	C0012634
27403105	sequence	C1519249
27403105	cognitive	C1516691
27403105	errors	C0743559
27403105	clinicians	C0871685
27403105	diagnostic	C0011900
27403105	delay	C0205421
27403105	errors	C0743559
27403105	minimised	C0392756
27403105	practice	C0205897
27403338	Evaluation	C0220825
27403338	Choroidal	C0008520
27403338	Thickness	C1280412
27403338	Patients	C0030705
27403338	Pseudoexfoliation Syndrome	C0206368
27403338	Pseudoexfoliation Glaucoma	C0206368
27403338	Purpose	C1285529
27403338	compare	C1707455
27403338	macular	C0332574
27403338	peripapillary	C0442163
27403338	choroidal	C0008520
27403338	thickness	C1280412
27403338	eyes	C0015392
27403338	pseudoexfoliation (PEX) syndrome	C0206368
27403338	PEX glaucoma	C0206368
27403338	normal	C0205307
27403338	eyes	C0015392
27403338	healthy	C3898900
27403338	controls	C0009932
27403338	prospective study	C0033522
27403338	eyes	C0015392
27403338	patients	C0030705
27403338	PEX syndrome	C0206368
27403338	eyes	C0015392
27403338	patients	C0030705
27403338	PEX glaucoma	C0206368
27403338	eyes	C0015392
27403338	age	C0001779
27403338	healthy	C3898900
27403338	subjects	C0681850
27403338	Choroidal	C0008520
27403338	thicknesses	C1280412
27403338	macular	C0332574
27403338	peripapillary	C0442163
27403338	areas	C0205146
27403338	measured	C0444706
27403338	spectral domain optical coherence tomography	C3876157
27403338	Gender	C0079399
27403338	age	C0001779
27403338	axial length	C2936396
27403338	not significantly	C1273937
27403338	groups	C0681860
27403338	mean values	C0444504
27403338	choroidal	C0008520
27403338	thickness	C1280412
27403338	macular	C0332574
27403338	peripapillary	C0442163
27403338	areas	C0205146
27403338	except	C0332300
27403338	superior	C1282910
27403338	quadrant	C1631280
27403338	patients	C0030705
27403338	PEX syndrome	C0206368
27403338	PEX glaucoma	C0206368
27403338	lower	C2003888
27403338	compared	C1707455
27403338	controls	C0009932
27403338	mean values	C0444504
27403338	macular	C0332574
27403338	peripapillary	C0442163
27403338	choroidal	C0008520
27403338	thickness	C1280412
27403338	PEX glaucoma	C0206368
27403338	group	C0681860
27403338	lower	C2003888
27403338	compared	C1707455
27403338	PEX syndrome	C0206368
27403338	group	C0681860
27403338	difference	C1705242
27403338	not significant	C1273937
27403338	findings	C0243095
27403338	study	C2603343
27403338	revealed	C0443289
27403338	macular	C0332574
27403338	peripapillary	C0442163
27403338	choroidal	C0008520
27403338	thicknesses	C1280412
27403338	decreased	C0205216
27403338	PEX syndrome	C0206368
27403338	PEX glaucoma	C0206368
27403338	cases	C0868928
27403338	choroid	C0008520
27403338	development	C1527148
27403338	glaucomatous	C0017601
27403338	damage	C1883709
27403338	patients	C0030705
27403338	PEX syndrome	C0206368
27403338	unclear	C3845108
27404944	Clinical Features	C0037088
27404944	Complications	C0009566
27404944	HLA-B27	C0019740
27404944	Acute Anterior Uveitis	C0701807
27404944	Metanalysis	C0920317
27404944	article	C1706852
27404944	literature-based	C0023866
27404944	metanalysis	C0920317
27404944	clinical features	C0037088
27404944	HLA-B27	C0019740
27404944	Acute Anterior Uveitis	C0701807
27404944	AAU	C0701807
27404944	examined	C0332128
27404944	observational studies	C1518527
27404944	participants	C0679646
27404944	Acute Anterior Uveitis	C0701807
27404944	HLA B27+	C0239961
27404944	HLA B27-	C0587081
27404944	articles	C1706852
27404944	HLA B27 uveitis	C0042164
27404944	articles	C1706852
27404944	review	C1552617
27404944	articles	C1706852
27404944	analyzed	C0936012
27404944	clinical characteristics	C0683325
27404944	metanalysis	C0920317
27404944	systemic disease	C0442893
27404944	sex distribution	C0036878
27404944	laterality	C0023114
27404944	visual acuity	C0042812
27404944	hypopion	C0020641
27404944	anterior chamber's fibrin	C0015982
27404944	elevated intraocular pressure	C0234708
27404944	IOP	C0021888
27404944	inflammation	C0021368
27404944	glaucoma	C0017601
27404944	posterior synechiae	C0152253
27404944	cataract	C0086543
27404944	cystoid macular edema	C0024440
27404944	papillitis	C0030353
27404944	relative risk	C0242492
27404944	RR	C0242492
27404944	outcome measured	C0086749
27404944	results	C1274040
27404944	HLA B27	C0019740
27404944	Acute Anterior Uveitis	C0701807
27404944	association with	C0332281
27404944	ankylosing spondylitis	C0038013
27404944	RR	C0242492
27404944	systemic diseases	C0442893
27404944	RR	C0242492
27404944	male	C0086582
27404944	prevalence	C0220900
27404944	RR	C0242492
27404944	unilateral	C0205092
27404944	RR	C0242492
27404944	bilateral	C0238767
27404944	RR	C0242492
27404944	involvement	C1314939
27404944	hypopion	C0020641
27404944	RR	C0242492
27404944	fibrinous	C0033684
27404944	reaction	C0443286
27404944	papillitis	C0030353
27404944	bilateral	C0238767
27404944	RR	C0242492
27404944	AAU	C0701807
27404944	frequent	C0332183
27404944	HLA-B27	C0019740
27404944	negative	C0205160
27404944	risk	C0035647
27404944	elevated IOP	C0234708
27404944	glaucoma	C0017601
27404944	RR	C0242492
27404944	B27- Acute Anterior Uveitis	C0701807
27404944	HLA B 27 positive	C4285788
27404944	negative	C0205160
27404944	AAU	C0701807
27404944	observed	C1441672
27404944	visual acuity	C0042812
27404944	complications	C0009566
27404944	posterior synechiae	C0152253
27404944	cataract	C0086543
27404944	maculare edema	C0024440
27404944	clinical evaluation	C4084924
27404944	therapeutic	C0302350
27404944	decision	C0679006
27404944	ophthalmologic	C0205481
27404944	condition	C0348080
27408381	Splenic Infarct	C0037998
27408381	Diagnosed	C0011900
27408381	Primary Bone Marrow	C0005953
27408381	CD5 Positive	C0882892
27408381	DLBCL	C0079744
27408381	Clinicopathological Correlation	C1707520
27408381	De novo	C1515568
27408381	CD5+	C0882892
27408381	Diffuse large B cell lymphoma	C0011900
27408381	DLBCL	C0079744
27408381	rare	C0522498
27408381	aggressive subtype	C0243095
27408381	DLBCL	C0079744
27408381	clinicopathologic	C0243095
27408381	entity	C1551338
27408381	complex molecular profile	C1704864
27408381	poor prognosis	C0278252
27408381	year	C0439234
27408381	female	C0086287
27408381	presented with	C0150312
27408381	pyrexia of unknown origin	C0015970
27408381	month	C0439231
27408381	examination	C0031809
27408381	severe pallor	C0030232
27408381	hepatosplenomegaly	C0019214
27408381	no palpable	C0522499
27408381	lymphadenopathy	C0497156
27408381	Complete blood count	C0009555
27408381	revealed	C0443289
27408381	bicytopenia	C1142446
27408381	normal total leucocyte count	C0438221
27408381	Liver	C0023901
27408381	renal function tests	C0022662
27408381	normal	C0205307
27408381	Ultrasonography abdomen	C0203464
27408381	revealed	C0443289
27408381	splenic enlargement	C0038002
27408381	two focal lesions	C0243095
27408381	splenic abscess	C0272412
27408381	infarcts	C0037998
27408381	Patient	C0030705
27408381	splenic infarct	C0037998
27408381	bicytopenia	C1142446
27408381	investigation	C0220825
27408381	elevated serum ferritin	C0241013
27408381	triglycerides	C0813230
27408381	LDH	C1275604
27408381	clinical	C0205210
27408381	suspicion	C0242114
27408381	infection	C3714514
27408381	haemophagocytic lymphohistiocytosis	C0024291
27408381	bone marrow aspiration	C0398523
27408381	bone marrow aspiration (BMA) and biopsy (BMBx)	C0005954
27408381	BMA	C0398523
27408381	biopsy	C0005558
27408381	extensive	C0205231
27408381	haemophagocytosis	C0876991
27408381	large lymphoma-like cells	C0027671
27408381	PET-CT	C1699633
27408381	enlarged spleen	C0038002
27408381	diffuse uptake	C0301639
27408381	BMBx	C0005954
27408381	nodular	C0028259
27408381	intrasinusoidal	C0442041
27408381	abnormal lymphoid cells	C0086574
27408381	immunohistochemistry	C0021044
27408381	cells	C0086574
27408381	positive for CD20	C4289894
27408381	CD5	C0054964
27408381	MUM1	C0299544
27408381	BCL-2	C1317122
27408381	BCL-6	C1829684
27408381	negative	C0205160
27408381	CD3	C0108779
27408381	CD10	C0025250
27408381	CD23	C0123242
27408381	CD34	C0054953
27408381	focal	C0205234
27408381	intrasinusoidal	C0442041
27408381	pattern	C0449774
27408381	clinicopathological profile	C1254363
27408381	diagnosis	C0011900
27408381	de novo	C1515568
27408381	CD5+	C0882892
27408381	DLBCL	C0079744
27408381	primary hepatosplenic	C0012634
27408381	pattern	C0449774
27408381	CD5+	C0882892
27408381	DLBCL	C0079744
27408381	splenic infarct	C0037998
27408381	very rare	C1855575
27408381	unusual	C2700116
27408381	diagnosis	C0011900
27408381	primary aggressive lymphoma	C1332225
27408381	haemophagocytosis	C0876991
27408381	established	C0443211
27408381	patient	C0030705
27408381	fever	C0015967
27408381	splenic infarct	C0037998
27408381	lymphadenopathy	C0497156
27408381	morphological	C0543482
27408381	assessment	C1516048
27408381	bone marrow aspirate	C0857285
27408381	biopsy	C0005558
27408381	correct diagnosis	C0011900
27412612	cost-effectiveness	C0010181
27412612	family	C0015576
27412612	family-based therapy	C0087111
27412612	treatment	C1522326
27412612	externalizing disorders	C0004936
27412612	substance use disorders	C0038586
27412612	delinquency	C0522174
27412612	review	C0282443
27412612	Family therapy	C0087111
27412612	family-based treatment	C1522326
27412612	children	C0008059
27412612	adolescents	C0205653
27412612	mental health care	C0184643
27412612	economic evaluations	C0150099
27412612	interventions	C0184661
27412612	review	C0282443
27412612	evaluate	C0220825
27412612	cost-effectiveness	C0010181
27412612	family	C0015576
27412612	family-based therapy	C0087111
27412612	externalizing disorders	C0004936
27412612	substance use disorders	C0038586
27412612	delinquency	C0522174
27412612	PubMed	C1138432
27412612	Education Resource information Centre	C1449627
27412612	ERIC	C1449627
27412612	Psycinfo	C1140129
27412612	Cochrane	C0242356
27412612	reviews	C0282443
27412612	studies	C0947630
27412612	economic evaluations	C0150099
27412612	family	C0015576
27412612	family-based interventions	C0184661
27412612	adolescents	C0205653
27412612	years	C0439234
27412612	treated	C1522326
27412612	substance use disorders	C0038586
27412612	delinquency	C0522174
27412612	externalizing disorders	C0004936
27412612	articles	C1706852
27412612	studies	C0947630
27412612	studies	C0947630
27412612	quality	C0332306
27412612	studies	C0947630
27412612	assessed	C1516048
27412612	studies	C0947630
27412612	family	C0015576
27412612	family-based interventions	C0184661
27412612	disorders	C0012634
27412612	outcomes	C0085565
27412612	quality	C0332306
27412612	economic evaluations	C0150099
27412612	study	C0947630
27412612	meta-analysis	C0920317
27412612	quality	C0332306
27412612	economic evaluations	C0150099
27412612	family	C0015576
27412612	family-based therapy	C0087111
27412612	treatment	C1522326
27412612	externalizing disorders	C0004936
27412612	adolescent	C0205653
27412612	substance use disorders	C0038586
27412612	delinquency	C0522174
27412612	cost-effectiveness	C0010181
27412612	family	C0015576
27412612	family-based therapy	C0087111
27412612	quality	C0332306
27420620	Regulation	C0017263
27420620	ABCA1	C1412058
27420620	ABCG1	C1412096
27420620	gene expression	C0017262
27420620	intraabdominal adipose tissue	C1563739
27420620	Tissue specific expression of genes	C1519516
27420620	encoding	C2700640
27420620	cholesterol	C0008377
27420620	transporters	C0007292
27420620	ABCA1	C3711161
27420620	ABCG1	C0963751
27420620	genes	C0017337
27420620	encoding	C2700640
27420620	transcriptional	C0040649
27420620	regulators	C0815047
27420620	adipogenesis	C0596843
27420620	LXRa	C0297439
27420620	LXRb	C0754148
27420620	PPARg	C3887582
27420620	RORa	C0284080
27420620	investigated	C1292732
27420620	intraabdominal adipose tissue	C1563739
27420620	IAT	C1563739
27420620	samples	C0370003
27420620	correlation	C1707520
27420620	ABCA1	C3711161
27420620	ABCG1 proteins	C0963751
27420620	RORa protein	C0284080
27420620	level	C0441889
27420620	suggests	C1705535
27420620	transcription factor	C0040648
27420620	RORa	C0284080
27420620	regulation	C1327622
27420620	IAT	C1563739
27420620	ABCA1	C3711161
27420620	ABCG1 protein	C0963751
27420620	levels	C0441889
27420620	ABCA1	C1412058
27420620	ABCG1	C1412096
27420620	gene expression	C0017262
27420620	correlated	C1707520
27420620	obesity	C0028754
27420620	indicators	C0021212
27420620	body mass index	C1305855
27420620	BMI	C1305855
27420620	waist circumference	C0455829
27420620	development	C1527148
27420620	obesity	C0028754
27420620	associated with	C0332281
27420620	decreased	C0205216
27420620	IAT	C1563739
27420620	levels	C0441889
27420620	RORa	C1335634
27420620	LXRb	C1417823
27420620	mRNA	C0035696
27420620	data	C1511726
27420620	suggest	C1705535
27420620	nuclear factor RORa	C0284080
27420620	significant	C0750502
27420620	regulation	C1327622
27420620	cholesterol metabolism	C1156530
27420620	control	C0243148
27420620	IAT	C1563739
27420620	expression	C1171362
27420620	ABCA1	C3711161
27420620	ABCG1	C0963751
27420620	level	C0441889
27420620	IAT	C1563739
27420620	LXRb	C1417823
27420620	gene expression	C0017262
27420620	associated with	C0332281
27420620	development	C1527148
27420620	obesity	C0028754
27425447	Triterpenoids	C1519655
27425447	stems	C0242767
27425447	Tripterygium regelii	C1059497
27425447	triterpenoids	C1519655
27425447	triregelolides	C1519655
27425447	triregeloic acid	C1519655
27425447	isolated	C0205409
27425447	stems	C0242767
27425447	Tripterygium regelii	C1059497
27425447	triterpene	C0041113
27425447	analogues	C0002776
27425447	compounds	C0041113
27425447	NMR spectroscopic	C0877853
27425447	HRESIMS	C0596495
27425447	Compounds	C0041113
27425447	4	C0041113
27425447	7	C0041113
27425447	8	C0041113
27425447	10	C0041113
27425447	13	C0041113
27425447	14	C0041113
27425447	17	C0041113
27425447	21-23	C0041113
27425447	isolated	C0205409
27425447	T. regelii	C1059497
27425447	Compounds	C1519655
27425447	3	C1519655
27425447	5	C0041113
27425447	6	C0041113
27425447	8	C0041113
27425447	9	C0041113
27425447	10	C0041113
27425447	14	C0041113
27425447	16	C0041113
27425447	inhibitory effects on the proliferation	C1156236
27425447	human breast cancer cells	C1512505
27425447	MCF-7	C0596890
27425447	concentration	C0392762
27427386	Biochemical	C0205474
27427386	mitochondrial	C0026237
27427386	genetic	C0314603
27427386	modifier	C3178895
27427386	phenotypic	C0031437
27427386	manifestation	C0205319
27427386	Leber's hereditary optic neuropathy	C0917796
27427386	mitochondrial DNA mutation	C0948444
27427386	Leber's hereditary optic neuropathy	C0917796
27427386	LHON	C0917796
27427386	mitochondrial disease	C0751651
27427386	Mitochondrial	C0026237
27427386	modifiers	C3178895
27427386	phenotypic expression	C0031437
27427386	LHON	C0917796
27427386	mitochondrial DNA	C0012929
27427386	mtDNA	C0012929
27427386	mutations	C0948444
27427386	study	C2603343
27427386	LHON	C0917796
27427386	susceptibility	C0012655
27427386	allele	C0002085
27427386	m.14502T > C	C0002085
27427386	p. 58I > V	C0002085
27427386	ND6 gene	C1537995
27427386	modulated	C0443264
27427386	phenotypic expression	C0031437
27427386	LHON	C0917796
27427386	m.11778G > A mutation	C0026882
27427386	Han Chinese	C0814942
27427386	pedigrees	C0030761
27427386	m.14502T > C	C0026882
27427386	m.11778G > A mutations	C0026882
27427386	penetrance	C0524899
27427386	optic neuropathy	C3887709
27427386	m.11778G > A mutation	C0026882
27427386	functional	C0205245
27427386	assays	C0005507
27427386	cybrid cell models	C0007600
27427386	mtDNA-less ρ(o) cells	C0007634
27427386	enucleated cells	C0007634
27427386	LHON	C0917796
27427386	patients	C0030705
27427386	m.11778G > A	C0026882
27427386	m.14502T > C mutations	C0026882
27427386	m.14502T > C	C0026882
27427386	m.11778G > A mutation	C0026882
27427386	mtDNA	C0012929
27427386	haplogroup	C0018591
27427386	cybrids cell lines	C0007600
27427386	m.14502T > C mutation	C0026882
27427386	effects	C1280500
27427386	mitochondrial	C0026237
27427386	functions	C0542341
27427386	m.11778G > A mutation	C0026882
27427386	mitochondrial	C0026237
27427386	dysfunctions	C3887504
27427386	cell lines	C0007600
27427386	m.14502T > C	C0026882
27427386	m.11778G > A mutations	C0026882
27427386	m.11778G > A	C0026882
27427386	m.14502T > C mutation	C0026882
27427386	m.14502T > C mutation	C0026882
27427386	complex I	C0171406
27427386	respiratory	C0521346
27427386	phenotypes	C0031437
27427386	m.11778G > A mutation	C0026882
27427386	defective	C0332452
27427386	complex I	C0171406
27427386	mitochondrial	C0026237
27427386	ATP	C0001480
27427386	reactive oxygen species	C0162772
27427386	mutant	C0596988
27427386	cells	C0007634
27427386	m.14502T > C	C0026882
27427386	m.11778G > A mutation	C0026882
27427386	11778G > A mutation	C0026882
27427386	pathophysiology	C0031847
27427386	LHON	C0917796
27427386	manifested by	C1280444
27427386	mtDNA	C0012929
27427386	mutations	C0948444
27427881	Improving	C1272745
27427881	Care Transitions	C4019079
27427881	Healthcare	C0086388
27427881	Settings	C1254362
27427881	Human Factors	C4035944
27427881	decades	C2981279
27427881	research	C0035168
27427881	care transition	C4019079
27427881	improvement	C2986411
27427881	intervention	C0184661
27427881	development	C1527148
27427881	unfavorable outcome	C1519790
27427881	measures	C1879489
27427881	associated with	C0332281
27427881	care transitions	C4019079
27427881	healthcare	C0086388
27427881	settings	C1254362
27427881	Readmissions	C0745042
27427881	rates	C1264674
27427881	outcome	C1274040
27427881	target	C1521840
27427881	intervention	C0184661
27427881	adverse events	C0877248
27427881	associated with	C0332281
27427881	care transitions	C4019079
27427881	issue	C0033213
27427881	patients	C0030705
27427881	dissatisfied	C0870433
27427881	quality	C0332306
27427881	care	C1947933
27427881	interventions	C0184661
27427881	care transitions	C4019079
27427881	disease	C0012634
27427881	specific	C0205369
27427881	substantial	C0205556
27427881	financial investments	C3826621
27427881	training	C0220931
27427881	allied healthcare professionals	C0002122
27427881	hospital-based discharge planning	C1563179
27427881	complex situation	C0205556
27427881	method of evaluation	C2911685
27427881	comprehensive	C1880156
27427881	in-depth	C0205125
27427881	context-driven	C1254370
27427881	investigation	C0220825
27427881	potential risks	C0035648
27427881	care transitions	C4019079
27427881	healthcare	C0086388
27427881	settings	C1254362
27427881	creation	C1706214
27427881	effective	C1704419
27427881	usable	C0205556
27427881	sustainable	C0443318
27427881	interventions	C0184661
27427881	Human Factors and Ergonomics	C0020120
27427881	HFE	C0020120
27427881	evaluates	C1550545
27427881	factors	C1521761
27427881	human performance	C0020115
27427881	article	C1706852
27427881	HFE	C0020120
27427881	improve	C1272745
27427881	care transitions	C4019079
27430240	Adenosine	C0001443
27430240	adenosine A2A receptor agonist	C2936552
27430240	CGS21680	C0055233
27430240	upregulate	C0949479
27430240	CD39	C0108783
27430240	CD73	C0000530
27430240	expression	C0597360
27430240	E2F-1	C1384539
27430240	CREB	C0056695
27430240	regulatory T cells	C0039198
27430240	isolated	C0205409
27430240	septic	C0333534
27430240	mice	C0025929
27430240	regulatory T cells	C0039198
27430240	Treg cells	C0039198
27430240	expression	C0597360
27430240	ectonucleoside triphosphate diphosphohydrolase 1	C0108783
27430240	ENTPD1	C0108783
27430240	CD39	C0108783
27430240	5'-ectonucleotidase	C0000530
27430240	NT5E	C0000530
27430240	CD73	C0000530
27430240	Treg cell	C0039198
27430240	surface	C0205148
27430240	increased	C0205217
27430240	sepsis	C0243026
27430240	factors	C0005515
27430240	high	C0205250
27430240	expression	C0597360
27430240	CD39	C0108783
27430240	CD73	C0000530
27430240	regulation of	C1327622
27430240	CD39	C0108783
27430240	CD73	C0000530
27430240	adenosine	C0001443
27430240	pathway	C1705987
27430240	Treg cells	C0039198
27430240	septic	C0333534
27430240	mouse model	C2986594
27430240	sepsis	C0243026
27430240	Treg cells	C0039198
27430240	flow cytometer	C0180279
27430240	Treg cells	C0039198
27430240	isolated	C0205409
27430240	peritoneal lavage	C0031148
27430240	splenocytes	C1519477
27430240	mice	C0025929
27430240	treated with	C0332293
27430240	adenosine	C0001443
27430240	adenosine A2A receptor agonist	C2936552
27430240	CGS21680	C0055233
27430240	transfected	C0040669
27430240	siRNA	C1099354
27430240	targeting	C1521840
27430240	E2F transcription factor 1	C1384539
27430240	E2F-1	C1384539
27430240	cyclic adenosine monophosphate (cAMP) response element-binding protein	C0056695
27430240	CREB	C0056695
27430240	transcription regulatory factors	C0040648
27430240	CD39	C0108783
27430240	CD73	C0000530
27430240	regulatory	C1327622
27430240	factors	C0005515
27430240	western blot analysis	C0949466
27430240	dual-luciferase reporter assay	C0022885
27430240	changes	C0392747
27430240	adenosine metabolism	C1158592
27430240	treated	C1522326
27430240	cells	C0007634
27430240	adenosine	C0001443
27430240	CGS21680	C0055233
27430240	upregulated	C0949479
27430240	CD39	C0108783
27430240	CD73	C0000530
27430240	expression	C0597360
27430240	E2F-1	C1384539
27430240	CREB	C0056695
27430240	CD39	C0108783
27430240	CD73	C0000530
27430240	expression	C0597360
27430240	upregulated	C0949479
27430240	adenosine	C0001443
27430240	CGS21680	C0055233
27430240	Adenosine triphosphate (ATP) hydrolysis	C1510699
27430240	adenosine	C0001443
27430240	generation	C3146294
27430240	inhibited	C3463820
27430240	knockdown	C0849355
27430240	E2F-1	C1384539
27430240	CREB	C0056695
27430240	accelerated	C0521110
27430240	CGS21680	C0055233
27430240	adenosine	C0001443
27430240	adenosine A2A receptor agonist	C2936552
27430240	E2F-1	C1384539
27430240	CREB	C0056695
27430240	factors	C0005515
27430240	high	C0205250
27430240	expression	C0597360
27430240	CD39	C0108783
27430240	CD73	C0000530
27430240	Treg cell	C0039198
27430240	surface	C0205148
27430240	sepsis	C0243026
27430240	Adenosine	C0001443
27430240	A2A receptor agonist	C2936552
27430240	signal transducer	C1152628
27430240	factors	C0005515
27430240	CD39	C0108783
27430240	CD73	C0000530
27430240	adenosine	C0001443
27430240	pathway	C1705987
27430240	accelerating	C0521110
27430240	adenosine	C0001443
27430240	generation	C3146294
27430240	research	C0035168
27430240	adenosine metabolism	C1158592
27430240	treatment	C0087111
27430240	sepsis	C0243026
27430264	Consumer	C1707496
27430264	Patient	C0030705
27430264	Knowledge	C0376554
27430264	Behavior	C0004927
27430264	Attitude	C0004271
27430264	Toward	C3875150
27430264	Medicinal	C0013227
27430264	Lifestyle Products	C3273359
27430264	Purchased	C0870238
27430264	Internet	C0282111
27430264	Web	C0282111
27430264	Based	C1527178
27430264	Survey	C0038951
27430264	lifestyle products	C3273359
27430264	improve	C0184511
27430264	people's	C0027361
27430264	physical	C2607857
27430264	mental	C0025361
27430264	performance	C0597198
27430264	Internet	C0282111
27430264	major	C0205164
27430264	role	C1705810
27430264	spread	C0332261
27430264	products	C1514468
27430264	literature	C0023866
27430264	authenticity	C0205556
27430264	medicines	C0013227
27430264	purchased	C0870238
27430264	Internet	C0282111
27430264	impact	C4049986
27430264	counterfeit medicines	C2936336
27430264	public	C0678367
27430264	health	C0018684
27430264	no data are available	C1546437
27430264	authenticity	C0205556
27430264	lifestyle products	C3273359
27430264	toxicity	C0040539
27430264	associated with	C0332281
27430264	use	C1524063
27430264	misuse	C0549649
27430264	investigate	C1292732
27430264	consumer	C0680971
27430264	patient attitudes	C0870289
27430264	toward	C3875150
27430264	purchase	C0870238
27430264	lifestyle products	C3273359
27430264	Internet	C0282111
27430264	knowledge	C0376554
27430264	product	C1514468
27430264	authenticity	C0205556
27430264	toxicity	C0040539
27430264	experiences	C0596545
27430264	counterfeit	C0205556
27430264	lifestyle products	C3273359
27430264	Web	C0282111
27430264	based	C1527178
27430264	study	C2603343
27430264	performed	C0884358
27430264	Uniform	C0205375
27430264	collection of data	C0010995
27430264	performed	C0884358
27430264	through	C0332273
27430264	anonymous	C2346787
27430264	online	C0029038
27430264	questionnaire	C0034394
27430264	Participants	C0679646
27430264	worldwide	C0332464
27430264	email	C0013849
27430264	social media	C3179065
27430264	personal communication	C0086792
27430264	complete	C0205197
27430264	online	C0029038
27430264	questionnaire	C0034394
27430264	total	C0439810
27430264	participants	C0679646
27430264	completed	C0205197
27430264	questionnaire	C0034394
27430264	results	C1274040
27430264	questionnaire	C0034394
27430264	participants	C0679646
27430264	purchased	C0870238
27430264	lifestyle products	C3273359
27430264	Internet	C0282111
27430264	mainly	C1542147
27430264	due to	C0678226
27430264	convenience	C3831015
27430264	reduced	C0392756
27430264	cost	C0010186
27430264	More than	C0439093
27430264	half	C2825407
27430264	participants	C0679646
27430264	purchased	C0870238
27430264	cosmetic products	C0010164
27430264	minority	C0205165
27430264	purchased	C0870238
27430264	medicinal products	C0013227
27430264	participants	C0679646
27430264	aware	C0004448
27430264	presence	C0150312
27430264	counterfeit	C0205556
27430264	lifestyle products	C3273359
27430264	Internet	C0282111
27430264	experienced	C0596545
27430264	counterfeit	C0205556
27430264	products	C1514468
27430264	cases	C0868928
27430264	counterfeit	C0205556
27430264	lifestyle products	C3273359
27430264	reported	C0700287
27430264	authorities	C1708333
27430264	participants	C0679646
27430264	experienced	C0596545
27430264	adverse effects	C0879626
27430264	counterfeit	C0205556
27430264	lifestyle products	C3273359
27430264	patients	C0030705
27430264	experienced	C0596545
27430264	counterfeit	C0205556
27430264	lifestyle products	C3273359
27430264	resulted in	C0332294
27430264	adverse effects	C0879626
27430264	health	C0018684
27430264	adverse effects	C0879626
27430264	reported	C0700287
27430264	study	C2603343
27430264	counterfeit	C0205556
27430264	products	C1514468
27430264	underreported	C0700287
27430264	authorities	C1708333
27430264	public awareness campaigns	C0679750
27430264	patient education	C0030688
27430264	needed	C0027552
27433451	Prune Belly Syndrome	C0033770
27433451	Associated with VACTERL	C1735591
27433451	Prune belly syndrome	C0033770
27433451	rare	C0522498
27433451	abnormality	C1704258
27433451	association with VACTERL	C1735591
27433451	rarer	C0522498
27433451	association	C1735591
27433451	reported	C0700287
27433451	literature	C0023866
27433451	reported	C0700287
27433451	majority	C0680220
27433451	stillbirths or died shortly after birth	C1850556
27433451	case	C1706256
27433451	Prune belly syndrome	C0033770
27433451	associated with VACTERL	C1735591
27434049	Changes	C0392747
27434049	Cardiovascular	C3887460
27434049	Health Status	C0018759
27434049	Risk of	C0035647
27434049	New-Onset Hypertension	C0745129
27434049	Kailuan	C1257890
27434049	Cohort Study	C0009247
27434049	American Heart Association	C0002458
27434049	cardiovascular	C3887460
27434049	health metrics	C0282574
27434049	cardiovascular diseases	C0007222
27434049	key	C3898777
27434049	risk factor	C0035648
27434049	high	C0205250
27434049	morbidity	C0026538
27434049	mortality	C0681679
27434049	cardiovascular diseases	C0007222
27434049	hypertension	C0020538
27434049	relationship	C0439849
27434049	health status	C0018759
27434049	attention	C0004268
27434049	influence	C4054723
27434049	individual	C0027361
27434049	health status	C0018759
27434049	changes	C0392747
27434049	risk of	C0035647
27434049	new-onset hypertension	C0745129
27434049	assess	C0184514
27434049	changes	C0392747
27434049	cardiovascular	C3887460
27434049	health status	C0018759
27434049	morbidity	C0026538
27434049	hypertension	C0020538
27434049	Kailuan	C1257890
27434049	cohort study	C0009247
27434049	north	C1709269
27434049	China	C0008115
27434049	Cardiovascular	C3887460
27434049	Health Score	C0449820
27434049	CHS	C0449820
27434049	evaluated	C0220825
27434049	follow-ups	C3274571
27434049	study population	C2348561
27434049	divided	C0332849
27434049	groups	C0441833
27434049	changes	C0392747
27434049	CHS score	C0449820
27434049	follow-ups	C3274571
27434049	morbidity	C0026538
27434049	hypertension	C0020538
27434049	collected	C1516698
27434049	during	C0347984
27434049	follow-ups	C3274571
27434049	Data analysis	C0010992
27434049	during	C0347984
27434049	median	C0876920
27434049	follow-up	C3274571
27434049	morbidity	C0026538
27434049	hypertension	C0020538
27434049	relationship	C0439849
27434049	standardized	C1255664
27434049	morbidity	C0026538
27434049	hypertension	C0020538
27434049	participants	C0679646
27434049	increased	C0205217
27434049	decrease	C0547047
27434049	future	C0016884
27434049	risk of	C0035647
27434049	new-onset hypertension	C0745129
27434049	CI	C0009667
27434049	relationship	C0439849
27434049	new-onset hypertension	C0745129
27434049	elevation	C3163633
27434049	cardiovascular	C3887460
27434049	health metrics	C0282574
27434049	Population	C1257890
27434049	prevention	C2700409
27434049	promotion	C0018738
27434049	lifestyle	C0023676
27434049	improvements	C2986411
27434049	critical	C1511545
27434049	reducing	C0392756
27434049	morbidity	C0026538
27434049	new-onset hypertension	C0745129
27435835	HIV	C0019682
27435835	tailored	C2986593
27435835	quit	C1947925
27435835	smoking	C0037369
27435835	counselling	C0010210
27435835	pilot	C0031928
27435835	intervention	C0184661
27435835	targeting	C1521840
27435835	depressive symptoms	C0086132
27435835	Nicotine Replacement Therapy	C1278444
27435835	Cardiovascular disease	C0007222
27435835	CVD	C0007222
27435835	rates	C0026538
27435835	people	C0027361
27435835	living with HIV/AIDS	C2963182
27435835	PHAs	C2963182
27435835	high	C0205250
27435835	Rates	C1521828
27435835	cigarette smoking	C0700219
27435835	leading	C1522538
27435835	contributor	C1880177
27435835	CVD	C0007222
27435835	PHAs	C2963182
27435835	higher	C0205250
27435835	general population	C0683971
27435835	PHAs	C2963182
27435835	high	C0205250
27435835	rates	C1521828
27435835	depression	C0011570
27435835	risk factor	C0035648
27435835	smoking	C0037369
27435835	cessation	C1880019
27435835	relapse	C0035020
27435835	pilot study	C0031928
27435835	examined	C0332128
27435835	effectiveness	C1280519
27435835	tailored	C2986593
27435835	session	C1883016
27435835	smoking	C0037369
27435835	cessation	C1880019
27435835	counselling programme	C0010210
27435835	PHAs	C2963182
27435835	depression	C0011570
27435835	Nicotine Replacement Therapy	C1278444
27435835	NRT	C1278444
27435835	cohort	C0599755
27435835	PHA	C2963182
27435835	smokers	C0337664
27435835	month	C0439231
27435835	follow-up	C1522577
27435835	participants	C0679646
27435835	biochemically	C0205474
27435835	verified	C1711411
27435835	abstinence	C3843422
27435835	smoking	C0037369
27435835	result	C2825142
27435835	compares	C1707455
27435835	quit	C1947925
27435835	smoking	C0037369
27435835	intervention	C0184661
27435835	studies	C0008972
27435835	high	C0205250
27435835	percentage	C0439165
27435835	HIV+	C0019699
27435835	smokers	C0337664
27435835	depression	C0011570
27435835	study	C0008972
27435835	baseline	C1442488
27435835	HIV+	C0019699
27435835	smokers	C0337664
27435835	clinical	C0205210
27435835	cut-off	C1442160
27435835	depression	C0011570
27435835	Centre for Epidemiological Studies - Depression (CES-D) scale	C0679604
27435835	HIV+	C0019699
27435835	smokers	C0337664
27435835	depression	C0011570
27435835	study	C0008972
27435835	baseline	C1442488
27435835	quantitatively	C0392762
27435835	lower	C2003888
27435835	depression	C0011570
27435835	month	C0439231
27435835	follow-up	C1522577
27435835	large	C0549177
27435835	effect size	C0814843
27435835	statistical significance	C0237881
27435835	depression	C0011570
27435835	relapse	C0035020
27435835	depression	C0011570
27435835	counselling programme	C0010210
27435835	adequately	C0205411
27435835	significant	C0750502
27435835	barrier	C0679881
27435835	smoking	C0037369
27435835	cessation	C1880019
27435835	PHAs	C2963182
27435835	pilot study	C0031928
27435835	importance	C3898777
27435835	tailored programmes	C2986593
27435835	PHAs	C2963182
27435835	quit	C1947925
27435835	smoking	C0037369
27435835	significance	C0750502
27435835	depressive symptoms	C0086132
27435835	tailored counselling programmes	C2986593
27435835	enhance	C2349975
27435835	quit	C1947925
27435835	rates	C1521828
27435835	PHAs	C2963182
27436524	Effects of	C1704420
27436524	complex	C0439855
27436524	life cycles	C0023675
27436524	genetic diversity	C0042333
27436524	cyclical parthenogenesis	C0030596
27436524	population	C1257890
27436524	genetic diversity	C0042333
27436524	species	C1705920
27436524	complex	C0439855
27436524	life cycles	C0023675
27436524	anticipate	C0681842
27436524	Cyclical parthenogenesis	C0030596
27436524	CP	C0030596
27436524	organisms	C0029235
27436524	clonal	C1522642
27436524	reproduction	C0035150
27436524	sexual event	C0036864
27436524	life cycle	C0023675
27436524	species	C1705920
27436524	crop	C0242775
27436524	pests	C0869004
27436524	aphids	C0003562
27436524	human parasites	C0585165
27436524	trematodes	C3889286
27436524	models	C3161035
27436524	evolutionary science	C0017398
27436524	Daphnia	C0010979
27436524	cyclical parthenogens	C0029235
27436524	life cycle	C0023675
27436524	genetic diversity	C0042333
27436524	distributions	C1704711
27436524	genetic diversity	C0042333
27436524	conditions	C0348080
27436524	CP	C0030596
27436524	clonal	C1522642
27436524	phase	C0205390
27436524	lengths	C1444754
27436524	Markov chain model	C0024828
27436524	CP	C0030596
27436524	single	C0205171
27436524	locus	C1708726
27436524	simulations	C0679083
27436524	two	C0205448
27436524	loci	C1708726
27436524	departures	C1706081
27436524	sexuality	C0036915
27436524	generations	C0079411
27436524	clonality	C1704387
27436524	convergence	C2700387
27436524	predictions	C0681842
27436524	clonality	C1704387
27436524	clonal	C1522642
27436524	phase	C0205390
27436524	mutations	C0026882
27436524	genetic drift	C0917892
27436524	sexual event	C0036864
27436524	CP	C0030596
27436524	genetic diversity	C0042333
27436524	single	C0205171
27436524	locus	C1708726
27436524	predictions	C0681842
27436524	sexuality	C0036915
27436524	recombination	C0034865
27436524	gametic phases	C0007613
27436524	full-sexuality	C0036915
27436524	predictions	C0681842
27436524	clonality	C1704387
27436524	CP	C0030596
27436524	partial	C0728938
27436524	clonality	C1704387
27436524	individuals	C0237401
27436524	clonally	C1704387
27436524	generation	C0079411
27436524	distribution	C1704711
27436524	genetic diversity	C0042333
27436524	predictions	C0681842
27436524	genetic diversity	C0042333
27436524	null model	C3161035
27436524	evolutionary	C0015219
27436524	demographic	C0011298
27436524	processes	C1522240
27436524	cyclical parthenogens	C0029235
27439116	Recent	C0332185
27439116	advances	C1519201
27439116	chitosan	C0162969
27439116	nanoparticulate	C1450054
27439116	pulmonary	C0024109
27439116	drug delivery	C0085104
27439116	biodegradable polymer	C0597998
27439116	encapsulated	C0205223
27439116	drug	C1254351
27439116	nanoparticles	C1450054
27439116	pulmonary	C0024109
27439116	route of administration	C0013153
27439116	drug delivery	C0085104
27439116	research	C0035168
27439116	Chitosan	C0162969
27439116	natural	C0205296
27439116	biodegradable	C0597998
27439116	biocompatible	C0005479
27439116	polysaccharide	C0032594
27439116	received	C1514756
27439116	carrier	C0013161
27439116	drug delivery	C0085104
27439116	nanoparticles	C1450054
27439116	chitosan	C0162969
27439116	CS	C0162969
27439116	synthetic derivatives	C0162969
27439116	investigated	C1292732
27439116	encapsulation	C2348438
27439116	delivery	C0205245
27439116	drugs	C1254351
27439116	improved	C0184511
27439116	targeting	C1521840
27439116	controlled release	C0868939
27439116	recent	C0332185
27439116	advances	C1519201
27439116	preparation	C1521827
27439116	use of	C1524063
27439116	micro-	C4085688
27439116	nanoparticles	C1450054
27439116	chitosan	C0162969
27439116	derivatives	C0162969
27439116	pulmonary	C0024109
27439116	delivery	C0205245
27439116	therapeutic agents	C0304231
27439116	drugs	C1254351
27439116	genes	C0017337
27439116	vaccines	C0042210
27439116	reviewed	C1709940
27439116	chitosan	C0162969
27439116	applications	C0205245
27439116	formulations	C0524527
27439116	routes of drug delivery	C0013153
27439116	review	C0282443
27439116	pulmonary	C0024109
27439116	delivery of drug-encapsulated nanoparticles	C1881966
27439116	chitosan	C0162969
27439116	derivatives	C0162969
27439116	controversial	C1254370
27439116	toxicological effects	C0600688
27439116	chitosan	C0162969
27439116	nanoparticles	C1450054
27439116	lung	C0024109
27439116	delivery	C0205245
27440255	Form	C0348078
27440255	function	C0542341
27440255	gene regulatory networks	C1720950
27440255	structure	C0678594
27440255	network motifs	C0205556
27440255	fundamental properties	C0871161
27440255	dynamical state space	C1254362
27440255	Network motifs	C0205556
27440255	motifs	C0205556
27440255	feed-forward loop	C0205556
27440255	regulatory networks	C1720950
27440255	Recent	C0332185
27440255	studies	C2603343
27440255	Boolean	C1552663
27440255	network	C1882071
27440255	motifs	C0205556
27440255	form	C0348078
27440255	function	C0542341
27440255	gene regulatory networks	C1720950
27440255	structure	C0678594
27440255	motif	C0205556
27440255	function	C0542341
27440255	gene expression	C0017262
27440255	patterns	C0449774
27440255	motif	C0205556
27440255	higher	C0205250
27440255	level	C0441889
27440255	definition	C1704788
27440255	function	C0542341
27440255	motif	C0205556
27440255	fundamental properties	C0871161
27440255	dynamical state space	C1254362
27440255	Boolean	C1552663
27440255	network	C1882071
27440255	basin entropy	C4068571
27440255	complexity	C0237523
27440255	measure	C0079809
27440255	dynamics	C3826426
27440255	Boolean	C1552663
27440255	networks	C1882071
27440255	diversity	C1880371
27440255	cyclic attractor lengths	C1444754
27440255	motif	C0205556
27440255	measures	C0079809
27440255	three-node	C2697524
27440255	motifs	C0205556
27440255	structural	C0678594
27440255	properties	C0871161
27440255	motif	C0205556
27440255	feedback loops	C0205556
27440255	feed-forward loops	C0205556
27440255	fundamental characteristics	C1521970
27440255	dynamical state space	C1254362
27440255	functional versatility	C0205245
27440255	higher	C0205250
27440255	level	C0441889
27440255	properties	C0871161
27440255	regulatory networks	C1720950
27440255	basin entropy	C4068571
27440255	cycle length	C1444754
27440255	diversity	C1880371
27440255	prevalence	C0220900
27440255	neural	C0598941
27440255	genetic regulatory networks	C1720950
27440255	motifs	C0205556
27440255	self-interactions	C1704675
27440255	literature	C0023866
27440725	Jak1	C0169658
27440725	STAT3	C0253050
27440725	Signals	C0037083
27440725	Essential	C0205224
27440725	Effectors	C0599560
27440725	USP6	C1175888
27440725	TRE17 Oncogene	C1175888
27440725	Tumorigenesis	C0596263
27440725	Bone	C0005967
27440725	soft tissue tumors	C0037579
27440725	BSTT	C0027651
27440725	development	C1527148
27440725	effective	C1704419
27440725	therapies	C0087111
27440725	report	C0684224
27440725	ubiquitin-specific protease 6	C1175888
27440725	USP6	C1175888
27440725	TRE17 oncogene	C1175888
27440725	overexpressed	C1514559
27440725	chromosome translocation	C0040715
27440725	human	C0086418
27440725	tumors	C0027651
27440725	aneurysmal bone cyst	C0152244
27440725	ABC	C0152244
27440725	benign	C0205183
27440725	lesion	C0221198
27440725	nodular fasciitis	C0410005
27440725	Ectopic expression	C1512167
27440725	USP6	C1175888
27440725	formation	C1522492
27440725	tumors	C0027651
27440725	key features	C2348519
27440725	ABC	C0152244
27440725	nodular fasciitis	C0410005
27440725	identity	C0017390
27440725	USP6's	C1175888
27440725	substrates	C0178623
27440725	report	C0684224
27440725	Jak1	C0169658
27440725	STAT3	C0253050
27440725	signaling pathway	C0037080
27440725	essential	C0205224
27440725	effector	C0599560
27440725	USP6	C1175888
27440725	BSTT	C0027651
27440725	formation	C1522492
27440725	USP6	C1175888
27440725	deubiquitinated	C1157996
27440725	Jak1	C0169658
27440725	leading	C1522538
27440725	stabilization	C0184512
27440725	activation	C0599177
27440725	STAT3	C0253050
27440725	tumorigenic	C0007621
27440725	potential	C3245505
27440725	USP6	C1175888
27440725	attenuated significantly by	C0332161
27440725	CRISPR	C3658200
27440725	deletion	C0017260
27440725	Jak1	C1334290
27440725	STAT3	C1367307
27440725	administration	C1621583
27440725	Jak family	C0597721
27440725	inhibitor	C1999216
27440725	Analysis	C0936012
27440725	primary clinical samples	C2347026
27440725	nodular fasciitis	C0410005
27440725	confirmed	C0750484
27440725	activation	C0599177
27440725	Jak1	C0169658
27440725	STAT3	C0253050
27440725	gene signature	C1708225
27440725	in vivo	C0681829
27440725	studies	C0947630
27440725	Jak1	C0169658
27440725	substrate	C0178623
27440725	USP6	C1175888
27440725	mechanistic rationale	C2699007
27440725	clinical investigation	C1261322
27440725	Jak	C0597721
27440725	STAT3	C0253050
27440725	inhibitors	C1999216
27440725	therapeutics	C0302350
27440725	treatment	C0087111
27440725	bone	C0005967
27440725	soft tissue tumors	C0037579
27440725	neoplasms	C0027651
27440725	USP6	C1175888
27440725	overexpression	C1514559
27441507	Evidence	C3887511
27441507	Integrating	C1881786
27441507	Palliative Care	C0030231
27441507	Oncology	C0027651
27441507	Practice	C0033284
27441507	Palliative care services	C0587605
27441507	provided	C1999230
27441507	traditional	C0443324
27441507	oncology care	C3244201
27441507	beneficial	C0205556
27441507	patients	C0030705
27441507	families	C0015576
27441507	article	C1706852
27441507	brief	C1879313
27441507	history	C0019664
27441507	palliative care	C0030231
27441507	implementing	C1705848
27441507	services	C0557854
27441507	currently	C0521116
27441507	established	C0443211
27441507	oncology programs	C1516732
27441507	discussion	C2584313
27441507	common barriers	C4045969
27442214	Secondary Ossification Center	C1184751
27442214	Appearance	C0700364
27442214	Closure in the Pelvis	C1293215
27442214	Proximal Femur	C0448190
27442214	ossification	C0029433
27442214	patterns	C0449774
27442214	pelvis	C0030797
27442214	skeletally	C0037253
27442214	immature	C0205252
27442214	patients	C0030705
27442214	pelvic	C0030797
27442214	radiographs	C1306645
27442214	sex	C1522384
27442214	comparisons	C1707455
27442214	secondary ossification centers	C1184751
27442214	evaluates	C0220825
27442214	chronology	C0008717
27442214	sex differences	C0036866
27442214	appearance	C0700364
27442214	closure of pelvic	C1293215
27442214	proximal femoral	C0448190
27442214	secondary ossification centers	C1184751
27442214	computed tomography	C0040405
27442214	CT	C0040405
27442214	Patients	C0030705
27442214	abdominal	C0412620
27442214	pelvic CT scans	C3842376
27442214	trauma centers	C0040786
27442214	retrospectively	C1514923
27442214	reviewed	C1709940
27442214	Patients	C0030705
27442214	ages	C0001779
27442214	imaging	C0011923
27442214	pelvis	C0030797
27442214	proximal femurs	C0448190
27442214	Patients	C0030705
27442214	orthopaedic trauma	C1274117
27442214	pathology	C0030664
27442214	affecting	C0392760
27442214	ossification	C0029433
27442214	CT scans	C0040405
27442214	assessed	C1516048
27442214	appearance	C0700364
27442214	closure	C0185003
27442214	secondary ossification centers	C1184751
27442214	anterior inferior iliac spine	C0223645
27442214	AIIS	C0223645
27442214	anterior superior iliac spine	C0223644
27442214	ASIS	C0223644
27442214	femoral head	C0015813
27442214	FH	C0015813
27442214	greater trochanter	C0223865
27442214	GT	C0223865
27442214	iliac crest	C0223651
27442214	IC	C0223651
27442214	ischial tuberosity	C0223656
27442214	IT	C0223656
27442214	lesser trochanter	C0223866
27442214	LT	C0223866
27442214	posterior superior iliac spine	C0223646
27442214	PSIS	C0223646
27442214	symphysis pubis	C0034015
27442214	SP	C0034015
27442214	triradiate cartilage	C0007301
27442214	TRC	C0007301
27442214	CT scans	C0040405
27442214	inclusion criteria	C1512693
27442214	males	C0086582
27442214	females	C0086287
27442214	appearance	C0700364
27442214	secondary ossification centers	C1184751
27442214	male	C0086582
27442214	GT	C0223865
27442214	LT	C0223866
27442214	AIIS	C0223645
27442214	IT	C0223656
27442214	ASIS	C0223644
27442214	PSIS	C0223646
27442214	IC	C0223651
27442214	SP	C0034015
27442214	female	C0086287
27442214	GT	C0223865
27442214	LT	C0223866
27442214	IT	C0223656
27442214	AIIS	C0223645
27442214	PSIS	C0223646
27442214	IC	C0223651
27442214	ASIS	C0223644
27442214	SP	C0034015
27442214	closure	C0185003
27442214	male	C0086582
27442214	TRC	C0007301
27442214	LT	C0223866
27442214	FH	C0015813
27442214	AIIS	C0223645
27442214	GT	C0223865
27442214	ASIS	C0223644
27442214	PSIS	C0223646
27442214	IT	C0223656
27442214	IC	C0223651
27442214	SP	C0034015
27442214	female	C0086287
27442214	LT	C0223866
27442214	TRC	C0007301
27442214	AIIS	C0223645
27442214	FH	C0015813
27442214	GT	C0223865
27442214	ASIS	C0223644
27442214	PSIS	C0223646
27442214	IT	C0223656
27442214	IC	C0223651
27442214	SP	C0034015
27442214	Female	C0086287
27442214	ossification centers	C1184744
27442214	males	C0086582
27442214	locations	C1515974
27442214	Female	C0086287
27442214	ossification centers	C1184744
27442214	males	C0086582
27442214	locations	C1515974
27442214	TRC	C0007301
27442214	IC	C0223651
27442214	SP	C0034015
27442214	appearance	C0700364
27442214	closure of the pelvis	C1293215
27442214	proximal femur	C0448190
27442214	secondary ossification centers	C1184751
27442214	females	C0086287
27442214	males	C0086582
27442214	ages of developmen	C1821962
27442214	sex differences	C0036866
27442214	skeletal development	C1160401
27442214	secondary ossification centers	C1184751
27442214	evaluate	C0220825
27442214	skeletal maturity	C3825673
27442214	pediatric	C0030755
27442214	pathology	C0030664
27442214	surgical management	C1515089
27442216	Pediatric	C0008059
27442216	Orthopaedic	C0037253
27442216	Trauma	C3714660
27442216	Associated Injuries	C3263723
27442216	Snowmobile	C2063141
27442216	ATV	C0683911
27442216	Dirtbike Accidents	C0683911
27442216	19-Year	C0439234
27442216	Pediatric	C0008059
27442216	Trauma Center	C0040786
27442216	study	C2603343
27442216	type	C0332307
27442216	severity	C0439793
27442216	orthopaedic	C0597457
27442216	associated injuries	C0412812
27442216	snowmobile	C2063141
27442216	All-terrain vehicles	C0683911
27442216	ATV	C0683911
27442216	motorized dirtbike accidents	C0683911
27442216	pediatric	C0008059
27442216	patient population	C0030705
27442216	patients	C0030705
27442216	snowmobile	C3714660
27442216	ATV-related	C3714660
27442216	dirtbike (n=363)-related trauma	C3714660
27442216	institution	C2607850
27442216	reviewed	C1709940
27442216	axial	C0016658
27442216	appendicular fractures	C0016658
27442216	procedures	C2700391
27442216	Snowmobile	C2063141
27442216	dirtbike accidents	C0683911
27442216	associated with	C0332281
27442216	fractures	C0016658
27442216	ATV group	C1257890
27442216	Snowmobile injuries	C0412812
27442216	spinal	C0080179
27442216	lower extremity fractures	C1542178
27442216	Snowmobile	C0599755
27442216	dirtbike cohorts	C0599755
27442216	femur fractures	C0015802
27442216	ATV cohort	C0599755
27442216	upper extremity	C1140618
27442216	hand	C0018563
27442216	scapula	C0036277
27442216	open fractures	C0016662
27442216	Head trauma	C0018674
27442216	associated injury	C0412812
27442216	patients	C0030705
27442216	ATV group	C1257890
27442216	Snowmobile	C0030705
27442216	ATV patients	C0030705
27442216	Injury Severity Score	C0021504
27442216	dirtbike patients	C0030705
27442216	ATV patients	C0030705
27442216	younger	C0332239
27442216	snowmobile	C0030705
27442216	dirtbike	C0030705
27442216	Pediatric	C0008059
27442216	snowmobile	C2063141
27442216	ATV	C0683911
27442216	dirtbike accidents	C0683911
27442216	severe	C0205082
27442216	orthopaedic	C0597457
27442216	associated injuries	C0412812
27442216	vehicle	C0348005
27442216	injury	C3263723
27442216	patterns	C0449774
27442216	Injury prevention	C0150638
27442216	safety mechanisms	C0150755
27442216	protective gear	C3840637
27442216	off-road vehicle	C0028892
27442216	strict laws	C0023150
27442216	age	C0001779
27443131	Hospitalist	C0600620
27443131	Co-management	C1273870
27443131	Pediatric	C1521725
27443131	Orthopaedic	C0524852
27443131	Surgical Patients	C0871463
27443131	Community Hospital	C0020003
27443131	hospitalist	C0600620
27443131	co-management	C1273870
27443131	pediatric	C1521725
27443131	surgical patients	C0871463
27443131	bettering	C0332272
27443131	patient safety	C1113679
27443131	decreasing	C0442797
27443131	negative	C3853545
27443131	patient outcomes	C1547647
27443131	comprehensive medical care	C0009586
27443131	dedicated resource	C0035201
27443131	patients	C0030705
27443131	postoperative care	C0032786
27443131	study	C2603343
27443131	characterize	C1880022
27443131	nature	C0349590
27443131	patients	C0030705
27443131	pediatric	C1521725
27443131	hospitalist	C0600620
27443131	authors	C3812881
27443131	hypothesize	C1512571
27443131	hospitalist	C0600620
27443131	co-management	C1273870
27443131	safe	C3266157
27443131	efficacious	C1280519
27443131	pediatric	C1521725
27443131	orthopaedic	C0524852
27443131	surgical patients	C0871463
27443131	admitted	C0184666
27443131	community hospital	C0020003
27443131	retrospective review	C0035363
27443131	pediatric	C1521725
27443131	orthopaedic	C0524852
27443131	surgical patients	C0871463
27443131	admitted	C0184666
27443131	community hospital	C0020003
27443131	pediatric	C1521725
27443131	hospitalist	C0600620
27443131	hospitalization	C0019993
27443131	pain control	C1304888
27443131	antibiotic infusion	C0199779
27443131	neurovascular monitoring	C1828265
27443131	Parameters	C0549193
27443131	postoperative care	C0032786
27443131	co-management	C1273870
27443131	assessed	C1516048
27443131	presence	C0150312
27443131	complications	C2362589
27443131	medication introduction	C1293116
27443131	hospitalist	C0600620
27443131	follow-up	C1522577
27443131	adherence	C1510802
27443131	readmission	C0030700
27443131	complication	C2362589
27443131	rates	C1521828
27443131	discharge	C0030685
27443131	patients	C0030705
27443131	assessed	C1516048
27443131	average age	C0001779
27443131	years	C0439234
27443131	percent	C0439165
27443131	patients	C0030705
27443131	associated comorbidity	C0009488
27443131	asthma	C0004096
27443131	attention deficit disorder	C0041671
27443131	autism	C0004352
27443131	pediatric	C1521725
27443131	hospitalist	C0600620
27443131	pain medication	C0508321
27443131	postoperative orders	C0032786
27443131	orthopaedics team	C0334954
27443131	percent	C0439165
27443131	patients	C0030705
27443131	breakthrough pain	C1135120
27443131	percent	C0439165
27443131	patients	C0030705
27443131	pain medication	C0508321
27443131	dosing	C0178602
27443131	schedule	C0030703
27443131	hospitalist	C0600620
27443131	team	C0871489
27443131	surgeon	C0582175
27443131	patients	C0030705
27443131	percent	C0439165
27443131	surgeon	C0582175
27443131	pain medication	C0508321
27443131	patient	C0030705
27443131	anesthesia	C0002903
27443131	surgeon	C0582175
27443131	patients	C0030705
27443131	hospitalists	C0600620
27443131	discharged patients	C0030685
27443131	patients	C0030705
27443131	follow-up appointment and schedule	C0184760
27443131	hospitalist	C0600620
27443131	every patient	C0030705
27443131	followed up	C1522577
27443131	days	C0439228
27443131	discharge	C0030685
27443131	complications	C2362589
27443131	hospital readmissions	C0600290
27443131	days	C0439228
27443131	discharge	C0030685
27443131	Hospitalist	C0600620
27443131	co-management	C1273870
27443131	pediatric	C1521725
27443131	orthopaedic	C0524852
27443131	surgical patients	C0871463
27443131	patients	C0030705
27443131	community hospital	C0020003
27443131	medical comorbidity	C0009488
27443131	medication management	C0150270
27443131	Hospitalist	C0600620
27443131	inpatient stay	C0420512
27443131	help	C1269765
27443131	streamline communication	C0009452
27443131	providers	C0018724
27443131	patients	C0030705
27443131	surgeon	C0582175
27443131	Co-management	C1273870
27443131	safe	C3266157
27443131	efficacious	C1280519
27443131	pediatric	C1521725
27443131	orthopaedic	C0524852
27443131	surgical patients	C0871463
27443131	patients	C0030705
27443131	admitted	C0184666
27443131	community hospital	C0020003
27444328	carbohydrate binding module	C0108401
27444328	contributes	C1880177
27444328	processivity	C0205556
27444328	catalytic activity	C0243102
27444328	non-modular hydrolase	C0020289
27444328	5 endoglucanase	C0384886
27444328	Fomitiporia mediterranea MF3/22	C1225186
27444328	FmEG	C0384886
27444328	Fomitiporia mediterranea	C1225186
27444328	non-modular endoglucanase	C0384886
27444328	24-amino acids	C0002520
27444328	extension	C0231448
27444328	13-amino acids	C0002520
27444328	linker-like peptide	C0030956
27444328	N-terminus	C1514562
27444328	312-amino acids	C0002520
27444328	GH5 catalytic domain	C0600499
27444328	CD	C0600499
27444328	C-terminus	C1514562
27444328	FmEG	C0384886
27444328	deletion	C1880274
27444328	N-terminal fragments	C0030935
27444328	fusion	C0162768
27444328	family 1 carbohydrate-binding module	C0108401
27444328	CBM1	C0108401
27444328	contribution	C1880177
27444328	CBM1	C0108401
27444328	FmEG	C0384886
27444328	processivity	C0205556
27444328	catalytic activity	C0243102
27444328	FmEG	C0384886
27444328	processivity	C0205556
27444328	cellobiose	C0007630
27444328	G2	C0007630
27444328	cellotriose	C1690565
27444328	G3	C1690565
27444328	main end products	C1514468
27444328	cellotriose	C1690565
27444328	G4	C1690565
27444328	minor end product	C1514468
27444328	filter paper	C0180859
27444328	FP	C0180859
27444328	G4	C1690565
27444328	regenerated amorphous cellulose	C0007648
27444328	RAC	C0007648
27444328	derivatives	C1690565
27444328	carboxymethylcellulose	C0007068
27444328	CMC	C0007068
27444328	same optimal	C2698651
27444328	pH	C0020283
27444328	temperature	C0039476
27444328	CBM1	C0108401
27444328	FmEG△24	C0384886
27444328	FmEG△37	C0384886
27444328	flexible peptide	C0030956
27444328	processivity	C0205556
27444328	catalytic activity	C1264638
27444328	FP	C0180859
27444328	RAC	C0007648
27444328	soluble	C1948047
27444328	ratio	C0456603
27444328	FP	C0180859
27444328	RAC	C0007648
27444328	FmEG△24	C0384886
27444328	CBM1	C0108401
27444328	FmEG△24	C0384886
27444328	CBM1	C0108401
27444328	FmEG△24	C0384886
27444328	2.67-fold more activity	C0243095
27444328	RAC	C0007648
27444328	FP	C0180859
27444328	CBM1	C0108401
27444328	FmEG△37	C0384886
27444328	FmEG△37	C0384886
27444328	CBM1	C0108401
27444328	FmEG	C0384886
27444328	alteration	C1515926
27444328	cleavage pattern	C0596311
27444328	insoluble celluloses	C0007648
27444328	processivity	C0205556
27444328	catalytic activity	C1264638
27444328	CBM1	C0108401
27444328	binding affinity	C0033618
27444328	N-terminal 24- or 37-amino acids	C0002520
27444328	spatial separation	C1254362
27444328	two domains	C1514562
27444328	processivity	C0205556
27444328	catalytic activity	C1264638
27444328	deletion	C1880274
27444328	N-terminal 24- or 37-amino acids	C0002520
27444328	significant reduction	C0392756
27444328	thermostability	C0597571
27444328	enzymatic activity	C0243102
27444636	Overnight	C0439583
27444636	switching	C2936279
27444636	oxcarbazepine	C0069751
27444636	eslicarbazepine acetate	C2725262
27444636	observational study	C1518527
27444636	clinical situations	C0013956
27444636	appropriate	C1548787
27444636	switch	C2936279
27444636	patients	C0030705
27444636	immediate-release	C1708470
27444636	oxcarbazepine	C0069751
27444636	OXC	C0069751
27444636	eslicarbazepine acetate	C2725262
27444636	ESL	C2725262
27444636	investigated	C1292732
27444636	effects of	C1704420
27444636	patients	C0030705
27444636	overnight	C0439583
27444636	OXC	C0069751
27444636	ESL	C2725262
27444636	retrospective	C0035363
27444636	single-center study	C2603343
27444636	patients	C0030705
27444636	drug-resistant	C0013203
27444636	focal epilepsy	C0014547
27444636	dose	C0678766
27444636	immediate-release	C1708470
27444636	OXC	C0069751
27444636	4 weeks	C1442465
27444636	switched	C2936279
27444636	overnight	C0439583
27444636	ESL	C2725262
27444636	Patients	C0030705
27444636	switched	C2936279
27444636	persistent	C0205322
27444636	seizures	C0036572
27444636	OXC	C0069751
27444636	unable	C1299582
27444636	tolerate	C4053931
27444636	OXC	C0069751
27444636	dosing	C0678766
27444636	adverse events	C0041755
27444636	Tolerability	C4053931
27444636	assessed	C1516048
27444636	Adverse Events Profile	C0282574
27444636	AEP	C0282574
27444636	quality of life	C0034380
27444636	assessed	C1516048
27444636	Quality of Life in Epilepsy Inventory 10	C0282574
27444636	QOLIE-10	C0282574
27444636	alertness	C1443086
27444636	assessed	C1516048
27444636	reaction time	C0034746
27444636	Test Battery for Attention Performance version 2.3	C0037585
27444636	Assessments	C1261322
27444636	performed	C0884358
27444636	immediately	C0205548
27444636	prior to	C0332152
27444636	5 days	C1442466
27444636	switching	C2936279
27444636	OXC	C0069751
27444636	ESL	C2725262
27444636	days	C0439228
27444636	analysis	C0936012
27444636	patients	C0030705
27444636	women	C0043210
27444636	men	C0025266
27444636	mean age 36 years	C0243095
27444636	switching	C2936279
27444636	OXC	C0069751
27444636	ESL	C2725262
27444636	improvements	C2986411
27444636	mean scores	C0449820
27444636	AEP	C0282574
27444636	QOLIE-10	C0282574
27444636	alertness	C1443086
27444636	Adverse Events Profile	C0282574
27444636	total scores	C0449820
27444636	improved	C0184511
27444636	patients	C0030705
27444636	QOLIE-10	C0282574
27444636	total scores	C0449820
27444636	improved	C0184511
27444636	patients	C0030705
27444636	alertness	C1443086
27444636	scores	C0449820
27444636	improved	C0184511
27444636	patients	C0030705
27444636	short-term	C0443303
27444636	single-center study	C2603343
27444636	overnight	C0439583
27444636	switch	C2936279
27444636	twice-daily	C0585361
27444636	OXC	C0069751
27444636	once-daily	C0556983
27444636	ESL	C2725262
27444636	patients	C0030705
27444636	drug-resistant	C0013203
27444636	focal epilepsies	C0014547
27444636	resulted	C2825142
27444636	improvements	C2986411
27444636	side effects	C0041755
27444636	quality of life	C0034380
27444636	alertness	C1443086
27445383	Complete	C0205197
27445383	Genome	C0017428
27445383	Sequences	C0162326
27445383	Outbreak	C0012652
27445383	Legionella pneumophila	C0023238
27445383	Isolates	C1764827
27445383	complete	C0205197
27445383	genome	C0017428
27445383	sequences	C0162326
27445383	Legionella pneumophila	C0023238
27445383	isolates	C1764827
27445383	associated with	C0332281
27445383	Legionnaires' disease	C0023241
27445383	outbreak	C0012652
27445383	New York	C0027976
27445383	clinical	C0205210
27445383	isolates	C1764827
27445383	D7630	C0023238
27445383	D7632	C0023238
27445383	environmental	C0014406
27445383	isolate	C1764827
27445383	D7631	C0023238
27445383	recovered	C0521108
27445383	outbreak	C0012652
27445383	isolate-specific	C1764827
27445383	virulence	C0042765
27445383	gene	C0017337
27445383	D7632	C0023238
27445383	isolates	C1764827
27445383	evaluating	C0220825
27445383	genomic	C0017428
27445383	resolution	C2699488
27445383	bioinformatics	C1140694
27445383	approaches	C1292724
27445383	L. pneumophila	C0023238
27445383	serogroup 1	C0449543
27445383	isolates	C1764827
27445389	Genome Sequence Analysis	C3854164
27445389	Infectious Bursal Disease Virus	C0021338
27445389	India	C0021201
27445389	infectious bursal disease virus	C0021338
27445389	IBDV	C0021338
27445389	isolate	C3494870
27445389	BGE14/ABT1/MVC/India	C0021338
27445389	virulent	C1520022
27445389	IBDV	C0021338
27445389	isolated	C3494870
27445389	broiler flocks	C0005595
27445389	India	C0021201
27445389	India	C0021201
27445389	genome sequence	C0017428
27445389	BGE14/ABT1/MVC/India	C0021338
27445389	strain	C1518614
27445389	segments A and B	C0017428
27445389	virulent	C1520022
27445389	IBDV	C0021338
27445389	strain	C1518614
27445389	attenuated	C0599946
27445389	IBDV	C0021338
27445389	genetic exchange	C1749881
27445389	attenuated	C0599946
27445389	virulent	C1520022
27445389	strains	C1518614
27445389	IBDV	C0021338
27445389	circulating	C0175630
27445389	in the field	C3539073
27445450	Patient Satisfaction	C0030702
27445450	Postpartum	C0086839
27445450	Teaching	C0220924
27445450	Methods	C0025663
27445450	Postpartum	C0086839
27445450	discharge instructions	C4282220
27445450	mother's	C0026591
27445450	birth	C0005615
27445450	experience	C0596545
27445450	Finding	C0243095
27445450	method	C0025663
27445450	discharge instructions	C4282220
27445450	increases	C0442805
27445450	mother's	C0026591
27445450	satisfaction	C0242428
27445450	hospital	C0019994
27445450	experience	C0596545
27445450	quasi-experimental study	C2985410
27445450	examined	C0332128
27445450	relationship	C0439849
27445450	new	C0205314
27445450	mothers'	C0026591
27445450	interaction	C0037420
27445450	nurses	C0028661
27445450	postpartum	C0086839
27445450	instructions	C1442085
27445450	traditional	C0443324
27445450	methods	C0025663
27445450	satisfaction	C0242428
27445450	discharge teaching	C0514209
27445450	new	C0205314
27445450	mothers	C0026591
27445450	satisfied	C0242428
27445450	methods	C0025663
27445450	discharge teaching	C0514209
27445450	agreement	C0680240
27445450	satisfaction	C0242428
27445450	traditional	C0443324
27445450	method	C0025663
27445450	discharge teaching	C0514209
27445450	attending	C1999232
27445450	discharge class	C0514209
27446352	Splicing	C0035687
27446352	ADAR2	C0001457
27446352	ADAR2	C0001457
27446352	RNA editing	C0162782
27446352	glioma	C0017638
27446352	alternative splicing	C0002345
27446352	RNA editing	C0162782
27446352	gene regulation	C0017263
27446352	transcriptome	C3178810
27446352	Adenosine deaminases	C0001457
27446352	RNA	C0035668
27446352	ADARs	C0001457
27446352	adenosine-to-inosine (A-to-I) editing	C1158747
27446352	RNA editing	C0162782
27446352	alternative splicing	C0002345
27446352	self-editing	C0162782
27446352	ADAR2	C0001457
27446352	pre-mRNA	C0026661
27446352	alternative splicing	C0002345
27446352	Alternative splicing	C0002345
27446352	splicing	C0035687
27446352	ADAR2	C0001457
27446352	pre-mRNA	C0026661
27446352	alternative splicing	C0002345
27446352	catalytic activities	C0243102
27446352	A-to-I RNA editing	C1158747
27446352	physiological processes	C0031845
27446352	humans	C0086418
27446352	diseases	C0012634
27446352	amyotrophic lateral sclerosis	C0002736
27446352	mood disorders	C0525045
27446352	epilepsy	C0014544
27446352	glioma	C0017638
27446352	editing	C0162782
27446352	glutamine	C0017797
27446352	arginine	C0003765
27446352	AMPA receptor subunit GluA2	C0536483
27446352	glioma	C0017638
27446352	ADAR2	C0001457
27446352	expression	C1171362
27446352	alteration	C1515926
27446352	catalytic activity	C0243102
27446352	ADAR2	C0001457
27446352	review	C0282443
27446352	literature	C0023866
27446352	experimental results	C2825142
27446352	ADAR2	C0001457
27446352	alternative splicing	C0002345
27446352	review	C0282443
27446352	splicing	C0035687
27446352	ADAR2	C0001457
27446352	ADAR2	C0001457
27446352	editing	C0162782
27446352	glioma	C0017638
27446352	expression	C1171362
27446352	ADAR2	C0001457
27446352	splicing	C0035687
27446352	enzyme activity	C0243102
27446352	RNA editing	C0162782
27446352	GluA2 subunit	C0536483
27446352	glutamine	C0017797
27446352	arginine	C0003765
27446352	glioma	C0017638
27446550	Heat-shock protein 60	C0109272
27446550	Porphyromonas gingivalis	C0085478
27446550	dysfunction	C3887504
27446550	human umbilical endothelial cells	C3179121
27446550	regulation	C1327622
27446550	endothelial-nitric oxide synthase	C0669365
27446550	vascular endothelial-cadherin	C0300423
27446550	periodontitis	C0031099
27446550	risk factor	C0035648
27446550	coronary heart disease	C0010068
27446550	CAD	C0010068
27446550	Porphyromonus gingivalis	C0085478
27446550	P. gingivalis	C0085478
27446550	periodontal	C0332275
27446550	pathogen	C0450254
27446550	inflammatory response	C1155266
27446550	CAD	C0010068
27446550	in vivo	C1515655
27446550	study	C2603343
27446550	P. gingivalis	C0085478
27446550	heat-shock protein 60	C0109272
27446550	HSP60	C0109272
27446550	dysfunction	C3887504
27446550	human umbilical vein endothelial cells	C3179121
27446550	HUVECs	C3179121
27446550	in vitro	C1533691
27446550	HUVECs	C3179121
27446550	stimulated	C1948023
27446550	P. gingivalis	C0085478
27446550	HSP60	C0109272
27446550	concentrations	C0392762
27446550	time-points	C2348792
27446550	levels	C0441889
27446550	vascular endothelial (VE)-cadherin	C0300423
27446550	endothelial nitric oxide synthase	C0669365
27446550	eNOS	C0669365
27446550	cysteinyl aspartate-specific protease-3	C0291573
27446550	caspase-3	C0291573
27446550	western blot	C0949466
27446550	analysis	C0936012
27446550	apoptotic	C0162638
27446550	rate	C1521828
27446550	HUVECs	C3179121
27446550	flow cytometry	C0016263
27446550	P. gingivalis	C0085478
27446550	HSP60	C0109272
27446550	concentration	C0392762
27446550	expression	C1171362
27446550	levels	C0441889
27446550	VE-cadherin	C0300423
27446550	eNOS protein	C0669365
27446550	h	C0439227
27446550	stimulation	C1948023
27446550	proteins	C0033684
27446550	low dose	C0445550
27446550	P. gingivalis	C0085478
27446550	HSP60	C0109272
27446550	P. gingivalis	C0085478
27446550	HSP60	C0109272
27446550	downregulated	C0013081
27446550	expression	C1171362
27446550	levels	C0441889
27446550	VE-cadherin	C0300423
27446550	eNOS protein	C0669365
27446550	HUVECs	C3179121
27446550	cleavage	C0596311
27446550	caspase-3	C0291573
27446550	concentrations	C0392762
27446550	P. gingivalis	C0085478
27446550	HSP60	C0109272
27446550	apoptosis	C0162638
27446550	HUVECs	C3179121
27446550	concentration	C0392762
27446550	dependent	C3244310
27446550	results	C1274040
27446550	P. gingivalis	C0085478
27446550	HSP60	C0109272
27446550	dysfunction	C3887504
27446550	apoptosis	C0162638
27446550	HUVECs	C3179121
27446550	downregulating	C0013081
27446550	expression	C1171362
27446550	levels	C0441889
27446550	VE-cadherin	C0300423
27446550	eNOS	C0669365
27446550	cleavage	C0596311
27446550	caspase-3	C0291573
27449818	Estradiol	C0014912
27449818	prodrugs	C0033262
27449818	EP	C0033262
27449818	oral	C0001563
27449818	estrogen treatment	C3173348
27449818	estrogen	C0014939
27449818	liver functions	C0232741
27449818	Oral	C0001563
27449818	parenteral	C0259961
27449818	estrogen administration	C3173348
27449818	systemic	C0205373
27449818	hepatic	C0205054
27449818	estrogenic effects	C0877035
27449818	lipids	C0023779
27449818	hemostatic factors	C0019116
27449818	GH	C0037663
27449818	IGF I	C0021665
27449818	angiotensinogen	C0003017
27449818	metabolic effects	C2945675
27449818	oral treatment	C0001563
27449818	estradiol	C0014912
27449818	E2	C0014912
27449818	prodrugs	C0033262
27449818	EP	C0033262
27449818	liver tissue	C0736268
27449818	Carbone17-OH sulfonamide [-O2-NH2] substituted esters	C1254350
27449818	E2	C0014912
27449818	EC508	C0014912
27449818	carbonic anhydrase II	C0007034
27449818	CA-II	C0007034
27449818	binding	C1149286
27449818	CA II	C0007034
27449818	erythrocytes	C0014792
27449818	EP	C0033262
27449818	portal vein blood	C2324289
27449818	liver	C0023884
27449818	passage	C0439799
27449818	Ovariectomized	C3687559
27449818	OVX	C3687559
27449818	rats	C0034721
27449818	orally treated	C0001563
27449818	Uteri	C0042149
27449818	dissected	C0205239
27449818	weighed	C3827964
27449818	Cholesterol fractions	C0201950
27449818	angiotensinogen	C0523500
27449818	plasma	C0032105
27449818	Oral E2	C0360514
27449818	ethinyl estradiol	C0015011
27449818	EE	C0015011
27449818	uterine	C0042149
27449818	growth	C0018270
27449818	hepatic	C0205054
27449818	estrogenic effects	C0877035
27449818	EP	C0033262
27449818	uterine growth	C1326619
27449818	plasma	C0032105
27449818	cholesterol	C0008377
27449818	angiotensinogen	C0003017
27449818	pharmacokinetic studies	C0201734
27449818	EC508	C0014912
27449818	intravenous	C0013125
27449818	oral administration	C0001563
27449818	male	C0086582
27449818	rats	C0034721
27449818	oral	C0001563
27449818	bioavailability	C0005508
27449818	blood	C0005767
27449818	plasma	C0032105
27449818	erythrocyte	C0014792
27449818	binding	C1145667
27449818	EC508	C0014912
27449818	in vivo	C1515655
27449818	liver	C0023884
27449818	passage	C0439799
27449818	systemic	C0205373
27449818	estrogenicity	C0014939
27449818	hepatic	C0205054
27449818	estrogenic effects	C0877035
27449818	systemic	C0205373
27449818	E2	C0014912
27449818	sulfonamide EP	C0033262
27449818	oral	C0001563
27449818	EP	C0033262
27449818	liver	C0023884
27449818	erythrocytes	C0014792
27449818	systemic	C0205373
27449818	estradiol	C0014912
27449818	hydrolysis	C0020291
27449818	hepatic	C0205054
27449818	estrogenic	C0720298
27449818	oral	C0001563
27449818	estrogen therapy	C0279494
27450789	Differences	C1705242
27450789	pain	C0030193
27450789	experience	C0596545
27450789	cooperation	C1321605
27450789	consecutive surgeries	C0543467
27450789	patients	C0030705
27450789	phacoemulsification	C0282545
27450789	study	C2603343
27450789	pain	C0030193
27450789	experience	C0596545
27450789	cooperation	C1321605
27450789	consecutive surgeries	C0543467
27450789	patients	C0030705
27450789	phacoemulsification	C0282545
27450789	eyes	C0015392
27450789	sub-Tenon's local anesthesia	C0002921
27450789	sedation	C0344106
27450789	study	C2603343
27450789	patients	C0030705
27450789	bilateral senile cataracts	C3864031
27450789	operations	C0543467
27450789	sedation	C0344106
27450789	corneal	C0010031
27450789	phacoemulsification technique	C0282545
27450789	sub-Tenon's local anesthesia	C0002921
27450789	surgeons	C0582175
27450789	surgery	C0543467
27450789	eye	C0015392
27450789	cataract	C0086543
27450789	eye	C0015392
27450789	operated	C3241922
27450789	3 months	C1442461
27450789	surgeon	C0582175
27450789	months	C0439231
27450789	patients	C0030705
27450789	pain	C0030193
27450789	experience	C0596545
27450789	induction	C0857127
27450789	maintenance	C0024501
27450789	anesthesia	C0002903
27450789	phacoemulsification surgery	C0282545
27450789	visual analogue scale	C0042815
27450789	VAS	C0042815
27450789	no pain	C3891813
27450789	unbearable pain	C3640014
27450789	surgery	C0543467
27450789	cooperation	C1321605
27450789	patient	C0030705
27450789	markedeye	C0015413
27450789	head movement	C0376591
27450789	lid squeezing	C0850674
27450789	surgeon	C0582175
27450789	VAS scores	C2732809
27450789	cooperation	C1321605
27450789	scores	C0449820
27450789	patients	C0030705
27450789	outcome measurements	C0086749
27450789	mean pain score	C0582148
27450789	eye	C0015392
27450789	eye	C0015392
27450789	administration	C1533734
27450789	sub-Tenon's anesthesia	C0002921
27450789	eye	C0015392
27450789	eye	C0015392
27450789	phacoemulsification surgery	C0282545
27450789	patient cooperation	C1321605
27450789	score	C0449820
27450789	surgery	C0543467
27450789	surgery	C0543467
27450789	differences	C1705242
27450789	surgeries	C0543467
27450789	outcome measures	C0086749
27450789	Patients	C0030705
27450789	phaco surgery	C0282545
27450789	eye	C0015392
27450789	pain	C0030193
27450789	worse	C1457868
27450789	cooperation	C1321605
27450789	phaco surgery	C0282545
27450789	eye	C0015392
27450789	surgeries	C0543467
27450789	months	C0439231
27450789	surgeon	C0582175
27450789	difficulty	C0332218
27450789	operation	C0543467
27450789	patient's cooperation	C1321605
27450789	surgeon	C0582175
27450789	contralateral eye surgery	C0038901
27450789	sedation	C0344106
27450789	analgesia	C3202977
27450789	surgery	C0543467
27450789	influence	C4054723
27450789	recent memory	C0233792
27450789	patient's	C0030705
27450789	pain	C0030193
27450789	experience	C0596545
27454738	Co-ChIP	C1328856
27454738	genome-wide mapping	C0079435
27454738	histone mark	C1257775
27454738	co-occurrence	C2745955
27454738	single-molecule resolution	C2699488
27454738	Histone modifications	C1156199
27454738	important	C3898777
27454738	role	C1705810
27454738	chromatin organization	C1156187
27454738	transcriptional regulation	C1158770
27454738	large amount	C3869890
27454738	genome-wide	C0017428
27454738	histone modification	C1156199
27454738	data	C1511726
27454738	collected	C1516695
27454738	different	C1705242
27454738	cells	C0007634
27454738	tissues	C0040300
27454738	co-occurrence	C2745955
27454738	modifications	C1156199
27454738	nucleosome	C0028623
27454738	present	C0449450
27454738	genome-wide quantitative method	C1510568
27454738	combinatorial indexed	C0918012
27454738	chromatin immunoprecipitation	C1328856
27454738	co-ChIP	C1328856
27454738	co-occurrence	C2745955
27454738	histone modifications	C1156199
27454738	nucleosomes	C0028623
27454738	co-ChIP	C1328856
27454738	study	C0681814
27454738	genome-wide	C0017428
27454738	co-occurrence	C2745955
27454738	chromatin marks	C1257775
27454738	pairwise combinations	C0205195
27454738	co-occurrence	C2745955
27454738	patterns	C0449774
27454738	co-occurrence	C2745955
27454738	H3K9me1	C0314621
27454738	H3K27ac	C0314621
27454738	super-enhancers	C0004793
27454738	apply	C4048755
27454738	co-ChIP	C1328856
27454738	measure	C0079809
27454738	distribution	C1704711
27454738	bivalent	C0392762
27454738	H3K4me3	C0314621
27454738	H3K27me3	C0314621
27454738	domains	C1514562
27454738	mouse embryonic stem cell	C4042879
27454738	mESC	C4042879
27454738	adult tissues	C0040300
27454738	observe	C1441672
27454738	dynamic	C0729333
27454738	changes	C0443172
27454738	discover	C1880355
27454738	loss	C1517945
27454738	de novo	C1515568
27454738	gain	C1517378
27454738	bivalency	C0392762
27454738	tissue-specific	C1955394
27454738	regulatory genes	C0017362
27454738	suggesting	C1705535
27454738	functional role	C1705810
27454738	bivalent	C0392762
27454738	domains	C1514562
27454738	stages	C1306673
27454738	development	C1527148
27454738	results	C0683954
27454738	co-ChIP	C1328856
27454738	reveal	C0443289
27454738	complex interactions	C1704675
27454738	histone modifications	C1156199
27456018	Hand-Assisted Laparoscopic	C2936499
27456018	Standard Laparoscopic Colectomy	C1517722
27456018	Outcomes	C0085415
27456018	Operative Time	C3494201
27456018	HAL	C2936499
27456018	colectomy	C0009274
27456018	technique	C0449851
27456018	laparoscopic surgery	C0751429
27456018	operative time	C3494201
27456018	data	C1511726
27456018	single-institution studies	C2603343
27456018	National Surgical Quality Improvement Program Participant Data Use File	C0242193
27456018	patients	C0030705
27456018	SL	C1517722
27456018	HAL	C2936499
27456018	colectomy	C0009274
27456018	Patients	C0030705
27456018	outcomes	C0085415
27456018	subgroup analysis	C0936012
27456018	patients	C0030705
27456018	segmental	C0205122
27456018	resections	C0015252
27456018	patients	C0030705
27456018	HAL	C2936499
27456018	colectomy	C0009274
27456018	Patients	C0030705
27456018	HAL	C2936499
27456018	SL colectomy	C1517722
27456018	rates	C1521828
27456018	postoperative ileus	C0400877
27456018	wound complication	C1096106
27456018	day	C0439228
27456018	readmission	C0030700
27456018	operative time	C3494201
27456018	segmental	C0205122
27456018	colectomies	C0009274
27456018	HAL	C2936499
27456018	rates	C1521828
27456018	wound complications	C1096106
27456018	postoperative ileus	C0400877
27456018	day	C0439228
27456018	readmission	C0030700
27456018	operative time	C3494201
27456018	HAL	C2936499
27456018	HAL	C2936499
27456018	colectomy	C0009274
27456018	risk	C0086930
27456018	wound complications	C1096106
27456018	postoperative ileus	C0400877
27456018	readmissions	C0030700
27456018	technique	C0449851
27456018	operative time	C3494201
27457539	Safety	C0036043
27457539	immunogenecity	C4054739
27457539	attenuated	C0042211
27457539	Rift Valley fever vaccine	C1548485
27457539	CL13T	C1548485
27457539	camels	C0006801
27457539	Rift Valley fever	C0035613
27457539	zoonotic	C1628327
27457539	viral disease	C0042769
27457539	enzootic	C0277551
27457539	endemic	C0277550
27457539	Africa	C0001737
27457539	Arabian Peninsula	C0003671
27457539	significant	C0750502
27457539	threat	C0749385
27457539	human	C0086418
27457539	animal	C0003062
27457539	health	C3534575
27457539	disease	C0035613
27457539	severe	C0205082
27457539	ruminants	C0035950
27457539	causing	C0678227
27457539	abortions	C0149814
27457539	pregnant	C0032961
27457539	animals	C0003062
27457539	sheep animals	C0036945
27457539	mortality	C0205848
27457539	young	C0332239
27457539	populations	C1257890
27457539	mortality rates	C0205848
27457539	severe	C0205082
27457539	clinical	C0205210
27457539	manifestation	C1280464
27457539	reported	C0684224
27457539	camel	C0006801
27457539	populations	C1257890
27457539	Africa	C0001737
27457539	currently	C0521116
27457539	available	C0470187
27457539	live vaccines	C0042211
27457539	RVF	C0035613
27457539	tested	C0039593
27457539	safety	C0036043
27457539	efficacy	C1280519
27457539	species	C1705920
27457539	study	C2603343
27457539	safety	C0036043
27457539	efficacy	C1280519
27457539	neutralizing antibody	C0475463
27457539	response	C0871261
27457539	thermostable live attenuated	C0042211
27457539	RVF CL13T vaccine	C1548485
27457539	evaluated	C0220825
27457539	camels	C0006801
27457539	different	C1705242
27457539	preliminary	C0439611
27457539	experiments	C0681814
27457539	camels	C0006801
27457539	camels	C0006801
27457539	pregnant	C0032961
27457539	camels	C0006801
27457539	study	C2603343
27457539	revealed	C0443289
27457539	CL13T vaccine	C1548485
27457539	safe	C0036043
27457539	use	C0457083
27457539	camels	C0006801
27457539	abortions	C0149814
27457539	teratogenic effects	C0232910
27457539	observed	C1441672
27457539	dose	C0178602
27457539	vaccine	C0042211
27457539	strong	C0442821
27457539	neutralizing antibody	C0475463
27457539	response	C0871261
27457539	months	C0439231
27457539	presence	C0150312
27457539	neutralization antibodies	C0475463
27457539	correlate with	C0332281
27457539	protection	C1545588
27457539	protection	C1545588
27457539	confirmed by	C0521093
27457539	experiments	C0681814
27457539	virulent	C1520022
27457539	RVF virus	C0035614
27458601	Autoantibodies	C0004358
27458601	MOG	C0069428
27458601	subgroup	C1515021
27458601	adult	C0001675
27458601	multiple sclerosis	C0026769
27458601	evaluate	C0220825
27458601	antibodies	C0003241
27458601	conformation	C0033625
27458601	myelin oligodendrocyte glycoprotein	C0069428
27458601	MOG	C0069428
27458601	subgroup	C1515021
27458601	adult	C0001675
27458601	patients	C0030705
27458601	clinically	C0205210
27458601	multiple sclerosis	C0026769
27458601	MS	C0026769
27458601	clinical	C0205210
27458601	phenotype	C0031437
27458601	severe	C0205082
27458601	spinal cord	C0037925
27458601	optic nerve	C0029130
27458601	brainstem	C0006121
27458601	Antibodies	C0003241
27458601	MOG	C0069428
27458601	investigated	C1292732
27458601	cell-based assay	C0005507
27458601	groups	C1257890
27458601	patients	C0030705
27458601	patients	C0030705
27458601	MS	C0026769
27458601	group 1	C1257890
27458601	age	C0001779
27458601	sex	C0079399
27458601	patients	C0030705
27458601	MS	C0026769
27458601	group 2	C1257890
27458601	brain-biopsied	C0740294
27458601	patients	C0030705
27458601	demyelinating diseases	C0011303
27458601	CNS	C3714787
27458601	MS	C0026769
27458601	classified	C0008902
27458601	MS type II	C0026769
27458601	group 3	C1257890
27458601	epitopes	C0003316
27458601	mutated	C0596611
27458601	variants	C0678941
27458601	MOG	C1417228
27458601	Antibodies	C0003241
27458601	MOG	C0069428
27458601	adult	C0001675
27458601	patients	C0030705
27458601	MS	C0026769
27458601	groups 2	C1257890
27458601	3	C1257890
27458601	patients	C0030705
27458601	tested	C0039593
27458601	MOG	C0069428
27458601	antibodies	C0003241
27458601	Patients	C0030705
27458601	MS	C0026769
27458601	antibodies	C0003241
27458601	MOG	C0069428
27458601	manifested	C0205319
27458601	concomitant	C0521115
27458601	severe	C0205082
27458601	brainstem	C0006121
27458601	spinal cord	C0037925
27458601	severe	C0205082
27458601	disease course	C0242656
27458601	relapse	C0035020
27458601	rates	C1521828
27458601	failure	C0162643
27458601	disease-modifying therapies	C0087111
27458601	treated with	C0332293
27458601	plasma exchange	C0032113
27458601	favorable response	C0221607
27458601	anti-MOG	C1291777
27458601	patients	C0030705
27458601	MS	C0026769
27458601	MS	C0026769
27458601	lesions	C0221198
27458601	brain MRI	C0412675
27458601	Longitudinal analysis	C0815265
27458601	years	C0439234
27458601	fluctuations	C0231239
27458601	anti-MOG reactivity	C1621287
27458601	Epitope mapping	C0242831
27458601	interindividual heterogeneity	C0019409
27458601	intraindividual stability	C0205360
27458601	antibody response	C0003261
27458601	Antibodies	C0003241
27458601	MOG	C0069428
27458601	subgroup	C1515021
27458601	adult	C0001675
27458601	MS	C0026769
27458601	clinical	C0205210
27458601	phenotype	C0031437
27458601	disease	C0012634
27458601	heterogeneity	C0019409
27459610	Acute Ph-negative lymphoblastic leukemias	C4289946
27459610	adults	C0001675
27459610	Risk factors	C0035648
27459610	ALL-2009 protocol	C2348563
27459610	risk factors	C0035648
27459610	RFs	C0035648
27459610	age	C0001779
27459610	immunophenotype	C0079611
27459610	baseline	C1442488
27459610	leukocytosis	C0023518
27459610	enhanced	C2349975
27459610	lactate dehydrogenase	C0022917
27459610	LDH	C0022917
27459610	activity	C0243102
27459610	remission	C0544452
27459610	risk group	C0684030
27459610	cytogenetic abnormalities	C0008625
27459610	patients	C0030705
27459610	acute lymphoblastic leukemia	C0023449
27459610	ALL	C0023449
27459610	ALL-2009 protocol	C2348563
27459610	protocol	C2348563
27459610	patients	C0030705
27459610	women	C0043210
27459610	including	C0332257
27459610	pregnant women	C0033011
27459610	men	C0025266
27459610	Ph-negative ALL	C4289946
27459610	phenotype	C0031437
27459610	patients	C0030705
27459610	patients	C0030705
27459610	B-cell ALL	C0279593
27459610	pre-B ALL	C0279593
27459610	ALL	C0023449
27459610	pre-B ALL	C0279593
27459610	patients	C0030705
27459610	T-cell ALL	C0279592
27459610	T-ALL	C0279592
27459610	thymic	C0040113
27459610	T-ALL	C0279592
27459610	mature	C0205286
27459610	T-ALL	C0279592
27459610	baseline	C1442488
27459610	clinical	C0205210
27459610	laboratory	C0022877
27459610	parameters	C0449381
27459610	leukocytosis	C0023518
27459610	B-ALL	C0279593
27459610	T-ALL	C0279592
27459610	phenotype	C0031437
27459610	B-ALL	C0279593
27459610	phenotype	C0031437
27459610	T-ALL	C0279592
27459610	LDH	C0022917
27459610	activity	C0243102
27459610	presence	C0150312
27459610	translocation t(4;11)	C0040715
27459610	high-risk group	C0684030
27459610	included	C0332257
27459610	patients	C0030705
27459610	B-ALL	C0279593
27459610	T-ALL	C0279592
27459610	patients	C0030705
27459610	T-ALL	C0279592
27459610	autologous bone marrow transplantation	C0194037
27459610	BMT	C0005961
27459610	Allogeneic BMT	C0149615
27459610	performed	C0884358
27459610	patients	C0030705
27459610	induction phase	C4049995
27459610	overall survival	C4086681
27459610	patients	C0030705
27459610	included	C0332257
27459610	investigation	C0220825
27459610	relapse-free	C0679867
27459610	patients	C0030705
27459610	B-ALL	C0279593
27459610	T-ALL	C0279592
27459610	overall survival rates	C0038954
27459610	Multivariate analysis	C0026777
27459610	including	C0332257
27459610	RFs	C0035648
27459610	T-ALL	C0279592
27459610	patient's	C0030705
27459610	age	C0001779
27459610	B-ALL	C0279593
27459610	chemotherapeutic	C0729502
27459610	allogeneic BMTs	C0149615
27459610	treatment	C0087111
27459610	results	C0456984
27459610	adult	C0001675
27459610	patients	C0030705
27459610	ALL	C0023449
27459610	cytostatic	C0010858
27459610	effects	C1280500
27459610	preserving	C0728887
27459610	cytostatic	C0010858
27459610	loading dose	C3714444
27459610	results	C0456984
27459610	Russian	C0035970
27459610	investigation	C0220825
27459610	allogeneic BMTs	C0149615
27459610	adult	C0001675
27459610	patients	C0030705
27459610	ALL	C0023449
27460285	Multidetector CT	C3179130
27460285	expected	C1517001
27460285	findings	C0243095
27460285	complications	C0009566
27460285	contemporary	C1254367
27460285	inguinal hernia repair	C0021446
27460285	surgery	C0543467
27460285	Inguinal hernia repair	C0021446
27460285	IHR	C0021446
27460285	prosthetic	C0175649
27460285	mesh	C0181805
27460285	implantation	C0021107
27460285	procedure	C0087111
27460285	general surgery	C2242991
27460285	performed	C0884358
27460285	open	C0348025
27460285	laparoscopic approach	C0393360
27460285	paper	C0030351
27460285	overview	C0814812
27460285	contemporary	C1254367
27460285	IHR	C0021446
27460285	techniques	C0449851
27460285	materials	C0520510
27460285	expected	C1517001
27460285	postoperative	C0231287
27460285	imaging findings	C1287399
27460285	iatrogenic injuries	C0854404
27460285	multidetector CT	C3179130
27460285	ideal	C1512612
27460285	modality	C0695347
27460285	operated	C0205245
27460285	groin region	C1279151
27460285	deeper	C0205125
27460285	intra-abdominal structures	C0588044
27460285	CT	C0040405
27460285	seroma	C0262627
27460285	mesh infections	C3888473
27460285	hemorrhages	C0019080
27460285	bowel	C0021853
27460285	complications	C0009566
27460285	urinary bladder	C0005682
27460285	injuries	C0403677
27460285	consistent	C0332290
27460285	therapeutic	C0302350
27460285	choice	C1707391
27460285	radiologists	C0334907
27460285	increasingly	C0442808
27460285	investigate	C1292732
27460285	suspected	C0750491
27460285	iatrogenic	C0439669
27460285	complications	C0009566
27460285	paper	C0030351
27460285	increased	C0205217
27460285	familiarity	C0600269
27460285	early	C1279919
27460285	CT	C0040405
27460285	studies	C1881134
27460285	IHR	C0021446
27460285	complications	C0009566
27460285	normal	C0205307
27460285	postoperative	C0231287
27460285	appearances	C0700364
27460285	focal	C0205234
27460285	pseudolesions	C1261287
27460285	avoid misinterpretation	C1254363
27460285	inappropriate	C1548788
27460285	management	C0376636
27460657	transcription factors	C0040648
27460657	MS188	C4277090
27460657	AMS	C1434242
27460657	complex	C0439855
27460657	activate	C1515877
27460657	expression	C1171362
27460657	CYP703A2	C2000791
27460657	sporopollenin biosynthesis	C2755351
27460657	Arabidopsis thaliana	C0162740
27460657	sexine layer	C1820011
27460657	pollen grain	C0032385
27460657	sporopollenins	C0075041
27460657	sporophytic secretory tapetum	C2717770
27460657	required	C1514873
27460657	biosynthesis of sporopollenin	C2755351
27460657	enzymes	C0014442
27460657	involved	C1314939
27460657	sporopollenin biosynthesis	C2755351
27460657	regulatory mechanism	C1152521
27460657	enzymes	C0014442
27460657	tapetal layer	C2717770
27460657	ABORTED MICROSPORES	C1434242
27460657	AMS	C1434242
27460657	MALE STERILE 188	C4277090
27460657	MYB103	C0769095
27460657	MYB80	C0769095
27460657	MS188	C4277090
27460657	MYB103	C0769095
27460657	MYB80	C0769095
27460657	tapetal cell	C2717770
27460657	transcription factors	C0040648
27460657	required	C1514873
27460657	pollen wall formation	C1326804
27460657	AMS	C1434242
27460657	functions	C0542341
27460657	upstream	C0522505
27460657	MS188	C4277090
27460657	AMS	C1434242
27460657	MS188	C4277090
27460657	target	C1521840
27460657	CYP703A2 gene	C1333195
27460657	involved	C1314939
27460657	sporopollenin biosynthesis	C2755351
27460657	AMS	C1434242
27460657	MS188	C4277090
27460657	localized	C0392752
27460657	tapetum	C2717770
27460657	CYP703A2	C2000791
27460657	localized	C0392752
27460657	tapetum	C2717770
27460657	locule	C1136229
27460657	Chromatin immunoprecipitation	C1328856
27460657	ChIP	C1328856
27460657	MS188	C4277090
27460657	bound	C1145667
27460657	promoter	C0086860
27460657	CYP703A2	C1333195
27460657	luciferase-inducible	C0024075
27460657	assay	C1510438
27460657	MS188	C4277090
27460657	activated	C1879547
27460657	expression	C1171362
27460657	CYP703A2	C2000791
27460657	Yeast two-hybrid	C1961118
27460657	electrophoretic mobility shift assays	C0949632
27460657	EMSAs	C0949632
27460657	MS188	C4277090
27460657	complexed	C0439855
27460657	AMS	C1434242
27460657	expression	C1171362
27460657	CYP703A2	C1333195
27460657	elevated levels	C3163633
27460657	MS188	C4277090
27460657	ams	C1434242
27460657	mutant	C0596988
27460657	data	C1511726
27460657	reveal	C0443289
27460657	MS188	C4277090
27460657	coordinates	C0700114
27460657	AMS	C1434242
27460657	activate	C1515877
27460657	CYP703A2	C2000791
27460657	sporopollenin biosynthesis	C2755351
27460657	plant	C0032098
27460657	tapetum	C2717770
27461472	Activation	C1879547
27461472	ephrinB-EphB receptor signalling	C2984386
27461472	rat spinal cord	C1882864
27461472	maintenance	C0024501
27461472	diabetic	C0241863
27461472	neuropathic pain	C3714625
27461472	Diabetic	C0241863
27461472	neuropathic pain	C3714625
27461472	DNP	C3714625
27461472	severe	C0205082
27461472	intractable	C0205269
27461472	clinic	C0442592
27461472	specific	C0205369
27461472	cellular	C0007613
27461472	molecular	C1148560
27461472	mechanisms	C0441712
27461472	DNP	C3714625
27461472	treatment	C0039798
27461472	limited	C0439801
27461472	investigated	C1292732
27461472	roles	C1705810
27461472	EphB1 receptor	C0907648
27461472	DNP	C3714625
27461472	Diabetic	C0241863
27461472	neuropathic pain	C3714625
27461472	male	C0086582
27461472	adult	C0001675
27461472	Sprague-Dawley rats	C0034715
27461472	streptozotocin	C0038432
27461472	STZ	C0038432
27461472	alloxan	C0002151
27461472	Western blot analysis	C0949466
27461472	immunohistochemistry	C0021044
27461472	expression	C1171362
27461472	EphB1 receptor	C0907648
27461472	activation	C1879547
27461472	glial cells	C0027836
27461472	pro-inflammatory cytokines	C0079189
27461472	spinal cord	C0037925
27461472	DNP	C3714625
27461472	manifested	C0205319
27461472	mechanical allodynia	C2936719
27461472	measuring	C0444706
27461472	incidence	C0021149
27461472	foot	C0016504
27461472	withdrawal	C0441655
27461472	response	C0871261
27461472	mechanical indentation	C0332467
27461472	hind	C2983612
27461472	paw	C0687080
27461472	electro von Frey filament	C3273359
27461472	Diabetic	C0241863
27461472	neuropathic pain	C3714625
27461472	high blood glucose	C2919432
27461472	simultaneously	C0521115
27461472	animals	C0003062
27461472	STZ	C0038432
27461472	alloxan	C0002151
27461472	Phosphorylation	C0031715
27461472	EphB1	C0907648
27461472	activation	C1879547
27461472	astrocytes	C0004112
27461472	microglial cells	C0206116
27461472	level	C0441889
27461472	tumour necrosis factor	C1456820
27461472	(TNF)-α	C1456820
27461472	interleukin (IL)-1β	C0021753
27461472	spinal cord	C0037925
27461472	rats	C0034721
27461472	DNP	C3714625
27461472	Spinal	C0521329
27461472	blocking	C0332206
27461472	EphB1 receptor	C0907648
27461472	activation	C1879547
27461472	STZ	C0038432
27461472	injection	C1533685
27461472	suppressed	C1260953
27461472	mechanical allodynia	C2936719
27461472	activation	C1879547
27461472	astrocytes	C0004112
27461472	microglial cells	C0206116
27461472	activity	C0441655
27461472	TNF-α	C1456820
27461472	IL-1β	C0021753
27461472	spinal	C0521329
27461472	treatment	C0039798
27461472	EphB1	C0907648
27461472	Fc	C0034805
27461472	early phase	C0814494
27461472	STZ	C0038432
27461472	injection	C1533685
27461472	induction	C0205263
27461472	DNP	C3714625
27461472	EphB1 receptor	C0907648
27461472	activation	C1879547
27461472	spinal cord	C0037925
27461472	critical	C1511545
27461472	maintenance	C0024501
27461472	induction	C0205263
27461472	diabetic	C0241863
27461472	pain	C0030193
27461472	EphB1 receptor	C0907648
27461472	potential	C3245505
27461472	target	C1521840
27461472	relieving	C0002766
27461472	diabetic	C0241863
27461472	pain	C0030193
27461472	Activation	C1879547
27461472	EphB1 receptor	C0907648
27461472	spinal cord	C0037925
27461472	critical	C1511545
27461472	maintaining	C1314677
27461472	diabetic	C0241863
27461472	neuropathic pain	C3714625
27461472	diabetic	C0241863
27461472	pain	C0030193
27461472	induction	C0205263
27461472	Spinal	C0521329
27461472	blocking	C0332206
27461472	EphB1 receptor	C0907648
27461472	activation	C1879547
27461472	suppresses	C1260953
27461472	diabetic	C0241863
27461472	neuropathic pain	C3714625
27463515	Conservation	C2347858
27463515	Red Kite	C0325557
27463515	Milvus milvus	C0325557
27463515	Aves	C0005595
27463515	Accipitriformes	C3669511
27463515	Affected	C0392760
27463515	Hybrid	C0020205
27463515	Zone	C1710706
27463515	Black Kite	C1016933
27463515	Milvus migrans migrans	C1016933
27463515	Central Europe	C0682369
27463515	Accipitriformes	C3669511
27463515	species	C1705920
27463515	reported	C0684224
27463515	hybrid	C0020205
27463515	zones	C1710706
27463515	red kite	C0325557
27463515	Milvus milvus	C0325557
27463515	black kite	C1016933
27463515	Milvus migrans migrans	C1016933
27463515	M. milvus	C0325557
27463515	endemic	C0302891
27463515	western Palearctic	C0681784
27463515	population	C0032659
27463515	breeding	C0006159
27463515	pairs	C1709450
27463515	species	C1705920
27463515	persecution	C0871062
27463515	ingestion	C0232478
27463515	rodenticide-treated baits	C0035805
27463515	illegal	C3242151
27463515	poisoning	C0032343
27463515	agricultural practices	C0001829
27463515	core	C0444669
27463515	range	C1514721
27463515	F1	C0314650
27463515	M. milvus	C0325557
27463515	M. migr. migrans	C1016933
27463515	hybrid	C0020205
27463515	offspring	C0680063
27463515	F2	C0314651
27463515	F3	C0680063
27463515	hybrids	C0020205
27463515	reported	C0684224
27463515	nesting	C0027776
27463515	success	C0597535
27463515	rates	C1521828
27463515	F1	C0314650
27463515	hybrids	C0020205
27463515	partial	C0728938
27463515	hybrid	C0020205
27463515	analyzed	C0936012
27463515	mitochondrial	C0026237
27463515	CO1	C1537985
27463515	CytB	C1537988
27463515	nuclear	C0007610
27463515	Myc	C0086661
27463515	DNA	C0012854
27463515	loci	C1708726
27463515	M. milvus	C0325557
27463515	M. migr. migrans	C1016933
27463515	F1	C0314650
27463515	hybrid	C0020205
27463515	central Europe	C0682369
27463515	agreement	C4255373
27463515	studies	C2603343
27463515	heterozygosity	C0019425
27463515	M. milvus	C0325557
27463515	locus	C1708726
27463515	populations	C0032659
27463515	examined	C0332128
27463515	species	C1705920
27463515	characterized	C1880022
27463515	gene flow	C1565556
27463515	populations	C0032659
27463515	haplotypes	C0018591
27463515	examined	C0332128
27463515	area	C0017446
27463515	haplotypes	C0018591
27463515	statistically significant	C0237881
27463515	aggregation	C0332621
27463515	region	C0017446
27463515	mitochondrial DNA	C0012929
27463515	species	C1705920
27463515	plumage	C0015731
27463515	species	C1705920
27463515	F1	C0314650
27463515	hybrids	C0020205
27463515	Haldane´s Rule	C0870077
27463515	investigated	C1292732
27463515	genomic	C0017428
27463515	methods	C0025664
27463515	gene flow	C1565556
27463515	paternal	C0337493
27463515	examined	C0332128
27463515	Myc gene	C0086661
27463515	divergence	C0443204
27463515	M. milvus	C0325557
27463515	M. migr. migrans	C1016933
27463515	central Europe	C0682369
27463515	population	C0032659
27463515	M. milvus	C0325557
27463515	gene flow	C1565556
27463515	origin	C0439659
27463515	M. milvus	C0325557
27464853	Extracellular	C0521119
27464853	Potassium	C0032821
27464853	Seizures	C0036572
27464853	Excitation	C0549255
27464853	Inhibition	C3463820
27464853	Ih	C1956068
27464853	Seizure activity	C0036572
27464853	extracellular	C0521119
27464853	potassium	C0032821
27464853	concentration	C1264643
27464853	K	C0597277
27464853	neuronal	C0027882
27464853	passive	C3686820
27464853	active	C0205177
27464853	membrane	C3161472
27464853	population	C1257890
27464853	activities	C0441655
27464853	study	C2603343
27464853	extracellular	C0521119
27464853	potassium	C0032821
27464853	seizure activities	C0036572
27464853	4-AP	C0000477
27464853	seizure	C0036572
27464853	model	C3161035
27464853	neocortex	C0175173
27464853	in vivo	C1515655
27464853	in vitro	C1533691
27464853	K	C0597277
27464853	prolonged	C0439590
27464853	seizure	C0036572
27464853	durations	C0449238
27464853	shortened interictal intervals	C1254367
27464853	depolarized	C1395184
27464853	neuronal	C0027882
27464853	resting membrane potential	C0025251
27464853	RMP	C0025251
27464853	K	C0597277
27464853	seizure like events	C0036572
27464853	SLEs	C0036572
27464853	blocked	C0332206
27464853	neurons	C0027882
27464853	depolarization	C1395184
27464853	blocked	C0332206
27464853	Spreading	C0332261
27464853	depression	C0011570
27464853	ictal events	C0036572
27464853	K	C0597277
27464853	concentration	C1264643
27464853	K	C0597277
27464853	in vivo	C1515655
27464853	in vitro	C1533691
27464853	mouse brain preparations	C1521713
27464853	human	C0086418
27464853	neocortical	C0175173
27464853	tissue	C0040300
27464853	epilepsy	C0014544
27464853	surgery	C0543467
27464853	Blocking	C0332206
27464853	hyperpolarization-activated cyclic nucleotide-gated (HCN) channels	C1956068
27464853	K	C0597277
27464853	influence	C4054723
27464853	SLEs	C0036572
27464853	K	C0597277
27464853	inhibitory actions	C3463820
27464853	K	C0597277
27464853	neuronal	C0027882
27464853	excitability	C0235169
27464853	seizure activity	C0036572
27465797	Activation	C0014429
27465797	general control nonderepressible 2 kinase	C2354171
27465797	protects	C1545588
27465797	human	C0086418
27465797	glomerular endothelial cells	C1182791
27465797	high-glucose	C0860803
27465797	induced	C0205263
27465797	molecular pathways	C1704259
27465797	protein	C0033684
27465797	restriction	C0443288
27465797	diabetic nephropathy	C0011881
27465797	DN	C0011881
27465797	renal	C0022646
27465797	endothelium	C0014257
27465797	pathogenesis	C0699748
27465797	evaluated	C0220825
27465797	general control nonderepressible 2 (GCN2) kinase	C2354171
27465797	activation	C0014429
27465797	sensor	C0600364
27465797	amino acid	C0002520
27465797	deprivation	C0871712
27465797	molecular pathways	C1704259
27465797	human	C0086418
27465797	glomerular endothelial cells	C1182791
27465797	GEnC	C1182791
27465797	GEnC	C1182791
27465797	cultured	C0430400
27465797	high	C0205250
27465797	high -glucose conditions	C0020456
27465797	GCN2 kinase	C2354171
27465797	activator	C2247123
27465797	tryptophanol	C0526839
27465797	Glucose transporter 1	C0168458
27465797	GLUT1	C0168458
27465797	expression	C1171362
27465797	assessed	C1516048
27465797	western blotting	C0005863
27465797	reactive oxygen species	C0162772
27465797	ROS	C0162772
27465797	fluorogenic probe	C0016321
27465797	Activities	C0243102
27465797	glyceraldehyde 3-phosphate dehydrogenase	C3536868
27465797	GAPDH	C3536868
27465797	protein kinase C	C0033634
27465797	PKC	C0033634
27465797	assessed	C1516048
27465797	commercial activity assays	C0005507
27465797	sorbitol	C0037688
27465797	colorimetrically	C1531834
27465797	methylglyoxal	C0034338
27465797	ELISA	C0014441
27465797	O-linked β-N-acetyl glucosamine (O-GlcNAc)-modified proteins	C0671368
27465797	western blotting	C0005863
27465797	High glucose	C0860803
27465797	induced	C0205263
27465797	GLUT1	C0168458
27465797	expression	C1171362
27465797	increased	C0205217
27465797	ROS	C0162772
27465797	inhibited	C0311403
27465797	GAPDH	C3536868
27465797	increased	C0205217
27465797	polyol	C0071629
27465797	pathway	C1704259
27465797	sorbitol	C0037688
27465797	PKC	C0033634
27465797	activity	C0243102
27465797	O-GlcNAc-modified proteins	C0671368
27465797	hexosamine	C0019477
27465797	pathway	C1704259
27465797	advanced glycation endproducts'	C0162574
27465797	precursor	C1709634
27465797	methylglyoxal	C0034338
27465797	Co-treatment	C0814472
27465797	GEnC	C1182791
27465797	tryptophanol	C0526839
27465797	high-glucose	C0860803
27465797	induced	C0205263
27465797	Activation	C0014429
27465797	GCN2 kinase	C2354171
27465797	GEnC	C1182791
27465797	high-glucose	C0860803
27465797	induced	C0205263
27465797	molecular pathways	C1704259
27465797	concurrently	C0205420
27465797	pathways	C1704259
27465797	DN	C0011881
27465797	pathogenesis	C0699748
27465797	GCN2 kinase	C2354171
27465797	pharmaceutical	C0031336
27465797	target	C1521840
27465797	treatment	C0087111
27465797	DN	C0011881
27467249	Juicer	C0037589
27467249	Provides	C1999230
27467249	Analyzing	C0936012
27467249	Loop-Resolution Hi-C Experiments	C0200892
27467249	Hi-C experiments	C0200892
27467249	3D structure	C0026377
27467249	genome	C0017428
27467249	generating	C3146294
27467249	terabases of data	C0150098
27467249	high-resolution	C1719039
27467249	contact maps	C0814036
27467249	Juicer	C0037589
27467249	open-source tool	C0037589
27467249	terabase-scale	C0392762
27467249	Hi-C datasets	C0150098
27467249	Juicer	C0037589
27467249	users	C1706077
27467249	without	C0332288
27467249	computational	C1880157
27467249	background	C1706907
27467249	transform	C1705163
27467249	raw sequence data	C0026382
27467249	contact maps	C0814036
27467249	Juicer	C0037589
27467249	hic file	C0242193
27467249	compressed	C0332260
27467249	contact matrices	C1704640
27467249	resolutions	C1706463
27467249	visualization	C0175631
27467249	analysis	C0936012
27467249	multiple scales	C0392762
27467249	Structural features	C0026377
27467249	loops	C1516509
27467249	domains	C0599845
27467249	automatically	C0004374
27467249	annotated	C1552720
27467249	Juicer	C0037589
27467249	open	C1996904
27467249	source	C0011001
27467249	software	C0037585
27467655	BJN Awards	C0004446
27467655	IV therapy	C0455142
27467655	Professor	C0015535
27467655	Nursing	C0028661
27467655	Centre of Research Excellence	C1516383
27467655	Nursing	C0028661
27467655	awarded	C0004446
27467655	BJN Awards	C0004446
27467655	IV Therapy	C0455142
27467655	Nurse	C0028661
27467655	Year	C0439234
27467655	field	C1254363
27470228	Stressful	C0231297
27470228	life events	C0557155
27470228	leucocyte telomere length	C1836777
27470228	lifestyle factors	C1517875
27470228	somatic	C2986476
27470228	mental health	C0025353
27470228	low grade inflammation	C0021368
27470228	relationship	C0439849
27470228	cohort	C0599755
27470228	Danish men	C0025266
27470228	born	C0005615
27470228	Exposure to	C0332157
27470228	psychosocial	C0542298
27470228	stress	C0038435
27470228	associated with	C0332281
27470228	risk	C0035647
27470228	somatic	C2986476
27470228	mental disorders	C0004936
27470228	relation	C0439849
27470228	relation	C0439849
27470228	immune system	C0020962
27470228	functioning	C0542341
27470228	stressful events	C0038444
27470228	life	C0376558
27470228	associated with	C0332281
27470228	leucocyte telomere length	C1836777
27470228	TL	C1836777
27470228	accumulated	C4055506
27470228	inflammation	C0021368
27470228	oxidative stress	C0242606
27470228	life course	C1510618
27470228	address	C1547607
27470228	childhood	C0231335
27470228	sensitive period	C1948053
27470228	relation	C0439849
27470228	stressful	C0231297
27470228	TL	C1836777
27470228	somatic	C2986476
27470228	mental health	C0025353
27470228	lifestyle	C0023676
27470228	markers	C0005516
27470228	low-grade inflammation	C0021368
27470228	cohort	C0599755
27470228	Danish men	C0025266
27470228	born	C0005615
27470228	birth	C0005615
27470228	Metropolit Cohort	C0599755
27470228	men	C0025266
27470228	health examination	C0420151
27470228	blood sampling	C0005834
27470228	quantitative PCR-based measurement	C2733022
27470228	TL	C1836777
27470228	relation	C0439849
27470228	stressful	C0231297
27470228	life events	C0557155
27470228	TL	C1836777
27470228	structural equation modelling	C0681947
27470228	estimate	C0750572
27470228	proportion	C1709707
27470228	effect	C1280500
27470228	somatic	C2986476
27470228	mental health	C0025353
27470228	cardiovascular disease	C0007222
27470228	body mass	C0518010
27470228	depressive mood	C0344315
27470228	lifestyle factors	C1517875
27470228	low grade inflammation	C0021368
27470228	C-reactive protein	C0006560
27470228	CRP	C0006560
27470228	interleukin (IL)-6	C0021760
27470228	IL-10	C0085295
27470228	Total number	C4288115
27470228	stressful events	C0038444
27470228	experienced	C0023672
27470228	during	C0347984
27470228	life course	C1510618
27470228	associated with	C0332281
27470228	TL	C1836777
27470228	sensitive periods	C1948053
27470228	number	C0237753
27470228	stressful events	C0038444
27470228	childhood	C0231335
27470228	associated with	C0332281
27470228	shorter TL	C1836777
27470228	stressful events	C0038444
27470228	childhood	C0231335
27470228	relation	C0439849
27470228	home	C0442519
27470228	effect	C1280500
27470228	stressful events	C0038444
27470228	childhood	C0231335
27470228	TL	C1836777
27470228	variables	C1705098
27470228	proportion	C1709707
27470228	depressive mood	C0344315
27470228	CRP	C0006560
27470228	stressful events	C0038444
27470228	childhood	C0231335
27470228	associated with	C0332281
27470228	shorter TL	C1836777
27470228	middle-aged men	C3825963
27470228	relation	C0439849
27470228	depressive mood	C0852545
27470228	low grade inflammation	C0021368
27470589	Description	C0678257
27470589	Ancylomarina subtilis gen. nov., sp. nov.	C0004611
27470589	isolated	C0205409
27470589	coastal sediment	C0557760
27470589	proposal	C1555306
27470589	Marinilabiliales ord. nov.	C0004611
27470589	transfer	C3244299
27470589	Marinilabiliaceae	C3557298
27470589	Prolixibacteraceae	C3800560
27470589	Marinifilaceae	C3986640
27470589	order	C1705177
27470589	Marinilabiliales	C0004611
27470589	Gram-stain-negative	C0018150
27470589	facultatively anaerobic	C1532741
27470589	moderately halophilic	C0599691
27470589	filamentous	C1979891
27470589	non-motile bacterium	C1301466
27470589	designated	C1524084
27470589	FA102T	C0018149
27470589	isolated	C0205409
27470589	marine sediment	C0282589
27470589	coast	C0442544
27470589	Weihai, China	C0008115
27470589	Phylogenetic analysis	C1519068
27470589	based	C1527178
27470589	16S rRNA gene sequences	C3537372
27470589	showed	C0870432
27470589	strain	C0456178
27470589	FA102T	C0018149
27470589	distinct	C2963144
27470589	evolutionary	C0015219
27470589	lineage	C1881379
27470589	family	C1704727
27470589	Marinifilaceae	C3986640
27470589	closest relative	C1821461
27470589	Marinifilum fragile JCM 15579T	C2990363
27470589	sequence similarity	C1710052
27470589	DNA	C0012854
27470589	G+C content	C1135899
27470589	novel	C0205314
27470589	strain	C0456178
27470589	predominant	C1542147
27470589	cellular	C0007634
27470589	fatty acids	C0015684
27470589	respiratory	C0521346
27470589	quinone	C0034435
27470589	iso-C15:0	C0044840
27470589	iso-C15:0 3-OH	C0754432
27470589	MK-7	C0078382
27470589	respectively	C1548787
27470589	basis	C1527178
27470589	phylogenetic	C0683236
27470589	phenotypic	C0031437
27470589	physiological	C0205463
27470589	data	C1511726
27470589	strain	C0456178
27470589	FA102T	C0018149
27470589	represents	C1882932
27470589	novel	C0205314
27470589	genus	C1708235
27470589	species	C1705920
27470589	Ancylomarina subtilis gen. nov., sp. nov.	C0004611
27470589	proposed	C1553874
27470589	type	C0332307
27470589	strain	C0456178
27470589	Ancylomarina subtilis	C0018149
27470589	FA102T	C0018149
27470589	KCTC 42257T	C0004611
27470589	DSM 28825T	C0004611
27470589	CICC 10902T	C0004611
27470589	new	C0205314
27470589	order	C1705177
27470589	Marinilabiliales	C0004611
27470589	proposed	C1553874
27470589	accommodate	C1832072
27470589	families	C1704727
27470589	previously	C0205156
27470589	classified	C0008902
27470589	order	C1705177
27470589	Bacteroidales	C1080663
27470589	Marinilabiliales ord. nov.	C0004611
27470589	families	C1704727
27470589	Marinilabiliaceae	C3557298
27470589	Prolixibacteraceae	C3800560
27470589	Marinifilaceae	C3986640
27470609	Treatment	C0087111
27470609	Rheumatoid Arthritis	C0003873
27470609	Risk	C1281905
27470609	Alzheimer's Disease	C0002395
27470609	Nested Case-Control Analysis	C0027775
27470609	increasingly	C0442808
27470609	accepted	C1272684
27470609	inflammation	C0021368
27470609	pathogenesis	C0699748
27470609	Alzheimer's disease	C0002395
27470609	AD	C0002395
27470609	several	C0443302
27470609	immune	C0020962
27470609	genes	C0017337
27470609	associated with	C0332281
27470609	AD	C0002395
27470609	tumor necrosis factor (TNF)-α	C1456820
27470609	proinflammatory cytokine	C0079189
27470609	autoimmune disorders	C0004364
27470609	rheumatoid arthritis	C0003873
27470609	RA	C0003873
27470609	AD	C0002395
27470609	RA	C0003873
27470609	similar	C2348205
27470609	pathological mechanisms	C0030660
27470609	production	C0003261
27470609	TNF-α,	C1456820
27470609	relationship	C0439849
27470609	AD	C0002395
27470609	RA	C0003873
27470609	unknown	C0439673
27470609	relative risk	C0242492
27470609	AD	C0002395
27470609	RA	C0003873
27470609	patients	C0030705
27470609	RA	C0003873
27470609	patients	C0030705
27470609	anti-TNF therapy	C0281481
27470609	RA	C0003873
27470609	associated with	C0332281
27470609	lower	C0205251
27470609	risk	C1281905
27470609	AD	C0002395
27470609	RA	C0003873
27470609	patients	C0030705
27470609	nested case-control study	C0027775
27470609	insured	C1548605
27470609	adults	C0001675
27470609	US states	C0041703
27470609	Puerto Rico	C0034044
27470609	US Virgin Islands	C0042752
27470609	Verisk Health claims database	C0242356
27470609	sub-cohort	C0599755
27470609	diagnosis	C0011900
27470609	RA	C0003873
27470609	controls	C0009932
27470609	RA	C0003873
27470609	AD	C0002395
27470609	cases	C1706256
27470609	matching	C0150103
27470609	cases	C1706256
27470609	age	C0001779
27470609	sex	C0079399
27470609	exposure assessment period	C1545382
27470609	methotrexate treatment	C0746573
27470609	assessed relative risk	C0086930
27470609	AD	C0002395
27470609	exposure to	C0332157
27470609	standard	C1442989
27470609	RA	C0003873
27470609	therapies	C0087111
27470609	anti-TNF agents	C1562242
27470609	infliximab	C0666743
27470609	adalimumab	C1122087
27470609	etanercept	C0717758
27470609	methotrexate	C0025677
27470609	prednisone	C0032952
27470609	sulfasalazine	C0036078
27470609	rituximab	C0393022
27470609	Odds ratios	C0028873
27470609	comorbidities	C0009488
27470609	coronary artery disease	C0010068
27470609	diabetes mellitus	C0011849
27470609	peripheral vascular disease	C0085096
27470609	AD	C0002395
27470609	prevalent	C1542147
27470609	RA	C0003873
27470609	patients	C0030705
27470609	without	C0332288
27470609	RA	C0003873
27470609	Chronic conditions	C4315615
27470609	coronary artery disease	C0010068
27470609	odds ratio	C0028873
27470609	OR	C0028873
27470609	confidence interval	C0009667
27470609	CI	C0009667
27470609	diabetes	C0011847
27470609	OR	C0028873
27470609	CI	C0009667
27470609	peripheral vascular disease	C0085096
27470609	OR	C0028873
27470609	CI	C0009667
27470609	relative risk	C0242492
27470609	AD	C0002395
27470609	RA	C0003873
27470609	patients	C0030705
27470609	Exposure to	C0332157
27470609	anti-TNF agents	C1562242
27470609	class	C1547013
27470609	immunosuppressive drugs	C0021081
27470609	associated with	C0332281
27470609	lowered	C1272755
27470609	risk	C1281905
27470609	AD	C0002395
27470609	RA	C0003873
27470609	patients	C0030705
27470609	OR	C0028873
27470609	CI	C0009667
27470609	OR	C0028873
27470609	CI	C0009667
27470609	Sub-group analysis	C2347789
27470609	anti-TNF agents	C1562242
27470609	etanercept	C0717758
27470609	OR	C0028873
27470609	CI	C0009667
27470609	OR	C0028873
27470609	CI	C0009667
27470609	associated with	C0332281
27470609	decreased	C0205216
27470609	risk	C1281905
27470609	AD	C0002395
27470609	RA	C0003873
27470609	patients	C0030705
27470609	increased	C0205217
27470609	risk	C1281905
27470609	AD	C0002395
27470609	RA	C0003873
27470609	population	C0032659
27470609	relative risk	C0242492
27470609	AD	C0002395
27470609	RA	C0003873
27470609	lowered	C1272755
27470609	exposed to	C0332157
27470609	etanercept	C0717758
27470609	Anti-TNF therapy	C0281481
27470609	etanercept	C0717758
27470609	promise	C1555307
27470609	potential	C3245505
27470609	treatment	C0087111
27470609	AD	C0002395
27472389	Dimerization	C2350408
27472389	EGFR	C0034802
27472389	HER2	C0069515
27472389	breast cancer	C0006142
27472389	cell motility	C0007608
27472389	STAT1	C0287920
27472389	ACTA2	C2716282
27472389	induction	C0205263
27472389	dimerization	C2350408
27472389	EGFR	C0034802
27472389	HER2	C0069515
27472389	prognosis	C0033325
27472389	induction	C0205263
27472389	tumor growth	C0598934
27472389	cell invasion	C2699153
27472389	compared	C1707455
27472389	EGFR	C0034802
27472389	homodimer	C0596448
27472389	mechanism	C0441712
27472389	dimerization	C2350408
27472389	breast cancer	C0006142
27472389	models	C0026336
27472389	expressions	C1171362
27472389	alpha-smooth muscle actin	C2716282
27472389	ACTA2	C2716282
27472389	signal transducer and activator of transcription 1	C0287920
27472389	STAT1	C0287920
27472389	increased	C0205217
27472389	overexpression	C1514559
27472389	HER2	C0069515
27472389	EGFR	C0034802
27472389	positive	C1446409
27472389	breast cancer	C0006142
27472389	cells	C0007634
27472389	ACTA2	C2716282
27472389	STAT1	C0287920
27472389	expression	C1171362
27472389	increased	C0205217
27472389	HER2	C0069515
27472389	positive	C1446409
27472389	breast cancer	C0006142
27472389	patients	C0030705
27472389	ACTA2	C2716282
27472389	expression	C1171362
27472389	decreased	C0205216
27472389	HER2 siRNA	C1099354
27472389	STAT1	C0287920
27472389	ACTA2	C2716282
27472389	expression	C1171362
27472389	ACTA2	C2716282
27472389	expression	C1171362
27472389	decreased	C0205216
27472389	treatment	C0087111
27472389	STAT1 inhibitor	C1254351
27472389	fludarabine	C0059985
27472389	JAK2 inhibitor	C1254351
27472389	AG490	C0381241
27472389	ACTA2	C2716282
27472389	expression	C1171362
27472389	increased	C0205217
27472389	STAT1	C0287920
27472389	overexpression	C1514559
27472389	ACTA2	C2716282
27472389	STAT1	C0287920
27472389	HER2	C0069515
27472389	increased	C0205217
27472389	free survival	C0242793
27472389	decreased	C0205216
27472389	high-risk	C0332167
27472389	breast cancer	C0006142
27472389	patients	C0030705
27472389	investigated	C1292732
27472389	ACTA2	C2716282
27472389	cell motility	C0007608
27472389	suppressed	C1260953
27472389	ACTA2 shRNA	C2930586
27472389	overexpression	C1514559
27472389	MDA-MB231	C1512505
27472389	HER2	C0069515
27472389	4T1 mammary carcinoma cells	C1512505
27472389	lung metastatic nodules	C0034079
27472389	decreased	C0205216
27472389	ACTA2	C2716282
27472389	knockdown mice	C0206745
27472389	induction	C0205263
27472389	ACTA2	C2716282
27472389	EGFR	C0034802
27472389	HER2	C0069515
27472389	dimerization	C2350408
27472389	JAK2	C0169661
27472389	STAT1	C0287920
27472389	signaling pathway	C0037080
27472389	ACTA2	C2716282
27472389	expression	C1171362
27472389	expression	C1171362
27472389	invasiveness	C0027626
27472389	metastasis	C0027627
27472389	breast cancer	C0006142
27472389	cells	C0007634
27473375	social	C0728831
27473375	cognitive treatment	C0009244
27473375	treatment	C1522326
27473375	participation	C0679823
27473375	partners	C3887537
27473375	persons	C0027361
27473375	relapsing remitting multiple sclerosis	C0751967
27473375	observation	C0700325
27473375	improved	C0184511
27473375	self-efficacy	C0600564
27473375	quality of life	C0034380
27473375	anxiety	C0003467
27473375	depression	C0011570
27473375	year	C0439234
27473375	persons	C0027361
27473375	multiple sclerosis	C0026769
27473375	MS	C0026769
27473375	self-efficacy	C0600564
27473375	positively	C1446409
27473375	health-related quality of life	C4279947
27473375	HRQoL	C4279947
27473375	physical activity	C0026606
27473375	observed	C1441672
27473375	months	C0439231
27473375	day	C0439228
27473375	social	C0728831
27473375	cognitive treatment	C0009244
27473375	treatment	C1522326
27473375	participation	C0679823
27473375	partners	C3887537
27473375	self-efficacy	C0600564
27473375	HRQoL	C4279947
27473375	improved	C0184511
27473375	persons	C0027361
27473375	relapsing remitting MS	C0751967
27473375	RRMS	C0751967
27473375	chronic	C0205191
27473375	nature of the disease	C0449786
27473375	beneficial	C0814225
27473375	changes	C0392747
27473375	treatment	C1522326
27473375	persons	C0027361
27473375	MS	C0026769
27473375	partners	C3887537
27473375	baseline	C1442488
27473375	months	C0439231
27473375	treatment	C0087111
27473375	self-efficacy	C0600564
27473375	control	C2587213
27473375	self-efficacy	C0600564
27473375	function	C0542341
27473375	physical	C0205485
27473375	mental	C0025353
27473375	HRQoL	C4279947
27473375	anxiety	C0003467
27473375	depression	C0011570
27473375	fatigue	C0015672
27473375	assessed	C1516048
27473375	self-report	C2700446
27473375	questionnaires	C0034394
27473375	Differences	C1705242
27473375	tested	C0039593
27473375	paired t test	C1709451
27473375	persons	C0027361
27473375	MS	C0026769
27473375	completed	C0205197
27473375	baseline	C1442488
27473375	assessment	C1516048
27473375	day	C0439228
27473375	treatment	C1522326
27473375	month	C0439231
27473375	questionnaires	C0034394
27473375	response	C1704632
27473375	rate	C1521828
27473375	RRMS	C0751967
27473375	progressive	C0205329
27473375	MS	C0026769
27473375	RR	C0751967
27473375	group	C0441833
27473375	self-efficacy	C0600564
27473375	control	C2587213
27473375	increased	C0205217
27473375	physical	C0205485
27473375	HRQoL	C4279947
27473375	depression	C0011570
27473375	anxiety	C0003467
27473375	decreased	C0205216
27473375	changes	C0392747
27473375	mental	C0025353
27473375	HRQoL	C4279947
27473375	fatigue	C0015672
27473375	failed	C0231175
27473375	statistically significant	C0237881
27473375	progressive	C0205329
27473375	group	C0441833
27473375	changes	C0392747
27473375	suggestive of	C0332299
27473375	improvement	C2986411
27473375	findings	C2607943
27473375	suggest	C1705535
27473375	day	C0439228
27473375	social	C0728831
27473375	cognitive treatment	C0009244
27473375	treatment	C1522326
27473375	participation	C0679823
27473375	partners	C3887537
27473375	long lasting	C1254367
27473375	beneficial	C0814225
27473375	effects	C1280500
27473375	self-efficacy	C0600564
27473375	HRQoL	C4279947
27473375	persons	C0027361
27473375	RRMS	C0751967
27473375	improvements	C2986411
27473375	anxiety	C0003467
27473375	depression	C0011570
27473375	month	C0439231
27473375	develop	C1527148
27473375	months	C0439231
27473380	Perineal injuries	C3544174
27473380	birth positions	C0243095
27473380	women	C0043210
27473380	low risk pregnancy	C0404841
27473380	homebirth	C0419367
27473380	birth positions	C0243095
27473380	associated with	C0332281
27473380	perineal injuries	C3544174
27473380	severe perineal trauma	C0559034
27473380	SPT	C0559034
27473380	unclear	C3845108
27473380	objective	C0018017
27473380	study	C2603343
27473380	prevalence	C0220900
27473380	perineal injuries	C3544174
27473380	severity	C0439793
27473380	low-risk	C3538919
27473380	population	C1257890
27473380	women	C0043210
27473380	birth at home	C0419367
27473380	prevalence	C0220900
27473380	perineal injuries	C3544174
27473380	SPT	C0559034
27473380	episiotomy	C0014586
27473380	birth positions	C0243095
27473380	Nordic countries	C0036273
27473380	population	C1257890
27473380	prospective cohort study	C1709709
27473380	home births	C0419367
27473380	Nordic countries	C0036273
27473380	assess medical outcomes	C3824997
27473380	questionnaire	C0034394
27473380	birth	C0005615
27473380	midwife	C0026083
27473380	Descriptive statistics	C1710191
27473380	bivariate analysis	C0681927
27473380	logistic regression	C0206031
27473380	data	C1511726
27473380	women	C0043210
27473380	home births	C0419367
27473380	home	C0442519
27473380	transfer to hospital	C0184736
27473380	prevalence	C0220900
27473380	SPT	C0559034
27473380	prevalence	C0220900
27473380	episiotomy	C0014586
27473380	maternal	C1858460
27473380	characteristics	C1521970
27473380	flexible	C0443220
27473380	sacrum	C3669209
27473380	positions	C0733755
27473380	sutured	C0205368
27473380	perineal injuries	C3544174
27473380	OR	C0028873
27473380	CI	C0009667
27473380	SPT	C0559034
27473380	OR	C0028873
27473380	CI	C0009667
27473380	Flexible	C0443220
27473380	sacrum	C3669209
27473380	positions	C0733755
27473380	associated with	C0332281
27473380	episiotomies	C0014586
27473380	OR	C0028873
27473380	CI	C0009667
27473380	prevalence	C0220900
27473380	SPT	C0559034
27473380	episiotomy	C0014586
27473380	women	C0043210
27473380	home birth	C0419367
27473380	Nordic countries	C0036273
27473380	Women	C0043210
27473380	birth positions	C0243095
27473380	birth	C0005615
27473380	flexible	C0443220
27473380	sacrum	C3669209
27473380	positions	C0733755
27473380	flexible	C0443220
27473380	sacrum	C3669209
27473380	positions	C0733755
27473380	SPT	C0559034
27473380	Flexible	C0443220
27473380	sacrum	C3669209
27473380	positions	C0733755
27473380	associated with	C0332281
27473380	episiotomies	C0014586
27473429	Parallel-processing	C0597171
27473429	continuous-flow device	C0179969
27473429	optimization	C2698650
27473429	free	C0332296
27473429	polymerase chain reaction	C0032520
27473429	parallel-processing	C0597171
27473429	four-station polymerase chain reaction	C0032520
27473429	PCR	C0032520
27473429	device	C0699733
27473429	performs	C0884358
27473429	continuous-flow	C0806140
27473429	PCR	C0032520
27473429	optimization	C2698650
27473429	annealing	C0920681
27473429	temperature	C0039476
27473429	annealing	C0920681
27473429	temperature	C0039476
27473429	station	C1883167
27473429	controlled	C2587213
27473429	independently	C0332291
27473429	device	C0699733
27473429	covers	C1999244
27473429	annealing	C0920681
27473429	temperature	C0039476
27473429	range	C1514721
27473429	wide	C0332464
27473429	perform	C0884358
27473429	PCR	C0032520
27473429	DNA fragment	C0684192
27473429	optimum	C2698651
27473429	annealing	C0920681
27473429	condition	C0348080
27473429	arrangement	C0870432
27473429	continuously	C0549178
27473429	obtain	C1301820
27473429	amplified	C1521871
27473429	amount	C1265611
27473429	DNA fragment	C0684192
27473429	stations	C1883167
27473429	device	C0699733
27473429	identical	C0205280
27473429	cylindrical	C0205114
27473429	stations	C1883167
27473429	diameter	C1301886
27473429	height	C0489786
27473429	polytetrafluoroethylene	C0032611
27473429	capillary reactor	C0376432
27473429	length	C1444754
27473429	wound helically	C0231467
27473429	up	C1282911
27473429	around	C0750503
27473429	station	C1883167
27473429	assembly	C1706853
27473429	designed	C1707689
27473429	minimize	C1524031
27473429	number	C0237753
27473429	heating blocks	C0181153
27473429	providing	C1999230
27473429	temperatures	C0039476
27473429	denaturation	C0301642
27473429	annealing	C0920681
27473429	extension	C0231448
27473429	shape	C0332479
27473429	compact	C1333134
27473429	cube	C1880194
27473429	height	C0489786
27473429	base	C1626935
27473429	reproducibility	C1514863
27473429	continuous-flow	C0806140
27473429	PCR	C0032520
27473429	high	C0205250
27473429	run	C1704688
27473429	run	C1704688
27473429	station	C1883167
27473429	station	C1883167
27473429	standard deviation	C0871420
27473429	amplification	C0683230
27473429	Performance	C1882330
27473429	optimization	C2698650
27473429	free	C0332296
27473429	DNA amplification	C0683230
27473429	evaluated	C0220825
27473429	DNA samples	C0444245
27473429	different	C1705242
27473429	annealing	C0920681
27473429	conditions	C0348080
27473429	product	C1514468
27473429	sizes	C0456389
27473429	demonstrated	C0443289
27473429	cases	C0868928
27473429	PCR	C0032520
27473429	successful	C1272703
27473429	station	C1883167
27473429	addition	C0332287
27473429	DNA fragment	C0684192
27473429	different	C1705242
27473429	lengths	C1444754
27473429	successfully	C1272703
27473429	amplified	C1521871
27473429	segmented	C0442059
27473429	flow	C0806140
27473429	mode	C1513371
27473429	contamination	C2349974
27473429	segments	C0442059
27473429	result	C1274040
27473429	device	C0699733
27473429	PCR	C0032520
27473429	module	C1709061
27473429	continuous-flow	C0806140
27473429	high-throughput on-line total DNA analysis	C0872186
27473429	system	C0449913
27473429	integrating	C0205195
27473429	modules	C1709061
27473429	cell	C0007634
27473429	lysis	C0024348
27473429	DNA extraction	C3839098
27473429	PCR	C0032520
27473429	product	C1514468
27473429	analysis	C0936012
27473951	Assessing	C1516048
27473951	sex-differences	C0036866
27473951	effect	C1280500
27473951	timing	C0449243
27473951	vaccination	C0042196
27473951	immunogenicity	C4277607
27473951	reactogenicity	C1691781
27473951	efficacy of vaccines	C3242199
27473951	young	C0332239
27473951	children	C0008059
27473951	study protocol	C2348563
27473951	individual	C0237401
27473951	participant	C0679646
27473951	data	C1511726
27473951	meta-analysis	C0920317
27473951	randomised controlled trials	C0206035
27473951	Disease	C0012634
27473951	incidence	C0021149
27473951	males	C0086582
27473951	females	C0086287
27473951	infectious	C0009450
27473951	inflammatory diseases	C1290884
27473951	Sex-differences	C0036866
27473951	immune responses	C0301872
27473951	vaccines	C0042210
27473951	viral vaccines	C0042742
27473951	adults	C0001675
27473951	evidence	C3887511
27473951	available	C0470187
27473951	sex-differences	C0036866
27473951	response	C1704632
27473951	immunisation	C0020971
27473951	infancy	C0231330
27473951	age group	C0027362
27473951	vaccines	C0042210
27473951	administered	C1521801
27473951	Factors	C1521761
27473951	sex	C1522384
27473951	timing	C0449243
27473951	coadministration	C1533734
27473951	vaccines	C0042210
27473951	influence	C4054723
27473951	immune response	C0301872
27473951	vaccination	C0042196
27473951	Individual	C0237401
27473951	participant	C0679646
27473951	data	C1511726
27473951	meta-analysis	C0920317
27473951	randomised controlled trials	C0206035
27473951	vaccines	C0042210
27473951	infants	C0021270
27473951	young	C0332239
27473951	children	C0008059
27473951	data	C1511726
27473951	randomised controlled trials	C0206035
27473951	accines	C0042210
27473951	diphtheria	C0012546
27473951	tetanus	C0039614
27473951	Bordetella pertussis	C0006017
27473951	polio	C0032371
27473951	Haemophilus influenzae type B	C0121772
27473951	hepatitis B	C0019163
27473951	Streptococcus pneumoniae	C0038410
27473951	Neisseria meningitidis	C0027575
27473951	measles	C0025007
27473951	mumps	C0026780
27473951	rubella	C0035920
27473951	varicella	C0008049
27473951	rotavirus	C0035870
27473951	analysis	C0936012
27473951	Outcomes	C1274040
27473951	measures	C1879489
27473951	immunogenicity	C4277607
27473951	immunoglobulins	C0021027
27473951	reactogenicity	C1691781
27473951	safety	C0036043
27473951	disease	C0012634
27473951	clinical efficacy	C3850123
27473951	Data	C1511726
27473951	trials	C0008976
27473951	vaccines	C0042210
27473951	components	C0449432
27473951	hierarchical	C0699032
27473951	models	C3161035
27473951	effect	C1280500
27473951	sex	C1522384
27473951	timing	C0449243
27473951	vaccinations	C0042196
27473951	outcome	C1274040
27473951	Systematic reviews	C1955832
27473951	published	C0034037
27473951	sex-differences	C0036866
27473951	answer questions	C0508431
27473951	field	C1521738
27473951	comparisons	C1707455
27473951	purpose	C1285529
27473951	clinical trial	C0008976
27473951	large	C0549177
27473951	degree	C0449286
27473951	reporting	C0700287
27473951	bias	C0242568
27473951	exists	C2987476
27473951	published	C0034037
27473951	literature	C0023866
27473951	improvements	C2986411
27473951	widespread	C0205391
27473951	availability of	C0470187
27473951	individual	C0237401
27473951	participant	C0679646
27473951	data	C1511726
27473951	randomised controlled trials	C0206035
27473951	extensive	C0205231
27473951	individual	C0237401
27473951	participant	C0679646
27473951	data	C1511726
27473951	meta-analyses	C0920317
27473951	previously	C0205156
27473951	impossible	C0243095
27473951	reducing	C0392756
27473951	effect	C1280500
27473951	publication	C0034036
27473951	reporting	C0700287
27473951	bias	C0242568
27473951	understanding	C0162340
27473951	infant	C0021270
27473951	immune response	C0301872
27473951	Preliminary results	C1548161
27473951	available	C0470187
27473951	results	C1274040
27473951	available	C0470187
27473951	No	C0332197
27473951	ethics	C0015000
27473951	review	C0282443
27473951	secondary analyses	C0683944
27473951	data	C1511726
27474969	ultrasensitive	C0332324
27474969	electrochemiluminescence	C3830326
27474969	sensor	C0183210
27474969	reduced graphene oxide	C2936695
27474969	copper sulfide	C0389357
27474969	composite	C0205199
27474969	capillary electrophoresis	C0201699
27474969	determination	C1148554
27474969	amlodipine besylate	C0354468
27474969	mice	C0025929
27474969	plasma	C0032105
27474969	electrochemiluminescence	C3830326
27474969	ECL	C3830326
27474969	sensor	C0183210
27474969	reduced graphene oxide	C2936695
27474969	copper sulfide	C0389357
27474969	rGO	C2936695
27474969	CuS	C0389357
27474969	composite	C0205199
27474969	capillary electrophoresis	C0201699
27474969	CE	C0201699
27474969	ultrasensitive	C0332324
27474969	detection	C1511790
27474969	amlodipine besylate	C0354468
27474969	AML	C0354468
27474969	rGO	C2936695
27474969	CuS	C0389357
27474969	composite	C0205199
27474969	hydrothermal method	C0449851
27474969	electrode	C0013812
27474969	modification	C3840684
27474969	electrochemical	C2350499
27474969	ECL	C3830326
27474969	sensor	C0183210
27474969	investigated	C1292732
27474969	enhance	C2349975
27474969	ECL	C3830326
27474969	intensity	C0871362
27474969	observed	C1441672
27474969	rGO	C2936695
27474969	CuS	C0389357
27474969	composite	C0205199
27474969	results	C0456984
27474969	presence	C3854307
27474969	rGO	C2936695
27474969	CuS	C0389357
27474969	composite	C0205199
27474969	electrode	C0013812
27474969	surface	C0205148
27474969	electron transfer rate	C1521828
27474969	electroactive	C0205177
27474969	center	C0205099
27474969	Ru(bpy)3(2+)	C1704241
27474969	electrode	C0013812
27474969	ECL	C3830326
27474969	sensor	C0183210
27474969	coupled	C1948027
27474969	CE	C0201699
27474969	selectivity	C1254595
27474969	CE	C0201699
27474969	ECL	C3830326
27474969	parameters	C0449381
27474969	separation	C0678621
27474969	detection	C1511790
27474969	optimum	C2698651
27474969	linear ranges	C1514721
27474969	AML	C0354468
27474969	detection limit	C2718050
27474969	method	C0871511
27474969	high sensitivity	C2346484
27474969	good selectivity	C1254595
27474969	linear range	C1514721
27474969	detection limit	C2718050
27474969	fine reproducibility	C1514863
27474969	AML	C0354468
27474969	mice	C0025929
27474969	plasma	C0032105
27474969	result	C0456984
27474969	potential	C3245505
27474969	pharmaceutical analysis	C0936012
27475696	Estrogen	C0014939
27475696	Progesterone	C0033308
27475696	hormone	C0019932
27475696	receptor expression	C0597360
27475696	oral cavity cancer	C0151546
27475696	increase	C0442805
27475696	incidence	C0021149
27475696	oral squamous cell carcinoma	C0585362
27475696	OSCC	C0585362
27475696	younger	C0332239
27475696	patients	C0030705
27475696	hypothesis	C1512571
27475696	tumors	C0027651
27475696	hormonally	C0019932
27475696	induced	C0205263
27475696	pregnancy	C0032961
27475696	young	C0332239
27475696	female	C0086287
27475696	patients	C0030705
27475696	risk factors	C0035648
27475696	alcohol	C0085762
27475696	tobacco abuse	C0040336
27475696	Estrogen Receptor alpha	C0665341
27475696	ERα	C0665341
27475696	Progesterone Receptor	C0034833
27475696	PR	C0034833
27475696	expression	C0597360
27475696	analyzed	C0936012
27475696	oral mucosa	C0026639
27475696	oral precursor lesions	C0221198
27475696	simple hyperplasia	C0456483
27475696	squamous intraepithelial neoplasia	C1302751
27475696	SIN I-III	C1302751
27475696	OSCC	C0585362
27475696	specimen	C0370003
27475696	OSCCs	C0585362
27475696	stratified	C0205363
27475696	young	C0332239
27475696	female	C0086287
27475696	cohort	C0599755
27475696	older	C3826770
27475696	patients	C0030705
27475696	young	C0332239
27475696	female	C0086287
27475696	cohort	C0599755
27475696	patients	C0030705
27475696	OSCC	C0585362
27475696	pregnancy	C0032961
27475696	Breast cancer	C0678222
27475696	tissues	C0040300
27475696	positive control	C1883676
27475696	ERα	C0665341
27475696	PR	C0034833
27475696	expression	C0597360
27475696	ERα	C0665341
27475696	expression	C0597360
27475696	oral precursor lesions	C0221198
27475696	squamous intraepithelial neoplasia	C1302751
27475696	SIN I-III	C1302751
27475696	OSCC	C0585362
27475696	specimen	C0370003
27475696	ERα	C0665341
27475696	positive	C1446409
27475696	OSCC	C0585362
27475696	samples	C0370003
27475696	older	C3826770
27475696	male	C0086582
27475696	patients	C0030705
27475696	patients	C0030705
27475696	young	C0332239
27475696	female	C0086287
27475696	cohort	C0599755
27475696	negatively	C0205160
27475696	ERα	C0665341
27475696	PR	C0034833
27475696	ER	C0034804
27475696	expression	C0597360
27475696	seldom	C0522498
27475696	risk factor	C0035648
27475696	OSCC	C0585362
27475696	PR	C0034833
27475696	expression	C0597360
27475696	relevant	C2347946
27475696	development	C1527148
27475696	OSCC	C0585362
27476541	Studying	C0681814
27476541	neuroprotective effect	C0815279
27476541	Atorvastatin	C0286651
27476541	small molecule	C1328819
27476541	drug	C1254351
27476541	high glucose	C0860803
27476541	induced	C0205263
27476541	neurotoxicity	C0235032
27476541	undifferentiated	C0205618
27476541	PC12 cells	C0085262
27476541	role	C1705810
27476541	NADPH oxidase	C0068355
27476541	Overproduction	C0205556
27476541	reactive oxygen species	C0162772
27476541	ROS	C0162772
27476541	NADPH oxidase	C0068355
27476541	NOX	C0068355
27476541	activation	C0014429
27476541	considered	C0750591
27476541	essential	C0205224
27476541	mechanism	C0441712
27476541	induced	C0205263
27476541	hyperglycemia	C0020456
27476541	tissues	C0040300
27476541	no comprehensive	C0205556
27476541	study	C0681814
27476541	role	C1705810
27476541	NOXs	C0068355
27476541	high glucose	C0860803
27476541	HG	C0860803
27476541	induced	C0205263
27476541	toxic effect	C0600688
27476541	neural tissues	C0027757
27476541	therapeutic	C0302350
27476541	strategy	C0679199
27476541	oxidative	C0311404
27476541	related	C0439849
27476541	pathologies	C0030664
27476541	introduced	C1292748
27476541	blocking	C0332206
27476541	undesirable actions	C3266814
27476541	NOX enzymes	C0068355
27476541	small molecules	C1328819
27476541	protective	C1545588
27476541	roles	C1705810
27476541	Statins	C0360714
27476541	ameliorating	C0205556
27476541	oxidative stress	C0242606
27476541	NOX	C0068355
27476541	inhibition	C1524081
27476541	tissues	C0040300
27476541	neural	C0027757
27476541	hypothesized	C1512571
27476541	different	C1705242
27476541	NOXs	C0068355
27476541	role	C1705810
27476541	HG	C0860803
27476541	induced	C0205263
27476541	neural cell injury	C0599732
27476541	postulate	C1705535
27476541	Atorvastatin	C0286651
27476541	small molecule	C1328819
27476541	modulate	C0443264
27476541	NOXs activity	C1151146
27476541	protect	C1545588
27476541	neural cells	C0027882
27476541	Undifferentiated	C0205618
27476541	PC12 cells	C0085262
27476541	treated with	C0332293
27476541	HG	C0860803
27476541	24 h	C0456696
27476541	presence	C0150312
27476541	absence	C0332197
27476541	Atorvastatin	C0286651
27476541	96 h	C0439227
27476541	cell viability	C0007620
27476541	measured	C0444706
27476541	MTT assay	C2986858
27476541	gene	C1956267
27476541	protein expressions profile	C3463810
27476541	NOX	C0068355
27476541	determined by	C0521095
27476541	RT-PCR	C0599161
27476541	western blotting	C0005863
27476541	Levels	C0441889
27476541	ROS	C0162772
27476541	malondialdehyde	C0024643
27476541	MDA	C0024643
27476541	evaluated	C1516048
27476541	Gene	C0017262
27476541	protein expression	C1171362
27476541	levels	C0441889
27476541	NOX	C0068355
27476541	consequently	C3845876
27476541	ROS	C0162772
27476541	MDA	C0024643
27476541	levels	C0441889
27476541	elevated	C3163633
27476541	HG	C0860803
27476541	treated	C1522326
27476541	PC12 cells	C0085262
27476541	Atorvastatin	C0286651
27476541	significantly	C0750502
27476541	decrease	C0547047
27476541	HG	C0860803
27476541	induced	C0205263
27476541	NOXs	C0068355
27476541	ROS	C0162772
27476541	MDA	C0024643
27476541	elevation	C0702240
27476541	improve	C0184511
27476541	impaired	C0221099
27476541	cell viability	C0007620
27476541	concluded	C1707478
27476541	HG	C0860803
27476541	elevate	C3163633
27476541	NOXs activity	C1151146
27476541	ROS	C0162772
27476541	MDA	C0024643
27476541	levels	C0441889
27476541	neural tissues	C0027757
27476541	Atorvastatin	C0286651
27476541	small molecule	C1328819
27476541	NOX inhibitor drug	C1254351
27476541	prevent	C2700409
27476541	delay	C0205421
27476541	diabetic complications	C0342257
27476541	neuropathy	C0442874
27477569	Intravascular	C0442123
27477569	Inflammation	C0021368
27477569	Triggers	C1444748
27477569	Intracerebral	C0442111
27477569	Activated	C1879547
27477569	Microglia	C0206116
27477569	Secondary Brain Injury	C0270611
27477569	Experimental	C1517586
27477569	Subarachnoid Hemorrhage	C0038525
27477569	eSAH	C0038525
27477569	Activation	C1879547
27477569	innate immunity	C0020969
27477569	secondary brain injury	C0270611
27477569	experimental	C1517586
27477569	subarachnoid hemorrhage	C0038525
27477569	eSAH	C0038525
27477569	Microglia	C0206116
27477569	accumulation	C4055506
27477569	activation	C1879547
27477569	brain	C0006104
27477569	neuronal cell death	C2754100
27477569	eSAH	C0038525
27477569	isolated	C0205409
27477569	mouse	C0025929
27477569	brain	C0006104
27477569	capillaries	C0935624
27477569	eSAH	C0038525
27477569	gene expression	C0017262
27477569	intercellular adhesion molecule-1	C1334074
27477569	ICAM-1	C1334074
27477569	P-selectin	C1335809
27477569	hypothesized	C1512571
27477569	extracerebral	C1254362
27477569	intravascular	C0442123
27477569	inflammatory processes	C1155266
27477569	reported	C0700287
27477569	microglia	C0206116
27477569	accumulation	C4055506
27477569	brain tissue	C0459385
27477569	eSAH	C0038525
27477569	knockout mice	C0206745
27477569	ICAM-1	C1334074
27477569	ICAM-1(-/-)	C1334074
27477569	P-selectin glycoprotein ligand-1	C1419941
27477569	PSGL-1(-/-)	C1419941
27477569	neutrophil	C0027950
27477569	endothelial	C0225336
27477569	interaction	C0007582
27477569	bleeding	C0019080
27477569	chronic	C0205191
27477569	cranial	C3163632
27477569	window model	C0026339
27477569	inhibition	C3463820
27477569	neutrophil recruitment	C0751982
27477569	endothelium	C0225336
27477569	ameliorated	C0243095
27477569	microglia	C0206116
27477569	accumulation	C4055506
27477569	neuronal cell death	C2754100
27477569	knockout animals	C1171353
27477569	activation	C1879547
27477569	CNS innate	C3714787
27477569	immune system	C0020962
27477569	vessel	C0042591
27477569	brain	C0006104
27477569	eSAH	C0038525
27477569	Microglia	C0206116
27477569	cells	C0007634
27477569	brain's	C0006104
27477569	innate immune system	C0020969
27477569	triggered	C1444748
27477569	inflammatory reaction	C0021368
27477569	microvasculature	C0243079
27477569	eSAH	C0038525
27477569	neuronal cell death	C2754100
27477569	research	C0035168
27477569	targets	C1521840
27477569	therapy	C0039798
27477569	patients	C0030705
27477569	eSAH	C0038525
27478387	Amphetamine Withdrawal	C0236665
27478387	Expression	C1171362
27478387	Organic Cation Transporter 3	C1453697
27478387	Serotonin Transporter	C0170657
27478387	Limbic	C0023715
27478387	Brain Regions	C0006104
27478387	Amphetamine withdrawal	C0236665
27478387	anxiety	C0003467
27478387	stress	C0038435
27478387	blunted	C1997138
27478387	ventral	C1704448
27478387	hippocampus	C0019564
27478387	vHipp	C0019564
27478387	central nucleus of the amygdala	C0175219
27478387	CeA	C0175219
27478387	serotonin	C0036751
27478387	responses	C0871261
27478387	Extracellular	C0521119
27478387	serotonin	C0036751
27478387	levels	C0441889
27478387	serotonin transporter	C0170657
27478387	SERT	C0170657
27478387	organic cation transporter 3	C1453697
27478387	OCT3	C1453697
27478387	vHipp	C0019564
27478387	OCT3	C1453697
27478387	expression	C1171362
27478387	24 hours	C1442770
27478387	amphetamine withdrawal	C0236665
27478387	SERT	C0170657
27478387	expression	C1171362
27478387	OCT3	C1453697
27478387	SERT	C0170657
27478387	expression	C1171362
27478387	CeA	C0175219
27478387	withdrawal	C2825032
27478387	limbic	C0023715
27478387	serotonergic neurotransmission	C2262837
27478387	two weeks	C4082118
27478387	withdrawal	C2825032
27478387	transporter	C0596902
27478387	expression	C1171362
27478387	Male	C0086582
27478387	rats	C0004728
27478387	amphetamine	C0002658
27478387	saline	C0036082
27478387	two weeks	C4082118
27478387	24 hours	C1442770
27478387	two weeks	C4082118
27478387	withdrawal	C2825032
27478387	transporter	C0596902
27478387	expression	C1171362
27478387	Western immunoblot	C0949466
27478387	OCT3	C1453697
27478387	SERT	C0170657
27478387	expression	C1171362
27478387	CeA	C0175219
27478387	withdrawal	C2825032
27478387	vHipp	C0019564
27478387	OCT3	C1453697
27478387	expression	C1171362
27478387	24 hours	C1442770
27478387	withdrawal	C2825032
27478387	dorsomedial hypothalamus	C0013055
27478387	No changes	C0442739
27478387	regions	C0005898
27478387	limbic	C0023715
27478387	OCT3	C1453697
27478387	SERT	C0170657
27478387	expression	C1171362
27478387	serotonergic	C0036751
27478387	imbalance	C1397014
27478387	negative affect	C1513916
27478387	amphetamine withdrawal	C0236665
27478553	Nutritional aspects	C0868998
27478553	night	C0240526
27478553	eating	C0013470
27478553	association with	C0332281
27478553	weight	C0005910
27478553	status	C0449438
27478553	Korean	C1556095
27478553	adolescents	C0205653
27478553	growing	C0205245
27478553	research	C0035168
27478553	night	C0240526
27478553	eating	C0013470
27478553	associated with	C0332281
27478553	poor diet	C0588012
27478553	quality	C0332306
27478553	negative	C0205160
27478553	health outcomes	C1550208
27478553	study	C0085973
27478553	nutritional aspects	C0868998
27478553	night	C0240526
27478553	eating	C0013470
27478553	factors	C1521761
27478553	association	C0439849
27478553	night	C0240526
27478553	eating	C0013470
27478553	body weight	C0005910
27478553	Korean	C1556095
27478553	adolescents	C0205653
27478553	study	C0085973
27478553	data	C1511726
27478553	day	C0439228
27478553	dietary recall	C0242481
27478553	demographic survey	C0011296
27478553	Korean	C1556095
27478553	adolescents	C0205653
27478553	years	C0439234
27478553	Korea	C0022771
27478553	National Health and Nutrition Examination Survey	C0376344
27478553	Night	C0240526
27478553	eating	C0013470
27478553	daily energy intake	C0564415
27478553	Subjects	C0080105
27478553	condition	C0348080
27478553	night	C0240526
27478553	eaters	C1257890
27478553	non-night eaters	C1257890
27478553	Logistic regression analysis	C0681925
27478553	factors	C1521761
27478553	night	C0240526
27478553	eating	C0013470
27478553	Multiple linear regression analyses	C0023733
27478553	relationship	C0439849
27478553	night	C0240526
27478553	eating	C0013470
27478553	BMI	C1305855
27478553	z-scores	C0871421
27478553	multinomial logistic regression analysis	C0681925
27478553	relationship	C0439849
27478553	night	C0240526
27478553	eating	C0013470
27478553	weight	C0005910
27478553	status	C0449438
27478553	Korean	C1556095
27478553	adolescents	C0205653
27478553	night	C0240526
27478553	eaters	C1257890
27478553	Night	C0240526
27478553	eaters	C1257890
27478553	increased	C0205217
27478553	breakfast	C2698559
27478553	skipping	C0560435
27478553	energy intake	C0006777
27478553	snacks	C0453863
27478553	proportion of energy intake from fat	C0564429
27478553	lower Dietary Diversity Scores	C0449820
27478553	non-night eaters	C1257890
27478553	Male	C0086582
27478553	adolescents	C0205653
27478553	times	C1632851
27478553	night	C0240526
27478553	eaters	C1257890
27478553	females	C0086287
27478553	Adolescents	C0205653
27478553	parents	C0030551
27478553	night	C0240526
27478553	eaters	C1257890
27478553	times	C1632851
27478553	night	C0240526
27478553	eaters	C1257890
27478553	parents	C0030551
27478553	Female	C0086287
27478553	adolescents	C0205653
27478553	relationship	C0439849
27478553	night	C0240526
27478553	eating	C0013470
27478553	BMI	C1305855
27478553	z-scores	C0871421
27478553	night	C0240526
27478553	eating	C0013470
27478553	increase	C0442805
27478553	overweight	C0497406
27478553	obese	C0028754
27478553	adolescents	C0205653
27478553	Night	C0240526
27478553	eating	C0013470
27478553	Korean	C1556095
27478553	adolescents	C0205653
27478553	undesirable dietary behaviours	C4019289
27478553	low diet quality	C2136285
27478553	BMI	C1305855
27478553	z-scores	C0871421
27478553	females	C0086287
27478553	Male	C0086582
27478553	gender	C0079399
27478553	parental	C0030551
27478553	night	C0240526
27478553	eating	C0013470
27478553	factors	C1521761
27478553	increased	C0205217
27478553	night	C0240526
27478553	eating	C0013470
27478553	night	C0240526
27478553	eating	C0013470
27478553	nutrition education	C0204934
27478553	intervention programs	C0599917
27478553	adolescents	C0205653
27480410	randomized trial	C0206034
27480410	Plasma-Lyte A	C0071213
27480410	0.9 % sodium chloride	C1725399
27480410	acute pediatric gastroenteritis	C0267446
27480410	efficacy	C1280519
27480410	Plasma-Lyte A	C0071213
27480410	PLA	C0071213
27480410	0.9 % sodium chloride	C1725399
27480410	NaCl	C1725399
27480410	intravenous (IV) fluid replacement	C0559692
27480410	children	C0008059
27480410	severe dehydration	C3472181
27480410	acute gastroenteritis	C0267446
27480410	AGE	C0267446
27480410	Prospective	C0033522
27480410	randomized	C0034656
27480410	double-blind study	C0013072
27480410	pediatric	C1521725
27480410	emergency departments	C0562508
27480410	EDs	C0562508
27480410	US	C0041703
27480410	Canada	C0006823
27480410	primary outcome measure	C3274433
27480410	serum bicarbonate level	C1261426
27480410	Secondary outcomes	C3274440
27480410	tolerability	C3274448
27480410	hypothesis	C1512571
27480410	PLA	C0071213
27480410	0.9 % NaCl	C1725399
27480410	improvement of 4-h bicarbonate	C0202059
27480410	Patients	C0030705
27480410	AGE	C0267446
27480410	severe dehydration	C3472181
27480410	Patients	C0030705
27480410	baseline	C1442488
27480410	bicarbonate level	C0428196
27480410	formed	C0205431
27480410	modified	C0392747
27480410	intent to treat	C1292734
27480410	mITT	C1292734
27480410	group	C1257890
27480410	baseline	C1442488
27480410	treatment	C0087111
27480410	groups	C1257890
27480410	PLA	C0071213
27480410	group	C1257890
27480410	PLA	C0071213
27480410	group	C1257890
27480410	increases in serum bicarbonate	C0858078
27480410	baseline	C1442488
27480410	0.9 % NaCl	C1725399
27480410	group	C1257890
27480410	baseline	C1442488
27480410	treatment	C0087111
27480410	groups	C1257890
27480410	fluid volumes	C0449971
27480410	PLA	C0071213
27480410	group	C1257890
27480410	abdominal pain	C0000737
27480410	dehydration	C0011175
27480410	patient	C0030705
27480410	clinically relevant worsening	C1546960
27480410	laboratory findings	C0587081
27480410	physical examination	C0031809
27480410	hospital admission rates	C0598610
27480410	similar	C2348205
27480410	patient	C0030705
27480410	treatment	C0087111
27480410	group	C1257890
27480410	hyponatremia	C0020625
27480410	patients	C0030705
27480410	hyperkalemia	C0020461
27480410	PLA	C0071213
27480410	0.9 % NaCl	C1725399
27480410	comparison	C1707455
27480410	0.9 % NaCl	C1725399
27480410	PLA	C0071213
27480410	rehydration	C0034997
27480410	children	C0008059
27480410	AGE	C0267446
27480410	improvement in serum bicarbonate	C0428301
27480410	dehydration	C0011175
27481539	relationships	C0439849
27481539	symptoms	C1457887
27481539	quality of life	C0034380
27481539	course	C0750729
27481539	cognitive-behavioral therapy	C0009244
27481539	panic disorder	C0030319
27481539	Japan	C0022341
27481539	study	C2603343
27481539	examined	C0332128
27481539	relationships	C0439849
27481539	changes	C0392747
27481539	symptoms	C1457887
27481539	changes	C0392747
27481539	quality of life	C0034380
27481539	QOL	C0034380
27481539	cognitive-behavioral therapy	C0009244
27481539	CBT	C0009244
27481539	panic disorder	C0030319
27481539	PD	C0030319
27481539	treated	C1522326
27481539	PD	C0030319
27481539	patients	C0030705
27481539	CBT	C0009244
27481539	Japan	C0022341
27481539	multiple regression analysis	C0034980
27481539	examined	C0332128
27481539	associations	C0439849
27481539	changes	C0392747
27481539	QOL	C0034380
27481539	changes	C0392747
27481539	PD	C0030319
27481539	symptoms	C1457887
27481539	comorbid psychological symptoms	C0233397
27481539	CBT	C0009244
27481539	Changes	C0392747
27481539	anticipatory anxiety	C0231397
27481539	agoraphobic fear	C0233702
27481539	avoidance	C0870186
27481539	somatization	C0149779
27481539	predictors	C2698872
27481539	changes	C0392747
27481539	QOL	C0034380
27481539	somatization	C0149779
27481539	anticipatory anxiety	C0231397
27481539	agoraphobic fear	C0233702
27481539	QOL	C0034380
27481539	CBT	C0009244
27481539	PD	C0030319
27481714	Coupling	C1948027
27481714	TRPV6	C1452353
27481714	TMEM16A	C2976269
27481714	epithelial principal cells	C0014597
27481714	rat epididymis	C1882657
27481714	epididymis	C0014533
27481714	congenial	C1524057
27481714	environment	C0014406
27481714	sperm maturation	C0037846
27481714	protection	C1545588
27481714	fluid	C0005889
27481714	acidic	C0920750
27481714	calcium	C0006675
27481714	concentration	C1446561
27481714	low	C0205251
27481714	length	C1444754
27481714	epididymal tubule	C0014533
27481714	ionic currents	C0162585
27481714	mechanisms	C0441712
27481714	calcium homeostasis	C1156269
27481714	rat epididymal	C1882657
27481714	epithelial cells	C0014597
27481714	study	C2603343
27481714	calcium regulation	C1156269
27481714	epididymis	C0014533
27481714	patch-clamp method	C0242625
27481714	rat	C0034693
27481714	cauda epididymal	C0228024
27481714	principal cells	C0007634
27481714	detect	C0442726
27481714	active	C0205177
27481714	Ca(2+)	C0596235
27481714	current	C0162585
27481714	characteristics	C1521970
27481714	epithelial	C0014609
27481714	calcium channel	C0006685
27481714	TRPV6	C1452353
27481714	Electrophysiological	C0850293
27481714	pharmacological data	C1831759
27481714	active calcium-activated chloride conductance	C1956140
27481714	CaCC	C1956140
27481714	extracellular	C0521119
27481714	calcium	C0006675
27481714	attenuates	C0599946
27481714	TRPV6	C1452353
27481714	conductance	C0678840
27481714	CaCC	C1956140
27481714	Lanthanide	C0205838
27481714	block	C0332206
27481714	time	C0040223
27481714	dependent	C0851827
27481714	TRPV6	C1452353
27481714	inhibited	C1516145
27481714	CaCC	C1956140
27481714	CaCC	C1956140
27481714	blocker	C0870261
27481714	niflumic acid	C0028067
27481714	inhibits	C1516145
27481714	whole-cell	C0007634
27481714	currents	C0162585
27481714	La(3+)	C0534702
27481714	whole-cell	C0007634
27481714	currents	C0162585
27481714	principal cells	C0007634
27481714	Membrane potential	C0025251
27481714	measurements	C0242485
27481714	La(3+)	C0534702
27481714	sensitive ion channels	C0022009
27481714	sensitive	C0332324
27481714	specific	C1552740
27481714	TMEM16A	C2976269
27481714	inhibitor	C0243077
27481714	tannic acid	C0039294
27481714	In vivo	C1515655
27481714	perfusion	C0031001
27481714	cauda epididymal tubule	C0228024
27481714	Ca(2+)	C0596235
27481714	reabsorption	C3852988
27481714	luminal side	C0524462
27481714	suppressed	C1260953
27481714	ruthenium red	C0035975
27481714	blocker	C0870261
27481714	epithelial	C0014609
27481714	Ca(2+) channels	C0006685
27481714	CaCC	C1956140
27481714	messenger RNA	C0035696
27481714	TRPV6	C1452353
27481714	TMEM16A	C2976269
27481714	rat epididymis	C1882657
27481714	proteins	C0033684
27481714	colocalize	C0392752
27481714	apical membrane	C0596119
27481714	principal cells	C0007634
27481714	data	C1511726
27481714	evidence	C3887511
27481714	coupling	C1948027
27481714	mechanism	C0441712
27481714	TRPV6	C1452353
27481714	TMEM16A	C2976269
27481714	principal cells	C0007634
27481714	regulation of calcium homeostasis	C1156269
27481714	epididymis	C0014533
27482869	Conversation	C0871703
27482869	Allen J. Wilcox	C0086418
27482869	Allen James Wilcox	C0086418
27482869	Columbus, OH	C3831044
27482869	medicine	C0025118
27482869	University of Michigan	C0041740
27482869	internship	C0237690
27482869	completed a master's degree	C2030948
27482869	maternal and child health	C4035700
27482869	PhD	C1512022
27482869	epidemiology	C0014507
27482869	University of North Carolina	C0041740
27482869	Chapel Hill	C0017446
27482869	graduation	C1711333
27482869	work	C0043227
27482869	National Institute of Environmental Health Sciences	C1955979
27482869	NIEHS	C1955979
27482869	US National Institutes of Health	C0027468
27482869	Durham, NC	C3830368
27482869	career	C0178534
27482869	research program	C0683935
27482869	perinatal epidemiology	C1518977
27482869	early pregnancy	C0747845
27482869	documented	C1301725
27482869	subclinical	C0205211
27482869	pregnancy loss	C0687675
27482869	humans	C0086418
27482869	established	C0443211
27482869	fertile days	C0015894
27482869	woman's	C0043210
27482869	menstrual cycle	C0025329
27482869	Chief of	C1706996
27482869	Epidemiology	C0014507
27482869	Branch	C1706131
27482869	Editor-in-Chief	C1522486
27482869	journal	C0162443
27482869	EPIDEMIOLOGY	C0014507
27482869	textbook	C0039712
27482869	Fertility and Pregnancy-An Epidemiologic Perspective	C0039712
27482869	published	C0034037
27482869	Oxford University Press	C1552679
27482869	elected	C0682233
27482869	American Epidemiological Society	C1708333
27482869	president	C0028811
27482869	president	C0028811
27482869	Society of Pediatric and Perinatal Epidemiological Research	C1708333
27482869	president	C0028811
27482869	Society of Epidemiological Research	C1708333
27482869	teaching	C0220924
27482869	appointments	C0003629
27482869	University of North Carolina	C0041740
27482869	Harvard University	C0041740
27482869	University of Bergen	C0041740
27482869	Norway	C0028423
27482869	awarded	C0004446
27482869	honorary	C2985253
27482869	doctoral degree	C1512027
27484604	Evaluation	C0220825
27484604	Spontaneous	C0205359
27484604	Bone Regeneration	C0005972
27484604	Enucleation	C0014392
27484604	Large	C0549177
27484604	Cysts	C0010709
27484604	Jaws	C0022359
27484604	Radiographic	C0444708
27484604	Computed	C1441526
27484604	Software	C0037585
27484604	Spontaneous	C0205359
27484604	regeneration of bone	C0005972
27484604	commonly	C0205214
27484604	small	C0700321
27484604	surgical	C0543467
27484604	defects	C1457869
27484604	enucleation	C0014392
27484604	cysts	C0010709
27484604	large	C0549177
27484604	surgical	C0543467
27484604	defects	C1457869
27484604	enucleation	C0014392
27484604	spontaneous	C0205359
27484604	regeneration of bone	C0005972
27484604	rare	C0522498
27484604	phenomenon	C1882365
27484604	depends	C1701901
27484604	factors	C1521761
27484604	age	C0001779
27484604	patient	C0030705
27484604	intact	C0205266
27484604	periosteum	C0031110
27484604	stabilization	C1293130
27484604	study	C2603343
27484604	included	C0332257
27484604	patients	C0030705
27484604	reported	C0700287
27484604	department of oral and maxillofacial surgery	C0019961
27484604	complaint	C0012634
27484604	pain	C0030193
27484604	swelling	C0038999
27484604	jaws	C0022359
27484604	diagnosed	C0011900
27484604	cyst	C0010709
27484604	sample	C2347026
27484604	included	C0332257
27484604	numbers	C0237753
27484604	male	C0086582
27484604	female	C0086287
27484604	subjects	C0681850
27484604	aged	C0001779
27484604	Panoramic radiographs	C0034579
27484604	pre-	C0445204
27484604	postoperatively	C0032790
27484604	enucleation	C0014392
27484604	dimensions	C0439534
27484604	cyst	C0010709
27484604	evaluated	C0220825
27484604	radiograph	C1306645
27484604	proforma	C0205245
27484604	Subsequent	C0332282
27484604	radiographs	C1306645
27484604	regular	C0205272
27484604	intervals	C1272706
27484604	standard	C0034925
27484604	parameters	C0549193
27484604	analyzed	C0936012
27484604	MCID™ analysis	C3203917
27484604	software	C0037585
27484604	imaging research	C1881134
27484604	Mean	C0444504
27484604	reduction	C0441610
27484604	cystic	C0205207
27484604	cavity	C1510420
27484604	size	C0456389
27484604	increase	C0442805
27484604	mean	C0444504
27484604	density	C0178587
27484604	intervals	C1272706
27484604	Spontaneous	C0205359
27484604	bone regeneration	C0005972
27484604	primary	C0205225
27484604	closure	C0185003
27484604	large	C0549177
27484604	cystic	C0205207
27484604	defect	C1457869
27484604	need	C0027552
27484604	placement	C0441587
27484604	foreign substances	C0729652
27484604	grafts	C0181074
27484604	eliminated	C0849355
27484604	complications	C0009566
27484604	resulting from	C0678226
27484604	placement	C0441587
27484604	foreign substance	C0729652
27484604	studies	C2603343
27484604	required	C1514873
27484604	larger	C0549177
27484604	sample	C2347026
27484604	longer	C0205166
27484604	follow-up	C1522577
27484604	durations	C0449238
27484604	confirm	C1456348
27484604	outcome of the present work	C0085415
27484604	benefit	C0814225
27484604	patients	C0030705
27484604	present	C0521116
27484604	study	C2603343
27484604	spontaneous	C0205359
27484604	bone regeneration	C0005972
27484604	accepted	C1272684
27484604	results	C0808233
27484604	simple	C0205352
27484604	enucleation	C0014392
27484604	jaw	C0022359
27484604	cyst	C0010709
27484604	aid	C1269765
27484604	graft material	C0181074
27484604	simple	C0205352
27484604	enucleation	C0014392
27484604	considered	C0750591
27484604	first line of treatment	C1708063
27484604	modality	C0695347
27484604	cystic	C0205207
27484604	lesion	C0221198
27484604	jaws	C0022359
27484604	surgical procedure	C0543467
27484604	decreases	C0547047
27484604	economic	C0013557
27484604	biologic	C0205460
27484604	costs	C0010186
27484604	reduces	C0441610
27484604	risk	C0035647
27484604	postoperative complications	C0032787
27484604	Follow-up	C1522577
27484604	patient's	C0030705
27484604	compliance	C1321605
27484604	success of treatment	C0679864
27485340	Membrane Protein Solubilization	C1621323
27485340	Composition	C0243176
27485340	Protein	C0033684
27485340	Detergent	C0011740
27485340	Complexes	C1704241
27485340	Membrane proteins	C0025252
27485340	typically expressed	C1171362
27485340	heterologous	C0439860
27485340	systems	C0449913
27485340	in vitro	C0681828
27485340	characterization	C1880022
27485340	critical step	C1261552
27485340	preparation	C1521827
27485340	membrane proteins	C0025252
27485340	expression	C1171362
27485340	system	C0449913
27485340	solubilization of the protein	C1621323
27485340	aqueous solution	C3255993
27485340	detergents	C0011740
27485340	lipids	C0023779
27485340	protein	C0033684
27485340	suitable	C3900053
27485340	purification	C0243114
27485340	structural	C0204514
27485340	functional	C0205245
27485340	analysis	C0936012
27485340	process	C1522240
27485340	protein	C0033684
27485340	unnatural	C0522502
27485340	environment	C0014406
27485340	protein	C0033684
27485340	detergent	C0011740
27485340	complex	C1704241
27485340	natural	C0205296
27485340	lipid	C0023779
27485340	minimum	C1524031
27485340	destabilization	C1622120
27485340	modification	C3840684
27485340	structure	C0678594
27485340	process	C1522240
27485340	difficult	C0332218
27485340	increasing	C0442808
27485340	membrane proteins	C0025252
27485340	successfully isolated	C0205409
27485340	expression	C1171362
27485340	systems	C0449913
27485340	general protocol	C2348563
27485340	protein	C0033684
27485340	detergent	C0011740
27485340	complexes	C1704241
27485340	critical steps	C1261552
27485340	analyze	C0936012
27485340	composition	C0243176
27485340	protein	C0033684
27485340	detergent	C0011740
27485340	complexes	C1704241
27485340	analysis	C0936012
27485340	compositional	C0243176
27485340	variation	C0205419
27486419	Predict	C0681842
27486419	Burnout	C0006433
27486419	Student Nurses	C0038496
27486419	ICWR-1 Model	C0026347
27486419	Individual	C0237401
27486419	Psychological Resilience	C0683253
27486419	nursing work	C0028677
27486419	demanding	C0441516
27486419	stressful	C0231297
27486419	high	C0205250
27486419	rate	C1521828
27486419	burnout	C0006433
27486419	employed	C0557351
27486419	nurses	C0028661
27486419	resilience	C0683253
27486419	psychological adjustment	C0683269
27486419	employed	C0557351
27486419	nurses	C0028661
27486419	theoretical model	C0026350
27486419	resilience	C0683253
27486419	includes	C0332257
27486419	several	C0443302
27486419	constructs	C2827421
27486419	literature	C0023866
27486419	resilience	C0683253
27486419	psychological functioning	C0233398
27486419	nursing students	C0038496
27486419	future	C0016884
27486419	nursing	C0028677
27486419	workforce	C2700616
27486419	important	C3898777
27486419	advance	C3854260
27486419	determinants	C1521761
27486419	resilience	C0683253
27486419	population	C1257890
27486419	Student nurses	C0038496
27486419	completed	C1556116
27486419	final	C3853528
27486419	practicum	C0032929
27486419	online survey	C0038951
27486419	measuring	C0444706
27486419	constructs	C2827421
27486419	ICWR-1 model	C0026347
27486419	students	C0038496
27486419	Australia	C0004340
27486419	Canada	C0006823
27486419	completed	C1556116
27486419	survey	C0038951
27486419	several	C0443302
27486419	demographics	C1704791
27486419	trait negative affect	C0233849
27486419	mindfulness	C3542996
27486419	self-efficacy	C0600564
27486419	coping	C0009967
27486419	resilience	C0683253
27486419	burnout	C0006433
27486419	measured	C0444706
27486419	structural equation modeling	C0681947
27486419	major	C0205164
27486419	pathways	C1705987
27486419	model	C0026347
27486419	resilience	C0683253
27486419	significant	C0750502
27486419	influence	C4054723
27486419	relationship	C0439849
27486419	mindfulness	C3542996
27486419	self-efficacy	C0600564
27486419	coping	C0009967
27486419	psychological adjustment	C0683269
27486419	burnout	C0006433
27486419	scores	C0449820
27486419	predicted	C0681842
27486419	Neuroticism	C1842981
27486419	relationship	C0439849
27486419	coping	C0009967
27486419	burnout	C0006433
27486419	potential	C3245505
27486419	approaches	C1292724
27486419	nursing students	C0038496
27486419	at risk	C1444641
27486419	burnout	C0006433
27487357	Medication Intervention	C2735670
27487357	Chronic Kidney Disease	C1561643
27487357	Patients	C0030705
27487357	Transitioning	C2700061
27487357	Hospital	C0019994
27487357	Home	C0442519
27487357	Study Design	C0035171
27487357	Baseline	C1442488
27487357	Characteristics	C1521970
27487357	hospital readmission	C0600290
27487357	rate	C1521828
27487357	population	C1257890
27487357	chronic kidney disease	C1561643
27487357	CKD	C1561643
27487357	risk	C0035647
27487357	needed	C0027552
27487357	CKD	C1561643
27487357	Medication Intervention Trial	C2735670
27487357	CKD	C1561643
27487357	MIT	C2735670
27487357	www.clinicaltrials.gov; NCTO1459770	C4287891
27487357	single-blind	C0037181
27487357	investigators	C0008961
27487357	randomized	C0034656
27487357	clinical trial	C0008976
27487357	Providence Health Care	C0086388
27487357	Spokane, Washington	C3827207
27487357	Study participants	C0681850
27487357	hospitalized patients	C0870668
27487357	CKD	C1561643
27487357	stages	C1306673
27487357	treated with	C0332293
27487357	kidney replacement therapy	C0206074
27487357	acute illness	C4061114
27487357	study intervention	C1096775
27487357	pharmacist-led	C1449564
27487357	home-based	C0338059
27487357	medication management	C0150270
27487357	intervention	C0184661
27487357	delivered	C1705822
27487357	days	C0439228
27487357	hospital discharge	C0586003
27487357	primary outcome	C1274040
27487357	hospital readmissions	C0600290
27487357	emergency departments	C0562508
27487357	urgent care centers	C1710587
27487357	days	C0439228
27487357	hospital discharge	C0586003
27487357	Secondary outcomes	C1274040
27487357	achievements	C0683272
27487357	guideline-based	C0162791
27487357	targets	C1521840
27487357	CKD	C1561643
27487357	risk factors	C0035648
27487357	complications	C0009566
27487357	Enrollment	C1516879
27487357	February	C3830166
27487357	May	C3812381
27487357	baseline	C1442488
27487357	age	C0001779
27487357	participants	C0679646
27487357	years	C0439234
27487357	women	C0043210
27487357	hypertension	C0020538
27487357	diabetes	C0011847
27487357	baseline	C1442488
27487357	estimated glomerular filtration	C3811844
27487357	rate	C1521828
27487357	urine albumin-to-creatinine ratio	C0455271
27487357	interquartile range	C1711350
27487357	diagnosis category	C1550395
27487357	hospital admission	C0184666
27487357	cardiovascular diseases	C0007222
27487357	single diagnosis	C0011900
27487357	admission	C0030673
27487357	community-acquired	C0456394
27487357	acute kidney injury	C0022660
27487357	Participants	C0679646
27487357	CKD	C1561643
27487357	MIT	C2735670
27487357	acutely ill	C4061114
27487357	hospitalized patients	C0870668
27487357	CKD	C1561643
27487357	medication management	C0150270
27487357	intervention	C0184661
27487357	hospital discharge	C0586003
27487357	study	C2603343
27487357	reduce	C0392756
27487357	post	C0687676
27487357	hospitalization	C0019993
27487357	acute care	C0679878
27487357	utilization	C0042153
27487357	CKD	C1561643
27487357	management	C0376636
27488290	Direct	C1947931
27488290	Repair	C1705181
27488290	Lumbar Pars Interarticularis	C3874316
27488290	Defects	C1457869
27488290	Utilizing	C0042153
27488290	Intraoperative O-Arm-Based Navigation	C0392304
27488290	Microendoscopic Techniques	C0014245
27488290	retrospective analysis	C0035363
27488290	clinical outcomes	C2985631
27488290	patients	C0030705
27488290	lumbar pars interarticulars	C3874316
27488290	defects	C1457869
27488290	treated	C0332154
27488290	direct	C1947931
27488290	repair	C1705181
27488290	aid	C1269765
27488290	intraoperative O-arm based navigation	C0392304
27488290	microendoscopic techniques	C0014245
27488290	aim	C1947946
27488290	study	C2603343
27488290	investigate	C1292732
27488290	efficacy	C1280519
27488290	safety	C0036043
27488290	direct	C1947931
27488290	screw	C0301559
27488290	repair	C1705181
27488290	using	C0457083
27488290	minimally invasive surgery	C0282624
27488290	lumbar pars interarticulars	C3874316
27488290	defects	C1457869
27488290	pilot study	C2603343
27488290	Direct	C1947931
27488290	repair	C1705181
27488290	pars interarticulars	C3874316
27488290	defects	C1457869
27488290	used	C0457083
27488290	treat	C0087111
27488290	young adult	C0238598
27488290	patients	C0030705
27488290	Reports	C0684224
27488290	concerning	C2699424
27488290	direct	C1947931
27488290	repair	C1705181
27488290	minimally invasive techniques	C0282624
27488290	pars interarticulars	C3874316
27488290	defects	C1457869
27488290	rare	C0522498
27488290	Review	C1552617
27488290	medical records	C0025102
27488290	identified	C0205396
27488290	consecutive	C1707491
27488290	patients	C0030705
27488290	treated	C0332154
27488290	intraoperative O-arm based navigation	C0392304
27488290	microendoscopic techniques	C0014245
27488290	Debridement	C0011079
27488290	autograft	C0040736
27488290	pars interarticularis	C3874316
27488290	defects	C1457869
27488290	performed	C0884358
27488290	microendoscopic procedure	C0014245
27488290	percutaneous	C0522523
27488290	bilateral	C0238767
27488290	intralaminar	C0205274
27488290	screws	C0301559
27488290	inserted	C0441587
27488290	utilizing	C0042153
27488290	intraoperative navigation	C0392304
27488290	clinical	C1516606
27488290	radiological	C0039431
27488290	data	C1511726
27488290	collected	C1516695
27488290	analyzed	C0936012
27488290	retrospectively	C1514923
27488290	patients	C0030705
27488290	mean	C0444504
27488290	age	C0001779
27488290	younger	C0332239
27488290	time	C0040223
27488290	treatment	C0087111
27488290	Symptoms	C1457887
27488290	included	C2700399
27488290	axial	C0205131
27488290	back pain	C0004604
27488290	patients	C0030705
27488290	concomitant	C0521115
27488290	radiculopathy	C0700594
27488290	Autograft	C0040736
27488290	used	C0457083
27488290	cases	C1706256
27488290	average	C1510992
27488290	follow-up	C1522577
27488290	duration	C0449238
27488290	range	C1514721
27488290	Symptoms	C1457887
27488290	resolved	C3714811
27488290	completely	C0205197
27488290	partially	C0728938
27488290	patients	C0030705
27488290	Low back pain	C0024031
27488290	visual analog scores	C2960751
27488290	decrease	C0547047
27488290	preoperative	C0445204
27488290	postoperative	C0032790
27488290	cases	C1706256
27488290	pars	C0229962
27488290	defects	C1457869
27488290	healing	C2004454
27488290	observed	C1441672
27488290	radiological	C0039431
27488290	follow-up	C1522577
27488290	patient	C0030705
27488290	bilateral fusion failure	C0332917
27488290	refused	C1705116
27488290	revision surgery	C0035110
27488290	mild complaint	C0436343
27488290	No complications	C4032686
27488290	dural tear	C1504340
27488290	nerve root injury	C0854396
27488290	infection	C3714514
27488290	occurred	C1709305
27488290	Minimally invasive	C0282624
27488290	direct	C1947931
27488290	repair	C1705181
27488290	pars interarticularis	C3874316
27488290	defects	C1457869
27488290	intralaminar	C0205274
27488290	screws	C0301559
27488290	using	C0457083
27488290	microendoscopic system	C0014245
27488290	navigation procedure	C0392304
27488290	provide	C1999230
27488290	effective	C1704419
27488290	treatment	C0087111
27488290	spondylolysis	C0038018
27488290	satisfactory	C0205410
27488290	clinical	C0205210
27488290	radiological	C0039431
27488290	outcomes	C1274040
27488290	need	C0027552
27488290	special tools	C0025080
27488290	steep	C0332218
27488290	learning curve	C0023185
27488293	Evidence	C3887511
27488293	Review	C0282443
27488293	Survey	C0038951
27488293	Expert Opinion	C0600219
27488293	Reconstruction	C0524865
27488293	Metastatic Spine Tumors	C0684550
27488293	Systematic	C0220922
27488293	review	C0282443
27488293	consensus	C0376298
27488293	expert opinion	C0600219
27488293	surgeons	C0582175
27488293	health care professionals	C0018724
27488293	guidelines	C0162791
27488293	surgical reconstruction	C0524865
27488293	metastatic	C0027627
27488293	spine disease	C0037933
27488293	evidence	C3887511
27488293	expert opinion	C0600219
27488293	surgical treatment	C0543467
27488293	spinal metastases	C0684550
27488293	surgical reconstruction	C0524865
27488293	bone graft	C0005976
27488293	during	C0347984
27488293	surgery	C0543467
27488293	metastatic spine tumors	C0684550
27488293	design	C1707689
27488293	reconstruction	C0524865
27488293	construct	C0005479
27488293	stabilize	C0184512
27488293	systematic	C0220922
27488293	review	C0282443
27488293	available	C0470187
27488293	medical	C0205476
27488293	literature	C0023866
27488293	combined	C0205195
27488293	consensus	C0376298
27488293	expert opinion	C0600219
27488293	survey	C0038951
27488293	spine	C0037949
27488293	surgeons	C0582175
27488293	treat	C0087111
27488293	metastatic spine tumors	C0684550
27488293	evidence	C3887511
27488293	literature	C0023866
27488293	guidance	C0150600
27488293	use of	C1524063
27488293	bone graft	C0005976
27488293	metastatic tumor	C0027627
27488293	reconstruction	C0524865
27488293	evidence	C3887511
27488293	literature	C0023866
27488293	use of	C1524063
27488293	graft type	C0449494
27488293	respondents	C0282122
27488293	bone graft	C0005976
27488293	bone graft	C0005976
27488293	substitutes	C0243003
27488293	fusion	C1293131
27488293	studies	C0008972
27488293	use of	C1524063
27488293	prefabricated prosthetic	C0175649
27488293	studies	C0008972
27488293	use of	C1524063
27488293	polymethyl methacrylate	C0005533
27488293	PMMA	C0005533
27488293	bone cement	C0005934
27488293	studies	C0008972
27488293	use of	C1524063
27488293	bone graft	C0005976
27488293	anterior	C0205094
27488293	column	C0037949
27488293	reconstruction	C0524865
27488293	use of	C1524063
27488293	structural allograft	C2367546
27488293	experts	C0009817
27488293	anterior	C0205094
27488293	reconstruction	C0524865
27488293	followed by	C0332283
27488293	cage	C0441239
27488293	reconstruction	C0524865
27488293	PMMA	C0005533
27488293	bone cement	C0005934
27488293	bony union	C0391889
27488293	importance	C3898777
27488293	maintenance	C0024501
27488293	spinal	C0037949
27488293	stability	C0205360
27488293	long term	C0443252
27488293	reconstruction	C0524865
27488293	bony union	C0391889
27488293	required	C1514873
27488293	patients	C0030705
27488293	shorter	C1806781
27488293	life expectancies	C0023671
27488293	literature	C0023866
27488293	use of	C1524063
27488293	anterior	C0205094
27488293	reconstruction	C0524865
27488293	prefabricated prosthetic	C0175649
27488293	PMMA	C0005533
27488293	bone cement	C0005934
27488293	use of	C1524063
27488293	anterior	C0205094
27488293	construct	C0005479
27488293	bilateral	C0238767
27488293	posterior	C0205095
27488293	instrumentation	C0021632
27488293	performing	C0450010
27488293	three-column reconstruction	C0524865
27488602	transesophageal echocardiography	C0206054
27488602	embolic strokes of undetermined source	C3888970
27488602	diagnostic yield	C0011933
27488602	transesophageal echocardiography	C0206054
27488602	TEE	C0206054
27488602	patients	C0030705
27488602	ischemic stroke	C0948008
27488602	IS	C0948008
27488602	diagnostic criteria	C0679228
27488602	embolic strokes of undetermined source	C3888970
27488602	ESUS	C3888970
27488602	patients	C0030705
27488602	IS	C0948008
27488602	ESUS	C3888970
27488602	hospital	C0019994
27488602	TEE examination	C0206054
27488602	tertiary care stroke centers	C0587437
27488602	during a 12-month period	C1254367
27488602	systematic review	C1955832
27488602	meta-analysis estimating	C0920317
27488602	TEE	C0206054
27488602	findings	C0243095
27488602	therapeutic management	C0039798
27488602	secondary stroke prevention	C1277289
27488602	IS	C0948008
27488602	patients	C0030705
27488602	ESUS	C3888970
27488602	underwent investigation	C1261322
27488602	TEE	C0206054
27488602	men	C0025266
27488602	NIH Stroke Scale score	C4028214
27488602	interquartile range	C1711350
27488602	TEE	C0206054
27488602	findings	C0243095
27488602	confidence interval	C0009667
27488602	CI	C0009667
27488602	study population	C2348561
27488602	TEE	C0206054
27488602	findings	C0243095
27488602	initiation	C1704686
27488602	anticoagulation therapy	C0003281
27488602	administration	C1533734
27488602	IV antibiotic therapy	C0338237
27488602	patent foramen ovale closure	C0189967
27488602	CI	C0009667
27488602	patients	C0030705
27488602	pooled rate	C1521828
27488602	anticoagulation therapy	C0003281
27488602	abnormal	C0205161
27488602	TEE	C0206054
27488602	findings	C0243095
27488602	IS	C0948008
27488602	patients	C0030705
27488602	meta-analysis	C0920317
27488602	CI	C0009667
27488602	subgroup analysis	C0936012
27488602	initiation	C1704686
27488602	anticoagulation therapy	C0003281
27488602	TEE	C0206054
27488602	patients	C0030705
27488602	cryptogenic stroke	C0332240
27488602	CI	C0009667
27488602	ESUS	C3888970
27488602	CI	C0009667
27488602	IS	C0948008
27488602	CI	C0009667
27488602	TEE	C0206054
27488602	findings	C0243095
27488602	appropriate	C1548787
27488602	therapeutic strategy	C0087111
27488602	patients	C0030705
27488602	ESUS	C3888970
27489603	Simultaneous	C0521115
27489603	thrombosis	C0040053
27489603	multiple coronary arteries	C0205042
27489603	patient	C0030705
27489603	rheumatoid arthritis	C0003873
27489603	case	C0868928
27489603	simultaneous	C0521115
27489603	coronary thrombosis of the left main	C0264689
27489603	left anterior descending artery	C0226032
27489603	right coronary artery	C0226042
27489603	patient	C0030705
27489603	diagnosed	C0430022
27489603	rheumatoid arthritis	C0003873
27492869	Unintentional Injuries	C0151736
27492869	Children	C0008059
27492869	Years	C1510829
27492869	Age	C0001779
27492869	Parental	C0030551
27492869	Knowledge	C0376554
27492869	Attitudes	C0004271
27492869	Behaviors	C0004927
27492869	Italy	C0022277
27492869	risk factors	C0035648
27492869	associated with	C0332281
27492869	unintentional injuries	C0151736
27492869	children	C0008059
27492869	years	C1510829
27492869	parents	C0030551
27492869	knowledge	C0376554
27492869	attitudes	C0004271
27492869	behaviors	C0004927
27492869	pediatric	C1521725
27492869	injuries	C3263723
27492869	preventive measures	C0814446
27492869	cross-sectional survey	C0010362
27492869	May	C3812381
27492869	July	C3829447
27492869	random sample	C0150105
27492869	parents	C0030551
27492869	children	C0008059
27492869	self-administered	C1519231
27492869	anonymous questionnaire	C0034394
27492869	parents	C0030551
27492869	children	C0008059
27492869	unintentional injury	C0151736
27492869	months	C0439231
27492869	children	C0008059
27492869	boys	C0870221
27492869	leading cause	C0552510
27492869	falls	C0000921
27492869	injuries	C3263723
27492869	home	C0442519
27492869	emergency department	C0562508
27492869	Parents	C0030551
27492869	unintentional injuries	C0151736
27492869	child	C0008059
27492869	injured	C0332664
27492869	respondents	C0282122
27492869	aware	C0004448
27492869	security measures	C0036547
27492869	pediatric	C1521725
27492869	injuries	C3263723
27492869	knowledge	C0376554
27492869	parents	C0030551
27492869	college level of education	C0013652
27492869	middle school education	C0870891
27492869	perceived	C0030971
27492869	education	C0013621
27492869	preventive measures	C0814446
27492869	pediatric	C1521725
27492869	injuries	C3263723
27492869	mean value	C0444504
27492869	Likert scale	C0451267
27492869	mothers	C0026591
27492869	public health	C0699943
27492869	educational programs	C0150562
27492869	parents	C0030551
27492869	prevention	C0814446
27492869	unintentional injuries	C0151736
27492869	children	C0008059
27492869	safety	C0036043
27492869	injury prevention	C0150638
27492869	reduce	C0547047
27492869	risks	C0035647
27492869	injuries	C3263723
27492869	home	C0442519
27494135	Truncated Bovine	C0007452
27494135	Integrin Alpha-v/Beta-6	C0166814
27494135	Universal Capture Ligand	C1749457
27494135	FMD	C0016514
27494135	Diagnosis	C0011900
27494135	Foot-and-mouth disease	C0016514
27494135	FMD	C0016514
27494135	endemic	C0277550
27494135	regions	C0205147
27494135	world	C2700280
27494135	epizootic	C0598393
27494135	animal diseases	C0003047
27494135	FMD	C0016514
27494135	livestock	C2936506
27494135	cattle	C0007452
27494135	sheep	C0036945
27494135	goats	C1510458
27494135	pigs	C0039005
27494135	enormous economic losses	C0681022
27494135	productivity	C0033269
27494135	trade restrictions	C0443288
27494135	Preparedness	C1318963
27494135	early diagnosis	C0596473
27494135	essential	C0205224
27494135	effective control	C0085557
27494135	FMD	C0016514
27494135	diagnostic assays	C1510438
27494135	dependent	C0851827
27494135	high-affinity	C0205556
27494135	anti-FMD virus	C0949945
27494135	FMDV	C0949945
27494135	serotype-specific antibodies	C0443640
27494135	animals	C0003062
27494135	rabbits	C3887509
27494135	guinea pigs	C0085979
27494135	virus	C0042776
27494135	soluble	C1948047
27494135	truncated forms	C0348078
27494135	bovine	C0007452
27494135	αvβ6	C0166814
27494135	bind	C1167622
27494135	FMDV	C0949945
27494135	RGD	C0052350
27494135	divalent cation dependent interaction	C1372999
27494135	trapping reagent	C0034760
27494135	FMDV	C0949945
27494135	sandwich ELISA	C0014441
27494135	inclusion	C1512693
27494135	FLAG	C0251594
27494135	His tags	C0019602
27494135	purification	C0597301
27494135	loss	C1517945
27494135	virus binding	C1721019
27494135	evidence	C3887511
27494135	combined	C0205195
27494135	guinea pig	C0085979
27494135	polyclonal serum	C0229671
27494135	serotype-specific monoclonal antibodies	C0003250
27494135	integrin	C0021701
27494135	detect	C0442726
27494135	viruses	C0042776
27494135	FMDV serotypes	C0884162
27494135	recombinant FMDV	C0597363
27494135	empty capsids	C0006933
27494135	stabilising disulphide bonds	C0596391
27494135	antigen	C0003320
27494135	ELISA	C0014441
27494135	inactivated virus antigen	C0003320
27494135	positive control	C1883676
27494135	assay	C1510438
27494135	results	C0456984
27494135	potential	C3245505
27494135	bovine	C0007452
27494135	αvβ6	C0166814
27494135	FMDV	C0949945
27494135	empty capsids	C0006933
27494135	FMD	C0016514
27494135	diagnostic assays	C1510438
27498180	Stress	C0038443
27498180	binge drinking	C0556346
27498180	toxic	C0600688
27498180	teenage	C0001578
27498180	brain	C0006104
27498180	Young adult	C0238598
27498180	university students	C0597615
27498180	binge	C0556346
27498180	alcohol	C0001948
27498180	high	C0205250
27498180	stress levels	C1319127
27498180	rodents	C0035804
27498180	heavy current alcohol use	C2030272
27498180	elevated	C3163633
27498180	stress	C0038443
27498180	depression scores	C3483981
27498180	associated with	C0332281
27498180	deficits	C2987487
27498180	high	C0205250
27498180	interference	C0521102
27498180	memory	C0025260
27498180	tasks	C3540678
27498180	early onset	C1833334
27498180	binge	C0556346
27498180	patterns	C0556328
27498180	cognitive deficits	C0009241
27498180	associative encoding	C0679058
27498180	executive functions	C0935584
27498180	Concentration	C0086045
27498180	Memory	C0025260
27498180	Task	C3540678
27498180	computerized version	C0009609
27498180	Concentration	C0086045
27498180	card game	C0870328
27498180	high	C0205250
27498180	interference	C0521102
27498180	young adults	C0238598
27498180	elevated	C3163633
27498180	stress	C4296662
27498180	depression	C3483981
27498180	alcohol consumption scores	C0449820
27498180	impaired	C0221099
27498180	Concentration	C0086045
27498180	Memory	C0025260
27498180	Task	C3540678
27498180	analyzed data	C0010992
27498180	higher	C0205250
27498180	alcohol consumption scores	C0449820
27498180	associated with	C0332281
27498180	impaired	C0221099
27498180	performance	C0597198
27498180	high	C0205250
27498180	interference	C0521102
27498180	memory	C0025260
27498180	task	C3540678
27498180	Kirwan and Stark's Mnemonic Similarity Test	C0392366
27498180	adolescent	C0205653
27498180	onset	C0206132
27498180	binge drinking	C0556346
27498180	poorer	C2700379
27498180	performance	C0597198
27498180	memory	C0025260
27498180	tests	C0392366
27498180	systematic test of spatial recognition memory	C0451414
27498180	associative learning	C0023185
27498180	task	C3540678
27498180	results	C0683954
27498180	consistent with	C0332290
27498180	rodents	C0035804
27498180	acute alcohol	C4038778
27498180	stress	C0038443
27498180	suppress	C1260953
27498180	neurogenesis	C0814002
27498180	adult	C0001675
27498180	hippocampus	C0019564
27498180	impairs	C0221099
27498180	performance	C0597198
27498180	high	C0205250
27498180	interference	C0521102
27498180	memory	C0025260
27498180	tasks	C3540678
27498180	adolescent	C0205653
27498180	onset	C0206132
27498180	binge drinking	C0556346
27498180	extensive	C0205231
27498180	brain damage	C0270611
27498180	cognitive deficits	C0009241
27500205	Kindlins	C0033684
27500205	Cancer	C0006826
27500205	Kindlins	C0033684
27500205	4.1-ezrin-ridixin-moesin (FERM) domain	C1514562
27500205	proteins	C0033684
27500205	kindlins	C0033684
27500205	mammals	C0024660
27500205	high	C0205250
27500205	sequence	C0002518
27500205	Kindlin-1	C0033684
27500205	expressed	C1171362
27500205	epithelial cells	C0014597
27500205	kindlin-2	C0033684
27500205	distributed	C1704711
27500205	abundant	C2346714
27500205	adherent cells	C0007634
27500205	kindlin-3	C0033684
27500205	expressed	C1171362
27500205	hematopoietic cells	C2323499
27500205	distributions	C1704711
27500205	exclusive	C1548966
27500205	cells	C0007634
27500205	express	C1171362
27500205	multiple	C0439064
27500205	kindlins	C0033684
27500205	transformed cells	C0007634
27500205	often	C0332183
27500205	aberrant	C0443127
27500205	expression	C1171362
27500205	isoforms	C0597298
27500205	levels	C0441889
27500205	kindlins	C0033684
27500205	kindlins	C0033684
27500205	major	C0205164
27500205	roles	C1705810
27500205	controlling	C2239193
27500205	integrin	C0021701
27500205	function	C1527118
27500205	In vitro studies	C0681828
27500205	in vivo studies	C0681829
27500205	mice	C0025929
27500205	deficient	C0011155
27500205	kindlins	C0033684
27500205	studies	C0681814
27500205	patients	C0030705
27500205	genetic	C0314603
27500205	deficiencies	C0011155
27500205	kindlins	C0033684
27500205	established	C0443211
27500205	capacity	C1516240
27500205	integrins	C0021701
27500205	mediate	C0205556
27500205	functions	C0542341
27500205	Kindlins	C0033684
27500205	adaptor proteins	C0033684
27500205	function	C0542341
27500205	emanate	C0700364
27500205	interaction	C1704675
27500205	binding	C1167622
27500205	cytoplasmic tails	C0521449
27500205	integrins	C0021701
27500205	actin cytoskeleton	C0025979
27500205	purpose	C1285529
27500205	review	C0282443
27500205	brief	C1879313
27500205	overview	C0814812
27500205	kindlin	C0033684
27500205	structure	C1510464
27500205	function	C1527118
27500205	consideration	C0518609
27500205	binding	C1167622
27500205	relationship	C0439849
27500205	kindlin	C0033684
27500205	family	C1335532
27500205	member	C1551024
27500205	cancer	C0006826
27500205	view	C0449911
27500205	correlations	C1707520
27500205	kindlin	C0033684
27500205	expression	C1171362
27500205	levels	C0441889
27500205	neoplasia	C0027651
27500205	association	C0439849
27500205	integrins	C0021701
27500205	tumor progression	C0178874
27500205	metastasis	C0027627
27500205	consider	C0750591
27500205	kindlins	C0033684
27500205	function	C0542341
27500205	attractive	C2346874
27500205	targets	C1521840
27500205	treatment of cancer	C0920425
27503306	Preclinical	C1709630
27503306	fibrinolysis	C0016017
27503306	patients	C0030705
27503306	ST-segment elevation myocardial infarction	C1536220
27503306	rural region	C0178837
27503306	current guidelines	C4291682
27503306	treatment	C0087111
27503306	patients	C0030705
27503306	ST-segment elevation myocardial infarction	C1536220
27503306	STEMI	C1536220
27503306	recommends	C0034866
27503306	preclinical	C1709630
27503306	fibrinolysis	C0016017
27503306	reperfusion therapy	C0035124
27503306	transportation	C1554194
27503306	times	C0040223
27503306	cardiac catheterisation	C0018795
27503306	available	C0470187
27503306	min	C0439232
27503306	remaining	C1527428
27503306	expertise	C0870520
27503306	method	C0449851
27503306	fibrinolysis	C0016017
27503306	presently	C0750528
27503306	rarely	C0522498
27503306	indicated	C1444656
27503306	rural area	C0178837
27503306	southwestern	C1710136
27503306	Germany	C0017480
27503306	emergency primary percutaneous coronary intervention	C1532297
27503306	routinely	C0205547
27503306	available	C0470187
27503306	min	C0439232
27503306	STEMI	C1536220
27503306	patients	C0030705
27503306	fibrinolysis	C0016017
27503306	plasminogen activator reteplase	C0256103
27503306	performed by	C1550369
27503306	emergency	C0013956
27503306	physicians	C0031831
27503306	practicality	C0205556
27503306	treatment	C0087111
27503306	complications	C0009566
27503306	mortality	C0205848
27503306	patients	C0030705
27503306	preclinical	C1709630
27503306	phase	C0205390
27503306	arrival	C1706079
27503306	hospital	C0019994
27503306	retrospectively studied	C0035363
27503306	mean time	C0040223
27503306	onset of	C0332162
27503306	symptoms	C1457887
27503306	medical contact	C0582446
27503306	min	C0439232
27503306	mean interval	C1272706
27503306	start	C0439659
27503306	fibrinolysis	C0016017
27503306	min	C0439232
27503306	min	C0439232
27503306	mandated	C0520248
27503306	Patients	C0030705
27503306	inferior STEMI	C2882099
27503306	represented	C1882932
27503306	largest	C0443228
27503306	subgroup	C1515021
27503306	cases	C0681850
27503306	complications	C0009566
27503306	infarction	C0021308
27503306	common	C0205214
27503306	prehospital	C2735050
27503306	phase	C0205390
27503306	cases	C0681850
27503306	cardiogenic shock	C0036980
27503306	cases	C0681850
27503306	complications	C0009566
27503306	manageable	C0243095
27503306	patient	C0030705
27503306	died	C1306577
27503306	arrival	C1706079
27503306	hospital	C0019994
27503306	lysis	C0024348
27503306	associated	C0332281
27503306	adverse effects	C0879626
27503306	uncomplicated	C0443334
27503306	mucosal haemorrhages	C0854375
27503306	mild allergic skin reactions	C0863090
27503306	seen	C0205397
27503306	emergency situations	C0013956
27503306	transportation	C1554194
27503306	times	C0040223
27503306	suitable	C3900053
27503306	cardiac catheterisation	C0018795
27503306	laboratory	C0022877
27503306	preclinical	C1709630
27503306	fibrinolysis	C0016017
27503306	STEMI	C1536220
27503306	workable method	C0449851
27503306	Success	C0597535
27503306	strategy	C0679199
27503306	strong training	C0220931
27503306	emergency	C0013956
27503306	physicians	C0031831
27503306	ECG	C1623258
27503306	lysis	C0024348
27503306	therapy	C0087111
27503306	co-operation	C0392337
27503306	cardiac centres	C0475309
27503899	method	C0449851
27503899	providing	C1999230
27503899	formative feedback	C4042837
27503899	large	C0549177
27503899	cohort	C0599755
27503899	first-year	C1254367
27503899	physiology	C0031842
27503899	anatomy	C0002808
27503899	students	C0038492
27503899	evidence	C3887511
27503899	demonstrates	C3687625
27503899	critical	C1511545
27503899	effective	C1704419
27503899	meaningful	C0205556
27503899	feedback	C2911691
27503899	enhance	C2349975
27503899	student	C0038492
27503899	learning	C0023185
27503899	Effective	C1704419
27503899	feedback	C2911691
27503899	part of	C1292711
27503899	learning	C0023185
27503899	cycle	C1511572
27503899	learning	C0023185
27503899	opportunity	C0683937
27503899	student	C0038492
27503899	inform	C1552002
27503899	teacher	C0221457
27503899	ongoing	C0549178
27503899	curriculum development	C0681362
27503899	Feedback	C2911691
27503899	considered	C0750591
27503899	important	C3898777
27503899	during	C0347984
27503899	first year	C1254367
27503899	university	C0041740
27503899	retention	C0333117
27503899	attenuate	C0599946
27503899	student	C0038492
27503899	performance anxieties	C0458631
27503899	solidify	C0205556
27503899	perceptions	C0030971
27503899	academic support	C0000875
27503899	individualized	C1881197
27503899	timely	C3827828
27503899	feedback	C2911691
27503899	first-year	C1254367
27503899	courses	C0681364
27503899	large	C0549177
27503899	diverse	C1880371
27503899	cohort	C0599755
27503899	classes	C0456387
27503899	time	C0040223
27503899	logistics	C0242415
27503899	feedback	C2911691
27503899	provide	C1999230
27503899	rapid	C0456962
27503899	cost-effect	C0010181
27503899	feedback	C2911691
27503899	large	C0549177
27503899	cohorts	C0599755
27503899	limited	C0439801
27503899	benefit	C0814225
27503899	students	C0038492
27503899	weaknesses	C0243095
27503899	knowledge	C0376554
27503899	present	C0150312
27503899	study	C2603343
27503899	describes	C1552738
27503899	method	C0449851
27503899	provide	C1999230
27503899	formative task-related feedback	C4042837
27503899	large	C0549177
27503899	cohort	C0599755
27503899	first-year	C1254367
27503899	physiology	C0031842
27503899	anatomy	C0002808
27503899	students	C0038492
27503899	student	C0038492
27503899	evaluations	C0220825
27503899	presented	C0449450
27503899	study	C2603343
27503899	method	C0449851
27503899	provided	C1999230
27503899	feedback	C2911691
27503899	students	C0038492
27503899	uncovered	C0439845
27503899	underlying misconceptions	C0243095
27503899	peer	C0679739
27503899	discussion	C2584313
27503899	provided	C1999230
27503899	new	C0205314
27503899	instruction	C0039401
27503899	allowing	C0683607
27503899	lecturer	C0920339
27503899	recognize	C0524637
27503899	common	C0205214
27503899	gaps	C3887622
27503899	knowledge	C0376554
27503899	ongoing	C0549178
27503899	curriculum development	C0681362
27503926	SIRT2	C2720168
27503926	Deacetylates	C2246982
27503926	Inhibits the Peroxidase Activity	C3893923
27503926	Peroxiredoxin-1	C0672553
27503926	Sensitize Breast Cancer Cells	C1512505
27503926	Oxidant Stress	C0242606
27503926	Inducing	C0205263
27503926	SIRT2	C2720168
27503926	protein deacetylase	C2246982
27503926	tumor suppressor activity	C1325410
27503926	breast	C0006142
27503926	liver tumors	C0345904
27503926	mutated	C1705285
27503926	substrates	C3891814
27503926	antitumor activity	C0243095
27503926	SIRT2	C2720168
27503926	binds	C1149286
27503926	deacetylates	C1511737
27503926	inhibits the peroxidase activity	C3893923
27503926	antioxidant protein peroxiredoxin	C0672553
27503926	Prdx-1	C0672553
27503926	breast cancer cells	C1512505
27503926	Ectopic	C0574895
27503926	overexpression	C0017262
27503926	SIRT2	C2720168
27503926	catalytically dead mutant	C0596988
27503926	increased	C0205217
27503926	intracellular levels	C0178719
27503926	reactive oxygen species	C0162772
27503926	ROS	C0162772
27503926	induced by hydrogen peroxide,	C0020281
27503926	increased	C0205217
27503926	levels	C0441889
27503926	overoxidized and multimeric form of Prdx-1	C0672553
27503926	activity as a molecular chaperone	C0243041
27503926	Elevated	C3163633
27503926	levels	C0441889
27503926	SIRT2	C1420071
27503926	sensitized breast cancer cells	C1512505
27503926	intracellular DNA damage	C0012860
27503926	cell death induced by oxidative stress	C3894015
27503926	increased	C0205217
27503926	levels	C0441889
27503926	nuclear FOXO3A	C1333633
27503926	proapoptotic BIM protein	C4282114
27503926	elevated	C3163633
27503926	levels	C0441889
27503926	SIRT2	C2720168
27503926	sensitized breast cancer cells	C1512505
27503926	arsenic trioxide	C0052416
27503926	therapeutic agent	C0304231
27503926	intracellular ROS	C0162772
27503926	inducing agents	C1254351
27503926	antisense RNA	C0080124
27503926	mediated attenuation	C0599946
27503926	SIRT2	C2720168
27503926	reversed	C1555029
27503926	ROS	C0162772
27503926	induced toxicity	C1516457
27503926	zebrafish	C0043457
27503926	embryo model system	C0013935
27503926	tumor suppressor activity	C1325410
27503926	SIRT2	C2720168
27503926	restrict	C0443288
27503926	antioxidant activity	C1148564
27503926	Prdx-1	C0672553
27503926	sensitizing breast cancer cells	C1512505
27503926	ROS	C0162772
27503926	induced DNA damage	C0012860
27503926	cell cytotoxicity	C0596402
27506129	development	C1527148
27506129	conjunctival hyperemia	C1761613
27506129	computer-assisted diagnosis tools	C0011905
27506129	feature	C2348519
27506129	selection	C1707391
27506129	class imbalance	C0282574
27506129	blood flow	C0232338
27506129	bulbar conjunctiva	C0229275
27506129	hyperemia	C0020452
27506129	red hue	C0678581
27506129	variable	C0439828
27506129	intensity	C0205556
27506129	hyperemia	C0020452
27506129	grading scale	C0282574
27506129	time consuming	C3827829
27506129	automatisation	C0004376
27506129	straightforward	C1272701
27506129	class imbalance	C0282574
27506129	correlated	C1707520
27506129	features	C2348519
27506129	features	C2348519
27506129	hyperemia	C0020452
27506129	automatic framework	C0282574
27506129	hyperemia	C0020452
27506129	grading	C0243095
27506129	Oversampling	C0282574
27506129	undersampling	C0282574
27506129	SMOTE approaches	C0282574
27506129	class imbalance	C0282574
27506129	regression methods	C0034980
27506129	grading scale	C0282574
27506129	features	C2348519
27506129	experts' values	C0243095
27506129	feature	C2348519
27506129	selection	C1707391
27506129	lowest mean square error	C0392762
27506129	MSE	C0392762
27506129	regression systems	C0034980
27506129	Multi-layer perceptron	C0870951
27506129	MLP	C0870951
27506129	random forest (RF) method	C0282574
27506129	MLP	C0870951
27506129	Correlation based feature selection	C0282574
27506129	CFS	C0282574
27506129	MSE	C0392762
27506129	MSE	C0392762
27506129	class imbalance problem	C0282574
27506129	SMOTE approach	C0282574
27506129	MSE	C0392762
27506129	Machine learning	C0376284
27506129	hyperemia	C0020452
27506129	grading	C0243095
27506129	intra- and inter-expert subjectivity	C0205556
27506129	computation	C1880157
27506129	time	C0040223
27506129	SMOTE	C0282574
27506129	oversampling approaches	C0282574
27506129	class imbalance problem	C0282574
27506129	feature	C2348519
27506129	selection	C1707391
27506129	features	C2348519
27506129	MSE	C0392762
27506129	system	C0015324
27506129	human expert	C0031831
27506129	experts	C0031831
27506129	system	C0015324
27506129	expert	C0031831
27506220	Medication	C2081612
27506220	rehabilitation	C0034992
27506220	health care consumption	C0814514
27506220	adults	C0001675
27506220	cerebral palsy	C0007789
27506220	population based study	C1709599
27506220	medication	C2081612
27506220	rehabilitation	C0034992
27506220	healthcare consumption	C0814514
27506220	adults	C0001675
27506220	CP	C0007789
27506220	function	C0542341
27506220	Gross Motor Function Classification System	C3873236
27506220	GMFCS	C3873236
27506220	Questionnaire	C0034394
27506220	cross-sectional study	C0010362
27506220	Brittany	C0017446
27506220	French county	C0079170
27506220	Adults	C0001675
27506220	cerebral palsy	C0007789
27506220	Questionnaires	C0034394
27506220	drugs	C0013227
27506220	orthotic devices	C0029365
27506220	mobility aids	C3495449
27506220	rehabilitation	C0034992
27506220	medical input	C0496675
27506220	sent	C1519246
27506220	members	C0680022
27506220	unique	C1710548
27506220	regional French	C0017446
27506220	network	C1882071
27506220	adults	C0001675
27506220	cerebral palsy	C0007789
27506220	questionnaire	C0034394
27506220	completed	C0205197
27506220	participant	C0679646
27506220	helper	C0682221
27506220	responders	C0919876
27506220	GMFCS level	C3873236
27506220	Participants	C0679646
27506220	large amount of healthcare	C0814514
27506220	Almost three-quarters	C2825406
27506220	orally administered drugs	C0013227
27506220	antispastic	C4020576
27506220	antiepileptic drugs	C0003299
27506220	most frequent	C0332183
27506220	patients	C0030705
27506220	rehabilitation	C0034992
27506220	physiotherapy	C0949766
27506220	mobility aid	C3495449
27506220	orthotic device	C0029365
27506220	frequency	C0439603
27506220	GMFCS level	C3873236
27506220	Specificities	C0037791
27506220	found	C0150312
27506220	GMFCS level	C3873236
27506220	participants	C0679646
27506220	GMFCS level	C3873236
27506220	high level	C0441889
27506220	medical input	C0496675
27506220	greater use of	C1524063
27506220	trunk-supporting devices	C0025080
27506220	antireflux	C0399651
27506220	laxative	C0282090
27506220	Profiles	C0237801
27506220	GMFCS levels	C3873236
27506220	Adults	C0001675
27506220	cerebral palsy	C0007789
27506220	large amount	C3869890
27506220	drugs	C0013227
27506220	mobility aids	C3495449
27506220	orthotic devices	C0029365
27506220	rehabilitation	C0034992
27506220	medical input	C0496675
27506220	Healthcare	C0086388
27506220	targeted	C1521840
27506220	cerebral palsy	C0007789
27506220	cerebral palsy -related issues	C0033213
27506220	GMFCS	C3873236
27506220	determinant	C1521761
27506220	healthcare consumption	C0814514
27506220	clinical practice	C0205897
27506220	target	C1521840
27506220	care	C1947933
27506220	appropriately	C1548787
27507702	Transcriptome sequencing	C4086963
27507702	de novo	C1515568
27507702	characterization	C1880022
27507702	Korean	C0022771
27507702	land snail	C0037378
27507702	Koreanohadra kurodana	C0037378
27507702	transcripts	C1519595
27507702	SSR	C1519302
27507702	markers	C0017393
27507702	Korean	C0022771
27507702	land snail	C0037378
27507702	Koreanohadra kurodana	C0037378
27507702	Gastropoda	C0324023
27507702	Bradybaenidae	C1040093
27507702	humid areas	C0563027
27507702	broadleaf forests	C0086312
27507702	shrubs	C0446286
27507702	individuals	C0237401
27507702	years	C0439234
27507702	species	C0684063
27507702	genomic level	C0017428
27507702	functions	C0542341
27507702	molecular	C1521991
27507702	genetics level	C0314603
27507702	study	C2603343
27507702	de novo	C1515568
27507702	transcriptome sequencing	C4086963
27507702	transcript	C1519595
27507702	dataset	C0150098
27507702	visceral mass tissue	C0040300
27507702	K. kurodana	C0037378
27507702	Illumina paired-end sequencing technology	C1513384
27507702	contigs	C1511491
27507702	unigenes	C1710539
27507702	N50	C0028630
27507702	length	C1444754
27507702	unigenes	C1710539
27507702	protein	C0002518
27507702	nucleotide sequences	C0004793
27507702	public databases	C0242356
27507702	direction	C0449738
27507702	unigenes	C1710539
27507702	COG	C0242356
27507702	GO	C1138831
27507702	KEGG	C0242356
27507702	InterProScan	C2826595
27507702	protein domain	C1514562
27507702	search	C1706202
27507702	GO	C1138831
27507702	analysis	C0936012
27507702	unigenes	C1710539
27507702	functional groups	C0598132
27507702	KEGG annotation	C0242356
27507702	metabolism pathway	C1291081
27507702	genes	C0017337
27507702	protein motifs	C1514562
27507702	zinc finger	C0080347
27507702	ribonuclease H	C0085431
27507702	reverse transcriptase	C0035379
27507702	ankyrin repeat domains	C1956127
27507702	simple sequence repeats	C1519302
27507702	SSRs	C1519302
27507702	length	C1444754
27507702	unigenes	C1710539
27507702	dinucleotide repeat motifs	C0282524
27507702	tri-	C0282537
27507702	tetranucleotide motifs	C0282521
27507702	unigenes	C1710539
27507702	adaptation	C0392673
27507702	defense mechanisms	C0011142
27507702	heat shock proteins 70	C0243043
27507702	Toll-like receptor 4	C1411976
27507702	AMP-activated protein kinase	C2350345
27507702	aquaporin-2	C0213238
27507702	identification	C0205396
27507702	characterization	C1880022
27507702	genes	C0017337
27507702	polymorphic	C1882417
27507702	SSR	C1519302
27507702	markers	C0017393
27507702	K. kurodana	C0037378
27507702	transcriptome	C3178810
27507702	http://bioinfo.sch.ac.kr/submission/	C0872179
27507702	phylogenetics study	C1519068
27507702	genetic diversity	C0042333
27507702	assessment	C1516048
27509301	Prediction	C0681842
27509301	Estrogenic	C0014939
27509301	Bioactivity	C0441655
27509301	Environmental Chemical	C0220806
27509301	Metabolites	C0870883
27509301	US Environmental Protection Agency's	C0041712
27509301	EPA	C0041712
27509301	Endocrine Disruptor Screening Program	C1254363
27509301	EDSP	C1254363
27509301	in vitro data	C1511726
27509301	ToxCast	C0282574
27509301	Tox21	C0282574
27509301	high-throughput screening assays	C2718002
27509301	endocrine	C0014136
27509301	activity	C0441655
27509301	environmental chemicals	C0220806
27509301	in vitro assays	C3850137
27509301	metabolic capacity	C0025520
27509301	inactive chemicals	C0220806
27509301	biotransformed	C0005576
27509301	metabolites	C0870883
27509301	endocrine	C0014136
27509301	bioactivity	C0441655
27509301	screening	C1305399
27509301	testing	C0039593
27509301	metabolism	C0025519
27509301	endocrine	C0014136
27509301	activity	C0441655
27509301	parent chemicals	C0220806
27509301	metabolites	C0870883
27509301	software	C0037585
27509301	metabolites	C0870883
27509301	parent compounds	C1706082
27509301	chemicals	C0220806
27509301	estrogenic	C0014939
27509301	metabolites	C0870883
27509301	compounds	C1706082
27509301	metabolites	C0870883
27509301	estrogenic	C0014939
27509301	activity	C0441655
27509301	ER	C0034804
27509301	QSAR	C0887819
27509301	models	C3161035
27509301	estrogen	C0014939
27509301	bioactivity	C0441655
27509301	parent compounds	C1706082
27509301	metabolites	C0870883
27509301	models	C3161035
27509301	chemicals	C0220806
27509301	estrogenicity	C0205245
27509301	parent chemical	C0220806
27509301	metabolites	C0870883
27509301	metabolite prediction software	C0037585
27509301	estrogenic	C0014939
27509301	metabolites	C0870883
27509301	parent chemicals	C0220806
27509301	metabolite	C0870883
27509301	estrogenic	C0014939
27509301	metabolites	C0870883
27509301	biotransformation	C0005576
27509301	products	C0005522
27509301	parent chemical	C0220806
27509301	QSAR	C0887819
27509301	models	C3161035
27509301	estrogenic	C0014939
27509301	activity	C0441655
27509301	estrogenic	C0014939
27509301	metabolites	C0870883
27509301	parent chemicals	C0220806
27509301	models	C3161035
27509301	parent compounds	C1706082
27509301	chemicals	C0220806
27509301	estrogenicity	C0205245
27509301	metabolites	C0870883
27509301	in silico	C3489666
27509301	detection	C0442726
27509301	chemicals	C0220806
27509301	estrogenic	C0014939
27509301	metabolites	C0870883
27509301	false negative	C0205558
27509301	in vitro assays	C3850137
27510000	Effects of	C1704420
27510000	Application	C4048755
27510000	Social Marketing	C0037424
27510000	Theory	C0871935
27510000	Health Belief Model	C3714363
27510000	Promoting	C0033414
27510000	Cervical Cancer Screening	C0281187
27510000	Targeted	C1521840
27510000	Women	C0043210
27510000	Sisaket Province	C1514578
27510000	Thailand	C0039725
27510000	Cervical cancer	C4048328
27510000	major	C0205164
27510000	public health problem	C0033213
27510000	Thailand	C0039725
27510000	ranked	C0699794
27510000	breast cancer	C0678222
27510000	Thai	C0337910
27510000	women	C0043210
27510000	reported	C0700287
27510000	low	C0205251
27510000	rate	C1521828
27510000	cervical cancer screening	C0281187
27510000	goal	C0018017
27510000	WHO	C0043237
27510000	aimed	C1947946
27510000	apply	C4048755
27510000	social marketing	C0037424
27510000	theory	C0871935
27510000	health belief model	C3714363
27510000	promoting	C0033414
27510000	cervical cancer screening	C0281187
27510000	Kanthararom District	C0017446
27510000	Sisaket Province	C1514578
27510000	total	C0439810
27510000	targeted	C1521840
27510000	women	C0043210
27510000	aged	C0001779
27510000	years	C0439234
27510000	randomly	C0034656
27510000	divided	C0332849
27510000	groups	C0441833
27510000	experimental group	C1257890
27510000	application	C4048755
27510000	social marketing	C0037424
27510000	theory	C0871935
27510000	health belief model	C3714363
27510000	program	C3484370
27510000	promoting	C0033414
27510000	cervical cancer screening	C0281187
27510000	control group	C0009932
27510000	received	C1514756
27510000	normal services	C1254363
27510000	research tools	C1516602
27510000	application	C4048755
27510000	social marketing	C0037424
27510000	theory	C0871935
27510000	health belief model	C3714363
27510000	program	C3484370
27510000	questionnaire	C0034394
27510000	evaluate	C1516048
27510000	perceptions	C0030971
27510000	cervical cancer	C4048328
27510000	Descriptive	C0678257
27510000	inferential statistics	C0002780
27510000	including	C0332257
27510000	paired	C1709450
27510000	sample ttest	C0392366
27510000	independent	C0332291
27510000	ttest	C0392366
27510000	analyze the data	C0010992
27510000	program	C3484370
27510000	mean score	C3533236
27510000	perception	C0030971
27510000	cervical cancer	C4048328
27510000	experimental group	C1257890
27510000	higher	C0205250
27510000	level	C0441889
27510000	S.D.	C0871420
27510000	control group	C0009932
27510000	S.D.	C0871420
27510000	statistical significance	C0237881
27510000	research	C0035168
27510000	appropriate	C1548787
27510000	communication	C0009452
27510000	process	C1522240
27510000	behavioral	C0004927
27510000	modification	C0392747
27510000	cervical cancer	C4048328
27510000	recommended	C0034866
27510000	program	C3484370
27510000	featuring	C2348519
27510000	social marketing	C0037424
27510000	health belief model	C3714363
27510000	promote	C0033414
27510000	cervical cancer screening	C0281187
27510000	targeted	C1521840
27510000	women	C0043210
27510000	promoted	C0033414
27510000	guideline	C0162791
27510000	health services	C0018747
27510000	health promotion	C0018738
27510000	disease prevention	C0679698
27510458	Visualization	C0011923
27510458	Intimal Flap	C0038925
27510458	Intracranial Arterial Dissection	C3665731
27510458	High-Resolution	C1719039
27510458	3T MRI	C0024485
27510458	Presence	C0150312
27510458	intimal flap	C0038925
27510458	critical	C1511545
27510458	imaging finding	C1287399
27510458	diagnosing	C0011900
27510458	intracranial artery dissection	C3665731
27510458	ICAD	C3665731
27510458	reports	C0684224
27510458	high-resolution	C1719039
27510458	magnetic resonance imaging	C0024485
27510458	MRI	C0024485
27510458	better	C0332272
27510458	intimal flaps	C0038925
27510458	compared	C1707455
27510458	MRI techniques	C0024485
27510458	clinical settings	C3176918
27510458	sequence	C1519249
27510458	high-resolution	C1719039
27510458	MRI	C0024485
27510458	gadolinium	C0016911
27510458	enhancement	C2349975
27510458	images	C1551337
27510458	quality	C0332306
27510458	scanning	C0441633
27510458	times	C0040223
27510458	evaluated	C0220825
27510458	nonenhanced high-resolution fast spin echo (HR-FSE) MRI	C0024485
27510458	sequence	C1519249
27510458	intimal flaps	C0038925
27510458	patients	C0030705
27510458	ICAD	C3665731
27510458	patients	C0030705
27510458	ICAD	C3665731
27510458	MRI	C0024485
27510458	2-dimensional	C1705052
27510458	T2-weighted FSE imaging	C0011923
27510458	sequence	C1519249
27510458	3T system	C0449913
27510458	scanning	C0441633
27510458	conventional	C0439858
27510458	modalities	C0695347
27510458	CT angiography	C1536105
27510458	magnetic resonance angiography	C0243032
27510458	digital subtraction angiography	C0002979
27510458	assessed	C1516048
27510458	imaging methods	C1275506
27510458	intimal flap	C0038925
27510458	double lumen sign	C0243095
27510458	participants	C0679646
27510458	compared	C1707455
27510458	results	C0683954
27510458	HR-FSE	C0024485
27510458	modalities	C0695347
27510458	HR-FSE	C0024485
27510458	images	C1551337
27510458	intimal flaps	C0038925
27510458	double lumen signs	C0243095
27510458	patients	C0030705
27510458	conventional	C0439858
27510458	modalities	C0695347
27510458	identified	C0205396
27510458	double lumen sign	C0243095
27510458	patients	C0030705
27510458	HR-FSE imaging	C0024485
27510458	3T system	C0449913
27510458	improved	C0184511
27510458	visualization	C0011923
27510458	intimal flaps	C0038925
27510458	assessing	C1516048
27510458	patients	C0030705
27510458	suspected	C0750491
27510458	ICAD	C3665731
27510458	diagnosed	C0011900
27510458	conventional	C0439858
27510458	imaging modalities	C1275506
27511456	Quantification	C1709793
27511456	intact	C0205266
27511456	plasma	C0032105
27511456	AGT	C0003017
27511456	reduced conformations	C0033625
27511456	ELISA	C0014441
27511456	pleiotropic actions	C3266814
27511456	renin-angiotensin system	C0035096
27511456	RAS	C0035096
27511456	availability of	C0470187
27511456	angiotensinogen	C0003017
27511456	AGT	C0003017
27511456	generates	C3146294
27511456	angiotensin I	C0003006
27511456	ANG I	C0003006
27511456	cleaved	C0205242
27511456	renin	C0035094
27511456	quantification	C1709793
27511456	intact	C0205266
27511456	AGT	C0003017
27511456	iAGT	C0003017
27511456	concentrations	C1264643
27511456	important	C3898777
27511456	actual	C0237400
27511456	renin substrate	C0003017
27511456	available	C0470187
27511456	iAGT	C0003017
27511456	conformation	C0033625
27511456	oxidized AGT	C0003017
27511456	oxi-AGT	C0003017
27511456	reduced AGT	C0003017
27511456	red-AGT	C0003017
27511456	disulfide bond	C1511997
27511456	oxi-AGT	C0003017
27511456	higher	C0205250
27511456	affinity	C1510827
27511456	renin	C0035094
27511456	RAS	C0035096
27511456	associated diseases	C0243083
27511456	determined	C0521095
27511456	iAGT	C0003017
27511456	oxi-AGT	C0003017
27511456	red-AGT	C0003017
27511456	levels	C0441889
27511456	plasma	C0032105
27511456	rats	C0034693
27511456	mice	C0025929
27511456	Blood samples	C0178913
27511456	obtained	C1301820
27511456	cardiac puncture	C0022885
27511456	immediately	C0205253
27511456	mixed	C0205430
27511456	inhibitor	C0243077
27511456	solution	C0037633
27511456	containing	C0332256
27511456	renin inhibitor	C1960108
27511456	Total	C0439810
27511456	AGT	C0003017
27511456	tAGT	C0003017
27511456	levels	C0441889
27511456	measured	C0444706
27511456	tAGT	C0003017
27511456	ELISA	C0014441
27511456	detects	C0442726
27511456	cleaved	C0205242
27511456	iAGT	C0003017
27511456	iAGT	C0003017
27511456	levels	C0441889
27511456	determined by	C0521095
27511456	iAGT	C0003017
27511456	ELISA	C0014441
27511456	detect	C0442726
27511456	red-AGT	C0003017
27511456	samples	C0178913
27511456	dithiothreitol	C0012789
27511456	reducing agent	C0376446
27511456	quantify	C1709793
27511456	total	C0439810
27511456	iAGT	C0003017
27511456	concentration	C1264643
27511456	tAGT	C0003017
27511456	levels	C0441889
27511456	rat	C0034693
27511456	mouse	C0025929
27511456	plasma	C0032105
27511456	iAGT	C0003017
27511456	levels	C0441889
27511456	tAGT	C0003017
27511456	rat	C0034693
27511456	plasma	C0032105
27511456	mouse	C0025929
27511456	plasma	C0032105
27511456	greater	C1704243
27511456	plasma	C0032105
27511456	renin	C0035094
27511456	activity	C0243102
27511456	mice	C0025929
27511456	ratios	C0456603
27511456	oxi-AGT	C0003017
27511456	red-AGT	C0003017
27511456	rat	C0034693
27511456	mouse	C0025929
27511456	Plasma	C0032105
27511456	iAGT	C0003017
27511456	oxi-AGT	C0003017
27511456	red-AGT	C0003017
27511456	suggesting	C1705535
27511456	oxidative stress	C0242606
27511456	influence	C4054723
27511456	ANG I	C0003006
27511456	generation	C3146294
27511456	AGT	C0003017
27511456	conformation	C0033625
27511456	lower	C2003888
27511456	availability of	C0470187
27511456	plasma	C0032105
27511456	iAGT	C0003017
27511456	mice	C0025929
27511456	suggests	C1705535
27511456	limiting	C0439801
27511456	factor	C1521761
27511456	ANG I	C0003006
27511456	formation	C1522492
27511456	species	C1705920
27513357	Carbon Monoxide	C0007018
27513357	Improves	C0184511
27513357	Efficacy	C1280519
27513357	Mesenchymal Stromal Cells	C3178844
27513357	During	C0347984
27513357	Sepsis	C0243026
27513357	Specialized	C1704211
27513357	Proresolving	C0243095
27513357	Lipid Mediators	C0599745
27513357	Mesenchymal stromal cells	C3178844
27513357	investigated	C1292732
27513357	cell-based therapy	C3658313
27513357	disease processes	C0030660
27513357	results	C2825142
27513357	animal models	C0599779
27513357	systemic inflammation	C3646020
27513357	sepsis	C0243026
27513357	Studies	C2603343
27513357	improve	C0184511
27513357	therapeutic	C0302350
27513357	potential	C3245505
27513357	mesenchymal stromal cells	C3178844
27513357	gas	C0017110
27513357	molecule	C0567416
27513357	improves	C0184511
27513357	outcome	C1274040
27513357	experimental	C1517586
27513357	sepsis	C0243026
27513357	carbon monoxide	C0007018
27513357	preconditioning	C0205245
27513357	mesenchymal stromal cells	C3178844
27513357	carbon monoxide	C0007018
27513357	ex vivo	C2348480
27513357	promote	C0033414
27513357	therapeutic	C0302350
27513357	benefit	C0814225
27513357	cells	C0007634
27513357	administered	C1521801
27513357	in vivo	C1515655
27513357	onset of	C0332162
27513357	polymicrobial	C0275524
27513357	sepsis	C0243026
27513357	mice	C0025929
27513357	Animal study	C0683949
27513357	primary cell culture	C1449562
27513357	Laboratory	C0022877
27513357	investigation	C0220825
27513357	BALB/c mice	C0025919
27513357	Polymicrobial	C0275524
27513357	sepsis	C0243026
27513357	induced	C0205263
27513357	cecal	C0007531
27513357	ligation	C0023690
27513357	puncture	C0034117
27513357	Mesenchymal stromal cells	C3178844
27513357	mesenchymal stromal cells	C3178844
27513357	conditioned	C0205556
27513357	carbon monoxide	C0007018
27513357	fibroblasts	C0016030
27513357	fibroblasts	C0016030
27513357	conditioned	C0205556
27513357	carbon monoxide	C0007018
27513357	delivered	C1705822
27513357	tail vein	C2985205
27513357	injections	C1533685
27513357	septic	C0333534
27513357	mice	C0025929
27513357	mice	C0025929
27513357	assessed	C1516048
27513357	survival	C0038952
27513357	bacterial	C0521009
27513357	clearance	C0449297
27513357	inflammatory response	C1155266
27513357	during	C0347984
27513357	sepsis	C0243026
27513357	groups	C0441833
27513357	Mesenchymal stromal cells	C3178844
27513357	assessed	C1516048
27513357	ability	C0085732
27513357	promote	C0033414
27513357	bacterial	C0521009
27513357	phagocytosis	C0031308
27513357	neutrophils	C0027950
27513357	specialized	C1704211
27513357	proresolving	C0243095
27513357	lipid mediators	C0599745
27513357	mesenchymal stromal cells	C3178844
27513357	function	C0031843
27513357	gene silencing	C0598496
27513357	Ex vivo	C2348480
27513357	preconditioning	C0205245
27513357	carbon monoxide	C0007018
27513357	mesenchymal stromal cells	C3178844
27513357	administered	C1521801
27513357	onset of	C0332162
27513357	sepsis	C0243026
27513357	therapeutic effect	C1527144
27513357	increased	C0205217
27513357	survival	C0038952
27513357	Carbon monoxide	C0007018
27513357	preconditioned	C0205217
27513357	mesenchymal stromal cells	C3178844
27513357	organ injury	C0332675
27513357	improve	C0184511
27513357	bacterial	C0521009
27513357	clearance	C0449297
27513357	promote	C0033414
27513357	resolution	C1514893
27513357	inflammation	C0021368
27513357	Mesenchymal stromal cells	C3178844
27513357	exposed to	C0332157
27513357	carbon monoxide	C0007018
27513357	docosahexaenoic acid	C0556150
27513357	substrate	C3891814
27513357	specialized	C1704211
27513357	proresolving	C0243095
27513357	lipid mediators	C0599745
27513357	D-series	C0205556
27513357	resolvins	C4288292
27513357	promoted	C0033414
27513357	survival	C0038952
27513357	Silencing	C0598496
27513357	lipoxygenase pathways	C1157322
27513357	5-lipoxygenase	C1151570
27513357	12	C1151569
27513357	15-lipoxygenase	C1324412
27513357	important	C3898777
27513357	enzymes	C0014442
27513357	specialized	C1704211
27513357	proresolving	C0243095
27513357	lipid mediator	C0599745
27513357	biosynthesis	C0005572
27513357	resulted	C1274040
27513357	therapeutic	C0302350
27513357	benefit	C0814225
27513357	mesenchymal stromal cells	C3178844
27513357	carbon monoxide	C0007018
27513357	data	C1511726
27513357	specialized	C1704211
27513357	proresolving	C0243095
27513357	lipid mediators	C0599745
27513357	contribute	C1880177
27513357	improved	C0184511
27513357	mesenchymal stromal cell	C3178844
27513357	efficacy	C1280519
27513357	exposed to	C0332157
27513357	carbon monoxide	C0007018
27513357	improved	C0184511
27513357	therapeutic response	C0521982
27513357	during	C0347984
27513357	sepsis	C0243026
27515404	Effect	C1280500
27515404	primary health care	C0033137
27515404	reforms	C2986411
27515404	Turkey	C0041400
27515404	health service utilization	C0030672
27515404	user satisfaction	C3650764
27515404	Strengthening	C1704419
27515404	primary health care	C0033137
27515404	PHC	C0033137
27515404	efficient	C0442799
27515404	responsive	C0205342
27515404	health systems	C0018696
27515404	empirical	C1880496
27515404	evidence	C3887511
27515404	income	C0021162
27515404	countries	C0454664
27515404	limited	C0439801
27515404	stepwise introduction	C1293116
27515404	family medicine	C0015607
27515404	provinces	C1514578
27515404	Turkey	C0041400
27515404	middle-income	C0870890
27515404	country	C0454664
27515404	PHC	C0033137
27515404	strengthening	C1704419
27515404	natural experiment	C0681814
27515404	assessing	C1516048
27515404	effect	C1280500
27515404	family medicine	C0015607
27515404	health service utilization	C0030672
27515404	user satisfaction	C3650764
27515404	effect	C1280500
27515404	health system	C0018696
27515404	reforms	C2986411
27515404	family medicine	C0015607
27515404	utilization	C0042153
27515404	assessed	C1516048
27515404	longitudinal	C0023981
27515404	province-level data	C0035168
27515404	years	C0439234
27515404	multivariate regression models	C0026336
27515404	supply-side variables	C0439828
27515404	demographics	C0681669
27515404	socio-economic development	C0086996
27515404	yearly	C0439234
27515404	trends	C0040833
27515404	User satisfaction	C3650764
27515404	primary	C0033137
27515404	secondary care	C3494402
27515404	services	C0018747
27515404	data	C1511726
27515404	annual Life Satisfaction Surveys	C0038951
27515404	Trends	C0040833
27515404	contact	C0332158
27515404	primary	C0033137
27515404	secondary	C3494402
27515404	public	C0020022
27515404	private	C0033173
27515404	reason for choice	C0008300
27515404	health services	C0018747
27515404	issues	C0744349
27515404	described	C1552738
27515404	stratified	C0205363
27515404	patient characteristics	C0815172
27515404	provider type	C2706153
27515404	rural/urban settings	C0017446
27515404	average number	C0449788
27515404	PHC	C0033137
27515404	consultations	C0009818
27515404	increased	C0205217
27515404	person	C0027361
27515404	year	C0439234
27515404	multivariate models	C0026336
27515404	family medicine	C0015607
27515404	introduction	C1293116
27515404	associated with	C0332281
27515404	increase	C0442805
27515404	PHC	C0033137
27515404	consultations	C0009818
27515404	person	C0027361
27515404	slower	C0439834
27515404	annual growth	C2911660
27515404	PHC	C0033137
27515404	secondary care	C3494402
27515404	consultations	C0009818
27515404	family medicine	C0015607
27515404	introduction	C1293116
27515404	growth	C2911660
27515404	PHC	C0033137
27515404	secondary care	C3494402
27515404	consultations	C0009818
27515404	person	C0027361
27515404	year	C0439234
27515404	PHC	C0033137
27515404	increased	C0205217
27515404	provider	C2706153
27515404	years	C0439234
27515404	proximity	C1514583
27515404	service satisfaction	C3650764
27515404	increased	C0205217
27515404	Reporting	C0700287
27515404	poor facility hygiene	C0745076
27515404	difficulty getting an appointment	C1822076
27515404	poor	C2700379
27515404	physician	C0031831
27515404	behaviour	C0004927
27515404	high	C0205250
27515404	costs of health care	C0085552
27515404	declined	C1511741
27515404	PHC	C0033137
27515404	settings	C0017446
27515404	higher	C0205250
27515404	urban	C2700386
27515404	low-income	C1331016
27515404	working-age	C0001779
27515404	populations	C1257890
27515772	Laparoscopic	C0031150
27515772	radical lymph node dissection	C0193854
27515772	advanced colon cancer	C4016406
27515772	hepatic flexure	C0227385
27515772	Complete mesocolic excision	C0728940
27515772	standard procedure	C0184661
27515772	colon cancer	C0699790
27515772	Gastroepiploic	C0447070
27515772	infrapyloric	C0229779
27515772	superficial pancreatic head lymph node	C0229783
27515772	metastases	C0024232
27515772	gastrocolic ligament	C0230229
27515772	colon cancer	C0699790
27515772	hepatic flexure	C0227385
27515772	metastases	C0024232
27515772	gastrocolic ligament	C0230229
27515772	colon cancer	C0699790
27515772	hepatic flexure	C0227385
27515772	single-center retrospective study	C0035363
27515772	patients	C0030705
27515772	T2	C0475373
27515772	invasive	C0205281
27515772	colon cancer	C0699790
27515772	tumor location	C3897292
27515772	laparoscopic right hemicolectomy	C0585464
27515772	extended right hemicolectomy	C0400043
27515772	institution	C0018704
27515772	April	C3715024
27515772	March	C3829202
27515772	Lymph node dissection	C0242382
27515772	gastrocolic ligament	C0230229
27515772	Complications	C0009566
27515772	patients	C0030705
27515772	Clavien-Dindo classification	C4055231
27515772	Lymph node metastases	C0024232
27515772	gastrocolic ligament	C0230229
27515772	patients	C0030705
27515772	metastasis	C0024232
27515772	mm	C0439200
27515772	Metastases	C0024232
27515772	gastrocolic ligament	C0230229
27515772	patients	C0030705
27515772	T2	C0475373
27515772	invasive	C0205281
27515772	colon cancer	C0699790
27515772	hepatic flexure	C0227385
27515772	Laparoscopy	C1883297
27515772	gastrocolic ligament resection	C0728940
27515772	study	C2603343
27515772	sample	C0370003
27515772	extended	C0231449
27515772	follow-up	C1522577
27515772	studies	C2603343
27515772	clinical relevance	C2347946
27515772	finding	C0243095
27515772	recurrence	C0034897
27515772	long-term	C0443252
27515772	survival	C0038952
27516747	Smartphone	C3204335
27516747	Psychotherapeutic	C0033968
27516747	Micro-Interventions	C0184661
27516747	Mood	C0026516
27516747	Real-World Setting	C1254367
27516747	mobile	C1136360
27516747	communication technology	C0681426
27516747	approach	C0449445
27516747	treat	C0087111
27516747	mental disorders	C0004936
27516747	quality of life	C0034380
27516747	Knowledge	C0376554
27516747	intervention	C0184661
27516747	components	C0449432
27516747	psychopathological	C0033927
27516747	processes	C1522240
27516747	psychotherapy	C0033968
27516747	approaches	C0449445
27516747	smartphone	C3204335
27516747	micro-interventions	C0184661
27516747	psychotherapeutic techniques	C0237915
27516747	video-clips	C3463807
27516747	mood changes	C0085633
27516747	neurofeedback	C2713543
27516747	study	C2603343
27516747	subjects	C0080105
27516747	neurofeedback	C2713543
27516747	condition	C0348080
27516747	daily	C0332173
27516747	smartphone	C3204335
27516747	micro-interventions	C0184661
27516747	days	C0439228
27516747	techniques	C0449851
27516747	viscerosensory	C0445254
27516747	attention	C0004268
27516747	emotional	C0849912
27516747	imagery	C0175631
27516747	facial expression	C0015457
27516747	contemplative	C1277196
27516747	repetition	C0205341
27516747	Changes	C0392747
27516747	mood	C0026516
27516747	Multidimensional Mood State Questionnaire	C0451394
27516747	good	C0205170
27516747	bad	C0205169
27516747	awake	C0234422
27516747	tired	C0557875
27516747	calm	C0522165
27516747	nervous	C0027769
27516747	men	C0025266
27516747	days	C0439228
27516747	analyses	C0936012
27516747	micro-intervention sessions	C0679644
27516747	viscerosensory	C0445254
27516747	attention	C0004268
27516747	sessions	C0679644
27516747	contemplative	C1277196
27516747	repetition	C0205341
27516747	sessions	C0679644
27516747	techniques	C0449851
27516747	models	C3161035
27516747	subjects	C0080105
27516747	mood	C0026516
27516747	confidence interval	C0009667
27516747	CI	C0009667
27516747	awake	C0234422
27516747	CI	C0009667
27516747	calmer	C0522165
27516747	CI	C0009667
27516747	pre	C1254367
27516747	post-micro-intervention	C1254367
27516747	mood	C0026516
27516747	improvements	C2986411
27516747	pre	C1254367
27516747	post-micro-intervention	C1254367
27516747	changes in mood	C0085633
27516747	day	C0439228
27516747	day	C0439228
27516747	GB mood	C0026516
27516747	CI	C0009667
27516747	AT mood	C0026516
27516747	CI	C0009667
27516747	CN mood	C0026516
27516747	CI	C0009667
27516747	findings	C0243095
27516747	smartphone	C3204335
27516747	micro-interventions	C0184661
27516747	short-term	C0443303
27516747	mood changes	C0085633
27516747	techniques	C0449851
27516747	psychotherapeutic	C0033968
27516747	approaches	C0449445
27516747	mindfulness	C3542996
27516747	psychotherapy	C0033968
27516747	transcendental meditation	C0150814
27516747	contemplative	C1277196
27516747	therapies	C0087111
27516747	techniques	C0449851
27516747	capability	C2698977
27516747	mood	C0026516
27516747	controlled studies	C0681867
27516747	patients	C0030705
27516747	Smartphone	C3204335
27516747	micro-interventions	C0184661
27516747	mood	C0026516
27516747	real-world settings	C1254367
27516747	psychotherapeutic interventions	C0582386
27516747	precision	C1547902
27516747	medicine approach	C0679624
27516747	data	C1511726
27516747	randomized trial	C0206034
27518527	Primary	C0205225
27518527	pituitary	C0032005
27518527	diffuse large B-cell lymphoma	C0079744
27518527	somatotroph hyperplasia	C0342369
27518527	acromegaly	C0001206
27518527	case report	C0085973
27518527	Diffuse large B-cell lymphoma	C0079744
27518527	DLBCL	C0079744
27518527	common	C0205214
27518527	type	C0332307
27518527	non-Hodgkin lymphoma	C0024305
27518527	lymphomas	C0024299
27518527	Patients	C0030705
27518527	present	C0150312
27518527	nonpainful	C0234226
27518527	mass	C0577559
27518527	neck	C0027530
27518527	groin	C0018246
27518527	abdomen	C0000726
27518527	associated with	C0332281
27518527	constitutional symptoms	C0009812
27518527	report	C0684224
27518527	authors	C3812881
27518527	rare	C0522498
27518527	case	C0868928
27518527	year	C1510829
27518527	woman	C0043210
27518527	hyperprolactinemia	C0020514
27518527	hypothyroidism	C0020676
27518527	acromegaly	C0001206
27518527	elevation	C0205250
27518527	insulin-like growth factor-1	C0021665
27518527	IGF-1	C0021665
27518527	elevated	C0205250
27518527	growth hormone-releasing hormone	C0037668
27518527	GHRH	C0037668
27518527	MRI	C0024485
27518527	demonstrated	C0443289
27518527	diffuse enlargement of the pituitary gland	C0877018
27518527	medical treatment	C0418981
27518527	patient	C0030705
27518527	persistent	C0205322
27518527	elevation	C0205250
27518527	IGF-1	C0021665
27518527	transsphenoidal biopsy	C0176118
27518527	yielded	C1999230
27518527	diagnosis	C0011900
27518527	DLBCL	C0079744
27518527	activated	C1879547
27518527	B-cell	C0004561
27518527	immunophenotype	C0079611
27518527	somatotroph hyperplasia	C0342369
27518527	stereo-tactic radiation therapy	C3896609
27518527	combination	C0205195
27518527	chemotherapy	C3665472
27518527	currently	C0521116
27518527	remission	C0687702
27518527	lymphoma	C0024299
27518527	normalized	C1882115
27518527	IGF-1	C0021665
27518527	levels	C0441889
27518527	medical therapy	C0418981
27518527	months	C0439231
27518527	histopathological	C0243140
27518527	diagnosis	C0011900
27518527	reported	C0684224
27518527	case	C0868928
27518527	differential diagnosis	C0011906
27518527	multidisciplinary evaluation	C0729737
27518527	critical	C1511545
27518527	intraoperative	C0456904
27518527	decision-making	C0011109
27518527	treating	C1522326
27518527	sellar	C0036609
27518527	lesions	C0221198
27524208	Doctor	C0031831
27524208	Competence	C0086035
27524208	Demand	C0441516
27524208	Healthcare	C0086388
27524208	Evidence	C3887511
27524208	Rural China	C0008115
27524208	agency	C0237463
27524208	problem	C0033213
27524208	patients	C0030705
27524208	doctors	C0031831
27524208	health economics literature	C0023866
27524208	empirical	C1880496
27524208	evidence	C3887511
27524208	patients	C0030705
27524208	evaluate	C1516048
27524208	better	C0332272
27524208	quality care	C0034379
27524208	mixed	C0205430
27524208	inconclusive	C1629507
27524208	household	C0020052
27524208	data	C1511726
27524208	assessment	C1516048
27524208	village	C0562518
27524208	doctors'	C0031831
27524208	clinical competence	C0008956
27524208	rural China	C0008115
27524208	no correlation	C0205556
27524208	doctor	C0031831
27524208	competence	C0086035
27524208	patients'	C0030705
27524208	healthcare	C0086388
27524208	utilisation	C0042153
27524208	confidence intervals	C0009667
27524208	Household	C0020052
27524208	perceptions	C0030971
27524208	quality	C0332306
27524208	important	C3898777
27524208	determinant	C1521761
27524208	care-seeking behaviour	C0018695
27524208	patients	C0030705
27524208	appear	C0700364
27524208	unable	C1299582
27524208	recognise	C0205396
27524208	competent	C0086035
27524208	doctors	C0031831
27524208	relationship	C0439849
27524208	doctor	C0031831
27524208	competence	C0086035
27524208	perceptions	C0030971
27524208	quality	C0332306
27524790	Unintentional	C1283932
27524790	insecticide poisoning	C0413048
27524790	age	C0001779
27524790	analysis	C0936012
27524790	calls	C0302186
27524790	Data	C1511726
27524790	assessed	C1516048
27524790	determine	C0205258
27524790	mechanisms	C0441712
27524790	insecticide poisoning	C0413048
27524790	young children	C0728836
27524790	<5 years	C0439234
27524790	age	C0001779
27524790	affects	C0001721
27524790	insecticide-poisoning	C0413048
27524790	patterns	C0449774
27524790	Records	C0034869
27524790	insecticide-related calls	C0302186
27524790	obtained	C1301820
27524790	stratified	C0205363
27524790	analysis	C0936012
27524790	call	C0302186
27524790	patterns	C0449774
27524790	age	C0001779
27524790	conducted	C0205245
27524790	insecticide-related calls	C0302186
27524790	received by	C1709850
27524790	young children	C0728836
27524790	calls	C0302186
27524790	peaked	C0444505
27524790	children	C0008059
27524790	aged one	C4082117
27524790	Ant	C0003455
27524790	cockroach	C0009208
27524790	baits	C1254354
27524790	accounted	C0392762
27524790	calls	C0302186
27524790	Sprays	C1154182
27524790	found	C0150312
27524790	pyrethroids	C0597329
27524790	pyrethrins	C0034245
27524790	piperonly butoxide	C0031962
27524790	organophosphate diazinon	C0012013
27524790	accounted	C0392762
27524790	calls	C0302186
27524790	Mouthing	C2584309
27524790	ingesting	C0232478
27524790	pest-control product	C0031253
27524790	consuming	C0441655
27524790	treatment	C0039798
27524790	mechanisms	C0441712
27524790	children	C0008059
27524790	age of two	C0439234
27524790	Topical	C0332237
27524790	exposure to	C0332157
27524790	sprays	C1154182
27524790	direct	C1947931
27524790	application	C1524063
27524790	child	C0008059
27524790	older sibling	C0337511
27524790	peaked	C0444505
27524790	children	C0008059
27524790	aged two	C0439234
27524790	calls	C0302186
27524790	medical attention	C0948564
27524790	child	C0008059
27524790	sought	C0743213
27524790	advised by	C0418832
27524790	Normal behaviours	C0004927
27524790	associated with	C0332281
27524790	child development	C0008071
27524790	mouthing	C2584309
27524790	behaviours	C0004927
27524790	peak of exposure	C0332157
27524790	one-year	C4082117
27524790	olds	C0008059
27524790	finding	C0243095
27524790	strategies	C0679199
27524790	minimise	C1524031
27524790	poisonings	C0032343
27524790	vulnerable population	C0949366
27525173	Synthetic	C0597550
27525173	Oligonucleotide	C0028953
27525173	Mir31	C2607480
27525173	Duchenne Muscular Dystrophy	C0013264
27525173	Exon-skipping	C0035687
27525173	synthetic	C0597550
27525173	antisense oligonucleotides	C0079925
27525173	therapies	C0087111
27525173	Duchenne muscular dystrophy	C0013264
27525173	DMD	C0013264
27525173	sequence-specific	C1624609
27525173	oligonucleotide	C0028953
27525173	patients	C0030705
27525173	discovery	C1880355
27525173	dystrophin	C0079259
27525173	mRNA	C0035696
27525173	translational suppression	C1519619
27525173	microRNA	C1101610
27525173	miR31	C2607480
27525173	miR31	C2607480
27525173	muscle	C0026845
27525173	DMD	C0013264
27525173	patients	C0030705
27525173	oligonucleotide	C0028953
27525173	exon skipping	C0035687
27525173	translational block	C1519619
27525173	synergistically	C2986495
27525173	exon skipping	C0035687
27525173	3'UTR	C0600600
27525173	DMD	C0013264
27525173	patients	C0030705
27525173	in-frame	C0080089
27525173	transcript	C1519595
27525173	investigations	C1261322
27525173	exon skipping	C0035687
27525173	miR31	C2607480
27525173	modulation	C0678672
27525173	in vitro	C3850137
27525173	models	C0026339
27525173	mdx mouse	C0206535
27525173	animal model	C0599779
27525173	DMD	C0013264
27525173	monitoring	C1283169
27525173	effects	C1280500
27525173	dystrophin	C0079259
27525173	transcriptional	C0040649
27525173	translational	C1519614
27525173	cell culture	C0007585
27525173	model	C0026339
27525173	in vivo	C1515655
27525173	data	C1511726
27525173	enhancement	C2349975
27525173	dystrophin	C0079259
27525173	translation	C1519614
27525173	miR31	C2607480
27525173	modulation	C0678672
27525173	oligonucleotide	C0028953
27525173	outcome	C0085415
27525173	investigations	C1261322
27525549	Undisclosed	C0439673
27525549	HIV infection	C0019693
27525549	art	C1963724
27525549	use	C0457083
27525549	kenya AIDS indicator survey 2012	C0038951
27525549	relevance	C2347946
27525549	targets	C1521840
27525549	HIV diagnosis	C0920550
27525549	treatment	C0087111
27525549	kenya	C0022558
27525549	assess	C0184514
27525549	impact	C4049986
27525549	undisclosed	C0439673
27525549	HIV infection	C0019693
27525549	antiretroviral (ARV) therapy	C1963724
27525549	ART	C1963724
27525549	national	C0681788
27525549	estimates	C0750572
27525549	diagnosed HIV	C2186509
27525549	ART	C1963724
27525549	coverage	C1999244
27525549	Kenya	C0022558
27525549	HIV-positive	C2186509
27525549	dried blood spot samples	C0178913
27525549	Kenya's second AIDS Indicator Survey	C0038951
27525549	tested	C0039593
27525549	ARV	C1979629
27525549	biomarker	C0005516
27525549	liquid chromatography-tandem mass spectrometry	C4049918
27525549	Estimates	C0750572
27525549	diagnosed HIV	C2186509
27525549	ART	C1963724
27525549	use	C0457083
27525549	self-report	C2700446
27525549	compared	C1707455
27525549	undisclosed	C0439673
27525549	HIV infection	C0019693
27525549	ART	C1963724
27525549	use	C0457083
27525549	ARV	C1979629
27525549	Multivariate analysis	C0026777
27525549	determined	C0521095
27525549	factors	C1521761
27525549	associated with	C0332281
27525549	undisclosed	C0439673
27525549	HIV infection	C0019693
27525549	ART	C1963724
27525549	use	C0457083
27525549	persons	C0027361
27525549	ART	C1963724
27525549	HIV-positive	C2186509
27525549	samples	C0178913
27525549	ARV	C1979629
27525549	biomarker	C0005516
27525549	detected	C0442726
27525549	ARV drugs	C0599685
27525549	reporting HIV-positive	C2186509
27525549	receiving	C1514756
27525549	ART	C1963724
27525549	reporting HIV-positive	C2186509
27525549	ART	C1963724
27525549	use	C0457083
27525549	reporting	C0700287
27525549	HIV-negative status	C0854048
27525549	reporting	C0700287
27525549	no	C1513916
27525549	previous	C0205156
27525549	HIV test	C1321876
27525549	undisclosed	C0439673
27525549	HIV infection	C0019693
27525549	ART	C1963724
27525549	use	C0457083
27525549	diagnosed HIV	C2186509
27525549	increased	C0205217
27525549	ART	C1963724
27525549	coverage	C1999244
27525549	increased	C0205217
27525549	Undisclosed	C0439673
27525549	HIV infection	C0019693
27525549	ART	C1963724
27525549	associated with	C0332281
27525549	aged	C0001792
27525549	health provider	C0018724
27525549	younger age	C4061789
27525549	higher wealth	C0699759
27525549	associated with	C0332281
27525549	undisclosed	C0439673
27525549	ART	C1963724
27525549	use	C0457083
27525549	Substantial	C0750502
27525549	levels	C0441889
27525549	undisclosed	C0439673
27525549	HIV infection	C0019693
27525549	ART	C1963724
27525549	use	C0457083
27525549	ART	C1963724
27525549	observed	C1441672
27525549	resulting in	C0332294
27525549	diagnosed HIV	C2186509
27525549	persons	C0027361
27525549	ART	C1963724
27525549	coverage	C1999244
27525549	persons	C0027361
27525549	self-reported	C2700446
27525549	ART	C1963724
27525549	status	C0449438
27525549	objective measures	C0870410
27525549	ART	C1963724
27525549	use	C0457083
27525549	national	C0681788
27525549	population	C1257890
27525549	sero-surveys	C0019700
27525549	improve	C0184511
27525549	monitoring	C1283169
27525549	treatment	C0087111
27525549	targets	C1521840
27525549	countries	C0454664
27526663	control	C0243148
27526663	function	C0542341
27526663	Arabidopsis	C0162741
27526663	ProDH1	C1418945
27526663	ProDH2 genes	C1424903
27526663	infection	C3714514
27526663	biotrophic	C0243095
27526663	necrotrophic	C0243095
27526663	pathogens	C0450254
27526663	Arabidopsis	C0162741
27526663	proline dehydrogenase (ProDH) genes	C1418945
27526663	ProDH1	C1418945
27526663	ProDH2	C1424903
27526663	encoding	C2700640
27526663	homologous	C1512488
27526663	functional	C0205245
27526663	isoenzymes	C0022173
27526663	ProDH1	C1418945
27526663	abiotic stress	C0449430
27526663	ProDH2	C1424903
27526663	years	C0439234
27526663	genes	C0017337
27526663	expression	C0017262
27526663	patterns	C0449774
27526663	weak	C1762617
27526663	transcriptional co-regulation	C1158770
27526663	activated	C1879547
27526663	pathogen	C0450254
27526663	infected	C0439663
27526663	tissues	C0040300
27526663	Arabidopsis plants	C0162741
27526663	silenced	C0598496
27526663	ProDH1	C1418945
27526663	2	C1424903
27526663	expression	C0017262
27526663	fail	C0231175
27526663	defences	C1154988
27526663	hemibiotrophic	C0243095
27526663	bacterial	C0004611
27526663	pathogen	C0450254
27526663	Pseudomonas syringae pv. tomato AvrRpm1	C0317966
27526663	Pst-AvrRpm1	C0317966
27526663	ProDH1	C1418945
27526663	ProDH2	C1424903
27526663	regulated	C0851285
27526663	salicylic acid	C0036079
27526663	SA	C0036079
27526663	prodh1	C0162741
27526663	prodh2	C0162741
27526663	mutant	C0596988
27526663	plants	C0032098
27526663	gene	C0017337
27526663	resistance	C4281815
27526663	Pst-AvrRpm1	C0317966
27526663	necrotrophic	C0243095
27526663	fungal pathogen	C3826297
27526663	Botrytis cinerea	C0579190
27526663	sensitivity	C0332324
27526663	ProDH1	C1418945
27526663	ProDH2	C1424903
27526663	jasmonic acid	C0064138
27526663	JA	C0064138
27526663	defence	C1154988
27526663	pathway	C1704259
27526663	ProDH1	C3657000
27526663	ProDH2	C3657000
27526663	resistance	C4281815
27526663	Pst-AvrRpm1	C0317966
27526663	B. cinerea	C0579190
27526663	ProDH2	C3657000
27526663	restriction	C0443288
27526663	B. cinerea	C0579190
27526663	growth	C0018270
27526663	ProDH1	C1418945
27526663	up-regulated	C0041904
27526663	SA	C0036079
27526663	JA	C0064138
27526663	ProDH2	C1424903
27526663	activated	C1879547
27526663	JA	C0064138
27526663	genes	C0017337
27526663	transcriptional inter-regulation	C1158770
27526663	basal	C0205112
27526663	infection	C3714514
27526663	conditions	C0348080
27526663	ProDH2	C1424903
27526663	disease resistance	C1136180
27526663	regulation	C0851285
27526663	complementary function	C0542341
27526663	enzyme isoforms	C0022173
27526663	infected	C0439663
27526663	tissues	C0040300
27526663	ProDH	C1418945
27526663	biotrophic	C0243095
27526663	necrotrophic	C0243095
27526663	pathogens	C0450254
27529135	Effect	C1280500
27529135	Protein	C0033684
27529135	Repetitiveness	C0205341
27529135	Protein-Protein Interaction	C0872079
27529135	Prediction	C0681842
27529135	Results	C1274040
27529135	Support Vector Machines	C2699740
27529135	computational approaches	C1516769
27529135	protein-protein interactions	C0872079
27529135	support vector machines	C2699740
27529135	SVMs	C2699740
27529135	methods	C0025663
27529135	repetitiveness	C0205341
27529135	datasets	C0150098
27529135	study	C2603343
27529135	repetitiveness	C0205341
27529135	datasets	C0150098
27529135	predicting	C0681842
27529135	results	C1274040
27529135	methods	C0025663
27529135	positive	C1446409
27529135	datasets	C0150098
27529135	proteins	C0033684
27529135	graph	C0681493
27529135	protein-protein interaction	C0872079
27529135	datasets	C0150098
27529135	negative	C0205160
27529135	datasets	C0150098
27529135	proteins	C0033684
27529135	repetitiveness	C0205341
27529135	graph	C0681493
27529135	adjacency matrix	C1879629
27529135	relationship	C0439849
27529135	SVM	C2699740
27529135	prediction	C0681842
27529135	results	C1274040
27529135	repeated	C0205341
27529135	proteins	C0033684
27529135	distributions	C1704711
27529135	repeated	C0205341
27529135	proteins	C0033684
27529135	datasets	C0150098
27529135	Protein	C0033684
27529135	repetitiveness	C0205341
27529135	positive	C1446409
27529135	negative	C0205160
27529135	datasets	C0150098
27529135	prediction	C0681842
27529135	result	C1274040
27529135	protein	C0033684
27529135	repetitiveness	C0205341
27529135	positive	C1446409
27529135	negative	C0205160
27529135	datasets	C0150098
27529135	result	C1274040
27529135	repetitiveness	C0205341
27529135	datasets	C0150098
27529135	protein-protein interactions	C0872079
27529135	prediction	C0681842
27529135	SVMs	C2699740
27529135	data	C1511726
27529135	repeat	C0205341
27529135	proteins	C0033684
27530053	sense of number	C0596887
27530053	sense of	C0424215
27530053	magnitude	C1704240
27530053	continuous	C0549178
27530053	magnitudes	C1704240
27530053	numerical	C0237753
27530053	cognition	C0009240
27530053	pitting	C0205323
27530053	theories	C0871935
27530053	theory	C0871935
27530053	number sense	C0596887
27530053	theory	C0871935
27530053	sense of number	C0596887
27530053	innate	C0021619
27530053	non-symbolic numerosity	C0871836
27530053	continuous	C0549178
27530053	magnitudes	C1704240
27530053	size	C0456389
27530053	area	C0205146
27530053	density	C0178587
27530053	theory	C0871935
27530053	numerosities	C0871836
27530053	continuous	C0549178
27530053	magnitudes	C1704240
27530053	numerosities	C0871836
27530053	sense of number	C0596887
27530053	innate	C0021619
27530053	number sense	C0596887
27530053	theory	C0871935
27530053	correlation	C1707520
27530053	numerosities	C0871836
27530053	continuous	C0549178
27530053	magnitudes	C1704240
27530053	non-symbolic numerosity processing	C0871836
27530053	continuous	C0549178
27530053	magnitudes	C1704240
27530053	behavioral	C0004939
27530053	imaging studies	C1881134
27530053	infants	C0021270
27530053	adults	C0001675
27530053	animals	C0003062
27530053	continuous	C0549178
27530053	magnitudes	C1704240
27530053	sense of	C0424215
27530053	magnitude	C1704240
27530053	theory	C0871935
27530053	theory	C0871935
27530053	continuous	C0549178
27530053	magnitudes	C1704240
27530053	numerosities	C0871836
27530053	number sense	C0596887
27530053	theory	C0871935
27530053	theory	C0871935
27530053	number sense	C0596887
27530053	innate	C0021619
27530053	hypothesis	C1512571
27530053	correlation	C1707520
27530053	numerosity	C0871836
27530053	continuous	C0549178
27530053	magnitudes	C1704240
27532007	Integrated Management Strategies	C0022885
27532007	Promote	C0033414
27532007	Protein	C0033684
27532007	Quality	C0332306
27532007	Cotton Embryos	C0010197
27532007	High	C0205250
27532007	Levels	C0441889
27532007	Soil	C0037592
27532007	Available	C0470187
27532007	N	C0028158
27532007	N	C0028158
27532007	Assimilation	C1254365
27532007	Protein	C0033684
27532007	Accumulation	C4055506
27532007	Rate	C1521828
27532007	Cottonseed	C0010197
27532007	source	C0449416
27532007	ruminant	C0035950
27532007	feed	C0003050
27532007	industrial	C0021267
27532007	purposes	C1285529
27532007	improve	C0184511
27532007	nutritional value	C0028722
27532007	cotton embryos	C0010197
27532007	study	C2603343
27532007	conventional management	C0022885
27532007	CM	C0022885
27532007	cotton	C0010197
27532007	management strategies	C0022885
27532007	IMS1	C0022885
27532007	IMS2	C0022885
27532007	performed	C0884358
27532007	soil	C0037592
27532007	fertility	C0243095
27532007	levels	C0441889
27532007	study	C2603343
27532007	relationships	C0439849
27532007	soil	C0037592
27532007	N	C0028158
27532007	N	C0028158
27532007	assimilation	C1254365
27532007	embryonic	C0036563
27532007	protein	C0033684
27532007	accumulation	C4055506
27532007	protein	C0033684
27532007	quality	C0332306
27532007	levels of proteins	C0202202
27532007	essential amino acids	C0201874
27532007	semi-essential amino acids	C0201874
27532007	glutamate	C0523665
27532007	lysine	C0523760
27532007	methionine	C0428210
27532007	higher	C0205250
27532007	IMS1	C0022885
27532007	IMS2	C0022885
27532007	embryos	C0036563
27532007	CM	C0022885
27532007	embryos	C0036563
27532007	changes	C0392747
27532007	positively	C1446409
27532007	correlated	C1707520
27532007	soil	C0037592
27532007	available	C0470187
27532007	N content	C0523793
27532007	glutamine synthetase activity	C1150667
27532007	peak	C0444505
27532007	protein	C0033684
27532007	accumulation	C4055506
27532007	rate	C1521828
27532007	negatively	C1513916
27532007	correlated	C1707520
27532007	free	C1996904
27532007	amino acid level	C1328436
27532007	results	C0683954
27532007	integrated management strategies	C0022885
27532007	rates	C1521828
27532007	timing	C0449243
27532007	N	C0028158
27532007	application	C4048755
27532007	raise	C0442805
27532007	level	C0441889
27532007	soil	C0037592
27532007	available	C0470187
27532007	N	C0028158
27532007	N	C0028158
27532007	assimilation	C1254365
27532007	cotton embryos	C0010197
27532007	protein content	C0202202
27532007	limited	C0439801
27532007	rate	C1521828
27532007	protein	C0033684
27532007	accumulation	C4055506
27532007	free	C1996904
27532007	amino acid content	C0201874
27532007	combination	C0205195
27532007	target yield	C0392762
27532007	fertilization	C1254365
27532007	growth	C0597252
27532007	N	C0028158
27532007	application	C4048755
27532007	high	C0205250
27532007	plant	C0032098
27532007	density	C0178587
27532007	seedling	C0242437
27532007	bio-organic fertilizer	C1289928
27532007	improve	C0184511
27532007	protein	C0033684
27532007	quality	C0332306
27532007	cotton embryos	C0010197
27532007	soil	C0037592
27532007	soil	C0037592
27532007	organic matter	C0029224
27532007	total	C0439810
27532007	nitrogen	C0028158
27533401	HIV	C0019682
27533401	epidemic	C0014499
27533401	public consultation	C0886172
27533401	HIV prevention	C0150413
27533401	tool	C0282574
27533401	PrEP	C3850098
27533401	pre-exposure prophylaxis	C3850098
27533401	HIV	C0019682
27533401	epidemic	C0014499
27533401	NHS England consultation	C1254363
27533401	September	C3828193
27534399	Osseointegration	C0079949
27534399	novel	C0205314
27534399	Ti-Nb-Zr-Ta-Si alloy	C0011323
27534399	dental implants	C0011373
27534399	in vivo	C1515655
27534399	study	C2603343
27534399	evaluate	C0220825
27534399	effects of	C1704420
27534399	Ti-Nb-Zr-Ta-Si alloy	C0011323
27534399	implants	C0011373
27534399	mineral apposition rate	C1521828
27534399	BIC contact	C0392762
27534399	rabbits	C3887509
27534399	Ti-Nb-Zr-Ta-Si alloy	C0011323
27534399	implants	C0011373
27534399	fabricated	C0205245
27534399	placed	C1533810
27534399	right	C0444532
27534399	femur	C0015811
27534399	sites	C1515974
27534399	rabbits	C3887509
27534399	titanium	C0040302
27534399	implants	C0011373
27534399	controls	C0009932
27534399	left	C0443246
27534399	femur	C0015811
27534399	Tetracycline	C0039644
27534399	alizarin red	C0051165
27534399	weeks	C0439230
27534399	week	C0439230
27534399	euthanization	C1136183
27534399	weeks	C0439230
27534399	weeks	C0439230
27534399	implantation	C0011370
27534399	animals	C0003062
27534399	euthanized	C3686530
27534399	Surface	C0205148
27534399	characterization	C1880022
27534399	implant-bone contact	C0392762
27534399	surface	C0205148
27534399	analysis	C0936012
27534399	performed	C0884358
27534399	scanning electron microscope	C0262878
27534399	energy dispersive X-ray detector	C0025080
27534399	Mineral apposition rate	C1521828
27534399	evaluated	C0220825
27534399	confocal laser scanning microscope	C0242841
27534399	Toluidine blue staining	C0523203
27534399	performed	C0884358
27534399	undecalcified	C0243095
27534399	sections	C1522472
27534399	histology	C0019638
27534399	histomorphology	C0332437
27534399	Scanning electron microscope	C0262878
27534399	histomorphology	C0332437
27534399	observation	C1554188
27534399	revealed	C0443289
27534399	direct contact	C0332158
27534399	implants	C0011373
27534399	bone	C0262950
27534399	groups	C0441833
27534399	healing	C0043240
27534399	period	C1948053
27534399	weeks	C0439230
27534399	Ti-Nb-Zr-Ta-Si alloy	C0011323
27534399	implants	C0011373
27534399	mineral apposition rate	C1521828
27534399	titanium	C0040302
27534399	implants	C0011373
27534399	no significant	C1273937
27534399	Ti-Nb-Zr-Ta-Si alloy	C0011323
27534399	implants	C0011373
27534399	titanium	C0040302
27534399	implants	C0011373
27534399	weeks	C0439230
27534399	No significant	C1273937
27534399	bone-to-implant contact	C0392762
27534399	observed	C1441672
27534399	Ti-Nb-Zr-Ta-Si alloy	C0011323
27534399	implants	C0011373
27534399	titanium	C0040302
27534399	implants	C0011373
27534399	implants	C0011373
27534399	healing	C0043240
27534399	period	C1948053
27534399	weeks	C0439230
27534399	weeks	C0439230
27534399	Ti-Nb-Zr-Ta-Si alloy	C0011323
27534399	implants	C0011373
27534399	close direct contact	C0332158
27534399	titanium	C0040302
27534399	implants	C0011373
27534399	implants	C0011373
27534399	improved	C0184511
27534399	mineral matrix apposition rate	C1521828
27534399	alternative	C1523987
27534399	material	C0520510
27534399	dental implants	C0011373
27534734	Simultaneous	C0521115
27534734	edited	C1711200
27534734	MRS	C0024487
27534734	GABA	C0016904
27534734	glutathione	C0017817
27534734	Edited	C1711200
27534734	MRS	C0024487
27534734	detection	C1511790
27534734	low	C0205251
27534734	concentration	C1446561
27534734	metabolites	C0870883
27534734	signals	C1710082
27534734	not	C1518422
27534734	resolved	C2699488
27534734	MR spectrum	C0024487
27534734	Tailored acquisitions	C1706701
27534734	designed	C0920454
27534734	detect	C1511790
27534734	example	C1707959
27534734	inhibitory	C3463820
27534734	neurotransmitter	C0027908
27534734	γ-aminobutyric acid	C0016904
27534734	GABA	C0016904
27534734	reduction-oxidation	C0030012
27534734	redox	C0030012
27534734	glutathione	C0017817
27534734	GSH	C0017817
27534734	single	C0205171
27534734	voxel	C2700259
27534734	edited	C1711200
27534734	experiments	C0681814
27534734	rate	C1521828
27534734	one	C0205447
27534734	metabolite	C0870883
27534734	per-experiment	C0681814
27534734	simultaneous	C0521115
27534734	detection	C1511790
27534734	overlapping	C1948020
27534734	signals	C1710082
27534734	GABA	C0016904
27534734	GSH	C0017817
27534734	using	C1524063
27534734	Hadamard Encoding and Reconstruction of Mega-Edited Spectroscopy	C0022885
27534734	HERMES	C0022885
27534734	HERMES	C0022885
27534734	applies	C4048755
27534734	orthogonal editing encoding	C2700640
27534734	following	C0332282
27534734	Hadamard scheme	C1519193
27534734	GSH-	C0017817
27534734	GABA	C0016904
27534734	edited	C1711200
27534734	difference	C1705242
27534734	spectra	C2827424
27534734	single multiplexed experiment	C0681814
27534734	TE	C2826100
27534734	editing	C1711200
27534734	pulses	C1947910
27534734	applied	C4048755
27534734	GSH	C0017817
27534734	GABA	C0016904
27534734	both	C1706086
27534734	offsets	C1711330
27534734	dual-lobe cosine-modulated pulse	C1947910
27534734	Hadamard combinations	C0282574
27534734	sub-experiments	C0681814
27534734	GABA	C0016904
27534734	GSH	C0017817
27534734	difference	C1705242
27534734	spectra	C2827424
27534734	HERMES	C0022885
27534734	excellent	C1961136
27534734	separation	C0443299
27534734	edited	C1711200
27534734	GABA	C0016904
27534734	GSH	C0017817
27534734	signals	C1710082
27534734	phantoms	C0282611
27534734	edited	C1711200
27534734	lineshapes	C0348078
27534734	agree	C3641827
27534734	well	C0205170
27534734	separate	C0443299
27534734	Mescher-Garwood Point-resolved Spectroscopy	C0022885
27534734	MEGA-PRESS	C0022885
27534734	acquisitions	C1706701
27534734	In vivo	C1515655
27534734	quality	C0332306
27534734	signal-to-noise ratio	C2986823
27534734	SNR	C2986823
27534734	HERMES	C0022885
27534734	spectra	C2827424
27534734	similar	C2348205
27534734	sequentially	C1705294
27534734	acquired	C0439661
27534734	MEGA-PRESS	C0022885
27534734	spectra	C2827424
27534734	benefit	C0814225
27534734	acquisition	C1706701
27534734	time	C0040223
27535586	Chitosan	C0162969
27535586	poly(2-hydroxyethyl methacrylate)	C0032509
27535586	core-shell microgels	C0013161
27535586	drug delivery carriers	C0085104
27535586	salicylic acid	C0036079
27535586	loading and release	C0205245
27535586	chitosan	C0162969
27535586	poly(2-hydroxyethyl methacrylate)	C0032509
27535586	CS	C0162969
27535586	PHEMA	C0032509
27535586	core-shell microgels	C0013161
27535586	drug delivery carriers	C0085104
27535586	CS	C0162969
27535586	PHEMA	C0032509
27535586	microgels	C0013161
27535586	emulsifier-free emulsion polymerisation	C0314672
27535586	N,N '-methylenebisacrylamide	C0067314
27535586	MBA	C0067314
27535586	crosslinker	C0029224
27535586	study on drug loading	C0013175
27535586	salicylic acid	C0036079
27535586	SA	C0036079
27535586	model drug	C1254351
27535586	encapsulation efficiency	C2348438
27535586	EE	C2348438
27535586	drug	C1254351
27535586	ratio	C0456603
27535586	EE	C2348438
27535586	crosslinking	C1254366
27535586	MBA	C0067314
27535586	EE	C2348438
27535586	pH	C0020283
27535586	release of SA	C3850077
27535586	pH	C0020283
27535586	pH	C0020283
27535586	release of SA	C3850077
27535586	NaCl	C0037494
27535586	pH	C0020283
27535586	ionic-sensitivity	C0205556
27535586	CS	C0162969
27535586	PHEMA	C0032509
27535586	sustained release delivery device	C1135768
27535586	oral delivery	C0302620
27536475	Breast Augmentation	C0191925
27536475	Conservation Surgery	C0917927
27536475	Radiation Therapy	C1522449
27536475	patients	C0030705
27536475	breast augmentation	C0191925
27536475	implants	C0021102
27536475	breast conservation surgery	C0917927
27536475	BCS	C0917927
27536475	radiotherapy	C1522449
27536475	retrospective study	C0035363
27536475	patients	C0030705
27536475	breast implant	C0179412
27536475	augmentation	C0191925
27536475	BCS	C0917927
27536475	radiotherapy	C1522449
27536475	women	C0043210
27536475	prosthetic	C0179412
27536475	breast reconstruction	C0085076
27536475	patients	C0030705
27536475	augmentation	C0191925
27536475	BCS	C0917927
27536475	radiotherapy	C1522449
27536475	mean	C0444504
27536475	age	C0001779
27536475	years	C1510829
27536475	range	C1514721
27536475	years	C1510829
27536475	patients	C0030705
27536475	one-stage implant	C0021107
27536475	breast augmentation	C0191925
27536475	patients	C0030705
27536475	two-stage expander	C0021107
27536475	implant augmentation	C0191925
27536475	surgeries	C0543467
27536475	breast implant	C0179412
27536475	patients	C0030705
27536475	contralateral	C0441988
27536475	augmentation	C0191925
27536475	patient	C0030705
27536475	oral	C1527415
27536475	antibiotics	C0003232
27536475	wound infection	C0043241
27536475	Patients	C0030705
27536475	cosmetic	C1390444
27536475	result	C1274040
27536475	breasts	C0006141
27536475	patients	C0030705
27536475	breast cancer	C0006142
27536475	BCS	C0917927
27536475	radiotherapy	C1522449
27536475	augmented	C0205217
27536475	breast implants	C0179412
27538372	Mitochondrial pyruvate dehydrogenase phosphatase 1	C1418818
27538372	differentiation of cardiomyocytes	C1817118
27538372	mouse embryonic stem cells	C4042879
27538372	Mitochondria	C0026237
27538372	embryonic stem cells	C0596508
27538372	ESCs	C0596508
27538372	differentiation	C0007589
27538372	cell lineages	C0282637
27538372	cardiomyocytes	C0225828
27538372	mitochondrial regulators	C0574031
27538372	rate of differentiation	C1521828
27538372	cell fate	C1540661
27538372	mitochondrial factor	C0033684
27538372	differentiation of ESCs	C1514964
27538372	cardiac myocytes	C0225828
27538372	cardiomyocyte differentiation	C1817118
27538372	mouse ESCs	C4042879
27538372	mESCs	C4042879
27538372	microarray assays	C1449575
27538372	messenger RNA	C0035696
27538372	mRNA	C0035696
27538372	expression	C0040649
27538372	differentiation day 8	C0243095
27538372	D8	C0243095
27538372	undifferentiated	C0205618
27538372	mESCs	C4042879
27538372	expressed genes	C0017337
27538372	Pdp1	C1418818
27538372	expression	C0017262
27538372	D8	C0243095
27538372	D0	C0205618
27538372	suppressed	C1260953
27538372	mitochondrial	C0026237
27538372	indices	C0918012
27538372	ATP	C0001480
27538372	membrane potential	C1156295
27538372	ROS	C3894464
27538372	mitochondrial Ca(2+)	C1658623
27538372	Pdp1	C1418818
27538372	overexpression	C0017262
27538372	mitochondrial	C0026237
27538372	indices	C0918012
27538372	pyruvate dehydrogenase activity	C1151688
27538372	expression	C0040649
27538372	cardiac differentiation	C2247990
27538372	marker mRNA	C0872263
27538372	cardiac differentiation	C2247990
27538372	rate	C1521828
27538372	knockdown	C2350567
27538372	Pdp1 gene	C1418818
27538372	expression	C0040649
27538372	cardiac differentiation	C2247990
27538372	marker mRNA	C0872263
27538372	cardiac differentiation	C2247990
27538372	rate	C1521828
27538372	mitochondrial PDP1	C1418818
27538372	cardiac differentiation	C2247990
27538372	differentiation stage	C1254367
27538372	ESCs	C0596508
27539945	Thermo-reversible capture and release	C1254366
27539945	DNA	C0012854
27539945	zwitterionic surfactants	C0038891
27539945	thermo-reversible capture and release	C1254366
27539945	DNA	C0012854
27539945	protonation	C0178812
27539945	deprotonation	C0599225
27539945	alkyldimethylamine oxide	C0029224
27539945	CnDMAO	C0029224
27539945	Tris-HCl	C1254353
27539945	buffer solution	C3190981
27539945	DNA	C0012854
27539945	C14DMAO	C0029224
27539945	Tris-HCl	C1254353
27539945	buffer solution	C3190981
27539945	pH	C0020283
27539945	transparent	C0522503
27539945	DNA	C0012854
27539945	molecules	C0567416
27539945	individuals	C0237401
27539945	binding	C1167622
27539945	C14DMAO	C0029224
27539945	weak	C1762617
27539945	increase	C0442805
27539945	temperature	C0039476
27539945	pH	C0020283
27539945	buffer solution	C3190981
27539945	decreases	C0547047
27539945	protonation	C0178812
27539945	C14DMAO	C0029224
27539945	C14DMAO	C0029224
27539945	H(+)	C0033727
27539945	C14DMAOH(+)	C0029224
27539945	increase of the turbidity	C0301634
27539945	samples	C0439861
27539945	binding	C1167622
27539945	protonated	C0178812
27539945	C14DMAOH(+)	C0029224
27539945	DNA	C0012854
27539945	formation	C1522492
27539945	DNA	C0012854
27539945	C14DMAOH(+)	C0029224
27539945	complexes	C1704241
27539945	DNA	C0012854
27539945	molecules	C0567416
27539945	compacted	C1333134
27539945	UV-vis	C1883416
27539945	UV-vis absorptions	C0022885
27539945	circular dichroism	C0008813
27539945	CD	C0008813
27539945	measurements	C0242485
27539945	atomic force microscopy	C0242849
27539945	AFM	C0242849
27539945	observations	C0302523
27539945	dynamic light scattering	C1882368
27539945	DLS	C1882368
27539945	measurements	C0242485
27539945	agarose gel electrophoresis	C0013856
27539945	AGE	C0013856
27539945	temperature	C0039476
27539945	compacted	C1333134
27539945	DNA	C0012854
27539945	molecules	C0567416
27539945	cycle	C1511572
27539945	loss	C1517945
27539945	efficiency	C0013682
27539945	effect of	C1704420
27539945	chain length	C0596310
27539945	CnDMAO	C0029224
27539945	C14DMAO	C0029224
27539945	C12DMAO	C0029224
27539945	phenomena	C1882365
27539945	higher	C0205250
27539945	critical	C1511545
27539945	surfactant	C0038891
27539945	concentration	C1446561
27539945	DNA	C0012854
27539945	compaction	C1333134
27539945	lower	C0205251
27539945	pH	C0020283
27539945	Tris-HCl	C1254353
27539945	buffer solution	C3190981
27539945	pH	C0020283
27539945	DNA	C0012854
27539945	C10DMAO	C0029224
27539945	DNA	C0012854
27539945	compaction	C1333134
27539945	Tris-HCl	C1254353
27539945	buffer solution	C3190981
27539945	lower	C0205251
27539945	pH	C0020283
27539945	higher	C0205250
27539945	C10DMAO	C0029224
27539945	concentration	C1446561
27539945	negative charges	C2825491
27539945	DNA	C0012854
27539945	molecules	C0567416
27539945	positive charges	C2825490
27539945	cationic CnDMAOH(+)	C0029224
27539945	micelles	C0025938
27539945	DNA	C0012854
27539945	compacted	C1333134
27539945	DNA	C0012854
27539945	CnDMAOH(+)	C0029224
27539945	complexes	C1704241
27539945	higher	C0205250
27539945	critical	C1511545
27539945	micelle	C0025938
27539945	concentration	C1264643
27539945	cmc	C1264643
27539945	chain length	C0596310
27539945	C10DMAOH(+)	C0029224
27539945	cationic C10DMAOH(+)	C0029224
27539945	micelles	C0025938
27539945	compact	C1333134
27539945	DNA	C0012854
27539945	efficient	C0442799
27539945	alternative approach	C0679761
27539945	stimuli-responsive gene therapy	C0017296
27539945	drug release	C3850077
27540024	Collaborating	C0282116
27540024	Systems	C0449913
27540024	Change	C0392747
27540024	Social Science Framework	C0596159
27540024	Academic Roles	C0683838
27540024	Community Partnerships	C0680453
27540024	Environmental health	C0014413
27540024	researchers	C0035173
27540024	government agencies	C0018105
27540024	community groups	C0683986
27540024	community	C0009462
27540024	academic	C0683838
27540024	partnerships	C1711206
27540024	effective strategy	C0679199
27540024	support	C1521721
27540024	science	C0036397
27540024	improvements	C2986411
27540024	environmental health	C0014413
27540024	Social sciences	C0037434
27540024	concepts	C0178566
27540024	approaches	C1254370
27540024	methods	C0025663
27540024	translational partnerships	C1711206
27540024	appropriate	C1548787
27540024	roles	C0086939
27540024	academic	C0683838
27540024	partners	C3887537
27540024	process	C1522240
27540024	changing	C0392747
27540024	systems	C0449913
27540024	policies	C0242456
27540024	practices	C0033284
27540024	programs	C3484370
27540024	planning	C0086960
27540024	evaluating	C1550157
27540024	sustaining	C0443318
27540024	partnerships	C1711206
27540024	conceptual framework	C1254370
27540024	academic	C0683838
27540024	partners	C3887537
27540024	different stages	C1306673
27540024	systems	C0449913
27540024	change	C0392747
27540024	framework	C1254370
27540024	academic	C0683838
27540024	community	C0009462
27540024	partnerships	C1711206
27540024	National Institute of Environmental Health Sciences	C1955979
27540024	Community Outreach and Engagement Cores	C1522486
27540024	framework	C1254370
27540024	academic	C0683838
27540024	partners	C3887537
27540024	appropriate	C1548787
27540024	expertise	C0870520
27540024	community	C0009462
27540024	improve	C0184511
27540024	environmental health	C0014413
27540584	novel	C0205314
27540584	mechanical simulator	C0183309
27540584	cannulation	C0917707
27540584	sphincterotomy	C0748895
27540584	Billroth II	C0192444
27540584	Roux-en-Y reconstruction	C0372024
27540584	patients	C0030705
27540584	Billroth II	C0192444
27540584	B II	C0192444
27540584	Roux-en-Y	C0372024
27540584	anatomy	C0700276
27540584	endoscopic retrograde cholangiopancreatography	C0008310
27540584	ERCP	C0008310
27540584	novel	C0205314
27540584	simulator	C0183309
27540584	simulated	C0679083
27540584	fluoroscopy	C0016356
27540584	cannulation	C0917707
27540584	sphincterotomy	C0748895
27540584	training	C0220931
27540584	simulation system	C4075558
27540584	built	C1706853
27540584	common	C0205214
27540584	chassis	C1707356
27540584	series	C0205549
27540584	previously	C0205156
27540584	ERCP	C0008310
27540584	simulators	C0183309
27540584	papilla	C3714556
27540584	organic	C0747055
27540584	material	C0520510
27540584	cut	C1883724
27540584	high frequency	C0205212
27540584	current	C1705970
27540584	advancement	C1280477
27540584	guidewires	C1708264
27540584	instruments	C0348000
27540584	transparent	C0522503
27540584	bile ducts	C0005400
27540584	window	C1704674
27540584	simulator	C0183309
27540584	fluoroscopy	C0016356
27540584	ERCP	C0008310
27540584	B II	C0192444
27540584	Roux-en-Y	C0372024
27540584	simulation system	C4075558
27540584	evaluated	C0220825
27540584	ERCP	C0008310
27540584	course	C0750729
27540584	technical problems	C1710348
27540584	novel	C0205314
27540584	simulator	C0183309
27540584	course	C0750729
27540584	sphincterotomy	C0748895
27540584	organic	C0747055
27540584	papillae	C3714556
27540584	exchanged	C0205245
27540584	seconds	C0457385
27540584	novel	C0205314
27540584	B II	C0192444
27540584	Roux-en-Y	C0372024
27540584	simulator	C0183309
27540584	favorable	C3640814
27540584	results	C1274040
27540584	trainees	C1522486
27540584	expert	C1611835
27540584	endoscopists	C1522486
27540584	categories	C0683312
27540584	assessed	C1516048
27540584	B II	C0192444
27540584	Roux-en-Y	C0372024
27540584	mechanical simulator	C0183309
27540584	simple	C0205352
27540584	practicable	C0205556
27540584	evaluation	C0220825
27540584	ERCP	C0008310
27540584	course	C0750729
27540584	results	C1274040
27542380	thermophilic	C0597570
27542380	ene-reductase	C0030016
27542380	acidophilic	C0333931
27542380	iron oxidizer	C0004611
27542380	Ene-reductases	C0030016
27542380	extremophiles	C4277715
27542380	biocatalysis	C2350294
27542380	higher	C0205250
27542380	stability	C0205360
27542380	properties	C0871161
27542380	genome	C0017428
27542380	acidophilic	C0333931
27542380	iron-oxidizing bacterium	C0004611
27542380	Ferrovum" sp. JA12	C3908921
27542380	thermophilic	C0597570
27542380	ene-reductase	C0030016
27542380	FOYE-1	C0030016
27542380	foye-1 gene	C0017337
27542380	pET16bp	C0032136
27542380	expression	C0017262
27542380	vector system	C0017397
27542380	enzyme	C0014442
27542380	Escherichia coli	C0014834
27542380	BL21 (DE3; pLysS) cells	C0007634
27542380	FOYE-1	C0030016
27542380	activity	C0243102
27542380	rates	C1521828
27542380	N-phenylmaleimide	C0068268
27542380	N-phenyl-2-methylmaleimide	C0029224
27542380	conversion	C0439836
27542380	nicotinamide cofactors	C0009235
27542380	NADPH	C0027303
27542380	NADH	C0027289
27542380	catalytic	C0007382
27542380	efficiency	C0013682
27542380	NADPH	C0027303
27542380	higher	C0205250
27542380	NADH	C0027289
27542380	temperature	C0039476
27542380	maximum	C0806909
27542380	pH optimum	C0020283
27542380	activity	C0243102
27542380	doubled	C1705764
27542380	findings	C0243095
27542380	FOYE-1	C0030016
27542380	biocatalyst	C0175921
27542380	synthesis	C1883254
27542380	succinimides	C0038623
27542380	thermophilic	C0597570
27542380	ene-reductase	C0030016
27542380	acidic habitat	C0871648
27542380	genomic	C0017428
27542380	neighborhood	C0014406
27542380	encoding	C2700640
27542380	gene	C0017337
27542380	FOYE-1	C0030016
27542380	quorum-sensing	C1154599
27545500	tanshinone I	C0075810
27545500	derivative	C1527240
27545500	activities	C3714634
27545500	antibiotics	C0003232
27545500	Staphylococcus aureus	C0038172
27545500	in vitro	C1533691
27545500	in vivo	C1515655
27545500	Infections	C3714514
27545500	Staphylococcus aureus	C0038172
27545500	discovery	C1880355
27545500	antibiotics	C0003232
27545500	resistant bacteria	C1444090
27545500	health	C0018684
27545500	problem	C0033213
27545500	hospital	C0019994
27545500	community settings	C1274109
27545500	antibiotic	C0003232
27545500	antibiotics	C0003232
27545500	study	C2603343
27545500	16-aldehyde tanshinone I	C1254351
27545500	ALT	C1254351
27545500	synthesized	C1883254
27545500	bacteriostatic activity	C3714634
27545500	synergistic	C2986495
27545500	additive	C0442796
27545500	activity	C3714634
27545500	ALT	C1254351
27545500	aminoglycoside antibiotics	C0003233
27545500	β-lactam antibiotics	C0026458
27545500	in vitro	C1533691
27545500	ALT	C1254351
27545500	streptomycin	C0038425
27545500	STR	C0038425
27545500	ampicillin	C0002680
27545500	AMP	C0002680
27545500	S. aureus	C0038172
27545500	murine infection model	C2986594
27545500	mechanistic insight	C0678659
27545500	ALT	C1254351
27545500	damage	C1883709
27545500	bacterial	C0004611
27545500	cell membrane	C3161472
27545500	accumulation	C4055506
27545500	antibiotics	C0003232
27545500	bacterial cells	C0563199
27545500	treating	C1522326
27545500	infections	C3714514
27545500	S. aureus	C0038172
27545500	application	C4048755
27545500	tanshinones	C0075810
27546367	argyrophilic	C0682551
27546367	nucleolar organizing region	C0028609
27546367	Ischemia/reperfusion (I/R) injury	C0035126
27546367	complex event	C0441471
27546367	observed	C1441672
27546367	vascular surgery	C0042381
27546367	functional	C0007613
27546367	structural	C0243092
27546367	cell damage	C0599732
27546367	Nucleolar-organizing regions	C0028609
27546367	NORs	C0028609
27546367	sites	C0205145
27546367	ribosomal genes	C0035899
27546367	chromosomes	C0008633
27546367	stained	C0487602
27546367	silver	C0037125
27546367	active	C0205177
27546367	proteins	C0033684
27546367	argyrophilic-NOR (AgNOR)-associated proteins	C1571148
27546367	effects of	C1704420
27546367	renal	C0022646
27546367	I/R injury	C0035126
27546367	NOR protein	C1571149
27546367	synthesis	C0597295
27546367	AgNOR proteins	C1571148
27546367	amount	C1265611
27546367	histopathological injuring score	C2825141
27546367	female	C0086287
27546367	wistar-albino rats	C0086893
27546367	animals	C0003062
27546367	randomly	C0439605
27546367	divided	C0332849
27546367	groups	C0441833
27546367	Control Group	C0009932
27546367	I/R	C0035126
27546367	Group	C0441833
27546367	I/R	C0035126
27546367	group	C0441833
27546367	rats	C0086893
27546367	renal pedicle	C0733948
27546367	occlusion	C0028778
27546367	reperfusion	C0684253
27546367	control group	C0009932
27546367	drug injections	C0392877
27546367	ischemia reperfusion	C0035126
27546367	performed	C0884358
27546367	animals	C0003062
27546367	histopathological injury score	C2825141
27546367	mean AgNOR number	C0243095
27546367	total AgNOR area	C0243095
27546367	nuclear area	C0243095
27546367	TAA	C0243095
27546367	NA	C0243095
27546367	detected	C0442726
27546367	rat	C0086893
27546367	control	C0009932
27546367	I/R	C0035126
27546367	groups	C0441833
27546367	significant	C0750502
27546367	histopathological injury scores	C2825141
27546367	control group	C0009932
27546367	I/R	C0035126
27546367	group	C0441833
27546367	significant	C0750502
27546367	mean AgNOR number	C0243095
27546367	TAA/NA ratio	C0456603
27546367	positive correlation	C1707520
27546367	TAA/NA ratio	C0456603
27546367	histopathological injury score	C2825141
27546367	mean AgNOR number	C0243095
27546367	histopathological injury score	C2825141
27546367	detection	C1511790
27546367	AgNOR proteins	C1571148
27546367	amount	C1265611
27546367	indicator	C1522602
27546367	information	C1533716
27546367	cellular behaviour	C0007613
27546367	self-protective	C0524828
27546367	tubular epithelial cells	C1266872
27546367	I/R injury	C0035126
27546367	cellular damage	C0599732
27546367	levels	C0441889
27548715	emotion	C0013987
27548715	expression	C0015457
27548715	social costs	C0814661
27548715	Parkinson's disease	C0030567
27548715	Patients	C0030705
27548715	Parkinson's disease	C0030567
27548715	PD	C0030567
27548715	perceived	C0030971
27548715	negatively	C0205160
27548715	healthy	C3898900
27548715	peers	C0679739
27548715	factors	C1521761
27548715	contribute	C1880177
27548715	negative	C0205160
27548715	social perception	C0037427
27548715	cohort	C0599755
27548715	PD	C0030567
27548715	patients	C0030705
27548715	healthy controls	C2986479
27548715	assessed	C1516048
27548715	emotion	C0013987
27548715	emotional	C0849912
27548715	intensity	C0522510
27548715	displayed	C0870432
27548715	dynamic	C0729333
27548715	facial expressions	C0015457
27548715	adults	C0001675
27548715	PD	C0030567
27548715	watched	C2371283
27548715	emotionally	C0013987
27548715	films	C4019020
27548715	Experiment	C0681814
27548715	age	C0001779
27548715	peers	C0679739
27548715	patients	C0030705
27548715	disease	C0012634
27548715	social desirability	C0037408
27548715	dimensions	C0439534
27548715	audiovisual	C2936644
27548715	stimuli	C0234402
27548715	interview excerpts	C0021821
27548715	films	C4019020
27548715	Experiment	C0681814
27548715	Experiment	C0681814
27548715	participants	C0679646
27548715	PD	C0030567
27548715	rated	C0871208
27548715	significantly more	C4055637
27548715	facially expressive	C0015457
27548715	healthy controls	C2986479
27548715	ratings	C0871208
27548715	PD	C0030567
27548715	patients	C0030705
27548715	experiencing	C0596545
27548715	negative	C0205160
27548715	emotion	C0013987
27548715	controls	C0243148
27548715	rated	C0871208
27548715	displaying	C0870432
27548715	positive	C1446409
27548715	emotion	C0013987
27548715	reported	C0700287
27548715	feeling	C1527305
27548715	Experiment	C0681814
27548715	results	C0456984
27548715	age-peers	C0679739
27548715	rated	C0871208
27548715	PD	C0030567
27548715	patients	C0030705
27548715	significantly less	C4055638
27548715	socially desirable	C0037408
27548715	control	C0243148
27548715	participants	C0679646
27548715	PD	C0030567
27548715	patients	C0030705
27548715	rated	C0871208
27548715	involved	C1314939
27548715	interested	C0543488
27548715	friendly	C2700214
27548715	optimistic	C0564470
27548715	physically attractive	C2346874
27548715	healthy controls	C2986479
27548715	results	C0456984
27548715	PD	C0030567
27548715	patients	C0030705
27548715	report	C0700287
27548715	feeling	C1527305
27548715	attributions	C0596130
27548715	emotions	C0013987
27548715	social characteristics	C0037401
27548715	significant	C0750502
27548715	social challenges	C0699806
27548715	disease	C0012634
27548715	changes	C0392747
27548715	ability	C0085732
27548715	modulate	C0443264
27548715	expression	C0015457
27548715	negative	C0205160
27548715	emotions	C0013987
27548715	contribute	C1880177
27548715	negative	C0205160
27548715	social	C0728831
27548715	impressions	C0596764
27548715	PD	C0030567
27548715	patients	C0030705
27549420	hospital	C0019994
27549420	geriatrics services	C4041524
27549420	Africa	C0001737
27549420	University of Benin Teaching Hospital	C0019994
27549420	geriatrics	C0017469
27549420	project	C1709701
27549420	healthcare	C0086388
27549420	needs	C0027552
27549420	elderly	C0001792
27549420	resource	C0035201
27549420	constraints	C0443288
27549420	Nigerian	C0028075
27549420	hospitals	C0019994
27549420	human	C0700103
27549420	infrastructural resources	C0392762
27549420	older adults	C0001792
27549420	healthcare	C0086388
27549420	needs	C0027552
27549420	health services	C0557829
27549420	elderly	C0001792
27549420	Africa	C0001737
27549420	Nigeria	C0028075
27549420	population	C1257890
27549420	healthcare facility	C0018704
27549420	services	C1704289
27549420	elderly	C0001792
27549420	University of Benin Teaching Hospital	C0019994
27549420	UBTH	C0019994
27549420	Nigeria	C0028075
27549420	geriatrics	C0017469
27549420	trained interdisciplinary teams	C0086390
27549420	healthcare services	C0557829
27549420	elderly	C0001792
27549420	UBTH	C0019994
27549420	geriatrics	C0017469
27549420	project	C1709701
27549420	interdisciplinary	C0597720
27549420	health services	C0018747
27549420	older adults	C0001792
27549420	training	C0220931
27549420	professional development	C0871147
27549420	geriatrics	C0017469
27549420	healthcare staff	C0557570
27549420	inpatient	C0021562
27549420	services	C1704289
27549420	acute care for elders	C0683810
27549420	ACE	C0683810
27549420	model	C0596657
27549420	ACE units	C0596657
27549420	resources	C0035201
27549420	geriatrics unit	C0017469
27549420	interdisciplinary team	C0086390
27549420	Family	C0015576
27549420	participation	C0679823
27549420	practice	C0086343
27549420	residents	C2347958
27549420	house officers	C0401975
27549420	internal medicine	C0013227
27549420	weekly	C0332174
27549420	rotations	C0035868
27549420	academic program	C3844065
27549420	weekly	C0332174
27549420	geriatric	C1704440
27549420	pharmacotherapy	C0013216
27549420	seminars	C2029815
27549420	weekly	C0332174
27549420	seminars	C2029815
27549420	weekly	C0332174
27549420	journal club meetings	C0556656
27549420	seminars	C2029815
27549420	geriatric assessment tools	C2585718
27549420	geriatric services	C4041524
27549420	practices	C0086343
27549420	human resources	C0700103
27549420	infrastructure	C1514880
27549420	services	C0557829
27549420	Africa	C0001737
27551992	Engaging	C2937292
27551992	adolescent girls	C0001588
27551992	transactional sex	C0033595
27551992	through	C0332273
27551992	compensated	C0205432
27551992	dating	C0237553
27551992	Transactional sex	C0033595
27551992	through	C0332273
27551992	compensated	C0205432
27551992	dating	C0237553
27551992	adolescent girls	C0001588
27551992	problem	C0033213
27551992	need	C0027552
27551992	public	C0678367
27551992	concern	C2699424
27551992	Compensated	C0205432
27551992	dating	C0237553
27551992	use of	C1524063
27551992	information communication technology	C0683867
27551992	advertise	C0001690
27551992	search	C1706202
27551992	bargain	C0871661
27551992	transactional sex	C0033595
27551992	technology	C0683867
27551992	enables	C1171285
27551992	sexual partners	C0036911
27551992	maintain	C0024501
27551992	privacy	C0080048
27551992	secrecy	C0871315
27551992	transactional sex	C0033595
27551992	secrecy	C0871315
27551992	necessitates	C0027552
27551992	girls	C0043210
27551992	disclosure	C0012625
27551992	life experiences	C0023672
27551992	order	C1705176
27551992	concern	C2699424
27551992	disclosure	C0012625
27551992	focus	C1285542
27551992	qualitative study	C0949415
27551992	girls	C0043210
27551992	practicing	C0237607
27551992	dating	C0237553
27551992	Hong Kong	C0019907
27551992	China	C0008115
27551992	Based	C1527178
27551992	disclosure	C0012625
27551992	study	C2603343
27551992	grounded theory	C1510611
27551992	engagement	C2937292
27551992	compensated	C0205432
27551992	dating	C0237553
27551992	referential choice	C0008300
27551992	referential choice theory	C0871935
27551992	choice	C0008300
27551992	reference	C0205543
27551992	family	C0015576
27551992	push	C0441722
27551992	social norms	C0237750
27551992	sustains	C0443318
27551992	engagement	C2937292
27551992	choice	C0008300
27551992	expectancy	C0679138
27551992	reinforcement	C0442805
27551992	experiential learning	C0243012
27551992	compensated	C0205432
27551992	dating	C0237553
27551992	theory	C0871935
27551992	engagement	C2937292
27551992	through	C0332273
27551992	diverting	C0743226
27551992	referential choice	C0008300
27551992	dating	C0237553
27552906	Numerical simulation	C0679083
27552906	emitted particle	C0597177
27552906	characteristics	C1521970
27552906	airway	C0458827
27552906	deposition	C0333562
27552906	distribution	C1378698
27552906	Symbicort(®) Turbuhaler(®)	C1735945
27552906	dry powder	C0032861
27552906	combination	C0013162
27552906	aerosol drug	C1112870
27552906	dry powder	C0032861
27552906	combinations	C0013162
27552906	asthma	C0004096
27552906	chronic obstructive pulmonary disease	C0024117
27552906	COPD	C0024117
27552906	management	C0376636
27552906	Symbicort(®) Turbuhaler(®)	C1735945
27552906	study	C2603343
27552906	simulate	C0679083
27552906	deposition	C0333562
27552906	distribution	C1378698
27552906	components	C0184498
27552906	drug	C1254351
27552906	airways	C0458827
27552906	airflow measurements	C0678216
27552906	Breathing	C0004048
27552906	parameters	C0549193
27552906	healthy adults	C0686750
27552906	females	C0086287
27552906	males	C0086582
27552906	acquired	C0439661
27552906	inhaling	C0004048
27552906	Turbuhaler(®)	C1553479
27552906	Individual	C0027361
27552906	emitted doses	C0178602
27552906	particle size	C0030608
27552906	distributions	C1378698
27552906	Symbicort(®) Turbuhaler(®)	C1735945
27552906	determined	C0521095
27552906	particle	C0597177
27552906	deposition	C0333562
27552906	model	C3161035
27552906	adapted	C0205245
27552906	validated	C0205245
27552906	simulate	C0679083
27552906	deposition	C0333562
27552906	budesonide	C0054201
27552906	inhaled corticosteroid	C1629043
27552906	ICS	C1629043
27552906	formoterol	C0060657
27552906	long acting β2 agonist	C2987634
27552906	LABA	C2987634
27552906	upper airways	C0225377
27552906	lungs	C0024109
27552906	healthy volunteers	C1708335
27552906	current	C0521116
27552906	simulations	C0679083
27552906	emitted doses	C0178602
27552906	dose	C0178602
27552906	ICS	C1629043
27552906	LABA	C2987634
27552906	component	C0184498
27552906	individual	C0027361
27552906	inhalation flow rate	C0231832
27552906	variability	C2827666
27552906	induced	C0205263
27552906	individual	C0027361
27552906	spread	C0332261
27552906	deposited	C0333562
27552906	lung	C0024109
27552906	doses	C0178602
27552906	range	C1514721
27552906	budesonide	C0054201
27552906	range	C1514721
27552906	formoterol	C0060657
27552906	Significant	C0750502
27552906	inter-gender	C0079399
27552906	differences	C1705242
27552906	observed	C1441672
27552906	lung	C0024109
27552906	dose	C0178602
27552906	budesonide	C0054201
27552906	dose	C0178602
27552906	females	C0086287
27552906	males	C0086582
27552906	formoterol	C0060657
27552906	deposited	C0333562
27552906	efficiency	C0013682
27552906	females	C0086287
27552906	males	C0086582
27552906	results	C1274040
27552906	importance	C3898777
27552906	breath-holding	C0235744
27552906	inhalation	C0004048
27552906	drug	C1254351
27552906	lung	C0024109
27552906	deposition	C0333562
27552906	occurred	C1709305
27552906	breath-hold	C0235744
27552906	breath-hold	C0235744
27552906	time	C0040223
27552906	depositions	C0333562
27552906	confirmed	C0521093
27552906	appropriate	C1548787
27552906	lung	C0024109
27552906	deposition	C0333562
27552906	Symbicort(®) Turbuhaler(®)	C1735945
27552906	genders	C0079399
27552906	optimal inhalation technique	C1998547
27552906	advised	C0034866
27552906	persons	C0027361
27552906	low vital capacity	C0476408
27552906	study	C2603343
27552906	personalized	C1709510
27552906	prediction	C0681842
27552906	airway	C0458827
27552906	deposition	C0333562
27552906	aerosol drugs	C1112870
27552906	numerical simulations	C0679083
27552906	methodology	C3266812
27552906	study	C2603343
27552906	applicable	C1706839
27552906	marketed	C3640197
27552906	drugs	C1254351
27552906	future	C0016884
27553395	Nutrient intake	C0558027
27553395	infants	C0021270
27553395	toddlers	C0682053
27553395	United Arab Emirates	C0041698
27553395	Infants	C0021270
27553395	Toddlers	C0682053
27553395	nutrient adequacy	C0006777
27553395	diet	C0012155
27553395	infants	C0021270
27553395	toddlers	C0682053
27553395	United Arab Emirates	C0041698
27553395	infants	C0021270
27553395	toddlers	C0682053
27553395	Al Ain	C0041698
27553395	Dubai	C0041698
27553395	March	C3829202
27553395	February	C3830166
27553395	nutrient intake	C0558027
27553395	infants	C0021270
27553395	toddlers	C0682053
27553395	breastfeeding	C0006147
27553395	energy intake	C0006777
27553395	infant girls	C0870604
27553395	Al Ain	C0041698
27553395	Dubai	C0041698
27553395	kcal	C0439259
27553395	kcal	C0439259
27553395	kcal	C0439259
27553395	kcal	C0439259
27553395	boys	C0870221
27553395	toddlers	C0682053
27553395	energy intake	C0006777
27553395	girls	C0870604
27553395	kcal	C0439259
27553395	kcal	C0439259
27553395	kcal	C0439259
27553395	kcal	C0439259
27553395	boys	C0870221
27553395	Iron intake	C0518043
27553395	low	C0205251
27553395	body mass index	C1305855
27553395	body weight	C0005910
27553395	height	C0005890
27553395	World Health Organization	C0043237
27553395	infants	C0021270
27553395	toddlers	C0682053
27553395	over	C0497406
27553395	underweight	C0041667
27553395	macronutrient	C2346926
27553395	intakes	C0558027
27553395	RDA	C0524787
27553395	over	C1257763
27553395	underfed	C0162429
27553875	HIV-1	C0019704
27553875	backward	C0439784
27553875	mutation rate	C3178846
27553875	transmitted drug-resistant	C0013203
27553875	strains	C1518614
27553875	threats	C0749385
27553875	antiretroviral therapy	C1963724
27553875	human immunodeficiency virus	C0019704
27553875	HIV-1	C0019704
27553875	infected	C2363741
27553875	patients	C0030705
27553875	increasing prevalence	C1512456
27553875	transmitted drug resistance	C0013203
27553875	HIV-1	C0019704
27553875	drug-resistant	C0013203
27553875	strains	C1518614
27553875	wild-type	C1883559
27553875	strains	C1518614
27553875	drug-resistant	C0013203
27553875	strains	C1518614
27553875	primary	C0205225
27553875	phase	C0205390
27553875	HIV-1 infection	C2363741
27553875	replaced	C0559956
27553875	wild-type	C1883559
27553875	strains	C1518614
27553875	replacement	C0559956
27553875	HIV-1 resistant	C1836231
27553875	mutations	C0026882
27553875	wild-type	C1883559
27553875	strains	C1518614
27553875	process	C1522240
27553875	backward	C0439784
27553875	mutation	C0026882
27553875	replacement	C0559956
27553875	dependent	C3244310
27553875	HIV-1	C0019704
27553875	mutation	C0026882
27553875	group	C0441833
27553875	backward	C0439784
27553875	mutation rates	C3178846
27553875	mutational	C0026882
27553875	groups	C0441833
27553875	HIV-1	C0019704
27553875	drug resistance	C0013203
27553875	stochastic model	C0871922
27553875	data	C1511726
27553875	individuals	C0237401
27553875	infected	C0439663
27553875	HIV-1	C0019704
27553875	strain	C1518614
27553875	drug resistance	C0013203
27553875	mutations	C0026882
27553875	period of time	C3259132
27553875	resistant	C0332325
27553875	strain	C1518614
27553875	replaced	C0559956
27553875	distribution	C1704711
27553875	simulations	C0679083
27553875	stochastic model	C0871922
27553875	observed	C1441672
27553875	clinical data	C1516606
27553875	replacement	C0559956
27553875	times	C1632851
27553875	mutation	C0026882
27553875	Lamivudine/Emtricitabine	C1977395
27553875	mutations	C0026882
27553875	backward	C0439784
27553875	mutation rate	C3178846
27553875	relative	C0205345
27553875	fitness	C1456706
27553875	classes	C0456387
27553875	protease inhibitors	C0033607
27553875	mutations	C0026882
27553875	backward	C0439784
27553875	mutation rate	C3178846
27553875	relative	C0205345
27553875	fitness	C1456706
27553875	mutation	C0026882
27553875	classes	C0456387
27553875	estimates	C0750572
27555752	Modeling	C0870071
27555752	hospital	C0019994
27555752	safety	C0036043
27555752	partnership	C3826012
27555752	preferences of patients	C0376409
27555752	families	C0015576
27555752	discrete	C0443299
27555752	choice	C0008300
27555752	conjoint experiment	C0681814
27555752	Patients	C0030705
27555752	families	C0015576
27555752	role	C1705810
27555752	improve	C2986411
27555752	health service	C0018747
27555752	safety	C0036043
27555752	objective	C0018017
27555752	study	C2603343
27555752	safety	C0036043
27555752	partnership	C3826012
27555752	preferences of patients	C0376409
27555752	families	C0015576
27555752	discrete	C0443299
27555752	choice	C0008300
27555752	conjoint experiment	C0681814
27555752	safety	C0036043
27555752	partnership	C3826012
27555752	preferences	C0376409
27555752	patients	C0030705
27555752	parents	C0030551
27555752	Participants	C0679646
27555752	choices	C0008300
27555752	safety	C0036043
27555752	partnerships	C3826012
27555752	partnership	C3826012
27555752	design	C1707689
27555752	attributes	C0037401
27555752	Participants	C0679646
27555752	preferred	C0558295
27555752	approach	C0449445
27555752	safety	C0036043
27555752	partnerships	C3826012
27555752	patients	C0030705
27555752	staff	C0025106
27555752	responsibility	C0678341
27555752	safety	C0036043
27555752	hospital staff	C0025109
27555752	opportunity to participate	C0814559
27555752	safety	C0036043
27555752	partnerships	C3826012
27555752	medication double checks	C1254363
27555752	immediate	C0205253
27555752	risk reduction	C1137094
27555752	analysis	C0936012
27555752	Actively engaged participants	C0679646
27555752	outpatients	C0029921
27555752	higher education	C2584301
27555752	anticipated	C3840775
27555752	benefits	C0814225
27555752	safety	C0036043
27555752	partnerships	C3826012
27555752	more confident	C3840600
27555752	ability	C0085732
27555752	contribute	C1880177
27555752	intent	C1283828
27555752	participating	C0679823
27555752	prefer	C0376409
27555752	engagement	C3508152
27555752	strategy	C0679199
27555752	scientific evidence	C3887511
27555752	preferred	C0558295
27555752	approach	C0449445
27555752	safety education	C1272340
27555752	disclosure of errors	C4046003
27555752	anticipated	C3840775
27555752	fewer	C0205388
27555752	benefits	C0814225
27555752	confident	C0558095
27555752	ability	C0085732
27555752	contribute	C1880177
27555752	participating	C0679823
27555752	engagement	C3508152
27555752	strategy	C0679199
27555752	signage	C4054026
27555752	preferred	C0558295
27555752	staff	C0025106
27555752	patients	C0030705
27555752	care	C0086388
27555752	errors	C0376531
27555752	Inpatients	C0021562
27555752	immigrant backgrounds	C2242882
27555752	less education	C0013658
27555752	Health services	C0018747
27555752	information	C1533716
27555752	risks	C0035647
27555752	partnership	C3826012
27555752	preferences	C0376409
27555752	opportunities	C0814559
27555752	individual differences	C0021228
27555752	positive response	C1514241
27555752	patients	C0030705
27555752	safety	C0036043
27555752	concerns	C2699424
27555898	ozone	C0030106
27555898	paracetic acid	C0030968
27555898	disinfection	C0012683
27555898	adhesion of	C0175633
27555898	resilient liners	C0440188
27555898	acrylic resin	C0001222
27555898	paracetic acid	C0030968
27555898	PAA	C0030968
27555898	ozone	C0030106
27555898	disinfection	C0012683
27555898	tensile bond strength	C0039526
27555898	TBS	C0039526
27555898	silicone-based	C0037114
27555898	resilient liners	C0440188
27555898	acrylic resins	C0001222
27555898	dumbbell shaped	C0686912
27555898	heat-polymerized	C0314672
27555898	acrylic resins	C0001222
27555898	specimens	C0370003
27555898	acrylic	C0001222
27555898	resilient liners	C0440188
27555898	specimens	C0370003
27555898	2 control	C0370003
27555898	control1	C0370003
27555898	control7	C0370003
27555898	PAA	C0030968
27555898	ozone	C0030106
27555898	disinfection	C0012683
27555898	PAA1	C0030968
27555898	PAA7	C0030968
27555898	ozone1	C0030106
27555898	ozone7	C0030106
27555898	distilled water	C0790233
27555898	control1	C0370003
27555898	control7	C0370003
27555898	PAA	C0030968
27555898	ozone	C0030106
27555898	water	C0043047
27555898	PAA	C0030968
27555898	ozone	C0030106
27555898	tensile	C0039526
27555898	tests	C0022885
27555898	TBS	C0039526
27555898	ANOVA	C0002780
27555898	Tukey's HSD test	C0022885
27555898	Adhesive	C0001516
27555898	strength	C0808080
27555898	Mollosil	C1436546
27555898	ozone	C0030106
27555898	disinfection	C0012683
27555898	PAA	C0030968
27555898	disinfection	C0012683
27555898	TBS	C0039526
27555898	Mollosil	C1436546
27555898	Molloplast B	C0128823
27555898	acrylic resin	C0001222
27555898	ozone	C0030106
27555898	disinfection	C0012683
27555898	TBS	C0039526
27555898	Molloplast B	C0128823
27555898	prolonged	C0439590
27555898	exposure to ozone	C0240618
27555898	adhesive	C0001516
27555898	strength	C0808080
27555898	adhesion	C0175633
27555898	resilient liners	C0440188
27555898	PAA	C0030968
27555898	disinfection	C0012683
27555898	ozonated	C3640178
27555898	water	C0043047
27555898	TBS	C0039526
27555898	Mollosil	C1436546
27555898	ozone	C0030106
27555898	adhesion	C0175633
27555898	Molloplast B	C0128823
27555898	denture base materials	C3504513
27563025	construction	C1521827
27563025	three-dimensional	C0450363
27563025	composite	C0009570
27563025	fibrous	C0439709
27563025	macrostructures	C0678594
27563025	with nanotextures	C0449582
27563025	biomedical	C1879848
27563025	applications	C4048755
27563025	biomedical	C1879848
27563025	nanotechnology	C0872323
27563025	three-dimensional	C0450363
27563025	macrostructures	C0678594
27563025	with nanotextures	C0449582
27563025	applications	C4048755
27563025	biological systems	C0460002
27563025	restoration	C0678689
27563025	regeneration	C0815081
27563025	body tissues	C0040300
27563025	organs	C0178784
27563025	conductive polymers	C0032521
27563025	electrical	C0442828
27563025	cues	C0010439
27563025	cells	C0007634
27563025	three-dimensional	C0450363
27563025	composite	C0009570
27563025	nanofibre	C1881960
27563025	macrostructures	C0678594
27563025	polycaprolactone	C0137734
27563025	PCL	C0137734
27563025	concentrations	C1446561
27563025	polyaniline	C0962453
27563025	PANi	C0962453
27563025	electrospinning technology	C0449851
27563025	3D	C0450363
27563025	structures	C0678594
27563025	cap-like macrostructures	C0678594
27563025	centimetre-scale	C0475210
27563025	thickness	C1280412
27563025	pore nanotextures	C0449582
27563025	nanometre-scale	C0439202
27563025	nanofibres	C1881960
27563025	biocompatibility	C0596177
27563025	3D	C0450363
27563025	PCL	C0137734
27563025	PANi	C0962453
27563025	composite	C0009570
27563025	nanofibre	C1881960
27563025	macrostructures	C0678594
27563025	mouse	C0025929
27563025	myoblasts	C0596995
27563025	C2C12 cells	C0596995
27563025	model	C2986594
27563025	cells	C0007634
27563025	C2C12 cells	C0596995
27563025	3D	C0450363
27563025	PCL	C0137734
27563025	PANi	C0962453
27563025	composite	C0009570
27563025	macrostructures	C0678594
27563025	PCL	C0137734
27563025	cells	C0007634
27563025	myoblast-like morphologies	C0332437
27563025	pseudopodia	C0033827
27563025	PANi	C0962453
27563025	cell proliferation	C0596290
27563025	PANi	C0962453
27563025	cell affinity	C3714634
27563025	conductive	C0205556
27563025	PANi	C0962453
27563025	3D	C0450363
27563025	composite	C0009570
27563025	nanofibre	C1881960
27563025	macrostructures	C0678594
27563025	myoblast differentiation	C1159966
27563025	myotube maturation	C2265916
27563025	electrospun	C0205556
27563025	3D	C0450363
27563025	PCL	C0137734
27563025	PANi	C0962453
27563025	composite	C0009570
27563025	nanofibre	C1881960
27563025	macrostructures	C0678594
27563025	macrostructures	C0678594
27563025	applications	C4048755
27563025	tissue engineering	C0596171
27569827	Mechanisms	C0441712
27569827	replacement	C0559956
27569827	circulating	C0175630
27569827	viruses	C0042776
27569827	seasonal	C4304723
27569827	pandemic influenza A viruses	C0029347
27569827	Seasonal influenza	C4304723
27569827	epidemics	C0014499
27569827	accumulation	C4055506
27569827	antigenic changes	C0003319
27569827	Pandemic influenza	C4304383
27569827	antigenic change	C0003319
27569827	influenza A virus	C0029347
27569827	originate	C0439659
27569827	hosts	C1167395
27569827	antigenic variants	C0003319
27569827	influenza A virus	C0029347
27569827	circulating	C0175630
27569827	seasonal	C0042776
27569827	pandemic viruses	C0042776
27569827	replacement	C0559956
27569827	mechanisms	C0441712
27569827	stochastic individual-based SEIR (susceptible-exposed-infectious-recovered) model	C0282574
27569827	viral strains	C1518614
27569827	circulating	C0175630
27569827	old strain	C1518614
27569827	newly emerged strain	C1518614
27569827	simulations	C0679083
27569827	replacement	C0559956
27569827	mechanisms	C0441712
27569827	Factors	C1521761
27569827	conditions	C0348080
27569827	virus	C0042776
27569827	host	C1167395
27569827	replacement	C0559956
27569827	tropical regions	C0017446
27569827	temperate regions	C0017446
27569827	magnitude	C1704240
27569827	epidemic	C0014499
27569827	old strain	C1518614
27569827	herd immunity	C1135927
27569827	old strain	C1518614
27569827	timing	C0449243
27569827	appearance	C0700364
27569827	new strain	C1518614
27569827	replacement	C0559956
27569827	replacement	C0559956
27569827	pandemic virus	C0042776
27569827	seasonal virus	C0042776
27569827	susceptibility	C1264642
27569827	reproductive	C0035150
27569827	pandemic virus	C0042776
27569827	replacement	C0559956
27569827	mechanisms	C0441712
27569827	virus transmission	C1160716
27569827	dynamics	C3826426
27569827	effective	C1704419
27569827	mitigate	C1553901
27569827	seasonal	C4304723
27569827	pandemic influenza	C4304383
27570140	Request	C1272683
27570140	fulfillment	C3242069
27570140	postpartum	C0086839
27570140	tubal ligation	C0520483
27570140	patients	C0030705
27570140	high-risk pregnancy	C0242786
27570140	Female sterilization	C0015787
27570140	methods	C0025663
27570140	contraception	C0700589
27570140	United States	C0041703
27570140	studies	C2603343
27570140	postpartum	C0086839
27570140	tubal ligation	C0520483
27570140	PPTL	C0520483
27570140	requests	C1272683
27570140	unfulfilled	C0205245
27570140	study	C2603343
27570140	obstetric	C0205484
27570140	medical risk	C0035647
27570140	status	C0449438
27570140	patients	C0030705
27570140	request	C1272683
27570140	completion	C0205197
27570140	PPTL	C0520483
27570140	study	C2603343
27570140	retrospective cohort study	C2985505
27570140	women	C0043210
27570140	delivering	C0005615
27570140	university hospital	C0020028
27570140	prenatal care	C0033052
27570140	faculty	C0015535
27570140	resident clinics	C0442592
27570140	High-risk	C0332167
27570140	status	C0449438
27570140	Society for Maternal-Fetal Medicine guidelines	C2945690
27570140	Documentation	C0920316
27570140	contraceptive plan	C0599880
27570140	administration	C1533734
27570140	contraceptive methods	C0700589
27570140	abstracted	C3259344
27570140	patient records	C0025102
27570140	pregnancies	C0032961
27570140	abstracted	C3259344
27570140	participants	C0679646
27570140	low risk	C3538919
27570140	high risk	C0332167
27570140	requested	C1272683
27570140	PPTL	C0520483
27570140	high-risk	C0332167
27570140	patients	C0030705
27570140	low-risk	C3538919
27570140	patients	C0030705
27570140	public insurance	C0021672
27570140	unintended index pregnancy	C0041747
27570140	patients	C0030705
27570140	requesting	C1272683
27570140	PPTL	C0520483
27570140	procedure	C0087111
27570140	postpartum	C0086839
27570140	Completion	C0205197
27570140	high-risk	C0332167
27570140	status	C0449438
27570140	race	C0034510
27570140	insurance status	C0376629
27570140	parity	C0030563
27570140	women	C0043210
27570140	unfulfilled	C0205245
27570140	PPTL	C0520483
27570140	request	C1272683
27570140	pregnancies	C0032961
27570140	months	C0439231
27570140	follow-up	C1522577
27570140	women	C0043210
27570140	high-risk pregnancies	C0242786
27570140	request	C1272683
27570140	PPTL	C0520483
27570140	complete	C0205197
27570140	procedure	C0087111
27570140	high-risk	C0332167
27570140	patients	C0030705
27570140	requests	C1272683
27570140	unfulfilled	C0205245
27570140	women	C0043210
27570140	high-risk pregnancies	C0242786
27570140	request	C1272683
27570140	PPTL	C0520483
27570140	complete	C0205197
27570140	procedure	C0087111
27570140	procedures	C0087111
27570140	urgent	C0439609
27570140	high-risk	C0332167
27570140	women	C0043210
27570140	patients	C0030705
27570140	procedure	C0087111
27572277	Gut microbiota	C2985398
27572277	Roux-en-Y gastric bypass	C0585179
27572277	sleeve gastrectomy	C3160799
27572277	diabetic	C0011847
27572277	rat	C0034721
27572277	model	C0012644
27572277	diversity	C1880371
27572277	discriminant	C0205235
27572277	genera	C1708235
27572277	metabolic	C0025519
27572277	changes	C0392747
27572277	gut microbiota	C2985398
27572277	bariatric surgery	C1456587
27572277	gut microbiota	C2985398
27572277	host	C1167395
27572277	metabolism	C0025519
27572277	Roux-en-Y gastric bypass	C0585179
27572277	RYGB	C0585179
27572277	sleeve gastrectomy	C3160799
27572277	SG	C3160799
27572277	gut microbiota	C2985398
27572277	food	C0016452
27572277	intake	C1512806
27572277	weight	C0005910
27572277	loss	C1517945
27572277	loss	C1517945
27572277	host	C1167395
27572277	metabolism	C0025519
27572277	diabetic	C0011847
27572277	fatty rats	C0034721
27572277	groups	C0441833
27572277	RYGB	C0585179
27572277	sham-operated	C0032042
27572277	RYGB	C0585179
27572277	sham-operated	C0032042
27572277	SG	C3160799
27572277	metabolic effects	C2945675
27572277	gut microbiota	C2985398
27572277	profile	C2003903
27572277	analyzed	C0936012
27572277	weeks	C0439230
27572277	discriminating	C0205235
27572277	genera	C1708235
27572277	metabolic markers	C1513159
27572277	RYGB	C0585179
27572277	procedures	C0087111
27572277	glucose	C0017725
27572277	improvement	C2986411
27572277	flora	C2985398
27572277	diversity	C1880371
27572277	weeks	C0439230
27572277	compared	C1707455
27572277	sham-operated	C0032042
27572277	RYGB	C0585179
27572277	Proteobacteria	C0751985
27572277	Gammaproteobacteria	C0751988
27572277	Betaproteobacteria	C0751987
27572277	Fusobacteria	C1222477
27572277	Clostridium	C0009054
27572277	SG	C3160799
27572277	Actinobacteria	C0600148
27572277	compared	C1707455
27572277	discriminant	C0205235
27572277	genera	C1708235
27572277	correlated	C1707520
27572277	changes	C0392747
27572277	metabolic	C0025519
27572277	phenotype	C0031437
27572277	correlations	C1707520
27572277	weight	C0005910
27572277	discriminant	C0205235
27572277	genera	C1708235
27572277	correlated	C1707520
27572277	serum insulin level	C1261415
27572277	food	C0016452
27572277	intake	C1512806
27572277	weight	C0005910
27572277	loss	C1517945
27572277	RYGB	C0585179
27572277	data	C1511726
27572277	RYGB	C0585179
27572277	SG	C3160799
27572277	surgery	C0038895
27572277	diversity	C1880371
27572277	microbiota	C2985398
27572277	diabetic	C0011847
27572277	fatty rats	C0034721
27572277	functions	C0025519
27572277	discriminate	C0205235
27572277	microbiota	C2985398
27572277	mechanisms	C0441712
27572277	postsurgical	C1254367
27572277	modulation	C0443264
27572277	gut microbiota	C2985398
27572277	improvements	C2986411
27572277	insulin resistance	C0021655
27576608	Ocular toxicity	C1262036
27576608	AUY922	C2348996
27576608	pigmented	C0034700
27576608	albino rats	C0684072
27576608	AUY922	C2348996
27576608	heat shock protein 90	C0243044
27576608	inhibitor	C1999216
27576608	ocular	C0015392
27576608	adverse events	C0877248
27576608	AEs	C0877248
27576608	ocular	C0015392
27576608	AEs	C0877248
27576608	patients	C0030705
27576608	investigative studies	C2603343
27576608	step-wise approach	C0449445
27576608	retinal structure	C0035298
27576608	pigmented	C0034700
27576608	Brown Norway	C0034700
27576608	albino (Wistar) rats	C0684072
27576608	Wistar	C0034716
27576608	rats	C0034721
27576608	administered	C1521801
27576608	AUY922	C2348996
27576608	AUC	C0376690
27576608	h	C0439227
27576608	Cmax	C2347813
27576608	patients	C0030705
27576608	AUY922	C2348996
27576608	rats	C0034721
27576608	morbidity	C0026538
27576608	mortality	C0596099
27576608	weekly	C0332174
27576608	treatment	C0087111
27576608	Electroretinography	C0013867
27576608	ERG	C0013867
27576608	changes	C0392747
27576608	doses	C0178602
27576608	ERG	C0013867
27576608	changes	C0392747
27576608	dose dependent	C1512045
27576608	consistent	C0332290
27576608	photoreceptors	C0031760
27576608	reversible	C0205343
27576608	ERG	C0013867
27576608	Cmax	C2347813
27576608	AUC	C0376690
27576608	Histopathological	C0243140
27576608	changes	C0392747
27576608	rats	C0034721
27576608	administered	C1521801
27576608	AUY922	C2348996
27576608	hour	C0439227
27576608	infusion	C0574032
27576608	AUY922	C2348996
27576608	disorganization	C4061689
27576608	outer segment photoreceptor	C1325525
27576608	morphology	C0332437
27576608	male	C0086582
27576608	Brown Norway rats	C0034700
27576608	disorganization	C4061689
27576608	administrations	C1533734
27576608	reversible	C0205343
27576608	week	C0439230
27576608	posttreatment period	C2709088
27576608	ocular	C0015392
27576608	response	C0871261
27576608	Brown Norway	C0034700
27576608	Wistar rats	C0034716
27576608	serum iron levels	C0036810
27576608	rhodopsin	C0035499
27576608	PDE6α	C1567350
27576608	β-transducin	C0040665
27576608	concentrations	C0392762
27576608	retinal pigment epithelium-specific protein RPE65	C1571376
27576608	expression	C0017262
27576608	infusions	C0574032
27576608	AUY922	C2348996
27576608	vehicle-treated controls	C0009932
27576608	AUY922	C2348996
27576608	retinal toxicity	C0877104
27576608	rats	C0034721
27576608	patients	C0030705
27576608	reversible	C0205343
27576608	molecular mechanism	C1258062
27580517	Assessment	C0220825
27580517	cerebral	C0006104
27580517	blood perfusion	C0599705
27580517	acetazolamide	C0000981
27580517	3D spiral ASL MRI	C3891302
27580517	pediatric	C1521725
27580517	patients	C0030705
27580517	clinical feasibility	C0015730
27580517	non-Cartesian cylindrically-distributed spiral 3D pseudo-continuous arterial spin labeling (pCASL) magnetic resonance imaging (MRI)	C3891302
27580517	pulse sequence	C3828438
27580517	pediatric	C1521725
27580517	patients	C0030705
27580517	quantifying	C1709793
27580517	cerebral blood flow	C0428714
27580517	CBF	C0428714
27580517	acetazolamide (ACZ) vasodilator	C0042402
27580517	MRI exams	C0024485
27580517	3 Tesla Philips Ingenia systems using 32 channel head coil arrays	C3273359
27580517	institutional review board approval	C2346499
27580517	3D spiral-based pCASL technique	C3891302
27580517	brain MRI exam	C0412675
27580517	pediatric	C1521725
27580517	patients	C0030705
27580517	patients	C0030705
27580517	administered	C3469597
27580517	ACZ	C0000981
27580517	clinically indicated	C2985739
27580517	whole-brain CBF measurements	C0005776
27580517	pre	C0332152
27580517	post	C0687676
27580517	ACZ	C0000981
27580517	cerebrovascular reserve	C0007818
27580517	3D spiral pCASL	C3891302
27580517	data	C1511726
27580517	cases	C0150093
27580517	patients	C0030705
27580517	CBF	C0428714
27580517	administration of	C3469597
27580517	ACZ	C0000981
27580517	patients	C0030705
27580517	CBF	C0428714
27580517	ACZ	C0000981
27580517	CBF	C0428714
27580517	ACZ	C0000981
27580517	statistically significant	C0237881
27580517	patients	C0030705
27580517	t-test analysis	C0871472
27580517	CBF	C0428714
27580517	perfusion	C0599705
27580517	MR angiography	C1636167
27580517	clinical findings	C0455712
27580517	3D cylindrically-distributed spiral pCASL MRI	C3891302
27580517	assess	C0184514
27580517	cerebral blood flow	C0428714
27580517	pediatric	C1521725
27580517	patients	C0030705
27580908	Assessing	C0184514
27580908	learning	C0023185
27580908	potential	C3245505
27580908	interactive	C0815244
27580908	digital game	C0870328
27580908	interactive-style	C0815244
27580908	didactic	C0205556
27580908	lecture	C0376683
27580908	didactic	C0205556
27580908	teaching	C0039401
27580908	medical student	C0038495
27580908	education	C0013621
27580908	Games	C0150593
27580908	educational	C0013621
27580908	possible	C0332149
27580908	interactive	C0815244
27580908	increasing	C0205217
27580908	learner	C1257890
27580908	satisfaction	C0242428
27580908	two-armed experiment	C0681814
27580908	evaluate	C0220825
27580908	student	C0038492
27580908	satisfaction	C0242428
27580908	content	C0456205
27580908	mastery	C0870851
27580908	pediatric radiology	C1518934
27580908	topic	C1555712
27580908	taught	C0348054
27580908	interactive	C0815244
27580908	digital game	C0870328
27580908	traditional	C0443324
27580908	didactic	C0205556
27580908	lecture	C0376683
27580908	Medical students	C0038495
27580908	participating	C0679823
27580908	radiology	C0034599
27580908	elective	C0439608
27580908	participate	C0679823
27580908	Student	C0038492
27580908	cohorts	C0599755
27580908	alternatively	C1523987
27580908	faculty	C0015535
27580908	supervised	C0039401
27580908	session	C1883017
27580908	playing	C0032214
27580908	interactive	C0815244
27580908	digital	C1883674
27580908	Tic-tac-toe	C0150593
27580908	quiz module	C1709061
27580908	pediatric gastrointestinal radiology	C0203054
27580908	didactic	C0205556
27580908	lecture	C0376683
27580908	topic	C1555712
27580908	Survey	C0038951
27580908	questions	C1522634
27580908	assessed	C1516048
27580908	learners'	C1257890
27580908	perceived	C0030971
27580908	ability to recall	C1718058
27580908	material	C0520510
27580908	satisfaction	C0242428
27580908	educational	C0013621
27580908	experience	C0596545
27580908	end-of-rotation	C1254367
27580908	exam	C4284036
27580908	reviewed	C1709940
27580908	evaluate	C0220825
27580908	quantitative measure	C0034384
27580908	learning	C0023185
27580908	groups	C0441833
27580908	Survey	C0038951
27580908	responses	C2911692
27580908	analyzed	C0936012
27580908	chi-squared test	C0008041
27580908	Exam	C4284036
27580908	groups	C0441833
27580908	analyzed	C0936012
27580908	Student's t-test	C0871453
27580908	Students	C0038492
27580908	lecture	C0376683
27580908	group	C0441833
27580908	higher	C0205250
27580908	test scores	C0237855
27580908	compared	C1707455
27580908	students	C0038492
27580908	game	C0150593
27580908	group	C0441833
27580908	Students	C0038492
27580908	lecture	C0376683
27580908	group	C0441833
27580908	reported	C0700287
27580908	greater	C1704243
27580908	understanding	C0162340
27580908	recall	C0034770
27580908	material	C0520510
27580908	students	C0038492
27580908	game	C0150593
27580908	group	C0441833
27580908	Students	C0038492
27580908	lecture	C0376683
27580908	group	C0441833
27580908	perceived	C0030971
27580908	lecture	C0376683
27580908	enjoyable	C3843343
27580908	time	C0040223
27580908	compared	C1707455
27580908	game	C0150593
27580908	group	C0441833
27580908	statistically significant	C0237881
27580908	difference	C3842396
27580908	lecture	C0376683
27580908	game	C0150593
27580908	group	C0441833
27580908	ability	C0085732
27580908	interest	C0162400
27580908	pre-survey	C1254367
27580908	statistically significant	C0237881
27580908	decrease	C0547047
27580908	interest	C0162400
27580908	digital	C1883674
27580908	interactive	C0815244
27580908	materials	C0520510
27580908	reported	C0700287
27580908	students	C0038492
27580908	game	C0150593
27580908	group	C0441833
27580908	experience	C0596545
27580908	traditional	C0443324
27580908	lecture	C0376683
27580908	digital game	C0870328
27580908	affected	C0392760
27580908	specific	C0205369
27580908	lecture	C0376683
27580908	digital	C1883674
27580908	content	C0456205
27580908	comparison	C1707455
27580908	digital	C1883674
27580908	module	C1709061
27583176	Predictors	C2698872
27583176	day	C0439228
27583176	mortality	C0205848
27583176	patients	C0030705
27583176	spontaneous	C0205359
27583176	primary	C0205225
27583176	intracerebral hemorrhage	C2937358
27583176	Intracerebral hemorrhage	C2937358
27583176	ICH	C2937358
27583176	life threatening	C2826244
27583176	early outcome assessment	C0029909
27583176	therapeutic efforts	C0087111
27583176	retrospectively	C1514923
27583176	analyzed	C0936012
27583176	data	C1511726
27583176	patients	C0030705
27583176	spontaneous	C0205359
27583176	primary	C0205225
27583176	ICH	C2937358
27583176	predictors	C2698872
27583176	day	C0439228
27583176	mortality	C0205848
27583176	clinical	C0205210
27583176	radiological	C0205483
27583176	therapeutical	C0302350
27583176	parameters	C0549193
27583176	outcome grading scoring systems	C0282574
27583176	ICH score	C0449820
27583176	FUNC score	C0449820
27583176	intracerebral hemorrhage grading scale	C0349674
27583176	ICH-GS	C0349674
27583176	population	C1257890
27583176	correlation	C1707520
27583176	scores	C0449820
27583176	day	C0439228
27583176	mortality	C0205848
27583176	study	C2603343
27583176	outcome grading scoring systems	C0282574
27583176	ICH score	C0449820
27583176	FUNC score	C0449820
27583176	intracerebral hemorrhage grading scale	C0349674
27583176	ICH-GS	C0349674
27583176	population	C1257890
27583176	correlation	C1707520
27583176	scores	C0449820
27583176	day	C0439228
27583176	mortality	C0205848
27583176	study	C2603343
27583176	patients	C0030705
27583176	age	C0001779
27583176	years	C0439234
27583176	Glasgow Coma Scale	C0017594
27583176	GCS	C0017594
27583176	admission	C0184666
27583176	ICH	C2937358
27583176	volume	C0449468
27583176	hematoma	C0018944
27583176	location	C1515974
27583176	basal ganglia	C0004781
27583176	surgical	C0543467
27583176	conservative treatment	C0459914
27583176	day	C0439228
27583176	mortality	C0205848
27583176	multivariate analysis	C0026777
27583176	GCS	C0017594
27583176	Odds ratio	C0028873
27583176	OR	C0028873
27583176	confidence interval	C0009667
27583176	CI	C0009667
27583176	bleeding	C0019080
27583176	volume	C0449468
27583176	OR	C0028873
27583176	CI	C0009667
27583176	infratentorial	C0441939
27583176	hematoma	C0018944
27583176	location	C1515974
27583176	OR	C0028873
27583176	CI	C0009667
27583176	predictors	C2698872
27583176	day	C0439228
27583176	mortality	C0205848
27583176	receiver operating characteristics	C0034772
27583176	analysis	C0936012
27583176	high-risk group	C0684030
27583176	short-term	C0443303
27583176	outcome	C1274040
27583176	GCS	C0017594
27583176	ICH	C2937358
27583176	volume	C0449468
27583176	supratentorially	C0441938
27583176	infratentorially	C0441939
27583176	Pearson correlation	C1709490
27583176	correlation	C1707520
27583176	ICH score	C0449820
27583176	day	C0439228
27583176	mortality	C0205848
27583176	FUNC score	C0449820
27583176	day	C0439228
27583176	mortality	C0205848
27583176	ICH-GS	C0349674
27583176	day	C0439228
27583176	mortality	C0205848
27583176	GCS	C0017594
27583176	score	C0449820
27583176	admission	C0184666
27583176	baseline	C1442488
27583176	volume	C0449468
27583176	localization	C0475264
27583176	hemorrhage	C0019080
27583176	predictors	C2698872
27583176	day	C0439228
27583176	mortality	C0205848
27583176	patients	C0030705
27583176	spontaneous	C0205359
27583176	primary	C0205225
27583176	intracerebral hemorrhage	C2937358
27583176	high-risk	C0332167
27583176	patients	C0030705
27583176	short-term	C0443303
27583176	outcome	C1274040
27583176	ICH score	C0449820
27583176	ICH-GS	C0349674
27583176	accurately	C0443131
27583176	predict	C2698872
27583176	day	C0439228
27583176	mortality	C0205848
27587730	Gga-miR-21	C1101610
27587730	inhibits	C0311403
27587730	chicken	C0008051
27587730	pre-adipocyte	C0206131
27587730	proliferation	C0596290
27587730	down-regulating	C0013081
27587730	Kruppel-like factor 5	C1416661
27587730	Gga-miR-21	C1101610
27587730	expressed	C0017262
27587730	chicken	C0008051
27587730	pre-adipocytes	C0206131
27587730	investigated	C1292732
27587730	gga-miR-21	C1101610
27587730	chicken	C0008051
27587730	pre-adipocyte	C0206131
27587730	proliferation	C0596290
27587730	Cell proliferation assay	C3899698
27587730	gene expression analysis	C1880945
27587730	proliferating cell nuclear antigen	C1366837
27587730	PCNA	C1366837
27587730	gga-miR-21	C1101610
27587730	mimic	C0441655
27587730	inhibited	C0311403
27587730	pre-adipocyte	C0206131
27587730	proliferation	C0596290
27587730	gga-miR-21	C1101610
27587730	inhibitor	C1999216
27587730	enhanced	C2349975
27587730	pre-adipocyte	C0206131
27587730	proliferation	C0596290
27587730	investigation	C1292732
27587730	Kruppel-like factor 5	C1416661
27587730	KLF5	C1416661
27587730	mRNA	C0035696
27587730	target	C1521840
27587730	gga-miR-21	C1101610
27587730	gga-miR-21	C1101610
27587730	mimic	C0441655
27587730	inhibited	C0311403
27587730	KLF5	C1416661
27587730	3(')UTR	C0600600
27587730	reporter	C0206414
27587730	activity	C0441655
27587730	decreased	C0205216
27587730	endogenous	C0205227
27587730	KLF5	C1416661
27587730	expression	C0017262
27587730	primary	C0205225
27587730	pre-adipocytes	C0206131
27587730	KLF5	C1416661
27587730	knockdown	C2350567
27587730	RNAi	C1136031
27587730	effect	C1280500
27587730	gga-miR-21	C1101610
27587730	mimic	C0441655
27587730	cell proliferation	C0596290
27587730	promoting	C0033414
27587730	effect	C1280500
27587730	gga-miR-21	C1101610
27587730	inhibitor	C1999216
27587730	pre-adipocyte	C0206131
27587730	proliferation	C0596290
27587730	attenuated	C0332161
27587730	KLF5	C1416661
27587730	knockdown	C2350567
27587730	miR-21	C1101610
27587730	chicken	C0008051
27587730	pre-adipocyte	C0206131
27587730	proliferation	C0596290
27587730	targeting	C0242613
27587730	KLF5	C1416661
27590047	application	C4048755
27590047	heterogeneous cluster grouping	C1704332
27590047	reflective writing	C0043266
27590047	medical humanities	C0020157
27590047	literature study	C2603343
27590047	enhance	C2349975
27590047	students'	C0038492
27590047	empathy	C0013989
27590047	critical thinking	C4279941
27590047	reflective writing	C0043266
27590047	interdisciplinary collaboration	C0597720
27590047	connections	C0449379
27590047	patients'	C0030705
27590047	diseases	C0012634
27590047	social	C0728831
27590047	cultural contexts	C0220814
27590047	study	C2603343
27590047	examined	C0332128
27590047	heterogeneous cluster grouping	C1704332
27590047	reflective writing	C0043266
27590047	medical humanities	C0020157
27590047	acquisition	C1706701
27590047	positive effects	C1280500
27590047	medical university	C0000872
27590047	students	C0038492
27590047	empathy	C0013989
27590047	critical thinking	C4279941
27590047	reflective writing	C0043266
27590047	15-week	C0439230
27590047	quasi-experimental design	C0815255
27590047	investigate	C1292732
27590047	learning outcomes	C1274040
27590047	cluster algorithms	C0002045
27590047	heterogeneous learning clusters	C1704332
27590047	experimental group	C0681860
27590047	non-heterogeneous learning clusters	C1704332
27590047	control group	C0009932
27590047	medical humanities	C0020157
27590047	literature study	C2603343
27590047	intervention	C0184661
27590047	Empathy Scale	C0349674
27590047	Patient Care	C0017313
27590047	ES	C0349674
27590047	PC	C0017313
27590047	critical thinking disposition assessment	C0220825
27590047	CTDA-R	C0220825
27590047	reflective writing test	C1254363
27590047	administered	C1521801
27590047	groups	C0441833
27590047	empathy scale	C0349674
27590047	behavioral empathy	C0013989
27590047	affective empathy	C0013989
27590047	post-test mean scores	C3533236
27590047	experimental group	C0681860
27590047	control group	C0009932
27590047	intelligent empathy	C0013989
27590047	critical thinking	C4279941
27590047	systematicity	C0220922
27590047	analyticity	C0936012
27590047	skepticism	C1510638
27590047	well-informed	C1254363
27590047	maturity	C0449989
27590047	skepticism	C1510638
27590047	reflective writing	C0043266
27590047	ideas	C1254370
27590047	voice	C0042939
27590047	point of view	C1254370
27590047	critical thinking	C4279941
27590047	representation	C1882932
27590047	depth of reflection	C0025361
27590047	personal growth	C0871850
27590047	focus	C1285542
27590047	context structure	C0449255
27590047	language	C0023008
27590047	conventions	C0086047
27590047	study	C2603343
27590047	heterogeneous cluster grouping	C1704332
27590047	reflective writing	C0043266
27590047	medical humanities	C0020157
27590047	interdisciplinary cooperation	C0392337
27590047	medical care	C0496675
27593786	Employing	C0557351
27593786	Electronic Traction Table	C0183817
27593786	Flexibility	C0242808
27593786	Adolescent Idiopathic Scoliosis	C0410702
27593786	study	C2603343
27593786	develop	C1527148
27593786	equipment	C0014672
27593786	assessment	C0220825
27593786	flexibility	C0242808
27593786	spine	C0037949
27593786	forces	C0441722
27593786	system	C0449913
27593786	adolescent idiopathic scoliosis	C0410702
27593786	AIS	C0410702
27593786	selection	C1707391
27593786	fusion levels	C0441889
27593786	surgical	C0543467
27593786	success	C0679864
27593786	patients	C0030705
27593786	AIS	C0410702
27593786	posterior	C0205095
27593786	instrumented spinal fusion	C0919636
27593786	clinic	C0442592
27593786	study	C2603343
27593786	Electronic Traction Table	C0183817
27593786	ETT	C0183817
27593786	clinic	C0442592
27593786	radiogical	C0549193
27593786	clinical	C0205210
27593786	parameters	C0549193
27593786	spine	C0037949
27593786	prescriptive angle	C0205556
27593786	Cobb angles	C0563192
27593786	postoperative angles	C0205556
27593786	longitudinal	C0205127
27593786	traction	C0040597
27593786	lateral pushing Cobb angles	C0563192
27593786	Longitudinal	C0205127
27593786	traction	C0040597
27593786	lateral pushing angles	C0563192
27593786	correction ratios	C0456603
27593786	significant	C0750502
27593786	longitudinal	C0205127
27593786	traction	C0040597
27593786	Cobb angle	C0563192
27593786	longitudinal	C0205127
27593786	traction	C0040597
27593786	lateral pushing minor Cobb angle	C0563192
27593786	postoperative minor Cobb angles	C0563192
27593786	deformity	C0302142
27593786	tractional	C0040597
27593786	rotational	C0035868
27593786	rotational forces	C0441722
27593786	technique	C0449851
27593786	flexibility	C0242808
27593786	operation	C0543467
27593786	Electronic traction table	C0183817
27593786	device	C0025080
27593786	preoperative flexibility	C0242808
27593786	longitudinal	C0205127
27593786	traction	C0040597
27593786	lateral pushing radiographs	C1306645
27593786	choosing	C1707391
27593786	fusion levels	C0441889
27593786	proximal	C0205107
27593786	distal	C0205108
27593786	vertebral column	C0037949
27595710	MEssaging for Diabetes	C1254363
27595710	Intervention	C0184661
27595710	Barriers	C0679881
27595710	Medication Adherence	C2364172
27595710	Low-Income	C1331016
27595710	Adults	C0001675
27595710	Type 2	C0011860
27595710	Nonadherence	C0746935
27595710	diabetes	C0011847
27595710	medication	C2081612
27595710	MEssaging for Diabetes	C1254363
27595710	MED	C1254363
27595710	mobile health	C2718080
27595710	mHealth	C2718080
27595710	intervention	C0184661
27595710	user	C1706077
27595710	barriers	C0679881
27595710	medication adherence	C2364172
27595710	MED	C1254363
27595710	users	C1706077
27595710	barriers	C0679881
27595710	barrier	C0679881
27595710	within-participant	C0679646
27595710	adherence	C1510802
27595710	glycemic control	C0205556
27595710	HbA1c	C0019018
27595710	Adults	C0001675
27595710	type 2 diabetes	C0011860
27595710	barriers	C0679881
27595710	adherence	C1510802
27595710	monthly	C0332177
27595710	months	C0439231
27595710	assessment	C0220825
27595710	barriers	C0679881
27595710	user	C1706077
27595710	month	C0439231
27595710	users	C1706077
27595710	text messages	C3178910
27595710	barriers	C0679881
27595710	barriers	C0679881
27595710	participant	C0679646
27595710	monthly	C0332177
27595710	t-tests	C0871472
27595710	within-participant	C0679646
27595710	barriers	C0679881
27595710	month	C0439231
27595710	regression models	C3161035
27595710	participant's	C0679646
27595710	adherence	C1510802
27595710	HbA1c	C0019018
27595710	Participants	C0679646
27595710	HbA1c	C0019018
27595710	month	C0439231
27595710	months	C0439231
27595710	months	C0439231
27595710	barriers	C0679881
27595710	cost	C0010186
27595710	medications	C2081612
27595710	medications	C2081612
27595710	medications	C2081612
27595710	Participants	C0679646
27595710	barrier	C0679881
27595710	month	C0439231
27595710	barrier	C0679881
27595710	adherence	C1510802
27595710	adherence	C1510802
27595710	text messages	C3178910
27595710	participants	C0679646
27595710	month	C0439231
27595710	barrier	C0679881
27595710	months	C0439231
27595710	HbA1c	C0019018
27595710	users	C1706077
27595710	barriers	C0679881
27595710	adherence	C1510802
27595710	mHealth	C2718080
27595710	interventions	C0184661
27595710	low-income	C1331016
27595710	patients	C0030705
27598262	Macular	C0332574
27598262	Ganglion Cell	C0228071
27598262	Inner Plexiform Layer	C1512785
27598262	Thickness	C1280412
27598262	Associated with	C0332281
27598262	Clinical Progression	C0242656
27598262	Mild Cognitive Impairment	C1719378
27598262	Alzheimers Disease	C0002395
27598262	macular	C0332574
27598262	ganglion cell	C0228071
27598262	inner plexiform layer	C1512785
27598262	GCIPL	C1512785
27598262	peripapillary retinal nerve fiber layer	C1517753
27598262	RNFL	C1517753
27598262	thicknesses	C1280412
27598262	disease progression	C0242656
27598262	mild cognitive impairment	C1719378
27598262	MCI	C1719378
27598262	Alzheimer's disease	C0002395
27598262	AD	C0002395
27598262	patients	C0030705
27598262	AD	C0002395
27598262	MCI	C1719378
27598262	elderly controls	C0009932
27598262	thicknesses	C1280412
27598262	RNFL	C1517753
27598262	GCIPL	C1512785
27598262	spectral-domain optic coherent tomography	C3876157
27598262	participants	C0679646
27598262	baseline	C1442488
27598262	patients	C0030705
27598262	MCI	C1719378
27598262	AD	C0002395
27598262	clinical	C0205210
27598262	neuropsychological tests	C0027902
27598262	baseline	C1442488
27598262	once every year thereafter for 2 years	C1254367
27598262	Clinical Dementia Rating scale-Sum of Boxes	C3827230
27598262	CDR-SB	C3827230
27598262	score	C0449820
27598262	negative	C0205160
27598262	relationships	C0439849
27598262	average GCIPL	C1512785
27598262	thickness	C1280412
27598262	GCIPL	C1512785
27598262	thickness	C1280412
27598262	superotemporal	C1275875
27598262	superonasal	C1275872
27598262	inferonasal sectors	C1275873
27598262	composite memory score	C0449820
27598262	positive	C1446409
27598262	associations	C0439849
27598262	average GCIPL	C1512785
27598262	thickness	C1280412
27598262	GCIPL	C1512785
27598262	thickness	C1280412
27598262	superotemporal	C1275875
27598262	inferonasal	C1275873
27598262	inferotemporal sectors	C1275868
27598262	temporal RNFL	C1517753
27598262	thickness	C1280412
27598262	GCIPL	C1512785
27598262	thicknesses	C1280412
27598262	GCIPL	C1512785
27598262	thickness	C1280412
27598262	inferonasal	C1275873
27598262	inferior	C0005898
27598262	inferotemporal sectors	C1275868
27598262	baseline	C1442488
27598262	reduced	C0392756
27598262	MCI	C1719378
27598262	patients	C0030705
27598262	AD	C0002395
27598262	MCI	C1719378
27598262	patients	C0030705
27598262	CDR-SB	C3827230
27598262	baseline	C1442488
27598262	years	C0439234
27598262	negative	C0205160
27598262	associations	C0439849
27598262	minimum GCIPL	C1512785
27598262	thicknesses	C1280412
27598262	GCIPL	C1512785
27598262	thickness	C1280412
27598262	superotemporal	C1275875
27598262	superior	C0005898
27598262	superonasal	C1275872
27598262	inferonasal sectors	C1275873
27598262	baseline	C1442488
27598262	GCIPL	C1512785
27598262	thickness	C1280412
27598262	biomarker	C0005516
27598262	progression	C0242656
27598262	MCI	C1719378
27598262	AD	C0002395
27598388	Green	C2350565
27598388	rapid	C0456962
27598388	synthesis	C1883254
27598388	silver	C0037125
27598388	nanoparticles	C1721060
27598388	Borago officinalis	C0522465
27598388	leaf	C0242724
27598388	extract	C0032081
27598388	anticancer	C0243095
27598388	antibacterial activities	C0243095
27598388	cost	C0010186
27598388	effective	C1704419
27598388	ecofriendly	C2350565
27598388	synthesis	C1883254
27598388	silver	C0037125
27598388	nanoparticles	C1721060
27598388	AgNPs	C1721060
27598388	Borago officinalis	C0522465
27598388	leaves	C0242724
27598388	extract	C0032081
27598388	efficiently	C0442799
27598388	biosynthesis	C1883254
27598388	AgNPs	C1721060
27598388	verified	C1547321
27598388	UV-Vis spectrum	C1883416
27598388	surface plasmon resonance	C0597731
27598388	SPR	C0597731
27598388	Transmission electron microscope (TEM) analysis	C0678118
27598388	particles	C1721060
27598388	spherical	C0332501
27598388	hexagonal	C1708361
27598388	irregular	C0205271
27598388	shape	C0332479
27598388	size	C0030608
27598388	ranging	C1514721
27598388	energy dispersive X-ray spectroscopy	C2699997
27598388	EDX	C2699997
27598388	elemental mapping	C0022885
27598388	purity	C1882508
27598388	maximum	C0806909
27598388	distribution	C1704711
27598388	silver	C0037125
27598388	AgNPs	C0037125
27598388	crystalline	C0444626
27598388	AgNPs	C0037125
27598388	identified	C0205396
27598388	X-ray diffraction	C0043301
27598388	XRD	C0043301
27598388	selected area diffraction pattern	C0022885
27598388	particle size	C0030608
27598388	analysis	C1524024
27598388	Z-average	C1510992
27598388	diameter	C1301886
27598388	AgNPs	C0037125
27598388	polydispersity index	C1882415
27598388	PDI	C1882415
27598388	Zeta potential	C0597697
27598388	analysis	C1524024
27598388	colloidal stability	C0205556
27598388	AgNPs	C0037125
27598388	efficacy	C1280519
27598388	AgNPs	C1721060
27598388	lung	C0024109
27598388	cancer cell lines	C0085983
27598388	A549	C4277577
27598388	cervical	C0007874
27598388	cancer cell line	C0085983
27598388	HeLa	C0018873
27598388	in vitro	C1533691
27598388	AgNPs	C1721060
27598388	cytotoxicity	C0596402
27598388	A549	C4277577
27598388	HeLa	C0018873
27598388	cancer cell line	C0085983
27598388	concentrations	C1446561
27598388	AgNPs	C0037125
27598388	antibacterial activity	C0243095
27598388	biofilm	C0081786
27598388	inhibition	C3463820
27598388	pathogenic	C3816499
27598388	bacteria	C0004611
27598388	B. officinalis	C0522465
27598388	leaves	C0242724
27598388	extract	C0032081
27598388	efficiently	C0442799
27598388	synthesis	C1883254
27598388	AgNPs	C0037125
27598388	AgNPs	C0037125
27598388	potentials	C3245505
27598388	anticancer	C0003392
27598388	antibacterial agents	C0279516
27598388	development	C1527148
27598388	anticancer	C0003392
27598388	antimicrobial agents	C1136254
27599942	Genotyping	C3178894
27599942	Staphylococcus aureus	C0038172
27599942	bovine mastitis	C0024895
27599942	phenotypic	C0031437
27599942	characteristics	C1521970
27599942	mastitis	C0024895
27599942	Staphylococcus aureus	C0038172
27599942	S. aureus	C0038172
27599942	animal	C0003062
27599942	health	C0018684
27599942	farmers	C0221460
27599942	acute mastitis	C0024895
27599942	risk	C0035647
27599942	persistent	C0205322
27599942	mastitis	C0024895
27599942	genetic variants	C0678941
27599942	strain	C1518614
27599942	infection	C3714514
27599942	study	C2603343
27599942	microarrays	C1709016
27599942	virulence	C0042765
27599942	genes	C0017337
27599942	S. aureus	C0038172
27599942	dairy cows	C0175925
27599942	acute clinical mastitis	C0024895
27599942	findings	C0243095
27599942	genotypic	C0017431
27599942	phenotypic	C0031437
27599942	characteristics	C1521970
27599942	virulence factors	C1136170
27599942	genes	C0017337
27599942	encoding	C2700640
27599942	hemolysin	C0019053
27599942	types	C0332307
27599942	leukocidins D	C0023504
27599942	lukM	C0293523
27599942	lukF-P83	C0033684
27599942	clumping factors A	C1871029
27599942	B	C0969304
27599942	fibrinogen binding protein	C1437844
27599942	fibronectin-binding protein A	C2976610
27599942	virulence factors	C1136170
27599942	fibronectin-binding protein B	C2976609
27599942	Staphylococcus aureus	C0038172
27599942	surface protein G	C0025252
27599942	Genes	C0017337
27599942	staphylococcal enterotoxins	C0597508
27599942	toxic shock syndrome toxin-1	C1617068
27599942	TSST-1	C1617068
27599942	pulsotype	C1518614
27599942	No	C1513916
27599942	beta-lactamase genes	C0017337
27599942	pulsotype	C1518614
27599942	pulsotypes	C1518614
27599942	human origin	C4287933
27599942	TSST-1	C1617068
27599942	enterotoxins	C0014372
27599942	hemolysins	C0019053
27599942	beta-lactamase	C0597979
27599942	genes	C0017337
27599942	study	C2603343
27599942	genotypic	C0017431
27599942	differences	C1705242
27599942	similarities	C2348205
27599942	pulsotypes	C1518614
27599942	S. aureus	C0038172
27599942	mastitis	C0024895
27599942	Sweden	C0038995
27599942	diagnostic tools	C0949688
27599942	udder	C0242386
27599942	health	C0018684
27599942	S. aureus	C0038172
27599942	genotype	C0017431
27600888	Uveitis	C0042164
27600888	spondyloarthritis	C0949690
27600888	patients	C0030705
27600888	association with	C0332281
27600888	HLA-B27 histocompatibility antigen	C0019740
27600888	prospective study	C0033522
27600888	prospective study	C0033522
27600888	clinical presentation	C2708283
27600888	course	C0750729
27600888	uveitis	C0042164
27600888	spondyloarthritis	C0949690
27600888	SpA	C0949690
27600888	patients	C0030705
27600888	association with	C0332281
27600888	HLA-B27 histocompatibility antigen	C0019740
27600888	study	C2603343
27600888	patients	C0030705
27600888	uveitis	C0042164
27600888	tested	C0039593
27600888	HLA-B27 antigen	C0019740
27600888	infections	C3714514
27600888	viral	C0042769
27600888	bacterial	C0004623
27600888	parasitic	C0747256
27600888	examined	C0332128
27600888	locomotive system	C0026860
27600888	involvement	C1314939
27600888	presence	C0150312
27600888	HLA-B27 antigen	C0019740
27600888	determined	C0521095
27600888	patients	C0030705
27600888	diagnosed	C0011900
27600888	entity	C1551338
27600888	SpA	C0949690
27600888	group	C0441833
27600888	remaining	C1527428
27600888	patients	C0030705
27600888	HLA-B27	C0019740
27600888	negative	C0205160
27600888	diagnosed	C0011900
27600888	entity	C1551338
27600888	SpA	C0949690
27600888	group	C0441833
27600888	patients	C0030705
27600888	diseases	C0012634
27600888	SpA	C0949690
27600888	group	C0441833
27600888	comparing	C1707455
27600888	groups	C0441833
27600888	HLA-B27-positive	C0239961
27600888	negative	C0205160
27600888	patients	C0030705
27600888	SpA	C0949690
27600888	uveitis	C0042164
27600888	statistically significant	C0237881
27600888	difference	C1705242
27600888	age of onset	C0206132
27600888	site	C1515974
27600888	frequency of attacks	C0439603
27600888	uni	C0205092
27600888	bilateral	C0238767
27600888	involvement	C1314939
27600888	performed	C0884358
27600888	comparison	C1707455
27600888	HLA-B27-positive	C0239961
27600888	negative	C0205160
27600888	patients	C0030705
27600888	SpA	C0949690
27600888	status	C0449438
27600888	revealed	C0443289
27600888	higher	C0205250
27600888	complication	C0009566
27600888	rate	C1521828
27600888	negative	C0205160
27600888	HLA-B27	C0019740
27600888	negative	C0205160
27600888	patients	C0030705
27600888	autoimmune	C3888523
27600888	infectious uveitis	C0042164
27600888	different	C1705242
27600888	long	C0205166
27600888	short	C1806781
27600888	remissions	C0544452
27600888	Assessing	C0184514
27600888	site	C1515974
27600888	course	C0750729
27600888	uveitis	C0042164
27600888	HLA-B27	C0019740
27600888	testing	C0039593
27600888	uveitis	C0042164
27600888	patients	C0030705
27600888	important	C3898777
27600888	etiological	C1314792
27600888	diagnosis	C0011900
27600888	Diseases	C0012634
27600888	SpA	C0949690
27600888	group	C0441833
27600888	times	C1632851
27600888	HLA-B27-positive	C0239961
27600888	patients	C0030705
27600888	compared	C1707455
27600888	HLA-B27	C0019740
27600888	negative	C0205160
27600888	Clinical presentation	C2708283
27600888	uveitis	C0042164
27600888	presence	C0150312
27600888	SpA	C0949690
27600888	HLA-B27-positive	C0239961
27600888	negative	C0205160
27600888	patients	C0030705
27600888	idiopathic uveitis	C0042164
27600888	HLA-B27	C0019740
27600888	associated	C0332281
27600888	syndrome	C0039082
27600888	entities	C1551338
27600888	SpA	C0949690
27600888	group	C0441833
27600888	severe	C0205082
27600888	clinical presentation	C2708283
27600888	course	C0750729
27600888	uveitis	C0042164
27600888	associated with	C0332281
27600888	worse prognosis	C0278252
27600888	Complications	C0009566
27600888	uveitis	C0042164
27600888	non-SpA	C0243095
27600888	HLA-B27	C0019740
27600888	negative	C0205160
27600888	patients	C0030705
27601111	Human	C0086418
27601111	brucellosis	C0006309
27601111	South Africa	C0037712
27601111	Public health	C3244304
27601111	diagnostic pitfalls	C0679836
27601111	Human	C0086418
27601111	brucellosis	C0006309
27601111	South Africa	C0037712
27601111	SA	C0037712
27601111	under-diagnosed	C0679837
27601111	under-reported	C0243095
27601111	clinicians	C0871685
27601111	affected patients	C0522476
27601111	nonspecific	C0750540
27601111	insidious	C1288298
27601111	nature of the disease	C0449786
27601111	case	C0868928
27601111	human	C0086418
27601111	brucellosis	C0006309
27601111	Brucella melitensis	C0006305
27601111	patient	C0030705
27601111	Western Cape Province	C0681784
27601111	SA	C0037712
27601111	described	C1552738
27601111	resulting	C0332294
27601111	staff members	C1552089
27601111	medical microbiology laboratories	C0022877
27601111	public health investigation	C1827659
27601111	article	C0282420
27601111	aims	C1947946
27601111	integration	C0243126
27601111	public health	C3244304
27601111	medical	C0199168
27601111	veterinary	C0042615
27601111	services	C0557854
27601111	exposing deficiencies	C0011155
27601111	public health	C3244304
27601111	veterinary	C0042615
27601111	laboratory	C0022877
27601238	Survey	C0038951
27601238	Trichinella infection	C0856687
27601238	domestic pigs	C1136016
27601238	historical	C2004062
27601238	endemic areas	C0205146
27601238	Henan province	C1514578
27601238	central China	C0008115
27601238	aim	C1947946
27601238	work	C0043227
27601238	investigate	C1292732
27601238	current situation	C0150312
27601238	Trichinella infection	C0856687
27601238	domestic pigs	C1136016
27601238	historical	C2004062
27601238	endemic areas	C0205146
27601238	Henan province	C1514578
27601238	central China	C0008115
27601238	diaphragm samples	C3687538
27601238	indoor-raised pigs	C1136016
27601238	collected	C1516698
27601238	five	C0205451
27601238	cities	C0008848
27601238	Henan	C1514578
27601238	examined	C0332128
27601238	artificial digestion method	C0025664
27601238	overall prevalence	C1707459
27601238	Trichinella infection	C0856687
27601238	pigs	C0039005
27601238	Trichinella larvae	C0546803
27601238	detected	C0442726
27601238	pigs	C0039005
27601238	Nanyang city	C0008848
27601238	Henan	C1514578
27601238	larval	C0023047
27601238	burden	C2828008
27601238	infected animals	C0237158
27601238	larvae	C0023047
27601238	muscles	C0026845
27601238	range	C1514721
27601238	larvae	C0546803
27601238	identified	C0205396
27601238	Trichinella spiralis	C0040892
27601238	multiple PCR	C3179032
27601238	study	C2603343
27601238	confirms	C0521093
27601238	existence	C2987476
27601238	swine	C0039005
27601238	trichinellosis	C0040896
27601238	Henan	C1514578
27601238	infection	C3714514
27601238	level	C0441889
27601238	minimum level	C0441889
27601238	infectious sources	C0314732
27601238	humans	C0086418
27601238	prevalence	C0220900
27601238	swine	C0039005
27601238	Trichinella infection	C0856687
27601238	Henan	C1514578
27601238	evaluated	C0220825
27601238	large scale	C0549177
27601238	pork samples	C3687765
27601238	meat	C0025017
27601238	food safety	C1456535
27601292	Voriconazole	C0393080
27601292	metabolism	C0683140
27601292	influenced	C4054723
27601292	severe	C0205082
27601292	inflammation	C0021368
27601292	prospective study	C0033522
27601292	infection	C3714514
27601292	inflammation	C0021368
27601292	several	C0443302
27601292	drug	C1254351
27601292	metabolizing	C0683140
27601292	enzymes	C0014442
27601292	liver	C0023884
27601292	down-regulated	C1327624
27601292	cytochrome P450 iso-enzymes	C0010762
27601292	voriconazole	C0393080
27601292	extensively	C0205231
27601292	metabolized	C0683140
27601292	cytochrome P450 iso-enzymes	C0010762
27601292	metabolism	C0683140
27601292	voriconazole	C0393080
27601292	influenced	C4054723
27601292	inflammation	C0021368
27601292	reduced	C0392756
27601292	clearance of the drug	C0683151
27601292	higher	C0205250
27601292	voriconazole	C0393080
27601292	trough concentrations	C3640757
27601292	influence	C4054723
27601292	inflammation	C0021368
27601292	voriconazole	C0393080
27601292	metabolism	C0683140
27601292	voriconazole	C0393080
27601292	trough concent ratio ns	C3640757
27601292	ratio	C0456603
27601292	prospective observational study	C0033522
27601292	University Medical Center	C0000872
27601292	Groningen	C0017446
27601292	Patients	C0030705
27601292	eligible	C1548635
27601292	inclusion	C1512693
27601292	treated with	C0332293
27601292	voriconazole	C0393080
27601292	Voriconazole	C0393080
27601292	voriconazole-N-oxide	C4263709
27601292	concentrations	C1446561
27601292	blood samples	C0178913
27601292	degree	C0449286
27601292	inflammation	C0021368
27601292	C-reactive protein (CRP) concentrations	C0201657
27601292	longitudinal data analysis	C0023981
27601292	assess	C0184514
27601292	effect	C1280500
27601292	inflammation	C0021368
27601292	metabolic	C0683140
27601292	ratio	C0456603
27601292	voriconazole	C0393080
27601292	trough concentration	C3640757
27601292	patients	C0030705
27601292	voriconazole	C0393080
27601292	trough concentrations	C3640757
27601292	longitudinal data analysis	C0023981
27601292	analysis	C0023981
27601292	inflammation	C0021368
27601292	CRP concentrations	C0201657
27601292	influence	C4054723
27601292	metabolic	C0683140
27601292	ratio	C0456603
27601292	voriconazole	C0393080
27601292	trough concentration	C3640757
27601292	voriconazole-N-oxide	C4263709
27601292	concentration	C1446561
27601292	factors	C1521761
27601292	influence	C4054723
27601292	voriconazole	C0393080
27601292	metabolism	C0683140
27601292	metabolic	C0683140
27601292	ratio	C0456603
27601292	decreased	C0205216
27601292	voriconazole-N-oxide	C4263709
27601292	concentration	C1446561
27601292	voriconazole	C0393080
27601292	trough concentration	C3640757
27601292	increased	C0205217
27601292	CRP	C0006560
27601292	voriconazole	C0393080
27601292	metabolism	C0683140
27601292	decreased	C0205216
27601292	inflammation	C0021368
27601292	higher	C0205250
27601292	voriconazole	C0393080
27601292	trough concentration	C3640757
27601292	frequent	C0332183
27601292	monitoring	C1283169
27601292	voriconazole	C0393080
27601292	serum concentrations	C0683149
27601292	severe	C0205082
27601292	inflammation	C0021368
27601594	Neoadjuvant Chemotherapy	C4272610
27601594	Ovarian Cancer	C0029925
27601594	Tumor-Infiltrating Lymphocyte	C0079722
27601594	Response	C0301909
27601594	Immunotherapy	C0278348
27601594	chemotherapy	C0392920
27601594	antitumor	C2986475
27601594	immunity	C0020964
27601594	immunogenic	C0872192
27601594	cell death	C0007587
27601594	T-cell activation	C1155065
27601594	tumor infiltration	C4060690
27601594	tumors	C0027651
27601594	immunotherapies	C0278348
27601594	checkpoint blockade	C1155873
27601594	platinum	C0032207
27601594	taxane	C0215136
27601594	chemotherapy	C0392920
27601594	ovarian cancer	C0029925
27601594	immunologic	C0205470
27601594	Experimental Design	C0015320
27601594	pre	C0332152
27601594	post	C0687676
27601594	neoadjuvant chemotherapy	C4272610
27601594	tumor samples	C0475358
27601594	high-grade serous carcinoma	C3839280
27601594	HGSC	C3839280
27601594	immunohistochemistry	C0021044
27601594	IHC	C0021044
27601594	immune cells	C0312740
27601594	post	C0687676
27601594	chemotherapy	C0392920
27601594	TIL	C0079722
27601594	cohort	C0599755
27601594	Neoadjuvant chemotherapy	C4272610
27601594	CD3	C0108779
27601594	CD8	C0085358
27601594	CD8	C0085358
27601594	TIA-1	C1429678
27601594	PD-1	C2986635
27601594	CD20	C0054946
27601594	TIL	C0079722
27601594	CD79a	C0286618
27601594	CD138	C1609943
27601594	plasma cells	C0032112
27601594	CD68	C0108799
27601594	macrophages	C0024432
27601594	MHC class I	C0019629
27601594	tumor cells	C0597032
27601594	Immunosuppressive	C4048329
27601594	cell	C0007634
27601594	FoxP3	C4282118
27601594	PD-1	C2986635
27601594	cells	C0039198
27601594	regulatory T cells	C0039198
27601594	IDO-1	C3529891
27601594	PD-L1	C4300350
27601594	macrophages	C0024432
27601594	tumor cells	C0597032
27601594	Hierarchical clustering	C1881045
27601594	TIL	C0079722
27601594	tumors	C0027651
27601594	immune markers	C0162489
27601594	chemotherapy	C4272610
27601594	TIL	C0079722
27601594	TIL	C0079722
27601594	negative	C0205160
27601594	negative	C0205160
27601594	chemotherapy	C0392920
27601594	TIL	C0079722
27601594	Chemotherapy	C4272610
27601594	TIL	C0079722
27601594	responses	C0301909
27601594	immune-suppressive mechanisms	C1840264
27601594	immunotherapy	C0278348
27601594	tumor microenvironment	C2936626
27602300	adder	C0206298
27602300	Vipera berus	C0206298
27602300	Southern Altay Mountains	C0442533
27602300	population characteristics	C0032661
27602300	distribution	C0037775
27602300	morphology	C0332437
27602300	phylogenetic position	C1519069
27602300	distributed	C0037775
27602300	snake	C0037382
27602300	Eurasia	C0017446
27602300	adder	C0206298
27602300	Vipera berus	C0206298
27602300	extensively	C0205231
27602300	investigated	C1292732
27602300	Europe	C0015176
27602300	Asia	C0003980
27602300	Southern Altay Mountains	C0442533
27602300	adder's	C0206298
27602300	southern	C1710133
27602300	distribution	C0037775
27602300	limit	C0439801
27602300	Central Asia	C0003982
27602300	population status	C0032671
27602300	assessed	C1516048
27602300	field surveys	C1517184
27602300	adder	C0206298
27602300	areas	C0205146
27602300	Southern Altay Mountains	C0442533
27602300	combination	C0205195
27602300	line transects	C0242481
27602300	random	C0439605
27602300	searches	C1706202
27602300	morphological characteristics	C0332437
27602300	collected specimens	C0200345
27602300	analyses	C0936012
27602300	external	C0205101
27602300	morphology	C0332437
27602300	molecular phylogeny	C0031797
27602300	results	C0683954
27602300	adder	C0206298
27602300	distributed	C0037775
27602300	survey	C0011296
27602300	sites	C0205145
27602300	recorded	C0034869
27602300	sightings	C1947978
27602300	Kanas river valley	C0563004
27602300	estimated	C0750572
27602300	encounter	C1947978
27602300	rate	C1521828
27602300	transects	C0242481
27602300	sightings	C1947978
27602300	occurrence	C2745955
27602300	melanism	C0025209
27602300	small size	C0748864
27602300	typical	C3538928
27602300	adders	C0206298
27602300	Southern Altay Mountains	C0442533
27602300	geographic populations	C0032659
27602300	nominate	C1707391
27602300	subspecies	C1883207
27602300	phylogenetic tree	C1519069
27602300	obtained	C1301820
27602300	Bayesian Inference	C0242196
27602300	DNA sequences	C0162326
27602300	mitochondrial cytochrome b	C0010744
27602300	grouped	C0439745
27602300	Northern clade	C0032659
27602300	species	C1705920
27602300	separate	C0443299
27602300	subspecies	C1883207
27602300	V. b. sachalinensis	C0206298
27602300	discovery	C1880355
27602300	distribution	C0037775
27602300	range	C1514721
27602300	V. berus	C0206298
27602300	basis	C1527178
27602300	researches	C0035168
27602300	hypothesis	C1512571
27602300	adder	C0206298
27602300	expands	C0205229
27602300	distribution	C0037775
27602300	border	C2828371
27602300	southwest	C1710136
27602300	mountains	C0442533
27602300	elevation	C0702240
27602300	gradient	C0812409
27602300	population	C1257890
27602300	abundance	C2346714
27602300	declines	C0547047
27602300	gradually	C0439833
27602300	drying climate	C0681771
27603112	Binding	C1145667
27603112	Pollutants	C0599786
27603112	Biomolecules	C0574031
27603112	Simulation Study	C0679083
27603112	cases	C0868928
27603112	world	C2700280
27603112	animals	C0003062
27603112	found dead	C0476463
27603112	dying	C0184532
27603112	symptoms	C1457887
27603112	thiamine	C0039841
27603112	(vitamin B) deficiency	C0042850
27603112	pollutants	C0599786
27603112	investigate	C0220825
27603112	biomolecules	C0574031
27603112	thiamin binding	C1523455
27603112	transport	C1159805
27603112	blocked	C0332206
27603112	pollutants	C0599786
27603112	in silico	C3489666
27603112	docking	C1522290
27603112	compound	C0574031
27603112	classes	C0456387
27603112	compounds	C0574031
27603112	prion protein	C4082486
27603112	ECF-type ABC transporter	C3158987
27603112	thi-box riboswitch receptor	C2936590
27603112	thiamin pyrophosphokinase	C0039850
27603112	YKoF protein	C0033684
27603112	molecular dynamics (MD) simulations	C2717775
27603112	stability	C0205360
27603112	complexes	C1704241
27603112	compound	C0574031
27603112	classes	C0456387
27603112	thiamin	C0039840
27603112	analogues	C0002776
27603112	control	C1550141
27603112	pesticides	C0031253
27603112	veterinary	C0042614
27603112	medicines	C0013227
27603112	polychlorinated biphenyls	C0032447
27603112	dioxins	C0012503
27603112	prevalent	C0220900
27603112	environment	C0014406
27603112	compounds	C0574031
27603112	bind	C1167622
27603112	ECF-type ABC transporter	C3158987
27603112	none binds stably	C0243095
27603112	prion protein	C4082486
27603112	riboswitch	C2936590
27603112	compounds	C0574031
27603112	binding pockets	C1254355
27603112	MD simulation	C2717775
27603112	RNA	C0035668
27603112	binding site	C0005456
27603112	YKoF	C0033684
27603112	thiamin pyrophosphokinase	C0039850
27603112	TPK	C0039850
27603112	compounds	C0574031
27603112	tightly bound	C1145667
27603112	TPK	C0039850
27603112	biomolecules	C0574031
27603112	pollutant	C0599786
27603112	induced	C0205263
27603112	conformational changes	C0301641
27603112	compounds	C0574031
27603112	quantitative methods	C1510568
27603112	free energy perturbation	C0678592
27603112	calculations	C1441506
27603112	conclusions	C1707478
27603112	study	C2603343
27603112	quantitative	C0034384
27603112	computational screening	C4297010
27603112	interactions	C1704675
27603112	biological entities	C0574031
27603112	pollutant molecules	C0599786
27604152	Characterisation	C1880022
27604152	methicillin-resistant Staphylococcus aureus	C1265292
27604152	clinical	C0205210
27604152	isolates	C1764827
27604152	animals	C0003062
27604152	New Zealand	C0027978
27604152	subclinical	C0205211
27604152	colonisation	C2242741
27604152	dogs	C0012984
27604152	cats	C0007450
27604152	Auckland	C0681784
27604152	characterise	C1880022
27604152	methicillin-resistant Staphylococcus aureus	C1265292
27604152	MRSA	C1265292
27604152	isolates	C1764827
27604152	infection sites	C0578491
27604152	animals	C0003062
27604152	New Zealand	C0027978
27604152	prevalence	C0220900
27604152	subclinical	C0205211
27604152	MRSA colonisation	C2242741
27604152	dogs	C0012984
27604152	cats	C0007450
27604152	veterinary clinics	C2936717
27604152	Auckland	C0681784
27604152	MRSA	C1265292
27604152	isolates	C1764827
27604152	clinical	C0205210
27604152	specimens	C0370003
27604152	New Zealand	C0027978
27604152	veterinary diagnostic laboratories	C0022877
27604152	June	C3829443
27604152	June	C3829443
27604152	genotypically characterised	C1880022
27604152	DNA microarray hybridisation analysis	C1522053
27604152	spa	C0038164
27604152	typing	C0087124
27604152	nasal	C0222095
27604152	perineal skin	C0222176
27604152	swabs	C0183753
27604152	cross-sectional sample	C0370003
27604152	dogs	C0012984
27604152	cats	C0007450
27604152	veterinary clinics	C2936717
27604152	Auckland	C0681784
27604152	period	C1948053
27604152	analysed	C0936012
27604152	MRSA	C1265292
27604152	culture	C2242979
27604152	MRSA	C1265292
27604152	clinical	C0205210
27604152	isolates	C1764827
27604152	characterisation	C1880022
27604152	laboratories	C0022877
27604152	isolates	C1764827
27604152	dogs	C0012984
27604152	isolates	C1764827
27604152	dog	C0012984
27604152	foal	C3669731
27604152	isolate	C1764827
27604152	source	C0449416
27604152	strain	C1518614
27604152	types	C0332307
27604152	identified	C0205396
27604152	AK3 (ST-5 SCCmecIV	C1265292
27604152	USA500 (ST8 SCCmecIV	C1265292
27604152	WSPP (ST30 SCCmecIV	C1265292
27604152	Rhine Hesse (ST5 SCCmecII	C1265292
27604152	EMRSA-15 (ST22 SCCmecIV	C1265292
27604152	MRSA	C1265292
27604152	isolated	C0205409
27604152	cultured swabs	C0183753
27604152	Methicillin-susceptible S. aureus	C1265292
27604152	detected	C0442726
27604152	swabs	C0183753
27604152	non-aureus staphylococci	C0038170
27604152	swabs	C0183753
27604152	MRSA	C1265292
27604152	subclinical	C0205211
27604152	colonisation	C2242741
27604152	prevalence	C0220900
27604152	CI	C0009667
27604152	cats	C0007450
27604152	dogs	C0012984
27604152	modest number	C0237753
27604152	MRSA	C1265292
27604152	isolates	C1764827
27604152	study	C0085973
27604152	laboratories	C0022877
27604152	clinical	C0205210
27604152	MRSA infection	C0343401
27604152	animals	C0003062
27604152	New Zealand	C0027978
27604152	sporadic	C0205422
27604152	strain	C1518614
27604152	types	C0332307
27604152	strain	C1518614
27604152	type	C0332307
27604152	diversity	C1880371
27604152	humans	C0086418
27604152	bias	C0242568
27604152	non-random sampling	C0150105
27604152	dogs	C0012984
27604152	cats	C0007450
27604152	colonisation	C4289767
27604152	prevalence	C0220900
27604152	consistent with	C0332290
27604152	prevalence	C0220900
27604152	subclinical	C0205211
27604152	colonisation	C2242741
27604152	humans	C0086418
27604152	New Zealand	C0027978
27604152	similarities	C2348205
27604152	epidemiology	C0014507
27604152	animal	C0003062
27604152	human	C0086418
27604152	MRSA infections	C0343401
27604152	decade	C2981279
27604152	prevalence	C0220900
27604152	human	C0086418
27604152	MRSA infections	C0343401
27604152	New Zealand	C0027978
27604152	increased	C0205217
27604152	study	C0085973
27604152	MRSA	C1265292
27604152	animals	C0003062
27604152	New Zealand	C0027978
27604152	clinical	C0205210
27604152	MRSA infection	C0343401
27604152	animals	C0003062
27604152	sporadic	C0205422
27604152	diversification	C0680948
27604152	strain	C1518614
27604152	types	C0332307
27604152	therapeutic	C0302350
27604152	veterinarians	C0242856
27604152	resistome	C2945710
27606547	Cloud-based MOTIFSIM	C0037589
27606547	Detecting	C0442726
27606547	Similarity	C2348205
27606547	DNA Motif	C3178798
27606547	Data Sets	C0150098
27606547	cloud-based MOTIFSIM	C0037589
27606547	Amazon Web Services	C1710664
27606547	AWS	C1710664
27606547	cloud	C4042841
27606547	tool	C0037589
27606547	version	C0333052
27606547	web-based tool version 2.0	C0037589
27606547	algorithm	C0002045
27606547	detecting	C0442726
27606547	similarity	C2348205
27606547	DNA motif	C3178798
27606547	data sets	C0150098
27606547	cloud	C4042841
27606547	version	C0333052
27606547	researchers	C0035173
27606547	computing resources	C0035201
27606547	AWS	C1710664
27606547	detect	C0442726
27606547	similarity	C2348205
27606547	DNA motif	C3178798
27606547	data sets	C0150098
27606547	next-generation sequencing technology	C2936622
27606547	tool	C0037589
27606547	AWS	C1710664
27607871	Utilization	C0042153
27607871	Outcomes	C0086750
27607871	Sentinel Lymph Node Biopsy	C0796693
27607871	Vulvar Cancer	C0375071
27607871	sentinel node biopsy	C0796693
27607871	women	C0043210
27607871	vulvar cancer	C0375071
27607871	Perspective database	C0242356
27607871	all-payer database	C0242356
27607871	collects data	C0010995
27607871	hospitals	C0019994
27607871	retrospective cohort study	C2985505
27607871	women	C0043210
27607871	vulvar cancer	C0375071
27607871	vulvectomy	C0195066
27607871	lymph node assessment	C0193842
27607871	Multivariable models	C0026336
27607871	factors	C0679238
27607871	sentinel node biopsy	C0796693
27607871	Length of stay	C0023303
27607871	cost	C0087112
27607871	women	C0043210
27607871	sentinel node biopsy	C0796693
27607871	lymphadenectomy	C0024203
27607871	women	C0043210
27607871	sentinel node biopsy	C0796693
27607871	inguinofemoral lymphadenectomy	C0398408
27607871	sentinel node biopsy	C0796693
27607871	confidence interval	C0009667
27607871	CI	C0009667
27607871	CI	C0009667
27607871	multivariable model	C0026336
27607871	women	C0043210
27607871	treated	C1522326
27607871	sentinel node biopsy	C0796693
27607871	women	C0043210
27607871	comorbidities	C0009488
27607871	treated	C1522326
27607871	rural hospitals	C0020023
27607871	procedure	C0796693
27607871	median	C2939193
27607871	length of stay	C0023303
27607871	sentinel node biopsy	C0796693
27607871	median	C2939193
27607871	interquartile range	C1711350
27607871	women	C0043210
27607871	inguinofemoral lymphadenectomy	C0398408
27607871	interquartile range	C1711350
27607871	sentinel node biopsy	C0796693
27607871	interquartile range	C1711350
27607871	interquartile range	C1711350
27607871	lymphadenectomy	C0024203
27607871	sentinel node biopsy	C0796693
27607871	vulvar cancer	C0375071
27607871	Sentinel lymph node biopsy	C0796693
27607871	shorter hospital stay	C3489408
27607871	decreased cost	C0010187
27607871	inguinofemoral lymphadenectomy	C0398408
27608421	Condition	C0348080
27608421	dependent	C0851827
27608421	co-regulation	C1327622
27608421	genomic clusters	C0017258
27608421	virulence factors	C1136170
27608421	grapevine trunk	C0012634
27608421	pathogen	C0450254
27608421	Neofusicoccum parvum	C2269732
27608421	ascomycete	C0003965
27608421	Neofusicoccum parvum	C2269732
27608421	causal agents	C0449411
27608421	Botryosphaeria dieback	C1011772
27608421	wood	C0043217
27608421	infecting	C0439663
27608421	fungus	C0016832
27608421	threat	C0749385
27608421	grape	C0018208
27608421	worldwide	C2700280
27608421	capability	C2698977
27608421	colonizing	C4289767
27608421	woody tissue	C1514137
27608421	combined	C0205195
27608421	secretion	C0036536
27608421	phytotoxic	C1407029
27608421	compounds	C1706082
27608421	pathogenicity	C1136169
27608421	virulence	C0042765
27608421	virulence factors	C1136170
27608421	transcriptional	C0040649
27608421	dynamics	C3826426
27608421	fungus	C0016832
27608421	feeds	C0016452
27608421	substrates	C3891814
27608421	colonizes	C4289767
27608421	woody stem	C2699642
27608421	assembled	C1706853
27608421	annotated	C1552720
27608421	highly	C0205250
27608421	contiguous	C0205283
27608421	genome	C0017428
27608421	single molecule real-time DNA sequencing	C0687728
27608421	Transcriptome profiling	C0752248
27608421	RNA-sequencing	C0917793
27608421	genome	C0017428
27608421	patterns	C0449774
27608421	expression	C0017262
27608421	virulence factors	C1136170
27608421	in vitro	C0681828
27608421	potato	C0032846
27608421	dextrose agar	C3266617
27608421	medium	C0010454
27608421	amended	C1691222
27608421	grape	C0018208
27608421	wood	C0043217
27608421	substrate	C3891814
27608421	planta	C0032098
27608421	Pairwise statistical testing	C0237913
27608421	differential	C1705242
27608421	expression	C0017262
27608421	co-expression network analysis	C1880945
27608421	physically	C0205485
27608421	clustered genes	C0017258
27608421	coding	C0017380
27608421	virulence	C0042765
27608421	functions	C0542341
27608421	substrate	C3891814
27608421	stage	C1306673
27608421	plant	C0032098
27608421	infection	C3714514
27608421	Co-expressed	C0017262
27608421	gene clusters	C0017258
27608421	genes	C0017337
27608421	associated with	C0332281
27608421	secondary metabolism	C0260000
27608421	cell wall degradation	C1157855
27608421	dynamic	C0729333
27608421	co-regulation	C1327622
27608421	transcriptional networks	C1720950
27608421	N. parvum	C2269732
27608421	virulence	C0042765
27608421	co-expressed	C0017262
27608421	clusters	C0017258
27608421	genes	C0017337
27608421	promoter region	C0033413
27608421	co-regulation	C1327622
27608421	transcription factor	C0040648
27608421	Co-expression analysis	C1880945
27608421	chromatin	C0008546
27608421	regulators	C1704735
27608421	correlated	C1707520
27608421	expression	C0017262
27608421	inducible	C0205263
27608421	clusters	C0017258
27608421	virulence factors	C1136170
27608421	regulation	C1327622
27608421	virulence	C0042765
27608421	N. parvum	C2269732
27608968	Congenital anomalies	C0000768
27608968	isotretinoin	C0022265
27608968	legal aspects	C0022433
27608968	neonate	C0021289
27608968	severe	C0205082
27608968	multiple abnormalities	C0000772
27608968	isotretinoin	C0022265
27608968	mother	C0026591
27608968	knowledge	C0376554
27608968	drug complications	C1393201
27608968	physical examination	C0031809
27608968	delivery	C0011209
27608968	congenital absence	C0332907
27608968	both eyes	C0229118
27608968	auricles	C0928075
27608968	anal atresia	C0003466
27608968	cleft palate	C0008925
27608968	severe	C0205082
27608968	respiratory distress	C0476273
27608968	atresia	C0243066
27608968	anus	C0003461
27608968	neonate	C0021289
27608968	neonatal	C0021289
27608968	intensive care unit	C0021708
27608968	reconstructive surgery	C0524865
27608968	drug	C1254351
27608968	pregnancy	C0032961
27608968	drug	C1254351
27608968	pregnancy	C0032961
27608968	side effects	C0041755
27608968	legal	C1301860
27608968	consequences	C0686907
27609556	Functional adaptation	C0392673
27609556	crustacean	C1704306
27609556	exoskeletal	C0596796
27609556	elements	C0013879
27609556	structural	C0678594
27609556	compositional	C0005885
27609556	diversity	C0282469
27609556	combined	C0205195
27609556	experimental	C0681814
27609556	theoretical study	C0039778
27609556	crustacean	C1704306
27609556	cuticle	C2699479
27609556	composite	C0205199
27609556	material	C0520510
27609556	animal	C0003062
27609556	continuous exoskeleton	C0596796
27609556	Nano-fibers	C1881960
27609556	chitin	C0008141
27609556	protein molecules	C0033684
27609556	organic	C0747055
27609556	matrix	C4050026
27609556	cuticle	C2699479
27609556	macroscale	C0392762
27609556	hierarchical	C0699032
27609556	levels	C0441889
27609556	exo-	C2699479
27609556	endocuticle	C2699479
27609556	mineral phase	C0026162
27609556	Mg	C0024467
27609556	calcite	C0205686
27609556	amorphous	C1979848
27609556	calcium carbonate	C0006681
27609556	phosphate	C0031603
27609556	hierarchical	C0699032
27609556	levels	C0441889
27609556	compositional	C0005885
27609556	diversity	C0282469
27609556	degree of freedom	C0205556
27609556	varying	C0392747
27609556	physical	C1998468
27609556	mechanical	C0205245
27609556	properties	C0871161
27609556	material	C0520510
27609556	cuticle	C2699479
27609556	versatile material	C0520510
27609556	skeletal	C0521324
27609556	elements	C0013879
27609556	adapted	C0392673
27609556	functions	C0542341
27609556	eco-physiological strains	C1518614
27609556	individual species	C1705920
27609556	review	C0282443
27609556	analytical	C0178476
27609556	experimental	C0681814
27609556	theoretical studies	C0039778
27609556	cuticle	C2699479
27609556	hierarchical	C0699032
27609556	levels	C0441889
27609556	structure	C0678594
27609556	composition	C0005885
27609556	physical properties	C1998468
27609556	multi-scale hierarchical modeling approach	C0026336
27609556	results	C1274040
27609556	studies	C2603343
27609556	systematically	C0220922
27609556	predicting	C0681842
27609556	structure	C0678594
27609556	composition	C0005885
27609556	property	C0871161
27609556	relations	C0439849
27609556	cuticle	C2699479
27609556	composites	C0205199
27609556	molecular	C1521991
27609556	level	C0441889
27609556	macro-scale	C0392762
27609556	modeling approach	C0026336
27609556	development	C1527148
27609556	biomimetic materials	C1136386
27609556	knowledge-based design approach	C0026336
27609916	Draft Genome Sequences	C2348746
27609916	Isolates	C3494793
27609916	Listeria monocytogenes Serotype 1/2a	C3472320
27609916	Subgroup	C1515021
27609916	ST204	C1518614
27609916	Listeria monocytogenes	C0023861
27609916	sequence type 204 (ST204) strains	C1518614
27609916	isolated	C0205409
27609916	range of food	C0016452
27609916	environmental	C0014406
27609916	clinical	C0205210
27609916	sources	C0449416
27609916	Australia	C0004340
27609916	draft genome sequences	C2348746
27609916	meat	C0025017
27609916	dairy associated sources	C0010947
27611704	Transferability	C0205556
27611704	Homoeolog-Specific Markers	C0017393
27611704	Bread	C0006138
27611704	Wheat	C0043137
27611704	Synthesized	C1883254
27611704	Hexaploid Wheat Lines	C0043137
27611704	Bread	C0006138
27611704	wheat	C0043137
27611704	Triticum aestivum	C1123020
27611704	allohexaploid genome	C0017428
27611704	differentiate	C2945687
27611704	homoeologous sequences	C0162774
27611704	chromosome A	C0008633
27611704	B	C0008633
27611704	D	C0008633
27611704	subgenomes	C0017428
27611704	chromosome	C0008633
27611704	genome	C0017428
27611704	sequence	C0004793
27611704	Chinese Spring	C0043137
27611704	wheat cultivar	C0043137
27611704	development	C1527148
27611704	polymerase chain reaction	C0032520
27611704	PCR	C0032520
27611704	markers	C0017393
27611704	Chinese Spring	C0043137
27611704	genes	C0017337
27611704	homoeolog-specific markers	C0017393
27611704	chromosomes 4B	C0008633
27611704	7B	C0008633
27611704	markers	C0017393
27611704	PCR assays	C0032520
27611704	4B	C0008633
27611704	7B	C0008633
27611704	synthetic hexaploid wheat (SHW) line	C0043137
27611704	hybridization	C0376343
27611704	Triticum turgidum	C0997189
27611704	diploid species	C1257909
27611704	Aegilops tauschii	C1007013
27611704	markers	C0017393
27611704	chromosomes 4B	C0008633
27611704	7B	C0008633
27611704	SHW	C0043137
27611704	markers	C0017393
27611704	Chinese Spring	C0043137
27611704	bread	C0006138
27611704	wheat	C0043137
27611704	SHW lines	C0043137
27611704	Homoeolog-specific markers	C0017393
27611704	genes	C0017337
27611704	genetic investigations	C0796344
27611704	chromosome	C0008633
27611704	expression	C0017262
27612561	Participation	C0679823
27612561	adherence	C1510802
27612561	physical exercise	C0015259
27612561	completion	C0205197
27612561	primary cancer	C1306459
27612561	treatment	C0087111
27612561	purpose	C1285529
27612561	study	C2603343
27612561	identify	C0020792
27612561	demographic	C0011292
27612561	clinical	C0205210
27612561	psychosocial	C0542298
27612561	physical	C0205485
27612561	environmental	C0014406
27612561	factors	C1521761
27612561	associated with	C0332281
27612561	participation	C0679823
27612561	adherence	C1510802
27612561	combined	C0205195
27612561	resistance	C4281815
27612561	endurance exercise	C0419120
27612561	program	C3484370
27612561	cancer survivors	C1516231
27612561	completion	C0205197
27612561	primary cancer	C1306459
27612561	treatment	C0087111
27612561	Data	C1511726
27612561	randomized	C3815594
27612561	controlled	C2587213
27612561	Resistance and Endurance exercise After ChemoTherapy	C0282574
27612561	REACT	C0282574
27612561	study	C2603343
27612561	study	C2603343
27612561	participants	C0679646
27612561	REACT	C0282574
27612561	study	C2603343
27612561	randomly	C0439605
27612561	allocated	C1706778
27612561	high intensity	C4081854
27612561	HI	C4081854
27612561	low	C0205251
27612561	moderate intensity	C4081855
27612561	LMI	C0522510
27612561	exercise	C0015259
27612561	program	C3484370
27612561	Patients	C0030705
27612561	participation	C0679823
27612561	rate	C1521828
27612561	cancer survivors	C1516231
27612561	participate	C0679823
27612561	REACT	C0282574
27612561	study	C2603343
27612561	Exercise	C0015259
27612561	adherence	C1510802
27612561	reflected	C0558058
27612561	participants	C0679646
27612561	attendance	C2827364
27612561	scheduled	C0205539
27612561	exercise	C0015259
27612561	sessions	C1883016
27612561	compliance	C1321605
27612561	prescribed	C0278329
27612561	exercises	C0015259
27612561	High	C0205250
27612561	session	C1883016
27612561	attendance	C2827364
27612561	rates	C1521828
27612561	attending	C1999232
27612561	sessions	C1883016
27612561	High	C0205250
27612561	compliance	C1321605
27612561	rates	C1521828
27612561	performing	C0884358
27612561	prescribed	C0278329
27612561	exercise	C0015259
27612561	sessions	C1883016
27612561	Correlates	C1707520
27612561	exercise	C0015259
27612561	adherence	C1510802
27612561	studied	C2603343
27612561	separately	C0443299
27612561	HI	C4081854
27612561	LMI	C0522510
27612561	exercise	C0015259
27612561	Demographic	C0011292
27612561	clinical	C0205210
27612561	physical	C0205485
27612561	factors	C1521761
27612561	assessed	C1516048
27612561	self-reported	C0681906
27612561	questionnaires	C0034394
27612561	Relevant	C2347946
27612561	clinical information	C2708733
27612561	extracted	C1301820
27612561	medical records	C0025102
27612561	Multivariable logistic regression analyses	C0681925
27612561	applied	C4048755
27612561	identify	C0020792
27612561	correlates	C1707520
27612561	significantly	C0750502
27612561	associated with	C0332281
27612561	participation	C0679823
27612561	high	C0205250
27612561	session	C1883016
27612561	attendance	C2827364
27612561	high	C0205250
27612561	compliance	C1321605
27612561	resistance	C4281815
27612561	high	C0205250
27612561	compliance	C1321605
27612561	endurance exercises	C0419120
27612561	Participants	C0679646
27612561	more likely	C3840799
27612561	higher education	C0424933
27612561	non-smokers	C0337672
27612561	lower	C0205251
27612561	psychological distress	C0815107
27612561	higher	C0205250
27612561	outcome	C0085415
27612561	expectations	C0679138
27612561	perceive	C0030971
27612561	more	C0205172
27612561	exercise	C0015259
27612561	barriers	C0679881
27612561	non-participants	C1257890
27612561	HI	C4081854
27612561	exercise	C0015259
27612561	higher	C0205250
27612561	self-efficacy	C0600564
27612561	significantly	C0750502
27612561	associated with	C0332281
27612561	high	C0205250
27612561	session	C1883016
27612561	attendance	C2827364
27612561	high	C0205250
27612561	compliance	C1321605
27612561	endurance exercises	C0419120
27612561	lower	C0205251
27612561	psychological distress	C0815107
27612561	significantly	C0750502
27612561	associated with	C0332281
27612561	high	C0205250
27612561	compliance	C1321605
27612561	resistance	C4281815
27612561	exercise	C0015259
27612561	LMI	C0522510
27612561	exercise	C0015259
27612561	non-smoker	C0337672
27612561	significantly	C0750502
27612561	associated with	C0332281
27612561	high	C0205250
27612561	compliance	C1321605
27612561	resistance	C4281815
27612561	exercises	C0015259
27612561	higher	C0205250
27612561	BMI	C1305855
27612561	significantly	C0750502
27612561	associated with	C0332281
27612561	high	C0205250
27612561	compliance	C1321605
27612561	resistance	C4281815
27612561	endurance exercises	C0419120
27612561	breast cancer survivors	C1516231
27612561	less	C0439092
27612561	likely	C0750492
27612561	report	C0700287
27612561	high	C0205250
27612561	compliance	C1321605
27612561	resistance	C4281815
27612561	endurance exercises	C0419120
27612561	LMI	C0522510
27612561	exercise	C0015259
27612561	compared	C1707455
27612561	survivors	C0206194
27612561	cancer	C0006826
27612561	discriminative	C0012632
27612561	ability	C0085732
27612561	multivariable	C0439828
27612561	models	C3161035
27612561	ranged	C1514721
27612561	demographic	C0011292
27612561	clinical	C0205210
27612561	psychosocial	C0542298
27612561	factors	C1521761
27612561	associated with	C0332281
27612561	participation	C0679823
27612561	adherence	C1510802
27612561	exercise	C0015259
27612561	cancer survivors	C1516231
27612561	Psychosocial	C0542298
27612561	factors	C1521761
27612561	more	C0205172
27612561	strongly	C0442821
27612561	associated with	C0332281
27612561	adherence	C1510802
27612561	HI	C4081854
27612561	LMI	C0522510
27612561	exercise	C0015259
27612561	study	C2603343
27612561	registered	C0684224
27612561	Netherlands Trial Register	C0034975
27612561	NTR2153	C0034975
27614652	In situ	C0444498
27614652	stabilization	C0205360
27614652	heavy metals	C0347988
27614652	metal	C0025552
27614652	contaminated	C0205279
27614652	paddy	C1083174
27614652	soil	C0037592
27614652	steel	C0038239
27614652	slag	C0885779
27614652	silicon	C0037107
27614652	fertilizer	C0015919
27614652	Steel	C0038239
27614652	slag	C0885779
27614652	silicon	C0037107
27614652	fertilizer	C0015919
27614652	mobility	C0425245
27614652	bioavailability	C0005508
27614652	heavy metals	C0347988
27614652	soil	C0037592
27614652	objective	C0018017
27614652	study	C2603343
27614652	evaluate	C0220825
27614652	influence	C4054723
27614652	particle size	C0030608
27614652	composition	C0243176
27614652	slag	C0885779
27614652	metal	C0025552
27614652	immobilization	C0205245
27614652	acidic	C0001128
27614652	soil	C0037592
27614652	metals	C0025552
27614652	uptake	C0243144
27614652	rice	C1140671
27614652	rice	C1140671
27614652	growth	C0220844
27614652	slag	C0885779
27614652	soil	C0037592
27614652	pH	C0020283
27614652	plant	C0032098
27614652	silicon	C0037107
27614652	concentrations	C1446561
27614652	soil	C0037592
27614652	decreased	C0205216
27614652	bioavailability	C0005508
27614652	metals	C0025552
27614652	control treatment	C0243148
27614652	pulverous slag	C0885779
27614652	S1	C0885779
27614652	more effective	C1704419
27614652	granular	C0205248
27614652	slag	C0885779
27614652	acid	C0001128
27614652	extractable fraction of	C1264633
27614652	Cd	C0006632
27614652	soil	C0037592
27614652	decreased	C0205216
27614652	S1	C0885779
27614652	Cu	C0009968
27614652	Zn	C0043481
27614652	decreased	C0205216
27614652	treated	C1522326
27614652	S1	C0885779
27614652	significantly lower	C4055638
27614652	Cd	C0006632
27614652	Cu	C0009968
27614652	Zn	C0043481
27614652	concentrations	C1446561
27614652	rice	C1140671
27614652	tissues	C1514137
27614652	controls	C0009932
27614652	pulverous slag	C0885779
27614652	promotes	C0033414
27614652	rice	C1140671
27614652	growth	C0220844
27614652	rice	C1140671
27614652	growth	C0220844
27614652	treated	C1522326
27614652	reduced	C0392756
27614652	particle size	C0030608
27614652	slag	C0885779
27614652	rice	C1140671
27614652	growth	C0220844
27614652	metals	C0025552
27614652	stabilization	C0205360
27616047	Plasmodium falciparum	C0032150
27616047	Choline Kinase	C0008415
27616047	Inhibition	C3463820
27616047	Decrease	C0547047
27616047	Phosphatidylethanolamine	C1450468
27616047	Parasite	C0030498
27616047	Death	C0011065
27616047	Malaria	C0024530
27616047	life-threatening	C2826244
27616047	disease	C0012634
27616047	species	C1705920
27616047	protozoan parasite	C0585171
27616047	Plasmodium	C0032148
27616047	P. falciparum	C0032150
27616047	Increasing	C0442808
27616047	parasitic	C0521066
27616047	resistance	C4281815
27616047	antimalarials	C0003374
27616047	novel	C0205314
27616047	treat	C0087111
27616047	disease	C0012634
27616047	enzymes	C0014442
27616047	synthesis	C1883254
27616047	phosphatidylcholine	C1959616
27616047	phosphatidylethanolamine	C1450468
27616047	drug targets	C1521840
27616047	treat	C0087111
27616047	malaria	C0024530
27616047	inhibition	C3463820
27616047	parasite's	C0030498
27616047	growth	C0018270
27616047	cures	C0679252
27616047	malaria	C0024530
27616047	mouse model	C2986594
27616047	study	C2603343
27616047	mode of action	C1524059
27616047	P. falciparum	C0032150
27616047	choline kinase	C0008415
27616047	inhibitors	C0243077
27616047	in vitro	C1533691
27616047	in vivo	C1515655
27616047	compounds	C0205198
27616047	binding	C1167622
27616047	choline	C0008405
27616047	ethanolamine	C0059696
27616047	binding site	C0005456
27616047	P. falciparum	C0032150
27616047	choline kinase	C0008415
27616047	inhibition	C3463820
27616047	compounds	C0205198
27616047	ethanolamine kinase activity	C1150468
27616047	P. falciparum	C0032150
27616047	choline kinase	C0008415
27616047	decrease	C0547047
27616047	phosphatidylethanolamine	C1450468
27616047	levels	C0441889
27616047	P. falciparum	C0032150
27616047	growth phenotype	C0031437
27616047	parasites	C0030498
27616047	death	C0011065
27616047	mode of action	C1524059
27616047	antimalarial development	C0243107
27616047	P. falciparum	C0032150
27616047	choline kinase	C0008415
27616751	Anti-CD45RB	C0003250
27616751	donor-specific spleen cells transfusion	C0199960
27616751	inhibition	C3463820
27616751	allograft skin rejection	C2891288
27616751	memory T cells	C0682639
27616751	memory T (Tm)cells	C0682639
27616751	rejection	C0018129
27616751	transplanted organs	C0524930
27616751	anti-CD45RB monoclonal antibody (α-CD45RB)	C0003250
27616751	donor	C0013018
27616751	specific	C0205369
27616751	tolerance	C0887937
27616751	study	C2603343
27616751	pre-sensitization	C1254367
27616751	female	C0086287
27616751	C57BL/6 mice	C1521751
27616751	skin	C1123023
27616751	female	C0086287
27616751	BLAB/c mice	C0026809
27616751	Tm cells	C0682639
27616751	rejection	C0018129
27616751	secondly	C0205436
27616751	transplanted	C0700106
27616751	allografts	C0450127
27616751	α-CD45RB	C0003250
27616751	tolerance	C0887937
27616751	skin allograft	C0440814
27616751	primarily	C0205225
27616751	transplanted	C0700106
27616751	tolerance	C0887937
27616751	pre-sensitized mice	C0026809
27616751	Donor-specific spleen cell transfusion	C0199960
27616751	DST	C0199960
27616751	tolerance	C0887937
27616751	pre-sensitized	C1254367
27616751	recipients	C0376387
27616751	α-CD45RB	C0003250
27616751	DST	C0199960
27616751	rejection	C0018129
27616751	memory T cells	C0682639
27616751	pre-sensitized mice	C0026809
27616751	CD25+ T-cell	C0039194
27616751	depletion	C0677960
27616751	α-CD45RB	C0003250
27616751	DST	C0199960
27616751	therapy	C0087111
27616751	recipients	C0376387
27616751	skin allograft	C0440814
27616751	tolerance	C0887937
27616751	adoptive transfer	C0376518
27616751	donor	C0013018
27616751	memory T cells	C0682639
27616751	tolerant	C0887937
27616751	recipients	C0376387
27616751	tolerance	C0887937
27616751	findings	C0243095
27616751	α-CD45RB	C0003250
27616751	DST	C0199960
27616751	rejection	C0018129
27616751	memory T cells	C0682639
27616751	skin allograft	C0440814
27616751	acceptance	C0301944
27616751	mice	C0026809
27617108	Recruitment	C2949735
27617108	Minority	C0026192
27617108	Adolescents	C0205653
27617108	Young Adults	C0238598
27617108	Randomised Clinical Trials	C0206035
27617108	Testing	C0039593
27617108	Design	C1707689
27617108	Technology Enhanced Community Health Nursing	C0886296
27617108	TECH-N	C0886296
27617108	Pelvic Inflammatory Disease	C0242172
27617108	Pelvic inflammatory disease	C0242172
27617108	PID	C0242172
27617108	disproportionately	C0205350
27617108	adolescent	C0205653
27617108	young adult	C0238598
27617108	AYA	C0027362
27617108	women	C0043210
27617108	influence	C4054723
27617108	reproductive health	C0242667
27617108	randomized controlled trials	C0206035
27617108	RCTs	C0206035
27617108	improve	C0184511
27617108	outpatient	C0029921
27617108	adherence	C1510802
27617108	reduce	C0392756
27617108	reproductive	C0035150
27617108	morbidity	C0026538
27617108	population	C1257890
27617108	research methods	C0086912
27617108	preliminary	C0439611
27617108	effectiveness	C1280519
27617108	recruitment	C2949735
27617108	retention	C0679857
27617108	intervention	C0886296
27617108	RCT	C0206035
27617108	technology-enhanced community-health nursing	C0886296
27617108	TECH-N	C0886296
27617108	intervention	C0886296
27617108	AYA	C0027362
27617108	PID	C0242172
27617108	AYA	C0027362
27617108	women	C0043210
27617108	aged	C0001779
27617108	years	C1510829
27617108	recruited	C2949735
27617108	acute PID	C0149959
27617108	visits	C1512346
27617108	outpatient clinics	C0002424
27617108	emergency departments	C0562508
27617108	ED	C0562508
27617108	participate	C0030699
27617108	IRB-approved	C2346499
27617108	Participants	C0679646
27617108	completed	C0205197
27617108	audio-computerized self-interview	C0021822
27617108	ACASI	C0021822
27617108	vaginal specimens	C0586773
27617108	randomized	C0034656
27617108	standard	C1442989
27617108	treatment	C0087111
27617108	intervention	C0886296
27617108	Intervention	C0886296
27617108	participants	C0679646
27617108	received	C1514756
27617108	text-messaging	C3178908
27617108	support	C1521721
27617108	days	C0439228
27617108	community health nurse (CHN) interventionist	C1522710
27617108	performed	C0884358
27617108	home visit with clinical assessment	C2046813
27617108	days	C0439228
27617108	enrollment	C1516879
27617108	patients	C0030705
27617108	course	C0750729
27617108	medications	C1254363
27617108	completed	C0205197
27617108	visits	C0848616
27617108	days	C0439228
27617108	adherence	C1510802
27617108	days	C0439228
27617108	days	C0439228
27617108	outreach worker	C0586969
27617108	STI	C0036916
27617108	testing	C0039593
27617108	performed	C0884358
27617108	day	C0439228
27617108	visits	C1512346
27617108	Exploratory analyses	C0936012
27617108	descriptive statistics	C1710191
27617108	recruitment	C2949735
27617108	retention	C0679857
27617108	follow-up	C1522577
27617108	data	C1511726
27617108	design	C1707689
27617108	intervention	C0886296
27617108	months	C0439231
27617108	patients	C0030705
27617108	eligible	C1548635
27617108	eligible	C1548635
27617108	patients	C0030705
27617108	recruited	C2949735
27617108	eligible	C1548635
27617108	patients	C0030705
27617108	enrolled	C1516879
27617108	participants	C0679646
27617108	African American	C0085756
27617108	mean	C0444504
27617108	age	C0001779
27617108	individuals	C0027361
27617108	TECH-N intervention	C0886296
27617108	completed	C0205197
27617108	nursing visits	C0848616
27617108	completed	C0205197
27617108	visits	C0848616
27617108	day	C0439228
27617108	window	C1272706
27617108	patients	C0030705
27617108	retained	C0333118
27617108	month	C0439231
27617108	follow-up	C1522577
27617108	period	C1948053
27617108	Biological	C0205460
27617108	data	C1511726
27617108	shift in the biological milieu	C0001398
27617108	Chlamydia trachomatis	C0518948
27617108	Mycoplasma genitalium	C3854370
27617108	Trichomonas vaginalis infections	C0040923
27617108	Preliminary	C0439611
27617108	data	C1511726
27617108	TECH-N	C0886296
27617108	urban	C0442529
27617108	low-income	C1331016
27617108	minority	C0026192
27617108	AYA	C0027362
27617108	PID	C0242172
27617108	recruited	C2949735
27617108	retained	C0333118
27617108	participate	C0030699
27617108	sexual	C2362326
27617108	reproductive health	C0242667
27617108	RCTs	C0206035
27617108	sufficient	C0205410
27617108	investment	C0021953
27617108	design	C1707689
27617108	infrastructure of the study	C1514880
27617108	Community	C0009462
27617108	sexual health	C2362326
27617108	interventions	C0184661
27617108	feasible	C0205556
27617108	acceptable	C1879533
27617108	population	C1257890
27617315	Prostate Health Index	C4084801
27617315	[-2]pro-prostate-specific antigen	C3710767
27617315	Chinese	C0152035
27617315	men	C0025266
27617315	prostate specific antigen	C0138741
27617315	normal	C0205307
27617315	digital rectal examination	C1384593
27617315	Prostate Health Index	C4084801
27617315	PHI	C4084801
27617315	[-2]pro-prostate-specific antigen	C3710767
27617315	%p2PSA	C3710767
27617315	Chinese	C0152035
27617315	men	C0025266
27617315	prostate-specific antigen	C0138741
27617315	PSA	C0138741
27617315	normal	C0205307
27617315	digital rectal examination	C1384593
27617315	DRE	C1384593
27617315	Chinese	C0152035
27617315	men	C0025266
27617315	PSA	C0138741
27617315	normal	C0205307
27617315	DRE	C1384593
27617315	transrectal ultrasound	C0373345
27617315	TRUS	C0373345
27617315	prostate biopsy	C0194804
27617315	Blood samples	C0178913
27617315	TRUS	C0373345
27617315	prostate biopsy	C0194804
27617315	total PSA	C2986589
27617315	tPSA	C2986589
27617315	free-to-total PSA	C2207083
27617315	fPSA	C2207083
27617315	%p2PSA	C3710767
27617315	PHI	C4084801
27617315	logistic regression	C0206031
27617315	receiver operating characteristic	C0034772
27617315	decision curve analyses	C0936012
27617315	DCA	C0936012
27617315	Chinese	C0152035
27617315	men	C0025266
27617315	men	C0025266
27617315	diagnosed	C0011900
27617315	prostate cancer	C0376358
27617315	biopsy	C0005558
27617315	men	C0025266
27617315	positive biopsies	C1514241
27617315	biopsies	C0005558
27617315	PHI	C4084801
27617315	PHI	C4084801
27617315	PHI	C4084801
27617315	chi-square test	C0008041
27617315	area under curves	C0376690
27617315	AUC	C0376690
27617315	base model	C3161035
27617315	age	C0001779
27617315	tPSA	C2986589
27617315	biopsy	C0005558
27617315	%p2PSA	C3710767
27617315	PHI	C4084801
27617315	base model	C3161035
27617315	improved	C0184511
27617315	AUC	C0376690
27617315	DCA	C0936012
27617315	positive biopsy	C1514241
27617315	biopsy	C0005558
27617315	Gleason 7 or above	C0332326
27617315	prostate cancers	C0376358
27617315	PHI	C4084801
27617315	PHI	C4084801
27617315	PHI	C4084801
27617315	chi-square test	C0008041
27617315	PHI	C4084801
27617315	men	C0025266
27617315	PSA	C0138741
27617315	normal	C0205307
27617315	DRE	C1384593
27617315	biopsies	C0005558
27617315	avoided	C1554079
27617315	PHI	C4084801
27617315	%p2PSA	C3710767
27617315	prostate cancer	C0376358
27617315	high grade prostate cancer	C0376358
27617315	PHI	C4084801
27617315	%p2PSA	C3710767
27617315	Chinese	C0152035
27617315	men	C0025266
27617315	normal	C0205307
27617315	DRE	C1384593
27621200	pilot study	C0031928
27621200	relationship	C0439849
27621200	self	C0036588
27621200	compassion	C0242270
27621200	self	C0036588
27621200	judgement	C0022423
27621200	self	C0036588
27621200	kindness	C0871641
27621200	compassion	C0242270
27621200	professional quality of life	C0034380
27621200	wellbeing	C0031206
27621200	UK	C0041700
27621200	community nurses	C0557521
27621200	Compassion fatigue	C4042834
27621200	burnout	C0006433
27621200	impact	C4049986
27621200	performance	C1882330
27621200	nurses	C0557521
27621200	relationship	C0439849
27621200	self	C0036588
27621200	compassion	C0242270
27621200	self	C0036588
27621200	judgement	C0022423
27621200	self	C0036588
27621200	kindness	C0871641
27621200	compassion	C0242270
27621200	professional quality of life	C0034380
27621200	wellbeing	C0031206
27621200	community nurses	C0557521
27621200	measure	C0079809
27621200	associations	C0332281
27621200	self	C0036588
27621200	compassion	C0242270
27621200	compassion fatigue	C4042834
27621200	wellbeing	C0031206
27621200	burnout	C0006433
27621200	community nurses	C0557521
27621200	Quantitative	C0392762
27621200	data	C1511726
27621200	collected	C1516698
27621200	standardised	C1442989
27621200	psychometric questionnaires	C0034394
27621200	Professional Quality of Life Scale	C0451401
27621200	Self-Compassion Scale	C0392762
27621200	short Warwick Edinburgh Mental Wellbeing Scale	C4075266
27621200	Compassion For Others Scale	C0392762
27621200	measure	C0079809
27621200	relationships	C0439849
27621200	self	C0036588
27621200	compassion	C0242270
27621200	compassion fatigue	C4042834
27621200	wellbeing	C0031206
27621200	burnout	C0006433
27621200	cross sectional	C0010362
27621200	registered community nurses	C0687673
27621200	postgraduate	C2983146
27621200	diploma	C4035742
27621200	University	C0041740
27621200	North of England	C0014282
27621200	study	C0031928
27621200	Results	C1274040
27621200	community nurses	C0557521
27621200	score	C0449820
27621200	high	C0205250
27621200	measures	C0079809
27621200	self	C0036588
27621200	compassion	C0242270
27621200	wellbeing	C0031206
27621200	less	C0547044
27621200	burnout	C0006433
27621200	Greater	C1704243
27621200	compassion	C0242270
27621200	satisfaction	C0242428
27621200	positively	C1446409
27621200	associated with	C0332281
27621200	compassion	C0242270
27621200	wellbeing	C0031206
27621200	negatively	C0205160
27621200	correlated	C1707520
27621200	burnout	C0006433
27621200	High	C0205250
27621200	levels	C0441889
27621200	self	C0036588
27621200	compassion	C0242270
27621200	lower	C2003888
27621200	levels	C0441889
27621200	burnout	C0006433
27621200	community nurses	C0557521
27621200	greater	C1704243
27621200	compassion	C0242270
27621200	satisfaction	C0242428
27621200	compassion	C0242270
27621200	increased	C0205217
27621200	wellbeing	C0031206
27621200	less	C0547044
27621200	burnout	C0006433
27621200	implications	C0205245
27621200	suggestions	C1705535
27621200	promotion	C0033414
27621200	greater	C1704243
27621200	compassion	C0242270
27622027	CD169	C1608815
27622027	identifies	C0243095
27622027	activated	C1515879
27622027	CD8(+) T cell	C0242629
27622027	subset	C0079720
27622027	regional lymph nodes	C1179441
27622027	predicts	C0681842
27622027	favorable	C3640814
27622027	prognosis	C0033325
27622027	colorectal cancer	C1527249
27622027	patients	C0030705
27622027	CD169	C1608815
27622027	macrophages	C0024432
27622027	Mϕ	C0024432
27622027	antigen presentation	C0206431
27622027	CD169 expression	C0017262
27622027	CD8(+) T lymphocytes	C0242629
27622027	regional lymph nodes	C1179441
27622027	LNs	C1179441
27622027	investigated	C1292732
27622027	function	C0031843
27622027	clinical relevance	C0243095
27622027	CD169(+)CD8(+) T cells	C0039194
27622027	tumor-draining LNs	C0024204
27622027	colorectal cancer	C1527249
27622027	CRC	C1527249
27622027	patients	C0030705
27622027	Fresh tumor-draining LN tissues	C0440747
27622027	randomly	C0439605
27622027	enrolled patients	C4316108
27622027	assessed	C1516048
27622027	flow cytometry	C0016263
27622027	activation	C1440937
27622027	differentiation	C0007589
27622027	CD169(+)CD8(+) T cells	C0039194
27622027	T cell-mediated killing of tumor cells	C1523368
27622027	tumor-draining LN	C0024204
27622027	CRC	C1527249
27622027	patients	C0030705
27622027	multiple-color immunofluorescence	C0016318
27622027	CD169(+)CD8(+) T cell	C0039194
27622027	distribution	C1704711
27622027	prognostic	C0220901
27622027	significance	C0205556
27622027	CD169(+)CD8(+) T cells	C0039194
27622027	evaluated	C0220825
27622027	Kaplan-Meier analysis	C1720943
27622027	fraction of	C1264633
27622027	CD8(+) T cells	C0242629
27622027	regional LNs	C1179441
27622027	peripheral blood	C0229664
27622027	tonsils	C0836921
27622027	tumors	C0027651
27622027	expressed surface CD169	C1608815
27622027	In situ	C0444498
27622027	detection	C1511790
27622027	draining LNs	C0024204
27622027	revealed	C0443289
27622027	localization	C0475264
27622027	CD169(+)CD8(+) T cells	C0039194
27622027	subcapsular sinus	C1518052
27622027	interfollicular regions	C1512836
27622027	associated with	C0332281
27622027	CD169(+) Mϕ	C0024432
27622027	CD169(+)CD8(+) T cell	C0039194
27622027	ratios	C0456603
27622027	peri-tumor	C1254362
27622027	LNs	C0024204
27622027	distant-tumor	C1254362
27622027	LNs	C0024204
27622027	CD169(+)CD8(+) T cells	C0039194
27622027	predominantly	C0205556
27622027	activation markers	C0005516
27622027	CD69	C0108800
27622027	HLA-DR	C0019764
27622027	PD-1	C0135710
27622027	CD45RA	C0108789
27622027	CD62L	C0125090
27622027	levels	C0441889
27622027	high	C0205250
27622027	granzyme B	C0061878
27622027	perforin	C0070410
27622027	TNF-α	C1456820
27622027	IFNγ	C3539881
27622027	levels	C0441889
27622027	tumor-killing efficiency	C1446301
27622027	ex vitro	C1254362
27622027	CD169(+)CD8(+) T cells	C0039194
27622027	infiltrating	C0332448
27622027	tumor-draining LNs	C0024204
27622027	decreased	C0205216
27622027	disease progression	C0242656
27622027	associated with	C0332281
27622027	CRC	C1527249
27622027	patient	C0030705
27622027	survival	C0038952
27622027	identified	C0205396
27622027	activated	C1440937
27622027	cytolytic CD169(+)CD8(+) T cells	C0039195
27622027	regional LNs	C1179441
27622027	prognostic factor	C1514474
27622027	indicator	C1522602
27622027	selecting	C1707391
27622027	patients	C0030705
27622027	immunotherapy	C0021083
27622771	Appearance	C0700364
27622771	Differences	C1705242
27622771	Lots	C3272563
27622771	Brands	C0592503
27622771	Shade	C0009393
27622771	Designations	C0600091
27622771	Dental Composite Resins	C0891703
27622771	purposes	C1285529
27622771	study	C2603343
27622771	investigate	C1292732
27622771	differences	C1705242
27622771	inherent	C2347662
27622771	appearance	C0700364
27622771	characteristics	C1521970
27622771	lots	C3272563
27622771	enamel dental composite resin	C0891703
27622771	shade	C0009393
27622771	brand	C0592503
27622771	compare	C1707455
27622771	differences	C1705242
27622771	shade	C0009393
27622771	designation	C0600091
27622771	different	C1705242
27622771	brand	C0592503
27622771	dental composite resins	C0891703
27622771	Appearance	C0700364
27622771	analyses	C0936012
27622771	proceeded	C0439659
27622771	lots	C3272563
27622771	shades	C0009393
27622771	A1	C0008902
27622771	B2	C0008902
27622771	D3	C0008902
27622771	manufactured	C0870840
27622771	company	C0683757
27622771	lot	C3272563
27622771	shade	C0009393
27622771	EA1	C0008902
27622771	manufactured	C0870840
27622771	Samples	C0370003
27622771	measured	C0444706
27622771	black	C0439541
27622771	white	C0220938
27622771	gray	C1269776
27622771	backings	C1706907
27622771	spectroradiometry	C0034603
27622771	Kubelka-Munk theory	C0871935
27622771	reflectivity	C4054089
27622771	lot	C3272563
27622771	studied	C2603343
27622771	CIELAB values	C0042295
27622771	color	C0009393
27622771	differences	C1705242
27622771	shades	C0009393
27622771	lots	C3272563
27622771	analyzed	C0936012
27622771	Translucency	C0522503
27622771	indicators	C0021212
27622771	compared	C1707455
27622771	lots	C3272563
27622771	thicknesses	C1280412
27622771	Differences	C1705242
27622771	inherent	C2347662
27622771	color	C0009393
27622771	lots	C3272563
27622771	shade	C0009393
27622771	designations	C0600091
27622771	brand	C0592503
27622771	acceptability	C0814633
27622771	threshold	C0449864
27622771	Color	C0009393
27622771	difference	C1705242
27622771	enamel composite resin	C0891703
27622771	shade	C0009393
27622771	A1	C0008902
27622771	composite resin	C0891703
27622771	shade	C0009393
27622771	EA1	C0008902
27622771	acceptability	C0814633
27622771	threshold	C0449864
27622771	Statistically significant	C0237881
27622771	differences	C1705242
27622771	translucency	C0522503
27622771	lots	C3272563
27622771	shade	C0009393
27622771	range	C1514721
27622771	thicknesses	C1280412
27622771	studied	C2603343
27622771	Appearance	C0700364
27622771	analyses	C0936012
27622771	indicate	C3146298
27622771	variation	C0205419
27622771	lots	C3272563
27622771	shade	C0009393
27622771	designations	C0600091
27622771	brands	C0592503
27622771	shade	C0009393
27622771	designations	C0600091
27622771	Optical	C0029144
27622771	applied	C4048755
27622771	important	C3898777
27622771	clinical	C0205210
27622771	appearance	C0700364
27622771	characterize	C1880022
27622771	inherent	C2347662
27622771	appearance	C0700364
27622771	aid	C1269765
27622771	appearance	C0700364
27622771	matching	C1708943
27622771	process	C1522240
27622771	dental composite resins	C0891703
27622771	restorative	C0204217
27622771	operative dental procedures	C0543467
27623277	Patient Preferences	C0376409
27623277	Treatment	C0087111
27623277	Choices	C1707391
27623277	Early-Stage	C2363430
27623277	Lung Cancer	C0242379
27623277	Decision-making	C0011109
27623277	lung cancer	C0242379
27623277	treatment	C0087111
27623277	complex	C0439855
27623277	provider	C0031831
27623277	recommendations	C0034866
27623277	patient's	C0030705
27623277	clinical	C0205210
27623277	condition	C0348080
27623277	patient preferences	C0376409
27623277	study	C2603343
27623277	considerations	C0518609
27623277	lung cancer	C0242379
27623277	treatment	C0087111
27623277	patient's	C0030705
27623277	perspective	C0871010
27623277	conjoint preference experiment	C0681814
27623277	respondents	C0282122
27623277	diagnosed	C0011900
27623277	lung cancer	C0242379
27623277	Respondents	C0282122
27623277	chose	C1707391
27623277	procedures	C0087111
27623277	treatment	C0087111
27623277	modalities	C3889585
27623277	treatment	C0087111
27623277	complications	C0009566
27623277	likelihood	C0033204
27623277	recurrence	C0034897
27623277	provider	C0031831
27623277	case	C0868928
27623277	volume	C0449468
27623277	distance	C0012751
27623277	needed	C1514873
27623277	travel	C0040802
27623277	treatment	C0087111
27623277	Conjoint analysis	C0681814
27623277	attributes	C1521970
27623277	responses	C1706817
27623277	analyzed	C0936012
27623277	Respondents	C0282122
27623277	minimally	C0547040
27623277	invasive operations	C4048276
27623277	treatment	C0087111
27623277	lung cancer	C0242379
27623277	stereotactic body radiation therapy	C3896609
27623277	SBRT	C3896609
27623277	thoracotomy	C0039991
27623277	Treatment	C0087111
27623277	risk of recurrence	C2986492
27623277	attributes	C1521970
27623277	conjoint experiment	C0681814
27623277	provider	C0031831
27623277	volume	C0449468
27623277	risk	C0035647
27623277	complications	C0009566
27623277	distance	C0012751
27623277	needed	C1514873
27623277	travel	C0040802
27623277	treatment	C0087111
27623277	Procedural	C0087111
27623277	treatment	C0087111
27623277	preferences	C0558295
27623277	demographics	C1521970
27623277	self-reported	C2700446
27623277	health status	C0018759
27623277	familiarity	C0600269
27623277	procedures	C0087111
27623277	Survey	C0038951
27623277	respondents	C0282122
27623277	minimally	C0547040
27623277	invasive operations	C4048276
27623277	SBRT	C3896609
27623277	thoracotomy	C0039991
27623277	treatment	C0087111
27623277	early-stage	C2363430
27623277	non-small cell lung cancer	C0007131
27623277	Treatment	C0087111
27623277	modality	C3889585
27623277	risk	C0035647
27623277	cancer recurrence	C0920420
27623277	treatment	C0087111
27623277	preferences	C0558295
27623277	Provider	C0031831
27623277	experience	C0596545
27623277	need	C1514873
27623277	travel	C0040802
27623277	lung cancer	C0242379
27623277	treatment	C0087111
27629431	Suppressed	C1260953
27629431	translation	C0597295
27629431	ULK1	C1313678
27629431	degradation	C0597297
27629431	potential	C3245505
27629431	mechanisms	C0441712
27629431	autophagy	C0004391
27629431	prolonged	C0439590
27629431	starvation	C0038187
27629431	Macroautophagy	C1155604
27629431	autophagy	C0004391
27629431	intracellular degradation	C1523935
27629431	activated	C1879547
27629431	starvation	C0038187
27629431	data	C1511726
27629431	transcriptional	C0040649
27629431	upregulation	C0041904
27629431	autophagy	C0004391
27629431	genes	C0017337
27629431	mechanism	C0441712
27629431	controls	C2587213
27629431	autophagy	C0004391
27629431	starvation	C0038187
27629431	upregulation	C0041904
27629431	mRNA	C0035696
27629431	autophagy	C0004391
27629431	initiation gene	C0017337
27629431	ULK1	C1421350
27629431	protein	C1313678
27629431	level	C0441889
27629431	reduced	C0392756
27629431	starvation	C0038187
27629431	autophagic	C0004391
27629431	proteasomal systems	C0033684
27629431	degradation	C0597297
27629431	ULK1	C1313678
27629431	prolonged	C0439590
27629431	nitrogen	C0028158
27629431	deprivation	C0871712
27629431	level	C0441889
27629431	reduced	C0392756
27629431	ATG7	C1825498
27629431	knockout cells	C0007634
27629431	cells	C0007634
27629431	treated	C1522326
27629431	lysosomal	C0024369
27629431	proteasomal inhibitors	C1443643
27629431	starvation	C0038187
27629431	protein translation	C0597295
27629431	diminished	C0205216
27629431	treatments	C0087111
27629431	proteosynthesis inhibitors	C0033671
27629431	cycloheximide	C0010572
27629431	anisomycin	C0003082
27629431	reduction	C0392756
27629431	ULK1	C1313678
27629431	inhibition	C3463820
27629431	mitochondrial	C0026237
27629431	respiratory complexes	C4235129
27629431	mitochondrial	C0026237
27629431	ATP synthase function	C2250396
27629431	absence	C0332197
27629431	substrates	C3891814
27629431	upregulation	C0041904
27629431	ULK1 mRNA	C0035696
27629431	protein expression	C1171362
27629431	AMPK	C2350345
27629431	dependent	C3244310
27629431	U1810 lung cancer cells	C0597032
27629431	culture medium	C0010454
27629431	inhibitors	C1999216
27629431	increase	C0442805
27629431	ULK1 protein	C1313678
27629431	U1810 cells	C0597032
27629431	ATG13	C3146638
27629431	ULK1	C1313678
27629431	expression	C1171362
27629431	diminished	C0205216
27629431	upregulation	C0041904
27629431	ULK1 protein	C1313678
27629431	starvation	C0038187
27629431	translation	C0597295
27629431	transcriptional	C0040649
27629431	upregulation	C0041904
27629431	ULK1 protein	C1313678
27629431	diminished	C0205216
27629431	model	C0026336
27629431	inhibition	C3463820
27629431	protein translation	C0597295
27629431	degradation	C0597297
27629431	autophagy	C0004391
27629431	starvation	C0038187
27631550	Neuroprotective Role	C0815279
27631550	MicroRNA-22	C1537720
27631550	6-Hydroxydopamine	C0085196
27631550	Induced	C0205263
27631550	Cell	C0007634
27631550	Model	C0684309
27631550	Parkinson's Disease	C0030567
27631550	Regulation	C0017263
27631550	Target	C1521840
27631550	Gene	C0017337
27631550	TRPM7	C1425224
27631550	Parkinson's disease	C0030567
27631550	PD	C0030567
27631550	prevalent	C0205391
27631550	neurodegenerative disorder	C0524851
27631550	symptomatic	C0231220
27631550	treatment	C0087111
27631550	available	C0470187
27631550	characterized	C1880022
27631550	progressive	C0205329
27631550	loss	C1517945
27631550	dopaminergic neurons	C1512035
27631550	midbrain	C0025462
27631550	microRNAs	C1101610
27631550	miRs	C1101610
27631550	regulate post-transcriptional	C1514248
27631550	gene expression	C0017262
27631550	neuronal disease	C0027765
27631550	study	C2603343
27631550	effects	C1280500
27631550	mechanism	C0441712
27631550	miR-22	C1537720
27631550	PC12 pheochromocytoma cells	C0085262
27631550	treated	C1522326
27631550	6-hydroxydopamine	C0085196
27631550	6-OHDA	C0085196
27631550	PD	C0030567
27631550	RT-PCR	C0599161
27631550	results	C1274040
27631550	expression	C0017262
27631550	miR-22	C1537720
27631550	downregulated	C0013081
27631550	6-OHDA	C0085196
27631550	treated	C1522326
27631550	PC12 cells	C0085262
27631550	overexpression	C0017262
27631550	miR-22	C1537720
27631550	promoted	C0033414
27631550	survival	C0007620
27631550	proliferation	C0596290
27631550	6-OHDA	C0085196
27631550	induced	C0205263
27631550	PC12 cells	C0085262
27631550	miR-22	C1537720
27631550	inhibitor	C1999216
27631550	reversed	C1555029
27631550	effects	C1280500
27631550	PC12 cells	C0085262
27631550	treated	C1522326
27631550	miR-22 mimics	C1537720
27631550	inhibitor	C1999216
27631550	following	C0332282
27631550	6-OHDA	C0085196
27631550	administration	C1533734
27631550	ROS	C0162772
27631550	production	C1148560
27631550	upregulation	C0041904
27631550	downregulation	C0013081
27631550	caspase-3 activity	C1150132
27631550	luciferase	C0024075
27631550	assay	C2717977
27631550	revealed	C0443289
27631550	transient receptor potential melastatin 7	C1425224
27631550	TRPM7	C1425224
27631550	direct	C1947931
27631550	target	C1521840
27631550	gene	C0017337
27631550	miR-22	C1537720
27631550	miR-22	C1537720
27631550	overexpression	C0017262
27631550	downregulated	C0013081
27631550	level	C0441889
27631550	TRPM7	C1425224
27631550	analysis	C0936012
27631550	miR-22	C1537720
27631550	6-OHDA	C0085196
27631550	induced	C0205263
27631550	PC12	C0085262
27631550	cell survival	C0007620
27631550	proliferation	C0596290
27631550	targeting	C1521840
27631550	TRPM7	C1425224
27631550	study	C2603343
27631550	miR-22	C1537720
27631550	overexpression	C0017262
27631550	neuroprotective	C0815279
27631550	reversal	C1555029
27631550	effects	C1280500
27631550	6-OHDA	C0085196
27631550	induced	C0205263
27631550	PC12	C0085262
27631550	cell growth	C0007595
27631550	apoptosis	C0162638
27631550	targeting	C1521840
27631550	TRPM7	C1425224
27633344	Obstacle course runs	C0038039
27633344	review	C0282443
27633344	injuries	C3263723
27633344	illnesses	C0221423
27633344	series	C0205549
27633344	Canadian	C0238884
27633344	events	C0441471
27633344	RACE	C0038039
27633344	obstacle course runs	C0038039
27633344	OCRs	C0038039
27633344	significant	C0750502
27633344	concerns	C2699424
27633344	safety	C0036043
27633344	injuries	C3263723
27633344	illnesses	C0221423
27633344	rural areas	C0178837
27633344	OCRs	C0038039
27633344	emergency medical services	C0013961
27633344	EMS	C0013961
27633344	Literature	C0023866
27633344	concerning	C2699424
27633344	safety	C0036043
27633344	events	C0441471
27633344	minimal	C0547040
27633344	media	C0009458
27633344	reports	C0684224
27633344	characterise	C1880022
27633344	injury	C3263723
27633344	illness	C0221423
27633344	OCRs	C0038039
27633344	level	C0441889
27633344	medical care	C0237078
27633344	study	C2603343
27633344	analysed	C0936012
27633344	OCR	C0038039
27633344	events	C0441471
27633344	Canada	C0006823
27633344	participants	C0679646
27633344	Data	C1511726
27633344	extracted	C0677145
27633344	event	C0441471
27633344	medical charts	C0007963
27633344	patients	C0030705
27633344	onsite	C0450429
27633344	medical team	C0086390
27633344	injury	C3263723
27633344	illness	C0221423
27633344	treatment	C0087111
27633344	disposition	C0743223
27633344	race participants	C0679646
27633344	treated	C1522326
27633344	OCR	C0038039
27633344	events	C0441471
27633344	participants	C0679646
27633344	medical complaints	C0025102
27633344	injuries	C3263723
27633344	musculoskeletal	C0497254
27633344	event	C0441471
27633344	medical care	C0237078
27633344	treatments	C0087111
27633344	first aid	C0016143
27633344	medical equipment	C0025080
27633344	patients	C0030705
27633344	patients	C0030705
27633344	hospital	C0019994
27633344	EMS	C0013961
27633344	fracture	C0016658
27633344	dislocation	C0012691
27633344	head injury	C0018674
27633344	chest pain	C0008031
27633344	fall from height	C1997329
27633344	abdominal pain	C0000737
27633344	race participants	C0679646
27633344	medical services	C0199168
27633344	minor	C0332673
27633344	musculoskeletal	C0272448
27633344	treated	C1522326
27633344	hospital	C0019994
27633344	EMS	C0013961
27633344	consistent with	C0332290
27633344	mass gathering	C3841750
27633344	events	C0441471
27634305	Modern	C0242324
27634305	Medical Management	C1444483
27634305	Changing	C0392747
27634305	Patient Outcomes	C1547647
27634305	Inflammatory Bowel Disease	C0021390
27634305	impact	C4049986
27634305	modern	C0242324
27634305	medical management	C1444483
27634305	inflammatory bowel disease	C0021390
27634305	IBD	C0021390
27634305	surgical necessity	C0587668
27634305	outcomes	C1274040
27634305	unclear	C3845108
27634305	surgery	C0543467
27634305	rates	C1521828
27634305	decreased	C0205216
27634305	outcomes	C1274040
27634305	worsened	C1457868
27634305	operating	C0543467
27634305	sicker	C0221423
27634305	patients	C0030705
27634305	introduction	C0579004
27634305	biologic medications	C1531518
27634305	Inpatient	C0021562
27634305	Sample	C0370003
27634305	ICD-9-CM codes	C1137112
27634305	inpatient	C0021562
27634305	admissions	C0184666
27634305	Crohn's disease	C0010346
27634305	ulcerative colitis	C0009324
27634305	Trends	C1521798
27634305	IBD	C0021390
27634305	nutrition	C0392209
27634305	surgeries	C0543467
27634305	postoperative complications	C0032787
27634305	admissions	C0184666
27634305	IBD	C0021390
27634305	study	C2603343
27634305	period	C1948053
27634305	Surgery	C0543467
27634305	rates	C1521828
27634305	unchanged	C0442739
27634305	study	C2603343
27634305	period	C1948053
27634305	admissions	C0184666
27634305	Crohn's disease	C0010346
27634305	ulcerative colitis	C0009324
27634305	rate	C1521828
27634305	poor nutrition	C0162429
27634305	increased	C0205217
27634305	ulcerative colitis	C0009324
27634305	Crohn's disease	C0010346
27634305	Rates	C1521828
27634305	postoperative	C0032790
27634305	anastomotic leak	C0919691
27634305	unchanged	C0442739
27634305	Postoperative infection	C0392618
27634305	rates	C1521828
27634305	decreased	C0205216
27634305	Crohn's disease	C0010346
27634305	trend	C1545470
27634305	ulcerative colitis	C0009324
27634305	Rates	C1521828
27634305	IBD	C0021390
27634305	surgery	C0038894
27634305	stable	C0205360
27634305	postoperative infectious complications	C0032787
27634305	stable	C0205360
27634305	decreased	C0205216
27634305	implementation	C0018726
27634305	biologic therapies	C1531518
27634305	increase	C0442805
27634305	poor nutrition	C0162429
27634305	surgical patients	C0871463
27635073	Clinical	C0205210
27635073	Experience	C0023672
27635073	Subcutaneous Implantable Cardioverter-Defibrillator	C3694431
27635073	Adults	C0001675
27635073	Congenital Heart Disease	C0152021
27635073	Sudden cardiac death	C0085298
27635073	mortality	C0205848
27635073	adults	C0001675
27635073	congenital heart disease	C0152021
27635073	subcutaneous	C0443315
27635073	implantable cardioverter-defibrillator	C0162589
27635073	ICD	C0162589
27635073	novel	C0205314
27635073	tool	C0336791
27635073	prevention	C2700409
27635073	sudden cardiac death	C0085298
27635073	clinical performance	C3266594
27635073	data	C1511726
27635073	adults	C0001675
27635073	congenital heart disease	C0152021
27635073	retrospective study	C0035363
27635073	year	C0439234
27635073	period	C1948053
27635073	performed	C0884358
27635073	patients	C0030705
27635073	median	C2347635
27635073	years	C0439234
27635073	diagnosis	C0011900
27635073	single ventricle	C0152424
27635073	physiology	C0031843
27635073	palliated	C1274136
27635073	Fontan operation	C0190010
27635073	aortopulmonary shunts	C0397538
27635073	d-transposition of the great arteries	C1275836
27635073	Mustard	C1306542
27635073	Senning	C0339890
27635073	tetralogy of Fallot	C0039685
27635073	aortic valve disease	C1260873
27635073	biventricular	C0699808
27635073	surgery	C0543467
27635073	cardiac device	C0018825
27635073	implanted	C0948629
27635073	ICD	C0162589
27635073	indication	C3146298
27635073	primary prevention	C0033144
27635073	secondary	C0679699
27635073	patient s	C0030705
27635073	subcutaneous	C0443315
27635073	ICD	C0162589
27635073	placement	C0441587
27635073	transvenous access	C0522521
27635073	ventricular lead	C2825199
27635073	placement	C0441587
27635073	intracardiac right-to-left shunt	C0489644
27635073	Ventricular arrhythmia	C0085612
27635073	induced	C0205263
27635073	Joules	C0439256
27635073	implant complication related to infection	C0085073
27635073	not	C0332288
27635073	device removal	C0752250
27635073	median	C2347635
27635073	follow-up	C1522577
27635073	months	C0439231
27635073	patients	C0030705
27635073	inappropriate	C0340944
27635073	patient	C0030705
27635073	appropriate shocks	C0036984
27635073	arrhythmic death	C3844298
27635073	asystole	C0018790
27635073	single ventricle	C0152424
27635073	patient	C0030705
27635073	Subcutaneous	C0443315
27635073	ICD	C0162589
27635073	implantation	C0021107
27635073	adults	C0001675
27635073	congenital heart disease	C0152021
27635073	patients	C0030705
27635073	candidates	C0030705
27635073	single ventricle	C0152424
27635073	heart disease	C0018799
27635073	transvenous options	C0522521
27635073	ICD	C0162589
27635073	placement	C0441587
27635073	variable	C0439828
27635073	anatomy	C1384516
27635073	study	C2603343
27635073	successful	C1272703
27635073	conversion	C0439836
27635073	induced	C0205263
27635073	ventricular arrhythmia	C0085612
27635073	reasonable	C0184784
27635073	rhythm	C0232187
27635073	discrimination	C0234412
27635073	follow-up	C1522577
27636509	Interaction	C1704675
27636509	multiple	C0439064
27636509	gene variants	C0678941
27636509	effects	C1280500
27636509	schizophrenia	C0036341
27636509	phenotypes	C0031437
27636509	Schizophrenia	C0036341
27636509	clinically	C0205210
27636509	heterogeneous disorder	C1858576
27636509	genetic architecture	C0314603
27636509	schizophrenia	C0036341
27636509	susceptibility	C0012655
27636509	genes	C0017337
27636509	identified	C0205396
27636509	inconsistent	C0442809
27636509	contradictory	C0205556
27636509	genetic association studies	C2717878
27636509	symptoms	C1457887
27636509	interaction	C1704675
27636509	genes	C0017337
27636509	interacting	C1704675
27636509	genes	C0017337
27636509	associated with	C0332281
27636509	specific	C0205369
27636509	sub-phenotypes	C0031437
27636509	schizophrenia	C0036341
27636509	schizophrenia	C0036341
27636509	investigates	C1292732
27636509	relationship	C0439849
27636509	schizophrenia	C0036341
27636509	susceptibility	C0012655
27636509	genes	C0017337
27636509	schizophrenia	C0036341
27636509	sub-phenotypes	C0031437
27636509	identifying	C0205396
27636509	multiple	C0439064
27636509	gene variant	C0678941
27636509	interactions	C1704675
27636509	SNPs	C0752046
27636509	genes	C0017337
27636509	genotyped	C3178894
27636509	Australian	C0238711
27636509	participants	C0679646
27636509	schizophrenia	C0036341
27636509	screened	C0220908
27636509	phenotypes	C0031437
27636509	Schizophrenia	C0036341
27636509	participants	C0679646
27636509	relevant	C2347946
27636509	phenotype	C0031437
27636509	clusters	C1704332
27636509	cluster analysis	C0009085
27636509	normalized	C1882115
27636509	phenotype	C0031437
27636509	cluster	C1704332
27636509	scores	C0449820
27636509	patient	C0030705
27636509	relationship	C0439849
27636509	genotypes	C0017431
27636509	normalized	C1882115
27636509	phenotype	C0031437
27636509	cluster	C1704332
27636509	scores	C0449820
27636509	linear regression analysis	C0034980
27636509	phenotype	C0031437
27636509	clusters	C1704332
27636509	identified	C0205396
27636509	symptoms	C1457887
27636509	phenotype	C0031437
27636509	clusters	C1704332
27636509	depression	C0011570
27636509	cluster 1	C1704332
27636509	speech disorder	C0037822
27636509	behavior symptoms	C2039359
27636509	cluster 2	C1704332
27636509	hallucination	C0018524
27636509	symptoms	C1457887
27636509	cluster 3	C1704332
27636509	delusion	C0011253
27636509	symptoms	C1457887
27636509	Interaction	C1704675
27636509	SNPs	C0752046
27636509	cluster 1	C1704332
27636509	symptoms	C1457887
27636509	SNPs	C0752046
27636509	cluster 2	C1704332
27636509	symptoms	C1457887
27636509	SNPs	C0752046
27636509	cluster 3	C1704332
27636509	symptoms	C1457887
27636509	interaction	C1704675
27636509	specific	C0205369
27636509	susceptibility	C0012655
27636509	genes	C0017337
27636509	specific	C0205369
27636509	clinical	C0205210
27636509	sub-phenotypes	C0031437
27636509	schizophrenia	C0036341
27636509	patient	C0030705
27636509	cohorts	C0599755
27636509	clinical	C0205210
27636509	data	C1511726
27636509	detection	C0442726
27636509	gene interactions	C0596610
27636509	schizophrenia	C0036341
27636509	clinical	C0205210
27636509	phenotypes	C0031437
27637577	DNMT1	C1414121
27637577	gene expression profile	C1956267
27637577	methylation	C0025723
27637577	promoter region	C0033413
27637577	patients	C0030705
27637577	ankylosing spondylitis	C0038013
27637577	Ankylosing spondylitis	C0038013
27637577	AS	C0038013
27637577	autoimmune disease	C0004364
27637577	chronic inflammatory arthritis	C0003864
27637577	methylation	C0025723
27637577	biology	C0005532
27637577	immunocytes	C0312737
27637577	surveyed	C0038951
27637577	disease	C0012634
27637577	etiology	C1314792
27637577	DNA methyltransferase 1	C1621352
27637577	DNMT1	C1621352
27637577	enzyme	C0014442
27637577	regulates	C1327622
27637577	patterns	C0449774
27637577	methylated cytosine	C0010843
27637577	aim	C1947946
27637577	investigation	C0220825
27637577	methylation	C0025723
27637577	CpG	C0056912
27637577	sites	C0205145
27637577	DNMT1	C1414121
27637577	promoter	C0086860
27637577	mRNA expression	C1515670
27637577	level	C0441889
27637577	gene	C0017337
27637577	peripheral blood mononuclear cells	C1321301
27637577	PBMCs	C1321301
27637577	AS	C0038013
27637577	patients	C0030705
27637577	PBMCs	C1321301
27637577	whole blood	C0370231
27637577	AS	C0038013
27637577	patients	C0030705
27637577	healthy	C3898900
27637577	individuals	C0027361
27637577	RNA	C0035668
27637577	DNA	C0012854
27637577	leukocytes	C0023516
27637577	extracted	C0185115
27637577	quantitative analysis	C0034384
27637577	real-time PCR	C1709846
27637577	SYBR Green PCR Master Mix	C0282574
27637577	methylation	C0025723
27637577	level	C0441889
27637577	PCR	C0032520
27637577	products	C0012854
27637577	bisulfite-treated DNA	C0012854
27637577	patients	C0030705
27637577	controls	C0009932
27637577	sequenced	C1294197
27637577	healthy	C3898900
27637577	controls	C0009932
27637577	expression level	C0017262
27637577	DNMT1	C1414121
27637577	AS	C0038013
27637577	patients	C0030705
27637577	downregulated	C0013081
27637577	Methylation	C0025723
27637577	DNMT1	C1414121
27637577	promoter	C0086860
27637577	AS	C0038013
27637577	patients	C0030705
27637577	controls	C0009932
27637577	negative	C0205160
27637577	correlation	C1707520
27637577	methylation	C0025723
27637577	expression level	C0017262
27637577	DNMT1	C1414121
27637577	AS	C0038013
27637577	patients	C0030705
27637577	methylation	C0025723
27637577	expression level	C0017262
27637577	DNMT1	C1414121
27637577	correlate	C1707520
27637577	clinical	C0205210
27637577	manifestations	C0205319
27637577	decreased	C0205216
27637577	expression level	C0017262
27637577	DNMT1	C1414121
27637577	hypermethylation	C1512554
27637577	DNMT1	C1414121
27637577	promoter	C0086860
27637577	PBMCs	C1321301
27637577	AS	C0038013
27637577	patients	C0030705
27637577	survey	C0038951
27637577	DNMT1	C1414121
27637577	expression	C0017262
27637577	altered	C0392747
27637577	methylation	C0025723
27637577	level	C0441889
27637577	target	C1521840
27637577	genes	C0017337
27637577	AS	C0038013
27642330	Antibacterial	C0279516
27642330	Activity	C0441655
27642330	Polyaniline	C0962453
27642330	Coated	C1522408
27642330	Silver	C0037125
27642330	Nanoparticles	C1721060
27642330	Synthesized	C1883254
27642330	Piper Betle Leaves Extract	C3643364
27642330	Plants	C0032098
27642330	natural resources	C0027492
27642330	alternative	C1523987
27642330	method	C0449851
27642330	nanoparticles	C1450054
27642330	synthesis	C1883254
27642330	study	C2603343
27642330	polyaniline	C0962453
27642330	coated	C1522408
27642330	silver	C0037125
27642330	nanoparticles	C1721060
27642330	AgNPs	C1721060
27642330	synthesized	C1883254
27642330	Piper betle leaves extract	C3643364
27642330	antibacterial	C0279516
27642330	activity	C0441655
27642330	activity	C0441655
27642330	Silver	C0037125
27642330	nanoparticles	C1721060
27642330	reduction	C0392756
27642330	silver nitrate	C0037129
27642330	NaBH4	C0074728
27642330	reducing agent	C0376446
27642330	Silver	C0037125
27642330	nanoparticles	C1721060
27642330	extracts	C0032081
27642330	coated	C1522408
27642330	polyaniline	C0962453
27642330	nanoparticles	C1721060
27642330	characterized	C1880022
27642330	Visual inspection	C2984756
27642330	Ultraviolet-visible spectroscopy	C0037812
27642330	UV	C0037812
27642330	Fourier transform infrared Spectroscopy	C0206055
27642330	FT-IR	C0206055
27642330	Transmission Electron Microscopy (TEM) techniques	C0678118
27642330	Antibacterial	C0279516
27642330	activities	C0441655
27642330	synthesized	C1883254
27642330	silver	C0037125
27642330	nanoparticles	C1721060
27642330	tested	C0039593
27642330	Staphylococcus aureus ATCC 25923	C0038172
27642330	Salmonella typhi ATCC 14028	C0036125
27642330	Escherichia coli ATCC 25922	C0014834
27642330	Pseudomonas aeruginosa ATCC 27853	C0033809
27642330	UV-Vis spectrum	C0037812
27642330	reaction mixture	C0439962
27642330	strong absorption peak	C0444505
27642330	FT-IR	C0206055
27642330	results	C0587081
27642330	Ag-NPs	C1721060
27642330	synthesized	C1883254
27642330	capped with bio-compounds	C0205556
27642330	P. betle	C3643364
27642330	TEM	C0678118
27642330	Ag-NPs	C1721060
27642330	dispersed	C0332624
27642330	spherical structures	C0332501
27642330	particle size	C0030608
27642330	result	C1274040
27642330	revealed	C0443289
27642330	Ag-Extract NPs	C1450054
27642330	inhibition	C3463820
27642330	S. aureus	C0038172
27642330	norfloxacin	C0028365
27642330	positive control	C1883676
27642330	inhibition	C3463820
27642330	S. aureus	C0038172
27642330	maximum zone	C1710706
27642330	inhibition	C3463820
27642330	S. typhi	C0036125
27642330	E. coli	C0014834
27642330	P. aeruginosa	C0033809
27642330	results	C1274040
27642330	study	C2603343
27642330	extrapolated	C3176113
27642330	human	C0086418
27642330	further studies	C0008972
27642330	antimicrobial	C1136254
27642330	activity	C0441655
27642330	Ag-Extract NPs	C1450054
27642330	drug development program	C0872152
27643901	Clinical Pearls	C2708733
27643901	Tremor	C0040822
27643901	Hyperkinetic Movement	C0424295
27643901	Disorders	C0004936
27643901	Hyperkinetic movements	C0424295
27643901	tremor	C0040822
27643901	myoclonus	C0027066
27643901	chorea	C0008489
27643901	dystonia	C0013421
27643901	neurologic	C0524851
27643901	medical conditions	C0012634
27643901	clinical evaluation	C4084924
27643901	diagnosis	C1704656
27643901	treatment	C0087111
27643901	patients	C0030705
27643901	abnormal movements	C0013384
27645371	children	C0008059
27645371	acute lymphoblastic leukemia	C0023449
27645371	abandoned	C1272694
27645371	therapy	C0087111
27645371	Experience	C0596545
27645371	challenges	C0805586
27645371	parental	C0030551
27645371	perspectives	C0449911
27645371	treatment	C0087111
27645371	subsidies	C0038574
27645371	intensified counseling	C0010210
27645371	Refusal for treatment	C0040809
27645371	therapy	C0087111
27645371	abandonment	C0452129
27645371	childhood	C0231335
27645371	acute lymphoblastic leukemia	C0023449
27645371	ALL	C0023449
27645371	resource	C0018741
27645371	countries	C0454664
27645371	study	C2603343
27645371	children	C0008059
27645371	ALL	C0023449
27645371	treatment	C0087111
27645371	abandoned	C1272694
27645371	children	C0008059
27645371	outcome	C1274040
27645371	therapy	C0087111
27645371	abandonment	C0452129
27645371	refusal	C0040809
27645371	outcome	C1274040
27645371	ALL	C0023449
27645371	abandonment	C0452129
27645371	treatment	C0087111
27645371	subsidies	C0038574
27645371	intensified multistage counseling	C0010210
27645371	children	C0008059
27645371	therapy	C0087111
27645371	refused upfront	C1705116
27645371	abandoned	C1272694
27645371	chemotherapy	C3665472
27645371	families	C0015576
27645371	Financial problems	C0549106
27645371	dependents	C1962923
27645371	home	C0442519
27645371	perceptions	C0030971
27645371	cancer	C0006826
27645371	abandonment	C0452129
27645371	Children abandoning treatment	C0243095
27645371	induction	C0857127
27645371	survival	C0038952
27645371	abandoned	C1272694
27645371	post induction	C1254367
27645371	Intensified preabandonment counseling	C0010210
27645371	treatment	C0087111
27645371	reduction	C0392756
27645371	abandonment rates	C1521828
27645763	Effect	C1280500
27645763	New-Onset	C0746890
27645763	Left Bundle Branch Block	C0023211
27645763	Transcatheter Aortic Valve Implantation	C3509486
27645763	CoreValve	C0184252
27645763	Mortality	C0205848
27645763	Frequency	C0439603
27645763	Re-Hospitalization	C0019993
27645763	Pacemaker	C0030163
27645763	New-onset	C0746890
27645763	conduction disturbances	C0232219
27645763	transcatheter aortic valve implantation	C3509486
27645763	TAVI	C3509486
27645763	complication	C0009566
27645763	left bundle branch block	C0023211
27645763	LBBB	C0023211
27645763	clinical	C0205210
27645763	impact	C4049986
27645763	new-onset	C0746890
27645763	LBBB	C0023211
27645763	TAVI	C3509486
27645763	controversial	C0680243
27645763	clinical	C0205210
27645763	impact	C4049986
27645763	new-onset	C0746890
27645763	LBBB	C0023211
27645763	mortality	C0205848
27645763	morbidity	C0178685
27645763	pacemakers	C0030163
27645763	admissions	C0030673
27645763	heart failure	C0018801
27645763	long-term follow-up	C1517942
27645763	patients	C0030705
27645763	aortic stenosis	C0003507
27645763	treated with	C0332293
27645763	implantation	C0021107
27645763	CoreValve prosthesis	C0184252
27645763	patients	C0030705
27645763	analysis	C0936012
27645763	patients	C0030705
27645763	pre-existing	C2347662
27645763	LBBB	C0023211
27645763	permanent pacemaker	C0281945
27645763	implanted	C0021102
27645763	hours	C0439227
27645763	implantation	C0021107
27645763	patients	C0030705
27645763	groups	C0441833
27645763	group	C0441833
27645763	persistent	C0205322
27645763	new-onset	C0746890
27645763	LBBB	C0023211
27645763	group	C0441833
27645763	conduction disturbances	C0232219
27645763	treatment	C0087111
27645763	groups	C0441833
27645763	followed up	C1522577
27645763	month	C0439231
27645763	months	C0439231
27645763	months	C0439231
27645763	yearly	C0332181
27645763	Persistent	C0205322
27645763	new-onset	C0746890
27645763	LBBB	C0023211
27645763	patients	C0030705
27645763	TAVI	C3509486
27645763	patients	C0030705
27645763	conduction disturbances	C0232219
27645763	follow-up	C1522577
27645763	time	C0040223
27645763	groups	C0441833
27645763	months	C0439231
27645763	months	C0439231
27645763	time	C0040223
27645763	groups	C0441833
27645763	mortality	C0205848
27645763	groups	C0441833
27645763	groups	C0441833
27645763	re-hospitalizations	C0019993
27645763	heart failure	C0018801
27645763	Group	C0441833
27645763	pacemaker implantation	C0189842
27645763	follow-up	C1522577
27645763	group	C0441833
27645763	new-onset	C0746890
27645763	LBBB	C0023211
27645763	associated with	C0332281
27645763	higher	C0205250
27645763	incidence	C0021149
27645763	permanent pacemaker	C0281945
27645763	CoreValve	C0184252
27645763	implantation	C0021107
27645763	associated with	C0332281
27645763	mortality	C0205848
27645763	re-hospitalization	C0019993
27647760	relationship	C0439849
27647760	polymorphisms	C0032529
27647760	BDNFOS	C1538322
27647760	BDNF genes	C1332408
27647760	heroin addiction	C0019337
27647760	Han Chinese population	C0814942
27647760	heroin	C0011892
27647760	addicts	C0858354
27647760	increasing	C0442808
27647760	world	C2700280
27647760	environmental	C0686732
27647760	genetic factors	C0814299
27647760	critical	C1511545
27647760	process	C1522240
27647760	heroin addiction	C0019337
27647760	aimed	C1947946
27647760	investigate	C1292732
27647760	associations	C0439849
27647760	single nucleotide polymorphisms	C0752046
27647760	SNPs	C0752046
27647760	LIN7C	C1425077
27647760	BDNFOS	C1538322
27647760	BDNF genes	C1332408
27647760	drug addiction	C1510472
27647760	Han Chinese population	C0814942
27647760	case-control study	C0007328
27647760	cases	C0868928
27647760	healthy controls	C2986479
27647760	Xi'an	C0681784
27647760	China	C0008115
27647760	SNPs	C0752046
27647760	selected	C1707391
27647760	genotyped	C1285573
27647760	MassARRAY technology	C0282574
27647760	Sequenom	C0683757
27647760	San Diego, CA	C3828258
27647760	USA	C0041703
27647760	Odds ratios	C0028873
27647760	OR	C0028873
27647760	confidence intervals	C0009667
27647760	CIs	C0009667
27647760	calculated	C1441506
27647760	unconditional logistic regression	C0206031
27647760	age	C0001779
27647760	sex	C0079399
27647760	chi-squared test	C0008041
27647760	rs7481311	C0678941
27647760	OR	C0028873
27647760	CI	C0009667
27647760	rs11030096	C0678941
27647760	OR	C0028873
27647760	CI	C0009667
27647760	BNDFOS	C1538322
27647760	associated with	C0332281
27647760	increased	C0205217
27647760	risk	C0035647
27647760	heroin addiction	C0019337
27647760	rs988712	C0678941
27647760	BDNFOS	C1538322
27647760	decreased	C0205216
27647760	risk	C0035647
27647760	heroin addiction	C0019337
27647760	OR	C0028873
27647760	CI	C0009667
27647760	genetic model	C0026343
27647760	analysis	C0936012
27647760	'T' allele	C0002085
27647760	rs988712	C0678941
27647760	BDNFOS	C1538322
27647760	heroin addiction	C0019337
27647760	additive model	C0026343
27647760	dominant model	C0026343
27647760	allele 'T'	C0002085
27647760	rs7481311	C0678941
27647760	BDNFOS	C1538322
27647760	elevated	C3163633
27647760	risk	C0035647
27647760	heroin addiction	C0019337
27647760	additive model	C0026343
27647760	recessive model	C0026343
27647760	dominant model	C0026343
27647760	allele 'C	C0002085
27647760	rs11030096	C0678941
27647760	associated with	C0332281
27647760	increased	C0205217
27647760	risk	C0035647
27647760	addiction	C0019337
27647760	dominant model	C0026343
27647760	additive model	C0026343
27647760	rs6265	C0678941
27647760	rs11030104	C0678941
27647760	rs10767664	C0678941
27647760	BDNF	C1332408
27647760	associated with	C0332281
27647760	decreased	C0205216
27647760	risk	C0035647
27647760	heroin addiction	C0019337
27647760	rs7481311	C0678941
27647760	BDNFOS	C1538322
27647760	significant	C0750502
27647760	Bonferroni correction	C2347434
27647760	results	C2825142
27647760	polymorphisms	C0032529
27647760	BDNFOS	C1538322
27647760	important	C3898777
27647760	heroin addiction	C0019337
27647760	susceptibility	C1264642
27647760	Chinese Han population	C0814942
27648525	Risk and protective factors	C0814287
27648525	associated with	C0332281
27648525	adolescent girls'	C0001588
27648525	substance use	C0237123
27648525	Data	C1511726
27648525	Facebook	C3179065
27648525	reductions	C0547047
27648525	teenage	C0001578
27648525	substance use	C0237123
27648525	adolescent girls	C0001588
27648525	rates	C1521828
27648525	substance use	C0237123
27648525	unacceptably high	C1299351
27648525	article	C1706852
27648525	girls	C0043210
27648525	substance use	C0237123
27648525	associated with	C0332281
27648525	risk and protective factors	C0814287
27648525	goal setting	C0025361
27648525	problem solving	C0033211
27648525	refusal skills	C0683255
27648525	peer use	C0683549
27648525	self-efficacy	C0600564
27648525	gender	C0079399
27648525	specific	C0205369
27648525	risk and protective factors	C0814287
27648525	communication style	C0178556
27648525	coping skills	C0086059
27648525	self-esteem	C0036597
27648525	body image	C0005891
27648525	perceived stress	C0038443
27648525	anxiety	C0003469
27648525	depression	C0011570
27648525	Cross-sectional data	C0010362
27648525	online surveys	C0178803
27648525	adolescent girls	C0001588
27648525	Facebook	C3179065
27648525	multivariate analyses	C0026777
27648525	correlates	C0871178
27648525	adolescent	C0205653
27648525	substance use	C0237123
27648525	gender	C0079399
27648525	specific	C0205369
27648525	risk and protective factors	C0814287
27648525	associated with	C0332281
27648525	alcohol	C0001948
27648525	cigarette	C0694535
27648525	drug use	C0242510
27648525	past-month marijuana use	C0871810
27648525	associated with	C0332281
27648525	factors	C1521761
27648525	Refusal skill	C0683255
27648525	peer use	C0683549
27648525	coping	C0009967
27648525	depressive mood	C0344315
27648525	associated with	C0332281
27648525	substance use	C0237123
27648525	Substance abuse prevention	C1171221
27648525	programs	C0043113
27648525	adolescent girls	C0001588
27648525	risk and protective factors	C0814287
27648525	problem solving	C0033211
27648525	refusal skill	C0683255
27648525	peer influences	C0683549
27648525	self-efficacy	C0600564
27648525	gender	C0079399
27648525	specific	C0205369
27648525	risk and protective factors	C0814287
27648525	communication style	C0178556
27648525	coping	C0009967
27648525	self-esteem	C0036597
27648525	body image	C0005891
27648525	perceived stress	C0038443
27648525	mood management	C0262715
27649824	Ethics	C0015000
27649824	Hype	C0683753
27649824	concern	C2699424
27649824	phenomenon	C1882365
27649824	science	C0036397
27649824	hype	C0683753
27649824	exaggerate	C0442801
27649824	near	C1706276
27649824	future	C0016884
27649824	application	C4048755
27649824	research results	C0683954
27649824	problem	C0033213
27649824	area of biomedicine	C1879848
27649824	topic	C1555712
27649824	genetics	C0017398
27649824	enthusiastic	C0558083
27649824	predictions	C0681842
27649824	world	C2700280
27649824	decades	C1254367
27649824	media	C0009458
27649824	researchers	C0035173
27649824	politicians	C0682232
27649824	biotech	C0005574
27649824	industry	C0021267
27649824	genome	C0017428
27649824	health care	C0086388
27649824	revolution	C0441716
27649824	revolution	C0441716
27649824	rhetoric	C0814791
27649824	genohype	C0683753
27649824	adverse	C0243095
27649824	social consequences	C0037397
27649824	public	C0162592
27649824	hurting	C3640015
27649824	long-term	C0443252
27649824	legitimacy	C0023262
27649824	field	C1521738
27649824	data	C1511726
27649824	nature	C0349590
27649824	magnitude	C1704240
27649824	harms	C0680558
27649824	proposition	C0035174
27649824	sustained	C0443318
27649824	science	C0036397
27649824	hype	C0683753
27649824	benefit	C0814225
27649824	robust	C2986815
27649824	science	C0036397
27649824	accurate	C0443131
27649824	public	C0162592
27649824	representations	C1882932
27649824	biomedical research	C0005540
27649824	consideration	C0518609
27649824	degree	C0449286
27649824	scholarship	C0036365
27649824	ethical	C0086264
27649824	legal	C0680513
27649824	social issues	C0683653
27649824	conclusions	C1707478
27649824	ELSI scholarship	C0036365
27649824	exaggerated	C0442801
27650225	Lubiprostone	C1684405
27650225	Accelerates	C0521110
27650225	Intestinal Transit	C0232484
27650225	Alleviates	C0205245
27650225	Small Intestinal Bacterial Overgrowth	C3160854
27650225	Patients	C0030705
27650225	Chronic Constipation	C0401149
27650225	Lubiprostone	C1684405
27650225	effective	C1704419
27650225	treatment	C1522326
27650225	chronic constipation	C0401149
27650225	CC	C0401149
27650225	mechanism of action	C1524059
27650225	lubiprostone	C1684405
27650225	increasing	C0442808
27650225	fluid secretion	C2263233
27650225	lubrication	C0024069
27650225	intestinal lumen	C0545876
27650225	effects	C1280500
27650225	lubiprostone	C1684405
27650225	gastrointestinal transit	C0232484
27650225	small intestinal bacterial overgrowth	C3160854
27650225	SIBO	C3160854
27650225	study	C2603343
27650225	investigate	C1292732
27650225	lubiprostone	C1684405
27650225	gastrointestinal transit	C0232484
27650225	SIBO	C3160854
27650225	patients	C0030705
27650225	constipation	C0009806
27650225	female patients	C0150905
27650225	mean age	C0001779
27650225	years	C0439234
27650225	range	C1514721
27650225	CC	C0401149
27650225	received	C1514756
27650225	weeks	C0439230
27650225	lubiprostone	C1684405
27650225	Stool consistency	C0426740
27650225	Bristol stool scale	C4084861
27650225	frequency of bowel movements	C0426642
27650225	BMs	C0011135
27650225	Gastric emptying time	C1954153
27650225	small bowel transit time	C1254358
27650225	colon	C0009368
27650225	transit time	C1254358
27650225	CTT	C1254358
27650225	small and large bowel transit time	C0232688
27650225	SLBTT	C0232688
27650225	gut	C0699819
27650225	transit time	C1254358
27650225	measured	C0444706
27650225	wireless motility capsule	C0430022
27650225	SIBO	C3160854
27650225	status	C0449438
27650225	lactulose breath test	C0344439
27650225	Data	C1511726
27650225	analyzed	C0936012
27650225	Wilcoxon rank	C0242931
27650225	Mann-Whitney U	C0242927
27650225	Spearman׳s rank correlation	C0242929
27650225	Chi-square tests	C0008041
27650225	Lubiprostone	C1684405
27650225	softened	C0870079
27650225	stool	C0015733
27650225	increased	C0205217
27650225	frequency of BM	C0426642
27650225	median	C0876920
27650225	times	C1632851
27650225	week	C0439230
27650225	CTT	C1254358
27650225	SLBTT	C0232688
27650225	shorter	C1282927
27650225	responders	C1257890
27650225	lubiprostone	C1684405
27650225	times	C1632851
27650225	increase	C0442805
27650225	number	C0237753
27650225	weekly	C0332174
27650225	BM	C0011135
27650225	compared	C1707455
27650225	nonresponders	C1257890
27650225	higher	C0205250
27650225	frequency of BM	C0426642
27650225	treatment	C1522326
27650225	correlated	C1707520
27650225	acceleration	C0000894
27650225	CTT	C1254358
27650225	SLBTT	C0232688
27650225	gut	C0699819
27650225	transit time	C1254358
27650225	patients	C0030705
27650225	tested	C0039593
27650225	SIBO	C3160854
27650225	baseline	C1442488
27650225	positive	C1446409
27650225	SIBO	C3160854
27650225	positive	C1446409
27650225	patients	C0030705
27650225	SIBO	C3160854
27650225	negative	C0205160
27650225	lubiprostone	C1684405
27650225	treatment	C1522326
27650225	CC	C0401149
27650225	lubiprostone	C1684405
27650225	frequency of BMs	C0426642
27650225	softens	C0870079
27650225	stool	C0015733
27650225	accelerates	C0521110
27650225	intestinal transit	C0232484
27650225	decreases	C0547047
27650225	SIBO	C3160854
27650225	improvement	C2986411
27650225	SIBO	C3160854
27650225	cleansing	C1947930
27650225	effect	C1280500
27650225	increased	C0205217
27650225	intestinal fluid	C0232671
27650225	mucus	C0026727
27650225	enhanced	C2349975
27650225	intestinal motility	C0021838
27650225	lubiprostone	C1684405
27650462	Minimally invasive treatment	C0282624
27650462	bleeding	C0019080
27650462	lesions	C0221198
27650462	small bowel	C0021852
27650462	Bleeding	C0019080
27650462	lesions	C0221198
27650462	small bowel	C0021852
27650462	identify	C0205396
27650462	obscure	C3844685
27650462	symptomatology	C1457887
27650462	Localizing	C0392752
27650462	lesions	C0221198
27650462	specific	C0205369
27650462	techniques	C0449851
27650462	Double-balloon enteroscopy	C2936452
27650462	DBE	C2936452
27650462	localize	C0392752
27650462	lesions	C0221198
27650462	minimally invasive surgical treatment	C0282624
27650462	robot	C0336537
27650462	assisted	C1269765
27650462	small bowel procedures	C3865550
27650462	combination	C0205195
27650462	DBE	C2936452
27650462	localization	C0392752
27650462	robotic resection	C4038855
27650462	jejunal resections	C3837064
27650462	ileal resections	C3837066
27650462	age	C0001779
27650462	years	C0439234
27650462	operative time	C3494201
27650462	minutes	C0439232
27650462	blood loss	C3163616
27650462	conversion-to-open	C3494226
27650462	post-operative	C0032790
27650462	complications	C0009566
27650462	day	C0439228
27650462	mortality	C0205848
27650462	length of stay	C0023303
27650462	days	C0439228
27650462	pathology	C0807321
27650462	consistent with	C0332290
27650462	malignancy	C4282132
27650462	cases	C0868928
27650462	combination	C0205195
27650462	double-balloon enteroscopy	C2936452
27650462	robotic technology	C4038855
27650462	accurate	C0443131
27650462	identification	C0205396
27650462	treatment	C1522326
27650462	lesions	C0221198
27650462	treat	C1522326
27650462	minimally invasive fashion	C0282624
27651955	Kinematic	C0600169
27651955	EMG	C0013839
27651955	Responses	C0871261
27651955	Pelvis	C0030797
27651955	Leg	C1140621
27651955	Assistance	C1521721
27651955	Force	C0336996
27651955	Treadmill Walking	C2712999
27651955	Children	C0008059
27651955	Cerebral Palsy	C0007789
27651955	Treadmill training	C2107089
27651955	locomotor function	C0023946
27651955	children	C0008059
27651955	cerebral palsy	C0007789
27651955	CP	C0007789
27651955	paradigms	C0681797
27651955	kinematic	C0600169
27651955	EMG	C0013839
27651955	responses	C0871261
27651955	force	C0336996
27651955	body	C1268086
27651955	treadmill walking	C2712999
27651955	paradigms	C0681797
27651955	objective	C0018017
27651955	study	C2603343
27651955	kinematic	C0600169
27651955	EMG	C0013839
27651955	responses	C0871261
27651955	pelvis	C0030797
27651955	leg	C1140621
27651955	assistance	C1521721
27651955	force	C0336996
27651955	children	C0008059
27651955	spastic CP	C0338596
27651955	participate	C0030699
27651955	study	C2603343
27651955	assistance	C1521721
27651955	force	C0336996
27651955	pelvis	C0030797
27651955	legs	C1140621
27651955	stance	C2019827
27651955	swing phase of gait	C2039052
27651955	robotic system	C1738367
27651955	walking	C0080331
27651955	Muscle	C0026845
27651955	activities	C0441655
27651955	spatial	C1254362
27651955	temporal	C2362314
27651955	gait parameters	C0016928
27651955	loading conditions	C4279935
27651955	walking	C0080331
27651955	spatial-temporal gait parameters	C0016928
27651955	walking	C0080331
27651955	treadmill training	C2107089
27651955	pelvis	C0030797
27651955	assistance	C1521721
27651955	improved	C0184511
27651955	step height	C0427127
27651955	leg	C1140621
27651955	assistance	C1521721
27651955	improved	C0184511
27651955	step length	C0427126
27651955	walking	C0080331
27651955	leg	C1140621
27651955	assistance	C1521721
27651955	reduced	C0392756
27651955	muscle	C0026845
27651955	activation	C1879547
27651955	ankle flexor	C0581542
27651955	swing phase of gait	C2039052
27651955	step length	C0427126
27651955	walking speed	C2009910
27651955	improved	C0184511
27651955	session	C1883016
27651955	treadmill training	C2107089
27651955	pelvis	C0030797
27651955	leg	C1140621
27651955	assistance	C1521721
27651975	Population "at Risk"	C0242444
27651975	Parkinson's Disease	C0030567
27651975	Evidence	C3887511
27651975	Case-Control Study	C0007328
27651975	multifactorial pathogenesis	C0699748
27651975	Parkinson's Disease	C0030567
27651975	PD	C0030567
27651975	populations "at risk"	C0242444
27651975	disease	C0030567
27651975	case-control study	C0007328
27651975	analyzed	C0936012
27651975	Italian	C0022277
27651975	population	C1257890
27651975	general criteria	C0243161
27651975	population "at risk"	C0242444
27651975	PD	C0030567
27651975	PD	C0030567
27651975	patients	C0030705
27651975	controls	C0009932
27651975	gender	C0079399
27651975	age	C0001779
27651975	matched	C0024908
27651975	urban	C2700386
27651975	geographical area	C0681784
27651975	subjects	C0080105
27651975	interviewed	C0021822
27651975	demographics	C0011298
27651975	family history	C0241889
27651975	PD	C0030567
27651975	occupational and environmental toxicants exposure	C0149685
27651975	smoking status	C1519386
27651975	alcohol consumption	C0001948
27651975	patients	C0030705
27651975	controls	C0009932
27651975	serum	C1550100
27651975	dosing	C0178602
27651975	iron	C0337439
27651975	copper	C0373587
27651975	mercury	C0428257
27651975	manganese	C0373677
27651975	Inductively Coupled-Plasma-Mass-Spectrometry	C1553183
27651975	ICP-MS	C1553183
27651975	Positive	C1446409
27651975	family history	C0241889
27651975	toxicants exposure	C0040537
27651975	non-current-smoker	C3496610
27651975	alcohol nonconsumer status	C0425322
27651975	risk factors	C0035648
27651975	population	C1257890
27651975	concurring risk factors	C0035648
27651975	overlapping	C1948020
27651975	same subject	C0080105
27651975	increased	C0205217
27651975	overall risk	C1444641
27651975	No significant differences	C3842396
27651975	measured	C0444706
27651975	metal	C0025552
27651975	serum	C1550100
27651975	levels	C0441889
27651975	findings	C0243095
27651975	concurrent	C0205420
27651975	PD	C0030567
27651975	risk factors	C0035648
27651975	at risk	C1444641
27651975	PD	C0030567
27651975	stratification	C1514983
27651975	questionnaires	C0034394
27651975	identifying subjects	C0949543
27651975	neuroprotective strategies	C0679199
27652926	Work	C0043227
27652926	process	C1522240
27652926	performance	C1286385
27652926	professional profile	C0679924
27652926	Hearing Health Network	C0018747
27652926	reference	C1561577
27652926	satisfaction	C0242428
27652926	analyze	C0936012
27652926	correlation	C1707520
27652926	satisfaction	C0022397
27652926	professionals	C0679924
27652926	Hearing Health Care network	C0018747
27652926	micro	C3811161
27652926	regions	C0205147
27652926	Minas Gerais state	C0681784
27652926	sociodemographic profile	C2003903
27652926	work	C0043227
27652926	process	C1522240
27652926	work performance	C1286385
27652926	health service	C0018747
27652926	cross-sectional	C0010362
27652926	observational	C1518527
27652926	analytic study	C0009247
27652926	non-probabilistic sample	C4288587
27652926	professionals	C0679924
27652926	Hearing Health Care services	C0018747
27652926	Data collection	C0010995
27652926	individual	C0237401
27652926	interviews	C0021822
27652926	municipality	C0600182
27652926	professional practice	C0033284
27652926	Associations	C0439849
27652926	Professional Satisfaction	C0022397
27652926	variable	C0439828
27652926	explanatory	C0681841
27652926	variables	C0439828
27652926	Sociodemographic Data	C1511726
27652926	Work Routine	C0205547
27652926	Developed	C0332253
27652926	Actions	C3266814
27652926	Professionals	C0679924
27652926	graduate studies	C0013630
27652926	satisfied	C4084799
27652926	human resources policy	C0162791
27652926	activities	C0441655
27652926	developed	C0332253
27652926	health	C0086388
27652926	civil servants	C0401892
27652926	satisfaction	C0242428
27652926	wage	C0036064
27652926	policy	C0242456
27652926	work schedule	C0237852
27652926	correlation analysis	C0010101
27652926	work	C0043227
27652926	process	C1522240
27652926	satisfaction	C0022397
27652926	revealed	C0443289
27652926	moderate	C1510992
27652926	positive	C1514241
27652926	correlation	C1707520
27652926	Health Promotion	C0018738
27652926	Actions	C3266814
27652926	Satisfaction	C0022397
27652926	Diagnostic Equipment	C0524922
27652926	Satisfaction	C0022397
27652926	Maintenance Equipment	C4035913
27652926	study	C2603343
27652926	higher	C0205250
27652926	level	C0441889
27652926	satisfaction	C0022397
27652926	professionals	C2698884
27652926	graduate studies	C0013630
27652926	human resources policy	C0162791
27652926	activities	C0441655
27652926	developed	C0332253
27652926	civil servants	C0401892
27652926	wage	C0036064
27652926	policy	C0242456
27652926	work schedule	C0237852
27652926	relevance	C2347946
27652926	study	C2603343
27652926	health professionals	C1704312
27652926	Health Care Network	C0018747
27652926	study	C2603343
27652926	satisfaction	C0022397
27652926	level	C0441889
27652926	improvements	C2986411
27652926	satisfied	C4084799
27652926	professionals	C2698884
27652926	improve	C0184511
27652926	service quality	C0871201
27652926	show greater creativity	C0517173
27652926	commitment	C0870312
27652926	performance	C1286385
27653010	Application	C0185125
27653010	Laparoscopic	C0031150
27653010	Lumbar Discectomy	C0408632
27653010	Artificial Disc Replacement	C2144940
27653010	Follow-Up	C1522577
27653010	prospective	C0033522
27653010	observational study	C1518527
27653010	patients	C0030705
27653010	diagnosed	C0011900
27653010	symptomatic	C0231220
27653010	degenerative disc disease	C0158266
27653010	artificial disc replacement	C2144940
27653010	ADR	C2144940
27653010	laparoscopic	C0031150
27653010	technique	C0449851
27653010	study	C2603343
27653010	aimed	C1947946
27653010	assess	C1516048
27653010	safety	C0036043
27653010	efficacy	C1280519
27653010	ADR	C2144940
27653010	laparoscopic	C0031150
27653010	technique	C0449851
27653010	lumbar disc herniation	C0281899
27653010	Symptomatic	C0231220
27653010	degenerative disc disease	C0158266
27653010	low back pain	C0024031
27653010	lumbar	C0024090
27653010	segmental	C0205122
27653010	instability	C1444783
27653010	ADR	C2144940
27653010	increased	C0205217
27653010	popularity	C0679970
27653010	alternative treatment	C0683466
27653010	lumbar disc herniation	C0281899
27653010	traditional	C0443324
27653010	approach	C0449445
27653010	spinal surgery	C0920347
27653010	risk	C0035647
27653010	catastrophic	C0007397
27653010	bleeding	C0019080
27653010	injury	C3263723
27653010	vessels	C0005847
27653010	iatrogenic	C0439669
27653010	injury	C3263723
27653010	viscera	C0042779
27653010	associated structures	C1285145
27653010	laparoscopic	C0031150
27653010	lumbar discectomy	C0408632
27653010	ADR	C2144940
27653010	represent	C1882932
27653010	alternative	C1523987
27653010	patients	C0030705
27653010	males	C0086582
27653010	females	C0086287
27653010	diagnosed	C0011900
27653010	symptomatic	C0231220
27653010	degenerative disc disease	C0158266
27653010	study	C2603343
27653010	cases	C0868928
27653010	cases	C0868928
27653010	patients	C0030705
27653010	ineffective	C3242229
27653010	conservative treatments	C0459914
27653010	patients	C0030705
27653010	surgery	C0543467
27653010	operation	C0543467
27653010	consent	C1511481
27653010	Three-dimensional	C0450363
27653010	computed tomographic angiography	C1536105
27653010	3D	C0450363
27653010	CTA	C1536105
27653010	iliac	C0020889
27653010	blood vessels	C0005847
27653010	completed	C0205197
27653010	surgery	C0543467
27653010	surgical procedures	C0543467
27653010	laparoscope	C0023036
27653010	patients	C0030705
27653010	followed up	C1522577
27653010	surgeries	C0543467
27653010	successfully	C1272703
27653010	completed	C0205197
27653010	average	C1510992
27653010	operation	C0543467
27653010	time	C0040223
27653010	range	C1514721
27653010	average	C1510992
27653010	hemorrhage	C0019080
27653010	range	C1514721
27653010	cases	C0868928
27653010	X-rays	C0043299
27653010	postoperative	C0032786
27653010	follow-up	C1522577
27653010	outcome	C1274040
27653010	mobilization	C0300926
27653010	displacement	C2347509
27653010	subsidence	C3805266
27653010	patients	C0030705
27653010	exception	C1705847
27653010	case	C0868928
27653010	prosthesis migration	C2930543
27653010	follow-up	C1522577
27653010	range	C1514721
27653010	mean	C0444504
27653010	visual analog scale	C2960751
27653010	VAS	C2960751
27653010	Oswestry scores	C2960603
27653010	decreased	C0205216
27653010	postoperatively	C0032790
27653010	mean	C0444504
27653010	improvement	C2986411
27653010	rate	C1521828
27653010	VAS score	C2960751
27653010	Lumbar	C0024090
27653010	ADR	C2144940
27653010	laparoscope	C0023036
27653010	minimally invasive	C2711297
27653010	treatment	C0039798
27653010	symptomatic	C0231220
27653010	degenerative disc disease	C0158266
27653010	severe	C0205082
27653010	lumbar discogenic pain	C3662826
27655308	Low literacy	C1401894
27655308	written drug information	C0033081
27655308	information-seeking	C0392349
27655308	leaflet	C3273178
27655308	evaluation	C1550157
27655308	preferences	C0558295
27655308	images	C1704922
27655308	Low-literate	C1518028
27655308	patients	C0030705
27655308	risk	C0035647
27655308	written drug information	C0033081
27655308	patient information	C1955348
27655308	group	C1257890
27655308	communication barriers	C0009454
27655308	information	C1533716
27655308	people	C0027361
27655308	low literacy	C1401894
27655308	written drug information	C0033081
27655308	patient	C0030705
27655308	leaflet	C3273178
27655308	images	C1704922
27655308	Food banks	C1561598
27655308	education institution	C0036375
27655308	Dutch language	C0376241
27655308	training	C0220931
27655308	Netherlands	C0027778
27655308	focus groups	C0016400
27655308	individual	C0237401
27655308	interviews	C0021822
27655308	low-literate participants	C1518028
27655308	thematic framework approach	C1254372
27655308	data	C1511726
27655308	outcome	C1274040
27655308	Low-literate people's	C1518028
27655308	experience	C1533716
27655308	patient information	C1955348
27655308	leaflets	C3273178
27655308	ideas	C1254370
27655308	improvements	C2986411
27655308	perceptions	C0030971
27655308	visuals	C0234621
27655308	Patient information	C1955348
27655308	leaflets	C3273178
27655308	information	C1533716
27655308	understand	C0162340
27655308	information sources	C0683836
27655308	leaflet	C3273178
27655308	organisation	C1300196
27655308	legibility	C0870803
27655308	readability	C0871211
27655308	Participants	C0679646
27655308	images	C1704922
27655308	leaflet's	C3273178
27655308	questions	C1522634
27655308	overview	C0814812
27655308	textual	C1527021
27655308	information	C1533716
27655308	recall	C0034770
27655308	confidence	C1704726
27655308	empowerment	C0679959
27655308	safety	C0036043
27655308	leaflet	C3273178
27655308	low-literate patients	C1518028
27655308	experience	C0596545
27655308	barriers in the communication	C0009454
27655308	written drug information	C0033081
27655308	visual	C0234621
27655308	textual	C1527021
27655308	explanations	C0681841
27655308	leaflet	C3273178
27655308	improve	C0184511
27655308	understanding	C0162340
27655308	low-literate target group	C1518028
27655319	flow cytometry	C0016263
27655319	method	C0025663
27655319	detecting	C0442726
27655319	histone acetylation	C1156200
27655319	levels	C0441889
27655319	Histone deacetylase inhibitors	C1512474
27655319	AIDS	C0001175
27655319	diseases	C0012634
27655319	anticancer drugs	C0003392
27655319	lack	C0332268
27655319	unified	C1706076
27655319	reliable	C3858758
27655319	method	C0025663
27655319	detecting	C0442726
27655319	histone acetylation	C1156200
27655319	levels	C0441889
27655319	basic	C0681833
27655319	clinical research	C0008972
27655319	study	C2603343
27655319	flow cytometry	C0016263
27655319	method	C0025663
27655319	detect	C1511790
27655319	detect	C0442726
27655319	histone acetylation	C1156200
27655319	levels	C0441889
27655319	comparing	C1707455
27655319	sample	C0370003
27655319	processing	C1709694
27655319	temperature	C0039476
27655319	ice	C0020746
27655319	room temperature	C1822393
27655319	room temperature	C1822393
27655319	permeabilization	C0007605
27655319	method	C0025663
27655319	intracellular	C0021868
27655319	nuclear	C0028584
27655319	antibody	C0003241
27655319	dose	C0178602
27655319	antibody titration	C0522986
27655319	antibody	C0003241
27655319	incubation time	C0040223
27655319	time gradient	C0812409
27655319	whole blood	C0370231
27655319	peripheral blood mononuclear cells	C1321301
27655319	optimized	C2698650
27655319	method	C0025663
27655319	in vitro	C1533691
27655319	experiment	C0681814
27655319	clinical trial	C0008976
27655319	Chidamide	C2932486
27655319	China	C0008115
27655319	FDA approved HDACi	C2700205
27655319	result	C1274040
27655319	confirmed	C0750484
27655319	flow cytometry	C0016263
27655319	method	C0025663
27655319	detecting	C0442726
27655319	histone acetylation	C1156200
27655319	levels	C0441889
27655319	reliable	C3858758
27655319	fast	C0456962
27655319	convenient	C3831015
27655319	method	C0025663
27655319	basic	C0681833
27655319	clinical research	C0008972
27659183	Performance	C1882330
27659183	safety	C0086139
27659183	collagenated xenogeneic bone block	C0181075
27659183	lateral alveolar ridge augmentation	C0002387
27659183	staged implant placement	C0021107
27659183	monocenter, prospective single-arm clinical study	C2826346
27659183	assess	C0184514
27659183	clinical safety	C2826199
27659183	performance	C1882330
27659183	collagenated xenogeneic bone block	C0181075
27659183	CXBB	C0181075
27659183	lateral alveolar ridge augmentation	C0002387
27659183	two-stage	C0574055
27659183	implant placement	C0021107
27659183	patients	C0030705
27659183	exhibiting	C0449450
27659183	single	C0205171
27659183	tooth	C0040426
27659183	gap	C3887622
27659183	surgical procedure	C0543467
27659183	included	C2700399
27659183	preparation	C1521827
27659183	mucoperiosteal flaps	C1881914
27659183	rigid fixation	C0185023
27659183	CXBB	C0181075
27659183	Geistlich Bio-Graft(®)	C0282574
27659183	osteosynthesis screw	C0005975
27659183	contour	C0876954
27659183	augmentation	C1293122
27659183	submerged healing	C0043240
27659183	primary endpoint	C2986535
27659183	final	C3853528
27659183	ridge	C0447361
27659183	width	C0487742
27659183	sufficient	C0205410
27659183	adequately	C0205410
27659183	dimensioned	C0439534
27659183	titanium implant	C2165380
27659183	sites	C0205145
27659183	Secondary outcomes	C3274440
27659183	included	C2700399
27659183	gain	C1517378
27659183	ridge	C0447361
27659183	width	C0487742
27659183	Clinical parameters	C2347800
27659183	bleeding on probing	C2698524
27659183	BOP	C2698524
27659183	probing depth	C1317646
27659183	PD	C1317646
27659183	mucosal recession	C0333047
27659183	MR	C0333047
27659183	assessed	C1516048
27659183	cementation of the crown	C0458893
27659183	final visit	C0204309
27659183	implant placement	C0021107
27659183	achieved	C1706701
27659183	patients	C0030705
27659183	exhibiting	C0449450
27659183	mean	C0444504
27659183	gain	C1517378
27659183	ridge	C0447361
27659183	width	C0487742
27659183	mean	C0444504
27659183	SD	C0871420
27659183	Histological	C0002809
27659183	analysis	C0936012
27659183	homogeneous	C0439713
27659183	osseous	C0262950
27659183	organization	C1300196
27659183	CXBB	C0181075
27659183	changes	C0392747
27659183	mean	C0444504
27659183	BOP	C2698524
27659183	PD	C1317646
27659183	MR	C0333047
27659183	values	C1522609
27659183	final visit	C0204309
27659183	amounted	C1265611
27659183	CXBB	C0181075
27659183	successfully	C0679864
27659183	support	C1521721
27659183	lateral alveolar ridge augmentation	C0002387
27659183	two-stage	C0574055
27659183	implant placement	C0021107
27659547	self-perceptions	C0242498
27659547	aging	C0001811
27659547	cancer	C0006826
27659547	physical	C0205485
27659547	mental health	C0025353
27659547	older people	C3826770
27659547	cancer	C0006826
27659547	A cross-sectional study	C0010362
27659547	Older people	C3826770
27659547	stigmas	C0011570
27659547	cancer	C0006826
27659547	aging	C0001811
27659547	studies	C2603343
27659547	negative	C0205160
27659547	view	C0449911
27659547	cancer	C0006826
27659547	level of depression	C1319226
27659547	studied	C2603343
27659547	elderly population	C0001792
27659547	negative	C0205160
27659547	self-perception	C0242498
27659547	aging	C0001811
27659547	consequences	C0686907
27659547	mental	C0025353
27659547	physical health	C4060919
27659547	aging	C0001811
27659547	pathological	C1521733
27659547	contexts	C0449255
27659547	oncology	C0027651
27659547	analyze	C0936012
27659547	stigmas	C0011570
27659547	health	C0018684
27659547	elderly	C0001792
27659547	oncology	C0027651
27659547	patients	C0030705
27659547	patients	C0030705
27659547	cancer	C0006826
27659547	breast	C0006142
27659547	gynecological	C0017411
27659547	lung	C0242379
27659547	hematological	C0018939
27659547	diagnosis	C0011900
27659547	self-perception	C0242498
27659547	age	C0001779
27659547	cancer	C0006826
27659547	health	C0018684
27659547	physical	C4060919
27659547	mental	C0025353
27659547	regressions	C0684321
27659547	patients	C0030705
27659547	negative	C0205160
27659547	self-perception	C0242498
27659547	aging	C0001811
27659547	negative	C0205160
27659547	cancer	C0006826
27659547	poorer	C2700379
27659547	global health	C1456573
27659547	negative	C0205160
27659547	self-perception	C0242498
27659547	aging	C0001811
27659547	associated with	C0332281
27659547	physical	C4060919
27659547	mental health	C0025353
27659547	negative	C0205160
27659547	cancer	C0006826
27659547	mental health	C0025353
27659547	stigmas	C0011570
27659547	independent	C0085862
27659547	patients	C0030705
27659547	cancer	C0006826
27659547	stigmatization	C0038330
27659547	negative	C0205160
27659547	self-perception	C0242498
27659547	aging	C0001811
27659547	cancer	C0006826
27659547	stigmas	C0011570
27659547	mental health	C0025353
27659547	Self-perception	C0242498
27659547	aging	C0001811
27659547	physical health	C4060919
27659547	Longitudinal studies	C0023981
27659547	analyze	C0936012
27659547	stigmatization	C0038330
27659547	health	C0018684
27659602	Aortic Root	C0549113
27659602	Natural History	C0175860
27659602	Root-Sparing Ascending Replacement	C0729662
27659602	Nonsyndromic	C2677304
27659602	Aneurysmal Patients	C0030705
27659602	native	C0302891
27659602	aortic tissue	C0040300
27659602	in situ	C0444498
27659602	root-sparing ascending aortic replacement	C0729662
27659602	concern	C2699424
27659602	potential	C3245505
27659602	later	C0205087
27659602	need	C0027552
27659602	root	C0549113
27659602	reoperation	C0035110
27659602	potential	C3245505
27659602	occurrence	C2745955
27659602	localized	C0392752
27659602	dissections	C0340643
27659602	rupture	C3203359
27659602	residual	C1609982
27659602	root	C0549113
27659602	purpose of this study	C0681832
27659602	evaluate	C0184514
27659602	natural growth	C0018270
27659602	aortic root	C0549113
27659602	root-sparing aortic replacement	C0729662
27659602	consecutive	C1707491
27659602	patients	C0030705
27659602	mean	C0444504
27659602	age	C0001779
27659602	years	C0439234
27659602	male	C0025266
27659602	root-sparing aortic replacement	C0729662
27659602	sufficient	C0205410
27659602	retrievable information	C1533716
27659602	aortic root	C0549113
27659602	diameter	C1301886
27659602	postoperative	C0032790
27659602	baseline	C1442488
27659602	follow-up	C1522577
27659602	imaging	C0079595
27659602	computed tomography	C0040405
27659602	echocardiography	C0013516
27659602	annual	C0332181
27659602	growth rate	C0449249
27659602	evaluated	C1516048
27659602	compared	C1707455
27659602	influence	C4054723
27659602	valve morphology	C0332437
27659602	concomitant	C0521115
27659602	aortic valve replacement	C0003506
27659602	years	C0439234
27659602	natural history	C0175860
27659602	require	C1514873
27659602	root	C0549113
27659602	enlargement	C2711450
27659602	mm	C0439200
27659602	threshold	C0449864
27659602	root	C0549113
27659602	diameter	C1301886
27659602	calculated	C1441506
27659602	estimated	C0750572
27659602	growth rate	C0449249
27659602	aortic root	C0549113
27659602	root-sparing aortic replacement	C0729662
27659602	mm	C0439200
27659602	per year	C0439508
27659602	mean	C0444504
27659602	mm	C0439200
27659602	underlying diameter	C1301886
27659602	less than	C0439092
27659602	aortic regions	C0225914
27659602	root aneurysm	C1298820
27659602	reoperation	C0035110
27659602	expected	C1517001
27659602	years	C0439234
27659602	average	C1510992
27659602	patients	C0030705
27659602	diameter	C1301886
27659602	mm	C0439200
27659602	at risk	C1444641
27659602	reoperation	C0035110
27659602	until	C1720302
27659602	after	C0687676
27659602	years	C0439234
27659602	have passed	C2828386
27659602	Neither	C4284892
27659602	valve morphology	C0332437
27659602	concomitant	C0521115
27659602	aortic valve replacement	C0003506
27659602	influenced	C4054723
27659602	rate	C1521828
27659602	root dilation	C1866956
27659602	nonsyndromic	C2677304
27659602	patients	C0030705
27659602	aortic root	C0549113
27659602	slowest	C0439834
27659602	growing	C0018270
27659602	portion	C0449719
27659602	thoracic aorta	C1522460
27659602	native	C0302891
27659602	root	C0549113
27659602	root-sparing ascending aortic replacement	C0729662
27659602	safe approach	C0449445
27659602	secondary root	C0549113
27659602	intervention	C0184661
27659602	aortic root	C0549113
27659602	diameters	C1301886
27659602	mm	C0439200
27660194	Physical Exercise	C0015259
27660194	Late-Life	C2362314
27660194	Depression	C0011581
27660194	Effects	C1280500
27660194	Heart Rate	C0018810
27660194	Variability	C2827666
27660194	Late-life	C2362314
27660194	major depression	C1269683
27660194	associated with	C0332281
27660194	increased	C0205217
27660194	cardiovascular risk	C1113685
27660194	impaired autonomic control of the heart	C0018799
27660194	reduced	C0392756
27660194	heart rate	C0018810
27660194	variability	C2827666
27660194	HRV	C2827666
27660194	antidepressant drug	C0003289
27660194	therapy	C0087111
27660194	associated with	C0332281
27660194	reductions	C0392756
27660194	HRV	C2827666
27660194	SEEDS study	C2603343
27660194	sertraline	C0074393
27660194	associated with	C0332281
27660194	physical exercise	C0015259
27660194	improvements	C2986411
27660194	HRV	C2827666
27660194	antidepressant drug	C0003289
27660194	therapy	C0087111
27660194	Single-blind	C0037181
27660194	randomized controlled trial	C0206035
27660194	Psychiatric consultation	C1548378
27660194	primary care	C0033137
27660194	Patients	C0030705
27660194	major depression	C1269683
27660194	primary care	C0033137
27660194	Sertraline	C0074393
27660194	tailored group	C0681860
27660194	physical exercise	C0015259
27660194	S + EX	C0681860
27660194	sertraline	C0074393
27660194	weeks	C0439230
27660194	HRV	C2827666
27660194	indices	C0918012
27660194	percentage of NN intervals greater than 50 msec	C0392762
27660194	pNN50	C0392762
27660194	square root of the mean squared differences of successive NN intervals	C0392762
27660194	RMSSD	C0392762
27660194	standard deviation	C0871420
27660194	heart rate	C0018810
27660194	SDHR	C0871420
27660194	standard deviation of the NN interval	C0871420
27660194	SDNN	C0871420
27660194	high-frequency band	C0392762
27660194	HF	C0392762
27660194	low-frequency band	C0392762
27660194	LF	C0392762
27660194	ratio	C0456603
27660194	LF/HF	C0456603
27660194	measured	C0444706
27660194	baseline	C1442488
27660194	week	C0439230
27660194	week	C0439230
27660194	Psychiatric	C0846574
27660194	medical assessments	C0582103
27660194	Participants	C0679646
27660194	improvements	C2986411
27660194	HRV	C2827666
27660194	indices	C0918012
27660194	pNN50	C0392762
27660194	RMSSD	C0392762
27660194	SDHR	C0871420
27660194	SDNN	C0871420
27660194	HF	C0392762
27660194	LF	C0392762
27660194	LF/HF	C0456603
27660194	patients	C0030705
27660194	S + EX group	C0681860
27660194	increases	C0442805
27660194	HRV	C2827666
27660194	indices	C0918012
27660194	RR	C0392762
27660194	pNN50	C0392762
27660194	RMSSD	C0392762
27660194	SDHR	C0871420
27660194	SDNN	C0871420
27660194	HF	C0392762
27660194	LF	C0392762
27660194	S group	C0681860
27660194	combination	C0205195
27660194	physical exercise	C0015259
27660194	sertraline	C0074393
27660194	positive	C1446409
27660194	effects	C1280500
27660194	autonomic control of the heart	C0232164
27660194	patients	C0030705
27660194	major depression	C1269683
27660632	Genome-Wide SNP Linkage Mapping	C0008630
27660632	QTL	C0597336
27660632	Analysis	C0796344
27660632	Fiber	C1260603
27660632	Quality	C0332306
27660632	Yield	C0392762
27660632	Traits	C0599883
27660632	Upland Cotton	C0010196
27660632	Recombinant Inbred Lines	C1514783
27660632	genes	C0017337
27660632	fiber	C1260603
27660632	quality	C0332306
27660632	yield	C0392762
27660632	traits	C0599883
27660632	markers	C0017393
27660632	marker-assisted selection	C0017395
27660632	MAS	C0017395
27660632	cotton	C0010196
27660632	breeding	C4042898
27660632	188 F8	C0010196
27660632	recombinant inbred lines	C1514783
27660632	RILs	C1514783
27660632	intraspecific	C0205369
27660632	cross	C4042898
27660632	HS46	C0010196
27660632	MARCABUCAG8US-1-88	C0010196
27660632	genotyped	C0017431
27660632	cotton	C0010196
27660632	single nucleotide polymorphism (SNP) assay	C3536614
27660632	Field trials	C0868962
27660632	Sanya, Hainan Province	C0681784
27660632	cropping	C4042899
27660632	seasons	C0036497
27660632	standard	C1442989
27660632	conditions	C0348080
27660632	significant	C0237881
27660632	differences	C1705242
27660632	RILs	C1514783
27660632	environments	C0014406
27660632	replications	C1883725
27660632	fiber	C1260603
27660632	quality	C0332306
27660632	yield	C0392762
27660632	traits	C0599883
27660632	heritabilities	C0439660
27660632	traits	C0599883
27660632	fiber	C1260603
27660632	length	C1444754
27660632	fiber	C1260603
27660632	uniformity	C0205375
27660632	micronaire	C0205556
27660632	fiber	C1260603
27660632	elongation	C0018270
27660632	fiber	C1260603
27660632	strength	C0039526
27660632	boll	C0010197
27660632	weight	C0043100
27660632	lint	C4019096
27660632	percentage	C0439165
27660632	cM	C0582522
27660632	centimorgans	C0582522
27660632	linkage map	C0008630
27660632	polymorphic	C1882417
27660632	SNP	C0752046
27660632	markers	C0017393
27660632	cM	C0582522
27660632	marker	C0017393
27660632	quantitative trait locus	C0597336
27660632	QTLs	C0597336
27660632	fiber	C1260603
27660632	quality	C0332306
27660632	yield	C0392762
27660632	traits	C0599883
27660632	chromosomes	C1135923
27660632	phenotypic	C0031437
27660632	variance	C1711260
27660632	stable	C0205360
27660632	QTLs	C0597336
27660632	environments	C0014406
27660632	regions	C1953345
27660632	hotspot	C2986491
27660632	cluster	C0017258
27660632	traits	C0599883
27660632	Chr05	C1135923
27660632	Chr09	C1135923
27660632	Chr10	C1135923
27660632	Chr14	C1135923
27660632	Chr19	C1135923
27660632	Chr20	C1135923
27660632	epistatic	C0017344
27660632	QTLs	C0597336
27660632	e-QTLs	C0597336
27660632	additive	C0442796
27660632	QTLs	C0597336
27660632	additive	C0442796
27660632	QTLs	C0597336
27660632	e-QTLs	C0597336
27660632	QTL	C0597336
27660632	clusters	C0017258
27660632	SNP	C0752046
27660632	markers	C0017393
27660632	target	C1521840
27660632	regions	C1953345
27660632	map-based cloning	C0598888
27660632	gene discovery	C2717881
27660632	MAS	C0017395
27660632	cotton	C0010196
27660632	breeding	C4042898
27667559	Effects	C1280500
27667559	intervention	C0184661
27667559	human	C0086418
27667559	amniotic	C0002630
27667559	epithelial cells	C0014597
27667559	COPD	C0024117
27667559	rat	C0034716
27667559	model	C0026336
27667559	study	C2603343
27667559	investigate	C1292732
27667559	effect	C1280500
27667559	intervention	C0184661
27667559	human	C0086418
27667559	amniotic	C0002630
27667559	epithelial cell	C0014597
27667559	hAEC	C0014597
27667559	rat	C0034716
27667559	model	C0026336
27667559	chronic obstructive pulmonary disease	C0024117
27667559	COPD	C0024117
27667559	specific pathogen-free	C0162470
27667559	Wistar rats	C0034716
27667559	randomized	C0206034
27667559	control	C0009932
27667559	COPD	C0024117
27667559	COPD	C0024117
27667559	hAEC	C0014597
27667559	groups	C0441833
27667559	COPD	C0024117
27667559	intratracheal	C1555389
27667559	LPS	C0023810
27667559	smoke	C0037366
27667559	fumigation	C0016804
27667559	days	C0439228
27667559	day	C0439228
27667559	model	C0026336
27667559	rats	C0034716
27667559	AEC	C0014597
27667559	group	C0441833
27667559	intratracheal instillation	C1555389
27667559	hAECs	C0014597
27667559	placenta	C0032043
27667559	healthy	C3898900
27667559	donors	C0013018
27667559	mean linear intercept	C1444754
27667559	MLI	C1444754
27667559	mean alveolar number	C0237753
27667559	MAN	C0237753
27667559	lung emphysema	C0034067
27667559	IL-8	C0079633
27667559	radioimmunoassay	C0034580
27667559	surfactant protein D	C0084692
27667559	SP-D	C0084692
27667559	ELISA	C0014441
27667559	matrix metalloproteinase (MMP)2	C0172537
27667559	MMP8	C0172956
27667559	expression	C1171362
27667559	PCR	C0032520
27667559	Smoke	C0037366
27667559	fumigation	C0016804
27667559	LPS	C0023810
27667559	COPD	C0024117
27667559	rat	C0034716
27667559	model	C0026336
27667559	emphysema	C0034067
27667559	airway inflammation	C0021368
27667559	elevated	C3163633
27667559	MLI	C1444754
27667559	MAN	C0237753
27667559	elevated	C3163633
27667559	systemic	C0205373
27667559	lung	C0024109
27667559	tissue	C0040300
27667559	levels	C0441889
27667559	IL-8	C0079633
27667559	SP-D	C0084692
27667559	expression	C1171362
27667559	MMP2	C0172537
27667559	MMP8	C0172956
27667559	Rats	C0034716
27667559	COPD	C0024117
27667559	hAEC	C0014597
27667559	group	C0441833
27667559	alleviated	C0392756
27667559	lung	C0024109
27667559	damage	C0010957
27667559	MLI	C1444754
27667559	MAN	C0237753
27667559	reduced	C0392756
27667559	systemic	C0205373
27667559	lung	C0024109
27667559	tissue	C0040300
27667559	levels	C0441889
27667559	IL-8	C0079633
27667559	SP-D	C0084692
27667559	MMP2	C0172537
27667559	MMP8	C0172956
27667559	expression	C1171362
27667559	intervention	C0184661
27667559	hAECs	C0014597
27667559	disease progression	C0242656
27667559	rats	C0034716
27667559	COPD	C0024117
27667560	Systematic	C0220922
27667560	Identification	C0020792
27667560	Pharmacological	C0007992
27667560	Targets	C1521840
27667560	Small-Molecule	C1328819
27667560	Phenotypic Screens	C0373483
27667560	Phenotypic	C0031437
27667560	drug discovery	C0920472
27667560	advantages	C0681074
27667560	target	C1521840
27667560	based	C1527178
27667560	methods	C0025663
27667560	drug leads	C0013227
27667560	tested	C0039593
27667560	systems	C0449913
27667560	more	C0205172
27667560	closely	C3810854
27667560	model	C0026339
27667560	distinct	C2963144
27667560	disease states	C0231294
27667560	potential	C3245505
27667560	disadvantage	C0205556
27667560	difficulty	C0332218
27667560	linking	C2986575
27667560	observed	C1441672
27667560	phenotype	C0031437
27667560	specific	C0205369
27667560	cellular	C0007634
27667560	target	C1521840
27667560	problem	C0033213
27667560	developed	C1527148
27667560	DePick	C0037589
27667560	computational	C1880157
27667560	de-convolution	C1707643
27667560	tool	C2827396
27667560	determine	C1148554
27667560	targets	C1521840
27667560	specifically	C0205369
27667560	linked	C2986575
27667560	small-molecule	C1328819
27667560	phenotypic screens	C0373483
27667560	applied	C1632850
27667560	DePick	C0037589
27667560	publicly	C0678367
27667560	screens	C0302765
27667560	predicted	C0681842
27667560	drug	C0013227
27667560	target	C1521840
27667560	phenotype	C0031437
27667560	associations	C0439849
27667560	literature	C0023866
27667560	based	C1527178
27667560	evidence	C3887511
27667560	predictions	C0681842
27667560	provide	C1999230
27667560	experimental	C1517586
27667560	support	C1521721
27667560	predicted	C0681842
27667560	associations	C0439849
27667560	Interestingly	C0543488
27667560	analysis	C0936012
27667560	discovery	C1880355
27667560	previously	C0205156
27667560	unrecognized	C4288068
27667560	connection	C0449379
27667560	Wnt signaling pathway	C1520113
27667560	aromatase	C0003805
27667560	CYP19A1	C3254086
27667560	results	C0683954
27667560	demonstrate	C0443289
27667560	DePick	C0037589
27667560	accelerate	C0521110
27667560	target	C1521840
27667560	de-convolution	C1707643
27667560	aid	C1269765
27667560	discovery	C1880355
27667560	functionally	C0205245
27667560	relevant	C2347946
27667560	biological	C0205460
27667560	relationships	C0439849
27667643	Yarn	C1512347
27667643	clinical yarning	C1512347
27667643	clinician	C0871685
27667643	patient	C0030705
27667643	communication	C0009452
27667643	Aboriginal	C0935542
27667643	health care	C0086388
27667643	communication	C0009452
27667643	clinical consultation	C0009818
27667643	communication	C0009452
27667643	Aboriginal	C0935542
27667643	patients	C0030705
27667643	practitioners	C0017319
27667643	doctors	C0031831
27667643	nurses	C0028661
27667643	allied health professionals	C0002122
27667643	problematic	C0033213
27667643	health care	C0086388
27667643	Aboriginal people	C0935542
27667643	overarching framework	C0282574
27667643	practitioners	C0017319
27667643	communication	C0009452
27667643	Aboriginal	C0935542
27667643	patients	C0030705
27667643	clinical yarning	C1512347
27667643	Clinical yarning	C1512347
27667643	patient	C0030705
27667643	Aboriginal	C0935542
27667643	cultural communication	C0009452
27667643	biomedical	C1879848
27667643	health and disease	C0679215
27667643	Clinical yarning	C1512347
27667643	social	C0728831
27667643	yarn	C1512347
27667643	practitioner	C0017319
27667643	interpersonal relationship	C0021797
27667643	diagnostic	C0348026
27667643	yarn	C1512347
27667643	practitioner	C0017319
27667643	patient's	C0030705
27667643	health story	C1254370
27667643	biomedical	C1879848
27667643	scientific lens	C0947630
27667643	yarn	C1512347
27667643	employs stories	C1254370
27667643	metaphors	C0302829
27667643	patients	C0030705
27667643	health issue	C0243095
27667643	collaborative management approach	C0681804
27667643	cultural	C0220814
27667643	research	C0242481
27667643	evidence	C3887511
27667643	Clinical yarning	C1512347
27667643	outcomes	C1274040
27667643	patients	C0030705
27667643	practitioners	C0017319
27668722	single-dose	C1960417
27668722	carbapenem	C0006968
27668722	exposure	C0743284
27668722	transcriptional expression	C0017262
27668722	blaNDM-1	C3699343
27668722	mexA	C0376623
27668722	Pseudomonas aeruginosa	C0033809
27668722	therapeutic option	C0302350
27668722	carbapenem antibiotic	C0006968
27668722	Pseudomonas aeruginosa	C0033809
27668722	acquired	C1155281
27668722	intrinsic resistance	C0949669
27668722	New Delhi metallo-β-lactamase	C2973511
27668722	carbapenem resistance determinant	C0949285
27668722	P. aeruginosa	C0033809
27668722	strain	C1518614
27668722	blaNDM-1	C3699343
27668722	overexpressed	C0017262
27668722	MexAB-OprM	C0029073
27668722	carbapenem	C0006968
27668722	therapy	C0338237
27668722	clinical isolates	C1764827
27668722	P. aeruginosa	C0033809
27668722	meropenem	C0066005
27668722	strains	C1518614
27668722	strain overexpressing	C0017262
27668722	MexAB-OprM	C0029073
27668722	no	C0332197
27668722	blaNDM-1	C3699343
27668722	blaNDM-1	C3699343
27668722	expressing	C0017262
27668722	MexAB-OprM	C0029073
27668722	strain	C1518614
27668722	blaNDM-1	C3699343
27668722	overexpressing	C0017262
27668722	MexAB-OprM	C0029073
27668722	P. aeruginosa PAO1	C4164297
27668722	P. aeruginosa K2733-PAO1	C4164297
27668722	ΔMexAB-OprM	C0029073
27668722	ΔMexCD-OprJ	C0029073
27668722	ΔMexEF-OprN	C0029073
27668722	ΔMexXY-OprM	C0029073
27668722	blaNDM-1	C3699343
27668722	cloned	C0598888
27668722	Strains	C1518614
27668722	Luria-Bertani broth	C2919900
27668722	meropenem	C0066005
27668722	Total RNA	C4086963
27668722	reverse transcribed	C0035380
27668722	cDNA	C0006556
27668722	Quantitative real-time PCR	C3179034
27668722	resistance mechanisms	C1517585
27668722	Meropenem	C0066005
27668722	exposure	C0743284
27668722	elevate transcription	C0040649
27668722	blaNDM-1	C3699343
27668722	mexA gene	C0376623
27668722	single-dose	C1960417
27668722	exposure to carbapenem	C0743284
27668722	efflux pump system	C3824504
27668722	role in bacterial survival	C0220921
27668722	NDM-1	C2973511
27668722	bacterial response to carbapenem antibiotic	C0683154
27668722	resistance mechanisms	C1517585
27668722	antimicrobials	C1136254
27669217	Inducible	C0205263
27669217	Expression	C0017262
27669217	ermB	C0017337
27669217	ermT	C0017337
27669217	High	C0205250
27669217	Macrolide Resistance	C3160879
27669217	Streptococcus gallolyticus subsp. pasteurianus	C1459658
27669217	Isolates	C1518614
27669217	China	C0008115
27669217	Streptococcus gallolyticus subsp. pasteurianus	C1459658
27669217	pathogen	C0450254
27669217	zoonotic agent	C1690490
27669217	opportunistic infections	C0029118
27669217	humans	C0086418
27669217	recognition	C0205396
27669217	subspecies	C1459658
27669217	human	C0086418
27669217	infectious diseases	C0004623
27669217	antibiotic resistance	C0949669
27669217	mechanism	C0441712
27669217	study	C2603343
27669217	molecular mechanism	C1148560
27669217	macrolide resistance	C3160879
27669217	S. gallolyticus subsp. pasteurianus	C1459658
27669217	isolates	C1518614
27669217	dead	C1306577
27669217	ducklings	C0013268
27669217	China	C0008115
27669217	isolates	C1518614
27669217	multi-drug resistance	C0242640
27669217	macrolide resistance	C3160879
27669217	MIC	C1304747
27669217	MIC	C1304747
27669217	erythromycin	C0014806
27669217	clarithromycin	C0055856
27669217	Efflux-encoding mefA	C0017337
27669217	mefE genes	C0017337
27669217	isolates	C1518614
27669217	23S rRNA	C0035704
27669217	mutations	C0026882
27669217	isolates	C1518614
27669217	macrolide	C0282563
27669217	MIC	C1304747
27669217	nucleotide	C0028630
27669217	substitutions	C1706204
27669217	genes	C0017337
27669217	ribosomal proteins L4	C0073302
27669217	L22	C0035552
27669217	ermB	C0017337
27669217	ermT genes	C0017337
27669217	genomes	C0017428
27669217	isolates	C1518614
27669217	genes	C0017337
27669217	independently	C0332291
27669217	virulent isolate AL101002	C1518614
27669217	Tn916	C1518614
27669217	IS1216	C1518614
27669217	expression	C0017262
27669217	ermB	C0017337
27669217	ermT	C0017337
27669217	isolates	C1518614
27669217	erythromycin	C0014806
27669217	inducible	C0205263
27669217	macrolide	C0282563
27669217	MICs	C1304747
27669217	isolates	C1518614
27669217	inducible	C0205263
27669217	expression	C0017262
27669217	ermB	C0017337
27669217	ermT	C0017337
27669217	macrolide resistance	C3160879
27669217	S. gallolyticus subsp. pasterianus	C1459658
27669217	isolates	C1518614
27669217	findings	C0243095
27669217	macrolide resistance	C3160879
27669217	S. gallolyticus subsp. pasteurianus	C1459658
27669217	ermB	C0017337
27669217	ermT	C0017337
27669669	Bilateral	C0238767
27669669	C1 laminar hooks	C0025080
27669669	C2 pedicle screw	C1961768
27669669	fixation	C0185023
27669669	treatment	C0087111
27669669	atlantoaxial subluxation	C0263905
27669669	Grisel syndrome	C0263885
27669669	etiologies	C0015127
27669669	atlantoaxial subluxaion	C0263905
27669669	Grisel syndrome	C0263885
27669669	GS	C0263885
27669669	subluxation	C0263905
27669669	spontaneously	C0205359
27669669	inflammatory	C0333348
27669669	processes	C1522240
27669669	head	C0018670
27669669	neck	C0027530
27669669	Diagnosis	C0011900
27669669	clinical history	C0262926
27669669	suspicion	C0242114
27669669	syndrome	C0039082
27669669	Nonsurgical treatment	C0087111
27669669	resolves	C2699488
27669669	symptoms	C1457887
27669669	cases	C0868928
27669669	surgical treatment	C0543467
27669669	repair	C0374711
27669669	subluxation	C0263905
27669669	surgical techniques	C0011918
27669669	instrumentation systems	C0348000
27669669	treat	C0087111
27669669	atlantoaxial subluxation	C0263905
27669669	consensus	C0376298
27669669	treatment method	C0087111
27669669	pediatric	C1521725
27669669	population	C1257890
27669669	case	C0868928
27669669	atlantoaxial subluxation	C0263905
27669669	child	C0008059
27669669	GS	C0263885
27669669	treated	C0332154
27669669	surgically	C0543467
27669669	alternative	C1523987
27669669	construct	C0025080
27669669	case report	C0085973
27669669	literature review	C0282441
27669669	case study	C0085973
27669669	year	C0439234
27669669	girl	C0870604
27669669	month	C0439231
27669669	history	C0332119
27669669	unresolved	C0443342
27669669	Fielding type II atlantoaxial subluxation	C0263905
27669669	GS	C0263885
27669669	conservative treatment	C0459914
27669669	patient's	C0030705
27669669	symptoms	C1457887
27669669	continued	C0549178
27669669	progress	C1280477
27669669	failed	C0231175
27669669	closed reduction	C0441610
27669669	attempts	C1516084
27669669	open reduction	C2370853
27669669	C1-C2 fusion	C0037935
27669669	performed	C0884358
27669669	atlas laminar hook	C0181209
27669669	axis pedicle polyaxial screws	C0301559
27669669	literature review	C0282441
27669669	surgical treatment	C0543467
27669669	GS	C0263885
27669669	performed	C0884358
27669669	surgery	C0038895
27669669	patient	C0030705
27669669	clinical	C0205210
27669669	functional recovery	C0599766
27669669	complete resolution	C2699488
27669669	symptoms	C1457887
27669669	month	C0439231
27669669	follow-up	C1522577
27669669	examination	C0582103
27669669	continual	C0439598
27669669	evidence	C3887511
27669669	satisfactory	C0438110
27669669	reduction	C0441610
27669669	fusion	C1293131
27669669	complications	C0009566
27669669	observed	C1441672
27669669	completion	C0205197
27669669	literature review	C0282441
27669669	GS	C0263885
27669669	cases	C0868928
27669669	treated	C1522326
27669669	surgically	C0543467
27669669	patient	C0030705
27669669	age	C0001779
27669669	years	C0439234
27669669	Conservative management	C0459914
27669669	GS	C0263885
27669669	common	C0205214
27669669	effective	C1704419
27669669	treatment	C0087111
27669669	surgical cases	C0868928
27669669	reported	C0700287
27669669	literature	C0023866
27669669	results	C1274040
27669669	Satisfactory	C0438110
27669669	clinical results	C2985631
27669669	fusion	C1293131
27669669	months	C0439231
27669669	post surgery	C0241311
27669669	pediatric	C1521725
27669669	patient	C0030705
27669669	atlantoaxial subluxation	C0263905
27669669	instability	C1444783
27669669	atlas laminar hook	C0181209
27669669	axis pedicle polyaxial screws	C0301559
27671177	Caries	C0333519
27671177	Dental Fluorosis	C0026618
27671177	Oral Health Behaviour	C1830927
27671177	12-Year	C0439234
27671177	School Children	C0260267
27671177	Moderate-Fluoride Drinking Water Community	C0009462
27671177	Quetta	C0017446
27671177	Pakistan	C0030211
27671177	prevalence	C0033105
27671177	dental caries	C0011334
27671177	relationship	C0439849
27671177	dental fluorosis	C0026618
27671177	oral health behaviour	C1830927
27671177	dietary behaviour	C4019289
27671177	12-year	C0439234
27671177	school children	C0260267
27671177	moderate-fluoride drinking water community	C0009462
27671177	Quetta	C0017446
27671177	Pakistan	C0030211
27671177	Cross-sectional study	C0010362
27671177	Government	C0036375
27671177	private schools	C0036375
27671177	Quetta	C0017446
27671177	November	C3828767
27671177	February	C3830166
27671177	children	C0008059
27671177	12-year	C0439234
27671177	schools	C0036375
27671177	data collection	C0010995
27671177	questionnaire	C0034394
27671177	children	C0008059
27671177	Dental caries	C0011334
27671177	status	C0449438
27671177	status	C0449438
27671177	examined	C0332128
27671177	WHO	C0043237
27671177	Dental caries	C0011334
27671177	children	C0008059
27671177	DMFT	C0012845
27671177	Boys	C0870221
27671177	dental caries	C0011334
27671177	girls	C0870604
27671177	Dental fluorosis	C0026618
27671177	children	C0008059
27671177	moderate	C0205081
27671177	Dental fluorosis	C0026618
27671177	status	C0449438
27671177	associated with	C0332281
27671177	dental caries	C0011334
27671177	status	C0449438
27671177	children	C0008059
27671177	children	C0008059
27671177	mild	C2945599
27671177	moderate	C0205081
27671177	severe	C0205082
27671177	fluorosis	C0026618
27671177	develop	C1527148
27671177	caries	C0333519
27671177	fluorosis	C0026618
27671177	association	C0439849
27671177	children's	C0008059
27671177	caries	C0333519
27671177	status	C0449438
27671177	paste	C0040462
27671177	brushing habit	C0040461
27671177	miswak	C0011379
27671177	visit	C0545082
27671177	dentist	C0011441
27671177	pastries	C0016452
27671177	juices	C1268568
27671177	children's	C0008059
27671177	dental caries	C0011334
27671177	status	C0449438
27671177	Dental caries	C0011334
27671177	children	C0008059
27671177	Quetta	C0017446
27671177	fluoride	C0016327
27671177	deficient	C0011155
27671177	countries	C0454664
27671177	prevalence	C0033105
27671177	dental fluorosis	C0026618
27671177	consumption	C2983605
27671177	pastries	C0016452
27671177	juices	C1268568
27671177	dental caries	C0011334
27671789	Proteomics	C0751973
27671789	analysis	C0002778
27671789	endogenous	C0205227
27671789	leaf	C0242724
27671789	SUMOylome	C0872079
27671789	SUMOylation	C1157990
27671789	post-translational modification	C0033666
27671789	regulates	C1327622
27671789	critical	C1511545
27671789	biological processes	C3714634
27671789	mammals	C0024660
27671789	yeast	C0043393
27671789	plants	C0032098
27671789	understand	C0162340
27671789	functional effects	C0935657
27671789	SUMOylation	C1157990
27671789	essential	C0205224
27671789	identification	C0020792
27671789	endogenous	C0205227
27671789	targets	C1521840
27671789	SUMOylation	C1157990
27671789	report	C0684224
27671789	results	C1274040
27671789	proteomic approach	C0872252
27671789	3D	C0450363
27671789	gels	C0017243
27671789	endogenous	C0205227
27671789	SUMO	C0911575
27671789	targets	C1521840
27671789	leaves	C0242724
27671789	Solanum tuberosum	C1145678
27671789	3D	C0450363
27671789	gels	C0017243
27671789	co-migration	C1254366
27671789	proteins	C0033684
27671789	major	C0205164
27671789	limitation	C0449295
27671789	2D	C1705052
27671789	gels	C0017243
27671789	highly sensitive	C0439822
27671789	CyDye DIGE fluor saturation dyes	C0016320
27671789	identified	C0205396
27671789	individual proteins	C0033684
27671789	probable	C0033204
27671789	SUMO	C0911575
27671789	targets	C1521840
27671789	leaves	C0242724
27671789	Solanum tuberosum	C1145678
27671789	method	C0871511
27671789	approaches	C1292724
27671789	possible	C0332149
27671789	future	C0016884
27671789	developments	C1527148
27671789	authors	C3812881
27671789	conflicts of interest	C0079152
27671789	authors	C3812881
27671789	approved	C0205540
27671789	manuscript	C0600659
27671789	agree	C3641827
27671789	submission	C1515022
27671789	Journal of Proteomics	C0162443
27676724	Antenatal	C2828394
27676724	consultation	C0009818
27676724	following	C0332282
27676724	limb malformation	C0206762
27676724	discovery	C1880355
27676724	ultrasound scan	C0041618
27676724	unit	C0019988
27676724	providing	C1999230
27676724	antenatal	C2828394
27676724	consultations	C0009818
27676724	following	C0332282
27676724	discovery	C1880355
27676724	limb malformation	C0206762
27676724	fetus	C0015965
27676724	consultations	C0009818
27676724	specific	C0205369
27676724	carried out	C2733037
27676724	multi-professional team	C0086390
27676724	requires	C1514873
27676724	rehabilitation	C1306847
27676724	doctor	C0031831
27676724	orthopedic surgeon	C0334891
27676724	occupational therapist	C0028807
27676724	upper limb malformation	C1404175
27676724	physiotherapist	C2362565
27676724	lower malformation	C1404177
27676724	psychologist	C0033908
27676724	multidisciplinary	C0242479
27676724	consultation	C0009818
27676724	unique	C1710548
27676724	pregnancy	C0032961
27676724	patient	C0030705
27676724	life story	C0681455
27676724	sonologist	C1522486
27676724	diagnosis	C0011900
27676724	couples	C0010222
27676724	shocked	C0436570
27676724	prenatal diagnosis	C0033053
27676724	acceptance	C0000899
27676724	child	C0008059
27676724	imaginary	C0025361
27676724	child	C0008059
27676724	Medical information	C0850397
27676724	perceived	C0030971
27676724	surfeit	C0205556
27676724	information	C1533716
27676724	difficult	C0332218
27676724	couple	C0010222
27676724	stunned	C4061448
27676724	overwhelming	C0205556
27676724	diagnosis	C0011900
27676724	critical	C1511545
27676724	medical description	C0517733
27676724	malformations	C0000768
27676724	potential treatments	C0087111
27676724	psychological support	C0600015
27676724	parents	C0030551
27676724	personal	C1519021
27676724	life story	C0681455
27676724	self-defense mechanism	C0011142
27676724	guilt feeling	C0018379
27676724	ethical aspect	C1136353
27676724	consultation	C0009818
27676724	important	C3898777
27676724	Team	C0086390
27676724	members	C0680022
27676724	neutral	C4050008
27676724	possible	C0332149
27676724	assessments	C0220825
27676724	couple	C0010222
27676724	decision	C0679006
27676724	continuation	C0805733
27676724	pregnancy	C0032961
27676724	request	C1272683
27676724	voluntary	C0439656
27676724	termination of pregnancy	C0392535
27676724	prenatal	C0678804
27676724	consultations	C0009818
27676724	importance	C0205556
27676724	multidisciplinary	C0205556
27676724	global	C2348867
27676724	care	C0086388
27678020	Bending rules	C0870077
27678020	shape	C0332479
27678020	perceptual	C0030971
27678020	generalisation	C0017324
27678020	gradient	C0812409
27678020	sensitive	C0332324
27678020	inference rules	C0870077
27678020	Generalising	C0017326
27678020	learned	C0023185
27678020	stimulus	C0234402
27678020	perceptually	C0030971
27678020	stimuli	C0234402
27678020	behavioural	C0004927
27678020	phenomenon	C1882365
27678020	evaluated	C0220825
27678020	rule	C0870077
27678020	learning	C0023185
27678020	mechanism	C0441712
27678020	generalisation	C0017324
27678020	assessed	C1516048
27678020	inference rules	C0870077
27678020	communicated	C0566001
27678020	verbal instructions	C1254363
27678020	generalisation	C0017324
27678020	Expectancy	C0679138
27678020	ratings	C0871208
27678020	ratings	C0871208
27678020	sensitive	C0332324
27678020	manipulation	C0018578
27678020	role	C1704326
27678020	inference rules	C0870077
27678020	generalisation	C0017324
27678020	study	C2603343
27678020	clinical	C0205210
27678020	implications	C0205245
27678020	targeting	C1521840
27678020	inference rules	C0870077
27678020	strategy	C0679199
27678020	excessive	C0442802
27678020	generalisation	C0017324
27678020	psychopathology	C0033927
27678044	Neuroticism	C1842981
27678044	Fatigue	C0015672
27678044	3 Months	C1442461
27678044	Ischemic Stroke	C0948008
27678044	Cross-Sectional Study	C0010362
27678044	examine	C0332128
27678044	neuroticism	C1842981
27678044	fatigue	C0015672
27678044	Chinese	C0008115
27678044	patients	C0030705
27678044	stroke	C0038454
27678044	Cross-sectional study	C0010362
27678044	Acute	C0205178
27678044	stroke unit	C0587502
27678044	Survivors	C0206194
27678044	ischemic stroke	C0948008
27678044	acute	C0205178
27678044	stroke unit	C0587502
27678044	personality trait	C0233849
27678044	neuroticism	C1842981
27678044	measured	C0444706
27678044	neuroticism	C1842981
27678044	subscale	C0459443
27678044	Chinese	C0008115
27678044	version	C0333052
27678044	NEO Five-Factor Inventory	C0031213
27678044	level	C0441889
27678044	fatigue	C0015672
27678044	measured	C0444706
27678044	Fatigue Assessment Scale	C2733557
27678044	National Institutes of Health Stroke Scale	C3472496
27678044	Geriatric Depression Scale	C0451184
27678044	Barthel Index	C0451019
27678044	Mini-Mental State Examination	C0451306
27678044	administered	C1521801
27678044	demographic	C0011298
27678044	clinical information	C2708733
27678044	Fatigue severity	C3813323
27678044	3 months	C1442461
27678044	stroke	C0038454
27678044	correlated	C1707520
27678044	Geriatric Depression Scale	C0451184
27678044	NEO Five-Factor Inventory	C0031213
27678044	neuroticism	C1842981
27678044	scores	C0449820
27678044	negatively	C0205160
27678044	correlated	C1707520
27678044	Barthel Index score	C1642833
27678044	Neuroticism	C1842981
27678044	independent	C1299583
27678044	depressive symptoms	C0086132
27678044	fatigue severity	C3813323
27678044	3 months	C1442461
27678044	stroke	C0038454
27678044	psychological	C0205486
27678044	screening programs	C3484370
27678044	detection	C1511790
27678044	patients	C0030705
27678044	high risk of	C0332167
27678044	poststroke depression	C2938940
27680006	Hematological	C0243095
27680006	biochemical	C0243095
27680006	toxicopathic effects	C0243095
27680006	subchronic	C4053983
27680006	acetamiprid	C1142891
27680006	toxicity	C0600688
27680006	Wistar rats	C0034716
27680006	Acetamiprid	C1142891
27680006	neonicotinoids	C1997222
27680006	investigates	C1292732
27680006	toxic effects	C0600688
27680006	oral administration	C1527415
27680006	doses	C0178602
27680006	acetamiprid	C1142891
27680006	LD50	C0023378
27680006	days	C0439228
27680006	male	C0086582
27680006	Wistar rats	C0034716
27680006	groups	C0441833
27680006	Hematological	C0243095
27680006	biochemical	C0243095
27680006	toxicopathic effects	C0243095
27680006	acetamiprid	C1142891
27680006	evaluated	C0220825
27680006	decrease	C0547047
27680006	body weight gain	C0043094
27680006	dose	C0178602
27680006	LD50	C0023378
27680006	acetamiprid	C1142891
27680006	increase	C0442805
27680006	liver	C0023884
27680006	weight	C0043100
27680006	dose	C0178602
27680006	level	C0441889
27680006	hematological constituents	C0729650
27680006	decrease	C0547047
27680006	RBC	C0014792
27680006	HGB	C0019046
27680006	HCT	C0518014
27680006	rats	C0034716
27680006	treated	C1522326
27680006	doses	C0178602
27680006	acetamiprid	C1142891
27680006	LD50	C0023378
27680006	increase	C0442805
27680006	WBC	C0023516
27680006	PLT	C0005821
27680006	doses	C0178602
27680006	acetamiprid	C1142891
27680006	induced liver toxicity	C4279912
27680006	increased	C0205217
27680006	activities	C0243102
27680006	aspartate aminotransferase	C0004002
27680006	AST	C0004002
27680006	alanine aminotransferase	C0001899
27680006	ALT	C0001899
27680006	alkaline phosphates	C0002059
27680006	ALPs	C0002059
27680006	lactate dehydrogenase	C0022917
27680006	LDH	C0022917
27680006	loss	C1517945
27680006	hepatic membrane architecture	C2331083
27680006	hepatocellular damage	C0151763
27680006	exposure to	C0332157
27680006	acetamiprid	C1142891
27680006	decrease	C0547047
27680006	levels	C0441889
27680006	superoxide dismutase	C0038838
27680006	catalase	C0007367
27680006	activities	C0243102
27680006	concomitant	C0521115
27680006	increase	C0442805
27680006	lipid peroxidation	C0023775
27680006	rat	C0034716
27680006	liver	C0023884
27680006	findings	C0243095
27680006	subchronic	C4053983
27680006	hepatotoxicity	C0235378
27680006	acetamiprid	C1142891
27680598	Sustained delivery	C1710261
27680598	vincristine	C0042679
27680598	orthotopic	C0574893
27680598	mouse sarcoma	C1522023
27680598	decreases	C0547047
27680598	tumor growth	C0598934
27680598	Sarcoma	C1261473
27680598	solid tumors	C0280100
27680598	children	C0008059
27680598	Surgery	C0543467
27680598	morbidity	C0026538
27680598	chemotherapy	C3665472
27680598	tumors	C0027651
27680598	sustained release	C1710261
27680598	silk	C0074529
27680598	tumor growth	C0598934
27680598	Human	C0086418
27680598	Ewing sarcoma	C0553580
27680598	cells A673	C0334227
27680598	cultured	C0430400
27680598	vincristine	C0042679
27680598	doxorubicin	C0013089
27680598	half maximal inhibitory concentration	C0600495
27680598	IC50	C0600495
27680598	Cells	C0334227
27680598	mouse	C0025929
27680598	hind leg	C1522391
27680598	orthotopic	C0574893
27680598	tumors	C0027651
27680598	Tumor volumes	C0475276
27680598	ultrasound	C0041618
27680598	interventions	C0184661
27680598	implantation	C0021107
27680598	drug-free	C0683584
27680598	silk	C0074529
27680598	Control	C0009932
27680598	doxorubicin	C0013089
27680598	(Dox400	C0013089
27680598	vincristine	C0042679
27680598	Vin50	C0042679
27680598	drug-free	C0683584
27680598	silk	C0074529
27680598	gel	C1382104
27680598	Control	C0009932
27680598	vincristine	C0042679
27680598	gel	C1382104
27680598	Vin50	C0042679
27680598	intravenous	C0348016
27680598	vincristine	C0042679
27680598	Vin50	C0042679
27680598	End-point	C2349179
27680598	Kaplan Meier	C1720943
27680598	ANOVA	C0002780
27680598	IC50	C0600495
27680598	vincristine	C0042679
27680598	doxorubicin	C0013089
27680598	Dox400	C0013089
27680598	1days	C0439228
27680598	end point	C2349179
27680598	DTEP	C2349179
27680598	Control	C0009932
27680598	DTEP	C2349179
27680598	Vin50	C0042679
27680598	DTEP	C2349179
27680598	slower growth	C4086857
27680598	Control	C0009932
27680598	Vin50	C0042679
27680598	Vin50	C0042679
27680598	DTEP	C2349179
27680598	Growth was slowest	C4086857
27680598	Vin50	C0042679
27680598	DTEP	C2349179
27680598	Sustained delivery	C1710261
27680598	vincristine	C0042679
27680598	sarcoma	C1261473
27680598	tumor	C0027651
27680598	silk	C0074529
27680598	gel	C1382104
27680598	decreased	C0547047
27680598	tumor growth	C0598934
27680598	intratumoral treatment	C1831733
27680598	decrease	C0547047
27680598	surgical excision	C0728940
27681567	Spinal	C0037949
27681567	load	C1318107
27681567	nurses	C0028661
27681567	emergency	C0013956
27681567	lifting	C0206244
27681567	obese	C0028754
27681567	patients	C0030705
27681567	preliminary results	C1548161
27681567	Nurses	C0028661
27681567	risk	C0035647
27681567	injury	C3263722
27681567	handling	C1832073
27681567	patients	C0030705
27681567	obese	C0028754
27681567	patients	C0030705
27681567	goal	C0018017
27681567	estimate	C0750572
27681567	spinal	C0037949
27681567	loads	C1318107
27681567	risk	C0035647
27681567	injury	C3263722
27681567	nurses	C0028661
27681567	lifting	C0206244
27681567	obese	C0028754
27681567	patients	C0030705
27681567	floor	C0016249
27681567	bariatric sheet	C0183235
27681567	hospital	C0019994
27681567	emergency	C0013956
27681567	male	C0086582
27681567	nurses	C0028661
27681567	study	C2603343
27681567	biomechanical analysis	C0430022
27681567	lifting	C0206244
27681567	obese	C0028754
27681567	in-patients	C0021562
27681567	experimental study	C0681814
27681567	groups	C0441833
27681567	Body Mass Index	C1305855
27681567	BMI	C1305855
27681567	Three-dimensional motion analysis	C0430022
27681567	optoelectronic system	C0025080
27681567	trunk	C0460005
27681567	kinematics	C0600169
27681567	loading	C1318107
27681567	spines	C0037949
27681567	nurses	C0028661
27681567	computed	C1441526
27681567	data	C1511726
27681567	nurse	C0028661
27681567	trunk	C0460005
27681567	flexed	C0231452
27681567	lift	C0206244
27681567	reduced	C0392756
27681567	range of motion	C2607871
27681567	values	C1522609
27681567	higher	C0205250
27681567	nurse	C0028661
27681567	patients	C0030705
27681567	higher	C0205250
27681567	BMIs	C1305855
27681567	kinetic parameters	C1706312
27681567	tension	C0026841
27681567	lumbar muscles	C0224323
27681567	movement	C0026649
27681567	lower	C0205251
27681567	values	C1522609
27681567	nurse	C0028661
27681567	patient's	C0030705
27681567	head	C0018670
27681567	feet	C0016504
27681567	patient groups	C0030705
27681567	data	C1511726
27681567	load	C1318107
27681567	spine	C0037949
27681567	nurse	C0028661
27681567	patient's	C0030705
27681567	recommended	C0034866
27681567	safety	C0036043
27681567	limits	C0439801
27685187	Expectations	C0679138
27685187	methodology	C3266812
27685187	translation	C0242481
27685187	animal research	C0003048
27685187	survey	C0038951
27685187	general public	C0683971
27685187	medical students	C0038495
27685187	animal	C0003062
27685187	researchers	C0035173
27685187	North America	C0028405
27685187	acceptable	C1879533
27685187	standards	C0038137
27685187	animal research	C0003048
27685187	AR	C0003048
27685187	methodology	C3266812
27685187	translation rate	C1521828
27685187	humans	C0086418
27685187	survey	C0038951
27685187	general public	C0683971
27685187	Sampling Survey International	C1552679
27685187	SSI	C1552679
27685187	Canada	C0006823
27685187	Amazon Mechanical Turk	C1552679
27685187	AMT	C1552679
27685187	USA	C0041703
27685187	Canadian city	C0006823
27685187	festival	C0015922
27685187	CF	C0015922
27685187	Canadian	C0006823
27685187	children's hospital	C0020017
27685187	CH	C0020017
27685187	medical students	C0038495
27685187	scientists	C0402112
27685187	authors	C3812881
27685187	academic	C1510747
27685187	paediatricians	C0237433
27685187	responses	C0871261
27685187	general public	C0683971
27685187	SSI	C1552679
27685187	AMT	C1552679
27685187	CF	C0015922
27685187	CH	C0020017
27685187	medical student	C0038495
27685187	responses	C0871261
27685187	scientist	C0402112
27685187	responses	C0871261
27685187	methodological quality	C0815254
27685187	general public	C0683971
27685187	medical student	C0038495
27685187	respondents	C0282122
27685187	AR	C0003048
27685187	high quality	C0332306
27685187	anaesthesia	C0002903
27685187	analgesia	C0002766
27685187	euthanasia	C0015187
27685187	optimal	C2698651
27685187	statistical design	C0681864
27685187	comprehensive	C1880156
27685187	literature review	C0282441
27685187	randomisation	C0034656
27685187	blinding	C0150108
27685187	costs	C0010186
27685187	acceptable	C1879533
27685187	justifications	C0392360
27685187	lower quality	C0332306
27685187	costs	C0010186
27685187	consultation	C0009818
27685187	laboratory staff	C0025106
27685187	expectations	C0679138
27685187	translation	C0242481
27685187	humans	C0086418
27685187	toxicity	C0600688
27685187	carcinogenicity	C0858970
27685187	teratogenicity	C0232910
27685187	treatment	C0039798
27685187	findings	C2607943
27685187	translation	C0242481
27685187	translation	C0242481
27685187	minority	C0026192
27685187	AR	C0003048
27685187	Medical students	C0038495
27685187	supportive	C1521721
27685187	AR	C0003048
27685187	translation	C0242481
27685187	Expectations	C0679138
27685187	AR	C0003048
27685187	empirical data	C1511726
27686952	Predicting	C0681842
27686952	violence	C0042693
27686952	recidivism	C0680458
27686952	males	C0086582
27686952	probation	C0687758
27686952	parole	C0814701
27686952	study	C2603343
27686952	evaluated	C1550157
27686952	Iowa	C0022037
27686952	Violence	C0042693
27686952	Victimization	C0376695
27686952	Instrument	C0038951
27686952	males	C0086582
27686952	Iowa	C0022037
27686952	probation	C0687758
27686952	released from prison	C0425147
27686952	parole	C0814701
27686952	supervision	C1273870
27686952	study	C2603343
27686952	potential	C3245505
27686952	Iowa	C0022037
27686952	Violence	C0042693
27686952	Victimization	C0376695
27686952	Instrument	C0038951
27686952	predict	C0681842
27686952	criminal offenses	C0680468
27686952	males	C0086582
27686952	months	C0439231
27686952	admission	C0457453
27686952	probation	C0687758
27686952	parole	C0814701
27686952	AUC	C0376690
27686952	analyses	C0936012
27686952	predictive	C0681890
27686952	Iowa	C0022037
27686952	Violence	C0042693
27686952	Victimization	C0376695
27686952	Instrument	C0038951
27686952	violence	C0042693
27686952	victimization	C0376695
27686952	predictive	C0681890
27686952	drug offenses	C0680484
27686952	instrument	C0038951
27686952	month	C0439231
27686952	follow-up	C1522577
27686952	Iowa	C0022037
27686952	Violence	C0042693
27686952	Victimization	C0376695
27686952	Instrument	C0038951
27686952	predicted	C0681842
27686952	violence	C0042693
27686952	Violence	C0042693
27686952	current	C0521116
27686952	findings	C2607943
27686952	potential	C3245505
27686952	expand	C0205229
27686952	jurisdictions	C0680647
27686952	populations	C1257890
27688111	Prognostic significance	C1514474
27688111	non-HPV16 genotypes	C0017431
27688111	oropharyngeal squamous cell carcinoma	C0280313
27688111	oropharyngeal squamous cell carcinoma	C0280313
27688111	OPSCC	C0280313
27688111	positive	C4288937
27688111	HPV16 genotype	C3872681
27688111	better	C0332272
27688111	overall survival	C4086681
27688111	compared	C1707455
27688111	HPV genotypes	C0807283
27688111	replicate	C1883725
27688111	modified by	C0205349
27688111	expression	C1171362
27688111	p16 tumor suppressor protein	C0249880
27688111	OPSCC	C0280313
27688111	Carolina Head and Neck Cancer Study	C1516225
27688111	CHANCE	C1516225
27688111	population based case-control study	C1709599
27688111	Tumors	C0027651
27688111	positive solely	C4288937
27688111	HPV16 genotype	C3872681
27688111	genotypes	C0017431
27688111	PCR	C0032520
27688111	classified	C0008902
27688111	HPV16-positive	C4288937
27688111	Tumors	C0027651
27688111	positive for	C4288937
27688111	high-risk	C0332167
27688111	HPV genotype	C3872595
27688111	classified	C0008902
27688111	non-HPV16-positive	C4288937
27688111	Expression	C1171362
27688111	p16	C0249880
27688111	tumor	C0027651
27688111	determined	C0521095
27688111	immunohistochemistry	C0021044
27688111	date of diagnosis	C2316983
27688111	date of death	C1148348
27688111	Overall survival	C4086681
27688111	Kaplan-Meier curves	C1720944
27688111	log-rank test	C0242928
27688111	Hazard ratios	C2985465
27688111	HR	C2985465
27688111	smoking	C0037369
27688111	alcohol use	C0001948
27688111	sex	C0079399
27688111	race	C0034510
27688111	age	C0001779
27688111	Cox proportional hazard regression	C0010235
27688111	HPV16-positive	C4288937
27688111	OPSCC	C0280313
27688111	better	C0332272
27688111	overall survival	C4086681
27688111	non-HPV16-positive	C4288937
27688111	OPSCC	C0280313
27688111	OPSCC	C0280313
27688111	positive	C1446409
27688111	p16 expression	C1171362
27688111	trend	C1521798
27688111	non-HPV16-positive	C4288937
27688111	OPSCC	C0280313
27688111	greater risk of	C0332167
27688111	death	C1306577
27688111	HPV16-positive	C4288937
27688111	tumors	C0027651
27688111	HR	C2985465
27688111	finding	C0243095
27688111	indicates	C1444656
27688111	HPV	C0021344
27688111	genotyping	C2368152
27688111	valuable prognostic significance	C1514474
27688111	p16	C0249880
27688111	status	C0449438
27688111	OPSCC	C0280313
27688111	HPV genotypes	C0807283
27689491	Randomized Trials	C0206034
27689491	Teen	C0205653
27689491	Outreach Program	C0871024
27689491	Louisiana	C0024024
27689491	Rochester	C0017446
27689491	New York	C0027976
27689491	evaluate	C0220825
27689491	Teen	C0205653
27689491	Outreach Program	C0871024
27689491	pregnancy prevention	C0679784
27689491	program	C0679717
27689491	community	C0009462
27689491	evaluated	C0220825
27689491	Teen	C0205653
27689491	Outreach Program	C0871024
27689491	positive youth development program	C1709697
27689491	cohorts	C0599755
27689491	youths	C0087178
27689491	states	C1301808
27689491	Louisiana	C0024024
27689491	agencies	C0237463
27689491	individualized	C1881197
27689491	randomized controlled trial	C0206035
27689491	youths	C0087178
27689491	treatment	C0087111
27689491	control condition	C0009932
27689491	agencies	C0237463
27689491	Rochester	C0017446
27689491	New York	C0027976
27689491	cluster	C1704332
27689491	randomized controlled trial	C0206035
27689491	no differences	C3842396
27689491	intervention	C0184661
27689491	control youths	C0009932
27689491	delay	C0205421
27689491	sexual	C0036864
27689491	onset	C0332162
27689491	Louisiana	C0024024
27689491	adjusted odds ratio	C0028873
27689491	AOR	C0028873
27689491	confidence interval	C0009667
27689491	CI	C0009667
27689491	Rochester	C0017446
27689491	New York	C0027976
27689491	AOR	C0028873
27689491	CI	C0009667
27689491	sex	C0009253
27689491	birth control	C0009871
27689491	Louisiana	C0024024
27689491	AOR	C0028873
27689491	CI	C0009667
27689491	Rochester	C0017446
27689491	AOR	C0028873
27689491	CI	C0009667
27689491	controlling	C2239193
27689491	covariates	C1705098
27689491	no	C1513916
27689491	short-term	C0443303
27689491	effects	C1280500
27689491	intervention	C0184661
27689491	Research	C0035168
27689491	long-term	C0023983
27689491	intermediate impacts	C1280500
27689491	youth development programs	C1709697
27689491	adolescent	C0205653
27689491	risk behaviors	C0086931
27690568	single session	C1883016
27690568	exhaustive exercise	C0015259
27690568	decreases	C0547047
27690568	circulating	C0175630
27690568	guanidinoacetic acid	C0061626
27690568	healthy	C3898900
27690568	men	C0025266
27690568	women	C0043210
27690568	evaluated	C0220825
27690568	effects of	C1704420
27690568	exercise	C0015259
27690568	circulating	C0175630
27690568	concentrations	C0457929
27690568	guanidinoacetic acid	C0061626
27690568	GAA	C0061626
27690568	creatine	C0010286
27690568	healthy volunteers	C3661466
27690568	running	C0035953
27690568	exhaustion	C0392674
27690568	free-weight bench-press	C0015259
27690568	volitional failure	C0026606
27690568	Blood	C0005767
27690568	exercise	C0015259
27690568	session	C1883016
27690568	Running	C0035953
27690568	induced	C0205263
27690568	decrease	C0547047
27690568	serum	C0229671
27690568	GAA	C0061626
27690568	free-weight exercise	C0015259
27690568	reduced	C0392756
27690568	GAA	C0061626
27690568	serum	C0229671
27690568	GAA	C0061626
27690568	biomarker	C0005516
27690568	exhaustion	C0392674
27692319	Anti-helminthic	C0003158
27692319	activity	C0205177
27692319	Momordica charantia L	C0330482
27692319	Fasciola hepatica eggs	C3662687
27692319	days	C0439228
27692319	incubation	C1439852
27692319	in vitro	C1533691
27692319	Fasciolosis	C0015652
27692319	parasitic disease	C0030499
27692319	trematode	C0040818
27692319	Fasciola hepatica	C0015648
27692319	human	C0086418
27692319	animal population	C1318101
27692319	world	C2700280
27692319	synthetic drugs	C0259849
27692319	treat	C0087111
27692319	condition	C0012634
27692319	natural selection	C0086685
27692319	resistant	C0332325
27692319	strains	C1518614
27692319	parasite	C0030498
27692319	anti-helminthic	C0003158
27692319	properties	C1292721
27692319	medicinal plants	C0032100
27692319	phytopharmaceuticals	C0577749
27692319	study	C2603343
27692319	anti-fasciolicide	C0205245
27692319	action	C3266814
27692319	Momordica charantia	C0330482
27692319	leaf	C0242724
27692319	extracts	C0032081
27692319	fractions	C1264633
27692319	eggs of F. hepatica parasites	C3662687
27692319	lyophilized	C0205222
27692319	crude extract	C1258023
27692319	CE	C1258023
27692319	M. charantia leaves	C0330482
27692319	sub-fractions	C1264633
27692319	liquid-liquid partitioning	C3178840
27692319	organic solvents	C0360100
27692319	analysed	C0936012
27692319	High Performance Liquid Chromatography	C0008562
27692319	HPLC	C0008562
27692319	suspended	C1553389
27692319	DMSO	C0012403
27692319	in vitro	C1533691
27692319	tests	C0022885
27692319	Quadruplicates	C0205175
27692319	F. hepatica eggs	C3662687
27692319	incubated	C1439852
27692319	M. charantia	C0330482
27692319	leaf	C0242724
27692319	CE	C1258023
27692319	concentrations	C1446561
27692319	days	C0439228
27692319	larvae	C0023047
27692319	eggs	C3662687
27692319	incubated	C1439852
27692319	CE	C1258023
27692319	concentrations	C1446561
27692319	Eggs	C3662687
27692319	incubated	C1439852
27692319	CE	C1258023
27692319	sub-fractions	C1264633
27692319	concentrations	C1446561
27692319	affected	C0392760
27692319	embryonic development	C0013936
27692319	n-butanol	C0089147
27692319	inhibition	C3463820
27692319	miracidia	C0023047
27692319	formation	C1522492
27692319	miracidia	C0023047
27692319	hatched	C0598016
27692319	control experiments	C0009932
27692319	DMSO	C0012403
27692319	embryogenesis	C0013936
27692319	abolished	C2746065
27692319	concentration	C1446561
27692319	albendazole sulphoxide	C0051091
27692319	ABZ(SO)	C0051091
27692319	Chemical analysis	C3495389
27692319	CE	C1258023
27692319	sub-fractions	C1264633
27692319	flavonoids	C0596577
27692319	HPLC-MS	C3641325
27692319	Quercetin	C0034392
27692319	flavonoids	C0596577
27692319	CE	C1258023
27692319	n-butanol	C0089147
27692319	subfraction	C1264633
27692319	study	C2603343
27692319	analyse	C0936012
27692319	anti-fasciolicide	C0205245
27692319	action	C3266814
27692319	M. charantia	C0330482
27692319	leaf	C0242724
27692319	CE	C1258023
27692319	subfractions	C1264633
27694780	Dabigatran	C2348066
27694780	oral anticoagulant	C0354604
27694780	Guidelines	C0162791
27694780	oral surgery procedures	C0524861
27694780	review of the literature	C0282441
27694780	Dabigatran	C2348066
27694780	drug	C1254351
27694780	anticoagulants	C0003280
27694780	venous thromboembolism	C1861172
27694780	stroke	C0038454
27694780	systemic arterial valve embolism	C0149876
27694780	thrombin	C0040018
27694780	patients	C0030705
27694780	increases	C0442805
27694780	risk of bleeding	C3251812
27694780	dental treatment	C0011331
27694780	bibliographic search	C0260071
27694780	PubMed	C1138432
27694780	Medline	C0025141
27694780	Cochrane Library	C0023625
27694780	anticoagulants	C0003280
27694780	dabigatran	C2348066
27694780	surgical treatments	C0543467
27694780	anatomical locations	C0923870
27694780	oral cavity	C0226896
27694780	randomized clinical trial	C0206034
27694780	narrative literature reviews	C0815257
27694780	case series	C0150093
27694780	clinical cases	C1706256
27694780	expert opinion	C0600219
27694780	clinical trials	C0008976
27694780	meta-analysis	C0920317
27694780	consensus	C0376298
27694780	procedure	C0543467
27694780	patients	C0030705
27694780	dabigatran	C2348066
27694780	risk	C0035647
27694780	embolism	C0013922
27694780	postoperative bleeding	C0032788
27694780	renal function	C0232804
27694780	invasive interventions	C4048276
27694780	anti-hemolytic measures	C0199176
27695680	FIDELIS	C0282574
27695680	projects	C1709701
27695680	contribute	C1880177
27695680	detection	C0442726
27695680	smear	C2019329
27695680	positive	C1514241
27695680	pulmonary tuberculosis	C0041327
27695680	China	C0008115
27695680	first phase of the Fund for Innovative DOTS Expansion through Local Initiatives to Stop TB	C0282574
27695680	FIDELIS	C0282574
27695680	projects	C1709701
27695680	China	C0008115
27695680	FIDELIS	C0282574
27695680	projects	C1709701
27695680	contribute	C1880177
27695680	increased	C0205217
27695680	case	C0868928
27695680	detection	C0442726
27695680	rate	C1521828
27695680	smear	C2019329
27695680	positive	C1514241
27695680	pulmonary tuberculosis	C0041327
27695680	PTB	C0041327
27695680	China	C0008115
27695680	compared	C1707455
27695680	case notification rates	C1521828
27695680	CNRs	C1521828
27695680	intervention year	C0439234
27695680	previous	C0205156
27695680	year	C0439234
27695680	FIDELIS	C0282574
27695680	areas	C0017446
27695680	compared	C1707455
27695680	difference	C1705242
27695680	CNRs	C1521828
27695680	intervention year	C0439234
27695680	previous	C0205156
27695680	year	C0439234
27695680	FIDELIS	C0282574
27695680	areas	C0017446
27695680	non-FI-DELIS	C0243095
27695680	areas	C0017446
27695680	province	C1514578
27695680	increase	C0442805
27695680	CNR	C1521828
27695680	intervention year	C0439234
27695680	compared	C1707455
27695680	previous	C0205156
27695680	year	C0439234
27695680	project	C1709701
27695680	differences	C1705242
27695680	CNR	C1521828
27695680	intervention year	C0439234
27695680	previous	C0205156
27695680	year	C0439234
27695680	ranged	C1514721
27695680	population	C1257890
27695680	FIDELIS	C0282574
27695680	areas	C0017446
27695680	non-FIDELIS	C0243095
27695680	areas	C0017446
27695680	Differences	C1705242
27695680	differences	C1705242
27695680	analysis	C0936012
27695680	differences	C1705242
27695680	CNRs	C1521828
27695680	FIDELIS	C0282574
27695680	areas	C0017446
27695680	statistically significantly	C0237881
27695680	different	C1705242
27695680	FIDELIS	C0282574
27695680	areas	C0017446
27695680	FIDELIS	C0282574
27695680	projects	C1709701
27695680	contributed	C1880177
27695680	increase	C0442805
27695680	case	C0868928
27695680	detection	C0442726
27695680	smear	C2019329
27695680	positive	C1514241
27695680	PTB	C0041327
27695680	China	C0008115
27695680	level	C0441889
27695680	evidence	C3887511
27695680	low	C0205251
27697757	Liver Fatty Acid Binding Protein	C0163315
27697757	Deficiency	C0011155
27697757	Oxidative Stress	C0242606
27697757	Inflammation	C0021368
27697757	Apoptosis	C0162638
27697757	Hepatotoxicity	C0235378
27697757	Induced	C0205263
27697757	Pyrazinamide	C0034239
27697757	Zebrafish	C0043457
27697757	Larvae	C0023047
27697757	Pyrazinamide	C0034239
27697757	PZA	C0034239
27697757	essential	C0205224
27697757	antitubercular drug	C0003448
27697757	hepatotoxicity	C0235378
27697757	potential	C3245505
27697757	effects of	C1704420
27697757	PZA	C0034239
27697757	exposure	C0332157
27697757	zebrafish	C0043457
27697757	Danio rerio	C0043457
27697757	larvae	C0023047
27697757	hepatotoxicity	C0235378
27697757	transgenic line	C0282641
27697757	zebrafish	C0043457
27697757	larvae	C0023047
27697757	expressed	C1171362
27697757	enhanced green fluorescent protein	C1258415
27697757	EGFP	C1258415
27697757	liver	C0023884
27697757	incubated	C1439852
27697757	PZA	C0034239
27697757	postfertilization	C0015914
27697757	endpoints	C2349179
27697757	mortality	C0205848
27697757	morphology	C0700329
27697757	changes	C0392747
27697757	size	C1450569
27697757	shape	C0332479
27697757	liver	C0023884
27697757	histological	C0019638
27697757	changes	C0392747
27697757	transaminase analysis	C0919834
27697757	apoptosis	C0162638
27697757	markers	C0005516
27697757	oxidative	C0242606
27697757	genetic damage	C0012860
27697757	expression	C0017262
27697757	genes	C0017337
27697757	evaluate	C0220825
27697757	PZA	C0034239
27697757	induced	C0205263
27697757	hepatotoxicity	C0235378
27697757	confirm	C0750484
27697757	PZA	C0034239
27697757	dose-dependent	C1512045
27697757	hepatotoxicity	C0235378
27697757	PZA	C0034239
27697757	induce	C0205263
27697757	marked	C1706089
27697757	injury	C3263723
27697757	zebrafish	C0043457
27697757	larvae	C0023047
27697757	liver atrophy	C0391996
27697757	elevations of transaminase levels	C0438717
27697757	oxidative stress	C0242606
27697757	hepatocyte apoptosis	C3269241
27697757	PZA	C0034239
27697757	induced	C0205263
27697757	hepatotoxicity	C0235378
27697757	changes	C0392747
27697757	gene expression levels	C3244092
27697757	zebrafish	C0043457
27697757	larvae	C0023047
27697757	exposed to	C0332157
27697757	PZA	C0034239
27697757	postexposure	C0332157
27697757	PZA	C0034239
27697757	decreased	C0205216
27697757	expression levels	C3244092
27697757	liver fatty acid binding protein	C0163315
27697757	L-FABP	C0163315
27697757	target gene	C1332838
27697757	peroxisome proliferator-activated receptor α	C0166415
27697757	PPAR-α	C0166415
27697757	severe	C0205082
27697757	oxidative stress	C0242606
27697757	hepatitis	C0019158
27697757	upregulation	C0041904
27697757	inflammatory cytokines	C0010813
27697757	tumor necrosis factor alpha	C1456820
27697757	TNF-α	C1456820
27697757	transforming growth factor β	C0040690
27697757	TGF-β	C0040690
27697757	L-FABP	C0163315
27697757	PPAR-α	C0166415
27697757	downregulation	C0949469
27697757	hepatotoxic response	C3549372
27697757	zebrafish	C0043457
27697757	larva	C0023047
27697757	liver cell	C0227525
27697757	apoptosis	C0162638
27697757	L-FABP	C0163315
27697757	biomarker	C0005516
27697757	early detection	C0596473
27697757	PZA	C0034239
27697757	induced	C0205263
27697757	liver damage	C0151763
27697757	zebrafish	C0043457
27697757	larvae	C0023047
27699206	Smooth	C0205357
27699206	Textured	C0205556
27699206	Surfaces	C0205148
27699206	Feature	C2348519
27699206	Category	C0683312
27699206	Selectivity	C1707391
27699206	Human	C0086418
27699206	Visual Cortex	C0042817
27699206	fMRI studies	C0376335
27699206	human	C0086418
27699206	lateral occipital (LO) cortex	C0028785
27699206	images	C1704922
27699206	objects	C0347997
27699206	compared	C1707455
27699206	nonobjects	C1551338
27699206	unresolved	C0443342
27699206	objects	C0347997
27699206	equivalent	C0205163
27699206	levels	C0441889
27699206	activity	C0441655
27699206	LO	C0028785
27699206	image features	C2346469
27699206	stronger	C0442821
27699206	activation	C1879547
27699206	unbiased parametric texture model	C3161035
27699206	predict	C0681842
27699206	preferred	C0234402
27699206	nonpreferred stimuli	C0234402
27699206	LO	C0028785
27699206	Observation	C0302523
27699206	psychophysical results	C1274040
27699206	predicted	C0681842
27699206	preferred	C0558295
27699206	stimuli	C0234402
27699206	objects	C0347997
27699206	nonobjects	C1551338
27699206	smooth	C0205357
27699206	textured	C0205556
27699206	surfaces	C0205148
27699206	predictions	C0681842
27699206	confirmed	C0521093
27699206	fMRI	C0376335
27699206	objects	C0347997
27699206	nonobjects	C1551338
27699206	preferences	C0558295
27699206	fusiform face area	C3536733
27699206	FFA	C3536733
27699206	Consistent with	C0332290
27699206	FFA	C3536733
27699206	LO	C0028785
27699206	nonfreckled	C0205556
27699206	smooth	C0205357
27699206	faces	C0205148
27699206	compared	C1707455
27699206	freckled	C0016689
27699206	textured	C0205556
27699206	faces	C0205148
27699206	functional	C0205245
27699206	connections	C0449379
27699206	LO	C0028785
27699206	FFA	C3536733
27699206	LO	C0028785
27699206	FFA	C3536733
27699206	information	C1533716
27699206	processing	C1709694
27699206	feature	C2348519
27699206	category	C0683312
27699206	selectivity	C1707391
27699206	smooth	C0205357
27699206	textured	C0205556
27699590	High-fructose diet	C1445913
27699590	high-fat diet	C0521974
27699590	induction	C0857127
27699590	insulin resistance	C0021655
27699590	diabetes	C0011847
27699590	hepatic	C0205054
27699590	pancreatic	C0030274
27699590	endoplasmic reticulum (ER) stress	C3178870
27699590	context	C0449255
27699590	high	C0205250
27699590	human	C0086418
27699590	consumption	C0457083
27699590	fructose	C0016745
27699590	diets	C0012155
27699590	need	C0027552
27699590	understand	C0162340
27699590	dietary	C2699635
27699590	fructose intake	C0556134
27699590	influence	C4054723
27699590	cellular	C0007634
27699590	molecular	C1521991
27699590	mechanisms	C0441712
27699590	affect	C1280500
27699590	β-cell dysfunction	C1969875
27699590	insulin resistance	C0021655
27699590	evidence	C3887511
27699590	exists	C2987476
27699590	relationship	C0439849
27699590	high	C0205250
27699590	fat	C0015677
27699590	induced	C0205263
27699590	insulin resistance	C0021655
27699590	metabolic disorders	C0025517
27699590	lack of	C0332268
27699590	studies	C2603343
27699590	high-fructose diet	C1445913
27699590	study	C2603343
27699590	effect	C1280500
27699590	different	C1705242
27699590	diets	C0012155
27699590	high-fat diet	C0521974
27699590	HFD	C0521974
27699590	high-fructose diet	C1445913
27699590	HFS	C1445913
27699590	combination	C0205195
27699590	HFS	C1445913
27699590	HFD	C0521974
27699590	diet	C0012155
27699590	glucose homeostasis	C1326961
27699590	insulin sensitivity	C0920563
27699590	male	C0086582
27699590	Wistar rats	C0034716
27699590	compared	C1707455
27699590	control animals	C1511501
27699590	fed	C2987508
27699590	normal	C0205307
27699590	pellet	C1998480
27699590	diet	C0012155
27699590	Investigations	C1292732
27699590	oral glucose tolerance test	C0029161
27699590	insulin tolerance test	C0236287
27699590	histopathology	C0430445
27699590	H&E	C0523207
27699590	Masson's trichrome staining	C1294297
27699590	mRNA expression	C1515670
27699590	real-time PCR	C1709846
27699590	protein expression	C1882495
27699590	Western blot	C0949466
27699590	caspase-3 activity	C1150132
27699590	colorimetry	C0009407
27699590	Rats	C0034721
27699590	high-fat	C0521974
27699590	fructose diets	C1445913
27699590	glucose	C0017725
27699590	intolerant	C0231200
27699590	insulin-resistant	C0021655
27699590	dyslipidemic	C0243095
27699590	Compared	C1707455
27699590	control animals	C1511501
27699590	rats	C0034721
27699590	different	C1705242
27699590	combination	C0205195
27699590	fat	C0521974
27699590	fructose diets	C1445913
27699590	increased	C0205217
27699590	mRNA	C1515670
27699590	protein expression	C1171362
27699590	ER stress	C3178870
27699590	markers	C0008963
27699590	pancreas	C0030274
27699590	liver	C0023884
27699590	Transcription factors	C0040648
27699590	β-cell function	C0007613
27699590	INSIG1	C1447572
27699590	SREBP1c	C0537474
27699590	PDX1	C1528563
27699590	hepatic	C0205054
27699590	gluconeogenesis	C0017715
27699590	FOXO1	C0250455
27699590	PEPCK	C4042244
27699590	adversely affected	C0879626
27699590	diet	C0012155
27699590	induced	C0205263
27699590	insulin-resistant	C0021655
27699590	rats	C0034721
27699590	convergence	C2700387
27699590	chronic	C0205191
27699590	ER stress	C3178870
27699590	apoptosis	C0162638
27699590	pancreas	C0030274
27699590	liver	C0023884
27699590	indicated	C1444656
27699590	increased	C0205217
27699590	levels	C0441889
27699590	CHOP mRNA	C0035696
27699590	increased	C0205217
27699590	JNK	C1150587
27699590	Caspase-3	C1150132
27699590	rats	C0034721
27699590	high-fat	C0521974
27699590	fructose diets	C1445913
27699590	study	C2603343
27699590	experimental	C1517586
27699590	support	C1521721
27699590	high-fructose diet	C1445913
27699590	equally	C0205163
27699590	causing	C0678227
27699590	metabolic disorders	C0025517
27701287	Immature	C0205252
27701287	stages	C1306673
27701287	larval	C0562676
27701287	chaetotaxy	C1515222
27701287	Notofairchildia stenygros	C1082670
27701287	Diptera	C0012578
27701287	Psychodidae	C0033888
27701287	Bruchomyiinae	C1082670
27701287	Bruchomyiinae	C1082670
27701287	plesiomorphic subfamily	C1711207
27701287	Psychodidae	C0033888
27701287	members	C1551338
27701287	primitive	C0205225
27701287	living	C0376558
27701287	Diptera	C0012578
27701287	Bruchomyiinae	C1082670
27701287	no	C1513916
27701287	medical	C0205476
27701287	importance	C3898777
27701287	evolutionary	C0015219
27701287	significance	C0750502
27701287	sister group	C0008903
27701287	Phlebotominae	C1123010
27701287	species	C1705920
27701287	subfamily	C1711207
27701287	natural environment	C0557745
27701287	adults	C0563200
27701287	immature	C0205252
27701287	stages	C1306673
27701287	flies	C0012578
27701287	egg	C0562677
27701287	larvae	C0562676
27701287	pupae	C0034120
27701287	Notofairchildia stenygros	C1082670
27701287	nomenclatural notes	C0600281
27701287	larval	C0562676
27701287	chaetotaxy	C1515222
27701287	scanning electron microscopy	C0026020
27701287	SEM	C0026020
27701287	optic microscopy	C0596569
27701287	morphology	C0332437
27701287	immature	C0205252
27701287	Nt. stenygros	C1082670
27701287	Bruchomyiinae	C1082670
27701287	Psychodidae	C0033888
27701287	species	C1705920
27701287	species	C1705920
27701287	Phlebotominae	C1123010
27701287	similar	C2348205
27701287	Bruchomyiinae	C1082670
27701287	Results	C0683954
27701287	study	C2603343
27701287	morphological	C0543482
27701287	differences	C1705242
27701287	immature	C0205252
27701287	stages	C1306673
27701287	Bruchomyiinae	C1082670
27701287	Phlebotominae	C1123010
27701287	abdominal	C0000726
27701287	pseudopods	C0033827
27701287	microtrichia	C0018494
27701287	cephalic	C0205096
27701287	integument	C0037267
27701287	larvae	C0562676
27701287	Phlebotominae	C1123010
27701287	morphological	C0543482
27701287	differences	C1705242
27701287	immature	C0205252
27701287	stages	C1306673
27701287	members	C1551338
27701287	subfamilies	C1711207
27701287	findings	C0243095
27701287	molecular studies	C2236970
27701287	Bruchomyiinae	C1082670
27701287	Phlebtominae	C1704307
27701287	evolutionarily	C0015219
27701287	not closely related	C1546988
27701287	Notofairchildia stenygros	C1082670
27701287	fourth	C0205438
27701287	species	C1705920
27701287	Bruchomyiinae	C1082670
27701287	immature	C0205252
27701287	stages	C1306673
27702870	clinical results	C0456984
27702870	ThermoCool® SmartTouch® Surround Flow catheter	C0490683
27702870	Biosense Webster ThermoCool(®) SmartTouch(®) Surround Flow (STSF) catheter	C0490683
27702870	ablation	C0547070
27702870	catheter	C0085590
27702870	Surround Flow	C0232177
27702870	SF	C0232177
27702870	technology	C0039421
27702870	quantify	C1709793
27702870	tissue	C0040300
27702870	contact	C0332158
27702870	ThermoCool(®) SF catheter	C0490683
27702870	Procedure	C0087111
27702870	data	C1511726
27702870	ablation procedures	C0547070
27702870	STSF catheter	C0490683
27702870	database	C0242356
27702870	procedures	C0087111
27702870	SF catheter	C0490683
27702870	STSF procedure	C0087111
27702870	procedure type	C0455713
27702870	operator	C1705274
27702870	experience	C0596545
27702870	patient age	C0001779
27702870	gender	C0079399
27702870	groups	C0681860
27702870	patient age	C0001779
27702870	gender	C0079399
27702870	procedure type	C0455713
27702870	Procedure duration	C1442476
27702870	groups	C0681860
27702870	IQR	C1711350
27702870	fluoroscopy duration	C4029016
27702870	shorter	C1806781
27702870	STSF group	C0681860
27702870	IQR	C1711350
27702870	No complication	C4032686
27702870	STSF group	C0681860
27702870	Complications	C0009566
27702870	cases	C1706256
27702870	SF group	C0681860
27702870	pericardial effusion	C0031039
27702870	drainage	C0013103
27702870	permanent	C0205355
27702870	pacing	C0199640
27702870	Complete procedural success	C3897822
27702870	cases	C1706256
27702870	STSF group	C0681860
27702870	cases	C1706256
27702870	SF group	C0681860
27702870	failure	C0086138
27702870	acute	C0205178
27702870	complication	C0009566
27702870	STSF group	C0681860
27702870	STSF catheter	C0490683
27702870	effective	C1704419
27702870	treating	C1522326
27702870	arrhythmias	C0003811
27702870	SF catheter	C0490683
27702870	safety	C0036043
27702870	efficacy	C1280519
27703752	Low birth weight	C0024032
27703752	features	C2348519
27703752	neuroticism	C1842981
27703752	mood disorder	C0525045
27703752	participants	C0679646
27703752	UK	C0041700
27703752	Biobank	C0206512
27703752	cohort	C0599755
27703752	Low birth weight	C0024032
27703752	risk	C0035647
27703752	affective disorders	C0001723
27703752	major depressive disorder	C1269683
27703752	MDD	C1269683
27703752	studies	C2603343
27703752	investigating	C1292732
27703752	associations	C0439849
27703752	birth weight	C0005612
27703752	bipolar disorder	C0005586
27703752	BD	C0005586
27703752	personality traits	C0233849
27703752	predispose	C0220898
27703752	affective disorders	C0001723
27703752	neuroticism	C1842981
27703752	cohorts	C0599755
27703752	assess	C1516048
27703752	very low birth weight	C0282666
27703752	low birth weight	C0024032
27703752	associated with	C0332281
27703752	higher neuroticism	C0564512
27703752	scores	C0449820
27703752	assessed	C1516048
27703752	middle age	C0026062
27703752	lifetime history	C0598779
27703752	MDD	C1269683
27703752	BD	C0005586
27703752	confounding factors	C0009673
27703752	Retrospective	C1514923
27703752	cohort study	C0009247
27703752	baseline	C1442488
27703752	data	C1511726
27703752	UK	C0041700
27703752	Biobank	C0206512
27703752	participants	C0679646
27703752	mental health	C0025353
27703752	birth weight	C0005612
27703752	data	C1511726
27703752	outcomes	C1274040
27703752	MDD	C1269683
27703752	BD	C0005586
27703752	neuroticism	C1842981
27703752	assessed	C1516048
27703752	Eysenck Personality Inventory Neuroticism scale - Revised	C0034394
27703752	EPIN-R	C0034394
27703752	normal birth weight	C0456136
27703752	very low	C0282666
27703752	low birth weight	C0024032
27703752	higher neuroticism	C0564512
27703752	scores	C0449820
27703752	increased	C0205217
27703752	MDD	C1269683
27703752	BD	C0005586
27703752	associations	C0439849
27703752	birth weight	C0005612
27703752	category	C0683312
27703752	MDD	C1269683
27703752	higher neuroticism	C0564512
27703752	findings	C0683954
27703752	intrauterine	C0694756
27703752	programming	C1720850
27703752	role	C1705810
27703752	lifetime	C4071830
27703752	vulnerability	C1821973
27703752	affective disorders	C0001723
27708411	DNA annealing	C0920681
27708411	Redβ	C0766456
27708411	homologous recombination	C0599773
27708411	intra- and inter-molecular interactions	C0678593
27708411	Single strand annealing proteins	C0033684
27708411	SSAPs	C0033684
27708411	Redβ	C0766456
27708411	homologous recombination	C0599773
27708411	annealing complementary DNA strands	C0006556
27708411	C-terminally truncated	C1514568
27708411	Redβ	C0766456
27708411	annealing	C0920681
27708411	nucleoprotein filament formation	C1158503
27708411	homologous recombination	C0599773
27708411	Mutations	C0026882
27708411	C-terminal domain	C1514562
27708411	single	C0012935
27708411	double stranded	C0311474
27708411	ss	C0012935
27708411	ds	C0311474
27708411	recombination	C0034865
27708411	assays	C0005507
27708411	Mutations	C0012878
27708411	critical amino acids	C0002520
27708411	dsDNA	C0311474
27708411	recombination	C1158522
27708411	ssDNA	C0012935
27708411	dsDNA recombination	C1158522
27708411	dsDNA recombination	C1158522
27708411	recombination	C1158522
27708411	co-immunoprecipitation experiments	C1449705
27708411	dsDNA recombination function	C1158522
27708411	Redα	C0033684
27708411	Redβ	C0766456
27708411	protein-protein interaction	C0872079
27708411	C-terminal domain	C1514562
27708411	N-terminus	C1514562
27708411	nucleoprotein filament formed	C1158503
27708411	C-terminally truncated	C1514568
27708411	Redβ	C0766456
27708411	C-terminal function	C1149341
27708411	interaction	C1511658
27708411	functional	C0205245
27708411	filaments	C0025979
27708411	C-terminal function	C1149341
27708411	Redβ	C0766456
27708411	host factor interaction	C1659605
27708411	Red recombination	C0599773
27708411	Redβ	C0766456
27708411	RAD52	C0663124
27708411	SSAPs	C0033684
27709647	Multi-drug-resistant	C0242640
27709647	Acinetobacter calcoaceticus-Acinetobacter baumannii complex	C2828037
27709647	infection	C3714514
27709647	outbreak	C0012652
27709647	dogs	C0012984
27709647	cats	C0007450
27709647	veterinary hospital	C0019996
27709647	Acinetobacter calcoaceticus-Acinetobacter baumannii complex	C2828037
27709647	severe	C0205082
27709647	outbreaks	C0012652
27709647	humans	C0086418
27709647	increasingly	C0442805
27709647	reported	C0700287
27709647	animals	C0003062
27709647	retrospective study	C0035363
27709647	severe	C0205082
27709647	outbreak	C0012652
27709647	dogs	C0012984
27709647	cats	C0007450
27709647	multidrug resistant member	C4076168
27709647	Acinetobacter calcoaceticus-Acinetobacter baumannii complex	C2828037
27709647	veterinary hospital	C0019996
27709647	study	C2603343
27709647	included	C0332257
27709647	dogs	C0012984
27709647	cats	C0007450
27709647	Acinetobacter calcoaceticus-Acinetobacter baumannii complex bacteria	C2828037
27709647	isolated	C0205409
27709647	urine	C0042036
27709647	animals	C0003062
27709647	respiratory tract	C0035237
27709647	tissues	C0040300
27709647	blood	C0005767
27709647	most	C0205393
27709647	common	C0205214
27709647	infection	C3714514
27709647	associated findings	C0449380
27709647	included	C0332257
27709647	fever	C0015967
27709647	purulent discharge	C0333274
27709647	endotracheal tubes	C0336630
27709647	hypotension	C0020649
27709647	neutropaenia	C0221023
27709647	Infection	C3714514
27709647	pneumonia	C0032285
27709647	urinary tract infection	C0042029
27709647	cellulitis	C0007642
27709647	sepsis	C0243026
27709647	Infection	C3714514
27709647	transmitted	C0242781
27709647	intensive care unit	C0021708
27709647	animals	C0003062
27709647	initially	C0205265
27709647	hospitalised	C0184666
27709647	mortality rate	C0205848
27709647	animals	C0003062
27709647	higher	C0205250
27709647	respiratory infection	C0035243
27709647	compared	C1707455
27709647	infections	C3714514
27709647	environmental	C0014406
27709647	cleaning	C1947930
27709647	disinfection	C0012683
27709647	staff education	C0588974
27709647	personal hygiene	C0564673
27709647	antisepsis	C0003424
27709647	decreased	C0205216
27709647	infection	C3714514
27709647	incidence	C0021149
27709647	Health care	C0018684
27709647	associated	C0332281
27709647	outbreaks	C0012652
27709647	multidrug resistant	C0242640
27709647	Acinetobacter calcoaceticus-Acinetobacter baumannii complex	C2828037
27709647	dogs	C0012984
27709647	cats	C0007450
27709647	highly	C0205250
27709647	fatal	C1302234
27709647	difficult	C0332218
27709647	eradicate	C2728502
27709647	monitoring	C1283169
27709647	antiseptic	C3536839
27709647	techniques	C0449851
27709647	antibiotic	C0003232
27709647	use	C0457083
27710934	crystal form	C0444626
27710934	unexpectedly results	C0243095
27710934	interwoven packing networks	C1510464
27710934	pseudo-translational symmetry	C1254362
27710934	Nonribosomal peptide synthetases	C0535847
27710934	NRPSs	C0535847
27710934	multimodular enzymes	C0014442
27710934	synthesize	C1883254
27710934	myriad	C0439064
27710934	diverse molecules	C0567416
27710934	Tailoring domains	C1514562
27710934	NRPSs	C0535847
27710934	nonribosomal peptide products	C0030956
27710934	Linear gramicidin synthetase	C0018160
27710934	contains	C2700400
27710934	formylation	C1159286
27710934	tailoring domain	C1514562
27710934	initiation module	C1709061
27710934	F-A	C1159286
27710934	PCP	C1514562
27710934	F-A	C1159286
27710934	di-domain	C1514562
27710934	crystal form	C0444626
27710934	solvent	C0037638
27710934	channels	C0439799
27710934	no density	C0178587
27710934	Asub subdomain	C1514562
27710934	packing	C2828395
27710934	removing	C1883720
27710934	Asub subdomain	C1514562
27710934	F-A	C1159286
27710934	sub	C1514562
27710934	crystal	C0444626
27710934	PCP domain	C1514562
27710934	crystal	C0444626
27710934	original packing network	C1510464
27710934	second network	C1510464
27710934	packing	C2828395
27710934	original network	C1510464
27710934	solvent	C0037638
27710934	channels	C0439799
27710934	space group of the crystal	C0444626
27714135	Folate	C0178638
27714135	single cell screening	C0597452
27714135	surface enhanced Raman microimaging	C0037815
27714135	nanotechnology	C0872323
27714135	biomedical settings	C0005540
27714135	early cancer diagnosis	C2350269
27714135	cancer cells	C0334227
27714135	expression	C0597360
27714135	plasma membrane	C0007603
27714135	molecular receptors	C1513401
27714135	assessing the stage of development of the disease	C3650728
27714135	single cell screening	C0597452
27714135	Surface Enhanced Raman Scattering (SERS) microimaging	C0037815
27714135	SERS	C0037815
27714135	SERS-labelled	C0037815
27714135	nanovector	C0872323
27714135	biofunctionalization	C0870589
27714135	gold nanoparticles	C1721060
27714135	folic acid	C0016410
27714135	treating the cells	C0007634
27714135	nanovector	C0872323
27714135	distinguish three different cell populations	C0596289
27714135	different cell lines	C0007600
27714135	cancer HeLa	C0018873
27714135	PC-3	C3890720
27714135	normal HaCaT lines	C0022567
27714135	expressions	C0597360
27714135	folate binding proteins	C2955669
27714135	nanovector	C0872323
27714135	binds much more efficiently	C1145667
27714135	cancer cell lines	C0334227
27714135	SERS	C0037815
27714135	cancer cells	C0334227
27714135	single cell diagnostics	C0597452
27714135	potentially	C3245505
27714135	theranostics	C4046052
27715500	Self-reported	C2700446
27715500	occupational injuries	C0521168
27715500	industrial	C0021267
27715500	beef	C0175923
27715500	slaughterhouse	C0000715
27715500	workers	C1527116
27715500	Midwestern United States	C0026081
27715500	workers	C1527116
27715500	meatpacking facilities	C0025019
27715500	United States	C0041703
27715500	high rates	C1521828
27715500	occupational injury	C0521168
27715500	injury	C3263723
27715500	research	C0035168
27715500	research indicates	C0242481
27715500	underreporting	C0700287
27715500	injury rates	C1822478
27715500	industry	C0021267
27715500	injury rates	C1822478
27715500	occupational injury	C0521168
27715500	meatpacking	C0025019
27715500	workers	C1527116
27715500	cross-sectional study	C0010362
27715500	workers	C1527116
27715500	industrial beefpacking plant	C0025019
27715500	Nebraska	C0027523
27715500	United States	C0041703
27715500	workers	C1527116
27715500	injury	C3263723
27715500	self-reported	C2700446
27715500	injury	C3263723
27715500	annual incidence rates	C1708485
27715500	self-reported	C2700446
27715500	injuries	C3263723
27715500	OSHA	C0041731
27715500	formula	C0489829
27715500	industry-wide data	C1511726
27715500	psychological distress	C0815107
27715500	Kessler-6 scale	C4300240
27715500	distress	C0231303
27715500	associated with	C0332281
27715500	occupational injury	C0521168
27715500	injury	C3263723
27715500	workers	C1527116
27715500	occupational injuries	C0521168
27715500	job transfer	C0681128
27715500	restriction during	C0347984
27715500	annual incidence rate	C1708485
27715500	injuries	C3263723
27715500	workers	C1527116
27715500	injuries	C3263723
27715500	plant	C0000715
27715500	injuries	C3263723
27715500	injuries	C3263723
27715500	metal mesh	C0181807
27715500	sleeves	C0183336
27715500	metal mesh	C0181807
27715500	gloves	C0441051
27715500	associated with	C0332281
27715500	injury	C3263723
27715500	carbon	C0007009
27715500	steel	C0038239
27715500	knife	C1706313
27715500	associated with	C0332281
27715500	moderate and severe	C0205556
27715500	injury	C3263723
27715500	self-reported	C2700446
27715500	occupational injury	C0521168
27715500	psychological distress	C0815107
27715500	Self-reported	C2700446
27715500	incidence rate	C1708485
27715500	severe	C0205082
27715500	injury	C3263723
27715500	industry estimates	C0750572
27715500	self-reports	C2700446
27715500	injury prevention	C0150638
27717775	Effect	C1280500
27717775	l-Arginine	C0003765
27717775	Dural Healing	C0043240
27717775	Induced	C0205263
27717775	Dural	C0013313
27717775	Defect	C1457869
27717775	Rat	C0034693
27717775	Model	C0026339
27717775	Incomplete	C0205257
27717775	repair	C0043240
27717775	dura mater	C0013313
27717775	result	C1274040
27717775	numerous	C0439064
27717775	complications	C0009566
27717775	cerebrospinal fluid leakage	C0023182
27717775	meningitis	C0025289
27717775	accurate	C0443131
27717775	repair	C0043240
27717775	dura mater	C0013313
27717775	essential	C0205224
27717775	effect	C1280500
27717775	systemic	C0205373
27717775	local	C0205276
27717775	supplementation	C2348609
27717775	l-arginine	C0003765
27717775	dural healing	C0043240
27717775	male	C0086582
27717775	Wistar rats	C0034716
27717775	divided	C0332849
27717775	control	C0009932
27717775	local	C0205276
27717775	systemic	C0205373
27717775	l-arginine	C0003765
27717775	groups	C0441833
27717775	rats	C0034716
27717775	group	C0441833
27717775	experimental incision	C0184898
27717775	lumbar segment of the dura mater	C2330954
27717775	cerebrospinal fluid leakage	C0023182
27717775	induced	C0205263
27717775	group	C0441833
27717775	divided	C0332849
27717775	subgroups	C1515021
27717775	weeks	C0439230
27717775	rats	C0034716
27717775	killed	C0015187
27717775	damaged	C1883709
27717775	segments	C0441635
27717775	dura	C0013313
27717775	separated	C0443299
27717775	histologically	C0205462
27717775	dural healing	C0043240
27717775	indicators	C1522602
27717775	cell types	C0007634
27717775	granulation tissue	C0018180
27717775	formation	C1522492
27717775	collagen	C0009325
27717775	deposit	C0333562
27717775	vascularization	C0042382
27717775	compared	C1707455
27717775	groups	C0441833
27717775	systematic	C0220922
27717775	supplementation	C2348609
27717775	l-arginine	C0003765
27717775	significant	C0750502
27717775	effect	C1280500
27717775	dural healing	C0043240
27717775	compared	C1707455
27717775	control group	C0009932
27717775	week	C0439230
27717775	granulation	C0018180
27717775	formation	C1522492
27717775	increased	C0205217
27717775	weeks	C0439230
27717775	collagen	C0009325
27717775	deposition	C0333562
27717775	neovascularization	C0027686
27717775	different	C1705242
27717775	compared	C1707455
27717775	control group	C0009932
27717775	comparison	C1707455
27717775	different	C1705242
27717775	groups	C0441833
27717775	weeks	C0439230
27717775	maximum	C0806909
27717775	changes	C0392747
27717775	healing	C0043240
27717775	indicators	C1522602
27717775	observed	C1441672
27717775	systemic	C0205373
27717775	group	C0441833
27717775	variations	C0205419
27717775	control group	C0009932
27717775	systemic	C0205373
27717775	supplementation	C2348609
27717775	l-arginine	C0003765
27717775	accelerate	C0521110
27717775	dural healing	C0043240
27717775	increasing	C0442808
27717775	level	C0441889
27717775	granulation tissue	C0018180
27717775	formation	C1522492
27717775	collagen	C0009325
27717775	deposition	C0333562
27717775	vascularization	C0042382
27722201	Birth Preparedness and Complication Readiness Practice	C1254363
27722201	Associated	C0439849
27722201	Factors	C1521761
27722201	Pregnant Women	C0033011
27722201	Northwest Ethiopia	C0015024
27722201	birth preparedness and complication readiness	C1254363
27722201	BPCR	C1254363
27722201	plan	C1301732
27722201	maternal mortality	C0024923
27722201	study	C2603343
27722201	assess	C0184514
27722201	status	C0449438
27722201	BPCR	C1254363
27722201	associated	C0439849
27722201	factors	C1521761
27722201	pregnant women	C0033011
27722201	South Wollo	C0015024
27722201	Northwest Ethiopia	C0015024
27722201	pregnant women	C0033011
27722201	Data	C1511726
27722201	interviewer	C0021821
27722201	administered questionnaire	C0034394
27722201	analyzed	C0936012
27722201	computer program	C0037585
27722201	SPSS version 20.00	C0333052
27722201	Results	C1274040
27722201	Pregnant women	C0033011
27722201	prepared	C4082130
27722201	elements	C3812827
27722201	BPCR	C1254363
27722201	Pregnant women	C0033011
27722201	danger signs	C0037088
27722201	pregnancy	C0032961
27722201	delivery	C0005615
27722201	postnatal period	C0871109
27722201	Women	C0043210
27722201	secondary education	C0683860
27722201	CI	C0009667
27722201	prepared	C4082130
27722201	illiterates	C0020899
27722201	Women	C0043210
27722201	lifetime history	C0598779
27722201	stillbirth	C0595939
27722201	attending	C1999232
27722201	ANC	C0033052
27722201	child	C0008059
27722201	pregnancy	C0032961
27722201	participating	C0679823
27722201	community	C0009462
27722201	BPCR	C1254363
27722201	group discussion	C0237576
27722201	male	C0086582
27722201	partner	C0682323
27722201	BPCR	C1254363
27722201	counseling	C0010210
27722201	ANC	C0033052
27722201	follow-up	C1522577
27722201	prepared	C4082130
27722201	Conclusions	C1707478
27722201	BPCR	C1254363
27722201	health communication	C1512347
27722201	partner	C0682323
27722201	BPCR	C1254363
27722201	counseling	C0010210
27722881	Fluoranthene	C0060514
27722881	degradation	C0005482
27722881	binding	C1167622
27722881	mechanism	C0441712
27722881	study	C2603343
27722881	active-site	C0205681
27722881	structure	C0678594
27722881	ring-hydroxylating dioxygenase	C0599874
27722881	Microbacterium paraoxydans JPM1	C4153571
27722881	study	C2603343
27722881	gram-positive fluoranthene-degrading bacterial	C0018154
27722881	strain	C1518614
27722881	isolated	C0205409
27722881	crude oil	C0031264
27722881	Dagang Oilfield	C3179127
27722881	identified	C0205396
27722881	Microbacterium paraoxydans JPM1	C4153571
27722881	analysis	C0936012
27722881	16S rDNA	C3537372
27722881	sequence	C0004793
27722881	days	C0439228
27722881	incubation	C1439852
27722881	strain	C1518614
27722881	JPM1	C4153571
27722881	initial	C0205265
27722881	amount	C1265611
27722881	fluoranthene	C0060514
27722881	metabolites	C0870883
27722881	9-fluorenone-1-carboxylic acid	C0574031
27722881	9-fluorenone	C0050227
27722881	phthalic acid	C0070968
27722881	benzoic acid	C0053225
27722881	culture solution	C0010454
27722881	gene sequence	C0004793
27722881	encoding	C2700640
27722881	aromatic-ring-hydroxylating dioxygenase	C0599874
27722881	amplified	C0017256
27722881	strain	C1518614
27722881	JPM1	C4153571
27722881	PCR	C0032520
27722881	protein sequence	C0002518
27722881	homology modeling method	C1512489
27722881	crystal structure	C0444626
27722881	dioxygenase	C0599874
27722881	interaction	C1704675
27722881	mechanism	C0441712
27722881	fluoranthene	C0060514
27722881	active site	C0205681
27722881	dioxygenase	C0599874
27722881	simulated	C0679083
27722881	analyzed	C0936012
27722881	molecular docking	C3494273
27722881	degrading	C0005482
27722881	pathway	C1704259
27722881	fluoranthene	C0060514
27722881	strain	C1518614
27722881	JPM1	C4153571
27722881	metabolites	C0870883
27722881	interaction analyses	C0237688
27722881	thermodynamic analysis	C0936012
27722881	strain	C1518614
27722881	JPM1	C4153571
27722881	high	C0205250
27722881	tolerance	C1704410
27722881	fluoranthene	C0060514
27722881	influence	C4054723
27722881	fluoranthene	C0060514
27722881	bacterial	C0004611
27722881	growth	C0018270
27722881	negligible	C0332269
27722881	concentrations	C1446561
27722881	study	C2603343
27722881	strain	C1518614
27722881	JPM1	C4153571
27722881	potential	C3245505
27722881	study	C2603343
27722881	bioremediation	C0598015
27722881	polycyclic aromatic hydrocarbon	C0032458
27722881	PAH	C0032458
27722881	contaminated	C0205279
27722881	sites	C0205145
27723907	Ultrasonography	C0041618
27723907	acute appendicitis	C0003615
27723907	physical examination	C0031809
27723907	laboratory support	C0022885
27723907	diagnosis	C0011900
27723907	acute appendicitis	C0003615
27723907	clinical practice	C0205897
27723907	negative appendectomy	C0003611
27723907	rate	C1521828
27723907	ultrasonography	C0041618
27723907	US	C0041618
27723907	reliable	C3858758
27723907	diagnostic method	C0086143
27723907	atypical	C0205182
27723907	presentation	C0449450
27723907	rule out	C0332196
27723907	differential diagnoses	C0011906
27723907	publications	C0034036
27723907	multidetector computed tomography	C3179130
27723907	CT	C3179130
27723907	false negative findings	C0205558
27723907	operation	C0543467
27723907	Extensive	C0205231
27723907	uncritical application	C0441485
27723907	children	C0008059
27723907	radiation exposure	C0418228
27723907	inadequate	C0205412
27723907	performance	C1882330
27723907	US	C0041618
27723907	egocentric	C0564559
27723907	economic	C0013557
27723907	preponderance	C0220900
27723907	US	C0041618
27723907	CT	C3179130
27723907	acute appendicitis	C0003615
27723907	US with graded compression	C0041618
27723907	diagnosing	C0011900
27723907	acute appendicitis	C0003615
27723907	visual	C0234621
27723907	arousal	C0003808
27723907	fostering	C0242298
27723907	clinical medicine	C0008964
27724977	Mesenchymal stem cells	C1257975
27724977	enhance	C2349975
27724977	oncolytic	C1518581
27724977	effect	C1280500
27724977	Newcastle disease virus	C0027984
27724977	glioma	C0017638
27724977	cells	C0007634
27724977	glioma	C0017638
27724977	stem cells	C0038250
27724977	secretion	C0036536
27724977	TRAIL	C0385242
27724977	Newcastle disease virus	C0027984
27724977	NDV	C0027984
27724977	avian paramyxovirus	C0206540
27724977	exerts	C0015264
27724977	oncolytic	C1518581
27724977	effects	C1280500
27724977	cancer cells	C0334227
27724977	Mesenchymal stem cells	C1257975
27724977	MSCs	C1257975
27724977	tumor growth	C0598934
27724977	deliver	C1705822
27724977	anti-tumor agents	C0003392
27724977	experimental	C1517586
27724977	glioblastoma	C0017636
27724977	GBM	C0017636
27724977	effects of	C1704420
27724977	NDV	C0027984
27724977	infected	C0439663
27724977	MSCs	C1257975
27724977	sources	C0449416
27724977	glioma	C0017638
27724977	cells	C0007634
27724977	glioma	C0017638
27724977	stem cells	C0038250
27724977	GSCs	C0038250
27724977	mechanisms	C0441712
27724977	effects	C1280500
27724977	glioma	C0017638
27724977	cell lines	C0085983
27724977	A172	C0085983
27724977	U87	C0085983
27724977	primary	C0205225
27724977	GSCs	C0038250
27724977	generated	C3146294
27724977	GBM	C0017636
27724977	tumors	C0027651
27724977	study	C0681814
27724977	MSCs	C1257975
27724977	derived	C1441547
27724977	bone marrow	C0005953
27724977	adipose tissue	C0001527
27724977	umbilical cord	C0041633
27724977	infected	C0439663
27724977	NDV	C0027984
27724977	MTH-68/H	C0965740
27724977	ability	C0085732
27724977	cells	C0007634
27724977	deliver	C1705822
27724977	virus	C0042776
27724977	glioma	C0017638
27724977	cell lines	C0085983
27724977	GSCs	C0038250
27724977	effects of	C1704420
27724977	NDV	C0027984
27724977	infected	C0439663
27724977	MSCs	C1257975
27724977	cell death	C0007587
27724977	stemness	C0205556
27724977	self-renewal	C1155711
27724977	GSCs	C0038250
27724977	examined	C0332128
27724977	mechanisms	C0441712
27724977	involved	C1314939
27724977	cytotoxic	C1511636
27724977	effects of	C1704420
27724977	NDV	C0027984
27724977	infected	C0439663
27724977	MSCs	C1257975
27724977	influence	C4054723
27724977	radiation sensitivity	C0034537
27724977	GSCs	C0038250
27724977	examined	C0332128
27724977	NDV	C0027984
27724977	induced	C0205263
27724977	dose-dependent	C1512045
27724977	cell death	C0007587
27724977	glioma	C0017638
27724977	cells	C0007634
27724977	low	C0205251
27724977	level	C0441889
27724977	apoptosis	C0162638
27724977	inhibition	C3463820
27724977	self-renewal	C1155711
27724977	GSCs	C0038250
27724977	MSCs	C1257975
27724977	derived	C1441547
27724977	bone marrow	C0005953
27724977	adipose	C0001527
27724977	umbilical cord	C0041633
27724977	infected	C0439663
27724977	NDV	C0027984
27724977	delivered	C1705822
27724977	virus	C0042776
27724977	co-cultured	C0282547
27724977	glioma	C0017638
27724977	cells	C0007634
27724977	GSCs	C0038250
27724977	Conditioned medium	C0162518
27724977	NDV	C0027984
27724977	infected	C0439663
27724977	MSCs	C1257975
27724977	induced	C0205263
27724977	higher	C0205250
27724977	level	C0441889
27724977	apoptosis	C0162638
27724977	tumor cells	C0597032
27724977	compared	C1707455
27724977	apoptosis	C0162638
27724977	induced	C0205263
27724977	direct infection	C1707758
27724977	similar	C2348205
27724977	virus titers	C2713348
27724977	results	C0683954
27724977	suggest	C1705535
27724977	factor(s)	C1521761
27724977	secreted	C1327616
27724977	infected	C0439663
27724977	MSCs	C1257975
27724977	sensitized	C0312864
27724977	glioma	C0017638
27724977	cells	C0007634
27724977	cytotoxic	C1511636
27724977	effects of	C1704420
27724977	NDV	C0027984
27724977	identified	C0205396
27724977	TRAIL	C0385242
27724977	mediator	C0205556
27724977	cytotoxic	C1511636
27724977	effects of	C1704420
27724977	infected	C0439663
27724977	MSCs	C1257975
27724977	demonstrated	C0205556
27724977	TRAIL	C0385242
27724977	NDV	C0027984
27724977	induction	C0205263
27724977	cell death	C0007587
27724977	glioma	C0017638
27724977	cells	C0007634
27724977	GSCs	C0038250
27724977	conditioned	C0348080
27724977	medium	C0439536
27724977	infected	C0439663
27724977	MSCs	C1257975
27724977	enhanced	C2349975
27724977	GSCs	C0038250
27724977	γ-radiation	C0017011
27724977	NDV	C0027984
27724977	infected	C0439663
27724977	umbilical cord	C0041633
27724977	derived	C1441547
27724977	MSCs	C1257975
27724977	novel	C0205314
27724977	effective	C1704419
27724977	therapeutic	C0302350
27724977	approach	C0449445
27724977	targeting	C1521840
27724977	GSCs	C0038250
27724977	GBM	C0017636
27724977	tumors	C0027651
27724977	γ-radiation	C0017011
27727312	Importance	C3898777
27727312	Ecological Factors	C0870460
27727312	Colony	C0441833
27727312	Handling	C1832073
27727312	Optimizing	C2698650
27727312	Health Status	C0018759
27727312	Apiaries	C3273359
27727312	Mediterranean	C0240321
27727312	Ecosystems	C0162358
27727312	analyzed	C0936012
27727312	apiaries	C3273359
27727312	natural environments	C0557745
27727312	Mediterranean	C0240321
27727312	ecosystem	C0162358
27727312	Madrid	C0037747
27727312	central Spain	C0037747
27727312	understand	C0162340
27727312	landscape	C0870781
27727312	management	C0680830
27727312	characteristics	C1521970
27727312	influence	C4054723
27727312	apiary	C3273359
27727312	health	C0018684
27727312	bee	C0004923
27727312	long term	C0443252
27727312	focused	C1285542
27727312	criteria	C0243161
27727312	habitat	C0871648
27727312	quality	C0332306
27727312	landscape	C0870781
27727312	heterogeneity	C0019409
27727312	climate	C0008946
27727312	management	C0680830
27727312	health	C0018684
27727312	subcriteria	C0243161
27727312	analytic hierarchy process	C0035177
27727312	AHP	C0035177
27727312	rank	C0699794
27727312	relevance	C2347946
27727312	Habitat	C0871648
27727312	quality	C0332306
27727312	relevance	C2347946
27727312	beehive	C3273359
27727312	management	C0680830
27727312	habitat	C0871648
27727312	quality	C0332306
27727312	subcriteria	C0243161
27727312	relevant	C2347946
27727312	orographic diversity	C1880371
27727312	elevation	C0702240
27727312	range	C1514721
27727312	important	C3898777
27727312	plant	C0032098
27727312	species	C1705920
27727312	located	C0332285
27727312	apiary	C3273359
27727312	important	C3898777
27727312	subcriteria	C0243161
27727312	beehive	C3273359
27727312	management	C0680830
27727312	honey	C0019906
27727312	production	C0033268
27727312	apiary	C3273359
27727312	location	C0450429
27727312	altitude	C0002349
27727312	wax	C0004924
27727312	renewal	C0205245
27727312	Temperature	C0039476
27727312	subcriterion	C0243161
27727312	climate	C0008946
27727312	pathogen	C0450254
27727312	Varroa	C0323623
27727312	loads	C0243095
27727312	significant	C0750502
27727312	health	C0018684
27727312	apiaries	C3273359
27727312	best values	C1299381
27727312	AHP	C0035177
27727312	analysis	C0936012
27727312	annual	C0332181
27727312	honey	C0019906
27727312	production	C0033268
27727312	colony	C0441833
27727312	productivity	C0033269
27727312	elevation	C0702240
27727312	range	C1514721
27727312	orographic diversity	C1880371
27727312	habitat	C0871648
27727312	quality	C0332306
27727312	apiaries	C3273359
27727312	best value	C1299381
27727312	beehive	C3273359
27727312	management	C0680830
27727312	best value	C1299381
27727312	health	C0018684
27727312	low	C0205251
27727312	pathogen	C0450254
27727312	load	C0243095
27727312	low	C0205251
27727312	average	C1510992
27727312	number	C0237753
27727312	viruses	C0042776
27727312	results	C1274040
27727312	importance	C3898777
27727312	environmental factors	C0870460
27727312	sanitary practices	C0205245
27727312	apiary	C3273359
27727312	health	C0018684
27727312	honey	C0019906
27727312	productivity	C0033269
27729085	Chordoma dedifferentiation	C1266174
27729085	proton beam therapy	C2169187
27729085	case report	C0007320
27729085	review of the literature	C0282441
27729085	Chordoma	C0008487
27729085	rare	C0522498
27729085	invasive	C0205281
27729085	bone tumor	C0005967
27729085	neuraxis	C1522496
27729085	primary	C0205225
27729085	histological varieties	C0027652
27729085	identified	C0205396
27729085	conventional	C0008487
27729085	chondroid	C1266173
27729085	dedifferentiated	C1266174
27729085	report	C0684224
27729085	case	C1706256
27729085	white	C0007457
27729085	girl	C0870604
27729085	conventional chordoma	C0008487
27729085	treated	C0332154
27729085	surgical resection	C0015252
27729085	mixed	C0205430
27729085	proton	C0729603
27729085	photon beam therapy	C3539769
27729085	recurrence	C0034897
27729085	resection cavity	C1515091
27729085	dedifferentiated morphology	C1266174
27729085	recurrent tumor	C0521158
27729085	express	C1171362
27729085	brachyury	C0170844
27729085	recently	C0332185
27729085	identified	C0205396
27729085	protein	C0033684
27729085	specific	C0205369
27729085	tissue	C0040300
27729085	notochordal	C0028439
27729085	origin	C0439659
27729085	short	C1806781
27729085	time period	C1948053
27729085	radiation therapy	C2169187
27729085	dedifferentiation	C2248595
27729085	low dose	C0445550
27729085	photons	C0086805
27729085	rarity	C0522498
27729085	dedifferentiated skull base chordomas	C2164487
27729085	pediatric	C1521725
27729085	patients	C0030705
27729085	alert	C3665546
27729085	clinicians	C0871685
27729085	possibility	C0332149
27729085	chordoma dedifferentiation	C1266174
27729085	proton beam therapy	C2169187
27732552	Volumetric absorptive microsampling	C0430022
27732552	home	C0442519
27732552	alternative	C1523987
27732552	tool	C0336791
27732552	monitoring	C1283169
27732552	HbA1c	C0019018
27732552	diabetes	C0011847
27732552	patients	C0030705
27732552	Microsampling techniques	C0449851
27732552	blood collection	C0005834
27732552	Dried blood spot (DBS) sampling	C3178862
27732552	blood collection	C0005834
27732552	heparinized capillaries	C0184108
27732552	standard	C1442989
27732552	techniques	C0022885
27732552	Volumetric absorptive microsampling	C0430022
27732552	VAMS	C0430022
27732552	technique	C0022885
27732552	volume	C0449468
27732552	blood	C0005767
27732552	tip	C3282898
27732552	blood drop	C0005767
27732552	study	C2603343
27732552	HbA1c	C0019018
27732552	monitoring	C1283169
27732552	VAMS sampling	C0430022
27732552	home	C0442519
27732552	analysis	C0936012
27732552	laboratory	C0022877
27732552	Diabetic	C0011847
27732552	patients	C0030705
27732552	study	C2603343
27732552	consultation	C0009818
27732552	endocrinologist	C0259863
27732552	venous	C0444255
27732552	adults	C0001675
27732552	capillary (children) sample	C0444254
27732552	HbA1c	C0019018
27732552	analysis	C0936012
27732552	DBS	C3178862
27732552	dried VAMS	C0430022
27732552	home	C0442519
27732552	laboratory	C0022877
27732552	pediatric	C1521725
27732552	patients	C0030705
27732552	VAMS	C0430022
27732552	consultation	C0009818
27732552	analysis	C0936012
27732552	wet VAMS	C0430022
27732552	HbA1c	C0019018
27732552	analyses	C0936012
27732552	Tosoh HLC-723 G8 high-performance liquid chromatography (HPLC) analyzer	C0179038
27732552	sampling	C0430022
27732552	home	C0442519
27732552	analysis	C0936012
27732552	days	C0439228
27732552	Results	C1274040
27732552	HbA1c	C0019018
27732552	VAMS	C0430022
27732552	venous	C0444255
27732552	capillary blood	C0444254
27732552	hospital	C0019994
27732552	concordance correlation coefficient	C1707429
27732552	CCC	C1707429
27732552	standard	C1442989
27732552	DBS	C3178862
27732552	HbA1c	C0019018
27732552	results	C1274040
27732552	wet VAMS	C0430022
27732552	CCC	C1707429
27732552	standard	C1442989
27732552	blood samples	C0178913
27732552	Patients	C0030705
27732552	VAMS	C0430022
27732552	DBS	C3178862
27732552	easy	C0332219
27732552	convenient	C3831015
27732552	use	C0457083
27732552	equipment	C0014672
27732552	standard	C1442989
27732552	clinical	C0205210
27732552	laboratory	C0022877
27732552	home	C0442519
27732552	dried VAMS	C0430022
27732552	DBS	C3178862
27732552	monitoring	C1283169
27732552	HbA1c	C0019018
27732552	HbA1c	C0019018
27732552	wet VAMS	C0430022
27732552	capillary microsamples	C0444254
27732647	Eyes	C0015392
27732647	Mirror	C0870904
27732647	Soul	C1510643
27732647	Eye	C0015392
27732647	Wrinkles	C2729169
27732647	Reveal	C0443289
27732647	Horse's	C0019944
27732647	Emotional State	C0935620
27732647	valid	C2349099
27732647	indicators	C1522602
27732647	emotional states	C0935620
27732647	animal welfare science	C0003061
27732647	investigated	C1292732
27732647	horses	C0019944
27732647	variation	C0205419
27732647	expression	C0700364
27732647	eye	C0015392
27732647	wrinkles	C2729169
27732647	contraction	C1140999
27732647	inner eyebrow	C0015420
27732647	reflects	C0558058
27732647	emotional valence	C0849912
27732647	horses	C0019944
27732647	positive	C1446409
27732647	negative	C0205160
27732647	conditions	C0348080
27732647	induce	C0205263
27732647	positive	C1446409
27732647	negative	C0205160
27732647	emotional states	C0935620
27732647	hypothesising	C1512571
27732647	positive	C1446409
27732647	emotions	C0013987
27732647	reduce	C0392756
27732647	negative	C0205160
27732647	emotions	C0013987
27732647	increase	C0442805
27732647	eye	C0015392
27732647	wrinkle	C2729169
27732647	expression	C0700364
27732647	horses	C0019944
27732647	exposed	C0332157
27732647	balanced	C0205415
27732647	positive	C1446409
27732647	grooming	C0018249
27732647	food anticipation	C0679106
27732647	negative	C0205160
27732647	condition	C0348080
27732647	food	C0016452
27732647	competition	C0679932
27732647	waving	C0441655
27732647	plastic bag	C3273359
27732647	condition	C0348080
27732647	seconds	C0457385
27732647	second	C0457385
27732647	control phase	C0205390
27732647	phases	C0205390
27732647	pictures	C0441468
27732647	eyes	C0015392
27732647	horse	C0019944
27732647	pictures	C0441468
27732647	condition	C0348080
27732647	phase	C0205390
27732647	randomly selected	C1707391
27732647	Pictures	C0441468
27732647	random order	C1705176
27732647	experimenters	C0870526
27732647	blind	C0150108
27732647	condition	C0348080
27732647	phase	C0205390
27732647	outcome measures	C0086749
27732647	qualitative	C0205556
27732647	impression	C1998467
27732647	eyelid	C0015426
27732647	shape	C0332479
27732647	markedness	C1706089
27732647	wrinkles	C2729169
27732647	presence	C0150312
27732647	eye white	C0036410
27732647	number	C0237753
27732647	wrinkles	C2729169
27732647	angle	C0205143
27732647	eyeball	C0015392
27732647	highest	C1522410
27732647	wrinkle	C2729169
27732647	angle	C0205143
27732647	decreased	C0205216
27732647	grooming	C0018249
27732647	increased	C0205217
27732647	food	C0016452
27732647	competition	C0679932
27732647	compared	C1707455
27732647	control phase	C0205390
27732647	phases	C0205390
27732647	food anticipation	C0679106
27732647	plastic bag	C3273359
27732647	condition	C0348080
27732647	No effects	C1301751
27732647	outcome measures	C0086749
27732647	detected	C0442726
27732647	measures	C0079809
27732647	assess	C1516048
27732647	eye	C0015392
27732647	wrinkle	C2729169
27732647	expression	C0700364
27732647	measure	C0079809
27732647	affected	C0392760
27732647	conditions	C0348080
27732647	horses	C0019944
27732647	exposed to	C0332157
27732647	Variation	C0205419
27732647	eye	C0015392
27732647	wrinkle	C2729169
27732647	expression	C0700364
27732647	provide	C0359589
27732647	information	C1533716
27732647	horse	C0019944
27732647	welfare	C0003061
27732647	validation	C1519941
27732647	specific	C0205369
27732647	measures	C0079809
27732647	different	C1705242
27732647	conditions	C0348080
27732923	Effective	C1704419
27732923	mercury(II)	C0025424
27732923	bioremoval	C1883720
27732923	aqueous solution	C3255993
27732923	electrochemical determination	C0259857
27732923	mercury	C0025424
27732923	elimination	C1883720
27732923	agricultural	C0001829
27732923	waste	C0043045
27732923	Allium Cepa L	C1262904
27732923	biomass	C0005535
27732923	removed	C0849355
27732923	mercury	C0025424
27732923	pseudo-second order kinetics	C0022702
27732923	Langmuir model	C0876936
27732923	adequately	C0205411
27732923	adsorption isotherm	C1254366
27732923	maximum	C0806909
27732923	mercury	C0025424
27732923	adsorption	C0001674
27732923	capacity	C1516240
27732923	biomass	C0005535
27732923	high	C0205250
27732923	density	C0178587
27732923	strong	C0442821
27732923	mercury	C0025424
27732923	chelating groups	C0007974
27732923	economically	C0013557
27732923	attractive	C2346874
27732923	implementation	C1708476
27732923	mercury	C0025424
27732923	selective electrode	C0201747
27732923	continuous	C0549178
27732923	determination	C1148554
27732923	real time	C1550177
27732923	proposed	C1553874
27732923	electrode	C1705652
27732923	replaces	C1550539
27732923	techniques	C0449851
27732923	atomic absorption spectroscopy	C0037806
27732923	real time	C1550177
27732923	studies	C2603343
27732923	perspective	C0449851
27732923	removing	C1883720
27732923	mercury(II)	C0025424
27732923	contaminated water	C0043056
27732923	environmental remediation	C3853059
27742350	Modeling	C0870071
27742350	nurse-patient assignments	C0578393
27742350	patient acuity	C3494263
27742350	travel	C0040802
27742350	distance	C0012751
27742350	metrics	C0242485
27742350	Balancing	C0205415
27742350	workload	C0085122
27742350	nurses	C0028661
27742350	hospital unit	C0019988
27742350	satisfaction	C0242428
27742350	safety	C0036043
27742350	nurses	C0028661
27742350	patients	C0030705
27742350	balance	C0205415
27742350	nurse	C0028661
27742350	workloads	C0085122
27742350	direct	C1947931
27742350	patient care activities	C0017313
27742350	indirect	C0439852
27742350	patient care activities	C0017313
27742350	non-patient care activities	C1254363
27742350	shift	C0333051
27742350	hospital unit	C0019988
27742350	location	C0450429
27742350	nurse's	C0028661
27742350	assigned	C1516050
27742350	patients	C0030705
27742350	relative	C0205345
27742350	resources	C0035201
27742350	unit	C0019988
27742350	important factors	C1521761
27742350	achieving	C1272277
27742350	workload	C0085122
27742350	balance	C0205415
27742350	hospitals	C0019994
27742350	nurse	C0028661
27742350	responsible	C1273518
27742350	shift	C0333051
27742350	assignment	C1516050
27742350	patients	C0030705
27742350	nurses	C0028661
27742350	experience	C0596545
27742350	past practices	C0237607
27742350	nurse-patient assignment	C0578393
27742350	process	C1522240
27742350	manual process	C1522240
27742350	nurse	C0028661
27742350	sort	C1947906
27742350	multiple decision criteria	C0243161
27742350	time	C0040223
27742350	methodology	C3266812
27742350	balanced	C0205415
27742350	nurse-patient workload assignments	C0578393
27742350	proposed	C1553874
27742350	methodology	C3266812
27742350	scoring	C0449820
27742350	metrics	C0242485
27742350	developed	C1527148
27742350	measures	C0079809
27742350	available	C0470187
27742350	hospital unit	C0019988
27742350	demonstrated	C0205245
27742350	complex scheduling	C0205539
27742350	problem	C0033213
27742350	methodology	C3266812
27742350	scheduling	C0205539
27742350	problem	C0033213
27742350	hospital unit	C0019988
27742350	approach	C0449445
27742350	workforce	C0024752
27742350	scheduling	C0205539
27742350	problems	C0033213
27742350	measures	C0079809
27742350	workload	C0085122
27742350	required	C1514873
27742350	elements	C1254372
27742350	work environment	C0162579
27742350	variability	C2827666
27742350	required	C1514873
27742350	tasks	C3540678
27742350	measurable	C1513040
27742350	perception	C0030971
27742350	relative	C0205345
27742350	intensity	C0522510
27742350	work elements	C1254372
27743686	Effect of	C1704420
27743686	alpha lipoic acid	C0023791
27743686	in vitro	C1533691
27743686	development	C0678723
27743686	bovine	C3667982
27743686	secondary preantral follicles	C0737234
27743686	study	C2603343
27743686	evaluate	C0220825
27743686	in vitro	C1533691
27743686	effect of	C1704420
27743686	alpha lipoic acid	C0023791
27743686	ALA	C0023791
27743686	culture medium	C0010454
27743686	development	C0678723
27743686	bovine	C3667982
27743686	secondary preantral follicles	C0737234
27743686	Bovine	C3667982
27743686	secondary preantral follicles	C0737234
27743686	collected	C1516698
27743686	divided	C0332849
27743686	groups	C0441833
27743686	size	C0456389
27743686	in vitro	C1533691
27743686	media	C0010454
27743686	doses	C0178602
27743686	ALA	C0023791
27743686	genes expression	C0017262
27743686	levels	C0441889
27743686	follicle-stimulating hormone beta-subunit	C1414828
27743686	FSHR	C1414828
27743686	insulin-like growth factor	C1334089
27743686	IGF-1	C1334089
27743686	Activin	C0017337
27743686	luteinizing hormone/choriogonadotropin receptor	C1416843
27743686	bone morphogenetic protein receptor type IA	C1332430
27743686	transforming growth factor beta receptor 1	C1424583
27743686	growth differentiation factor 9	C1333668
27743686	BCL2-associated X protein	C0812198
27743686	BAX	C0812198
27743686	C-Myc	C0079068
27743686	real-time polymerase chain reaction	C1709846
27743686	protein expression	C1171362
27743686	levels	C0441889
27743686	FSHR	C0034806
27743686	IGF-1	C0021665
27743686	BAX	C0219474
27743686	Western blot analysis	C0949466
27743686	results	C1254595
27743686	in vitro	C1533691
27743686	ALA	C0023791
27743686	induced	C0205263
27743686	significant	C0750502
27743686	increase in the growth	C1155901
27743686	development	C0678723
27743686	secondary preantral follicles	C0737234
27743686	culture	C0430400
27743686	period	C1948053
27743686	compared	C1707455
27743686	control	C0009932
27743686	FSHR	C1414828
27743686	IGF-1	C1334089
27743686	luteinizing hormone/choriogonadotropin receptor	C1416843
27743686	bone morphogenetic protein receptor type IA	C1332430
27743686	transforming growth factor beta receptor 1	C1424583
27743686	growth differentiation factor 9	C1333668
27743686	Activin A genes	C0017337
27743686	upregulated	C0041904
27743686	ALA	C0023791
27743686	treated	C1522326
27743686	follicles	C0737234
27743686	compared	C1707455
27743686	control	C0009932
27743686	preapoptotic genes	C0017337
27743686	BAX	C0812198
27743686	C-Myc	C0079068
27743686	downregulated	C0013081
27743686	treated	C1522326
27743686	follicles	C0737234
27743686	compared	C1707455
27743686	control	C0009932
27743686	protein levels	C0428479
27743686	FSHR	C0034806
27743686	IGF-1	C0021665
27743686	expressed	C1171362
27743686	treated	C1522326
27743686	follicles	C0737234
27743686	compared	C1707455
27743686	control	C0009932
27743686	BAX protein	C0219474
27743686	downregulated	C0013081
27743686	treated	C1522326
27743686	follicles	C0737234
27743686	groups	C0441833
27743686	ALA	C0023791
27743686	culture medium	C0010454
27743686	enhances	C2349975
27743686	secondary preantral follicles	C0737234
27743686	development	C0678723
27743686	growth	C1155901
27745564	proxies	C1521761
27745564	cognitive reserve	C2936352
27745564	evaluated	C0220825
27745564	population	C1257890
27745564	healthy	C3898900
27745564	older adults	C0001792
27745564	tools	C1516602
27745564	estimate	C0750572
27745564	individual's	C0027361
27745564	cognitive reserve	C2936352
27745564	CR	C2936352
27745564	assessed	C1516048
27745564	adequacy	C0205410
27745564	CR	C2936352
27745564	proxy	C1521761
27745564	appropriate	C1548787
27745564	estimate	C0750572
27745564	CR	C2936352
27745564	common	C0205214
27745564	assessment	C0220825
27745564	CR	C2936352
27745564	proxies	C1521761
27745564	literature	C0023866
27745564	years of education	C4054327
27745564	calculation	C1441506
27745564	comprehensive	C1880156
27745564	index	C0918012
27745564	most significant	C1299394
27745564	parameters	C0449381
27745564	estimation	C0680844
27745564	CR	C2936352
27745564	CR	C2936352
27745564	proxies	C1521761
27745564	education	C0013621
27745564	occupation	C0028811
27745564	leisure activities	C0023292
27745564	older adults	C0001792
27745564	Regression analyses	C0034980
27745564	indices	C0918012
27745564	CR	C2936352
27745564	ICR-standard	C0918012
27745564	ICR-detailed	C0918012
27745564	index	C0918012
27745564	CR	C2936352
27745564	ICR-standard	C0918012
27745564	calculated	C1441506
27745564	combination	C0205195
27745564	common	C0205214
27745564	measures	C0079809
27745564	reserve	C2936352
27745564	literature	C0023866
27745564	number of schooling years	C4054327
27745564	complexity	C0439855
27745564	occupation	C0028811
27745564	current	C0521116
27745564	participation	C0679823
27745564	stimulating	C1948023
27745564	activities	C0441655
27745564	ICR-detailed	C0918012
27745564	calculated	C1441506
27745564	most significant	C1299394
27745564	parameters	C0449381
27745564	initial	C0205265
27745564	analyses	C0936012
27745564	CR	C2936352
27745564	highest level of education	C4264309
27745564	combined	C0205195
27745564	training courses	C0040607
27745564	last	C1517741
27745564	occupation	C0028811
27745564	amount	C1265611
27745564	participation	C0679823
27745564	social	C2371613
27745564	intellectual activities	C0013652
27745564	comparison	C1707455
27745564	indices	C0918012
27745564	ICR-standard	C0918012
27745564	ICR-detailed	C0918012
27745564	associated with	C0332281
27745564	greater	C1704243
27745564	minimization	C0392756
27745564	effects of	C1704420
27745564	age	C0001779
27745564	cognition	C0009240
27745564	ICR-detailed	C0918012
27745564	associated	C0332281
27745564	minimization	C0392756
27745564	ICR-standard	C0918012
27745564	ICR-detailed	C0918012
27745564	CR	C2936352
27745564	great	C0549177
27745564	importance	C3898777
27745564	measuring	C0444706
27745564	CR	C2936352
27745564	proxies	C1521761
27745564	clinical tool	C1516602
27745564	comprehensive	C1880156
27745564	accurate	C0443131
27745564	estimation	C0680844
27745564	CR	C2936352
27750105	Discordance	C3639994
27750105	pathology report	C0807321
27750105	central pathology review	C2347585
27750105	breast cancer	C0006142
27750105	adjuvant treatment	C0677850
27750105	Pathological	C1521733
27750105	predictive factors	C0683956
27750105	markers	C0005516
27750105	breast cancer	C0006142
27750105	adjuvant therapy	C0677850
27750105	randomized clinical trials	C0206034
27750105	variability	C2827666
27750105	pathology report	C0807321
27750105	central pathology review	C2347585
27750105	discordance	C3639994
27750105	rate	C1521828
27750105	DR	C1521828
27750105	inter-rater agreement	C0870740
27750105	local	C0205276
27750105	central	C0205099
27750105	histopathological report	C0684224
27750105	clinical	C0205210
27750105	treatment decision	C4061230
27750105	retrospective analysis	C0035363
27750105	breast cancer tumors	C1458155
27750105	local pathologists	C0334866
27750105	reviewed	C1709940
27750105	Pathology Division	C0587487
27750105	European Institute of Oncology	C1708333
27750105	inter-rater agreement	C0870740
27750105	central pathology	C0030664
27750105	Ki-67	C0208804
27750105	grading	C0441799
27750105	hormone receptors	C0019929
27750105	ER	C0034804
27750105	PgR	C0034833
27750105	HER2/neu	C1512413
27750105	Bland-Altman plots	C0242481
27750105	Ki-67	C0208804
27750105	ER	C0034804
27750105	PgR	C0034833
27750105	DR	C1521828
27750105	ER	C0034804
27750105	PgR	C0034833
27750105	HER2	C0069515
27750105	pathology specimens	C0444061
27750105	Cancer Centers	C1513817
27750105	reviewed	C1709940
27750105	ER	C0034804
27750105	CI	C0009667
27750105	PgR	C0034833
27750105	CI	C0009667
27750105	Ki-67	C0208804
27750105	CI	C0009667
27750105	grading	C0441799
27750105	CI	C0009667
27750105	HER2	C0069515
27750105	CI	C0009667
27750105	DR	C1521828
27750105	HER2	C0069515
27750105	ER	C0034804
27750105	PgR	C0034833
27750105	Her2	C0069515
27750105	ER	C0034804
27750105	PgR	C0034833
27750105	systemic	C0205373
27750105	prescription	C0033080
27750105	retrospective analysis	C0035363
27750105	central pathological review	C2347585
27750105	decision-making process	C2364257
27750105	breast cancer	C0006142
27750105	clinical trials	C0008976
27753022	Implementing	C1708476
27753022	Non-Invasive	C0205303
27753022	Prenatal Diagnosis	C0033053
27753022	NIPD	C0033053
27753022	National Health Service Laboratory	C0022877
27753022	Dominant	C1527180
27753022	Recessive	C0678943
27753022	Disorders	C0012634
27753022	UK National Health Service regional genetics laboratory	C0022877
27753022	NIPD	C0033053
27753022	autosomal dominant	C0443147
27753022	de novo	C1515568
27753022	conditions	C0348080
27753022	achondroplasia	C0001080
27753022	thanataphoric dysplasia	C0039743
27753022	Apert syndrome	C0001193
27753022	paternal	C0337493
27753022	mutation	C0026882
27753022	exclusion	C0680251
27753022	cystic fibrosis	C0010674
27753022	bespoke tests	C0683443
27753022	NIPD	C0033053
27753022	risks	C0035648
27753022	associated with	C0332281
27753022	invasive testing	C0430022
27753022	prenatal diagnosis	C0033053
27753022	more	C0205172
27753022	families	C0015576
27753022	high	C0205250
27753022	genetic risk	C1517512
27753022	definitive	C0443196
27753022	diagnosis	C0011900
27753022	autosomal recessive diseases	C0265388
27753022	complicated	C0231242
27753022	predominance	C0332251
27753022	maternal	C0026591
27753022	mutant	C0596988
27753022	allele	C0002085
27753022	cell-free DNA	C4289789
27753022	sample	C2347026
27753022	variety	C2346866
27753022	different	C1705242
27753022	approaches	C0449445
27753022	Validation	C1519941
27753022	diagnostic	C0348026
27753022	implementation	C1708476
27753022	NIPD	C0033053
27753022	congenital adrenal hyperplasia	C0001627
27753022	CAH	C0001627
27753022	complicated	C0231242
27753022	presence	C0150312
27753022	pseudogene	C0033799
27753022	different	C1705242
27753022	approach	C0449445
27753022	assay	C0005507
27753022	targeting	C1521840
27753022	approximately	C0332232
27753022	heterozygous	C0019425
27753022	SNPs	C0752046
27753022	CAH gene	C1413861
27753022	CYP21A2	C1413861
27753022	high-risk	C0332167
27753022	parental	C0030551
27753022	haplotypes	C0018591
27753022	approach	C0449445
27753022	inheritance	C0242538
27753022	parental	C0030551
27753022	alleles	C0002085
27753022	identified	C0205396
27753022	NIPD	C0033053
27753022	measures	C0079809
27753022	fetal	C0015965
27753022	inheritance	C0242538
27753022	parental	C0030551
27753022	mutations	C0026882
27753022	utility	C3827682
27753022	NIPD	C0033053
27753022	multi-disorder panel	C0022885
27753022	autosomal recessive disease	C0265388
27753022	testing	C0039593
27753022	applicable	C1706839
27753022	families	C0015576
27753022	serious	C0205404
27753022	genetic conditions	C0019247
27756117	Silk fibroin	C4050636
27756117	carrier system	C0013161
27756117	delivery	C1705822
27756117	fibrinogen	C0016006
27756117	thrombin	C0040018
27756117	coagulant	C0009117
27756117	supplements	C2348609
27756117	control	C2587213
27756117	bleeding	C0019080
27756117	interventions	C0184661
27756117	traumatic injury	C3263723
27756117	Hemostatic devices	C0019120
27756117	delivering	C0677249
27756117	blood clotting	C0302148
27756117	agents	C0009117
27756117	fibrinogen	C0016006
27756117	increasingly	C0442808
27756117	efficacy	C1280519
27756117	application	C0185125
27756117	method	C0025663
27756117	incorporate	C0243126
27756117	coagulant	C0009117
27756117	supplements	C2348609
27756117	fibrinogen	C0016006
27756117	thrombin	C0040018
27756117	silk protein	C4050636
27756117	sponges	C0441126
27756117	coagulants	C0009117
27756117	aqueous	C0043047
27756117	silk	C0074529
27756117	molding	C0022885
27756117	freeze-drying	C0016698
27756117	water annealing	C0022885
27756117	combination	C0205195
27756117	system	C0449913
27756117	delivery	C1705822
27756117	fibrinogen	C0016006
27756117	hemostatic potential	C0019116
27756117	Concentration ratios	C1264681
27756117	silk	C0074529
27756117	fibrinogen	C0016006
27756117	thrombin	C0040018
27756117	fibrin	C0015982
27756117	polymeric	C0032521
27756117	network	C1882071
27756117	silk	C0074529
27756117	spongy structure	C0678594
27756117	interconnected	C0683595
27756117	silk	C0074529
27756117	intact	C0205266
27756117	network	C1882071
27756117	mechanical characterization	C1880022
27756117	fibrinogen-releasing	C1283071
27756117	silk	C0074529
27756117	sponges	C0441126
27756117	induction	C0205263
27756117	fibrinogen	C0016006
27756117	polymerization	C0314672
27756117	fibrin	C0015982
27756117	network	C1882071
27756117	reduced	C0392756
27756117	permanent	C0205355
27756117	deformation	C0333067
27756117	fibrinogen	C0016006
27756117	silk	C0074529
27756117	sponges	C0441126
27756117	fibrin	C0015982
27756117	formation	C1522492
27756117	linear	C0205132
27756117	elastic behavior	C0013764
27756117	Calcein-AM	C0252016
27756117	PI	C0033470
27756117	stainings	C0038128
27756117	MTT assay	C2986858
27756117	uniform	C0205375
27756117	cell adhesion	C0007577
27756117	surface	C0205148
27756117	cytocompatibility	C1524057
27756117	silk	C0074529
27756117	fibrin	C0015982
27756117	sponges	C0441126
27756117	co-delivery	C1705822
27756117	thrombin	C0040018
27756117	fibrinogen	C0016006
27756117	silk	C0074529
27756117	carrier material	C0013161
27756117	mechanically	C0443254
27756117	robust	C2986815
27756117	durable system	C0205556
27756117	preserving	C0728887
27756117	hemostatic features	C0019116
27756117	coagulant substances	C0009117
27756117	generation	C3146294
27756117	hemostatic devices	C0019120
27757318	natural killer cells	C0022688
27757318	antitumor activity	C0243095
27757318	epigenetic imprinting	C0242614
27757318	CD4(+) T cell	C0039215
27757318	Natural killer (NK) cell	C0022688
27757318	infusions	C0574032
27757318	patients	C0030705
27757318	cancer	C0006826
27757318	NK cell	C0022688
27757318	activation	C1326120
27757318	infusion	C0574032
27757318	NK cells	C0022688
27757318	cytokines	C0079189
27757318	IL-12	C0123759
27757318	15	C0254610
27757318	18	C0383327
27757318	NK cell	C0022688
27757318	antitumor activity	C0243095
27757318	NK cells	C0022688
27757318	in vitro	C3850137
27757318	IL-12	C0123759
27757318	15	C0254610
27757318	18	C0383327
27757318	IL-15	C0254610
27757318	antitumor activity	C0243095
27757318	1 mo	C1254367
27757318	lymphopenic	C0024312
27757318	RAG-2(-/-)	C1419248
27757318	mice	C0026809
27757318	NK cell	C0022688
27757318	IFNγ	C0021745
27757318	non-coding sequence	C0021920
27757318	CNS	C0021920
27757318	Ifng	C1334085
27757318	locus	C1708726
27757318	transcription	C0040649
27757318	Ifng	C1334085
27757318	xenograft melanoma mouse model	C0012644
27757318	human	C0086418
27757318	IL-12	C0123759
27757318	15	C0254610
27757318	18	C0383327
27757318	NK cells	C0022688
27757318	tumors	C0027651
27757318	RAG-2(-/-)	C1419248
27757318	mice	C0026809
27757318	CD4(+) T cells	C0039215
27757318	NK cells	C0022688
27757318	IFNγ	C0021745
27757318	IL-2	C0021756
27757318	CD4(+) T cell	C0039215
27757318	activation	C1326120
27757318	homeostatic proliferation	C1326161
27757318	macrophages	C0024432
27757318	NK cell	C0022688
27757318	antitumor activity	C0243095
27757318	NK cells	C0022688
27757318	cytokines	C0079189
27757318	epigenetic imprinting	C0242614
27757318	IFNγ	C0021745
27757318	phenotype	C0031437
27757318	cytokine	C0079189
27757318	NK cells	C0022688
27757318	CD4(+) T cell	C0039215
27757318	activation	C1326120
27757318	lymphopenic	C0024312
27757318	NK cell	C0022688
27757318	cancer immunotherapy	C0278348
27759568	Survey	C0018762
27759568	Neonatal Intensive Care Unit	C0021709
27759568	Nurse	C0028661
27759568	Attitudes	C0004271
27759568	Therapeutic Hypothermia Treatment	C0020674
27759568	traumatic	C0332663
27759568	parent	C0030551
27759568	babies	C0021270
27759568	treated with	C0332293
27759568	therapeutic hypothermia	C0020674
27759568	TH	C0020674
27759568	research	C0035168
27759568	assessed	C1516048
27759568	neonatal intensive care unit	C0021709
27759568	NICU	C0021709
27759568	nurse	C0028661
27759568	hypothermic	C0020672
27759568	babies	C0021270
27759568	parents	C0030551
27759568	NICU	C0021709
27759568	nurse	C0028661
27759568	attitudes	C0004271
27759568	TH	C0020674
27759568	perceptions	C0030971
27759568	baby	C0021270
27759568	pain	C0030193
27759568	sedation	C0344106
27759568	nurse	C0028661
27759568	parent	C0030551
27759568	education	C0013621
27759568	decision making	C0011109
27759568	initiation	C1704686
27759568	TH	C0020674
27759568	survey	C0018762
27759568	nurses	C0028661
27759568	NICUs	C0021709
27759568	responses	C1706817
27759568	nurses	C0028661
27759568	responses	C1706817
27759568	response	C1706817
27759568	Overwhelming	C0522501
27759568	urban	C0020029
27759568	rural institutions	C0020023
27759568	NICU	C0021709
27759568	nurses	C0028661
27759568	TH	C0020674
27759568	TH	C0020674
27759568	long-term	C0443252
27759568	outcomes	C0085415
27759568	TH	C0020674
27759568	Nurses	C0028661
27759568	urban institution	C0020029
27759568	treatment	C0087111
27759568	baby	C0021270
27759568	pain	C0030193
27759568	sedation	C0344106
27759568	nurses	C0028661
27759568	institutions	C0337951
27759568	nurse	C0028661
27759568	parent	C0030551
27759568	education	C0013621
27759568	TH	C0020674
27759568	decision making	C0011109
27759568	initiation	C1704686
27759568	TH	C0020674
27759568	NICU	C0021709
27759568	nurses	C0028661
27759568	outcomes	C0085415
27759568	babies	C0021270
27759568	treatment	C0087111
27759568	TH	C0020674
27759568	parents	C0030551
27759568	education	C0013621
27759568	TH	C0020674
27759568	Research	C0035168
27759568	TH treatment	C0020674
27759568	parent	C0030551
27759568	baby	C0021270
27759877	Pharmacological Venous Thromboembolism Prophylaxis	C0199242
27759877	Meningioma	C0025286
27759877	Patients	C0030705
27759877	Clinical Practice	C0695275
27759877	report	C2936319
27759877	Turkish Neurosurgery	C1552762
27759877	retrospective study	C0035363
27759877	intracranial meningioma	C0349604
27759877	patients	C0030705
27759877	open surgery	C4283938
27759877	venous thromboembolism	C1861172
27759877	VTE	C1861172
27759877	patients	C0030705
27759877	VTE	C1861172
27759877	deep vein thrombosis	C0149871
27759877	DVT	C0149871
27759877	pulmonary embolism	C0034065
27759877	PE	C0034065
27759877	complication	C0009566
27759877	meningioma surgery	C1096493
27759877	patients	C0030705
27759877	prophylaxis	C0199176
27759877	VTE	C1861172
27759877	pharmacological prophylaxis	C0420172
27759877	clinical extrapolation	C0205245
27760149	BEST	C0282574
27760149	Next-Generation	C1254367
27760149	Biomedical Entity Search Tool	C0282574
27760149	Knowledge	C0376554
27760149	Discovery	C1880355
27760149	Biomedical Literature	C0025120
27760149	volume	C1690016
27760149	publications	C0034036
27760149	rapidly	C0456962
27760149	increases	C0205217
27760149	searching	C1706202
27760149	relevant	C2347946
27760149	information	C1533716
27760149	literature	C0023866
27760149	challenging	C0243095
27760149	standard	C1442989
27760149	search engines	C2348167
27760149	PubMed	C1138432
27760149	desirable	C0205556
27760149	advanced search tool	C2348167
27760149	directly	C1947931
27760149	returns	C0332156
27760149	relevant	C2347946
27760149	biomedical	C0205556
27760149	entities	C1551338
27760149	targets	C0085104
27760149	drugs	C0013227
27760149	mutations	C0026882
27760149	existing	C0243095
27760149	tools	C0037589
27760149	submit	C1515023
27760149	query	C1522634
27760149	PubMed	C1138432
27760149	process	C1522240
27760149	abstracts	C0600678
27760149	information	C1533716
27760149	query	C1522634
27760149	time	C0040223
27760149	resulting	C1274040
27760149	slow	C0439834
27760149	time	C0040223
27760149	limited	C0439801
27760149	coverage	C1999244
27760149	fraction of	C1264633
27760149	PubMed corpus	C1138432
27760149	tools	C0037589
27760149	preprocess	C1882455
27760149	PubMed corpus	C1138432
27760149	time	C0040223
27760149	constantly	C1948059
27760149	updated	C1519814
27760149	produce	C0678227
27760149	outdated	C3645590
27760149	results	C1274040
27760149	tools	C0037589
27760149	process	C1522240
27760149	sophisticated	C0205556
27760149	queries	C1522634
27760149	searches	C1706202
27760149	mutations	C0026882
27760149	co-occur	C1709305
27760149	query	C1522634
27760149	literature	C0023866
27760149	problems	C0033213
27760149	introduce	C1292748
27760149	BEST	C0282574
27760149	biomedical entity search tool	C0282574
27760149	BEST	C0282574
27760149	returns	C0332156
27760149	result	C1274040
27760149	different	C1705242
27760149	biomedical	C0205556
27760149	entities	C1551338
27760149	including	C0332257
27760149	genes	C0017337
27760149	diseases	C0012634
27760149	drugs	C0013227
27760149	targets	C0085104
27760149	transcription factors	C0040648
27760149	miRNAs	C1101610
27760149	mutations	C0026882
27760149	relevant	C2347946
27760149	query	C1522634
27760149	knowledge	C0376554
27760149	BEST	C0282574
27760149	system	C0449913
27760149	processes	C1522240
27760149	text	C1527021
27760149	queries	C1522634
27760149	returns	C0332156
27760149	up-to-date	C0243095
27760149	results	C1274040
27760149	real time	C1550177
27760149	including	C0332257
27760149	mutation	C0026882
27760149	information	C1533716
27760149	results	C1274040
27760149	BEST	C0282574
27761213	Alanine	C0001898
27761213	Serine	C0036720
27761213	Variant	C0205419
27761213	Calcium Sensing Receptor	C0249742
27761213	Colorectal Cancer	C1527249
27761213	Risk	C0035647
27761213	effect	C1280500
27761213	calcium	C0006675
27761213	colorectal cancer	C1527249
27761213	CRC	C1527249
27761213	role	C1705810
27761213	calcium sensing receptor	C0249742
27761213	CaSR	C0249742
27761213	calcium homeostasis	C3653518
27761213	investigated	C1292732
27761213	CaSR gene	C1413136
27761213	rs1801725	C0678941
27761213	A986S variant	C0678941
27761213	associated with	C0332281
27761213	susceptibility	C1264642
27761213	CRC	C1527249
27761213	risk	C0035647
27761213	case-control study	C0007328
27761213	cases	C0868928
27761213	CRC	C1527249
27761213	controls	C0009932
27761213	subjects	C0681850
27761213	genotyped	C0017431
27761213	CaSR gene	C1413136
27761213	A986S variant	C0678941
27761213	PCR	C0032520
27761213	RFLP method	C3714764
27761213	No significant	C1273937
27761213	difference	C1705242
27761213	observed	C1441672
27761213	A986S variant	C0678941
27761213	CaSR gene	C1413136
27761213	genotype	C0017431
27761213	allele frequencies	C0017270
27761213	cases	C0868928
27761213	controls	C0009932
27761213	lack	C0332268
27761213	difference	C1705242
27761213	adjustment	C0456081
27761213	age	C0001779
27761213	BMI	C1305855
27761213	sex	C1522384
27761213	smoking status	C1519386
27761213	family history	C0241889
27761213	CRC	C1527249
27761213	No evidence	C0332125
27761213	effect	C1280500
27761213	modification	C3840684
27761213	association	C0439849
27761213	A986S variant	C0678941
27761213	CRC	C1527249
27761213	BMI	C1305855
27761213	sex	C1522384
27761213	tumor site	C0475445
27761213	observed	C1441672
27761213	risk	C0035647
27761213	obesity	C0028754
27761213	relation	C0439849
27761213	A986S variant	C0678941
27761213	controls	C0009932
27761213	cases	C0868928
27761213	analyzed	C0936012
27761213	no significant difference	C3842396
27761213	normal weight	C2712185
27761213	BMI	C1305855
27761213	overweight	C0497406
27761213	obese	C0028754
27761213	BMI	C1305855
27761213	subjects	C0681850
27761213	findings	C0243095
27761213	effect	C1280500
27761213	CaSR gene	C1413136
27761213	A986S variant	C0678941
27761213	CRC	C1527249
27761213	risk	C0035647
27761213	finding	C0243095
27761213	confirmation	C0750484
27761213	role	C1705810
27761213	gene variant	C0678941
27761213	carcinogenesis	C0596263
27761213	investigated	C1292732
27762482	Treatment	C0087111
27762482	erythematotelangiectatic rosacea	C1449852
27762482	fractionation	C3161031
27762482	high-fluence	C0205212
27762482	pulsed dye laser	C1289859
27762482	lasers	C0023089
27762482	treatment	C0087111
27762482	erythematotelangiectatic rosacea	C1449852
27762482	ETR	C1449852
27762482	systemic	C1515119
27762482	topical therapy	C0150349
27762482	pulsed dye lasers	C1289859
27762482	PDLs	C1289859
27762482	ETR	C1449852
27762482	purpuragenic	C0034150
27762482	fluence	C0376249
27762482	purpura	C0034150
27762482	postinflammatory hyperpigmentation	C0333616
27762482	PIH	C0333616
27762482	patients	C0030705
27762482	nonpurpuragenic	C0243095
27762482	fluence	C0376249
27762482	high fluence	C0205212
27762482	PDL	C1289859
27762482	purpura	C0034150
27762482	fractionation	C3161031
27762482	high fluence	C0205212
27762482	PDL	C1289859
27762482	patients	C0030705
27762482	ETR	C1449852
27762482	patients	C0030705
27762482	PDL	C1289859
27762482	Erythema	C0041834
27762482	telangiectasia	C0039446
27762482	physicians	C0031831
27762482	digital photographs	C3899375
27762482	patients	C0030705
27762482	erythema	C0041834
27762482	telangiectasia	C0039446
27762482	Purpura	C0034150
27762482	PIH	C0333616
27762482	patients	C0030705
27762482	fractionation	C3161031
27762482	high-fluence	C0205212
27762482	PDL	C1289859
27762482	treatment	C0087111
27762482	ETR	C1449852
27764714	Propulsion strategy	C0679199
27764714	gait	C0016928
27764714	primary school	C0033145
27764714	children	C0008059
27764714	effect	C1280500
27764714	age	C0001779
27764714	speed	C0678536
27764714	strategy	C0679199
27764714	generate	C3146294
27764714	power	C3854080
27764714	propulsion	C0026649
27764714	walking	C0080331
27764714	running	C0035953
27764714	marker	C0005516
27764714	gait	C0016928
27764714	maturation	C0678723
27764714	elastic energy	C1442080
27764714	recycling	C0334213
27764714	study	C2603343
27764714	investigated	C0220825
27764714	ankle	C0003086
27764714	hip	C0019552
27764714	power	C3854080
27764714	generation	C3146294
27764714	propulsion strategy	C0679199
27764714	PS	C0679199
27764714	late stance	C2019827
27764714	early swing phases	C2039052
27764714	walking	C0080331
27764714	running	C0035953
27764714	typically developing	C0870861
27764714	TD	C0870861
27764714	children	C0008059
27764714	years	C0439234
27764714	years	C0439234
27764714	three-dimensional	C0450363
27764714	gait analysis	C0558820
27764714	Peak	C0444505
27764714	ankle	C0003086
27764714	power	C3854080
27764714	generation	C3146294
27764714	push-off	C0444505
27764714	peakA2	C0444505
27764714	peak	C0444505
27764714	hip	C0019552
27764714	power	C3854080
27764714	generation	C3146294
27764714	early swing	C2039052
27764714	peakH3	C0444505
27764714	propulsion strategy	C0679199
27764714	(PS)	C0679199
27764714	peakA2	C0444505
27764714	(peakA2+peakH3	C0444505
27764714	calculated	C0444686
27764714	ankle	C0003086
27764714	power	C3854080
27764714	propulsion	C0026649
27764714	Mean	C0444504
27764714	PS	C0679199
27764714	values	C0042295
27764714	decreased	C0205216
27764714	speed	C0678536
27764714	increased	C0205217
27764714	comfortable walking	C0080331
27764714	fast	C0456962
27764714	walking	C0080331
27764714	fast	C0456962
27764714	running	C0035953
27764714	jogging	C0022400
27764714	PS	C0679199
27764714	age	C0001779
27764714	fast	C0456962
27764714	walking	C0080331
27764714	speed	C0678536
27764714	fast	C0456962
27764714	walking	C0080331
27764714	older children	C1455726
27764714	generated	C3146294
27764714	peakA2	C0444505
27764714	peakH3	C0444505
27764714	younger children	C0728836
27764714	kinetics	C0022702
27764714	running	C0035953
27764714	propulsion	C0026649
27764714	age	C0001779
27764714	years	C0439234
27764714	skills	C0678856
27764714	fast	C0456962
27764714	walking	C0080331
27764714	neuromuscular	C1979768
27764714	maturity	C0678732
27764714	findings	C0243095
27764714	running	C0035953
27764714	skill	C0678856
27764714	matures	C0678723
27764714	early	C1279919
27764714	TD	C0870861
27764714	children	C0008059
27764968	relationship	C0439849
27764968	anthropometry	C0003188
27764968	body composition	C0005885
27764968	computed tomography	C0040405
27764968	Atherosclerosis	C0004153
27764968	South Asians	C1519427
27764968	Living	C0376558
27764968	America	C0002454
27764968	relationships	C0439849
27764968	anthropometry	C0003188
27764968	body composition	C0005885
27764968	sex	C1522384
27764968	relationships	C0439849
27764968	South Asians	C1519427
27764968	US	C0041703
27764968	cross-sectional study	C0010362
27764968	participants	C0679646
27764968	Atherosclerosis	C0004153
27764968	South Asians	C1519427
27764968	Living	C0376558
27764968	America	C0002454
27764968	(MASALA) Study	C2603343
27764968	BMI	C1305855
27764968	abdominal CT scans	C0412620
27764968	measurement	C0242485
27764968	visceral	C1563740
27764968	subcutaneous fat	C0222331
27764968	Linear regression	C0023733
27764968	model	C3161035
27764968	anthropometric measures	C2598146
27764968	body composition	C0005885
27764968	anthropometry	C0003188
27764968	height	C0005890
27764968	associated with	C0332281
27764968	visceral fat	C1563740
27764968	significant	C0750502
27764968	visceral fat	C1563740
27764968	significant	C0750502
27764968	heterogeneity	C0019409
27764968	sex	C1522384
27764968	waist circumference	C0455829
27764968	visceral fat	C1563740
27764968	women	C0043210
27764968	men	C0025266
27764968	waist-to-hip ratio	C0205682
27764968	women	C0043210
27764968	men	C0025266
27764968	height	C0005890
27764968	anthropometry	C0003188
27764968	associated with	C0332281
27764968	subcutaneous fat	C0222331
27764968	significant	C0750502
27764968	significant	C0750502
27764968	heterogeneity	C0019409
27764968	sex	C1522384
27764968	weight	C0005910
27764968	women	C0043210
27764968	men	C0025266
27764968	BMI	C1305855
27764968	waist circumference	C0455829
27764968	hip circumference	C0562350
27764968	participants	C0679646
27764968	relationships	C0439849
27764968	anthropometric measures	C2598146
27764968	visceral	C1563740
27764968	subcutaneous fat	C0222331
27764968	race	C0034510
27764968	ethnic groups	C0015031
27764968	weaker	C1762617
27764968	heterogeneity	C0019409
27764968	sex	C1522384
27764968	researchers	C0035173
27764968	sex	C1522384
27764968	South Asians	C1519427
27764968	subcutaneous fat	C0222331
27764968	waist circumference	C0455829
27764968	visceral fat	C1563740
27765873	Active	C0205177
27765873	packaging	C0030176
27765873	chicken meats	C0677521
27765873	modified	C0392747
27765873	atmosphere	C0935443
27765873	oxygen	C0030054
27765873	scavengers	C1254355
27765873	effects of	C1704420
27765873	modified	C0392747
27765873	atmosphere	C0935443
27765873	packaging	C0030176
27765873	MAP	C0935443
27765873	CO2	C0007012
27765873	N2	C0028158
27765873	iron	C0302583
27765873	oxygen	C0030054
27765873	scavengers	C1254355
27765873	OS	C1254355
27765873	packaging system	C0178791
27765873	microbiological	C0025953
27765873	oxidative	C0311404
27765873	changes	C0392747
27765873	chicken thigh meats	C0677521
27765873	refrigerated storage	C1698986
27765873	day	C0439228
27765873	intervals	C1272706
27765873	Total aerobic mesophilic bacteria counts	C0392762
27765873	acceptability limit	C0392762
27765873	control group	C0009932
27765873	MAP	C0935443
27765873	AIR	C0001861
27765873	MAP	C0935443
27765873	OS	C1254355
27765873	samples	C0370003
27765873	OS	C1254355
27765873	utilization	C0042153
27765873	reductions	C0392756
27765873	Pseudomonas spp.	C0033808
27765873	counts	C0439157
27765873	storage	C1698986
27765873	AIR	C0001861
27765873	MAP	C0935443
27765873	groups	C0441833
27765873	MAP	C0935443
27765873	OS	C1254355
27765873	groups	C0441833
27765873	coliform counts	C0805715
27765873	AIR	C0001861
27765873	group	C0441833
27765873	reduction	C0392756
27765873	cases	C0868928
27765873	OS	C1254355
27765873	utilization	C0042153
27765873	TBARS	C0162781
27765873	values	C1522609
27765873	carbonyl	C0456205
27765873	sulphydryl contents	C0456205
27765873	stages	C1306673
27765873	refrigerated storage	C1698986
27765873	AIR	C0001861
27765873	MAP	C0935443
27765873	groups	C0441833
27765873	effects	C1280500
27765873	MAP	C0935443
27765873	suppressed	C1260953
27765873	microbiological growth	C2911660
27765873	lipid	C2612546
27765873	protein oxidation	C1159301
27765873	chicken thigh meats	C0677521
27765873	day	C0439228
27765873	shelf-life	C4279909
27765873	effects of	C1704420
27765873	OS	C1254355
27766173	Multidrug Resistance	C0242640
27766173	Acinetobacter Baumannii	C0314787
27766173	Ladoke Akintola University Teaching Hospital	C0019994
27766173	Osogbo, Nigeria	C0028075
27766173	Acinetobacter baumannii	C0314787
27766173	pathogen	C0450254
27766173	healthcare-associated infections	C0010356
27766173	Ladoke Akintola University Teaching Hospital	C0019994
27766173	Isolates	C3494793
27766173	assayed	C1510438
27766173	standard protocol	C0442711
27766173	isolates	C3494793
27766173	molecular techniques	C1513384
27766173	blaOXA, blaTEM, blaCTX-M, and blaSHV genes	C1442492
27766173	strains	C0314787
27766173	A. baumannii	C0314787
27766173	isolates	C3494793
27766173	A. baumannii	C0314787
27766173	patients	C0030705
27766173	age group	C0027362
27766173	male	C0086582
27766173	patients	C0030705
27766173	infected	C0439663
27766173	female	C0086287
27766173	Patients	C0030705
27766173	intensive care unit	C0021708
27766173	ICU	C0021708
27766173	infected	C0439663
27766173	organism	C0029235
27766173	isolates	C3494793
27766173	resistance	C4281815
27766173	amikacin	C0002499
27766173	ciprofloxacin	C0008809
27766173	ceftriaxone	C0007561
27766173	ceftazidime	C0007559
27766173	resistance	C4281815
27766173	antibiotics	C0003232
27766173	study	C2603343
27766173	piperacillin	C0031955
27766173	imipenem	C0066005
27766173	gentamycin	C3854019
27766173	meropenem	C0066005
27766173	isolates	C3494793
27766173	resistant	C4281815
27766173	colistin	C0002499
27766173	PCR	C0032520
27766173	results	C0456984
27766173	blaOXA, blaTEM, and blaCTX-M genes	C1442492
27766173	positive	C1446409
27766173	isolates	C3494793
27766173	blaSHV	C1442492
27766173	not detected	C0442737
27766173	isolates	C3494793
27766173	study	C2603343
27766173	revealed	C0443289
27766173	strains	C0314787
27766173	A. baumannii	C0314787
27766173	isolated	C0205409
27766173	multiple drug resistant	C0242640
27766173	monitoring	C1283169
27766173	prescription	C0033080
27766173	detection	C1511790
27766173	resistance	C4281815
27766173	antibiotics	C0003232
27766173	organism	C0029235
27766286	Dataset	C0150098
27766286	molecular dynamics simulations	C2717775
27766286	bilayers	C0205556
27766286	amyloidogenic peptide	C0030956
27766286	VDSWNVLVAG	C0002518
27766286	Bgl2p-glucantransferase	C0014442
27766286	S. cerevisiae	C0036025
27766286	cell wall	C0007623
27766286	amyloidogenic peptide	C0030956
27766286	VDSWNVLVAG	C0002518
27766286	Bgl2p-glucantransferase	C0014442
27766286	Saccharomyces cerevisiae	C0036025
27766286	cell wall	C0007623
27766286	analog	C0243071
27766286	VESWNVLVAG	C0002518
27766286	four	C0205450
27766286	bilayers	C0205556
27766286	orientation	C1704322
27766286	peptides	C0030956
27766286	layers	C0205556
27766286	layers	C0205556
27766286	bilayers	C0205556
27766286	models	C3161035
27766286	molecular dynamics	C0596957
27766286	MD	C0596957
27766286	changes	C0392747
27766286	secondary structure	C0162807
27766286	simulations	C0679083
27766286	data	C1511726
27766286	article	C1706852
27766286	information	C1533716
27766286	models	C3161035
27766286	β-strands	C0600383
27766286	organization	C1300196
27766286	oligomer	C0599219
27766286	structure	C0678594
27766286	results	C1274040
27766286	research article	C1706852
27766286	Structural model	C0026349
27766286	amyloid fibrils	C1449651
27766286	amyloidogenic peptide	C0030956
27766286	Bgl2p-glucantransferase	C0014442
27766286	S. cerevisiae	C0036025
27766286	cell wall	C0007623
27766286	analog	C0243071
27766286	morphology	C0332437
27766286	amyloid fibrils	C1449651
27768206	Straight configuration saphenous vein	C0036186
27768206	transposition	C1293442
27768206	popliteal artery	C0032649
27768206	vascular access	C0750138
27768206	saphenous vein	C0036186
27768206	vascular graft	C0740038
27768206	peripheral artery	C0489868
27768206	surgery	C0543467
27768206	rarely	C0522498
27768206	vascular access	C0750138
27768206	literature	C0023866
27768206	straight configuration saphenous vein	C0036186
27768206	transposition	C1293442
27768206	popliteal artery	C0032649
27768206	scarce	C0522498
27768206	straight configuration saphenous vein	C0036186
27768206	transposition	C1293442
27768206	popliteal artery	C0032649
27768206	vascular access	C0750138
27768206	surgical technique	C0011918
27768206	follow-up	C1522577
27768206	young	C0238598
27768206	men	C0025266
27768206	years	C0439234
27768206	lower-limb vascular access	C0457913
27768206	hemodialysis	C0019004
27768206	patient	C0030705
27768206	paraplegic	C0030486
27768206	upper extremity vascular access	C0749854
27768206	patient	C0030705
27768206	infected	C0439663
27768206	upper extremity arteriovenous graft	C0749781
27768206	(AVG	C0749781
27768206	closed	C0587267
27768206	AVFs	C0003855
27768206	arm veins	C0042449
27768206	patients	C0030705
27768206	received	C1514756
27768206	autologous	C0439859
27768206	lower extremity	C4266545
27768206	straight configuration saphenous vein	C0036186
27768206	transpositions	C1293442
27768206	popliteal artery	C0032649
27768206	spinal anesthesia	C0002928
27768206	Cannulation	C0917707
27768206	fistula	C0080304
27768206	month	C0439231
27768206	no early complications	C0231243
27768206	Slight swelling	C0038999
27768206	leg	C1140621
27768206	appeared	C0700364
27768206	patients	C0030705
27768206	fistulas	C0080304
27768206	functional	C0205245
27768206	months	C0439231
27768206	straight configuration saphenous vein	C0036186
27768206	transposition	C1293442
27768206	popliteal artery	C0032649
27768206	long and straight segment	C0441635
27768206	cannulation	C0917707
27768206	autologous	C0439859
27768206	vascular access	C0750138
27768206	patients	C0030705
27768380	Inhibited	C0311403
27768380	Temperament	C0039474
27768380	Hippocampal	C0019564
27768380	Volume	C1113695
27768380	Offspring	C0680063
27768380	Parents	C0030551
27768380	Bipolar Disorder	C0005586
27768380	suggested	C1705535
27768380	inhibited	C0311403
27768380	temperament	C0039474
27768380	associated with	C0332281
27768380	increased	C0205217
27768380	risk	C0035647
27768380	anxiety	C0003469
27768380	mood disorder	C0525045
27768380	bipolar disorder	C0005586
27768380	increased	C0205217
27768380	risk	C0035647
27768380	unknown	C0439673
27768380	examine	C0332128
27768380	temperament	C0039474
27768380	symptomatic	C0231220
27768380	asymptomatic	C0231221
27768380	child	C0008059
27768380	offspring	C0680063
27768380	parents	C0030551
27768380	bipolar disorder	C0005586
27768380	OBD	C0005586
27768380	investigate	C1292732
27768380	inhibited	C0311403
27768380	inhibited	C0311403
27768380	temperament	C0039474
27768380	associated with	C0332281
27768380	aberrant	C0443127
27768380	hippocampal	C0019564
27768380	volumes	C1113695
27768380	compared	C1707455
27768380	healthy control	C2986479
27768380	HC	C2986479
27768380	youth	C0087178
27768380	OBD	C0005586
27768380	group	C0681860
27768380	youth	C0087178
27768380	current	C0521116
27768380	psychiatric symptoms	C0233401
27768380	(OBD(+)s)	C0005586
27768380	without	C0332288
27768380	psychiatric symptoms	C0233401
27768380	compared	C1707455
27768380	HC	C2986479
27768380	youth	C0087178
27768380	Temperament	C0039474
27768380	characteristics	C1521970
27768380	measured	C0444706
27768380	Revised Dimensions of Temperament Survey	C0430022
27768380	Magnetic resonance imaging	C0024485
27768380	measure	C0079809
27768380	hippocampal	C0019564
27768380	volumes	C1113695
27768380	association	C0439849
27768380	temperament	C0039474
27768380	hippocampal	C0019564
27768380	volumes	C1113695
27768380	tested	C0039593
27768380	multiple regression analysis	C0681923
27768380	Compared	C1707455
27768380	OBD(-)s group	C0681860
27768380	OBD(+)s	C0005586
27768380	group	C0681860
27768380	significantly more	C4055637
27768380	inhibited	C0311403
27768380	inhibited	C0311403
27768380	temperament	C0039474
27768380	traits	C0599883
27768380	less	C0547044
27768380	flexibility	C0443220
27768380	more	C0205172
27768380	negative	C0205160
27768380	mood	C0026516
27768380	less	C0547044
27768380	regular	C0205272
27768380	rhythm	C0871269
27768380	daily	C0332173
27768380	routines	C0205547
27768380	OBD(-)s group	C0681860
27768380	novel	C0205314
27768380	situations	C0348080
27768380	compared	C1707455
27768380	OBD(+)s	C0005586
27768380	HC	C2986479
27768380	groups	C0681860
27768380	OBD(+)s	C0005586
27768380	group	C0681860
27768380	inhibited	C0311403
27768380	inhibited	C0311403
27768380	temperament	C0039474
27768380	associated with	C0332281
27768380	right	C0444532
27768380	hippocampal	C0019564
27768380	volumes	C1113695
27768380	symptomatic	C0231220
27768380	OBD	C0005586
27768380	characterized	C1880022
27768380	inhibited	C0311403
27768380	inhibited	C0311403
27768380	temperament	C0039474
27768380	inversely	C0439850
27768380	correlated	C1707520
27768380	hippocampal	C0019564
27768380	volume	C1113695
27768380	longitudinal studies	C0023981
27768380	needed	C0027552
27768380	inverse	C0439850
27768380	correlations	C1707520
27768380	hippocampal	C0019564
27768380	volume	C1113695
27768380	inhibited	C0311403
27768380	inhibited	C0311403
27768380	temperament	C0039474
27768380	markers	C0005516
27768380	risk	C0035647
27768380	bipolar disorder	C0005586
27771331	Dynamic	C0729333
27771331	disorder	C0205556
27771331	non-exponential	C0392762
27771331	kinetics	C0022702
27771331	protein mechanical unfolding	C1655065
27771331	Protein unfolding	C1655065
27771331	single molecule force spectroscopy	C4279975
27771331	studies	C0947630
27771331	stretched exponential	C0205556
27771331	kinetics	C0022702
27771331	protein unfolding	C1655065
27771331	constant pulling force	C0441722
27771331	molecular	C1521991
27771331	origin	C0439659
27771331	mechanical unfolding	C1655065
27771331	ubiquitin	C0041538
27771331	NuG2	C0033684
27771331	Molecular Dynamics (MD) simulations	C2717775
27771331	proteins	C0033684
27771331	kinetics	C0022702
27771331	stretched exponentials	C0205556
27771331	stretching exponents	C1711342
27771331	experiments	C0681814
27771331	absent	C0332197
27771331	MD simulations	C2717775
27771331	non-exponential	C0392762
27771331	kinetics	C0022702
27771331	dynamic	C0729333
27771331	disorder	C0205556
27771331	conformational	C0026377
27771331	fluctuations	C0231241
27771331	nanosecond timescale	C1254367
27771331	study	C2603343
27771331	dynamic	C0729333
27771331	disorder	C0205556
27771331	protein kinetics	C0022702
27771331	time scales	C1254367
27771331	MD simulations	C2717775
27771746	GTPV	C0206574
27771746	bidirectional	C1706937
27771746	promoter region	C0033413
27771746	goat pox chick embryo-attenuated virus	C0206574
27771746	GTPV	C0206574
27771746	vaccine	C0042210
27771746	immune responses	C0301872
27771746	genome	C0017428
27771746	express	C0017262
27771746	exogenous	C0205228
27771746	genes	C0017337
27771746	virus	C0206574
27771746	ideal	C1512612
27771746	vector	C0599566
27771746	recombinant live vaccines	C0034862
27771746	infectious diseases	C0009450
27771746	ruminant animals	C0035950
27771746	bidirectional	C1706937
27771746	promoter region	C0033413
27771746	GTPV	C0206574
27771746	PbVV(±)	C0086860
27771746	PbVV(±)	C0086860
27771746	ETF-l	C0082367
27771746	VITF-3	C0040648
27771746	transcribed	C0040649
27771746	opposite	C1521805
27771746	directions	C0449738
27771746	recombinant goat pox virus	C0206574
27771746	rGTPV	C0206574
27771746	PbVV(+)	C0086860
27771746	promoter	C0086860
27771746	enhance	C2349975
27771746	Brucella OMP31	C1621913
27771746	expression	C1171362
27771746	PbVV	C0086860
27771746	promoter element	C0086860
27771746	enhanced green fluorescent protein	C1258415
27771746	EGFP	C1258415
27771746	PbVV(-) promoter	C0086860
27771746	P7.5 promoter	C0086860
27771746	vaccinia virus	C0042216
27771746	EGFP	C1258415
27771746	expression	C1171362
27771746	fluorescence intensity	C0026022
27771746	EGFP	C1258415
27771746	expressed	C1171362
27771746	cells	C0007634
27771746	fluorescence microscopy	C0026022
27771746	flow cytometry	C0016263
27771746	PbVV(+) promoter	C0086860
27771746	Brucella OMP31	C1621913
27771746	expression	C1171362
27771746	anti-Brucella-OMP31 monoclonal antibody	C0003250
27771746	western blotting	C0005863
27771746	OMP31	C1621913
27771746	mRNA expression	C1515670
27771746	qRT-PCR	C1514628
27771746	effective	C1704419
27771746	multivalent vaccines	C1514218
27771746	rGTPV	C0206574
27771746	expression	C1171362
27771746	exogenous	C0205228
27771746	genes	C0017337
27772556	Psychometric analysis	C0033920
27772556	Patient Health Questionnaire	C1879301
27772556	Danish	C0011318
27772556	patients	C0030705
27772556	implantable cardioverter defibrillator	C0162589
27772556	DEFIB-WOMEN study	C0681876
27772556	psychometric properties	C0033920
27772556	Patient Health Questionnaire	C4083201
27772556	PHQ-9	C4083201
27772556	measure	C0079809
27772556	depressive symptoms	C0086132
27772556	large	C0549177
27772556	Danish	C0011318
27772556	national cohort	C0599755
27772556	patients	C0030705
27772556	heart disease	C0018799
27772556	implanted	C0021107
27772556	implantable cardioverter defibrillator	C0162589
27772556	ICD	C0162589
27772556	item response theory	C0870753
27772556	prospective cohort	C0599755
27772556	patients	C0030705
27772556	implanted	C0021107
27772556	ICD	C0162589
27772556	men	C0025266
27772556	PHQ-9	C4083201
27772556	implant	C0021107
27772556	Data	C1511726
27772556	analyzed	C0936012
27772556	item response theory models	C0870753
27772556	partial credit model	C0026348
27772556	generalized partial credit model	C0026348
27772556	analysis	C0936012
27772556	disordered response	C1706817
27772556	thresholds	C0449864
27772556	items	C0871791
27772556	partial credit model	C0026348
27772556	items	C0871791
27772556	generalized partial credit model	C0026348
27772556	respondents	C0282122
27772556	difficulty	C0332218
27772556	discriminating	C0012632
27772556	response	C1706817
27772556	response	C1706817
27772556	options	C1518601
27772556	rescored	C0449820
27772556	PHQ-9	C4083201
27772556	models	C0026348
27772556	unidimensionality	C0205556
27772556	precision	C1706245
27772556	rescored	C0449820
27772556	PHQ-9	C4083201
27772556	Items	C0871509
27772556	differential functioning	C0205245
27772556	DIF	C0205245
27772556	educational level	C0013658
27772556	age	C0001779
27772556	indication	C3146298
27772556	ICD	C0162589
27772556	implantation	C0021107
27772556	severity	C0439793
27772556	heart failure	C0018801
27772556	influence	C4054723
27772556	depression	C0011570
27772556	outcomes	C1274040
27772556	patients	C0030705
27772556	ICD	C0162589
27772556	DIF	C0205245
27772556	gender	C0079399
27772556	items	C0871509
27772556	partial credit model	C0026348
27772556	generalized partial credit model	C0026348
27772556	item set	C0871509
27772556	unidimensionality	C0205556
27772556	reliability	C2347947
27772556	Danish version	C0010969
27772556	PHQ-9	C4083201
27772556	confirmed	C0750484
27772556	associated	C0332281
27772556	consequences	C0686907
27772556	response	C1706817
27772556	options	C1518601
27772556	Likert scale	C0451267
27772556	examined	C0332128
27772556	PHQ-9	C4083201
27772556	screening	C1710032
27772556	tool	C0037589
27772556	outcome measure	C0086749
27773614	Geographical variations	C0935553
27773614	incidence	C0021149
27773614	management	C0376636
27773614	survival	C0038954
27773614	hepatocellular carcinoma	C2239176
27773614	Western country	C0454664
27773614	Information	C1533716
27773614	incidence	C0021149
27773614	management	C0376636
27773614	prognosis	C0033325
27773614	hepatocellular carcinoma	C2239176
27773614	HCC	C2239176
27773614	population samples	C2348150
27773614	regional	C0205147
27773614	data	C1511726
27773614	registries	C0034975
27773614	Comprehensive	C1880156
27773614	national	C1555720
27773614	evaluations	C0220825
27773614	country	C0454664
27773614	lacking	C0332268
27773614	study	C2603343
27773614	investigate	C1292732
27773614	regional	C0205147
27773614	variations	C0205419
27773614	HCC	C2239176
27773614	care	C1947933
27773614	France	C0016674
27773614	observational study	C1518527
27773614	data	C1511726
27773614	French	C1556084
27773614	administrative databases	C0242356
27773614	patients	C0030705
27773614	HCC	C2239176
27773614	diagnosed	C0011900
27773614	incidence	C0021149
27773614	HCC	C2239176
27773614	access	C0444454
27773614	surgery	C0543467
27773614	survival	C0038954
27773614	national level	C0681788
27773614	geographical levels	C0681784
27773614	French regions	C0454828
27773614	French	C1556084
27773614	departments	C1704729
27773614	France	C0016674
27773614	divided administratively	C2919030
27773614	influence	C4054723
27773614	outcome	C1274040
27773614	hospital	C0019994
27773614	HCC	C2239176
27773614	managed	C1273870
27773614	assessed	C1516048
27773614	national level	C0681788
27773614	median survival	C2986586
27773614	months	C0439231
27773614	patients	C0030705
27773614	curative treatment	C1273390
27773614	regions	C0017446
27773614	departments	C1704729
27773614	incidence	C0021149
27773614	access	C0444454
27773614	curative treatment	C1273390
27773614	median survival	C2986586
27773614	range	C1514721
27773614	months	C0439231
27773614	administrative type	C0001554
27773614	annual	C0332181
27773614	HCC	C2239176
27773614	caseload	C0814777
27773614	hospital	C0019994
27773614	patients	C0030705
27773614	admitted	C0184666
27773614	independent	C0085862
27773614	influence	C4054723
27773614	treatment	C0087111
27773614	survival	C0038954
27773614	insurance coverage	C0376629
27773614	citizens	C0682134
27773614	national	C1555720
27773614	measures	C0079809
27773614	reduce inequities	C0242503
27773614	management	C0376636
27773614	cancer patients	C1516213
27773614	recommendations	C0034866
27773614	HCC	C2239176
27773614	surveillance	C0038842
27773614	management	C0376636
27773614	percentage	C0439165
27773614	patients	C0030705
27773614	curative treatment	C1273390
27773614	survival	C0038954
27773614	postcode	C0421454
27773614	hospital	C0019994
27773614	patients	C0030705
27773614	managed	C1273870
27773614	influence	C4054723
27773614	accessibility	C0814423
27773614	good care	C1947933
27773614	survival	C0038954
27773614	Population-based studies	C1709599
27773614	countries	C0454664
27773614	survival	C0038954
27773614	patients	C0030705
27773614	malignancy	C4282132
27773614	effectiveness	C1280519
27773614	health systems	C1456613
27773614	incidence	C0021149
27773614	cancer	C0006826
27773614	quality	C0332306
27773614	registration	C1514821
27773614	country	C0454664
27773614	minimal	C0547040
27773614	countries	C0454664
27773614	study	C2603343
27773614	country	C0454664
27773614	incidence	C0021149
27773614	curative treatment	C1273390
27773614	rate	C1521828
27773614	survival	C0038954
27773614	patients	C0030705
27773614	HCC	C2239176
27773614	Evidence	C3887511
27773614	care	C1947933
27773614	survival	C0038954
27773614	country	C0454664
27773614	strengthen the impetus	C0205556
27773614	government	C0018104
27773614	clinicians	C0871685
27773614	disparities	C1955989
27778231	Identification	C0205396
27778231	predictive	C0681890
27778231	markers	C0008963
27778231	dexamethasone	C0011777
27778231	resistance	C0013203
27778231	childhood	C0231335
27778231	acute lymphoblastic leukemia	C0023449
27778231	Response	C0683154
27778231	dexamethasone	C0011777
27778231	DEXA	C0011777
27778231	hallmark drug	C1254351
27778231	treatment	C0039798
27778231	childhood	C0231335
27778231	acute lymphoblastic leukemia	C0023449
27778231	ALL	C0023449
27778231	prognostic factors	C1514474
27778231	prediction of outcome	C0033325
27778231	ALL	C0023449
27778231	Identification	C0205396
27778231	predictive	C0681890
27778231	markers	C0008963
27778231	chemoresistance	C0013203
27778231	therapeutic protocol	C0040808
27778231	effect adverse	C0879626
27778231	drug targets	C0085104
27778231	2DE	C0013860
27778231	MS	C0037813
27778231	proteomics study	C0022885
27778231	DEXA	C0011777
27778231	resistant cell line	C0007600
27778231	REH	C0007600
27778231	model	C0026336
27778231	DEXA	C0011777
27778231	patients	C0030705
27778231	drug treatment	C0013216
27778231	proteomic methods	C0022885
27778231	expressed	C1171362
27778231	proteins	C0033684
27778231	detected	C0442726
27778231	voltage dependent anion channel 1	C0753015
27778231	VDAC1	C0753015
27778231	sorting Nexin 3	C1741224
27778231	SNX3	C1741224
27778231	prefoldin subunit 6	C1743484
27778231	PFDN6	C1743484
27778231	expression	C1171362
27778231	proteins	C0033684
27778231	DEXA	C0011777
27778231	treatment	C0039798
27778231	REH cells	C0007600
27778231	expression	C1171362
27778231	proteins	C0033684
27778231	mRNA	C0035696
27778231	level	C0441889
27778231	quantitative PCR method	C2733022
27778231	proteins	C0033684
27778231	proteins	C0033684
27778231	roles	C1705810
27778231	drug resistance	C0013203
27778231	regulation of apoptosis	C1148568
27778231	VDAC1	C0753015
27778231	protein trafficking	C0599895
27778231	SNX3	C1741224
27778231	protein folding	C0162847
27778231	PFDN6	C1743484
27778231	mRNA	C0035696
27778231	expression level	C3244092
27778231	proteins	C0033684
27778231	assessed	C1516048
27778231	bone marrow samples	C0438737
27778231	children	C0008059
27778231	newly diagnosed	C1518321
27778231	ALL	C0023449
27778231	non-cancerous samples	C0370003
27778231	controls	C0009932
27778231	molecular subtypes	C0449560
27778231	leukemia	C0023418
27778231	mRNA	C0035696
27778231	expression	C1171362
27778231	VDAC1	C0753015
27778231	SNX3	C1741224
27778231	PFDN6	C1743484
27778231	ALL	C0023449
27778231	samples	C0370003
27778231	non-cancerous samples	C0370003
27778231	VDAC1	C0753015
27778231	mRNA	C0035696
27778231	expression	C1171362
27778231	proteins	C0033684
27778231	high-risk	C0332167
27778231	samples	C0370003
27778231	standard	C1442989
27778231	risk	C0035647
27778231	cases	C0868928
27778231	diagnostic	C0348026
27778231	prognostic	C0220901
27778231	value	C0042295
27778231	proteins	C0033684
27778231	childhood	C0231335
27778231	ALL	C0023449
27778231	investigation	C0220825
27778231	protein-protein interaction	C0872079
27778231	STRING	C1547402
27778231	database	C0242356
27778231	proteins	C0033684
27778231	signaling pathway	C0037080
27778231	NR3C1	C1370369
27778231	dexamethasone	C0011777
27778231	target	C0243095
27778231	proteomic study	C0022885
27778231	DEXA	C0011777
27778231	resistant	C0013203
27778231	leukemic cells	C1517806
27778231	VDAC1	C0753015
27778231	SNX3	C1741224
27778231	PFDN6	C1743484
27778231	proteins	C0033684
27778231	biomarkers	C0005516
27778231	prognosis	C0033325
27778231	chemotherapy	C3665472
27778231	childhood	C0231335
27778231	ALL	C0023449
27779321	Benthic injury dose-response models	C0282574
27779321	polychlorinated biphenyl	C0032447
27779321	contaminated	C0205279
27779321	sediment	C1550099
27779321	equilibrium partitioning	C0282574
27779321	study	C2603343
27779321	sediment	C1550099
27779321	polychlorinated biphenyl	C0032447
27779321	PCB	C0032447
27779321	dose-response model	C0282574
27779321	benthic invertebrate	C0599636
27779321	PCBs	C0032447
27779321	equilibrium partitioning (EqP) approach	C0282574
27779321	PCB	C0032447
27779321	sediment	C1550099
27779321	concentrations	C0457929
27779321	Aroclor 1254	C0052391
27779321	gradient	C0812409
27779321	toxic effects	C0600688
27779321	benthic organisms	C0599636
27779321	aquatic	C0563034
27779321	toxicity	C0600688
27779321	studies	C2603343
27779321	study	C2603343
27779321	EqP	C0282574
27779321	sediment	C1550099
27779321	dose-response	C0678790
27779321	gradient	C0812409
27779321	PCBs	C0032447
27779321	chronic	C0205191
27779321	aquatic	C0563034
27779321	toxicity	C0600688
27779321	literature	C0023866
27779321	aqueous	C0599956
27779321	PCB	C0032447
27779321	concentrations	C0457929
27779321	benthic invertebrate	C0599636
27779321	aquatic	C0563034
27779321	toxic effect	C0600688
27779321	data	C1511726
27779321	studies	C2603343
27779321	common metric	C0025867
27779321	percent injury	C0392762
27779321	organic carbon	C0007011
27779321	sediment	C1550099
27779321	PCB	C0032447
27779321	concentrations	C0457929
27779321	organic carbon	C0007011
27779321	aqueous	C0599956
27779321	PCB	C0032447
27779321	toxicity	C0600688
27779321	data set	C0150098
27779321	EqP	C0282574
27779321	US Environmental Protection Agency's	C0041712
27779321	EPIWEB 4.1	C0037585
27779321	water-organic carbon partition coefficient	C1518903
27779321	KOC	C1518903
27779321	dose-response numerical model	C0282574
27779321	sediment	C1550099
27779321	PCB	C0032447
27779321	concentrations	C0457929
27779321	biological effects	C1511145
27779321	median effective concentration	C1446561
27779321	models	C0282574
27779321	tables	C1706074
27779321	percent injury	C0392762
27779321	benthic biota	C1253910
27779321	Aroclor	C0052391
27779321	sediment	C1550099
27779321	concentrations	C0457929
27779321	model	C0282574
27779321	EPIWEB	C0037585
27779321	KOC	C1518903
27779321	mean benthic injury	C0392762
27779321	sediment	C1550099
27779321	concentrations	C0457929
27779321	Aroclor 1254	C0052391
27779321	organic carbon	C0007011
27779321	model	C0282574
27779321	site-specific	C0449604
27779321	KOC	C1518903
27779321	tables	C1706074
27779321	equations	C0552449
27779321	dose-response	C0678790
27779321	sediment	C1550099
27779321	concentration	C0457929
27779702	Extract of Caulis Spatholobi	C0032081
27779702	Caulis Spatholobi	C0242767
27779702	blocker	C1254351
27779702	tumor cell	C0597032
27779702	tumor cell ‑induced platelet aggregation	C0032176
27779702	breast cancer	C0006142
27779702	metastasis	C0027627
27779702	Metastasis	C0027627
27779702	breast cancer	C0006142
27779702	malignant progression	C0948048
27779702	hematogenous metastasis	C0027627
27779702	cancer cells	C0334227
27779702	platelet	C0005821
27779702	hypercoagulable state	C0398623
27779702	factor	C1521761
27779702	coagulation	C0005778
27779702	system	C0449913
27779702	metastasis	C0027627
27779702	platelet	C0005821
27779702	tumor cell	C0597032
27779702	tumor cell	C0597032
27779702	metastasis	C0027627
27779702	tumor cell	C0597032
27779702	tumor cell ‑induced platelet aggregation	C0032176
27779702	TCIPA	C0032176
27779702	suppression	C1519692
27779702	tumor metastasis	C0027627
27779702	aspirin	C0004057
27779702	ASA	C0004057
27779702	tumor‑platelet (T‑P) complex,	C0243092
27779702	ethanol	C0001962
27779702	extracts of Caulis Spatholobi	C0032081
27779702	Caulis Spatholobi	C0242767
27779702	SET	C0032081
27779702	hypercoagulation state	C0398623
27779702	tumor metastasis	C0027627
27779702	survival	C0038952
27779702	breast	C0006141
27779702	cancer cell	C0334227
27779702	model	C0026336
27779702	MTT	C0201596
27779702	anti‑aggregation assay stimulated by ADP	C0005507
27779702	optimum treatment time	C0040223
27779702	optimum dose	C0178602
27779702	SET	C0032081
27779702	confocal microscopy	C0242842
27779702	SET	C0032081
27779702	formation	C1522492
27779702	T‑P complex	C0243092
27779702	n vitro	C1533691
27779702	FACS analysis	C0079366
27779702	fluorescent value	C0392762
27779702	T‑P complex	C0243092
27779702	drug‑treated groups.	C0441833
27779702	In vivo	C1515655
27779702	4T1 cells	C0597032
27779702	injected	C1533685
27779702	mouse	C0025929
27779702	tail vein	C2985205
27779702	dynamic visualization	C0430022
27779702	small animal imaging system	C2697665
27779702	metastatic intensity	C0392762
27779702	survival curve	C0392762
27779702	analyzed	C0936012
27779702	hematoxylin and eosin (H&E) staining	C0523207
27779702	lung	C0024109
27779702	tissue	C0040300
27779702	SET	C0032081
27779702	inhibition	C3463820
27779702	metastasis	C0027627
27779702	survival rate	C0038954
27779702	mice	C0025929
27779702	molecular mechanism	C1148560
27779702	study	C2603343
27779702	anti‑TCIPA	C0005507
27779702	zymography	C1517469
27779702	T‑PCR assay	C0599161
27779702	molecular mechanism	C1148560
27779702	SET	C0032081
27779702	‑T interaction	C0007582
27779702	drug efficacy	C0598333
27779702	pharmacological	C0205464
27779702	breast	C0006141
27779702	metastasis	C0027627
27779702	TCIPA	C0032176
27779702	clinical	C0205210
27779702	cancer treatment	C0920425
27781034	Generalized Epilepsy	C0014548
27781034	Myoclonic Seizures	C0014550
27781034	22q11.2 Deletion Syndrome	C0012236
27781034	juvenile myoclonic epilepsy	C0270853
27781034	JME	C0270853
27781034	22q11.2 deletion syndrome	C0012236
27781034	22q11DS	C0012236
27781034	recurrent copy number variants	C1511518
27781034	genetic	C0017399
27781034	generalized epilepsy	C0014548
27781034	GGE	C0014548
27781034	correlation	C1707520
27781034	22q11DS	C0012236
27781034	GGE	C0014548
27781034	myoclonic seizures	C0014550
27781034	routine diagnostics	C0086143
27781034	individuals	C0027361
27781034	uncommon	C0522498
27781034	combination	C0205195
27781034	22q11DS	C0012236
27781034	JME	C0270853
27781034	screened	C0220908
27781034	literature	C0023866
27781034	reports	C0684224
27781034	epilepsy phenotype	C0031437
27781034	22q11DS	C0012236
27781034	screened	C0220908
27781034	database	C0242356
27781034	22q11DS	C0012236
27781034	patients	C0030705
27781034	individual	C0027361
27781034	JME	C0270853
27781034	cases	C0868928
27781034	GGE	C0014548
27781034	novel	C0205314
27781034	published	C0034037
27781034	cases	C0868928
27781034	co-occurrence	C0243095
27781034	22q11DS	C0012236
27781034	GGE	C0014548
27781034	patients	C0030705
27781034	GGE	C0014548
27781034	associated with	C0332281
27781034	myoclonic seizures	C0014550
27781034	diagnosis	C0011900
27781034	JME	C0270853
27781034	individuals	C0027361
27781034	22q11DS	C0012236
27781034	cases	C0868928
27781034	diagnosis	C0011900
27781034	focal	C0014547
27781034	generalized epilepsy	C0014548
27781034	cases	C0868928
27781034	focal epilepsy	C0014547
27781034	syndrome-associated hypocalcaemia	C0020598
27781034	cerebral bleeds	C2937358
27781034	structural brain anomalies	C3280971
27781034	GGE	C0014548
27781034	study	C2603343
27781034	individuals	C0027361
27781034	22q11DS	C0012236
27781034	GGE	C0014548
27781034	JME	C0270853
27781034	disorders	C0012634
27781034	frequently co-occur	C0243095
27781034	reported prevalence	C0220900
27781034	case series	C0150093
27781034	22q11DS	C0012236
27781034	individuals	C0027361
27781034	epilepsy	C0014544
27781034	GGE	C0014548
27781034	22q11.2	C1521104
27781034	GGE	C0014548
27781034	candidate genes	C1332838
27781034	aetiological	C0015127
27781034	correlation	C1707520
27781034	GABAB receptor	C0052887
27782044	Normal Levels	C0441889
27782044	Urinary	C0042036
27782044	CC16 Protein	C1505089
27782044	Comments on Beamer et al. Association	C0282574
27782044	Children's	C0008059
27782044	Urinary	C0042036
27782044	CC16	C1505089
27782044	Levels	C0262923
27782044	Arsenic Concentrations	C0373548
27782044	Multiple Environmental Media	C1254372
27782044	Max Clara	C0086418
27782044	cell	C0007634
27782044	human	C0086418
27782044	lung	C0024109
27782044	exocrine secretory cell type containing granules	C0230676
27782044	proteins	C0033684
27782129	Colletotrichum species	C0320203
27782129	anthracnose	C0032080
27782129	tea plants	C0032098
27782129	Camellia sinensis (L.) O. Kuntze	C0949852
27782129	China	C0008115
27782129	Anthracnose	C0032080
27782129	Colletotrichum	C0320203
27782129	diseases	C0032080
27782129	Camellia sinensis	C0949852
27782129	research	C0035168
27782129	diversity	C1880371
27782129	geographical distribution	C0681686
27782129	Colletotrichum	C0320203
27782129	China	C0008115
27782129	study	C0681814
27782129	Colletotrichum	C0320203
27782129	isolates	C1764827
27782129	collected	C1516698
27782129	diseased	C0032080
27782129	leaves	C0242724
27782129	Ca. sinensis	C0949852
27782129	tea production	C1518533
27782129	provinces	C1514578
27782129	China	C0008115
27782129	Multi-locus phylogenetic analysis	C1519068
27782129	morphological identification	C1294314
27782129	collected	C1516698
27782129	isolates	C1764827
27782129	species	C1705920
27782129	species	C1705920
27782129	C. camelliae	C2642537
27782129	C. cliviae	C2803492
27782129	C. fioriniae	C2813833
27782129	C. fructicola	C2804746
27782129	C. karstii	C3397324
27782129	C. siamense	C2804749
27782129	record species	C1705920
27782129	C. aenigma	C3584139
27782129	C. endophytica	C3746379
27782129	C. truncatum	C2790917
27782129	species	C1705920
27782129	C. wuxiense	C0016832
27782129	strain	C1518614
27782129	Colletotrichum sp.	C0320203
27782129	species	C1705920
27782129	C. camelliae	C2642537
27782129	C. fructicola	C2804746
27782129	species	C1705920
27782129	anthracnose	C0032080
27782129	Ca. sinensis	C0949852
27782129	study	C0681814
27782129	evidence	C3887511
27782129	phylogenetic analysis	C1519068
27782129	ApMat and GS sequences	C0162326
27782129	taxonomic	C0008903
27782129	relationships	C0439849
27782129	C. gloeosporioides	C1531932
27782129	species complex	C1705920
27782129	pathogenicity	C1136169
27782129	tests	C0022885
27782129	C. camelliae	C2642537
27782129	C. aenigma	C3584139
27782129	C. endophytica	C3746379
27782129	invasive	C0205281
27782129	species	C1705920
27782129	inoculation	C2987620
27782129	leaves	C0242724
27782129	Ca. sinensis	C0949852
27784873	ATP	C0001480
27784873	release	C1283071
27784873	bladder urothelium	C0227692
27784873	serosa	C0036760
27784873	model	C0012644
27784873	partial bladder outlet obstruction	C0005694
27784873	Overactive bladder	C0878773
27784873	health problem	C0243095
27784873	elderly people	C0001792
27784873	Adenosine triphosphate	C0001480
27784873	ATP	C0001480
27784873	released	C1283071
27784873	urinary bladder cells	C0227599
27784873	smooth muscle contraction	C1155937
27784873	sensory signal	C0597440
27784873	micturition	C0042034
27784873	ATP	C0001480
27784873	pathophysiology	C0277785
27784873	overactive bladder	C0878773
27784873	ATP	C0001480
27784873	overactive bladder	C0878773
27784873	partial bladder outlet obstruction	C0005694
27784873	pBOO	C0005694
27784873	model	C0012644
27784873	rats	C0034693
27784873	bladder	C0005682
27784873	pBOO	C0005694
27784873	increase	C0442805
27784873	bladder	C0005682
27784873	weight	C0043100
27784873	hypertrophy	C0020564
27784873	sub-urothelium	C0227598
27784873	sub-serosal area	C0036760
27784873	non	C1518422
27784873	voiding bladder contraction	C0232850
27784873	urine	C0042036
27784873	Basal	C0205112
27784873	ATP	C0001480
27784873	urothelium	C0227692
27784873	serosa	C0036760
27784873	pBOO	C0005694
27784873	rats	C0034693
27784873	rats	C0034693
27784873	Distention	C0005687
27784873	ATP	C0001480
27784873	release	C1283071
27784873	urothelium	C0227692
27784873	pBOO	C0005694
27784873	rats	C0034693
27784873	distention	C0005687
27784873	induced	C0205263
27784873	ATP	C0001480
27784873	release	C1283071
27784873	serosa	C0036760
27784873	pBOO	C0005694
27784873	rats	C0034693
27784873	ATP	C0001480
27784873	released	C1283071
27784873	serosa	C0036760
27784873	non	C1518422
27784873	voiding contractions	C0232850
27784873	overactive bladder	C0878773
27784873	symptoms	C1457887
27786249	putative vectors	C0012656
27786249	Bogia Coconut Syndrome	C0032080
27786249	phytoplasma	C1004784
27786249	loop-mediated isothermal amplification	C3539922
27786249	single-insect feeding media	C0016452
27786249	Phytoplasmas	C1004784
27786249	insect vectored mollicutes	C3179193
27786249	disease	C0012634
27786249	crops	C0032098
27786249	insect species	C0021585
27786249	vectors	C0012656
27786249	phytoplasma	C1004784
27786249	disease	C0012634
27786249	disease-free plants	C0032098
27786249	insects	C0021585
27786249	months	C0439231
27786249	transmission	C1521797
27786249	molecular testing	C0752096
27786249	phytoplasma	C1004784
27786249	DNA	C0012854
27786249	sucrose	C0376597
27786249	solution	C0037633
27786249	insects	C0021585
27786249	fed	C2987508
27786249	study	C2603343
27786249	feeding medium method	C0022885
27786249	loop-mediated isothermal amplification (LAMP) assay	C3539922
27786249	insect	C0021585
27786249	specimens	C2347026
27786249	Hemiptera taxa	C0018992
27786249	Papua New Guinea	C0030375
27786249	Bogia coconut syndrome	C0032080
27786249	BCS	C0032080
27786249	LAMP assay	C3539922
27786249	phytoplasma	C1004784
27786249	DNA	C0012854
27786249	feeding solution	C0016452
27786249	head	C0018670
27786249	tissue	C0040300
27786249	insects	C0021585
27786249	taxa	C1515221
27786249	Derbidae	C1063109
27786249	Lophopidae	C1063149
27786249	Flatidae	C1003013
27786249	Ricaniidae	C1063157
27786249	taxa	C1515221
27786249	heads	C0018670
27786249	single-insect feeding medium tests	C0022885
27786249	LAMP assays	C3539922
27786249	putative vectors	C0012656
27786249	transmission	C1521797
27786249	tests	C0039593
27786249	phytoplasma	C1004784
27786249	pathosystems	C0030664
27786291	Non-toxigenic	C0445099
27786291	environmental	C0014406
27786291	Vibrio cholerae O1	C0318248
27786291	strain	C1518614
27786291	Haiti	C0018510
27786291	provides	C1999230
27786291	evidence	C3887511
27786291	pre-pandemic	C1615608
27786291	cholera	C0008354
27786291	Hispaniola	C0454978
27786291	Vibrio cholerae	C0042629
27786291	ubiquitous	C2348867
27786291	aquatic environments	C0563034
27786291	environmental	C0014406
27786291	toxigenic	C0445332
27786291	V. cholerae O1	C0318248
27786291	strains	C1518614
27786291	serving	C1519269
27786291	source	C0449416
27786291	recurrent	C2945760
27786291	cholera epidemics	C0008354
27786291	pandemic	C1615608
27786291	disease	C0012634
27786291	long-term	C0443252
27786291	survival	C0220921
27786291	V. cholerae	C0042629
27786291	strains	C1518614
27786291	aquatic environmental	C0563034
27786291	reservoirs	C0442537
27786291	monitoring	C0014416
27786291	Haitian	C0018510
27786291	aquatic environment	C0563034
27786291	cholera epidemic	C0008354
27786291	isolated	C0205409
27786291	two	C0205448
27786291	novel	C0205314
27786291	non-toxigenic	C0445099
27786291	ctxA/B	C0017337
27786291	negative	C0205160
27786291	Vibrio cholerae O1	C0318248
27786291	two	C0205448
27786291	isolates	C1764827
27786291	whole-genome sequencing	C3640076
27786291	investigated	C1292732
27786291	through	C0332273
27786291	comparative	C1707455
27786291	genomics	C0887950
27786291	Bayesian coalescent analysis	C0242196
27786291	isolates	C1764827
27786291	tree	C0040811
27786291	strains	C1518614
27786291	clinical	C0205210
27786291	cholera	C0008354
27786291	possessing	C3154893
27786291	genomic components	C0017428
27786291	pandemic	C1615608
27786291	lineages	C1881379
27786291	diverge	C0443299
27786291	modern	C0521116
27786291	cholera	C0008354
27786291	strains	C1518614
27786291	Vibrio Pathogenicity Island	C0017258
27786291	(VPI)-1	C0017258
27786291	present	C0150312
27786291	SXT/R391-family ICE	C0017258
27786291	VPI-2	C0017258
27786291	absent	C0332197
27786291	Rugose phenotype	C0031437
27786291	conversion	C0439836
27786291	vibriophage	C0042776
27786291	resistance	C4281815
27786291	evidenced	C0332120
27786291	persistence	C0546816
27786291	aquatic environments	C0563034
27786291	identification	C0205396
27786291	V. cholerae O1	C0318248
27786291	strains	C1518614
27786291	Haitian	C0018510
27786291	environment	C0563034
27786291	reported	C0011000
27786291	cholera	C0008354
27786291	pandemic	C1615608
27786291	understanding	C0162340
27786291	history	C0019665
27786291	pandemics	C1615608
27786291	similar	C2348205
27786291	environmental	C0563034
27786291	strains	C1518614
27786291	acquire	C1706701
27786291	virulence	C0220936
27786291	genes	C0017337
27786291	Haitian	C0018510
27786291	epidemic	C0014499
27786291	clone	C1522642
27786291	cholera toxin	C0008356
27786291	producing	C0678227
27786291	CTXϕ	C0008356
27788142	Pre-Eclampsia	C0032914
27788142	Ontology	C1707788
27788142	Disease Ontology	C1707788
27788142	Pre-Eclampsia	C0032914
27788142	Pre-eclampsia	C0032914
27788142	PE	C0032914
27788142	clinical syndrome	C0221444
27788142	new-onset hypertension	C0745129
27788142	proteinuria	C0033687
27788142	≥20 weeks of gestation	C1998040
27788142	cause	C0015127
27788142	maternal	C3656218
27788142	perinatal morbidity	C0848215
27788142	mortality	C0205848
27788142	abundant	C2346714
27788142	data	C1511726
27788142	PE	C0032914
27788142	risk factors	C0035648
27788142	pathological findings	C0205469
27788142	data	C1511726
27788142	Clinical data	C1516606
27788142	PE	C0032914
27788142	patients	C0030705
27788142	semantic	C0036612
27788142	heterogeneity	C0019409
27788142	disparate terminology	C0028275
27788142	phenomena	C1882365
27788142	clinical studies	C0008972
27788142	heterogenic	C1512426
27788142	clinical data	C1516606
27788142	situations	C0868928
27788142	situation	C0868928
27788142	semantic	C0036612
27788142	framework	C1254372
27788142	research	C0035168
27788142	pathology	C0205469
27788142	PE	C0032914
27788142	heterogenic	C1512426
27788142	clinical data	C1516606
27788142	PE	C0032914
27788142	patients	C0030705
27788142	ontology	C1707788
27788142	clinical features	C0683325
27788142	treatments	C0087111
27788142	genetic factors	C0814299
27788142	environmental factors	C0686732
27788142	aspects	C1879746
27788142	PE	C0032914
27788142	pre-eclampsia	C0032914
27788142	ontology	C1707788
27788142	PEO	C1707788
27788142	ontologies	C1707788
27788142	PEO	C1707788
27788142	Basic Formal Ontology	C1518584
27788142	BFO	C1518584
27788142	PEO	C1707788
27788142	concepts	C0178566
27788142	terms	C1515273
27788142	PE	C0032914
27788142	clinical	C0008972
27788142	biomedical research	C0005540
27788142	PE	C0032914
27788142	PEO	C1707788
27788142	enhance	C2349975
27788142	PE	C0032914
27788142	information retrieval	C0079623
27788142	clinical	C0008972
27788142	biomedical research	C0005540
27788142	fields	C0683945
27790175	Predictors	C2698872
27790175	Moderators	C1881878
27790175	Spontaneous	C0205359
27790175	Pretend Play	C2371970
27790175	Children	C0008059
27790175	Autism Spectrum Disorder	C1510586
27790175	pretend play	C2371970
27790175	children's	C0008059
27790175	normative	C0205307
27790175	cognitive development	C0679035
27790175	inconsistent	C0442809
27790175	findings	C0243095
27790175	examining	C1292732
27790175	relation	C0439849
27790175	Spontaneous	C0205359
27790175	pretend play	C2371970
27790175	atypical	C0205182
27790175	development	C0243107
27790175	autism spectrum disorder	C1510586
27790175	ASD	C1510586
27790175	ASD	C1510586
27790175	traits	C0599883
27790175	continuum	C0595960
27790175	general population	C0683971
27790175	investigating	C1292732
27790175	pretend play	C2371970
27790175	ASD	C1510586
27790175	symptoms	C1457887
27790175	variations	C0205419
27790175	ASD	C1510586
27790175	traits	C0599883
27790175	ASD	C1510586
27790175	populations	C1257890
27790175	ASD	C1510586
27790175	symptoms	C1457887
27790175	relation	C0439849
27790175	pretend play	C2371970
27790175	cognitive development	C0679035
27790175	study	C2603343
27790175	rigorous observational methods	C0870991
27790175	spontaneous	C0205359
27790175	pretend play	C2371970
27790175	min	C0439232
27790175	free-play sessions	C1254363
27790175	discrete	C0443299
27790175	toy	C0040565
27790175	blinded coders	C1707428
27790175	pretense development	C0025361
27790175	attribution of pretend properties	C0871161
27790175	APP	C0871161
27790175	object substitution	C1706204
27790175	OS	C1706204
27790175	imaginary objects	C0025361
27790175	examined	C1292732
27790175	pretend play	C2371970
27790175	production	C0025361
27790175	analyzed	C0936012
27790175	relation	C0439849
27790175	ASD	C1510586
27790175	symptoms	C1457887
27790175	theory of mind	C0935573
27790175	ToM	C0935573
27790175	verbal ability	C1145677
27790175	familiarity	C0600269
27790175	interest	C0543488
27790175	specific	C0205369
27790175	toys	C0040565
27790175	children	C0008059
27790175	males	C0086582
27790175	threshold	C0449864
27790175	ASD	C1510586
27790175	diagnosis	C0011900
27790175	parent	C0030551
27790175	ASD	C1510586
27790175	symptoms	C1457887
27790175	play sessions	C1254363
27790175	measures	C0079809
27790175	verbal IQ	C0582577
27790175	ToM	C0935573
27790175	measure	C0079809
27790175	child	C0008059
27790175	ASD	C1510586
27790175	symptoms	C1457887
27790175	parents	C0030551
27790175	survey	C0038951
27790175	child's	C0008059
27790175	interest	C0543488
27790175	familiarity	C0600269
27790175	play session	C1254363
27790175	toys	C0040565
27790175	ToM	C0935573
27790175	predicted	C0681842
27790175	APP	C0871161
27790175	interest	C0543488
27790175	toys	C0040565
27790175	predicted	C0681842
27790175	OS	C1706204
27790175	pretend play	C2371970
27790175	production	C0025361
27790175	children	C0008059
27790175	ASD	C1510586
27790175	symptoms	C1457887
27790175	verbal ability	C1145677
27790175	predicted	C0681842
27790175	pretend play	C2371970
27790175	production	C0025361
27790175	children	C0008059
27790175	ASD	C1510586
27790175	symptoms	C1457887
27790175	ToM	C0935573
27790175	predicted	C0681842
27790175	pretend play	C2371970
27790175	production	C0025361
27790175	ASD	C1510586
27790175	symptoms	C1457887
27790175	pretend play	C2371970
27790175	ToM	C0935573
27790175	verbal ability	C1145677
27790175	pretend play	C2371970
27790175	children	C0008059
27790175	ASD	C1510586
27790175	symptoms	C1457887
27790175	treatment	C0087111
27790175	pretend ability	C0085732
27790175	children	C0008059
27790175	ASD	C1510586
27790175	symptoms	C1457887
27791169	Allelic	C0002085
27791169	diversity	C1880371
27791169	NLR gene	C0017337
27791169	BPH9	C0017337
27791169	rice	C1140671
27791169	planthopper	C0600234
27791169	variation	C0042333
27791169	Brown planthopper	C0600234
27791169	BPH	C0600234
27791169	Nilaparvata lugens Stål	C1051066
27791169	insect	C0021585
27791169	pests	C0869004
27791169	rice	C1140671
27791169	Oryza sativa L.	C1140671
27791169	BPH	C0600234
27791169	resistance genes	C2945710
27791169	chromosome regions	C1953345
27791169	molecular cloning	C0009017
27791169	characterization	C1880022
27791169	BPH	C0600234
27791169	resistance gene	C2945710
27791169	BPH9	C0017337
27791169	long arm of rice chromosome 12	C1276871
27791169	BPH9	C0017337
27791169	nucleotide-binding	C1148916
27791169	leucine-rich repeat	C1517773
27791169	NLR	C1517773
27791169	protein	C0033684
27791169	endomembrane system	C1167315
27791169	cell death	C0007587
27791169	phenotype	C0031437
27791169	BPH9	C0017337
27791169	salicylic acid	C0036079
27791169	jasmonic acid	C0064138
27791169	signaling pathways	C0037080
27791169	rice	C1140671
27791169	plants	C0032098
27791169	antixenosis	C1254365
27791169	antibiosis	C0003219
27791169	BPH	C0600234
27791169	BPH	C0600234
27791169	resistance genes	C2945710
27791169	chromosome 12L	C0008633
27791169	BPH1	C0017337
27791169	literature	C0023866
27791169	locus	C1708726
27791169	BPH1/9	C0017337
27791169	genes	C0017337
27791169	allelotypes	C0002085
27791169	BPH1/9-1	C0017337
27791169	-2	C0017337
27791169	-7	C0017337
27791169	-9	C0017337
27791169	allelotypes	C0002085
27791169	levels	C0441889
27791169	resistance	C1514892
27791169	biotypes	C0449562
27791169	BPH	C0600234
27791169	coding region	C0079941
27791169	BPH1/9	C0017337
27791169	diversity	C1880371
27791169	rice germplasm	C1140671
27791169	nucleotide-binding	C1148916
27791169	NB	C1148916
27791169	leucine-rich repeat	C1517773
27791169	LRR	C1517773
27791169	domains	C1514562
27791169	repository	C3847505
27791169	allele	C0002085
27791169	diversity	C1880371
27791169	rice	C1140671
27791169	plant	C0032098
27791169	genetic information	C0017399
27791169	insect	C0021585
27791169	herbivores	C0562691
27791169	allelic variation	C0042333
27791169	artificial shuffling	C0242481
27791169	gene	C0017337
27791169	breeding	C0006159
27791169	biotypes	C0449562
27791169	BPH	C0600234
27791362	Nontoxic	C1518413
27791362	Formulations	C0439962
27791362	Scintillation	C0678573
27791362	Nanocrystals	C1721058
27791362	X-ray Computed Tomography	C0040405
27791362	Contrast Agents	C0009924
27791362	X-ray computed tomography	C0040405
27791362	CT	C0040405
27791362	noninvasive	C2986496
27791362	clinical	C0205210
27791362	in vivo	C1515655
27791362	imaging techniques	C0079595
27791362	X-ray device	C0183263
27791362	contrast	C1979874
27791362	enhancement technologies	C0969683
27791362	study	C2603343
27791362	metal tungstates	C0077513
27791362	CaWO4	C0054486
27791362	contrast agents	C0009924
27791362	X-ray	C0043299
27791362	radiation	C0851346
27791362	CT imaging	C0040405
27791362	X-ray	C0043299
27791362	mass attenuation	C0599946
27791362	tungsten	C0041383
27791362	W	C0041383
27791362	formulation	C0439962
27791362	CaWO4	C0054486
27791362	CWO	C0054486
27791362	nanoparticles	C1450054
27791362	NPs	C1450054
27791362	encapsulated	C0205223
27791362	poly(ethylene glycol-b-d,l-lactic acid) (PEG-PLA) block copolymer (BCP) capsule	C0257395
27791362	PEG-PLA	C0257395
27791362	encapsulated	C0205223
27791362	CWO NPs	C1450054
27791362	CT	C0040405
27791362	contrast	C1979874
27791362	iodine	C0021968
27791362	radiocontrast agents	C0009924
27791362	Iohexol	C0022005
27791362	W	C0041383
27791362	I	C0021968
27791362	atoms	C0567415
27791362	PEG-PLA	C0257395
27791362	coated	C1522408
27791362	CWO NPs	C1450054
27791362	nontoxic	C1518413
27791362	maximum tolerated dose	C0752079
27791362	MTD	C0752079
27791362	material	C0520510
27791362	mice	C0026809
27791362	body weight	C0005910
27791362	intravenous (IV) administration	C0013125
27791362	dextran	C0086140
27791362	coated	C1522408
27791362	iron oxide	C0060240
27791362	nanoparticles	C1450054
27791362	clinically	C0205210
27791362	MRI	C0024485
27791362	contrast agents	C0009924
27791362	MTD	C0752079
27791362	mice	C0026809
27791362	dose	C0178602
27791362	injected	C0449894
27791362	PEG-PLA	C0257395
27791362	CWO NPs	C1450054
27791362	no	C1513916
27791362	histopathologic	C0677043
27791362	damage	C1883709
27791362	excretory organs	C0178784
27791362	heart	C0018787
27791362	liver	C0023884
27791362	lungs	C0024109
27791362	spleen	C0037993
27791362	kidney	C0022646
27791362	dose	C0178602
27791362	mice	C0026809
27791362	blood circulation	C0005775
27791362	half-life	C0018517
27791362	NPs	C1450054
27791362	mice	C0026809
27791362	renal	C0022646
27791362	hepatobiliary systems	C1711359
27791362	intratumorally administered	C1517565
27791362	PEG-PLA	C0257395
27791362	coated	C1522408
27791362	CWO NPs	C1450054
27791362	tumor-bearing mouse model	C2986594
27791362	week	C0439230
27791362	PEG-PLA	C0257395
27791362	coated	C1522408
27791362	CWO NPs	C1450054
27791362	materials	C0520510
27791362	CT	C0040405
27791362	contrast	C1979874
27791364	Albumin	C0001924
27791364	Gd	C0016911
27791364	CuS	C0056599
27791364	Nanotheranostic Agent	C0304231
27791364	In Vivo	C1515655
27791364	Photoacoustic	C3897929
27791364	Photoacoustic / Magnetic Resonance Imaging -Guided Tumor -Targeted Photothermal Therapy	C0087111
27791364	Magnetic Resonance Imaging	C0024485
27791364	Tumor	C0027651
27791364	Photothermal therapy	C0087111
27791364	PTT	C0087111
27791364	skin	C1123023
27791364	skin cancer therapy	C0920425
27791364	clinic	C0442592
27791364	noninvasiveness	C0205556
27791364	low systemic adverse effects	C0261794
27791364	biocompatible PTT agents	C0304231
27791364	accurate	C0443131
27791364	imaging	C0011923
27791364	monitoring	C1283169
27791364	diagnosis	C0011900
27791364	biocompatible Gd -integrated CuS nanotheranostic agent	C0304231
27791364	Gd	C0016911
27791364	CuS	C0056599
27791364	Gd	C0016911
27791364	CuS	C0056599
27791364	BSA	C0036774
27791364	synthesized	C1883254
27791364	biomimetic strategy	C0679199
27791364	bovine serum albumin	C0036774
27791364	BSA	C0036774
27791364	biotemplate	C1705542
27791364	physiological temperature	C0039476
27791364	Gd	C0016911
27791364	CuS	C0056599
27791364	BSA	C0036774
27791364	nanoparticles	C1450054
27791364	NPs	C1450054
27791364	ultrasmall sizes	C0748864
27791364	photothermal conversion efficiency	C0243095
27791364	photostability	C0243095
27791364	near-infrared (NIR) laser	C1289901
27791364	irradiation	C0851346
27791364	doped Gd species	C0016911
27791364	tunable NIR absorbance	C0205556
27791364	Gd	C0016911
27791364	CuS	C0056599
27791364	BSA	C0036774
27791364	NPs	C1450054
27791364	tumor-contrasted imaging	C0011923
27791364	photoacoustic	C3897929
27791364	photoacoustic and magnetic resonance imaging modalities	C1275506
27791364	magnetic resonance imaging	C0024485
27791364	Gd	C0016911
27791364	Gd: CuS @ BSA -mediated PTT	C0087111
27791364	CuS	C0056599
27791364	BSA	C0036774
27791364	therapy efficacy	C0243095
27791364	NIR absorption	C0243095
27791364	photothermal conversion efficiency	C0243095
27791364	immune response	C0301872
27791364	triggered by	C1444748
27791364	Gd	C0016911
27791364	Gd: CuS @ BSA -mediated PTT	C0087111
27791364	CuS	C0056599
27791364	BSA	C0036774
27791364	toxicity studies	C0242890
27791364	in vitro	C1533691
27791364	in vivo	C1515655
27791364	Gd	C0016911
27791364	CuS	C0056599
27791364	BSA	C0036774
27791364	NPs	C1450054
27791364	biocompatible agents	C3273359
27791364	biodistribution study	C0242481
27791364	NPs	C1450054
27791364	hepatic clearance	C0678764
27791364	body	C0242821
27791364	practicality	C0205556
27791364	versatility	C0205556
27791364	albumin	C0001924
27791364	albumin -mediated biomimetic mineralization	C1254366
27791364	nanotheranostic agent	C0304231
27791364	Gd	C0016911
27791364	CuS	C0056599
27791364	BSA	C0036774
27791364	NPs	C1450054
27791364	imaging guidance	C0442972
27791364	tumor ablation properties	C0087111
27791364	spatial resolution	C0205556
27791364	deep tissue penetration	C0205556
27791364	tissue	C0040300
27793144	Family	C0015576
27793144	healthcare professionals	C1704312
27793144	perceptions	C0030971
27793144	hospice	C0085555
27793144	home	C0442519
27793144	programme	C0679897
27793144	children	C0008059
27793144	study	C2603343
27793144	Parents	C0030551
27793144	improvement	C2986411
27793144	quality of life	C0034380
27793144	provision	C1283218
27793144	hospice	C0085555
27793144	supportive care	C0344211
27793144	service	C0018747
27793144	home	C0442519
27793144	study	C2603343
27793144	families	C0015576
27793144	nurse	C0028661
27793144	hospice	C0085555
27793144	home	C0442519
27793144	programme	C0679897
27793144	experiences	C0596545
27793144	healthcare professionals	C1704312
27793144	programme	C0679897
27793144	study	C2603343
27793144	telephone interviews	C0021823
27793144	parents	C0030551
27793144	focus groups	C0016400
27793144	individual	C0237401
27793144	interviews	C0021822
27793144	healthcare professionals	C1704312
27793144	parents	C0030551
27793144	families	C0015576
27793144	programme	C0679897
27793144	care	C0086388
27793144	healthcare professionals	C1704312
27793144	programme	C0679897
27793144	parents	C0030551
27793144	telephone interviews	C0021823
27793144	focus groups	C0016400
27793144	external stakeholders	C1257890
27793144	participants	C0679646
27793144	in-patient	C0030705
27793144	hospice staff	C0025106
27793144	participants	C0679646
27793144	hospice	C0085555
27793144	participants	C0679646
27793144	interviews	C0021822
27793144	individual	C0237401
27793144	stakeholders	C1257890
27793144	focus group	C0016400
27793144	interviews	C0021822
27793144	parents	C0030551
27793144	care	C0086388
27793144	healthcare professionals	C1704312
27793144	communication	C0009452
27793144	services	C0018747
27793144	education and training	C0582584
27793144	lone working	C0043227
27793144	hospice	C0085555
27793144	home	C0442519
27793144	programme	C0679897
27793144	study	C2603343
27793144	programme	C0679897
27793144	clarification	C2986669
27793144	services	C0018747
27793144	communication	C0009452
27793144	services	C0018747
27793144	families	C0015576
27793568	Functional	C0205245
27793568	1,3a,6a-triazapentalene	C3253155
27793568	scaffold	C1254350
27793568	Design	C1707689
27793568	fluorescent probes	C0016321
27793568	kinesin spindle protein	C1173400
27793568	KSP	C1173400
27793568	1,3a,6a-Triazapentalene	C3253155
27793568	fluorescent	C0016321
27793568	chromophore	C0596335
27793568	study	C2603343
27793568	triazapentalene	C3253155
27793568	biphenyl-type	C0005580
27793568	inhibitors	C0033671
27793568	kinesin spindle protein	C1173400
27793568	KSP	C1173400
27793568	fluorescent probes	C0016321
27793568	intracellular	C0178719
27793568	visualization	C0234621
27793568	protein	C0033684
27793568	Microscopic	C0205288
27793568	studies	C2603343
27793568	novel	C0205314
27793568	triazapentalene	C3253155
27793568	labeled	C1708632
27793568	compounds	C1706082
27793568	inhibitory	C3463820
27793568	activity	C0205177
27793568	KSP	C1173400
27793568	cultured cells	C0007635
27793568	information	C1533716
27793568	intracellular	C0178719
27793568	distribution	C1704711
27794068	C4b binding protein	C0056193
27794068	negatively regulates	C0013081
27794068	TLR1	C0971363
27794068	2	C0754728
27794068	response	C0871261
27794068	TLR2	C0754728
27794068	associates with	C0332281
27794068	TLR1	C0971363
27794068	microbial	C0599840
27794068	lipoproteins	C0023820
27794068	Pam3CSK4	C1698795
27794068	triacylated lipoprotein	C0023820
27794068	anchored	C1624581
27794068	extracellular domain	C1517050
27794068	TLR1	C0971363
27794068	TLR2	C0754728
27794068	induces	C0205263
27794068	pro-inflammatory	C0021368
27794068	signals	C3537152
27794068	C4b binding protein	C0056193
27794068	C4BP	C0056193
27794068	complement pathway	C1305430
27794068	inhibitor	C1999216
27794068	TLR2	C0754728
27794068	Immunoprecipitation assay	C0021069
27794068	anti-TLR2 mAb	C0021054
27794068	C4BP	C0056193
27794068	binds to	C1167622
27794068	TLR2	C0754728
27794068	C4BP-deficient	C1413001
27794068	mice	C0206745
27794068	Pam3CSK4	C1698795
27794068	induced	C0205263
27794068	IL-6	C0021760
27794068	levels	C0441889
27794068	increased	C0205217
27794068	compared	C1707455
27794068	wild type mice	C0025929
27794068	C4BP	C0056193
27794068	expressing	C1171362
27794068	cells	C0007634
27794068	Pam3CSK4	C1698795
27794068	induced	C0205263
27794068	IL-8 production	C1819461
27794068	reduced	C0392756
27794068	C4BP	C0056193
27794068	expression levels	C3244092
27794068	reveal	C0443289
27794068	C4BP	C0056193
27794068	negative regulation	C0013081
27794068	TLR1	C0971363
27794068	2	C0754728
27794068	dependent	C0079189
27794068	pro-inflammatory	C0021368
27794068	cytokine production	C1327413
27794068	fluorescent conjugated	C0016321
27794068	Pam3CSK4	C1698795
27794068	C4BP	C0056193
27794068	blocks	C0332206
27794068	binding of	C1167622
27794068	Pam3CSK4	C1698795
27794068	TLR1	C0971363
27794068	2	C0754728
27794068	exogenous	C0205228
27794068	C4BP	C0056193
27794068	inhibits	C3463820
27794068	Pam3CSK4	C1698795
27794068	induced signaling	C1511122
27794068	IL-8 production	C1819461
27794068	C4BP	C0056193
27794068	binding to	C1167622
27794068	TLR2	C0754728
27794068	consequent	C3845876
27794068	neutralization	C2987668
27794068	activity	C1152633
27794068	pro-inflammatory	C0021368
27794068	cytokine production	C1327413
27794068	C4BP	C0056193
27794068	negative regulator	C0013081
27794068	TLR1	C0971363
27794068	2	C0754728
27794068	activity	C1152633
27794381	Effect	C1280500
27794381	emodin	C0013982
27794381	mobility signal transduction system	C0037083
27794381	gallbladder	C0016976
27794381	smooth muscle	C1267092
27794381	Guinea pig	C0085979
27794381	cholelithiasis	C0008350
27794381	study	C2603343
27794381	effect	C1280500
27794381	emodin	C0013982
27794381	protein	C1171362
27794381	gene expressions	C0017262
27794381	massagers	C0815029
27794381	mobility signal transduction system	C0037083
27794381	cholecyst	C0016976
27794381	smooth muscle cells	C0596981
27794381	guinea pig	C0085979
27794381	cholesterol calculus	C0333018
27794381	guinea pigs	C0085979
27794381	groups	C0441833
27794381	control group	C0009932
27794381	gall-stone	C1392480
27794381	GS	C1392480
27794381	group	C0441833
27794381	emodin	C0013982
27794381	group	C0441833
27794381	ursodeoxycholic acid	C0042105
27794381	UA	C0042105
27794381	group	C0441833
27794381	Cholesterol calculus	C0333018
27794381	models	C0026336
27794381	guinea pigs	C0085979
27794381	GS	C1392480
27794381	emodin	C0013982
27794381	UA	C0042105
27794381	groups	C0441833
27794381	lithogenic diet	C0012155
27794381	emodin	C0013982
27794381	UA	C0042105
27794381	group	C0441833
27794381	weeks	C0439230
27794381	histomorphological	C0332437
27794381	ultrastructure	C0041623
27794381	change	C0392747
27794381	gallbladder	C0016976
27794381	detected	C0442726
27794381	microscope	C0181839
27794381	electron microscope	C0181845
27794381	plasma	C0032105
27794381	cholecystokinin	C0008328
27794381	CCK	C0008328
27794381	[Ca(2+)]i	C0596235
27794381	analyzed	C0936012
27794381	radioimmunoassay	C0034580
27794381	flow cytometry	C0016263
27794381	protein	C0033684
27794381	mRNA	C0035696
27794381	Gsα	C0086903
27794381	Giα	C0086706
27794381	Cap	C0073423
27794381	cholecyst	C0016976
27794381	cells	C0596981
27794381	determined by	C0521095
27794381	western blotting	C0005863
27794381	real time polymerase chain reaction	C1709846
27794381	RT-PCR	C1709846
27794381	Emodin	C0013982
27794381	UA	C0042105
27794381	pathogenic	C3816499
27794381	changes	C0392747
27794381	epithelial cells	C0014597
27794381	muscle cells	C0596981
27794381	gallbladder	C0016976
27794381	guinea pig	C0085979
27794381	cholesterol calculus	C0333018
27794381	microscope	C0181839
27794381	transmission electron microscope	C0262880
27794381	cholecyst	C0016976
27794381	cells	C0596981
27794381	GS	C1392480
27794381	group	C0441833
27794381	CCK	C0008328
27794381	levels	C0441889
27794381	plasma	C0032105
27794381	[Ca(2+)]i	C0596235
27794381	decreased	C0205216
27794381	protein	C0033684
27794381	mRNA	C0035696
27794381	GS	C1392480
27794381	down-regulated	C0013081
27794381	protein	C0033684
27794381	mRNA	C0035696
27794381	Gi	C0086706
27794381	Cap	C0073423
27794381	up-regulated	C0041904
27794381	Emodin	C0013982
27794381	significantly	C0750502
27794381	decreased	C0205216
27794381	formative	C1522492
27794381	rate	C1521828
27794381	gallstone	C1392480
27794381	pathogenic	C3816499
27794381	change	C0392747
27794381	epithelial cells	C0014597
27794381	muscle cells	C0596981
27794381	CCK	C0008328
27794381	levels	C0441889
27794381	plasma	C0032105
27794381	[Ca(2+)]i	C0596235
27794381	cholecyst	C0016976
27794381	cells	C0596981
27794381	protein	C0033684
27794381	mRNA	C0035696
27794381	Gs	C0086903
27794381	cholecyst	C0016976
27794381	cells	C0596981
27794381	reduced	C0392756
27794381	protein	C0033684
27794381	mRNA	C0035696
27794381	Gi	C0086706
27794381	Cap	C0073423
27794381	cholecyst	C0016976
27794381	cells	C0596981
27794381	guinea pig	C0085979
27794381	cholesterol calculus	C0333018
27794381	dysfunction	C3887504
27794381	gallbladder contraction	C0232772
27794381	disorders	C0012634
27794381	mobility signal transduction system	C0037083
27794381	cholecyst	C0016976
27794381	smooth muscle cells	C0596981
27794381	including	C0332257
27794381	plasma	C0032105
27794381	CCK	C0008328
27794381	[Ca(2+)]i	C0596235
27794381	cholecyst	C0016976
27794381	cells	C0596981
27794381	abnormal protein	C0311448
27794381	mRNA	C0035696
27794381	Gs	C0086903
27794381	Gi	C0086706
27794381	Cap	C0073423
27794381	Emodin	C0013982
27794381	enhance	C2349975
27794381	contractibility of gallbladder	C0232772
27794381	alleviate	C0547047
27794381	cholestasis	C0008370
27794381	regulating	C1327622
27794381	plasma	C0032105
27794381	CCK	C0008328
27794381	levels	C0441889
27794381	[Ca(2+)]i	C0596235
27794381	cholecyst	C0016976
27794381	cells	C0596981
27794381	protein	C0033684
27794381	mRNA	C0035696
27794381	Gs	C0086903
27794381	Gi	C0086706
27794381	Cap	C0073423
27796450	Quantification	C1709793
27796450	urinary	C1524119
27796450	mono-hydroxylated metabolites	C0870883
27796450	polycyclic aromatic hydrocarbons	C0032458
27796450	on-line solid phase extraction	C1720880
27796450	high performance liquid chromatography-tandem mass spectrometry	C4054772
27796450	Human	C0086418
27796450	exposure to	C0332157
27796450	polycyclic aromatic hydrocarbons	C0032458
27796450	PAHs	C0032458
27796450	assessed	C1516048
27796450	monitoring	C1283169
27796450	urinary	C1524119
27796450	mono-hydroxylated PAHs	C0032458
27796450	OH-PAHs	C0032458
27796450	Gas chromatography	C0008555
27796450	GC	C0008555
27796450	separate	C0443299
27796450	OH-PAHs	C0032458
27796450	quantification	C1709793
27796450	mass spectrometry	C0037813
27796450	biomonitoring	C0005517
27796450	studies	C2603343
27796450	GC	C0008555
27796450	derivatization	C0449851
27796450	time consuming	C3827829
27796450	developed	C1527148
27796450	on-line solid phase extraction	C1720880
27796450	coupled	C1948027
27796450	isotope	C0022262
27796450	dilution	C1948037
27796450	high performance liquid chromatography-tandem mass spectrometry	C4054772
27796450	on-line-SPE	C1720880
27796450	HPLC-MS	C4054772
27796450	MS	C0037813
27796450	method	C0025663
27796450	quantification	C1709793
27796450	urine	C0042036
27796450	1-OH-naphthalene	C0027375
27796450	2-OH-naphthalene	C0027375
27796450	2-OH-fluorene	C0060517
27796450	3-OH-fluorene	C0060517
27796450	1-OH-phenanthrene	C0031367
27796450	2-OH	C0031367
27796450	3-OH-phenanthrene	C0031367
27796450	4-OH-phenanthrene	C0031367
27796450	1-OH-pyrene	C0072667
27796450	method	C0025663
27796450	employed	C0557351
27796450	well plate platform	C4283957
27796450	on-line SPE	C1720880
27796450	good sensitivity	C2346484
27796450	limits	C0439801
27796450	detection	C1511790
27796450	ranged	C1514721
27796450	urine	C0042036
27796450	Accuracy	C0443131
27796450	calculated	C1443182
27796450	recovery	C0237820
27796450	percentage	C0439165
27796450	spiking	C0348018
27796450	levels	C0441889
27796450	varied	C0205419
27796450	depending	C1701901
27796450	analyte	C0443354
27796450	inter	C1548610
27796450	intra	C0347985
27796450	day precision	C1561539
27796450	calculated	C1443182
27796450	repeated	C0205341
27796450	measurements	C0242485
27796450	quality control	C0034378
27796450	materials	C0520510
27796450	varied	C0205419
27796450	Adequate	C0205411
27796450	method	C0025663
27796450	performance	C1882330
27796450	confirmed by	C0521093
27796450	acceptable	C1879533
27796450	recovery	C0237820
27796450	NIST	C0021622
27796450	standard reference	C0034925
27796450	materials	C0520510
27796450	high-throughput	C0872047
27796450	on-line-SPE	C1720880
27796450	HPLC-MS	C4054772
27796450	MS	C0037813
27796450	method	C0025663
27796450	large	C0549177
27796450	scale	C1522412
27796450	epidemiological studies	C0002783
27796450	Graphical abstract	C0870616
27796450	LC-MS chromatogram	C1883002
27796450	urinary	C1524119
27796450	mono-hydroxylated PAH	C0032458
27796450	metabolites	C0870883
27796510	Utility	C0205245
27796510	applicability	C0205245
27796510	"Childhood Obesity Risk Evaluation" (CORE)-index	C0282574
27796510	obesity	C0028754
27796510	childhood	C0231335
27796510	adolescence	C0001578
27796510	Greece	C0018226
27796510	early	C1279919
27796510	life	C0376558
27796510	Early	C1279919
27796510	identification	C0150323
27796510	infants	C0021270
27796510	high risk	C0332167
27796510	obese	C0028754
27796510	later	C0205087
27796510	childhood	C0231335
27796510	adolescence	C0001578
27796510	obesity	C0028754
27796510	prevention	C2700409
27796510	initiative	C1287154
27796510	utility	C0205245
27796510	applicability	C0205245
27796510	"Childhood Obesity Risk Evaluation (CORE)" index	C0282574
27796510	screening	C1710032
27796510	tool	C0336791
27796510	early	C1279919
27796510	prediction	C0681842
27796510	obesity	C0028754
27796510	childhood	C0231335
27796510	adolescence	C0001578
27796510	Anthropometric	C1511726
27796510	socio-demographic data	C1511726
27796510	collected	C1516695
27796510	cross-sectionally	C0205556
27796510	retrospectively	C1514923
27796510	sample	C0370003
27796510	children	C0008059
27796510	adolescents	C0205653
27796510	calculating	C1441506
27796510	CORE-index score	C0282574
27796510	Logistic regression analyses	C0681925
27796510	associations	C0439849
27796510	CORE-index score	C0282574
27796510	obesity	C0028754
27796510	gender	C0079399
27796510	age group	C0027362
27796510	cut-off point analysis	C0242481
27796510	optimal	C2698651
27796510	value	C1522609
27796510	CORE-index score	C0282574
27796510	differentiates	C0205615
27796510	obese	C0028754
27796510	non-obese children	C0008059
27796510	Mean CORE-index score	C0282574
27796510	total	C0439810
27796510	sample	C0370003
27796510	sd	C0871420
27796510	increase	C0442805
27796510	CORE-index score	C0282574
27796510	associated with	C0332281
27796510	C.I.	C0009667
27796510	increased	C0205217
27796510	likelihood	C0033204
27796510	obesity	C0028754
27796510	childhood	C0231335
27796510	adolescence	C0001578
27796510	optimal	C2698651
27796510	cut-off value	C0392762
27796510	CORE-index score	C0282574
27796510	predicted	C0681842
27796510	obesity	C0028754
27796510	highest	C1522410
27796510	sensitivity and specificity	C0036668
27796510	utility	C0205245
27796510	applicability	C0205245
27796510	CORE-index	C0282574
27796510	screening	C1710032
27796510	tool	C0336791
27796510	early	C1279919
27796510	identification	C0150323
27796510	infants	C0021270
27796510	higher risk	C0332167
27796510	obese	C0028754
27796510	childhood	C0231335
27796510	adolescence	C0001578
27796510	tool	C0336791
27796510	health professionals	C1704312
27796510	infants	C0021270
27796510	high risk	C0332167
27796510	counselling	C0010210
27796510	parents	C0030551
27796510	caregivers	C0085537
27796510	effectiveness	C1280519
27796510	early	C1279919
27796510	obesity	C0028754
27796510	prevention	C2700409
27796510	initiatives	C1287154
27796510	Childhood	C0231335
27796510	obesity	C0028754
27796510	epidemic proportions	C1709707
27796510	perinatal	C0243095
27796510	socio-demographic indices	C0243095
27796510	identified	C0205396
27796510	childhood	C0231335
27796510	obesity	C0028754
27796510	children	C0008059
27796510	CORE-index	C0282574
27796510	screening	C1710032
27796510	tool	C0336791
27796510	obesity	C0028754
27796510	risk	C0035647
27796510	year-old	C1510829
27796510	children	C0008059
27796510	utility	C0205245
27796510	applicability	C0205245
27796510	CORE-index	C0282574
27796510	screening	C1710032
27796510	tool	C0336791
27796510	age	C0001779
27796510	years	C1510829
27796510	CORE-index	C0282574
27796510	cost-effective	C0205556
27796510	screening	C1710032
27796510	tool	C0336791
27796510	health professionals	C1704312
27796510	obesity	C0028754
27796510	preventive measures	C0033107
27796510	early	C1279919
27796510	life	C0376558
27796974	Methodology	C3266812
27796974	development	C1527148
27796974	aquatic environmental	C0563034
27796974	assessment	C0220825
27796974	Water Framework Directive	C0282574
27796974	aims	C1947946
27796974	ecological	C0162358
27796974	status	C0449438
27796974	surface	C0205148
27796974	ground water bodies	C0596631
27796974	quality	C0332306
27796974	evaluation	C0220825
27796974	waters	C0043047
27796974	special	C0205555
27796974	water	C0043047
27796974	chemistry	C0079107
27796974	parameters	C0549193
27796974	Water Framework Directive	C0282574
27796974	legal regulations	C0680575
27796974	purpose	C1285529
27796974	quantitative	C0392762
27796974	water	C0043047
27796974	quality	C0332306
27796974	assessment	C0220825
27796974	method	C0025663
27796974	provide	C1999230
27796974	rapid	C0456962
27796974	accurate	C0443131
27796974	reliable	C3858758
27796974	information	C1533716
27796974	quality	C0332306
27796974	surface	C0205148
27796974	waters	C0043047
27796974	water	C0043047
27796974	chemistry	C0079107
27796974	parameters	C0549193
27796974	Quality	C0332306
27796974	classes	C0456387
27796974	defined	C0442825
27796974	water	C0043047
27796974	chemistry	C0079107
27796974	parameter	C0549193
27796974	legal limit values	C0752073
27796974	water	C0043047
27796974	parameters	C0549193
27796974	weight indices	C0392762
27796974	calculated	C1443182
27796974	outcome	C1274040
27796974	paired comparison	C0086766
27796974	water	C0043047
27796974	chemistry	C0079107
27796974	parameters	C0549193
27796974	normalized	C1882115
27796974	matrix	C1704640
27796974	parametric level analysis	C0681933
27796974	water	C0043047
27796974	chemistry	C0079107
27796974	parameters	C0549193
27796974	aquatic environment index	C0282574
27796974	AEI	C0282574
27796974	calculated	C1443182
27796974	provided	C1999230
27796974	general information	C0332118
27796974	quality	C0332306
27796974	water	C0043047
27796974	water	C0043047
27796974	chemistry	C0079107
27796974	parameters	C0549193
27796974	method	C0025663
27796974	Lake	C0337049
27796974	Balaton	C0017446
27796974	Hungary	C0020174
27796974	water	C0043047
27796974	samples	C0370003
27796974	Balatonfüred City	C0017446
27796974	lake	C0337049
27796974	area	C0017446
27796974	analyzed	C0936012
27796974	evaluated	C0220825
27796974	method	C0025663
27797717	WDR26	C4307325
27797717	promotes	C0033414
27797717	mitophagy	C1820119
27797717	cardiomyocytes	C0225828
27797717	induced	C0205263
27797717	hypoxia	C0242184
27797717	Parkin	C1570554
27797717	translocation	C0599893
27797717	Myocardial ischemia	C0151744
27797717	heart	C0018787
27797717	condition	C0348080
27797717	reduction	C0392756
27797717	blood flow	C0232338
27797717	heart	C0018787
27797717	heart	C0018787
27797717	receiving	C1514756
27797717	oxygen	C0030054
27797717	Myocardial ischemia	C0151744
27797717	cause of death	C0007465
27797717	globally	C0205246
27797717	Heart	C0018787
27797717	ischemic preconditioning	C0376466
27797717	IPC	C0376466
27797717	protective effect	C1280500
27797717	myocardial cell	C0225828
27797717	death	C0007587
27797717	induced	C0205263
27797717	ischemia	C0022116
27797717	ischemia-reperfusion injury	C0035126
27797717	WDR26	C4307325
27797717	identified	C0205396
27797717	protein	C0033684
27797717	increased	C0205217
27797717	rat	C0034693
27797717	cardiac	C0018787
27797717	IPC	C0376466
27797717	WDR26	C4307325
27797717	promote	C0033414
27797717	proliferation	C0596290
27797717	H9c2 cells	C0007634
27797717	cardiomyocytes	C0225828
27797717	oxidative stress	C0242606
27797717	inhibiting	C3463820
27797717	apoptosis	C0162638
27797717	role	C1705810
27797717	myocardial ischemia	C0151744
27797717	study	C2603343
27797717	WDR26	C4307325
27797717	myocardial ischemia	C0151744
27797717	H9c2 cell	C0007634
27797717	hypoxia	C0242184
27797717	results	C1274040
27797717	WDR26	C4307325
27797717	induced	C0205263
27797717	myocardial ischemia	C0151744
27797717	H9c2 cell	C0007634
27797717	hypoxia	C0242184
27797717	WDR26	C4307325
27797717	H9c2 cells	C0007634
27797717	hypoxia	C0242184
27797717	injury	C3263722
27797717	inhibiting	C3463820
27797717	LDH	C0022917
27797717	cell viability	C0007620
27797717	WDR26	C4307325
27797717	promotes	C0033414
27797717	hypoxia	C0242184
27797717	induced	C0205263
27797717	autophagy	C0004391
27797717	hypoxia	C0242184
27797717	H9c2 cells	C0007634
27797717	H9c2 cell	C0007634
27797717	hypoxia	C0242184
27797717	WDR26	C4307325
27797717	increases	C0442805
27797717	mitochondrial membrane potential	C1720920
27797717	increases	C0442805
27797717	Parkin	C1570554
27797717	translocation	C0599893
27797717	mitochondria	C0026237
27797717	Parkin	C1570554
27797717	translocated	C0599893
27797717	mitochondria	C0026237
27797717	WDR26	C4307325
27797717	increase	C0442805
27797717	mitochondria	C0026237
27797717	protein ubiquitination	C1816438
27797717	hypoxia	C0242184
27797717	H9c2 cells	C0007634
27797717	WDR26	C4307325
27797717	hypoxia	C0242184
27797717	WDR26	C4307325
27797717	hypoxia	C0242184
27797717	autophagy	C0004391
27797717	mitophagy	C1820119
27797717	study	C2603343
27797717	novel	C0205314
27797717	WDR26	C4307325
27797717	cardiomyocyte	C0225828
27797717	injury	C3263722
27797717	hypoxia	C0242184
27797717	WDR26	C4307325
27797717	target	C1521840
27797717	treatment	C0087111
27797717	myocardial ischemia	C0151744
27798219	Impact	C4049986
27798219	antibiotic	C0003232
27798219	de-escalation	C3651014
27798219	clinical outcomes	C1274040
27798219	community-acquired	C0456394
27798219	pneumococcal pneumonia	C0032300
27798219	antibiotic	C0003232
27798219	de-escalation	C3651014
27798219	reduces	C0392756
27798219	adverse drug effects	C0041755
27798219	costs	C0085123
27798219	evidence	C3887511
27798219	community-acquired pneumococcal pneumonia	C0032300
27798219	CAPP	C0032300
27798219	lacking	C0332268
27798219	retrospective	C1514923
27798219	analysis	C0936012
27798219	data	C1511726
27798219	cohort	C0599755
27798219	hospitalized adults	C0001585
27798219	CAPP	C0032300
27798219	Pneumococcal	C0032300
27798219	aetiology	C1314792
27798219	established	C0443211
27798219	patients	C0030705
27798219	positive cultures	C0159125
27798219	Streptococcus pneumoniae	C0038410
27798219	blood	C0005767
27798219	sterile fluids	C0005889
27798219	sputum	C0038056
27798219	positive	C1446409
27798219	urinary antigen test	C1319561
27798219	De-escalation therapy	C3651014
27798219	antibiotic therapy	C0338237
27798219	penicillin	C0220892
27798219	amoxicillin	C0002645
27798219	amoxicillin/clavulanate	C0054066
27798219	admission	C0184666
27798219	outcomes	C1274040
27798219	day	C0439228
27798219	mortality	C0205848
27798219	length of hospital stay	C3826195
27798219	LOS	C3826195
27798219	Adjustment	C0456081
27798219	performed	C0884358
27798219	multivariate	C0026777
27798219	propensity score	C2718044
27798219	analyses	C0936012
27798219	CAPP	C0032300
27798219	antibiotic	C0003232
27798219	de-escalation	C3651014
27798219	admission	C0184666
27798219	performed	C0884358
27798219	cases	C0868928
27798219	adjustment	C0456081
27798219	antibiotic	C0003232
27798219	de-escalation	C3651014
27798219	associated with	C0332281
27798219	risk	C0035647
27798219	mortality	C0205848
27798219	OR	C0028873
27798219	CI	C0009667
27798219	protective factor	C0679688
27798219	prolonged	C0439590
27798219	LOS	C3826195
27798219	median	C0876920
27798219	OR	C0028873
27798219	CI	C0009667
27798219	results	C1274040
27798219	patients	C0030705
27798219	high-risk	C0332167
27798219	pneumonia	C0032285
27798219	clinical instability	C1444783
27798219	bacteraemia	C0004610
27798219	No significant differences	C3842396
27798219	documented	C1301725
27798219	adverse drug reactions	C0041755
27798219	readmission	C0184666
27798219	days	C0439228
27798219	Antibiotic	C0003232
27798219	de-escalation	C3651014
27798219	effective	C1704419
27798219	reducing	C0392756
27798219	duration	C0449238
27798219	LOS	C3826195
27798219	adversely affect	C0879626
27798219	outcomes	C1274040
27798219	patients	C0030705
27798219	CAPP	C0032300
27798219	bacteraemia	C0004610
27798219	severe disease	C0012634
27798219	clinically unstable	C0443343
27798906	Radiation	C0851346
27798906	induced	C0205263
27798906	Parotid Gland Atrophy	C0341045
27798906	Patients	C0030705
27798906	Head and Neck Cancer	C0278996
27798906	Carbon-ion Radiotherapy	C3494442
27798906	study	C0008972
27798906	clarify	C2986669
27798906	relationship	C0439849
27798906	dosimetric	C0034603
27798906	factors	C1521761
27798906	parotid gland (PG) atrophy	C0341045
27798906	carbon ion radiotherapy	C3494442
27798906	C-ion RT	C3494442
27798906	patients	C0030705
27798906	head and neck tumours	C0018671
27798906	PGs	C0030580
27798906	patients	C0030705
27798906	treated with	C0332293
27798906	total doses	C0034620
27798906	relative biological effectiveness	C3825732
27798906	RBE	C3825732
27798906	PG	C0030580
27798906	volumes	C0449468
27798906	measured	C2700258
27798906	computed tomographic images	C1551337
27798906	C-ion RT	C3494442
27798906	months	C0439231
27798906	median	C0876920
27798906	follow-up	C1522577
27798906	period	C1948053
27798906	months	C0439231
27798906	range	C1514721
27798906	months	C0439231
27798906	Univariate analysis	C0683962
27798906	PG	C0030580
27798906	volumes	C0449468
27798906	RBE	C3825732
27798906	V5	C0449468
27798906	V10	C0449468
27798906	V15	C0449468
27798906	V20	C0449468
27798906	mean	C0444504
27798906	dose	C0034620
27798906	maximum	C0806909
27798906	dose	C0034620
27798906	associated with	C0332281
27798906	PG atrophy	C0341045
27798906	Multivariate analysis	C0026777
27798906	V5	C0449468
27798906	associated with	C0332281
27798906	atrophy	C0341045
27798906	Increasing	C0442808
27798906	V5	C0449468
27798906	risk factor	C0035648
27798906	PG atrophy	C0341045
27798906	C-ion RT	C3494442
27799314	IL-27	C1706289
27799314	Suppression	C0021079
27799314	Experimental	C1517586
27799314	Allergic Asthma	C0155877
27799314	TLR7	C1579758
27799314	8	C1579755
27799314	Agonist	C2987634
27799314	R848	C3642356
27799314	Resiquimod	C0965594
27799314	models of experimental	C0684309
27799314	allergic asthma	C0155877
27799314	TLR7	C1579758
27799314	8	C1579755
27799314	agonist	C2987634
27799314	resiquimod	C0965594
27799314	R848	C3642356
27799314	inhibitor	C1999216
27799314	type 2 helper cell	C0242633
27799314	inflammatory responses	C1155266
27799314	therapeutic effects	C1527144
27799314	model of experimental	C0684309
27799314	allergic asthma	C0155877
27799314	induction	C0857127
27799314	IL-27	C1706289
27799314	R848	C3642356
27799314	ameliorative	C0332272
27799314	R848	C3642356
27799314	inhibited	C0311403
27799314	hallmarks	C1512330
27799314	experimental	C1517586
27799314	allergic asthma	C0155877
27799314	airway hyperreactivity	C0004096
27799314	eosinophilic	C0333930
27799314	airway	C0458827
27799314	inflammation	C0021368
27799314	mucus hypersecretion	C0155872
27799314	Ag	C0003320
27799314	specific Ig	C0358334
27799314	production	C0003261
27799314	R848	C3642356
27799314	IL-5	C0021759
27799314	IL-13	C0214743
27799314	IL-17	C0384648
27799314	IFN-γ	C3539881
27799314	IL-27	C1706289
27799314	Neutralization	C2987668
27799314	IL-27	C1706289
27799314	therapeutic effect	C1527144
27799314	R848	C3642356
27799314	experimental	C1517586
27799314	asthma	C0004096
27799314	model	C0684309
27799314	R848	C3642356
27799314	suppression	C0021079
27799314	IL-27	C1706289
27799314	In vitro	C1533691
27799314	R848	C3642356
27799314	induced	C0857127
27799314	IL-27	C1706289
27799314	murine	C0026809
27799314	alveolar macrophages	C0085236
27799314	dendritic cells	C0011306
27799314	enhanced	C2349975
27799314	expression	C1171362
27799314	programmed death-ligand 1	C4300350
27799314	expression	C1171362
27799314	monocytes	C0085236
27799314	dendritic cells	C0011306
27799314	regulate	C1327622
27799314	peripheral tolerance	C3179073
27799314	murine	C0026809
27799314	human	C0086418
27799314	in vitro	C1533691
27799314	IL-27	C1706289
27799314	enhanced	C2349975
27799314	secretion	C1327616
27799314	IFN-γ	C3539881
27799314	inhibited	C0311403
27799314	IL-5	C0021759
27799314	IL-13	C0214743
27799314	Th2	C0242633
27799314	R848	C3642356
27799314	suppression	C0021079
27799314	experimental	C1517586
27799314	asthma	C0004096
27799314	IL-27	C1706289
27799314	IL-27	C1706289
27799314	Th2	C0242633
27799314	allergic diseases	C1504369
27799834	functional	C0205245
27799834	patients	C0030705
27799834	revision arthroscopic repair	C1997575
27799834	rotator cuff tears	C0263912
27799834	without	C0332288
27799834	arthroscopic	C0443142
27799834	suprascapular nerve release	C3515385
27799834	functional	C0205245
27799834	patients	C0030705
27799834	revision repair	C1997575
27799834	rotator cuff tears	C0263912
27799834	retracted medial	C1254362
27799834	glenoid	C1261046
27799834	Goutallier Grade 4 atrophy	C0026846
27799834	release of the suprascapular nerve	C3515385
27799834	patients	C0030705
27799834	Grade 3 atrophy	C0026846
27799834	revision rotator cuff repair	C1997575
27799834	RTCR	C1997575
27799834	nerve release	C3515385
27799834	patients	C0030705
27799834	nerve release	C3515385
27799834	functional	C0205245
27799834	University of California	C1883464
27799834	Los Angeles	C0024015
27799834	shoulder rating scale	C0681889
27799834	UCLA	C0681889
27799834	patients	C0030705
27799834	revision repair	C1997575
27799834	rotator cuff tears	C0263912
27799834	release of the suprascapular nerve	C3515385
27799834	suprascapular notch	C0816410
27799834	preoperative	C0445204
27799834	postoperative	C0032790
27799834	UCLA score	C0237855
27799834	patients	C0030705
27799834	group	C1257890
27799834	patients	C0030705
27799834	revision RTCR	C1997575
27799834	without	C0332288
27799834	suprascapular nerve release	C3515385
27799834	groups	C1257890
27799834	preoperatively	C0445204
27799834	follow-up	C1522577
27799834	preoperative	C0445204
27799834	UCLA score	C0237855
27799834	nerve-release group	C1257890
27799834	follow-up	C1522577
27799834	group	C1257890
27799834	preoperative	C0445204
27799834	UCLA score	C0237855
27799834	follow-up	C1522577
27799834	preoperative	C0445204
27799834	UCLA score	C0237855
27799834	nerve-release group	C1257890
27799834	postoperative	C0032790
27799834	UCLA score	C0237855
27799834	groups	C1257890
27799834	nerve-release group	C1257890
27799834	flexion	C0231452
27799834	strength	C0517349
27799834	pain relief	C0451615
27799834	Patients	C0030705
27799834	release of the suprascapular nerve	C3515385
27799834	revision RTCR	C1997575
27799834	pain relief	C0451615
27799834	active forward flexion	C0231452
27799834	strength	C0517349
27799834	group	C1257890
27799834	without	C0332288
27799834	nerve release	C3515385
27801735	Fading	C0205216
27801735	With Time	C0332311
27801735	PD-L1	C4300350
27801735	Immunoreactivity	C0597879
27801735	Non-Small Cells Lung Cancer	C0007131
27801735	Tissues	C0040300
27801735	Methodological Study	C0025662
27801735	Blockade	C0332206
27801735	inhibitory immune checkpoints	C1155874
27801735	immunologic	C0205470
27801735	option	C1518601
27801735	tumor therapy	C0920425
27801735	Inhibition	C3463820
27801735	programmed cell death protein 1	C2986635
27801735	ligand	C0023688
27801735	programmed death-ligand 1	C4300350
27801735	PD-L1	C4300350
27801735	clinical trials	C0008976
27801735	advanced	C0205179
27801735	melanoma	C0025202
27801735	non-small cell lung cancer	C0007131
27801735	NSCLC	C0007131
27801735	bladder	C0005695
27801735	kidney cancer	C1378703
27801735	immunohistochemical	C1441616
27801735	IHC	C1441616
27801735	expression	C1171362
27801735	PD-L1	C4300350
27801735	reagents	C0034760
27801735	clones	C1522642
27801735	cell	C0007634
27801735	expression	C1171362
27801735	subjective	C0439655
27801735	interpretation	C0438231
27801735	PD-L1	C4300350
27801735	immunoreactivity	C0597879
27801735	epithelial cells	C0014597
27801735	lymphocytes	C0024264
27801735	issue	C0033213
27801735	NSCLC	C0007131
27801735	surgical specimens	C1292533
27801735	pathologic examination	C4086729
27801735	January	C3829466
27801735	July	C3829447
27801735	microarray approach	C1449575
27801735	IHC expression	C1441616
27801735	PD-L1	C4300350
27801735	tumor-infiltrating lymphocytes	C0079722
27801735	tumor cells	C0597032
27801735	TCs	C0597032
27801735	ICH staining	C1441616
27801735	tumor histology	C1516204
27801735	grade	C0919553
27801735	tissue blocks	C0040300
27801735	finding	C0243095
27801735	fading	C0205216
27801735	PD-L1	C4300350
27801735	IHC expression	C1441616
27801735	TCs	C0597032
27801735	tissues	C0040300
27801735	PD-L1	C4300350
27801735	expression	C0017262
27801735	tumor-infiltrating lymphocytes	C0079722
27801735	years	C0439234
27801735	similar	C2348205
27801735	significant higher	C1299395
27801735	immunoreactivity	C0597879
27801735	TCs	C0597032
27801735	high grade	C0205082
27801735	NSCLC	C0007131
27801735	squamous carcinoma	C0007137
27801735	histotype	C0449574
27801735	low grade	C1282907
27801735	tumors	C0019638
27801735	adenocarcinoma	C0001418
27801735	histology	C0019638
27801735	IHC evaluation	C1441616
27801735	PD-L1	C4300350
27801735	NSCLC	C0007131
27801735	archival tissues	C0040300
27801735	pathology setting	C0030664
27801735	tissue blocks	C0040300
27801735	year	C0439234
27801889	Differential	C1705242
27801889	transcriptome	C3178810
27801889	expression	C0017262
27801889	human	C0086418
27801889	nucleus accumbens	C0028633
27801889	loneliness	C0023974
27801889	Loneliness	C0023974
27801889	associated with	C0332281
27801889	impaired	C0684336
27801889	mental	C0025353
27801889	physical health	C0018684
27801889	lonely individuals	C0237401
27801889	differential expression	C1519516
27801889	inflammatory	C0333348
27801889	genes	C0017337
27801889	peripheral	C0205100
27801889	leukocytes	C0023516
27801889	diminished	C0205216
27801889	activation	C0017255
27801889	brain	C0006104
27801889	reward regions	C1273723
27801889	nucleus accumbens	C0028633
27801889	gene expression	C0017262
27801889	human	C0086418
27801889	brain	C0006104
27801889	genome-wide RNA expression	C0017262
27801889	post-mortem	C0004398
27801889	nucleus accumbens	C0028633
27801889	donors	C0013018
27801889	loneliness	C0023974
27801889	measures	C0079809
27801889	Loneliness	C0023974
27801889	associated with	C0332281
27801889	differentially expressed transcripts	C1519595
27801889	genes	C0017337
27801889	genes	C0017337
27801889	DEGs	C0017337
27801889	false discovery rate	C1880720
27801889	associated with	C0332281
27801889	behavioral processes	C0004927
27801889	neurological disease	C0027765
27801889	psychological disorders	C0004936
27801889	cancer	C0006826
27801889	organismal	C0029235
27801889	injury	C0178314
27801889	skeletal	C0263661
27801889	muscular disorders	C0026848
27801889	networks	C1882071
27801889	upstream	C0522505
27801889	RNA regulators	C0017362
27801889	DEGs	C0017337
27801889	associated with	C0332281
27801889	Alzheimer's disease	C0002395
27801889	AD	C0002395
27801889	genes	C0017337
27801889	correlated	C1707520
27801889	loneliness	C0023974
27801889	sample	C0370003
27801889	gene expression analyses	C1880945
27801889	AD	C0002395
27801889	diagnosis	C0011900
27801889	targets	C1521840
27801889	mechanistic studies	C0242481
27801889	gene	C0017337
27801889	nucleus accumbens	C0028633
27801889	gene regulatory mechanisms	C0017263
27801889	diseases	C0012634
27801889	loneliness	C0023974
27801889	Molecular Psychiatry advance online publication	C0034036
27801889	November	C3828767
27802570	Quality Properties	C0871161
27802570	Kiwifruit	C0440282
27802570	Treated by	C0332293
27802570	Cinnamaldehyde	C0055754
27802570	Citral	C0055809
27802570	Microbial	C0599840
27802570	Antioxidant Capacity	C1148564
27802570	Cold Storage	C0010405
27802570	evaluate	C0220825
27802570	microbiological	C0025953
27802570	characteristics	C1521970
27802570	antioxidant	C1148564
27802570	physiological activities	C0031843
27802570	kiwifruits	C0440282
27802570	Actinida deliciosa	C0971874
27802570	cinnamaldehyde	C0055754
27802570	citral	C0055809
27802570	fumigation	C0016804
27802570	treatments	C1522326
27802570	storage	C1698986
27802570	Essential oils	C0028908
27802570	EOs	C0028908
27802570	treatment	C1522326
27802570	viable counts	C0750480
27802570	yeast	C0043393
27802570	mold	C0369241
27802570	EOs	C0028908
27802570	antioxidant activities	C1148564
27802570	kiwifruit	C0440282
27802570	enhanced	C2349975
27802570	phenolics	C0359916
27802570	flavonoids	C0596577
27802570	fruit	C0016767
27802570	tissue	C1514137
27802570	ascorbic acid	C0003968
27802570	treated	C1522326
27802570	groups	C0441833
27802570	rate	C1521828
27802570	MDA	C0024643
27802570	malondialdehyde	C0024643
27802570	H2 O2	C0020281
27802570	hydrogen peroxide	C0020281
27802570	O2(-)	C0038836
27802570	superoxide anion	C0038836
27802570	effectively	C1704419
27802570	decreased	C0205216
27802570	Physicochemical characteristics	C1521970
27802570	kiwifruits	C0440282
27802570	treated	C1522326
27802570	group	C0441833
27802570	flesh luminosity	C0009393
27802570	firmness	C1545487
27802570	EOs	C0028908
27802570	decreased	C0205216
27802570	reducing sugar	C0026492
27802570	increased	C0205217
27802570	soluble protein	C0033684
27802570	amino acid	C0002520
27802570	EOs	C0028908
27802570	treatment	C1522326
27802570	positive effects	C1280500
27802570	senescence	C3546449
27802570	enhancing	C2349975
27802570	antioxidant capacities	C1148564
27802570	kiwifruit	C0440282
27803787	Anti-inflammatory effect	C1515999
27803787	Yu-Ping-Feng-San	C1676720
27803787	TGF-β1	C1704256
27803787	signaling suppression	C3158357
27803787	rat	C0034721
27803787	model	C0012644
27803787	COPD	C0024117
27803787	Yu-Ping-Feng-San	C1676720
27803787	YPFS	C1676720
27803787	Chinese medicine	C0013227
27803787	treatment	C1522326
27803787	diseases	C0012634
27803787	respiratory systems	C0035237
27803787	chronic obstructive pulmonary disease	C0024117
27803787	COPD	C0024117
27803787	chronic inflammatory disease	C1290886
27803787	molecular mechanism	C3537153
27803787	transforming growth factor beta 1	C1704256
27803787	TGF-β1	C1704256
27803787	Smad2	C1566792
27803787	signaling pathway	C0037080
27803787	inflammatory cytokines	C0079189
27803787	YPFS	C1676720
27803787	attenuate	C0599946
27803787	inflammatory response	C1155266
27803787	TGF-β1	C1704256
27803787	Smad2	C1566792
27803787	signaling	C3537152
27803787	COPD	C0024117
27803787	rats	C0034721
27803787	cigarette smoke extract	C0239059
27803787	CSE	C0239059
27803787	treated	C1522326
27803787	human	C0086418
27803787	bronchial epithelial (Beas-2B) cells	C1711178
27803787	COPD	C0024117
27803787	rat	C0034721
27803787	model	C0012644
27803787	exposure	C0332157
27803787	cigarette smoke	C0239059
27803787	intratracheal instillation	C1555389
27803787	lipopolysaccharide	C0023810
27803787	YPFS	C1676720
27803787	animals	C0003062
27803787	efficacy	C1280519
27803787	YPFS	C1676720
27803787	severity	C0439793
27803787	pulmonary pathological damage	C0030660
27803787	pro-inflammation cytokines	C0079189
27803787	collagen related genes	C0017337
27803787	activation	C1879547
27803787	TGF-β1	C1704256
27803787	Smad2	C1566792
27803787	signaling pathway	C0037080
27803787	CSE	C0239059
27803787	treated	C1522326
27803787	cells	C0007634
27803787	effect	C1280500
27803787	YPFS	C1676720
27803787	TGF-β1	C1704256
27803787	Smad2	C1566792
27803787	signaling	C3537152
27803787	knockdown	C2350567
27803787	Smad2	C1334468
27803787	Si-RNA	C1099354
27803787	pretreatment	C3539076
27803787	inhibitor	C1999216
27803787	TGF-β1	C1704256
27803787	YPFS	C1676720
27803787	injury of lung	C0273115
27803787	suppressed	C1260953
27803787	pro-inflammatory cytokines	C0079189
27803787	collagen deposition	C0333584
27803787	COPD	C0024117
27803787	animals	C0003062
27803787	exogenous TGF-β1	C1704256
27803787	IL-1β	C0021753
27803787	IL-6	C0021760
27803787	TNFα	C1456820
27803787	YPFS	C1676720
27803787	inflammatory response	C1155266
27803787	down-regulated	C0013081
27803787	TGF-β1	C1704256
27803787	Smad2	C1566792
27803787	signaling	C3537152
27803787	in vivo	C1515655
27803787	in vitro	C1533691
27803787	knockdown	C2350567
27803787	Smad2	C1334468
27803787	inhibition	C3463820
27803787	TGF-β1	C1704256
27803787	anti-inflammatory effect	C1515999
27803787	YPFS	C1676720
27803787	CSE	C0239059
27803787	treated	C1522326
27803787	cells	C0007634
27803787	YPFS	C1676720
27803787	anti-inflammatory effects	C1515999
27803787	suppressing	C1260953
27803787	phosphorylation	C0031715
27803787	Smad2	C1566792
27803787	TGF-β1	C1704256
27803787	Smad2	C1566792
27803787	signaling pathway	C0037080
27803787	YPFS	C1676720
27803787	anti-inflammation	C1515999
27803787	COPD	C0024117
27803787	rats	C0034721
27803787	CSE	C0239059
27803787	treated	C1522326
27803787	Beas-2B cells	C1711178
27806658	association	C0439849
27806658	maternal	C1858460
27806658	hydronephrosis	C0020295
27806658	acute	C0205178
27806658	flank pain	C0016199
27806658	pregnancy	C0032961
27806658	prospective	C0033522
27806658	pilot-study	C0031928
27806658	Maternal	C1858460
27806658	hydronephrosis	C0020295
27806658	flank pain	C0016199
27806658	pregnancy	C0032961
27806658	aimed	C1947946
27806658	investigate	C1292732
27806658	maternal	C1858460
27806658	hydronephrosis	C0020295
27806658	flank pain	C0016199
27806658	intensity	C1320357
27806658	consecutive	C1707491
27806658	women	C0043210
27806658	singleton pregnancies	C0032961
27806658	acute	C0205178
27806658	flank pain	C0016199
27806658	prospectively	C0033522
27806658	evaluated	C0220825
27806658	renal	C0022646
27806658	ultrasonography	C0041618
27806658	pain	C0030193
27806658	questionnaires	C0034394
27806658	visual analogue scale	C0042815
27806658	pain intensity	C1320357
27806658	study	C2603343
27806658	significant	C0750502
27806658	correlation	C1707520
27806658	hydronephrosis	C0020295
27806658	flank pain	C0016199
27806658	Spearman's test	C1710141
27806658	consecutive	C1707491
27806658	women	C0043210
27806658	left-sided	C0443246
27806658	right-sided	C0444532
27806658	bilateral	C0238767
27806658	pain	C0030193
27806658	mean	C0444504
27806658	gestational age	C0017504
27806658	women	C0043210
27806658	pain	C0030193
27806658	weeks	C0439230
27806658	consultation	C0009818
27806658	mean	C0444504
27806658	VAS score	C1508029
27806658	women	C0043210
27806658	hydronephrosis	C0020295
27806658	renal	C0022646
27806658	correlation	C1707520
27806658	hydronephrosis	C0020295
27806658	pain intensity	C1320357
27806658	Women	C0043210
27806658	mean	C0444504
27806658	gestational age	C0017504
27806658	weeks	C0439230
27806658	infants	C0021270
27806658	mean	C0444504
27806658	birthweight	C0005612
27806658	Hydronephrosis	C0020295
27806658	finding	C0243095
27806658	pregnant women	C0033011
27806658	acute	C0205178
27806658	flank pain	C0016199
27806658	hydronephrosis	C0020295
27806658	pain intensity	C1320357
27806658	study	C2603343
27806658	normal pregnancy	C0232989
27806658	outcomes	C0032972
27806658	women	C0043210
27806921	Simulating	C0679083
27806921	potential	C3245505
27806921	role	C1705810
27806921	media coverage	C0681284
27806921	infected	C0439663
27806921	bats	C0008139
27806921	Ebola	C0282687
27806921	outbreak	C0012652
27806921	epidemiological	C1516907
27806921	models	C0026336
27806921	developed	C1527148
27806921	transmission dynamics	C0040722
27806921	Ebola virus (EBOV) disease	C0282687
27806921	West Africa	C0001747
27806921	severity	C0392364
27806921	epidemic	C0014499
27806921	compartmental model	C2986731
27806921	media impact	C4049986
27806921	effect	C1280500
27806921	infected	C0439663
27806921	bats	C0008139
27806921	calibrated	C0006751
27806921	data	C1511726
27806921	cumulative	C1511559
27806921	number of deaths	C0205848
27806921	confirmed	C0750484
27806921	cases	C1706256
27806921	estimated	C0750572
27806921	CI	C0009667
27806921	CI	C0009667
27806921	epidemic	C0014499
27806921	estimated	C0750572
27806921	similar	C2348205
27806921	data	C1511726
27806921	reported	C0700287
27806921	World Health Organization	C0043237
27806921	sensitivity analysis	C0936012
27806921	indicated	C1444656
27806921	increase	C0442805
27806921	media impact	C4049986
27806921	number	C0237753
27806921	infectious	C1550587
27806921	bats	C0008139
27806921	daily	C0332173
27806921	increase	C0442805
27806921	cumulative	C1511559
27806921	number	C0237753
27806921	confirmed	C0750484
27806921	cases	C1706256
27806921	deaths	C0205848
27806921	epidemiological parameters	C1516907
27806921	media coverage	C0681284
27806921	peak time	C3840073
27806921	value	C1522609
27806921	cumulative	C1511559
27806921	confirmed	C0750484
27806921	cases	C1706256
27806921	deaths	C0205848
27806921	cumulative	C1511559
27806921	confirmed	C0750484
27806921	cases	C1706256
27806921	deaths	C0205848
27806921	media	C0009458
27806921	mechanism	C0441712
27806921	media impact	C4049986
27806921	control	C0243148
27806921	Ebola	C0282687
27806921	outbreak	C0012652
27806921	infectious	C1550587
27806921	bats	C0008139
27806921	potential	C3245505
27806921	source	C0449416
27806921	epidemic	C0014499
27810802	Body	C0242821
27810802	Diffusion Weighted Imaging	C0598801
27810802	Non-CPMG Fast Spin Echo	C0079595
27810802	SS-FSE	C0079595
27810802	fast	C0456962
27810802	technique	C0079595
27810802	off-resonance	C2828093
27810802	distortions	C2919017
27810802	EPI	C0162734
27810802	EPI	C0162734
27810802	SS-FSE	C0079595
27810802	diffusion weighted imaging	C0598801
27810802	DWI	C0598801
27810802	Carr-Purcell-Meiboom-Geill (CPMG) condition	C0243095
27810802	Non-CPMG	C0243095
27810802	phase	C0205390
27810802	cycling	C1511572
27810802	SS-FSE	C0079595
27810802	DWI	C0598801
27810802	places	C0442504
27810802	constraints	C0443288
27810802	reconstruction	C0205245
27810802	resolved	C3714811
27810802	parallel imaging	C0079595
27810802	improved	C0184511
27810802	echo stability	C0205360
27810802	short duration	C0439593
27810802	DIVERSE	C1880371
27810802	radiofrequency	C2347883
27810802	pulses	C1710082
27810802	signal-to-noise ratio	C2986823
27810802	SNR	C2986823
27810802	EPI	C0162734
27810802	nCPMG	C0243095
27810802	SS-FSE	C0079595
27810802	acquisitions	C1708464
27810802	reconstruction techniques	C0449851
27810802	similar	C2348205
27810802	values	C0042295
27810802	Diffusion imaging	C0598801
27810802	nCPMG	C0243095
27810802	SS-FSE	C0079595
27810802	similar	C2348205
27810802	SNR	C2986823
27810802	EPI	C0162734
27810802	acquisition	C1708464
27810802	apparent diffusion coefficient	C3890194
27810802	values	C0042295
27810802	higher	C0205250
27810802	EPI	C0162734
27810802	In vivo	C1515655
27810802	images	C1704922
27810802	image quality	C0806487
27810802	distortion	C2919017
27810802	distortion	C2919017
27810802	free	C0332296
27810802	DWI	C0598801
27810802	images	C1704922
27810802	areas	C0205146
27810802	significant	C0750502
27810802	off-resonance	C2828093
27810802	SNR	C2986823
27810802	Parallel imaging	C0079595
27810802	DIVERSE	C1880371
27810802	RF	C2347883
27810802	pulses	C1708464
27810802	shorter ETL	C1254367
27810802	implementations	C1708476
27810802	reduces	C0392756
27810802	phase	C0205390
27810802	encode	C2700640
27810802	direction	C0449738
27810802	blur	C1511231
27810802	SAR	C1155281
27810802	accumulation	C4055506
27812530	Modification	C0392747
27812530	Mechanical Properties	C0871161
27812530	Polymerization	C0314672
27812530	Temperature	C0039476
27812530	Handling Time	C0040223
27812530	Polymethylmethacrylate	C0005533
27812530	Cement	C0005934
27812530	Applicability	C4048755
27812530	Vertebroplasty	C1303192
27812530	Polymethylmethacrylate	C0005533
27812530	PMMA	C0005533
27812530	bone cement	C0005934
27812530	bone	C0262950
27812530	void	C0229984
27812530	filler	C0005934
27812530	vertebroplasty	C1303192
27812530	PMMA	C0005533
27812530	material's	C0005479
27812530	stiffness	C0018599
27812530	exothermic polymerization	C0314672
27812530	short	C1806781
27812530	handling time	C0040223
27812530	study	C2603343
27812530	modified	C0392747
27812530	bone cement	C0005934
27812530	problems	C0033213
27812530	Modified	C0392747
27812530	bone cements	C0005934
27812530	prepared	C1521827
27812530	PMMA	C0005533
27812530	volume fractions	C0560268
27812530	castor oil	C0007343
27812530	peak	C0444505
27812530	polymerization	C0314672
27812530	temperatures	C0039476
27812530	peak	C0444505
27812530	polymerization	C0314672
27812530	temperature	C0039476
27812530	porosities	C0080037
27812530	densities	C0178587
27812530	modulus	C2350289
27812530	maximum	C0806909
27812530	compression strengths	C0376507
27812530	standard	C1442989
27812530	castor oil	C0007343
27812530	modified	C0392747
27812530	cements	C0005934
27812530	investigated	C1292732
27812530	ambient temperature	C0428692
27812530	precooling	C0678568
27812530	conditions	C0348080
27812530	specimens	C0370003
27812530	parameters	C0549193
27812530	Increasing	C0205217
27812530	castor oil	C0007343
27812530	precooling	C0678568
27812530	treatment	C1522326
27812530	decreased	C0205216
27812530	peak	C0444505
27812530	polymerization	C0314672
27812530	temperatures	C0039476
27812530	increased	C0205217
27812530	duration	C0449238
27812530	peak	C0444505
27812530	polymerization	C0314672
27812530	temperature	C0039476
27812530	mechanical properties	C0871161
27812530	material	C0005479
27812530	density	C0178587
27812530	modulus	C2350289
27812530	maximum	C0806909
27812530	compression strength	C0376507
27812530	decreased	C0205216
27812530	increasing	C0205217
27812530	castor oil	C0007343
27812530	content	C0456205
27812530	preparation	C1521827
27812530	temperature	C0039476
27812530	room temperature	C0428692
27812530	precooling	C0678568
27812530	mechanical properties	C0871161
27812530	castor oil	C0007343
27812530	PMMA	C0005533
27812530	precooling	C0678568
27812530	modified	C0392747
27812530	bone cement	C0005934
27812530	modulus	C2350289
27812530	polymerization	C0314672
27812530	temperature	C0039476
27812530	handling time	C0040223
27812530	applicability	C4048755
27812530	safety	C0036043
27812530	vertebroplasty	C1303192
27813022	case	C0868928
27813022	retrograde intussusception	C0400855
27813022	Roux-en-Y anastomosis	C0002804
27813022	total gastrectomy	C0017118
27813022	review of the literature	C0282441
27813022	old man	C0086582
27813022	total gastrectomy	C0017118
27813022	Roux-en-Y reconstruction	C0372024
27813022	gastric cancer	C0699791
27813022	admitted	C0184666
27813022	hospital	C0019994
27813022	complaints	C0871764
27813022	abdominal pain	C0000737
27813022	palpable	C0522499
27813022	abdominal tumor	C0000735
27813022	hematemesis	C0018926
27813022	On admission	C0809949
27813022	abdominal tenderness	C0232498
27813022	improving	C1272745
27813022	abdominal tumor	C0000735
27813022	palpable	C0522499
27813022	Mild inflammatory	C0021368
27813022	anemia	C0002871
27813022	blood examination	C3826648
27813022	Abdominal	C0000726
27813022	computed tomography	C0040405
27813022	tumor	C0027651
27813022	layered structure	C0205556
27813022	left abdomen	C0000726
27813022	patient	C0030705
27813022	diagnosed	C0011900
27813022	intestinal obstruction	C0021843
27813022	intussusception	C0021933
27813022	surgery	C0543467
27813022	performed	C0884358
27813022	Retrograde intussusception	C0400855
27813022	Y anastomosis	C0002805
27813022	manual reduction	C0185114
27813022	Hutchinson procedure	C0087111
27813022	intestinal	C0021853
27813022	color	C0009393
27813022	reduction	C0441610
27813022	intestinal resection	C1096244
27813022	required	C1514873
27813022	Postoperative recovery	C4304804
27813022	patient	C0030705
27813022	discharged	C0030685
27813022	surgery	C0543467
27813022	Reports	C0684224
27813022	jejunal	C0022378
27813022	intussusception	C0021933
27813022	total gastrectomy	C0017118
27813022	Roux-en-Y reconstruction	C0372024
27813022	jejunal	C0022378
27813022	intussusception	C0021933
27813022	total gastrectomy	C0017118
27813022	Roux-en-Y reconstruction	C0372024
27815033	Brassinosteroid	C0038317
27815033	induced	C0205263
27815033	changes	C0392747
27815033	lipid	C0023779
27815033	composition	C0243176
27815033	leaves	C0242724
27815033	Pisum sativum L.	C1262903
27815033	senescence	C1326530
27815033	effect of	C1704420
27815033	steroid	C0038317
27815033	phytohormone	C0032082
27815033	24-epibrassinolide	C0243833
27815033	EBR	C0243833
27815033	composition	C0243176
27815033	lipid	C0023779
27815033	classes	C0456387
27815033	free fatty acids	C0015688
27815033	triacylglycerols	C0041004
27815033	galactolipids	C0060960
27815033	detached	C0687118
27815033	pea	C1262903
27815033	leaves	C0242724
27815033	EBR	C0243833
27815033	senescence	C1326530
27815033	increased	C0205217
27815033	content	C0456205
27815033	free fatty acids	C0015688
27815033	triacylglycerols	C0041004
27815033	detached	C0687118
27815033	leaves	C0242724
27815033	mock-treated leaves	C0242724
27815033	content	C0456205
27815033	identified	C0205396
27815033	fatty acids	C0015684
27815033	galactolipids	C0060960
27815033	decreased	C0205216
27815033	detached	C0687118
27815033	leaves	C0242724
27815033	treated	C1522326
27815033	EBR	C0243833
27815033	mock-treated leaves	C0242724
27815033	findings	C2607943
27815033	free fatty acids	C0015688
27815033	polar	C0813983
27815033	lipids	C0023779
27815033	esterification	C2612539
27815033	neutral lipids	C0023779
27815033	detached	C0687118
27815033	leaves	C0242724
27815033	EBR	C0243833
27815033	treatment	C1522326
27815033	steroid	C0038317
27815033	phytohormones	C0032082
27815033	regulation	C1327622
27815033	leaf	C0242724
27815033	senescence	C1326530
27815033	alteration	C1515926
27815033	cell	C0007634
27815033	lipid	C0023779
27815033	composition	C0243176
27818984	Posterior dislocation	C1265659
27818984	sternoclavicular joint	C0038291
27818984	report	C0684224
27818984	cases	C0868928
27818984	report	C0684224
27818984	cases	C0868928
27818984	young	C0332239
27818984	patients	C0030705
27818984	sporting accident	C0337205
27818984	posterior traumatic dislocation	C1265659
27818984	sternoclavicular joint	C0038291
27818984	patients	C0030705
27818984	closed reduction	C0185500
27818984	limb	C0015385
27818984	sling	C0183346
27818984	patient	C0030705
27818984	reduction	C1293152
27818984	recurrence	C0034897
27818984	dislocation	C1265659
27818984	surgical treatment	C0543467
27818984	relevance	C2347946
27818984	computed tomography	C0040405
27818984	diagnosing	C1704656
27818984	reduction procedure	C1293152
27818984	study	C2603343
27818984	treatment	C0087111
27818984	rare	C0522498
27818984	injury	C3263722
27818984	posterior dislocation	C1265659
27818984	sternoclavicular joint	C0038291
27820159	graphical risk tool	C1254363
27820159	willingness to take	C0243095
27820159	migraine	C0149931
27820159	prophylactic	C0199176
27820159	medications	C0013227
27820159	migraine	C0149931
27820159	sufferers	C0030705
27820159	daily	C0332173
27820159	prophylactic therapy	C0199176
27820159	frequency	C0439603
27820159	headache	C0018681
27820159	Food and Drug Administration	C0041714
27820159	approved	C0205540
27820159	several	C0439064
27820159	medications	C0013227
27820159	migraine	C0149931
27820159	prophylaxis	C0199176
27820159	sufferers	C0030705
27820159	treatments	C0087111
27820159	clinically significant	C0750502
27820159	benefits	C0814225
27820159	side effect	C0879626
27820159	profiles	C1979963
27820159	headache	C0018681
27820159	sufferers	C0030705
27820159	community	C0009462
27820159	local	C0205276
27820159	headache	C0018681
27820159	clinics	C0442592
27820159	print	C0033161
27820159	television	C0039461
27820159	advertising	C0001690
27820159	Participants	C0679646
27820159	headache	C0018681
27820159	median	C0876920
27820159	frequency	C0439603
27820159	headache	C0018681
27820159	days per month	C0556971
27820159	sufferers	C0030705
27820159	cross-sectional, single-site, study	C0010362
27820159	Participants	C0679646
27820159	probability	C0033204
27820159	side effects	C0879626
27820159	several	C0439064
27820159	blinded	C0150108
27820159	medication	C0013227
27820159	profiles	C1979963
27820159	divalproex sodium	C0886883
27820159	venlafaxine	C0078569
27820159	gabapentin	C0060926
27820159	propranolol	C0033497
27820159	topiramate	C0076829
27820159	likelihood	C0033204
27820159	side effect	C0879626
27820159	profiles	C1979963
27820159	medication	C0013227
27820159	participants	C0679646
27820159	willing to take	C0243095
27820159	medication	C0013227
27820159	headache	C0018681
27820159	reduction	C0392756
27820159	level	C0441889
27820159	days per month	C0556971
27820159	side effect	C0879626
27820159	profile	C1979963
27820159	divalproex sodium	C0886883
27820159	associated with	C0332281
27820159	smallest willingness to take	C0243095
27820159	gabapentin	C0060926
27820159	propranolol	C0033497
27820159	topiramate	C0076829
27820159	participants	C0679646
27820159	willingness to take	C0243095
27820159	medications	C0013227
27820159	reduction	C0392756
27820159	headache	C0018681
27820159	frequency	C0439603
27820159	Several	C0439064
27820159	predictors	C2698872
27820159	willingness to take	C0243095
27820159	high	C0205250
27820159	headache	C0018681
27820159	disability	C0231170
27820159	depressive symptoms	C0086132
27820159	pain medication	C0002771
27820159	concerns	C2699424
27820159	fear	C0015726
27820159	tolerance	C0220929
27820159	findings	C0243095
27820159	informed	C1522154
27820159	side effect	C0879626
27820159	profiles	C1979963
27820159	medications	C0013227
27820159	patients	C0030705
27820159	treatments	C0087111
27820849	Genome-Wide Detection	C2350277
27820849	Selective Signatures	C0017393
27820849	Chicken	C0008051
27820849	High Density SNPs	C0752046
27820849	Chicken	C0008051
27820849	model	C0026339
27820849	genetic	C0314603
27820849	mechanism	C0441712
27820849	phenotypic	C0031437
27820849	genomic	C0017428
27820849	evolution	C0015219
27820849	population size	C0032683
27820849	human	C0086418
27820849	selection	C1707391
27820849	Extended Haplotype Homozygosity	C0545278
27820849	EHH	C0545278
27820849	core regions	C0004793
27820849	SNP	C0752046
27820849	Chicken	C0008051
27820849	chip	C3897601
27820849	F2 population	C0441833
27820849	hens	C0005595
27820849	reciprocal crosses	C0010364
27820849	White Leghorn	C0008051
27820849	Dongxiang chicken	C0008051
27820849	core regions	C0004793
27820849	length	C1444754
27820849	identified	C0205396
27820849	genome	C0017428
27820849	autosomes	C0596142
27820849	core regions	C0004793
27820849	Genes	C0017337
27820849	candidate regions	C0004793
27820849	positive selection	C2347644
27820849	economic traits	C0205556
27820849	panel	C0441833
27820849	genes	C0017337
27820849	AASDHPPT	C1422497
27820849	GDPD5	C1539559
27820849	PAR3	C1414507
27820849	SOX6	C1424266
27820849	GPC1	C1415193
27820849	signal pathway	C0037080
27820849	AKT1	C0812228
27820849	detected	C0442726
27820849	P-values	C1709380
27820849	enrichment analyses	C0936012
27820849	genes	C0017337
27820849	associated with	C0332281
27820849	immune function	C1817756
27820849	sensory organ development	C1160370
27820849	neurogenesis	C0814002
27820849	positive selection	C2347644
27820849	chicken	C0008051
27820849	core regions	C0004793
27820849	genes	C0017337
27820849	GWAS	C2350277
27820849	genes	C0017337
27820849	positive selection	C2347644
27820849	egg	C0013710
27820849	production	C0441655
27820849	Findings	C2607943
27820849	genome-wide map	C0079435
27820849	selection signature	C0017393
27820849	chicken	C0008051
27820849	genome	C0017428
27820849	genetic	C0314603
27820849	mechanisms	C0441712
27820849	phenotypic	C0031437
27820849	diversity	C1880371
27820849	poultry	C0032850
27820849	breeding	C0006159
27822855	Genotyping	C3178894
27822855	TaqMan Allelic Discrimination	C3178894
27822855	Allele-Specific Genotyping Assays	C3178894
27822855	Real-time PCR	C1709846
27822855	genotyping methods	C3178894
27822855	TaqMan allelic discrimination assays	C3178894
27822855	allele-specific genotyping	C3178894
27822855	useful	C3827682
27822855	screening	C0813145
27822855	single nucleotide polymorphisms	C0752046
27822855	samples	C0370003
27822855	different	C1705242
27822855	individuals	C0027361
27822855	tissues	C0040300
27822855	pre	C0332152
27822855	amplified DNA	C0683230
27822855	real-time PCR	C1709846
27822855	based	C1527178
27822855	methods	C0025663
27822855	TaqMan	C3178894
27822855	well-established	C0443211
27822855	alternative	C1523987
27822855	methods	C0025663
27822855	allele-specific genotyping	C3178894
27822855	alternatives	C1523987
27822855	genotyping	C3178894
27822855	short tandem repeat	C1519302
27822855	(STR)	C1519302
27822855	length	C1444754
27822855	polymorphisms	C0032529
27822855	relevant	C2347946
27822855	aspects	C1521970
27822855	developing	C1527148
27822855	assay	C1510438
27822855	SNP	C0752046
27822855	STR	C1519302
27822855	TaqMan	C3178894
27822855	allele-specific genotyping	C3178894
27822855	primer	C0206416
27822855	probe	C0012893
27822855	optimization	C2698650
27822855	reaction	C0443286
27822855	conditions	C0348080
27822855	experimental procedure for typing	C3178894
27822855	samples	C0370003
27822855	data	C1511726
27822855	evaluation	C0220825
27822855	goal	C0018017
27822855	provide	C1999230
27822855	guideline	C0162791
27822855	developing	C1527148
27822855	genotyping assays	C3178894
27822855	approaches	C1292724
27822855	reproducible	C1514863
27822855	genotype calls	C3178894
27822855	involving	C1314939
27822855	minimal	C0547040
27822855	optimization	C2698650
27824163	P2X7 receptors	C0386482
27824163	rodent	C0035804
27824163	PCP	C0031381
27824163	induced	C0205263
27824163	schizophrenia	C0036341
27824163	model	C0012644
27824163	P2X7 receptors	C0386482
27824163	P2X7Rs	C0386482
27824163	ligand-gated ion channels	C0815090
27824163	sensitive	C0332324
27824163	extracellular	C0521119
27824163	ATP	C0001480
27824163	examined	C0332128
27824163	P2X7R	C0386482
27824163	animal model	C0599779
27824163	schizophrenia	C0036341
27824163	PCP	C0031381
27824163	induced	C0205263
27824163	schizophrenia	C0036341
27824163	model	C0012644
27824163	genetic deletion	C1511760
27824163	pharmacological	C0205464
27824163	inhibition	C3463820
27824163	P2X7Rs	C0386482
27824163	alleviate	C1301676
27824163	schizophrenia-like	C0243095
27824163	behavioral	C0004927
27824163	alterations	C1515926
27824163	P2rx7+/+	C1418215
27824163	mice	C0025929
27824163	PCP	C0031381
27824163	induced	C0205263
27824163	hyperlocomotion	C3540840
27824163	stereotype behavior	C0038271
27824163	ataxia	C0004134
27824163	social withdrawal	C0424095
27824163	P2X7 receptor	C1418215
27824163	deficient	C0011155
27824163	mice	C0206745
27824163	P2rx7-/-	C1418215
27824163	social interactions	C0037420
27824163	increased	C0205217
27824163	PCP	C0031381
27824163	induced	C0205263
27824163	hyperlocomotion	C3540840
27824163	stereotype behavior	C0038271
27824163	alleviated	C1301676
27824163	P2X7 receptor antagonist	C2936582
27824163	JNJ-47965567	C2936582
27824163	effect of	C1280500
27824163	gene deficiency	C1511760
27824163	PCP	C0031381
27824163	induced	C0205263
27824163	behavioral changes	C0542299
27824163	PCP	C0031381
27824163	induced	C0205263
27824163	social withdrawal	C0424095
27824163	PCP	C0031381
27824163	treatment	C1522326
27824163	upregulates	C0041904
27824163	increases	C0442805
27824163	functional	C0205245
27824163	responsiveness	C0205342
27824163	P2X7Rs	C0386482
27824163	prefrontal cortex	C0162783
27824163	young adult	C0238598
27824163	animals	C0003062
27824163	amplitude	C0678555
27824163	NMDA	C0080093
27824163	evoked	C1444748
27824163	currents	C1705970
27824163	layer V pyramidal neurons	C0206441
27824163	cortical	C0007776
27824163	decreased	C0205216
27824163	genetic deletion	C1511760
27824163	P2rx7	C1418215
27824163	JNJ-47965567	C2936582
27824163	PCP	C0031381
27824163	induced	C0205263
27824163	alterations	C1515926
27824163	mRNA expression	C1515670
27824163	schizophrenia-related	C0036341
27824163	genes	C0017337
27824163	NR2A	C1415299
27824163	NR2B	C1415300
27824163	neuregulin 1	C0626201
27824163	NR1	C0914905
27824163	GABA α1	C1565610
27824163	absent	C0332197
27824163	young adult	C0238598
27824163	P2rx7-/-	C1418215
27824163	animals	C1517490
27824163	findings	C0243095
27824163	P2X7R	C0386482
27824163	potential	C3245505
27824163	therapeutic	C0302350
27824163	target	C1521840
27824163	schizophrenia	C0036341
27826436	flavor	C0982164
27826436	nutritional	C1521739
27826436	characteristic	C1521970
27826436	strawberry	C0457802
27826436	varieties	C1883525
27826436	cultured	C0001829
27826436	soilless system	C0439861
27826436	Strawberry fruits	C0457802
27826436	cv. Benihoppe	C0457802
27826436	Tochiotome	C0457802
27826436	Sachinoka	C0457802
27826436	Guimeiren	C0457802
27826436	flavor	C0982164
27826436	nutritional	C1521739
27826436	parameters	C0549193
27826436	principal component analysis	C0429865
27826436	hierarchical clustering analysis	C1881045
27826436	volatile compounds	C2350439
27826436	composition	C0243176
27826436	sugar	C0242209
27826436	acid	C0369760
27826436	concentration	C1446561
27826436	sweetness	C0678582
27826436	total soluble sugars	C0242209
27826436	total organic acids	C0369760
27826436	varieties	C1883525
27826436	volatile compounds	C2350439
27826436	identified	C0205396
27826436	determined	C0521095
27826436	cv. Benihoppe	C0457802
27826436	Tochiotome	C0457802
27826436	Sachinoka	C0457802
27826436	Guimeiren strawberry fruits	C0457802
27826436	extracted	C0185115
27826436	head-space solid-phase microextraction	C1720881
27826436	HS-SPME	C1720881
27826436	Esters	C0014898
27826436	chemical composition	C0243176
27826436	varieties	C1883525
27826436	Furaneol	C0378287
27826436	cultivars	C0032098
27826436	Sachinoka	C0457802
27826436	Guimeiren	C0457802
27826436	mesifuran	C0457802
27826436	cv. Tochiotome	C0457802
27826436	Tochiotome	C0457802
27826436	Sachinoka	C0457802
27826436	content	C1446561
27826436	linalool	C0064997
27826436	(E)-nerolidol	C0955941
27826436	Sachinoka	C0457802
27826436	highest	C0205250
27826436	content	C1446561
27826436	total sugars	C0242209
27826436	total acids	C0369760
27826436	Guimeiren	C0457802
27826436	sweetness	C0678582
27826436	index	C0918012
27826436	cultivars	C0032098
27826436	Firmness	C1545487
27826436	Tochiotome	C0457802
27826436	highest	C0205250
27826436	varieties	C1883525
27826436	highest	C0205250
27826436	total soluble solids TSS value	C0392762
27826436	cv. Sachinoka	C0457802
27826436	Guimeiren	C0457802
27826436	Tochiotome	C0457802
27826436	varieties	C1883525
27826436	Sachinoka	C0457802
27826436	highest	C0205250
27826436	titratable acidity TA value	C0368606
27826436	content	C1446561
27826436	ascorbic acid	C0003968
27826436	AsA	C0003968
27826436	cv. Tochiotome	C0457802
27826436	higher	C0205250
27826436	no significant	C1273937
27826436	difference	C1705241
27826436	cultivars	C0032098
27826436	Benihoppe	C0457802
27826436	Tochiotome	C0457802
27826436	Sachinoka	C0457802
27826436	Fructose	C0016745
27826436	glucose	C0017725
27826436	sugars	C0242209
27826436	cultivars	C0032098
27826436	Citric acid	C0055819
27826436	organic acid	C0369760
27826436	cv. Tochiotome	C0457802
27826436	cv. Sachinoka	C0457802
27826436	cv. Guimeiren	C0457802
27826436	Tochiotome	C0457802
27826436	higher	C0205250
27826436	ratios	C0456603
27826436	TSS	C1635078
27826436	TA	C0368606
27826436	total sugars	C0242209
27826436	total organic acids	C0369760
27826436	acid	C0369760
27826436	content	C1446561
27826436	comprehensive evaluation score	C0449820
27826436	Sachinoka	C0457802
27826436	Guimeiren	C0457802
27826436	Tochiotome	C0457802
27826436	Benihoppe	C0457802
27828852	Prognostic value	C0449821
27828852	GLUT-1	C0168458
27828852	expression	C1171362
27828852	oral squamous cell carcinoma	C0585362
27828852	prisma-compliant meta-analysis	C0282574
27828852	studies	C2603343
27828852	evaluated	C0220825
27828852	correlation	C1707520
27828852	glucose transporter-1	C0168458
27828852	GLUT-1	C0168458
27828852	expression	C1171362
27828852	prognosis	C0033325
27828852	oral squamous cell carcinoma	C0585362
27828852	OSCC	C0585362
27828852	results	C1274040
27828852	inconsistent	C0442809
27828852	inconclusive	C1629507
27828852	meta-analysis	C0920317
27828852	assess	C0184514
27828852	prognostic	C0220901
27828852	significance	C0750502
27828852	GLUT-1	C0168458
27828852	OSCC	C0585362
27828852	Electronic databases	C3841595
27828852	PubMed	C1138432
27828852	Embase	C0282574
27828852	Web of Science	C0282574
27828852	relevant studies	C2603343
27828852	July	C3829447
27828852	Odds ratio	C0028873
27828852	OR	C0028873
27828852	confidence interval	C0009667
27828852	CI	C0009667
27828852	evaluate	C0220825
27828852	relationship	C1705630
27828852	GLUT-1	C0168458
27828852	clinical features	C3810252
27828852	hazard ratio	C2985465
27828852	HR	C2985465
27828852	CI	C0009667
27828852	measure	C0079809
27828852	effect	C1280500
27828852	GLUT-1	C0168458
27828852	overall survival	C4086681
27828852	OS	C4086681
27828852	statistically significant	C0237881
27828852	studies	C2603343
27828852	subjects	C0080105
27828852	meta-analysis	C0920317
27828852	pooled data	C1511726
27828852	GLUT-1	C0168458
27828852	expression	C1171362
27828852	associated with	C0332281
27828852	advanced tumor stages	C1300072
27828852	OR	C0028873
27828852	CI	C0009667
27828852	higher tumor grade	C0441800
27828852	OR	C0028873
27828852	CI	C0009667
27828852	tumor size	C0475440
27828852	OR	C0028873
27828852	CI	C0009667
27828852	lymph node metastasis	C0332397
27828852	OR	C0028873
27828852	CI	C0009667
27828852	tobacco use	C0543414
27828852	OR	C0028873
27828852	CI	C0009667
27828852	distant metastasis	C1302548
27828852	OR	C0028873
27828852	CI	C0009667
27828852	increased	C0205217
27828852	GLUT-1	C0168458
27828852	expression	C1171362
27828852	correlated	C1707520
27828852	shorter OS	C4086681
27828852	HR	C2985465
27828852	CI	C0009667
27828852	significant publication bias	C0206086
27828852	detected	C0442726
27828852	meta-analysis	C0920317
27828852	GLUT-1	C0168458
27828852	overexpression	C1514559
27828852	aggressive clinical features	C3810252
27828852	worse OS	C4086681
27828852	OSCC	C0585362
27828852	studies	C2603343
27828852	GLUT-1	C0168458
27828852	prognostic	C0220901
27828852	biomarker	C0005516
27828852	OSCC	C0585362
27828996	Biogeography	C2936603
27828996	Evolution	C0282688
27828996	Ciliate	C0008781
27828996	Genus	C1708235
27828996	Euplotes	C0085343
27828996	Spirotrichea	C1004715
27828996	Euplotia	C0085343
27828996	Description	C0678257
27828996	Euplotes curdsi sp. nov	C0085343
27828996	Ciliates	C0008781
27828996	diverse	C1880371
27828996	ecologically	C0870460
27828996	important	C3898777
27828996	phylum	C1709533
27828996	unicellular protists	C0597305
27828996	genera	C1708235
27828996	Euplotes	C0085343
27828996	morphospecies	C1705920
27828996	molecularly tested	C0039593
27828996	Euplotes	C0085343
27828996	taxa	C1515221
27828996	characterizations	C1880022
27828996	morphological	C0543482
27828996	observations	C0302523
27828996	sequencing	C1561491
27828996	molecular markers	C0005516
27828996	comparison	C1707455
27828996	literature	C0023866
27828996	Euplotes curdsi sp. nov	C0085343
27828996	distinguishable	C0205615
27828996	combination	C0205195
27828996	features	C2348519
27828996	length	C1444754
27828996	oval or elongated shape	C0332437
27828996	narrow peristome	C0332437
27828996	adoral membranelles	C0332437
27828996	conspicuous paroral membrane	C0596901
27828996	double-eurystomus dorsal argyrome type	C0332437
27828996	dorsolateral kineties	C0332437
27828996	frontoventral cirri	C0332437
27828996	populations	C0032659
27828996	species	C1705920
27828996	brackish	C0337056
27828996	marine samples	C0017446
27828996	Mediterranean	C0025138
27828996	White Sea	C0017446
27828996	SSU rRNA gene	C0017337
27828996	sequences	C1517495
27828996	populations	C0032659
27828996	phylogeny	C0031797
27828996	genus	C1708235
27828996	Euplotes	C0085343
27828996	molecular	C1521991
27828996	phylogenetic tree	C0205556
27828996	aspects	C1879746
27828996	biogeographical history	C0019665
27828996	genus	C1708235
27828996	evolution	C0282688
27828996	taxonomic	C0008903
27828996	characters	C1521970
27828996	descriptions	C0678257
27828996	data	C1511726
27828996	recurrent	C2945760
27828996	trends	C1521798
27828996	freshwater	C0016710
27828996	morphological	C0543482
27828996	evolution	C0282688
27828996	Euplotes	C0085343
27831982	Comparative Effectiveness	C2718022
27831982	Treatments	C0087111
27831982	Chronic Low Back Pain	C0457949
27831982	Multiple Treatment Comparison Analysis	C4277638
27831982	systematic review	C1955832
27831982	network meta-analysis	C4277638
27831982	current treatment options	C2827774
27831982	chronic low back pain	C0457949
27831982	LBP	C0457949
27831982	randomized controlled trials	C0206035
27831982	RCTs	C0206035
27831982	compare	C1707455
27831982	effectiveness	C1280519
27831982	treatments	C0087111
27831982	mixed-treatment comparison	C4277638
27831982	MTC	C4277638
27831982	evidence-based	C3887511
27831982	assessment	C0220825
27831982	treatment options	C0683525
27831982	LBP	C0457949
27831982	systematic search	C0035168
27831982	RCTs	C0206035
27831982	MEDLINE	C0025141
27831982	Cochrane Collaboration Library	C0023621
27831982	selected studies	C2603343
27831982	preoperative	C0445204
27831982	postoperative	C0032790
27831982	ODI	C2960603
27831982	VAS back pain scores	C2732809
27831982	additional surgeries	C2081627
27831982	complications	C0009566
27831982	Standard and network meta-analytic techniques	C4277638
27831982	RCTs	C0206035
27831982	analysis	C0936012
27831982	total disk replacement	C2144940
27831982	TDR	C2144940
27831982	fusion	C0186045
27831982	TDR	C2144940
27831982	exercise	C1522704
27831982	cognitive behavioral therapy	C0009244
27831982	CBT	C0009244
27831982	fusion	C0186045
27831982	exercise	C1522704
27831982	CBT	C0009244
27831982	fusion	C0186045
27831982	physical therapy	C0949766
27831982	PT	C0949766
27831982	MTC	C4277638
27831982	ODI change scores	C2960603
27831982	pooled mean difference	C1705241
27831982	fusion	C0186045
27831982	exercise	C1522704
27831982	CBT	C0009244
27831982	pooled mean difference	C1705241
27831982	TDR	C2144940
27831982	exercise	C1522704
27831982	CBT	C0009244
27831982	pooled mean difference	C1705241
27831982	fusion	C0186045
27831982	PT	C0949766
27831982	pooled mean differences	C1705241
27831982	TDR	C2144940
27831982	fusion	C0186045
27831982	PT	C0949766
27831982	structured exercise	C1522704
27831982	CBT	C0009244
27831982	pooled mean difference	C1705241
27831982	exercise	C1522704
27831982	CBT	C0009244
27831982	PT	C0949766
27831982	TDR	C2144940
27831982	PT	C0949766
27831982	pooled mean difference	C1705241
27831982	TDR	C2144940
27831982	PT	C0949766
27831982	surgery rates	C1521828
27831982	treatment options	C0683525
27831982	treatments	C0087111
27831982	benefit	C0814225
27831982	patients	C0030705
27831982	chronic LBP	C0457949
27831982	MTC analysis	C4277638
27831982	TDR	C2144940
27831982	most effective	C1704419
27831982	treatment	C0087111
27831982	PT	C0949766
27831982	least effective	C1704419
27831982	treatment	C0087111
27831982	chronic LBP	C0457949
27831982	review	C0282443
27831982	limited number	C0449788
27831982	RCT studies	C0206035
27831982	treatment	C0087111
27831982	modality	C0695347
27831982	patients	C0030705
27832159	Inhibitor	C0014432
27832159	Delta-5 Desaturase	C0057338
27832159	Insulin Resistance	C0021655
27832159	Reduces Body Weight	C1262477
27832159	Diet	C0012155
27832159	Obese	C0028754
27832159	C57BL/6J Mice	C1521751
27832159	Obesity	C0028754
27832159	inflammation	C0021368
27832159	metabolic	C0311400
27832159	inflammation	C0021368
27832159	Delta-5 desaturase	C0057338
27832159	D5D	C0057338
27832159	enzyme	C0014442
27832159	dihomo-γ-linolenic acid	C0000658
27832159	DGLA	C0000658
27832159	arachidonic acid	C0003695
27832159	AA	C0003695
27832159	D5D	C0057338
27832159	inhibition	C1524081
27832159	DGLA	C0000658
27832159	anti-inflammatory	C1515999
27832159	eicosanoids	C0013725
27832159	AA	C0003695
27832159	eicosanoids	C0013725
27832159	synergistic	C2986495
27832159	improvement	C2986411
27832159	reduced	C0392756
27832159	insulin resistance	C0021655
27832159	anti-obesity	C0376607
27832159	D5D	C0057338
27832159	compound-326	C1254351
27832159	orally	C0442027
27832159	small-molecule	C1328819
27832159	high-fat diet	C0453819
27832159	obese (DIO) mouse	C0025933
27832159	model	C0012644
27832159	D5D	C0057338
27832159	inhibition	C1524081
27832159	blood	C0005767
27832159	AA	C0003695
27832159	DGLA	C0000658
27832159	profiles	C2022317
27832159	DIO mice	C0025933
27832159	compound-326	C1254351
27832159	insulin resistance	C0021655
27832159	body weight loss	C1262477
27832159	calorie intake	C4281687
27832159	macrophage infiltration into adipose tissue	C4014887
27832159	mRNA analysis	C0872262
27832159	energy expenditure	C0014272
27832159	administration	C1533734
27832159	compound-326	C1254351
27832159	body weight loss	C1262477
27832159	D5D	C0057338
27832159	inhibitor	C0014432
27832159	compound-326	C1254351
27832159	obese	C0028754
27832159	diabetic	C0011847
27832159	patients	C0030705
27832181	Blood Collection Tubes	C0184104
27832181	Storage Temperature	C3640194
27832181	Siemens ADVIA Centaur XP	C3831595
27832181	Measuring 25-Hydroxyvitamin D	C2984945
27832181	Siemens ADVIA Centaur XP	C3831595
27832181	measurement of 25-hydroxyvitamin D	C2984945
27832181	25OHD	C0535968
27832181	VACUETTE® tubes with Serum Clot Activator and Gel	C0184104
27832181	tubes	C0184104
27832181	temperatures	C0039476
27832181	25OHD results	C2984945
27832181	Siemens ADVIA Centaur XP	C3831595
27832181	Serum	C0229671
27832181	vacuum blood collection tubes	C0184104
27832181	25OHD was analyzed	C2984945
27832181	Siemens ADVIA Centaur XP	C3831595
27832181	liquid chromatography tandem mass spectrometry	C4049918
27832181	LC-MS/MS	C4049918
27832181	Significantly higher	C4055638
27832181	25OHD values	C2984945
27832181	Siemens ADVIA Centaur XP	C3831595
27832181	VACUETTE® tubes with serum clot activator and gel	C0184104
27832181	VACUETTE® tubes with clot activator	C0184104
27832181	VACUETTE® tubes	C0184104
27832181	25OHD values	C2984945
27832181	LC-MS/MS	C4049918
27832181	IMPROVEVACUTER® tubes with serum clot activator and ge	C0184104
27832181	significantly increased	C4055637
27832181	Siemens ADVIA Centaur XP	C3831595
27832181	VACUETTE® tubes	C0184104
27832181	25OHD results	C2984945
27832181	Siemens ADVIA Centaur XP	C3831595
27832181	serum	C0229671
27832181	IMPROVEVACUTER® tubes	C0184104
27832181	freezing	C0016701
27832181	25OHD	C0535968
27832181	assay platform	C3273359
27832198	Evolution	C0015219
27832198	Fitness	C3824713
27832198	Cost-Neutral	C0243095
27832198	Mutant	C0596988
27832198	PfCRT	C0962247
27832198	P. falciparum	C0032150
27832198	4-Aminoquinoline	C0048060
27832198	Drug Resistance	C0013203
27832198	Altered	C0392747
27832198	Parasite	C0030498
27832198	Metabolism	C0025519
27832198	Digestive Vacuole	C1167024
27832198	Physiology	C0031842
27832198	Southeast Asia	C0003983
27832198	multidrug-resistant	C0242640
27832198	Plasmodium falciparum strains	C0032150
27832198	allelic	C0002085
27832198	variants	C0678941
27832198	parasite	C0030498
27832198	drug resistance	C0013203
27832198	genes	C0017337
27832198	P. falciparum chloroquine resistance transporter	C0017337
27832198	pfcrt	C0017337
27832198	reductions	C0441610
27832198	deployment	C2825812
27832198	4-aminoquinoline	C0048060
27832198	drug	C1254351
27832198	chloroquine	C0008269
27832198	CQ	C0008269
27832198	mutant	C0678941
27832198	pfcrt	C0017337
27832198	alleles	C0002085
27832198	CQ	C0008269
27832198	efficacy	C1280519
27832198	parasite	C0030498
27832198	pfcrt	C0017337
27832198	locus	C1708726
27832198	highly	C0205250
27832198	mutated	C0026882
27832198	allele	C0002085
27832198	Cam734 pfcrt	C0017337
27832198	parasite	C0030498
27832198	CQ	C0008269
27832198	resistance	C0013203
27832198	fitness	C3824713
27832198	cost	C4049986
27832198	pfcrt	C0017337
27832198	zinc-finger nucleases	C0597094
27832198	genetically dissect	C0205239
27832198	allele	C0002085
27832198	pathogenic	C3816499
27832198	asexual blood-stage infection	C3714514
27832198	Comparative analysis	C0683941
27832198	drug resistance	C0013203
27832198	growth	C0018270
27832198	recombinant parasites	C0030498
27832198	express	C0017262
27832198	Cam734	C0017337
27832198	variants	C0678941
27832198	Dd2	C0017337
27832198	Southeast Asian	C0003983
27832198	variant	C0678941
27832198	wild-type	C1883559
27832198	pfcrt	C0017337
27832198	PfCRT	C0962247
27832198	mutations	C0026882
27832198	parasite	C0030498
27832198	antimalarial agents	C0003374
27832198	GC03	C0017337
27832198	strain	C1518614
27832198	pfcrt	C0017337
27832198	studies	C2603343
27832198	allele	C0002085
27832198	Cam734	C0017337
27832198	CQ	C0008269
27832198	resistance	C0013203
27832198	A144F	C0026882
27832198	mutation	C0026882
27832198	Southeast Asia	C0003983
27832198	impacts	C4049986
27832198	Cam734	C0017337
27832198	mutations	C0026882
27832198	CQ	C0008269
27832198	resistance	C0013203
27832198	parasite	C0030498
27832198	growth rates	C0449249
27832198	Biochemical assays	C0005507
27832198	impact	C4049986
27832198	mutant	C0596988
27832198	PfCRT	C0962247
27832198	isoforms	C0597298
27832198	parasite	C0030498
27832198	metabolism	C0025519
27832198	nucleoside triphosphate	C0597106
27832198	levels	C0441889
27832198	hemoglobin catabolism	C1157963
27832198	heme	C0018966
27832198	digestive vacuole	C1167024
27832198	volume	C0449468
27832198	pH	C0020283
27832198	complex molecular basis	C4246449
27832198	physiological	C0205463
27832198	impact	C4049986
27832198	PfCRT	C0962247
27832198	antimalarial	C0003374
27832198	drug resistance	C0013203
27832198	pfcrt	C0017337
27832198	alleles	C0002085
27832198	efficacy	C1280519
27832198	antimalarial drug	C0003374
27832198	regimens	C0040808
27832581	Effect	C1280500
27832581	nutritionally induced	C0392209
27832581	hyperlipidaemia	C0020473
27832581	in vitro	C1533691
27832581	bovine	C3667982
27832581	embryo	C0013935
27832581	fatty acid	C0015684
27832581	diet	C0012155
27832581	study	C2603343
27832581	examined	C0332128
27832581	effects of	C1704420
27832581	dietary	C0012155
27832581	hyperlipidaemia	C0020473
27832581	preimplantation embryo development	C1446949
27832581	fatty acid	C0015684
27832581	FA	C0015684
27832581	diet	C0012155
27832581	in vivo	C1515655
27832581	in vitro	C1533691
27832581	bovine	C3667982
27832581	model	C0599779
27832581	cows	C0007452
27832581	fed	C3853577
27832581	diets	C0012155
27832581	feeding	C2987508
27832581	maintenance control diet	C0012155
27832581	CONT	C0012155
27832581	high	C0205250
27832581	starch	C0311120
27832581	diet	C0012155
27832581	saturated fat	C0597423
27832581	SAT	C0597423
27832581	high	C0205250
27832581	starch	C0311120
27832581	diet	C0012155
27832581	omega-3	C0015689
27832581	unsaturated fat	C0012172
27832581	UNSAT	C0012172
27832581	feeding	C2987508
27832581	sequences	C1519249
27832581	fed	C3853577
27832581	CONT	C0012155
27832581	SAT1	C0597423
27832581	UNSAT2	C0012172
27832581	fed	C3853577
27832581	CONT	C0012155
27832581	UNSAT1	C0012172
27832581	SAT2	C0597423
27832581	Serum	C0229671
27832581	dietary	C0012155
27832581	period	C1948053
27832581	analysed	C0936012
27832581	tested	C0039593
27832581	bovine	C3667982
27832581	in vitro	C1533691
27832581	embryo culture	C0920489
27832581	SAT	C0597423
27832581	UNSAT	C0012172
27832581	diets	C0012155
27832581	hyperlipidaemia	C0020473
27832581	hypercholesterolaemia	C0020443
27832581	free FAs	C0015688
27832581	insulin sensitivity	C0920563
27832581	serum	C0229671
27832581	metabolites	C0870883
27832581	FA profile	C0202009
27832581	diet	C0012155
27832581	feeding	C2987508
27832581	sequence	C1519249
27832581	SAT1	C0597423
27832581	SAT2	C0597423
27832581	serum	C0229671
27832581	blastocyst	C1281743
27832581	blastocyst	C1281743
27832581	mRNA expression	C1515670
27832581	apoptosis	C0162638
27832581	oxidative stress	C0242606
27832581	UNSAT1	C0012172
27832581	UNSAT2	C0012172
27832581	serum	C0229671
27832581	embryo	C0013935
27832581	quality	C0332306
27832581	in vitro	C1533691
27832581	sequence	C1519249
27832581	feeding	C2987508
27832581	substitution	C1706204
27832581	saturated fat	C0597423
27832581	omega-3 fat	C0015689
27832581	high-caloric diet	C0301590
27832581	hyperlipidaemia	C0020473
27832581	FA profile	C0202009
27832581	blastocysts	C1281743
27832581	normolipidaemic controls	C0009932
27834716	Draft Genome Sequence	C2348746
27834716	Soil	C0037592
27834716	Isolate	C1764827
27834716	Lysinibacillus fusiformis M5	C1095838
27834716	Potential	C3245505
27834716	Hypoxanthine	C0020684
27834716	Lysinibacillus fusiformis strain M5	C1095838
27834716	potential	C3245505
27834716	hypoxanthine	C0020684
27834716	isolated	C1764827
27834716	clay	C0055863
27834716	soil	C0037592
27834716	draft genome sequence	C2348746
27834716	annotated	C2936606
27834716	studies	C2603343
27834716	L. fusiformis M5.	C1095838
27834754	Impact	C4049986
27834754	Clinical Trial	C0008976
27834754	Results	C0456984
27834754	Temporal	C2362314
27834754	Trends	C0040833
27834754	Carotid Endarterectomy	C0014099
27834754	Stenting	C2348535
27834754	Randomized trials	C0206034
27834754	conflicting	C1705242
27834754	data	C1511726
27834754	efficacy	C1280519
27834754	carotid-artery stenting	C2348535
27834754	endarterectomy	C0014098
27834754	impact	C4049986
27834754	conflicting	C1705242
27834754	clinical trial publications	C1096775
27834754	utilization	C0815187
27834754	utilization rates	C1521828
27834754	carotid revascularization procedures	C3495793
27834754	population-level time-series analysis	C0681939
27834754	individuals	C0237401
27834754	carotid endarterectomy	C0014099
27834754	stenting	C2348535
27834754	Ontario	C0029040
27834754	Canada	C0006823
27834754	primary analysis	C0936012
27834754	temporal	C2362314
27834754	changes	C1705241
27834754	rates	C1521828
27834754	carotid revascularization procedures	C3495793
27834754	publications	C0034036
27834754	randomized trials	C0206034
27834754	Secondary analyses	C0683944
27834754	changes	C1705241
27834754	overall	C1561607
27834754	age	C0001779
27834754	sex	C0079399
27834754	carotid-artery symptom	C1457887
27834754	operator specialty-specific procedure rates	C1521828
27834754	patients	C0030705
27834754	endarterectomy	C0014098
27834754	stenting	C2348535
27834754	carotid revascularization	C3495793
27834754	procedures	C0184661
27834754	individuals	C0237401
27834754	procedures	C0184661
27834754	rate	C1521828
27834754	endarterectomy	C0014098
27834754	decreased	C0205216
27834754	rate	C1521828
27834754	carotid-artery stenting	C2348535
27834754	increased	C0205217
27834754	marked increase	C0442805
27834754	stenting	C2348535
27834754	publication	C0034036
27834754	SAPPHIRE trial	C0242481
27834754	Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy	C0242481
27834754	stenting	C2348535
27834754	unchanged	C0442739
27834754	randomized trials	C0206034
27834754	endarterectomy	C0014098
27834754	decreased	C0205216
27834754	trials	C0681815
27834754	overall rates	C1521828
27834754	carotid revascularization	C3495793
27834754	endarterectomy	C0014098
27834754	rate	C1521828
27834754	carotid-artery stenting	C2348535
27834754	risen	C0205217
27834754	publication	C0034036
27834754	stenting	C2348535
27834754	SAPPHIRE trial	C0242481
27834754	conflicting	C1705242
27834754	randomized trials	C0206034
27834754	associated with	C0332281
27834754	decreasing rate	C0442797
27834754	carotid endarterectomy	C0014099
27837821	Electronic tongues	C4279906
27837821	wine	C0043188
27837821	sensory	C0445254
27837821	descriptors	C0282354
27837821	work	C0043227
27837821	reports	C0684224
27837821	application	C4048755
27837821	electronic tongue	C4279906
27837821	tool	C0336791
27837821	analysis	C0936012
27837821	wine	C0043188
27837821	discrimination	C0242568
27837821	maturing	C0205286
27837821	barrels	C3273359
27837821	prediction	C0681842
27837821	global	C2348867
27837821	scores	C0449820
27837821	sensory panel	C0027363
27837821	red wine	C0349371
27837821	samples	C0370003
27837821	analysed	C0936012
27837821	voltammetric sensor array	C0183210
27837821	sample	C0370003
27837821	pretreatment	C3539076
27837821	responses	C0443286
27837821	preprocessed	C1522240
27837821	fast Fourier transform	C0002045
27837821	FFT	C0002045
27837821	compression	C0728907
27837821	reduction	C0392756
27837821	signal	C1710082
27837821	complexity	C0439855
27837821	coefficients	C1707429
27837821	inputs	C1708517
27837821	qualitative	C0205556
27837821	quantitative	C0392762
27837821	models	C0026336
27837821	linear discriminant analysis	C0012630
27837821	LDA	C0012630
27837821	partial least squares regression	C0034980
27837821	PLS	C0034980
27837821	results	C0683954
27837821	classification	C0008902
27837821	rate	C1521828
27837821	discrimination	C0242568
27837821	barrel	C3273359
27837821	wine	C0043188
27837821	maturing	C0205286
27837821	normalized NRMSE	C0079809
27837821	ageing	C0001811
27837821	time	C0040223
27837821	months	C0439231
27837821	prediction	C0681842
27837821	scores	C0449820
27837821	trained sensory panel	C0027363
27837821	test	C0039593
27837821	subset	C1515021
27837915	optimizing	C2698650
27837915	dental implant	C0392413
27837915	Surface	C0205148
27837915	characterization	C1880022
27837915	Ti	C0040302
27837915	TiZr	C4041873
27837915	implant materials	C0440216
27837915	Targeting	C1521840
27837915	enhanced	C2349975
27837915	osseointegration	C0079949
27837915	kinetics	C0022702
27837915	goal	C0018017
27837915	study	C2603343
27837915	characterize	C1880022
27837915	surface	C0205148
27837915	morphology	C0332437
27837915	composition	C0486616
27837915	Ti	C0040302
27837915	TiZr	C4041873
27837915	dental implant	C0392413
27837915	substrates	C3891814
27837915	surface	C0205148
27837915	treatments	C1522326
27837915	treatments	C1522326
27837915	SLA	C0392413
27837915	SLActive	C0392413
27837915	rapid	C0456962
27837915	osseointegration	C0079949
27837915	techniques	C0449851
27837915	applied	C4048755
27837915	characterize	C1880022
27837915	different	C1705242
27837915	substrate	C0205148
27837915	surface	C0205148
27837915	treatment	C1522326
27837915	combinations	C0205195
27837915	TiSLA	C0392413
27837915	TiSLActive	C0392413
27837915	TiZrSLA	C0392413
27837915	TiZrSLActive	C0392413
27837915	Contact	C0332158
27837915	angle	C0205143
27837915	measurements	C0242485
27837915	hydrophilic	C0475370
27837915	hydrophobic	C0598629
27837915	Surface	C0205148
27837915	morphology	C0332437
27837915	scanning electron microscopy	C0026020
27837915	X-ray diffraction	C0043301
27837915	Raman μ-spectroscopy	C0037815
27837915	X-ray photoelectron spectroscopy	C2700282
27837915	composition	C0486616
27837915	surface	C0205148
27837915	Consistent with	C0332290
27837915	previous	C0205156
27837915	surface	C0205148
27837915	morphology	C0332437
27837915	differ	C1705242
27837915	nanoscale	C1553036
27837915	SLActive	C0392413
27837915	substrates	C3891814
27837915	displaying	C0870432
27837915	nano	C1553036
27837915	protrusions	C0333056
27837915	Spectroscopic	C0037812
27837915	data	C1511726
27837915	substrates	C3891814
27837915	surface	C0205148
27837915	films	C1522408
27837915	titanium oxide	C0145999
27837915	TiO2	C0145999
27837915	stoichiometry	C0597526
27837915	Raman μ-spectroscopy	C0037815
27837915	reveals	C0443289
27837915	amorphous	C1979848
27837915	TiO2	C0145999
27837915	phase	C0205390
27837915	present	C0150312
27837915	TiSLA	C0392413
27837915	rutile	C0141060
27837915	TiO2	C0145999
27837915	evidenced	C3887511
27837915	TiSLActive	C0392413
27837915	TiZrSLA	C0392413
27837915	TiZrSLActive	C0392413
27837915	TiZr	C4041873
27837915	alloy	C0002154
27837915	substrates	C3891814
27837915	evidence	C3887511
27837915	discrete	C0443299
27837915	phases	C0205390
27837915	oxidized	C0030011
27837915	Zr	C0043506
27837915	X-ray photoelectron spectra	C2700282
27837915	samples	C0370003
27837915	terminated	C1692758
27837915	adventitious	C1517294
27837915	carbon	C0007009
27837915	thicker	C1280412
27837915	TiSLA	C0392413
27837915	TiZrSLA	C0392413
27837915	previous	C0205156
27837915	in vivo studies	C0681829
27837915	acquired	C0439661
27837915	data	C1511726
27837915	nanoscale	C1553036
27837915	protrusions	C0333056
27837915	thinner	C0205168
27837915	layer	C1522408
27837915	adventitious	C1517294
27837915	carbon	C0007009
27837915	contribute	C1880177
27837915	rapid	C0456962
27837915	osseointegration	C0079949
27837915	SLActive	C0392413
27837915	dental implants	C0392413
27837915	Composition	C0486616
27837915	surface	C0205148
27837915	oxide	C0030015
27837915	layer	C1522408
27837915	less	C0547044
27837915	important	C3898777
27837915	osseointegration	C0079949
27837915	kinetics	C0022702
27837917	Cocaine	C0009170
27837917	Use	C1524063
27837917	Reverses	C1555029
27837917	Striatal Plasticity	C0027880
27837917	Produced	C0678227
27837917	During	C0347984
27837917	Cocaine	C0009170
27837917	Relapse	C0035020
27837917	two	C0205448
27837917	component	C1705248
27837917	process	C1522240
27837917	highly	C0205250
27837917	motivated	C0026605
27837917	phase	C0205390
27837917	followed by	C0332283
27837917	drug-using	C0242510
27837917	phase	C0205390
27837917	resulting in	C0332294
27837917	temporary	C0205374
27837917	satiation	C0036239
27837917	rodents	C0035804
27837917	requires	C1514873
27837917	transient synaptic potentiation	C0206249
27837917	t-SP	C0206249
27837917	cortical glutamatergic synapses	C0039062
27837917	nucleus accumbens	C0028633
27837917	core	C0444669
27837917	medium spiny neurons	C0682698
27837917	unknown	C0439673
27837917	drug use	C0242510
27837917	affects	C0001721
27837917	plasticity	C0027880
27837917	modeled	C3714583
27837917	phases	C0205390
27837917	relapse	C0035020
27837917	extinction	C0015347
27837917	cocaine	C0009170
27837917	self-administration	C0036589
27837917	assess	C1516048
27837917	cocaine	C0009170
27837917	affects	C0001721
27837917	t-SP	C0206249
27837917	associated with	C0332281
27837917	Rats	C0034721
27837917	self-administer	C0036589
27837917	cocaine	C0009170
27837917	yoked	C1710702
27837917	saline	C0036082
27837917	control animals	C1511501
27837917	extinction	C0015347
27837917	reinstatement	C0678335
27837917	initiated	C1704686
27837917	minutes	C0439232
27837917	followed by	C0332283
27837917	minutes	C0439232
27837917	contingent	C1701901
27837917	cocaine	C0009170
27837917	access	C1554204
27837917	cocaine	C0009170
27837917	discontinued	C1444662
27837917	unreinforced lever pressing ensued	C0243095
27837917	Three	C0205449
27837917	measures	C0079809
27837917	t-SP	C0206249
27837917	assayed	C1510438
27837917	during	C0347984
27837917	reinstatement	C0678335
27837917	dendritic spine	C0872341
27837917	morphology	C0332437
27837917	alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid	C0051318
27837917	AMPA	C0051318
27837917	N-methyl-D-aspartate	C0079883
27837917	NMDA	C0079883
27837917	ratios	C0456603
27837917	matrix metalloproteinase	C0025543
27837917	activity	C0243102
27837917	found	C0243095
27837917	cocaine	C0009170
27837917	minutes	C0439232
27837917	collapsed	C0392748
27837917	three	C0205449
27837917	measures	C0079809
27837917	t-SP	C0206249
27837917	baseline	C1442488
27837917	cocaine	C0009170
27837917	discontinued	C1444662
27837917	minutes	C0439232
27837917	dendritic spine	C0872341
27837917	morphology	C0332437
27837917	AMPA	C0051318
27837917	NMDA	C0079883
27837917	ratios	C0456603
27837917	animals	C0003062
27837917	motivated	C0026605
27837917	lever pressing	C0243095
27837917	positively	C1446409
27837917	correlated	C1707520
27837917	changes	C0392747
27837917	spine	C2752558
27837917	morphology	C0332437
27837917	cocaine	C0009170
27837917	access	C1554204
27837917	reversed	C1555029
27837917	relationship	C0439849
27837917	novel	C0205314
27837917	modification	C0392747
27837917	reinstatement	C0678335
27837917	paradigm	C0681797
27837917	cocaine	C0009170
27837917	reversed	C1555029
27837917	synaptic plasticity	C1254358
27837917	motivation	C0026605
27837917	drug	C1254351
27838742	Delicaflavone	C1254351
27838742	induces	C0205263
27838742	autophagic cell death	C1326207
27838742	lung cancer	C0684249
27838742	Akt	C1515844
27838742	mTOR	C1515673
27838742	p70S6K	C0073337
27838742	signaling pathway	C0037080
27838742	potential	C3245505
27838742	anticancer agents	C0003392
27838742	natural sources	C0449416
27838742	effective	C1704419
27838742	novel	C0205314
27838742	chemotherapeutic agents	C0729502
27838742	study	C2603343
27838742	data	C1511726
27838742	in vitro	C1533691
27838742	in vivo	C1515655
27838742	anticancer effects	C0243095
27838742	delicaflavone	C1254351
27838742	biflavonoid	C0596577
27838742	Selaginella doederleinii	C1210298
27838742	Delicaflavone	C1254351
27838742	favorable	C3640814
27838742	anticancer	C0243095
27838742	properties	C0243178
27838742	MTT assay	C2986858
27838742	xenograft model	C1520166
27838742	human	C0086418
27838742	non-small cell lung cancer	C0007131
27838742	male	C0086582
27838742	BALB/c nude mice	C0025929
27838742	adverse effect	C0559546
27838742	transmission electron microscopy	C0678118
27838742	acridine orange	C0001185
27838742	Cyto-ID®Autophagy	C0004391
27838742	dyes	C0013343
27838742	Western blot	C0949466
27838742	analysis	C0936012
27838742	RT-PCR assay	C1709846
27838742	delicaflavone	C1254351
27838742	induces	C0205263
27838742	autophagic cell death	C1326207
27838742	increasing	C0442808
27838742	LC3-II	C3711208
27838742	LC3-I	C3714087
27838742	autophagy-related proteins	C4277731
27838742	promoting	C0033414
27838742	generation	C3146294
27838742	acidic vesicular organelles	C0029219
27838742	autolysosomes	C0230822
27838742	cytoplasm	C0010834
27838742	lung cancer	C0684249
27838742	A549	C4277577
27838742	PC-9 cells	C0007634
27838742	time	C0040223
27838742	dose-dependent	C1512045
27838742	Delicaflavone	C1254351
27838742	downregulated	C0013081
27838742	expression of phospho-Akt	C2697945
27838742	phospho-mTOR	C0033684
27838742	phospho-p70S6K	C0033684
27838742	time	C0040223
27838742	dose-dependent	C1512045
27838742	suggesting	C1705535
27838742	induced	C0205263
27838742	autophagy	C0004391
27838742	inhibiting	C3463820
27838742	Akt	C1515844
27838742	mTOR	C1515673
27838742	p70S6K	C0073337
27838742	pathway	C0037080
27838742	A549	C4277577
27838742	PC-9 cells	C0007634
27838742	Delicaflavone	C1254351
27838742	potential	C3245505
27838742	anticancer agent	C0003392
27838742	induce	C0205263
27838742	autophagic cell death	C1326207
27838742	human	C0086418
27838742	non-small cell lung cancer	C0007131
27838742	Akt	C1515844
27838742	mTOR	C1515673
27838742	p70S6K	C0073337
27838742	signaling pathway	C0037080
27838742	Delicaflavone	C1254351
27838742	anti-lung cancer effects	C0243095
27838742	in vitro	C1533691
27838742	in vivo	C1515655
27838742	Delicaflavone	C1254351
27838742	induced	C0205263
27838742	autophagic cell death	C1326207
27838742	Akt	C1515844
27838742	mTOR	C1515673
27838742	p70S6K	C0073337
27838742	signaling pathway	C0037080
27838742	Delicaflavone	C1254351
27838742	side effects	C0879626
27838742	xenograft mouse model	C1520166
27838742	Delicaflavone	C1254351
27838742	potential	C3245505
27838742	therapeutic agent	C0304231
27838742	lung cancer	C0684249
27838742	Delicaflavone	C1254351
27838742	anti-lung cancer effects	C0243095
27838742	in vitro	C1533691
27838742	in vivo	C1515655
27838742	Delicaflavone	C1254351
27838742	autophagic cell death	C1326207
27838742	Akt	C1515844
27838742	mTOR	C1515673
27838742	p70S6K	C0073337
27838742	signaling pathway	C0037080
27838742	Delicaflavone	C1254351
27838742	side effects	C0879626
27838742	xenograft mouse model	C1520166
27838742	Delicaflavone	C1254351
27838742	potential	C3245505
27838742	therapeutic agent	C0304231
27838742	lung cancer	C0684249
27840131	Determinants	C1521761
27840131	On-Road	C0442650
27840131	Driving	C0004379
27840131	Multiple Sclerosis	C0026769
27840131	investigate	C1292732
27840131	cognitive	C1516691
27840131	visual	C0234621
27840131	motor deficits	C0521654
27840131	dimensions	C0233849
27840131	on-road	C0442650
27840131	driving	C0004379
27840131	individuals	C0237401
27840131	multiple sclerosis	C0026769
27840131	MS	C0026769
27840131	cross-sectional study	C0010362
27840131	MS clinic	C3839267
27840131	driving	C0004379
27840131	simulator	C0679083
27840131	lab	C0022877
27840131	Active drivers	C0684312
27840131	MS	C0026769
27840131	Off-road	C0442650
27840131	cognitive	C1516691
27840131	visual	C0234621
27840131	motor functions	C0234130
27840131	specific	C0205369
27840131	driving skills	C0683900
27840131	skills	C0683900
27840131	categorized	C0871968
27840131	hierarchic clusters	C0009085
27840131	operational	C3241922
27840131	tactical	C0683900
27840131	visuo-integrative	C0234621
27840131	mixed driving	C0683900
27840131	Stepwise regression analysis	C0034980
27840131	off-road	C0442650
27840131	on-road	C0442650
27840131	test	C0039593
27840131	cluster	C1704332
27840131	Visuospatial function	C0814069
27840131	inhibition	C0021467
27840131	binocular acuity	C0429540
27840131	vertical visual field	C1301505
27840131	stereopsis	C0011586
27840131	variance	C1711260
27840131	on-road	C0442650
27840131	score	C0449820
27840131	Attentional shift	C4274597
27840131	stereopsis	C0011586
27840131	glare recovery	C1321305
27840131	assistive devices	C0036605
27840131	operational cluster	C0009085
27840131	Visuospatial function	C0814069
27840131	inhibition	C0021467
27840131	reasoning	C0684328
27840131	binocular acuity	C0429540
27840131	stereopsis	C0011586
27840131	tactical cluster	C0009085
27840131	visuo-integrative mode	C0026347
27840131	binocular acuity	C0429540
27840131	stereopsis	C0011586
27840131	Inhibition	C0021467
27840131	binocular acuity	C0429540
27840131	model	C0026348
27840131	mixed cluster	C0009085
27840131	impairments	C0221099
27840131	on-road	C0442650
27840131	driving	C0004379
27840131	targeted	C1521840
27840131	driving	C0004379
27840131	intervention programs	C0599917
27840131	MS	C0026769
27842161	Netarsudil	C1254351
27842161	Increases	C0442805
27842161	Outflow Facility	C0430894
27842161	Human	C0086418
27842161	Eyes	C0015392
27842161	Multiple	C0439064
27842161	Mechanisms	C0441712
27842161	Netarsudil	C1254351
27842161	Rho kinase/norepinephrine transporter inhibitor	C0033671
27842161	phase 3 clinical development	C0282461
27842161	glaucoma	C0017601
27842161	treatment	C0087111
27842161	metabolite	C0870883
27842161	netarsudil-M1	C1254351
27842161	outflow facility	C0430894
27842161	C	C0430894
27842161	outflow	C1254359
27842161	hydrodynamics	C2936194
27842161	morphology	C0332437
27842161	conventional	C0439858
27842161	outflow pathway	C1705987
27842161	enucleated human eyes	C1396718
27842161	Paired	C1709450
27842161	human	C0086418
27842161	eyes	C0015392
27842161	perfused	C0031001
27842161	netarsudil-M1	C1254351
27842161	vehicle solution	C0042444
27842161	constant pressure	C0033095
27842161	hours	C0439227
27842161	fluorescent microspheres	C0026032
27842161	perfusion	C0031001
27842161	media	C0009924
27842161	trace	C1552622
27842161	outflow patterns	C1254359
27842161	perfusion	C0031001
27842161	fixation	C0185023
27842161	percentage effective filtration length	C1444754
27842161	PEFL	C1444754
27842161	measured	C0444706
27842161	lengths	C1444754
27842161	tracer	C1522485
27842161	distribution	C1704711
27842161	trabecular meshwork	C0040573
27842161	TM	C0040573
27842161	episcleral veins	C0226616
27842161	ESVs	C0226616
27842161	inner wall	C1254362
27842161	IW	C1254362
27842161	Schlemm's canal	C0229108
27842161	global	C2348867
27842161	confocal imaging	C0242842
27842161	Morphologic changes	C1260954
27842161	trabecular	C0040573
27842161	outflow pathway	C1705987
27842161	confocal	C0242842
27842161	light	C0430389
27842161	electron microscopy	C0026019
27842161	Perfusion	C0031001
27842161	netarsudil-M1	C1254351
27842161	significantly	C0750502
27842161	increased	C0205217
27842161	C	C0430894
27842161	paired	C1709450
27842161	significantly	C0750502
27842161	increased	C0205217
27842161	PEFL	C1444754
27842161	IW	C1254362
27842161	ESVs	C0226616
27842161	eyes	C0015392
27842161	PEFL	C1444754
27842161	significantly	C0750502
27842161	ESVs	C0226616
27842161	IW	C1254362
27842161	associated with	C0332281
27842161	increased	C0205217
27842161	cross-sectional area	C0205146
27842161	ESVs	C0226616
27842161	Percentage effective filtration length	C1444754
27842161	ESVs	C0226616
27842161	C	C0430894
27842161	significant	C0750502
27842161	increase	C0442805
27842161	juxtacanalicular connective tissue	C0009780
27842161	JCT	C0009780
27842161	thickness	C1280412
27842161	eyes	C0015392
27842161	Netarsudil	C1254351
27842161	acutely	C0205178
27842161	increased	C0205217
27842161	C	C0430894
27842161	JCT	C0009780
27842161	ESVs	C0226616
27842161	redistribution	C0332620
27842161	outflow	C1254359
27842161	larger area	C0205146
27842161	IW	C1254362
27842161	ESVs	C0226616
27842329	Geographical	C0681784
27842329	Factors	C1521761
27842329	Associated With	C0332281
27842329	Health Disparities	C1171307
27842329	Prostate Cancer	C0376358
27842329	Treatment	C0087111
27842329	variation	C1705242
27842329	prostate cancer	C0376358
27842329	clinical	C0205210
27842329	clinician	C0871685
27842329	factors	C1521761
27842329	patient preferences	C0376409
27842329	availability of	C0470187
27842329	resources	C0018741
27842329	access	C0444454
27842329	physicians	C0031831
27842329	treating facilities	C0018704
27842329	research	C0035168
27842329	treatment	C0087111
27842329	disparities	C1705242
27842329	men	C0025266
27842329	prostate cancer	C0376358
27842329	race	C0034510
27842329	socioeconomic factors	C0037464
27842329	geography	C0017444
27842329	disparities	C1705242
27842329	racial	C0682075
27842329	socioeconomic differences	C0682194
27842329	patients	C0376409
27842329	live	C2982691
27842329	barriers	C4045969
27842329	care	C0086388
27842329	areas	C0681784
27842329	access	C0444454
27842329	care	C0086388
27842329	health resources	C0018741
27842329	Research	C0035168
27842329	treatment	C0087111
27842329	patterns	C0449774
27842329	disparities	C1705242
27842329	prostate cancer	C0376358
27842329	Geographical Information System	C0815319
27842329	GIS	C0815319
27842329	searched	C1706202
27842329	Studies	C2603343
27842329	English-language	C0376245
27842329	articles	C1706852
27842329	research	C0035168
27842329	US	C0041703
27842329	populations	C1257890
27842329	articles	C1706852
27842329	information	C1533716
27842329	spatial	C0037775
27842329	geographical	C0681784
27842329	analyses	C0936012
27842329	assess	C1516048
27842329	differences	C1705242
27842329	disparities	C1705242
27842329	prostate cancer	C0376358
27842329	treatment	C0087111
27842329	GIS	C0815319
27842329	research	C0035168
27842329	geographical	C0681784
27842329	spatial determinants	C1521761
27842329	prostate cancer	C0376358
27842329	disparities	C1705242
27842329	reviewed	C1709940
27842329	geographical	C0681784
27842329	analyses	C0936012
27842329	state level	C0683927
27842329	Florida	C0016253
27842329	geographical	C0681784
27842329	disparities	C1705242
27842329	men	C0025266
27842329	prostate cancer	C0376358
27842329	reviewed	C1709940
27842329	evidence	C3887511
27842329	geographical	C0681784
27842329	factors	C1521761
27842329	disparities	C1705242
27842329	prostate cancer	C0376358
27842329	Disparities	C1705242
27842329	prostate cancer	C0376358
27842329	common	C0205214
27842329	persistent	C0205322
27842329	treatment	C0087111
27842329	Geographical	C0681784
27842329	analysis	C0936012
27842329	information	C1533716
27842329	disparate	C1705242
27842329	groups	C1257890
27842329	live	C2982691
27842329	map	C0024779
27842329	access	C0444454
27842329	care	C0086388
27842329	information	C1533716
27842329	public health officials	C2826212
27842329	health-systems administrators	C0018707
27842329	clinicians	C0871685
27842329	policymakers	C0242170
27842329	geographical	C0681784
27842329	barriers	C4045969
27842329	disparities in care	C1955989
27845771	miR-9600	C1101610
27845771	Suppresses	C1260953
27845771	Tumor Progression	C0178874
27845771	Paclitaxel	C0144576
27845771	Sensitivity	C0205556
27845771	Non-small-cell Lung Cancer	C0007131
27845771	Altering	C1515926
27845771	STAT3	C1367307
27845771	Expression	C0017262
27845771	MicroRNAs	C1101610
27845771	identified	C0205396
27845771	center stage	C1300072
27845771	cancer biology	C1516164
27845771	cell proliferation	C0596290
27845771	migration	C1622501
27845771	negatively	C0205160
27845771	regulate gene expression	C0017263
27845771	translation	C0678935
27845771	targeted mRNAs	C0035696
27845771	degradation	C0243125
27845771	characterized	C1880022
27845771	identified	C0205396
27845771	miR-9600	C1101610
27845771	target	C1521840
27845771	human	C0086418
27845771	non-small-cell lung cancer	C0007131
27845771	NSCLC	C0007131
27845771	miR-9600	C1101610
27845771	downregulated	C0013081
27845771	NSCLC	C0007131
27845771	tissues	C0040300
27845771	cells	C0007634
27845771	signal transducer and activator of transcription 3	C1367307
27845771	STAT3	C1367307
27845771	putative target gene	C0017337
27845771	inhibited	C0311403
27845771	miR-9600	C1101610
27845771	miR-9600	C1101610
27845771	suppressed	C1260953
27845771	protein expression	C1171362
27845771	STAT3	C1367307
27845771	no significant	C3694175
27845771	influence	C4054723
27845771	mRNA	C0035696
27845771	levels	C0441889
27845771	miR-9600	C1101610
27845771	STAT3	C1367307
27845771	miR-9600	C1101610
27845771	inhibited	C0311403
27845771	cell growth	C0007595
27845771	expression	C1171362
27845771	cell cycle	C0007586
27845771	proteins	C0033684
27845771	inhibited	C0311403
27845771	cell migration	C1622501
27845771	invasion	C2699153
27845771	human	C0086418
27845771	NSCLC	C0007131
27845771	cell lines	C0085983
27845771	miR-9600	C1101610
27845771	suppressed	C1260953
27845771	tumor growth	C0598934
27845771	nude mice	C0025932
27845771	miR-9600	C1101610
27845771	tumorigenesis	C0007621
27845771	metastasis	C4255448
27845771	targeting	C1148560
27845771	STAT3	C1367307
27845771	identified	C0205396
27845771	miR-9600	C1101610
27845771	paclitaxel	C0144576
27845771	cisplatin	C0008838
27845771	sensitivity	C0205556
27845771	downregulating	C0013081
27845771	STAT3	C1367307
27845771	chemotherapy	C3665472
27845771	induced	C0205263
27845771	apoptosis	C0162638
27845771	miR-9600	C1101610
27845771	therapeutic	C0302350
27845771	target	C1521840
27845771	NSCLC	C0007131
27846748	Beneficial effects	C0683156
27846748	natural eggshell membrane	C3651790
27846748	NEM	C3651790
27846748	arthritis	C0003864
27846748	collagen-induced arthritic	C0971858
27846748	rats	C0034721
27846748	study	C2603343
27846748	evaluate	C0220825
27846748	potential efficacy	C1280519
27846748	natural eggshell membrane	C3651790
27846748	NEM	C3651790
27846748	collagen-induced arthritic	C0971858
27846748	rats	C0034721
27846748	rodent model of inflammation	C1519106
27846748	rheumatoid arthritis	C0003873
27846748	Rats	C0034721
27846748	type II collagen-induced arthritis	C0971858
27846748	CIA	C0971858
27846748	daily	C0332173
27846748	oral gavage	C2698653
27846748	study days	C2826182
27846748	vehicle	C0042444
27846748	NEM	C3651790
27846748	body weight	C0005910
27846748	Rats	C0034721
27846748	euthanized	C2983562
27846748	study day	C2826182
27846748	Efficacy	C1280519
27846748	assessed	C1516048
27846748	daily	C0332173
27846748	ankle	C0003086
27846748	caliper	C0175720
27846748	measurements	C0242485
27846748	measurements	C0242485
27846748	ankle	C0003086
27846748	diameter	C1301886
27846748	area under the curve	C0376690
27846748	AUCd0-17	C0376690
27846748	histopathologic evaluation	C0677043
27846748	ankles	C0003086
27846748	knees	C0022742
27846748	Serum	C0229671
27846748	biomarkers	C0005516
27846748	cartilage function	C0231581
27846748	inflammation	C0021368
27846748	collagen type II C-telopeptide	C2825914
27846748	CTXII	C2825914
27846748	cartilage oligomeric matrix protein	C3715143
27846748	COMP	C3715143
27846748	alpha-2-macroglobulin	C0523483
27846748	A2M	C0523483
27846748	measured	C0444706
27846748	ELISA	C0014441
27846748	Treatment	C0039798
27846748	NEM	C3651790
27846748	significant beneficial effects	C0683156
27846748	daily	C0332173
27846748	ankle	C0003086
27846748	diameter	C1301886
27846748	measurements	C0242485
27846748	ankle	C0003086
27846748	diameter	C1301886
27846748	AUC	C0376690
27846748	Ankle	C0003086
27846748	knee	C0022742
27846748	histopathology scores	C0428093
27846748	significantly reduced	C0392756
27846748	reduction	C0392756
27846748	histopathology scores	C0428093
27846748	ankle	C0003086
27846748	knee	C0022742
27846748	rats	C0034721
27846748	NEM	C3651790
27846748	serum	C0229671
27846748	CTXII	C2825914
27846748	COMP	C3715143
27846748	A2M	C0523483
27846748	NEM	C3651790
27846748	treated	C1522326
27846748	rats	C0034721
27846748	NEM	C3651790
27846748	inflammatory arthritis	C0003864
27846748	inflammation	C0021368
27846748	pannus	C0333350
27846748	cartilage damage	C0549421
27846748	bone resorption	C0005974
27846748	periosteal bone formation	C0231565
27846748	study	C2603343
27846748	CTXII	C0631180
27846748	COMP	C0601900
27846748	A2M	C0002198
27846748	biomarkers	C0005516
27846748	NEM	C3651790
27853255	cell membrane	C3161472
27853255	bio-inspired	C0872312
27853255	simultaneous	C0521115
27853255	monovalent	C0678553
27853255	anion	C0003075
27853255	selectivity	C1707391
27853255	antifouling properties	C0243178
27853255	anion	C0003075
27853255	membrane	C0025256
27853255	bio-inspired method	C0872312
27853255	simultaneously	C0521115
27853255	monovalent	C0678553
27853255	anion	C0003075
27853255	selectivity	C1707391
27853255	antifouling properties	C0243178
27853255	anion	C0003075
27853255	membranes	C0025256
27853255	polydopamine	C3252413
27853255	PDA	C3252413
27853255	N-O-sulfonic acid benzyl chitosan	C0162969
27853255	NSBC	C0162969
27853255	innermost	C0205102
27853255	outermost	C0205101
27853255	layers	C1561572
27853255	PDA	C3252413
27853255	middle	C0444598
27853255	layer	C1561572
27853255	NSBC	C0162969
27853255	Fourier transform infrared spectroscopy	C0206055
27853255	scanning electron microscopy	C0026020
27853255	PDA	C3252413
27853255	NSBC	C0162969
27853255	membranes	C0025256
27853255	hydrophilicity	C0475370
27853255	membranes	C0025256
27853255	electrodialysis experiments	C0683122
27853255	Cl(-)	C0596019
27853255	SO4(2-)	C3536965
27853255	monovalent	C0678553
27853255	anion	C0003075
27853255	selectivity	C1707391
27853255	Cl(-)	C0596019
27853255	SO4(2-)	C3536965
27853255	permselectivity	C0031164
27853255	membranes	C0025256
27853255	commercial membrane	C0025256
27853255	electrodialysis	C0683122
27853255	ED	C0683122
27853255	membranes	C0025256
27853255	antifouling properties	C0243178
27853255	Sodium dodecyl benzene sulfonate	C0142877
27853255	SDBS	C0142877
27853255	fouling	C3826310
27853255	ED	C0683122
27853255	membrane	C0025256
27853255	modified membrane	C0025256
27855073	Loop 2 Region	C1514562
27855073	Ribosomal Protein uS5	C0073335
27855073	Spectinomycin	C0001268
27855073	Sensitivity	C0427965
27855073	Translational Fidelity	C3824282
27855073	Ribosome Biogenesis	C1156140
27855073	Ribosomal protein uS5	C0073335
27855073	essential component	C1705248
27855073	small ribosomal subunit	C1167012
27855073	subunit assembly	C1156143
27855073	maintenance of translational fidelity	C3824282
27855073	ribosome's	C0035553
27855073	response	C0871261
27855073	antibiotic spectinomycin	C0001268
27855073	uS5 mutations	C0026882
27855073	decoding	C1148560
27855073	interface	C1148560
27855073	uS4	C0073333
27855073	residues	C1709915
27855073	uS4-uS5 interface	C1148560
27855073	decoding process	C1522240
27855073	interface-remote area	C1254362
27855073	loop 2 region	C1514562
27855073	residues	C1709915
27855073	mutagenesis	C0079866
27855073	Escherichia. coli	C0014834
27855073	unique mutants	C0596988
27855073	loop 2	C1514562
27855073	resistance	C4281815
27855073	spectinomycin	C0001268
27855073	fidelity of translation	C3824282
27855073	rRNA	C0035701
27855073	ribosome biogenesis	C1156140
27855073	defects	C1457869
27856752	Multiplex	C0205556
27856752	social	C0728831
27856752	ecological	C0565987
27856752	network analysis	C0242481
27856752	reveals	C0443289
27856752	social changes	C0037400
27856752	affect	C0392760
27856752	community	C0009462
27856752	robustness	C2986815
27856752	resource	C0178640
27856752	depletion	C0392756
27856752	Network analysis	C0242481
27856752	provides	C1999230
27856752	complex	C0439855
27856752	influences	C4054723
27856752	social	C0680343
27856752	ecological structures	C0565987
27856752	community	C0009462
27856752	household	C0020052
27856752	network studies	C0242481
27856752	social	C0728831
27856752	ecological systems	C0162358
27856752	simple	C0205352
27856752	unweighted networks	C1882071
27856752	multiplex	C0205556
27856752	directed	C0449738
27856752	weighted networks	C1882071
27856752	subsistence	C0024501
27856752	food	C0016452
27856752	collected	C1516695
27856752	indigenous	C1512704
27856752	communities	C0009462
27856752	Arctic	C0003740
27856752	Alaska	C0001905
27856752	economic	C0013557
27856752	ecological	C0565987
27856752	changes	C0392747
27856752	future	C0016884
27856752	scenarios	C0683579
27856752	changes	C0392747
27856752	social	C0728831
27856752	relations	C0439849
27856752	households	C0020052
27856752	effects	C1280500
27856752	community	C0009462
27856752	robustness	C2986815
27856752	changes	C0392747
27856752	specific	C0205369
27856752	wild food resources	C0178640
27857693	Heavy Resistance Training	C0872279
27857693	Hypoxia	C0242184
27857693	Enhances	C2349975
27857693	1RM	C4054321
27857693	Squat	C0241236
27857693	Performance	C0597198
27857693	heavy resistance training	C0872279
27857693	hypoxia	C0242184
27857693	IHRT	C0872279
27857693	effective	C1704419
27857693	improving	C1272745
27857693	strength	C0237897
27857693	power	C0424581
27857693	increasing	C0442808
27857693	lean mass	C0424678
27857693	training	C2673163
27857693	pair-matched	C0085145
27857693	placebo-controlled study	C0599724
27857693	design	C1707689
27857693	resistance-trained	C0872279
27857693	participants	C0679646
27857693	IHRT	C0872279
27857693	FIO2	C2370852
27857693	placebo	C0009932
27857693	FIO2	C2370852
27857693	group	C0681860
27857693	Participants	C0679646
27857693	matched	C1708943
27857693	strength	C0237897
27857693	training	C0872279
27857693	Both	C1706086
27857693	groups	C0681860
27857693	performed	C0884358
27857693	sessions	C1883016
27857693	weeks	C0439230
27857693	IHRT	C0872279
27857693	placebo	C0009932
27857693	participants	C0679646
27857693	tested	C0039593
27857693	1RM	C4054321
27857693	20-m	C3842775
27857693	sprint	C0454374
27857693	body composition	C0005885
27857693	countermovement jump	C0221189
27857693	pre	C0332152
27857693	mid	C1254367
27857693	post	C0687676
27857693	training	C0872279
27857693	compared	C1707455
27857693	magnitude	C1704240
27857693	based	C1527178
27857693	inferences	C0679201
27857693	Groups	C0681860
27857693	not clearly	C3845108
27857693	different	C1705242
27857693	test	C0039593
27857693	baseline	C1442488
27857693	Training	C0872279
27857693	improved	C0184511
27857693	both	C1706086
27857693	absolute	C0205344
27857693	IHRT	C0872279
27857693	effect size	C0814843
27857693	ES	C0814843
27857693	placebo	C0009932
27857693	ES	C0814843
27857693	relative	C0205345
27857693	1RM	C4054321
27857693	IHRT	C0872279
27857693	ES	C0814843
27857693	placebo	C0009932
27857693	ES	C0814843
27857693	post	C0687676
27857693	both	C1706086
27857693	groups	C0681860
27857693	increased	C0205217
27857693	absolute	C0205344
27857693	IHRT	C0872279
27857693	ES	C0814843
27857693	placebo	C0009932
27857693	ES	C0814843
27857693	relative	C0205345
27857693	1RM	C4054321
27857693	IHRT	C0872279
27857693	ES	C0814843
27857693	placebo	C0009932
27857693	ES	C0814843
27857693	change	C0392747
27857693	IHRT	C0872279
27857693	greater	C1704243
27857693	placebo	C0009932
27857693	both	C1706086
27857693	absolute	C0205344
27857693	greater	C1704243
27857693	change	C0392747
27857693	Confidence Interval	C0009667
27857693	CI	C0009667
27857693	ES	C0814843
27857693	relative	C0205345
27857693	strength	C0237897
27857693	greater	C1704243
27857693	change	C0392747
27857693	CI	C0009667
27857693	ES	C0814843
27857693	relative	C0205345
27857693	greater	C1704243
27857693	change	C0392747
27857693	IHRT	C0872279
27857693	both	C1706086
27857693	absolute	C0205344
27857693	greater	C1704243
27857693	change	C0392747
27857693	CI	C0009667
27857693	ES	C0814843
27857693	relative	C0205345
27857693	1RM	C4054321
27857693	greater	C1704243
27857693	change	C0392747
27857693	CI	C0009667
27857693	ES	C0814843
27857693	IHRT	C0872279
27857693	increased	C0205217
27857693	countermovement jump	C0221189
27857693	peak	C0444505
27857693	power	C0424581
27857693	Post	C0687676
27857693	ES	C0814843
27857693	difference	C1705242
27857693	IHRT	C0872279
27857693	placebo	C0009932
27857693	unclear	C3845108
27857693	CI	C0009667
27857693	ES	C0814843
27857693	no clear	C3845108
27857693	differences	C1705242
27857693	speed	C0678536
27857693	body composition	C0005885
27857693	Heavy resistance training	C0872279
27857693	hypoxia	C0242184
27857693	effective	C1704419
27857693	placebo	C0009932
27857693	improving	C1272745
27857693	absolute	C0205344
27857693	relative	C0205345
27857693	strength	C0237897
27857788	Ultrasonography	C0041618
27857788	magnetic resonance imaging	C0024485
27857788	evaluation	C0220825
27857788	pediatric	C1521725
27857788	spinal anomalies	C0266498
27857788	Spinal dysraphisms	C0080178
27857788	congenital abnormalities	C0000768
27857788	spine	C0037949
27857788	fusion	C0332466
27857788	midline	C0549183
27857788	mesenchymal	C1513143
27857788	bony	C0443157
27857788	neural	C3714606
27857788	structures	C0678594
27857788	Imaging	C0011923
27857788	evaluation	C0220825
27857788	patients	C0030705
27857788	concurrent	C0205420
27857788	anomalies	C0000768
27857788	corrected	C0205202
27857788	simultaneously	C0521115
27857788	repeat surgeries	C0035110
27857788	study	C2603343
27857788	evaluate	C0220825
27857788	Spinal dysraphisms	C0080178
27857788	USG	C0041618
27857788	MRI	C0024485
27857788	correlate	C1707520
27857788	imaging	C0011923
27857788	findings	C2607943
27857788	operative	C1882154
27857788	findings	C2607943
27857788	patients	C0030705
27857788	surgery	C0543467
27857788	Hospital	C0019994
27857788	observational study	C1518527
27857788	period	C1948053
27857788	year	C0439234
27857788	cases	C1706256
27857788	sexes	C1522384
27857788	years	C0439234
27857788	age	C0001779
27857788	spinal dysraphism	C0080178
27857788	USG	C0041618
27857788	cases	C1706256
27857788	acoustic window	C1254362
27857788	evaluation	C0220825
27857788	MRI	C0024485
27857788	cases	C1706256
27857788	USG	C0041618
27857788	findings	C2607943
27857788	MRI	C0024485
27857788	findings	C2607943
27857788	operative	C1882154
27857788	follow up	C3274571
27857788	cases	C1706256
27857788	operative management	C0150270
27857788	analysed	C0936012
27857788	percentage	C0439165
27857788	arithmetic mean	C0392762
27857788	cases	C1706256
27857788	male	C0086582
27857788	cases	C1706256
27857788	female	C0086287
27857788	Neonatal period	C0935562
27857788	age group	C0027362
27857788	Closed	C0587267
27857788	spinal dysraphism	C0080178
27857788	open	C0175566
27857788	cases	C1706256
27857788	spinal	C0521329
27857788	USG	C0041618
27857788	MRI	C0024485
27857788	examinations	C0582103
27857788	operative	C1882154
27857788	correlation	C1707520
27857788	USG	C0041618
27857788	findings	C2607943
27857788	confirmatory	C0750484
27857788	cases	C1706256
27857788	MRI	C0024485
27857788	findings	C2607943
27857788	confirmatory	C0750484
27857788	cases	C1706256
27857788	USG	C0041618
27857788	modality	C1275506
27857788	evaluation	C0220825
27857788	spinal dysraphism	C0080178
27857788	screening	C1710032
27857788	suspected	C0750491
27857788	cases	C1706256
27857788	MRI	C0024485
27857788	abnormal	C0205161
27857788	USG	C0041618
27857788	findings	C2607943
27857788	concurrent	C0205420
27857788	abnormalities	C0000768
27857788	anatomical	C0220784
27857788	details	C1522508
27857788	surgical planning	C0599880
27857970	BORA	C1824391
27857970	PLK1	C1579259
27857970	regulation	C1158894
27857970	cancer therapy	C0920425
27857970	mitotic kinase polo like kinase 1	C1579259
27857970	PLK1	C1579259
27857970	overexpressed	C1514559
27857970	cancers and its inhibition	C1512773
27857970	slows down proliferation	C1156236
27857970	increases apoptosis	C2248382
27857970	cancer cell lines	C0334227
27857970	PLK1 is activated	C1819041
27857970	PLK1 inhibitors	C1449702
27857970	anticancer properties	C0003392
27857970	regulatory loop	C0678662
27857970	PLK1 activation	C1819041
27857970	cyclin-dependent kinase 1	C2353787
27857970	CDK1	C2353787
27858508	Activation of transcription	C0162493
27858508	nuclear bodies	C0230595
27858508	zebrafish	C0043457
27858508	embryos	C0013935
27858508	Nuclear bodies	C0230595
27858508	cellular compartments	C2335889
27858508	lack	C0332268
27858508	lipid bilayers	C0023768
27858508	specific	C0205369
27858508	RNAs	C0035668
27858508	proteins	C0033684
27858508	nuclear bodies	C0230595
27858508	nuclear bodies	C0230595
27858508	investigate	C1292732
27858508	Cajal bodies	C0751972
27858508	CBs	C0751972
27858508	histone locus bodies	C2752281
27858508	HLBs	C2752281
27858508	nucleoli	C0007609
27858508	splicing machinery	C0314666
27858508	histone mRNA 3' end processing	C1158725
27858508	rRNA processing	C1156152
27858508	embryos	C0013935
27858508	zebrafish	C0043457
27858508	Danio rerio	C0043457
27858508	embryo	C0013935
27858508	nuclear body	C0230595
27858508	zygotic	C0043544
27858508	transcription	C0040649
27858508	activated	C1879547
27858508	CBs	C0751972
27858508	fertilization	C0015914
27858508	HLB	C2752281
27858508	nucleolar	C0007609
27858508	components	C0243092
27858508	foci	C0205234
27858508	histone	C0019652
27858508	genes	C0017337
27858508	rDNA	C0012933
27858508	active	C0205177
27858508	HLB	C2752281
27858508	blocked	C0332206
27858508	transcription inhibition	C1514673
27858508	nascent histone transcripts	C1519595
27858508	HLB	C2752281
27858508	components	C0243092
27858508	U7 snRNP	C0162464
27858508	base-pairing	C0600436
27858508	nascent histone transcripts	C1519595
27858508	localization	C1158693
27858508	HLBs	C2752281
27858508	HLBs	C2752281
27858508	CBs	C0751972
27858508	snRNAs	C0035709
27858508	CBs	C0751972
27858508	HLBs	C2752281
27858508	contribution	C1880177
27858508	protein	C0033684
27858508	constituents	C0729650
27858508	nuclear bodies	C0230595
27858508	nucleolar	C0007609
27858508	HLB	C2752281
27858508	CB	C0751972
27858508	components	C0243092
27858508	early	C1279919
27858508	embryogenesis	C0013936
27858508	transcription	C0040649
27858508	transcription	C0040649
27858508	specific	C0205369
27858508	gene loci	C1708726
27858508	nuclear body	C0230595
27858508	components	C0243092
27858508	specificity	C0037791
27858508	regulatory	C1704735
27858508	functions	C0031843
27859167	Variation in the age	C0699810
27859167	first reproduction	C0035150
27859167	different strategies	C0205556
27859167	individual quality	C0332306
27859167	age	C0001779
27859167	first reproduction	C0035150
27859167	demographic parameter	C0011292
27859167	high selective pressure	C0460139
27859167	variable	C0439828
27859167	variability	C2827666
27859167	hypotheses	C1512571
27859167	variability	C2827666
27859167	expression	C0565975
27859167	individual strategies	C0205556
27859167	allocation strategies	C1706778
27859167	fitness components	C0031812
27859167	individual difference	C0021228
27859167	intrinsic quality	C0205102
27859167	individuals	C0237401
27859167	fitness components	C0031812
27859167	tested	C0039593
27859167	hypotheses	C1512571
27859167	Wandering Albatross	C0325368
27859167	relationships	C0439849
27859167	age	C0001779
27859167	first reproduction	C0035150
27859167	adult	C0001675
27859167	demographic	C0011298
27859167	traits	C0599883
27859167	finite mixture capture recapture modeling	C0870071
27859167	age	C0001779
27859167	first reproduction	C0035150
27859167	negatively	C1513916
27859167	reproductive	C0035150
27859167	performances	C0597198
27859167	adult	C0001675
27859167	survival	C0038952
27859167	individual quality	C0332306
27859167	variation	C2827666
27859167	age	C0001779
27859167	first reproduction	C0035150
27859167	age	C0001779
27859167	first breeding	C0006159
27859167	predictor	C2698872
27859167	quality	C0332306
27859167	seabird species	C0325368
27859268	Heterogeneity	C0019409
27859268	colorectal cancer	C1527249
27859268	risk	C0035647
27859268	tumour	C0027651
27859268	characteristics	C1521970
27859268	prospective study	C0033522
27859268	UK	C0041700
27859268	women	C0043210
27859268	Associations	C0439849
27859268	behavioural	C0004927
27859268	personal	C1519021
27859268	factors	C1521761
27859268	colorectal cancer	C1527249
27859268	risk	C0035647
27859268	tumour	C0027651
27859268	characteristics	C1521970
27859268	UK	C0041700
27859268	prospective study	C0033522
27859268	risk factors	C0035648
27859268	colorectal cancer	C1527249
27859268	risk	C0035647
27859268	anatomical sites	C0005898
27859268	morphological	C0543482
27859268	subtypes	C0449560
27859268	women	C0043210
27859268	colorectal cancers	C1527249
27859268	follow-up	C1522577
27859268	national cancer registry	C0805443
27859268	data	C1511726
27859268	Cox regression	C0010235
27859268	relative risks	C0242492
27859268	Statistical significance	C0237881
27859268	colorectal cancer	C1527249
27859268	risk	C0035647
27859268	associated with	C0332281
27859268	height	C0005890
27859268	body mass index	C1305855
27859268	BMI	C1305855
27859268	smoking	C0037369
27859268	alcohol intake	C0001948
27859268	physical activity	C0026606
27859268	parity	C0030563
27859268	menopausal hormone therapy	C0282402
27859268	smoking	C0037369
27859268	heterogeneity	C0019409
27859268	morphological	C0543482
27859268	types	C0332307
27859268	relative risks	C0242492
27859268	smokers	C0337664
27859268	signet ring cell	C0333727
27859268	neuroendocrine tumours	C0206754
27859268	Obese	C0028754
27859268	women	C0043210
27859268	at higher risk	C3843761
27859268	signet ring cell	C0333727
27859268	tumours	C0027651
27859268	adenocarcinomas	C0001418
27859268	colorectal cancers	C1527249
27859268	cohort	C0599755
27859268	risk factor	C0035648
27859268	associations	C0439849
27859268	heterogeneity	C0019409
27859268	risk	C0035647
27859268	tumours	C0027651
27859268	right colon	C1305188
27859268	left colon	C0227388
27859268	rectum	C0034896
27859268	factors	C0035648
27859268	epidemiological	C0014507
27859268	findings	C0243095
27859268	molecular studies	C0946228
27859268	developmental	C0458003
27859268	pathways	C1705987
27859268	tumour	C0027651
27859268	types	C0332307
27859998	Impact	C4049986
27859998	alcohol use	C0001948
27859998	EEG dynamics	C0013819
27859998	response inhibition	C1510574
27859998	cotwin control analysis	C0242481
27859998	alcohol misuse	C0678254
27859998	associated with	C0332281
27859998	behavioral disinhibition	C0424296
27859998	neurophysiological mechanisms	C1327471
27859998	relationship	C0439849
27859998	inhibition	C1510574
27859998	cognitive control	C0392335
27859998	electrophysiological theta-band dynamics	C0850293
27859998	medial frontal cortex	C2951740
27859998	MFC	C2951740
27859998	power enhancement	C1254358
27859998	functional connectivity	C1254358
27859998	MFC	C2951740
27859998	dorsal prefrontal cortex	C4019080
27859998	dPFC	C4019080
27859998	alcohol misuse	C0678254
27859998	men	C0025266
27859998	women	C0043210
27859998	risk	C0035647
27859998	physical	C0871083
27859998	neurocognitive correlates	C0871178
27859998	drinking	C0001948
27859998	study	C2603343
27859998	alcohol misuse	C0678254
27859998	deleterious effect	C0879626
27859998	theta-band	C0204631
27859998	response inhibition	C1510574
27859998	EEG dynamics	C0013819
27859998	sample	C1257890
27859998	twins	C0041427
27859998	cotwin control (CTC) design	C0035171
27859998	risk	C0035647
27859998	alcohol use	C0001948
27859998	causal effects	C1280500
27859998	alcohol exposure	C4038778
27859998	Drinking	C0001948
27859998	associated with	C0332281
27859998	theta-band	C0204631
27859998	MFC power	C1254358
27859998	MFC	C2951740
27859998	dPFC	C4019080
27859998	connectivity	C0229984
27859998	response inhibition	C1510574
27859998	effect	C1280500
27859998	women	C0043210
27859998	CTC analysis	C0242481
27859998	women	C0043210
27859998	theta-band	C0204631
27859998	MFC power	C1254358
27859998	MFC	C2951740
27859998	dPFC	C4019080
27859998	connectivity	C0229984
27859998	deleterious causal effects	C0879626
27859998	alcohol exposure	C4038778
27859998	diminished	C0205216
27859998	theta-band	C0204631
27859998	MFC power	C1254358
27859998	MFC	C2951740
27859998	dPFC	C4019080
27859998	connectivity	C0229984
27859998	neurophysiological mechanisms	C1327471
27859998	alcohol-related disinhibition	C0424296
27859998	normative levels	C0243095
27859998	alcohol use	C0001948
27859998	adulthood	C0700597
27859998	causal effects	C1280500
27859998	response inhibition	C1510574
27859998	EEG dynamics	C0013819
27861593	Neutrophil	C0027950
27861593	Monocyte	C0026473
27861593	Function	C0007613
27861593	Patients	C0030705
27861593	Chronic Hepatitis C	C0524910
27861593	Antiviral Therapy	C0280274
27861593	Regimens	C0040808
27861593	Protease Inhibitors	C0033607
27861593	Interferon	C0021747
27861593	Real-life data	C1511726
27861593	increased	C0205217
27861593	incidence	C0021149
27861593	bacterial infections	C0004623
27861593	patients	C0030705
27861593	liver disease	C0023895
27861593	receiving	C1514756
27861593	protease inhibitor	C0033607
27861593	PI	C0033607
27861593	antiviral regimen	C0040808
27861593	hepatitis C	C0220847
27861593	HCV	C0220847
27861593	PIs	C0033607
27861593	innate immune responses	C0020969
27861593	inhibition of proteases	C1524081
27861593	anti-bacterial functions	C0544570
27861593	neutrophils	C0027950
27861593	monocytes	C0026473
27861593	study	C1706256
27861593	assess	C0184514
27861593	phagocytic and oxidative burst	C0085416
27861593	capacity	C1516240
27861593	neutrophils	C0027950
27861593	monocytes	C0026473
27861593	patients	C0030705
27861593	receiving	C1514756
27861593	PI	C0033607
27861593	antiviral regimen	C0040808
27861593	cytokine secretion	C1327414
27861593	neutrophil	C0027950
27861593	stimulation	C0007613
27861593	flagellin	C0016194
27861593	patients	C0030705
27861593	chronic HCV	C0524910
27861593	cirrhosis	C0023890
27861593	study	C1706256
27861593	received	C1514756
27861593	triple therapy	C0087111
27861593	Group A	C0441835
27861593	pegylated-interferon	C0021747
27861593	ribavirin	C0035525
27861593	weeks	C0439230
27861593	PI	C0033607
27861593	telaprevir	C1876229
27861593	boceprevir	C1738934
27861593	simeprevir	C2605855
27861593	patients	C0030705
27861593	received	C1514756
27861593	interferon	C0021747
27861593	interferon -free regimen	C0040808
27861593	Group B	C0008902
27861593	simeprevir	C2605855
27861593	sofosbuvir	C2976303
27861593	Phagocytosis and oxidative burst	C0085416
27861593	capacity	C1516240
27861593	flow cytometry	C0016263
27861593	baseline	C1442488
27861593	week	C0439230
27861593	week	C0439230
27861593	therapy	C0087111
27861593	neutrophils	C0027950
27861593	Group A	C0441835
27861593	patients	C0030705
27861593	oxidative burst	C0085416
27861593	rate	C1521828
27861593	oxidative	C0311404
27861593	enzymatic activity per cell	C2267219
27861593	decreased	C0205216
27861593	study period	C1254367
27861593	Pairwise comparisons	C0086766
27861593	decrease	C0547047
27861593	baseline	C1442488
27861593	week	C0439230
27861593	therapy	C0087111
27861593	introduction	C1293116
27861593	PI	C0033607
27861593	oxidative	C0311404
27861593	enzymatic activity per cell	C2267219
27861593	monocytes	C0026473
27861593	decrease	C0547047
27861593	study period	C1254367
27861593	decrease	C0547047
27861593	baseline	C1442488
27861593	week	C0439230
27861593	therapy	C0087111
27861593	patients	C0030705
27861593	Group A	C0441835
27861593	findings	C2607943
27861593	Group B	C0008902
27861593	patients	C0030705
27861593	Cytokine secretion	C1327414
27861593	study	C1706256
27861593	groups	C0441833
27861593	data	C1511726
27861593	interferon	C0021747
27861593	PI	C0033607
27861593	deleterious effect	C1280500
27861593	neutrophil	C0027950
27861593	monocyte	C0026473
27861593	phagocytic and oxidative burst	C0085416
27861593	capacity	C1516240
27861593	cohort	C0599755
27861593	patients	C0030705
27861593	HCV	C0220847
27861593	advanced liver fibrosis	C0239946
27863934	Child death	C0524343
27863934	maternal	C1858460
27863934	psychosis-like experiences	C0033975
27863934	low-	C0024045
27863934	middle-income	C0870890
27863934	countries	C0454664
27863934	depression	C0011570
27863934	child death	C0524343
27863934	mental wellbeing	C0025353
27863934	women	C0043210
27863934	low-	C0024045
27863934	middle-income	C0870890
27863934	countries	C0454664
27863934	LMICs	C0454664
27863934	child mortality	C0008083
27863934	association	C0439849
27863934	child death	C0524343
27863934	psychosis-like experiences	C0033975
27863934	PLEs	C0033975
27863934	depression	C0011570
27863934	association	C0439849
27863934	Data	C0010100
27863934	LMICs	C0454664
27863934	World Health Survey	C0018762
27863934	WHS	C0018762
27863934	women	C0043210
27863934	birth	C0005615
27863934	years	C0439234
27863934	self-reported	C0681906
27863934	lifetime	C4071830
27863934	psychosis diagnosis	C0596905
27863934	World Mental Health Survey	C3481515
27863934	Composite International Diagnostic Interview	C0451085
27863934	CIDI	C0451085
27863934	diagnosis	C1704656
27863934	month	C0439231
27863934	DSM-IV	C0220952
27863934	depression	C0011570
27863934	positive psychotic symptoms	C0871189
27863934	Depression	C0011570
27863934	self-reported	C0681906
27863934	lifetime	C4071830
27863934	depression diagnosis	C0596905
27863934	month	C0439231
27863934	depression	C0011570
27863934	logistic regression analyses	C0681925
27863934	potential confounders	C0009673
27863934	women	C0043210
27863934	child death	C0524343
27863934	PLEs	C0033975
27863934	depression	C0011570
27863934	OR	C0028873
27863934	depression	C0011570
27863934	OR	C0028873
27863934	CI	C0009667
27863934	depression	C0011570
27863934	delusion of control	C0233685
27863934	associated with	C0332281
27863934	child death	C0524343
27863934	OR	C0028873
27863934	CI	C0009667
27863934	Child death	C0524343
27863934	mental wellbeing	C0025353
27863934	women	C0043210
27863934	LMICs	C0454664
27863934	adverse health outcomes	C3858647
27863934	associated with	C0332281
27863934	PLEs	C0033975
27863934	depression	C0011570
27863934	symptoms	C1457887
27863934	mental health care	C0184643
27863934	mothers	C0026591
27863934	child loss	C0848031
27863934	LMICs	C0454664
27864317	Prednisolone	C0032950
27864317	associated with	C0332281
27864317	worse lipid profile	C0740400
27864317	hydrocortisone	C0020268
27864317	patients	C0030705
27864317	adrenal insufficiency	C0001623
27864317	Prednisolone	C0032950
27864317	glucocorticoid	C0017710
27864317	replacement therapy	C0279033
27864317	adrenal insufficiency	C0001623
27864317	AI	C0001623
27864317	data	C1511726
27864317	AI	C0001623
27864317	associated with	C0332281
27864317	bone mineral density	C0005938
27864317	Data	C1511726
27864317	risk factors	C0035648
27864317	cardiovascular disease	C0007222
27864317	patients	C0030705
27864317	AI	C0001623
27864317	treated	C1522326
27864317	prednisolone	C0032950
27864317	cause	C0007465
27864317	mortality	C0205848
27864317	data	C1511726
27864317	European Adrenal Insufficiency Registry	C0282574
27864317	EU-AIR	C0282574
27864317	EU-AIR	C0282574
27864317	centres	C0475309
27864317	Germany	C0017480
27864317	Netherlands	C0027778
27864317	Sweden	C0038995
27864317	UK	C0041700
27864317	patients	C0030705
27864317	AI	C0001623
27864317	Patients	C0030705
27864317	prednisolone	C0032950
27864317	hydrocortisone	C0020268
27864317	identified	C0205396
27864317	grouped	C0439745
27864317	prednisolone	C0032950
27864317	hydrocortisone	C0020268
27864317	gender	C0079399
27864317	age	C0001779
27864317	duration	C0449238
27864317	type of disease	C0457464
27864317	Data	C1511726
27864317	baseline	C1442488
27864317	follow-up	C1522577
27864317	visits	C1512346
27864317	Data	C1511726
27864317	patients	C0030705
27864317	congenital adrenal hyperplasia	C0001627
27864317	excluded	C2828389
27864317	mean ± s.d. total	C0392762
27864317	low-density lipoprotein (LDL) cholesterol	C0023824
27864317	LDL	C0023823
27864317	levels	C0441889
27864317	identified	C0205396
27864317	patients	C0030705
27864317	prednisolone	C0032950
27864317	hydrocortisone	C0020268
27864317	baseline	C1442488
27864317	follow-up	C1522577
27864317	HbA1c	C0019018
27864317	high-density lipoprotein	C0023821
27864317	triglyceride levels	C0428475
27864317	body mass index	C1305855
27864317	systolic	C0221155
27864317	diastolic blood pressure	C0235222
27864317	waist circumference	C0455829
27864317	matched	C1708943
27864317	analysis	C0936012
27864317	LDL levels	C0428473
27864317	patients	C0030705
27864317	prednisolone	C0032950
27864317	hydrocortisone	C0020268
27864317	risk	C0035647
27864317	cardiovascular disease	C0007222
27864317	group	C0441833
27866504	Oxytocin	C0030095
27866504	Reduces	C0392756
27866504	Face	C0015450
27866504	Processing	C1709694
27866504	Time	C0040223
27866504	Leaves	C0205556
27866504	Recognition	C0524637
27866504	Accuracy	C0443131
27866504	Eye	C0015392
27866504	Gaze	C0553544
27866504	Unaffected	C2986417
27866504	Previous	C0205156
27866504	studies	C0681814
27866504	oxytocin	C0030095
27866504	OXT	C0030095
27866504	improve	C0184511
27866504	recognition	C0524637
27866504	emotional	C0849912
27866504	facial expressions	C0015457
27866504	proposed	C1553874
27866504	effect	C1280500
27866504	mediated	C0086597
27866504	increase	C0442805
27866504	attention	C0004268
27866504	eye-region	C0446453
27866504	faces	C0015450
27866504	evidence	C3887511
27866504	inconsistent	C0442809
27866504	few	C0205388
27866504	studies	C0681814
27866504	directly	C1947931
27866504	tested	C0039593
27866504	effect	C1280500
27866504	oxytocin	C0030095
27866504	emotion	C0013987
27866504	recognition	C0524637
27866504	altered	C0392747
27866504	eye	C0015392
27866504	gaze	C0553544
27866504	Methods	C0025663
27866504	double-blind	C0013072
27866504	within	C0332285
27866504	subjects	C0080105
27866504	randomized control experiment	C0681814
27866504	healthy	C3898900
27866504	male participants	C0025266
27866504	received	C1514756
27866504	IU	C0439453
27866504	intranasal	C0001560
27866504	OXT	C0030095
27866504	placebo	C1696465
27866504	identical	C0205280
27866504	experimental	C1517586
27866504	sessions	C1883016
27866504	separated	C0443299
27866504	week	C0439230
27866504	interval	C1272706
27866504	Visual attention	C0589102
27866504	eye-region	C0446453
27866504	assessed	C1516048
27866504	participants	C0679646
27866504	completed	C0205197
27866504	static	C0441463
27866504	facial	C0015450
27866504	emotion	C0013987
27866504	recognition	C0524637
27866504	task	C3540678
27866504	medium intensity	C0522510
27866504	facial expressions	C0015457
27866504	OXT	C0030095
27866504	no effect	C1301751
27866504	emotion	C0013987
27866504	recognition	C0524637
27866504	accuracy	C0443131
27866504	recognition	C0524637
27866504	performance	C1882330
27866504	improved	C0184511
27866504	face	C0015450
27866504	processing	C1709694
27866504	faster	C0456962
27866504	emotions	C0013987
27866504	influence	C4054723
27866504	OXT	C0030095
27866504	effect	C1280500
27866504	marginally	C1947914
27866504	significant	C0750502
27866504	Consistent with	C0332290
27866504	previous	C0205156
27866504	study	C0681814
27866504	dynamic stimuli	C0234402
27866504	OXT	C0030095
27866504	no effect	C1301751
27866504	eye	C0015392
27866504	gaze	C0553544
27866504	patterns	C0449774
27866504	viewing	C0449911
27866504	static	C0441463
27866504	emotional	C0849912
27866504	faces	C0015450
27866504	recognition	C0524637
27866504	accuracy	C0443131
27866504	face	C0015450
27866504	processing	C1709694
27866504	time	C0040223
27866504	findings	C0243095
27866504	suggest	C1705535
27866504	OXT	C0030095
27866504	induced	C0205263
27866504	enhanced	C2349975
27866504	facial	C0015450
27866504	emotion	C0013987
27866504	recognition	C0524637
27866504	mediated	C0086597
27866504	increase	C0442805
27866504	attention	C0004268
27866504	eye-region	C0446453
27866504	faces	C0015450
27866504	previously	C0205156
27866504	assumed	C3242379
27866504	several	C0443302
27866504	methodological	C3266812
27866504	issues	C0033213
27866504	discrepant findings	C0243095
27866504	suggest	C1705535
27866504	effect	C1280500
27866504	OXT	C0030095
27866504	visual attention	C0589102
27866504	task	C3540678
27866504	requirements	C1514873
27866508	psychiatric rehabilitation	C0204512
27866508	USA	C0041703
27866508	American	C0596070
27866508	researchers	C0035173
27866508	world	C2700280
27866508	developing	C1527148
27866508	evaluating	C0220825
27866508	disseminating	C0205221
27866508	evidence	C3887511
27866508	psychiatric rehabilitation	C0204512
27866508	practices	C1510541
27866508	people	C0027361
27866508	serious	C0205404
27866508	mental illness	C0004936
27866508	USA	C0041703
27866508	industrialized nations	C0282613
27866508	access	C0018748
27866508	high-quality	C0034379
27866508	mental health	C0025355
27866508	psychiatric services	C3526598
27866508	essay	C0684224
27866508	evidence-based practices	C1510541
27866508	USA	C0041703
27866508	practices	C0034024
27866508	barriers	C3260965
27866508	availability	C0018748
27866508	people	C0027361
27866508	benefit	C0086387
27866508	services	C0025355
27866508	overcoming	C2983310
27866508	barriers	C3260965
27866508	Factors	C1521761
27866508	sustainment	C0024501
27866508	effective	C1704419
27866508	client	C0008942
27866508	practices	C0034024
27866508	availability	C0470187
27866508	adequate and stable funding	C0243098
27866508	committed leadership	C0023181
27866508	influence	C4054723
27866508	promoting	C0033414
27866508	spread	C0332261
27866508	sustainment	C0024501
27866508	well-implemented evidence-based practices	C1510541
27866508	adoption	C1708476
27866508	fidelity scales	C0680011
27866508	learning	C0023185
27866508	communities	C0009462
27866595	Modifiable	C0392747
27866595	Healthy Lifestyle Behaviors	C4277664
27866595	Health Outcomes	C1550208
27866595	Health Promotion Program	C0018738
27866595	impact of	C4049986
27866595	healthy lifestyle choices	C4277664
27866595	health-related outcomes	C1550208
27866595	fragmented	C1708096
27866595	cross-sectional nature	C0010362
27866595	assessing the relative impact	C1160858
27866595	modifiable	C0392747
27866595	behaviors	C0004927
27866595	long-term	C0443252
27866595	outcomes	C1550208
27866595	working adult population	C1527116
27866595	remains challenging	C0205556
27866595	self-reported	C2700446
27866595	healthy lifestyle behaviors	C4277664
27866595	health outcomes	C1550208
27866595	cohort	C0599755
27866595	participants	C0679646
27866595	voluntary	C0439656
27866595	workplace	C0162579
27866595	wellness program	C0043113
27866595	Cox proportional-hazards models	C0010235
27866595	computed hazard ratios	C2985465
27866595	HRs	C2985465
27866595	lifestyle characteristics	C0023676
27866595	time	C0040223
27866595	self-reported	C2700446
27866595	chronic diseases	C0008679
27866595	death	C0011065
27866595	Data were collected	C4019276
27866595	Behaviors	C0004927
27866595	future outcomes	C0086749
27866595	low-fat diet	C0242970
27866595	aerobic exercise	C0001701
27866595	nonsmoking	C0812017
27866595	adequate sleep	C2364286
27866595	dose-response effect	C4284887
27866595	dietary fat intake	C0425440
27866595	hypertension	C0020538
27866595	obesity	C0028754
27866595	diabetes	C0011847
27866595	heart disease	C0018799
27866595	hypercholesterolemia	C0020443
27866595	dietary fat intake	C0425440
27866595	aerobic exercise	C0001701
27866595	behavior	C0004927
27866595	development of outcomes	C0086750
27866595	sedentary	C0205254
27866595	participants	C0679646
27866595	exercised	C0015259
27866595	new-onset diabetes	C0743128
27866595	HR	C2985465
27866595	CI	C0009667
27866595	heart disease	C0018799
27866595	HR	C2985465
27866595	CI	C0009667
27866595	hypercholesterolemia	C0020443
27866595	HR	C2985465
27866595	CI	C0009667
27866595	Low-fat diet	C0242970
27866595	adequate sleep	C2364286
27866595	healthy behaviors	C4277664
27866595	eating a daily breakfast	C0814440
27866595	Modifiable	C0392747
27866595	lifestyle behaviors	C0023676
27866595	health promotion programs	C0018738
27866595	evidence-based manner	C1510541
27866595	workplace	C0162579
27866595	health promotion	C0018738
27866595	low-fat diet	C0242970
27866595	aerobic exercise	C0001701
27866595	nonsmoking	C0812017
27866595	adequate sleep	C2364286
27867086	Diazoxide	C0012022
27867086	prevents	C1292733
27867086	reactive oxygen species	C0162772
27867086	mitochondrial damage	C1096176
27867086	anti-hypertrophic effects	C0243095
27867086	Pathological	C0205469
27867086	cardiac hypertrophy	C1383860
27867086	characterized	C1880022
27867086	wall	C0446987
27867086	thickening	C0205400
27867086	chamber	C0729936
27867086	enlargement	C0020564
27867086	heart	C0018787
27867086	pressure	C4284008
27867086	volume	C0449468
27867086	condition	C0348080
27867086	improve	C0184511
27867086	organ	C0178784
27867086	contractile function	C1258017
27867086	sustained	C0443318
27867086	dysfunctional	C3887504
27867086	mitochondria	C0026237
27867086	oxidative stress	C0242606
27867086	Mitochondrial ATP-sensitive K(+) channels	C0764439
27867086	mitoKATP	C0764439
27867086	modulate	C0443264
27867086	redox status	C0030012
27867086	cell	C0007634
27867086	protect	C1545588
27867086	cardiac	C0018787
27867086	insults	C1883709
27867086	hypothesis	C1512571
27867086	mitoKATP	C0764439
27867086	opening	C1882151
27867086	diazoxide	C0012022
27867086	isoproterenol	C0022245
27867086	induced	C0205263
27867086	cardiac hypertrophy	C1383860
27867086	in vivo	C1515655
27867086	reactive oxygen species	C0162772
27867086	(ROS	C0162772
27867086	mitochondrial	C0026237
27867086	Ca(2+)	C0596235
27867086	induced	C0205263
27867086	swelling	C0038999
27867086	induce	C0205263
27867086	cardiac hypertrophy	C1383860
27867086	Swiss mice	C0162416
27867086	treated	C1522326
27867086	intraperitoneally	C0442120
27867086	isoproterenol	C0022245
27867086	day	C0439228
27867086	days	C0439228
27867086	Diazoxide	C0012022
27867086	day	C0439228
27867086	mitoKATP	C0764439
27867086	5-hydroxydecanoate	C0098450
27867086	day	C0439228
27867086	mitoKATP	C0764439
27867086	blocker	C0870261
27867086	Isoproterenol	C0022245
27867086	treated	C1522326
27867086	mice	C0025929
27867086	elevated	C3163633
27867086	heart	C0018787
27867086	weight	C0043100
27867086	tibia	C1279118
27867086	length	C1444754
27867086	ratios	C0456603
27867086	increased	C0205217
27867086	myocyte	C0225828
27867086	cross-sectional areas	C0243095
27867086	hypertrophic	C0333959
27867086	hearts	C0018787
27867086	higher	C0205250
27867086	levels	C0441889
27867086	H2O2	C0020281
27867086	glutathione peroxidase activity	C1151528
27867086	mitoKATP	C0764439
27867086	opening	C1882151
27867086	diazoxide	C0012022
27867086	blocked	C0332206
27867086	isoproterenol	C0022245
27867086	effects	C1280500
27867086	reversed	C1555029
27867086	5-hydroxydecanoate	C0098450
27867086	Isolated	C0205409
27867086	mitochondria	C0026237
27867086	Isoproterenol	C0022245
27867086	induced	C0205263
27867086	hypertrophic	C0333959
27867086	hearts	C0018787
27867086	increased	C0205217
27867086	susceptibility	C0231204
27867086	Ca(2+)	C0596235
27867086	induced	C0205263
27867086	swelling	C0038999
27867086	mitochondrial permeability transition pore	C0908146
27867086	opening	C1882151
27867086	MitokATP	C0764439
27867086	opening	C1882151
27867086	Ca(2+)	C0596235
27867086	induced	C0205263
27867086	mitochondrial swelling	C0026244
27867086	effect	C1280500
27867086	blocked	C0332206
27867086	5-hydroxydecanoate	C0098450
27867086	mitoKATP	C0764439
27867086	opening	C1882151
27867086	negatively	C0205160
27867086	regulates	C1327622
27867086	cardiac hypertrophy	C1383860
27867086	oxidative	C0311404
27867086	impairment	C0221099
27867086	mitochondrial damage	C1096176
27871510	Anticholinergic	C0242896
27871510	premedication	C0033045
27871510	bradycardia	C0428977
27871510	spinal anesthesia	C0002928
27871510	dexmedetomidine	C0113293
27871510	sedation	C0344106
27871510	randomized	C0206034
27871510	double-blind	C0013072
27871510	placebo-controlled study	C0599724
27871510	dexmedetomidine	C0113293
27871510	patients	C0030705
27871510	spinal anesthesia	C0002928
27871510	incidence	C0220856
27871510	bradycardia	C0428977
27871510	parasympathetic	C0030510
27871510	activation	C1879547
27871510	effectiveness	C1280519
27871510	atropine	C0004259
27871510	premedication	C0033045
27871510	preventing	C1292733
27871510	incidence	C0220856
27871510	bradycardia	C0428977
27871510	hemodynamic effect	C0019010
27871510	patients	C0030705
27871510	spinal anesthesia	C0002928
27871510	sedation	C0344106
27871510	dexmedetomidine	C0113293
27871510	Randomized	C0206034
27871510	double-blind	C0013072
27871510	placebo-controlled study	C0599724
27871510	Operating room	C0029064
27871510	patients	C0113293
27871510	years	C1510829
27871510	American Society of Anesthesiology class I-II	C0037459
27871510	study	C2603343
27871510	spinal anesthesia	C0002928
27871510	patients	C0113293
27871510	groups	C0681860
27871510	group A	C0681860
27871510	group C	C0681860
27871510	spinal anesthesia	C0002928
27871510	dexmedetomidine	C0113293
27871510	infused	C0574032
27871510	loading dose	C0678767
27871510	minutes	C0439232
27871510	infusion	C0574032
27871510	loading dose	C0678767
27871510	dexmedetomidine	C0113293
27871510	patients	C0113293
27871510	group A	C0681860
27871510	intravenous bolus	C1522229
27871510	atropine	C0004259
27871510	patients	C0113293
27871510	group C	C0681860
27871510	intravenous normal saline	C2064712
27871510	bolus	C1511237
27871510	Data	C1511726
27871510	administration	C1533734
27871510	atropine	C0004259
27871510	ephedrine	C0014479
27871510	Hemodynamic	C4281788
27871510	data	C1511726
27871510	heart rate	C0018810
27871510	systolic blood pressure	C0871470
27871510	diastolic blood pressure	C0428883
27871510	DBP	C0428883
27871510	mean blood pressure	C0428886
27871510	MBP	C0428886
27871510	incidence	C0220856
27871510	bradycardia	C0428977
27871510	atropine	C0004259
27871510	treatment	C0087111
27871510	significantly higher	C4055637
27871510	group C	C0681860
27871510	group A	C0681860
27871510	incidence	C0220856
27871510	hypotension	C0020649
27871510	ephedrine	C0014479
27871510	treatment	C0087111
27871510	no significant difference	C3842396
27871510	groups	C0681860
27871510	Systolic blood pressure	C0871470
27871510	heart rate	C0018810
27871510	no significant differences	C3842396
27871510	groups	C0681860
27871510	group A	C0681860
27871510	increases	C0205217
27871510	DBP	C0428883
27871510	MBP	C0428886
27871510	group C	C0681860
27871510	Prophylactic	C0199176
27871510	atropine	C0004259
27871510	incidence	C0220856
27871510	bradycardia	C0428977
27871510	patients	C0113293
27871510	spinal anesthesia	C0002928
27871510	dexmedetomidine	C0113293
27871510	sedation	C0344106
27871510	DBP	C0428883
27871510	MBP	C0428886
27871510	increases	C0205217
27871510	patients	C0113293
27871510	prophylactic	C0199176
27871510	atropine	C0004259
27871510	administrated	C1533734
27871510	atropine	C0004259
27871510	premedication	C0033045
27871510	administered	C1533734
27872234	Downregulation	C0013081
27872234	Endothelial Transient Receptor Potential Vanilloid Type 4 Channel	C1563722
27872234	Small-Conductance of Ca2+-Activated K+ Channels	C1571638
27872234	Impaired	C0221099
27872234	Endothelium-Dependent Hyperpolarization	C0082428
27872234	Hypertension	C0020538
27872234	Endothelium-dependent hyperpolarization	C0082428
27872234	EDH	C0082428
27872234	responses	C1704632
27872234	impaired	C0221099
27872234	hypertension	C0020538
27872234	mechanisms	C0441712
27872234	activation	C1879547
27872234	small-	C1571638
27872234	intermediate-conductance of Ca(2+)-activated K(+) channels	C1571649
27872234	SKCa	C1571638
27872234	IKCa	C1571649
27872234	EDH	C0082428
27872234	responses	C1704632
27872234	reported	C0684224
27872234	Ca(2+) influx	C3158761
27872234	endothelial transient receptor potential vanilloid type 4 channel	C1563722
27872234	TRPV4	C1563722
27872234	prerequisite	C0679209
27872234	activation	C1879547
27872234	SKCa	C1571638
27872234	IKCa	C1571649
27872234	endothelial cells	C0225336
27872234	attempted	C1516084
27872234	impairment	C0221099
27872234	EDH	C0082428
27872234	hypertension	C0020538
27872234	dysfunction	C3887504
27872234	TRPV4	C1563722
27872234	S	C1571638
27872234	IKCa	C1571649
27872234	superior mesenteric arteries	C0162861
27872234	stroke-prone spontaneously hypertensive rats	C0034705
27872234	SHRSP	C0034705
27872234	Wistar-Kyoto (WKY) rats	C0034709
27872234	WKY	C0034709
27872234	arteries	C0003842
27872234	EDH	C0082428
27872234	responses	C1704632
27872234	reduced	C0392756
27872234	combination	C0205195
27872234	SKCa	C1571638
27872234	IKCa	C1571649
27872234	blockers	C0870261
27872234	apamin	C0003521
27872234	TRAM-34	C0916207
27872234	1-[(2-chlorophenyl)diphenylmethl]-1H-pyrazole	C0916207
27872234	blockade	C0332206
27872234	TRPV4	C1563722
27872234	antagonist	C0243076
27872234	RN-1734	C2744078
27872234	HC-067047	C3493142
27872234	SHRSP	C0034705
27872234	arteries	C0003842
27872234	EDH-mediated hyperpolarization	C0082428
27872234	relaxation	C0035028
27872234	significantly	C0750502
27872234	impaired	C0221099
27872234	WKY	C0034709
27872234	GSK1016790A	C2604031
27872234	TRPV4	C1563722
27872234	activator	C0243192
27872234	hyperpolarization	C2262820
27872234	relaxation	C0035028
27872234	WKY	C0034709
27872234	arteries	C0003842
27872234	SHRSP	C0034705
27872234	arteries	C0003842
27872234	GSK1016790A	C2604031
27872234	hyperpolarization	C2262820
27872234	relaxation	C0035028
27872234	absent	C0332197
27872234	Hyperpolarization	C2262820
27872234	relaxation	C0035028
27872234	cyclohexyl-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-pyrimidin-4-yl]-amine	C2976731
27872234	SKCa	C1571638
27872234	activator	C0243192
27872234	marginally	C1947914
27872234	decreased	C0205216
27872234	SHRSP	C0034705
27872234	arteries	C0003842
27872234	WKY	C0034709
27872234	arteries	C0003842
27872234	expression	C1171362
27872234	endothelial TRPV4	C1563722
27872234	SKCa	C1571638
27872234	significantly decreased	C4055638
27872234	SHRSP	C0034705
27872234	mesenteric arteries	C0162861
27872234	WKY	C0034709
27872234	function	C0542341
27872234	expression	C1171362
27872234	IKCa	C1571649
27872234	SHRSP	C0034705
27872234	arteries	C0003842
27872234	findings	C0243095
27872234	EDH	C0082428
27872234	responses	C1704632
27872234	impaired	C0221099
27872234	superior mesenteric arteries	C0162861
27872234	SHRSP	C0034705
27872234	reduction	C0441610
27872234	TRPV4	C1563722
27872234	SKCa	C1571638
27872234	input	C1708517
27872234	EDH	C0082428
27873109	Bioavailability	C1706947
27873109	health risk assessment	C0679809
27873109	potentially	C3245505
27873109	toxic elements	C0032346
27873109	Thriasio Plain, near Athens	C0017446
27873109	Greece	C0018226
27873109	concentrations	C1446561
27873109	potentially	C3245505
27873109	toxic elements	C0032346
27873109	PTEs	C0032346
27873109	areas of intense industrial activity	C3846701
27873109	Thriasio Plain	C0017446
27873109	plain near Athens	C0017446
27873109	Greece	C0018226
27873109	heavy industry	C0524640
27873109	residential	C0442506
27873109	horticultural	C4300640
27873109	area	C0205146
27873109	PTEs	C0032346
27873109	soils	C0037592
27873109	soils	C0037592
27873109	indigenous	C0302891
27873109	plant species	C0032098
27873109	assessing the health risk	C0679809
27873109	associated with	C0332281
27873109	soil	C0037592
27873109	ingestion	C0232478
27873109	Samples of soils	C3687777
27873109	roadsides	C0442650
27873109	plants	C0032098
27873109	area	C0205146
27873109	Concentrations	C1446561
27873109	Al	C0002367
27873109	As	C0003818
27873109	Cd	C0006632
27873109	Co	C0009148
27873109	Cr	C0008574
27873109	Cu	C0009968
27873109	Fe	C0302583
27873109	Mn	C0024706
27873109	Mo	C0026402
27873109	Ni	C0028013
27873109	Pb	C0023175
27873109	V	C0042306
27873109	Zn	C0043481
27873109	soils	C0037592
27873109	plant tissues	C1514137
27873109	As	C0003818
27873109	Cd	C0006632
27873109	Cr	C0008574
27873109	Cu	C0009968
27873109	Ni	C0028013
27873109	Pb	C0023175
27873109	Zn	C0043481
27873109	regulatory	C0220905
27873109	limits	C1549649
27873109	Element	C0013879
27873109	concentrations	C1446561
27873109	plants	C0032098
27873109	indigenous	C0302891
27873109	plants	C0032098
27873109	excluder	C0332196
27873109	Copper	C0009968
27873109	Zn	C0043481
27873109	soil	C0037592
27873109	plant	C0032098
27873109	coefficients	C1707429
27873109	elements	C0013879
27873109	Cu	C0009968
27873109	associated with	C0332281
27873109	Cu	C0009968
27873109	releasing	C0391871
27873109	industrial	C0021267
27873109	activity	C0441655
27873109	Risk assessment analysis	C0086930
27873109	As	C0003818
27873109	element	C0013879
27873109	health	C0018684
27873109	risk	C0035647
27873109	soil	C0037592
27873109	ingestion	C0232478
27873109	Cr	C0008574
27873109	Pb	C0023175
27873109	Mn	C0024706
27873109	multi	C0439064
27873109	element	C0013879
27873109	contamination	C0259846
27873109	PTEs	C0032346
27873109	As	C0003818
27873109	Cr	C0008574
27873109	Pb	C0023175
27873109	tolerance	C1704410
27873109	limits	C0439801
27873109	exposure to	C0332157
27873109	toxic elements	C0032346
27873109	Mn	C0024706
27875010	Nutrients	C0678695
27875010	thermal ecophysiology	C1254359
27875010	intertidal	C1254362
27875010	macroalga	C0036500
27875010	multiple stressors	C0597530
27875010	multiple drivers	C1254370
27875010	Urbanization	C0041938
27875010	coastlines	C0681784
27875010	nutrients	C0678695
27875010	terrestrial environment	C0014406
27875010	nearshore habitats	C0871648
27875010	nutrient	C0678695
27875010	coastal	C0681784
27875010	marine organisms	C0599383
27875010	eutrophication	C0015191
27875010	reduced	C0392756
27875010	oxygen	C0030054
27875010	positive effects	C1280500
27875010	food	C0016452
27875010	availability	C0470187
27875010	species	C1705920
27875010	nitrogen-limited	C0028158
27875010	macroalgae	C0036500
27875010	Nutrient	C0678695
27875010	enrichment	C1254366
27875010	environment	C0014406
27875010	potential	C3245505
27875010	negative impacts	C4049986
27875010	increasing	C0442808
27875010	temperatures	C0039476
27875010	species	C1705920
27875010	physiological response	C1254359
27875010	organisms	C0029235
27875010	simultaneous	C0205420
27875010	changes	C0392747
27875010	multiple drivers	C1254370
27875010	global	C2348867
27875010	climate change	C2718051
27875010	ecological	C0162358
27875010	responses	C0871261
27875010	local levels	C0683925
27875010	nutrient	C0678695
27875010	enrichment	C1254366
27875010	nitrogen	C0028158
27875010	availability	C0470187
27875010	growth	C0018270
27875010	Fucus vesiculosus	C1083174
27875010	macroalgal	C0036500
27875010	species	C0036500
27875010	North Atlantic rocky intertidal zone	C0004166
27875010	nutrient	C0678695
27875010	algal blades	C2698828
27875010	tissue growth	C1621966
27875010	individuals	C0441833
27875010	ambient	C1879688
27875010	photosynthesis	C0031764
27875010	nutrient	C0678695
27875010	tissues	C1514137
27875010	saturating irradiance	C1282930
27875010	temperature	C0039476
27875010	Respiration	C0035203
27875010	nutrient	C0678695
27875010	treatment	C1522326
27875010	photosynthetic	C0031764
27875010	oxygen	C0030054
27875010	nutrient	C0678695
27875010	tissue	C1514137
27875010	ambient	C1879688
27875010	elevated	C3163633
27875010	temperatures	C0039476
27875010	study	C2603343
27875010	literature	C0023866
27875010	responses to changes	C0871261
27875010	multiple drivers	C1254370
27875010	studying	C2603343
27875010	impacts	C0282165
27875010	global	C2348867
27875010	climate change	C2718051
27875010	environmental	C0014406
27875010	conditions	C0348080
27876084	trial	C0008976
27876084	septic shock	C0036983
27876084	reversal	C0443290
27876084	quicker	C0456962
27876084	pediatric	C1521725
27876084	patients	C0030705
27876084	randomized	C0034656
27876084	early	C1279919
27876084	goal-directed fluid-sparing strategy	C1271494
27876084	usual care	C0511425
27876084	SQUEEZE	C0008976
27876084	study protocol	C2348563
27876084	pilot randomized controlled trial	C0206035
27876084	Current	C0521116
27876084	pediatric	C1521725
27876084	septic shock	C0036983
27876084	resuscitation	C0035273
27876084	guidelines	C0162791
27876084	American College of Critical Care Medicine	C1708333
27876084	early	C1279919
27876084	goal-directed administration	C1271494
27876084	intravascular	C0442123
27876084	fluid	C0005889
27876084	vasoactive	C1980011
27876084	medication	C0013227
27876084	infusions	C0574032
27876084	persistent	C0205322
27876084	fluid-refractory shock	C0349412
27876084	accumulating	C4055506
27876084	adult	C0001675
27876084	pediatric	C1521725
27876084	data	C1511726
27876084	excessive	C0442802
27876084	fluid administration	C0522792
27876084	worse	C1457868
27876084	patient	C0030705
27876084	outcomes	C1274040
27876084	increased risk of death	C2749787
27876084	optimal amount	C1265611
27876084	intravascular	C0442123
27876084	fluid	C0005889
27876084	early	C1279919
27876084	pediatric	C1521725
27876084	septic shock	C0036983
27876084	resuscitation	C0035273
27876084	initiation	C1704686
27876084	vasoactive support	C1980011
27876084	SQUEEZE Pilot Trial	C0008976
27876084	pragmatic	C0871858
27876084	two-arm	C0242481
27876084	parallel-group	C2826345
27876084	open-label	C1709323
27876084	prospective pilot randomized controlled trial	C0206035
27876084	Participants	C0679646
27876084	children	C0008059
27876084	aged	C0001779
27876084	days	C0439228
27876084	years	C0439234
27876084	suspected	C0750491
27876084	confirmed	C0750484
27876084	septic shock	C0036983
27876084	resuscitation	C0035273
27876084	participants	C0679646
27876084	enrolled	C1516879
27876084	exception	C1705847
27876084	consent	C1511481
27876084	process	C1522240
27876084	randomly	C0439605
27876084	assigned	C1516050
27876084	concealed	C0443189
27876084	allocation	C1706778
27876084	Usual Care	C0511425
27876084	control	C0009932
27876084	Fluid Sparing (intervention) resuscitation strategy	C0035273
27876084	primary	C0205225
27876084	objective	C0018017
27876084	pilot trial	C0008976
27876084	feasibility	C0015730
27876084	enroll	C1516879
27876084	participants	C0679646
27876084	study protocol	C2348563
27876084	primary outcome measure	C3274433
27876084	success	C0679864
27876084	participant	C0679646
27876084	enrollment	C1516879
27876084	rate	C1521828
27876084	participants	C0679646
27876084	site	C0205145
27876084	month	C0439231
27876084	enrollment	C1516879
27876084	objectives	C0018017
27876084	appropriateness	C0814634
27876084	eligibility criteria	C1516637
27876084	completeness	C0439812
27876084	clinical outcomes	C1274040
27876084	endpoints	C2349179
27876084	planned	C1301732
27876084	multisite trial	C0206012
27876084	nested translational study	C0008972
27876084	SQUEEZE-D	C0008972
27876084	feasibility	C0015730
27876084	cell-free DNA	C4289789
27876084	procoagulant molecule	C1292267
27876084	prognostic utility	C0220901
27876084	blood samples	C0178913
27876084	children	C0008059
27876084	enrolled	C1516879
27876084	SQUEEZE Pilot Trial	C0008976
27876084	baseline	C1442488
27876084	degree	C0449286
27876084	fluid	C0005889
27876084	resuscitation	C0035273
27876084	timing	C0449243
27876084	initiation	C1704686
27876084	vasoactive support	C1980011
27876084	therapeutic	C0302350
27876084	targets	C1521840
27876084	children	C0008059
27876084	septic shock	C0036983
27876084	prospective study	C0033522
27876084	date	C0011008
27876084	question	C1522634
27876084	children	C0008059
27876084	developed countries	C0282613
27876084	Canada	C0006823
27876084	Recruitment	C2949735
27876084	SQUEEZE Pilot Trial	C0008976
27876084	opened	C3483819
27876084	Findings	C0243095
27876084	feasibility	C0015730
27876084	planned	C1301732
27876084	multicenter trial	C0206012
27876084	overall	C1561607
27876084	research question	C0681799
27876145	Entropy-driven reactions	C0443286
27876145	living	C0376558
27876145	cells	C0007634
27876145	assay	C1510438
27876145	let-7a microRNA	C1101610
27876145	Imaging	C0079595
27876145	microRNA	C1101610
27876145	miRNA	C1101610
27876145	living	C0376558
27876145	cells	C0007634
27876145	monitoring	C0005517
27876145	expression	C0017262
27876145	distribution	C1704711
27876145	miRNA	C1101610
27876145	research	C0035168
27876145	miRNA	C1101610
27876145	diseases	C0012634
27876145	expression levels	C3244092
27876145	down-regulation	C0013081
27876145	cellular	C0007634
27876145	miRNA	C1101610
27876145	associated with	C0332281
27876145	diseases	C0012634
27876145	enzyme	C0014442
27876145	free	C0332296
27876145	amplification strategies	C0887815
27876145	intracellular	C0178719
27876145	miRNA	C1101610
27876145	assay	C1510438
27876145	entropy-driven reaction	C0443286
27876145	amplification	C0887815
27876145	assay	C1510438
27876145	miRNA	C1101610
27876145	detection limit	C2718050
27876145	signal	C1710082
27876145	amplification	C1521871
27876145	signal	C1710082
27876145	enhancement	C2349975
27876145	specific	C0205369
27876145	miRNA	C1101610
27876145	living	C0376558
27876145	cells	C0007634
27876145	accurate	C0443131
27876145	information	C1533716
27876145	cellular	C0007634
27876145	miRNA	C1101610
27876145	biological events	C3714634
27876145	highly sensitive	C0439822
27876145	simultaneous	C0521115
27876145	imaging	C0079595
27876145	multiple	C0439064
27876145	biomarkers	C0005516
27876145	accuracy	C0598285
27876145	early disease diagnosis	C0596473
27878205	Iterative	C1854293
27878205	Development	C1527148
27878205	Evaluation	C0220825
27878205	Pharmacogenomic	C1138555
27878205	Clinical Decision Support System	C0525070
27878205	Warfarin Dosing	C0366686
27878205	Pharmacogenomic	C1138555
27878205	dosing	C0178602
27878205	patient	C0030705
27878205	implementation	C1708476
27878205	clinical	C0205210
27878205	challenges	C0805586
27878205	evaluate	C0220825
27878205	clinical decision support system	C0525070
27878205	CDSS	C0525070
27878205	pharmacogenomic	C1138555
27878205	warfarin dosing	C0366686
27878205	designed	C1707689
27878205	physicians	C0031831
27878205	pharmacists	C0031323
27878205	physicians	C0031831
27878205	pharmacists	C0031323
27878205	prescribing	C0278329
27878205	tasks	C3540678
27878205	simulated patient	C3825675
27878205	scenarios	C0683579
27878205	iterations	C1854293
27878205	development	C1527148
27878205	validation	C1519941
27878205	phases	C0205390
27878205	pharmacogenomic	C1138555
27878205	CDSS	C0525070
27878205	prototype	C0205556
27878205	scenario	C0683579
27878205	usability	C1510648
27878205	measured	C0444706
27878205	efficiency	C0013682
27878205	recorded	C0034869
27878205	time to task completion	C1316026
27878205	participants	C0679646
27878205	perceived	C0030971
27878205	satisfaction	C0242428
27878205	Kruskal-Wallis and Mann Whitney U tests	C0282574
27878205	qualitatively analyzed	C0022885
27878205	Usability	C1510648
27878205	development	C1527148
27878205	iteration	C1854293
27878205	CDSS	C0525070
27878205	design	C1707689
27878205	second	C0457385
27878205	validation	C1519941
27878205	iteration	C1854293
27878205	CDSS	C0525070
27878205	validation	C1519941
27878205	iteration	C1854293
27878205	participants	C0679646
27878205	time to complete tasks	C1316026
27878205	median	C0549183
27878205	seconds	C0457385
27878205	seconds	C0457385
27878205	development	C1527148
27878205	iteration	C1854293
27878205	increase	C0442805
27878205	time on task	C0871530
27878205	increase	C0442805
27878205	time	C0040223
27878205	CDSS	C0525070
27878205	design	C1707689
27878205	Efficiency	C0013682
27878205	pharmacists	C0031323
27878205	physicians	C0031831
27878205	development	C1527148
27878205	iteration	C1854293
27878205	validation	C1519941
27878205	iteration	C1854293
27878205	increased	C0205217
27878205	CDSS	C0525070
27878205	CDSS	C0525070
27878205	doses	C0178602
27878205	validation	C1519941
27878205	iteration	C1854293
27878205	iteration	C1854293
27878205	second	C0457385
27878205	iteration	C1854293
27878205	satisfaction	C0242428
27878205	iterations	C1854293
27878205	qualitative analysis	C0022885
27878205	second	C0457385
27878205	prototype	C0205556
27878205	pharmacogenomic	C1138555
27878205	CDSS	C0525070
27878205	warfarin	C0043031
27878205	drug	C1254351
27878205	CDSS	C0525070
27878205	prototype	C0205556
27878205	increased	C0205217
27878205	time	C0040223
27878205	tool	C0871532
27878205	doses	C0178602
27878205	pharmacogenomics	C1138555
27878205	CDSS	C0525070
27878205	design	C1707689
27878205	clinical testing	C1516634
27879507	Pedicle Screw	C1961768
27879507	Combined	C0205195
27879507	Lateral Mass Screw	C0005975
27879507	Fixation	C0185023
27879507	Treatment	C0087111
27879507	Basilar Invagination	C3887851
27879507	Congenital C2-C3 Fusion	C0022738
27879507	Clinical evaluation	C4084924
27879507	surgical	C0543467
27879507	fixation	C0185023
27879507	technique	C0449851
27879507	combined	C0205195
27879507	pedicle screw	C1961768
27879507	lateral mass screw	C0005975
27879507	LMS	C0005975
27879507	technique	C0449851
27879507	treatment	C0087111
27879507	congenital C2-C3 fusion	C0022738
27879507	basilar invagination	C3887851
27879507	BI	C3887851
27879507	Posterior	C0205095
27879507	occipitocervical	C0027530
27879507	fixation	C0185023
27879507	C2 pedicle screw	C1961768
27879507	BI	C3887851
27879507	cases	C0868928
27879507	BI	C3887851
27879507	concurrent	C0205420
27879507	congenital C2-C3 fusion	C0022738
27879507	C2 pedicles	C0456605
27879507	thinner	C0205168
27879507	normal	C0205307
27879507	population	C1257890
27879507	fail	C0231175
27879507	issue	C0033213
27879507	combining	C0205195
27879507	pedicle screw	C1961768
27879507	LMS	C0005975
27879507	strengthen	C0808080
27879507	fixation	C0185023
27879507	patients	C0030705
27879507	combined	C0205195
27879507	pedicle screw	C1961768
27879507	LMS	C0005975
27879507	fixation	C0185023
27879507	retrospectively studied	C0035363
27879507	instrument	C0348000
27879507	position	C0733755
27879507	fusion	C0699952
27879507	status	C0449438
27879507	complications	C0009566
27879507	analyzed	C0936012
27879507	spinal cord	C0037929
27879507	vertebral artery injury	C0433912
27879507	follow-up	C1522577
27879507	time	C0040223
27879507	months	C0439231
27879507	fusion	C0699952
27879507	patients	C0030705
27879507	radiologically	C0043299
27879507	cases	C0868928
27879507	recurred	C0034897
27879507	BI	C3887851
27879507	instrument	C0348000
27879507	failure	C0162643
27879507	fusion	C0699952
27879507	occiput	C0230005
27879507	C2	C0456605
27879507	revision	C0558347
27879507	patients	C0030705
27879507	complications	C0009566
27879507	instrument	C0348000
27879507	failure	C0162643
27879507	cerebrospinal fluid leakage	C0023182
27879507	intracranial	C0524466
27879507	infection	C3714514
27879507	clinical	C0205210
27879507	outcome	C1274040
27879507	technique	C0449851
27879507	treatment	C0087111
27879507	BI	C3887851
27879507	congenital C2-C3 fusion	C0022738
27881529	Co-occurrence	C2745955
27881529	clustering	C0012641
27881529	health	C0018684
27881529	conditions	C0348080
27881529	age	C0001779
27881529	cross-sectional	C0010362
27881529	findings	C2607943
27881529	Millennium Cohort Study	C0009247
27881529	co-occurrence	C2745955
27881529	clustering	C0012641
27881529	adverse	C0877248
27881529	health	C0018684
27881529	conditions	C0348080
27881529	year	C1510829
27881529	children	C0008059
27881529	differences	C1705242
27881529	sociodemographic factors	C0011292
27881529	prospective cohort study	C1709709
27881529	Children	C0008059
27881529	UK	C0041700
27881529	year	C1510829
27881529	singleton	C1313913
27881529	children	C0008059
27881529	data	C1511726
27881529	health	C0018684
27881529	conditions	C0348080
27881529	sociodemographic information	C1533716
27881529	complete	C0205197
27881529	cases	C0868928
27881529	Prevalence	C0220900
27881529	co-occurrence	C2745955
27881529	clustering	C0012641
27881529	health	C0018684
27881529	conditions	C0348080
27881529	wheeze	C0043144
27881529	eczema	C0013595
27881529	long-standing illness	C0221423
27881529	wheeze	C0043144
27881529	eczema	C0013595
27881529	injury	C3263723
27881529	socioemotional difficulties	C0013985
27881529	Strengths and Difficulties Questionnaire	C3472494
27881529	unfavourable weight	C0005910
27881529	thin	C0041667
27881529	overweight	C0497406
27881529	obese	C0028754
27881529	normal	C0005910
27881529	children	C0008059
27881529	adverse	C0877248
27881529	health	C0018684
27881529	conditions	C0348080
27881529	co-occurrence	C2745955
27881529	Co-occurrence	C2745955
27881529	boys	C0870221
27881529	children	C0008059
27881529	income	C0021162
27881529	households	C0020052
27881529	Latent class analysis	C0936012
27881529	classes	C0456387
27881529	normative	C0205307
27881529	atopic	C0392707
27881529	burdened	C2828008
27881529	socioemotional burdened	C0013985
27881529	unfavourable weight	C0005910
27881529	injury	C3263723
27881529	eczema	C0013595
27881529	injury	C3263723
27881529	eczema	C0013595
27881529	unfavourable weight	C0005910
27881529	co-occurrence	C2745955
27881529	class	C0456387
27881529	membership	C0680038
27881529	sociodemographic factors	C0011292
27881529	boys	C0870221
27881529	children	C0008059
27881529	mothers	C0026591
27881529	educational attainment	C0013658
27881529	children	C0008059
27881529	income	C0021162
27881529	households	C0020052
27881529	socioemotional burdened	C0013985
27881529	class	C0456387
27881529	Children	C0008059
27881529	mothers	C0026591
27881529	educational attainment	C0013658
27881529	normative	C0205307
27881529	eczema	C0013595
27881529	unfavourable weight	C0005910
27881529	classes	C0456387
27881529	Co-occurrence	C2745955
27881529	adverse	C0877248
27881529	health	C0018684
27881529	conditions	C0348080
27881529	age	C0001779
27881529	associated with	C0332281
27881529	adverse	C0877248
27881529	socioeconomic	C0748878
27881529	circumstances	C1254372
27881529	Holistic	C0019844
27881529	child	C0008059
27881529	care	C1947933
27881529	boys	C0870221
27881529	income	C0021162
27881529	groups	C0441833
27881529	prevent	C2700409
27881529	reduce	C0392756
27881529	co-occurrence	C2745955
27881529	later	C0205087
27881529	childhood	C0231335
27881529	adolescence	C0001578
27882444	Genomic	C0017428
27882444	characterization	C1880022
27882444	wild-bird	C0325328
27882444	origin	C0243095
27882444	pigeon	C0325912
27882444	paramyxovirus type 1	C0027984
27882444	PPMV-1	C0027984
27882444	isolated	C0205409
27882444	northwest region of China	C0008115
27882444	Pigeon	C0325912
27882444	paramyxovirus type-1	C0027984
27882444	PPMV-1	C0027984
27882444	enzootic	C0598394
27882444	pigeon	C0325912
27882444	flocks	C1633987
27882444	severe	C0205082
27882444	economic losses	C0681022
27882444	poultry	C0032850
27882444	industry	C0021267
27882444	countries	C0454664
27882444	PPMV-1	C0027984
27882444	isolate	C1764827
27882444	PPMV-1/QL-01/CH/15	C0027984
27882444	isolated	C0205409
27882444	woodpecker	C0326243
27882444	northwest region of China	C0008115
27882444	genome	C0017428
27882444	sequenced	C3854164
27882444	results	C1274040
27882444	virus	C0042776
27882444	genome	C0017428
27882444	length	C1444754
27882444	gene arrangement 3'-NP-P-M-F-HN-L-5'	C0887940
27882444	amino acid	C0002520
27882444	mutations	C0026882
27882444	identified	C0205396
27882444	functional domains	C1514562
27882444	F	C0162768
27882444	HN proteins	C0019822
27882444	pathogenicity index	C1136169
27882444	isolate	C1764827
27882444	evaluated	C0220825
27882444	mean death time	C1301931
27882444	MDT	C1301931
27882444	intracerebral pathogenicity index	C1136169
27882444	ICPI	C1136169
27882444	isolate	C1764827
27882444	mesogenic	C0205556
27882444	Sequencing	C1294197
27882444	results	C1274040
27882444	virulent	C1520022
27882444	Newcastle disease virus	C0027984
27882444	cleavage motif (112)R-R-Q-K-R-F(117)	C0002518
27882444	fusion protein	C0162768
27882444	cleavage site	C0002518
27882444	Morbidity	C0026538
27882444	mortality	C0205848
27882444	inoculation	C2987620
27882444	pigeons	C0325912
27882444	virus	C0042776
27882444	nonpathogenic	C0243095
27882444	chickens	C0008051
27882444	immune responses	C0301872
27882444	pigeons	C0325912
27882444	chickens	C0008051
27882444	induced	C0205263
27882444	in vivo	C1515655
27882444	HI serum antibody titers	C2229730
27882444	results	C1274040
27882444	phylogenetic	C1519068
27882444	evolutionary distance analysis	C0936012
27882444	PPMV-1	C0027984
27882444	strain	C1518614
27882444	sub-genotype VIa	C0441756
27882444	class II	C0441886
27882444	identification	C0599616
27882444	analysis	C0936012
27882444	PPMV-1	C0027984
27882444	co-circulation	C0237318
27882444	wild birds	C0325328
27882444	domestic pigeon	C0999232
27882444	flocks	C1633987
27882444	China	C0008115
27882444	data	C1511726
27882444	study	C2603343
27882444	wild birds	C0325328
27882444	dissemination	C0205221
27882444	PPMV-1	C0027984
27882444	references	C1514811
27882444	improving	C1272745
27882444	distribution	C0037775
27882444	evolution	C0015219
27882444	PPMV-1	C0027984
27882444	China	C0008115
27882455	Memory consolidation	C0679057
27882455	effects	C1280500
27882455	memory stabilization	C0025361
27882455	item integration	C0025361
27882455	older adults	C0001792
27882455	study	C2603343
27882455	differential effects	C1274040
27882455	aging	C0001811
27882455	consolidation processes	C0679057
27882455	memory traces	C0870873
27882455	memory stabilization	C0025361
27882455	consolidation processes	C0679057
27882455	integrating	C0025361
27882455	memory traces	C0870873
27882455	knowledge	C0376554
27882455	item integration	C0025361
27882455	Older adults	C0001792
27882455	learned	C0023185
27882455	nonwords	C0282574
27882455	memory	C0025260
27882455	nonwords	C0282574
27882455	nonwords	C0282574
27882455	English	C0376245
27882455	words	C0282574
27882455	hours	C0439227
27882455	Participants	C0679646
27882455	nonwords	C0282574
27882455	recognition	C0524637
27882455	recall	C0034770
27882455	nonwords	C0282574
27882455	processing	C1709694
27882455	similar-sounding words	C0282574
27882455	delayed test	C0451414
27882455	memory consolidation processes	C0679057
27882455	item integration	C0025361
27882455	memory stabilization processes	C0025361
27882455	memories	C0025260
27882455	older adults	C0001792
27883264	Mucosa	C0026727
27883264	associated	C0332281
27883264	biohydrogenating microbes	C0445623
27883264	colon	C3888384
27883264	microbiome	C1956108
27883264	stress	C0038435
27883264	associated with	C0332281
27883264	high concentrations	C1446561
27883264	poly-unsaturated fat	C2362518
27883264	Polyunsaturated fatty acids	C0032615
27883264	PUFAs	C0032615
27883264	colon	C3888384
27883264	microbiome	C1956108
27883264	homeostasis	C0019868
27883264	exerting	C0015264
27883264	specific	C0205369
27883264	antimicrobial	C0003232
27883264	effects	C1280500
27883264	mucosal	C0026727
27883264	biofilm	C1561572
27883264	formation	C1522492
27883264	gut mucosal interface	C0836209
27883264	standardized batch incubations	C1439852
27883264	Mucosal-Simulator of the Human Microbial Intestinal Ecosystem	C0282574
27883264	M-SHIME	C0282574
27883264	in vitro	C1533691
27883264	luminal	C0524461
27883264	mucosal	C0026727
27883264	effects of	C1704420
27883264	PUFA	C0032615
27883264	Western diet	C3849996
27883264	linoleic acid	C0023749
27883264	LA	C0023749
27883264	High concentrations	C1446561
27883264	LA	C0023749
27883264	decrease	C0547047
27883264	butyrate	C0006521
27883264	production	C0205245
27883264	Faecalibacterium prausnitzii	C0317558
27883264	LA	C0023749
27883264	biohydrogenation	C0020286
27883264	vaccenic acid	C0301702
27883264	VA	C0301702
27883264	stearic acid	C0038229
27883264	SA	C0038229
27883264	faecal	C0015733
27883264	batch incubations	C1439852
27883264	LA	C0023749
27883264	biohydrogenation	C0020286
27883264	butyrate	C0006521
27883264	production	C0205245
27883264	positively correlated	C1707520
27883264	SA	C0038229
27883264	inhibit	C3463820
27883264	butyrate	C0006521
27883264	production	C0205245
27883264	M-SHIME	C0282574
27883264	mucosal	C0026727
27883264	environment	C0014406
27883264	stimulated	C1948023
27883264	biohydrogenation	C0020286
27883264	SA	C0038229
27883264	F. prausnitzii	C0317558
27883264	inhibition	C3463820
27883264	LA	C0023749
27883264	preference	C0558295
27883264	biohydrogenating	C0020286
27883264	genera	C1708235
27883264	Roseburia	C0995401
27883264	Pseudobutyrivibrio	C1012458
27883264	mucosal	C0026727
27883264	Co-culture	C0282547
27883264	batch incubations	C1439852
27883264	Roseburia hominis	C1667633
27883264	F. prausnitzii	C0317558
27883264	validated	C1519941
27883264	observations	C0302523
27883264	Correlations	C1707520
27883264	networks	C1882071
27883264	Roseburia	C0995401
27883264	Pseudobutyrivibrio	C1012458
27883264	luminal	C0524461
27883264	mucosal SHIME microbiota	C3496041
27883264	LA	C0023749
27883264	induced stress	C0038435
27883264	results	C1274040
27883264	cross-shielding interactions	C1704675
27883264	microbiome	C1956108
27883264	importance	C3898777
27883264	biohydrogenating	C0020286
27883264	mucosal	C0026727
27883264	bacteria	C0004611
27883264	recovery	C0237820
27883264	LA	C0023749
27883264	stress	C0038435
27884439	Genetic	C0314603
27884439	parameters	C0449381
27884439	tick count	C0750480
27884439	udder	C0242386
27884439	health	C0018684
27884439	commercial	C0680536
27884439	indigenous	C1512704
27884439	ewes	C0699762
27884439	South Africa	C0037712
27884439	genetics	C0314603
27884439	tick infestation	C0040196
27884439	sheep	C0036945
27884439	host resistance	C4281815
27884439	pest control programs	C0031249
27884439	udder	C0242386
27884439	health scores	C1550208
27884439	site-specific	C0449604
27884439	tick count	C0750480
27884439	mating	C1260875
27884439	weight	C0043100
27884439	reproduction	C0035150
27884439	records	C0034869
27884439	ewes	C0699762
27884439	indigenous	C1512704
27884439	Namaqua Afrikaner	C1269178
27884439	NA	C1269178
27884439	fat-tailed breed	C1704650
27884439	commercial	C0680536
27884439	Dorper	C1296152
27884439	SA Mutton Merino (SAMM) breeds	C1269346
27884439	Udder	C0242386
27884439	scored	C0449820
27884439	udder	C0242386
27884439	intact	C0205266
27884439	udder	C0242386
27884439	damaged severely	C0010957
27884439	ticks	C0040196
27884439	counted	C0750480
27884439	three locations	C1545955
27884439	body sites	C1545955
27884439	counted	C0750480
27884439	head and thoracic limb	C0229962
27884439	HTLTC	C0229962
27884439	udder-pelvic limb	C1268092
27884439	UPLTC	C1268092
27884439	perineum-breech-tail	C0039259
27884439	PBTTC	C0039259
27884439	counts	C0750480
27884439	total tick count	C0750480
27884439	TTC	C0750480
27884439	Reproduction	C0035150
27884439	traits	C0599883
27884439	lambs	C1123019
27884439	weaned	C0043084
27884439	ewe lambed	C0243095
27884439	lamb weaned	C0043084
27884439	ewe lambed	C0243095
27884439	Udder	C0242386
27884439	health scores	C1550208
27884439	NA	C1269178
27884439	ewes	C0699762
27884439	Dorpers	C1296152
27884439	SAMM	C1269346
27884439	ewes	C0699762
27884439	NA	C1269178
27884439	ewes	C0699762
27884439	HTLTC	C0229962
27884439	UPLTC	C1268092
27884439	TTC	C0750480
27884439	commercial	C0680536
27884439	breeds	C1704650
27884439	PBTTC	C0039259
27884439	Dorpers	C1296152
27884439	Heritability	C4062865
27884439	estimates	C0750572
27884439	HTLTC	C0229962
27884439	UPLTC	C1268092
27884439	PBTTC	C0039259
27884439	TTC	C0750480
27884439	udder	C0242386
27884439	health score	C1550208
27884439	Animal permanent environment	C0871648
27884439	PBTTC	C0039259
27884439	Significant genetic correlations	C0678931
27884439	HTLTC	C0229962
27884439	UPLTC	C1268092
27884439	UPLTC	C1268092
27884439	udder	C0242386
27884439	health score	C1550208
27884439	HTLTC	C0229962
27884439	UPLTC	C1268092
27884439	UPLTC	C1268092
27884439	PBTTC	C0039259
27884439	ewes	C0699762
27884439	UPLTC	C1268092
27884439	TTC	C0750480
27884439	impaired	C0221099
27884439	udder	C0242386
27884439	health	C0018684
27884439	Udder	C0242386
27884439	health score	C1550208
27884439	tick counts	C0750480
27884439	reproduction	C0035150
27884439	traits	C0599883
27884439	indigenous	C1512704
27884439	NA	C1269178
27884439	breed	C1704650
27884439	commercial	C0680536
27884439	breeds	C1704650
27884439	HTLTC	C0229962
27884439	UPLTC	C1268092
27884439	TTC	C0750480
27884439	udder	C0242386
27884439	health score	C1550208
27884439	NA	C1269178
27884439	breed	C1704650
27884439	pastoral conditions	C0030643
27884439	tick	C0040196
27884439	tolerance	C1704410
27884439	breeds	C1704650
27886280	Starvation	C0038187
27886280	antibiotics	C0003232
27886280	formation	C0007613
27886280	persister cells	C0563199
27886280	Pseudomonas aeruginosa	C0033809
27886280	Planktonic	C0032071
27886280	stationary and exponential cultures	C0430402
27886280	Pseudomonas aeruginosa	C0033809
27886280	highly resistant	C0332325
27886280	killing	C1306577
27886280	bactericidal antimicrobials	C0003232
27886280	persisters	C0563199
27886280	cells	C0563199
27886280	multidrug tolerant	C0013220
27886280	recalcitrance	C0205245
27886280	biofilm	C0081786
27886280	infections	C3714514
27886280	study	C0085973
27886280	investigate	C1292732
27886280	formation	C0007613
27886280	persister cells	C0563199
27886280	P. aeruginosa	C0033809
27886280	stationary	C0430402
27886280	exponential cultures	C0430402
27886280	different	C1705242
27886280	class	C0456387
27886280	antimicrobials	C0003232
27886280	susceptibilities	C1264642
27886280	P. aeruginosa PAO1 wild-type	C0033809
27886280	mutant strains	C1518614
27886280	antimicrobials	C0003232
27886280	standard microtiter broth dilution method	C2827874
27886280	persister	C0563199
27886280	formation	C0007613
27886280	dose	C1512045
27886280	time	C0040223
27886280	killing experiments	C0022885
27886280	performed	C0884358
27886280	antibiotics	C0003232
27886280	Ceftazidime	C0007559
27886280	Cephalosporin	C3536856
27886280	efficacy	C1280519
27886280	culture	C0430402
27886280	Stationary-phase cells	C0563199
27886280	tolerant	C0013220
27886280	imipenem	C0020933
27886280	Carbapenem	C0006968
27886280	exponential cells	C0563199
27886280	fraction of	C1264633
27886280	persisters	C0563199
27886280	high	C0205250
27886280	imipenem	C0020933
27886280	concentration	C0392762
27886280	populations	C1257890
27886280	Polymyxin B	C0032535
27886280	Polymyxin	C0032539
27886280	low concentrations	C0392762
27886280	cell populations	C1257890
27886280	polymyxin B	C0032535
27886280	concentration	C0392762
27886280	exponential cells	C0563199
27886280	regrowth	C0205245
27886280	stationary population	C1257890
27886280	Stationary cells	C0563199
27886280	tolerant	C0013220
27886280	tobramycin	C0040341
27886280	Aminoglycoside	C0002556
27886280	exponential cells	C0563199
27886280	higher concentration	C0392762
27886280	tobramycin	C0040341
27886280	eliminated	C0849355
27886280	survivors	C0441833
27886280	Ciprofloxacin	C0008809
27886280	Fluoroquinolone	C0949665
27886280	low concentration	C0392762
27886280	killing	C1306577
27886280	cultures	C0430402
27886280	P. aeruginosa	C0033809
27886280	persisters	C0563199
27886280	killing	C1306577
27886280	Stationary cells	C0563199
27886280	tolerant	C0013220
27886280	exponential cells	C0563199
27886280	assays	C0005507
27886280	nutrient	C0678695
27886280	deprivation	C0871712
27886280	serine	C0036720
27886280	starvation	C0038187
27886280	stringent and general stress response	C0149784
27886280	increased tolerance	C0151956
27886280	P. aeruginosa	C0033809
27886280	exponential and stationary planktonic cells	C0563199
27886280	production	C0007613
27886280	persisters	C0563199
27887026	Chaetomium thermophilum	C1225414
27887026	formate dehydrogenase	C0016570
27887026	reduction	C0301630
27887026	hydrogen carbonate	C0973231
27887026	HCO3 -	C0973231
27887026	formate	C0220832
27887026	formate dehydrogenases	C0016570
27887026	FDHs	C0016570
27887026	cofactor	C0178555
27887026	recycling	C0282114
27887026	chemoenzymatic synthesis	C1511130
27887026	FDH	C0016570
27887026	CO2	C0007012
27887026	conversion	C0439836
27887026	CO2	C0007012
27887026	products	C1514468
27887026	formate	C0220832
27887026	HCOO(-)	C0220832
27887026	investigated	C1292732
27887026	reduction	C0301630
27887026	CO2	C0007012
27887026	hydrogen carbonate	C0973231
27887026	HCO3(-)	C0973231
27887026	formate	C0220832
27887026	FDHs	C0016570
27887026	Candida methylica	C1011924
27887026	CmFDH	C0016570
27887026	Chaetomium thermophilum	C1225414
27887026	CtFDH	C0016570
27887026	NADH	C0027289
27887026	reaction	C0443286
27887026	catalytic performance	C0243102
27887026	HCO3(-)	C0973231
27887026	substrate	C3891814
27887026	measuring	C0444706
27887026	kinetic rates	C1254367
27887026	productivity assays	C1510438
27887026	CtFDH	C0016570
27887026	efficiency	C0013682
27887026	converting	C0439836
27887026	HCO3(-)	C0973231
27887026	formate	C0220832
27887026	CmFDH	C0016570
27887026	CmFDH	C0016570
27887026	oxidation	C0030011
27887026	formate	C0220832
27887026	pH	C0020283
27887026	reduction	C0301630
27887026	pH	C0020283
27887026	high concentrations	C1446561
27887026	HCO3(-)	C0973231
27887026	reaction rate	C0678608
27887026	CtFDH	C0016570
27887026	HCO3(-)	C0973231
27887026	active site	C0205681
27887026	active site	C0205681
27887026	hydride transfer	C1148560
27887026	CO2	C0007012
27887026	reduction	C0301630
27887026	hydride donated	C1148560
27887026	NADH	C0027289
27887026	carbon atom	C0007009
27887026	HCO3(-)	C0973231
27887026	electrons	C0013852
27887026	molecule	C0567416
27887026	hydrogen carbonate	C0973231
27887026	hydride	C0003075
27887026	formate	C0220832
27887026	hydroxide ions	C0220853
27887578	Evaluation	C0015196
27887578	international	C1512888
27887578	educational programme	C0150562
27887578	health care professionals	C1704312
27887578	management	C1273870
27887578	perinatal	C0178795
27887578	death	C0011065
27887578	IMproving Perinatal mortality Review and Outcomes Via Education	C0150562
27887578	IMPROVE	C0150562
27887578	Stillbirths	C0595939
27887578	neonatal deaths	C0410916
27887578	devastating events	C0441471
27887578	parents	C0030551
27887578	clinicians	C0205210
27887578	global public health	C1456573
27887578	concerns	C2699424
27887578	clinical management	C1516615
27887578	deaths	C0011065
27887578	investigation	C0220825
27887578	assessment	C0220825
27887578	bereavement care	C0085882
27887578	families	C0015576
27887578	educational programme	C0150562
27887578	health care professionals	C1704312
27887578	maternal	C1858460
27887578	child health	C0008078
27887578	Perinatal Society of Australia and New Zealand Guideline for Perinatal Mortality	C0162791
27887578	IMproving Perinatal mortality Review and Outcomes Via Education	C0150562
27887578	IMPROVE	C0150562
27887578	programme	C0150562
27887578	stillbirth	C0595939
27887578	interactive skills	C0559197
27887578	stations	C1883167
27887578	participants	C0679646
27887578	pre-	C0150562
27887578	post-programme	C0150562
27887578	knowledge	C0376554
27887578	confidence	C1704726
27887578	management	C1273870
27887578	perinatal	C0178795
27887578	deaths	C0011065
27887578	satisfaction	C0242428
27887578	programme	C0150562
27887578	international	C1512888
27887578	IMPROVE programme	C0150562
27887578	health professionals	C1704312
27887578	maternity hospitals	C0020010
27887578	Australian	C0004340
27887578	states	C1301808
27887578	territories	C0681784
27887578	internationally	C1512888
27887578	Vietnam	C0042658
27887578	Fiji	C0016080
27887578	Netherlands	C0027778
27887578	assistance	C0010210
27887578	International Stillbirth Alliance	C1708333
27887578	ISA	C1708333
27887578	programme materials	C0282574
27887578	consultation	C0009818
27887578	translation	C0040712
27887578	Vietnam programme	C0150562
27887578	Participants	C0679646
27887578	pre-	C0150562
27887578	post-programme	C0150562
27887578	evaluation	C0015196
27887578	questionnaires	C0034394
27887578	knowledge	C0376554
27887578	confidence	C1704726
27887578	perinatal	C0178795
27887578	death	C0011065
27887578	management	C1273870
27887578	satisfaction questionnaire	C0034394
27887578	IMPROVE	C0150562
27887578	workshops	C0242262
27887578	participants	C0679646
27887578	Australia	C0004340
27887578	participants	C0679646
27887578	internationally	C1512888
27887578	Evaluations	C0015196
27887578	significant	C0750502
27887578	improvement	C2936612
27887578	pre-	C0150562
27887578	post-programme	C0150562
27887578	knowledge	C0376554
27887578	confidence	C1704726
27887578	stations	C1883167
27887578	satisfaction	C0242428
27887578	settings	C0162579
27887578	IMPROVE programme	C0150562
27887578	Australia	C0004340
27887578	international	C1512888
27887578	settings	C0162579
27887578	ISA	C1708333
27887578	research	C0035168
27887578	improvements	C2936612
27887578	knowledge	C0376554
27887578	sustained	C0443318
27887578	death	C0011065
27887578	changes in clinical practice	C0205897
27887578	improvement	C2936612
27887578	parents'	C0030551
27887578	care	C1947933
27887578	programme	C0150562
27887578	low-income	C1331016
27887578	countries	C0454664
27887587	personal	C1519021
27887587	recovery	C2004454
27887587	goals	C0018017
27887587	collaborative	C0681804
27887587	qualitative study	C0949415
27887587	Recovery	C2004454
27887587	subjective process	C1522240
27887587	personal	C1519021
27887587	expectations	C0679138
27887587	goals	C0018017
27887587	hopes	C0392347
27887587	study	C2603343
27887587	persons	C0027361
27887587	Community Mental Health Centre	C0475309
27887587	CMHC	C0475309
27887587	expectations	C0679138
27887587	treatment	C0087111
27887587	goals	C0018017
27887587	hopes	C0392347
27887587	recovery	C2004454
27887587	health professionals	C1704312
27887587	treatment	C0087111
27887587	hermeneutic	C0870642
27887587	service users	C0030705
27887587	expectations	C0679138
27887587	treatment	C0087111
27887587	goals	C0018017
27887587	hopes	C0392347
27887587	recovery	C2004454
27887587	health professionals	C1704312
27887587	CMHC	C0475309
27887587	years	C0439234
27887587	treatment	C0087111
27887587	health professionals	C1704312
27887587	goals	C0018017
27887587	hopes	C0392347
27887587	collaborative approach	C0282116
27887587	co-researcher	C0035173
27887587	study	C2603343
27887587	Data	C1511726
27887587	data	C1511726
27887587	thematic analysis	C0936012
27887587	participants	C0679646
27887587	health professionals	C1704312
27887587	CMHC	C0475309
27887587	recovery	C2004454
27887587	goals	C0018017
27887587	developing an understanding of oneself	C0205556
27887587	mental health problems	C1446377
27887587	feelings	C1527305
27887587	behaviours	C0004927
27887587	being 'pushed' into social arenas	C0243095
27887587	finding helpful medication	C0243095
27887587	counselling	C0010210
27887587	family	C0851511
27887587	practical	C0243095
27887587	financial issues	C0243095
27887587	participants	C0679646
27887587	expectations	C0679138
27887587	counselling	C0010210
27887587	family	C0851511
27887587	practical	C0243095
27887587	financial challenges	C0243095
27887587	CMHC	C0475309
27887587	service users	C0030705
27887587	recovery	C2004454
27887587	everyday life	C0376558
27887587	professional	C1704312
27887587	helpers	C0341652
27887587	recovery	C2004454
27887587	health professionals	C1704312
27887587	service user's	C0030705
27887587	personal	C1519021
27887587	goals	C0018017
27887587	hopes	C0392347
27887587	needs	C0027552
27887587	desires	C0871633
27887587	recovery	C2004454
27887587	goals	C0018017
27887587	counselling	C0010210
27887587	family	C0851511
27887587	practical	C0243095
27887587	financial issues	C0243095
27888348	Pathogenesis	C0699748
27888348	COPD	C0024117
27888348	Asthma	C0004096
27888348	Asthma	C0004096
27888348	COPD	C0024117
27888348	diseases of the respiratory tract	C0035242
27888348	unmet	C3274904
27888348	medical	C0205476
27888348	needs	C0027552
27888348	review	C0282443
27888348	pathogenesis	C0699748
27888348	chronic inflammatory diseases	C1290886
27888348	lung	C0024109
27888348	review	C0282443
27888348	conditions	C0348080
27888348	treatment	C0087111
27888348	pharmacology	C0031330
27888348	treatment	C0087111
27888348	asthma	C0004096
27888348	COPD	C0024117
27891581	Antigen specificity	C1536991
27891581	anti-red blood cell IgG-Fc alloantibody	C0003241
27891581	glycosylation	C0017982
27891581	severity	C0439793
27891581	haemolytic disease of the fetus and newborn	C0014761
27891581	Haemolytic disease of the fetus and newborn	C0014761
27891581	HDFN	C0014761
27891581	disease	C0012634
27891581	fetal	C0015965
27891581	red blood cells	C0014792
27891581	RBC	C0014792
27891581	destroyed	C1948029
27891581	maternal anti-RBC IgG alloantibodies	C0729663
27891581	HDFN	C0014761
27891581	anti-D	C0140430
27891581	due to	C0678226
27891581	anti-K	C0313239
27891581	-c	C0432626
27891581	-E	C0947659
27891581	N-linked glycosylation	C1622430
27891581	anti-D	C0140430
27891581	low	C0205251
27891581	fucosylation	C3271553
27891581	increasing	C0442808
27891581	affinity	C0003255
27891581	IgG-Fc receptor IIIa	C1521898
27891581	IIIb	C0966831
27891581	correlated	C1707520
27891581	HDFN	C0014761
27891581	disease	C0012634
27891581	severity	C0439793
27891581	pregnant women	C0033011
27891581	anti-c	C0432626
27891581	-E	C0947659
27891581	-K	C0313239
27891581	alloantibodies	C0022144
27891581	screening cohort	C0422390
27891581	investigated	C1292732
27891581	Fc-tail glycosylation	C0376322
27891581	antibodies	C0003241
27891581	trigger	C1444748
27891581	immunisation	C0020971
27891581	pregnancy outcome	C0032972
27891581	Anti-c	C0432626
27891581	-E	C0947659
27891581	-K	C0313239
27891581	independent of	C0332291
27891581	event	C0441471
27891581	immunisation	C0020971
27891581	different	C1705242
27891581	Fc-glycosylation	C0376322
27891581	IgG	C0020852
27891581	IgG fraction	C0020852
27891581	anti-D	C0140430
27891581	Fc-galactosylation	C1159287
27891581	sialylation	C4235385
27891581	anti-c	C0432626
27891581	HDFN	C0014761
27891581	disease	C0012634
27891581	severity	C0439793
27891581	anti-K	C0313239
27891581	Fc-fucosylation	C1159287
27891581	correlated	C1707520
27891581	severe	C0205082
27891581	fetal anaemia	C2349595
27891581	IgG-Fc glycosylation	C0376322
27891581	anti-RBC antibodies	C0003241
27891581	antigen	C0003320
27891581	features	C2348519
27891581	clinical potency	C3850123
27891581	predict	C0681842
27891581	severity	C0439793
27891581	treatment	C0039798
27892235	poor pay	C0871051
27892235	NHS	C0027462
27892235	pay	C0871051
27892235	campaign	C0680899
27892235	NHS	C0027462
27892235	public	C0683971
27892522	SARS	C1175175
27892522	CoV	C0010076
27892522	peptides	C0030956
27892522	membrane	C0596901
27892522	surface	C0205148
27892522	ordering	C1254362
27892522	curvature	C1254362
27892522	Viral membrane fusion	C1721020
27892522	membrane-anchored	C1622010
27892522	viral fusion glycoproteins	C0042716
27892522	S2	C3658241
27892522	subunit	C0599220
27892522	spike glycoprotein	C3658241
27892522	severe acute respiratory syndrome	C1175175
27892522	SARS	C1175175
27892522	coronavirus	C0010076
27892522	CoV	C0010076
27892522	internal domains	C1514562
27892522	fusion peptides	C0030956
27892522	FP	C0030956
27892522	virus entry	C1537068
27892522	membrane fusion	C0025246
27892522	studied	C2603343
27892522	molecular	C1521991
27892522	lipid	C0023779
27892522	rearrangements	C0596965
27892522	bilayer	C0023768
27892522	fusion peptide	C0030956
27892522	membrane	C0596901
27892522	interactions	C1704675
27892522	differential scanning calorimetry	C0006780
27892522	DSC	C0006780
27892522	electron spin resonance	C0013845
27892522	ESR	C0013845
27892522	membrane fusion	C0025246
27892522	mechanism	C0441712
27892522	promoted	C0033414
27892522	SARS	C1175175
27892522	FPs	C0030956
27892522	DSC	C0006780
27892522	data	C1511726
27892522	peptides	C0030956
27892522	structural	C0678594
27892522	integrity	C0205266
27892522	anionic vesicles	C1622418
27892522	hypothesis	C1512571
27892522	peptides	C0030956
27892522	curvature	C1254362
27892522	phosphatidylethanolamine	C0031618
27892522	membranes	C0596901
27892522	ESR	C0013845
27892522	FPs	C0030956
27892522	lipid	C0023779
27892522	packing	C2828395
27892522	ordering	C1254362
27892522	intramembrane	C0596901
27892522	water content	C0392762
27892522	anionic membranes	C0596901
27892522	bilayer	C0023768
27892522	curvature	C1254362
27892522	significance	C0750502
27892522	ordering effect	C1280500
27892522	membrane	C0596901
27892522	dehydration	C1963090
27892522	curvature	C1254362
27892522	phospholipids	C0031676
27892522	SARS	C1175175
27892522	CoV	C0010076
27892522	membrane fusion	C0025246
27894019	defense mechanism	C1154988
27894019	Antarctic	C0920736
27894019	sponges	C0032699
27894019	computational study	C4297010
27894019	secondary metabolite	C0870883
27894019	erebusinone	C0870883
27894019	Ereb	C0870883
27894019	Antarctic	C0920736
27894019	sea sponge	C4102027
27894019	Isodictya erinacea	C4102027
27894019	bioactivity	C0005520
27894019	Ereb	C0870883
27894019	inhibit	C3463820
27894019	molting	C0282576
27894019	arthropod species	C0003903
27894019	Orchomene plebs	C3780008
27894019	Xanthurenic acid	C0078610
27894019	XA	C0078610
27894019	endogenous	C0205227
27894019	molt regulator	C1704735
27894019	arthropods	C0003903
27894019	XA	C0078610
27894019	inhibits	C3463820
27894019	molting	C0282576
27894019	binding	C1167622
27894019	P450 enzymes	C0010762
27894019	CYP315a1	C0010762
27894019	CYP314a1	C0010762
27894019	hydroxylations	C0020365
27894019	molt-inducing hormone	C0019932
27894019	20-hydroxyecdysone	C0013495
27894019	20E	C0013495
27894019	crystal structures	C0444626
27894019	biochemical assays	C0430027
27894019	CYP315a1	C0010762
27894019	CYP314a1	C0010762
27894019	exploration	C0936012
27894019	XA	C0078610
27894019	Ereb's	C0870883
27894019	molt	C0282576
27894019	inhibition	C3463820
27894019	mechanisms	C0441712
27894019	computational techniques	C1516769
27894019	homology modeling	C1512489
27894019	molecular dynamics simulations	C2717775
27894019	binding site	C1149343
27894019	bioinformatics	C1140694
27894019	flexible receptor-flexible ligand docking	C1522290
27894019	Born surface area calculations	C0002045
27894019	structure-function relationships	C0038477
27894019	P450s	C0010762
27894019	inhibitors	C0243077
27894019	Ereb	C0870883
27894019	XA	C0078610
27894019	Ereb	C0870883
27894019	CYP315a1	C0010762
27894019	aromatic residues	C1254350
27894019	binding site	C1149343
27894019	XA	C0078610
27894019	CYP315a1	C0010762
27894019	CYP314a1	C0010762
27894019	aromatic	C1254350
27894019	charged nature	C0022023
27894020	anatomical mummies	C0026779
27894020	Mombello	C0681784
27894020	detection	C0442726
27894020	cocaine	C0009170
27894020	nicotine	C0028040
27894020	caffeine	C0006644
27894020	hair	C0018494
27894020	psychiatric patients	C0748064
27894020	Mombello Psychiatric Hospital	C0020021
27894020	Limbiate	C0681784
27894020	Milan	C0681784
27894020	Senavra Hospital	C0019994
27894020	Psychiatric Hospital	C0020021
27894020	Province of Milan	C0681784
27894020	bodies	C0242821
27894020	Mombello patients	C0748064
27894020	dissected	C0205239
27894020	preserved	C0033085
27894020	Giuseppe Paravicini	C0086418
27894020	anatomist	C0334865
27894020	asylum	C0870166
27894020	aim	C1947946
27894020	study	C0008972
27894020	assemblage	C0010995
27894020	sample	C2347026
27894020	head hair	C1261040
27894020	preparations	C1521827
27894020	toxicological	C0205472
27894020	analysis	C0936012
27894020	high performance liquid chromatography	C0008562
27894020	cocaine	C0009170
27894020	metabolite	C0870883
27894020	benzoylecgonine	C0053258
27894020	detected	C0442726
27894020	hair samples	C2347026
27894020	concentrations	C1446561
27894020	cocaine	C0009170
27894020	benzoylecgonine	C0053258
27894020	cocaine	C0009170
27894020	medicine	C0013227
27894020	patients	C0020021
27894020	ingested	C0232478
27894020	drug	C0013227
27894020	detection	C0442726
27894020	cocaine	C0009170
27894020	analyses	C0936012
27894020	nicotine	C0028040
27894020	caffeine	C0006644
27894020	intake	C1512806
27895988	Terahertz identification	C2350265
27895988	quantification	C1709793
27895988	neurotransmitter	C0027908
27895988	neurotrophy mixture	C0027754
27895988	Terahertz spectroscopy	C2350265
27895988	investigating	C1292732
27895988	fingerprint spectrum	C0016128
27895988	substances	C0439861
27895988	cancerous	C0006826
27895988	tissues	C0040300
27895988	absorption	C2825050
27895988	substances	C0439861
27895988	tissues	C0040300
27895988	overlap	C1948020
27895988	quantitative	C0392762
27895988	analyze	C0936012
27895988	cancer cell	C0334227
27895988	diagnose	C0011900
27895988	accurately	C0443131
27895988	neurotransmitters	C0027908
27895988	γ-aminobutyric acid	C0016904
27895988	L-glutamic acid	C0061472
27895988	dopamine hydrochloride	C0282151
27895988	metabolites	C0870883
27895988	inositol	C0021547
27895988	creatine	C0010286
27895988	neurons	C0027882
27895988	terahertz spectra	C2350265
27895988	mixture ratios	C0456603
27895988	characteristic	C1521970
27895988	absorption	C2825050
27895988	baseline	C1442488
27895988	least square method	C0023189
27895988	proportions	C1709707
27895988	goodness of fit	C0870608
27895988	nerve substances	C0027908
27895988	quantitative	C0392762
27895988	analysis	C0936012
27896576	calcium hydroxyapatite	C0115137
27896576	Deflux	C0299556
27896576	injection	C0021485
27896576	bladder neck	C0227716
27896576	improvement	C2986411
27896576	urinary incontinence	C0042024
27896576	bladder exstrophy-epispadias complex	C1838703
27896576	study	C2603343
27896576	efficacy	C1280519
27896576	endoscopic injection	C3522839
27896576	calcium hydroxyapatite	C0115137
27896576	CaHA	C0115137
27896576	bladder neck	C0227716
27896576	BN	C0227716
27896576	patients	C0030705
27896576	urinary incontinence	C0042024
27896576	bladder exstrophy-epispadias complex	C1838703
27896576	BEEC	C1838703
27896576	retrospective cohort study	C2985505
27896576	retrospectively studied	C0035363
27896576	medical charts	C0184826
27896576	female	C0086287
27896576	male	C0086582
27896576	patients	C0030705
27896576	BEEC	C1838703
27896576	CaHA	C0115137
27896576	Deflux	C0299556
27896576	injection	C0021485
27896576	continence improvement	C1536613
27896576	incontinent	C0021167
27896576	patients	C0030705
27896576	endoscopic submucosal injection	C3522839
27896576	CaHA	C0115137
27896576	autologous	C0439859
27896576	plasma	C0032105
27896576	Patients	C0030705
27896576	control group	C0009932
27896576	Deflux	C0299556
27896576	injection	C0021485
27896576	follow-up	C1522577
27896576	injection	C0021485
27896576	post-injection complication	C0274425
27896576	detected	C0442726
27896576	patients	C0030705
27896576	follow-up	C1522577
27896576	patients	C0030705
27896576	dry	C1512080
27896576	injections	C0021485
27896576	incontinence	C0021167
27896576	patients	C0030705
27896576	no change	C0442739
27896576	patient	C0030705
27896576	Deflux	C0299556
27896576	injection	C0021485
27896576	complete dryness	C1512080
27896576	improvement	C2986411
27896576	incontinence	C0021167
27896576	no change	C0442739
27896576	patients	C0030705
27896576	no significant difference	C3842396
27896576	continence achievement	C0442964
27896576	CaHA	C0115137
27896576	Deflux	C0299556
27896576	statistical analysis	C0871424
27896576	not significantly different	C3842396
27896576	bladder capacity	C0429807
27896576	preliminary results	C1548161
27896576	study	C2603343
27896576	revealed	C0443289
27896576	CaHA	C0115137
27896576	bulking agent	C1320234
27896576	treatment	C0087111
27896576	urinary incontinence	C0042024
27896576	BEEC	C1838703
27898905	Opportunities	C0683937
27898905	genomic	C0017428
27898905	prediction	C0681842
27898905	fertility	C0015895
27898905	endocrine	C0014136
27898905	classical	C0443177
27898905	fertility	C0015895
27898905	traits	C0599883
27898905	dairy cattle	C0007452
27898905	Endocrine	C0014136
27898905	fertility	C0015895
27898905	traits	C0599883
27898905	progesterone	C0033308
27898905	concentration	C1446561
27898905	levels	C0441889
27898905	milk	C0026131
27898905	alternative	C1523987
27898905	indicators	C1522602
27898905	fertility	C0015895
27898905	dairy cows	C0007452
27898905	farm	C0557759
27898905	management	C1273870
27898905	decisions	C0679006
27898905	cow	C0007452
27898905	reproductive	C0035150
27898905	physiology	C0031843
27898905	classical	C0443177
27898905	traits	C0599883
27898905	insemination	C0021586
27898905	data	C1511726
27898905	use of	C1524063
27898905	endocrine	C0014136
27898905	fertility	C0015895
27898905	traits	C0599883
27898905	genomic	C0017428
27898905	evaluations	C0015195
27898905	improvement	C2986411
27898905	accuracy	C0443131
27898905	endocrine	C0014136
27898905	fertility	C0015895
27898905	traits	C0599883
27898905	concurrent	C0205420
27898905	classical	C0443177
27898905	traits	C0599883
27898905	genomic	C0017428
27898905	prediction	C0681842
27898905	fertility	C0015895
27898905	quantified	C1709793
27898905	impact	C4049986
27898905	traits	C0599883
27898905	animals	C0003062
27898905	investigated	C1292732
27898905	Endocrine	C0014136
27898905	classical	C0443177
27898905	fertility	C0015895
27898905	lactations	C0022925
27898905	Holstein cows	C0324069
27898905	Ireland	C0022067
27898905	Netherlands	C0027778
27898905	Sweden	C0038995
27898905	United Kingdom	C0041700
27898905	endocrine	C0014136
27898905	traits	C0599883
27898905	commencement of luteal activity	C1254358
27898905	C-LA	C1254358
27898905	proportion	C1709707
27898905	samples	C0370003
27898905	luteal activity	C1254358
27898905	PLA	C0370003
27898905	classical	C0443177
27898905	trait	C0599883
27898905	interval	C1272706
27898905	interval	C1272706
27898905	C-LA	C1254358
27898905	endocrine	C0014136
27898905	trait	C0599883
27898905	classical	C0443177
27898905	trait	C0599883
27898905	investigated	C1292732
27898905	target	C1521840
27898905	breeding goal	C1521840
27898905	trait	C0599883
27898905	fertility	C0015895
27898905	C-LA	C1254358
27898905	PLA	C0370003
27898905	predictor	C2698872
27898905	traits	C0599883
27898905	Genomic EBV	C0017428
27898905	GEBV	C0017428
27898905	fertility	C0015895
27898905	genomic BLUP	C1710191
27898905	bivariate models	C0026336
27898905	SNP	C0752046
27898905	fertility	C0015895
27898905	traits	C0599883
27898905	univariate models	C0026336
27898905	accuracy	C0443131
27898905	GEBV	C0017428
27898905	cross-validation	C0681935
27898905	accuracy	C0443131
27898905	GEBV	C0017428
27898905	bivariate	C0681927
27898905	predictions	C0681842
27898905	endocrine	C0014136
27898905	fertility	C0015895
27898905	trait	C0599883
27898905	classical	C0443177
27898905	fertility	C0015895
27898905	trait	C0599883
27898905	Accuracy	C0443131
27898905	GEBV	C0017428
27898905	predicting	C0681842
27898905	phenotypes	C0031437
27898905	univariate model	C0026336
27898905	predicting	C0681842
27898905	bivariate model	C0026336
27898905	C-LA	C1254358
27898905	accuracy	C0443131
27898905	increased	C0205217
27898905	training animals	C0003062
27898905	phenotyped	C0031437
27898905	C-LA	C1254358
27898905	phenotyping	C0031437
27898905	training animals	C0003062
27898905	C-LA	C1254358
27898905	accuracy	C0443131
27898905	increased	C0205217
27898905	validation	C1519941
27898905	animals	C0003062
27898905	phenotyped	C0031437
27898905	C-LA	C1254358
27898905	no	C1513916
27898905	substantial increase	C0442805
27898905	accuracy	C0443131
27898905	predicting	C0681842
27898905	bivariate analysis	C0681927
27898905	PLA	C0370003
27898905	accuracy	C0443131
27898905	study	C2603343
27898905	genomic	C0017428
27898905	predictions	C0681842
27898905	fertility	C0015895
27898905	endocrine	C0014136
27898905	traits	C0599883
27898905	improvement	C2986411
27898905	accuracy	C0443131
27898905	prediction	C0681842
27898905	classical	C0443177
27898905	traits	C0599883
27898905	studies	C2603343
27898905	larger	C0549177
27898905	training populations	C1257890
27898905	greater	C1704243
27898905	improvements	C2986411
27901092	Microfluidic	C1257867
27901092	design	C1707689
27901092	crosslinked Hyaluronic Acid Nanoparticles	C1450054
27901092	cHANPs	C1450054
27901092	enhanced MRI	C1707501
27901092	Recent	C0332185
27901092	advancements	C3854260
27901092	imaging diagnostics	C0011923
27901092	nanostructures	C1450053
27901092	Magnetic Resonance Imaging	C0024485
27901092	MRI	C0024485
27901092	Contrast Agents	C0009924
27901092	CAs	C0009924
27901092	chemically	C0220806
27901092	modify	C0392747
27901092	clinically	C0205210
27901092	approved	C0205540
27901092	compounds	C1706082
27901092	microfluidic platforms	C1257867
27901092	controlled	C2587213
27901092	continuous	C0549178
27901092	production	C1883254
27901092	microfluidic platform	C1257867
27901092	synthesize	C1883254
27901092	crosslinked Hyaluronic Acid NanoParticles	C1450054
27901092	cHANPs	C1450054
27901092	clinically	C0205210
27901092	relevant	C2347946
27901092	MRI	C0024485
27901092	CAs	C0009924
27901092	gadolinium diethylenetriamine penta-acetic acid	C0060933
27901092	Gd-DTPA	C0060933
27901092	microfluidic	C1257867
27901092	process	C1522240
27901092	degree	C0441889
27901092	control	C2587213
27901092	particle	C1450054
27901092	synthesis	C1883254
27901092	production	C1883254
27901092	monodisperse particles	C1450054
27901092	interference	C0521102
27901092	Gd-DTPA	C0060933
27901092	polymer	C0032521
27901092	precipitation	C0032931
27901092	process	C1522240
27901092	parameters	C0549193
27901092	hydrophilic-lipophilic balance	C0392762
27901092	HLB	C0392762
27901092	surfactants	C0038891
27901092	pH	C0020283
27901092	conditions	C0348080
27901092	production	C1883254
27901092	design	C1707689
27901092	Gd	C0060933
27901092	cHANPs	C1450054
27901092	relaxation rate T1	C2697937
27901092	T1	C2697937
27901092	Gd	C0060933
27901092	cHANPs	C1450054
27901092	value	C1522609
27901092	relevant	C2347946
27901092	clinical	C0205210
27901092	Gd-DTPA	C0060933
27901092	solution	C0037633
27901092	microfluidic	C1257867
27901092	intravascularly	C0442123
27901092	injectable	C1272883
27901092	biocompatible hydrogel	C0063083
27901092	nanoparticles	C1450054
27901092	clinically	C0205210
27901092	approved	C0205540
27901092	CAs	C0009924
27901092	implementation	C1708476
27901092	diagnostics	C1704338
27901092	therapy	C0087111
27901092	applications	C4048755
27902303	Arthrobacter ginkgonis sp. nov.	C0003876
27902303	actinomycete	C0600148
27902303	isolated	C0205409
27902303	rhizosphere	C2936389
27902303	Ginkgo biloba L	C0330206
27902303	Gram-stain-positive	C0855278
27902303	aerobic	C1510824
27902303	actinobacterial strain	C0600148
27902303	SYP-A7299T	C0003876
27902303	rod-coccus growth lifecycle	C0562679
27902303	isolated	C0205409
27902303	rhizosphere	C2936389
27902303	Ginkgo biloba L	C0330206
27902303	Phylogenetic analyses	C1519068
27902303	16S rRNA gene sequences	C0035899
27902303	strain SYP-A7299T	C0003876
27902303	genus	C1708235
27902303	Arthrobacter	C0003876
27902303	Arthrobacter halodurans JSM 078085T	C2762206
27902303	16S rRNA gene sequence	C0035899
27902303	similarity	C2348205
27902303	DNA	C0012854
27902303	DNA	C0012854
27902303	relatedness value	C0392762
27902303	strain SYP-A7299T	C0003876
27902303	A. halodurans JSM 078085T	C2762206
27902303	cell-wall	C0007623
27902303	peptidoglycan	C0030958
27902303	A4α	C0030958
27902303	glucose	C0017725
27902303	galactose	C0016945
27902303	whole-cell sugars	C0242209
27902303	polar lipids	C0023779
27902303	diphosphatidylglycerol	C0574031
27902303	phosphatidylglycerol	C0031614
27902303	phosphatidylinositol	C0031621
27902303	glycolipids	C0017950
27902303	polar lipid	C0023779
27902303	menaquinone	C0086605
27902303	MK-8(H2)	C0084980
27902303	MK-9(H2)	C0127520
27902303	cellular fatty acids	C0015684
27902303	anteiso-C15: 0	C0646611
27902303	iso-C15: 0	C0044840
27902303	anteiso-C17: 0	C0044862
27902303	DNA	C0012854
27902303	G+C content	C1135899
27902303	morphological	C0543482
27902303	physiological	C0205463
27902303	biochemical	C0205474
27902303	chemotaxonomic characters	C0205245
27902303	strain SYP-A7299T	C0003876
27902303	species	C1705920
27902303	genus	C1708235
27902303	Arthrobacter	C0003876
27902303	Arthrobacter ginkgonis sp. nov.	C0003876
27902303	type strain	C1518614
27902303	SYP-A7299T	C0003876
27902303	=DSM 100491T=KCTC 39 592T	C0003876
27902690	Decoding	C0870395
27902690	Interactions	C1373094
27902690	Regulating	C0243148
27902690	Active State	C0679217
27902690	Mechanics	C0376706
27902690	Eukaryotic	C0684063
27902690	Protein Kinases	C0033640
27902690	Eukaryotic	C0684063
27902690	protein kinases	C0033640
27902690	regulate	C0243148
27902690	cellular functions	C0007613
27902690	phosphorylating	C1158886
27902690	targeted	C1521840
27902690	protein	C0033684
27902690	substrates	C3891814
27902690	through	C0332273
27902690	highly	C0205250
27902690	conserved	C0443318
27902690	catalytic core	C0243092
27902690	active state	C0679217
27902690	catalytic core	C0243092
27902690	oscillates	C0695434
27902690	open	C0175566
27902690	intermediate	C0205103
27902690	closed	C0677512
27902690	conformations	C0033625
27902690	Currently	C0521116
27902690	intramolecular interactions	C1373094
27902690	regulate	C0243148
27902690	active state	C0679217
27902690	mechanics	C0376706
27902690	not well understood	C0205556
27902690	cAMP-dependent protein kinase	C0010531
27902690	representative	C1882932
27902690	model	C0026336
27902690	coupled	C1948027
27902690	biochemical	C0205474
27902690	biophysical	C1511162
27902690	computational techniques	C1516769
27902690	highly	C0205250
27902690	conserved	C2347858
27902690	electrostatic	C0683119
27902690	hydrophobic interactions	C0678607
27902690	harmoniously	C0699798
27902690	regulate	C0243148
27902690	mechanics	C0376706
27902690	include	C0332257
27902690	previously	C0205156
27902690	identified	C0205396
27902690	salt bridge	C0023745
27902690	lysine	C0024337
27902690	β3-strand	C0600383
27902690	glutamate	C0220839
27902690	αC-helix	C0162805
27902690	electrostatic interaction	C0683119
27902690	phosphorylated	C0031715
27902690	activation	C1879547
27902690	loop	C0445022
27902690	αC-helix	C0162805
27902690	ensemble	C0444667
27902690	hydrophobic	C0598629
27902690	residues	C1709915
27902690	decades	C2981279
27902690	highly	C0205250
27902690	conserved	C0443318
27902690	β3	C0600383
27902690	β3 -lysine	C0024337
27902690	essential	C0205224
27902690	phosphoryl transfer	C1148560
27902690	findings	C2607943
27902690	β3	C0600383
27902690	β3 -lysine	C0024337
27902690	phosphoryl transfer	C1148560
27902690	essential	C0205224
27902690	active state	C0679217
27902690	mechanics	C0376706
27903185	Acute	C0205178
27903185	clinical	C0205210
27903185	adverse radiation effects	C0392615
27903185	Gamma Knife surgery	C2960266
27903185	vestibular schwannomas	C0027859
27903185	Vestibular schwannomas	C0027859
27903185	VSs	C0027859
27903185	Gamma Knife surgery	C2960266
27903185	GKS	C2960266
27903185	studies	C2603343
27903185	long-term	C0443252
27903185	morbidity	C0178685
27903185	adverse radiation effects	C0392615
27903185	AREs	C0392615
27903185	acute	C0205178
27903185	clinical	C0205210
27903185	AREs	C0392615
27903185	short-term	C0443303
27903185	investigated	C1292732
27903185	incidence	C0021149
27903185	type	C0332307
27903185	outcomes	C0086750
27903185	reported	C0684224
27903185	patients	C0030705
27903185	treated	C1522326
27903185	months	C0439231
27903185	follow-up	C1522577
27903185	disabling	C0596452
27903185	symptom	C1457887
27903185	months	C0439231
27903185	GKS	C2960266
27903185	affected	C0392760
27903185	quality of life	C0034380
27903185	symptom	C1457887
27903185	outcome	C0086750
27903185	prescribed	C0278329
27903185	dose	C0178602
27903185	patients	C0030705
27903185	inclusion	C1512693
27903185	acute	C0205178
27903185	clinical	C0205210
27903185	AREs	C0392615
27903185	mean	C0444504
27903185	followup	C1522577
27903185	months	C0439231
27903185	range	C1514721
27903185	months	C0439231
27903185	mean	C0444504
27903185	days	C0439228
27903185	median	C0876920
27903185	days	C0439228
27903185	range	C1514721
27903185	days	C0439228
27903185	patients	C0030705
27903185	de novo	C1515568
27903185	symptoms	C1457887
27903185	symptoms	C1457887
27903185	vertigo	C0042571
27903185	gait disturbance	C0575081
27903185	exacerbation	C0235874
27903185	symptom	C1457887
27903185	hearing loss	C3887873
27903185	gait disturbance	C0575081
27903185	vertigo	C0042571
27903185	univariate	C0683962
27903185	logistic regression analysis	C0681925
27903185	factors	C1521761
27903185	statistically significant	C0237881
27903185	age	C0001779
27903185	odds ratio	C0028873
27903185	OR	C0028873
27903185	baseline	C1442488
27903185	Gardner-Robertson	C0451213
27903185	GR	C0451213
27903185	OR	C0028873
27903185	pure tone average	C0392762
27903185	baseline	C1442488
27903185	OR	C0028873
27903185	Koos grade	C0349674
27903185	baseline	C1442488
27903185	Koos Grade I	C0349674
27903185	Koos Grade II	C0349674
27903185	OR	C0028873
27903185	Koos Grade III	C0349674
27903185	OR	C0028873
27903185	statistically significant	C0237881
27903185	isocenters	C1881275
27903185	OR	C0028873
27903185	maximal	C0806909
27903185	dose	C0178602
27903185	cochlea	C0009197
27903185	OR	C0028873
27903185	Fractional polynomial regression analysis	C0034980
27903185	outcome	C0086750
27903185	radiation dose rate	C0560131
27903185	maximal	C0806909
27903185	vestibular	C0042606
27903185	dose	C0178602
27903185	sample size	C0242618
27903185	precludes	C0332206
27903185	analysis	C0936012
27903185	clinical	C0205210
27903185	acute	C0205178
27903185	AREs	C0392615
27903185	patients	C0030705
27903185	months	C0439231
27903185	disabling	C0596452
27903185	morbidity	C0178685
27903185	cases	C1706256
27903185	complete hearing loss	C0581883
27903185	GR Class I	C0451213
27903185	V	C0451213
27903185	hemifacial spasm	C0278152
27903185	persistent	C0205322
27903185	dysgeusia	C0013378
27903185	Acute	C0205178
27903185	effects	C1280500
27903185	radiosurgery	C0085203
27903185	VS	C0027859
27903185	de novo	C1515568
27903185	vertigo	C0042571
27903185	gait disturbance	C0575081
27903185	exacerbation	C0235874
27903185	hearing loss	C3887873
27903185	de novo	C1515568
27903185	vestibular	C0042606
27903185	symptom	C1457887
27903185	vestibular	C0042606
27903185	dose	C0178602
27903185	cases	C1706256
27903185	effects	C1280500
27903185	steroid therapy	C0149783
27903185	AREs	C0392615
27903185	rare	C0522498
27903410	Long-chain n-3 PUFA	C0015689
27903410	supplied	C1999230
27903410	usual	C3538928
27903410	diet	C0012155
27903410	decrease	C0547047
27903410	plasma stearoyl-CoA desaturase	C0038233
27903410	index	C0918012
27903410	non-hypertriglyceridemic	C0243095
27903410	older adults	C0001792
27903410	vascular	C0005847
27903410	risk	C0035647
27903410	activity	C0243102
27903410	stearoyl-CoA desaturase-1	C2002916
27903410	SCD1	C2002916
27903410	central enzyme	C0014442
27903410	synthesis	C1883254
27903410	monounsaturated fatty acids	C0015687
27903410	MUFA	C0015687
27903410	associated with	C0332281
27903410	de novo	C1515568
27903410	lipogenesis	C1563744
27903410	experimental models	C0086272
27903410	SCD1	C2002916
27903410	down-regulated	C0013081
27903410	polyunsaturated fatty acids	C0032615
27903410	PUFA	C0032615
27903410	clinical studies	C0008972
27903410	effect	C1280500
27903410	long-chain n-3 PUFA	C0015689
27903410	LCn-3PUFA	C0015689
27903410	supplied	C1999230
27903410	regular diet	C0012155
27903410	absence	C0332197
27903410	fatty fish	C0453017
27903410	fish oil	C0556145
27903410	supplementation,	C0242295
27903410	related	C0439849
27903410	changes	C0392747
27903410	plasma SCD1	C2002916
27903410	index	C0918012
27903410	assessed	C1516048
27903410	C16:1n-7	C0069966
27903410	C16:0	C0030234
27903410	ratio	C0456603
27903410	adiposity	C1563743
27903410	traits	C0599883
27903410	nutrient intake	C1287879
27903410	changes	C0392747
27903410	sub-cohort	C0599755
27903410	non-hypertriglyceridemic	C0243095
27903410	subjects	C0080105
27903410	PREDIMED (PREvención con DIeta MEDiterranea) trial	C0008976
27903410	changes	C0392747
27903410	fasting	C0015663
27903410	triglycerides	C0041004
27903410	plasma SCD1	C2002916
27903410	index	C0918012
27903410	increased	C0205217
27903410	body weight	C0005910
27903410	confidence interval	C0009667
27903410	BMI	C1305855
27903410	dietary	C0012155
27903410	LCn-3PUFA	C0015689
27903410	MUFA	C0015687
27903410	plant-derived PUFA	C1318902
27903410	associated with	C0332281
27903410	decreased	C0205216
27903410	plasma SCD1	C2002916
27903410	index	C0918012
27903410	increase	C0442805
27903410	LCn-3PUFA	C0015689
27903410	associations	C0439849
27903410	food	C0016452
27903410	groups	C0441833
27903410	fatty fish	C0453017
27903410	intake	C1512806
27903410	increase	C0442805
27903410	data	C1511726
27903410	clinical	C0205210
27903410	evidence	C3887511
27903410	down-regulation	C0013081
27903410	plasma SCD1	C2002916
27903410	index	C0918012
27903410	LCn-3PUFA	C0015689
27903410	context	C0449255
27903410	changes	C0392747
27903410	fish	C0016163
27903410	consumption	C2983605
27903410	customary	C3538928
27903410	non-supplemented	C0243095
27903410	diet	C0012155
27905023	Distinct cortical and sub-cortical neurogenic domains	C2333134
27905023	GABAergic	C1816494
27905023	interneuron	C0021792
27905023	precursor	C1709634
27905023	transcription factors	C0040648
27905023	NKX2.1	C1452466
27905023	OLIG2	C2347389
27905023	COUP-TFII	C1506576
27905023	fetal	C0521457
27905023	human	C0086418
27905023	telencephalon	C0231028
27905023	similarities	C2348205
27905023	differences	C1705242
27905023	cortical GABAergic interneuron generation	C1818464
27905023	rodent	C0035804
27905023	primate	C0033147
27905023	telencephalon	C0231028
27905023	expression	C1171362
27905023	interneuron	C0021792
27905023	precursor	C1709634
27905023	transcription factors	C0040648
27905023	markers	C0005516
27905023	immunohistochemistry	C0021044
27905023	post-conceptional weeks	C3827345
27905023	PCW	C3827345
27905023	human	C0086418
27905023	telencephalon	C0231028
27905023	NKX2.1	C1452466
27905023	OLIG2	C2347389
27905023	COUP-TFII	C1506576
27905023	expression	C1171362
27905023	neurogenic domains	C0027882
27905023	cortex	C0007776
27905023	CGE compartments	C1268212
27905023	lateral	C0205093
27905023	medial	C0205098
27905023	ventral	C1704448
27905023	NKX2.1	C1452466
27905023	expression	C1171362
27905023	MGE	C1268212
27905023	medial	C0205098
27905023	CGE	C1268212
27905023	ventral	C1704448
27905023	septum	C0936188
27905023	developmental stage	C0870411
27905023	interneuron	C0021792
27905023	NKX2.1	C1452466
27905023	precursor	C1709634
27905023	rodents	C0035804
27905023	OLIG2	C2347389
27905023	immunoreactivity	C0597879
27905023	GABAergic cells	C0815002
27905023	proliferative	C0596290
27905023	zones	C1710706
27905023	MGE	C1268212
27905023	septum	C0936188
27905023	NKX2.1	C1452466
27905023	OLIG2	C2347389
27905023	expression	C1171362
27905023	LGE	C1268212
27905023	CGE	C1268212
27905023	cortex	C0007776
27905023	PCW	C3827345
27905023	OLIG2	C2347389
27905023	cells	C0815002
27905023	medial	C0205098
27905023	anterior	C0205094
27905023	cortical wall	C0007776
27905023	migratory	C0232901
27905023	pathway	C1705987
27905023	interneuron	C0021792
27905023	precursor	C1709634
27905023	septum	C0936188
27905023	medial	C0205098
27905023	cortex	C0007776
27905023	PCW	C3827345
27905023	OLIG2	C2347389
27905023	cells	C0815002
27905023	cortex	C0007776
27905023	dividing	C0332849
27905023	cortical	C0007776
27905023	progenitor	C0038250
27905023	markers	C0005516
27905023	COUP-TFII	C1506576
27905023	progenitor cells	C0038250
27905023	localized	C0392752
27905023	ventral	C1704448
27905023	CGE	C1268212
27905023	ventral	C1704448
27905023	cortex	C0007776
27905023	COUP-TFII	C1506576
27905023	PAX6	C4308210
27905023	proliferative	C0596290
27905023	zones	C1710706
27905023	TBR1	C3501502
27905023	calretinin	C0054544
27905023	mitotic	C1513354
27905023	cortical neurons	C2333134
27905023	COUP-TFII	C1506576
27905023	progenitors	C0038250
27905023	pyramidal cells	C0206441
27905023	interneurons	C0021792
27905023	migrated	C0232902
27905023	cortex	C0007776
27905023	ventral	C1704448
27905023	CGE	C1268212
27905023	anteriorly	C0205094
27905023	LGE	C1268212
27905324	Primary neuroendocrine carcinoma	C0206695
27905324	breast	C0006141
27905324	single Center experience	C0596545
27905324	review of the literature	C0282441
27905324	Neuroendocrine carcinoma	C0206695
27905324	breast	C0006141
27905324	extremely	C0205403
27905324	rare	C0522498
27905324	tumor	C0027651
27905324	standard	C1442989
27905324	treatment	C0087111
27905324	established	C0443211
27905324	cases	C1706256
27905324	literature	C0023866
27905324	authors	C3812881
27905324	cases	C1706256
27905324	January	C3829466
27905324	December	C3830550
27905324	review of literature	C0282441
27905324	patients	C0030705
27905324	quadrantectomy	C0337354
27905324	cases	C1706256
27905324	axillary nodal dissection	C0024203
27905324	mastectomy	C0024881
27905324	axillary nodal dissection	C0024203
27905324	Tumor size	C0475440
27905324	T1	C0475372
27905324	T2	C0475373
27905324	N0	C0441959
27905324	N1	C0441962
27905324	TNM classification	C0809869
27905324	Pathological specimens	C0444061
27905324	stained	C2986582
27905324	hematoxylin	C0018964
27905324	eosin	C0021212
27905324	immunohistochemical	C1441616
27905324	panel	C0441833
27905324	antibodies	C0813154
27905324	Neuron-specific enolase	C0003320
27905324	Chromogranin	C0486578
27905324	Synaptophysin	C0487636
27905324	Estrogen	C1545287
27905324	Progesterone receptors	C1545448
27905324	c-erb	C0003320
27905324	Ki-67	C0208804
27905324	cases	C1706256
27905324	markers	C0162490
27905324	Neuron-specific enolase	C0003320
27905324	Chromogranin	C0486578
27905324	Synaptophysin	C0487636
27905324	Estrogen	C1545287
27905324	Progesterone receptors	C1545448
27905324	Ki-67	C0208804
27905324	patients	C0030705
27905324	Adjuvant chemotherapy	C0085533
27905324	administrated	C1533734
27905324	patients	C0030705
27905324	Ki-67	C0208804
27905324	patients	C0030705
27905324	treated	C1522326
27905324	radiotherapy	C1522449
27905324	hormonal therapy	C0279025
27905324	Neuroendocrine breast tumor	C3544078
27905324	entity	C1551338
27905324	treatment	C0087111
27905324	correlate	C1707520
27905324	size of tumor	C0475440
27905324	lymph node	C0024204
27905324	status	C0449438
27905324	Ki-67	C0208804
27905324	index	C0600653
27905324	breast cancer	C0678222
27905324	Diagnosis	C0011900
27905324	Neuroendocrine breast carcinoma	C0206695
27905972	parametric model	C3161035
27905972	assess	C1516048
27905972	delay	C0205421
27905972	compression	C0392756
27905972	mortality	C0205848
27905972	decrease	C0547047
27905972	mortality	C0205848
27905972	ages	C0001779
27905972	age	C0001779
27905972	pattern	C0449774
27905972	mortality	C0205848
27905972	mortality	C0205848
27905972	delay	C0205421
27905972	differences	C1705242
27905972	rate	C1521828
27905972	decrease	C0547047
27905972	ages	C0001779
27905972	shape	C0332479
27905972	age-at-death	C1546180
27905972	distribution	C1704711
27905972	mortality	C0205848
27905972	compression	C0392756
27905972	expansion	C0442805
27905972	Evidence	C3887511
27905972	compression	C0392756
27905972	delay	C0205421
27905972	mortality	C0205848
27905972	parametric models	C3161035
27905972	age	C0001779
27905972	pattern	C0449774
27905972	mortality	C0205848
27905972	mortality	C0205848
27905972	delay	C0205421
27905972	mortality	C0205848
27905972	compression	C0392756
27905972	models	C3161035
27905972	delay	C0205421
27905972	compression	C0392756
27905972	adult	C0001675
27905972	old ages	C1999167
27905972	mortality	C0205848
27905972	compression	C0392756
27905972	modal age	C0001779
27905972	death	C1306577
27905972	different	C1705242
27905972	mechanisms	C0441712
27905972	paper	C1706852
27905972	parametric model	C3161035
27905972	age	C0001779
27905972	pattern	C0449774
27905972	mortality	C0205848
27905972	compression	C0392756
27905972	different	C1705242
27905972	stages of life	C0680083
27905972	delay	C0205421
27905972	mortality	C0205848
27905972	CoDe model	C3161035
27905972	model	C3161035
27905972	parameters	C0549193
27905972	constant	C1948059
27905972	time	C0040223
27905972	time	C0040223
27905972	parameters	C0549193
27905972	delay	C0205421
27905972	mortality	C0205848
27905972	compression	C0392756
27905972	mortality	C0205848
27905972	infancy	C0231330
27905972	adolescence	C0001578
27905972	young adulthood	C0680085
27905972	late adulthood	C0700597
27905972	old age	C1999167
27905972	model	C3161035
27905972	infant	C0021270
27905972	mortality	C0205848
27905972	functions	C0542341
27905972	mixed logistic model	C0023965
27905972	different	C1705242
27905972	slopes	C0807955
27905972	adult	C0001675
27905972	middle	C0026062
27905972	old age	C1999167
27905972	modal age	C0001779
27905972	death	C1306577
27905972	parameter	C0549193
27905972	delay	C0205421
27905972	mortality	C0205848
27905972	CoDe model	C3161035
27905972	age	C0001779
27905972	specific	C0205369
27905972	probabilities	C0033204
27905972	death	C1306577
27905972	Japanese	C1556094
27905972	French	C1556084
27905972	American	C0596070
27905972	Danish	C1257890
27905972	men	C0025266
27905972	women	C0043210
27905972	age	C0001779
27905972	pattern	C0449774
27905972	mortality	C0205848
27905972	Delay	C0205421
27905972	mortality	C0205848
27905972	increase	C0442805
27905972	life expectancy	C0023671
27905972	birth	C0005615
27905972	compression	C0392756
27905972	mortality	C0205848
27905972	mortality declines	C0282251
27905972	young age	C4061789
27905972	compression	C0392756
27905972	mortality	C0205848
27905972	late adulthood age	C0700597
27905972	Mortality	C0205848
27905972	compression	C0392756
27905972	old age	C1999167
27905972	life expectancy	C0023671
27905972	CoDe model	C3161035
27905972	age	C0001779
27905972	pattern	C0449774
27905972	mortality	C0205848
27905972	mortality	C0205848
27905972	delay	C0205421
27905972	compression	C0392756
27905972	different	C1705242
27905972	stages of life	C0680083
27905972	increase	C0442805
27905972	life expectancy	C0023671
27906155	Prevalence	C0033105
27906155	Hypothyroidism	C0020676
27906155	Andalusia, Spain,	C0037747
27906155	Thyroid Hormone	C0040135
27906155	Comsumption	C0678263
27906155	Hypothyroidism	C0020676
27906155	hormone deficiency	C0599750
27906155	prevalence	C0033105
27906155	Spain	C0037747
27906155	prevalence	C0033105
27906155	registration	C1514821
27906155	patients	C0030705
27906155	thyroid hormones	C0040135
27906155	Andalusia (South Spain)	C0037747
27906155	patients	C0030705
27906155	levothyroxine	C1881373
27906155	Andalusian Health Service	C0018747
27906155	Prevalence	C0033105
27906155	confidence intervals	C0009667
27906155	management area	C0683738
27906155	sex	C1522384
27906155	age groups	C0027362
27906155	evaluated	C0220825
27906155	people	C0027361
27906155	female	C0086287
27906155	levothyroxine	C1881373
27906155	prevalence	C0033105
27906155	hypothyroidism	C0020676
27906155	CI	C0009667
27906155	population	C1257890
27906155	females	C0086287
27906155	CI	C0009667
27906155	males	C0086582
27906155	CI	C0009667
27906155	4.5-fold	C1254367
27906155	population	C1257890
27906155	women	C0043210
27906155	CI	C0009667
27906155	CI	C0009667
27906155	prevalence	C0033105
27906155	adult	C0001675
27906155	women	C0043210
27906155	western provinces	C1514578
27906155	CI	C0009667
27906155	eastern provinces	C1514578
27906155	CI	C0009667
27906155	coastal areas	C0017446
27906155	CI	C0009667
27906155	mountainous ones	C1257890
27906155	CI	C0009667
27906155	high prevalence	C1512456
27906155	hypothyroidism	C0020676
27906155	adult	C0001675
27906155	population	C1257890
27906155	Andalusia	C0037747
27906155	countries	C0454664
27906155	associated with	C0332281
27906155	females	C0086287
27906155	age	C0001779
27906155	prevalence	C0033105
27906155	illness	C0221423
27906155	geographically-related	C0681784
27906155	variability	C2827666
27909142	Disease Activity	C1384960
27909142	Increased Risk of	C0332167
27909142	Cardiovascular Death	C0376297
27909142	Patients	C0030705
27909142	Psoriatic Arthritis	C0003872
27909142	cardiovascular (CV) morbidity	C1301700
27909142	mortality	C0376297
27909142	patients	C0030705
27909142	psoriatic arthritis	C0003872
27909142	PsA	C0003872
27909142	mortality rate	C0205848
27909142	cause of death	C0007465
27909142	CV events	C1320716
27909142	patients	C0030705
27909142	northern	C1709269
27909142	Sweden	C0038995
27909142	PsA	C0003872
27909142	Patients	C0030705
27909142	PsA	C0003872
27909142	standardized mortality ratio	C1710186
27909142	SMR	C1710186
27909142	standardized incidence ratio	C2828391
27909142	SIR	C2828391
27909142	CV events	C1320716
27909142	National Causes of Death Register	C0282574
27909142	National Inpatient Care Register	C0282574
27909142	Sweden	C0038995
27909142	general population	C0683971
27909142	inflammatory	C0333348
27909142	disease activity index	C4065474
27909142	DAI	C4065474
27909142	SMR	C1710186
27909142	overall mortality	C0026565
27909142	diseases of the circulatory system	C0728936
27909142	International Classification of Diseases	C0870733
27909142	regression analysis	C0034980
27909142	DAI	C4065474
27909142	death	C1306577
27909142	stratifying	C0205363
27909142	patients	C0030705
27909142	causes of death	C0007465
27909142	diseases of the circulatory system	C0728936
27909142	malignant neoplasms	C0006826
27909142	Peripheral	C1704436
27909142	axial disease	C3805913
27909142	death	C1306577
27909142	peripheral disease	C1704436
27909142	SIR	C2828391
27909142	CV event	C1320716
27909142	myocardial infarction	C0027051
27909142	stroke	C0018843
27909142	men	C0025266
27909142	Patients	C0030705
27909142	PsA	C0003872
27909142	SMR	C1710186
27909142	death	C1306577
27909142	diseases of the circulatory system	C0728936
27909142	general population	C0683971
27909142	patients	C0030705
27909142	death	C1306577
27909142	DAI	C4065474
27909142	axial involvement	C3805913
27909142	peripheral disease	C1704436
27909142	disease phenotypes	C4086242
27910818	Histomorphometric	C0200760
27910818	transcriptome	C3178810
27910818	evaluation	C0220825
27910818	healing bone	C1321023
27910818	treated with	C0332293
27910818	novel	C0205314
27910818	human particulate dentin	C0011429
27910818	powder	C0032861
27910818	Human particulate dentin	C0011429
27910818	HPD	C0011429
27910818	potential	C3245505
27910818	alternative	C1523987
27910818	bone grafting	C0005976
27910818	material	C0181074
27910818	mechanism	C0441712
27910818	bone healing	C1321023
27910818	molecular	C1521991
27910818	level	C0441889
27910818	grafting	C1961139
27910818	HPD	C0011429
27910818	study	C2603343
27910818	assessed	C1516048
27910818	histological	C0205462
27910818	global	C2348867
27910818	gene expression	C0017262
27910818	bone tissues	C0391978
27910818	grafted	C0700106
27910818	HPD	C0011429
27910818	HPD	C0011429
27910818	prepared	C4082130
27910818	X-ray diffraction	C0043301
27910818	XRD	C0043301
27910818	energy dispersive x-ray spectroscopy	C2699997
27910818	EDX	C2699997
27910818	performed	C0884358
27910818	confirm	C1456348
27910818	crystal structure	C0444626
27910818	organic compound	C0029224
27910818	residues	C1709915
27910818	surface morphology	C0332437
27910818	Bony	C0443157
27910818	defects	C1457869
27910818	created	C1706214
27910818	heads	C0018670
27910818	New Zealand White rabbits	C0324547
27910818	Sterilized	C0205556
27910818	HPD	C0011429
27910818	grafting material	C0181074
27910818	quality	C0332306
27910818	quantity	C1265611
27910818	new bone formation	C0029433
27910818	evaluated	C0220825
27910818	micro-CT	C2350281
27910818	histologic	C0205462
27910818	analyses	C0936012
27910818	during	C0347984
27910818	experimental	C1517586
27910818	periods	C1948053
27910818	microarray assay	C0022885
27910818	bone tissue	C0391978
27910818	blood samples	C0178913
27910818	post-implantation	C1254367
27910818	results	C0456984
27910818	XRD	C0043301
27910818	EDX	C2699997
27910818	HPD	C0011429
27910818	physical	C0597237
27910818	chemical properties	C0243178
27910818	similar	C2348205
27910818	natural	C0205296
27910818	hydroxyapatite	C0020326
27910818	New bone formation	C0029433
27910818	observed	C1441672
27910818	HPD	C0011429
27910818	implantation	C0021107
27910818	compared	C1707455
27910818	controls	C0009932
27910818	hematoxylin and eosin staining	C0523207
27910818	micro-CT	C2350281
27910818	bone volume	C1317149
27910818	HPD	C0011429
27910818	treated	C1522326
27910818	animals	C0003062
27910818	higher	C0205250
27910818	control group	C0009932
27910818	observation	C0302523
27910818	times	C1632851
27910818	Microarray analysis	C1449575
27910818	vascular development	C1621270
27910818	immune	C0439662
27910818	inflammatory	C0333348
27910818	genes	C0017337
27910818	expressed	C0017262
27910818	early	C2363430
27910818	healing	C0043240
27910818	stage	C0205390
27910818	gene coding	C3839127
27910818	IL-1 antagonist	C3536785
27910818	IL1RN	C1416402
27910818	expressed	C0017262
27910818	inhibit	C0021469
27910818	inflammatory response	C1155266
27910818	CCL2 gene	C1337092
27910818	activated	C1879547
27910818	normal	C0205307
27910818	level	C0441889
27910818	BMP2	C1332424
27910818	RUNX2	C1419771
27910818	COL1A	C0017337
27910818	OPN	C1420369
27910818	expression	C0017262
27910818	up-regulated	C0041904
27910818	CCL2	C1337092
27910818	predominated	C0332251
27910818	osteoblastogenesis	C1159974
27910818	HPD	C0011429
27910818	treated	C1522326
27910818	bony	C0443157
27910818	defect	C1457869
27910818	early stage	C2363430
27910818	healing	C0043240
27910818	HPD	C0011429
27910818	accelerated	C0521110
27910818	bone regeneration	C0005972
27910818	augmentation	C0332509
27910818	results	C0456984
27910818	suggested	C1705535
27910818	HPD	C0011429
27910818	provided	C1999230
27910818	potential	C3245505
27910818	bone graft	C0005976
27910818	resource	C0178514
27910818	during	C0347984
27910818	bone	C0262950
27910818	healing process	C2004454
27913563	person	C0027361
27913563	docto	C0031831
27913563	work-life balance	C4277700
27913563	doctors	C0031831
27913563	training	C0220931
27913563	qualitative study	C0949415
27913563	Investigate	C1292732
27913563	work-life balance	C4277700
27913563	doctors	C0031831
27913563	training	C0220931
27913563	UK	C0041700
27913563	trainers	C0453962
27913563	Qualitative	C0205556
27913563	interviews	C0021822
27913563	trainers	C0453962
27913563	Postgraduate medical training	C0871106
27913563	London	C0023973
27913563	Yorkshire	C0017446
27913563	Humber	C0017446
27913563	Kent	C0454861
27913563	Surrey	C0454877
27913563	Sussex	C0017446
27913563	Wales	C0043015
27913563	junior doctor	C0031831
27913563	contract	C0332522
27913563	dispute	C0680226
27913563	General Medical Council	C0029246
27913563	study	C2603343
27913563	postgraduate medical training	C0871106
27913563	trainers	C0453962
27913563	UK	C0041700
27913563	graduates	C0588053
27913563	International Medical Graduates	C0016553
27913563	training	C0220931
27913563	specialties	C0037778
27913563	General Practice	C0086343
27913563	Medicine	C0025118
27913563	Obstetrics and Gynaecology	C1274104
27913563	Psychiatry	C0033873
27913563	Radiology	C0034599
27913563	Surgery	C0038894
27913563	Foundation	C0016617
27913563	Postgraduate training	C0871106
27913563	work-life imbalance	C4277572
27913563	Long	C0205166
27913563	hours	C0439227
27913563	work	C0043227
27913563	revision	C0439617
27913563	completion	C1554962
27913563	e-portfolio	C0205556
27913563	workplaces	C0162579
27913563	disrupt	C0332454
27913563	personal lives	C0682273
27913563	separation	C0599245
27913563	friends	C0079382
27913563	family	C0015576
27913563	cope	C0009967
27913563	stresses	C0038443
27913563	learning	C0023185
27913563	training	C0220931
27913563	leaving	C1706081
27913563	lack	C0332268
27913563	social support	C0037438
27913563	stresses	C0038443
27913563	training	C0220931
27913563	Low	C0205251
27913563	morale	C0438698
27913563	harm	C0438698
27913563	well-being	C1821407
27913563	feeling	C1527305
27913563	dehumanised	C1135946
27913563	Work-life imbalance	C4277572
27913563	severe	C0205082
27913563	children	C0008059
27913563	women	C0043210
27913563	lack	C0332268
27913563	less-than	C0439092
27913563	full-time positions	C2584323
27913563	discriminatory	C0012632
27913563	attitudes	C0004271
27913563	Female	C0086287
27913563	talked	C0234856
27913563	choose	C1707391
27913563	specialty	C0037778
27913563	work-life balance	C4277700
27913563	General Practice	C0086343
27913563	junior doctor	C0031831
27913563	contract	C0332522
27913563	exacerbate	C0436331
27913563	existing	C0205556
27913563	problems	C0033213
27913563	lack	C0332268
27913563	work-life balance	C4277700
27913563	postgraduate medical training	C0871106
27913563	negatively	C3853545
27913563	impacted	C0333125
27913563	learning	C0023185
27913563	well-being	C1821407
27913563	Women	C0043210
27913563	children	C0008059
27913563	affected	C0392760
27913563	group	C0441833
27913563	benefit	C0814225
27913563	greatest	C0205393
27913563	changes	C0392747
27913563	improve	C0184511
27913563	work-life balance	C4277700
27920749	Reappraisal	C1254363
27920749	Attentional Bias	C4277667
27920749	Angry	C0002957
27920749	Angry Faces	C0015457
27920749	attentional bias	C4277667
27920749	emotional	C0849912
27920749	information	C1533716
27920749	disorders	C0012634
27920749	emotion	C0013987
27920749	dysregulation	C0004936
27920749	anxiety	C0003469
27920749	depression	C0011570
27920749	substance abuse	C0740858
27920749	reappraisal	C1254363
27920749	emotion regulation	C2370884
27920749	strategy	C0679199
27920749	subjective experience	C0596545
27920749	emotions	C0013987
27920749	reappraisal	C1254363
27920749	attentional biases	C4277667
27920749	emotional	C0849912
27920749	information	C1533716
27920749	research	C0035168
27920749	investigated	C1292732
27920749	instruction-induced state reappraisal	C1254363
27920749	Study 1	C2603343
27920749	trait reappraisal	C1254363
27920749	Study 2	C2603343
27920749	attentional biases	C4277667
27920749	happy	C3280055
27920749	angry	C0002957
27920749	angry faces	C0015457
27920749	Study 1	C2603343
27920749	healthy	C3898900
27920749	young women	C0043210
27920749	groups	C0441833
27920749	up	C0441833
27920749	down	C0441833
27920749	no-regulation	C0441833
27920749	Participants	C0679646
27920749	reappraise	C1254363
27920749	emotions	C0013987
27920749	emotional	C0849912
27920749	experience	C0596545
27920749	emotionally negative film clip	C0282574
27920749	Attentional bias	C4277667
27920749	dot-probe task	C0039333
27920749	pictures	C0441469
27920749	angry	C0002957
27920749	happy	C0018592
27920749	facial expressions	C0015457
27920749	Study 2	C2603343
27920749	group	C0441833
27920749	healthy	C3898900
27920749	young men	C0025266
27920749	women	C0043210
27920749	Participants	C0679646
27920749	trait reappraisal	C1254363
27920749	suppression	C0728721
27920749	state	C0700613
27920749	trait anxiety	C0003467
27920749	dot-probe task	C0039333
27920749	participants	C0679646
27920749	Statistical tests	C0237913
27920749	Study 1	C2603343
27920749	participants	C0679646
27920749	reappraised	C1254363
27920749	negative emotions	C0013987
27920749	emotionally negative film clip	C0282574
27920749	attentional bias	C4277667
27920749	angry	C0002957
27920749	angry faces	C0015457
27920749	compared	C1707455
27920749	participants	C0679646
27920749	reappraised	C1254363
27920749	negative emotions	C0013987
27920749	Multiple regression analyses	C0034980
27920749	Study 2	C2603343
27920749	trait reappraisal	C1254363
27920749	angry	C0002957
27920749	angry faces	C0015457
27920749	state anxiety	C0700613
27920749	disengagement	C0441655
27920749	angry	C0002957
27920749	angry faces	C0015457
27920749	trait suppression	C0728721
27920749	disengagement	C0441655
27920749	happy faces	C3280055
27920749	instruction-induced state reappraisal	C1254363
27920749	trait reappraisal	C1254363
27920749	attentional bias	C4277667
27920749	negative	C0205160
27920749	information	C1533716
27920749	emotion regulation	C2370884
27920749	emotional	C0849912
27920749	information	C1533716
27921269	Graded Structure	C0008902
27921269	Sexual	C0036864
27921269	Definitions	C1704788
27921269	Categorizations	C0008902
27921269	Had Sex	C0243095
27921269	Virginity	C0282349
27921269	Loss	C0745777
27921269	Homosexual	C0019898
27921269	Heterosexual	C1527360
27921269	Men	C0025266
27921269	Women	C0043210
27921269	Definitions	C1704788
27921269	sexual behavior	C0036864
27921269	hierarchy	C0019523
27921269	acts	C0441655
27921269	sex	C0009253
27921269	virginity	C0282349
27921269	loss	C0745777
27921269	research	C0035168
27921269	theoretical	C0871935
27921269	explanation	C0681841
27921269	hierarchy	C0019523
27921269	sexual	C0036864
27921269	definitions	C1704788
27921269	graded categorical structure	C0008902
27921269	membership	C0680038
27921269	judgments	C0022423
27921269	Moderation	C1881878
27921269	graded structure	C0008902
27921269	sexual orientation	C0205949
27921269	identity	C0424215
27921269	sexual	C0036864
27921269	definitions	C1704788
27921269	year	C1510829
27921269	participants	C0679646
27921269	online survey	C0038951
27921269	rating	C0871208
27921269	behaviors	C0004927
27921269	had sex	C0243095
27921269	virginity	C0282349
27921269	loss	C0745777
27921269	Participants	C0679646
27921269	groups	C0681860
27921269	heterosexual	C1527360
27921269	male	C0025266
27921269	female	C0043210
27921269	gay male	C0242657
27921269	lesbian	C1533642
27921269	ratings	C0871208
27921269	hierarchy	C0019523
27921269	bidirectional genital acts	C0036864
27921269	rated	C0871208
27921269	higher	C0205250
27921269	unidirectional	C0036864
27921269	nonpenetrative contact	C0563018
27921269	rated	C0871208
27921269	higher	C0205250
27921269	acts	C0441655
27921269	no genital contact	C0243095
27921269	Moderation	C1881878
27921269	graded structure	C0008902
27921269	predictions	C0681842
27921269	groups	C0681860
27921269	lesbian group	C0681860
27921269	ratings	C0871208
27921269	genital contact	C0036864
27921269	unidirectional	C0036864
27921269	nonpenetrative	C0563018
27921269	evidence	C3887511
27921269	gay male	C0242657
27921269	anal intercourse	C0556628
27921269	ratings	C0871208
27921269	effects	C1280500
27921269	group	C0681860
27921269	variation	C0205419
27921269	experience	C0596545
27921269	contextual perspective	C0004271
27921269	identity	C0424215
27921269	implications	C3146298
27921269	findings	C0243095
27921269	research	C0035168
27921269	graded structure	C0008902
27921269	benefit	C0814225
27921269	research	C0035168
27921269	sexual	C0036864
27921269	definitions	C1704788
27921269	definitions	C1704788
27921401	soybean isoflavone	C4076257
27921401	intestinal	C0021853
27921401	antioxidant capacity	C1148564
27921401	cytokines	C0079189
27921401	piglets	C0039005
27921401	fed	C2987508
27921401	oxidized	C0030011
27921401	fish oil	C0016157
27921401	glycitein	C0253391
27921401	synthetic	C1883254
27921401	soybean isoflavone	C4076257
27921401	ISF	C4076257
27921401	intestinal	C0021853
27921401	antioxidant capacity	C1148564
27921401	morphology	C0332437
27921401	cytokine	C0079189
27921401	piglets	C0039005
27921401	fed	C2987508
27921401	oxidized	C0030011
27921401	fish oil	C0016157
27921401	piglets	C0039005
27921401	treatments	C0001563
27921401	control group	C0009932
27921401	fed	C2987508
27921401	basal diet	C2983588
27921401	fresh	C0443224
27921401	fish oil	C0016157
27921401	dosage	C0178602
27921401	oxidized	C0030011
27921401	fish oil	C0016157
27921401	ISF	C4076257
27921401	oxidized	C0030011
27921401	fish oil	C0016157
27921401	ISF	C4076257
27921401	feeding	C2987508
27921401	supplementation	C0242297
27921401	oxidized	C0030011
27921401	fish oil	C0016157
27921401	malondialdehyde	C0024643
27921401	MDA	C0024643
27921401	oxidized glutathione	C0061516
27921401	GSSG	C0061516
27921401	interleukin-1β	C0021753
27921401	IL-1β	C0021753
27921401	tumor necrosis factor-α	C1456820
27921401	TNF-α	C1456820
27921401	interleukin-2	C0021756
27921401	IL-2	C0021756
27921401	nuclear factor κ B	C0079904
27921401	(NF-κB	C0079904
27921401	inducible nitric oxide synthase	C0132555
27921401	iNOS	C0132555
27921401	NO	C0028128
27921401	Caspase-3	C0291573
27921401	jejunal mucosa	C0227308
27921401	villous	C0227266
27921401	height	C0489786
27921401	duodenum	C0013303
27921401	secretory immunoglobulin A	C0020838
27921401	(sIgA	C0020838
27921401	IL-4	C0021758
27921401	jejunal mucosa	C0227308
27921401	supplementation	C0242297
27921401	fresh	C0443224
27921401	oil	C0016157
27921401	oxidized	C0030011
27921401	fish oil	C0016157
27921401	ISF	C4076257
27921401	oxidized	C0030011
27921401	fish oil	C0016157
27921401	ISF	C4076257
27921401	villous	C0227266
27921401	height	C0489786
27921401	sIgA	C0020838
27921401	IL-4	C0021758
27921401	jejunal mucosa	C0227308
27921401	IL-1β	C0021753
27921401	IL-2	C0021756
27921401	jejunal mucosa	C0227308
27921401	oxidized	C0030011
27921401	fish oil	C0016157
27921401	dietary supplementation	C0242297
27921401	ISF	C4076257
27921401	oxidized	C0030011
27921401	fish oil	C0016157
27921401	intestinal morphology	C0021853
27921401	antioxidant capacity	C1148564
27921401	immune function	C1817756
27921401	piglets	C0039005
27921401	piglets	C0039005
27923134	Evolution	C3825184
27923134	Enhanced	C2349975
27923134	Footing	C1527178
27923134	Snake	C0037382
27923134	Limb Development	C1517884
27923134	loss	C1517945
27923134	limbs	C0015385
27923134	snake	C0037382
27923134	evolution	C3825184
27923134	long-distance	C0456966
27923134	cis-acting enhancer	C1516561
27923134	Sonic Hedgehog	C1335824
27923134	progressive	C0205329
27923134	degeneration	C1880269
27923134	binding sites	C1514535
27923134	transcription factors	C0040648
27923134	progressive	C0205329
27923134	limblessness	C0205556
27923134	occurring	C1709305
27923134	reptiles	C0035161
27923790	Dynamin-related protein 1	C0669938
27923790	mediates	C0205245
27923790	low glucose	C0017725
27923790	induced	C0205263
27923790	endothelial dysfunction	C0856169
27923790	human	C0086418
27923790	arterioles	C0003847
27923790	glycemic regulation	C1327622
27923790	increased	C0205217
27923790	incidence	C0021149
27923790	hypoglycemia	C0020615
27923790	Hypoglycemic	C0020615
27923790	burden	C2828008
27923790	adverse	C0001688
27923790	cardiovascular complications	C0161816
27923790	acutely	C0205178
27923790	chronically	C0205191
27923790	endothelial dysfunction	C0856169
27923790	data	C1511726
27923790	mitochondrial dysfunction	C4021734
27923790	hypoglycemia	C0020615
27923790	induced	C0205263
27923790	endothelial dysfunction	C0856169
27923790	mechanisms	C0441712
27923790	linkage	C0205245
27923790	unknown	C0439673
27923790	clinically	C0205210
27923790	relevant	C2347946
27923790	low-glucose	C0017725
27923790	LG	C0017725
27923790	exposures	C0332157
27923790	acutely	C0205178
27923790	induce	C0205263
27923790	endothelial dysfunction	C0856169
27923790	activation	C1879547
27923790	mitochondrial fission process	C0230871
27923790	Characterization	C1880022
27923790	mitochondrial morphology	C0243095
27923790	cultured	C0205245
27923790	endothelial cells	C0225336
27923790	confocal microscopy	C0242842
27923790	Isolated	C0205409
27923790	human	C0086418
27923790	arterioles	C0003847
27923790	effect	C1280500
27923790	LG	C0017725
27923790	induced	C0205263
27923790	mitochondrial fission	C0230871
27923790	formation	C1522492
27923790	detrimental reactive oxygen species	C1537052
27923790	ROS	C1537052
27923790	bioavailability	C0005508
27923790	nitric oxide	C0028128
27923790	NO	C0028128
27923790	endothelial-dependent vascular relaxation	C1258036
27923790	Fluorescence microscopy	C0026022
27923790	changes	C0392747
27923790	mitochondrial	C0026237
27923790	ROS	C1537052
27923790	NO	C0028128
27923790	levels	C0441889
27923790	videomicroscopy	C0242940
27923790	measure	C0079809
27923790	vasodilation	C0042401
27923790	response	C0205245
27923790	Pharmacological	C0205464
27923790	disruption	C0332453
27923790	profission protein	C0033684
27923790	Drp1	C0669938
27923790	Mdivi-1	C2933581
27923790	LG	C0017725
27923790	exposure	C0332157
27923790	reduced	C0392756
27923790	mitochondrial fragmentation	C0230871
27923790	vascular endothelial cells	C1257792
27923790	LG	C0017725
27923790	LG	C0017725
27923790	Mdivi-1	C2933581
27923790	prevented	C1292733
27923790	formation	C1522492
27923790	vascular	C0005847
27923790	ROS	C1537052
27923790	LG	C0017725
27923790	LG	C0017725
27923790	Mdivi-1	C2933581
27923790	increased	C0205217
27923790	presence	C0150312
27923790	NO	C0028128
27923790	LG	C0017725
27923790	LG	C0017725
27923790	Mdivi-1	C2933581
27923790	improved	C0184511
27923790	vascular dilation	C0042401
27923790	response	C0205245
27923790	acetylcholine	C0001041
27923790	LG	C0017725
27923790	LG	C0017725
27923790	Mdivi-1	C2933581
27923790	maximum	C0806909
27923790	dose	C0178602
27923790	decreased	C0205216
27923790	expression	C1171362
27923790	Drp1	C0669938
27923790	siRNA	C1099354
27923790	knockdown	C2350567
27923790	LG	C0017725
27923790	conditions	C0348080
27923790	improved	C0184511
27923790	vascular relaxation	C1258036
27923790	Exposure to	C0332157
27923790	LG	C0017725
27923790	endothelial dysfunction	C0856169
27923790	coupled	C1948027
27923790	altered	C0392747
27923790	mitochondrial	C0026237
27923790	phenotypes	C0031437
27923790	isolated	C0205409
27923790	human	C0086418
27923790	arterioles	C0003847
27923790	Disruption	C0332453
27923790	Drp1	C0669938
27923790	subsequent	C0332282
27923790	mitochondrial fragmentation	C0230871
27923790	prevents	C1292733
27923790	impaired	C0221099
27923790	vascular dilation	C0042401
27923790	restores	C0205245
27923790	mitochondrial	C0026237
27923790	phenotype	C0031437
27923790	mitochondrial fission	C0230871
27923790	primary	C0205225
27923790	mediator	C0205556
27923790	LG	C0017725
27923790	induced	C0205263
27923790	endothelial dysfunction	C0856169
27923790	Acute	C0205178
27923790	low-glucose	C0017725
27923790	exposure	C0332157
27923790	induces	C0205263
27923790	mitochondrial fragmentation	C0230871
27923790	endothelial cells	C0225336
27923790	Drp1	C0669938
27923790	associated with	C0332281
27923790	impaired	C0221099
27923790	endothelial	C0225336
27923790	function	C0007613
27923790	human	C0086418
27923790	arterioles	C0003847
27923790	Targeting	C0599894
27923790	Drp1	C0669938
27923790	prevents	C1292733
27923790	fragmentation	C0230871
27923790	vasofunction	C1254358
27923790	therapeutic	C0302350
27923790	target	C1521840
27923790	cardiovascular complications	C0161816
27923790	diabetics	C0241863
27923790	http://ajpheart.podbean.com/e/mitochondrial-dynamics-impact-endothelial-function/	C1704666
27925180	Yin Yang	C0017337
27925180	gene expression	C0017262
27925180	ratio	C0456603
27925180	signature	C1708225
27925180	ER+	C2938924
27925180	node- breast cancer	C3160889
27925180	Breast cancer	C0006142
27925180	causes	C0015127
27925180	cancer	C0006826
27925180	death	C0011065
27925180	women	C0043210
27925180	complex	C0439855
27925180	heterogeneous	C0019409
27925180	disease	C0012634
27925180	clinical	C0205210
27925180	outcomes	C0085415
27925180	Stratifying	C0205363
27925180	patients	C0030705
27925180	subgroups	C1515021
27925180	outcomes	C0085415
27925180	clinical decision making	C4042877
27925180	study	C0008972
27925180	groups	C0441833
27925180	genes	C0017337
27925180	Yin and Yang	C0017337
27925180	prognostic	C1511294
27925180	expression	C0017262
27925180	ratio	C0456603
27925180	signature	C1708225
27925180	METABRIC	C0242356
27925180	cohort	C0086027
27925180	gene signature	C1708225
27925180	stratifying	C0205363
27925180	breast cancer	C0006142
27925180	patients	C0030705
27925180	risk levels	C3166291
27925180	low-risk	C3538919
27925180	patients	C0030705
27925180	adjuvant	C1522673
27925180	systemic therapy	C1515119
27925180	intermediate	C0205103
27925180	low-risk	C3538919
27925180	patients	C0030705
27925180	treated with	C0332293
27925180	hormonal therapy	C0279025
27925180	intermediate	C0205103
27925180	high-risk groups	C0684030
27925180	treated	C0332293
27925180	chemotherapy	C3665472
27925180	hormonal therapy	C0279025
27925180	gene signature	C1708225
27925180	risk level	C3166291
27925180	stratifications	C0008902
27925180	breast cancer	C0006142
27925180	patients	C0030705
27925180	validated	C1519941
27925180	datasets	C0150098
27925180	low-risk	C3538919
27925180	group	C1257890
27925180	estrogen receptor-positive	C2938924
27925180	node negative	C3160889
27925180	ER+	C2938924
27925180	node-	C3160889
27925180	patients	C0030705
27925180	datasets	C0150098
27925180	adjuvant therapy	C0677850
27925180	year	C0439234
27925180	disease-specific survival rate	C2986538
27925180	Concordance Index	C0918012
27925180	YMR	C2698560
27925180	ER+	C2938924
27925180	node negative	C3160889
27925180	patients	C0030705
27925180	commercially	C0680536
27925180	signatures	C1708225
27925180	YMR	C2698560
27925180	significance	C0750502
27925180	HR	C2985465
27925180	stratifying	C0205363
27925180	ER+	C2938924
27925180	node-	C3160889
27925180	subgroup	C1515021
27925180	OncotypeDx	C2698560
27925180	HR	C2985465
27925180	MammaPrint	C2827401
27925180	HR	C2985465
27925180	rorS	C2698560
27925180	HR	C2985465
27925180	NPI	C2698560
27925180	HR	C2985465
27925180	YMR	C2698560
27925180	signature	C1708225
27925180	clinical	C0205210
27925180	tool	C0037589
27925180	subgroup	C1515021
27925180	low-risk	C3538919
27925180	ER+	C2938924
27925180	node-	C3160889
27925180	patients	C0030705
27925180	adjuvant	C1522673
27925180	hormonal therapy	C0279025
27925180	AHT	C0279025
27925484	Risk Factors	C0035648
27925484	Associated With	C0332281
27925484	Repeated	C0205341
27925484	HIV Testing	C0459958
27925484	Internet	C0282111
27925484	Men Who Have Sex With Men	C2827413
27925484	Men who have sex with men	C2827413
27925484	MSM	C2827413
27925484	represent	C1882932
27925484	disproportionately	C0205350
27925484	impacted	C0333125
27925484	risk group	C0684030
27925484	HIV	C0019682
27925484	incidence	C0021149
27925484	at-risk	C1444641
27925484	U.S	C0041703
27925484	studies	C2603343
27925484	identified	C0205396
27925484	risk factors	C0035648
27925484	associated with	C0332281
27925484	HIV testing	C0459958
27925484	frequency	C0871396
27925484	within	C0332285
27925484	outside	C0205101
27925484	health care settings	C0086388
27925484	MSM	C2827413
27925484	prospective cohort	C1709709
27925484	mailed	C0024492
27925484	at-home specimen collection kits	C0025080
27925484	followed	C1254367
27925484	year	C0439234
27925484	Incidence density rate ratios	C0456603
27925484	IDRR	C0456603
27925484	testing	C0039593
27925484	calculated	C1441506
27925484	generalized	C0205246
27925484	estimating	C0750572
27925484	equations	C0552449
27925484	association	C0439849
27925484	HIV testing	C0459958
27925484	behavioral	C0004927
27925484	factors	C1521761
27925484	incidence rate	C1708485
27925484	testing	C0039593
27925484	higher	C0205250
27925484	Black	C0005680
27925484	MSM	C2827413
27925484	White	C0007457
27925484	MSM	C2827413
27925484	IDRR	C0456603
27925484	confidence interval	C0009667
27925484	CI	C0009667
27925484	higher	C0205250
27925484	MSM	C2827413
27925484	condomless	C0848723
27925484	condomless anal intercourse partners	C0036911
27925484	anal	C0003461
27925484	CAI	C0036911
27925484	MSM	C2827413
27925484	no	C0205160
27925484	CAI	C0036911
27925484	IDRR	C0456603
27925484	CI	C0009667
27925484	Increasing	C0442808
27925484	availability of	C0470187
27925484	HIV testing	C0459958
27925484	outside	C0205101
27925484	health care settings	C0086388
27925484	at-home testing kits	C0973155
27925484	conjunction	C2699427
27925484	targeted	C1521840
27925484	behavioral	C0004927
27925484	interventions	C1314939
27925484	biomedical	C1879848
27925484	treatment preventions	C0087111
27925527	nursingstandard.com	C2349146
27925527	Nurse	C0028661
27925527	suspended	C1705537
27925527	months	C0439231
27925527	Nursing and Midwifery Council	C0033282
27925527	NMC	C0033282
27925527	concealing	C0443189
27925527	high temperature	C0015967
27925527	colleague	C0028661
27925527	Ebola	C0282687
27925527	rcni.com/donna-wood	C2349146
27928244	Theory of Mind	C0935573
27928244	Adolescents	C0205653
27928244	Bipolar Disorder	C0005586
27928244	Euthymic Phase	C0233475
27928244	Strange Stories Test	C0282574
27928244	evaluated	C0220825
27928244	theory of mind	C0935573
27928244	ToM	C0935573
27928244	adolescents	C0205653
27928244	diagnosed	C0011900
27928244	bipolar disorder	C0005586
27928244	BD	C0005586
27928244	euthymic period	C0233475
27928244	typically developing (TD) group	C0441833
27928244	BD	C0005586
27928244	group	C0441833
27928244	inpatients	C0021562
27928244	euthymic phase	C0233475
27928244	TD ‎group	C0441833
27928244	age	C0001779
27928244	gender	C0079399
27928244	IQ	C0456149
27928244	students	C0038492
27928244	diagnosis	C0011900
27928244	‎comorbid disorders	C0012634
27928244	semi-structured interview	C0681913
27928244	Kiddie Schedule for Affective Disorders ‎and Schizophrenia-Present and Lifetime Version	C0681913
27928244	K-SADS-PL	C0681913
27928244	BD	C0005586
27928244	adolescents	C0205653
27928244	‎evaluate	C0220825
27928244	attention deficit hyperactivity disorder	C1263846
27928244	ADHD	C1263846
27928244	mania	C0338831
27928244	Conner's ‎Parent Rating Scale-Revised version (CPRS-R)	C0681889
27928244	Young Mania Rating Scale	C4087288
27928244	YMRS	C4087288
27928244	Ravens Progressive Matrices	C0451407
27928244	evaluate	C0220825
27928244	intellectual ability	C0423898
27928244	groups	C0441833
27928244	Happe Strange Stories test	C0282574
27928244	ToM	C0935573
27928244	participants	C0679646
27928244	Data	C1511726
27928244	t-test	C0871472
27928244	analysis of covariance	C0814908
27928244	Pearson Correlation analysis	C0010101
27928244	groups	C0441833
27928244	BD	C0005586
27928244	group's	C0441833
27928244	mentalizing scores	C2959458
27928244	TD group	C0441833
27928244	ToM	C0935573
27928244	impairments	C0221099
27928244	adolescents	C0205653
27928244	BD	C0005586
27928244	trait marker	C0017393
27928244	social problems	C0037431
27928244	remission‏	C0597370
27932585	TYW3	C0033684
27932585	Taw3	C0033684
27932585	SAM-dependent methyltransferases	C0969403
27932585	S-adenosylmethionine (SAM)-dependent methyltransferases	C0969403
27932585	regulate	C1327622
27932585	biological processes	C3714634
27932585	modification	C2752381
27932585	proteins	C0033684
27932585	nucleic acids	C0028606
27932585	polysaccharides	C0032594
27932585	metabolites	C0870883
27932585	TYW3	C0033684
27932585	Taw3	C0033684
27932585	SAM-dependent methyltransferase	C0969403
27932585	tRNA modification	C1158758
27932585	wybutosine	C1171957
27932585	decoding	C1519614
27932585	protein synthesis	C0597295
27932585	crystal structure	C0230587
27932585	Taw3	C0033684
27932585	TYW3	C0033684
27932585	Sulfolobus solfataricus	C0995927
27932585	α/β fold	C0162847
27932585	S/T)xSSCxGR	C0002518
27932585	aspartate	C0085845
27932585	histidine	C0019602
27932585	TYW3	C0033684
27932585	Taw3	C0033684
27932585	cluster	C1704332
27932585	catalytic	C0175921
27932585	structural	C1510464
27932585	sequence	C0002518
27932585	TYW3	C0033684
27932585	Taw3	C0033684
27932585	SAM-dependent methyltransferases	C0969403
27932585	site-directed mutagenesis	C0079870
27932585	in vivo complementation assays	C0017381
27932585	mass spectrometry	C0037813
27932585	ligand docking	C1522290
27932585	cofactor binding	C1323251
27932585	assays	C1510438
27932585	active site	C0205681
27932585	TYW3	C0033684
27932585	cofactor binding	C1323251
27932585	methyltransferase activity	C1152247
27933285	Developmental	C0458003
27933285	Profile	C1979963
27933285	Diagnoses	C1704656
27933285	Children	C0008059
27933285	Motor Stereotypies	C3898226
27933285	Motor stereotypies	C3898226
27933285	difficulty	C0332218
27933285	non-clinical behaviors	C0004927
27933285	physiological	C0031843
27933285	transient	C0205374
27933285	symptoms	C1457887
27933285	disorders	C0012634
27933285	primary stereotypies	C4302136
27933285	associated with	C0332281
27933285	autistic spectrum disorder	C1510586
27933285	ASD	C1510586
27933285	intellectual disabilities	C3714756
27933285	genetic syndromes	C0567439
27933285	sensory impairment	C4062750
27933285	study	C2603343
27933285	obtain	C1301820
27933285	assessment	C0220825
27933285	relationship	C0439849
27933285	stereotypies	C0038273
27933285	neurodevelopmental disorders	C1535926
27933285	studied	C2603343
27933285	children	C0008059
27933285	girls	C0870604
27933285	aged	C0001779
27933285	months	C0439231
27933285	consultation	C0009818
27933285	persistence	C0518691
27933285	increased	C0205217
27933285	severity	C0392364
27933285	motor stereotypies	C3898226
27933285	patients	C0030705
27933285	diagnosis	C1704656
27933285	ASD	C1510586
27933285	assessment	C0220825
27933285	Motor Severity Stereotypy Scale	C0349674
27933285	MSSS	C0349674
27933285	Repetitive Behavior Scale-Revised	C0475483
27933285	RBS-R	C0475483
27933285	Raven's Colored Progressive Matrices	C4305179
27933285	Child Behavior CheckList	C0870266
27933285	ages	C0001779
27933285	CBCL	C0870266
27933285	Social Responsiveness Scale	C0349674
27933285	(SRS)	C0349674
27933285	Autism Diagnostic Observation Schedule-second edition	C0282574
27933285	ADOS 2	C0282574
27933285	patients	C0030705
27933285	motor stereotypies	C3898226
27933285	periods of time	C1948053
27933285	months	C0439231
27933285	MSSS	C0349674
27933285	child	C0870604
27933285	limited	C0439801
27933285	number	C0237753
27933285	stereotypies	C0038273
27933285	frequency	C0871396
27933285	intensity	C0522510
27933285	mild	C2945599
27933285	interference	C0521102
27933285	stereotypies	C0038273
27933285	variable	C0439828
27933285	impairment	C0221099
27933285	life	C0376558
27933285	mild	C2945599
27933285	RBS-R	C0475483
27933285	scores	C0449820
27933285	stereotypic behaviors	C0038271
27933285	children	C0008059
27933285	children	C0008059
27933285	repetitive behaviors	C1827547
27933285	ritualistic behavior	C2266670
27933285	sameness behavior	C1827547
27933285	patients	C0030705
27933285	normal cognitive level	C4231661
27933285	CBCL	C0870266
27933285	evidenced	C3887511
27933285	behavioral problems	C0233514
27933285	children	C0008059
27933285	internalizing problems	C1457887
27933285	attention	C0004268
27933285	withdrawn	C2825032
27933285	SRS	C0349674
27933285	tested	C0039593
27933285	patients	C0030705
27933285	obtained	C1301820
27933285	clinical scores	C3533165
27933285	clinical	C0205210
27933285	range	C1514721
27933285	ADOS 2	C0282574
27933285	patients	C0030705
27933285	obtained	C1301820
27933285	scores	C0449820
27933285	moderate	C0205081
27933285	level	C0441889
27933285	ASD	C1510586
27933285	symptoms	C1457887
27933285	mild	C2945599
27933285	level	C0441889
27933285	signs	C0037088
27933285	ASD	C1510586
27933285	Motor stereotypies	C3898226
27933285	children	C0008059
27933285	normal cognitive level	C4231661
27933285	diagnostic	C0348026
27933285	issue	C0033213
27933285	tailored	C0870097
27933285	assessment	C0220825
27933285	developmental	C0458003
27933285	profile	C2003903
27933285	standardized tests	C0237892
27933285	misdiagnosis	C0679838
27933285	motor stereotypies	C3898226
27933285	movement disorder	C0026650
27933664	Left ventricular	C0225897
27933664	rotational	C0445237
27933664	mechanics	C0376706
27933664	infants	C0021270
27933664	hypoxic ischemic encephalopathy	C0752304
27933664	preterm infants	C4048294
27933664	weeks	C0439230
27933664	postmenstrual age	C3828508
27933664	comparison	C1707455
27933664	healthy	C3898900
27933664	term controls	C0009932
27933664	data	C1511726
27933664	left ventricle	C0225897
27933664	LV	C0225897
27933664	rotational physiology	C0031842
27933664	neonates	C0021289
27933664	rotational	C0445237
27933664	mechanics	C0376706
27933664	infants	C0021270
27933664	hypoxic ischemic encephalopathy	C0752304
27933664	HIE	C0752304
27933664	premature infants	C4048294
27933664	weeks	C0439230
27933664	weeks	C0439230
27933664	postmenstrual age	C3828508
27933664	PMA	C3828508
27933664	preterm group	C1257890
27933664	compare	C1707455
27933664	healthy	C3898900
27933664	term controls	C0009932
27933664	term controls	C0009932
27933664	compared	C1707455
27933664	parameters	C0549193
27933664	preterm infants	C4048294
27933664	chronic lung disease	C0746102
27933664	CLD	C0746102
27933664	Echocardiography	C0013516
27933664	hours	C0439227
27933664	birth	C0005615
27933664	weeks	C0439230
27933664	PMA	C3828508
27933664	LV	C0225897
27933664	basal	C0205112
27933664	rotation	C0035868
27933664	twist	C0231467
27933664	twist	C0231467
27933664	LV length	C1444754
27933664	twist rate	C1521828
27933664	LVTR	C1521828
27933664	untwist rate	C1521828
27933664	LVUTR	C1521828
27933664	One-way ANOVA	C1709320
27933664	compare	C1707455
27933664	values	C0042295
27933664	gestation	C0032961
27933664	birthweight	C0005612
27933664	HIE	C0752304
27933664	group	C1257890
27933664	term controls	C0009932
27933664	preterm group	C1257890
27933664	gestation	C0032961
27933664	weight	C0043100
27933664	weeks	C0439230
27933664	HIE	C0752304
27933664	twist	C0231467
27933664	LVTR	C1521828
27933664	LVUTR	C1521828
27933664	preterm group	C1257890
27933664	clockwise	C3831073
27933664	basal	C0205112
27933664	rotation	C0035868
27933664	term group	C1257890
27933664	counterclockwise	C3830994
27933664	apical	C0205111
27933664	rotation	C0035868
27933664	Preterm infants	C4048294
27933664	CLD	C0746102
27933664	apical	C0205111
27933664	rotation	C0035868
27933664	twist	C0231467
27933664	compared	C1707455
27933664	infants	C0021270
27933664	CLD	C0746102
27933664	Infants	C0021270
27933664	HIE	C0752304
27933664	rotational	C0445237
27933664	mechanics	C0376706
27933664	Preterm infants	C4048294
27933664	weeks	C0439230
27933664	PMA	C3828508
27933664	comparable	C1707455
27933664	measurements	C0242485
27933664	twist	C0231467
27933664	term infants	C0456128
27933664	basal	C0205112
27933664	basal	C0205112
27933664	apical	C0205111
27933664	rotation	C0035868
27933664	Infants	C0021270
27933664	CLD	C0746102
27933664	apical	C0205111
27933664	rotation	C0035868
27938365	Comparing	C1707455
27938365	effects of	C1704420
27938365	different	C1705242
27938365	dynamic sitting strategies	C0454281
27938365	wheelchair seating	C0438917
27938365	lumbar-pelvic angle	C0024090
27938365	Prolonged	C0439590
27938365	static sitting	C4270719
27938365	wheelchair	C0043143
27938365	associated with	C0332281
27938365	increased	C0205217
27938365	risk	C0035647
27938365	lower back pain	C0024031
27938365	wheelchair seating system	C0438917
27938365	key factor	C1521761
27938365	risk	C0035647
27938365	spinal	C0521329
27938365	loading	C0205245
27938365	sitting position	C0277814
27938365	study	C2603343
27938365	dynamic sitting strategies	C0454281
27938365	DSSs	C0454281
27938365	examined	C0332128
27938365	lumbar prominent dynamic sitting	C0454281
27938365	LPDS	C0454281
27938365	back reclined dynamic sitting	C0454281
27938365	BRDS	C0454281
27938365	femur upward dynamic sitting	C0454281
27938365	FUDS	C0454281
27938365	lumbar prominent with back reclined dynamic sitting	C0454281
27938365	LBDS	C0454281
27938365	lumbar prominent with femur upward dynamic sitting	C0454281
27938365	LFDS	C0454281
27938365	back reclined with femur upward dynamic sitting	C0454281
27938365	BFDS	C0454281
27938365	lumbar prominent with back reclined with femur upward dynamic sitting	C0454281
27938365	LBFDS	C0454281
27938365	objective	C0018017
27938365	study	C2603343
27938365	analyze	C0936012
27938365	biomechanical	C3658372
27938365	effects of	C1704420
27938365	sitting strategies	C0454281
27938365	lumbar-pelvic angles	C0024090
27938365	able-bodied	C0424576
27938365	participants	C0679646
27938365	recruited	C0205245
27938365	study	C2603343
27938365	participants	C0679646
27938365	performed	C0884358
27938365	LPDS	C0454281
27938365	BRDS	C0454281
27938365	FUDS	C0454281
27938365	LBDS	C0454281
27938365	LFDS	C0454281
27938365	BFDS	C0454281
27938365	LBFDS	C0454281
27938365	random	C0439605
27938365	order	C1705176
27938365	lumbar-pelvic angle	C0024090
27938365	parameters	C0549193
27938365	static	C0441463
27938365	lumbar angle	C0024090
27938365	static	C0441463
27938365	pelvic angle	C0030797
27938365	lumbar range of motion	C0575375
27938365	pelvic range of motion	C0243095
27938365	measured	C0444706
27938365	compared	C1707455
27938365	Results	C1274040
27938365	LBDS	C0454281
27938365	LBFDS	C0454281
27938365	enabled	C1171285
27938365	beneficial	C0205556
27938365	lumbar movements	C1286136
27938365	difference	C1705242
27938365	strategies	C0679199
27938365	nonsignificant	C1273937
27938365	BRDS	C0454281
27938365	BFDS	C0454281
27938365	enabled	C1171285
27938365	beneficial	C0205556
27938365	pelvic movements	C0454470
27938365	difference	C1705242
27938365	strategies	C0679199
27938365	nonsignificant	C1273937
27938365	DSSs	C0454281
27938365	LPDS	C0454281
27938365	LFDS	C0454281
27938365	enabled	C1171285
27938365	beneficial	C0205556
27938365	lumbar	C1286136
27938365	pelvic movements	C0454470
27938365	no significant	C1273937
27938365	difference	C1705242
27938365	observed	C1441672
27938365	strategies	C0679199
27938365	identified	C0205396
27938365	effects	C1280500
27938365	differences	C1705242
27938365	DSSs	C0454281
27938365	lumbar-pelvic angles	C0024090
27938365	Wheelchair users	C0853966
27938365	choose	C1707391
27938365	suitable	C3900053
27938365	DSS	C0454281
27938365	meets	C1550543
27938365	needs	C0027552
27938365	findings	C0243095
27938365	reference	C1706462
27938365	practicing physicians	C0017319
27938365	wheelchair users	C0853966
27938365	choose	C1707391
27938365	appropriate	C1548787
27938365	wheelchair seating	C0438917
27939207	heavy metal	C0347988
27939207	health risk	C0679809
27939207	HMHR	C0679809
27939207	quantification	C1709793
27939207	sources	C0449416
27939207	southern	C1710133
27939207	city	C0008848
27939207	China	C0008115
27939207	ME2	C0037585
27939207	HMHR	C0679809
27939207	model	C0596657
27939207	Heavy metals	C0347988
27939207	Cr	C0008574
27939207	Co	C0009148
27939207	Ni	C0028013
27939207	As	C0003818
27939207	Cd	C0006632
27939207	Pb	C0023175
27939207	PM	C1720884
27939207	adversely affecting	C0879626
27939207	human	C0086418
27939207	health	C0018684
27939207	source	C0449416
27939207	heavy metals	C0347988
27939207	source	C0449416
27939207	specific	C0205369
27939207	heavy metal	C0347988
27939207	health risk	C0679809
27939207	HMHR	C0679809
27939207	effective	C1704419
27939207	risks	C0035647
27939207	exposure to	C0332157
27939207	heavy metals	C0347988
27939207	PM2.5	C1720884
27939207	particulate matter	C1720884
27939207	PM	C1720884
27939207	aerodynamic diameter	C1301886
27939207	Multilinear Engine 2	C0037585
27939207	ME2	C0037585
27939207	risk assessment	C0086930
27939207	model	C0596657
27939207	quantify	C1709793
27939207	source	C0449416
27939207	contributions	C1880177
27939207	HMHR	C0679809
27939207	heavy metal	C0347988
27939207	non-cancer risk	C1513916
27939207	non-HMCR	C1513916
27939207	cancer risk	C0596244
27939207	HMCR	C0596244
27939207	model	C0596657
27939207	ME2-HMHR	C0596657
27939207	source	C0449416
27939207	contributions	C1880177
27939207	heavy metals	C0347988
27939207	ME2	C0037585
27939207	model	C0596657
27939207	source	C0449416
27939207	contributions	C1880177
27939207	risk assessment	C0086930
27939207	model	C0596657
27939207	source	C0449416
27939207	contributions	C1880177
27939207	HMHR	C0679809
27939207	Huzou	C0008115
27939207	China	C0008115
27939207	sources	C0449416
27939207	Soil	C0037592
27939207	dust	C0013330
27939207	source	C0449416
27939207	non-HMCR	C1513916
27939207	HMCR	C0596244
27939207	source	C0449416
27939207	contributions	C1880177
27939207	soil	C0037592
27939207	dust	C0013330
27939207	coal	C0009131
27939207	combustion	C0681531
27939207	cement dust	C2220339
27939207	dust	C0013330
27939207	vehicle	C0004380
27939207	sources	C0449416
27939207	soil	C0037592
27939207	dust	C0013330
27939207	contributor	C1880177
27939207	HMCR	C0596244
27939207	impact	C4049986
27939207	soil	C0037592
27939207	dust	C0013330
27939207	PM2.5	C1720884
27939207	abundance	C2346714
27939207	heavy metals	C0347988
27939207	soil	C0037592
27939207	dust	C0013330
27940576	Aspirin	C0004057
27940576	Suppresses	C1260953
27940576	Growth	C0018270
27940576	PI3K	C1335212
27940576	Mutant	C0678941
27940576	Breast Cancer	C0678222
27940576	Activating	C0599177
27940576	AMPK	C2350345
27940576	Inhibiting	C3463820
27940576	mTORC1	C2975458
27940576	incidence	C0021149
27940576	oncogenic	C0029016
27940576	mutations	C0026882
27940576	PIK3CA	C1335212
27940576	gene encoding	C3839127
27940576	catalytic subunit	C0600499
27940576	PI3K	C0044602
27940576	PI3K	C0044602
27940576	inhibitors	C0014432
27940576	clinical benefit	C1333602
27940576	breast cancer	C0678222
27940576	patients	C0030705
27940576	Recent	C0332185
27940576	epidemiologic studies	C0002783
27940576	suggested	C1705535
27940576	therapeutic	C0302350
27940576	benefit	C0814225
27940576	aspirin	C0004057
27940576	cancers	C0006826
27940576	oncogenic PIK3CA	C0044602
27940576	mutant	C0678941
27940576	PIK3CA	C0044602
27940576	expressing	C0017262
27940576	breast cancer cells	C1512505
27940576	sensitivity	C0332324
27940576	aspirin	C0004057
27940576	growth	C0007595
27940576	suppression	C0007613
27940576	wild-type	C1883559
27940576	Aspirin	C0004057
27940576	decreased	C0205216
27940576	viability	C0007620
27940576	anchorage-independent growth	C1515979
27940576	mutant	C0678941
27940576	PIK3CA	C0044602
27940576	breast cancer cells	C1512505
27940576	independently	C1299583
27940576	effects	C1280500
27940576	COX-2	C0387583
27940576	NF-κB	C0079904
27940576	effects of	C1704420
27940576	aspirin	C0004057
27940576	AMP-activated protein kinase	C2350345
27940576	AMPK	C2350345
27940576	activation	C0599177
27940576	mTORC1	C2975459
27940576	inhibition	C1519312
27940576	autophagy	C0004391
27940576	oncogenic	C0029016
27940576	PIK3CA	C0044602
27940576	mouse	C0025929
27940576	mammary tumors	C1458155
27940576	treated	C1522326
27940576	aspirin	C0004057
27940576	decreased	C0205216
27940576	tumor growth	C0598934
27940576	kinetics	C0022702
27940576	combination	C0205195
27940576	therapy	C0087111
27940576	aspirin	C0004057
27940576	PI3K	C0044602
27940576	inhibitor	C1999216
27940576	attenuated	C0599946
27940576	tumor growth	C0598934
27940576	evaluation	C0220825
27940576	aspirin	C0004057
27940576	PI3K	C0044602
27940576	inhibitors	C1254351
27940576	combination	C0205195
27940576	therapy	C0087111
27940576	targeting	C1521840
27940576	breast cancer	C0678222
27941728	Prevalence	C0683919
27941728	Psychiatric Disorders	C3841734
27941728	Female	C0086287
27941728	Juvenile Offenders	C0022443
27941728	Inmates	C0033167
27941728	Juvenile Developmental Centers	C1708333
27941728	special	C0205555
27941728	group	C1257890
27941728	youth	C0087178
27941728	population	C1257890
27941728	conflict	C0009671
27941728	law	C0728724
27941728	vulnerable	C0332324
27941728	psychiatric illness	C1404970
27941728	objective	C0018017
27941728	study	C2603343
27941728	prevalence	C0683919
27941728	type	C0332307
27941728	psychiatric disorders	C3841734
27941728	institutionalized	C0562359
27941728	female	C0086287
27941728	juvenile offenders	C0022443
27941728	non-offenders	C1257890
27941728	same	C0445247
27941728	age	C0001779
27941728	sex	C1522384
27941728	socioeconomic group	C0086996
27941728	community	C0009462
27941728	association	C0004083
27941728	mental disorders	C0004936
27941728	examined	C0332128
27941728	female	C0086287
27941728	inmates	C0033167
27941728	Juvenile Development Centers	C1708333
27941728	randomly	C0439605
27941728	selected	C1707391
27941728	comparison	C1707455
27941728	subjects	C0681850
27941728	community	C0009462
27941728	One stage-structured assessment	C1254363
27941728	psychopathology	C0033927
27941728	structured	C1300196
27941728	valid	C2349099
27941728	Bangla	C0023008
27941728	version	C0333052
27941728	Development and Well-Being Assessment	C1254363
27941728	DAWBA	C1254363
27941728	Development and Well-Being Assessment	C1254363
27941728	psychiatric	C0205487
27941728	diagnosis	C0011900
27941728	ICD-10	C1137110
27941728	diagnostic criteria	C0679228
27941728	research	C0035168
27941728	result	C0683954
27941728	revealed	C0443289
27941728	conflict	C0009671
27941728	law	C0728724
27941728	mental disorder	C0004936
27941728	non-offenders	C1257890
27941728	psychiatric disorder	C3841734
27941728	offenders	C0699726
27941728	psychiatric disorders	C3841734
27941728	Major Depressive Disorder	C1269683
27941728	MDD	C1269683
27941728	combined	C0205195
27941728	MDD	C1269683
27941728	Post Traumatic Stress Disorder	C0038436
27941728	PTSD	C0038436
27941728	non-offenders	C1257890
27941728	psychiatric disorder	C3841734
27941728	MDD	C1269683
27941728	concluded	C1707478
27941728	considerable	C4288581
27941728	psychiatric disorders	C3841734
27941728	prevalent	C0683919
27941728	female	C0086287
27941728	juvenile offenders	C0022443
27941728	comparison	C1707455
27941728	non-offenders	C1257890
27941728	Broad	C0332464
27941728	replication study	C0681825
27941728	confirm	C1456348
27941728	findings	C0243095
27941815	Association	C0439849
27941815	neutrophil	C0027950
27941815	lymphocyte	C0024264
27941815	ratio	C0456603
27941815	differentiated thyroid cancer	C1337013
27941815	meta-analysis	C0920317
27941815	association	C0439849
27941815	neutrophil	C0027950
27941815	lymphocyte	C0024264
27941815	ratio	C0456603
27941815	NLR	C0456603
27941815	differentiated thyroid cancer	C1337013
27941815	DTC	C1337013
27941815	conducted	C0884358
27941815	systematic	C0220922
27941815	meta-analysis	C0920317
27941815	prospective cohort studies	C0033522
27941815	published	C1704324
27941815	patients	C0030705
27941815	cohorts	C0599755
27941815	pretreatment	C3539076
27941815	baseline	C1442488
27941815	NLR	C0456603
27941815	data	C1511726
27941815	patients	C0030705
27941815	thyroid nodules	C0040137
27941815	meta-analysis	C0920317
27941815	cohorts	C0599755
27941815	NLR	C0456603
27941815	patients	C0030705
27941815	DTC	C1337013
27941815	cases	C1706256
27941815	statistically	C0237881
27941815	patients	C0030705
27941815	benign nodules	C0749467
27941815	cases	C1706256
27941815	CI	C0009667
27941815	P	C1709380
27941815	NLR	C0456603
27941815	patients	C0030705
27941815	DTC	C1337013
27941815	patients	C0030705
27941815	benign nodules	C0749467
27941815	studies	C0947630
27941815	association	C0439849
27941815	NLR	C0456603
27941815	papillary thyroid carcinoma	C0238463
27941815	patients	C0030705
27941815	stratified	C0205363
27941815	age	C0001779
27941815	years	C1510829
27941815	cases	C1706256
27941815	CI	C0009667
27941815	P	C1709380
27941815	elevated	C3163633
27941815	NLR	C0456603
27941815	reliable	C3858758
27941815	indicator	C1522602
27941815	progressing	C0205329
27941815	DTC	C1337013
27941815	patients	C0030705
27941815	goiters	C0018021
27941815	NLR	C0456603
27941815	patients	C0030705
27941815	aged	C0001779
27941815	years	C1510829
27941815	aged	C0001779
27941815	years	C1510829
27941815	investigations	C0220825
27941815	NLR	C0456603
27941815	prognosis	C0011900
27941815	DTC	C1337013
27941943	Transcriptomic	C3178810
27941943	allelopathic	C3658358
27941943	effects of	C1704420
27941943	garlic	C0993630
27941943	allelochemical	C0220806
27941943	diallyl disulfide	C0057693
27941943	tomato	C0242772
27941943	roots	C0242726
27941943	Garlic	C0993630
27941943	allelopathic	C3658358
27941943	crop	C0242775
27941943	continuous	C0549178
27941943	cropping	C4042899
27941943	vegetable crops	C0242775
27941943	Diallyl disulfide	C0057693
27941943	DADS	C0057693
27941943	allelochemicals	C0220806
27941943	garlic	C0993630
27941943	promotes	C0033414
27941943	tomato	C0242772
27941943	root growth	C1524120
27941943	global	C2348867
27941943	transcriptome	C3178810
27941943	profiles	C1956267
27941943	DADS	C0057693
27941943	treated	C1522326
27941943	tomato	C0242772
27941943	roots	C0242726
27941943	investigated	C1292732
27941943	potential	C3245505
27941943	growth-promoting mechanisms	C0682777
27941943	detected	C0442726
27941943	differentially expressed	C0017262
27941943	genes	C0017337
27941943	DEGs	C0017337
27941943	DEGs	C0017337
27941943	assimilatory sulfate reduction	C2612332
27941943	glutathione metabolism	C1158188
27941943	up-regulated	C0041904
27941943	short-term	C0443303
27941943	DADS	C0057693
27941943	treatment	C1522326
27941943	increased activity of defensive enzymes	C3267013
27941943	up-regulation	C0041904
27941943	peroxidase genes	C0017337
27941943	observed	C1441672
27941943	DADS	C0057693
27941943	induce	C0205263
27941943	tomato	C0242772
27941943	resistance	C4281815
27941943	plant-pathogen interactions	C1752856
27941943	DEGs	C0017337
27941943	calcium signaling	C0600431
27941943	inhibited	C0311403
27941943	encoding	C2700640
27941943	pathogenesis-related proteins	C0070140
27941943	up-regulated	C0041904
27941943	plant	C0032098
27941943	hormone synthesis	C0596715
27941943	signal transduction	C0037083
27941943	significantly affected	C0392760
27941943	DADS	C0057693
27941943	expression	C0017262
27941943	trends	C1521798
27941943	genes	C0017337
27941943	pathways	C1704259
27941943	research	C0035168
27941943	comprehensive	C1880156
27941943	information	C1533716
27941943	changes	C0392747
27941943	tomato	C0242772
27941943	root	C0242726
27941943	transcriptome	C3178810
27941943	affected	C0392760
27941943	DADS	C0057693
27941943	studies	C2603343
27941943	DADS	C0057693
27941943	responsive	C0205342
27941943	genes	C0017337
27941943	enhance	C2349975
27941943	current	C0521116
27941943	mechanisms	C0678659
27941943	DADS	C0057693
27941943	continuous	C0549178
27941943	cropping	C4042899
27965426	Mitotic	C1513354
27965426	phosphotyrosine	C0070948
27965426	network analysis	C0868995
27965426	tyrosine phosphorylation	C1519726
27965426	Polo-like kinase 1	C0290178
27965426	PLK1	C0290178
27965426	Tyrosine phosphorylation	C1519726
27965426	associated with	C0332281
27965426	cell proliferation	C0596290
27965426	cell cycle	C0007586
27965426	serine and threonine phosphorylation	C1519253
27965426	phosphorylation	C0031715
27965426	dynamic	C0729333
27965426	mitotic phase	C3893712
27965426	cell cycle	C0007586
27965426	mitotic	C1513354
27965426	phosphotyrosine	C0070948
27965426	functionally	C0542341
27965426	relevant	C2347946
27965426	mitotic	C1513354
27965426	phosphotyrosine	C0070948
27965426	sites	C0205145
27965426	characterized	C1880022
27965426	modification	C0392747
27965426	prevalent	C0220900
27965426	examined	C0332128
27965426	tyrosine phosphorylation	C1519726
27965426	mitotic human cells	C0230518
27965426	spindle-associated proteins	C0033684
27965426	Database mining	C1328866
27965426	mitotic	C1513354
27965426	phosphotyrosine	C0070948
27965426	sites	C0205145
27965426	network analysis	C0868995
27965426	tyrosine-phosphorylated proteins	C0033684
27965426	kinetochore	C0242609
27965426	spindle	C1166795
27965426	SRC family kinases	C0282625
27965426	Polo-like kinase 1	C0290178
27965426	PLK1	C0290178
27965426	signaling	C3537152
27965426	spindle	C1166795
27965426	subnetwork	C1882071
27965426	phosphorylated	C1519061
27965426	Tyr(217)	C0041485
27965426	kinase domain	C1519724
27965426	Substitution	C0525038
27965426	Tyr(217)	C0041485
27965426	phosphomimetic residue	C1254350
27965426	PLK1	C0290178
27965426	activity	C1537044
27965426	in vitro	C1533691
27965426	cells	C0007634
27965426	analysis	C0936012
27965426	Tyr(217)	C0041485
27965426	phosphorylation	C0031715
27965426	phosphorylation of Thr(210)	C1158892
27965426	activation loop	C0445022
27965426	phosphorylation	C0031715
27965426	PLK1	C0290178
27965426	activity	C1537044
27965426	mitotic	C1513354
27965426	tyrosine phosphorylation	C1519726
27965426	serine/threonine kinase	C0072402
27965426	mitotic cells	C0230518
27965426	tyrosine phosphorylation	C1519726
27965426	unrecognized	C4288068
27965426	regulatory events	C1514829
27965426	complexes	C0439855
27965426	structures	C0243092
27965426	cell cycle	C0007586
27975020	Divided	C0332849
27975020	Sliding	C0332246
27975020	Superficial Temporal Artery	C0226130
27975020	Flap	C0038925
27975020	Primary	C0205225
27975020	Donor-site	C1444716
27975020	Closure	C0185003
27975020	Superficial temporal artery	C0226130
27975020	STA	C0226130
27975020	flaps	C0038925
27975020	reconstruction	C0524865
27975020	hair-bearing areas	C0005898
27975020	primary closure	C0441503
27975020	donor site	C1444716
27975020	size	C0456389
27975020	skin island	C1123023
27975020	large	C0549177
27975020	skin grafts	C0040748
27975020	donor site	C1444716
27975020	baldness	C0002170
27975020	divided	C0332849
27975020	sliding	C0332246
27975020	flap	C0038925
27975020	technique	C0449851
27975020	primary donor-site closure	C0441503
27975020	latissimus dorsi musculocutaneous	C0224362
27975020	flap	C0038925
27975020	technique	C0449851
27975020	hair-bearing STA	C0226130
27975020	flap	C0038925
27975020	primary donor-site closure	C0441503
27975020	preventing	C2700409
27975020	baldness	C0002170
27975020	skin grafting	C0037297
27975020	STA	C0226130
27975020	flap	C0038925
27975020	divided	C0332849
27975020	creation	C1706214
27975020	flap	C0038925
27975020	divided	C0332849
27975020	sliding	C0332246
27975020	STA	C0226130
27975020	flap	C0038925
27975020	donor-site	C1444716
27975020	problem	C0033213
27975020	investigation	C0220825
27975020	validate	C1519941
27975020	maximum	C0806909
27975020	possible	C0332149
27975020	flap	C0038925
27975020	size	C0456389
27975020	technique	C0449851
27975020	small	C0700321
27975020	defects	C0243067
27975020	skin cancer	C0007114
27975020	ablation	C0547070
27975020	trauma	C3714660
27975061	Influence	C4054723
27975061	Surface Properties	C0038884
27975061	Adhesion Forces	C0441722
27975061	Attachment	C1947904
27975061	Streptococcus mutans	C0038409
27975061	Zirconia	C0078814
27975061	In Vitro	C1533691
27975061	Zirconia	C0078814
27975061	prevalent material	C0520510
27975061	dentistry	C0011438
27975061	foreign bodies	C0016542
27975061	inserted	C0441587
27975061	bacteria	C0004611
27975061	oral cavity	C0226896
27975061	effect	C1280500
27975061	surface properties	C0038884
27975061	surface roughness	C4313424
27975061	hydrophobicity	C0598629
27975061	adhesion	C0175633
27975061	biofilm formation	C1325881
27975061	Streptococcus mutans	C0038409
27975061	S. mutans	C0038409
27975061	zirconia	C0078814
27975061	Atomic force microscopy	C0242849
27975061	zirconia	C0078814
27975061	surface	C0205148
27975061	morphology	C0332437
27975061	adhesion forces	C0441722
27975061	S. mutans	C0038409
27975061	zirconia	C0078814
27975061	results	C1274040
27975061	surface roughness	C4313424
27975061	nanoscale	C0392762
27975061	different	C1705242
27975061	tested groups	C0441833
27975061	Coarse	C0205194
27975061	Medium	C0439536
27975061	Fine	C0205232
27975061	contact angles	C0205143
27975061	Coarse group	C0441833
27975061	Medium	C0439536
27975061	Fine groups	C0441833
27975061	surface roughness	C4313424
27975061	hydrophobicity	C0598629
27975061	adhesion forces	C0441722
27975061	attachment	C1947904
27975061	S. mutans	C0038409
27975061	zirconia	C0078814
27975061	influence	C4054723
27975061	development	C1527148
27975061	biofilm	C0081786
27975061	surface roughness	C4313424
27975061	nanoscale	C0392762
27975061	hydrophobicity	C0598629
27975061	zirconia	C0078814
27975061	influence	C4054723
27975061	S. mutans	C0038409
27975061	adhesion force	C0441722
27975061	attachment	C1947904
27975061	biofilm formation	C1325881
27977319	thiamine	C0039840
27977319	symbioses	C0039029
27977319	Root nodule	C1720942
27977319	symbiosis	C0039029
27977319	arbuscular mycorrhiza	C1138420
27977319	Lotus japonicus	C1940771
27977319	THIC	C0017337
27977319	expressed	C0017262
27977319	organs	C0032098
27977319	encoded protein	C0033684
27977319	catalyzes	C0007382
27977319	thiamine biosynthesis	C1157735
27977319	Loss of function	C0243095
27977319	chlorosis	C0008272
27977319	thiamine	C0039840
27977319	phenotype	C0031437
27977319	mortality	C0205848
27977319	thiamine's	C0039840
27977319	symbiosis	C0039029
27977319	THI1	C0017337
27977319	thiamine-biosynthesis gene	C0017337
27977319	expressed	C0017262
27977319	roots	C0242726
27977319	nodules	C1720942
27977319	seeds	C0036563
27977319	thi1 mutant	C0678941
27977319	green leaves	C0242724
27977319	small	C0700321
27977319	nodules	C1720942
27977319	immature	C0205252
27977319	seeds	C0036563
27977319	phenotypes	C0031437
27977319	THI1	C0017337
27977319	complementation	C0178654
27977319	exogenous	C0205228
27977319	thiamine	C0039840
27977319	THI1	C0017337
27977319	nodule	C1720942
27977319	enlargement	C0542341
27977319	seed maturation	C2265562
27977319	colonization	C4289767
27977319	arbuscular mycorrhiza	C1138420
27977319	AM	C1138420
27977319	fungus	C0016832
27977319	Rhizophagus irregularis	C2664655
27977319	thi1 mutant	C0678941
27977319	exogenous	C0205228
27977319	thiamine	C0039840
27977319	spores	C0038029
27977319	R. irregularis	C2664655
27977319	thiamine	C0039840
27977319	host plants	C0868970
27977319	thiamine biosynthesis genes	C0017337
27977319	thiamine	C0039840
27977319	progeny	C0680063
27977319	phenotypes	C0031437
27977319	spore formation	C1159442
27977319	hyphal growth	C1156247
27977319	thiamine's	C0039840
27977319	AM	C1138420
27977439	Bilateral	C0238767
27977439	sternal	C0038293
27977439	infusion	C0574032
27977439	ropivacaine	C0073571
27977439	length of stay	C0023303
27977439	ICU	C0021708
27977439	cardiac surgery	C0018821
27977439	increased	C0205217
27977439	respiratory risk	C0548981
27977439	randomised controlled trial	C0206035
27977439	bilateral	C0238767
27977439	infusion	C0574032
27977439	local anaesthetic	C0002934
27977439	solution	C0525069
27977439	sternotomy	C0185792
27977439	wound	C0043250
27977439	bilateral	C0238767
27977439	sternal	C0038293
27977439	technique	C0449851
27977439	reducing	C0392756
27977439	pain	C0030193
27977439	sternotomy	C0185792
27977439	effects	C1280500
27977439	technique	C0449851
27977439	intensive care	C0085559
27977439	cardiac patients	C0741926
27977439	increased	C0205217
27977439	risk	C0035647
27977439	respiratory complications	C0161818
27977439	Randomised, observer-blind controlled trial	C0206035
27977439	French University Hospital	C0020028
27977439	adults	C0001675
27977439	open-heart surgery	C0189745
27977439	age	C0001779
27977439	years	C0439234
27977439	BMI	C1305855
27977439	chronic obstructive pulmonary disease	C0024117
27977439	active smoking habit	C1266863
27977439	bilateral	C0238767
27977439	sternal	C0038293
27977439	infusion	C0574032
27977439	ropivacaine	C0073571
27977439	catheter	C0085590
27977439	'intervention' group	C2986530
27977439	standardised care	C1947933
27977439	'control' group	C0009932
27977439	Analgesia	C3202977
27977439	paracetamol	C0000970
27977439	self-administered	C1519231
27977439	intravenous	C1522726
27977439	morphine	C0026549
27977439	length of time	C1254367
27977439	readiness	C1318963
27977439	discharge	C0030685
27977439	ICU	C0021708
27977439	assessed	C1516048
27977439	committee	C2699414
27977439	experts	C0009817
27977439	No effect	C1301751
27977439	groups	C0441833
27977439	primary outcome	C3274433
27977439	intention to treat	C2718028
27977439	median values	C0042295
27977439	control	C0009932
27977439	intervention groups	C2986530
27977439	postoperative	C0241311
27977439	delays	C0205421
27977439	effects	C1280500
27977439	intervention	C0184661
27977439	dynamic pain	C0030193
27977439	patient satisfaction	C0030702
27977439	occurrence of nausea	C2219665
27977439	vomiting	C0042963
27977439	occurrence	C2745955
27977439	delirium	C0011206
27977439	mental confusion	C0009676
27977439	occurrence	C2745955
27977439	pulmonary complications	C0281169
27977439	patients	C0030705
27977439	symptoms	C1457887
27977439	neurological symptoms	C0235031
27977439	healthy volunteers	C1708335
27977439	small size effect	C0814843
27977439	analgesic effects	C0948482
27977439	time	C0040223
27977439	ICU	C0021708
27977439	EudraCT	C4289562
27977439	ClinicalTrials.gov	C4086204
27977762	Pupil Sizes	C0517965
27977762	Scale	C0349674
27977762	Attentional Load	C0589051
27977762	Task	C3540678
27977762	Experience	C0596545
27977762	Multiple	C0439064
27977762	Object	C0347997
27977762	Tracking	C0546881
27977762	Task	C3540678
27977762	changes	C0392747
27977762	attentional load	C0589051
27977762	pupil size	C0517965
27977762	modulations	C0443264
27977762	changes	C0392747
27977762	attentional load	C0589051
27977762	task	C3540678
27977762	experience	C0596545
27977762	scale	C0349674
27977762	pupil size	C0517965
27977762	modulations	C0443264
27977762	investigated	C1292732
27977762	changes	C0392747
27977762	affect	C0001721
27977762	pupil sizes	C0517965
27977762	manipulate	C0018578
27977762	attentional load	C0589051
27977762	participants	C0679646
27977762	tracked	C0546881
27977762	zero	C0919414
27977762	five	C0205451
27977762	objects	C0347997
27977762	randomly	C0439605
27977762	objects	C0347997
27977762	computer	C0009622
27977762	screen	C1705053
27977762	investigate	C1292732
27977762	effects of	C1704420
27977762	task	C3540678
27977762	experience	C0596545
27977762	three	C0205449
27977762	consecutive	C1707491
27977762	days	C0439228
27977762	pupil sizes	C0517965
27977762	increment	C1705117
27977762	attentional load	C0589051
27977762	days	C0439228
27977762	systematic	C0220922
27977762	pupil size	C0517965
27977762	reductions	C0392756
27977762	model fit	C0870608
27977762	pupil size	C0517965
27977762	modulations	C0443264
27977762	attentional load	C0589051
27977762	task	C3540678
27977762	experience	C0596545
27977762	task performance	C0039333
27977762	predictors	C2698872
27977762	model	C3161035
27977762	attentional load	C0589051
27977762	task	C3540678
27977762	experience	C0596545
27977762	predictors	C2698872
27977762	model fit	C0870608
27977762	performance	C0039333
27977762	predictor	C2698872
27977762	model	C3161035
27977762	model fit	C0870608
27977762	results	C1274040
27977762	pupillometry	C0260180
27977762	viable	C0443348
27977762	metric	C0025867
27977762	attentional load	C0589051
27977762	task	C3540678
27977762	experience	C0596545
27977762	visuospatial	C0814069
27977762	tasks	C3540678
27984742	Evolutionary	C0282688
27984742	History	C0019665
27984742	ADP-Ribosylation	C0596043
27984742	DNA	C0012854
27984742	Targeting	C1521840
27984742	Toxin	C0040549
27984742	Antitoxin	C0003445
27984742	Module DarTG	C1709061
27984742	Molecular Cell	C1513407
27984742	DarTG	C1709061
27984742	toxin	C0040549
27984742	antitoxin	C0003445
27984742	module	C1709061
27984742	DarT	C0014442
27984742	toxin	C0040549
27984742	ADP-ribosylates	C0596043
27984742	single-stranded DNA	C0012935
27984742	DarG	C0033684
27984742	antitoxin	C0003445
27984742	counteracts	C0443286
27984742	DarT	C0014442
27984742	binding	C1167622
27984742	enzymatic	C0014442
27984742	remova	C1883720
27984742	ADP-ribosylation	C0596043
27986797	Growth differentiation factor 15	C0668195
27986797	myomitokine	C0574031
27986797	governing systemic energy homeostasis	C3157768
27986797	Reduced	C0392756
27986797	mitochondrial electron transport chain	C1325653
27986797	activity	C0441655
27986797	promotes	C0033414
27986797	longevity	C0023980
27986797	improves	C0184511
27986797	energy homeostasis	C3157043
27986797	cell-autonomous	C0007613
27986797	non-autonomous factors	C0007613
27986797	multiple model systems	C0026339
27986797	mitohormetic	C3178757
27986797	effect	C1280500
27986797	mitochondrial unfolded protein response	C2612628
27986797	UPR(mt)	C2612628
27986797	adaptive stress-response	C0149784
27986797	pathway	C1705987
27986797	activated	C1879547
27986797	mitochondrial	C0026237
27986797	proteotoxic stress	C0449430
27986797	mice	C0025929
27986797	skeletal muscle-specific	C0242692
27986797	deficiency	C0011155
27986797	Crif1	C2352141
27986797	muscle-specific	C0026845
27986797	knockout	C0206745
27986797	MKO	C0206745
27986797	integral protein	C0033684
27986797	large mitoribosomal subunit	C1166894
27986797	39S	C2611782
27986797	growth differentiation factor 15	C0668195
27986797	GDF15	C0668195
27986797	UPR(mt)	C2612628
27986797	cell-non-autonomous	C0007613
27986797	myomitokine	C0574031
27986797	regulates systemic energy homeostasis	C3157768
27986797	MKO mice	C0206745
27986797	protected	C1545588
27986797	obesity	C0028754
27986797	sensitized	C1325847
27986797	insulin	C0021641
27986797	associated with	C0332281
27986797	elevated	C3163633
27986797	GDF15	C0668195
27986797	secretion	C1159339
27986797	UPR(mt)	C2612628
27986797	activation	C1879547
27986797	ob/ob mice	C0206745
27986797	recombinant	C0034861
27986797	GDF15	C0668195
27986797	decreased	C0205216
27986797	body weight	C0005910
27986797	improved	C0184511
27986797	insulin sensitivity	C0920563
27986797	elevated	C3163633
27986797	oxidative metabolism	C0282636
27986797	lipid mobilization	C0023773
27986797	liver	C0023884
27986797	muscle	C0026845
27986797	adipose tissue	C0001527
27986797	GDF15	C0668195
27986797	potent	C3245505
27986797	mitohormetic	C3178757
27986797	signal	C3537152
27986797	onset of obesity	C0243095
27986797	insulin resistance	C0021655
27987927	Synthesis	C1883254
27987927	characterization	C1880022
27987927	acetylated amylose	C0002732
27987927	development	C1527148
27987927	inclusion complexes	C1254350
27987927	rifampicin	C0035608
27987927	Amylose	C0002732
27987927	AM	C0002732
27987927	inclusion complexes	C1254350
27987927	agents	C0450442
27987927	complexes	C1704241
27987927	considered	C0750591
27987927	biomaterial	C0005479
27987927	guest molecules	C0567416
27987927	released	C0391871
27987927	later	C0205087
27987927	applications	C0205245
27987927	pharmaceutical industry	C0013185
27987927	Rifampicin	C0035608
27987927	RIF	C0035608
27987927	active	C0205177
27987927	drug	C1254351
27987927	Mycobacterium tuberculosis	C0026926
27987927	administration	C1533734
27987927	RIF	C0035608
27987927	dosages	C0178602
27987927	side-effects	C0001688
27987927	native	C0302891
27987927	amylose	C0002732
27987927	AM	C0002732
27987927	formation	C1522492
27987927	complexes	C1704241
27987927	water solubility	C0597682
27987927	degree	C0449286
27987927	substitution	C1706204
27987927	DS	C1706204
27987927	solubilizing	C0037628
27987927	acetylated amylose	C0002732
27987927	AMA	C0002732
27987927	water	C0043047
27987927	neutral pH	C1882074
27987927	observed	C1441672
27987927	native	C0302891
27987927	amylose	C0002732
27987927	trace	C0442822
27987927	solubility	C0037628
27987927	acetylated amylose	C0002732
27987927	characterized	C1880022
27987927	Fourier Transform Infrared (FT-IR) spectroscopy	C0206055
27987927	Scanning Electron Microscopy	C0026020
27987927	SEM	C0026020
27987927	FT-IR	C0206055
27987927	results	C1274040
27987927	indicated	C1444656
27987927	acetylation	C0001038
27987927	anhydroglucose	C0017725
27987927	units	C0439148
27987927	amylose	C0002732
27987927	low	C0205251
27987927	DS	C1706204
27987927	SEM	C0026020
27987927	results	C1274040
27987927	smooth surfaces	C0205148
27987927	amylose	C0002732
27987927	granules	C3853628
27987927	changed	C0392747
27987927	surfaces	C0205148
27987927	acetylation	C0001038
27987927	Ultraviolet absorption spectroscopy	C0260250
27987927	UV-vis	C0260250
27987927	analysis	C0936012
27987927	confirmed	C0521093
27987927	formation	C1522492
27987927	quantification	C1709793
27987927	native	C0302891
27987927	AM	C0002732
27987927	RIF	C0035608
27987927	AMA	C0002732
27987927	RIF	C0035608
27987927	amylose	C0002732
27987927	inclusion complexes	C1254350
27987927	characterization	C1880022
27987927	solution	C0037633
27987927	performed	C0884358
27987927	dynamic light scattering	C1882368
27987927	DLS	C1882368
27987927	zeta potential	C0597697
27987927	ZP	C0597697
27987927	measurements	C0242485
27987927	average size	C0456389
27987927	inclusion complexes	C1254350
27987927	determined by	C0521095
27987927	DLS	C1882368
27987927	ranged	C1514721
27987927	ZP	C0597697
27987927	analysis	C0936012
27987927	complexes	C1704241
27987927	stable	C0205360
27987927	presence	C0150312
27987927	RIF	C0035608
27987927	development	C1527148
27987927	effective	C1704419
27987927	preparation	C1521827
27987927	amylose	C0002732
27987927	inclusion complexes	C1254350
27987927	further	C1517331
27987927	application	C0205245
27987927	drug delivery systems	C0085104
27990563	Selective	C1707391
27990563	reaching	C2584321
27990563	macaques	C0024398
27990563	evidence	C3887511
27990563	action	C3266814
27990563	attention	C0004268
27990563	monkey	C0026447
27990563	selects	C1707391
27990563	food	C0016452
27990563	other	C0205394
27990563	viable	C0443348
27990563	objects	C0347997
27990563	near	C1706276
27990563	vicinity	C0205146
27990563	desired	C0871633
27990563	item	C0016452
27990563	governs	C0243148
27990563	pattern	C0449774
27990563	direction	C0449738
27990563	animal's	C0003062
27990563	reaching	C2584321
27990563	action	C3266814
27990563	selection	C1707391
27990563	important	C3898777
27990563	component	C1552020
27990563	controlling	C2587213
27990563	animal's	C0003062
27990563	action	C3266814
27990563	selection	C1707391
27990563	process	C1522240
27990563	cases	C0868928
27990563	presence	C3854307
27990563	other	C0205394
27990563	objects	C0347997
27990563	constitute	C1522492
27990563	potential	C3245505
27990563	obstacles	C0347997
27990563	constraints	C0443288
27990563	movement	C0026649
27990563	execution	C1705848
27990563	pervious	C0205326
27990563	other	C0205394
27990563	objects	C0347997
27990563	direct	C1947931
27990563	influence	C4054723
27990563	organization	C0029237
27990563	response	C0871261
27990563	kinematics	C0600169
27990563	macaques	C0024398
27990563	reaching	C2584321
27990563	movements	C0026649
27990563	examined	C0332128
27990563	current	C0521116
27990563	study	C2603343
27990563	analysed	C0936012
27990563	selectively	C1707391
27990563	reached	C2584321
27990563	grasp	C0220843
27990563	food item	C0016452
27990563	absence	C0332197
27990563	presence	C3854307
27990563	potential	C3245505
27990563	obstacles	C0347997
27990563	stones	C0347997
27990563	affect	C0001721
27990563	arm	C0446516
27990563	trajectory	C0449738
27990563	Changes	C0392747
27990563	movement	C0026649
27990563	parameterization	C0681933
27990563	noted	C4288581
27990563	temporal	C2362314
27990563	measures	C0079809
27990563	movement	C0026649
27990563	time	C0040223
27990563	spatial ones	C1254362
27990563	trajectory	C0449738
27990563	presence	C3854307
27990563	stones	C0347997
27990563	vicinity	C0205146
27990563	acting	C0001241
27990563	hand	C0018563
27990563	stalled	C1947925
27990563	reaching	C2584321
27990563	movement	C0026649
27990563	affected	C0001721
27990563	arm	C0446516
27990563	trajectory	C0449738
27990563	hand	C0018563
27990563	veered away	C1277225
27990563	stone	C0347997
27990563	not	C1518422
27990563	physical	C0205485
27990563	obstacle	C0347997
27990563	nearby	C1706276
27990563	objects	C0347997
27990563	motor response	C1285623
27990563	macaques	C0024398
27990563	attentional	C0004268
27990563	mechanisms	C0441712
27990563	successful	C1272703
27990563	action	C3266814
27990563	selection	C1707391
27990563	revealed	C0443289
27990563	reaching	C2584321
27990563	path	C0449738
27990563	data	C1511726
27990563	human	C0086418
27990563	studies	C2603343
27990563	indicating	C0392360
27990563	potential	C3245505
27990563	obstacles	C0347997
27990563	internally	C0205102
27990563	represented	C1882932
27990563	finding	C0243095
27990563	basic	C1527178
27990563	cognitive	C1516691
27990563	operations	C3241922
27990563	action	C3266814
27990563	selection	C1707391
27990563	macaques	C0024398
27991454	novel	C0205314
27991454	method	C0025663
27991454	interactive	C1704675
27991454	multi-objective	C1571702
27991454	dose-guided patient positioning	C1561964
27991454	intensity-modulated radiation therapy	C1512814
27991454	IMRT	C1512814
27991454	imaging	C0011923
27991454	data	C1511726
27991454	accurate	C0443131
27991454	patient alignment	C0548501
27991454	anatomical landmarks	C0504075
27991454	anatomical changes	C0392747
27991454	patient position	C0449850
27991454	dose	C0178602
27991454	patient alignment	C0548501
27991454	imaging	C0011923
27991454	data	C1511726
27991454	dose	C0178602
27991454	calculation	C1441506
27991454	finding	C0243095
27991454	optimal	C2698651
27991454	dose	C0178602
27991454	distribution	C1704711
27991454	dose	C0178602
27991454	patient alignment	C0548501
27991454	clinical	C0205210
27991454	objectives	C0018017
27991454	multi-objective	C1571702
27991454	dose	C0178602
27991454	distributions	C1704711
27991454	patient shifts	C0086388
27991454	dose	C0178602
27991454	interpolation	C3494285
27991454	Pareto-efficient patient shifts	C0086388
27991454	interactive	C1704675
27991454	dose	C0178602
27991454	Dose	C0178602
27991454	interpolation	C3494285
27991454	accuracy	C0443131
27991454	multi-objective	C1571702
27991454	dose-guided positioning	C1561964
27991454	head and neck	C0278996
27991454	H&N	C0278996
27991454	prostate cancer	C0600139
27991454	patients	C0030705
27991454	Dose-guided positioning	C1561964
27991454	compared	C1707455
27991454	CT	C0040405
27991454	imaging	C0011923
27991454	data	C1511726
27991454	Dose	C0178602
27991454	interpolation	C3494285
27991454	accuracy	C0443131
27991454	high	C0205250
27991454	dose	C0178602
27991454	H&N	C0278996
27991454	prostate cases	C0600139
27991454	comparison	C1707455
27991454	dose	C0178602
27991454	calculations	C1441506
27991454	patients	C0030705
27991454	dose-guided positioning	C1561964
27991454	dose	C0178602
27991454	distribution	C1704711
27991454	compared	C1707455
27991454	bony anatomy based alignment	C1706765
27991454	H&N	C0278996
27991454	dose	C0178602
27991454	parotid glands	C0030580
27991454	bony alignment	C1706765
27991454	clinical target volume	C0454198
27991454	CTV	C0454198
27991454	compared	C1707455
27991454	prostate	C0600139
27991454	patients	C0030705
27991454	CTV	C0454198
27991454	compared	C1707455
27991454	compared	C1707455
27991454	H&N	C0278996
27991454	prostate cases	C0600139
27991454	dose-guided positioning	C1561964
27994448	Clinical	C2985631
27994448	radiological	C0043299
27994448	outcome	C1274040
27994448	pneumothorax	C0032326
27994448	endoscopic lung volume reduction	C0375931
27994448	valves	C0042296
27994448	Valve	C0042296
27994448	implantation	C0021107
27994448	therapy	C0087111
27994448	patients	C0030705
27994448	advanced	C0205179
27994448	emphysema	C0034067
27994448	minimally invasive treatmen	C0282624
27994448	associated with	C0332281
27994448	complications	C0009566
27994448	common	C0205214
27994448	pneumothorax	C0032326
27994448	Pneumothorax	C0032326
27994448	rapid	C0456962
27994448	target	C1521840
27994448	lobe	C0225752
27994448	volume reduction	C0524689
27994448	predictor	C2698872
27994448	clinical	C0205210
27994448	benefit	C0814225
27994448	complication	C0009566
27994448	objective	C0018017
27994448	study	C2603343
27994448	exploratory data analysis	C3899452
27994448	patients	C0030705
27994448	pneumothorax	C0032326
27994448	endoscopic valve therapy	C0087111
27994448	emphysema	C0034067
27994448	study	C2603343
27994448	performed	C0884358
27994448	retrospective evaluation	C0035363
27994448	pneumothorax	C0032326
27994448	management	C0376636
27994448	impact	C4049986
27994448	pneumothorax	C0032326
27994448	clinical outcomes	C2985631
27994448	patients	C0030705
27994448	valve therapy	C0087111
27994448	consecutive	C1707491
27994448	patients	C0030705
27994448	Pneumothorax	C0032326
27994448	rate	C0026538
27994448	valve therapy	C0087111
27994448	Pneumothorax	C0032326
27994448	management	C0376636
27994448	chest tube insertion	C0189476
27994448	valve	C0042296
27994448	removal	C0015252
27994448	surgical intervention	C0549433
27994448	patients	C0030705
27994448	pneumothorax	C0032326
27994448	patients	C0030705
27994448	modest	C0205081
27994448	significant	C0750502
27994448	improvements	C2986411
27994448	lung function	C0231921
27994448	parameters	C0549193
27994448	forced expiratory volume	C0016529
27994448	residual volume	C0035190
27994448	total lung capacity	C0040509
27994448	Persistent	C0205322
27994448	lobar atelectasis	C0004144
27994448	recovering	C1709864
27994448	pneumothorax	C0032326
27994448	associated with	C0332281
27994448	relevant	C2347946
27994448	clinical	C0205210
27994448	improvement	C2986411
27994448	observed	C1441672
27994448	patients	C0030705
27994448	Pneumothorax	C0032326
27994448	frequent	C0332183
27994448	severe	C0205082
27994448	complication	C0009566
27994448	valve therapy	C0087111
27994448	intervention	C0184661
27994448	pneumothorax	C0032326
27994448	impair	C0221099
27994448	clinical status	C0449440
27994448	patients	C0030705
27994448	Patients	C0030705
27994448	lobar atelectasis	C0004144
27994448	benefit	C0814225
27994448	recovering	C1709864
27994448	pneumothorax	C0032326
27994448	lung function	C0231921
27994448	parameters	C0549193
27994535	3Mo	C0026336
27994535	Model	C0026336
27994535	Music	C0026867
27994535	Based	C1527178
27994535	Biofeedback	C0005491
27994535	domain	C1880389
27994535	sports	C0038039
27994535	motor	C0234130
27994535	rehabilitation	C0034992
27994535	major	C0205164
27994535	importance	C3898777
27994535	regulate	C1327622
27994535	control	C2587213
27994535	physiological processes	C0031845
27994535	physical motion	C0026597
27994535	most	C0205393
27994535	optimal	C2698651
27994535	purpose	C1285529
27994535	real-time	C1550177
27994535	auditory feedback	C0596134
27994535	physiological	C0205463
27994535	physical	C0205485
27994535	information	C1533716
27994535	based	C1527178
27994535	sound signals	C0037709
27994535	sonification	C0449851
27994535	proven	C0456369
27994535	useful	C3827682
27994535	use	C0457083
27994535	music	C0026867
27994535	biofeedback	C0005491
27994535	systems	C0449913
27994535	less	C0439092
27994535	explored	C1280903
27994535	current	C0521116
27994535	article	C1706852
27994535	use	C0457083
27994535	music	C0026867
27994535	musical	C0026867
27994535	principles	C0178566
27994535	major	C0205164
27994535	value	C1554112
27994535	mere	C0547040
27994535	sound signals	C0037709
27994535	benefit	C0814225
27994535	psychological	C0205486
27994535	physical	C0205485
27994535	optimization	C2698650
27994535	sports	C0038039
27994535	motor	C0234130
27994535	rehabilitation	C0034992
27994535	tasks	C3540678
27994535	article	C1706852
27994535	present	C0449450
27994535	3Mo model	C0026336
27994535	main	C1542147
27994535	functions	C0542341
27994535	music	C0026867
27994535	contribute	C1880177
27994535	benefits	C0814225
27994535	functions	C0542341
27994535	power	C0808080
27994535	music	C0026867
27994535	Motivate	C0026605
27994535	Monitor	C1283169
27994535	Modify	C0392747
27994535	physiological	C0205463
27994535	physical	C0205485
27994535	processes	C1522240
27994535	model	C0026336
27994535	concepts	C0178566
27994535	theories	C0871935
27994535	human	C0086418
27994535	sensorimotor interaction	C0237434
27994535	music	C0026867
27994535	specifies	C1521902
27994535	psychological	C0205486
27994535	physiological	C0205463
27994535	principles	C0178566
27994535	3Mo model	C0026336
27994535	intended	C1283828
27994535	provide	C1999230
27994535	conceptual framework	C1254372
27994535	guides	C0681464
27994535	future	C0016884
27994535	research	C0035168
27994535	musical	C0026867
27994535	biofeedback	C0005491
27994535	systems	C0449913
27994535	domain	C1880389
27994535	sports	C0038039
27994535	motor	C0234130
27994535	rehabilitation	C0034992
27994640	Analysis	C0002778
27994640	tilianin	C0966451
27994640	acacetin	C0100994
27994640	Agastache rugosa	C1008095
27994640	high-performance liquid chromatography	C0008562
27994640	ionic liquids	C1720867
27994640	ultrasound	C0220934
27994640	extraction	C0684295
27994640	Ionic liquid	C1720867
27994640	1-butyl-3-methylimidazolium bromide	C1956443
27994640	methanol	C0001963
27994640	ultrasonic	C0220934
27994640	extraction	C0684295
27994640	ILUAE	C0684295
27994640	extract	C0684295
27994640	tilianin	C0966451
27994640	acacetin	C0100994
27994640	aerial parts	C1136056
27994640	Agastache rugose	C1008095
27994640	A. rugose	C1008095
27994640	reversed phase high performance liquid chromatographic	C2717789
27994640	RP-HPLC	C2717789
27994640	ultraviolet detection	C0449335
27994640	RP-HPLC-UV)	C0449335
27994640	InertSustain RP-C18 column	C1705246
27994640	mobile phase	C3469601
27994640	methanol	C0001963
27994640	acetic acid	C0000983
27994640	gradient	C0812409
27994640	elution	C1441565
27994640	detection wavelength	C0449819
27994640	flow rate	C2826285
27994640	column	C1705246
27994640	temperature	C0039476
27994640	optimized	C2698650
27994640	conditions	C0348080
27994640	tilianin	C0966451
27994640	acacetin	C0100994
27994640	method	C0449851
27994640	ILUAE	C0684295
27994640	traditional methods	C0449851
27994640	higher	C0205250
27994640	efficiency	C0013682
27994640	higher	C0205250
27994640	reproducibility	C1514863
27994640	environmental friendly	C0014406
27994640	active	C0205177
27994640	compounds	C1706082
27994640	traditional Chinese medicines	C0025124
27994640	TCMs	C0025124
27994913	Evaluation	C0220825
27994913	MIF -173 G/C	C1334507
27994913	Polymorphism	C0678951
27994913	Turkish	C0549217
27994913	Patients	C0030705
27994913	Ankylosing Spondylitis	C0038013
27994913	Ankylosing spondylitis	C0038013
27994913	AS	C0038013
27994913	chronic inflammatory disease	C1290886
27994913	spine	C0037949
27994913	sacroiliac joints	C0036036
27994913	Macrophage migration inhibitory (MIF) factor	C0024429
27994913	regulatory	C1704735
27994913	cytokine	C0079189
27994913	inhibits	C3463820
27994913	immune cell migration	C1326500
27994913	MIF gene	C1334507
27994913	promoter	C0314621
27994913	polymorphisms	C0678951
27994913	progression	C0242656
27994913	inflammatory disorders	C1290884
27994913	investigate	C1292732
27994913	MIF gene -173 G/C	C1334507
27994913	single-nucleotide polymorphism	C0752046
27994913	SNP	C0752046
27994913	AS	C0038013
27994913	Cross-sectional study	C0010362
27994913	study	C2603343
27994913	AS	C0038013
27994913	normal	C3898900
27994913	controls	C0009932
27994913	MIF gene -173 G/C	C1334507
27994913	SNP	C0752046
27994913	analyzed	C0936012
27994913	polymerase chain reaction	C0032520
27994913	restriction fragment length polymorphism method	C3714764
27994913	significant	C0750502
27994913	groups	C1257890
27994913	genotype	C0017431
27994913	wild-type	C1883559
27994913	G/G	C0017431
27994913	G/C+C/C genotypes	C0017431
27994913	clinical characteristics	C0683325
27994913	significant	C0750502
27994913	age	C0001779
27994913	duration of disease	C0872146
27994913	AS	C0038013
27994913	patients	C0030705
27994913	significant	C0750502
27994913	AS	C0038013
27994913	disease	C0012634
27994913	MIF -173 G/C	C1334507
27994913	polymorphism	C0678951
27994913	MIF -173 G/C	C1334507
27994913	polymorphism	C0678951
27994913	C allele	C0002085
27994913	duration of disease	C0872146
27994913	AS	C0038013
27994913	patients	C0030705
27995510	Global	C2348867
27995510	Cerebral Edema	C0006114
27995510	Aneurysmal Subarachnoid Hemorrhage	C0751530
27995510	clinical	C0205210
27995510	literature	C0023866
27995510	cerebral edema	C0006114
27995510	early brain injury	C0270611
27995510	aneurysmal subarachnoid hemorrhage	C0751530
27995510	aSAH	C0751530
27995510	Aneurysm rupture	C0162869
27995510	global	C2348867
27995510	cerebral edema	C0006114
27995510	cerebral edema	C0006114
27995510	aSAH	C0751530
27995510	clinical course	C0449259
27995510	quantitative analysis	C0034384
27995510	cerebral edema	C0006114
27995510	poor outcome	C3806166
27995510	global	C2348867
27995510	cerebral edema	C0006114
27995510	global	C2348867
27995510	ischemia	C0022116
27995510	aneurysm rupture	C0162869
27995510	dysfunction	C3887504
27995510	autoregulation	C0019868
27995510	blood breakdown	C2937287
27995510	products	C1514468
27995510	neuroinflammation	C1408627
27995510	hyponatremia	C0020625
27995510	endocrine abnormalities	C4025823
27995510	molecular	C1521991
27995510	level	C0441889
27995510	aquaporin-4	C0292777
27995510	matrix metalloproteinase-9	C0165519
27995510	SUR1	C3711621
27995510	TRPM4 cation channels	C1384655
27995510	vascular endothelial growth factor	C1171892
27995510	bradykinin	C0006100
27995510	cellular	C0007634
27995510	molecular	C1521991
27995510	global	C2348867
27995510	cerebral edema	C0006114
27995510	aSAH	C0751530
27995510	edema	C0013604
27995510	patients	C0030705
27995510	aSAH	C0751530
27995510	status	C0449438
27995510	pathological process	C0030660
27995510	cerebral edema	C0006114
27995510	aSAH	C0751530
27995510	medical therapies	C0418981
27995510	devastating	C0332663
27995510	disease	C0012634
27995969	Biliary	C0005423
27995969	Phospholipids	C0031676
27995969	Sustain	C0443318
27995969	Enterocyte	C0682610
27995969	Proliferation	C0596290
27995969	Intestinal Tumor	C0021841
27995969	Progression	C0178874
27995969	Nuclear Receptor	C0206588
27995969	Lrh1	C1448055
27995969	mice	C0025929
27995969	crypt compartment	C3686613
27995969	intestinal epithelium	C0226890
27995969	phospholipids	C0031676
27995969	accumulation	C4055506
27995969	phospholipids	C0031676
27995969	colorectal tumors	C0009404
27995969	biliary	C0005423
27995969	phospholipid	C0031676
27995969	flow	C0806140
27995969	proliferative power	C1514485
27995969	normal	C0682610
27995969	dysplastic enterocytes	C1512101
27995969	Abcb4	C1412071
27995969	mice	C0025929
27995969	biliary	C0005423
27995969	phospholipid	C0031676
27995969	secretion	C0036536
27995969	Abcb4	C1412071
27995969	mice	C0025929
27995969	protected	C1545588
27995969	intestinal	C0021853
27995969	tumorigenesis	C0007621
27995969	molecular	C1521991
27995969	level	C0441889
27995969	transcriptional activity	C1148759
27995969	nuclear receptor	C0206588
27995969	Liver Receptor Homolog-1	C1448055
27995969	Lrh1	C1448055
27995969	reduced	C0392756
27995969	Abcb4	C1412071
27995969	mice	C0025929
27995969	re-activation	C4086768
27995969	tumor	C0027651
27995969	burden	C2828008
27995969	control	C0009932
27995969	mice	C0025929
27995969	Feeding	C2987508
27995969	Abcb4	C1412071
27995969	mice	C0025929
27995969	diet supplemented	C0242295
27995969	phospholipids	C0031676
27995969	overcomes	C2983310
27995969	intestinal tumor	C0021841
27995969	phenotype	C0031437
27995969	absence	C0332197
27995969	biliary	C0005423
27995969	phospholipids	C0031676
27995969	Abcb4 gene	C1412071
27995969	protection	C1545588
27995969	phospholipids	C0031676
27995969	intestinal	C0021853
27995969	tumorigenesis	C0007621
27995969	Abcb4	C1412071
27995969	mice	C0025929
27995969	mice	C0025929
27995969	intestinal	C0021853
27995969	specific	C0205369
27995969	ablation	C0547070
27995969	Lrh1	C1448055
27995969	nuclear hormone receptor	C0887829
27995969	activates	C1879547
27995969	phospholipids	C0031676
27995969	data	C1511726
27995969	biliary	C0005423
27995969	phospholipids	C0031676
27995969	intestinal mucosa	C0021839
27995969	proliferation	C1514485
27995969	tumor progression	C0178874
27995969	activation	C1879547
27995969	nuclear receptor	C0206588
27995969	Lrh1	C1448055
27999200	Metalloproteinase	C0025543
27999200	meprin α	C1622778
27999200	migration	C1622501
27999200	invasion	C1269955
27999200	human	C0086418
27999200	hepatocarcinoma	C2239176
27999200	cells	C0334227
27999200	oncoprotein	C0029005
27999200	Reptin	C1120857
27999200	Hepatocellular carcinoma	C2239176
27999200	associated with	C0332281
27999200	high	C0205250
27999200	rate	C1521828
27999200	intra-hepatic	C0205054
27999200	invasion	C1269955
27999200	poor prognosis	C0278252
27999200	Meprin alpha	C1622778
27999200	Mep1A	C1622778
27999200	secreted	C1327616
27999200	metalloproteinase	C0025543
27999200	cancer invasion	C1269955
27999200	Mep1A	C1622778
27999200	target	C1521840
27999200	Reptin	C1120857
27999200	protein that is oncogenic	C0029005
27999200	HCC	C2239176
27999200	Mep1A	C1622778
27999200	regulation	C1327622
27999200	Reptin	C1120857
27999200	HCC	C2239176
27999200	Reptin	C1120857
27999200	oncogenic	C0007090
27999200	effects	C1280500
27999200	MepA	C1622778
27999200	Reptin	C1120857
27999200	expression	C1171362
27999200	human	C0086418
27999200	HCC	C2239176
27999200	qRT-PCR	C1514628
27999200	cultured cells	C0007635
27999200	PCR	C0032520
27999200	western blot	C0949466
27999200	enzymatic activity measurements	C0681902
27999200	Cell growth	C0007595
27999200	assessed	C1516048
27999200	counting	C0007584
27999200	MTS assay	C2986858
27999200	Cell migration	C1622501
27999200	Boyden chambers	C3874231
27999200	wound healing	C0043240
27999200	assays	C0005507
27999200	cell invasion	C1269955
27999200	Boyden chambers	C3874231
27999200	Silencing	C0598496
27999200	Reptin	C1419774
27999200	decreased	C0205216
27999200	Mep1A	C1622778
27999200	expression	C1171362
27999200	activity	C0441655
27999200	meprin β	C1451346
27999200	Mep1A	C1622778
27999200	meprin β	C1451346
27999200	overexpressed	C1514559
27999200	human	C0086418
27999200	HCC	C2239176
27999200	high	C0205250
27999200	expression	C1171362
27999200	correlated	C1707520
27999200	poor prognosis	C0278252
27999200	Mep1A	C1622778
27999200	Reptin	C1120857
27999200	expressions	C1171362
27999200	correlated	C1707520
27999200	Silencing	C0598496
27999200	Mep1A	C1417113
27999200	cell proliferation	C0596290
27999200	decreased	C0205216
27999200	cell migration	C1622501
27999200	invasion	C1269955
27999200	HuH7	C0007601
27999200	Hep3B cells	C0007601
27999200	overexpression	C1514559
27999200	Mep1A	C1622778
27999200	recombinant	C1514798
27999200	Mep1A	C1622778
27999200	increased	C0205217
27999200	migration	C1622501
27999200	invasion	C1269955
27999200	overexpression	C1514559
27999200	Mep1A	C1622778
27999200	normal	C0205307
27999200	cell migration	C1622501
27999200	cells	C0334227
27999200	Reptin	C1120857
27999200	depleted	C0333668
27999200	Mep1A	C1622778
27999200	overexpressed	C1514559
27999200	HCC	C2239176
27999200	induces	C0205263
27999200	HCC	C2239176
27999200	cell migration	C1622501
27999200	invasion	C1269955
27999200	Mep1A	C1622778
27999200	expression	C1171362
27999200	Reptin	C1120857
27999200	Mep1A	C1622778
27999200	Reptin	C1120857
27999200	induced	C0205263
27999200	migration	C1622501
27999200	Mep1A	C1622778
27999200	target	C1521840
27999200	HCC	C2239176
28000391	Psychosocial impact	C0033963
28000391	families	C0015576
28000391	infant	C0021270
28000391	hypoplastic left heart syndrome	C0152101
28000391	during and after the interstage monitoring period	C1254367
28000391	prospective mixed-method study	C0033522
28000391	parents' experiences	C0596545
28000391	coping ability	C0009967
28000391	quality of life	C0034380
28000391	monitoring	C0030695
28000391	sick child	C0260101
28000391	hypoplastic left heart syndrome	C0152101
28000391	home	C0442519
28000391	Interstage home monitoring	C0030695
28000391	children	C0008059
28000391	hypoplastic left heart syndrome	C0152101
28000391	mortality	C0008083
28000391	Norwood stages I and II	C2242650
28000391	psychosocial impact	C0033963
28000391	interstage home monitoring	C0030695
28000391	Prospective mixed-method study	C0033522
28000391	psychosocial impact	C0033963
28000391	parents	C0030551
28000391	interstage home monitoring	C0030695
28000391	quantitative assessment	C0034384
28000391	Short Form Health Survey questionnaire	C1714475
28000391	Family Scale administered	C0243095
28000391	discharge	C0030685
28000391	before and after stage II	C1254367
28000391	qualitative assessment	C0034375
28000391	semi-structured interviews	C0681913
28000391	postdischarge	C1320368
28000391	coping strategies	C0474179
28000391	after hospital discharge	C1320368
28000391	before and after stage II	C1254367
28000391	infants	C0021270
28000391	males	C0086582
28000391	hypoplastic left heart syndrome	C0152101
28000391	univentricular heart malformations	C0018798
28000391	parents	C0030551
28000391	mother/father	C0030551
28000391	parent	C0030551
28000391	households	C0020052
28000391	single mother	C0337491
28000391	no interstage deaths	C0243095
28000391	Mental Health	C0025353
28000391	Composite Summary scores	C4055211
28000391	parents	C0030551
28000391	mothers	C0026591
28000391	fathers	C0015671
28000391	vitality	C0424589
28000391	mothers	C0026591
28000391	fathers	C0015671
28000391	before and after stage II	C1254367
28000391	Family Scale values	C0243095
28000391	social burdens	C2828008
28000391	mothers	C0026591
28000391	coping strategy	C0474179
28000391	fragile emotional balance	C0233459
28000391	parents	C0030551
28000391	interstage home monitoring	C0030695
28000391	protective intervention	C0184661
28000391	psychosocial burden	C0033963
28000391	before and after stage II	C1254367
28000391	family	C0015576
28000391	parents	C0030551
28000391	parenthood	C0337469
28000391	Healthcare professionals	C0018724
28000391	parents	C0030551
28000391	vulnerable interstage period	C1254367
28000391	psychosocial	C0542298
28000391	nursing support	C0028678
28002085	Rates	C1521828
28002085	predictors	C2698872
28002085	injury	C0178314
28002085	population	C0032659
28002085	based	C1527178
28002085	cohort	C0599755
28002085	people	C0027361
28002085	living	C0376558
28002085	HIV	C0019693
28002085	Injuries	C0178314
28002085	global	C2348867
28002085	burden	C2828008
28002085	disease	C0012634
28002085	epidemiology	C0014508
28002085	injury	C0178314
28002085	people living with HIV	C0019693
28002085	PLHIV	C0019693
28002085	not been well	C3841798
28002085	elucidated	C2986669
28002085	study	C2603343
28002085	characterize	C1880022
28002085	rates	C1521828
28002085	predictors	C2698872
28002085	injury	C0178314
28002085	PLHIV	C0019693
28002085	compared	C1707455
28002085	general population	C0683971
28002085	British Columbia	C0006193
28002085	BC	C0006193
28002085	Canada	C0006823
28002085	population	C0032659
28002085	based	C1527178
28002085	dataset	C0150098
28002085	created	C1707531
28002085	linkage	C0242239
28002085	between	C0205103
28002085	BC Centre for Excellence in HIV/AIDS	C1708333
28002085	PopulationDataBC	C1511726
28002085	PLHIV	C0019693
28002085	aged	C0001779
28002085	20 years	C0439234
28002085	older	C0580836
28002085	compared	C1707455
28002085	random	C0439605
28002085	sample	C0370003
28002085	adult	C0001675
28002085	general population	C0683971
28002085	International	C1512888
28002085	Classification	C0008902
28002085	Diseases	C0012634
28002085	used	C1524063
28002085	classify	C0008902
28002085	unintentional	C0151736
28002085	intentional injuries	C0151737
28002085	based	C1527178
28002085	external cause	C1407879
28002085	injury	C0178314
28002085	Generalized estimating equation	C0026348
28002085	GEE	C0026348
28002085	Poisson regression models	C0023962
28002085	estimate	C0750572
28002085	effect	C1280500
28002085	HIV	C0019693
28002085	status	C0449438
28002085	rates	C1521828
28002085	unintentional	C0151736
28002085	intentional injury	C0151737
28002085	identify	C0205396
28002085	correlates	C1707520
28002085	injury	C0178314
28002085	PLHIV	C0019693
28002085	incidence rate	C1708485
28002085	unintentional injury	C0151736
28002085	person	C0027361
28002085	years	C0439234
28002085	confidence interval	C0009667
28002085	CI	C0009667
28002085	PLHIV	C0019693
28002085	person	C0027361
28002085	years	C0439234
28002085	CI	C0009667
28002085	general population	C0683971
28002085	PLHIV	C0019693
28002085	deaths	C1306577
28002085	due to	C0678226
28002085	injury	C0178314
28002085	compared	C1707455
28002085	deaths	C1306577
28002085	general population	C0683971
28002085	models	C0026348
28002085	PLHIV	C0019693
28002085	report	C0700287
28002085	unintentional	C0151736
28002085	incidence rate	C1708485
28002085	ratio	C0456603
28002085	CI	C0009667
28002085	intentional injury	C0151737
28002085	incidence rate	C1708485
28002085	ratio	C0456603
28002085	CI	C0009667
28002085	compared	C1707455
28002085	general population	C0683971
28002085	identified	C0205396
28002085	elevated	C3163633
28002085	rates	C1521828
28002085	intentional	C0151737
28002085	unintentional injury	C0151736
28002085	PLHIV	C0019693
28002085	Injuries	C0178314
28002085	largely	C0549177
28002085	preventable	C1547273
28002085	targeted	C1521840
28002085	needed	C0027552
28002085	decrease	C0547047
28002085	burden	C2828008
28002085	injury	C0178314
28002085	related	C0439849
28002085	disability	C0231170
28002085	death	C1306577
28002085	PLHIV	C0019693
28005193	TREK-1 (K2P2.1) K(+) channels	C0754471
28005193	suppressed	C1260953
28005193	patients	C0030705
28005193	atrial fibrillation	C0004238
28005193	heart failure	C0018801
28005193	provide	C1999230
28005193	therapeutic targets	C0302350
28005193	rhythm control	C0243148
28005193	Atrial fibrillation	C0004238
28005193	AF	C0004238
28005193	cardiac arrhythmia	C0003811
28005193	Concomitant heart failure	C0018801
28005193	HF	C0018801
28005193	therapeutic	C0302350
28005193	challenge	C1315011
28005193	prolonged	C0439590
28005193	atrial electrical refractoriness	C0034954
28005193	non-failing hearts	C0018787
28005193	downregulation	C0013081
28005193	atrial repolarizing	C1371280
28005193	TREK-1 (K2P2.1) K(+) channels	C0754471
28005193	contributes	C1880177
28005193	electrical remodeling	C3658220
28005193	AF	C0004238
28005193	HF	C0018801
28005193	TREK-1 gene transfer	C1517499
28005193	rhythm control	C0243148
28005193	normalization	C1882115
28005193	atrial effective refractory periods	C0428938
28005193	AF	C0004238
28005193	subset	C2986480
28005193	patients	C0030705
28005193	chronic AF	C0694539
28005193	HF	C0018801
28005193	atrial TREK-1	C0754471
28005193	mRNA	C0035696
28005193	levels	C0441889
28005193	left atrium	C0225860
28005193	right atrium	C0225844
28005193	sinus rhythm	C0232201
28005193	SR	C0232201
28005193	subjects	C0080105
28005193	Human	C0086418
28005193	findings	C0243095
28005193	porcine model	C0026336
28005193	atrial tachypacing-induced AF	C0004238
28005193	reduced	C0392756
28005193	left ventricular function	C0080310
28005193	TREK-1	C0754471
28005193	mRNA	C0035696
28005193	protein	C0754471
28005193	suppressed	C1260953
28005193	AF	C0004238
28005193	animals	C0003062
28005193	compared	C1707455
28005193	SR	C0232201
28005193	Downregulation	C0013081
28005193	repolarizing	C1371280
28005193	TREK-1 channels	C0754471
28005193	prolongation	C0439590
28005193	atrial effective refractory periods	C0428938
28005193	baseline	C1442488
28005193	consistent with	C0332290
28005193	prior	C0332152
28005193	observations	C0302523
28005193	humans	C0086418
28005193	HF	C0018801
28005193	preclinical	C1709630
28005193	therapeutic approach	C0302350
28005193	pigs	C0039005
28005193	randomized	C0034656
28005193	atrial Ad-TREK-1 gene therapy	C0017296
28005193	sham treatment	C0032042
28005193	Gene transfer	C1517499
28005193	effectively	C1280519
28005193	increased	C0205217
28005193	TREK-1 protein	C0754471
28005193	levels	C0441889
28005193	attenuated	C0599946
28005193	atrial effective refractory period	C0428938
28005193	prolongation	C0439590
28005193	porcine AF model	C0026336
28005193	Ad-TREK-1	C0754471
28005193	SR	C0232201
28005193	prevalence	C0033105
28005193	AF	C0004238
28005193	animals	C0003062
28005193	compared	C1707455
28005193	AF	C0004238
28005193	conclusion	C1707478
28005193	TREK-1	C0754471
28005193	downregulation	C0013081
28005193	rhythm control	C0243148
28005193	Ad-TREK-1 transfer	C1517499
28005193	suggest	C1705535
28005193	mechanistic and potential therapeutic	C0087111
28005193	significance	C0750502
28005193	TREK-1 channels	C0754471
28005193	subgroup	C1515021
28005193	AF	C0004238
28005193	patients	C0030705
28005193	HF	C0018801
28005193	prolonged	C0439590
28005193	atrial effective refractory periods	C0428938
28005193	Functional correction	C0205245
28005193	TREK-1 gene therapy	C0017296
28005193	novel	C0205314
28005193	paradigm	C0681797
28005193	AF	C0004238
28009593	Rasch Rating Scale	C0871207
28009593	Analysis	C0936012
28009593	Presence	C0150312
28009593	Nursing	C0028677
28009593	Scale	C0681889
28009593	RN	C0687673
28009593	phenomenon	C1882365
28009593	nursing	C0028677
28009593	presence	C0150312
28009593	emotional	C0849912
28009593	connection	C0449379
28009593	nurse	C0028661
28009593	patient	C0030705
28009593	technical skills	C0449851
28009593	performed	C0884358
28009593	nurse	C0028661
28009593	Presence	C0150312
28009593	Nursing	C0028677
28009593	Scale	C0681889
28009593	RN	C0687673
28009593	version	C0333052
28009593	PONS	C0681889
28009593	RN	C0687673
28009593	developed	C1527148
28009593	measure	C0079809
28009593	nurses'	C0028661
28009593	perceptions	C0030971
28009593	ability	C0085732
28009593	present	C0150312
28009593	patients	C0030705
28009593	study	C2603343
28009593	summarizes	C1706244
28009593	process	C1522240
28009593	re-evaluation	C0681840
28009593	psychometric properties	C0033920
28009593	PONS	C0681889
28009593	RN	C0687673
28009593	sample	C1257890
28009593	registered nurses	C0687673
28009593	providing	C1999230
28009593	direct	C1947931
28009593	patient care	C0017313
28009593	responded	C2911692
28009593	item	C1551338
28009593	questionnaire	C0034394
28009593	Rasch rating scale model	C0871207
28009593	assessing	C0184514
28009593	construct validity	C0681897
28009593	PONS	C0681889
28009593	RN	C0687673
28009593	data	C1511726
28009593	principal component analysis	C0429865
28009593	PCA	C0429865
28009593	residuals	C1609982
28009593	supported	C1521721
28009593	appropriateness	C0814634
28009593	subscales	C0459443
28009593	2-dimensional	C1705052
28009593	structure	C0678594
28009593	results	C0683954
28009593	item	C1551338
28009593	person	C0027361
28009593	fit	C2349186
28009593	analysis	C0936012
28009593	rating scale	C0681889
28009593	functioning	C0205245
28009593	analysis	C0936012
28009593	reliability analysis	C0814892
28009593	demonstrated	C0443289
28009593	item	C1551338
28009593	Presence	C0150312
28009593	Nursing	C0028677
28009593	Scale	C0681889
28009593	RN	C0687673
28009593	measures	C0079809
28009593	high	C0205250
28009593	validity and reliability	C0814892
28009593	sub-scales	C0459443
28009593	rn	C0687673
28009695	Elastin	C0013765
28009695	Differentially Regulated	C2755857
28009695	Pressure Therapy	C1956078
28009695	Porcine	C3665571
28009695	Model	C0599779
28009695	Hypertrophic Scar	C0162810
28009695	Beneficial effects	C1280500
28009695	pressure therapy	C1956078
28009695	hypertrophic scars	C0162810
28009695	mechanisms	C0441712
28009695	study	C2603343
28009695	elastin	C0013765
28009695	scar	C0162810
28009695	pliability	C0242808
28009695	relationship	C0439849
28009695	Vancouver Scar Scale	C0349674
28009695	VSS	C0349674
28009695	scores	C0449820
28009695	pressure-treated	C1956078
28009695	scars	C0162810
28009695	elastin	C0013765
28009695	Hypertrophic scars	C0162810
28009695	weekly	C0332174
28009695	VSS	C0349674
28009695	biopsy	C0005558
28009695	procurement	C0243095
28009695	Pressure treatment	C1956078
28009695	day	C0439228
28009695	postinjury	C1254367
28009695	Treated	C0087111
28009695	scars	C0162810
28009695	compared	C1707455
28009695	shams	C0032042
28009695	Treatment	C0087111
28009695	weeks	C0439230
28009695	day	C0439228
28009695	scars	C0162810
28009695	weekly	C0332174
28009695	day	C0439228
28009695	Transcript	C1519595
28009695	protein levels	C0428479
28009695	elastin	C0013765
28009695	quantified	C1709793
28009695	Pressure treatment	C1956078
28009695	VSS	C0349674
28009695	scores	C0449820
28009695	compared	C1707455
28009695	sham-treated	C0032042
28009695	scars	C0162810
28009695	Pliability	C0242808
28009695	VSSP	C0242808
28009695	day	C0439228
28009695	pretreatment	C3539076
28009695	VSSP	C0242808
28009695	Without treatment	C0032042
28009695	sham-treated	C0032042
28009695	scars	C0162810
28009695	pliable	C0242808
28009695	pressure-treated	C1956078
28009695	scars	C0162810
28009695	pliable	C0242808
28009695	elastin	C0013765
28009695	scars	C0162810
28009695	day	C0439228
28009695	uninjured skin	C1123023
28009695	treatment	C0087111
28009695	elastin	C0013765
28009695	increased	C0205217
28009695	increase	C0442805
28009695	day	C0439228
28009695	sham	C0032042
28009695	scars	C0162810
28009695	increase	C0442805
28009695	Quantification	C1709793
28009695	Verhoeff-Van Gieson staining	C1294321
28009695	findings	C0243095
28009695	immunofluorescence	C0079603
28009695	alignment	C1706765
28009695	elastin fibers	C0013765
28009695	Pressure treatment	C1956078
28009695	increased	C0205217
28009695	protein level expression	C1171362
28009695	elastin	C0013765
28009695	compared	C1707455
28009695	sham	C0032042
28009695	scars	C0162810
28009695	findings	C0243095
28009695	extracellular matrix's	C0015350
28009695	pressure	C0033095
28009695	scar	C0162810
28009695	treatment	C0087111
28009695	rehabilitation	C0034992
28009695	improvements	C2986411
28009695	functional	C0205245
28009695	psychosocial	C0542298
28009695	outcomes	C1274040
28009695	patients	C0030705
28011059	Epigenome-wide analysis	C2350277
28011059	SMAD3	C0919432
28011059	methylation	C0376452
28011059	birth	C0005615
28011059	asthma in children	C0264408
28011059	asthmatic	C0004096
28011059	mothers	C0026591
28011059	mechanisms	C0441712
28011059	asthma	C0004096
28011059	inception	C1522492
28011059	epigenetic	C1516924
28011059	mechanisms	C0441712
28011059	asthma	C0004096
28011059	pathogenesis	C0699748
28011059	asthma	C0004096
28011059	inception	C1522492
28011059	assess	C0184514
28011059	asthma	C0004096
28011059	birth	C0005615
28011059	epigenetic	C1516924
28011059	mechanisms	C0441712
28011059	DNA methylation	C0376452
28011059	asthma	C0004096
28011059	inception	C1522492
28011059	Methylated CpG Island Recovery Assay chip	C1328856
28011059	survey	C0038951
28011059	DNA methylation	C0376452
28011059	cord blood	C0162371
28011059	mononuclear cells	C0806987
28011059	children	C0008059
28011059	nonasthmatic	C0080105
28011059	asthmatic	C0004096
28011059	subjects	C0080105
28011059	age	C0001779
28011059	years	C0439234
28011059	Infant	C0021270
28011059	Immune	C0439662
28011059	Study	C2603343
28011059	IIS	C2603343
28011059	birth	C0005615
28011059	cohort	C0599755
28011059	asthma	C0004096
28011059	SMAD3	C0919432
28011059	methylation	C0376452
28011059	IIS	C2603343
28011059	replication	C0598312
28011059	cohorts	C0599755
28011059	Manchester	C0681784
28011059	Asthma	C0004096
28011059	Allergy Study	C0945823
28011059	Childhood Origins of Asthma	C0264408
28011059	Study	C2603343
28011059	analyzed	C0936012
28011059	bisulfite sequencing	C3831347
28011059	Illumina 450K arrays	C0022885
28011059	Cord blood	C0162371
28011059	mononuclear cell	C0806987
28011059	IL-1β	C1702300
28011059	levels	C0441889
28011059	measured	C0444706
28011059	ELISA	C0014441
28011059	Neonatal	C0021289
28011059	immune	C0439662
28011059	cells	C0007634
28011059	methylated regions	C0004793
28011059	IIS	C2603343
28011059	children	C1257890
28011059	asthma	C0004096
28011059	age	C0001779
28011059	years	C0439234
28011059	cohorts	C0599755
28011059	methylation	C0376452
28011059	SMAD3	C0919432
28011059	asthma	C0004096
28011059	associated	C0332281
28011059	methylated regions	C0004793
28011059	increased	C0205217
28011059	asthmatic	C0264408
28011059	children	C0008059
28011059	asthmatic	C0004096
28011059	mothers	C0026591
28011059	associated with	C0332281
28011059	childhood asthma	C0264408
28011059	risk	C0035647
28011059	SMAD3	C0919432
28011059	methylation	C0376452
28011059	IIS	C2603343
28011059	neonates	C0021289
28011059	maternal	C0026591
28011059	asthma	C0004096
28011059	associated with	C0332281
28011059	neonatal	C0021289
28011059	IL-1β	C1702300
28011059	innate inflammatory mediator	C0243042
28011059	childhood asthma	C0264408
28011059	birth	C0005615
28011059	epigenetic	C1516924
28011059	modifications	C0392747
28011059	immunoregulatory	C0678889
28011059	proinflammatory	C0333348
28011059	pathways	C1704259
28011059	Maternal	C0026591
28011059	asthma	C0004096
28011059	epigenetic	C1516924
28011059	mechanisms	C0441712
28011059	inception	C1522492
28013205	Clinical	C0205210
28013205	correlates	C1707520
28013205	faecal incontinence	C0015732
28013205	systemic sclerosis	C0036421
28013205	therapeutic avenues	C0679624
28013205	prevalence	C0683921
28013205	severity	C0392364
28013205	faecal incontinence	C0015732
28013205	FI	C0015732
28013205	SSc	C0036421
28013205	association	C0439849
28013205	intestinal	C0021853
28013205	manifestations	C0205319
28013205	potential	C3245505
28013205	predictors	C2698872
28013205	FI	C0015732
28013205	impact	C4049986
28013205	quality of life	C0034380
28013205	cross-sectional study	C0010362
28013205	SSc	C0036421
28013205	subjects	C0030705
28013205	Canadian Scleroderma Research Group	C1708333
28013205	cohort	C0599755
28013205	questionnaires	C0034394
28013205	Jorge-Wexner score	C0349674
28013205	FI	C0015732
28013205	severity scale	C0681887
28013205	Bristol stool scale	C4084861
28013205	stool consistency	C0426740
28013205	FI	C0015732
28013205	Quality-of-Life scale	C0451401
28013205	Constipation	C0009806
28013205	Rome III criteria	C0679228
28013205	Associations	C0439849
28013205	Jorge-Wexner score	C0349674
28013205	clinical variables	C1836458
28013205	multivariate regression analyses	C0034980
28013205	subjects	C0030705
28013205	FI	C0015732
28013205	mild	C2945599
28013205	moderate to severe	C1299393
28013205	patients	C0030705
28013205	stools	C0015733
28013205	constipation	C0009806
28013205	previously	C0205156
28013205	treated	C1522326
28013205	small intestinal bacterial overgrowth	C3160854
28013205	SIBO	C3160854
28013205	Variables	C0439828
28013205	independently	C0085862
28013205	associated with	C0332281
28013205	FI	C0015732
28013205	loose	C2129214
28013205	stools	C0015733
28013205	odds ratio	C0028873
28013205	OR	C0028873
28013205	CI	C0009667
28013205	constipation	C0009806
28013205	OR	C0028873
28013205	CI	C0009667
28013205	P	C1709380
28013205	history	C0683519
28013205	SIBO	C3160854
28013205	OR	C0028873
28013205	CI	C0009667
28013205	urinary incontinence	C0042024
28013205	OR	C0028873
28013205	CI	C0009667
28013205	Quality of life	C0034380
28013205	measured	C0444706
28013205	FI	C0015732
28013205	Quality-of-Life scale	C0451401
28013205	inversely	C0439850
28013205	correlated	C1707520
28013205	FI	C0015732
28013205	severity	C0521117
28013205	correlation	C1707520
28013205	coefficients	C1707429
28013205	P	C1709380
28013205	FI	C0015732
28013205	common	C0205214
28013205	severe	C0205082
28013205	SSc	C0036421
28013205	Loose stools	C2129214
28013205	SIBO	C3160854
28013205	constipation	C0009806
28013205	urinary incontinence	C0042024
28013205	strongly	C0442821
28013205	associated with	C0332281
28013205	FI	C0015732
28013205	targeting	C1521840
28013205	anorectal	C3870603
28013205	dysfunction	C0277785
28013205	concomitant	C0521115
28013205	treatment	C0087111
28013205	clinical	C0205210
28013205	correlates	C1707520
28013205	improvement	C2986411
28013205	FI	C0015732
28013205	quality of life	C0034380
28013205	SSc	C0036421
28013256	training	C0220931
28013256	practice	C0033284
28013256	impact	C4049986
28013256	ENGAGE	C1708333
28013256	Ireland's	C0022067
28013256	national men's health training programme	C0040607
28013256	Ireland's	C0022067
28013256	National Men's Health Policy	C0027458
28013256	recommended	C0034866
28013256	training programmes	C0040607
28013256	tailored	C2986593
28013256	needs	C0027552
28013256	working	C0043227
28013256	health	C1704312
28013256	allied health professionals	C0002122
28013256	ENGAGE	C1708333
28013256	recommendation	C0034866
28013256	study	C2603343
28013256	evaluated	C0220825
28013256	impact	C4049986
28013256	ENGAGE	C1708333
28013256	frontline service providers'	C0679886
28013256	self-reported knowledge	C1948177
28013256	skills	C0678856
28013256	capacity	C1516240
28013256	practice	C0033284
28013256	post	C0687676
28013256	training	C0220931
28013256	ENGAGE	C1708333
28013256	Trainers	C0453962
28013256	training programmes	C0040607
28013256	participants	C0679646
28013256	study	C2603343
28013256	subset	C1515021
28013256	training	C0220931
28013256	participants	C0679646
28013256	Quantitative	C0392762
28013256	methodologies	C0038949
28013256	post	C0687676
28013256	post	C0687676
28013256	training	C0220931
28013256	questionnaire	C0034394
28013256	Overall	C1561607
28013256	participants	C0679646
28013256	satisfied	C4084799
28013256	training	C0220931
28013256	immediately	C0205253
28013256	post	C0687676
28013256	training	C0220931
28013256	follow up	C0589120
28013256	Participants'	C0679646
28013256	self-reported level of knowledge	C1948177
28013256	skill	C0678856
28013256	capacity	C1516240
28013256	priorities	C0439607
28013256	men	C0025266
28013256	influencing	C4054723
28013256	practice	C0033284
28013256	organisation	C0029236
28013256	increased	C0205217
28013256	immediately	C0205253
28013256	training	C0220931
28013256	exception	C1705847
28013256	improving	C1272745
28013256	capacity	C1516240
28013256	men	C0025266
28013256	influencing	C4054723
28013256	practice	C0033284
28013256	organisation	C0029236
28013256	improvements	C2936612
28013256	sustained	C0443318
28013256	post	C0687676
28013256	training	C0220931
28013256	majority	C0680220
28013256	service providers	C0679886
28013256	reported	C0700287
28013256	ENGAGE	C1708333
28013256	impacted	C4049986
28013256	work	C0043227
28013256	practice	C0033284
28013256	post	C0687676
28013256	training	C0220931
28013256	findings	C0243095
28013256	suggest	C1705535
28013256	ENGAGE	C1708333
28013256	succeeded	C0243095
28013256	improving	C1272745
28013256	service providers'	C0679886
28013256	capacity	C1516240
28013256	work	C0043227
28013256	men	C0025266
28013256	improving	C1272745
28013256	gender	C0079399
28013256	competency	C0086035
28013256	health	C0018684
28013256	health related services	C0018747
28013256	increase	C0205217
28013256	utilisation	C0042155
28013256	services	C0018747
28013256	men	C0025266
28013256	improve	C0184511
28013256	health outcomes	C0085565
28013256	men	C0025266
28017476	Double strand break	C1511667
28017476	induction	C0205263
28017476	kinetics	C0022702
28017476	hypersensitivity	C0020517
28017476	keratinocytes	C0022567
28017476	subtherapeutic	C0302350
28017476	doses	C0178602
28017476	weeks	C0439230
28017476	radiotherapy	C1522449
28017476	hyper-radiosensitivity	C0034537
28017476	HRS	C0034537
28017476	quantifying	C1709793
28017476	DNA double strand break (DSB) foci	C3159064
28017476	epidermis	C0014520
28017476	biopsies	C0005558
28017476	radiotherapeutic	C0034619
28017476	dose fractions	C0178602
28017476	aim	C1947946
28017476	study	C2603343
28017476	HRS	C0034537
28017476	week	C0439230
28017476	radiotherapy	C1522449
28017476	treatment	C0087111
28017476	foci	C3159064
28017476	foci	C3159064
28017476	dose fractions	C0178602
28017476	patients	C0030705
28017476	prostate cancer	C0600139
28017476	week	C0439230
28017476	radiotherapy treatment	C1522449
28017476	RT	C1522449
28017476	dose fractions	C0178602
28017476	skin	C1123023
28017476	RT	C1522449
28017476	treatment	C0087111
28017476	skin biopsies	C0150866
28017476	dose fractions	C0178602
28017476	DSB-foci	C3159064
28017476	markers	C0012872
28017476	γH2AX	C1415406
28017476	53BP1	C1420865
28017476	epidermal	C0014520
28017476	keratinocytes	C0022567
28017476	immunofluorescence	C0016318
28017476	immunohistochemical staining	C1508788
28017476	digital image analysis	C2348290
28017476	HRS	C0034537
28017476	keratinocytes	C0022567
28017476	dose-response relationships	C0678790
28017476	DSB foci	C3159064
28017476	treatment course	C0454268
28017476	independent of	C0332291
28017476	sampling	C0441621
28017476	time	C0040223
28017476	quantification	C1709793
28017476	method	C0025663
28017476	Foci	C3159064
28017476	dose fractions	C0178602
28017476	DSB	C1511667
28017476	foci	C3159064
28017476	dose fractions	C0178602
28017476	doses	C0178602
28017476	foci	C3159064
28017476	damage	C0012860
28017476	induction	C0205263
28017476	comparison	C1707455
28017476	γH2AX	C1415406
28017476	53BP1	C1420865
28017476	quantifications	C1709793
28017476	double-staine	C2986582
28017476	biopsies	C0005558
28017476	HRS	C0034537
28017476	dose-response relationships	C0678790
28017476	evidence	C3887511
28017476	HRS	C0034537
28017476	assessed	C1516048
28017476	γH2AX	C1415406
28017476	53BP1	C1420865
28017476	DSB foci	C3159064
28017476	week	C0439230
28017476	treatment course	C0454268
28017476	daily	C0332173
28017476	subtherapeutic	C0302350
28017476	dose fractions	C0178602
28027760	CT angiography	C1536105
28027760	planning	C1301732
28027760	transcatheter aortic valve replacement	C3509486
28027760	automated tube voltage selection	C0392762
28027760	Image quality	C0806487
28027760	radiation	C0851346
28027760	exposure	C0332157
28027760	assess	C0184514
28027760	image quality	C0806487
28027760	accuracy	C0598285
28027760	CT angiography	C1536105
28027760	CTA	C1536105
28027760	transcatheter aortic valve replacement	C3509486
28027760	TAVR	C3509486
28027760	planning	C1301732
28027760	3rd generation dual-source CT	C0040405
28027760	DSCT	C0040405
28027760	patients	C0030705
28027760	TAVR	C3509486
28027760	planning	C1301732
28027760	CTA	C1536105
28027760	3rd generation DSCT	C0040405
28027760	two-part protocol	C0008971
28027760	retrospectively	C1514923
28027760	ECG-gated coronary CTA	C1634617
28027760	CCTA	C1634617
28027760	prospectively	C0205556
28027760	ECG-triggered aortoiliac CTA	C1536105
28027760	contrast medium	C0009924
28027760	Automated tube voltage selection	C0392762
28027760	advanced iterative reconstruction	C2986769
28027760	Effective dose	C4019308
28027760	ED	C4019308
28027760	signal-to-noise	C2986823
28027760	SNR	C2986823
28027760	contrast-to-noise ratios	C0392762
28027760	CNR	C0392762
28027760	Five-point scales	C0282574
28027760	subjective	C0439655
28027760	image quality analysis	C1297895
28027760	patients	C0030705
28027760	TAVR	C3509486
28027760	sizing parameters	C0449381
28027760	Image quality	C0806487
28027760	CCTA	C1634617
28027760	aortoiliac CTAs	C1536105
28027760	CTA	C1536105
28027760	studies	C0008972
28027760	decreased	C0205216
28027760	objective	C1571702
28027760	image quality	C0806487
28027760	SNR	C2986823
28027760	CNR	C0392762
28027760	Mean	C0444504
28027760	ED	C4019308
28027760	increased	C0205217
28027760	CCTA	C1634617
28027760	aortoiliac CTA	C1536105
28027760	patients	C0030705
28027760	TAVR	C3509486
28027760	annulus	C0225957
28027760	diameter	C1301886
28027760	patients	C0030705
28027760	No	C1513916
28027760	severe	C0205082
28027760	cardiac	C0161816
28027760	vascular complications	C0009566
28027760	3rd generation DSCT	C0040405
28027760	diagnostic	C0348026
28027760	image quality	C0806487
28027760	TAVR	C3509486
28027760	planning	C1301732
28027760	CTA	C1536105
28027760	assessment	C0220825
28027760	TAVR	C3509486
28027760	device	C0025080
28027760	delivery	C1705822
28027760	reducing	C0392756
28027760	radiation dose	C4019308
28033191	Giant	C0017526
28033191	Aneurysmal Bone Cyst	C0152244
28033191	Mandibular Condyle	C0024688
28033191	Aneurysmal bone cyst	C0152244
28033191	ABC	C0152244
28033191	rare	C0522498
28033191	rapidly	C0456962
28033191	expanding	C0205229
28033191	locally	C1517927
28033191	destructive	C1948029
28033191	easily	C0332219
28033191	misdiagnosed	C0679838
28033191	lesion	C0221198
28033191	ABC	C0152244
28033191	condyle	C0024688
28033191	rare	C0522498
28033191	year	C0439234
28033191	old	C0580836
28033191	female	C0086287
28033191	giant	C0017526
28033191	ABC	C0152244
28033191	left mandibular condyle	C0205091
28033191	mandibular condyle	C0024688
28033191	patient	C0030705
28033191	treated with	C0332293
28033191	surgical resection	C0015252
28033191	affected	C0392760
28033191	bone	C0262950
28033191	mandibular reconstruction	C2242551
28033191	autologous	C0439859
28033191	bone	C0262950
28033191	Follow-up to date	C3694716
28033191	signs	C0311392
28033191	recurrence	C0034897
28033191	clinical	C0205210
28033191	feature	C2348519
28033191	imaging finding	C1287399
28033191	pathogenesis	C0699748
28033191	treatment methods	C0087111
28033191	ABCs	C0152244
28034730	Association	C0439849
28034730	postpartum depression	C0221074
28034730	practice	C0032893
28034730	exclusive breastfeeding	C0242205
28034730	months	C0439231
28034730	life	C0376558
28034730	investigate	C1292732
28034730	association	C0439849
28034730	postpartum depression	C0221074
28034730	occurrence	C2745955
28034730	exclusive breastfeeding	C0242205
28034730	cross-sectional study	C0010362
28034730	states	C1301808
28034730	Northeast region	C0017446
28034730	vaccination campaign	C4279933
28034730	mother	C0026591
28034730	child	C0008059
28034730	pairs	C1709450
28034730	children	C0008059
28034730	aged	C0001779
28034730	days	C0439228
28034730	months	C0439231
28034730	Edinburgh Postnatal Depression Scale	C0451144
28034730	screen	C0220908
28034730	postpartum depression	C0221074
28034730	outcome	C1274040
28034730	lack	C0332268
28034730	exclusive breastfeeding	C0242205
28034730	occurrence	C2745955
28034730	practice	C1254370
28034730	preceding	C0332152
28034730	interview	C0021822
28034730	Postpartum depression	C0221074
28034730	explanatory variable	C0681885
28034730	covariates	C0814913
28034730	socioeconomic	C0037464
28034730	demographic conditions	C0011292
28034730	maternal health care	C0024922
28034730	prenatal	C0033052
28034730	delivery	C0011209
28034730	postnatal care	C0032782
28034730	child's biological factors	C0205556
28034730	Multivariate logistic regression analysis	C0026777
28034730	confounding factors	C0009673
28034730	Exclusive breastfeeding	C0242205
28034730	observed	C1441672
28034730	infants	C0021270
28034730	women	C0043210
28034730	symptoms	C1457887
28034730	postpartum depression	C0221074
28034730	multivariate logistic regression analysis	C0026777
28034730	exclusive breastfeeding	C0242205
28034730	absence	C0332197
28034730	mothers	C0026591
28034730	symptoms	C1457887
28034730	postpartum depression	C0221074
28034730	younger subjects	C2349001
28034730	benefits	C0814225
28034730	Bolsa Família Program	C0681136
28034730	antenatal care	C0033052
28034730	pregnancy	C0032961
28034730	Postpartum depression	C0221074
28034730	reducing	C0392756
28034730	practice	C1254370
28034730	exclusive breastfeeding	C0242205
28034730	disorder	C0012634
28034730	prenatal	C0033052
28034730	early postpartum	C0233066
28034730	support guidelines	C0282451
28034730	breastfeeding	C0006147
28034730	low socioeconomic status	C1328812
28034730	women	C0043210
28035661	Evidence of	C0332120
28035661	toothpick	C3273359
28035661	groove	C1184482
28035661	formation	C1522492
28035661	Neandertal	C3178755
28035661	anterior	C0205094
28035661	posterior	C0205095
28035661	teeth	C0040426
28035661	microscopic examination	C0026018
28035661	Neandertal	C3178755
28035661	dentitions	C0011443
28035661	El Sidrón	C0017446
28035661	Spain	C0037747
28035661	Hortus	C0017446
28035661	France	C0016674
28035661	unusual	C2700116
28035661	microstriations	C1254365
28035661	mesial	C1708982
28035661	distal sides	C0205108
28035661	tooth	C0040426
28035661	cervix	C0446455
28035661	similar	C2348205
28035661	toothpick	C3273359
28035661	grooves	C1184482
28035661	Homo species	C1300203
28035661	early stages	C2363430
28035661	formation	C1522492
28035661	experimental replication	C0237832
28035661	groove	C1184482
28035661	grass	C0018210
28035661	stalks	C2700372
28035661	Comparisons	C1707455
28035661	isolated	C0205409
28035661	Neandertal	C3178755
28035661	teeth	C0040426
28035661	experimental	C1517586
28035661	dental	C0226984
28035661	specimens	C0370003
28035661	marks	C0037088
28035661	initial stages	C2363430
28035661	toothpick	C3273359
28035661	groove	C1184482
28035661	formation	C1522492
28035661	five-grade recording scale	C0349674
28035661	groove	C1184482
28035661	formation process	C1522492
28035661	Hortus	C0017446
28035661	individuals	C0027361
28035661	incidence	C0021149
28035661	individuals	C0027361
28035661	El Sidrón	C0017446
28035661	individuals	C0027361
28035661	Toothpick	C3273359
28035661	grooves	C1184482
28035661	El Sidrón	C0017446
28035661	earliest stages	C2363430
28035661	development	C1527148
28035661	grooves	C1184482
28035661	Hortus	C0017446
28035661	Neandertals	C3178755
28035661	well-developed	C0205556
28035661	Toothpick	C3273359
28035661	grooves	C1184482
28035661	incisors	C0021156
28035661	canines	C0010482
28035661	differences	C1705242
28035661	occlusal	C0447303
28035661	dental wear	C2717979
28035661	Hortus	C0017446
28035661	individuals	C0027361
28035661	age	C0001779
28035661	meat	C0025017
28035661	diet	C0012155
28035661	food	C0016452
28035661	debris	C0440266
28035661	probing	C0449851
28035661	cleaning methodology	C1947930
28035661	identification	C0205396
28035661	characterization	C1880022
28035661	incipient	C0205256
28035661	toothpick	C3273359
28035661	grooves	C1184482
28035661	human	C0086418
28035661	fossil	C0016614
28035661	record	C0034869
28035661	contribute	C1880177
28035661	increase	C0442805
28035661	knowledge	C0376554
28035661	Neandertals	C3178755
28035661	behavioral	C0018464
28035661	oral care habits	C0424439
28035718	THSD7A	C2745341
28035718	expression	C1171362
28035718	human	C0086418
28035718	cancer	C0006826
28035718	Thrombospondin Type-1 Domain containing 7A	C2745341
28035718	THSD7A	C2745341
28035718	membranous nephropathy	C4054536
28035718	female patient	C0150905
28035718	synchronously	C0439580
28035718	suffering	C0751408
28035718	THSD7A	C2745341
28035718	positive	C1514241
28035718	malignancy	C0205282
28035718	THSD7A	C2745341
28035718	tumor antigen	C0041361
28035718	tissue spots	C2316370
28035718	tumor entities	C1276705
28035718	immunohistochemistry	C0021044
28035718	tissue microarrays	C1519522
28035718	THSD7A	C2745341
28035718	expression	C1171362
28035718	different neoplasias	C0027651
28035718	staining patterns	C0449778
28035718	gain and loss	C0243095
28035718	THSD7A	C2745341
28035718	expression	C1171362
28035718	expression status	C1171362
28035718	non-tumor tissue	C0040300
28035718	tumor-specific markers	C0041365
28035718	tumor entities	C1276705
28035718	prognostic value	C0449821
28035718	THSD7A	C2745341
28035718	tumor development	C1850355
28035718	therapy	C4087167
28042065	Civil Society	C0680324
28042065	Drug Policy Reform	C0815220
28042065	Health	C0018684
28042065	Human Welfare	C0037440
28042065	India	C0021201
28042065	lack	C0332268
28042065	adequate	C0205411
28042065	opioids	C0242402
28042065	India	C0021201
28042065	analgesics	C0002771
28042065	agonist	C2987634
28042065	therapies	C0087111
28042065	severe	C0205082
28042065	unalleviated pain	C0030193
28042065	languish	C1762617
28042065	suffering	C0683278
28042065	drug dependence	C1510472
28042065	India	C0021201
28042065	opium	C0029112
28042065	exporter	C0402574
28042065	prohibitive	C0683610
28042065	narcotics law	C0027413
28042065	control	C0243148
28042065	harmful use of drugs	C0013146
28042065	availability	C0470187
28042065	access	C0444454
28042065	opioids	C0242402
28042065	medical	C0678312
28042065	scientific	C0683933
28042065	purposes	C1285529
28042065	Amendment	C0680532
28042065	law	C1947938
28042065	national regulatory framework	C0220868
28042065	access	C0444454
28042065	essential	C0205224
28042065	opioid analgesics	C0002772
28042065	achievement	C0001072
28042065	policy reforms	C0815220
28042065	law enforcement	C0162469
28042065	drug policy	C0683727
28042065	mitigate	C1553901
28042065	human suffering,	C0683278
28042065	multilayered complexities	C0037431
28042065	policy framework	C0242456
28042065	adverse	C0205169
28042065	impact	C0814716
28042065	reform	C0206597
28042065	civil society movement	C0680411
28042065	health care professionals	C1704312
28042065	lawyers	C0086530
28042065	media	C4054555
28042065	policy analysts	C0870132
28042065	government officials	C0242304
28042065	public	C0034035
28042065	challenges	C0805586
28042065	reform	C0680438
28042065	success	C0597535
28042065	access	C0018748
28042065	opioid	C0242402
28042065	medications	C0150270
28042065	executive arm of the government	C0335161
28042065	interim	C2827738
28042065	measures	C0033107
28042065	judicial intervention	C0178362
28042065	public	C0034035
28042065	interest	C0021729
28042065	litigation	C0079706
28042065	crafting a viable policy document	C0242440
28042065	legislative approval	C0680796
28042065	implementation	C1708476
28042065	drug policy reforms	C0683727
28042065	global	C2348867
28042065	policy	C0242456
28042065	mandates	C0814715
28042065	humanitarian	C0037440
28042065	healthcare	C0086388
28042065	quality-of-life	C0034380
28042065	considerations	C0518609
28042600	Efficacy	C1280519
28042600	Synbiotics	C2936470
28042600	Treatment	C0087111
28042600	Bacillary Dysentery	C1527298
28042600	Children	C0008059
28042600	Double-Blind	C0013072
28042600	Randomized	C0206035
28042600	Placebo-Controlled Study	C0599724
28042600	Bacillary dysentery	C1527298
28042600	children's	C0008059
28042600	admission to hospitals	C0184666
28042600	assess	C0184514
28042600	probiotic	C0525033
28042600	prebiotic	C2717875
28042600	synbiotics	C2936470
28042600	effects	C1280500
28042600	children	C0008059
28042600	dysentery	C0013369
28042600	randomized clinical trial	C0206034
28042600	children	C0008059
28042600	dysentery	C0013369
28042600	groups	C0441833
28042600	synbiotic	C2936470
28042600	group	C0441833
28042600	tablet	C0039225
28042600	/day	C0439505
28042600	synbiotic	C2936470
28042600	days	C0439228
28042600	placebo	C1696465
28042600	group	C0441833
28042600	placebo	C1696465
28042600	tablets	C0039225
28042600	tablet	C0039225
28042600	probiotics	C0525033
28042600	standard	C1442989
28042600	treatment	C0087111
28042600	administered	C1521801
28042600	patients	C0030705
28042600	Duration	C0449238
28042600	hospitalization	C0019993
28042600	dysentery	C0013369
28042600	fever	C0015967
28042600	weight loss	C1262477
28042600	assessed	C1516048
28042600	group	C0441833
28042600	no significant difference	C3842396
28042600	groups	C0441833
28042600	baseline	C1442488
28042600	characteristics	C1521970
28042600	mean duration	C0449238
28042600	dysentery	C0013369
28042600	reduced	C0392756
28042600	mean duration	C0449238
28042600	fever	C0015967
28042600	reduced	C0392756
28042600	synbiotic	C2936470
28042600	group	C0441833
28042600	days	C0439228
28042600	comparison	C1707455
28042600	placebo	C1696465
28042600	group	C0441833
28042600	days	C0439228
28042600	Average amount	C1265611
28042600	weight loss	C1262477
28042600	synbiotic	C2936470
28042600	group	C0441833
28042600	comparison	C1707455
28042600	placebo	C1696465
28042600	group	C0441833
28042600	no significant difference	C3842396
28042600	mean duration	C0449238
28042600	hospitalization	C0019993
28042600	groups	C0441833
28042600	synbiotics	C2936470
28042600	adjuvant therapy	C0677850
28042600	standard	C1442989
28042600	treatment	C0087111
28042600	dysentery	C0013369
28042600	reduces	C0392756
28042600	duration	C0449238
28042600	dysentery	C0013369
28042600	fever	C0015967
28042600	rate of weight losses	C1262477
28042600	trial	C0008976
28042600	registered	C1514821
28042936	Effect	C1280500
28042936	type 2 diabetes mellitus	C0011860
28042936	pharmacokinetics	C0031328
28042936	transplacental transfer	C0678748
28042936	nifedipine	C0028066
28042936	hypertensive	C0020538
28042936	pregnant women	C0033011
28042936	Diabetes mellitus	C0011849
28042936	inhibit	C3463820
28042936	cytochrome P450 3A4	C1142644
28042936	enzyme	C0014442
28042936	metabolism	C0683140
28042936	nifedipine	C0028066
28042936	treatment	C0087111
28042936	hypertension	C0020538
28042936	pregnant women	C0033011
28042936	aimed	C1947946
28042936	assess	C0184514
28042936	effect	C1280500
28042936	type 2 diabetes mellitus	C0011860
28042936	T2DM	C0011860
28042936	pharmacokinetics	C0031328
28042936	placental transfer	C0678748
28042936	nifedipine	C0028066
28042936	amniotic fluid	C0002638
28042936	hypertensive	C0020538
28042936	pregnant women	C0033011
28042936	study	C2603343
28042936	hypertensive	C0020538
28042936	pregnant women	C0033011
28042936	control group	C0009932
28042936	CG	C0009932
28042936	hypertensive	C0020538
28042936	pregnant women	C0033011
28042936	T2DM	C0011860
28042936	nifedipine	C0028066
28042936	week	C0439230
28042936	gestation	C0032961
28042936	blood samples	C0178913
28042936	administration	C1533734
28042936	medication	C0013227
28042936	At delivery	C3263555
28042936	samples	C0178913
28042936	maternal	C0026591
28042936	fetal blood	C0015925
28042936	amniotic fluid	C0002638
28042936	determination	C1148554
28042936	nifedipine	C0028066
28042936	median	C0876920
28042936	pharmacokinetic	C0031328
28042936	parameters	C0549193
28042936	CG	C0009932
28042936	peak plasma concentration	C0683150
28042936	Cmax	C0683150
28042936	time to reach Cmax	C2348796
28042936	tmax	C2348796
28042936	area under the plasma concentration	C0376690
28042936	time curve	C2986848
28042936	AUC	C0376690
28042936	half-life	C0018517
28042936	volume of distribution	C0683148
28042936	bioavailability	C0005508
28042936	Vd	C0683148
28042936	F	C0005508
28042936	ClT	C0683152
28042936	F	C0005508
28042936	parameters	C0549193
28042936	T2DM	C0011860
28042936	group	C1257890
28042936	Cmax	C0683150
28042936	tmax	C2348796
28042936	AUC	C0376690
28042936	Vd	C0683148
28042936	F	C0005508
28042936	total clearance	C0683152
28042936	ClT	C0683152
28042936	F	C0005508
28042936	ratios	C0456603
28042936	plasma concentrations	C0683150
28042936	nifedipine	C0028066
28042936	umbilical vein	C0041637
28042936	intervillous space	C0230968
28042936	amniotic fluid	C0002638
28042936	maternal	C0026591
28042936	CG	C0009932
28042936	T2DM	C0011860
28042936	amniotic fluid	C0002638
28042936	maternal	C0026591
28042936	plasma	C0032105
28042936	ratio	C0456603
28042936	groups	C1257890
28042936	ratios	C0456603
28042936	plasma concentrations	C0683150
28042936	umbilical artery	C0041632
28042936	umbilical vein	C0041637
28042936	CG	C0009932
28042936	T2DM	C0011860
28042936	influence	C4054723
28042936	T2DM	C0011860
28042936	pharmacokinetics	C0031328
28042936	placental transfer	C0678748
28042936	nifedipine	C0028066
28042936	hypertensive	C0020538
28042936	women	C0043210
28042936	controlled	C2911690
28042936	diabetes	C0011847
28050885	Results	C1274040
28050885	International Postmarketing Surveillance Study	C0033267
28050885	pl-VEGF165	C1254351
28050885	Safety	C0036043
28050885	Efficacy	C1280519
28050885	Patients	C0030705
28050885	Peripheral Arterial Disease	C1704436
28050885	treatment	C0087111
28050885	chronic	C0205191
28050885	lower limb	C0023216
28050885	ischemia	C0022116
28050885	vascular surgeons	C0586909
28050885	pharmacological	C0205464
28050885	therapies	C0087111
28050885	disease progression	C0242656
28050885	treatment methods	C0087111
28050885	pl-VEGF165	C1254351
28050885	gene therapy	C0017296
28050885	drug	C1254351
28050885	Russia	C0035970
28050885	treatment	C0087111
28050885	atherosclerotic	C0333482
28050885	peripheral arterial disease	C1704436
28050885	PAD	C1704436
28050885	clinical studies	C0008972
28050885	study	C2603343
28050885	drug	C1254351
28050885	gene construction	C0012931
28050885	pl-VEGF165	C1254351
28050885	active substance	C0574031
28050885	postmarketing surveillance study	C0033267
28050885	safety	C0036043
28050885	side effects	C0879626
28050885	efficacy	C1280519
28050885	gene therapy	C0017296
28050885	patients	C0030705
28050885	clinical practice	C0205897
28050885	patients	C0030705
28050885	stage II-III	C1306673
28050885	chronic	C0205191
28050885	limb	C0015385
28050885	ischemia	C0022116
28050885	Fontaine classification	C0282574
28050885	healthcare facilities	C0018704
28050885	Russia	C0035970
28050885	Ukraine	C0041580
28050885	study	C2603343
28050885	control group	C0009932
28050885	conservative therapy	C0459914
28050885	prostaglandins	C0033554
28050885	prostacyclins	C0205911
28050885	treatment group	C1257890
28050885	treatment	C0087111
28050885	pl-VEGF165	C1254351
28050885	intramuscular injections	C0021492
28050885	dose	C0178602
28050885	Pain-free walking distance	C0243095
28050885	PWD	C0243095
28050885	efficacy	C1280519
28050885	Fontaine	C0282574
28050885	stages II-III	C1306673
28050885	blood flow linear velocity	C0243095
28050885	BFLV	C0243095
28050885	ankle-brachial index	C1328319
28050885	ABI	C1328319
28050885	months	C0439231
28050885	safety	C0036043
28050885	pl-VEGF165	C1254351
28050885	gene transfer	C1517499
28050885	trial protocol	C4255259
28050885	months	C0439231
28050885	adverse events	C0877248
28050885	AEs	C0877248
28050885	serious adverse events	C0877248
28050885	SAEs	C0877248
28050885	visits	C0008952
28050885	medical care	C3825410
28050885	PWD	C0243095
28050885	treatment group	C1257890
28050885	mean	C0444504
28050885	control group	C0009932
28050885	BFLV	C0243095
28050885	ABI values	C1328319
28050885	treatment group	C1257890
28050885	control group	C0009932
28050885	therapeutic effect	C1527144
28050885	stage III	C0205578
28050885	disease	C0012634
28050885	PWD	C0243095
28050885	No	C1513916
28050885	angiogenic therapy	C0087111
28050885	AEs	C0877248
28050885	side effects	C0879626
28050885	limb salvage	C0949591
28050885	treatment	C1257890
28050885	control groups	C0009932
28050885	results	C1274040
28050885	study	C2603343
28050885	phase IIb	C1706096
28050885	III	C0282461
28050885	clinical study	C0008972
28050885	pl-VEGF165	C1254351
28050885	intramuscular	C0442117
28050885	gene transfer	C1517499
28050885	treatment	C0087111
28050885	claudication	C1456822
28050885	chronic	C0205191
28050885	lower limb	C0023216
28050885	ischemia	C0022116
28050885	clinical practice	C0205897
28051263	Psychological factors	C0033898
28051263	associated with	C0332281
28051263	NAFLD	C0400966
28051263	NASH	C3241937
28051263	systematic review	C1955832
28051263	Nonalcoholic fatty liver disease	C0400966
28051263	NAFLD	C0400966
28051263	chronic liver diseases	C0341439
28051263	pathogenesis	C0699748
28051263	NAFLD	C0400966
28051263	severe	C0205082
28051263	nonalcoholic steatohepatitis	C3241937
28051263	NASH	C3241937
28051263	mechanisms	C0441712
28051263	review	C1552617
28051263	psychological factors	C0033898
28051263	associated with	C0332281
28051263	NAFLD	C0400966
28051263	NASH	C3241937
28051263	factors	C1521761
28051263	investigated	C1292732
28051263	emotional	C0849912
28051263	cognitive	C1516691
28051263	behavioral	C0004927
28051263	electronic databases	C3841595
28051263	English language	C0376245
28051263	period	C1948053
28051263	PubMed	C1138432
28051263	Thomson ISI - Web of Science	C0242356
28051263	Scopus	C0242356
28051263	ProQuest	C0242356
28051263	ScienceDirect	C0242356
28051263	emotional	C0849912
28051263	factors	C1521761
28051263	depression	C0011570
28051263	anxiety	C0003467
28051263	investigation	C1292732
28051263	cognitive functioning	C0392335
28051263	contents	C0456205
28051263	processes	C1522240
28051263	initiate	C1704686
28051263	lifestyle changes	C0870811
28051263	behavioral	C0004927
28051263	factors	C1521761
28051263	physical activity	C0026606
28051263	nutrition	C1442959
28051263	food intake	C0013470
28051263	substance	C0439861
28051263	consumption	C1947907
28051263	coffee	C0009237
28051263	alcohol	C0001967
28051263	cigarettes	C0677453
28051263	factors	C1521761
28051263	protective factors	C0679688
28051263	vulnerability factors	C0035648
28051263	NAFLD	C0400966
28051263	NASH	C3241937
28051263	cognitive-behavioral disease	C0556006
28051263	management	C0376636
28051263	lifestyle changes	C0870811
28051263	diet	C0012155
28051263	exercise	C0015259
28054422	clustering	C1522242
28054422	protein universe	C0033684
28054422	Active site profile-based clustering	C1522242
28054422	protein structures	C1510464
28054422	sequences	C0002518
28054422	Protein function	C1527118
28054422	molecular functional level	C0935587
28054422	amino acids	C0002520
28054422	functional families	C1254370
28054422	superfamily	C1254370
28054422	Active site profiling	C0242481
28054422	DASP	C2348167
28054422	DASP2	C2348167
28054422	sequence databases	C0950141
28054422	active site profiling	C0242481
28054422	TuLIP	C0025663
28054422	Two-Level Iterative clustering Process	C0025663
28054422	clustering process	C1522242
28054422	active site profiling	C0242481
28054422	superfamily	C1254370
28054422	clusters	C1704332
28054422	TuLIP	C0025663
28054422	functionally relevant families	C1254370
28054422	Structure-Function Linkage Database	C0242356
28054422	SFLD	C0242356
28054422	DASP2	C2348167
28054422	clusters	C1704332
28054422	multiple functional families	C1254370
28054422	TuLIP	C0025663
28054422	clusters	C1704332
28054422	DASP2	C2348167
28054422	functionally relevant group	C1254370
28054422	clustering	C1522242
28054422	functionally relevant group	C1254370
28054422	TuLIP	C0025663
28054422	enolase	C0031691
28054422	glutathione transferase	C0017837
28054422	structures	C0596527
28054422	superfamilies	C1254370
28054422	SFLD	C0242356
28054422	Correlation	C1707520
28054422	structures	C0678594
28054422	statistically significant analysis	C0871424
28054422	TuLIP	C0025663
28054422	enolase	C0031691
28054422	clusters	C1704332
28054422	DASP2 GenBank	C0598211
28054422	sequences	C0002518
28054422	F-measure	C0079809
28054422	performance analysis	C0936012
28054422	enolase	C0031691
28054422	GEMMA	C0025663
28054422	SCI-PHY	C0025663
28054422	TuLIP	C0025663
28054422	enolase families	C0031691
28054422	literature	C0023866
28054712	Early	C1279919
28054712	high school engagement	C2584312
28054712	students	C0038492
28054712	attention/deficit hyperactivity disorder	C1263846
28054712	Students	C0038492
28054712	attention/deficit hyperactivity disorder	C1263846
28054712	ADHD	C1263846
28054712	peers	C0679739
28054712	academic achievement	C0700132
28054712	education attainment	C0013658
28054712	School engagement	C2584312
28054712	engagement	C2584312
28054712	education	C0013621
28054712	outcomes	C1274040
28054712	school engagement	C2584312
28054712	students	C0038492
28054712	ADHD	C1263846
28054712	high school transition	C0871305
28054712	period	C1948053
28054712	low school engagement	C0243095
28054712	Participants	C0679646
28054712	adolescents	C0205653
28054712	years	C0439234
28054712	year	C0439234
28054712	high school	C0599395
28054712	diagnosed	C1704656
28054712	ADHD	C1263846
28054712	Participants	C0679646
28054712	paediatric	C0030755
28054712	practices	C0205897
28054712	Cross-sectional study	C0010362
28054712	school engagement	C2584312
28054712	Data	C1511726
28054712	assessment	C0220825
28054712	child	C0008059
28054712	parent	C0030551
28054712	teacher	C0221457
28054712	surveys	C0038951
28054712	School engagement	C2584312
28054712	student attitudes	C0871447
28054712	school	C0036375
28054712	cognitive	C0009240
28054712	emotional	C0013987
28054712	suspension	C4272256
28054712	rates	C1521828
28054712	behavioural	C0004927
28054712	Multivariable regression analyses	C0034980
28054712	student	C0038492
28054712	family	C0015576
28054712	school factors	C0814325
28054712	engagement	C2584312
28054712	students	C0038492
28054712	ADHD	C1263846
28054712	year	C0439234
28054712	high school	C0599395
28054712	peers	C0679739
28054712	year	C0439234
28054712	attitudes	C0004271
28054712	high rates of suspension	C0243095
28054712	years	C0439234
28054712	suspensions	C4272256
28054712	attitudes	C0004271
28054712	adolescent	C0205653
28054712	depression	C0011570
28054712	adolescent	C0205653
28054712	supervision	C0038842
28054712	devaluing	C0564495
28054712	education	C0013621
28054712	Conduct problems	C0684326
28054712	hyperactivity	C0424295
28054712	increased likelihood of being suspended	C0243095
28054712	cognitive ability	C0392334
28054712	family	C0015576
28054712	socio-economic status	C0086996
28054712	schools	C0036375
28054712	risk	C0035647
28054712	individual	C0237401
28054712	family	C0015576
28054712	factors	C4035944
28054712	adolescent	C0205653
28054712	depression	C0011570
28054712	behavioural problems	C0233514
28054712	education	C0013621
28054712	values	C0042295
28054712	family	C0015576
28054712	supervision	C0038842
28054712	high school transition	C0871305
28054712	students	C0038492
28054712	ADHD	C1263846
28058258	Proliferation	C0596290
28058258	Endothelial Cells	C0225336
28058258	Enhanced	C2349975
28058258	Plasma	C0017110
28058258	Nonthermal plasma	C0752188
28058258	medical treatment technique	C0679624
28058258	reactive chemical species	C0162772
28058258	ROS	C0162772
28058258	living body	C0242821
28058258	plasma	C0017110
28058258	plasma	C0017110
28058258	gas	C0017110
28058258	liquid	C0302908
28058258	interface	C1254362
28058258	biomedical application	C0752188
28058258	gas	C0017110
28058258	liquid	C0302908
28058258	plasma	C0017110
28058258	living cells	C0007634
28058258	plasma	C0017110
28058258	gas	C0017110
28058258	liquid	C0302908
28058258	interface	C1254362
28058258	plasma	C0017110
28058258	enhancement	C2349975
28058258	proliferation	C0596290
28058258	endothelial cells	C0225336
28058258	plasma	C0017110
28058258	H2O2	C0020281
28058258	HNO2	C0028214
28058258	HNO3	C0068808
28058258	phosphate buffered	C0991865
28058258	saline	C0036082
28058258	Mg(++)	C0024467
28058258	Ca(++)	C0006675
28058258	PBS	C0991865
28058258	concentration	C1446561
28058258	600-second discharge	C3864299
28058258	pH	C0020283
28058258	PBS	C0991865
28058258	plasma	C0017110
28058258	discharge time	C3864299
28058258	Temperature	C0039476
28058258	PBS	C0991865
28058258	cell-cultured	C0007635
28058258	plasma	C0017110
28058258	discharge for 600 s	C3864299
28058258	treatment	C1522326
28058258	treatment	C1522326
28058258	plasma	C0017110
28058258	enhanced	C2349975
28058258	proliferation	C0596290
28058258	endothelial cells	C0225336
28058258	treatment	C1522326
28058258	H2O2	C0020281
28058258	cell proliferation	C0596290
28058258	ROS	C0162772
28058258	plasma	C0017110
28058258	treatment	C1522326
28058258	enhancement	C2349975
28058258	cell proliferation	C0596290
28058258	biomedical applications	C0752188
28058258	gas	C0017110
28058258	liquid	C0302908
28058258	plasma	C0017110
28058834	pH	C0020283
28058834	Transmembrane Activity	C1148560
28058834	Peptide	C0030956
28058834	Gold Nanostars	C0018026
28058834	Computed Tomography	C0040405
28058834	Photoacoustic Imaging	C3897929
28058834	Photothermal Therapy	C0454527
28058834	Progress	C1280477
28058834	multifunctional nanomaterials	C1450053
28058834	tumor therapy	C0920425
28058834	development	C1527148
28058834	tumor	C0027651
28058834	targeting	C1521840
28058834	delivery strategies	C0087111
28058834	approach	C1292724
28058834	pH	C0020283
28058834	strategy	C0449851
28058834	target	C1521840
28058834	acidic solid tumor microenvironment	C2936626
28058834	pH (low) insertion peptides	C2606266
28058834	pHLIPs	C2606266
28058834	pH	C0020283
28058834	transmembrane activity	C1148560
28058834	fold	C0332462
28058834	insert	C0205245
28058834	lipid bilayer	C0023768
28058834	tumor cells	C0597032
28058834	acidity	C1254365
28058834	cellular internalization	C1254366
28058834	nanomaterials	C1450053
28058834	synchronously	C0439580
28058834	gold nanostars	C0018026
28058834	GNSs	C0018026
28058834	pHLIPs	C2606266
28058834	GNS	C0018026
28058834	pHLIP	C2606266
28058834	targeting	C1521840
28058834	photothermal therapeutic	C0454527
28058834	PTT	C0454527
28058834	efficiency	C0013682
28058834	GNS	C0018026
28058834	pHLIP	C2606266
28058834	characteristics	C1521970
28058834	size	C0456389
28058834	biocompatibility	C0596177
28058834	GNS	C0018026
28058834	mPEG	C0066763
28058834	cellular internalization	C1254366
28058834	GNS	C0018026
28058834	pHLIP	C2606266
28058834	cells	C0007634
28058834	media	C1705217
28058834	pH	C0020283
28058834	pH	C0020283
28058834	tumor	C0027651
28058834	accumulation	C4055506
28058834	GNS	C0018026
28058834	pHLIP	C2606266
28058834	GNS	C0018026
28058834	mPEG	C0066763
28058834	intravenous injection	C0021494
28058834	MCF-7	C0596890
28058834	breast tumor	C1458155
28058834	animal models	C0012644
28058834	GNS	C0018026
28058834	pHLIP	C2606266
28058834	signals	C1710082
28058834	GNS	C0018026
28058834	mPEG	C0066763
28058834	computed tomography	C0040405
28058834	CT	C0040405
28058834	photoacoustic (PA) imaging	C3897929
28058834	targeting	C1521840
28058834	efficiency	C0013682
28058834	PTT	C0454527
28058834	efficacy	C1280519
28058834	tumors	C0027651
28058834	side effects	C0879626
28058834	tissues	C0040300
28058834	GNS	C0018026
28058834	pHLIP	C2606266
28058834	tumor	C0027651
28058834	targeting	C1521840
28058834	pHLIPs	C2606266
28058834	characteristics	C1521970
28058834	GNS	C0018026
28058834	GNS s	C0018026
28058834	tumor	C0027651
28058834	imaging	C0011923
28058834	therapy	C0087111
28059412	cyclopropanation	C1511131
28059412	polycyclopropanated polyketide	C3179052
28059412	jawsamycin	C0003240
28059412	biosynthesis	C0005572
28059412	Jawsamycin	C0003240
28059412	polyketide	C3179052
28059412	nucleoside	C0028621
28059412	polycyclopropane	C0010587
28059412	polyketide chain	C3179052
28059412	cyclopropane	C0010587
28059412	jawsamycin	C0003240
28059412	cyclopropanation	C1511131
28059412	mechanism	C0441712
28059412	enzymatic	C0014442
28059412	synthesis	C0005572
28059412	polyketide	C3179052
28059412	cyclopropanation	C1511131
28059412	reaction rates	C0678608
28059412	condensation	C0596312
28059412	cyclopropanation reactions	C1511131
28061895	laparoscopic radical antegrade modular pancreatosplenectomy	C0519801
28061895	left-sided pancreatic cancer	C0346647
28061895	institution	C2607850
28061895	oncological outcomes	C0679250
28061895	Laparoscopic surgery	C0751429
28061895	pancreatic cancer	C0346647
28061895	technical difficulties	C1710348
28061895	oncological	C0027651
28061895	safety	C0036043
28061895	Radical antegrade modular pancreatosplenectomy	C0842939
28061895	RAMPS	C0842939
28061895	negative margin	C1709157
28061895	radical lymph node dissection	C0184919
28061895	favorable	C3640814
28061895	laparoscopic application	C0393360
28061895	laparoscopic	C0031150
28061895	RAMPS	C0842939
28061895	patients	C0030705
28061895	left-sided pancreatic cancer	C0346647
28061895	trocars	C0041158
28061895	operative procedures	C0543467
28061895	range of dissection	C0242382
28061895	RAMPS	C0842939
28061895	Strasberg	C0805191
28061895	follow-up data	C1704685
28061895	patients	C0030705
28061895	pancreatic ductal adenocarcinoma	C1335302
28061895	operative time	C3494201
28061895	estimated blood loss	C1443559
28061895	length of postoperative hospital stay	C0023303
28061895	postoperative	C0032787
28061895	morbidities	C0026538
28061895	patients	C0030705
28061895	urinary retention	C0080274
28061895	lymph nodes	C0024204
28061895	negative margins	C1709157
28061895	follow-up	C1522577
28061895	disease free survival	C0242793
28061895	overall survival rates	C0038954
28061895	laparoscopic	C0031150
28061895	RAMPS	C0842939
28061895	perioperative	C1518988
28061895	survival outcomes	C0038954
28061895	Laparoscopic	C0031150
28061895	RAMPS	C0842939
28061895	oncologically	C0027651
28061895	feasible procedure	C3831015
28061895	patients	C0030705
28061895	left-sided pancreatic cancer	C0346647
28063131	Individual	C0237401
28063131	classification	C0008902
28063131	strong	C0442821
28063131	risk	C0035647
28063131	attitudes	C0004271
28063131	lottery	C0392762
28063131	types	C0332307
28063131	age groups	C0027362
28063131	Empirical	C1880496
28063131	evaluations	C1292732
28063131	risk	C0035647
28063131	attitudes	C0004271
28063131	weak	C1762617
28063131	definition	C1704788
28063131	risk	C0035647
28063131	risky	C0035647
28063131	riskless options	C1518601
28063131	lottery	C0392762
28063131	outcome	C1274040
28063131	individuals	C0237401
28063131	weak	C1762617
28063131	risk	C0035647
28063131	choice	C1707391
28063131	contexts	C0449255
28063131	risky	C0035647
28063131	riskless gains	C1517378
28063131	weak	C1762617
28063131	risk	C0035647
28063131	contexts	C0449255
28063131	losses	C1517945
28063131	phenomenon	C1882365
28063131	reflection effect	C1882365
28063131	age differences	C0699810
28063131	risk	C0035647
28063131	attitudes	C0004271
28063131	weak	C1762617
28063131	definition	C1704788
28063131	reflection effect	C1882365
28063131	increases	C0442805
28063131	diminishes	C0205216
28063131	older	C1254367
28063131	weak	C1762617
28063131	risk	C0035647
28063131	attitudes	C0004271
28063131	generalizability	C0205556
28063131	use of	C1524063
28063131	strong	C0442821
28063131	strong	C0442821
28063131	definition	C1704788
28063131	risk	C0035647
28063131	options	C1518601
28063131	value	C1522609
28063131	different	C1705242
28063131	degrees	C0449286
28063131	risk	C0035647
28063131	outcome	C1274040
28063131	variance	C1711260
28063131	reanalysis	C0936012
28063131	data	C1511726
28063131	results	C1274040
28063131	individuals	C0237401
28063131	manifests	C0205319
28063131	reflection effect	C1882365
28063131	strong	C0442821
28063131	definition	C1704788
28063131	risk	C0035647
28063131	lottery	C0392762
28063131	pair types	C0332307
28063131	older adults	C0001792
28063131	risk	C0035647
28063131	younger	C0332239
28063131	adults	C0001675
28064539	Treating	C1522326
28064539	binge	C0596170
28064539	(fat) body	C0015665
28064539	Representations	C1882932
28064539	fatness	C4024583
28064539	gold standard	C0150110
28064539	psychological	C0205486
28064539	treatment manual	C0814280
28064539	binge eating disorder	C0596170
28064539	reports	C0700287
28064539	results	C0456984
28064539	Foucauldian	C0086418
28064539	discourse analysis	C0870428
28064539	representations	C1882932
28064539	fatness	C4024583
28064539	empirically	C1880496
28064539	psychological	C0205486
28064539	treatment manual	C0814280
28064539	binge eating disorder	C0596170
28064539	condition	C0348080
28064539	characterized	C1880022
28064539	weight	C0005910
28064539	shape	C0348078
28064539	Analyses	C0936012
28064539	indicate	C1444656
28064539	manual	C0024763
28064539	weight loss	C1262477
28064539	relatively	C0205345
28064539	treating	C1522326
28064539	diagnostic	C0348026
28064539	symptoms	C1457887
28064539	mechanisms	C0441712
28064539	binge eating disorder	C0596170
28064539	critical concerns	C3869780
28064539	observations	C0302523
28064539	findings	C0243095
28064539	psychology's	C0033909
28064539	medical framing	C0205556
28064539	fatness	C4024583
28064539	obesity	C0028754
28064539	gold standard	C0150110
28064539	intervention	C1273869
28064539	psychology	C0033909
28064539	discipline	C0237070
28064539	weight loss	C1262477
28064539	associated with	C0332281
28064539	binge eating disorder	C0596170
28064539	fat bodies	C0015665
28064539	practitioners	C0017319
28064539	problem	C0033213
28064539	fat shame	C0036938
28064539	society	C0037455
28064539	individual	C0237401
28064539	body	C0242821
28064539	provide	C1999230
28064539	individuals	C0237401
28064539	fat stigma	C0277787
28064539	oppression	C0235132
28064539	provide	C1999230
28064539	bodies	C0242821
28066382	Diversity	C1880371
28066382	Planctomycetes	C1222577
28066382	Soils	C0037592
28066382	Lichen	C0023657
28066382	Sub-Arctic	C0003740
28066382	Ecosystems	C0162358
28066382	Northwestern	C1709274
28066382	Siberia	C0037045
28066382	terrestrial	C0562020
28066382	ecosystems	C0162358
28066382	tundra	C3850151
28066382	lichens	C0023657
28066382	genera	C1708235
28066382	Cladonia	C1080962
28066382	Cetraria	C1094116
28066382	microbial	C0599840
28066382	lichen	C0023657
28066382	ecosystems	C0162358
28066382	sub-arctic zone	C0003740
28066382	northwestern	C1709274
28066382	Siberia	C0037045
28066382	forested	C0086312
28066382	tundra	C3850151
28066382	soil	C0037592
28066382	shallow acidic peatland	C0017446
28066382	study	C2603343
28066382	soil	C0037592
28066382	peat	C0030739
28066382	lichen	C0023657
28066382	colonized	C4289767
28066382	bacteria	C0004611
28066382	phylum	C1709533
28066382	Planctomycetes	C1222577
28066382	planctomycetes	C1222577
28066382	fluorescence	C0016315
28066382	in situ hybridization	C0162788
28066382	cells per gram of wet weight	C0392762
28066382	16S rRNA	C3537372
28066382	gene fragments	C0017337
28066382	Planctomycetes	C1222577
28066382	16S rRNA	C3537372
28066382	gene	C0017337
28066382	Illumina pair-end sequencing	C1553778
28066382	soil	C0037592
28066382	peat samples	C0030739
28066382	Lichen	C0023657
28066382	planctomycetes	C1222577
28066382	diversity	C1880371
28066382	operational taxonomic units	C0683955
28066382	sequence identity	C1710052
28066382	soil	C0037592
28066382	tundra	C3850151
28066382	family	C1704727
28066382	Planctomycetaceae	C0995267
28066382	Planctomycetes	C1222577
28066382	sequences	C0162326
28066382	Phycisphaera-related group WD2101	C2791840
28066382	order	C1705177
28066382	Tepidisphaerales	C4087581
28066382	peat	C0030739
28066382	Isosphaera	C0995268
28066382	Singulisphaera group	C2291815
28066382	lineages	C1881379
28066382	genera	C1708235
28066382	Gemmata	C0995258
28066382	Planctopirus	C4103516
28066382	Rubinisphaera	C4103506
28066382	habitats	C0871648
28066382	Singulisphaera-like bacteria	C0004611
28066382	soil	C0037592
28066382	peat samples	C0030739
28066382	planctomycetes	C1222577
28066382	low temperatures	C0009264
28066382	growth	C0018270
28066382	polysaccharides	C0032594
28066382	lichenan	C0064959
28066382	lichen	C0023657
28066382	phytomass	C0005535
28066591	Relationship	C0439849
28066591	polycythemia	C0032461
28066591	in-hospital mortality	C0085556
28066591	chronic obstructive pulmonary disease	C0024117
28066591	patients	C0030705
28066591	low-risk	C3538919
28066591	pulmonary embolism	C0034065
28066591	Pulmonary embolism	C0034065
28066591	PE	C0034065
28066591	frequent	C0332183
28066591	subjects	C0080105
28066591	chronic obstructive pulmonary disease	C0024117
28066591	COPD	C0024117
28066591	associated with	C0332281
28066591	mortality	C0079320
28066591	multi-center retrospective study	C0035363
28066591	investigate	C1292732
28066591	polycythemia	C0032461
28066591	associated with	C0332281
28066591	in-hospital mortality	C0085556
28066591	COPD	C0024117
28066591	patients	C0030705
28066591	low-risk	C3538919
28066591	PE	C0034065
28066591	COPD	C0024117
28066591	patients	C0030705
28066591	PE	C0034065
28066591	Patients	C0030705
28066591	PESI score	C0243095
28066591	demographic	C0011298
28066591	clinical	C0205210
28066591	laboratory information	C0677075
28066591	time of admission	C3854259
28066591	medical records	C0025102
28066591	subjects	C0080105
28066591	hospital discharge	C0586003
28066591	mortality	C0079320
28066591	patients	C0030705
28066591	COPD	C0024117
28066591	PE	C0034065
28066591	low risk	C3538919
28066591	polycythemia	C0032461
28066591	polycythemia	C0032461
28066591	polycythemia	C0032461
28066591	significantly lower	C4055638
28066591	forced expiratory volume in one second (FEV1) level	C2238302
28066591	lower PaO2	C2363807
28066591	SpO2	C2317096
28066591	higher PaCO2	C0391839
28066591	COPD	C0024117
28066591	patients	C0030705
28066591	polycythemia	C0032461
28066591	higher	C0205250
28066591	proportion	C1709707
28066591	arrhythmia	C0003811
28066591	electrocardiogram	C0013798
28066591	ECG	C0013798
28066591	hospital duration time	C0392762
28066591	higher	C0205250
28066591	mechanical ventilation rate	C2223989
28066591	noninvasive	C2986496
28066591	invasive	C0205281
28066591	higher	C0205250
28066591	in-hospital mortality	C0085556
28066591	Multivariate logistic regression analysis	C0681925
28066591	polycythemia	C0032461
28066591	associated with	C0332281
28066591	mortality	C0079320
28066591	COPD	C0024117
28066591	patients	C0030705
28066591	low-risk	C3538919
28066591	PE	C0034065
28066591	Polycythemia	C0032461
28066591	risk factor	C0035648
28066591	in-hospital mortality	C0085556
28066591	COPD	C0024117
28066591	patients	C0030705
28066591	PE	C0034065
28066591	low risk	C3538919
28069279	Masitinib	C2351398
28069279	treatment	C0087111
28069279	severely	C0205082
28069279	symptomatic	C0231220
28069279	indolent systemic mastocytosis	C0272203
28069279	randomised	C0034656
28069279	placebo-controlled	C1706408
28069279	phase 3 study	C0282461
28069279	Indolent systemic mastocytosis	C0272203
28069279	subvariant	C0205556
28069279	smouldering systemic mastocytosis	C3897042
28069279	lifelong	C4274169
28069279	associated with	C0332281
28069279	reduced quality of life	C1963786
28069279	Masitinib	C2351398
28069279	inhibits	C3463820
28069279	KIT	C0033640
28069279	LYN kinases	C1442804
28069279	indolent systemic mastocytosis	C0272203
28069279	pathogenesis	C0699748
28069279	safety	C1705187
28069279	efficacy	C1707887
28069279	masitinib	C2351398
28069279	placebo	C1696465
28069279	severely symptomatic	C0436345
28069279	patients	C0030705
28069279	unresponsive	C0205269
28069279	optimal	C2698651
28069279	symptomatic	C0231220
28069279	treatments	C0087111
28069279	randomised	C0034656
28069279	double-blind	C0013072
28069279	placebo-controlled	C1706408
28069279	phase 3 study	C0282461
28069279	adults	C0001675
28069279	aged	C0001779
28069279	indolent	C0272203
28069279	smouldering systemic mastocytosis	C3897042
28069279	WHO	C0043237
28069279	classification	C0008902
28069279	documented	C0920316
28069279	mastocytosis	C0024899
28069279	histological criteria	C0449574
28069279	countries	C0454664
28069279	patients	C0030705
28069279	cutaneous	C0221912
28069279	systemic mastocytosis	C0221013
28069279	protocol amendment	C1507394
28069279	Patients	C0030705
28069279	randomised	C0034656
28069279	oral	C1527415
28069279	masitinib	C2351398
28069279	placebo	C1696465
28069279	severe symptoms	C0436345
28069279	primary endpoint	C2986535
28069279	response	C0521982
28069279	improvement	C2986411
28069279	baseline	C1442488
28069279	severe baseline symptom	C0436345
28069279	pruritus	C0033774
28069279	score	C0449820
28069279	Hamilton Rating Scale for Depression	C0451203
28069279	Fatigue Impact Scale	C2733557
28069279	treatment effect	C0087113
28069279	methodology	C0086912
28069279	rare diseases	C0678236
28069279	generalised estimating equation model	C0282574
28069279	intention-to-treat	C2718028
28069279	population	C1257890
28069279	participants	C0679646
28069279	treatment	C0087111
28069279	non-treatment-related cause	C0243095
28069279	safety	C1705187
28069279	patients	C0030705
28069279	dose	C0870450
28069279	study drug	C0013175
28069279	trial	C0008976
28069279	ClinicalTrials.gov, number NCT00814073	C0008976
28069279	Feb	C3830166
28069279	July	C3829447
28069279	patients	C0030705
28069279	randomly assigned	C0814868
28069279	masitinib	C2351398
28069279	placebo	C1696465
28069279	weeks	C0439230
28069279	masitinib	C2351398
28069279	associated with	C0332281
28069279	response	C0521982
28069279	primary endpoint	C2986535
28069279	responses	C0521982
28069279	responses	C0521982
28069279	weighted generalised estimating equation	C0205556
28069279	placebo	C1696465
28069279	odds ratio	C0028873
28069279	Frequent	C0332183
28069279	severe adverse events	C1519255
28069279	placebo	C1696465
28069279	diarrhoea	C0011991
28069279	masitinib	C2351398
28069279	group	C0441833
28069279	placebo	C1696465
28069279	group	C0441833
28069279	asthenia	C0004093
28069279	frequent	C0332183
28069279	serious adverse events	C1519255
28069279	diarrhoea	C0011991
28069279	patients	C0030705
28069279	urticaria	C0042109
28069279	life-threatening	C2826244
28069279	toxicities	C0600688
28069279	patient	C0030705
28069279	placebo	C1696465
28069279	group	C0441833
28069279	died	C1546956
28069279	unrelated	C1704623
28069279	study treatment	C3161471
28069279	study findings	C0683954
28069279	masitinib	C2351398
28069279	effective	C1704419
28069279	tolerated agent	C1254351
28069279	treatment	C0087111
28069279	severely symptomatic	C0436345
28069279	indolent	C0272203
28069279	smouldering systemic mastocytosis	C3897042
28069303	Attributable risk	C0814766
28069303	ambient	C1879688
28069303	PM10	C1720884
28069303	mortality	C0205848
28069303	years of life lost	C2713320
28069303	Chengdu	C0681784
28069303	China	C0008115
28069303	Attributable risk	C0814766
28069303	planning	C0018727
28069303	evaluating public health interventions	C0557980
28069303	attributable risk	C0814766
28069303	air pollutants	C0001869
28069303	temporal relationships	C0449235
28069303	exposure	C0332157
28069303	risk	C0035647
28069303	attributable risk	C0814766
28069303	ambient	C1879688
28069303	air pollutants	C0001869
28069303	basin regions	C0681784
28069303	Sichuan Basin	C0681784
28069303	China	C0008115
28069303	PM10	C1720884
28069303	deaths	C1306577
28069303	Basin region	C0681784
28069303	distributed lag non-linear model	C0392762
28069303	attributable risk	C0814766
28069303	Chengdu	C0681784
28069303	China	C0008115
28069303	association	C0439849
28069303	PM10	C1720884
28069303	years of life lost	C2713320
28069303	YLL	C2713320
28069303	analysis	C0936012
28069303	population-attributable fractions	C1264633
28069303	non-accidental	C0521130
28069303	respiratory	C0521346
28069303	cardiovascular mortality	C0205848
28069303	PM10	C1720884
28069303	cumulative increases	C0442805
28069303	YLL	C2713320
28069303	non-accidental	C0521130
28069303	respiratory	C0521346
28069303	cardiovascular mortality	C0205848
28069303	inverse U-shaped pattern	C0449774
28069303	cumulative risk	C0035647
28069303	PM10	C1720884
28069303	YLL	C2713320
28069303	mortality	C0205848
28069303	PM10	C1720884
28069303	effects	C1280500
28069303	YLL	C2713320
28069303	men	C0025266
28069303	elderly	C0001792
28071754	Far-infrared	C1289903
28071754	protects	C1545588
28071754	vascular endothelial cells	C1257792
28071754	advanced glycation end products	C0162574
28071754	induced	C0205263
28071754	injury	C0178314
28071754	PLZF	C1674035
28071754	autophagy	C0004391
28071754	diabetic mice	C0085243
28071754	advanced glycation end products	C0162574
28071754	AGEs	C0162574
28071754	diabetic	C0011847
28071754	patients	C0030705
28071754	induces	C0205263
28071754	vascular endothelial	C0014261
28071754	injury	C0178314
28071754	Promyelocytic leukemia zinc finger protein	C1674035
28071754	PLZF	C1674035
28071754	transcription factor	C0040648
28071754	activated	C2253861
28071754	low-temperature	C0009264
28071754	far-infrared	C1289903
28071754	FIR	C1289903
28071754	irradiation	C1282930
28071754	exert beneficial effects	C3714634
28071754	vascular endothelium	C0014261
28071754	study	C2603343
28071754	investigated	C1292732
28071754	influence	C4054723
28071754	FIR	C1289903
28071754	induced	C0205263
28071754	PLZF	C1674035
28071754	activation	C2253861
28071754	AGE	C0162574
28071754	induced	C0205263
28071754	endothelial	C0014261
28071754	injury	C0178314
28071754	both	C1706086
28071754	in vitro	C0681828
28071754	in vivo	C0681829
28071754	FIR	C1289903
28071754	irradiation	C1282930
28071754	inhibited	C0311403
28071754	AGE	C0162574
28071754	induced	C0205263
28071754	apoptosis	C0162638
28071754	human umbilical vein endothelial cells	C3179121
28071754	HUVECs	C3179121
28071754	PLZF	C1674035
28071754	activation	C2253861
28071754	increased	C0205217
28071754	expression	C1171362
28071754	phosphatidylinositol-3 kinases	C2936824
28071754	PI3K	C2936824
28071754	important	C3898777
28071754	kinases	C0031727
28071754	autophagic	C0004391
28071754	signaling pathway	C0037080
28071754	FIR	C1289903
28071754	induced	C0205263
28071754	PLZF	C1674035
28071754	activation	C2253861
28071754	autophagy	C0004391
28071754	HUVEC	C3179121
28071754	through	C0332273
28071754	upregulation	C0041904
28071754	PI3K	C2936824
28071754	Immunofluorescence	C0016318
28071754	staining	C0487602
28071754	AGEs	C0162574
28071754	HUVECs	C3179121
28071754	localized	C0392752
28071754	lysosomes	C0024369
28071754	FIR	C1289903
28071754	induced	C0205263
28071754	autophagy	C0004391
28071754	promoted	C0033414
28071754	AGEs	C0162574
28071754	degradation	C0243125
28071754	HUVECs	C3179121
28071754	nicotinamide	C0028027
28071754	streptozotocin	C0038432
28071754	induced	C0205263
28071754	diabetic mice	C0085243
28071754	FIR	C1289903
28071754	therapy	C0087111
28071754	reduced	C0392756
28071754	serum AGEs	C0217068
28071754	AGEs	C0162574
28071754	deposition	C0333562
28071754	vascular endothelium	C0014261
28071754	FIR	C1289903
28071754	therapy	C0087111
28071754	reduced	C0392756
28071754	diabetes	C0011847
28071754	induced	C0205263
28071754	inflammatory markers	C4087233
28071754	vascular endothelium	C0014261
28071754	improved	C0184511
28071754	vascular endothelial	C0014261
28071754	function	C1254358
28071754	protective effects	C3179279
28071754	FIR	C1289903
28071754	therapy	C0087111
28071754	not found	C0442737
28071754	PLZF	C1674035
28071754	knockout mice	C0206745
28071754	data	C1511726
28071754	suggest	C1705535
28071754	FIR	C1289903
28071754	induced	C0205263
28071754	PLZF	C1674035
28071754	activation	C2253861
28071754	vascular endothelial cells	C1257792
28071754	vascular endothelium	C0014261
28071754	diabetic mice	C0085243
28071754	AGE	C0162574
28071754	induced	C0205263
28071754	injury	C0178314
28072576	Ultrasonic computed tomography imaging	C0729619
28072576	iron oxide nanoparticles	C3652446
28072576	Iron oxide nanoparticles	C3652446
28072576	IONPs	C3652446
28072576	increasingly	C0442805
28072576	intensively investigated	C1292732
28072576	field	C1521738
28072576	medical imaging	C0025086
28072576	currently	C0521116
28072576	FDA	C0041714
28072576	approved	C0205540
28072576	magnetic resonance imaging	C0024485
28072576	MRI	C0024485
28072576	highly	C0205250
28072576	visualize	C0234621
28072576	ultrasound	C1456803
28072576	Previous	C0205156
28072576	reports	C0684224
28072576	conventional	C0439858
28072576	ultrasound B-scan (pulse-echo) imaging technique	C0203325
28072576	limited	C0439801
28072576	detectability	C3830527
28072576	particles	C0597177
28072576	aim	C1947946
28072576	study	C0681814
28072576	feasibility	C3827682
28072576	imaging	C0011923
28072576	IONPs	C3652446
28072576	through-transmission ultrasound methodology	C3266812
28072576	ultrasonic computed tomography	C0430022
28072576	UCT	C0430022
28072576	IONPs	C3652446
28072576	acoustically	C0001166
28072576	analysed	C0936012
28072576	quantify	C1709793
28072576	effect	C1280500
28072576	speed	C0678536
28072576	sound	C0037709
28072576	SOS	C0037709
28072576	acoustic	C0001166
28072576	attenuation	C0599946
28072576	function	C0542341
28072576	concentration	C1446561
28072576	through-transmission projection	C0430022
28072576	UCT imaging	C0729619
28072576	performed	C0884358
28072576	breast	C0006141
28072576	breast mimicking phantom	C0597204
28072576	ex vivo	C2348480
28072576	ex vivo tissue model	C1519523
28072576	IONPs	C3652446
28072576	MRI scan	C0024485
28072576	performed	C0884358
28072576	verify	C1711411
28072576	particles	C0597177
28072576	examined	C0332128
28072576	ultrasound	C1456803
28072576	experiment	C0681814
28072576	imaged	C1704254
28072576	magnetic resonance	C0917874
28072576	clinically relevant	C2347946
28072576	concentrations	C1446561
28072576	results	C0683954
28072576	consistent	C0332290
28072576	concentration	C1446561
28072576	dependent	C3244310
28072576	speed	C0678536
28072576	sound	C0037709
28072576	increase	C0442805
28072576	IONPs	C3652446
28072576	Imaging	C0011923
28072576	based	C1527178
28072576	property	C0871161
28072576	substantial contrast-to-noise ratio	C0392762
28072576	improvement	C2986411
28072576	SOS	C0037709
28072576	effect	C1280500
28072576	discernible	C0205396
28072576	image	C1704254
28072576	contrast	C1979874
28072576	detection	C0442726
28072576	particles	C0597177
28072576	existence	C1547035
28072576	location	C0450429
28072576	both	C1706086
28072576	raster-scan projection	C0430022
28072576	UCT imaging	C0729619
28072576	significant	C0750502
28072576	change	C0392747
28072576	acoustic	C0001166
28072576	attenuation coefficient	C2986722
28072576	noted	C4288581
28072576	Based	C1527178
28072576	findings	C0243095
28072576	concluded	C1707478
28072576	IONPs	C3652446
28072576	effective	C1704419
28072576	SOS	C0037709
28072576	based	C1527178
28072576	contrast agent	C0009924
28072576	potentially useful	C3827682
28072576	ultrasonic	C1456803
28072576	breast	C0006141
28072576	imaging	C0011923
28072576	particle	C0597177
28072576	capacity	C1516240
28072576	significantly enhancing	C2349975
28072576	diagnosis accuracy	C0598285
28072576	multimodal	C1513743
28072576	MRI	C0024485
28072576	ultrasound imaging	C0041618
28072576	capabilities	C2698977
28073595	Genetically	C0314603
28073595	encoded	C2700640
28073595	calcium indicators	C0596234
28073595	long-term	C0443252
28073595	calcium	C0006675
28073595	dynamics	C0596957
28073595	apoptosis	C0162638
28073595	Intracellular calcium release	C1820193
28073595	essential	C0205224
28073595	regulating	C0596286
28073595	cellular functions	C0007613
28073595	Specific	C0205369
28073595	spatio-temporal	C3494293
28073595	patterns	C0449774
28073595	cytosolic	C1383501
28073595	calcium	C0006675
28073595	elevations	C3163633
28073595	critical	C1511545
28073595	determinants	C1521761
28073595	cell fate	C1540661
28073595	pro-apoptotic	C1516044
28073595	cellular	C0007634
28073595	stressors	C0597530
28073595	apoptotic program	C1159821
28073595	hours	C0439227
28073595	days	C0439228
28073595	measurement	C0242485
28073595	long-term	C0443252
28073595	calcium	C0006675
28073595	dynamics	C0596957
28073595	essential	C0205224
28073595	understanding	C0162340
28073595	mechanistic	C0441712
28073595	role	C1705810
28073595	calcium	C0006675
28073595	apoptotic cell death	C0162638
28073595	technical	C0449851
28073595	limitations	C0449295
28073595	calcium	C0006675
28073595	sensitive	C0332324
28073595	dyes	C0013343
28073595	measure	C0079809
28073595	cytosolic	C1383501
28073595	calcium	C0006675
28073595	long-term	C0443252
28073595	calcium	C0006675
28073595	dynamics	C0596957
28073595	living cells	C0007634
28073595	treatment	C0087111
28073595	apoptosis	C0162638
28073595	inducing	C0205263
28073595	drugs	C0013227
28073595	Genetically	C0314603
28073595	encoded	C2700640
28073595	calcium indicators	C0596234
28073595	overcome	C2983310
28073595	limitations	C0449295
28073595	calcium	C0006675
28073595	sensitive	C0332324
28073595	dyes	C0013343
28073595	performance	C1882330
28073595	genetically	C0314603
28073595	encoded	C2700640
28073595	calcium	C0006675
28073595	indicators	C0021212
28073595	GCaMP6s	C0596234
28073595	GCaMP6f	C0596234
28073595	ratiometric dye	C0016320
28073595	Fura-2	C0079389
28073595	GCaMP6s	C0596234
28073595	Fura-2	C0079389
28073595	agonist	C2987634
28073595	induced	C0205263
28073595	calcium	C0006675
28073595	transients	C0205374
28073595	utility	C0457083
28073595	GCaMP6s	C0596234
28073595	continuously	C0549178
28073595	measuring	C0444706
28073595	apoptotic	C1516044
28073595	calcium release	C0201925
28073595	course	C0750729
28073595	hours	C0439227
28073595	treatment	C0087111
28073595	staurosporine	C0075193
28073595	GCaMP6s	C0596234
28073595	measuring	C0444706
28073595	apoptotic	C1516044
28073595	calcium release	C0201925
28073595	courses	C0750729
28073595	significant	C0750502
28073595	heterogeneity	C0019409
28073595	calcium release	C0201925
28073595	dynamics	C0596957
28073595	cells	C0007634
28073595	staurosporine	C0075193
28073595	GCaMP6s	C0596234
28073595	excellent	C1961136
28073595	indicator	C0021212
28073595	monitoring	C1283169
28073595	long-term	C0443252
28073595	changes	C0392747
28073595	cytosolic	C1383501
28073595	calcium	C0006675
28073595	apoptosis	C0162638
28075235	Staphylococcus pseudintermedius	C1680786
28075235	Human	C0086418
28075235	Infection	C3714514
28075235	Cases	C0868928
28075235	Spain	C0037747
28075235	Dog	C0012984
28075235	Human	C0086418
28075235	Transmission	C0242781
28075235	Staphylococcus pseudintermedius	C1680786
28075235	opportunistic pathogen	C0450254
28075235	identified	C0205396
28075235	infectious agent	C0314732
28075235	colonizer	C2747813
28075235	dogs	C0012984
28075235	S. pseudintermedius	C1680786
28075235	detected	C0442726
28075235	humans	C0086418
28075235	people	C0027361
28075235	contact with	C0332158
28075235	dogs	C0012984
28075235	study	C0681814
28075235	possible	C0332149
28075235	S. pseudintermedius	C1680786
28075235	pet	C0031268
28075235	human	C0086418
28075235	transmission	C0242781
28075235	analyzed	C0936012
28075235	clinical	C0205210
28075235	human	C0086418
28075235	cases	C0868928
28075235	patients	C0030705
28075235	dog	C0012984
28075235	owners	C1704784
28075235	S. pseudintermedius	C1680786
28075235	detected	C0442726
28075235	colonizer	C2747813
28075235	healthy	C3898900
28075235	animals	C0003062
28075235	S. pseudintermedius	C1680786
28075235	isolates	C1764827
28075235	patients	C0030705
28075235	dogs	C0012984
28075235	household	C0020052
28075235	identical	C0205280
28075235	pulsed-field gel electrophoresis	C0085117
28075235	patterns	C0449774
28075235	sequence types	C2359784
28075235	STs	C2359784
28075235	antimicrobial resistance	C1456627
28075235	phenotypes and genotypes	C0678920
28075235	methicillin susceptible	C0079830
28075235	Resistance	C4281815
28075235	erythromycin	C0014806
28075235	clindamycin	C0008947
28075235	tetracycline	C0039644
28075235	trimetoprim-sulfamethoxazole	C0041044
28075235	ciprofloxacin	C0008809
28075235	identified	C0205396
28075235	S. pseudintermedius	C1680786
28075235	strains	C1518614
28075235	lineages	C1881379
28075235	ST241	C2359784
28075235	ST521	C2359784
28075235	detected	C0442726
28075235	strains	C1518614
28075235	dog	C0012984
28075235	owner	C1704784
28075235	patients	C0030705
28075235	strains	C1518614
28075235	other	C0205394
28075235	patients	C0030705
28075235	presented	C0449450
28075235	STs	C2359784
28075235	ST719	C2359784
28075235	ST720	C2359784
28075235	knowledge	C0376554
28075235	description	C0678257
28075235	human	C0086418
28075235	infections	C3714514
28075235	S. pseudintermedius	C1680786
28075235	Spain	C0037747
28075514	TANGO	C0282574
28075514	screening tool	C0220908
28075514	comorbidities	C0009488
28075514	causal pathway	C0282654
28075514	nocturia	C0028734
28075514	robust screening metric	C1710032
28075514	urinary tract	C0042027
28075514	comorbidities	C0009488
28075514	multidisciplinary assessment	C0729737
28075514	patients	C0030705
28075514	nocturia	C0028734
28075514	Variables	C0439828
28075514	association with	C0332281
28075514	nocturia	C0028734
28075514	night	C0240526
28075514	Discriminating	C0205235
28075514	tools	C0220908
28075514	comorbidities	C0009488
28075514	questionnaire	C0034394
28075514	medical	C0205476
28075514	checklist	C1707357
28075514	clinical measures	C3266594
28075514	Short-Form	C2964478
28075514	SF	C2964478
28075514	screening tool	C0220908
28075514	tool	C0220908
28075514	individuals	C0237401
28075514	nocturia	C0028734
28075514	Sleep	C0037313
28075514	Continence	C0442964
28075514	Falls	C0085639
28075514	Rehabilitation service	C0587660
28075514	routine care	C0262500
28075514	Data collected	C4019276
28075514	descriptive analysis	C0678257
28075514	nocturia	C0028734
28075514	screening metric	C1710032
28075514	TANGO	C0282574
28075514	TANGO	C0282574
28075514	Targeting	C1521840
28075514	individual's Aetiology	C0015127
28075514	Nocturia	C0028734
28075514	demographic characteristics	C0683970
28075514	statistical	C0871424
28075514	structural framework	C0026349
28075514	TANGO	C0282574
28075514	SF	C2964478
28075514	TANGO	C0282574
28075514	SF	C2964478
28075514	patient	C0030705
28075514	nocturia	C0028734
28075514	screening tool	C0220908
28075514	diagnostic	C0348026
28075514	morbidities	C0026538
28075514	clinical relevance	C0683325
28075514	nocturia	C0028734
28075514	patients	C0030705
28075514	disciplines	C0237070
28075514	medical specialties	C0037778
28075514	TANGO	C0282574
28075514	smooth inequalities	C0242503
28075514	associated with	C0332281
28075514	assessment	C0220825
28075514	care	C1947933
28075514	patients	C0030705
28075514	nocturia	C0028734
28077027	Probabilistic	C0033204
28077027	acute	C0205178
28077027	risk assessment	C0086930
28077027	cumulative exposure	C2986588
28077027	organophosphorus	C0360429
28077027	carbamate pesticides	C0360422
28077027	dietary vegetables	C0042440
28077027	fruits	C0016767
28077027	Shanghai	C0681784
28077027	populations	C1257890
28077027	Organophosphorus pesticides	C0360429
28077027	OPs	C0360429
28077027	carbamate pesticides	C0360422
28077027	CPs	C0360422
28077027	pesticides	C0031253
28077027	China	C0008115
28077027	protecting	C1545588
28077027	agricultural commodities	C0242775
28077027	determined	C0521095
28077027	cumulative acute exposure	C2986588
28077027	OPs	C0360429
28077027	CPs	C0360422
28077027	Shanghai	C0681784
28077027	residents	C2347958
28077027	vegetables	C0042440
28077027	fruits	C0016767
28077027	VFs	C0016452
28077027	food consumption	C2983605
28077027	data	C1511726
28077027	obtained	C1301820
28077027	Shanghai Food Consumption Survey	C0038951
28077027	SHFCS	C0038951
28077027	participants	C0679646
28077027	aged	C0001779
28077027	years	C0439234
28077027	pesticide residue	C0031251
28077027	data	C1511726
28077027	obtained	C1301820
28077027	Shanghai	C0681784
28077027	monitoring	C1283169
28077027	programme	C3484370
28077027	organophosphates	C0360429
28077027	carbamates	C0360422
28077027	samples	C0444315
28077027	VFs	C0016452
28077027	probabilistic	C0033204
28077027	performed	C0884358
28077027	recommended	C0034866
28077027	EFSA	C0282574
28077027	optimistic model	C3161035
28077027	zero	C0919414
28077027	processing	C0016487
28077027	factors	C1521761
28077027	PFs	C1521761
28077027	pessimistic model	C3161035
28077027	replaced by	C1299987
28077027	limit of detection	C2718050
28077027	LOD	C2718050
28077027	without	C0332288
28077027	PFs	C1521761
28077027	relative potency factor (RPF) method	C0025663
28077027	pesticides	C0031253
28077027	index compound	C1706082
28077027	IC	C1706082
28077027	methamidophos	C0066080
28077027	chlorpyrifos	C0013328
28077027	separately	C0443299
28077027	pessimistic model	C3161035
28077027	methamidophos	C0066080
28077027	IC	C1706082
28077027	risk	C0035647
28077027	exposure	C0332157
28077027	ARfD	C0454255
28077027	day	C0439228
28077027	populations	C1257890
28077027	preschool children	C0008100
28077027	school-age children	C2827631
28077027	adults	C0001675
28077027	no risk	C4036089
28077027	exposure	C0332157
28077027	ARfD	C0454255
28077027	methamidophos	C0066080
28077027	optimistic model	C3161035
28077027	chlorpyrifos	C0013328
28077027	day	C0439228
28077027	optimistic	C0564470
28077027	pessimistic models	C3161035
28077027	populations	C1257890
28077027	Chinese habits	C2242848
28077027	eating	C0013470
28077027	processed food	C0344355
28077027	vegetables	C0042440
28077027	cooked	C0335326
28077027	fruits	C0016767
28077027	washed	C1548982
28077027	peeled	C0441602
28077027	acute	C0205178
28077027	risk	C0035647
28077027	exposure to	C0332157
28077027	VF	C0016452
28077027	sourced	C0449416
28077027	OPs	C0360429
28077027	CPs	C0360422
28077027	Shanghai	C0681784
28077155	MODEM	C0700032
28077155	comprehensive	C1880156
28077155	approach	C0449445
28077155	modelling	C0870071
28077155	outcome	C0085415
28077155	costs	C0010186
28077155	impacts	C4049986
28077155	interventions	C0184661
28077155	dementia	C0497327
28077155	Protocol	C0442711
28077155	paper	C0030351
28077155	MODEM project	C0700032
28077155	comprehensive	C1880156
28077155	approach	C0449445
28077155	MODelling	C0870071
28077155	outcome	C0085415
28077155	costs	C0010186
28077155	impacts	C4049986
28077155	interventions	C0184661
28077155	DEMentia	C0497327
28077155	changes	C0392747
28077155	future	C0016884
28077155	treatment	C0087111
28077155	care	C1947933
28077155	people	C0027361
28077155	dementia	C0497327
28077155	support	C0344211
28077155	family	C0015576
28077155	unpaid	C0557361
28077155	carers	C1305660
28077155	result	C1274040
28077155	outcomes	C0085415
28077155	efficient	C0442799
28077155	use of	C1524063
28077155	resources	C0035201
28077155	MODEM	C0700032
28077155	systematic	C0220922
28077155	mapping	C1283195
28077155	literature	C0023866
28077155	effective	C1704419
28077155	cost	C0010186
28077155	effective	C1704419
28077155	interventions	C0184661
28077155	dementia	C0497327
28077155	care	C1947933
28077155	findings	C2607943
28077155	data	C1511726
28077155	cohort	C0599755
28077155	model	C3161035
28077155	quality of life	C0034380
28077155	cost	C0010186
28077155	impacts	C4049986
28077155	evidence	C3887511
28077155	interventions	C0184661
28077155	available	C0470187
28077155	England	C0014282
28077155	period	C1948053
28077155	Modelling	C0870071
28077155	models	C3161035
28077155	combining	C0205195
28077155	microsimulation	C0869023
28077155	macrosimulation methods	C0869023
28077155	modelling	C0870071
28077155	costs	C0010186
28077155	outcomes	C0085415
28077155	care	C1947933
28077155	individual	C0027361
28077155	life-course	C1510618
28077155	dementia diagnosis	C0497327
28077155	individuals	C0027361
28077155	England	C0014282
28077155	whole	C0444667
28077155	Project	C0700032
28077155	online	C0683828
28077155	Dementia Evidence Toolkit	C0282574
28077155	evidence	C3887511
28077155	summaries	C1706244
28077155	literature	C0023866
28077155	database	C0242356
28077155	available	C0470187
28077155	papers	C0030351
28077155	academic journals	C0162443
28077155	MODEM Legacy Model	C3161035
28077155	local commissioners	C0679924
28077155	services	C0557854
28077155	model	C3161035
28077155	populations	C1257890
28077155	Modelling	C0870071
28077155	effects of	C1704420
28077155	evidence	C3887511
28077155	cost	C0010186
28077155	effective	C1704419
28077155	interventions	C0184661
28077155	information	C1533716
28077155	available	C0470187
28077155	potential	C3245505
28077155	improve	C0184511
28077155	health	C0018684
28077155	quality of life	C0034380
28077155	people	C0027361
28077155	dementia	C0497327
28077155	carers	C1305660
28077155	resources	C0035201
28077286	Assessment	C0936012
28077286	neuroanatomical	C0220784
28077286	behavioural effects	C0815123
28077286	in ovo	C2827729
28077286	methylmercury	C0025794
28077286	exposure	C0332157
28077286	zebra finches	C0326833
28077286	Taeniopygia guttata	C0326833
28077286	Methylmercury	C0025794
28077286	MeHg	C0025794
28077286	crosses	C2828360
28077286	blood brain barrier	C0005854
28077286	known	C0205309
28077286	neuro	C0205494
28077286	toxicant	C0599787
28077286	MeHg	C0025794
28077286	accumulation	C4055506
28077286	brain	C0006104
28077286	causes	C0015127
28077286	histopathological	C0243140
28077286	alterations	C0392747
28077286	neurobehavioral	C2986478
28077286	changes	C0392747
28077286	impairments	C0221099
28077286	cognitive	C1516691
28077286	motor functions	C0234130
28077286	mammalian	C0024660
28077286	models	C0012644
28077286	birds	C0005595
28077286	neurotoxic effects	C0235032
28077286	MeHg	C0025794
28077286	pre	C0332152
28077286	hatching	C0598016
28077286	brain	C0006104
28077286	consequent	C3845876
28077286	behavioral alterations	C0542299
28077286	adult	C0001675
28077286	birds	C0005595
28077286	not	C1518422
28077286	received	C1514756
28077286	attention	C0004268
28077286	passerine birds	C0600537
28077286	poorly	C0205169
28077286	represented	C1882932
28077286	MeHg	C0025794
28077286	neurotoxicology	C0597059
28077286	studies	C2603343
28077286	comparison	C1707455
28077286	avian	C0005595
28077286	orders	C3858829
28077286	study	C2603343
28077286	used	C1524063
28077286	egg	C0013710
28077286	injection method	C0456651
28077286	investigate	C1292732
28077286	long term effects	C0023983
28077286	in ovo	C2827729
28077286	MeHg	C0025794
28077286	exposure	C0332157
28077286	brain	C0006104
28077286	histopathology	C0243140
28077286	courtship behavior	C0237550
28077286	model	C0012644
28077286	songbird	C0600538
28077286	species	C1705920
28077286	zebra finch	C0326833
28077286	Taeniopygia guttata	C0326833
28077286	Egg	C0013710
28077286	treatment	C1522326
28077286	groups	C0681860
28077286	included	C0332257
28077286	low	C0205251
28077286	MeHg	C0025794
28077286	dose	C0178602
28077286	Hg	C0025424
28077286	egg	C0013710
28077286	high	C0205250
28077286	MeHg	C0025794
28077286	dose	C0178602
28077286	Hg	C0025424
28077286	egg	C0013710
28077286	vehicle control	C0042444
28077286	water	C0043047
28077286	No adverse effects	C0853204
28077286	in ovo	C2827729
28077286	MeHg	C0025794
28077286	treatment	C1522326
28077286	detected	C0442726
28077286	courtship	C0237548
28077286	courtship song quality	C0332306
28077286	mating behavior	C1154349
28077286	experimental	C1517586
28077286	males	C0086582
28077286	sexually maturity	C0233891
28077286	suggest	C1705535
28077286	observable	C1285601
28077286	neurobehavioral effects	C0815123
28077286	MeHg	C0025794
28077286	exposure	C0332157
28077286	timing	C0040223
28077286	exposure	C0332157
28077286	during	C0347984
28077286	offspring	C0680063
28077286	development	C0243107
28077286	neuroanatomical	C0220784
28077286	analysis	C0936012
28077286	indicated	C1444656
28077286	increase	C0442805
28077286	telencephalon	C0039452
28077286	volume	C0449468
28077286	increased	C0205217
28077286	MeHg	C0025794
28077286	concentrations	C1446561
28077286	suggest	C1705535
28077286	prolonged	C0439590
28077286	inflammatory response	C1155266
28077286	region of the brain	C1273723
28081044	Evaluation	C0220825
28081044	Condom Barriers Scale	C0349674
28081044	Young	C0238598
28081044	Black Men Who Have Sex With Men	C2827413
28081044	Reliability and Validity	C0035036
28081044	Subscales	C0349674
28081044	Reliable	C0035037
28081044	valid	C2349099
28081044	scale	C0349674
28081044	measures	C0086749
28081044	barriers	C0004764
28081044	condom use	C0679782
28081044	young	C0238598
28081044	black men who have sex with men	C2827413
28081044	YBMSM	C2827413
28081044	Condom Barriers Scales	C0349674
28081044	YBMSM	C2827413
28081044	clinic-based	C0205210
28081044	sample	C2347026
28081044	YBMSM	C2827413
28081044	computer-assisted	C2362103
28081044	self-interview	C0021822
28081044	measure	C0086749
28081044	abbreviated version	C0282574
28081044	Condom Barriers Scale	C0349674
28081044	Reliability	C0035037
28081044	criterion validity	C2699472
28081044	subscales	C0349674
28081044	reliable	C0035037
28081044	partner	C0036911
28081044	barriers	C0004764
28081044	Cronbach α	C0392762
28081044	sensation	C0036658
28081044	barriers	C0004764
28081044	motivation	C0026605
28081044	barriers	C0004764
28081044	complete absence of barriers	C0517435
28081044	partner	C0036911
28081044	sensation	C0036658
28081044	motivation	C0026605
28081044	subscales	C0349674
28081044	significantly	C0237881
28081044	associated with	C0332281
28081044	condomless	C0420844
28081044	insertive	C0233979
28081044	anal sex	C0282347
28081044	Ps	C0392762
28081044	condomless	C0420844
28081044	receptive	C0544683
28081044	anal sex	C0282347
28081044	Ps	C0392762
28081044	subscales	C0349674
28081044	significantly	C0237881
28081044	associated with	C0332281
28081044	measures	C0086749
28081044	condomless	C0420844
28081044	sex	C0009253
28081044	continuous	C0549178
28081044	level	C0441889
28081044	Ps	C0392762
28081044	sensation	C0036658
28081044	barriers	C0004764
28081044	associated with	C0332281
28081044	condomless	C0420844
28081044	anal sex	C0282347
28081044	subscales	C0349674
28081044	significantly	C0237881
28081044	associated with	C0332281
28081044	condom use	C0679782
28081044	problems	C1546466
28081044	Ps	C0392762
28081044	measure	C0086749
28081044	condomless	C0420844
28081044	oral sex	C0282348
28081044	Ps	C0392762
28081044	partner	C0036911
28081044	barriers	C0004764
28081044	sensation	C0036658
28081044	barriers	C0004764
28081044	subscale	C0349674
28081044	significantly	C0237881
28081044	associated with	C0332281
28081044	positive	C1514241
28081044	Chlamydia	C0008148
28081044	gonorrhea	C0018081
28081044	subscales	C0349674
28081044	reliability	C0035037
28081044	validity	C0042284
28081044	measures	C0086749
28081044	observational	C1518527
28081044	experimental research	C0681814
28081044	YBMSM	C2827413
28082609	Variation	C0042333
28082609	Intensity	C0522510
28082609	Selection	C0036576
28082609	Codon	C0009221
28082609	Bias	C0242568
28082609	Time	C0040223
28082609	Contrasting Patterns	C0449774
28082609	Base Composition	C0004790
28082609	Evolution	C0015219
28082609	Drosophila	C0013138
28082609	degenerate	C1880269
28082609	coding sites	C0079941
28082609	genome	C0017428
28082609	selection	C0036576
28082609	demography	C0011292
28082609	evolution	C0015219
28082609	base composition	C0004790
28082609	changes	C0392747
28082609	sites	C0079941
28082609	Drosophila	C0013138
28082609	issue	C0033213
28082609	whole-genome polymorphism data set	C3242346
28082609	D. simulans	C0998507
28082609	analyzed	C0936012
28082609	samples	C0444241
28082609	D. simulans	C0998507
28082609	polymorphism data set	C3242346
28082609	D. melanogaster	C0013139
28082609	D. yakuba	C0998511
28082609	outgroup	C0871022
28082609	evidence	C3887511
28082609	selection	C0036576
28082609	sites	C0079941
28082609	lineages	C0282637
28082609	substantial period	C1948053
28082609	intensity	C0522510
28082609	selection	C0036576
28082609	GC content	C1135899
28082609	model	C0026339
28082609	base composition	C0004790
28082609	evolution	C0015219
28082609	observed	C1441672
28082609	biased	C0242568
28082609	substitution pattern	C0449774
28082609	lineages	C0282637
28082609	ancestral reduction	C0392756
28082609	selection	C0036576
28082609	intensity	C0522510
28082609	result	C0456984
28082609	increase	C0442805
28082609	mutational	C0026882
28082609	bias	C0242568
28082609	polymorphism-based methods	C0796451
28082609	estimating	C0750572
28082609	selection	C0036576
28082609	coefficients	C1707429
28082609	selection	C0036576
28082609	intensity	C0522510
28082609	codon	C0009221
28082609	stable	C0205360
28082609	D. simulans	C0998507
28082609	long-term	C0443252
28082609	estimates	C0750572
28082609	D. melanogaster	C0013139
28082609	higher	C0205250
28082609	short-term	C0443303
28082609	continuing	C0549178
28082609	decline	C0282251
28082609	selection	C0036576
28082609	intensity	C0522510
28082609	extent	C0439792
28082609	short-term	C0443303
28082609	estimates	C0750572
28082609	selection	C0036576
28082609	active	C0205177
28082609	GC	C1135899
28082609	genome	C0017428
28082609	evidence	C3887511
28082609	complex	C0439855
28082609	evolutionary patterns	C0449774
28082609	neutral short introns	C0021920
28082609	standard	C0034925
28082609	GC	C1135899
28082609	biased	C0242568
28082609	gene conversion	C0017259
28082609	model	C0026339
28082609	results	C0456984
28082609	dynamic	C0729333
28082609	base composition	C0004790
28082609	evolution	C0015219
28083459	Case	C0868928
28083459	Koch's Spine	C0041330
28083459	Treated	C1522326
28083459	Modified	C0392747
28083459	Transpedicular Vertebral Curettage	C0010468
28083459	Posterior	C0205095
28083459	Fixation	C0185023
28083459	Technique	C0449851
28083459	Tuberculosis	C0041296
28083459	TB	C0041296
28083459	chronic	C0205191
28083459	granulomatous infection	C1610637
28083459	acid-fast mycobacterium tuberculosis bacilli	C0026926
28083459	Spinal involvement	C0444534
28083459	TB	C0041296
28083459	Spinal TB	C0041330
28083459	Pott's disease	C0041330
28083459	skeletal TB	C0041329
28083459	thoracolumbar junction	C0224591
28083459	level	C0441889
28083459	spine	C0037949
28083459	diagnosis	C0011900
28083459	treatment	C0087111
28083459	neurological complications	C0235029
28083459	spinal deformity	C0575157
28083459	report	C0684224
28083459	case	C0868928
28083459	young	C0332239
28083459	female	C0086287
28083459	tuberculosis	C0041330
28083459	D12-L1	C0507384
28083459	treated	C1522326
28083459	posterior	C0205095
28083459	decompression	C1829459
28083459	modified	C0392747
28083459	transpedicular approach	C0010468
28083459	posterior	C0205095
28083459	instrumentation	C0356967
28083459	outcome	C1274040
28084061	comparison	C1707455
28084061	comorbidity indices	C1516737
28084061	predicting	C0681842
28084061	inpatient	C0021562
28084061	rehabilitation	C0034991
28084061	outcomes	C0085415
28084061	Comorbid conditions	C1275743
28084061	health care	C0086388
28084061	comorbidity index	C1516737
28084061	predicting	C0681842
28084061	impact	C4049986
28084061	comorbidities	C0009488
28084061	rehabilitation	C0034991
28084061	outcomes	C0085415
28084061	determined	C0521095
28084061	Compare	C1707455
28084061	associations	C0439849
28084061	comorbidity	C0009488
28084061	measured	C0444706
28084061	Charlson Comorbidity Index	C1516737
28084061	CCI	C1516737
28084061	Cumulative Index Rating Scale	C0681889
28084061	CIRS	C0681889
28084061	rehabilitation	C0034991
28084061	outcomes	C0085415
28084061	determine	C0521095
28084061	comorbidity indices	C1516737
28084061	variation	C0205419
28084061	rehabilitation	C0034991
28084061	outcomes	C0085415
28084061	Prospective open-cohort study	C1709709
28084061	Inpatient	C0021562
28084061	rehabilitation	C0034991
28084061	ward	C1305702
28084061	Melbourne	C0004340
28084061	Australia	C0004340
28084061	Adults	C0001675
28084061	admitted	C0184666
28084061	inpatient	C0021562
28084061	rehabilitation	C0034991
28084061	outcomes	C0085415
28084061	demographic	C0011292
28084061	age	C0001779
28084061	gender	C0079399
28084061	discharge	C0030685
28084061	destination	C0079220
28084061	clinical	C0205210
28084061	outcomes	C0085415
28084061	reason	C0566251
28084061	rehabilitation	C0034991
28084061	length of stay	C0023303
28084061	Functional Independence Measure	C0451172
28084061	CCI	C1516737
28084061	CIRS	C0681889
28084061	regression analyses	C0034980
28084061	performed	C0884358
28084061	determine	C0521095
28084061	influence	C4054723
28084061	comorbidity	C0009488
28084061	dependent variables	C0871711
28084061	LOS	C0023303
28084061	rehabilitation	C0034991
28084061	change	C0443172
28084061	Functional Independence Measure-motor	C0451172
28084061	score	C0449820
28084061	rehabilitation	C0034991
28084061	discharge	C0030685
28084061	admission	C0184666
28084061	discharge	C0030685
28084061	destination	C0079220
28084061	home	C0442519
28084061	mean	C0444504
28084061	age	C0001779
28084061	years	C0439234
28084061	females	C0086287
28084061	patients	C0030705
28084061	previously	C0205156
28084061	lived at home	C0425078
28084061	family	C0015576
28084061	relatives	C0080103
28084061	reason	C0566251
28084061	rehabilitation	C0034991
28084061	orthopaedic	C1136201
28084061	conditions	C0348080
28084061	people	C0027361
28084061	discharged	C0030685
28084061	home	C0442519
28084061	LOS	C0023303
28084061	days	C0439228
28084061	patients	C0030705
28084061	comorbidity	C0009488
28084061	recorded	C0034869
28084061	CCI	C1516737
28084061	patients	C0030705
28084061	comorbidity	C0009488
28084061	recorded	C0034869
28084061	CIRS	C0681889
28084061	comorbidities	C0009488
28084061	difference	C1705242
28084061	CCI	C1516737
28084061	CIRS	C0681889
28084061	ability	C0085732
28084061	variance	C1711260
28084061	LOS	C0023303
28084061	R2	C2827748
28084061	comorbidities	C0009488
28084061	change	C0443172
28084061	disability	C0231170
28084061	rehabilitation	C0034991
28084061	R2	C2827748
28084061	comorbidities	C0009488
28084061	discharge	C0030685
28084061	destination	C0079220
28084061	comorbidities	C0009488
28084061	comorbidities	C0009488
28084061	demographic	C0011292
28084061	clinical information	C2708733
28084061	CIRS	C0681889
28084061	CCI	C1516737
28084061	patient	C0030705
28084061	sample	C0370003
28084061	provide	C1999230
28084061	information	C1533716
28084061	impact	C4049986
28084061	comorbidities	C0009488
28084061	rehabilitation	C0034991
28084061	outcomes	C0085415
28084061	research	C0035168
28084061	determine	C0521095
28084061	appropriate	C1548787
28084061	measure	C0079809
28084061	comorbidity	C0009488
28084061	relevance	C2347946
28084061	inpatient	C0021562
28084061	rehabilitation	C0034991
28084061	outcomes	C0085415
28085490	Internet Gaming	C3842705
28085490	Disorder	C0004936
28085490	Unique Variance	C1711260
28085490	Psychological Distress	C0815107
28085490	Disability	C0231170
28085490	Comorbid	C1275743
28085490	Depression	C0011570
28085490	OCD	C0028768
28085490	ADHD	C1263846
28085490	Anxiety	C0003467
28085490	study	C2603343
28085490	knowledge	C0376554
28085490	relationship	C0439849
28085490	Internet Gaming Disorder	C0004936
28085490	IGD	C0004936
28085490	mental disorders	C0004936
28085490	comorbidities	C0009488
28085490	anxiety	C0003467
28085490	depression	C0011570
28085490	Attention Deficit Hyperactivity Disorder	C1263846
28085490	ADHD	C1263846
28085490	obsessive compulsive disorder	C0028768
28085490	OCD	C0028768
28085490	assessing	C0184514
28085490	IGD	C0004936
28085490	unique variance	C1711260
28085490	distress	C0231303
28085490	disability	C0231170
28085490	online survey	C0038951
28085490	convenience sample	C0150095
28085490	Internet gaming	C3842705
28085490	Participants	C0679646
28085490	meeting criteria	C1254372
28085490	IGD	C0004936
28085490	Personal Internet Gaming Disorder Evaluation-9	C0242481
28085490	PIE-9	C0242481
28085490	higher comorbidity	C0009488
28085490	depression	C0011570
28085490	OCD	C0028768
28085490	ADHD	C1263846
28085490	anxiety	C0003467
28085490	IGD	C0004936
28085490	criteria	C0243161
28085490	IGD	C0004936
28085490	proportion	C1709707
28085490	unique variance	C1711260
28085490	distress	C0231303
28085490	disability	C0231170
28085490	IGD	C0004936
28085490	larger proportion	C1709707
28085490	unique variance	C1711260
28085490	disability	C0231170
28085490	anxiety	C0003467
28085490	ADHD	C1263846
28085490	proportion	C1709707
28085490	depression	C0011570
28085490	Replications	C1883725
28085490	clinical samples	C2349001
28085490	longitudinal designs	C1707689
28085490	structured diagnostic interviews	C0681913
28087237	Real	C0237400
28087237	Impact	C4049986
28087237	Urinary Incontinence	C0042024
28087237	Female Sexual Dysfunction	C1112442
28087237	Case Control Study	C0007328
28087237	Urinary incontinence	C0042024
28087237	UI	C0042024
28087237	associated with	C0332281
28087237	negative	C0205160
28087237	effects	C1280500
28087237	women's	C0043210
28087237	sexuality	C0036915
28087237	Women's	C0043210
28087237	sexuality	C0036915
28087237	sexual function	C0278092
28087237	complex	C0439855
28087237	issue	C0033213
28087237	role	C1705810
28087237	UI	C0042024
28087237	not completely	C0205257
28087237	assess	C1516048
28087237	impact	C4049986
28087237	UI	C0042024
28087237	female sexual function	C0278098
28087237	comparing	C1707455
28087237	population	C1257890
28087237	control group	C0009932
28087237	continent	C0443192
28087237	women	C0043210
28087237	case-control study	C0007328
28087237	evaluated	C0220825
28087237	continent	C0443192
28087237	incontinent	C0231238
28087237	women	C0043210
28087237	age	C0001779
28087237	range	C1514721
28087237	sexuality	C0036915
28087237	patients	C0030705
28087237	evaluated	C0220825
28087237	anamnesis	C0021055
28087237	physical examination	C0031809
28087237	self-report	C2700446
28087237	quality-of-life questionnaires	C0451149
28087237	incontinent	C0231238
28087237	women	C0043210
28087237	pad test	C0430973
28087237	Patients	C0030705
28087237	sexual activity	C0036864
28087237	evaluated	C0220825
28087237	role	C1705810
28087237	UI	C0042024
28087237	sexual abstinence	C0036899
28087237	Sexual abstinence	C0036899
28087237	absence of sexual activity	C3840693
28087237	sexually active	C0241028
28087237	women	C0043210
28087237	self-report	C2700446
28087237	Sexuality	C0036915
28087237	Quotient	C2347741
28087237	Female	C0086287
28087237	Version	C0333052
28087237	questionnaire	C0034394
28087237	women	C0043210
28087237	study	C2603343
28087237	incontinent	C0231238
28087237	continent	C0443192
28087237	Sexual abstinence	C0036899
28087237	women	C0043210
28087237	Incontinent	C0231238
28087237	women	C0043210
28087237	higher prevalence	C1512456
28087237	sexual abstinence	C0036899
28087237	counterparts	C0682323
28087237	Age	C0001779
28087237	marital status	C0024819
28087237	UI	C0042024
28087237	isolated	C0205409
28087237	predictive factors	C0683956
28087237	sexual abstinence	C0036899
28087237	incontinent	C0231238
28087237	women	C0043210
28087237	Sexually active	C0241028
28087237	women	C0043210
28087237	incontinent	C0231238
28087237	continent	C0443192
28087237	demographic	C0011298
28087237	data	C1511726
28087237	frequency	C0439603
28087237	sexual activity	C0036864
28087237	incontinent	C0231238
28087237	women	C0043210
28087237	sexual desire	C1409687
28087237	foreplay	C0558138
28087237	harmony	C0699798
28087237	partner	C3887537
28087237	sexual comfort	C1331418
28087237	sexual satisfaction	C0871356
28087237	Women	C0043210
28087237	greater	C1704243
28087237	urinary leakage	C3897214
28087237	pad test	C0430973
28087237	weight	C0043100
28087237	sexual function	C0278092
28087237	score	C0449820
28087237	Women	C0043210
28087237	UI	C0042024
28087237	sexual abstinent	C0036899
28087237	continent	C0443192
28087237	women	C0043210
28087237	women	C0043210
28087237	UI	C0042024
28087237	sexual desire	C1409687
28087237	sexual comfort	C1331418
28087237	sexual satisfaction	C0871356
28087237	counterparts	C0682323
28087237	frequency	C0439603
28087237	sexual activity	C0036864
28087473	Salvianolic Acids	C3252265
28087473	Injection	C1272883
28087473	SAFI	C1272883
28087473	suppresses	C1260953
28087473	inflammatory responses	C1155266
28087473	activated	C1879547
28087473	microglia	C0206116
28087473	attenuate	C0599946
28087473	brain damage	C0270611
28087473	focal cerebral ischemia	C0917798
28087473	Inflammatory reactions	C0021368
28087473	microglia	C0206116
28087473	brain	C0006104
28087473	roles	C1705810
28087473	ischemia	C0007786
28087473	reperfusion (I/R) cerebral injuries	C3854511
28087473	Microglia	C0206116
28087473	activation	C1879547
28087473	TLR4	C2247725
28087473	NF-κB signal pathways	C1513838
28087473	Salvianolic acids	C3252265
28087473	injection	C1272883
28087473	SAFI	C1272883
28087473	clinical practice	C0205897
28087473	treat	C1522326
28087473	ischemic stroke	C0948008
28087473	reported	C0700287
28087473	neuroprotective effects	C0815279
28087473	mechanisms	C0441712
28087473	studied	C2603343
28087473	effect	C1280500
28087473	SAFI	C1272883
28087473	inflammatory responses	C1155266
28087473	LPS	C0023810
28087473	stimulated	C1948023
28087473	BV-2	C4075604
28087473	microglia	C0206116
28087473	discover	C1880355
28087473	beneficial	C0814225
28087473	in vitro	C0681828
28087473	effects	C1280500
28087473	SAFI	C1272883
28087473	in vivo	C0681829
28087473	therapeutic effect	C1527144
28087473	MCAO	C0740391
28087473	Middle cerebral artery occlusion	C0740391
28087473	rat	C0034721
28087473	model	C0012644
28087473	employed	C0557351
28087473	mechanism	C0441712
28087473	SAFI	C1272883
28087473	treating	C1522326
28087473	ischemic stroke	C0948008
28087473	Rats	C0034721
28087473	SAFI	C1272883
28087473	group	C0441833
28087473	SAFI	C1272883
28087473	I	C0917798
28087473	R injury	C3854511
28087473	results	C1274040
28087473	SAFI	C1272883
28087473	treatment	C1522326
28087473	significantly decreased	C4055638
28087473	neuroinflammation	C0021368
28087473	infarction	C0021308
28087473	volume	C0449468
28087473	vehicle	C0042444
28087473	group	C0441833
28087473	Activation	C1879547
28087473	microglia cells	C0206116
28087473	reduced	C0392756
28087473	TLR4	C2247725
28087473	NF-κB signals	C1513838
28087473	inhibited	C0311403
28087473	SAFI	C1272883
28087473	treatment	C1522326
28087473	ischemic	C0475224
28087473	hemisphere	C0228174
28087473	reduced	C0392756
28087473	expression	C1171362
28087473	release	C0680255
28087473	cytokines	C0079189
28087473	IL-1β	C0021753
28087473	IL-6	C0021760
28087473	study	C2603343
28087473	evidence	C3887511
28087473	SAFI	C1272883
28087473	effectively	C1704419
28087473	brain	C0006104
28087473	cerebral ischemia	C0917798
28087473	attenuating	C0599946
28087473	inflammation	C0021368
28087473	microglia	C0206116
28087491	Dynamics	C3826426
28087491	bacterial	C0521009
28087491	class Bacilli	C1040746
28087491	deepest valley lake	C0337049
28087491	Kashmir	C0681784
28087491	Manasbal Lake	C0337049
28087491	bacteria	C0004611
28087491	ecological indicators	C0021212
28087491	aquatic systems	C0162358
28087491	comprehensive and systematic analysis	C0936012
28087491	Manasbal Lake	C0337049
28087491	deepest spring fed valley lake	C0337049
28087491	Kashmir	C0681784
28087491	analyze	C0936012
28087491	bacterial community composition	C2936393
28087491	BCC	C2936393
28087491	systematic	C1710275
28087491	regular sampling of waters	C0597681
28087491	waters	C0043047
28087491	sampling stations	C0449705
28087491	Lake	C0337049
28087491	degree of human interference	C0205556
28087491	zones	C1710706
28087491	ecological interests	C1254370
28087491	isolated	C0205409
28087491	species	C1705920
28087491	identified	C0205396
28087491	Bergey's Manual specification	C0282574
28087491	micro and macro morphological characteristics	C1521970
28087491	biochemical characteristics	C1521970
28087491	culture media	C0010454
28087491	confirmation	C0750484
28087491	sequencing	C1561491
28087491	16s rRNA gene	C0035899
28087491	universal bacterial primers	C0073429
28087491	27F	C0073429
28087491	1429R	C0073429
28087491	sampling stations	C0449705
28087491	class Bacilli	C1040746
28087491	maximum	C0806909
28087491	relative abundance	C2346714
28087491	contribution	C1880177
28087491	bacterial species	C1705920
28087491	process	C1522240
28087491	identification	C0205396
28087491	Bacillus aerius	C2617064
28087491	Bacillus altitudinis	C2617063
28087491	Bacillus anthracis	C0004589
28087491	Bacillus cereus	C0004590
28087491	Bacillus ginsengisoli	C3717612
28087491	Bacillus pumilus	C0314874
28087491	Bacillus safensis	C2654376
28087491	Bacillus stratosphericus	C2617062
28087491	Bacillus subtilis	C0004595
28087491	Bacillus tequilensis	C1462983
28087491	Bacillus thermocopriae	C3721500
28087491	Bacillus thuringiensis	C0004597
28087491	Brevibacillus agri strain	C1015757
28087491	Lysinibacillus boronitolerans	C1664577
28087491	Lysinibacillus pakistanensis	C3557569
28087491	Lysinibacillus sphaericus	C0314884
28093376	angle	C0205143
28093376	fixation failure	C0410837
28093376	femoral neck fractures	C0015806
28093376	cannulated compression screws	C0005975
28093376	angle	C0205143
28093376	deformity	C0302142
28093376	affected	C0392760
28093376	lower extremity	C0023216
28093376	measurement	C0242485
28093376	orientation	C1704322
28093376	femoral neck fracture	C0015806
28093376	retrospective study	C0035363
28093376	reproducibility	C1514863
28093376	short-term prognosis	C0033325
28093376	treated	C1522326
28093376	cannulated compression screws	C0005975
28093376	measurement	C0242485
28093376	treatment	C0087111
28093376	femoral neck fractures	C0015806
28093376	patients	C0030705
28093376	femoral neck fractures	C0015806
28093376	cannulated compression screws	C0005975
28093376	retrospectively analyzed	C0936012
28093376	angle	C0205143
28093376	fracture line	C1254362
28093376	vertical	C0205128
28093376	neck axis	C1522496
28093376	ICC	C1707429
28093376	reproducibility	C1514863
28093376	angles	C0205143
28093376	pre-operative	C0445204
28093376	post-operative	C0032790
28093376	radiographs	C1306645
28093376	angles	C0205143
28093376	fractures	C0016658
28093376	groups	C0441833
28093376	months	C0439231
28093376	fixation	C0016641
28093376	radiographs	C1306645
28093376	fractures	C0016658
28093376	ICC	C1707429
28093376	pre-operative	C0445204
28093376	radiographs	C1306645
28093376	confidence interval	C0009667
28093376	CI	C0009667
28093376	CI	C0009667
28093376	angles	C0205143
28093376	inter-rater reproducibility	C1514863
28093376	pre-operative	C0445204
28093376	post-operative	C0032790
28093376	radiographs	C1306645
28093376	fixation failure	C0410837
28093376	rate	C1521828
28093376	screw loosening	C0410830
28093376	fracture displacement	C0585059
28093376	femoral neck	C0015815
28093376	CI	C0009667
28093376	CI	C0009667
28093376	CI	C0009667
28093376	failure rates	C1521828
28093376	fractures	C0016658
28093376	post-operative	C0032790
28093376	CI	C0009667
28093376	CI	C0009667
28093376	inter-rater reproducibility	C1514863
28093376	short-term prognosis	C0033325
28093376	femoral neck fractures	C0015806
28093376	cannulated compression screws	C0005975
28094646	Retirement	C0035345
28094646	crisis	C0231224
28094646	warnings	C1550014
28094646	reality	C0871222
28094646	figures	C0237753
28094646	startling	C0243095
28094646	NHS	C0027461
28094646	staff	C0028698
28094646	retire	C0035345
28094646	surged	C0442805
28094646	consequences	C0686907
28094646	alarming	C0205404
28094646	shortage	C0392762
28094646	nurses	C0028661
28094646	healthcare professionals	C1704312
28094646	inevitable	C0205423
28095477	Burden	C0162698
28095477	Mental Disorders	C0004936
28095477	Eastern Mediterranean Region	C0282645
28095477	Eastern Mediterranean Region	C0282645
28095477	EMR	C0282645
28095477	increase	C0442805
28095477	chronic disorders	C0008679
28095477	mental illness	C0004936
28095477	study	C0008972
28095477	burden	C0162698
28095477	mental disorders	C0004936
28095477	EMR	C0282645
28095477	data	C1511726
28095477	Global Burden of Disease study	C4277729
28095477	GBD	C4277729
28095477	DALYs	C4300518
28095477	disability-adjusted life years	C4300518
28095477	assessment	C0220825
28095477	premature mortality	C1855073
28095477	years of life lost	C2713320
28095477	YLLs	C2713320
28095477	years lived with disability	C1254367
28095477	YLDs	C1254367
28095477	DALYs	C4300518
28095477	YLLs	C2713320
28095477	YLDs	C1254367
28095477	mental disorders	C0004936
28095477	total disease burden	C0162698
28095477	EMR	C0282645
28095477	DALYS	C4300518
28095477	population	C1257890
28095477	DALYS	C4300518
28095477	males	C0086582
28095477	females	C0086287
28095477	high-income	C0948433
28095477	high-income countries	C0454664
28095477	DALYS	C4300518
28095477	males	C0086582
28095477	females	C0086287
28095477	middle-income	C0870890
28095477	countries	C0454664
28095477	DALYS	C4300518
28095477	males	C0086582
28095477	females	C0086287
28095477	low-income	C1331016
28095477	countries	C0454664
28095477	Females	C0086287
28095477	burden	C0162698
28095477	mental disorders	C0004936
28095477	males	C0086582
28095477	ages	C0001779
28095477	years of age	C1510829
28095477	DALYs	C4300518
28095477	age group	C0027362
28095477	age group	C0027362
28095477	DALYs	C4300518
28095477	burden	C0162698
28095477	mental disorders	C0004936
28095477	EMR	C0282645
28095477	DALYs	C4300518
28095477	DALYs	C4300518
28095477	mental disorders group	C1257890
28095477	EMR	C0282645
28095477	depressive disorders	C0011581
28095477	DALYs	C4300518
28095477	anxiety disorders	C0003469
28095477	EMR	C0282645
28095477	Palestine	C0681784
28095477	burden of mental disorders	C0162698
28095477	mental disorders	C0004936
28095477	EMR countries	C0454664
28095477	mental disorder burden	C0162698
28095477	EMR ministries	C0683710
28095477	provision	C1821241
28095477	mental health services	C0025355
28095477	stigma of mental illness	C3825632
28095477	accelerating	C0442808
28095477	burden of mental health	C0162698
28095477	instability	C1444783
28095477	mental health problems	C1446377
28095477	increased	C0205217
28095477	burden of diseases	C0162698
28095477	region	C0017446
28096993	Father	C0015671
28096993	Daughter	C0011011
28096993	inherited	C0439660
28096993	cutis aplasia	C0282160
28096993	family	C0015576
28096993	Marfan syndrome	C0024796
28096993	case report	C0085973
28096993	case	C0868928
28096993	newborn	C0021289
28096993	co-occurrence	C2745955
28096993	Marfan syndrome	C0024796
28096993	aplasia cutis congenita	C0282160
28096993	ACC	C0282160
28096993	family history	C0241889
28096993	significant	C0750502
28096993	Marfan syndrome	C0024796
28096993	ACC	C0282160
28096993	father	C0015671
28096993	case	C0868928
28096993	details	C1522508
28096993	mutation	C0026882
28096993	Marfan syndrome	C0024796
28096993	coinheritance	C0728826
28096993	Marfan syndrome	C0024796
28096993	ACC	C0282160
28099123	Hyperandrogenemia	C1299574
28099123	women	C0043210
28099123	polycystic ovary syndrome	C0032460
28099123	prevalence	C0220900
28099123	characteristics	C1521970
28099123	association with	C0332281
28099123	body mass index	C1305855
28099123	Hyperandrogenemia	C1299574
28099123	diagnostic	C0348026
28099123	diagnosis	C0011900
28099123	polycystic ovary syndrome	C0032460
28099123	PCOS	C0032460
28099123	estimate	C0750572
28099123	prevalence	C0220900
28099123	characteristics	C1521970
28099123	hyperandrogenemia	C1299574
28099123	women	C0043210
28099123	PCOS	C0032460
28099123	investigate	C1292732
28099123	clinical	C0205210
28099123	biochemical	C0205474
28099123	characteristics	C1521970
28099123	body mass index	C1305855
28099123	BMI	C1305855
28099123	presence	C0150312
28099123	hyperandrogenemia	C1299574
28099123	women	C0043210
28099123	diagnosed	C0011900
28099123	PCOS	C0032460
28099123	Hyperandrogenemia	C1299574
28099123	testosterone	C0039601
28099123	T	C0039601
28099123	free testosterone	C0443483
28099123	FT	C0443483
28099123	∆4 androstenedione	C4284099
28099123	Δ4-A	C4284099
28099123	hormone	C0019932
28099123	Patients	C0030705
28099123	stratified	C0205363
28099123	groups	C1257890
28099123	BMI	C1305855
28099123	threshold	C0449864
28099123	Hyperandrogenemia	C1299574
28099123	present	C0150312
28099123	patients	C0030705
28099123	Elevated	C3163633
28099123	T	C0039601
28099123	elevated	C3163633
28099123	FT	C0443483
28099123	Δ4-A	C4284099
28099123	patients	C0030705
28099123	normal weight	C2712185
28099123	women	C0043210
28099123	BMI	C1305855
28099123	hyperandrogenemia	C1299574
28099123	hip circumference	C0562350
28099123	HOMA-IR	C3639411
28099123	increased	C0205217
28099123	T	C0039601
28099123	FT	C0443483
28099123	Δ4-A	C4284099
28099123	17-hydroxyprogesterone	C0045010
28099123	17-OHP	C0045010
28099123	dehydroepiandrosterone sulfate	C0057277
28099123	DHEAS	C0057277
28099123	white blood cells	C0023516
28099123	WBC	C0023516
28099123	neutrophils	C0027950
28099123	women	C0043210
28099123	hyperandrogenemia	C1299574
28099123	overweight	C0497406
28099123	women	C0043210
28099123	T	C0039601
28099123	FT	C0443483
28099123	Δ4-A	C4284099
28099123	17-OHP	C0045010
28099123	DHEAS	C0057277
28099123	cortisol	C0020268
28099123	measured	C0444706
28099123	thyroid-stimulating hormone (TSH) levels	C0202230
28099123	women	C0043210
28099123	hyperandrogenemia	C1299574
28099123	prevalence	C0220900
28099123	hyperandrogenemia	C1299574
28099123	PCOS	C0032460
28099123	women	C0043210
28099123	Women	C0043210
28099123	BMI	C1305855
28099123	significant	C0750502
28099123	androgens	C0002844
28099123	WBC	C0023516
28099123	neutrophils	C0027950
28099123	HOMA-IR	C3639411
28099123	women	C0043210
28099123	BMI	C1305855
28099123	androgens	C0002844
28099123	TSH	C2825077
28099123	cortisol	C0020268
28099123	presence	C0150312
28099123	hyperandrogenemia	C1299574
28099370	Course	C0750729
28099370	Approach	C0449445
28099370	Doctor	C0031831
28099370	Nursing Practice Project	C0008967
28099370	Student	C0038492
28099370	Concept	C0178566
28099370	Completion	C0205197
28099370	course	C0750729
28099370	approach	C0449445
28099370	doctor	C0031831
28099370	nursing practice project	C0008967
28099370	students	C0038492
28099370	work	C0043227
28099370	groups	C0441833
28099370	faculty member	C0015535
28099370	complete	C0205197
28099370	projects	C1709701
28099370	minimum	C1524031
28099370	practicum	C0032929
28099370	hours	C0439227
28099370	semester	C2348178
28099370	courses	C0750729
28099370	Project teams	C0871489
28099370	agency	C0237463
28099370	community	C0009462
28099370	mentors	C0025369
28099370	Project findings	C0243095
28099370	disseminated	C0205221
28099370	written	C0684224
28099370	oral reports	C0684224
28099370	approach	C0449445
28099370	faculty	C0015535
28099370	resources	C0024752
28099370	students	C0038492
28099370	mentoring	C4255266
28099370	opportunities	C1254370
28099370	reflection	C0037397
28099370	time	C0040223
28099370	project development	C1527148
28105138	Clinical	C0205210
28105138	angiographic	C0002978
28105138	correlation	C1707520
28105138	high-sensitivity C-reactive protein	C0006560
28105138	acute ST elevation myocardial infarction	C1303258
28105138	Vascular inflammation	C0947751
28105138	inflammatory responses	C1155266
28105138	pathogenesis	C0699748
28105138	acute	C0205178
28105138	atherothrombotic	C1963943
28105138	events	C0441471
28105138	acute coronary syndrome	C0948089
28105138	ACS	C0948089
28105138	myocardial infarction	C0027051
28105138	MI	C0027051
28105138	ST segment elevation myocardial infarction	C1536220
28105138	STEMI	C1536220
28105138	clinical	C0205210
28105138	forms	C0348078
28105138	ACS	C0948089
28105138	C-reactive protein	C0006560
28105138	CRP	C0006560
28105138	acute phase prsotein	C0001347
28105138	high-sensitivity methods	C3839560
28105138	hs-CRP	C3839560
28105138	elevated	C3163633
28105138	level	C0428528
28105138	body fluids	C0005889
28105138	chronic inflammatory	C0021376
28105138	status	C0449438
28105138	hs-CRP	C3839560
28105138	level	C0428528
28105138	inflammatory	C0021368
28105138	marker	C0005516
28105138	coronary artery disease	C0010054
28105138	CAD	C0010054
28105138	study	C2603343
28105138	investigated	C1292732
28105138	correlation	C1707520
28105138	hs-CRP	C3839560
28105138	level	C0428528
28105138	clinical	C0205210
28105138	angiographic	C0002978
28105138	features	C2348519
28105138	STEMI	C1536220
28105138	risk factors	C0035648
28105138	complications	C0009566
28105138	myocardial infarction	C0027051
28105138	angiographically significant	C0750502
28105138	CAD	C0010054
28105138	patients	C0030705
28105138	STEMI	C1536220
28105138	analyzed	C0936012
28105138	interval	C1272706
28105138	symptom onset	C4086878
28105138	reperfusion therapy	C0035124
28105138	window period	C1948053
28105138	h	C0439227
28105138	hs-CRP	C3839560
28105138	non-diabetic patients	C0030705
28105138	compared	C1707455
28105138	diabetic	C0011847
28105138	patients	C0030705
28105138	correlation	C1707520
28105138	hs-CRP	C3839560
28105138	hs-troponin T	C3827339
28105138	hs-CRP	C3839560
28105138	values	C0042295
28105138	patients	C0030705
28105138	mortality	C0205848
28105138	study	C2603343
28105138	atherosclerosis	C0004153
28105138	clinical applications	C1254363
28105138	therapy	C0087111
28105138	disease	C0012634
28105595	Bioelectrochemical	C2350499
28105595	anaerobic	C3641081
28105595	sewage treatment	C0597443
28105595	technology	C0039421
28105595	Arctic	C0003740
28105595	communities	C0009462
28105595	study	C2603343
28105595	wastewater	C0450237
28105595	treatment	C1522326
28105595	technology	C0039421
28105595	remote	C0205157
28105595	northern	C1709269
28105595	communities	C0009462
28105595	technology	C0039421
28105595	based	C1527178
28105595	enhanced	C2349975
28105595	biodegradation	C0005482
28105595	organic carbon	C0302333
28105595	anaerobic	C3641081
28105595	methanogenic	C0025621
28105595	microbial	C0599840
28105595	electrochemical	C2350499
28105595	bioelectrochemical	C2350499
28105595	degradation processes	C0243125
28105595	biomethane	C0029224
28105595	production	C1522492
28105595	microbial	C0599840
28105595	electrochemical	C2350499
28105595	degradation	C0243125
28105595	membraneless flow	C0243095
28105595	bioanode	C0003103
28105595	biocathode	C0007441
28105595	operating	C3242339
28105595	applied	C4048755
28105595	voltage	C0598352
28105595	water	C0043047
28105595	electrolysis	C0013829
28105595	threshold	C0449864
28105595	Laboratory	C0022877
28105595	wastewater	C0450237
28105595	treatment	C1522326
28105595	tests	C0392366
28105595	broad range	C0332464
28105595	mesophilic	C0205081
28105595	psychrophilic temperatures	C0009264
28105595	synthetic	C2004457
28105595	wastewater	C0450237
28105595	biochemical oxygen demand	C3826658
28105595	BOD5	C3826658
28105595	removal	C1883720
28105595	efficiency	C0013682
28105595	effluent	C1546612
28105595	BOD5	C3826658
28105595	concentration	C1446561
28105595	electricity	C0013790
28105595	consumption	C0457083
28105595	chemical oxygen demand	C2936287
28105595	COD	C2936287
28105595	removed	C0849355
28105595	observed	C1441672
28105595	Low	C0205251
28105595	energy	C1442080
28105595	consumption	C0457083
28105595	enhanced	C2349975
28105595	methane	C0025617
28105595	production	C1522492
28105595	positive	C1446409
28105595	energy	C1442080
28105595	balance	C0205415
28105595	bioelectrochemical	C2350499
28105595	treatment	C1522326
28105595	system	C0449913
28106001	Impact	C4049986
28106001	femoral artery	C0015801
28106001	puncture	C0034117
28106001	digital subtraction angiography	C0002979
28106001	road mapping	C1283195
28106001	vascular	C1393529
28106001	bleeding	C0019080
28106001	complications	C0009566
28106001	transcatheter aortic valve implantation	C3509486
28106001	large	C0549177
28106001	diameter	C1301886
28106001	risk	C0035647
28106001	vascular	C1393529
28106001	bleeding	C0019080
28106001	complications	C0009566
28106001	transcatheter aortic valve implantation	C3509486
28106001	TAVI	C3509486
28106001	analysis	C0936012
28106001	assess	C0184514
28106001	impact	C4049986
28106001	femoral artery	C0015801
28106001	puncture	C0034117
28106001	technique	C0449851
28106001	digital subtraction angiography	C0002979
28106001	DSA	C0002979
28106001	road mapping	C1283195
28106001	TAVI	C3509486
28106001	periprocedural	C1141861
28106001	vascular	C0005847
28106001	bleeding	C0019080
28106001	analysis	C0936012
28106001	TAVI	C3509486
28106001	patients	C0030705
28106001	prospective institutional database	C0242356
28106001	femoral artery	C0015801
28106001	puncture	C0034117
28106001	technique	C0449851
28106001	DSA	C0002979
28106001	road mapping	C1283195
28106001	technique	C0449851
28106001	vascular	C0005847
28106001	puncture	C0034117
28106001	angiographic	C0002978
28106001	data	C1511726
28106001	bony	C0443157
28106001	iliofemoral	C1279169
28106001	landmarks	C0504075
28106001	radiopaque object	C0181739
28106001	patients	C0030705
28106001	TAVI	C3509486
28106001	road mapping	C1283195
28106001	technique	C0449851
28106001	RM group	C0441833
28106001	patients	C0030705
28106001	TAVI	C3509486
28106001	road mapping	C1283195
28106001	control group	C0009932
28106001	periprocedural anticoagulation	C0003281
28106001	groups	C0441833
28106001	single suture-based closure device	C0025080
28106001	endpoints	C2349179
28106001	VARC-2 criteria	C0282574
28106001	RM group	C0441833
28106001	years	C0439234
28106001	years	C0439234
28106001	control group	C0009932
28106001	females	C0086287
28106001	groups	C0441833
28106001	baseline logistic EuroSCORE	C3164744
28106001	RM	C0441833
28106001	control group	C0009932
28106001	sheath size	C0456389
28106001	RM	C0441833
28106001	control group	C0009932
28106001	associated with	C0332281
28106001	implantation	C0021107
28106001	RM group	C0441833
28106001	vascular complications	C1393529
28106001	bleeding	C0019080
28106001	days	C0439228
28106001	lower	C0205251
28106001	RM group	C0441833
28106001	control group	C0009932
28106001	analysis	C0936012
28106001	complications	C0009566
28106001	road map group	C0441833
28106001	statistical significance	C0237881
28106001	vascular	C1393529
28106001	bleeding	C0019080
28106001	complications	C0009566
28106001	all-cause mortality	C0178686
28106001	groups	C0441833
28106001	femoral artery	C0015801
28106001	puncture	C0034117
28106001	technique	C0449851
28106001	DSA	C0002979
28106001	road mapping	C1283195
28106001	associated with	C0332281
28106001	vascular	C1393529
28106001	bleeding	C0019080
28106001	complications	C0009566
28106001	TAVI	C3509486
28106001	simple	C0205352
28106001	effective	C1704419
28106001	patient outcomes	C2987124
28107521	Differential	C1705242
28107521	Roles	C1552020
28107521	AXIN1	C1438871
28107521	AXIN2	C1454580
28107521	Tankyrase	C0963182
28107521	Inhibitor-Induced	C0014432
28107521	Formation	C1522492
28107521	Degradasomes	C1180347
28107521	β-Catenin	C0105770
28107521	Degradation	C0243125
28107521	Inhibition	C1524081
28107521	tankyrase enzymes	C0963182
28107521	TNKS1	C1504783
28107521	TNKS2	C1448153
28107521	highly	C0205250
28107521	dynamic	C0729333
28107521	assemblies	C0872376
28107521	β-catenin	C0105770
28107521	destruction complex	C1704241
28107521	components	C1179435
28107521	degradasomes	C1180347
28107521	promote	C0033414
28107521	degradation	C0243125
28107521	β-catenin	C0105770
28107521	reduced	C0392756
28107521	Wnt signaling	C1520113
28107521	activity	C0205177
28107521	colorectal cancer	C1527249
28107521	cells	C0007634
28107521	AXIN1	C1438871
28107521	AXIN2	C1454580
28107521	Conductin	C1454580
28107521	rate-limiting	C0489879
28107521	factors	C1521761
28107521	stability	C0205360
28107521	function	C0542341
28107521	endogenous	C0205227
28107521	destruction complexes	C1704241
28107521	stabilized	C0184512
28107521	TNKS	C0963182
28107521	inhibition	C1524081
28107521	degradation	C0243125
28107521	AXIN	C3178961
28107521	proteasome	C1180347
28107521	role	C1552020
28107521	AXIN1	C1438871
28107521	AXIN2	C1454580
28107521	scaffolding proteins	C0033684
28107521	Wnt signaling pathway	C1520113
28107521	remains	C1527428
28107521	incompletely	C0205257
28107521	understood	C0162340
28107521	relative	C0205345
28107521	contribution	C1880177
28107521	formation	C1522492
28107521	degradasomes	C1180347
28107521	protein	C0033684
28107521	assemblies	C0872376
28107521	morphological	C0543482
28107521	functional	C0205245
28107521	correlates	C1707520
28107521	endogenous	C0205227
28107521	β-catenin	C0105770
28107521	destruction complexes	C1704241
28107521	SW480	C0007634
28107521	colorectal cancer	C1527249
28107521	cells	C0007634
28107521	treated	C1522326
28107521	tankyrase inhibitor	C0014432
28107521	TNKSi	C0014432
28107521	G007-LK	C3658785
28107521	found	C0150312
28107521	AXIN1	C1438871
28107521	degradasome	C1180347
28107521	formation	C1522492
28107521	formation	C1522492
28107521	degradasomes	C1180347
28107521	capacity	C1516240
28107521	degrade	C0243125
28107521	β-catenin	C0105770
28107521	considerably	C0750591
28107521	impaired	C0221099
28107521	G007-LK-treated	C3658785
28107521	cells	C0007634
28107521	AXIN2	C1454580
28107521	findings	C0243095
28107521	novel	C0205314
28107521	insights	C0233820
28107521	differential	C1705242
28107521	functional roles	C1705810
28107521	AXIN1	C1438871
28107521	AXIN2	C1454580
28107521	β-catenin	C0105770
28107521	destruction complex	C1704241
28107548	MRI	C0024485
28107548	prostate cancer	C0376358
28107548	detection	C0011900
28107548	high-level representation	C0683878
28107548	hierarchical	C0699032
28107548	classification	C0008902
28107548	high-level feature representation	C0683878
28107548	deep neural networks	C0870951
28107548	detection	C0011900
28107548	prostate cancer	C0376358
28107548	high-level feature representation	C0683878
28107548	hierarchical	C0699032
28107548	classification	C0008902
28107548	detection	C0011900
28107548	results	C1274040
28107548	High-level feature representation	C0683878
28107548	deep learning network	C0870951
28107548	multiparametric MR	C4304904
28107548	images	C1704922
28107548	data	C1511726
28107548	high-level features	C2346469
28107548	hierarchical	C0699032
28107548	classification	C0008902
28107548	method	C0025663
28107548	multiple random forest classifiers	C0282574
28107548	iteratively constructed	C1707689
28107548	detection	C0011900
28107548	results	C1274040
28107548	prostate cancer	C0376358
28107548	experiments	C0681814
28107548	patient	C0030705
28107548	method	C0025663
28107548	section-based evaluation	C0220825
28107548	SBE	C0220825
28107548	sensitivity	C0332324
28107548	specificity	C0037791
28107548	high-level features	C2346469
28107548	method	C0025663
28107548	performance	C1882330
28107548	conventional	C0205214
28107548	handcrafted features	C2346469
28107548	LBP	C2346469
28107548	Haar-like features	C2346469
28107548	detecting	C0011900
28107548	prostate cancer	C0376358
28107548	regions	C0005898
28107548	context	C0449255
28107548	features	C2348519
28107548	hierarchical	C0699032
28107548	classification	C0008902
28107548	effective	C1704419
28107548	cancer	C0006826
28107548	detection	C0011900
28107548	result	C1274040
28113841	Quantitative Susceptibility Mapping	C0006117
28113841	Structural Feature based Collaborative Reconstruction	C0020912
28113841	SFCR	C0020912
28113841	Human	C0086418
28113841	Brain	C0006104
28113841	reconstruction	C0020912
28113841	MR	C0917874
28113841	quantitative susceptibility mapping	C0006117
28113841	QSM	C0006117
28113841	local phase	C0205390
28113841	measurements	C0242485
28113841	regularization strategies	C0205245
28113841	priori	C0332152
28113841	information	C1533716
28113841	magnitude	C1704240
28113841	phase images	C1704922
28113841	proposed	C1553874
28113841	anatomy	C0700276
28113841	magnitude	C1704240
28113841	phase images	C1704922
28113841	susceptibility maps	C0024779
28113841	erroneous	C1547323
28113841	estimation	C0750572
28113841	reconstructed susceptibility map	C0024779
28113841	structural feature based collaborative reconstruction	C0020912
28113841	SFCR	C0020912
28113841	QSM	C0006117
28113841	magnitude	C1704240
28113841	susceptibility	C1547045
28113841	information	C1533716
28113841	SFCR	C0020912
28113841	algorithm	C0002045
28113841	consecutive steps	C1261552
28113841	reconstruction models	C3161035
28113841	structural feature	C0678594
28113841	norm constraint	C0443288
28113841	norm constraint	C0443288
28113841	structure	C0678594
28113841	features	C2348519
28113841	noise	C0028263
28113841	artifacts	C0085089
28113841	M-step	C1261552
28113841	susceptibility map	C0024779
28113841	reconstructed	C0020912
28113841	compressed sensing model	C3161035
28113841	magnitude	C1704240
28113841	S-step	C1261552
28113841	susceptibility map	C0024779
28113841	spatial domain	C1254362
28113841	constraints	C0443288
28113841	susceptibility map	C0024779
28113841	M-step	C1261552
28113841	Simulations	C0679083
28113841	in vivo	C1515655
28113841	human	C0086418
28113841	experiments	C0681814
28113841	MRI	C0024485
28113841	SFCR	C0020912
28113841	quality	C0332306
28113841	susceptibility maps	C0024779
28113841	RMSE	C0871425
28113841	MSSIM	C0871425
28113841	susceptibility	C1547045
28113841	gray matter	C0018220
28113841	multiple head positions	C0582540
28113841	supine position	C0038846
28113841	COSMOS	C0449913
28113841	result	C1274040
28117535	High	C0205250
28117535	HbA1c	C0019018
28117535	onset	C0332162
28117535	predictor	C2698872
28117535	metabolic control	C1513158
28117535	individual	C0237401
28117535	child	C0008059
28117535	type 1 diabetes mellitus	C0011854
28117535	metabolic control	C1513158
28117535	onset	C0332162
28117535	type 1 diabetes	C0011854
28117535	metabolic control	C1513158
28117535	clinical	C0205210
28117535	parameters	C0449381
28117535	childhood	C0231335
28117535	transition	C2700061
28117535	pediatric care	C3839839
28117535	adult	C0001675
28117535	diabetes care	C0150544
28117535	Data	C1511726
28117535	onset	C0332162
28117535	months	C0439231
28117535	years	C0439234
28117535	diagnosis	C0011900
28117535	transition	C2700061
28117535	HbA1c	C0019018
28117535	clinical	C0205210
28117535	parameters	C0449381
28117535	patients	C0030705
28117535	Swedish pediatric quality registry, SWEDIABKIDS	C0282574
28117535	patients	C0030705
28117535	adult	C0001675
28117535	diabetes care	C0150544
28117535	Children	C0008059
28117535	HbA1c	C0019018
28117535	patients	C0030705
28117535	low	C0205251
28117535	group	C1257890
28117535	diagnosis	C0011900
28117535	metabolic control	C1513158
28117535	childhood	C0231335
28117535	children	C0008059
28117535	HbA1c	C0019018
28117535	patients	C0030705
28117535	high	C0205250
28117535	group	C1257890
28117535	diagnosis	C0011900
28117535	high	C0205250
28117535	HbA1c	C0019018
28117535	follow-up	C1522577
28117535	individual	C0237401
28117535	no significant	C1273937
28117535	correlation	C1707520
28117535	high	C0205250
28117535	HbA1c	C0019018
28117535	onset	C0332162
28117535	follow-up	C1522577
28117535	follow-up	C1522577
28117535	children	C0008059
28117535	high	C0205250
28117535	group	C1257890
28117535	smokers	C0337664
28117535	physically active	C0556453
28117535	retinopathy	C0035309
28117535	children	C0008059
28117535	low	C0205251
28117535	group	C1257890
28117535	High	C0205250
28117535	HbA1c	C0019018
28117535	onset	C0332162
28117535	associated with	C0332281
28117535	high	C0205250
28117535	HbA1c	C0019018
28117535	follow-up	C1522577
28117535	group	C1257890
28117535	predictor	C2698872
28117535	metabolic control	C1513158
28117535	individual	C0237401
28117535	diabetes	C0011847
28117535	team	C0871489
28117535	diagnosis	C0011900
28117535	high	C0205250
28117535	goals	C0018017
28117535	achievement	C0001072
28117535	metabolic control	C1513158
28117535	decrease	C0547047
28117535	risk	C0035647
28117535	microvascular complications	C3837959
28117965	Photosensitizer	C0162713
28117965	Decorated	C1254366
28117965	Red Blood Cells	C0014792
28117965	Ultra-Sensitive Light-Responsive Drug Delivery System	C0085104
28117965	Red blood cells	C0014792
28117965	RBCs	C0014792
28117965	abundant	C2346714
28117965	cells	C0007634
28117965	blood	C0005767
28117965	natural drug delivery system	C1254365
28117965	DDS	C1254365
28117965	biocompatibility	C0596177
28117965	photosensitizer	C0162713
28117965	chlorin e6	C0055367
28117965	Ce6	C0055367
28117965	decorated	C1254366
28117965	membrane	C0596901
28117965	RBCs	C0014792
28117965	mixing	C1720722
28117965	membrane	C0596901
28117965	integrity	C1947912
28117965	stability	C0205360
28117965	light	C0023693
28117965	irradiation	C1282930
28117965	density	C0178587
28117965	generated	C3146294
28117965	singlet oxygen	C0074565
28117965	Ce6	C0055367
28117965	result of photodynamic effect	C0940920
28117965	disruption	C0332453
28117965	RBC	C0014792
28117965	membrane	C0596901
28117965	doxorubicin	C0013089
28117965	DOX	C0013089
28117965	DOX	C0013089
28117965	chemotherapy	C3665472
28117965	drug	C0013227
28117965	model	C3161035
28117965	light-responsive RBC-based DDS	C0085104
28117965	decorating	C1254366
28117965	Ce6	C0055367
28117965	cell membrane	C0007603
28117965	DOX	C0013089
28117965	cells	C0007634
28117965	light	C0023693
28117965	triggered	C1444748
28117965	cell membrane	C0007603
28117965	trigger	C1444748
28117965	DOX	C0013089
28117965	light-controlled chemotherapy	C3665472
28117965	specificity	C0037791
28117965	RBC	C0014792
28117965	biomolecules	C0567416
28117965	enzymes	C0014442
28117965	catalytic	C0007382
28117965	function	C0542341
28117965	light	C0023693
28117965	work	C0043227
28117965	biocompatible cell-based DDS	C0085104
28117965	stimuli	C0234402
28117965	cancer therapy	C0920425
28117965	applications	C4048755
28117965	biotechnologies	C0005574
28119436	Validation	C1519941
28119436	Neogen® Fentanyl	C0015846
28119436	ELISA	C0014441
28119436	Blood	C0005767
28119436	Urine	C0042036
28119436	Neogen® Fentanyl	C0015846
28119436	enzyme-linked immunosorbent assay	C0014441
28119436	Scientific Working Group	C1257890
28119436	Forensic Toxicology	C1721026
28119436	Standard Practices	C0086343
28119436	Validation	C1519941
28119436	Forensic Toxicology	C1721026
28119436	Laboratory Guidelines.	C4291774
28119436	whole blood	C0370231
28119436	urine	C0042036
28119436	validation	C1519941
28119436	evaluation	C0220825
28119436	sensitivity	C1511883
28119436	precision	C1706245
28119436	specificity	C0037791
28119436	carryover	C0205556
28119436	plate drift	C0205556
28119436	evaluation	C0220825
28119436	limit of detection	C2718050
28119436	blood	C0005767
28119436	urine	C0042036
28119436	Precision	C1706245
28119436	concentrations	C1446561
28119436	replicates	C1883725
28119436	whole blood	C0370231
28119436	coefficient of variation	C0681921
28119436	CV	C0681921
28119436	urine	C0042036
28119436	CV	C0681921
28119436	concentrations	C1446561
28119436	replicates	C1883725
28119436	Cross-reactivity	C0010357
28119436	evaluated	C0220825
28119436	norfentanyl	C0214194
28119436	acetyl fentanyl	C3700366
28119436	4-anilino-N-phenethylpiperidine	C2713534
28119436	beta-hydroxythiofentanyl	C4305828
28119436	butyryl fentanyl	C4305826
28119436	furanyl fentanyl	C0015846
28121744	Everolimus	C0541315
28121744	Treatment	C0087111
28121744	Pseudomyogenic Hemangioendothelioma	C0018915
28121744	Pseudomyogenic hemangioendothelioma	C0018915
28121744	PMH	C0018915
28121744	vascular neoplasm	C0282607
28121744	soft tissue	C0225317
28121744	young adults	C0238598
28121744	Metastatic	C1522484
28121744	PMH	C0018915
28121744	fatal	C1302234
28121744	effective	C1704419
28121744	medications	C0013227
28121744	case	C1706256
28121744	boy	C0870221
28121744	metastatic	C1522484
28121744	PMH	C0018915
28121744	responded to treatment	C0521982
28121744	everolimus	C0541315
28121744	mammalian target of rapamycin inhibitor	C2746052
28121744	Immunohistochemistry	C0021044
28121744	mammalian target of rapamycin	C1307407
28121744	expressed	C1171362
28121744	PMH	C0018915
28121744	biopsy specimens	C0677862
28121744	reduction	C0392756
28121744	PMH	C0018915
28121744	tumor size	C0475440
28121744	treatment	C0087111
28122243	Roles	C1521970
28122243	Acetylation	C0001038
28122243	Phosphorylation	C0031715
28122243	LIFR	C0125607
28122243	Dependent	C3244310
28122243	Self-Renewal	C1155711
28122243	Growth	C0018270
28122243	Signaling	C0037080
28122243	Mouse Embryonic Stem Cells	C4042879
28122243	LIF	C0125606
28122243	self-renewal	C1155711
28122243	mouse embryonic stem cells	C4042879
28122243	mESCs	C4042879
28122243	absence	C0332268
28122243	cells	C0007634
28122243	differentiate	C2945687
28122243	LIF	C0125606
28122243	LIF receptor	C0125607
28122243	LIFR	C0125607
28122243	activates	C1879547
28122243	JAK-STAT3 pathway	C0037080
28122243	remains unknown	C0439673
28122243	receptor complex	C1523873
28122243	triggers	C1444748
28122243	differentiation	C2945687
28122243	self-renewal	C1155711
28122243	LIFR	C0125607
28122243	cytoplasmic domain	C1511625
28122243	self-renewal	C1155711
28122243	domain	C1880389
28122243	juxtamembrane region	C1622525
28122243	differentiation	C2945687
28122243	domain	C1880389
28122243	C-terminal region	C1707271
28122243	differentiation	C2945687
28122243	domain	C1880389
28122243	SPXX repeats	C0030956
28122243	phosphorylated	C0031715
28122243	MAPK	C0752312
28122243	restrict	C0443288
28122243	STAT3 activation	C2248236
28122243	self-renewal	C1155711
28122243	domain	C1880389
28122243	3K motif	C0660452
28122243	acetylated	C0001038
28122243	mESCs	C4042879
28122243	LIFR	C0125607
28122243	homodimerization	C1512485
28122243	STAT3	C0253050
28122243	hypo- or hyper-activation	C1879547
28122243	depending	C3244310
28122243	presence	C0150312
28122243	absence	C0332197
28122243	gp130	C0082758
28122243	LIFR	C0125607
28122243	activated	C1879547
28122243	STAT3	C0253050
28122243	restricts	C0443288
28122243	differentiation	C2945687
28122243	cytokine	C0079189
28122243	induction	C0205263
28122243	LIFR	C0125607
28122243	acetylation	C0001038
28122243	serine phosphorylation	C1519253
28122243	differentially	C2945687
28122243	stem cell	C0038250
28122243	self-renewal	C1155711
28122243	differentiation	C2945687
28122925	Interprofessional	C0021799
28122925	primary care	C0033137
28122925	team meetings	C0589031
28122925	qualitative	C0205556
28122925	approach	C0449445
28122925	observations	C0302523
28122925	personal	C1519021
28122925	opinions	C0683292
28122925	people	C0027361
28122925	multiple chronic conditions	C3266262
28122925	primary care services	C0018747
28122925	increases	C0442805
28122925	Professionals	C0679924
28122925	disciplines	C0013996
28122925	collaborate	C0282116
28122925	coordinate	C0700114
28122925	care	C1947933
28122925	health care needs	C0086388
28122925	lack	C0332268
28122925	information	C1533716
28122925	interprofessional	C0021799
28122925	team (IPT) meetings	C0589031
28122925	study	C2603343
28122925	interprofessional	C0021799
28122925	collaboration	C0282116
28122925	primary care	C0033137
28122925	team meetings	C0589031
28122925	Netherlands	C0027778
28122925	current practice	C0033284
28122925	personal	C1519021
28122925	opinions	C0683292
28122925	Qualitative study	C0949415
28122925	observations	C0302523
28122925	team meeting	C0589031
28122925	interviews	C0683518
28122925	participants	C0679646
28122925	IPT meetings	C0589031
28122925	primary care practices	C0033137
28122925	video recordings	C0042650
28122925	Experiences	C0596545
28122925	semi-structured interviews	C0681913
28122925	participants	C0679646
28122925	health care professionals	C0018724
28122925	disciplines	C0013996
28122925	team meetings	C0589031
28122925	data	C1511726
28122925	analysed	C0936012
28122925	content analysis	C0681915
28122925	participants	C0679646
28122925	opinions	C0683292
28122925	team meetings	C0589031
28122925	observations	C0302523
28122925	team meetings	C0589031
28122925	lacked	C0332268
28122925	team coordinator	C1711307
28122925	leader	C0401960
28122925	discrepancy	C1290905
28122925	findings	C0243095
28122925	observations	C0302523
28122925	interviews	C0021822
28122925	interviews	C0021822
28122925	Team structure and composition	C1257890
28122925	Patient-centredness	C0243024
28122925	Interaction	C0021797
28122925	Attitude	C0004271
28122925	motivation	C0026605
28122925	IPT meetings	C0589031
28122925	improvements	C2986411
28122925	patient-centredness	C0243024
28122925	leadership	C0023181
28122925	chairpersons	C1524106
28122925	discrepancy	C1290905
28122925	observations	C0302523
28122925	interviews	C0021822
28122925	improve	C2986411
28122925	team members	C1551024
28122925	awareness	C0004448
28122925	aspects	C1879746
28122925	improved	C2986411
28122925	training	C0220931
28122925	challenges	C0805586
28123739	Urachal carcinoma	C2931202
28123739	Report	C0684224
28123739	cases	C1706256
28123739	review of	C0699752
28123739	literature	C0023866
28123739	Urachal carcinoma	C2931202
28123739	rare	C0522498
28123739	tumor	C0027651
28123739	ovaries	C0029939
28123739	less often	C3843156
28123739	adnexal	C0001575
28123739	region	C0005898
28123739	urinary system	C1508753
28123739	present	C0449450
28123739	cases	C1706256
28123739	urachal carcinoma	C2931202
28123739	case	C1706256
28123739	male	C0025266
28123739	patient	C0030705
28123739	presented	C0449450
28123739	painless hematuria	C0473235
28123739	blood clots	C0302148
28123739	month	C0439231
28123739	case	C1706256
28123739	woman	C0043210
28123739	presented	C0449450
28123739	gross hematuria	C0473237
28123739	mild	C2945599
28123739	dysuria	C0013428
28123739	urgency and frequent urination	C0085606
28123739	year	C0439234
28123739	surgical resection	C0728940
28123739	patients	C0030705
28123739	diagnosed	C0011900
28123739	urachal adenocarcinoma	C2931201
28123739	mixed	C0205430
28123739	type	C0332307
28123739	urachal mucinous adenocarcinoma	C2931201
28123739	histopathological	C0243140
28123739	examination	C0582103
28123739	review of	C0699752
28123739	published	C0034037
28123739	cases	C1706256
28123739	relevant	C2347946
28123739	literature	C0023866
28123739	presented	C0449450
28123739	aim	C1947946
28123739	present	C0150312
28123739	study	C0008972
28123739	understand	C0162340
28123739	disease	C0027651
28123739	better	C0332272
28123739	reduce	C0392756
28123739	rate	C1521828
28123739	clinical	C0205210
28123739	pathological	C1521733
28123739	misdiagnosis	C0679838
28125612	Recombinant	C0017387
28125612	Human	C0086418
28125612	Anti-Platelet scFv Antibody	C0370058
28125612	scFv	C1883036
28125612	Pichia pastoris	C0997362
28125612	Atheroma	C0264956
28125612	Cells	C0007634
28125612	immune system	C0020962
28125612	progression	C0242656
28125612	atherosclerotic plaque	C2936350
28125612	plaque	C0332461
28125612	instability	C1444783
28125612	rupture	C3203359
28125612	acute	C0205178
28125612	atherothrombotic	C1963943
28125612	coronary artery disease	C0010054
28125612	cerebrovascular disease	C0007820
28125612	peripheral arterial disease	C0085096
28125612	cloning	C0525050
28125612	expression	C1171362
28125612	purification	C1998793
28125612	immunoreactivity	C0597879
28125612	assessment	C0220825
28125612	recombinant	C1514798
28125612	single-chain variable fragment	C1883036
28125612	scFv	C1883036
28125612	human	C0086418
28125612	anti-αIIbβ3 antibody	C0016011
28125612	HuAb	C0016011
28125612	atheromatous	C0264956
28125612	lesions	C0221198
28125612	presence	C0150312
28125612	platelets	C0005821
28125612	platelets	C0005821
28125612	atheroma plaques	C2936350
28125612	inflammation	C0021368
28125612	platelet	C0005821
28125612	leucocyte	C0023516
28125612	aggregates	C0205418
28125612	thrombi	C0087086
28125612	formation	C1522492
28125612	relevant	C2347946
28125612	biomarkers	C0005516
28125612	atherosclerotic	C0333482
28125612	progression	C0242656
28125612	DNA sequence	C0162326
28125612	encodes	C2700640
28125612	anti-αIIbβ3 TEG4 scFv	C1883036
28125612	phage-display selection	C3494191
28125612	activated	C1879547
28125612	platelets	C0005821
28125612	inserted	C1512796
28125612	eukaryote	C0684063
28125612	vector	C1514152
28125612	pPICZαA	C1514152
28125612	tag sequence	C0162326
28125612	encoding	C2700640
28125612	cysteines	C0010654
28125612	specific	C0205369
28125612	grafting experiments	C0022885
28125612	recombinant protein	C0034861
28125612	expressed	C1171362
28125612	high	C0205250
28125612	Pichia pastoris	C0997362
28125612	culture	C0010454
28125612	P. pastoris	C0997362
28125612	expression	C1171362
28125612	system	C0449913
28125612	secretion	C0036536
28125612	recombinant proteins	C0034861
28125612	supernatant	C1550101
28125612	scFv	C1883036
28125612	cytoplasm	C0010834
28125612	bacteria	C0004611
28125612	low	C0205251
28125612	yield	C0392762
28125612	low	C0205251
28125612	solubility	C0037628
28125612	reduced	C0392756
28125612	affinity	C0003255
28125612	improved	C0184511
28125612	recovery	C0237820
28125612	highly	C0205250
28125612	purified	C1998793
28125612	biologically active scFv fragments	C0574031
28125612	scFv	C1883036
28125612	grafted	C0700106
28125612	site	C0205145
28125612	nanoparticles	C1450054
28125612	imaging	C0011923
28125612	atherosclerotic plaques	C2936350
28125612	inflammatory	C0333348
28125612	processes	C1522240
28125612	high risk of	C0332167
28125612	instability	C1444783
28125734	Identification	C0205396
28125734	MiR-21-5p	C1101610
28125734	Functional Regulator	C0017362
28125734	Mesothelin	C1334533
28125734	Expression	C0017262
28125734	MicroRNA	C1101610
28125734	Affinity	C1510827
28125734	Coupled	C1948027
28125734	Next Generation Sequencing	C2936622
28125734	MicroRNAs	C1101610
28125734	miRNAs	C1101610
28125734	small non-coding RNAs	C0887909
28125734	regulate	C0017263
28125734	mRNA expression	C1515670
28125734	silencing	C0598496
28125734	target	C1521840
28125734	transcripts	C1519595
28125734	binding	C1167622
28125734	miRNA recognition elements (MREs)	C0314659
28125734	3'untranslated region	C0600600
28125734	3'UTR	C0600600
28125734	identification	C0205396
28125734	bona fide	C2323869
28125734	targets	C1521840
28125734	researchers working	C0243095
28125734	functional aspect	C0205245
28125734	miRNAs	C1101610
28125734	method (miR-CATCH)	C0449851
28125734	biotinylated	C1159274
28125734	DNA	C0012854
28125734	antisense oligonucleotides	C0079925
28125734	mRNA	C0035696
28125734	miRNAs::mRNA interactions	C1523523
28125734	physiological cellular	C1325880
28125734	miR-CATCH technique	C0449851
28125734	mesothelin (MSLN) gene	C1334533
28125734	coupled	C1948027
28125734	next generation sequencing	C2936622
28125734	NGS	C2936622
28125734	miRNAs	C1101610
28125734	regulate	C0017263
28125734	MSLN mRNA	C1334533
28125734	protein levels	C0428479
28125734	malignant pleural mesothelioma	C0812413
28125734	MPM	C0812413
28125734	Biotinylated	C1159274
28125734	MSLN oligos	C1334533
28125734	miRNA::MSLN mRNA complexes	C1099355
28125734	cell line (Met-5A)	C0007600
28125734	expresses	C1171362
28125734	MSLN	C0380162
28125734	MiRNAs	C1101610
28125734	targeting	C1521840
28125734	MSLN mRNA	C1334533
28125734	NGS	C2936622
28125734	miR-21-5p	C1101610
28125734	miR-100-5p	C1101610
28125734	validation analyses	C0936012
28125734	MiR-21-5p	C1101610
28125734	modulate	C0443264
28125734	MSLN	C1334533
28125734	expression	C0017262
28125734	miRNA	C1101610
28125734	mimic	C0393040
28125734	experiments	C0681814
28125734	malignant	C0334227
28125734	cell lines	C0007600
28125734	miRNA	C1101610
28125734	inhibitor	C1999216
28125734	experiments	C0681814
28125734	luciferase	C0024075
28125734	assays	C0005507
28125734	Mero-14 cells	C0007634
28125734	miR-21-5p	C1101610
28125734	regulator	C0017362
28125734	MSLN	C1334533
28125734	in vitro experiments	C0681828
28125734	treatment	C0087111
28125734	miR-21-5p	C1101610
28125734	mimic	C0393040
28125734	proliferation	C1514485
28125734	MPM	C0812413
28125734	cell lines	C0007600
28125734	miR-CATCH technique	C0449851
28125734	coupled	C1948027
28125734	NGS	C2936622
28125734	in vitro	C1533691
28125734	validation	C1519941
28125734	method	C0449851
28125734	miRNA::mRNA interactions	C1523523
28125734	MiR-21-5p	C1101610
28125734	regulator	C0017362
28125734	MSLN	C1334533
28125734	functional role	C0205245
28125734	cellular growth	C0007595
28127340	Zoonotic	C1628327
28127340	Non-zoonotic	C0243095
28127340	Parasites	C0030498
28127340	Wild	C0445392
28127340	Rodents	C0035804
28127340	Turkman Sahra, Northeastern Iran	C0022065
28127340	study	C2603343
28127340	collect informative data	C0010995
28127340	parasitic infection	C0747256
28127340	wild	C0445392
28127340	rodents	C0035804
28127340	finding	C0243095
28127340	parasites	C0030498
28127340	medical	C0205476
28127340	importance	C3898777
28127340	human	C0086418
28127340	total number	C4288115
28127340	wild	C0445392
28127340	rodents	C0035804
28127340	captured	C0205245
28127340	rural areas	C0178837
28127340	Turkmen Sahra, Golestan Province	C0022065
28127340	handmade traps	C0699733
28127340	Animals	C0003062
28127340	anesthetized	C1720436
28127340	surveyed	C0038951
28127340	ectoparasite	C0562634
28127340	carcasses	C0229961
28127340	dissected	C0205239
28127340	examination	C0332128
28127340	endoparsites	C0320225
28127340	species	C1705920
28127340	rodents	C0035804
28127340	including	C0332257
28127340	Mus musculus	C0025914
28127340	Rattus norvegicus	C0034693
28127340	Rhombomys opimus	C1646173
28127340	Meriones libycus	C1681293
28127340	captured	C0205245
28127340	Parasitic infestation	C1384353
28127340	detected	C0442726
28127340	sampled	C0870078
28127340	rodents	C0035804
28127340	Parasite infestation	C1384353
28127340	rates	C1521828
28127340	sampled	C0870078
28127340	rodents	C0035804
28127340	Hymenolepis diminuta	C0322197
28127340	Cryptosporidium spp	C1744526
28127340	Trichuris spp	C0684063
28127340	Cysticercus fasciolaris	C0322189
28127340	Angiostrongylus spp	C1641848
28127340	Capillaria sp	C0006896
28127340	Rhipicephalus spp	C0323464
28127340	Nosopsyllus fasciatus	C0323233
28127340	Laelaps nuttalli	C3012304
28127340	genera	C1708235
28127340	species	C1705920
28127340	identified	C0205396
28127340	parasites	C0030498
28127340	zoonotic	C1628327
28127340	public health	C3244304
28127340	importance	C3898777
28127340	L. nuttalli	C3012304
28127340	N. fasciatus	C0323233
28127340	non-zoonotic	C0243095
28127340	detected	C0442726
28127340	parasites	C0030498
28127340	survey	C0038951
28127340	Harboring	C0332257
28127340	wide	C0332464
28127340	zoonotic	C1628327
28127340	parasites	C0030498
28127340	sampled	C0870078
28127340	wild	C0445392
28127340	rodents	C0035804
28127340	particularly	C0205369
28127340	nearby	C1706276
28127340	villages	C0562518
28127340	potential	C3245505
28127340	risk	C0035647
28127340	native inhabitants	C0079891
28127340	controlling	C2587213
28127340	rodents	C0035804
28127340	population	C1257890
28127340	residential regions	C0442506
28127340	improving	C0184511
28127340	awareness	C0004448
28127340	local	C0205276
28127340	people	C0027361
28127340	risk	C0035647
28127340	disease transmission	C0242781
28127340	rodents	C0035804
28127340	necessary	C3898777
28127853	successful	C1272703
28127853	aging	C0001811
28127853	pilot study	C0031928
28127853	intergenerational	C0598500
28127853	health promotion program	C0043113
28127853	evaluate	C0220825
28127853	effectiveness	C1280519
28127853	intergenerational	C0598500
28127853	health promotion program	C0043113
28127853	research project	C0700032
28127853	total	C0439810
28127853	participants	C0679646
28127853	week	C0439230
28127853	program	C0043113
28127853	completed	C0205197
28127853	pre-test and post-test	C0032919
28127853	middle-aged	C0205847
28127853	older adults	C0001792
28127853	recruited	C2949735
28127853	Taipei	C0017446
28127853	young adults	C0238598
28127853	recruited	C2949735
28127853	principal investigator's	C1521895
28127853	university	C0041740
28127853	Attitudes toward Aging Scale	C0282574
28127853	Spiritual Health Scale	C0282574
28127853	assessment	C0220825
28127853	instruments	C0282574
28127853	study	C2603343
28127853	results	C0683954
28127853	significant	C0750502
28127853	improvements	C2986411
28127853	Attitudes toward Aging Scale	C0282574
28127853	young adult	C0238598
28127853	group	C0441833
28127853	years	C1510829
28127853	Spiritual Health Scale	C0282574
28127853	older adult	C0001792
28127853	group	C0441833
28127853	aged	C0001779
28127853	years	C1510829
28127853	evaluation	C0220825
28127853	participants	C0679646
28127853	satisfied	C0242428
28127853	program	C0043113
28127853	results	C0683954
28127853	successful	C1272703
28127853	aging	C0001811
28127853	intergenerational	C0598500
28127853	learning	C0013621
28127863	Signs	C0037088
28127863	dysarthria	C0013362
28127863	adults	C0001675
28127863	22q11.2 deletion syndrome	C0012236
28127863	study	C2603343
28127863	adults	C0001675
28127863	22q11.2 deletion syndrome	C0012236
28127863	22q11DS	C0012236
28127863	dysarthria	C0013362
28127863	intelligibility	C0589416
28127863	tests	C0683443
28127863	compared	C1707455
28127863	control group	C0009932
28127863	participants	C0679646
28127863	22q11.2 deletion	C2910370
28127863	males	C0086582
28127863	females	C0086287
28127863	age	C0001779
28127863	years	C0439234
28127863	compared	C1707455
28127863	control group	C0009932
28127863	gender	C0079399
28127863	age	C0001779
28127863	males	C0086582
28127863	females	C0086287
28127863	age	C0001779
28127863	years	C0439234
28127863	Assessment	C1516048
28127863	non-verbal and verbal tasks	C0430022
28127863	respiration	C0035203
28127863	phonation	C0031577
28127863	oral motor function	C0563145
28127863	velopharyngeal function	C4027435
28127863	articulation	C0234830
28127863	prosody	C0233743
28127863	Swedish Test of Intelligibility	C0451496
28127863	STI	C0451496
28127863	assessments	C1516048
28127863	inter-rater	C0870740
28127863	intra-rater reliability	C0392762
28127863	participants	C0679646
28127863	22q11DS	C0012236
28127863	problems	C0033213
28127863	control group	C0009932
28127863	STI	C0451496
28127863	speech deviation	C0243095
28127863	rated	C0871208
28127863	speech	C0037817
28127863	respiration	C0035203
28127863	phonation	C0031577
28127863	oral motor function	C0563145
28127863	velopharyngeal function	C4027435
28127863	study	C2603343
28127863	neurological etiology	C1314792
28127863	structural etiology	C1314792
28127863	speech difficulties	C0233715
28127863	22q11DS	C0012236
28127863	Signs	C0037088
28127863	speech motor planning	C0025361
28127863	speech motor programming	C0025361
28127863	studies	C2603343
28127863	results	C1274040
28127863	studies	C2603343
28127863	structural brain abnormalities	C1866933
28127863	neurological speech symptoms	C1457887
28127863	clinical purposes	C1285529
28127863	clinicians	C0871685
28127863	speech symptoms	C0478143
28127863	individuals	C0237401
28127863	22q11DS	C0012236
28127863	etiology	C1314792
28127863	speech symptoms	C0478143
28128937	Sulfur	C0038774
28128937	Zinc	C0043481
28128937	Availability	C0470187
28128937	Co-granulated	C3853628
28128937	Zn	C0043481
28128937	Elemental Sulfur	C0038774
28128937	Fertilizers	C0015919
28128937	Acidification	C2987513
28128937	oxidation	C0030011
28128937	elemental sulfur	C0038774
28128937	ES	C0038774
28128937	ZnO	C0043491
28128937	slow	C0439834
28128937	release	C1283071
28128937	sulfur	C0038774
28128937	S	C0038774
28128937	zinc	C0043481
28128937	Zn	C0043481
28128937	granular	C3853628
28128937	fertilizer	C0015919
28128937	ES	C0038774
28128937	ZnO	C0043491
28128937	evaluated	C1516048
28128937	effect	C1280500
28128937	microorganisms	C0445623
28128937	carbon	C0007009
28128937	source	C0449416
28128937	granule	C3853628
28128937	evaluated	C1516048
28128937	granulated	C3853628
28128937	ES-Zn fertilizers	C1289929
28128937	without	C0332288
28128937	S-oxidizing microorganisms	C0445623
28128937	ZnSO4	C0078794
28128937	ZnO	C0043491
28128937	center	C0205099
28128937	Petri dishes	C1322960
28128937	contrasting	C1979874
28128937	pH	C0020283
28128937	soils	C0037592
28128937	Soil	C0037592
28128937	pH	C0020283
28128937	CaCl2	C0006686
28128937	S	C0038774
28128937	Zn	C0043481
28128937	ES	C0038774
28128937	evaluated	C1516048
28128937	soil sections	C0037592
28128937	fertilizer	C0015919
28128937	application site	C0205145
28128937	visualization test	C0022885
28128937	Zn	C0043481
28128937	diffusion	C0012222
28128937	significant	C0750502
28128937	pH decrease	C0728725
28128937	observed	C1441672
28128937	acidic	C0001128
28128937	soil	C0037592
28128937	ES-Zn fertilizer	C1289929
28128937	treatments	C1522326
28128937	alkaline	C1979842
28128937	soil	C0037592
28128937	Acidithiobacillus thiooxidans	C0039878
28128937	inoculated treatment	C0427946
28128937	Zn	C0043481
28128937	visualization tests	C0022885
28128937	Zn	C0043481
28128937	concentrations	C1446561
28128937	higher	C0205250
28128937	acidic	C0001128
28128937	alkaline	C1979842
28128937	soil	C0037592
28128937	Elemental S oxidation	C1159425
28128937	greater	C1704243
28128937	acidic	C0001128
28128937	soil	C0037592
28128937	alkaline	C1979842
28128937	soil	C0037592
28128937	ES-Zn granular fertilizers	C1289929
28128937	increased	C0205217
28128937	S	C0038774
28128937	Zn	C0043481
28128937	concentrations	C1446561
28128937	soil	C0037592
28128937	slow	C0439834
28128937	release	C1283071
28128937	nutrients	C0678695
28128937	soil	C0037592
28129238	Impact	C4049986
28129238	Blood Transfusions	C0005841
28129238	Survival	C0038952
28129238	Locally	C1517927
28129238	Advanced	C0205179
28129238	Cervical Cancer	C4048328
28129238	Patients	C0030705
28129238	Neoadjuvant Chemotherapy	C4272610
28129238	Radical Surgery	C0543467
28129238	Transfusions	C0005841
28129238	progresses	C1272688
28129238	modern medicine	C0242324
28129238	evidence	C3887511
28129238	transfusions	C0005841
28129238	survival	C0038952
28129238	outcomes	C0085415
28129238	patients	C0030705
28129238	affected	C0392760
28129238	solid cancers	C0006826
28129238	study	C0008972
28129238	aimed	C1947946
28129238	investigate	C1292732
28129238	perioperative	C1518988
28129238	blood transfusion	C0005841
28129238	locally	C1517927
28129238	advanced	C0205179
28129238	cervical cancer	C4048328
28129238	patients	C0030705
28129238	affected	C0392760
28129238	locally	C1517927
28129238	advanced	C0205179
28129238	cervical cancer	C4048328
28129238	neoadjuvant chemotherapy	C4272610
28129238	radical surgery	C0543467
28129238	retrospectively	C0035363
28129238	searched	C1706202
28129238	test	C0039593
28129238	impact	C4049986
28129238	perioperative	C1518988
28129238	transfusions	C0005841
28129238	survival	C0038952
28129238	outcomes	C0085415
28129238	year	C0439234
28129238	survival	C0038952
28129238	outcomes	C0085415
28129238	Kaplan-Meier	C2827659
28129238	Cox models	C0010234
28129238	study	C0008972
28129238	patients	C0030705
28129238	patients	C0030705
28129238	blood transfusion	C0005841
28129238	univariate analysis	C0683962
28129238	observed	C1441672
28129238	transfusion	C0005841
28129238	risk	C0035647
28129238	developing	C0332253
28129238	recurrence	C1458156
28129238	hazard ratio	C2985465
28129238	HR	C2985465
28129238	confidence interval	C0009667
28129238	CI	C0009667
28129238	P	C0033204
28129238	year	C0439234
28129238	disease-free survival	C0242793
28129238	noncomplete	C3272974
28129238	clinical response	C4055223
28129238	neoadjuvant chemotherapy	C4272610
28129238	HR	C2985465
28129238	CI	C0009667
28129238	P	C0033204
28129238	pathological	C4050242
28129238	P	C0033204
28129238	response	C4050242
28129238	neoadjuvant chemotherapy	C4272610
28129238	parametrial	C1518890
28129238	P	C0033204
28129238	vaginal	C0042232
28129238	P	C0033204
28129238	lymph node	C0024204
28129238	P	C0033204
28129238	multivariate analysis	C0026777
28129238	vaginal	C0042232
28129238	HR	C2985465
28129238	CI	C0009667
28129238	P	C0033204
28129238	lymph node	C0024204
28129238	HR	C2985465
28129238	CI	C0009667
28129238	P	C0033204
28129238	P	C0033204
28129238	disease-free survival	C0242793
28129238	outcomes	C0085415
28129238	observed	C1441672
28129238	patients	C0030705
28129238	blood transfusion	C0005841
28129238	HR	C2985465
28129238	CI	C0009667
28129238	P	C0033204
28129238	overall survival	C4086681
28129238	observed	C1441672
28129238	lymph node	C0024204
28129238	P	C0033204
28129238	vaginal	C0042232
28129238	P	C0033204
28129238	survival	C0038952
28129238	blood transfusions	C0005841
28129238	risk	C0035647
28129238	developing	C0332253
28129238	recurrence	C1458156
28129238	LAAC	C4048328
28129238	patients	C0030705
28129238	treated	C0332293
28129238	neoadjuvant chemotherapy	C4272610
28129238	radical surgery	C0543467
28129238	unclear	C3845108
28129238	prospective studies	C0033522
28130404	Tissue	C0040300
28130404	antiviral	C0243095
28130404	T cell immunity	C1817907
28130404	human	C0086418
28130404	CMV infection	C0010823
28130404	T cell	C0039194
28130404	responses	C0301872
28130404	viruses	C0042776
28130404	tissue	C0040300
28130404	human	C0086418
28130404	antiviral	C0243095
28130404	T cells	C0039194
28130404	blood	C0005767
28130404	Cytomegalovirus	C0010825
28130404	CMV	C0010825
28130404	humans	C0086418
28130404	T cell immunity	C1817907
28130404	tissue	C0040300
28130404	immune responses	C0301872
28130404	human	C0086418
28130404	CMV	C0010825
28130404	CMV	C0010825
28130404	T cells	C0039194
28130404	virus	C0042776
28130404	persistence	C1547035
28130404	CMV	C0010825
28130404	T cell	C0039194
28130404	homeostasis	C0019868
28130404	blood	C0005767
28130404	lymphoid	C0024296
28130404	mucosa	C0026724
28130404	secretory tissues	C0040300
28130404	CMV	C0010825
28130404	seropositive	C0521143
28130404	seronegative	C0521144
28130404	donors	C0013018
28130404	CMV	C0010825
28130404	T cells	C0039194
28130404	distribution patterns	C0449775
28130404	blood	C0005767
28130404	bone marrow	C0005953
28130404	BM	C0005953
28130404	lymph nodes	C0024204
28130404	LN	C0024204
28130404	frequency	C1561548
28130404	function	C0542341
28130404	blood	C0005767
28130404	tissues	C0040300
28130404	CMV	C0010825
28130404	genomes	C0017428
28130404	detected	C0442726
28130404	lung	C0024109
28130404	spleen	C0037993
28130404	BM	C0005953
28130404	blood	C0005767
28130404	LN	C0024204
28130404	CMV	C0010825
28130404	T cells	C0039194
28130404	blood	C0005767
28130404	BM	C0005953
28130404	samples	C0370003
28130404	virus detection	C1154657
28130404	lung	C0024109
28130404	CMV	C0010825
28130404	T cells	C0039194
28130404	virus	C0042776
28130404	LNs	C0024204
28130404	CMV	C0010825
28130404	T cells	C0039194
28130404	phenotypes	C0031437
28130404	virus	C0042776
28130404	T cell	C0039194
28130404	differentiation	C0007589
28130404	enhanced	C2349975
28130404	viral	C0521026
28130404	persistence	C1547035
28130404	tissue	C0040300
28130404	T cell	C0039194
28130404	CMV	C0010825
28130404	control	C0085557
28130404	viral	C0521026
28130404	tissue	C0040300
28130404	intrinsic factors	C0021918
28130404	homeostasis	C0019868
28130404	tissue	C0040300
28130404	T cells	C0039194
28130404	lifespan	C0870809
28135040	Lipid levels	C0523744
28135040	risk	C0035647
28135040	recurrent venous thrombosis	C1735901
28135040	results	C1274040
28135040	MEGA follow-up study	C0016441
28135040	lipid levels	C0523744
28135040	risk	C0035647
28135040	recurrent venous thrombosis	C1735901
28135040	unclear	C3845108
28135040	Lipids	C0023779
28135040	assessed	C1516048
28135040	patients	C0030705
28135040	venous thrombosis	C0042487
28135040	followed	C0332283
28135040	years	C0439234
28135040	Lipids	C0023779
28135040	associated with	C0332281
28135040	recurrence	C0034897
28135040	patients	C0030705
28135040	events	C0441471
28135040	Testing lipid levels	C0523744
28135040	useful	C3827682
28135040	identify	C0205396
28135040	patients	C0030705
28135040	increased	C0205217
28135040	risk	C0035647
28135040	recurrence	C0034897
28135040	risk factors	C0035648
28135040	recurrent venous thrombosis	C1735901
28135040	duration	C0449238
28135040	anticoagulation	C0003281
28135040	association	C0439849
28135040	lipid levels	C0523744
28135040	venous thrombosis	C0042487
28135040	data	C1511726
28135040	lipids	C0023779
28135040	risk	C0035647
28135040	recurrence	C0034897
28135040	assess	C1516048
28135040	association	C0439849
28135040	lipid levels	C0523744
28135040	recurrent venous thrombosis	C1735901
28135040	Patients	C0030705
28135040	Patients	C0030705
28135040	venous thrombosis	C0042487
28135040	MEGA study	C0016441
28135040	included	C0332257
28135040	Follow-up	C1522577
28135040	started	C1272689
28135040	date	C0011008
28135040	end	C0444930
28135040	anticoagulant treatment	C0150457
28135040	Percentile	C1264641
28135040	categories	C0683312
28135040	total	C0543421
28135040	low-density lipoprotein	C0023824
28135040	high-density lipoprotein cholesterol	C0023822
28135040	triglycerides	C0041004
28135040	apolipoproteins B	C0003593
28135040	A1	C0085201
28135040	established	C0443211
28135040	reference	C0034925
28135040	percentile	C1264641
28135040	Lipids	C0023779
28135040	measured	C0444706
28135040	months	C0439231
28135040	discontinuing	C1444662
28135040	anticoagulation	C0003281
28135040	Results	C1274040
28135040	patients	C0030705
28135040	years	C0439234
28135040	recurrence	C0034897
28135040	incidence rate	C1708485
28135040	patient	C0030705
28135040	years	C0439234
28135040	confidence interval	C0009667
28135040	CI	C0009667
28135040	hazard ratios	C2985465
28135040	ranging	C1514721
28135040	CI	C0009667
28135040	CI	C0009667
28135040	percentile	C1264641
28135040	category	C0683312
28135040	reference	C0034925
28135040	association	C0439849
28135040	percentile	C1264641
28135040	categories	C0683312
28135040	recurrence	C0034897
28135040	lipid levels	C0523744
28135040	age-	C0001779
28135040	sex	C0079399
28135040	models	C0026339
28135040	further	C1517331
28135040	adjustments	C0456081
28135040	body mass index	C1305855
28135040	diabetes	C0011847
28135040	estrogen	C0014939
28135040	statin	C0360714
28135040	use	C0457083
28135040	duration	C0449238
28135040	anticoagulation	C0003281
28135040	Subgroup	C1515021
28135040	analyses	C0936012
28135040	stratified	C0205363
28135040	provoked	C1444748
28135040	events	C0441471
28135040	location	C0450429
28135040	deep vein thrombosis	C0149871
28135040	pulmonary embolism	C0034065
28135040	sex	C0079399
28135040	reveal	C0443289
28135040	association	C0439849
28135040	lipid levels	C0523744
28135040	Testing lipid levels	C0523744
28135040	identify	C0205396
28135040	patients	C0030705
28135040	increased	C0205217
28135040	risk	C0035647
28135040	recurrent venous thrombosis	C1735901
28135040	study	C2603343
28135040	events	C0441471
28135040	influence	C4054723
28135040	duration	C0449238
28135040	anticoagulation	C0003281
28143560	Insecticidal effects	C0596781
28143560	deltamethrin	C0057233
28143560	laboratory	C0022877
28143560	field	C1521738
28143560	populations	C0032659
28143560	Culicoides species	C0010446
28143560	host	C1167395
28143560	contact	C0392367
28143560	reduction	C0392756
28143560	methods	C0242481
28143560	India	C0021201
28143560	Bluetongue virus	C0005867
28143560	BTV	C0005867
28143560	transmitted	C0242781
28143560	Culicoides	C0010446
28143560	biting midges	C0007747
28143560	bluetongue	C0005866
28143560	BT	C0005866
28143560	clinical disease	C0012634
28143560	sheep	C0036945
28143560	BT	C0005866
28143560	detrimental effect	C0879626
28143560	farmers	C0221460
28143560	India	C0021201
28143560	hyperendemic outbreaks	C0277550
28143560	southern states	C1301808
28143560	country	C0454664
28143560	method	C0242481
28143560	toxic effects	C0600688
28143560	deltamethrin	C0057233
28143560	Culicoides	C0010446
28143560	deltamethrin	C0057233
28143560	traditional control methods	C3824729
28143560	farmers	C0221460
28143560	India	C0021201
28143560	deltamethrin	C0057233
28143560	colonised strain	C0456178
28143560	Culicoides nubeculosus Meigen	C0322767
28143560	World Health Organisation	C0043237
28143560	exposure assay	C0005507
28143560	method	C0242481
28143560	field	C1521738
28143560	populations	C0032659
28143560	Culicoides spp.	C0010446
28143560	India	C0021201
28143560	field	C1521738
28143560	population	C0032659
28143560	C. oxystoma	C0322770
28143560	India	C0021201
28143560	deltamethrin	C0057233
28143560	laboratory-reared	C0022885
28143560	C.nubeculosus	C0322767
28143560	C. nubeculosus	C0322767
28143560	deltamethrin	C0057233
28143560	ambient temperatures	C0428692
28143560	mortality rate	C0205848
28143560	Behavioural assays	C0005507
28143560	C. nubeculosus	C0322767
28143560	WHO	C0043237
28143560	tubes	C1561954
28143560	deltamethrin	C0057233
28143560	field	C1521738
28143560	experiments	C0681814
28143560	India	C0021201
28143560	repellent	C0544309
28143560	toxic effects	C0600688
28143560	deltamethrin	C0057233
28143560	Traditional methods	C0242481
28143560	application	C4048755
28143560	neem oil	C0068484
28143560	burning	C1254366
28143560	neem	C1060234
28143560	leaves	C0242724
28143560	no	C1513916
28143560	protection	C1545588
28143560	field	C1521738
28143560	Culicoides	C0010446
28143560	India	C0021201
28143560	deltamethrin	C0057233
28143560	laboratory-bred	C0022885
28143560	C. nubeculosus	C0322767
28143560	traditional methods	C0242481
28143560	insect control	C0021569
28143560	protection	C1545588
28143560	sheep	C0036945
28143560	susceptibility	C1326888
28143560	deltamethrin	C0057233
28143560	field	C1521738
28143560	populations	C0032659
28143560	Culicoides	C0010446
28143560	resistance	C0021575
28143560	synthetic pyrethrioids	C1254351
28143560	insect control	C0021569
28143560	methods	C0242481
28143560	vaccination	C0042196
28143560	Indian	C0021201
28143560	livestock	C2936506
28143560	BTV	C0005867
28143560	transmission	C0242781
28144189	Correlation	C1707520
28144189	Lipid	C0023779
28144189	Profile	C1979963
28144189	BMI	C1305855
28144189	Bone Mineral Density	C0005938
28144189	Postmenopausal	C0206159
28144189	Women	C0043210
28144189	reduction	C0392756
28144189	bone density	C0005938
28144189	osteoporosis	C0029456
28144189	postmenopausal	C0206159
28144189	women	C0043210
28144189	elevated	C3163633
28144189	lipid	C0023779
28144189	parameters	C0449381
28144189	Body Mass Index	C1305855
28144189	BMI	C1305855
28144189	study	C2603343
28144189	correlation	C1707520
28144189	lipid	C0023779
28144189	parameters	C0449381
28144189	BMI	C1305855
28144189	osteoporosis	C0029456
28144189	postmenopausal	C0206159
28144189	women	C0043210
28144189	study	C2603343
28144189	matched	C1708943
28144189	type	C0332307
28144189	experimental	C1517586
28144189	group	C0441833
28144189	controls	C0009932
28144189	experimental	C1517586
28144189	group	C0441833
28144189	females	C0043210
28144189	postmenopausal	C0206159
28144189	age	C0001779
28144189	DEXA method	C1510486
28144189	diagnosed	C0011900
28144189	osteoporosis	C0029456
28144189	University Medical Center of RS	C0000872
28144189	control group	C0009932
28144189	females	C0043210
28144189	postmenopausal	C0206159
28144189	age	C0001779
28144189	diagnosed	C0011900
28144189	osteoporosis	C0029456
28144189	groups	C0441833
28144189	matched	C1708943
28144189	age	C0001779
28144189	years	C1510829
28144189	participants	C0679646
28144189	study	C2603343
28144189	biochemical analysis of blood	C0005774
28144189	analysis	C0936012
28144189	lipid	C0023779
28144189	profile	C1979963
28144189	total cholesterol	C0543421
28144189	LDL cholesterol	C0023824
28144189	triglycerides	C0041004
28144189	TG	C0041004
28144189	HDL cholesterol	C0023822
28144189	values	C0042295
28144189	BMI	C1305855
28144189	waist circumference	C0455829
28144189	WC	C0455829
28144189	Analysis	C0936012
28144189	data	C1511726
28144189	research	C0035168
28144189	univariate logistic regression	C0206031
28144189	values	C0042295
28144189	lipid	C0023779
28144189	parameters	C0449381
28144189	total cholesterol	C0543421
28144189	LDL	C0023824
28144189	TG	C0041004
28144189	significantly	C0750502
28144189	associated with	C0332281
28144189	osteoporosis	C0029456
28144189	multivariate logistic model	C0023965
28144189	total cholesterol	C0543421
28144189	independent	C0085862
28144189	risk factor	C0035648
28144189	osteoporosis	C0029456
28144189	postmenopausal	C0206159
28144189	women	C0043210
28144189	BMI	C1305855
28144189	values	C0042295
28144189	not	C1513916
28144189	statistically significantly	C0237881
28144189	associated with	C0332281
28144189	osteoporosis	C0029456
28144189	decrease	C0547047
28144189	bone mineral density	C0005938
28144189	osteoporosis	C0029456
28144189	postmenopausal	C0206159
28144189	women	C0043210
28144189	risk factors	C0035648
28144189	identification	C0205396
28144189	effective	C1704419
28144189	prevention	C2700409
28144189	disease	C0029456
28144189	elderly	C0001792
28144577	Heterotopic ossification	C0029396
28144577	recombinant human bone morphogenetic protein-7	C1445625
28144577	incidence	C0021149
28144577	heterotopic ossification	C0029396
28144577	recombinant human bone morphogenetic protein-7	C1445625
28144577	rhBMP-7	C1445625
28144577	treatment	C0087111
28144577	nonunions	C3897107
28144577	Bone morphogenetic proteins	C0053932
28144577	BMPs	C0053932
28144577	bone formation	C0029433
28144577	auto-induction	C1148560
28144577	Recombinant human BMP-7	C1445625
28144577	bone grafts	C0181075
28144577	patients	C0030705
28144577	treatment	C0087111
28144577	long bone nonunions	C3897107
28144577	patients	C0030705
28144577	evaluated	C0220825
28144577	radiographicaly	C0841672
28144577	development	C1527148
28144577	heterotopic ossification	C0029396
28144577	standard	C1442989
28144577	assessment	C0220825
28144577	nonunion	C3897107
28144577	healing	C0043240
28144577	patients	C0030705
28144577	radiographic	C0444708
28144577	signs	C0037088
28144577	heterotopic ossification	C0029396
28144577	CT scan	C0040405
28144577	Nonunion	C3897107
28144577	site	C0205145
28144577	palpation	C0030247
28144577	ROM evaluation	C1562926
28144577	adjacent	C0205117
28144577	joints	C0022417
28144577	Factors	C1521761
28144577	patient	C0030705
28144577	age	C0001779
28144577	gender	C0079399
28144577	nonunion	C3897107
28144577	location	C0450429
28144577	size	C0456389
28144577	chronicity	C0547045
28144577	number of previous procedures	C2700391
28144577	infection	C3714514
28144577	surrounding	C1282914
28144577	tissues	C0040300
28144577	condition	C0348080
28144577	surgical procedure	C0543467
28144577	graft	C0181074
28144577	fixation	C0185023
28144577	type	C0332307
28144577	amount	C1265611
28144577	rhBMP-7	C1445625
28144577	correlated	C1707520
28144577	development	C1527148
28144577	heterotopic ossification	C0029396
28144577	statistical analysis	C0871424
28144577	Pearsons χ (2) test	C0237913
28144577	nonunions	C3897107
28144577	treated	C1522326
28144577	rhBMP-7	C1445625
28144577	healed	C0205249
28144577	procedures	C2700391
28144577	Heterotopic bone formation	C0029396
28144577	patients	C0030705
28144577	radiological evaluation	C0220825
28144577	nonunion	C3897107
28144577	mean time	C0040223
28144577	rhBMP-7	C1445625
28144577	application	C4048755
28144577	heterotopic ossification	C0029396
28144577	femur	C0015811
28144577	cases	C1706256
28144577	tibia	C1279118
28144577	humerus	C0020164
28144577	patient	C0030705
28144577	patients	C0030705
28144577	palpable mass	C0746412
28144577	patient	C0030705
28144577	para-articular knee nonunion	C3897107
28144577	treated	C1522326
28144577	rhBMP-7	C1445625
28144577	size	C0456389
28144577	heterotopic ossification	C0029396
28144577	knee range of motion	C0576094
28144577	patients	C0030705
28144577	heterotopic ossification	C0029396
28144577	male	C0086582
28144577	Statistical analysis	C0871424
28144577	patient's	C0030705
28144577	gender	C0079399
28144577	factor	C1521761
28144577	development	C1527148
28144577	heterotopic ossification	C0029396
28144577	Heterotopic ossification	C0029396
28144577	rhBMP-7	C1445625
28144577	nonunions	C3897107
28144577	clinical outcome	C1274040
28144577	cases	C1706256
28144577	male	C0086582
28144577	patients	C0030705
28145492	Hypocretin/Orexin Peptides	C1113688
28145492	Excite	C0549255
28145492	Rat	C0034693
28145492	Neuroendocrine	C0027912
28145492	Dopamine Neurons	C1512035
28145492	Orexin 2 Receptor	C0671880
28145492	Activation	C1879547
28145492	Mixed	C0205430
28145492	Cation	C0007447
28145492	Current	C0162585
28145492	Hypocretin/Orexin	C1113688
28145492	H/O	C1113688
28145492	neurons	C0027882
28145492	lateral hypothalamus	C0020654
28145492	compelling	C0815217
28145492	modulator candidates	C0027361
28145492	chronobiology	C0008716
28145492	neuroendocrine	C0027912
28145492	output	C1709366
28145492	consequence	C0686907
28145492	hormone release	C0815016
28145492	anterior pituitary	C0032008
28145492	effects	C1280500
28145492	H/O peptides	C1113688
28145492	tuberoinfundibular dopamine (TIDA) neurons	C1512035
28145492	cells	C0007634
28145492	control	C0243148
28145492	inhibition	C3463820
28145492	pituitary	C0032005
28145492	secretion of prolactin	C2611224
28145492	whole cell recordings	C0242624
28145492	performed	C0884358
28145492	male	C0086582
28145492	rat	C0034693
28145492	hypothalamic slices	C0449445
28145492	H/O-A	C0671870
28145492	H/O-B	C0671872
28145492	excited	C0549255
28145492	TIDA neurons	C1512035
28145492	inducing	C0205263
28145492	reversible	C0205343
28145492	depolarising	C1395184
28145492	phasic to tonic discharge	C1254362
28145492	H/O	C1113688
28145492	induced	C0205263
28145492	inward	C0439786
28145492	current	C0162585
28145492	underpinning	C1521721
28145492	effect	C1280500
28145492	post-synaptic	C1167384
28145492	presence	C0150312
28145492	tetrodotoxin	C0039705
28145492	appeared	C0700364
28145492	Na(+)	C0037492
28145492	dependent	C0851827
28145492	transient receptor potential-like channel	C1563722
28145492	blocked	C0332206
28145492	2-APB	C0669933
28145492	diminished	C0205216
28145492	removal	C1883720
28145492	extracellular	C0521119
28145492	Na(+)	C0037492
28145492	consequence of	C0686907
28145492	OX2R receptor	C0671880
28145492	activation	C1879547
28145492	blocked	C0332206
28145492	OX2R receptor	C0671880
28145492	antagonist	C0243076
28145492	TCS OX2 29	C3492123
28145492	OX1R receptor	C0597357
28145492	antagonist	C0243076
28145492	SB 334867	C1097132
28145492	Application	C0185125
28145492	hormone	C0019932
28145492	melatonin	C0025219
28145492	failed	C0231175
28145492	alter	C0392747
28145492	TIDA	C1512035
28145492	membrane potential	C0025251
28145492	oscillatory activity	C0695434
28145492	description	C0678257
28145492	electrophysiological effects	C0850293
28145492	H/Os	C1113688
28145492	TIDA network	C1512035
28145492	identifies	C0205396
28145492	cellular mechanisms	C3537153
28145492	contribute	C1880177
28145492	circadian rhythmicity	C0008810
28145492	prolactin secretion	C2611224
28145617	Improving	C1272745
28145617	consumers	C1707496
28145617	mental health organizations	C0178740
28145617	mental ill health	C0004936
28145617	Stigmatizing	C0277787
28145617	consumers	C1707496
28145617	working	C0043227
28145617	mental health organizations	C0178740
28145617	mental health policies	C3244237
28145617	organizations	C0920545
28145617	work	C0043227
28145617	collaboratively	C0282116
28145617	consumers	C1707496
28145617	producing	C0678227
28145617	delivering	C0011211
28145617	services	C0557854
28145617	social exchange theory	C0683615
28145617	mutual	C1709100
28145617	exchange	C0678640
28145617	maximise	C0806909
28145617	benefits	C0814225
28145617	partnership	C0680453
28145617	current	C0521116
28145617	study	C2603343
28145617	perspectives	C0678958
28145617	working	C0043227
28145617	organizations	C0920545
28145617	level	C0441889
28145617	consumer	C1707496
28145617	leadership	C0023181
28145617	Interviews	C0021822
28145617	participants	C0679646
28145617	range	C1514721
28145617	mental health organizations	C0178740
28145617	Data	C1511726
28145617	analyzed	C0936012
28145617	thematic analytic	C0936012
28145617	discursive	C4068735
28145617	psychological techniques	C0033903
28145617	Findings	C0243095
28145617	stigma	C0277787
28145617	organizations	C0920545
28145617	consumers	C1707496
28145617	leadership positions	C0023181
28145617	consumers	C1707496
28145617	perceived	C0030971
28145617	work	C0043227
28145617	mental health organizations	C0178740
28145617	discourses	C2584313
28145617	consumers	C1707496
28145617	mental health organizations	C0178740
28145617	mental health system	C0178740
28145617	ability	C0085732
28145617	safety	C0150755
28145617	support	C0037438
28145617	consumers	C1707496
28145617	social exchange theory	C0683615
28145617	authors	C3812881
28145617	organizations	C0920545
28145617	stigma	C0277787
28145617	promote	C0033414
28145617	consumers	C1707496
28145617	maximize	C0806909
28145617	mutual	C1709100
28145617	benefits	C0814225
28148830	sex	C1522384
28148830	intraspecies	C1705920
28148830	variation	C0205419
28148830	ocean	C0028814
28148830	acidification	C2987513
28148830	responses	C0871261
28148830	Ocean	C0028814
28148830	acidification	C2987513
28148830	OA	C2987513
28148830	major threat	C0749385
28148830	ecosystems	C0162358
28148830	globally	C2348867
28148830	significant	C0750502
28148830	ecological	C0162358
28148830	economic	C0013557
28148830	importance	C3898777
28148830	number	C0237753
28148830	complexity	C0237523
28148830	experiments	C0681814
28148830	examining	C0332128
28148830	effects of	C1704420
28148830	OA	C2987513
28148830	substantially	C0750502
28148830	increased	C0205217
28148830	past	C1444637
28148830	decade	C2981279
28148830	attempt	C1516084
28148830	address	C1547607
28148830	multi-stressor	C0597530
28148830	interactions	C1704675
28148830	long-term	C0443252
28148830	responses	C0871261
28148830	increasing	C0442808
28148830	range	C1514721
28148830	aquatic organisms	C0596121
28148830	differences	C1705242
28148830	response	C0871261
28148830	males	C0086582
28148830	females	C0086287
28148830	elevated pCO2	C0858343
28148830	investigated	C1292732
28148830	fewer	C0205388
28148830	date	C0011008
28148830	difficulty	C0332218
28148830	sex	C1522384
28148830	non-destructively	C1254370
28148830	early life stages	C0680083
28148830	sex	C1522384
28148830	significantly	C0750502
28148830	impact	C4049986
28148830	organism	C0029235
28148830	responses	C0871261
28148830	OA	C2987513
28148830	affecting	C0392760
28148830	physiology	C0031843
28148830	reproduction	C0035150
28148830	biochemistry	C0205474
28148830	ultimately survival	C0220921
28148830	impacts	C4049986
28148830	ecological theory	C0871935
28148830	differential	C0443199
28148830	resource allocation	C0086914
28148830	reproduction	C0035150
28148830	predict	C0681842
28148830	females	C0086287
28148830	sensitive	C0332324
28148830	OA	C2987513
28148830	production cost	C0220812
28148830	eggs	C0029974
28148830	compared	C1707455
28148830	sperm	C0037868
28148830	sex	C1522384
28148830	specific studies	C2603343
28148830	significant	C0750502
28148830	differences	C1705242
28148830	responses	C0871261
28148830	males	C0086582
28148830	females	C0086287
28148830	OA	C2987513
28148830	consequences	C0686907
28148830	forecasting	C0220831
28148830	natural	C0205296
28148830	populations	C1257890
28148830	near-future	C0016884
28148830	ocean	C0028814
28149055	Computational analysis	C4297010
28149055	conserved coil	C0444764
28149055	functional residues	C1709915
28149055	mitochondrial genomic sequences	C3863348
28149055	dermatophytes	C0011635
28149055	Dermatophyte	C0011635
28149055	fungi	C0016832
28149055	invade	C1517574
28149055	keratinized	C0232387
28149055	tissue	C0040300
28149055	humans	C0086418
28149055	animals	C0003062
28149055	infection	C3714514
28149055	dermatophytosis	C0011636
28149055	genera	C1708235
28149055	Microsporum	C0026033
28149055	Trichophyton	C0040933
28149055	Epidermophyton	C0014529
28149055	infection	C3714514
28149055	groin	C0018246
28149055	tinea cruris	C1384589
28149055	beard	C0221982
28149055	tinea barbae	C2349994
28149055	scalp	C0036270
28149055	tinea capitis	C0040250
28149055	feet	C0016504
28149055	tinea pedis	C0040259
28149055	glabrous skin	C1180283
28149055	tinea corporis	C0040252
28149055	nail	C0027342
28149055	tinea unguium	C0040261
28149055	hand	C0018563
28149055	tinea manuum	C0153246
28149055	evolutionary	C0015219
28149055	relationship	C0439849
28149055	three genera	C1708235
28149055	dermatophyte	C0011635
28149055	epidemiologically important	C1516907
28149055	pathogenicity	C1136169
28149055	Mitochondrial DNA	C0012929
28149055	evolves	C0282688
28149055	more rapidly	C0456962
28149055	nuclear DNA	C1179920
28149055	rate of mutation	C3178846
28149055	less affected	C0392760
28149055	genetic recombination	C0034865
28149055	important tool	C2827396
28149055	phylogenetic studies	C1519068
28149055	conserved coil	C0444764
28149055	functional residues	C1709915
28149055	Trichophyton rubrum	C0040935
28149055	Trichophyton mentagrophytes	C0040934
28149055	Epidermophyton floccosum	C0014530
28149055	Microsporum canis	C0319950
28149055	Protein coding sequences	C0079941
28149055	mitochondrial genome	C1819716
28149055	similar sequences	C0162326
28149055	homology modelling	C1512489
28149055	structure	C1510464
28149055	pocket	C0599218
28149055	identification	C0936012
28149055	comparative analysis	C0683941
28149055	protein sequences	C0002518
28149055	active sites	C0205681
28149055	genera	C1708235
28149055	Trichophyton	C0040933
28149055	Microsporum	C0026033
28149055	Epidermophyton floccosum	C0014530
28149055	protein sequences	C0002518
28149055	conserved coil	C0444764
28149055	functional residues	C1709915
28149055	E. floccusum	C0014530
28149055	lesser infectivity	C0030657
28149055	organism	C0029235
28149055	functional residues	C1709915
28149055	disease	C0012634
28149055	putative target sites	C1521840
28149055	drug designing	C0013171
28149591	Non-intubated	C0087111
28149591	subxiphoid	C4039027
28149591	uniportal video-assisted thoracoscopic thymectomy	C4304660
28149591	thymectomy	C0040071
28149591	glasses-free	C0243095
28149591	3D	C0450363
28149591	vision	C0042789
28149591	Trans-sternal thymectomy	C0405560
28149591	accepted	C1272684
28149591	standard	C1442989
28149591	surgical procedure	C0543467
28149591	thymic masses	C0040113
28149591	Recently	C0332185
28149591	minimally	C0547040
28149591	invasive	C0038895
28149591	methods	C0025663
28149591	video-assisted thoracoscopic surgery	C4304660
28149591	(VATS)	C4304660
28149591	non-intubated	C0087111
28149591	anesthesia	C0002903
28149591	emerged	C0700364
28149591	methods	C0025663
28149591	advantages	C0814225
28149591	including	C0332257
28149591	reductions	C0392756
28149591	surgical trauma	C4060629
28149591	postoperative associated pain	C0030201
28149591	VATS	C4304660
28149591	cosmetic	C0442965
28149591	benefits	C0814225
28149591	Considering	C0750591
28149591	advantages	C0814225
28149591	subxiphoid	C4039027
28149591	uniportal VATS	C4304660
28149591	thymic mass	C1515430
28149591	glasses-free	C0243095
28149591	3D	C0450363
28149591	thoracoscopic	C0442425
28149591	display system	C0871584
28150347	Trends	C0040833
28150347	dietary intake	C1286104
28150347	adults	C0001675
28150347	type 2 diabetes	C0011860
28150347	NHANES	C0376344
28150347	Dietary	C0012155
28150347	recommendations	C0034866
28150347	adults	C0001675
28150347	diabetes	C0011860
28150347	healthy diet	C0452415
28150347	portion sizes	C3658326
28150347	trends	C0040833
28150347	energy	C0006777
28150347	nutrient intakes	C0006777
28150347	US	C0041703
28150347	adults	C0001675
28150347	type 2 diabetes	C0011860
28150347	Participants	C0679646
28150347	adults	C0001675
28150347	aged	C0001779
28150347	years	C0439234
28150347	cross-sectional National Health and Nutrition Examination Surveys	C0376344
28150347	Diabetes	C0011860
28150347	self-report	C2700446
28150347	physician's	C0031831
28150347	diagnosis	C0011900
28150347	Intake of energy	C0006777
28150347	nutrients	C0678695
28150347	h	C0439227
28150347	participants	C0679646
28150347	food	C0016452
28150347	Linear regression	C0023733
28150347	test	C0039593
28150347	trends	C0040833
28150347	intake	C1286104
28150347	time	C0040223
28150347	participants	C0679646
28150347	demographic characteristics	C0683970
28150347	adults	C0001675
28150347	diabetes	C0011860
28150347	energy intake	C0006777
28150347	increased	C0205217
28150347	1689 kcal	C0439259
28150347	1895 kcal	C0439259
28150347	plateau	C2964353
28150347	energy intake	C0006777
28150347	younger	C0238598
28150347	older adults	C0001792
28150347	men	C0025266
28150347	women	C0043210
28150347	non-Hispanic whites	C0221786
28150347	non-Hispanic blacks	C0085756
28150347	percentage	C0439165
28150347	calories	C1556156
28150347	carbohydrate	C0453802
28150347	total fat	C0012171
28150347	protein	C0453858
28150347	Percentage	C0439165
28150347	calories	C1556156
28150347	saturated fat	C0682953
28150347	study	C2603343
28150347	periods	C1948053
28150347	recommendations	C0034866
28150347	Fibre intake	C0474451
28150347	recommendations	C0034866
28150347	Sodium	C0037570
28150347	cholesterol	C0008395
28150347	calcium	C0006726
28150347	intakes	C1286104
28150347	increased	C0205217
28150347	energy intake	C0006777
28150347	adults	C0001675
28150347	diabetes	C0011860
28150347	dietary	C0012155
28150347	trends	C0040833
28150347	diabetes	C0011860
28150347	data	C1511726
28150347	plateau	C2964353
28150347	energy intake	C0006777
28150347	adults	C0001675
28150347	diabetes	C0011860
28150347	increase	C0442805
28150347	fibre	C0012173
28150347	reduce	C0547047
28150347	saturated fat	C0682953
28152029	Clonal	C1522642
28152029	serotype	C0449943
28152029	dynamics	C3826426
28152029	serogroup 6	C1532752
28152029	isolates	C1764827
28152029	invasive pneumococcal disease	C1320214
28152029	Portugal	C0032729
28152029	serogroup 6	C1532752
28152029	Streptococcus pneumoniae	C0038410
28152029	serotypes	C0449943
28152029	identified	C0205396
28152029	introduction	C0579004
28152029	pneumococcal conjugate vaccines	C0206515
28152029	PCVs	C0206515
28152029	decrease	C0547047
28152029	6B-2 variant	C0205419
28152029	invasive pneumococcal disease	C1320214
28152029	IPD	C1320214
28152029	6B-1	C0205419
28152029	post	C0687676
28152029	conjugate vaccine	C0206515
28152029	introduction	C0579004
28152029	decrease	C0547047
28152029	CC273 isolates	C1764827
28152029	Serotype 6C	C3697188
28152029	associated with	C0332281
28152029	adult	C0001675
28152029	IPD	C1320214
28152029	increased	C0205217
28152029	age group	C0027362
28152029	lineages	C0282637
28152029	CC315	C0282637
28152029	CC395	C0282637
28152029	lineages	C0282637
28152029	expressed	C1171362
28152029	serogroup 6	C1532752
28152029	serotypes	C0449943
28152029	children	C0008059
28152029	findings	C2607943
28152029	cross-protection	C2717886
28152029	PCVs	C0206515
28152029	serotype 6C	C3697188
28152029	IPD	C1320214
28152029	vaccinated	C1519885
28152029	children	C0008059
28152029	adults	C0001675
28152029	Serotype 6A	C2732283
28152029	serogroup 6	C1532752
28152029	serotype	C0449943
28152029	children	C0008059
28152029	decreased	C0205216
28152029	adult	C0001675
28152029	IPD	C1320214
28152029	serogroup 6	C1532752
28152029	serotypes	C0449943
28152029	detected	C0442726
28152029	phenotypic	C0031437
28152029	genotypic	C0017431
28152029	assays	C1510438
28152029	adequate	C0205411
28152029	serotypes	C0449943
28152029	serogroup 6	C1532752
28152029	isolates	C1764827
28152097	Minimally invasive	C2711297
28152097	percutaneous nephrolithotomy	C0162428
28152097	impacted	C0333125
28152097	proximal	C0205107
28152097	ureteral stones	C0041952
28152097	systematic review	C1955832
28152097	meta-analysis	C0920317
28152097	Urinary stones	C0451641
28152097	medical	C0205476
28152097	disorders	C0012634
28152097	treatment	C1522326
28152097	impacted proximal ureteral stones	C0041952
28152097	proximal	C0205107
28152097	IPUS	C0041952
28152097	urologists	C0260314
28152097	aim	C1947946
28152097	study	C2603343
28152097	compare the efficacy	C1707887
28152097	safety	C1705187
28152097	minimally invasive	C2711297
28152097	percutaneous nephrolithotomy	C0162428
28152097	MI	C2711297
28152097	PCNL	C0162428
28152097	ureteroscopic lithotripsy	C0558630
28152097	URL	C0558630
28152097	treatment	C1522326
28152097	IPUS	C0041952
28152097	meta-analysis	C0920317
28152097	studies	C0008972
28152097	PubMed	C1138432
28152097	Embase	C0242356
28152097	Cochrane Library	C0242356
28152097	1978 to November 2016	C0585341
28152097	analyzed	C0936012
28152097	Stata 12.0	C0037589
28152097	RevMan 5.3	C0037589
28152097	Odds ratios	C0028873
28152097	OR	C0028873
28152097	standard mean difference	C0444504
28152097	SMD	C0444504
28152097	binary	C1706942
28152097	continuous variables	C3242610
28152097	confidence intervals	C0009667
28152097	CIs	C0009667
28152097	study	C2603343
28152097	PRISMA guidelines	C0282458
28152097	prospective studies	C0033522
28152097	included	C0332257
28152097	meta-analysis	C0920317
28152097	MI	C2711297
28152097	PCNL	C0162428
28152097	URL	C0558630
28152097	MI	C2711297
28152097	PCNL	C0162428
28152097	associated with	C0332281
28152097	longer postoperative	C0032790
28152097	hospital stay	C3489408
28152097	URL	C0558630
28152097	SMD	C0444504
28152097	CI	C0009667
28152097	difference	C1705242
28152097	observed	C1441672
28152097	operative time	C3494201
28152097	SMD	C0444504
28152097	CI	C0009667
28152097	MI	C2711297
28152097	PCNL	C0162428
28152097	OR	C0028873
28152097	CI	C0009667
28152097	OR	C0028873
28152097	CI	C0009667
28152097	URL	C0558630
28152097	surgical conversion	C3494226
28152097	OR	C0028873
28152097	CI	C0009667
28152097	postoperative	C0032790
28152097	shock wave lithotripsy	C0015359
28152097	OR	C0028873
28152097	CI	C0009667
28152097	complications	C0009566
28152097	differences	C1705242
28152097	observed	C1441672
28152097	between	C0205103
28152097	MI	C2711297
28152097	PCNL	C0162428
28152097	URL	C0558630
28152097	OR	C0028873
28152097	CI	C0009667
28152097	hematuria	C0018965
28152097	OR	C0028873
28152097	CI	C0009667
28152097	MI	C2711297
28152097	PCNL	C0162428
28152097	optimal	C2698651
28152097	considered	C0750591
28152097	preferred	C0558295
28152097	treatment method	C0087111
28152097	IPUS	C0041952
28152097	better efficacy	C1280519
28152097	safety	C1705187
28152097	URL	C0558630
28152097	required	C1514873
28152097	future	C0016884
28154341	Predictive Factors	C0683956
28154341	Long-term	C0443252
28154341	Outcome	C1274040
28154341	Subthalamic Nucleus	C0152355
28154341	Deep Brain Stimulation	C0394162
28154341	Parkinson's Disease	C0030567
28154341	usefulness	C3827682
28154341	subthalamic nucleus	C0152355
28154341	deep brain stimulation	C0394162
28154341	STN	C0152355
28154341	DBS	C0394162
28154341	treatment	C1522326
28154341	Parkinson's disease	C0030567
28154341	PD	C0030567
28154341	preoperative	C0445204
28154341	predictive factors	C0683956
28154341	long-term	C0443252
28154341	outcome	C1274040
28154341	STN	C0152355
28154341	DBS	C0394162
28154341	not	C1518422
28154341	sufficiently	C0205410
28154341	established	C0443211
28154341	study	C2603343
28154341	predictive factors	C0683956
28154341	subjects	C0681850
28154341	patients	C0030705
28154341	classified	C0008902
28154341	two	C0205448
28154341	groups	C0681860
28154341	basis	C1527178
28154341	activities of daily living	C0001288
28154341	ADL	C0001288
28154341	five years	C0439234
28154341	after	C0687676
28154341	STN	C0152355
28154341	DBS	C0394162
28154341	surgery	C0543467
28154341	patients	C0030705
28154341	assigned	C1516050
28154341	independent	C0332291
28154341	ADL	C0001288
28154341	group	C0681860
28154341	group I	C0681860
28154341	patients	C0030705
28154341	dependent	C3244310
28154341	ADL	C0001288
28154341	group	C0681860
28154341	group D	C0681860
28154341	Group I	C0681860
28154341	patients	C0030705
28154341	Schwab and England (S&E) scale	C4034311
28154341	S&E	C4034311
28154341	score	C0449820
28154341	during	C0347984
28154341	off-period	C1948053
28154341	patients	C0030705
28154341	independent	C0332291
28154341	ADL	C0001288
28154341	all the time	C2003902
28154341	Group D	C0681860
28154341	patients	C0030705
28154341	score	C0449820
28154341	lower	C0205251
28154341	during	C0347984
28154341	off-period	C1948053
28154341	patients	C0030705
28154341	independent	C0332291
28154341	ADL	C0001288
28154341	entire	C0439751
28154341	day	C0439228
28154341	studied	C2603343
28154341	differences	C1705242
28154341	preoperative state	C0178808
28154341	two	C0205448
28154341	groups	C0681860
28154341	Statistically significant	C0237881
28154341	differences	C1705242
28154341	PD	C0030567
28154341	onset age	C0206132
28154341	age	C0001779
28154341	surgery	C0543467
28154341	preoperative	C0445204
28154341	unified Parkinson's disease rating scale	C4034309
28154341	UPDRS	C4034309
28154341	part I	C0449719
28154341	score	C0449820
28154341	part II	C0449719
28154341	score	C0449820
28154341	total	C0439810
28154341	subscore	C0449820
28154341	axial symptoms	C4314351
28154341	part III	C0449719
28154341	mini-mental state examination (MMSE) score	C2960235
28154341	S&E	C4034311
28154341	score	C0449820
28154341	logistic regression analysis	C0681925
28154341	significant	C0750502
28154341	independent	C0332291
28154341	variables	C0439828
28154341	long-term	C0443252
28154341	independent	C0332291
28154341	ADL	C0001288
28154341	age	C0001779
28154341	surgery	C0543467
28154341	MMSE score	C2960235
28154341	preoperative	C0445204
28154341	S&E scale	C4034311
28154341	score	C0449820
28154341	during	C0347984
28154341	off-period	C1948053
28154341	PD	C0030567
28154341	onset age	C0206132
28154341	age	C0001779
28154341	surgery	C0543467
28154341	preoperative	C0445204
28154341	high	C0205250
28154341	level	C0441889
28154341	ADL	C0001288
28154341	cognitive function	C0392335
28154341	axial symptoms	C4314351
28154341	important	C3898777
28154341	predictive factors	C0683956
28154341	long-term	C0443252
28154341	outcome	C1274040
28154341	STN	C0152355
28154341	DBS	C0394162
28157408	Persuades	C3825845
28157408	Analysis	C0936012
28157408	Persuasion	C3825845
28157408	Choices	C0008300
28157408	Antibiotic	C0003232
28157408	Free	C1996904
28157408	Food	C0016452
28157408	Personal communication	C0086792
28157408	person	C0027361
28157408	persuades	C3825845
28157408	behavior	C0004927
28157408	behaviors	C0004927
28157408	spread	C0332261
28157408	understand	C0162340
28157408	personal communication	C0086792
28157408	spreads	C0332261
28157408	behavior	C0004927
28157408	investigated	C1292732
28157408	adults'	C0001675
28157408	likelihood	C0033204
28157408	persuading	C3825845
28157408	social network	C0150775
28157408	buy	C0870238
28157408	antibiotic	C0003232
28157408	free	C1996904
28157408	food	C0016452
28157408	attempted	C1516084
28157408	persuade	C3825845
28157408	behavioral	C0004927
28157408	determinants	C1521761
28157408	homophily	C0205556
28157408	superdiffuser	C0205556
28157408	traits	C0037401
28157408	potential	C3245505
28157408	consumers	C1707496
28157408	findings	C0243095
28157408	behavioral	C0004927
28157408	determinants	C1521761
28157408	behavioral	C0004927
28157408	intentions	C0162425
28157408	mavenism	C0205556
28157408	predicted	C0681842
28157408	intentions	C0162425
28157408	persuade	C3825845
28157408	Homophily	C0205556
28157408	mavenism	C0205556
28157408	connectivity	C0205245
28157408	predicted	C0681842
28157408	patterns	C0449774
28157408	interpersonal	C0021797
28157408	persuasion	C3825845
28157408	vegetarians	C0042441
28157408	homophily	C0205556
28157408	action	C3266814
28157408	behavioral	C0004927
28157408	determinants	C1521761
28157408	mavenism	C0205556
28157408	predicted	C0681842
28157408	persuasion	C3825845
28157408	intentions	C0162425
28157408	Persuasiveness	C3825845
28157408	associated with	C0332281
28157408	targeting	C1521840
28157408	network	C0150775
28157408	members	C0680022
28157408	mavenism	C0205556
28157408	associated with	C0332281
28157408	structurally	C0678594
28157408	central	C0205099
28157408	members	C0680022
28158248	Modeling	C0870071
28158248	flux	C2348693
28158248	metabolites	C0870883
28158248	juvenile hormone	C0022439
28158248	biosynthesis	C0220781
28158248	pathway	C1704259
28158248	generalized additive models	C0026336
28158248	ordinary differential equations	C0282574
28158248	Juvenile hormone	C0022439
28158248	JH	C0022439
28158248	development	C1527148
28158248	reproductive maturation	C0036887
28158248	insects	C0021585
28158248	corpora allata	C0010085
28158248	CA	C0010085
28158248	female	C0086287
28158248	adult mosquitoes	C0026584
28158248	fluctuating	C0231241
28158248	levels	C0441889
28158248	JH	C0022439
28158248	ovarian development	C1160265
28158248	nutritional	C1521739
28158248	signals	C0037083
28158248	rate	C1521828
28158248	JH	C0022439
28158248	biosynthesis	C0220781
28158248	rate	C1521828
28158248	flux	C2348693
28158248	isoprenoids	C0682996
28158248	pathway	C1704259
28158248	changes	C0392747
28158248	precursor	C3891814
28158248	enzyme	C0014442
28158248	levels	C0441889
28158248	comprehensive	C1880156
28158248	study	C2603343
28158248	changes	C0392747
28158248	enzymatic activities	C0243102
28158248	precursor	C3891814
28158248	mosquito	C0026584
28158248	Aedes aegypti	C0322859
28158248	JH	C0022439
28158248	biosynthesis	C0220781
28158248	pathway	C1704259
28158248	studies	C2603343
28158248	quantitative approaches	C0681919
28158248	changes	C0392747
28158248	metabolic	C0311400
28158248	reactions	C0443286
28158248	pathway	C1704259
28158248	JH	C0022439
28158248	synthesis	C0220781
28158248	generalized additive models	C0026336
28158248	GAMs	C0026336
28158248	changes	C0392747
28158248	metabolite	C0870883
28158248	concentrations	C0457929
28158248	changes	C0392747
28158248	enzymatic activities	C0243102
28158248	substrate	C3891814
28158248	concentrations	C0457929
28158248	Changes	C0392747
28158248	substrate	C3891814
28158248	concentrations	C0457929
28158248	model	C0026336
28158248	metabolic	C0311400
28158248	steps	C1261552
28158248	analyzed	C0936012
28158248	enzymatic activities	C0243102
28158248	fitness	C2349186
28158248	GAMs	C0026336
28158248	substrate	C3891814
28158248	concentrations	C0457929
28158248	GAMs	C0026336
28158248	experimental	C1517586
28158248	data	C1511726
28158248	ordinary differential equations	C0282574
28158248	ODE	C0282574
28158248	changes	C0392747
28158248	metabolites	C0870883
28158248	function	C0542341
28158248	levels	C0441889
28158248	enzymatic catalytic activities	C0243102
28158248	results	C1274040
28158248	models	C0026336
28158248	changes	C0392747
28158248	flux	C2348693
28158248	metabolites	C0870883
28158248	JH	C0022439
28158248	pathway	C1704259
28158248	design	C1707689
28158248	validate	C1519941
28158248	experimental	C1517586
28158248	manipulations	C0205245
28158248	JH	C0022439
28158248	synthesis	C0220781
28160457	Associations	C0439849
28160457	human breast milk	C0885503
28160457	hormones	C0019932
28160457	adipocytokines	C1955907
28160457	infant growth	C0205714
28160457	body composition	C0005885
28160457	first 6 months of life	C3280927
28160457	human breast milk	C0885503
28160457	HBM	C0885503
28160457	HBM	C0885503
28160457	maternal	C1858460
28160457	body mass index	C1305855
28160457	BMI	C1305855
28160457	sex	C0079399
28160457	stage of lactation	C0022925
28160457	HBM	C0885503
28160457	insulin	C0021641
28160457	glucose	C0017725
28160457	leptin	C0299583
28160457	IL-6	C0021760
28160457	TNF-α	C1456820
28160457	associations	C0439849
28160457	infant	C0021270
28160457	body composition	C0005885
28160457	breastfeeding infants	C1623041
28160457	mothers	C1623040
28160457	lactation	C0022925
28160457	Infants	C0021270
28160457	body composition measured	C1285593
28160457	dual-energy X-ray absorptiometry	C1510486
28160457	HBM	C0885503
28160457	interaction	C1704675
28160457	maternal	C1858460
28160457	BMI	C1305855
28160457	infant sex	C0079399
28160457	insulin levels	C0202098
28160457	insulin was 229% higher	C0428405
28160457	obese	C0028754
28160457	mothers	C0026591
28160457	female infants	C2222300
28160457	normal weight	C2712185
28160457	mothers	C0026591
28160457	nursing	C0006147
28160457	nursing	C0006147
28160457	female infants	C2222300
28160457	obese	C0028754
28160457	mothers	C0026591
28160457	male infants	C2216472
28160457	leptin	C0299583
28160457	association	C0439849
28160457	BMI	C1305855
28160457	overweight	C0497406
28160457	obese	C0028754
28160457	mothers	C0026591
28160457	higher leptin levels	C2747815
28160457	normal weight	C2712185
28160457	mothers	C0026591
28160457	Leptin	C0299583
28160457	BMI	C1305855
28160457	sex	C0079399
28160457	inverse	C0439850
28160457	relationship	C0439849
28160457	leptin	C0299583
28160457	levels	C0441889
28160457	infant length	C0455806
28160457	percent fat	C0518026
28160457	total fat mass	C3656665
28160457	trunk fat mass	C3656665
28160457	associations	C0439849
28160457	interactions	C1704675
28160457	glucose	C0017725
28160457	TNF-α	C1456820
28160457	IL-6	C0021760
28160457	maternal	C1858460
28160457	BMI	C1305855
28160457	infant	C0021270
28160457	sex	C0079399
28160457	stage of lactation	C0022925
28160457	insulin	C0021641
28160457	leptin	C0299583
28161861	Aryl hydrocarbon receptor (AhR) rs2066853	C0596123
28161861	gene polymorphism	C0678951
28161861	infertile	C0021359
28161861	oligoasthenoteratozoospermic	C0028960
28161861	men	C0025266
28161861	seminal	C1519232
28161861	oxidative stress	C0242606
28161861	aryl hydrocarbon receptor (AhR) rs2066853	C0596123
28161861	gene polymorphism	C0678951
28161861	infertile	C0021359
28161861	oligoasthenoteratozoospermic	C0028960
28161861	OAT	C0028960
28161861	men	C0025266
28161861	seminal	C1519232
28161861	oxidative stress	C0242606
28161861	OS	C0242606
28161861	Egyptian men	C0025266
28161861	semen analysis	C0202533
28161861	fertile	C0015895
28161861	normozoospermic controls	C4231237
28161861	infertile	C0021359
28161861	OAT	C0028960
28161861	men	C0025266
28161861	history taking	C0199182
28161861	clinical examination	C1274016
28161861	semen analysis	C0202533
28161861	estimation	C0750572
28161861	seminal	C1519232
28161861	glutathione peroxidase	C0017822
28161861	GPx	C0017822
28161861	malondialdehyde	C0024643
28161861	MDA	C0024643
28161861	AhR rs2066853	C0596123
28161861	gene polymorphism	C0678951
28161861	blood	C0005767
28161861	PCR	C0032520
28161861	RFLP	C0035268
28161861	infertile	C0021359
28161861	OAT	C0028960
28161861	men	C0025266
28161861	fertile	C0015895
28161861	controls	C0009932
28161861	AhR rs2066853	C0596123
28161861	genotypes	C0017431
28161861	decreased	C0205216
28161861	prevalence	C0033105
28161861	wild	C1883559
28161861	homozygous genotype GG	C0019904
28161861	heterozygous genotype GA	C0019425
28161861	increased	C0205217
28161861	prevalence	C0033105
28161861	homozygous genotype AA	C0019904
28161861	alleles	C0002085
28161861	AhR rs2066853	C0596123
28161861	OAT	C0028960
28161861	men	C0025266
28161861	fertile	C0015895
28161861	men	C0025266
28161861	decreased	C0205216
28161861	prevalence	C0033105
28161861	G allele	C0002085
28161861	increased	C0205217
28161861	prevalence	C0033105
28161861	A allele	C0002085
28161861	Seminal	C1519232
28161861	MDA	C0024643
28161861	increase	C0205217
28161861	seminal	C1519232
28161861	GPx	C0017822
28161861	decrease	C0205216
28161861	AA	C0019904
28161861	GA	C0019425
28161861	AA genotypes	C0019904
28161861	GG genotype	C0019904
28161861	AhR rs2066853	C0596123
28161861	genotype	C0017431
28161861	polymorphism	C0678951
28161861	decreased	C0205216
28161861	sperm	C0037868
28161861	increased	C0205217
28161861	seminal	C1519232
28161861	oxidative stress	C0242606
28161861	infertile	C0021359
28161861	OAT	C0028960
28161861	men	C0025266
28161910	Associations	C0439849
28161910	gender	C0079399
28161910	proxy	C0600420
28161910	female	C0086287
28161910	menopausal status	C1513126
28161910	histological	C0205462
28161910	features	C2348519
28161910	drug-induced liver injury	C0860207
28161910	Gender	C0079399
28161910	menopause	C0025320
28161910	type	C0332307
28161910	severity	C0439793
28161910	drug-induced liver injury	C0860207
28161910	DILI	C0860207
28161910	influencing	C4054723
28161910	host	C1167395
28161910	responses	C1704632
28161910	injury	C3263723
28161910	aim	C1947946
28161910	study	C2603343
28161910	assess	C1516048
28161910	associations	C0439849
28161910	gender	C0079399
28161910	female	C0086287
28161910	age	C0001779
28161910	proxy	C0600420
28161910	menopause	C0025320
28161910	histological	C0205462
28161910	features	C2348519
28161910	liver injury	C0160390
28161910	adults	C0001675
28161910	Drug-Induced Liver Injury	C0860207
28161910	Network	C1882071
28161910	DILIN	C1882071
28161910	registry	C0034975
28161910	participants	C0679646
28161910	causality	C0015127
28161910	score	C0449820
28161910	probable	C0332148
28161910	liver biopsy	C0193388
28161910	DILI	C0860207
28161910	chronic liver disease	C0341439
28161910	Biochemical	C0205474
28161910	histological	C0205462
28161910	injury	C3263723
28161910	types	C0332307
28161910	hepatocellular	C0151763
28161910	cholestatic/mixed injury	C1737228
28161910	cohort	C0599755
28161910	divided	C0332849
28161910	gender	C0079399
28161910	age	C0001779
28161910	categories	C0683312
28161910	men	C0025266
28161910	women	C0043210
28161910	women	C0043210
28161910	age	C0001779
28161910	Interaction	C1704675
28161910	gender	C0079399
28161910	age	C0001779
28161910	category	C0683312
28161910	assessed	C1516048
28161910	Hepatocellular injury	C0151763
28161910	women	C0043210
28161910	biochemical	C0205474
28161910	injury	C3263723
28161910	types	C0332307
28161910	black race	C0005680
28161910	possible	C0332149
28161910	ageing	C0001811
28161910	effects	C1280500
28161910	severe	C0205082
28161910	hepatitis	C0019158
28161910	biopsies	C0005558
28161910	women	C0043210
28161910	compared	C1707455
28161910	men	C0025266
28161910	women	C0043210
28161910	Compared	C1707455
28161910	men	C0025266
28161910	biopsies	C0005558
28161910	women	C0043210
28161910	greater	C1704243
28161910	plasma cell infiltration	C0391861
28161910	hepatocyte apoptosis	C3269241
28161910	hepatocyte	C0227525
28161910	rosettes	C0035863
28161910	lobular	C0205417
28161910	iron	C0302583
28161910	positive	C1514241
28161910	hepatocytes	C0227525
28161910	histological	C0205462
28161910	cholestasis	C0008370
28161910	associations	C0439849
28161910	cases	C0868928
28161910	amoxicillin/clavulanic acid	C0054066
28161910	anabolic steroids	C0002744
28161910	nitrofurantoin	C0028156
28161910	DILI	C0860207
28161910	gender	C0079399
28161910	distributions	C1704711
28161910	Gender	C0079399
28161910	proxy	C0600420
28161910	menopause	C0025320
28161910	associated with	C0332281
28161910	features	C2348519
28161910	inflammation	C0021368
28161910	injury	C3263723
28161910	DILI	C0860207
28165738	Anticancer Compound	C0003392
28165738	Natural	C0205296
28165738	Oridonin	C0069639
28165738	Apoptosis	C0162638
28165738	Cell Cycle Arrest	C1155873
28165738	Mitochondrial Pathway	C1513340
28165738	cytotoxicity	C0596402
28165738	natural	C0205296
28165738	ent-kaurene diterpenoid	C1254351
28165738	oridonin	C0069639
28165738	oridonin	C0069639
28165738	cancer therapy	C0920425
28165738	moderate potency	C0678792
28165738	oridonin	C0069639
28165738	A-ring modified analogues, and their derivatives	C0002776
28165738	substituents on 14-OH position	C1254350
28165738	synthesized	C1883254
28165738	evaluated	C0220825
28165738	anticancer	C0003392
28165738	efficacy	C1280519
28165738	derivatives	C0243072
28165738	oridonin	C0069639
28165738	drug	C1254351
28165738	sensitive	C0332324
28165738	drug-resistant	C0013203
28165738	cancer cells	C0334227
28165738	compound, 13p	C0003392
28165738	200-fold	C1254367
28165738	efficacious	C1280519
28165738	oridonin	C0069639
28165738	MCF-7 cancer cells	C0596890
28165738	13p	C0003392
28165738	apoptosis	C0162638
28165738	cell cycle arrest	C1155873
28165738	G2/M phase	C1517347
28165738	mitochondrial membrane potential	C1720920
28165738	Bax/Bcl-2	C0219474
28165738	activated caspase-3	C4290004
28165738	cleavage	C0597304
28165738	MCF-7 cells	C0596890
28165738	treatment	C0087111
28165738	13p	C0003392
28165738	mitochondrial pathway	C1513340
28165738	13p	C0003392
28165738	apoptosis	C0162638
28165738	13p	C0003392
28165738	tumor growth	C0598934
28165738	mouse	C0025929
28165738	xenograft models	C1520166
28165738	no observable toxic effect	C0857329
28166758	Stromal alterations	C1336512
28166758	ovarian cancers	C0029925
28166758	wavelength	C0449819
28166758	dependent	C0851827
28166758	Second Harmonic Generation microscopy	C0026018
28166758	optical scattering	C0596837
28166758	Ovarian cancer	C0029925
28166758	gynecological	C0018417
28166758	cancer	C0006826
28166758	survival rate	C0038954
28166758	specific rates	C2986538
28166758	dependent	C0851827
28166758	disease	C0012634
28166758	diagnosis	C0011900
28166758	screening	C0220908
28166758	imaging tools	C1512629
28166758	early lesions	C0221198
28166758	subtypes	C0872379
28166758	ovarian cancer	C0029925
28166758	treatments	C0087111
28166758	screening	C0220908
28166758	imaging tools	C1512629
28166758	wavelength	C0449819
28166758	dependent	C0851827
28166758	collagen	C0009325
28166758	Second Harmonic Generation (SHG) imaging microscopy	C0026018
28166758	optical scattering measurements	C0027692
28166758	structural	C1510464
28166758	differences	C1705242
28166758	extracellular matrix	C0015350
28166758	ECM	C0015350
28166758	stroma	C0927195
28166758	benign tumors	C0086692
28166758	endometrioid tumors	C0474809
28166758	low	C3839184
28166758	high-grade serous tumors	C3839280
28166758	SHG	C0026018
28166758	signatures	C1704864
28166758	conversion	C0439836
28166758	efficiency	C0013682
28166758	optical scattering	C0596837
28166758	organization	C1300196
28166758	collagen	C0009325
28166758	sub-micron	C0439201
28166758	size scale	C0282574
28166758	structural	C1510464
28166758	information	C1533716
28166758	wavelength	C0449819
28166758	dependence	C0851827
28166758	size	C0456389
28166758	distribution	C1704711
28166758	collagen fibrils	C1179626
28166758	fibers	C0225325
28166758	wavelengths	C0449819
28166758	wavelength	C0449819
28166758	dependence	C0851827
28166758	metrics	C0015350
28166758	structural	C1510464
28166758	differences	C1705242
28166758	collagen	C0009325
28166758	organization	C1300196
28166758	classification	C0008902
28166758	type I and II serous tumors	C0476122
28166758	type I endometrioid tumors	C0474809
28166758	ECM	C0015350
28166758	serous malignancies	C0476122
28166758	SHG	C0026018
28166758	metrics	C0015350
28166758	optical scattering measurements	C0027692
28166758	linear discriminant model	C3161035
28166758	tissues	C0040300
28166758	high-grade serous tumors	C3839280
28166758	tissue types	C2713035
28166758	High-grade serous tumors	C3839280
28166758	ovarian cancers	C0029925
28166758	histological analysis	C0679557
28166758	etiology	C1314792
28166758	in vivo	C0681829
28166758	screening tool	C0220908
28166758	SHG	C0026018
28166758	optical scattering measurements	C0027692
28166758	information	C1533716
28166758	superior diagnostic power	C0430022
28166758	clinical imaging	C0011923
28166758	modalities	C1275506
28166758	measurements	C0242485
28166758	subtypes	C0872379
28166758	ovarian cancer	C0029925
28166758	treatment protocols	C0040808
28166758	altered	C1515926
28166758	collagen	C0009325
28166758	histological analysis	C0679557
28166758	etiology	C1314792
28166758	in vivo	C0681829
28166758	screening tool	C0220908
28166758	ovarian malignancies	C1140680
28166758	metastasize	C0027627
28166758	clinical imaging	C0011923
28167866	Metal-on-Metal Bearings	C3494213
28167866	Total Hip Arthroplasty	C0040508
28167866	Hip Resurfacing	C1719285
28167866	Review Article	C0282443
28167866	metal-on-metal (MoM) bearings	C3494213
28167866	hip arthroplasty	C0186193
28167866	MoM bearings	C3494213
28167866	metal-on-polyethylene	C3880938
28167866	lower risk of	C3538919
28167866	dislocation	C0012691
28167866	larger head sizes	C0205556
28167866	trend	C1521798
28167866	re-introduction	C0376495
28167866	MoM bearing	C3494213
28167866	evidence	C3887511
28167866	MoM bearing	C3494213
28167866	successful	C1272703
28167866	MoM bearings	C3494213
28167866	reintroduction	C0376495
28167866	metal-on-metal bearings	C3494213
28167866	total hip arthroplasty	C0040508
28167866	metal-on-metal bearings	C3494213
28167866	stemmed total hip arthroplasty	C0040508
28167866	metal-on-metal hip resurfacing	C1955625
28167866	orthopaedics	C0029355
28167866	metal-on-metal hip resurfacing	C1955625
28167866	total hip arthroplasty	C0040508
28167866	literature	C0023866
28167866	strategy	C0679199
28167866	MEDLINE	C0025141
28167866	Embase	C0242356
28167866	quality articles	C1706852
28167866	inclusion criteria	C1512693
28167866	review	C0282443
28167866	metal-on-metal	C3494213
28167866	total hip arthroplasty	C0040508
28167866	hip resurfacing	C1719285
28167866	articles	C1706852
28167866	articles	C1706852
28167866	review	C0282443
28167866	Metal-on-metal hip resurfacing	C3881498
28167866	treatment	C0087111
28167866	specific	C0205369
28167866	patient populations	C2361270
28167866	appropriate	C1548787
28167866	implant design	C0021107
28167866	metal-on-metal total hip arthroplasty	C3881498
28167866	all patient populations	C2361270
28167866	follow-up	C1522577
28167866	patients	C0030705
28167866	metal-on-metal hip resurfacing	C1955625
28167866	critical	C1511545
28167866	long-term	C0443252
28167866	outcomes	C0085415
28167866	patients	C0030705
28167866	complications	C0009566
28167893	Morphogenetic	C0026559
28167893	Alterations	C1515926
28167893	Alternaria alternata	C0320062
28167893	Exposed to	C0332157
28167893	Dicarboximide Fungicide	C0392419
28167893	Iprodione	C0123904
28167893	Fungicide-resistant	C0332325
28167893	Alternaria alternata	C0320062
28167893	control	C2587213
28167893	Alternaria diseases	C0026946
28167893	crop	C0242775
28167893	fields	C0001829
28167893	investigate	C1292732
28167893	cytological	C0205471
28167893	fungicide	C0392419
28167893	resistance	C1514892
28167893	mechanisms	C0441712
28167893	A. alternata	C0320062
28167893	dicarboximide fungicide	C0392419
28167893	iprodione	C0123904
28167893	A. alternata	C0320062
28167893	isolated	C0205409
28167893	cactus	C0330340
28167893	brown spot	C1705203
28167893	cultured	C0200954
28167893	potato-dextrose agar	C1254353
28167893	PDA	C1254353
28167893	without	C0332288
28167893	iprodione	C0123904
28167893	fungal cultures	C0200954
28167893	different	C1705242
28167893	growth	C0018270
28167893	characteristics	C1521970
28167893	no	C3686837
28167893	initial	C0205265
28167893	full	C0443225
28167893	growth	C0018270
28167893	observed	C1441672
28167893	light	C0430389
28167893	electron microscopy	C0026019
28167893	Mycelia	C0949695
28167893	grow	C0018270
28167893	one day after incubation	C1649476
28167893	DAI	C1649476
28167893	continued	C0549178
28167893	full	C0443225
28167893	growth	C0018270
28167893	control-growth	C0018270
28167893	Con-G	C0018270
28167893	PDA	C1254353
28167893	fungicide	C0392419
28167893	PDA	C1254353
28167893	iprodione	C0123904
28167893	no fungal growth	C3686837
28167893	iprodione-no growth	C3686837
28167893	Ipr-N	C3686837
28167893	DAI	C1649476
28167893	initial	C0205265
28167893	growth	C0018270
28167893	iprodione-initial growth	C0018270
28167893	Ipr-I	C0018270
28167893	DAI	C1254367
28167893	colonies	C1947989
28167893	expanded	C0205229
28167893	continuously	C0549178
28167893	full	C0443225
28167893	growth	C0018270
28167893	iprodione-growth	C0018270
28167893	Ipr-G	C0018270
28167893	Ipr-I	C0018270
28167893	morphogenetic	C0026559
28167893	changes	C0392747
28167893	resisting	C1514892
28167893	fungicidal	C1321381
28167893	toxicity	C0040539
28167893	Con-G	C0018270
28167893	multicellular conidia	C0038029
28167893	cell walls	C3826300
28167893	septa	C0243092
28167893	intact	C0205266
28167893	dense	C0439794
28167893	cytoplasm	C0010834
28167893	Ipr-N	C3686837
28167893	fungal	C0016832
28167893	sporulation	C2613267
28167893	inhibited	C0311403
28167893	undeveloped	C0243095
28167893	unicellular conidia	C0038029
28167893	degraded	C0243095
28167893	necrotic	C0027540
28167893	cytoplasm	C0010834
28167893	Ipr-I	C0018270
28167893	conspicuous cellular changes	C1265925
28167893	sporulation	C2613267
28167893	multicellular conidia	C0038029
28167893	double layered	C0205400
28167893	thickened	C0205400
28167893	cell walls	C3826300
28167893	accumulation	C4055506
28167893	proliferated	C1514485
28167893	lipid bodies	C0230704
28167893	conidial	C0038029
28167893	cytoplasm	C0010834
28167893	inhibit	C0311403
28167893	penetration	C0205321
28167893	fungicide	C0392419
28167893	conidial	C0038029
28167893	cells	C0007634
28167893	fungicide	C0392419
28167893	associated	C0332281
28167893	toxicity	C0040539
28167893	energy	C1442080
28167893	nutritional	C1521739
28167893	sources	C0449416
28167893	fungal	C0016832
28167893	growth	C0018270
28167893	mature	C0205286
28167893	colonies	C1947989
28167893	Ipr-G	C0018270
28167893	multicellular conidia	C0038029
28167893	cell walls	C3826300
28167893	intact	C0205266
28167893	cytoplasm	C0010834
28167893	lipid bodies	C0230704
28167893	Con-G	C0018270
28168514	diagnostic image	C1551337
28168514	quality	C0806487
28168514	coronary angiography	C0085532
28168514	third-generation dual-source CT	C0040405
28168514	usage	C0457083
28168514	coronary CT angiography	C1634617
28168514	CTA	C1634617
28168514	patients	C0030705
28168514	acute	C0522051
28168514	chronic chest pain	C1740831
28168514	diagnostic accuracy	C0598285
28168514	Agatston score	C0449820
28168514	AS	C0449820
28168514	heart rate	C0018810
28168514	arrhythmia	C0003811
28168514	severe obesity	C0028756
28168514	third-generation dual-source CT	C0040405
28168514	DSCT	C0040405
28168514	CTA	C1634617
28168514	clinical setting	C3176918
28168514	patients	C0030705
28168514	BMI	C1305855
28168514	male	C0025266
28168514	CTA	C1634617
28168514	DSCT	C0040405
28168514	retrospective single-center analysis	C0936012
28168514	contrast-enhanced volume dataset	C0150098
28168514	sequential	C0441633
28168514	SSM	C0441633
28168514	helical scan mode	C0441633
28168514	HSM	C0441633
28168514	Coronary segments	C1283333
28168514	diagnostic	C0806487
28168514	non-diagnostic image quality	C0806487
28168514	invasive angiography	C0002971
28168514	diagnostic accuracy	C0598285
28168514	CTA	C1634617
28168514	SSM	C0441633
28168514	HSM	C0441633
28168514	diagnostic image	C1551337
28168514	quality	C0806487
28168514	AS	C0449820
28168514	influence	C4054723
28168514	diagnostic image	C1551337
28168514	quality	C0806487
28168514	SSM	C0441633
28168514	HSM	C0441633
28168514	Diagnostic image	C1551337
28168514	quality	C0806487
28168514	SSM	C0441633
28168514	patients	C0030705
28168514	AS	C0449820
28168514	SSM	C0441633
28168514	sensitivity	C1511883
28168514	specificity	C0037791
28168514	PPV	C1514243
28168514	NPV	C1513918
28168514	HSM	C0441633
28168514	sensitivity	C1511883
28168514	specificity	C0037791
28168514	PPV	C1514243
28168514	NPV	C1513918
28168514	diagnostic accuracy	C0598285
28168514	SSM	C0441633
28168514	radiation doses	C4019308
28168514	HSM	C0441633
28168514	age	C0599755
28168514	BMI	C1305855
28168514	cohorts	C0599755
28168514	SSM	C0441633
28168514	third-generation DSCT	C0040405
28168514	dose	C0178602
28168514	diagnostic image	C1551337
28168514	quality	C0806487
28168514	patients	C0030705
28168514	AS	C0449820
28168514	heart rate	C0018810
28168514	heart rhythm	C0232187
28168514	obesity	C0028754
28171748	Antagonistic	C1148560
28171748	Self-Organizing Patterning	C0376678
28171748	Control	C2587213
28171748	Maintenance	C2371947
28171748	Regeneration	C0034963
28171748	Anteroposterior	C0442212
28171748	Axis	C1522496
28171748	Planarians	C0032068
28171748	Planarian	C0032068
28171748	flatworms	C0032211
28171748	maintain	C2371947
28171748	body	C1268086
28171748	regenerate	C0334213
28171748	arbitrary	C1264693
28171748	tissue	C0040300
28171748	fragments	C0486805
28171748	phenomena	C1882365
28171748	self-maintaining	C0024501
28171748	self-organizing patterning	C0376678
28171748	mechanisms	C0441712
28171748	molecular	C1521991
28171748	mechanisms	C0441712
28171748	morphogenic	C1152630
28171748	gradient	C0812409
28171748	canonical Wnt signaling	C3178960
28171748	gene expression	C0017262
28171748	planarian	C0032068
28171748	anteroposterior	C0442212
28171748	A/P	C0442212
28171748	axis	C1522496
28171748	results	C0683954
28171748	gradient	C0812409
28171748	formation	C1522492
28171748	autonomously	C0332291
28171748	tail	C0039259
28171748	autoregulatory	C0019868
28171748	Wnt	C0753137
28171748	Wnt	C0935995
28171748	expression	C1171362
28171748	gradient	C0812409
28171748	steady state	C0678587
28171748	regeneration	C0034963
28171748	Functional	C0205245
28171748	antagonism	C1148560
28171748	tail	C0039259
28171748	Wnt	C0753137
28171748	gradient	C0812409
28171748	unknown	C0439673
28171748	head	C0018670
28171748	patterning	C0376678
28171748	spatial	C0037775
28171748	proportions	C1709707
28171748	planarian	C0032068
28171748	A/P	C0442212
28171748	axis	C1522496
28171748	mutually	C1709100
28171748	exclusive	C1548966
28171748	molecular fate	C1148560
28171748	during	C0347984
28171748	regeneration	C0034963
28171748	results	C0683954
28171748	planarian	C0032068
28171748	A/P	C0442212
28171748	axis	C1522496
28171748	self-organizing patterning	C0376678
28171748	deployed	C2825812
28171748	functionally	C0205245
28171748	coupled	C1948027
28171748	mutual	C1709100
28171748	antagonism	C1148560
28179911	Characterization	C1880022
28179911	Ectopic Expression	C1512167
28179911	CoWRI1	C1517488
28179911	AP2/EREBP	C1517488
28179911	Transcription Factor	C0040648
28179911	Coconut	C0009210
28179911	Cocos nucifera L	C0009210
28179911	Endosperm	C2717855
28179911	Seeds	C0036563
28179911	Oil	C0032085
28179911	Transgenic	C0085245
28179911	Arabidopsis thaliana	C0162740
28179911	Rice	C1140671
28179911	Oryza sativa L	C1140671
28179911	Coconut	C0009210
28179911	Cocos nucifera L.	C0009210
28179911	tropical	C0041183
28179911	crop	C0242775
28179911	monocotyledonous family	C1704727
28179911	Arecaceae	C0682477
28179911	Palmaceae	C0682477
28179911	genes	C0017337
28179911	metabolic processes	C0025519
28179911	coconut	C0009210
28179911	endosperm	C2717855
28179911	investigated	C1292732
28179911	study	C2603343
28179911	WRI1	C1517488
28179911	gene family	C1517488
28179911	coconut	C0009210
28179911	endosperm	C2717855
28179911	CoWRI1	C1517488
28179911	transcriptional	C0040649
28179911	activities	C0441655
28179911	interactions	C1704675
28179911	acetyl-CoA carboxylase	C0001022
28179911	BCCP2	C0213275
28179911	promoter	C0086860
28179911	CoWRI1	C1517488
28179911	yeast two-hybrid	C0599647
28179911	yeast one-hybrid	C0599647
28179911	characterization	C1880022
28179911	seed	C0036563
28179911	expression	C0017262
28179911	Arabidopsis	C0162741
28179911	endosperm	C2717855
28179911	expression	C0017262
28179911	rice	C1140671
28179911	transgenic	C0085245
28179911	Arabidopsis	C0162741
28179911	over-expressions	C0017262
28179911	CoWRI1	C1517488
28179911	T2	C0085245
28179911	lines	C1140671
28179911	quantitative real-time PCR	C3179034
28179911	mRNA	C0035696
28179911	genes	C0017337
28179911	encoding	C2700640
28179911	enzymes	C0014442
28179911	fatty acid biosynthesis	C0596562
28179911	triacylglycerols	C0041004
28179911	BCCP2	C0017337
28179911	KASI	C0017337
28179911	MAT	C0017337
28179911	ENR	C0017337
28179911	FATA	C0017337
28179911	GPDH	C0017337
28179911	assayed	C0005507
28179911	seeds	C0036563
28179911	lipid	C0023779
28179911	fatty acids	C0015684
28179911	C16:0	C0030234
28179911	C18:0	C0038228
28179911	homozygous	C0019904
28179911	T2	C0085245
28179911	transgenic	C0085245
28179911	rice lines	C1140671
28179911	G5	C1140671
28179911	G2	C1140671
28179911	CoWRI1	C1517488
28179911	expression	C0017262
28179911	CoWRI1	C1517488
28179911	transcripts	C1519595
28179911	wild type	C1883559
28179911	Analyses	C0936012
28179911	seed	C0036563
28179911	oil	C0032085
28179911	starch	C0038179
28179911	protein	C0033684
28179911	T2	C0085245
28179911	transgenic lines	C0085245
28179911	seed	C0036563
28179911	oil	C0032085
28179911	transgenic lines	C0085245
28179911	starch	C0038179
28179911	protein	C0033684
28179911	analysis	C0936012
28179911	fatty acid	C0015684
28179911	palmitic acid	C0030234
28179911	C16:0	C0030234
28179911	linolenic acid	C0125903
28179911	C18:3	C0125903
28179911	seeds	C0036563
28179911	transgenic	C0085245
28179911	rice lines	C1140671
28179911	oleic acid	C0028928
28179911	C18:1	C0028928
28179929	Tooth Discoloration	C0040434
28179929	Resulting	C0678226
28179929	Nano	C1553036
28179929	Zinc Oxide-Eugenol	C0043492
28179929	Sealer	C0676273
28179929	quality	C0332306
28179929	endodontic sealer	C0676273
28179929	tooth color	C0475833
28179929	friendly	C2700214
28179929	study	C2603343
28179929	tooth discoloration	C0040434
28179929	potential	C3245505
28179929	nano	C1553036
28179929	zinc oxide-eugenol	C0043492
28179929	NZOE	C0043492
28179929	sealer	C0676273
28179929	tooth discoloration	C0040434
28179929	pulp chamber	C0034099
28179929	human	C0086418
28179929	maxillary central	C0021156
28179929	lateral incisors	C0021156
28179929	filled	C1708059
28179929	sealers	C0676273
28179929	AH-26	C0051001
28179929	resin-based sealer	C0051001
28179929	Pulpdent	C0072601
28179929	sealer	C0676273
28179929	ZOE	C0043492
28179929	NZOE	C0043492
28179929	sealer	C0676273
28179929	Color	C0009393
28179929	measurements	C0242485
28179929	baseline	C1442488
28179929	before placement	C1524072
28179929	sealers	C0676273
28179929	h	C0439227
28179929	h	C0439227
28179929	h	C0439227
28179929	week	C0439230
28179929	month	C0439231
28179929	sealers	C0676273
28179929	Easy Shade spectrophotometer	C0183400
28179929	Data	C1511726
28179929	analyzed	C0936012
28179929	SPSS software	C0037585
28179929	one-way ANOVA	C1709320
28179929	ANOVA	C0002780
28179929	observed	C1441672
28179929	paired comparison test	C0282574
28179929	NZOE	C0043492
28179929	sealer	C0676273
28179929	tooth discoloration	C0040434
28179929	potential	C3245505
28179929	comparison	C1707455
28179929	AH-26	C0051001
28179929	ZOE	C0043492
28179929	sealer	C0676273
28183116	identity	C0017390
28183116	Palearctic	C0681784
28183116	species	C1705920
28183116	wolf spider	C0323749
28183116	genus	C1708235
28183116	Trebacosa	C3409647
28183116	Araneae	C0037913
28183116	Lycosidae	C0323749
28183116	paper	C1706852
28183116	Trebacosa brunhesi	C3409647
28183116	synonym	C0871468
28183116	Trebacosa europaea	C3409647
28183116	examination	C1292732
28183116	specimens	C0370003
28183116	localities	C0017446
28183116	species	C1705920
28183116	type	C0332307
28183116	species	C1705920
28183116	genus	C1708235
28183116	Trebacosa marxi	C3409648
28183116	specimens	C0370003
28183116	localities	C0017446
28183116	T. europaea	C3409647
28183116	inter-	C0205369
28183116	intraspecific differences	C1705242
28183116	genus	C1708235
28183116	Scanning electron micrographs	C0026020
28183116	structure	C0678594
28183116	female's genitalia	C0017421
28183596	numerical	C0237753
28183596	study	C2603343
28183596	functionally graded materials	C3273359
28183596	stent	C0038257
28183596	design	C1707689
28183596	Undesirable	C1883420
28183596	deformation	C2919017
28183596	stent	C0038257
28183596	significant	C0178324
28183596	injure	C3263723
28183596	blood vessel	C0005847
28183596	plaque	C0332461
28183596	reduce/minimize	C0243095
28183596	undesirable	C1883420
28183596	deformations	C2919017
28183596	Functionally Graded Materials	C3273359
28183596	FGM	C3273359
28183596	Finite Element (FE) method	C3826344
28183596	employed	C0557351
28183596	simulate	C0679083
28183596	expansion	C0442805
28183596	stent	C0038257
28183596	displacement	C2347509
28183596	stenosis	C1261287
28183596	plaque	C0332461
28183596	hyperelastic	C0450146
28183596	plaque	C0332461
28183596	elastoplastic stents	C0441289
28183596	Dogboning	C0001688
28183596	foreshortening	C0243095
28183596	maximum	C0806909
28183596	stress	C0038435
28183596	plaque	C0332461
28183596	pressure	C0033095
28183596	expand	C0205229
28183596	stent	C0038257
28183596	stent	C0038257
28183596	materials	C0520510
28183596	FGMs	C3273359
28183596	lower	C0547044
28183596	dogboning	C0001688
28183596	stents	C0038257
28183596	uniform	C0205375
28183596	materials	C0520510
28183596	stent	C0038257
28183596	lowest	C1708760
28183596	heterogeneous index	C0918012
28183596	lowest	C1708760
28183596	dogboning	C0001688
28183596	Steel	C0038239
28183596	stent	C0038257
28183596	lowest	C1708760
28183596	foreshortening	C0243095
28183596	expansion pressure	C4049814
28183596	difference	C1705241
28183596	lower	C0547044
28183596	dogboning	C0001688
28183596	FGM	C3273359
28183596	heterogeneous index	C0918012
28183596	suitable	C3900053
28183596	results	C1274040
28183596	results	C1274040
28183596	material	C0520510
28183596	parameters	C0549193
28183596	crucial	C1511545
28183596	effects	C1280500
28183596	deformation	C2919017
28183596	stent	C0038257
28183596	result	C1274040
28183596	design	C1707689
28183596	FGM	C3273359
28183596	parameters	C0549193
28183596	biomechanical	C0009563
28183596	optimization	C2698650
28186384	Women's	C0043210
28186384	human papillomavirus	C0021344
28186384	self-sampling	C0080142
28186384	UK	C0041700
28186384	cervical	C0007874
28186384	screening programme	C1254363
28186384	Testing	C0039593
28186384	human papillomavirus	C0021344
28186384	HPV	C0021344
28186384	cervical	C0007874
28186384	screening programme	C1254363
28186384	HPV	C0021344
28186384	HPV	C0021344
28186384	self-sampling	C0080142
28186384	policy	C0242456
28186384	practice	C0237607
28186384	potential	C3245505
28186384	barriers	C4296486
28186384	HPV	C0021344
28186384	self-sampling	C0080142
28186384	cross-sectional survey	C0010362
28186384	women	C0043210
28186384	Logistic regression analysis	C0681925
28186384	determinants	C1521761
28186384	self-sampling	C0080142
28186384	women	C0043210
28186384	self-sampling	C0080142
28186384	Interviews	C0021822
28186384	survey	C0038951
28186384	participants	C0679646
28186384	HPV	C0021344
28186384	Lower	C0205556
28186384	intention	C0162425
28186384	associated with	C0332281
28186384	lower	C0205556
28186384	lower	C0205556
28186384	education	C0013621
28186384	lower	C0205556
28186384	perceived	C0030971
28186384	HPV	C0021344
28186384	cervical cancer	C0302592
28186384	Interviews	C0021822
28186384	personal	C1519021
28186384	barriers	C4296486
28186384	Personal	C1519021
28186384	barriers	C4296486
28186384	knowledge	C0376554
28186384	HPV	C0021344
28186384	self-sampling	C0080142
28186384	women's	C0043210
28186384	low confidence	C0558092
28186384	low confidence	C0558092
28186384	lack of confidence	C0558092
28186384	cervical	C0007874
28186384	screening programme	C1254363
28186384	sample	C0370003
28186384	contamination	C2349974
28186384	identity theft	C3658363
28186384	research	C0035168
28186384	HPV	C0021344
28186384	self-sampling	C0080142
28186384	policy	C0242456
28186384	practice	C0237607
28186384	Personal	C1519021
28186384	system-related barriers	C0243095
28186384	low confidence	C0558092
28186384	cervical	C0007874
28186384	screening	C1710032
28186384	HPV	C0021344
28186384	self-sampling	C0080142
28186384	cervical	C0007874
28186384	screening programme	C1254363
28186729	N-Terminal	C1706793
28186729	Hypothesis	C1512571
28186729	Alzheimer's Disease	C0002395
28186729	amyloid	C0002716
28186729	abeta peptide	C0078939
28186729	Aβ	C0078939
28186729	hypothesis	C1512571
28186729	years	C0439234
28186729	dominant	C1527180
28186729	model	C3161035
28186729	Alzheimer's disease	C0002395
28186729	AD	C0002395
28186729	pathogenesis	C0699748
28186729	development	C1527148
28186729	treatments	C0087111
28186729	controversial	C0680243
28186729	lack	C0332268
28186729	mechanistic path	C0441712
28186729	cleavage products	C0439861
28186729	amyloid precursor protein	C0085151
28186729	APP	C0085151
28186729	soluble	C1948047
28186729	Aβ monomer	C3484390
28186729	molecular	C1521991
28186729	fragments	C0332255
28186729	deleterious effects	C1280500
28186729	synaptic form	C0597545
28186729	function	C0542341
28186729	review of	C0699752
28186729	literature	C0023866
28186729	published work	C0034036
28186729	aggregation kinetics	C0022702
28186729	structural	C0678594
28186729	morphology	C0332437
28186729	Aβ	C0078939
28186729	clearance	C0449297
28186729	molecular	C1521991
28186729	simulations	C0679083
28186729	long-term potentiation	C0206249
28186729	measurements	C0242485
28186729	inhibition binding	C2259198
28186729	binding	C1167622
28186729	monoclonal antibody	C0003250
28186729	aducanumab	C4043101
28186729	hypothesize	C1512571
28186729	N-terminal domains	C1706793
28186729	neurotoxic	C0260049
28186729	Aβ oligomers	C0078939
28186729	causing	C0678227
28186729	disease	C0012634
28188533	Generation	C3146294
28188533	High-Quality	C0332306
28188533	SWATH(®)	C0282574
28188533	Acquisition	C1706701
28188533	Data	C1511726
28188533	Label-free	C0243095
28188533	Quantitative	C0392762
28188533	Proteomics Studies	C0872252
28188533	TripleTOF(®) Mass Spectrometers	C0183396
28188533	Data	C1511726
28188533	independent	C0332291
28188533	acquisition	C1706701
28188533	mass spectrometry technique	C0037813
28188533	MS	C0037813
28188533	MS/MS	C0599748
28188533	analysis	C0936012
28188533	detectable	C3830527
28188533	species	C1551338
28188533	information	C1533716
28188533	data	C1511726
28188533	mined	C1328866
28188533	acquire	C1706701
28188533	high-quality	C0332306
28188533	SWATH(®)	C0282574
28188533	Acquisition	C1706701
28188533	data	C1511726
28188533	large	C0549177
28188533	quantitative	C0392762
28188533	proteomic studies	C0872252
28188533	variable	C0439828
28188533	sized	C0456389
28188533	Q1 windows	C0282574
28188533	acquisition	C1706701
28188533	MS/MS	C0599748
28188533	data	C1511726
28188533	generating	C3146294
28188533	specificity	C0037791
28188533	quantitative	C0392762
28188533	data	C1511726
28192171	Alkaptonuria	C0002066
28192171	Fourier-transform infrared microscopy	C0596777
28192171	FTIRM	C0596777
28192171	low energy X-ray fluorescence microscopy	C0026022
28192171	LEXRF	C0026022
28192171	correlative study	C1511524
28192171	rare disease	C0678236
28192171	Alkaptonuria	C0002066
28192171	AKU	C0002066
28192171	ultra-rare disease	C0678236
28192171	associated	C0332281
28192171	lack	C0332268
28192171	enzyme	C0014442
28192171	tyrosine catabolism	C1156678
28192171	deficiency	C0011155
28192171	accumulation	C4055506
28192171	homogentisic acid	C0019881
28192171	HGA	C0019881
28192171	ochronotic pigment	C0028818
28192171	joint	C0022417
28192171	cartilage	C0007301
28192171	severe	C0205082
28192171	arthropathy	C0022408
28192171	Secondary amyloidosis	C0002726
28192171	unequivocally	C4053896
28192171	assessed	C1516048
28192171	comorbidity	C0009488
28192171	AKU	C0002066
28192171	arthropathy	C0022408
28192171	ochronotic pigment	C0028818
28192171	structurally	C0678594
28192171	amyloid	C0002716
28192171	Synchrotron Radiation	C0599746
28192171	Infrared	C0596777
28192171	X-Ray Fluorescence microscopies	C0026022
28192171	bio-assays	C0005507
28192171	analytical	C0936012
28192171	chemical composition	C0243176
28192171	morphology	C0332437
28192171	AKU	C0002066
28192171	cartilage	C0007301
28192171	evinced	C0205319
28192171	AKU	C0002066
28192171	cartilage	C0007301
28192171	proteoglycans	C0033692
28192171	depletion	C0333668
28192171	increased Sodium levels	C0595879
28192171	accumulation	C4055506
28192171	lipids	C0023779
28192171	peri-lacunar regions	C0229984
28192171	amyloid	C0002716
28192171	formation	C1522492
28192171	increase	C0442805
28192171	aromatic compounds	C1510940
28192171	oxygen-containing species	C0684299
28192171	depletion	C0333668
28192171	Magnesium	C0024467
28192171	content	C1264655
28192171	localized	C0392752
28192171	peri-lacunar region	C0229984
28192171	presence	C0150312
28192171	calcium carbonate	C0006681
28192171	proximity	C1514583
28192171	cartilage lacunae	C0225370
28192171	common	C0205214
28192171	AKU	C0002066
28192171	arthropathy	C0022408
28192171	disease	C0012634
28192171	presence	C0150312
28192171	amyloids	C0002716
28192171	peculiar	C0205161
28192171	calcifications	C1533591
28192171	analyses	C0936012
28192171	AKU	C0002066
28192171	cartilage	C0007301
28192171	disease	C0012634
28192171	new	C0205314
28192171	Ochronotic pigment	C0028818
28192171	AKU	C0002066
28192171	tissue degeneration	C1623047
28192171	bio-assays	C0005507
28192171	composition	C0243176
28192171	structural	C0678594
28192171	relationship	C0439849
28192171	amyloids	C0002716
28192171	present	C0521116
28192171	work	C0035168
28192171	integration	C0243126
28192171	analytical	C0936012
28192171	standardized	C1442989
28192171	analyses	C0936012
28193256	Unbiased estimates	C1711255
28193256	cerebrospinal fluid	C0007806
28193256	β-amyloid 1-42	C0169424
28193256	cutoffs	C1442160
28193256	memory clinic	C0442592
28193256	population	C1257890
28193256	cutoff	C1442160
28193256	β-amyloid 1-42	C0169424
28193256	cerebrospinal fluid	C0007806
28193256	CSF	C0007806
28193256	marker	C0005516
28193256	Alzheimer's disease	C0002395
28193256	AD	C0002395
28193256	data-driven	C3899452
28193256	Gaussian mixture modeling	C0026348
28193256	memory clinic	C0442592
28193256	population	C1257890
28193256	cross-sectional	C0010362
28193256	prospective cohort study	C1709709
28193256	subjects	C2349001
28193256	subjective cognitive decline	C0234985
28193256	mild cognitive impairment	C1270972
28193256	AD	C0002395
28193256	dementia	C0497327
28193256	dementia	C0497327
28193256	AD	C0002395
28193256	Amsterdam	C0681784
28193256	Dementia	C0497327
28193256	Cohort	C0599755
28193256	CSF	C0007806
28193256	β-amyloid 1-42	C0169424
28193256	cutoffs	C1442160
28193256	data-driven	C3899452
28193256	Gaussian mixture modeling	C0026348
28193256	total population	C3258257
28193256	subgroups	C1515021
28193256	clinical diagnosis	C0332140
28193256	age	C0001779
28193256	apolipoprotein E (APOE) genotype	C1446118
28193256	investigated	C1292732
28193256	abnormal	C0205161
28193256	β-amyloid 1-42	C0169424
28193256	data-driven	C3899452
28193256	cutoff	C1442160
28193256	predict	C0681842
28193256	progression	C0449258
28193256	AD	C0002395
28193256	dementia	C0497327
28193256	abnormal	C0205161
28193256	β-amyloid 1-42	C0169424
28193256	clinical diagnosis	C0332140
28193256	cutoff	C1442160
28193256	Cox proportional hazards regression	C0010235
28193256	group	C0441833
28193256	patients	C0030705
28193256	cutoff	C1442160
28193256	abnormal	C0205161
28193256	CSF	C0007806
28193256	β-amyloid 1-42	C0169424
28193256	CI	C0009667
28193256	cutoffs	C1442160
28193256	diagnostic	C0011900
28193256	APOE genotype	C1446118
28193256	subgroups	C1515021
28193256	cutoff	C1442160
28193256	higher	C0205250
28193256	elderly	C0001792
28193256	subjects	C2349001
28193256	subjects	C2349001
28193256	data-driven	C3899452
28193256	cutoff	C1442160
28193256	higher	C0205250
28193256	clinical diagnosis	C0332140
28193256	cutoff	C1442160
28193256	predictive	C0681890
28193256	accuracy	C0443131
28193256	progression	C0449258
28193256	AD	C0002395
28193256	dementia	C0497327
28193256	subjects	C2349001
28193256	HR	C2985465
28193256	p	C1709380
28193256	Mixture modeling	C0026348
28193256	robust	C2986815
28193256	method	C0025663
28193256	cutoffs	C1442160
28193256	CSF	C0007806
28193256	β-amyloid 1-42	C0169424
28193256	biological	C0205460
28193256	changes	C0392747
28193256	AD	C0002395
28193256	cutoffs	C1442160
28193256	clinical diagnosis	C0332140
28195652	Identification	C0205396
28195652	anti-mycobacterial	C0360390
28195652	functional	C0205245
28195652	properties	C0871161
28195652	piperidinol derivatives	C1254351
28195652	Tuberculosis	C0041296
28195652	TB	C0041296
28195652	global	C2348867
28195652	health	C0018684
28195652	threat	C0749385
28195652	cause of death	C0007465
28195652	infectious agent	C0314732
28195652	worldwide	C2348867
28195652	TB	C0041296
28195652	drug	C0013227
28195652	regimen	C0040808
28195652	inadequate	C0205412
28195652	anti-tubercular agents	C1254351
28195652	prevalence	C0220900
28195652	drug-resistant TB	C0206525
28195652	study	C2603343
28195652	investigate	C1292732
28195652	piperidinol compound derivative	C1254351
28195652	active	C0205177
28195652	Mycobacterium tuberculosis	C0026926
28195652	bacillus	C0004587
28195652	antibacterial	C0279516
28195652	properties	C0871161
28195652	piperidinol compound	C1254351
28195652	bis-Mannich base	C0024728
28195652	analogue	C0243071
28195652	evaluated	C0220825
28195652	M. smegmatis	C0317761
28195652	Gram-negative organisms	C0018150
28195652	Cytotoxicity	C0596402
28195652	studies	C2603343
28195652	selectivity index	C0918012
28195652	compounds	C1254351
28195652	resistant	C0332325
28195652	mutants	C0596988
28195652	M. smegmatis	C0317761
28195652	piperidinol	C1254351
28195652	bis-Mannich base lead derivatives	C1254351
28195652	genome sequencing	C1328887
28195652	genetic modifications	C4277689
28195652	compounds	C1254351
28195652	piperidinol	C1254351
28195652	bis-Mannich base analogue	C1254351
28195652	mycobacteria	C0026912
28195652	organism	C0029235
28195652	cytotoxicity	C0596402
28195652	selectivity index	C0918012
28195652	mycobacteria	C0026912
28195652	genome sequencing	C1328887
28195652	M. smegmatis	C0317761
28195652	strains	C1518614
28195652	resistant	C0332325
28195652	lead compounds	C1254351
28195652	identification	C0205396
28195652	single nucleotide polymorphisms	C0752046
28195652	results	C0683954
28195652	piperidinol moiety	C1254351
28195652	compound class	C1254351
28195652	anti-tubercular agents	C1254351
28197133	Metatranscriptomics	C0752248
28197133	Bacterial	C0004611
28197133	Eukaryotic Fibrolytic Communities	C0004611
28197133	Rumen	C0035946
28197133	Dairy Cow	C3687529
28197133	Mixed	C0205430
28197133	Diet	C0012155
28197133	Ruminants	C0035950
28197133	energy	C1442080
28197133	degradation	C0243125
28197133	plant	C0032098
28197133	polysaccharides	C0032594
28197133	activity	C0441655
28197133	rumen	C0035946
28197133	microbiota	C1000792
28197133	process	C1522240
28197133	in vitro	C1533691
28197133	microbiota members	C1000792
28197133	enzymes	C0014442
28197133	in vivo	C1515655
28197133	RNA-sequencing	C0917793
28197133	expression	C0017262
28197133	genes	C0017337
28197133	carbohydrate-active enzymes	C0014442
28197133	CAZymes	C0014442
28197133	rumen	C0035946
28197133	microbiota	C1000792
28197133	lactating dairy cow	C3687529
28197133	microorganisms	C0445623
28197133	fiber	C1260603
28197133	community	C0009462
28197133	Functional analysis	C0936012
28197133	CAZymes	C0014442
28197133	transcripts	C1519595
28197133	CAZyme	C0014442
28197133	GH94	C0055033
28197133	cellobiose-phosphorylase	C0055033
28197133	GH13	C0002712
28197133	amylase	C0002712
28197133	GH43	C0062220
28197133	GH10	C0062220
28197133	hemicellulases	C0062220
28197133	GH9	C1260229
28197133	GH48	C1260229
28197133	cellulases	C1260229
28197133	PL11	C0032491
28197133	pectinase	C0032491
28197133	GH2	C0014442
28197133	GH3	C0014442
28197133	oligosaccharidases	C0014442
28197133	fibrolytic bacteria	C0004611
28197133	Prevotella	C0242946
28197133	Ruminocccus	C0318074
28197133	Fibrobacter	C0995400
28197133	contribution	C1880177
28197133	fungi	C0016832
28197133	ciliate protozoa	C0008781
28197133	polysaccharide	C0032594
28197133	degradation	C0243125
28197133	protozoa	C0033739
28197133	rumen	C0035946
28197133	fibrolytic bacterial community	C0004611
28197133	CAZyme	C0014442
28197133	transcripts	C1519595
28197133	strains	C0004611
28197133	metatranscriptomics	C0752248
28197133	rumen	C0035946
28197133	microbial community	C0445623
28197156	Fine Mapping	C1283195
28197156	Carbon Assimilation Rate 8	C0017337
28197156	Quantitative Trait Locus	C0597336
28197156	Flag Leaf	C0242724
28197156	Nitrogen	C0028158
28197156	Content	C0456205
28197156	Stomatal	C1955855
28197156	Conductance	C0392762
28197156	Photosynthesis	C0031764
28197156	Rice	C1140671
28197156	Increasing	C0442808
28197156	rate	C1521828
28197156	leaf photosynthesis	C0031764
28197156	grain yield	C0392762
28197156	rice	C1140671
28197156	Oryza sativa	C1140671
28197156	variation	C0205419
28197156	CO2 assimilation rate	C1521828
28197156	rice cultivars	C1140671
28197156	quantitative genetics	C1514626
28197156	genes	C0017337
28197156	photosynthesis	C0031764
28197156	location	C0450429
28197156	Carbon Assimilation Rate 8	C0017337
28197156	CAR8	C0017337
28197156	crossing	C0010366
28197156	indica cultivar	C1659274
28197156	Japanese	C0022341
28197156	commercial	C0680536
28197156	cultivar	C0032098
28197156	Fine mapping	C1283195
28197156	CAR8	C0017337
28197156	encodes	C2700640
28197156	putative Heme Activator Protein 3	C0033684
28197156	OsHAP3	C0033684
28197156	CCAAT-box-binding transcription factor	C0526260
28197156	OsHAP3H	C0017337
28197156	Sequencing analysis	C1328887
28197156	indica	C1659274
28197156	allele	C0002085
28197156	CAR8	C0017337
28197156	1-bp deletion	C0162773
28197156	bp	C0600436
28197156	start codon	C0242610
28197156	truncated protein	C1144558
28197156	amino acids	C0002520
28197156	CAR8	C0017337
28197156	identical	C0205280
28197156	DTH8	C0017337
28197156	Ghd8	C0017337
28197156	LHD1	C0017337
28197156	rice	C1140671
28197156	flowering	C1820370
28197156	date	C0011008
28197156	increase	C0442805
28197156	A	C1521828
28197156	increase	C0442805
28197156	RuBP regeneration rate	C1521828
28197156	increased	C0205217
28197156	leaf	C0242724
28197156	nitrogen	C0028158
28197156	content	C0456205
28197156	reduced	C0392756
28197156	stomatal	C1955855
28197156	limitation	C0449295
28197156	increased	C0205217
28197156	stomatal	C1955855
28197156	conductance	C0392762
28197156	A	C1521828
28197156	allele	C0002085
28197156	hydraulic conductivity	C0205556
28197156	promote	C0033414
28197156	stomatal	C1955855
28197156	conductance	C0392762
28197156	CAR8	C0017337
28197156	physiological aspects	C0031843
28197156	photosynthesis	C0031764
28197156	analysis	C0936012
28197156	molecular functions	C1148560
28197156	CAR8	C0017337
28197156	association	C0439849
28197156	photosynthesis	C0031764
28197156	flowering	C1820370
28197156	genetic	C0314603
28197156	mechanisms	C0441712
28197156	improve	C0184511
28197156	photosynthesis	C0031764
28197156	rice	C1140671
28197156	crops	C0868961
28197965	Allogeneic stem cell transplantation	C2242529
28197965	adult	C0001675
28197965	patients	C0030705
28197965	acute lymphoblastic leukemia	C0023449
28197965	central nervous system involvement	C4050309
28197965	study	C2603343
28197965	Adult	C0001675
28197965	ALL	C0023449
28197965	Working Group	C1883562
28197965	Japan	C0022341
28197965	Society	C0037455
28197965	Hematopoietic Cell Transplantation	C1705576
28197965	prognosis	C0033325
28197965	adult	C0001675
28197965	acute lymphoblastic leukemia	C0023449
28197965	ALL	C0023449
28197965	patients	C0030705
28197965	central nervous system (CNS) involvement	C4050309
28197965	CNS+	C4050309
28197965	allogeneic hematopoietic stem cell transplantation	C1705576
28197965	allo-SCT	C1705576
28197965	retrospectively	C1514923
28197965	outcomes	C0085415
28197965	allo-SCT	C1705576
28197965	patients	C0030705
28197965	CNS involvement	C4050309
28197965	patients	C0030705
28197965	without	C0332288
28197965	CNS involvement	C4050309
28197965	CNS-	C4050309
28197965	database	C0242356
28197965	Japan	C0022341
28197965	criteria	C0243161
28197965	study	C2603343
28197965	diagnosis	C1704656
28197965	ALL	C0023449
28197965	years	C1510829
28197965	allo-SCT	C1705576
28197965	first	C0205435
28197965	SCT	C1705576
28197965	Data	C1511726
28197965	patients	C0030705
28197965	CNS+ patients	C0030705
28197965	CNS- patients	C0030705
28197965	analyses	C0936012
28197965	CNS- patients	C0030705
28197965	CNS+ patients	C0030705
28197965	younger	C0332239
28197965	worse	C1457868
28197965	disease	C0012634
28197965	status	C0449438
28197965	SCT	C1705576
28197965	performance status	C1518965
28197965	PS	C1518965
28197965	SCT	C1705576
28197965	Incidence	C0021149
28197965	relapse	C0035020
28197965	CNS+ patients	C0030705
28197965	incidence	C0021149
28197965	CNS	C3714787
28197965	relapse	C0035020
28197965	probability	C0033204
28197965	year	C0439234
28197965	overall survival	C4086681
28197965	OS	C4086681
28197965	CNS- patients	C0030705
28197965	univariate analysis	C0683962
28197965	patients	C0030705
28197965	received	C1514756
28197965	SCT	C1705576
28197965	CR	C0677874
28197965	no difference	C3842396
28197965	probability	C0033204
28197965	OS	C4086681
28197965	CNS+	C4050309
28197965	CNS-	C4050309
28197965	patients	C0030705
28197965	CNS involvement	C4050309
28197965	unfavorable	C3640815
28197965	effect	C1280500
28197965	OS	C4086681
28197965	multivariate analysis	C0026777
28197965	CNS+ patients	C0030705
28197965	CR	C0677874
28197965	OS	C4086681
28197965	CNS- patients	C0030705
28203067	Silent strain of caregiving	C1328742
28203067	best predictors	C0035648
28203067	distress	C0231303
28203067	family carers	C0086279
28203067	geriatric patients	C0870602
28203067	best predictors	C0035648
28203067	distress suffered	C0231303
28203067	family carers	C0086279
28203067	FCs	C0086279
28203067	geriatric patients	C0870602
28203067	cross-sectional study	C0010362
28203067	FC	C0086279
28203067	geriatric patient	C0870602
28203067	dyads	C0870454
28203067	negative impact of care	C0243095
28203067	NIoC	C0243095
28203067	subscale	C0459443
28203067	COPE index	C0392762
28203067	lower stress	C4075362
28203067	higher stress	C4075362
28203067	FCs	C0086279
28203067	process of providing care	C2735110
28203067	explanatory	C0681841
28203067	variables	C2673413
28203067	sociodemographic	C0011292
28203067	care-related attributes	C0086388
28203067	patient-related results	C0243095
28203067	geriatric assessments	C0017463
28203067	disease	C0012634
28203067	profiles	C0747306
28203067	explanatory	C0681841
28203067	variables	C2673413
28203067	highest predictive powe	C0681890
28203067	distress	C0231303
28203067	FCs	C0086279
28203067	multiple logistic regression (LR) model	C0681925
28203067	LR	C0681925
28203067	statistical information criteria	C0237881
28203067	statistical robustness	C0237881
28203067	discriminative power	C2945687
28203067	model	C0026336
28203067	cross-validation method	C0681935
28203067	age	C0001779
28203067	FCs	C0086279
28203067	geriatric patients	C0870602
28203067	explanatory	C0681841
28203067	variables	C2673413
28203067	predictors	C0035648
28203067	statistical model	C0026348
28203067	distress	C0231303
28203067	lower self-evaluation of health	C0175637
28203067	self-appraisal	C2936632
28203067	coping	C0009967
28203067	caregiver	C0086279
28203067	lower	C0205251
28203067	general support	C1276367
28203067	care	C1947933
28203067	motor retardation	C0424230
28203067	cared	C1947933
28203067	Timed Up and Go (TUG) test	C3161512
28203067	TUG test	C3161512
28203067	patient	C0030705
28203067	predictor	C0035648
28203067	distress	C0231303
28203067	variables	C2673413
28203067	NIoC	C0243095
28203067	mobility of geriatric patients	C2094221
28203067	kinesitherapeutic methods	C0087111
28203067	hospital stay	C3489408
28203067	FCs	C0086279
28203549	Microbiological	C0025953
28203549	Clinical Characteristics	C0683325
28203549	Hypermucoviscous Klebsiella pneumoniae	C0001699
28203549	Isolates	C1764827
28203549	Associated with	C0332281
28203549	Invasive Infections	C4285937
28203549	China	C0008115
28203549	distinctive syndrome	C0039082
28203549	caused by	C0015127
28203549	hypermucoviscous Klebsiella pneumoniae	C0001699
28203549	HMKP	C0001699
28203549	pyogenic liver abscess	C0267830
28203549	PLA	C0267830
28203549	globally emerging disease	C0872315
28203549	study	C2603343
28203549	K. pneumoniae	C0001699
28203549	isolates	C1764827
28203549	associated with	C0332281
28203549	various types	C0332307
28203549	invasive infections	C4285937
28203549	HMKP	C0001699
28203549	associated with	C0332281
28203549	PLA	C0267830
28203549	Multivariate regression analysis	C0026777
28203549	male patients	C0150904
28203549	years	C0439234
28203549	PLA	C0267830
28203549	diabetes mellitus	C0011849
28203549	hypertension	C0020538
28203549	independent	C0085862
28203549	risk factors	C0035648
28203549	HMKP infections	C0948802
28203549	K2	C0449547
28203549	capsular	C0205151
28203549	serotype	C0449943
28203549	HMKP	C0001699
28203549	isolates	C1764827
28203549	K1	C0449547
28203549	Seventy-five percentage	C0439165
28203549	K1	C0449547
28203549	HMKP	C0001699
28203549	isolates	C1764827
28203549	associated with	C0332281
28203549	PLA	C0267830
28203549	K2	C0449547
28203549	HMKP	C0001699
28203549	isolates	C1764827
28203549	accounted	C0750591
28203549	more types	C0332307
28203549	invasive infections	C4285937
28203549	positive	C1446409
28203549	rates	C1521828
28203549	iutA	C0017337
28203549	mrkD	C0017337
28203549	aerobactin	C0017337
28203549	iroN	C0017337
28203549	rmpA	C0017337
28203549	HMKP	C0001699
28203549	isolates	C1764827
28203549	significantly higher	C4055637
28203549	non-HMKP	C0001699
28203549	isolates	C1764827
28203549	correlation	C1707520
28203549	magA	C0017337
28203549	ybtS	C0017337
28203549	alls	C0017337
28203549	wcaG	C0017337
28203549	K1	C0449547
28203549	isolates	C1764827
28203549	mrkD	C0017337
28203549	exclusively detected	C0442726
28203549	HMKP	C0001699
28203549	K2	C0449547
28203549	isolates	C1764827
28203549	K1	C0449547
28203549	K2	C0449547
28203549	HMKP	C0001699
28203549	non-HMKP	C0001699
28203549	isolates	C1764827
28203549	positive	C1446409
28203549	rmpA	C0017337
28203549	Aerobactin	C0017337
28203549	found	C0150312
28203549	K1	C0449547
28203549	K2	C0449547
28203549	isolates	C1764827
28203549	ST23	C0449943
28203549	found	C0150312
28203549	most prevalent	C0332183
28203549	ST	C0449943
28203549	HMKP	C0001699
28203549	isolates	C1764827
28203549	K1	C0449547
28203549	K2	C0449547
28203549	K5	C0449547
28203549	K20	C0449547
28203549	K57	C0449547
28203549	found	C0150312
28203549	K1	C0449547
28203549	isolates	C1764827
28203549	ST65	C0449943
28203549	most prevalent	C0332183
28203549	ST	C0449943
28203549	found	C0150312
28203549	K2	C0449547
28203549	isolates	C1764827
28203549	ST23-K1	C0449547
28203549	HMKP	C0001699
28203549	isolates	C1764827
28203549	associated with	C0332281
28203549	PLA	C0267830
28203549	ST65-K2	C0449547
28203549	isolates	C1764827
28203549	correlated	C1707520
28203549	types of infections	C0457463
28203549	ST23-K1	C0449547
28203549	isolates	C1764827
28203549	PFGE	C0085117
28203549	results	C1274040
28203549	homology	C2697616
28203549	HMKP	C0001699
28203549	isolates	C1764827
28203549	diverse	C1880371
28203549	five	C0205451
28203549	PFGE	C0085117
28203549	clusters	C1704332
28203549	similarity	C2348205
28203549	accounted	C0750591
28203549	three	C0205449
28203549	isolates	C1764827
28203549	five	C0205451
28203549	PFGE	C0085117
28203549	clusters	C1704332
28203549	accounted	C0750591
28203549	isolates	C1764827
28203549	study	C2603343
28203549	found	C0150312
28203549	hypertension	C0020538
28203549	male patients	C0150904
28203549	years	C0439234
28203549	old	C0580836
28203549	independent	C0085862
28203549	risk factors	C0035648
28203549	composition	C0486616
28203549	ST types	C0449943
28203549	PFGE	C0085117
28203549	clusters	C1704332
28203549	K. pneumoniae	C0001699
28203549	K2	C0449547
28203549	isolates	C1764827
28203549	diverse	C1880371
28203549	K1	C0449547
28203549	isolates	C1764827
28203549	K1	C0449547
28203549	K2	C0449547
28203549	HMKP	C0001699
28203549	isolates	C1764827
28203549	specific profiles	C2003903
28203549	virulence	C0042765
28203549	associated	C0750490
28203549	genes	C0017337
28208888	Haemoglobinopathies	C0019045
28208888	β-Thalassaemia	C0005283
28208888	Tribals	C0040881
28208888	Working	C0043227
28208888	Tea	C0039400
28208888	Gardens	C4019428
28208888	Assam	C0681784
28208888	India	C0021201
28208888	Prevalence	C0220900
28208888	haemoglobinopathies	C0019045
28208888	β-thalassaemia	C0005283
28208888	very high	C0205250
28208888	India	C0021201
28208888	information	C1533716
28208888	tribals	C0040881
28208888	working	C0043227
28208888	tea	C0039400
28208888	gardens	C4019428
28208888	Assam	C0681784
28208888	very less	C0205251
28208888	study	C2603343
28208888	prevalence	C0220900
28208888	haemoglobinopathies	C0019045
28208888	β-thalassaemia	C0005283
28208888	tribals	C0040881
28208888	working	C0043227
28208888	tea	C0039400
28208888	gardens	C4019428
28208888	Assam	C0681784
28208888	tribals	C0040881
28208888	working	C0043227
28208888	tea	C0039400
28208888	gardens	C4019428
28208888	Assam	C0681784
28208888	analysed	C0936012
28208888	Complete Blood Count	C0009555
28208888	CBC	C0009555
28208888	High Pressure Liquid Chromatography	C0008562
28208888	HPLC	C0008562
28208888	detection	C1511790
28208888	haemoglobinopathies	C0019045
28208888	β-thalassaemia	C0005283
28208888	study	C2603343
28208888	prevalence	C0220900
28208888	sickle cell anaemia	C0002895
28208888	β-thalassaemia	C0005283
28208888	very high	C0205250
28208888	population	C1257890
28208888	results	C1274040
28208888	indicated	C1444656
28208888	prevalence	C0220900
28208888	β-thalassaemia	C0005283
28208888	Munda ethnic group	C0015031
28208888	prevalence	C0220900
28208888	sickle cell anaemia	C0002895
28208888	Lohar ethnic group	C0015031
28208888	study	C2603343
28208888	presence	C0150312
28208888	HbE	C0019024
28208888	tribals	C0040881
28208888	working	C0043227
28208888	tea	C0039400
28208888	gardens	C4019428
28208888	Assam	C0681784
28208888	findings	C0243095
28208888	sickle cell anaemia	C0002895
28208888	β-thalassaemia	C0005283
28208888	health	C0018684
28208888	problem	C0033213
28208888	tribals	C0040881
28208888	working	C0043227
28208888	tea	C0039400
28208888	gardens	C4019428
28208888	Assam	C0681784
28208888	diagnostic facilities	C0011929
28208888	haemoglobinopathy	C0019045
28208888	thalassaemia	C0039730
28208888	established	C0443211
28208888	areas	C0205146
28208888	haemoglobinopathy	C0019045
28208888	thalassaemia	C0039730
28208888	database	C0242356
28208888	collection	C1516698
28208888	haematological analysis laboratories	C0022877
28208888	genetic counselling clinics	C0442592
28208888	prenatal diagnosis centres	C0565990
28208888	neonatal screening centres	C0565990
28208923	Long Term	C0443252
28208923	Outcome	C1274040
28208923	Patients	C0030705
28208923	Esophageal Stenting	C1654920
28208923	Cancer Esophagus	C0152018
28208923	Rural Hospital	C0020023
28208923	Punjab	C0681784
28208923	India	C0021201
28208923	Cancer of the esophagus	C0152018
28208923	cause	C0085978
28208923	cancer deaths	C1516192
28208923	Punjab	C0681784
28208923	India	C0021201
28208923	Patients	C0030705
28208923	present	C0150312
28208923	dysphagia	C0011168
28208923	symptom	C1457887
28208923	advanced disease	C0679246
28208923	time	C0040223
28208923	presentation	C0449450
28208923	tertiary care centre	C0587437
28208923	Palliative procedures	C1285158
28208923	important	C3898777
28208923	Stenting	C2348535
28208923	option	C1518601
28208923	palliate	C1285530
28208923	symptoms	C1457887
28208923	dysphagia	C0011168
28208923	patient	C0030705
28208923	suffering the most	C0518881
28208923	success	C0679864
28208923	rate	C1521828
28208923	early	C0231243
28208923	long term	C0443252
28208923	complications	C0009566
28208923	mortality	C0205848
28208923	esophageal stenting	C1654920
28208923	malignant esophageal stricture	C0341129
28208923	patients	C0030705
28208923	One hundred	C1704407
28208923	patients	C0030705
28208923	esophageal stenting	C1654920
28208923	January	C3829466
28208923	January	C3829466
28208923	included	C0332257
28208923	study	C2603343
28208923	retrospectively analysed	C0035363
28208923	data	C1511726
28208923	patient	C0030705
28208923	characteristics	C1521970
28208923	causes	C1314792
28208923	non-operability	C0205187
28208923	early	C0231243
28208923	long term	C0443252
28208923	complications	C0009566
28208923	re-interventions	C0184661
28208923	efficacy	C1280519
28208923	mortality	C0205848
28208923	patients	C0030705
28208923	indications	C3146298
28208923	stenting	C2348535
28208923	advanced disease	C0679246
28208923	amenable	C3900053
28208923	surgery	C0543467
28208923	metastatic disease	C2939420
28208923	CVA	C0038454
28208923	cardiac	C0262402
28208923	respiratory problem	C1659989
28208923	surgery	C0543467
28208923	patients	C0030705
28208923	patients	C0030705
28208923	squamous cell carcinoma	C0007137
28208923	adenocarcinoma	C0001418
28208923	patients	C0030705
28208923	presented	C0449450
28208923	dysphagia	C0011168
28208923	chest pain	C0008031
28208923	recurrent cough	C3553459
28208923	recurrent vomiting	C0750325
28208923	dysphagia	C0011168
28208923	liquids	C0302908
28208923	solids	C0302909
28208923	complete dysphagia	C0011168
28208923	stenting	C2348535
28208923	significant	C0750502
28208923	improvement	C2986411
28208923	dysphagia	C0011168
28208923	score	C0449820
28208923	Post procedure	C3272301
28208923	stay	C0023303
28208923	days	C0439228
28208923	patient	C0030705
28208923	procedure	C0184661
28208923	complication	C0009566
28208923	post procedural bleed	C0919874
28208923	days	C0439228
28208923	stenting	C2348535
28208923	death	C1306577
28208923	patient	C0030705
28208923	Minor	C0558080
28208923	complications	C0009566
28208923	present	C0150312
28208923	patients	C0030705
28208923	treated	C1522326
28208923	affecting	C0392760
28208923	efficacy	C1280519
28208923	procedure	C0184661
28208923	include	C2700399
28208923	pain	C0030193
28208923	stenting	C2348535
28208923	stent obstruction	C0028778
28208923	stent migration	C4087543
28208923	minor	C0558080
28208923	complications	C0009566
28208923	treated	C1522326
28208923	except	C0332300
28208923	patients	C0030705
28208923	re-stenting	C2348535
28208923	Esophageal stenting	C1654920
28208923	procedure	C0184661
28208923	stay	C0023303
28208923	patient	C0030705
28208923	hospital	C0019994
28208923	patients	C0030705
28208923	morbidity	C0026538
28208923	effectively	C1704419
28208923	technical glitches	C1710348
28208923	patient	C0030705
28208923	counseled	C0600047
28208923	procedure	C0184661
28208923	prevent	C1292733
28208923	manage	C2587213
28208923	post procedure	C3272301
28208923	complications	C0009566
28209454	Treatment	C0039798
28209454	Carcinoma In Situ of the Glans Penis	C0686217
28209454	Topical Imiquimod	C3215046
28209454	Carbon Dioxide Laser	C0392251
28209454	Excision	C0728940
28209454	Different	C1705242
28209454	approaches	C1292724
28209454	described	C1552738
28209454	carcinoma in situ (CIS) of the glans penis	C0686217
28209454	erythroplasia of Queyrat	C0154089
28209454	including	C0332257
28209454	topical chemotherapy	C1519552
28209454	immunotherapy	C0021083
28209454	laser	C0441543
28209454	surgical excision	C0728940
28209454	evaluated	C0728940
28209454	efficacy	C1280519
28209454	topical imiquimod	C3215046
28209454	IQ	C3215046
28209454	carbon dioxide laser	C0392251
28209454	ablation	C0348007
28209454	lesion	C0221198
28209454	patients affected	C0522476
28209454	CIS	C0686217
28209454	glans	C1550261
28209454	treated	C0332293
28209454	IQ	C3215046
28209454	carbon dioxide laser	C0392251
28209454	ablation	C0348007
28209454	patient	C0030705
28209454	performed	C0884358
28209454	histologic examination	C0019637
28209454	before	C0332152
28209454	after	C0687676
28209454	IQ	C3215046
28209454	toxicity	C0013221
28209454	adverse effects	C0879626
28209454	After treatment	C2709088
28209454	histologic examination	C0019637
28209454	no residual tumor	C0332652
28209454	patients	C0030705
28209454	complete response	C4050307
28209454	CR	C4050307
28209454	stable disease	C0677946
28209454	patients	C0030705
28209454	progressive disease	C1335499
28209454	patients	C0030705
28209454	CR	C4050307
28209454	human papillomavirus	C0021344
28209454	related	C0439849
28209454	lesions	C0221198
28209454	no	C1513916
28209454	relapses	C0035020
28209454	after	C0687676
28209454	follow-up	C1522577
28209454	months	C0439231
28209454	patients	C0030705
28209454	progressive disease	C1335499
28209454	penectomy	C0194708
28209454	patients	C0030705
28209454	alive	C2584946
28209454	follow-up examination	C0260832
28209454	patients	C0030705
28209454	mild	C2945599
28209454	toxicity	C0013221
28209454	burning erythema	C0085624
28209454	no	C1513916
28209454	major	C0205164
28209454	adverse effects	C0879626
28209454	treatment	C0039798
28209454	IQ	C3215046
28209454	glans	C1550261
28209454	CIS	C0686217
28209454	effective	C1704419
28209454	human papillomavirus	C0021344
28209454	related	C0439849
28209454	lesions	C0221198
28209454	histologic examination	C0019637
28209454	before	C0332152
28209454	after	C0687676
28209454	IQ	C3215046
28209454	treatment	C0039798
28209454	patients	C0030705
28209454	rarity	C0522498
28209454	disease	C0012634
28209454	limitation	C0449295
28209454	IQ	C3215046
28209454	follow-up	C1522577
28209454	protocol	C0442711
28209454	mandatory	C0683517
28209454	lack	C0332268
28209454	long-term	C0443252
28209454	efficacy	C1280519
28209459	Progressive	C0205329
28209459	subcortical	C0815275
28209459	calcifications	C1533591
28209459	venous hypertension	C0340766
28209459	intracranial	C0524466
28209459	dural arteriovenous fistula	C0752156
28209459	Intracranial	C0524466
28209459	dural arteriovenous fistulas	C0752156
28209459	dAVF	C0752156
28209459	acquired lesions	C1711164
28209459	reported	C0700287
28209459	findings	C0243095
28209459	CT	C0040405
28209459	haemorrhage	C0019080
28209459	focal oedema	C0006114
28209459	progressive	C0205329
28209459	subcortical	C0815275
28209459	calcification	C1533591
28209459	CT	C0040405
28209459	venous hypertension	C0340766
28209459	dAVF	C0752156
28209945	Static Cold Storage	C0010405
28209945	Hypothermic Machine Perfusion	C0193410
28209945	Oxidative Stress Factors	C0696141
28209945	Adhesion Molecules	C1720822
28209945	Zinc Finger Transcription Factor Proteins	C2700330
28209945	Liver Transplantation	C0023911
28209945	static cold storage	C0010405
28209945	SCS	C0010405
28209945	hypothermic machine perfusion	C0193410
28209945	HMP	C0193410
28209945	oxidative stress factors	C0696141
28209945	OSF	C0696141
28209945	adhesion molecules	C1720822
28209945	AM	C1720822
28209945	zinc finger transcription factor	C2700330
28209945	Snail	C2700330
28209945	liver transplantation	C0023911
28209945	dogs	C0012984
28209945	donor	C0262458
28209945	group	C0441833
28209945	SCS	C0010405
28209945	group	C0441833
28209945	HMP	C0193410
28209945	group	C0441833
28209945	groups	C0441833
28209945	Livers retrieved	C0023911
28209945	group	C0441833
28209945	transplanted	C0023911
28209945	group	C0441833
28209945	SCS	C0010405
28209945	livers	C0023884
28209945	group	C0441833
28209945	transplanted	C0023911
28209945	group	C0441833
28209945	HMP	C0193410
28209945	group	C0441833
28209945	euthanized	C3686530
28209945	livers	C0023884
28209945	group	C0441833
28209945	dogs	C0012984
28209945	liver transplants	C0023911
28209945	groups	C0441833
28209945	liver	C0023884
28209945	sampling process	C0036150
28209945	OSF	C0696141
28209945	AM	C1720822
28209945	groups	C0441833
28209945	no significant differences	C3842396
28209945	transplantation	C0040732
28209945	chemokine CXCL14	C3180772
28209945	Snail	C2700330
28209945	groups	C0441833
28209945	no significant differences	C3842396
28209945	group	C0441833
28209945	P-selectin	C0134835
28209945	group	C0441833
28209945	transplantation	C0040732
28209945	HIF-1α	C1528324
28209945	chemokine CXCL14	C3180772
28209945	P-selectin	C0134835
28209945	Snail	C2700330
28209945	group	C0441833
28209945	group	C0441833
28209945	HMP	C0193410
28209945	OSF	C0696141
28209945	inflammatory factors	C0333348
28209945	conducive	C0243095
28209945	liver transplantation	C0023911
28210319	Physiology	C0031843
28210319	respiratory disturbances	C4314646
28210319	muscular dystrophies	C0026850
28210319	Muscular dystrophy	C0026850
28210319	myopathies	C0026848
28210319	progressive	C0205329
28210319	skeletal muscle wasting	C0541794
28210319	respiratory muscles	C0035231
28210319	Respiratory failure	C1145670
28210319	respiratory system	C0035237
28210319	fails	C0231175
28210319	gas exchange functions	C0678852
28210319	feature	C2348519
28210319	muscular dystrophy	C0026850
28210319	death	C1306577
28210319	consequence of	C0686907
28210319	lung	C0024109
28210319	failure	C1145670
28210319	pump failure	C1145670
28210319	recurrent	C2945760
28210319	aspiration	C0700198
28210319	progressive	C0205329
28210319	weakness of respiratory muscles	C1836141
28210319	increase	C0442805
28210319	contract	C0678852
28210319	resistive and elastic components	C0205556
28210319	breathing	C0035203
28210319	increase	C0442805
28210319	airway obstruction	C0001883
28210319	chest wall	C0205076
28210319	lung	C0024109
28210319	stiffening	C0427008
28210319	respiratory disturbances	C4314646
28210319	muscular dystrophy	C0026850
28210319	restrictive pulmonary function	C3806472
28210319	hypoventilation	C3203358
28210319	thoracoabdominal	C0444467
28210319	hypercapnia	C0020440
28210319	dyspnoea	C0013404
28210319	impaired regulation of breathing	C0548979
28210319	inefficient cough	C0455777
28210319	sleep disordered breathing	C0037315
28210319	muscular dystrophy	C0026850
28210319	progression	C0242656
28210319	symptom	C1457887
28210319	prognosis	C0033325
28210319	degree of respiratory involvement	C0243095
28210319	feature	C2348519
28210319	muscular dystrophy	C0026850
28210319	respiratory failure	C1145670
28210319	respiratory system	C0035237
28210319	oxygenation	C0597398
28210319	carbon dioxide elimination	C0221102
28210319	lung	C0024109
28210319	respiratory failure	C1145670
28210319	recurrent	C2945760
28210319	aspiration	C0700198
28210319	hypoxaemia	C0700292
28210319	hypercarbia	C0020440
28210319	Ventilatory failure	C0398353
28210319	muscular dystrophy	C0026850
28210319	increased	C0205217
28210319	respiratory load	C0243095
28210319	respiratory muscles weakness	C1836141
28210319	Respiratory load	C0243095
28210319	increases	C0442805
28210319	muscular dystrophy	C0026850
28210319	scoliosis	C0036439
28210319	chest wall compliance	C0429679
28210319	decrease	C0547047
28210319	atelectasis	C0004144
28210319	fibrosis	C0016059
28210319	lung compliance	C0024112
28210319	decrease	C0547047
28210319	airway obstruction	C0001883
28210319	airway resistance	C4048282
28210319	increase	C0442805
28210319	consequences of	C0686907
28210319	respiratory pump failure	C1145670
28210319	restrictive pulmonary function	C3806472
28210319	hypoventilation	C3203358
28210319	thoracoabdominal	C0444467
28210319	hypercapnia	C0020440
28210319	dyspnoea	C0013404
28210319	impaired regulation of breathing	C0548979
28210319	inefficient cough	C0455777
28210319	sleep disordered breathing	C0037315
28210319	mechanisms	C0457994
28210319	respiratory disturbances	C4314646
28210319	patients	C0030705
28210319	muscular dystrophy	C0026850
28210319	respiratory disturbances	C4314646
28210319	patients	C0030705
28210319	muscular dystrophy	C0026850
28210319	description	C3259023
28210319	muscular dystrophy	C0026850
28210319	respiratory implications	C0243095
28215507	Significance	C0750502
28215507	uterine corpus tumor	C0153574
28215507	invasion	C1269955
28215507	early-stage	C1517886
28215507	cervical cancer	C0007847
28215507	characteristics	C1521970
28215507	survival	C0038952
28215507	outcomes	C1274040
28215507	women	C0043210
28215507	surgically-treated	C0543467
28215507	cervical cancer	C0007847
28215507	uterine corpus tumor	C0153574
28215507	invasion	C1269955
28215507	Surveillance, Epidemiology, and End Results Program	C0242638
28215507	cervical cancer	C0007847
28215507	patients	C0030705
28215507	hysterectomy	C0020699
28215507	Logistic regression models	C0681925
28215507	risk factors	C0035648
28215507	uterine corpus tumor	C0153574
28215507	invasion	C1269955
28215507	multivariable analysis	C0026777
28215507	Association	C0439849
28215507	uterine corpus tumor	C0153574
28215507	invasion	C1269955
28215507	cause-specific survival	C1707318
28215507	CSS	C1707318
28215507	cervical cancer	C0007847
28215507	Cox proportional hazard regression models	C0034980
28215507	multivariable analysis	C0026777
28215507	uterine corpus	C0153574
28215507	invasion	C1269955
28215507	non-invasion	C0205303
28215507	Median	C0876920
28215507	follow-up	C1522577
28215507	time	C0040223
28215507	deaths	C0011065
28215507	cervical cancer	C0007847
28215507	Uterine corpus	C0153574
28215507	invasion	C1269955
28215507	independently	C0085862
28215507	associated with	C0332281
28215507	older age	C0001779
28215507	non-squamous histology	C4048239
28215507	high-grade tumors	C1334017
28215507	large tumor size	C0475440
28215507	nodal	C0443268
28215507	metastasis	C0027627
28215507	multivariable analysis	C0026777
28215507	univariable analysis	C0683962
28215507	uterine corpus tumor	C0153574
28215507	invasion	C1269955
28215507	associated with	C0332281
28215507	decreased	C0205216
28215507	CSS	C1707318
28215507	non-invasion	C0205303
28215507	controlling	C2239193
28215507	significant	C0750502
28215507	prognostic factors	C1514474
28215507	uterine corpus tumor	C0153574
28215507	invasion	C1269955
28215507	independent	C0085862
28215507	prognostic factor	C1514474
28215507	decreased	C0205216
28215507	CSS	C1707318
28215507	adjusted-hazard ratio	C2985465
28215507	confidence interval	C0009667
28215507	stage T1b	C0475385
28215507	uterine corpus tumor	C0153574
28215507	invasion	C1269955
28215507	independent	C0085862
28215507	prognostic factor	C1514474
28215507	decreased	C0205216
28215507	CSS	C1707318
28215507	adjusted-hazard ratio	C2985465
28215507	Uterine corpus tumor	C0153574
28215507	invasion	C1269955
28215507	associated with	C0332281
28215507	decreased	C0205216
28215507	CSS	C1707318
28215507	stage T1b1	C0730458
28215507	disease	C0153574
28215507	stage T1b2	C0730459
28215507	disease	C0153574
28215507	Uterine corpus tumor	C0153574
28215507	invasion	C1269955
28215507	independent	C0085862
28215507	prognostic factor	C1514474
28215507	decreased	C0205216
28215507	survival	C0038952
28215507	women	C0043210
28215507	early-stage	C1517886
28215507	cervical cancer	C0007847
28220186	gene targeting	C0242613
28220186	non-homologous end-joining	C2984257
28220186	Lipomyces starkeyi	C1002871
28220186	strains	C1518614
28220186	Microbial	C0599840
28220186	lipids	C0023779
28220186	production	C0033268
28220186	oleochemicals	C0220806
28220186	biodiesel	C2717894
28220186	Oleaginous yeasts	C0043393
28220186	alternative	C1523987
28220186	lipid	C0023779
28220186	producers	C0043393
28220186	plants	C0032098
28220186	animals	C0003062
28220186	chemical	C0007983
28220186	fuel industries	C0021267
28220186	oleaginous yeast	C0043393
28220186	Lipomyces starkeyi	C1002871
28220186	lipid	C0023779
28220186	producer	C0043393
28220186	lipid	C0023779
28220186	productivity	C0441655
28220186	cost-effective production	C0033268
28220186	oleochemicals	C0220806
28220186	fuels	C0556991
28220186	Genetic	C0017387
28220186	metabolic engineering	C3179022
28220186	L. starkeyi	C1002871
28220186	lipid	C0023779
28220186	production	C0033268
28220186	mechanisms	C0441712
28220186	lipid	C0023779
28220186	biosynthesis pathways	C0005572
28220186	integrative transformation system	C0205245
28220186	drug	C1254351
28220186	marker	C0017393
28220186	L. starkeyi	C1002871
28220186	gene-targeting	C0242613
28220186	frequencies	C0017270
28220186	non-homologous recombination	C0034865
28220186	L. starkeyi	C1002871
28220186	Genetic engineering tools	C0017387
28220186	L. starkeyi	C1002871
28220186	genetic tool	C0017387
28220186	application	C0205245
28220186	L. starkeyi	C1002871
28220186	gene-targeting system	C0242613
28220186	L. starkeyi	C1002871
28220186	mutants	C0678941
28220186	disrupting	C0332454
28220186	genes	C0017337
28220186	LsKu70p	C0033684
28220186	LsKu80p	C0033684
28220186	LsLig4p	C0033684
28220186	homology	C2697616
28220186	yeasts	C0043393
28220186	Ku70p	C0033684
28220186	Ku80p	C0033684
28220186	Lig4p	C0033684
28220186	non-homologous end-joining pathway	C2984257
28220186	Deletion	C0017260
28220186	LsLIG4 gene	C0017337
28220186	homologous recombination	C0034865
28220186	efficiency	C0013682
28220186	LsURA3	C0017337
28220186	locus	C1708726
28220186	wild-type	C1883559
28220186	strain	C1518614
28220186	2000-bp homologous flanking regions	C0004793
28220186	homologous recombination	C0034865
28220186	efficiencies	C0013682
28220186	mutant	C0678941
28220186	∆l sku70∆lslig4	C0678941
28220186	mutant	C0678941
28220186	∆lsku70∆lsku80∆lslig4	C0678941
28220186	L. starkeyi	C1002871
28220186	∆lslig4	C0678941
28220186	strains	C1518614
28220186	recipient strains	C1518614
28220186	genetic	C0017387
28220186	metabolic engineering	C3179022
28220186	approaches	C1292724
28220186	yeast	C0043393
28220959	clinical	C0205210
28220959	dietary	C0012155
28220959	psychological	C0205486
28220959	risk factors	C0035648
28220959	relapse	C0035020
28220959	ulcerative colitis	C0009324
28220959	clinical	C0205210
28220959	endoscopic	C0442418
28220959	histological	C0205462
28220959	remission	C0597370
28220959	relapse	C0035020
28220959	patients	C0030705
28220959	ulcerative colitis	C0009324
28220959	UC	C0009324
28220959	clinical	C0205210
28220959	endoscopic	C0442418
28220959	histological	C0205462
28220959	remission	C0597370
28220959	follow up	C1522577
28220959	relapse	C0035020
28220959	patients	C0030705
28220959	UC	C0009324
28220959	clinical	C0205210
28220959	endoscopic	C0442418
28220959	histological	C0205462
28220959	remission	C0597370
28220959	risk	C0035647
28220959	relapse	C0035020
28220959	Patients	C0030705
28220959	UC	C0009324
28220959	clinical	C0205210
28220959	endoscopic	C0442418
28220959	histological	C0205462
28220959	remission	C0597370
28220959	followed up	C1522577
28220959	year	C0439234
28220959	clinical	C0205210
28220959	dietary	C0012155
28220959	psychological	C0205486
28220959	factors	C0035648
28220959	relapse	C0035020
28220959	relapse	C0035020
28220959	infection	C3714514
28220959	antibiotic	C0003232
28220959	NSAIDs	C0003211
28220959	patient	C0030705
28220959	compliance	C1321605
28220959	medications	C2081612
28220959	patients	C0030705
28220959	males	C0025266
28220959	age	C0001779
28220959	years	C0439234
28220959	followed up	C1522577
28220959	months	C0439231
28220959	relapsed	C0035020
28220959	relapse	C0035020
28220959	months	C0439231
28220959	univariate analysis	C0683962
28220959	NSAIDs	C0003211
28220959	days	C0439228
28220959	relapse	C0035020
28220959	respiratory tract infection	C0035243
28220959	weeks	C0439230
28220959	steroids	C0038317
28220959	consumption	C1947907
28220959	calcium	C0006675
28220959	riboflavin	C0035527
28220959	vitamin A	C0042839
28220959	consumption	C1947907
28220959	sugars	C0242209
28220959	multivariate analysis	C0026777
28220959	NSAIDs	C0003211
28220959	intake	C1512806
28220959	Vitamin A	C0042839
28220959	predictors	C2698872
28220959	relapse	C0035020
28220959	relapse	C0035020
28220959	follow up	C1522577
28220959	months	C0439231
28220959	patients	C0030705
28220959	UC	C0009324
28220959	clinical	C0205210
28220959	endoscopic	C0442418
28220959	histological	C0205462
28220959	remission	C0597370
28220959	predictors	C2698872
28220959	relapse	C0035020
28220959	NSAIDs	C0003211
28220959	days	C0439228
28220959	relapse	C0035020
28220959	Vitamin A	C0042839
28221032	Reduction	C0301630
28221032	H2O2	C0020281
28221032	Electron Transport	C0013846
28221032	Decaheme Cytochrome	C0010749
28221032	ITO	C0669925
28221032	Electrode	C1705652
28221032	decaheme cytochrome MtrC	C0010749
28221032	Shewanella oneidensis MR-1	C1028266
28221032	immobilized	C0014444
28221032	ITO	C0669925
28221032	electrode	C1705652
28221032	H2O2	C0020281
28221032	reduction	C0301630
28221032	MtrC	C0010749
28221032	peroxidase activity	C1151518
28221032	horseradish peroxidase	C0019941
28221032	heme	C0018966
28221032	cofactors	C0009235
28221032	electronic communication	C0683826
28221032	electrode	C1705652
28221032	ITO	C0669925
28221032	electrode	C1705652
28221032	immobilization	C1254366
28221032	MtrC	C0010749
28221032	current density	C2349035
28221032	SHE	C1705652
28221032	UV-visible	C1883416
28221032	Resonance Raman spectroelectrochemical studies	C0037815
28221032	catalytic	C0007382
28221032	potential	C3245505
28221032	multiheme cytochromes	C0010749
28221032	catalyze	C0007382
28221032	technologically	C0681539
28221032	MtrC	C0010749
28221032	biotechnological	C0005574
28221032	H2O2	C0020281
28221032	reduction	C0301630
28221032	fuel cells	C3273359
28221032	biosensors	C0600364
28221291	Ophthalmic Manifestations	C0015411
28221291	Facial	C0015450
28221291	Dog Bites	C0259797
28221291	Children	C0008059
28221291	ophthalmic manifestations	C0015411
28221291	periocular injuries	C4290297
28221291	pediatric	C1521725
28221291	facial	C0015450
28221291	dog bites	C0259797
28221291	retrospective	C1514923
28221291	review	C0282443
28221291	children	C0008059
28221291	younger	C0332239
28221291	years	C0439234
28221291	medical	C0205476
28221291	attention	C0004268
28221291	dog bite	C0259797
28221291	face	C0015450
28221291	January	C3829466
28221291	May	C3812381
28221291	performed	C0884358
28221291	large tertiary	C0205372
28221291	pediatric hospital	C0020017
28221291	Data	C1511726
28221291	type	C0332307
28221291	location of injury	C0552513
28221291	surgical intervention	C0549433
28221291	complications	C1264516
28221291	collected	C1516698
28221291	total	C0439810
28221291	children	C0008059
28221291	aged	C0001779
28221291	years	C0439234
28221291	identified	C0205396
28221291	dog bite	C0259797
28221291	dog bite s	C0259797
28221291	Dog bite	C0259797
28221291	Dog bite s	C0259797
28221291	face	C0015450
28221291	occurred	C2745955
28221291	most	C0205393
28221291	patients	C0030705
28221291	children	C0008059
28221291	facial	C0015450
28221291	dog bite injuries	C0259797
28221291	suffered	C0683278
28221291	ophthalmic manifestations	C0015411
28221291	average	C1510992
28221291	age	C0001779
28221291	years	C0439234
28221291	Eyelid injuries	C0339089
28221291	occurred	C2745955
28221291	children	C0008059
28221291	sustained	C0443318
28221291	canalicular system	C0460002
28221291	injuries	C0005658
28221291	suffered	C0683278
28221291	corneal abrasions	C0010032
28221291	patients	C0030705
28221291	sustained	C0443318
28221291	facial	C0015450
28221291	nerve injury	C0161479
28221291	resulting in	C0332294
28221291	lagophthalmos	C0152226
28221291	patients	C0030705
28221291	suffered	C0683278
28221291	vision loss	C0456909
28221291	Complications	C1264516
28221291	occurred	C2745955
28221291	patients	C0030705
28221291	most	C0205393
28221291	common	C1522138
28221291	epiphora	C1024522
28221291	patients	C0030705
28221291	upper eyelid ptosis	C0748090
28221291	prominent	C0205402
28221291	scar formation	C1822291
28221291	patients	C0030705
28221291	children	C0008059
28221291	needed	C0027552
28221291	secondary procedure	C0445275
28221291	correct	C2349182
28221291	complications	C1264516
28221291	authors	C3812881
28221291	report	C0684224
28221291	clinical features	C2348519
28221291	management	C3273539
28221291	largest series	C0205549
28221291	ophthalmic	C0015408
28221291	periocular injuries	C4290297
28221291	associated with	C0332281
28221291	pediatric	C1521725
28221291	facial	C0015450
28221291	dog bite	C0259797
28221291	dog bite s	C0259797
28221291	injuries	C0005658
28221291	occur	C2745955
28221291	dog bite	C0259797
28221291	dog bite s	C0259797
28221291	face	C0015450
28221291	ocular adnexa	C0229243
28221291	early	C1279919
28221291	appropriate	C1548787
28221291	surgical management	C1515089
28221291	complications	C1264516
28221291	need	C0027552
28221291	revision surgery	C0035110
28221291	common	C1522138
28222192	Blastocystis subtyping	C3106936
28222192	intestinal parasites	C0021832
28222192	children	C0008059
28222192	geographical regions of Colombia	C3245499
28222192	Blastocystis	C0005707
28222192	enteric protist colonizing	C4289767
28222192	people	C0027361
28222192	non-human hosts	C1167395
28222192	genetic diversity	C0042333
28222192	subdivision of the genus	C1708235
28222192	multiple subtypes	C0449560
28222192	ST	C0449560
28222192	non-human hosts	C1167395
28222192	Blastocystis STs	C3106936
28222192	18S alleles	C0002085
28222192	symptomatic	C0231220
28222192	abdominal pain	C0000737
28222192	anal pruritus	C0033775
28222192	diarrhea	C0011991
28222192	headache	C0018681
28222192	nauseas	C0027497
28222192	vomit	C0042963
28222192	asymptomatic	C0231221
28222192	children	C0008059
28222192	geographical regions of Colombia	C3245499
28222192	fecal samples	C0455051
28222192	national survey	C0681817
28222192	intestinal parasites	C0021832
28222192	children	C0008059
28222192	Blastocystis positive	C0005707
28222192	DNA extraction	C3839098
28222192	Real Time PCR	C1709846
28222192	sequencing	C1294197
28222192	Blastocystis	C3687300
28222192	primers	C0206415
28222192	small subunit	C1167012
28222192	rRNA gene	C0035899
28222192	ST identification	C1261145
28222192	DNA	C0012854
28222192	Ascaris lumbricoides	C0003955
28222192	Trichuris trichiura	C0040913
28222192	hookworms	C1265425
28222192	Necator americanus	C0002826
28222192	Ancylostoma duodenale	C0162314
28222192	Giardia duodenalis	C0017535
28222192	Entamoeba complex	C1285568
28222192	Entamoeba coli	C0320420
28222192	Hymenolepis nana	C0322196
28222192	Endolimax nana	C0320452
28222192	Neobalantidium coli	C0004694
28222192	Blastocystis	C0005707
28222192	positive samples	C1514241
28222192	ST1	C3106801
28222192	ST2	C3106925
28222192	ST3	C3106933
28222192	ST4	C3961358
28222192	ST6	C3106938
28222192	ST7	C3106936
28222192	alleles	C0002085
28222192	ST1	C3106801
28222192	alleles	C0002085
28222192	ST2	C3106925
28222192	alleles	C0002085
28222192	ST3	C3106933
28222192	allele	C0002085
28222192	ST4	C3961358
28222192	allele	C0002085
28222192	ST6	C3106938
28222192	allele	C0002085
28222192	ST7	C3106936
28222192	high-resolution	C1719039
28222192	molecular markers	C0005516
28222192	Blastocystis	C0005707
28222192	transmission	C1521797
28222192	Stramenopila	C1004618
28222192	health and disease	C0679215
28223077	municipal solid waste	C1550151
28223077	landfill	C0599634
28223077	influence	C4054723
28223077	polychlorinated dibenzo-p-dioxins	C4277576
28223077	polychlorinated dibenzofurans	C4277574
28223077	PCDD	C4277576
28223077	Fs	C4277574
28223077	ambient air	C0001861
28223077	case study	C0085973
28223077	East China	C0008115
28223077	Municipal solid waste	C1550151
28223077	MSW	C1550151
28223077	landfill	C0599634
28223077	disposal	C1707797
28223077	MSW	C1550151
28223077	MSW	C1550151
28223077	disposed	C1707797
28223077	landfills	C0599634
28223077	world	C2700280
28223077	influence	C4054723
28223077	MSW	C1550151
28223077	landfill	C0599634
28223077	polychlorinated dibenzo-p-dioxins	C4277576
28223077	polychlorinated dibenzofurans	C4277574
28223077	PCDD	C4277576
28223077	Fs	C4277574
28223077	surrounding atmosphere	C0935443
28223077	ambient air	C0001861
28223077	analyzed	C0936012
28223077	surrounding sites	C0205145
28223077	background site	C0205145
28223077	upwind site	C0205145
28223077	downwind site	C0205145
28223077	MSW	C1550151
28223077	landfill	C0599634
28223077	East China	C0008115
28223077	study	C2603343
28223077	concentrations	C1446561
28223077	PCDD	C4277576
28223077	Fs	C4277574
28223077	PCDD	C4277576
28223077	Fs	C4277574
28223077	ambient air	C0001861
28223077	surrounding sites	C0205145
28223077	background site	C0205145
28223077	upwind site	C0205145
28223077	downwind site	C0205145
28223077	toxic equivalent concentrations	C1446561
28223077	TEQ	C1446561
28223077	PCDD	C4277576
28223077	Fs	C4277574
28223077	ambient air	C0001861
28223077	surrounding sites	C0205145
28223077	background site	C0205145
28223077	upwind site	C0205145
28223077	downwind site	C0205145
28223077	congener profiles	C1979963
28223077	PCDD	C4277576
28223077	Fs	C4277574
28223077	TEQ	C1446561
28223077	background atmosphere	C0935443
28223077	surrounding atmosphere	C0935443
28223077	landfill	C0599634
28223077	statistically significant	C0237881
28223077	PCDD	C4277576
28223077	Fs	C4277574
28223077	TEQ	C1446561
28223077	ambient air	C0001861
28223077	downwind site	C0205145
28223077	upwind site	C0205145
28223077	landfill	C0599634
28223077	influence	C4054723
28223077	PCDD	C4277576
28223077	Fs	C4277574
28223077	ambient air	C0001861
28223077	downwind site	C0205145
28223077	percentile	C1264641
28223077	carcinogenic risk	C0596244
28223077	CR	C0596244
28223077	PCDD	C4277576
28223077	Fs	C4277574
28223077	ambient air	C0001861
28223077	urrounding sites	C0205145
28223077	background site	C0205145
28223077	upwind site	C0205145
28223077	downwind site	C0205145
28223077	much lower than the threshold value	C0443151
28223077	CR	C0596244
28223077	landfill	C0599634
28223077	influence	C4054723
28223077	CR	C0596244
28223077	PCDD	C4277576
28223077	Fs	C4277574
28223077	surrounding atmosphere	C0935443
28223077	cancer risk	C0596244
28223077	non-carcinogenic risk	C4036089
28223077	non-CR	C4036089
28223077	analysis	C0936012
28223077	landfill	C0599634
28223077	influence	C4054723
28223077	non-CR	C4036089
28223077	PCDD	C4277576
28223077	Fs	C4277574
28223077	surrounding atmosphere	C0935443
28223077	non-carcinogenic effects	C1301751
28224642	Methodological considerations	C1879746
28224642	community	C0009462
28224642	water fluoridation	C0016323
28224642	cessation	C1880019
28224642	study	C2603343
28224642	High-quality	C0814847
28224642	research	C0242481
28224642	community	C0009462
28224642	water fluoridation	C0016323
28224642	CWF	C0016323
28224642	CWF	C0016323
28224642	cessation	C1880019
28224642	dental health	C0011365
28224642	CWF	C0016323
28224642	cessation	C1880019
28224642	studies	C2603343
28224642	methodological complexity	C0237523
28224642	study	C2603343
28224642	systematic review	C1955832
28224642	cessation	C1880019
28224642	studies	C2603343
28224642	methodological considerations	C1879746
28224642	CWF	C0016323
28224642	cessation	C1880019
28224642	studies	C2603343
28224642	future	C0016884
28224642	methodological aspects	C1879746
28224642	study design	C0035171
28224642	comparison community	C0009462
28224642	target population	C0039309
28224642	time frame	C0872291
28224642	sampling strategy	C0449370
28224642	clinical indicators	C1522602
28224642	assessment criteria	C0935549
28224642	biomarkers	C0005516
28224642	recommendations	C2936699
28224642	planning	C0018727
28224642	future	C0016884
28224642	CWF	C0016323
28224642	cessation	C1880019
28224642	studies	C2603343
28224642	dental caries	C0011334
28224642	study design	C0035171
28224642	research question	C0681799
28224642	recommendations	C0034866
28224642	methodological aspects	C1879746
28224642	epidemiological study	C0002783
28224642	CWF	C0016323
28224642	cessation	C1880019
28224642	dental caries	C0011334
28224642	researchers	C0035173
28224642	optimize	C2698650
28224642	resources	C0035201
28224642	study	C2603343
28229061	Central Myxoma	C0027149
28229061	Myxofibroma	C0205766
28229061	Jaws	C0022359
28229061	Clinico	C0442592
28229061	Epidemiologic	C0014508
28229061	Review	C0282443
28229061	Myxomas	C0027149
28229061	benign	C0205183
28229061	rare tumors	C4054123
28229061	connective-tissue	C0009780
28229061	origin	C0439659
28229061	hard (central)	C0040300
28229061	soft tissues	C0225317
28229061	body	C0242821
28229061	aim	C1947946
28229061	study	C0008972
28229061	central myxoma of the jaw	C1404550
28229061	clinic	C0442592
28229061	epidemiologic	C0014508
28229061	environment	C0014406
28229061	patients	C0030705
28229061	central myxoma of the jaw	C1404550
28229061	Oral and Maxillofacial Surgery department	C1704729
28229061	regional University Teaching Hospital	C0020027
28229061	retrospectively studied	C0035363
28229061	age	C0001779
28229061	sex	C1522384
28229061	site of tumor	C0475445
28229061	duration	C0449238
28229061	signs/symptoms	C3540840
28229061	treatment given	C0580351
28229061	complications	C0009566
28229061	Data	C1511726
28229061	analyzed	C0936012
28229061	Statistical Package for Social Sciences (SPSS) version 16	C0037585
28229061	SPSS Inc	C0683757
28229061	Chicago	C0008044
28229061	IL	C0020898
28229061	USA	C0041703
28229061	Microsoft Excel 2007	C0037585
28229061	Microsoft	C0683757
28229061	Redmond	C0008848
28229061	WA	C0043038
28229061	USA	C0041703
28229061	Results	C1274040
28229061	descriptive statistics	C2828391
28229061	tables	C1706074
28229061	charts	C0684240
28229061	test for significance	C0392366
28229061	Pearson Chi-square	C0008041
28229061	patients	C0030705
28229061	period	C1948053
28229061	reviewed	C1709940
28229061	females	C0086287
28229061	males	C0086582
28229061	male-to-female ratio	C0682069
28229061	ages	C0001779
28229061	patients	C0030705
28229061	ranged	C1514721
28229061	years	C1510829
28229061	years	C1510829
28229061	mandible	C0024687
28229061	cases	C0868928
28229061	maxilla	C0024947
28229061	cases	C0868928
28229061	combination	C0205195
28229061	maxilla	C0024947
28229061	zygoma	C1269549
28229061	case	C0868928
28229061	Bucco-lingual	C0229962
28229061	bucco-palatal	C0229962
28229061	expansion	C0205229
28229061	cases	C0868928
28229061	Histological	C0205462
28229061	assessment	C0220825
28229061	tissue specimens	C1292533
28229061	fibromyxoma	C0205766
28229061	accounted	C0085978
28229061	cases	C0868928
28229061	cases	C0868928
28229061	diagnosed	C0011900
28229061	myxoma	C0027149
28229061	patients	C0030705
28229061	jaw resections	C2090639
28229061	mandibulectomies	C0185566
28229061	patients	C0030705
28229061	maxillectomies	C0407722
28229061	patients	C0030705
28229061	duration of hospital stay	C4019086
28229061	ranged	C1514721
28229061	days	C0439228
28229061	days	C0439228
28229061	Complications	C0009566
28229061	patients	C0030705
28229061	surgical wound infections	C0038941
28229061	patients	C0030705
28229061	environment	C0014406
28229061	large tumors	C0475278
28229061	follow-up	C1522577
28229061	review	C1552617
28229061	radical	C0439807
28229061	patients	C0030705
28229097	Pediatric	C1521725
28229097	Hypovitaminosis D	C0042870
28229097	Perspectives	C1879746
28229097	Clinical	C0683325
28229097	Implications	C1707478
28229097	Vitamin D	C0042866
28229097	secosteroid	C0036532
28229097	essential	C0205224
28229097	development	C0678723
28229097	maintenance	C0024501
28229097	healthy	C3898900
28229097	bone	C0262950
28229097	adult	C0001675
28229097	pediatric	C1521725
28229097	populations	C1257890
28229097	Low level	C1611820
28229097	25-hydroxy vitamin D	C0006657
28229097	25-(OH)-D	C0006657
28229097	children	C0008059
28229097	adverse	C0879626
28229097	health outcomes	C1550208
28229097	rickets	C0035579
28229097	osteomalacia	C0029442
28229097	osteomalacic myopathy	C0410213
28229097	sarcopenia	C0872084
28229097	weakness	C3714552
28229097	growth retardation	C0151686
28229097	hypocalcemia	C0020598
28229097	seizure	C0036572
28229097	tetany	C0039621
28229097	autism	C0004352
28229097	cardiovascular diseases	C0007222
28229097	diabetes mellitus	C0011849
28229097	cancers	C0006826
28229097	prostate	C0376358
28229097	colon	C0009375
28229097	breast	C0006142
28229097	infectious diseases	C0009450
28229097	viral	C0042769
28229097	tuberculosis	C0041296
28229097	autoimmune diseases,	C0004364
28229097	multiple sclerosis	C0026769
28229097	Hashimoto's thyroiditis	C0677607
28229097	Risk factors	C0035648
28229097	hypovitaminosis D	C0042870
28229097	people	C0027361
28229097	darker skin pigmentation	C0037290
28229097	use	C1524063
28229097	sunscreen	C0038818
28229097	insufficient	C0205412
28229097	ultraviolet B	C0564461
28229097	exposure	C0332157
28229097	prematurity	C0021294
28229097	living in northern latitudes	C0337646
28229097	malnutrition	C0162429
28229097	obesity	C0028754
28229097	exclusive breastfeeding	C0242205
28229097	low maternal vitamin D level	C0243095
28229097	medications	C0013227
28229097	drinking	C0684271
28229097	unfortified cow's milk	C0349374
28229097	liver failure	C0085605
28229097	chronic renal insufficiency	C0403447
28229097	cystic fibrosis	C0010674
28229097	asthma	C0004096
28229097	sickle cell hemoglobinopathy	C1399386
28229097	review	C0282443
28229097	vitamin D deficiency	C0042870
28229097	adverse	C0879626
28229097	health outcomes	C1550208
28229097	pediatric	C1521725
28229097	age groups	C0027362
28229097	recommended treatment regimen	C0516913
28229097	review	C0282443
28232316	ecological	C0565987
28232316	gradients	C0812409
28232316	leaf	C0242724
28232316	margin	C0205284
28232316	entirety	C0439751
28232316	Evaluating	C0015196
28232316	roles	C1705810
28232316	biomechanics	C0005537
28232316	hydraulics	C1518533
28232316	vein geometry	C0449829
28232316	bud	C2700462
28232316	packing	C2828395
28232316	recent	C0332185
28232316	commentary	C0282411
28232316	proposed	C1553874
28232316	constraints	C0443288
28232316	packing	C2828395
28232316	young	C0332239
28232316	leaves	C0242724
28232316	buds	C2700462
28232316	positive	C1446409
28232316	association	C0750490
28232316	non-entire	C0205556
28232316	leaf	C0242724
28232316	margins	C0205284
28232316	latitude	C1627936
28232316	consider	C0750591
28232316	alternative	C1523987
28232316	explanations	C0681841
28232316	review	C1552617
28232316	logic	C0023963
28232316	evidence	C3887511
28232316	major	C0205164
28232316	hypotheses	C1512571
28232316	functional	C0205245
28232316	significance	C0750502
28232316	marginal	C0205284
28232316	teeth	C0242724
28232316	putative	C0750591
28232316	effects	C1280500
28232316	leaf	C0242724
28232316	cooling	C0678568
28232316	optimal	C2698651
28232316	areas	C0205146
28232316	major	C0205164
28232316	veins	C0042449
28232316	enhanced	C0205217
28232316	leaf	C0242724
28232316	margin	C0205284
28232316	photosynthesis	C0031764
28232316	hydathodal function	C0007613
28232316	defense	C1880266
28232316	against	C0521124
28232316	herbivores	C0562691
28232316	bud	C2700462
28232316	packing	C2828395
28232316	Theoretical	C0871935
28232316	empirical	C1880496
28232316	problems	C0033213
28232316	hypotheses	C1512571
28232316	except	C0332300
28232316	support-supply hypothesis	C1512571
28232316	thinner	C0205168
28232316	leaves	C0242724
28232316	non-entire	C0205556
28232316	margins	C0205284
28232316	Phylogenetically	C0871077
28232316	structured analyses	C0936012
28232316	angiosperms	C0330208
28232316	El Yunque	C0681784
28232316	flora	C0314761
28232316	genus	C1708235
28232316	Viburnum	C0969714
28232316	non-entire	C0205556
28232316	margins	C0205284
28232316	indeed	C2984081
28232316	common	C0205214
28232316	thinner	C0205168
28232316	leaves	C0242724
28232316	angiosperms	C0330208
28232316	association	C0750490
28232316	leaf	C0242724
28232316	thickness	C1280412
28232316	non-entire	C0205556
28232316	leaf	C0242724
28232316	margins	C0205284
28232316	stronger	C0442821
28232316	latitude	C1627936
28232316	outline	C0600661
28232316	synthetic model	C3161035
28232316	biomechanics	C0005537
28232316	hydraulics	C1518533
28232316	vein	C0042449
28232316	geometry	C0449829
28232316	rates	C0449249
28232316	leaf	C0242724
28232316	expansion	C0007595
28232316	development	C1527148
28232316	resting	C0679218
28232316	buds	C2700462
28232316	leaf	C0242724
28232316	thickness	C1280412
28232316	drive	C1287104
28232316	patterns	C0449774
28232316	distribution	C0037775
28232316	entire	C0439751
28232316	non-entire	C0205556
28232316	leaf	C0242724
28232316	margins	C0205284
28232316	model	C3161035
28232316	dominance	C0870441
28232316	entire	C0439751
28232316	margins	C0205284
28232316	tropics	C0681784
28232316	Mediterranean scrub	C0282645
28232316	tundra	C3850151
28232316	non-entire	C0205556
28232316	margins	C0205284
28232316	cold temperate	C0009264
28232316	deciduous forests	C0086312
28232316	tropical	C0681784
28232316	vines	C0330100
28232316	early-successional trees	C0040811
28232316	entire	C0439751
28232316	leaf	C0242724
28232316	margins	C0205284
28232316	monocots	C0331451
28232316	Spinose-toothed leaves	C0242724
28232316	short-statured	C0349588
28232316	evergreen trees	C0040811
28232316	shrubs	C0446286
28232316	Mediterranean scrub	C0282645
28232316	semiarid habitats	C0871648
28233508	Viral Vector	C1520007
28233508	Biosafety	C1443933
28233508	Laboratory Animal Research	C0003048
28233508	Viral vector	C1520007
28233508	research	C0035168
28233508	presents	C0449450
28233508	unique	C1710548
28233508	occupational health	C0079920
28233508	safety	C0036043
28233508	challenges	C0805586
28233508	institutions	C2607850
28233508	rapid	C0456962
28233508	development	C1527148
28233508	in vivo	C1515655
28233508	in vitro	C1533691
28233508	gene-editing technologies	C4277689
28233508	Risks	C0035647
28233508	human	C0086418
28233508	animal	C0003062
28233508	health	C0018684
28233508	incumbent	C3898777
28233508	institutions	C2607850
28233508	appropriately	C1548787
28233508	evaluate	C0220825
28233508	viral vector	C1520007
28233508	usage	C0457083
28233508	research	C0035168
28233508	basis	C1527178
28233508	available	C0470187
28233508	information	C1533716
28233508	governmental regulations	C0034982
28233508	guidelines	C0162791
28233508	review	C1552617
28233508	factors	C1521761
28233508	risk assessment	C0086930
28233508	viral vector	C1520007
28233508	usage	C0457083
28233508	animals	C0003062
28233508	relevant	C2347946
28233508	regulatory documents	C1301746
28233508	associated with	C0332281
28233508	research	C0035168
28233508	most	C0205393
28233508	commonly	C0205214
28233508	viral vectors	C1520007
28233508	research	C0035168
28233508	review	C1552617
28233508	particularly	C0205369
28233508	focused	C1285542
28233508	background	C1706907
28233508	research	C0035168
28233508	associated	C0332281
28233508	health	C0018684
28233508	environmental risks	C0686732
28233508	related	C0439849
28233508	adenoviral	C0001483
28233508	adeno-associated viral	C1564874
28233508	lentiviral	C0079679
28233508	herpesviral	C0019369
28233508	vectors	C1520007
28234635	Liver Inflammation	C0019158
28234635	Decreased	C0205216
28234635	Canalicular	C0005393
28234635	Bile Transporter	C0618375
28234635	Expression	C1171362
28234635	Pediatric	C1521725
28234635	Onset	C0206132
28234635	Intestinal Failure	C0012634
28234635	liver disease	C0023895
28234635	complication	C0009566
28234635	parenteral nutrition	C0030547
28234635	PN	C0030547
28234635	intestinal failure	C0012634
28234635	IF	C0012634
28234635	pathogenesis	C0699748
28234635	investigated	C1292732
28234635	molecular	C1521991
28234635	mechanisms	C0441712
28234635	liver injury	C0160390
28234635	pediatric	C1521725
28234635	onset	C0206132
28234635	IF	C0012634
28234635	Liver	C0023884
28234635	expression	C1171362
28234635	canalicular	C0005393
28234635	phospholipid	C0031676
28234635	ABCB4	C1260069
28234635	bile acid	C0005390
28234635	ABCB11	C1313221
28234635	sterol	C0038323
28234635	ABCG5/8	C0971221
28234635	transporters	C0007292
28234635	upstream regulators	C0033684
28234635	LXR	C4277606
28234635	FXR	C1173940
28234635	pro-inflammatory cytokines	C0079189
28234635	interleukin-6	C0021760
28234635	IL6	C0021760
28234635	tumor necrosis factor	C0041368
28234635	TNF	C0041368
28234635	investigated	C1292732
28234635	patients	C0030705
28234635	IF	C0012634
28234635	age	C0001779
28234635	IQR	C1711350
28234635	biochemical	C0205474
28234635	histologic	C0205462
28234635	liver injury	C0160390
28234635	PN	C0030547
28234635	serum	C0229671
28234635	plant sterols	C0031866
28234635	fibroblast growth factor 19	C1431711
28234635	α-tocopherol	C0969677
28234635	Patients	C0030705
28234635	PN	C0030547
28234635	liver injury	C0160390
28234635	patients	C0030705
28234635	weaning	C0043084
28234635	PN	C0030547
28234635	Histologic	C0205462
28234635	portal inflammation	C2748698
28234635	PN	C0030547
28234635	dependent	C3244310
28234635	weaned	C0043084
28234635	patients	C0030705
28234635	progression	C0242656
28234635	cholestasis	C0008370
28234635	liver fibrosis	C0239946
28234635	Patients	C0030705
28234635	portal inflammation	C2748698
28234635	liver	C0023884
28234635	RNA expression	C0040649
28234635	IL6	C1334122
28234635	TNF	C0812246
28234635	repression	C0920533
28234635	FXR	C1173940
28234635	canalicular	C0005393
28234635	bile transporter	C0618375
28234635	gene	C0017337
28234635	RNA expression	C0040649
28234635	ABCB4	C1412071
28234635	ABCB11	C1412070
28234635	decreased	C0205216
28234635	protein expression	C1171362
28234635	ABCB11	C1313221
28234635	ABCB4	C1260069
28234635	upregulation	C0041904
28234635	LXR	C4277606
28234635	ABCG5/8	C1422255
28234635	RNA expression	C0040649
28234635	suppressed	C1260953
28234635	patients	C0030705
28234635	portal inflammation	C2748698
28234635	PN	C0030547
28234635	increased	C0205217
28234635	serum	C0229671
28234635	levels	C0441889
28234635	plant sterols	C0031866
28234635	stigmasterol	C0038329
28234635	avenasterol	C0031866
28234635	sitosterol	C0220914
28234635	serum	C0229671
28234635	citrulline	C0008864
28234635	marker	C0005516
28234635	enterocyte mass	C0682610
28234635	portal inflammation	C2748698
28234635	pediatric	C1521725
28234635	onset	C0206132
28234635	IF	C0012634
28234635	PN	C0030547
28234635	intestinal	C0021853
28234635	compromise	C2945640
28234635	liver inflammation	C0019158
28234635	associates	C0332281
28234635	progression	C0242656
28234635	biochemical	C0205474
28234635	histologic	C0205462
28234635	liver injury	C0160390
28234635	reducing	C0392756
28234635	expression	C1171362
28234635	canalicular	C0005393
28234635	bile transporters	C0618375
28236586	Impaired mobility	C0518456
28236586	depressed mood	C0344315
28236586	cognitive impairment	C0338656
28236586	polypharmacy	C2922974
28236586	disability	C0231170
28236586	cancer	C0006826
28236586	outpatients	C0029921
28236586	Physical Frailty	C0424594
28236586	Elderly	C0001792
28236586	Cancer patients	C1516213
28236586	PF	C0424594
28236586	EC	C1516213
28236586	cohort study	C0009247
28236586	disability	C0231170
28236586	oncologic factors	C4294904
28236586	disability	C0231170
28236586	outpatients	C0029921
28236586	cancer	C0006826
28236586	Physical Frailty	C0424594
28236586	Elderly	C0001792
28236586	Cancer patients	C1516213
28236586	PF	C0424594
28236586	EC	C1516213
28236586	France	C0016674
28236586	prospective bicentric observational cohort study	C1709709
28236586	outpatients	C0029921
28236586	cancer	C0006826
28236586	cross-sectional analysis	C0010362
28236586	oncologic factors	C4294904
28236586	geriatric	C1704440
28236586	variables	C0439828
28236586	disability	C0231170
28236586	comprehensive	C1880156
28236586	geriatric assessment	C0017463
28236586	CGA	C0017463
28236586	Disability	C0231170
28236586	impairment	C0221099
28236586	activities of daily living	C0001288
28236586	ADL	C0001288
28236586	instrumental activities of daily living	C1290928
28236586	(IADL	C1290928
28236586	Univariate	C0683962
28236586	multivariate	C0026777
28236586	logistic models	C0023965
28236586	disabled patients	C0018576
28236586	multivariate	C0026777
28236586	models	C0023965
28236586	receiver operating characteristic curve	C0035787
28236586	AUC	C0376690
28236586	ROC	C0035787
28236586	logistic model	C0023965
28236586	women	C0043210
28236586	cancer	C0006826
28236586	disability	C0231170
28236586	oncologic factors	C4294904
28236586	cancer site	C0872338
28236586	cancer extension	C1704231
28236586	disability	C0231170
28236586	Impaired mobility	C0518456
28236586	poor functional status	C0598463
28236586	depressive mood	C0344315
28236586	cognitive impairment	C0338656
28236586	polypharmacy	C2922974
28236586	disability	C0231170
28236586	Disability	C0231170
28236586	cancer	C0006826
28236586	outpatients	C0029921
28236586	cancer treatment	C0920425
28236586	oncologic factors	C4294904
28236586	Impaired mobility	C0518456
28236586	depressed mood	C0344315
28236586	cognitive impairment	C0338656
28236586	polypharmacy	C2922974
28236586	disability	C0231170
28236586	cancer treatment	C0920425
28236586	corrective actions	C1947976
28236586	patient	C1516213
28236586	autonomy	C0598368
28236586	treatment	C0920425
28236586	follow-up	C1522577
28237762	Synthesis	C0007987
28237762	SAR	C0038477
28237762	molecular docking	C3494273
28237762	study	C2603343
28237762	non-β-lactam inhibitors	C0014432
28237762	TEM type β-lactamase	C0597979
28237762	acylated phenoxyanilide	C1254351
28237762	thiourea compounds	C1254351
28237762	investigated	C1292732
28237762	inhibit	C1524081
28237762	TEM type β-lactamase enzyme	C0597979
28237762	compounds 4g	C1254351
28237762	5c	C1254351
28237762	inhibition	C1524081
28237762	potency	C1710560
28237762	micromolar	C0439194
28237762	action	C3266814
28237762	non-covalent binding	C1167622
28237762	TEM-171	C0597979
28237762	active site	C0205681
28237762	structure activity relationship	C0038477
28237762	carbon chain length	C0596310
28237762	substituents in ortho- and para-positions	C0680963
28237762	acylated phenoxyanilide	C1254351
28237762	molecular modelling	C0600115
28237762	study	C2603343
28237781	Metabolic responses	C4054530
28237781	Daphnia similis	C1005664
28237781	chronic	C0205191
28237781	AgNPs	C1721060
28237781	GC-Q-TOF/MS	C0599827
28237781	LC-Q-TOF/MS	C0599827
28237781	Silver	C0037125
28237781	nanoparticles	C1721060
28237781	AgNPs	C1721060
28237781	nanomaterials	C1450053
28237781	fast-growing	C4086299
28237781	increased	C0205217
28237781	AgNPs	C1721060
28237781	environment	C0014406
28237781	health and ecological risks	C0035647
28237781	chronic toxicity tests	C1136118
28237781	metabolic	C0870883
28237781	changes	C0392747
28237781	Daphna similis	C1005664
28237781	exposure to	C0332157
28237781	AgNPs	C1721060
28237781	non-targeted mass spectrometry	C0037813
28237781	metabolomics	C1328813
28237781	baseline	C1442488
28237781	metabolite	C0870883
28237781	change	C0392747
28237781	aquatic organism	C0596121
28237781	Daphnia crustacean	C0010979
28237781	life-cycle	C0023675
28237781	dynamic kinetic pattern	C0243095
28237781	Daphnia's	C0010979
28237781	metabolome	C2350399
28237781	cycle	C0023675
28237781	day	C0439228
28237781	day	C0439228
28237781	level	C0441889
28237781	metabolites	C0870883
28237781	increasing	C0442808
28237781	day	C0439228
28237781	day	C0439228
28237781	baseline	C1442488
28237781	level	C0441889
28237781	day	C0439228
28237781	day	C0439228
28237781	samples	C0370003
28237781	exposed to	C0332157
28237781	environmental concentrations	C0392762
28237781	AgNPs	C1721060
28237781	morphological or structural changes	C0243095
28237781	metabolite	C0870883
28237781	changes	C0392747
28237781	days	C0439228
28237781	changes	C0392747
28237781	steady state	C0678587
28237781	day	C0439228
28237781	changes	C0392747
28237781	metabolites	C0870883
28237781	amino acids	C0002520
28237781	serine	C0036720
28237781	threonine	C0040005
28237781	tyrosine	C0041485
28237781	sugars	C0242209
28237781	d-allose	C0894158
28237781	fatty acids	C0015684
28237781	arachidonic acid	C0003695
28237781	metabolites	C0870883
28237781	Daphnia	C0010979
28237781	chronic	C0205191
28237781	AgNPs	C1721060
28237781	stress	C0038442
28237781	findings	C2607943
28237781	capability	C2698977
28237781	metabolomics	C1328813
28237781	metabolic responses	C4054530
28237781	environmental	C0014406
28237781	silver	C0037125
28237781	nanoparticles	C1721060
28237953	relative effectiveness	C0035023
28237953	high-intensity	C4081854
28237953	low-intensity models	C0392762
28237953	behaviour change	C0542299
28237953	communication interventions	C1274143
28237953	abortion	C0156543
28237953	care-seeking	C0018695
28237953	Bihar	C0681784
28237953	Jharkhand	C0681784
28237953	India	C0021201
28237953	cross-sectional study	C0010362
28237953	effectiveness	C1280519
28237953	high-intensity model	C4081854
28237953	HIM	C4081854
28237953	low-intensity model	C0392762
28237953	LIM	C0392762
28237953	behaviour change	C0542299
28237953	communication interventions	C1274143
28237953	Bihar	C0681784
28237953	Jharkhand	C0681784
28237953	India	C0021201
28237953	women's	C0043210
28237953	knowledge	C1948177
28237953	safe abortion	C0156543
28237953	dose effect	C0683160
28237953	intervention	C0184661
28237953	cross-sectional household surveys	C0010362
28237953	married	C0555047
28237953	women	C0043210
28237953	aged	C0001779
28237953	intervention	C0184661
28237953	districts	C0681784
28237953	Difference-in-difference models	C0392762
28237953	efficacy	C1280519
28237953	intervention	C0184661
28237953	sociodemographic characteristics	C0243095
28237953	intervention	C0184661
28237953	abortion	C0156543
28237953	knowledge	C0376554
28237953	HIM	C4081854
28237953	intervention	C0184661
28237953	comprehensive knowledge	C0376554
28237953	abortion	C0156543
28237953	knowledge	C0376554
28237953	legality of abortion	C0000812
28237953	safe abortion care	C3697217
28237953	knowledge	C0376554
28237953	abortion	C0156543
28237953	intervention	C0184661
28237953	abortion	C0156543
28237953	care-seeking	C0018695
28237953	behaviour	C0004927
28237953	women	C0043210
28237953	safe abortion	C0156543
28237953	postabortion complications	C0851640
28239461	Tissue	C0040300
28239461	MicroRNA	C1101610
28239461	diagnostic	C1511876
28239461	prognostic biomarkers	C1514475
28239461	patients	C0030705
28239461	resectable	C0015252
28239461	pancreatic ductal adenocarcinoma	C1335302
28239461	periampullary cancers	C1335377
28239461	aim	C1947946
28239461	study	C2603343
28239461	diagnostic	C0348026
28239461	prognostic	C0220901
28239461	microRNA	C1101610
28239461	expression profiles	C1956267
28239461	tissue	C0040300
28239461	patients	C0030705
28239461	pancreatic cancer	C0235974
28239461	periampullary cancers	C1335377
28239461	Expression	C0017262
28239461	microRNAs	C1101610
28239461	formalin	C0949307
28239461	paraffin-embedded tissue	C1519524
28239461	patients	C0030705
28239461	resected	C0015252
28239461	pancreatic ductal adenocarcinoma	C1335302
28239461	ampullary cancer	C0262401
28239461	duodenal cancer	C0541912
28239461	distal	C0205108
28239461	common bile duct cancer	C0740277
28239461	gastric cancer	C0024623
28239461	chronic pancreatitis	C0149521
28239461	normal pancreas	C0940731
28239461	microRNAs	C1101610
28239461	PCR	C0032520
28239461	Fluidigm platform	C0282574
28239461	microRNAs	C1101610
28239461	expressed	C0017262
28239461	patients	C0030705
28239461	pancreatic cancer	C0235974
28239461	healthy controls	C2986479
28239461	chronic pancreatitis	C0149521
28239461	patients	C0030705
28239461	miRNAs	C1101610
28239461	upregulated	C0041904
28239461	miR-21-5p	C1537719
28239461	23a-3p	C1842758
28239461	31-5p	C1537742
28239461	34c-5p	C1537747
28239461	93-3p	C1537750
28239461	135b-3p	C1537788
28239461	155-5p	C1537811
28239461	186-5p	C1537820
28239461	196b-5p,	C1537832
28239461	203	C1537841
28239461	205-5p	C4284346
28239461	210	C1537846
28239461	222-3p	C1537860
28239461	451	C1826031
28239461	492	C1826046
28239461	614	C1826193
28239461	miR-622	C1826201
28239461	downregulated	C0013081
28239461	miR-122-5p	C1865068
28239461	130b-3p	C1537780
28239461	216b	C2239687
28239461	217	C1537853
28239461	miR-375	C1537896
28239461	MicroRNAs	C1101610
28239461	diagnostic	C0348026
28239461	complexity	C0439855
28239461	microRNAs	C1101610
28239461	associated with	C0332281
28239461	prognosis	C0033325
28239461	let-7 g	C1621390
28239461	miR-29a-5p	C1835841
28239461	34a-5p	C1537745
28239461	125a-3p	C1537770
28239461	146a-5p	C1826002
28239461	187	C1537821
28239461	205-5p	C4284346
28239461	212-3p	C1537848
28239461	222-5p	C1537860
28239461	miR-450b-5p	C2239697
28239461	Prognostic indices	C0033326
28239461	expression	C0017262
28239461	microRNAs	C1101610
28239461	pancreatic	C0235974
28239461	ampullary cancer	C0262401
28239461	study	C2603343
28239461	pancreatic cancer	C0235974
28239461	tissue	C0040300
28239461	microRNA	C1101610
28239461	expression profile	C1956267
28239461	periampullary cancers	C1335377
28239461	chronic pancreatitis	C0149521
28239461	normal pancreas	C0940731
28239461	prognostic	C0220901
28239461	microRNAs	C1101610
28239461	microRNA	C1101610
28239461	associated with	C0332281
28239461	overall survival	C4086681
28239461	patients	C0030705
28239461	resected	C0015252
28239461	pancreatic cancer	C0235974
28239481	Effectiveness	C1280519
28239481	workers	C1527116
28239481	general health examination	C0420142
28239481	Korea	C0022771
28239481	health examination period	C1254363
28239481	compliance	C3714738
28239481	retrospective cohort study	C2985505
28239481	evaluated	C0220825
28239481	effectiveness	C1280519
28239481	Workers	C1527116
28239481	General Health Examination	C0420142
28239481	health examination period	C1254363
28239481	compliance	C3714738
28239481	retrospective cohort	C2985505
28239481	health examination	C1254363
28239481	participants	C0679646
28239481	cardio	C0007222
28239481	cerebrovascular disease	C0007820
28239481	stratification	C1514983
28239481	age	C0001779
28239481	sex	C1522384
28239481	national health insurance type	C0027452
28239481	cumulative	C1511559
28239481	incidence	C0021149
28239481	cardio	C0007222
28239481	cerebrovascular disease	C0007820
28239481	health examination	C1254363
28239481	compliance	C3714738
28239481	health examination period	C1254363
28239481	compliance	C3714738
28239481	compliant group	C1257890
28239481	cumulative	C1511559
28239481	incidence	C0021149
28239481	cardio	C0007222
28239481	cerebrovascular disease	C0007820
28239481	non-compliant group	C1257890
28239481	sex	C1522384
28239481	working	C0043227
28239481	age	C0001779
28239481	workplace	C0162579
28239481	policyholder	C1551367
28239481	cardio	C0007222
28239481	cerebrovascular disease	C0007820
28239481	health examination period	C1254363
28239481	statistically significant	C0237881
28239481	ischemic heart disease	C0151744
28239481	participants	C0679646
28239481	men	C0025266
28239481	office workers	C2230102
28239481	higher relative risk of	C0332167
28239481	ischemic heart disease	C0151744
28239481	non-office workers	C1527116
28239481	confidence interval	C0009667
28239481	ischemic	C0475224
28239481	cerebrovascular disease	C0007820
28239481	hemorrhagic	C0333275
28239481	cerebrovascular disease	C0007820
28239481	men	C0025266
28239481	cardio	C0007222
28239481	cerebrovascular disease	C0007820
28239481	women	C0043210
28239481	Workers	C1527116
28239481	General Health Examinations	C0420142
28239481	non-office workers	C1527116
28239481	prevention	C0199176
28239481	ischemic heart disease	C0151744
28239481	office workers	C2230102
28239481	age	C0001779
28239481	men	C0025266
28239481	prevention	C0199176
28239481	cardio	C0007222
28239481	cerebrovascular disease	C0007820
28239481	occupational characteristics	C0521127
28239481	health examination period	C1254363
28240704	Calibration	C0006751
28240704	Self-Report	C2700446
28240704	Measures	C0079809
28240704	Physical Activity	C0026606
28240704	Sedentary Behavior	C3824706
28240704	Calibration	C0006751
28240704	equations	C0552449
28240704	potential	C3245505
28240704	improve	C1272747
28240704	accuracy	C4035952
28240704	self-report	C2700446
28240704	measures	C0079809
28240704	physical activity	C0026606
28240704	PA	C0026606
28240704	sedentary behavior	C3824706
28240704	SB	C3824706
28240704	re-scaling	C1947916
28240704	potentially	C3245505
28240704	estimates	C0750572
28240704	calibration	C0006751
28240704	models	C0026348
28240704	estimate	C0750572
28240704	PA	C0026606
28240704	SB	C3824706
28240704	representative	C1299385
28240704	adults	C0001675
28240704	Physical Activity	C0026606
28240704	Measurement Survey	C0376688
28240704	PAMS	C0376688
28240704	Participants	C0679646
28240704	PAMS	C0376688
28240704	trials	C0681815
28240704	Sensewear armband (SWA)	C1301852
28240704	monitor	C0596972
28240704	24 hours	C0439584
28240704	telephone	C0021823
28240704	administered	C1519231
28240704	physical activity recall	C1254363
28240704	PAR	C1254363
28240704	statistical model	C0026348
28240704	validation	C2984648
28240704	procedures	C2700391
28240704	calibration	C0006751
28240704	models	C0026348
28240704	predict	C0681843
28240704	objectively	C0683957
28240704	measured	C0079809
28240704	SB	C3824706
28240704	moderate to vigorous PA	C0026606
28240704	MVPA	C0026606
28240704	self-reported	C2700446
28240704	PAR	C1254363
28240704	Equivalence	C0814870
28240704	equivalence	C0814870
28240704	predicted	C0681843
28240704	objective	C0683957
28240704	measures	C0079809
28240704	SB	C3824706
28240704	MVPA	C0026606
28240704	SB	C3824706
28240704	MVPA	C0026606
28240704	sex	C1522384
28240704	age	C3172266
28240704	education	C0424927
28240704	BMI	C1305855
28240704	Cross-validation	C0681935
28240704	analyses	C0002780
28240704	SB	C3824706
28240704	MVPA	C0026606
28240704	Equivalence	C0814870
28240704	predicted	C0681843
28240704	statistically	C0237881
28240704	objective	C0683957
28240704	SB	C3824706
28240704	MVPA	C0026606
28240704	regression	C0034980
28240704	models	C0026348
28240704	statistically	C0237881
28240704	self-report	C2700446
28240704	measures	C0079809
28240704	population	C1257890
28240704	models	C0026348
28240704	estimates	C0750572
28240704	PAR	C1254363
28240704	statistically	C0237881
28240704	SB	C3824706
28240704	MVPA	C0026606
28240704	SWA	C1301852
28240704	monitor	C0596972
28240704	estimates	C0750572
28240704	individual behavior	C0946284
28241859	Human	C0086418
28241859	amnion	C1305379
28241859	epithelial cells	C0014597
28241859	cell death	C0007587
28241859	immunomodulation	C1963758
28241859	microglia	C0206116
28241859	mouse model	C2986594
28241859	perinatal brain injury	C2347482
28241859	Human	C0086418
28241859	amnion	C1305379
28241859	epithelial cells	C0014597
28241859	hAECs	C0014597
28241859	clonogenic	C0392762
28241859	reduce	C0205216
28241859	inflammatory	C0021368
28241859	induced	C0205263
28241859	tissue injury	C0037578
28241859	Perturbation	C0332453
28241859	immune response	C0301872
28241859	pathogenesis	C0699748
28241859	perinatal brain injury	C2347482
28241859	modulating	C0443264
28241859	response	C0301872
28241859	novel	C0205314
28241859	therapy	C0087111
28241859	treating	C1522326
28241859	injury	C2347482
28241859	immunomodulatory	C1963758
28241859	hAECs	C0014597
28241859	animal models	C0599779
28241859	investigation	C0220825
28241859	effects	C1280500
28241859	brain	C0006104
28241859	immune	C0439662
28241859	cells	C0007634
28241859	injury	C2347482
28241859	investigate	C0220825
28241859	effects	C1280500
28241859	hAECs	C0014597
28241859	microglia	C0206116
28241859	immune responders	C0301872
28241859	injury	C2347482
28241859	brain	C0006104
28241859	mouse model	C2986594
28241859	neonatal	C2939425
28241859	inflammation	C0021368
28241859	perinatal	C0178795
28241859	hyperoxia	C0242706
28241859	risk factors	C0035648
28241859	perinatal brain injury	C2347482
28241859	embryonic	C0013936
28241859	day	C0439228
28241859	administered	C1533734
28241859	lipopolysaccharide	C0023810
28241859	LPS	C0023810
28241859	saline	C0036082
28241859	control	C1550141
28241859	intra-amniotically	C1512912
28241859	C57Bl/6 J mouse pups	C1521751
28241859	postnatal	C0443281
28241859	day	C0439228
28241859	LPS	C0023810
28241859	pups	C1521751
28241859	hyperoxia	C0242706
28241859	oxygen	C0030054
28241859	control pups	C0009932
28241859	normoxia	C0311411
28241859	days	C0439228
28241859	Pups	C1521751
28241859	hAECs	C0014597
28241859	saline	C0036082
28241859	intravenously	C1737200
28241859	controls	C0009932
28241859	LPS	C0023810
28241859	hyperoxia	C0242706
28241859	pups	C1521751
28241859	reduced	C0205216
28241859	body weight	C0005910
28241859	increased	C0205217
28241859	density	C0178587
28241859	apoptotic	C1516044
28241859	cells	C0007634
28241859	TUNEL	C1515232
28241859	cortex	C0007776
28241859	striatum	C0010097
28241859	white matter	C0682708
28241859	astrocytes	C0004112
28241859	GFAP	C0017626
28241859	white matter	C0682708
28241859	activated	C1515877
28241859	microglia	C0206116
28241859	CD68	C0215872
28241859	cortex	C0007776
28241859	striatum	C0010097
28241859	microglia	C0206116
28241859	density	C0178587
28241859	Iba1	C0312586
28241859	hAEC	C0014597
28241859	administration	C1533734
28241859	decreased	C0205216
28241859	body weight	C0005910
28241859	reduced	C0205216
28241859	apoptosis	C0162638
28241859	astrocyte	C0004112
28241859	areal coverage	C1999244
28241859	white matter	C0682708
28241859	increased	C0205217
28241859	density	C0178587
28241859	activated	C1515877
28241859	microglia	C0206116
28241859	primary	C0205225
28241859	microglia	C0206116
28241859	CD45	C1435882
28241859	CD11b	C1136310
28241859	LPS	C0023810
28241859	co-culture	C0282547
28241859	hAEC	C0014597
28241859	conditioned medium	C0162518
28241859	hAEC	C0014597
28241859	conditioned medium	C0162518
28241859	increased	C0205217
28241859	microglial	C0206116
28241859	phagocytic activity	C0031308
28241859	decreased	C0205216
28241859	microglia	C0206116
28241859	apoptosis	C0162638
28241859	decreased	C0205216
28241859	M1 activation markers	C0024426
28241859	CD86	C1528561
28241859	hAECs	C0014597
28241859	LPS	C0023810
28241859	release	C1963578
28241859	cytokines	C0079189
28241859	modulate	C0443264
28241859	microglia	C0206116
28241859	activity	C0441655
28241859	data	C1511726
28241859	hAECs	C0014597
28241859	immunomodulate	C1963758
28241859	brain	C0006104
28241859	microglia	C0206116
28241859	release	C1963578
28241859	trophic factors	C1579754
28241859	observation	C0302523
28241859	hAECs	C0014597
28241859	therapeutic utility	C0087111
28241859	management	C0376636
28241859	perinatal brain injury	C2347482
28243201	Identification	C0205396
28243201	DNA Methylation	C0376452
28243201	Biomarkers	C0041366
28243201	Chemotherapy	C3665472
28243201	Response	C0521982
28243201	Colorectal Cancer	C1527249
28243201	Resistance	C0013203
28243201	5-Fluorouracil	C0016360
28243201	5-FU	C0016360
28243201	treatment	C1522326
28243201	colorectal cancer	C1527249
28243201	CRC	C1527249
28243201	risk of recurrence	C2986492
28243201	DNA methylation	C0376452
28243201	mechanisms	C0920474
28243201	recurrent disease	C0277556
28243201	contribution	C1880177
28243201	drug resistance	C0013203
28243201	clarified	C2986669
28243201	study	C0008972
28243201	methylation	C0376452
28243201	phenotype	C0031437
28243201	CRC	C1527249
28243201	identification	C0205396
28243201	markers	C0041366
28243201	chemotherapy	C3665472
28243201	response	C0521982
28243201	DNA methylation	C0376452
28243201	profiling	C2003903
28243201	non-recurrent	C0439597
28243201	recurrent	C2945760
28243201	CRC	C1527249
28243201	patients	C0030705
28243201	Illumina Infinium HumanMethylation450 Beadchip assay	C1880239
28243201	CRC	C1527249
28243201	cells	C0334227
28243201	genetic backgrounds	C4042916
28243201	response	C0521982
28243201	5-FU	C0016360
28243201	global methylation	C0376452
28243201	levels	C0441889
28243201	HT29	C0282639
28243201	SW48	C0085983
28243201	treated	C1522326
28243201	5-FU	C0016360
28243201	DNA methylation	C0376452
28243201	inhibitor	C1999216
28243201	5-aza-2'-deoxycytidine	C0049065
28243201	5-azadC	C0049065
28243201	effects	C1280500
28243201	drug	C1254351
28243201	classes	C0456387
28243201	cell viability	C0007620
28243201	global methylation	C0376452
28243201	profiles	C1979963
28243201	genome-wide methylation study	C2350277
28243201	clinical	C0205210
28243201	specimens	C0370003
28243201	recurrent	C2945760
28243201	CRCs	C1527249
28243201	methylation	C0376452
28243201	levels	C0441889
28243201	non-recurrent	C0439597
28243201	CRCs	C1527249
28243201	identified	C0205396
28243201	methylated genes	C0017337
28243201	genes	C0017337
28243201	hyper	C0243095
28243201	genes	C0017337
28243201	hypomethylated	C0243095
28243201	recurrent	C2945760
28243201	group	C0441833
28243201	non-recurrent	C0439597
28243201	hypermethylated and hypomethylated genes	C0017337
28243201	recurrent	C2945760
28243201	non-recurrent	C0439597
28243201	methylation	C0376452
28243201	hypermethylated genes	C0017337
28243201	MAPK signaling pathway	C1518102
28243201	regulator	C1704735
28243201	apoptosis	C0162638
28243201	hypomethylated genes	C0017337
28243201	PI3K-AKT signaling pathway	C0037080
28243201	proliferation process	C1514485
28243201	5-azadC	C0049065
28243201	treatment	C1522326
28243201	response	C0521982
28243201	5-FU	C0016360
28243201	growth inhibition	C1512773
28243201	5-FU	C0016360
28243201	hypermethylated cell lines SW48	C0085983
28243201	genes	C0017337
28243201	recurrent	C2945760
28243201	CRCs	C1527249
28243201	therapeutic	C0087111
28243201	targets	C1521840
28243201	patients	C0030705
28243201	chemoresistance	C0013203
28243201	aberrant	C0443127
28243201	methylation	C0376452
28243201	CCNEI	C0017337
28243201	CCNDBP1	C1413177
28243201	PON3	C1418756
28243201	DDX43	C1425700
28243201	CHL1	C1413393
28243201	CRC	C1527249
28243201	associated with	C0332281
28243201	recurrence	C0034897
28243201	CRC	C1527249
28243201	5-azadC	C0049065
28243201	5-FU	C0016360
28243201	MAPK signaling pathway	C1518102
28243909	Effect	C1280500
28243909	Successive Administration	C1533734
28243909	Vancomycin	C0042313
28243909	Amikacin	C0002499
28243909	Auditory Function	C0018767
28243909	Immature Animals	C0596750
28243909	Effect	C1280500
28243909	successive administration	C1533734
28243909	vancomycin	C0042313
28243909	amikacin	C0002499
28243909	therapeutic	C0302350
28243909	doses	C0178602
28243909	immature	C0205252
28243909	auditory organ	C0587901
28243909	compared	C1707455
28243909	single	C0205171
28243909	administration	C3469597
28243909	same	C0445247
28243909	drugs	C1254351
28243909	chronic	C0205191
28243909	experiments	C0205664
28243909	immature	C0205252
28243909	rabbits	C3887509
28243909	recording	C2355580
28243909	short-latency	C0242465
28243909	auditory brainstem response	C0085854
28243909	ABR	C0085854
28243909	distortion product otoacoustic emission	C0430676
28243909	DPOAE	C0430676
28243909	Drug administration	C3469597
28243909	increased	C0205217
28243909	ABR	C0085854
28243909	threshold	C0004312
28243909	Ototoxic	C0235280
28243909	antibiotics	C0003232
28243909	DPOAE	C0430676
28243909	affected	C0392760
28243909	activity	C3668946
28243909	outer hair cells	C1518683
28243909	No	C1513916
28243909	enhancement	C2349975
28243909	ototoxic effects	C0235280
28243909	observed	C1441672
28243909	successive administration	C1533734
28243909	antibiotics	C0003232
28244578	Water	C0043047
28244578	safety	C0036043
28244578	healthcare facilities	C0018704
28244578	Vieste Charter	C0282574
28244578	Study Group	C0035173
28244578	Hospital	C0019994
28244578	Hygiene	C0020405
28244578	Italian Society of Hygiene, Preventive Medicine and Public Health	C1274109
28244578	GISIO-SItI	C1274109
28244578	Local Health Authority	C1274109
28244578	Foggia	C0017446
28244578	Apulia	C0017446
28244578	Italy	C0022277
28244578	National Convention	C0086047
28244578	water	C0043047
28244578	healthcare facilities	C0018704
28244578	Vieste-Pugnochiuso	C0017446
28244578	Vieste Charter	C0282574
28244578	collaboration	C0282116
28244578	experts	C0009817
28244578	National Institute of Health	C0920537
28244578	the Ministry of Health	C0683710
28244578	risk factors	C0035648
28244578	affect	C2237113
28244578	water	C0043047
28244578	safety	C0036043
28244578	healthcare facilities	C0018704
28244578	regulatory frameworks	C0282574
28244578	management of installations	C1254363
28244578	quality	C0332306
28244578	water	C0043047
28244578	risks	C0035647
28244578	health facilities	C0018704
28244578	water safety plans	C0871600
28244578	treatments	C1522326
28244578	healthcare facilities	C0018704
28244578	responsibility	C0678341
28244578	maintenance	C0024501
28244578	facilities	C0018704
28244578	multidisciplinary approach	C0449445
28244578	education	C0013621
28244578	research	C0035168
28244578	regional and national coordination	C0700114
28244578	communication	C0009452
28244917	In Vivo	C1515655
28244917	Three-Dimensional	C0450363
28244917	Patellar	C0030647
28244917	Mechanics	C0376706
28244917	Normal	C0205307
28244917	Knees	C0022742
28244917	Compared	C1707455
28244917	Domed	C0444914
28244917	Anatomic	C0220784
28244917	Patellar	C0030647
28244917	Components	C1708963
28244917	Patellofemoral	C0447801
28244917	complications	C1171258
28244917	revision surgery	C0035110
28244917	following	C0332282
28244917	total knee arthroplasty	C0086511
28244917	TKA	C0086511
28244917	High	C0205250
28244917	forces	C0441722
28244917	patellofemoral articulation	C0447801
28244917	coupled	C1948027
28244917	small	C0700321
28244917	patellofemoral	C0447801
28244917	contact area	C0205146
28244917	design	C1707689
28244917	study	C2603343
28244917	three-dimensional	C0450363
28244917	3D	C0450363
28244917	in vivo	C1515655
28244917	mechanics	C0376706
28244917	domed	C0444914
28244917	anatomically	C0220784
28244917	shaped	C0332479
28244917	patellar	C0030647
28244917	components	C1708963
28244917	compared	C1707455
28244917	native	C0302891
28244917	patellae	C0030647
28244917	normal	C0205307
28244917	knees	C0022742
28244917	treated with	C0332293
28244917	LCS-PS (low contact stress-posterior stabilized) TKA	C0086511
28244917	anatomically	C0220784
28244917	shaped	C0332479
28244917	patellar	C0030647
28244917	component	C1708963
28244917	treated with	C0332293
28244917	PFC Sigma RP-PS (press-fit condylar Sigma rotating platform-posterior stabilized) TKA	C0086511
28244917	domed	C0444914
28244917	patellar	C0030647
28244917	component	C1708963
28244917	analyzed	C0936012
28244917	fluoroscopic	C0016356
28244917	surveillance	C0220920
28244917	patient	C0030705
28244917	performed	C0884358
28244917	weight-bearing	C0085086
28244917	deep	C0205125
28244917	knee bend	C0243095
28244917	full	C0443225
28244917	knee extension	C2237139
28244917	maximum	C0806909
28244917	knee flexion	C0240114
28244917	segmented	C0441635
28244917	computed tomography	C0412645
28244917	CT	C0412645
28244917	scans	C0441633
28244917	computer-assisted-design	C0162517
28244917	CAD	C0162517
28244917	models	C3161035
28244917	implanted	C0021102
28244917	components	C1708963
28244917	Three-dimensional	C0450363
28244917	patellofemoral	C0447801
28244917	kinematics	C0600169
28244917	3D	C0450363
28244917	2D	C1705052
28244917	Contact mechanics	C0376706
28244917	calculated	C1441506
28244917	distance map	C0024779
28244917	articulating patellar	C0030647
28244917	femoral surfaces	C0828554
28244917	patellar	C0030647
28244917	component	C1708963
28244917	good	C0205170
28244917	rotational kinematics	C0600169
28244917	femoral trochlea	C0223886
28244917	compared	C1707455
28244917	normal	C0205307
28244917	patella	C0030647
28244917	contact areas	C0205146
28244917	TKA	C0086511
28244917	groups	C0441833
28244917	knee flexion	C0240114
28244917	mean	C0444504
28244917	standard deviation	C0871420
28244917	LCS-PS group	C0441833
28244917	Sigma RP-PS group	C0441833
28244917	areas	C0205146
28244917	smaller	C0547044
28244917	reported	C0684224
28244917	normal	C0205307
28244917	patella	C0030647
28244917	Contact points	C3714763
28244917	TKA	C0086511
28244917	groups	C0441833
28244917	center	C0205099
28244917	patellar	C0030647
28244917	components	C1708963
28244917	designs	C1707689
28244917	performed	C0884358
28244917	satisfactorily	C0205410
28244917	patellofemoral	C0447801
28244917	contact areas	C0205146
28244917	reduced	C0392756
28244917	comparison	C1707455
28244917	native	C0302891
28244917	patella	C0030647
28245342	Assessment	C1516048
28245342	Extravascular Implantable Defibrillator	C0162589
28245342	Feasibility	C0443348
28245342	Substernal Ventricular Pacing	C1285520
28245342	objective	C0018017
28245342	study	C0681814
28245342	assess	C1516048
28245342	feasibility	C0443348
28245342	ventricular pacing	C1285520
28245342	thresholds	C0449864
28245342	within	C0332285
28245342	substernal space	C0230145
28245342	new	C0205314
28245342	extravascular ICD	C0162589
28245342	configuration	C0449830
28245342	pacing	C1285520
28245342	capabilities	C2698977
28245342	patients	C0030705
28245342	midline sternotomy	C1282959
28245342	duodecapolar diagnostic pacing catheter	C0085590
28245342	positioned	C0733755
28245342	substernal space	C0230145
28245342	anterior	C0205094
28245342	pericardium	C0031050
28245342	cutaneous patch	C0241148
28245342	left lateral position	C0450414
28245342	Different	C1705242
28245342	unipolar	C0443340
28245342	bipolar	C0443156
28245342	pacing	C1285520
28245342	configurations	C0449830
28245342	assessed	C1516048
28245342	Strength-duration curves	C0022885
28245342	performed	C0884358
28245342	optimal	C2698651
28245342	output	C0204709
28245342	mA	C0450172
28245342	pulse width	C0487742
28245342	milliseconds	C0439223
28245342	patients	C0030705
28245342	mean	C0444504
28245342	age	C0001779
28245342	years	C0439234
28245342	included	C0332257
28245342	ventricular	C1522565
28245342	configuration	C0449830
28245342	mean	C0444504
28245342	bipolar	C0443156
28245342	pacing	C1285520
28245342	thresholds	C0449864
28245342	milliseconds	C0439223
28245342	mA	C0450172
28245342	patients	C0030705
28245342	mA	C0450172
28245342	patients	C0030705
28245342	mA	C0450172
28245342	patients	C0030705
28245342	mA	C0450172
28245342	patients	C0030705
28245342	electrode	C0013812
28245342	spacing	C1710137
28245342	successful	C1272703
28245342	bipolar	C0443156
28245342	configuration	C0449830
28245342	Unipolar	C0443340
28245342	pacing	C1285520
28245342	successful	C1272703
28245342	patients	C0030705
28245342	mean	C0444504
28245342	thresholds	C0449864
28245342	mA	C0450172
28245342	milliseconds	C0439223
28245342	patients	C0030705
28245342	mA	C0450172
28245342	milliseconds	C0439223
28245342	patients	C0030705
28245342	mA	C0450172
28245342	milliseconds	C0439223
28245342	patients	C0030705
28245342	mA	C0450172
28245342	milliseconds	C0439223
28245342	patients	C0030705
28245342	Ventricular pacing	C1285520
28245342	pacing	C1285520
28245342	substernal space	C0230145
28245342	patients	C0030705
28245342	midline sternotomy	C1282959
28245342	feasible	C0443348
28245342	Closed	C0587267
28245342	sternum	C0038293
28245342	studies	C2603343
28245342	needed	C0027552
28245342	pacing	C1285520
28245342	thresholds	C0449864
28245342	accurately	C0443131
28249376	Effects	C1280500
28249376	specific blend	C0439861
28249376	essential oils	C0028910
28249376	apparent	C0750489
28249376	nutrient	C0678695
28249376	digestion	C0012238
28249376	rumen	C0035946
28249376	fermentation	C0015852
28249376	rumen	C0035946
28249376	microbial populations	C0599840
28249376	sheep	C0036945
28249376	alfalfa hay	C2827434
28249376	concentrate diet	C0012155
28249376	experiment	C0205664
28249376	investigate	C1292732
28249376	effects	C1280500
28249376	mixture	C0439962
28249376	essential oils	C0028910
28249376	MEO	C0028910
28249376	thyme	C0304119
28249376	clove	C0028906
28249376	cinnamon EO	C0301249
28249376	rumen	C0035946
28249376	microbial fermentation	C0015852
28249376	nutrient	C0678695
28249376	apparent	C0750489
28249376	digestibility	C0243095
28249376	blood	C0005767
28249376	metabolites	C0870883
28249376	fistulated sheep	C0036945
28249376	sheep	C0036945
28249376	ruminal fistulas	C0302142
28249376	repeated measurement design	C0282574
28249376	periods	C0439531
28249376	effect	C1280500
28249376	MEO	C0028910
28249376	apparent	C0750489
28249376	nutrient	C0678695
28249376	digestibility	C0243095
28249376	rumen	C0035946
28249376	fermentation	C0015852
28249376	characteristics	C1521970
28249376	rumen	C0035946
28249376	microbial population	C0599840
28249376	blood	C0005767
28249376	chemical metabolites	C0870883
28249376	Animals	C0003062
28249376	alfalfa hay	C2827434
28249376	concentrate diet	C0012155
28249376	Ruminal pH	C0020283
28249376	volatile fatty acids	C0015691
28249376	VFA	C0015691
28249376	concentration	C0392762
28249376	molar proportion of individual	C0392762
28249376	VFA	C0015691
28249376	acetate: propionate ratio	C0392762
28249376	methane production	C1855163
28249376	MEO	C0028910
28249376	control	C0009932
28249376	Small peptides	C0030956
28249376	Small peptides plus amino acid nitrogen	C0392762
28249376	large peptides	C0030956
28249376	large peptides nitrogen concentration	C0392762
28249376	rumen fluid	C0227245
28249376	MEO	C0028910
28249376	supplementation	C0242297
28249376	rumen fluid	C0227245
28249376	ammonia	C0002607
28249376	concentration	C0392762
28249376	morning feeding	C2987508
28249376	sheep	C0036945
28249376	MEO	C0028910
28249376	control	C0009932
28249376	MEO	C0028910
28249376	morning feeding	C2987508
28249376	ammonia	C0002607
28249376	nitrogen concentration	C0392762
28249376	sheep	C0036945
28249376	MEO	C0028910
28249376	control	C0009932
28249376	diet	C0012155
28249376	Ruminal protozoa	C0033739
28249376	hyper ammonia producing (HAP) bacteria	C0004611
28249376	counts	C0004618
28249376	MEO	C0028910
28249376	diet	C0012155
28249376	control	C0009932
28249376	red	C0014772
28249376	white blood cells	C0427512
28249376	hemoglobin	C0518015
28249376	hematocrit	C0518014
28249376	glucose	C0337438
28249376	beta-hydroxybutyric acid	C0047456
28249376	cholesterol	C0201950
28249376	total protein	C0555903
28249376	albumin	C0201838
28249376	blood urea nitrogen	C0005845
28249376	aspartate aminotransferase	C0201899
28249376	alanine aminotransferase	C0201836
28249376	concentration	C0392762
28249376	Apparent	C0750489
28249376	total tract digestibility	C0243095
28249376	dry matter	C0439861
28249376	crude proten	C0033684
28249376	organic matter	C0439861
28249376	neutral detergent fiber	C0439861
28249376	MEO	C0028910
28249376	supplementation	C0242297
28249376	supplementation	C0242297
28249376	MEO	C0028910
28249376	limited effects	C1280500
28249376	apparent	C0750489
28249376	nutrient	C0678695
28249376	digestibility	C0243095
28249376	ruminal fermentation	C0015852
28249376	protozoa	C0033739
28249376	HAP bacteria	C0004611
28249376	count	C0004618
28249376	blood cells	C0005773
28249376	metabolites	C0870883
28249723	High throughput	C0872186
28249723	selection	C1707391
28249723	antibiotic-resistant	C0949285
28249723	transgenic	C0085245
28249723	Arabidopsis plants	C0162741
28249723	Kanamycin	C0022487
28249723	resistance	C0949285
28249723	most	C0205393
28249723	frequently	C0332183
28249723	antibiotic-resistance	C0949285
28249723	marker	C0005516
28249723	Arabidopsis	C0162741
28249723	transformations	C3714584
28249723	method	C0025663
28249723	frequently	C0332183
28249723	escape	C0014832
28249723	untransformed plants	C0032098
28249723	high	C0205250
28249723	seedling	C0242437
28249723	density	C0178587
28249723	selection	C1707391
28249723	developed	C1527148
28249723	robust	C2986815
28249723	high	C0205250
28249723	density	C0178587
28249723	selection	C1707391
28249723	method	C0025663
28249723	top	C1704458
28249723	agar	C0001771
28249723	Arabidopsis thaliana	C0162740
28249723	Top	C1704458
28249723	agar	C0001771
28249723	effectively	C1704419
28249723	suppressed	C0443189
28249723	growth	C0220844
28249723	untransformed wild-type plants	C0330098
28249723	selection	C1707391
28249723	media	C0010454
28249723	high	C0205250
28249723	density	C0178587
28249723	Survival	C0038952
28249723	transformed	C3714584
28249723	plants	C0032098
28249723	selection	C1707391
28249723	confirmed	C0750484
28249723	green	C0332583
28249723	true	C0205238
28249723	leaves	C0242724
28249723	expression	C0017262
28249723	firefly luciferase	C0311727
28249723	reporter gene	C0206414
28249723	Top	C1704458
28249723	agar	C0001771
28249723	method	C0025663
28249723	selection	C1707391
28249723	large	C0549177
28249723	amount	C1265611
28249723	seeds	C0036563
28249723	Arabidopsis	C0162741
28249723	transformation	C3714584
28251683	Limb	C0015385
28251683	remote ischaemic postconditioning	C2936234
28251683	induced	C0205263
28251683	elevation	C0205217
28251683	fibulin-5	C1452861
28251683	neuroprotection	C0598958
28251683	rats	C0034721
28251683	cerebral ischaemia	C0917798
28251683	reperfusion injury	C0035126
28251683	Activation	C1879547
28251683	AKT pathway	C1515844
28251683	Limb	C0015385
28251683	remote ischaemic postconditioning	C2936234
28251683	RIPostC	C2936234
28251683	treatment	C0087111
28251683	brain ischaemia injury	C2945681
28251683	study	C2603343
28251683	fibulin-5	C1452861
28251683	neuroprotection	C0598958
28251683	RIPostC	C2936234
28251683	cerebral ischaemia	C0917798
28251683	reperfusion (I/R) injury	C0035126
28251683	rats	C0034721
28251683	middle cerebral artery occlusion	C0740391
28251683	MCAO	C0740391
28251683	model	C0026339
28251683	rats	C0034721
28251683	RIPostC	C2936234
28251683	minutes	C0439232
28251683	occlusion	C0740391
28251683	minutes	C0439232
28251683	bilateral	C0238767
28251683	femoral artery	C0015801
28251683	reperfusion	C0035124
28251683	downregulate	C0013081
28251683	fibulin-5	C1452861
28251683	level	C0441889
28251683	fibulin-5 siRNA	C1099354
28251683	injected	C1533685
28251683	lateral ventricle	C0152279
28251683	hours	C0439227
28251683	MCAO	C0740391
28251683	study	C2603343
28251683	RIPostC	C2936234
28251683	attenuated	C0599946
28251683	cerebral I	C0917798
28251683	R injury	C0035126
28251683	decreasing	C0442797
28251683	infarct	C0021308
28251683	volume	C0449468
28251683	neurobehavioral score	C0449820
28251683	suppressing	C1260953
28251683	blood brain barrier	C0005854
28251683	BBB	C0005854
28251683	leakage	C0015376
28251683	mRNA	C0035696
28251683	protein levels	C0428479
28251683	fibulin-5	C1452861
28251683	upregulated	C0041904
28251683	RIPostC	C2936234
28251683	hours	C0439227
28251683	hours	C0439227
28251683	reperfusion	C0035124
28251683	Downregulation	C0013081
28251683	fibulin-5	C1452861
28251683	attenuated	C0599946
28251683	neuroprotection	C0598958
28251683	RIPostC	C2936234
28251683	fibulin-5	C1452861
28251683	upregulated	C0041904
28251683	RIPostC	C2936234
28251683	activation	C1879547
28251683	PI3K/AKT pathway	C1515844
28251683	results	C1274040
28251683	evidence	C3887511
28251683	upregulation	C0041904
28251683	fibulin-5	C1452861
28251683	RIPostC	C2936234
28251683	cerebral I	C0917798
28251683	R injury	C0035126
28251753	Optomechanical Control	C0443254
28251753	Quantum Yield	C0392762
28251753	Trans-Cis Ultrafast Photoisomerization	C0596342
28251753	Retinal	C0035331
28251753	Chromophore	C0596335
28251753	Model	C0026336
28251753	quantum yield	C0392762
28251753	photochemical reaction	C2350502
28251753	fundamental quantities	C1265611
28251753	photochemistry	C0031739
28251753	transduction of light energy into chemical energy	C0376451
28251753	Nature	C0349590
28251753	photoreceptors	C0031760
28251753	reactivity	C0678596
28251753	chromophore	C0596335
28251753	molecular environment	C0014406
28251753	quantum yields	C0392762
28251753	retinal	C0035331
28251753	chromophore	C0596335
28251753	rhodopsin proteins	C0035499
28251753	mechanical forces	C0563538
28251753	molecular system	C1521991
28251753	reactivity	C0678596
28251753	tensile forces	C0039526
28251753	retinal	C0035331
28251753	chromophore	C0596335
28251753	model	C0026336
28251753	substantial and regular increase	C0205556
28251753	trans-to-cis photoisomerization	C0596342
28251753	quantum yield	C0392762
28251753	cis photoisomer	C1254350
28251753	rationale	C2699007
28251753	mechanochemical effect	C2350457
28251753	photoisomerization mechanism	C2350502
28252207	Quality	C0332306
28252207	nursing intensity data	C0028694
28252207	inter-rater reliability	C0870740
28252207	patient	C0030705
28252207	classification	C0008902
28252207	two decades	C2981279
28252207	clinical	C0205210
28252207	use	C0457083
28252207	study	C2603343
28252207	measure	C0079809
28252207	inter-rater reliability	C0870740
28252207	Oulu Patient Classification	C0008902
28252207	methods	C0025664
28252207	reliability testing	C0237829
28252207	Oulu Patient Classification	C0008902
28252207	RAFAELA(®) System	C0282574
28252207	assist	C1269765
28252207	nursing managers	C0454680
28252207	allocation	C1706778
28252207	nursing	C0028682
28252207	resources	C0018741
28252207	increased	C0205217
28252207	intensity	C0522510
28252207	inpatient care	C0019993
28252207	years	C0439234
28252207	reliability testing	C0237829
28252207	classification	C0008902
28252207	clinical	C0205210
28252207	use	C0457083
28252207	years	C0439234
28252207	Retrospective	C1514923
28252207	statistical study	C0038208
28252207	test	C0237829
28252207	inter-rater reliability	C0870740
28252207	nurses	C0028661
28252207	classified	C0008902
28252207	patients	C0030705
28252207	ratings	C0871208
28252207	annually	C0332181
28252207	standardization	C0038136
28252207	Data	C1511726
28252207	parallel classifications	C0008902
28252207	obtained	C1301820
28252207	inpatient	C0021562
28252207	different	C1705242
28252207	specialties	C0037778
28252207	university hospital	C0020028
28252207	Finland	C0016132
28252207	Parallel classification	C0008902
28252207	practices	C4035713
28252207	reliability	C2347947
28252207	classification	C0008902
28252207	calculated	C1441506
28252207	statistical coefficients	C1707429
28252207	Inter-rater reliability	C0870740
28252207	coefficients	C1707429
28252207	nursing	C0028682
28252207	intensity	C0522510
28252207	category	C0683312
28252207	practices	C4035713
28252207	detectable	C0442726
28252207	differences	C1705242
28252207	agreement	C0205556
28252207	levels	C0441889
28252207	occurred	C1709305
28252207	Planning and Coordination of Nursing Care	C3863893
28252207	Guiding of Care	C1254363
28252207	Continued Care	C0009853
28252207	Emotional Support	C0600015
28252207	descriptions	C0678257
28252207	clarify	C2986669
28252207	concepts	C0178566
28252207	nursing documentation	C0184600
28252207	promote	C0033414
28252207	level	C0441889
28252207	agreement	C0205556
28252207	results	C1274040
28252207	agreement	C0205556
28252207	kappa coefficients	C1707429
28253085	Water pipe	C4302493
28253085	Smoking	C0037369
28253085	Secondhand Tobacco Smoke	C0375734
28253085	Effects	C1280500
28253085	CYP1A2	C1620185
28253085	CYP2A6	C3884187
28253085	Phenotypes	C0031437
28253085	Caffeine Urine Test	C0042014
28253085	Public policies	C0085098
28253085	cigarette smoking	C0700219
28253085	exposure	C0332157
28253085	secondhand smoke	C0375734
28253085	associated diseases	C0243083
28253085	tobacco consumption	C0543414
28253085	water pipe	C4302493
28253085	smoking	C0037369
28253085	water pipe	C4302493
28253085	smoking	C0037369
28253085	cytochrome P450 (CYP450) activities	C1149063
28253085	drug interaction	C0687133
28253085	potential	C3245505
28253085	humans	C0086418
28253085	secondhand smoke	C0375734
28253085	drug metabolism	C0683140
28253085	healthy volunteers	C1708335
28253085	water pipe smokers	C3697029
28253085	secondhand tobacco smoke	C0375734
28253085	persons	C0027361
28253085	controls	C0009932
28253085	systematically compared	C1707455
28253085	CYP1A2	C1620185
28253085	CYP2A6	C3884187
28253085	enzyme activities	C0243102
28253085	in vivo	C1515655
28253085	caffeine urine test	C0042014
28253085	self-reported	C2700446
28253085	duration	C0449238
28253085	water pipe	C4302493
28253085	smoking	C0037369
28253085	h	C0439227
28253085	week	C0439230
28253085	years	C0439234
28253085	exposure	C0332157
28253085	secondhand smoke	C0375734
28253085	group	C1257890
28253085	h	C0439227
28253085	self-reported	C2700446
28253085	weekly	C0332174
28253085	exposure	C0332157
28253085	tobacco smoke	C0439994
28253085	cigarettes	C0677453
28253085	smoked	C0239059
28253085	hour	C0439227
28253085	years	C0439234
28253085	Analysis	C0936012
28253085	variance	C1711260
28253085	CYP1A2	C1620185
28253085	CYP2A6	C3884187
28253085	activities	C0243102
28253085	study	C2603343
28253085	groups	C1257890
28253085	water pipe	C4302493
28253085	secondhand smoke	C0375734
28253085	exposure	C0332157
28253085	CYP1A2	C1620185
28253085	CYP2A6	C3884187
28253085	activities	C0243102
28253085	analysis	C0936012
28253085	exposure	C0332157
28253085	controls	C0009932
28253085	water pipe	C4302493
28253085	secondhand smoke	C0375734
28253085	in vivo	C1515655
28253085	activities	C0243102
28253085	drug metabolism	C0683140
28253085	pathways	C1704259
28253085	constituents	C0729650
28253085	tobacco consumption	C0543414
28253085	water pipe	C4302493
28253085	drug metabolism	C0683140
28253085	cigarette smoke	C0239059
28253085	studies	C2603343
28253085	water pipe	C4302493
28253085	secondhand tobacco smoke	C0375734
28253085	CYP450	C0010762
28253085	smoke	C0439994
28253085	exposure	C0332157
28254329	wettability	C0162598
28254329	zeta potential	C0597697
28254329	hydroxylation	C0020365
28254329	hydroxylation degree	C0243095
28254329	biological response	C0243095
28254329	biomaterials	C0005479
28254329	composition	C0205556
28254329	electric charge	C0563548
28254329	wettability	C0162598
28254329	roughness	C0205556
28254329	implant	C0021102
28254329	surfaces	C0205148
28254329	influence	C4054723
28254329	interaction	C1704675
28254329	biological fluids	C0005889
28254329	tissues	C0040300
28254329	systematic studies	C0242481
28254329	materials	C0520510
28254329	experimental conditions	C0348080
28254329	lacking	C0332268
28254329	scientific literature	C0023866
28254329	research	C0035168
28254329	investigate	C1292732
28254329	correlations	C1707520
28254329	surface characteristics	C0449588
28254329	wettability	C0162598
28254329	zeta potential	C0597697
28254329	hydroxylation	C0020365
28254329	hydroxylation degree	C0243095
28254329	biological response	C0243095
28254329	protein	C0033684
28254329	protein adsorption	C0243095
28254329	blood	C0005767
28254329	wettability	C0162598
28254329	cell	C0007577
28254329	bacterial adhesion	C0004614
28254329	biomaterials	C0005479
28254329	surfaces	C0205148
28254329	implantable biomaterials	C0005479
28254329	Roughness	C0205556
28254329	smooth surfaces	C0205148
28254329	controlled protocol	C2348563
28254329	roughness effects	C0205556
28254329	oxides	C0030015
28254329	ZrO2	C0021521
28254329	Al2O3	C0002374
28254329	SiO2	C0037098
28254329	metals	C0025552
28254329	316LSS steel	C0038239
28254329	Ti	C0040302
28254329	Nb	C0028101
28254329	polymers	C0032521
28254329	corona treated polystyrene	C0032604
28254329	cell culture	C1331092
28254329	untreated polystyrene	C0032604
28254329	bacteria culture	C0430402
28254329	biomedical applications	C3273359
28254329	surfaces	C0205148
28254329	characterized	C1880022
28254329	contact profilometry	C0242481
28254329	SEM	C0026020
28254329	EDS	C2699997
28254329	XPS	C2700282
28254329	FTIR	C0206055
28254329	zeta potential	C0597697
28254329	wettability	C0162598
28254329	fluids	C0302908
28254329	Protein	C0033684
28254329	Protein adsorption	C0243095
28254329	blood	C0005767
28254329	wettability	C0162598
28254329	bacterial	C0004614
28254329	cell adhesion	C0007577
28254329	investigate	C1292732
28254329	correlations	C1707520
28254329	surface physiochemical properties	C0038884
28254329	biological responses	C0243095
28254329	XPS	C2700282
28254329	electrokinetic measurements	C0392762
28254329	techniques	C0449851
28254329	hydroxylation	C0020365
28254329	hydroxylation degree	C0243095
28254329	surface charge	C0392762
28254329	isoelectric point	C0022171
28254329	wettability	C0162598
28254329	blood	C0005767
28254329	test	C0392366
28254329	tests	C0392366
28254329	Hydroxylation	C0020365
28254329	Hydroxylation degree	C0243095
28254329	wettability	C0162598
28254329	water	C0043047
28254329	surface charge	C0392762
28254329	Wetting tests	C0242481
28254329	media	C1705217
28254329	materials	C0520510
28254329	protein	C0033684
28254329	protein absorption	C0243095
28254329	hydroxylation	C0020365
28254329	hydroxylation degree	C0243095
28254329	charge	C0392762
28254329	wettability	C0162598
28254329	maximum	C0806909
28254329	surfaces	C0205148
28254329	wettability	C0162598
28254329	water	C0043047
28254329	protein	C0033684
28254329	media	C1705217
28254329	surface charge	C0392762
28254329	bacterial adhesion	C0004614
28254329	no effect	C1301751
28254329	surface charge	C0392762
28254329	protein	C0033684
28254329	protein adsorption	C0243095
28254329	acid component	C0205556
28254329	surface energy	C1442080
28254329	hydroxylation	C0020365
28254329	hydroxylation degree	C0243095
28254329	wettability	C0162598
28254329	surface charge	C0392762
28254329	energy	C1442080
28254329	polar component	C0205556
28254329	cell adhesion	C0007577
28254329	viability	C0007620
28254935	Persistent	C0205322
28254935	effects	C1280500
28254935	pre-Columbian	C0032659
28254935	plant	C0032098
28254935	domestication	C0175819
28254935	Amazonian forest	C0086312
28254935	composition	C0486616
28254935	pre-Columbian	C0032659
28254935	societies	C0037455
28254935	Amazonian	C0086312
28254935	landscapes	C0870781
28254935	basin-wide analysis	C0936012
28254935	pre-Columbian	C0032659
28254935	impacts	C4049986
28254935	Amazonian forests	C0086312
28254935	archaeological sites	C0205145
28254935	Amazonia	C0681784
28254935	abundances	C2346714
28254935	woody	C0040811
28254935	species	C1705920
28254935	domesticated	C0175819
28254935	pre-Columbian	C0032659
28254935	peoples	C0027361
28254935	Domesticated	C0175819
28254935	species	C1705920
28254935	nondomesticated species	C1705920
28254935	hyperdominant	C1527180
28254935	abundance	C2346714
28254935	richness	C0205556
28254935	domesticated	C0175819
28254935	species	C1705920
28254935	forests	C0086312
28254935	archaeological sites	C0205145
28254935	southwestern and eastern Amazonia	C0681784
28254935	archaeological sites	C0205145
28254935	abundance	C2346714
28254935	domesticated	C0175819
28254935	species	C1705920
28254935	analyses	C0936012
28254935	tree	C0040811
28254935	communities	C0009462
28254935	Amazonia	C0681784
28254935	history	C0019665
28254935	plant	C0032098
28254935	domestication	C0175819
28254935	Amazonian	C0086312
28254935	peoples	C0027361
28256742	Halogenated phenolic compounds	C1959882
28256742	wild fish	C0016163
28256742	Canadian Areas	C0006823
28256742	Concern	C2699424
28256742	halogenated phenolic compounds	C1959882
28256742	plasma	C0032105
28256742	brown bullhead	C0328325
28256742	Ameiurus nebulosus	C0328325
28256742	Canadian Areas	C0006823
28256742	Concern	C2699424
28256742	AOCs	C0006823
28256742	thyroid	C0040132
28256742	disrupting chemicals	C1568245
28256742	Hydroxylated polychlorinated biphenyls	C0032447
28256742	OH-PCBs	C0032447
28256742	AOCs	C0006823
28256742	detection	C1511790
28256742	frequency	C0439603
28256742	Detroit River	C0337050
28256742	AOC	C0006823
28256742	OH-PCBs	C0032447
28256742	pentachloro, hexachloro, and heptachloro congeners	C0678518
28256742	thyroid hormones	C0040135
28256742	Pentachlorophenol	C0030855
28256742	PCP	C0030855
28256742	fish	C0016163
28256742	Prince Edward Bay	C3203003
28256742	Bay of Quinte Lake reference site	C3203003
28256742	Hillman Marsh	C0475311
28256742	the Wheatley Harbour reference site	C0475311
28256742	sources of contamination	C2728510
28256742	Elevated PCP concentrations	C0524230
28256742	plasma	C0032105
28256742	brown bullhead	C0328325
28256742	Toronto and Region AOC	C0006823
28256742	Triclosan	C0040958
28256742	Toronto and Region AOC	C0006823
28256742	wastewater	C0450237
28256742	plasma	C0032105
28256742	brown bullhead	C0328325
28256742	Bay of Quinte	C3203003
28256742	AOC	C0006823
28256742	polybrominated diphenyl ethers	C2350562
28256742	Toronto and Region AOC	C0006823
28256742	Bay of Quinte	C3203003
28256742	AOC	C0006823
28256742	Trenton and Belleville	C0006823
28256742	Distribution patterns	C0449775
28256742	properties	C0243178
28256742	usage	C0457083
28256742	investigation	C0683933
28256742	characteristics	C1521970
28256742	AOC	C0006823
28257468	genetic	C0314603
28257468	variation	C0042333
28257468	resistance	C1514892
28257468	infection	C3714514
28257468	Drosophila melanogaster genetic reference panel	C0013139
28257468	Individuals	C0027361
28257468	disease	C0012634
28257468	genetic	C0314603
28257468	variation	C0042333
28257468	individual	C0027361
28257468	variation	C0042333
28257468	resistance	C1514892
28257468	tolerance	C1704410
28257468	fungal pathogen Metarhizium anisopliae Ma549	C0997672
28257468	Drosophila melanogaster Genetic Reference Panel	C0013139
28257468	DGRP	C0013139
28257468	host defense	C0520990
28257468	Ma549	C0997672
28257468	defense	C1880266
28257468	bacterium	C0004611
28257468	Pseudomonas aeruginosa Pa14	C0033809
28257468	DGRP	C0013139
28257468	phenotypes	C0031437
28257468	oxidative stress	C0242606
28257468	sensitivity	C0332324
28257468	starvation	C0038187
28257468	stress resistance	C0678683
28257468	hemolymph	C0019051
28257468	glucose levels	C0337438
28257468	sleep	C0037313
28257468	indices	C0918012
28257468	polymorphisms	C0032529
28257468	associated with	C0332281
28257468	differences	C1705242
28257468	mean survival times	C0086595
28257468	microenvironmental	C4072789
28257468	plasticity	C0678558
28257468	differ	C1705242
28257468	ability	C0085732
28257468	adapt	C0392673
28257468	variable	C0439828
28257468	pathogen	C0450254
28257468	exposures	C0332157
28257468	polymorphisms	C0032529
28257468	increasing	C0442808
28257468	resistance	C1514892
28257468	Ma549	C0997672
28257468	sex biased	C0242568
28257468	non-coding regions	C0021920
28257468	effect	C1280500
28257468	defense	C1880266
28257468	host defense	C0520990
28257468	correlated	C1707520
28257468	longevity	C0023980
28257468	fecundity	C0015895
28257468	Ma549	C0997672
28257468	minor alleles	C0002085
28257468	Pa14	C0033809
28257468	susceptible	C0231204
28257468	Pa14	C0033809
28257468	resistant	C1514892
28257468	pathway	C1705987
28257468	analysis	C0936012
28257468	Pa14	C0033809
28257468	Ma549	C0997672
28257468	resistance	C1514892
28257468	genes	C0017337
28257468	functionally	C0205245
28257468	processes	C1522240
28257468	phagocytosis	C0031308
28257468	engulfment	C1159764
28257468	cell mobility	C1516353
28257468	intermediary metabolism	C0025519
28257468	protein phosphorylation	C1158886
28257468	axon guidance	C2984268
28257468	response to DNA damage	C1155291
28257468	drug metabolism	C0683140
28257468	Functional	C0205245
28257468	testing	C0039593
28257468	insertional mutagenesis	C0079868
28257468	candidate genes	C0017337
28257468	tested	C0039593
28257468	influence	C4054723
28257468	susceptibility	C0231204
28257468	Ma549	C0997672
28257468	candidate genes	C0017337
28257468	homologs	C0162774
28257468	studies	C0008972
28257468	human	C0086418
28257468	disease	C0012634
28257468	genes	C0017337
28257468	variation	C0042333
28257468	susceptibility	C0231204
28257468	species	C1705920
28260547	Surrogate	C4053457
28260547	inaccuracy	C0443236
28260547	older adults'	C0001792
28260547	desire	C0871633
28260547	life-sustaining interventions	C0871803
28260547	decisional	C0679006
28260547	incapacity	C3176592
28260547	erroneous	C1547323
28260547	quality-of-life assessments	C0281588
28260547	Family members	C0086282
28260547	decisions	C0679006
28260547	relative	C0080103
28260547	desire	C0871633
28260547	treatments	C0087111
28260547	quality-of-life assessments	C0281588
28260547	data	C1511726
28260547	community-dwelling	C4045975
28260547	adults	C0001675
28260547	years	C0439234
28260547	quality of life	C0034380
28260547	desire	C0871633
28260547	interventions	C0184661
28260547	health states	C0683314
28260547	current state	C0683314
28260547	mild	C2945599
28260547	moderate	C0205081
28260547	stroke	C0038454
28260547	brain cancer	C0006118
28260547	severe	C0205082
28260547	dementia	C0497327
28260547	ratings	C0871208
28260547	Likert-type scales	C0451267
28260547	rating scales	C0681889
28260547	surrogate	C4053457
28260547	older adult	C0001792
28260547	quality-of-life	C0034380
28260547	ratings	C0871208
28260547	older adult	C0001792
28260547	surrogate	C4053457
28260547	surrogates'	C4053457
28260547	inaccuracy	C0443236
28260547	desire	C0871633
28260547	treatment	C0087111
28260547	quality-of-life	C0034380
28260547	ratings	C0871208
28260547	predictor	C2698872
28260547	inaccuracy	C0443236
28260547	health states	C0683314
28260547	current health state	C0683314
28260547	regression coefficients	C1707429
28260547	negative	C0205160
28260547	surrogate	C4053457
28260547	quality of life	C0034380
28260547	older adult	C0001792
28260547	older adult	C0001792
28260547	desire	C0871633
28260547	quality-of-life	C0034380
28260547	ratings	C0871208
28260547	surrogates'	C4053457
28260547	desire	C0871633
28260547	life-sustaining interventions	C0871803
28260547	quality of life	C0034380
28260547	cognitive decline	C0234985
28260547	family members	C0086282
28260547	decisions	C0679006
28262340	Gain-of-function mutation	C0026882
28262340	SCN5A	C1419864
28262340	ventricular arrhythmias	C0085612
28262340	early onset	C1833334
28262340	atrial fibrillation	C0004238
28262340	Mutations	C0026882
28262340	SCN5A	C1419864
28262340	gene	C0017337
28262340	encoding	C2700640
28262340	cardiac	C0018787
28262340	sodium channel (NaV1.5)	C0037492
28262340	spectrum	C2827424
28262340	inherited	C0439660
28262340	cardiac arrhythmia disorders	C0003811
28262340	study	C2603343
28262340	genetic	C0314603
28262340	functional determinants	C1521761
28262340	Dutch	C0013331
28262340	family	C0015576
28262340	phenotype	C0031437
28262340	ventricular arrhythmias	C0085612
28262340	adrenergic	C0599756
28262340	component	C1705248
28262340	isolation	C0205409
28262340	combination	C0205195
28262340	heart function	C0232164
28262340	early onset	C1833334
28262340	years	C0439234
28262340	atrial fibrillation	C0004238
28262340	generation	C0079411
28262340	sequencing	C0162326
28262340	proband	C1948021
28262340	generation	C0079411
28262340	Dutch	C0013331
28262340	family	C0015576
28262340	missense mutation	C0599155
28262340	SCN5A-(p.M1851V)	C1419864
28262340	clinical	C0205210
28262340	phenotype	C0031437
28262340	family	C0015576
28262340	functionally	C0205245
28262340	genetic	C0314603
28262340	defect	C1457869
28262340	patch clamp	C0920630
28262340	electrophysiological studies	C0850293
28262340	human embryonic	C0868971
28262340	kidney cells	C0553257
28262340	transfected	C0040669
28262340	mutant	C0596988
28262340	wild-type Nav1.5	C1419864
28262340	current	C1705970
28262340	inactivation	C0544461
28262340	inactivation	C0544461
28262340	SCN5A-M1851V channels	C0037492
28262340	voltage	C0598352
28262340	dependence	C3244310
28262340	inactivation	C0544461
28262340	positive	C1446409
28262340	potentials	C3245505
28262340	TTX	C0039705
28262340	sensitive	C0332324
28262340	window current	C1705970
28262340	SCN5A-M1851V channels	C0037492
28262340	upstroke velocity	C0439830
28262340	SCN5A-M1851V channels	C0037492
28262340	depolarization voltage	C0598352
28262340	negative	C0205160
28262340	mutation	C0026882
28262340	gain-of-function mechanism	C0441712
28262340	channel	C0037492
28262340	window current	C1705970
28262340	clinical	C0205210
28262340	phenotype	C0031437
28262340	ventricular arrhythmias	C0085612
28262340	atrial fibrillation	C0004238
28262340	findings	C0243095
28262340	cardiac arrhythmias	C0003811
28262340	mutations	C0026882
28262340	SCN5A	C1419864
28263181	cancer	C0006826
28263181	Warburg effect	C1520120
28263181	testable	C0332265
28263181	example	C1707959
28263181	minimum	C1524031
28263181	entropy	C0376522
28263181	production rate	C0392762
28263181	principle	C0178566
28263181	Cancer cells	C0334227
28263181	consume	C0205245
28263181	glucose	C0017725
28263181	glycolytic fermentation	C1158288
28263181	lactate	C0376261
28263181	respiration	C0035203
28263181	characteristic	C1521970
28263181	Warburg effect	C1520120
28263181	moles	C0439189
28263181	ATP	C0001480
28263181	respiration	C0035203
28263181	fermentation	C0015852
28263181	moles	C0439189
28263181	ATP	C0001480
28263181	mole	C0439189
28263181	glucose	C0017725
28263181	consumed	C0205245
28263181	function	C0542341
28263181	Warburg effect	C1520120
28263181	Productions	C0205245
28263181	free energy	C0678591
28263181	ΔG	C1637382
28263181	enthalpy	C0599530
28263181	ΔH	C1710184
28263181	entropy	C0376522
28263181	ΔS	C1710185
28263181	mole	C0439189
28263181	linearly	C0205132
28263181	fraction (x) of	C1264633
28263181	glucose	C0017725
28263181	consumed	C0205245
28263181	fermentation	C0015852
28263181	frequently	C0332183
28263181	estimated	C0750572
28263181	calculation	C1441506
28263181	pure	C0237400
28263181	respiration	C0035203
28263181	fermentative	C0015852
28263181	metabolism	C0025519
28263181	decreases	C0547047
28263181	production	C0205245
28263181	entropy	C0376522
28263181	mole	C0439189
28263181	glucose	C0017725
28263181	consumed	C0205245
28263181	cancer cells	C0334227
28263181	hypothesize	C1512571
28263181	increased	C0205217
28263181	fermentation	C0015852
28263181	cancer cells	C0334227
28263181	accomplish	C0205556
28263181	Prigogine theorem	C0282574
28263181	trend	C1521798
28263181	minimize	C0392762
28263181	rate	C1521828
28263181	production	C0205245
28263181	entropy	C0376522
28263181	theorem	C0282574
28263181	open cellular systems	C0007634
28263181	steady state	C0678587
28263181	evolve	C1280477
28263181	minimize	C0392762
28263181	rates	C1521828
28263181	entropy	C0376522
28263181	production	C0205245
28263181	modified	C0184511
28263181	replicating	C1883725
28263181	cells	C0007634
28263181	entropy	C0376522
28263181	rate	C1521828
28263181	CO2	C0007012
28263181	concentrations	C1446561
28263181	ppm	C0439187
28263181	glucose	C0017725
28263181	respiration	C0035203
28263181	entropy	C0376522
28263181	fermentation	C0015852
28263181	experimental	C1517586
28263181	tests	C0022885
28263181	validate	C1456348
28263181	hypothesis	C1512571
28263181	minimization	C0392762
28263181	rate	C1521828
28263181	entropy	C0376522
28263181	production	C0205245
28263181	Warburg effect	C1520120
28263519	Potential	C3245505
28263519	drug-drug interactions	C0687133
28263519	prescriptions	C0033080
28263519	elderly	C0001792
28263519	patients	C0030705
28263519	primary health care	C0033137
28263519	Elderly	C0001792
28263519	patients	C0030705
28263519	high risk	C0332167
28263519	drug-drug interactions	C0687133
28263519	DDIs	C0687133
28263519	study	C2603343
28263519	evaluates	C0220825
28263519	potential	C3245505
28263519	DDIs	C0687133
28263519	elderly	C0001792
28263519	patients	C0030705
28263519	primary health care	C0033137
28263519	outpatient clinic	C0029916
28263519	Online database systems	C0242356
28263519	DDIs	C0687133
28263519	prescriptions	C0033080
28263519	patients	C0030705
28263519	clinical severity	C1836458
28263519	DDIs	C0687133
28263519	Lexi-Interact Online database	C0242356
28263519	prescriptions	C0033080
28263519	DDIs	C0687133
28263519	detected	C0442726
28263519	DDIs	C0687133
28263519	prescriptions	C0033080
28263519	Prescriptions	C0033080
28263519	patients	C0030705
28263519	patients	C0030705
28263519	significantly higher	C4055637
28263519	DDIs	C0687133
28263519	frequency	C0205212
28263519	DDIs	C0687133
28263519	increased	C0205217
28263519	drugs	C1254351
28263519	prescription	C0033080
28263519	Acetylsalicylic acid	C0004057
28263519	salbutamol	C0001927
28263519	frequently	C0332183
28263519	prescribed	C0278329
28263519	drugs	C1254351
28263519	clinically important	C0243095
28263519	DDIs	C0687133
28263519	acetylsalicylic acid	C0004057
28263519	escitalopram	C1099456
28263519	interact	C1704675
28263519	Beers criteria	C4042847
28263519	predicted clinical outcomes	C1333602
28263519	DDIs	C0687133
28263519	therapeutic efficacy	C2348767
28263519	adverse	C0559546
28263519	toxic reactions	C0542243
28263519	Prediction	C0681842
28263519	DDIs	C0687133
28263519	elderly	C0001792
28263519	patients	C0030705
28263519	prescribing	C0033080
28263519	drug safety	C0678800
28263519	nonsteroidal anti-inflammatory agents	C0003211
28263519	selective serotonin reuptake inhibitors	C0360105
28263519	beta-2 adrenergic receptor agonists	C2936789
28265530	Discontinued	C1444662
28265530	Splenogonadal Fusion	C0266636
28265530	Bilateral Empty Scrotum	C1261504
28265530	Month	C1510828
28265530	Boy	C0870221
28265530	Splenogonadal fusion	C0266636
28265530	rare	C0522498
28265530	congenital anomaly	C0000768
28265530	splenic tissue	C0771377
28265530	adherent	C0334154
28265530	gonads	C0018067
28265530	Bostroem	C0086418
28265530	German	C1556085
28265530	pathologist	C0334866
28265530	case	C1706256
28265530	month	C1510828
28265530	boy	C0870221
28265530	case	C1706256
28265530	bilateral empty scrotum	C1261504
28265530	routine	C0205547
28265530	laparoscopic	C0521291
28265530	exploration	C1280903
28265530	right vas deferens	C0228039
28265530	testicular vessels	C4266473
28265530	right internal inguinal ring	C0932530
28265530	right inguinal	C0230318
28265530	exploration	C1280903
28265530	blind ending	C0243095
28265530	vas deferens	C0042360
28265530	testicular vessels	C4266473
28265530	left testis	C0227998
28265530	intra-abdominally	C1512910
28265530	internal ring	C1512866
28265530	mass	C0577573
28265530	upper pole	C0227991
28265530	Wedge biopsy	C0192152
28265530	upper pole of the testicle	C0227991
28265530	site	C1515974
28265530	mass	C0577573
28265530	tissue diagnosis	C1546905
28265530	orchidopexy	C0194907
28265530	Histology	C0344441
28265530	splenic tissue	C0771377
28265530	splenogonadal fusion	C0266636
28265530	rare	C0522498
28265530	condition	C0012634
28265530	surgeons	C0582175
28265530	rare disease	C0678236
28265530	unnecessary	C0376708
28265530	interventions	C0808232
28265530	orchiectomy	C0029189
28267199	Real-world impact	C4049986
28267199	non-breast cancer-specific death	C1408354
28267199	overall survival	C4086681
28267199	resectable	C1514888
28267199	breast cancer	C0006142
28267199	occurrence rate	C1521828
28267199	non-breast cancer-specific death	C1408354
28267199	non-BCSD	C1408354
28267199	impact	C4049986
28267199	patients	C0030705
28267199	breast cancer	C0006142
28267199	Women	C0043210
28267199	resectable	C1514888
28267199	breast cancer	C0006142
28267199	Surveillance, Epidemiology, and End Results database	C0242638
28267199	analyzed	C0936012
28267199	outcome	C1274040
28267199	events	C0441471
28267199	breast cancer	C0006142
28267199	breast cancer-specific death	C1516192
28267199	BCSD	C1516192
28267199	non-BCSD	C1408354
28267199	survival	C0038952
28267199	Binary logistics	C0206031
28267199	estimate	C0750572
28267199	occurrence rates	C1521828
28267199	non-BCSD	C1408354
28267199	BCSD	C1516192
28267199	clinicopathological factors	C1521761
28267199	Gray method	C0282574
28267199	measure	C0079809
28267199	cumulative incidence	C0021149
28267199	non-BCSD	C1408354
28267199	BCSD	C1516192
28267199	ratio	C0456603
28267199	non-BCSDs	C1408354
28267199	causes of death	C0007465
28267199	stacked	C3272897
28267199	cumulative incidence	C0021149
28267199	function plots	C0681493
28267199	impact	C4049986
28267199	non-BCSD	C1408354
28267199	overall survival	C4086681
28267199	OS	C4086681
28267199	Models of Cox proportional hazards regression	C0010235
28267199	competing risk regression	C0034980
28267199	suitable model	C3161035
28267199	non-BCSDs	C1408354
28267199	BCSDs	C1516192
28267199	oldest age group	C0027362
28267199	black race	C0005680
28267199	single or divorced marital status	C4060922
28267199	associated with	C0332281
28267199	non-BCSDs	C1408354
28267199	age	C0001779
28267199	hormone receptor-positive (HoR+) status	C1562029
28267199	increased	C0205217
28267199	non-BCSD	C1408354
28267199	patients	C0030705
28267199	grade 1, stage I disease	C0012634
28267199	HoR+ status	C1562029
28267199	non-BCSD	C1408354
28267199	causes of death	C0007465
28267199	incorrect interpretations	C3845771
28267199	inaccuracy	C0443236
28267199	Cox proportional hazards model	C0010235
28267199	competing risk model	C0034980
28267199	OS	C4086681
28267199	impaired	C0221099
28267199	non-BCSD	C1408354
28267199	breast cancer	C0006142
28267199	clinical trial	C0008976
28267199	planning	C1254363
28267199	oldest	C0001795
28267199	patients	C0030705
28267199	HoR+	C1562029
28267199	breast cancer	C0006142
28267199	non-BCSD	C1408354
28267199	competing risk event	C0814316
28267199	American Cancer Society	C0002455
28268504	Hip	C0019552
28268504	segmentation	C2697664
28268504	MRI	C0024485
28268504	infants	C0021270
28268504	DDH	C0019555
28268504	diagnosis	C0011900
28268504	treatment planning	C0599880
28268504	Diagnosis	C0011900
28268504	surgical management	C1515089
28268504	Developmental Dysplasia of the Hip	C0019555
28268504	DDH	C0019555
28268504	physical examination	C0031809
28268504	ultrasound scanning	C0041618
28268504	Magnetic Resonance Imaging	C0024485
28268504	MRI	C0024485
28268504	techniques	C0449851
28268504	treatment planning	C0599880
28268504	semi-automatic	C0205554
28268504	method	C0025663
28268504	segment surface models	C3161035
28268504	acetabulum	C0000962
28268504	MRI	C0024485
28268504	images	C1551337
28268504	method	C0025663
28268504	clinical	C0205210
28268504	knowledge	C0376554
28268504	intensity priors	C0876936
28268504	Random Walker (RW) formulation	C0002045
28268504	modified	C0392747
28268504	RW	C0002045
28268504	compensates	C0205432
28268504	incomplete	C0205257
28268504	blurred	C0205556
28268504	boundaries	C2828371
28268504	image	C1551337
28268504	information	C1533716
28268504	neighboring slices	C1254362
28268504	sequence	C1519249
28268504	node weights	C0392762
28268504	pilot study	C0031928
28268504	evaluate	C0220825
28268504	segmentation	C2697664
28268504	infant	C0021270
28268504	hip	C0019552
28268504	MRI	C0024485
28268504	sequences	C1519249
28268504	MR scanner	C0183115
28268504	Contours	C0876954
28268504	semi-automated	C0205554
28268504	segmentation	C2697664
28268504	compared	C1707455
28268504	manually	C3842330
28268504	segmented	C2697664
28268504	hip	C0019552
28268504	contours	C0876954
28268504	Dice Ratio	C0456603
28268504	DR	C0456603
28268504	Hausdorff Distance	C0012751
28268504	HD	C0012751
28268504	Root Mean Square	C2347976
28268504	RMS	C2347976
28268504	method	C0025663
28268504	DR	C0456603
28268504	HD	C0012751
28268504	RMS	C2347976
28268504	DR	C0456603
28268504	HD	C0012751
28268504	RMS	C2347976
28268504	right	C0834313
28268504	left acetabular contours	C0834314
28268504	higher	C0205250
28268504	conventional	C0439858
28268504	RW	C0002045
28268504	segmentation	C2697664
28268504	execution	C1705848
28268504	time	C0040223
28268504	segmentation	C2697664
28268504	algorithm	C0002045
28268504	seconds	C0457385
28268504	CPU	C1707144
28268917	basal cell carcinoma	C0007117
28268917	high-definition optical coherence tomography	C0920367
28268917	Basal cell carcinoma	C0007117
28268917	BCC	C0007117
28268917	non-melanoma skin cancer	C0699893
28268917	BCC	C0007117
28268917	invasive	C0205281
28268917	biopsies	C0005558
28268917	high-definition optical coherence tomography	C0920367
28268917	HD-OCT	C0920367
28268917	non-invasive	C0205303
28268917	in vivo imaging method	C1708481
28268917	skin	C1123023
28268917	BCC	C0007117
28268917	HD-OCT	C0920367
28268917	images	C1551337
28268917	histopathological architecture	C0243140
28268917	BCC	C0007117
28268917	HD-OCT	C0920367
28268917	BCC	C0007117
28268917	detection method	C0430022
28268917	skin surface	C1180212
28268917	segmentation	C0700381
28268917	surface flattening	C0016203
28268917	BCC	C0007117
28268917	effectiveness	C1280519
28268917	BCC	C0007117
28269352	Fall	C0085639
28269352	risk factors	C0035648
28269352	analysis	C0936012
28269352	sample entropy	C0376522
28269352	plantar	C0230463
28269352	kinematic	C1254365
28269352	signal	C1710082
28269352	stance phase	C2019827
28269352	Falls	C0085639
28269352	multi-causal phenomenon	C1882365
28269352	complex	C0439855
28269352	interaction	C1704675
28269352	research	C0035168
28269352	study	C2603343
28269352	effect	C1280500
28269352	multiple	C0439064
28269352	variables	C0439828
28269352	potential	C3245505
28269352	risk of falls	C1268740
28269352	construct	C2827421
28269352	elderly fall risk assessment model	C3161035
28269352	demographics	C0011298
28269352	data	C1511726
28269352	gait characteristics	C2045693
28269352	subjects	C2349001
28269352	Malianwa Street	C0442658
28269352	aged	C0001779
28269352	years old	C1510829
28269352	participated	C0679823
28269352	questionnaire	C0034394
28269352	survey	C0038951
28269352	Participants	C0679646
28269352	groups	C0441833
28269352	high	C0684030
28269352	medium	C2348561
28269352	low risk	C3538919
28269352	group	C0441833
28269352	score	C0449820
28269352	elderly fall risk assessment scale	C0349674
28269352	data	C1511726
28269352	ground reaction force	C0336996
28269352	GRF	C0336996
28269352	ground reaction moment	C1254365
28269352	GRM	C1254365
28269352	record	C2355580
28269352	performed	C0884358
28269352	walking	C0080331
28269352	comfortable state	C1822395
28269352	demographic	C0683970
28269352	variables	C0439828
28269352	sample entropy	C0376522
28269352	GRF	C0336996
28269352	GRM	C1254365
28269352	impulse difference	C1705241
28269352	bilateral foot	C4299794
28269352	potential	C3245505
28269352	explanatory	C0681841
28269352	variables	C0439828
28269352	risk assessment	C0086930
28269352	model	C3161035
28269352	investigated	C1292732
28269352	groups	C0441833
28269352	difference	C1705241
28269352	variable	C0439828
28269352	Statistical differences	C1705241
28269352	found	C0150312
28269352	variables	C0439828
28269352	age	C0001779
28269352	impulse difference	C1705241
28269352	sample entropy	C0376522
28269352	GRF	C0336996
28269352	vertical	C0205128
28269352	direction	C0449738
28269352	sample entropy	C0376522
28269352	GRM	C1254365
28269352	anterior-posterior	C1999039
28269352	direction	C0449738
28269352	multiple	C0439064
28269352	regression analysis	C0034980
28269352	results	C1274040
28269352	indicated	C1444656
28269352	age	C0001779
28269352	impulse difference	C1705241
28269352	sample entropy	C0376522
28269352	GRM	C1254365
28269352	individuals	C0237401
28269352	levels of fall risk	C1532976
28269352	results	C1274040
28269352	potentially	C3245505
28269352	useful	C3827682
28269352	fall risk assessment	C1532976
28269352	monitor	C0150369
28269352	state	C1442792
28269352	physical function	C0516981
28269352	elderly population	C0001792
28269453	Endurance	C0518031
28269453	personalized fitness planner	C0282574
28269453	Endurance	C0518031
28269453	important	C3898777
28269453	factor	C1521761
28269453	cardiovascular fitness	C2981722
28269453	capacity	C1516240
28269453	individual	C0237401
28269453	perform	C0884358
28269453	exercise	C0015259
28269453	longer duration	C0449238
28269453	increased	C0205217
28269453	intensity	C0522510
28269453	subject specific	C0205369
28269453	exercise	C0015259
28269453	parameters	C0549193
28269453	endurance	C0518031
28269453	individual	C0237401
28269453	statistical technique	C1710191
28269453	model	C3161035
28269453	endurance	C0518031
28269453	factors	C1521761
28269453	observations	C0302523
28269453	individuals	C0237401
28269453	over time	C0040223
28269453	proposed	C1553874
28269453	model	C3161035
28269453	device	C0025080
28269453	endurance	C0518031
28269453	subject	C0681850
28269453	exercise regime	C0454291
28269453	test user	C1548600
28269453	fitness planner	C0282574
28269453	exercise regimes	C0454291
28269453	fitness	C1456706
28269453	goal	C0018017
28269712	Heart rate	C0018810
28269712	variability	C2827666
28269712	biomarker	C0005516
28269712	sedation depth	C0235195
28269712	estimation	C0750572
28269712	ICU	C0021708
28269712	patients	C0030705
28269712	automated patient-specific system	C0596139
28269712	level of sedation	C2226609
28269712	ICU	C0021708
28269712	patients	C0030705
28269712	heart rate	C0018810
28269712	variability	C2827666
28269712	signal	C1710082
28269712	presented	C0449450
28269712	paper	C0282420
28269712	ECG	C0013798
28269712	mechanically ventilated	C0199470
28269712	adult	C0001675
28269712	patients	C0030705
28269712	administered	C1521801
28269712	sedatives	C0036557
28269712	ICU setting	C0021708
28269712	support vector machine	C2699740
28269712	sedation depth	C0235195
28269712	monitoring	C1283169
28269712	heart rate	C0018810
28269712	variability	C2827666
28269712	measures	C0079809
28269712	leave-one-subject-out cross validation	C0681935
28269712	classifier	C4291659
28269712	training	C0040607
28269712	performance	C1882330
28269712	evaluations	C0220825
28269712	patient-specific system	C0596139
28269712	provided	C1999230
28269712	sensitivity	C0036667
28269712	specificity	C0037791
28269712	AUC	C0376690
28269712	physiological	C0205463
28269712	signals	C1710082
28269712	patient	C0030705
28269712	specific	C0205369
28269712	sedation level	C2226609
28269712	prediction	C0681842
28269712	system	C0449913
28269712	automated multimodal system	C0596139
28269712	clinical	C0205210
28269712	staff	C0851286
28269712	ICUs	C0021708
28269712	interpret	C1285553
28269712	sedation level	C2226609
28269712	patient	C0030705
28270369	RELIABILITY AND VALIDITY	C0035036
28270369	DIABETES EATING PROBLEM SURVEY-REVISED	C0012158
28270369	TURKISH	C0549217
28270369	CHILDREN	C0008059
28270369	ADOLESCENTS	C0205653
28270369	TYPE 1 DIABETES MELLITUS	C0011854
28270369	study	C2603343
28270369	examine	C1292732
28270369	reliability and validity	C0035036
28270369	Turkish	C0549217
28270369	version	C0333052
28270369	Diabetes Eating Problem Survey-Revised	C0012158
28270369	DEPS-R	C0012158
28270369	children	C0008059
28270369	adolescent	C0205653
28270369	Type 1 Diabetes Mellitus	C0011854
28270369	children	C0008059
28270369	adolescents	C0205653
28270369	type 1 diabetes	C0011854
28270369	ages	C0001779
28270369	years	C0439234
28270369	DEPS-R	C0012158
28270369	Turkish	C0549217
28270369	version	C0333052
28270369	tests	C0039593
28270369	validity	C2349101
28270369	confirmatory factor analysis	C0870334
28270369	investigate	C1292732
28270369	factor structure	C0870541
28270369	Turkish	C0549217
28270369	version	C0333052
28270369	DEPS-R	C0012158
28270369	Turkish	C0549217
28270369	version	C0333052
28270369	DEPS-R	C0012158
28270369	satisfactory	C0205410
28270369	Cronbach's	C0870731
28270369	correlated	C1707520
28270369	ag	C0001779
28270369	hemoglobin A1c levels	C1261236
28270369	BMI	C1305855
28270369	SDS	C0449820
28270369	criterion validity	C2699472
28270369	DEPS-R	C0012158
28270369	scores	C0449820
28270369	Turkish	C0549217
28270369	version	C0333052
28270369	samples	C1257890
28270369	females	C0086287
28270369	males	C0086582
28270369	Disturbed eating behaviors	C4062871
28270369	insulin	C0021641
28270369	restriction	C0443288
28270369	metabolic control	C1513158
28270369	self-administered	C1519231
28270369	diabetes	C0011854
28270369	screening	C1710032
28270369	disordered eating behavior	C4062871
28270369	clinical	C0205210
28270369	care	C0086388
28270369	adolescents	C0205653
28270369	type 1 diabetes	C0011854
28270369	Turkish	C0549217
28270369	version	C0333052
28270369	DEPS-R	C0012158
28270369	screening	C1710032
28270369	disordered eating behaviors	C4062871
28270369	type 1 diabetes	C0011854
28270369	disordered eating behaviors	C4062871
28271342	comparison	C1707455
28271342	localization	C0475264
28271342	rectal carcinomas	C0007113
28271342	general	C0205246
28271342	rules	C0870077
28271342	Japanese classification of colorectal carcinoma	C0008902
28271342	JCCRC	C0008902
28271342	Western	C1705493
28271342	guidelines	C0162791
28271342	aim	C1947946
28271342	compare	C1707455
28271342	localization	C0475264
28271342	rectal cancers	C0007113
28271342	classified	C0008902
28271342	general	C0205246
28271342	rules	C0870077
28271342	Japanese classification of colorectal carcinoma	C0008902
28271342	JCCRC	C0008902
28271342	European Society for Medical Oncology	C1708333
28271342	ESMO	C1708333
28271342	National Comprehensive Cancer Network	C1513893
28271342	NCCN	C1513893
28271342	guidelines	C0162791
28271342	rigid endoscopic	C0014245
28271342	measurements	C0242485
28271342	medical records	C0025102
28271342	patients	C0030705
28271342	scheduled	C0205539
28271342	receive	C1514756
28271342	curative surgery	C1511562
28271342	histologically	C0205462
28271342	rectal adenocarcinoma	C0149978
28271342	during	C0347984
28271342	investigated	C1292732
28271342	Rigid proctoscopy	C0033251
28271342	performed	C0884358
28271342	patients	C0030705
28271342	rectal cancer	C0007113
28271342	located in	C0332285
28271342	upper	C1282910
28271342	Ra	C1282910
28271342	lower	C0441994
28271342	Rb	C0441994
28271342	division	C1293097
28271342	double-contrast barium enema	C0412118
28271342	median	C0876920
28271342	height	C0489786
28271342	anal verge	C0227423
28271342	range	C1514721
28271342	rigid proctoscopy	C0033251
28271342	cancers	C0006826
28271342	assigned	C1516050
28271342	Ra	C1282910
28271342	Rb	C0441994
28271342	cancers	C0006826
28271342	Ra	C1282910
28271342	Rb	C0441994
28271342	located	C0332285
28271342	within	C0332285
28271342	anal verge	C0227423
28271342	rigid proctoscopy	C0033251
28271342	Ra	C1282910
28271342	Rb	C0441994
28271342	cancers	C0006826
28271342	located in	C0332285
28271342	mid	C0444598
28271342	low	C0205251
28271342	rectum	C0034896
28271342	Ra	C1282910
28271342	Rb	C0441994
28271342	cancers	C0006826
28271342	rectal cancers	C0007113
28271342	NCCN	C1513893
28271342	guidelines	C0162791
28271342	classifications	C0008902
28271342	mid-	C0444598
28271342	low	C0205251
28271342	rectal cancers	C0007113
28271342	ESMO	C1708333
28271342	guidelines	C0162791
28271600	Natural orifice transluminal endoscopic surgery	C2936208
28271600	snake-mechanism	C0441712
28271600	movable pulley	C1709769
28271600	Natural orifice transluminal endoscopic surgery	C2936208
28271600	technique	C0449851
28271600	develop	C1527148
28271600	advanced	C0205179
28271600	surgical robot	C3204163
28271600	mechanism	C0441712
28271600	natural orifice surgery	C2936206
28271600	active-controlled overtube-type platform	C1710360
28271600	channels	C0439799
28271600	endoscopic camera	C0179535
28271600	surgical	C0543467
28271600	tools	C0336791
28271600	platform	C1710360
28271600	suggest	C1705535
28271600	advanced	C0205179
28271600	snake mechanism	C0441712
28271600	movable pulleys	C1709769
28271600	snake mechanism	C0441712
28271600	degrees of freedom	C0205245
28271600	stiffness	C0205556
28271600	maneuverability	C0205556
28271600	active-controlled platform	C1710360
28271600	satisfactory	C0205410
28271600	prototypes	C3161035
28271600	ex vivo	C2348480
28271600	experiments	C0681814
28271600	mechanism	C0441712
28271600	snake-like robotic	C0336537
28271600	platform	C1710360
28271600	natural orifice surgery	C2936206
28271600	suggested	C1705535
28271600	snake mechanism	C0441712
28271600	movable pulleys	C1709769
28271600	stiffness	C0205556
28271600	maneuverability	C0205556
28271600	mechanism	C0441712
28271600	alternative	C1523987
28271600	platform	C1710360
28271600	natural orifice surgery	C2936206
28272254	β-blockers	C0001645
28272254	regression	C0597370
28272254	left ventricular mass	C0455825
28272254	hypertension	C0020538
28272254	patients	C0030705
28272254	Bayesian network	C0026348
28272254	meta-analysis	C0920317
28272254	Left ventricular hypertrophy	C0149721
28272254	LVH	C0149721
28272254	patients	C0030705
28272254	hypertension	C0020538
28272254	HT	C0020538
28272254	expert consensus document	C1301746
28272254	American	C0596070
28272254	angiotensin-converting enzyme inhibitor	C0003015
28272254	ACEI	C0003015
28272254	angiotensin receptor blockers	C0815017
28272254	ARBs	C0815017
28272254	therapeutic drugs	C0013227
28272254	efficacy	C1280519
28272254	fat-soluble and selective β1-receptor blockers	C0304516
28272254	FS-β-B	C0304516
28272254	β-blockers	C0001645
28272254	regression	C0597370
28272254	LVH	C0149721
28272254	analysis	C0920317
28272254	compare	C1707455
28272254	efficacy	C1280519
28272254	FS-β-B	C0304516
28272254	antihypertensive drugs	C0003364
28272254	ACEI	C0003015
28272254	ARBs	C0815017
28272254	calcium channel blockers	C0006684
28272254	CCBs	C0006684
28272254	diuretics	C0012798
28272254	regression	C0597370
28272254	LVH	C0149721
28272254	Relative	C0205345
28272254	trials	C0008976
28272254	PubMed	C1138432
28272254	Web of Science	C2349146
28272254	OVID EBM Reviews	C0282443
28272254	Cochrane databases	C0242356
28272254	papers	C1706852
28272254	examined	C1292732
28272254	Bayesian	C0026348
28272254	meta-analysis	C0920317
28272254	randomized controlled trials	C0206035
28272254	RCTs	C0206035
28272254	regression	C0597370
28272254	LVH	C0149721
28272254	Sensitivity analysis	C0936012
28272254	regression analysis	C0034980
28272254	heterogeneity	C0019409
28272254	Inconsistency analysis	C0936012
28272254	analysis	C0920317
28272254	trials	C0008976
28272254	network	C0026348
28272254	consistent	C0332290
28272254	RCTs	C0206035
28272254	patients	C0030705
28272254	HT	C0020538
28272254	LVH	C0149721
28272254	analysis	C0920317
28272254	Bayesian network	C0026348
28272254	meta-analysis	C0920317
28272254	statistically significant	C0237881
28272254	groups	C0441833
28272254	FS-β-B	C0304516
28272254	ACEI	C0003015
28272254	CI	C0009667
28272254	FS-β-B	C0304516
28272254	ARB	C0815017
28272254	Cl	C0009667
28272254	FS-β-B	C0304516
28272254	efficacy	C1280519
28272254	compared	C1707455
28272254	diuretic	C0012798
28272254	CI	C0009667
28272254	CCB	C0006684
28272254	CI	C0009667
28272254	probabilities	C0033204
28272254	efficacious	C1280519
28272254	treatments	C0087111
28272254	FS-β-B	C0304516
28272254	ARB	C0815017
28272254	ACEI	C0003015
28272254	CCB	C0006684
28272254	diuretic	C0012798
28272254	analysis	C0920317
28272254	FS-β-B	C0304516
28272254	therapeutic drugs	C0013227
28272254	HT	C0020538
28272254	LVH	C0149721
28272254	patients	C0030705
28272254	efficacy	C1280519
28272254	FS-β-B	C0304516
28272254	regression	C0597370
28272254	LVH	C0149721
28272254	quality	C0332306
28272254	trials	C0008976
28272842	Improved	C0184511
28272842	risk	C0035647
28272842	stratification	C1514983
28272842	patients	C0030705
28272842	urothelial carcinoma	C2145472
28272842	Paris	C0030561
28272842	System	C0449913
28272842	Reporting	C0700287
28272842	Urinary Cytology	C2979983
28272842	Paris	C0030561
28272842	System	C0449913
28272842	Reporting	C0700287
28272842	Urinary Cytology	C2979983
28272842	TPS	C2979983
28272842	cytomorphologic	C0243092
28272842	criteria	C0243161
28272842	diagnosis	C0011900
28272842	high-grade urothelial carcinoma	C2145472
28272842	HGUC	C2145472
28272842	urinary tract cytology	C2979983
28272842	UTC	C2979983
28272842	specimens	C0370003
28272842	elevated	C3163633
28272842	nuclear-to-cytoplasmic (N/C) ratio	C0333907
28272842	atypical	C0205182
28272842	nuclear	C0007610
28272842	borders	C0205284
28272842	moderate	C0205081
28272842	severe	C0205082
28272842	hyperchromasia	C0333910
28272842	coarse chromatin	C1868540
28272842	malignant	C0205282
28272842	UTC	C2979983
28272842	specimens	C0370003
28272842	degenerative	C1880269
28272842	changes	C0392747
28272842	malignant cells	C0334227
28272842	TPS	C2979983
28272842	cytomorphologic	C0243092
28272842	criteria	C0243161
28272842	UTC	C2979983
28272842	specimens	C0370003
28272842	patients	C0030705
28272842	diagnosis	C0011900
28272842	HGUC	C2145472
28272842	reviewed	C1709940
28272842	reclassified	C0205542
28272842	TPS	C2979983
28272842	criteria	C0243161
28272842	presence	C0150312
28272842	TPS	C2979983
28272842	cytomorphologic	C0243092
28272842	criteria	C0243161
28272842	HGUC	C2145472
28272842	specimen	C0370003
28272842	atypical	C0205182
28272842	cells	C0007634
28272842	criteria	C0243161
28272842	specimens	C0370003
28272842	diagnosed	C0011900
28272842	HGUC	C2145472
28272842	significantly	C0750502
28272842	change	C0392747
28272842	reclassification	C0008902
28272842	approximately	C0332232
28272842	indeterminate	C0205258
28272842	specimens	C0370003
28272842	reclassified	C0205542
28272842	risk	C0035647
28272842	category	C0683312
28272842	cytomorphologic	C0243092
28272842	N/C ratio	C0333907
28272842	specimens	C0370003
28272842	approximately	C0332232
28272842	specimens	C0370003
28272842	specimens	C0370003
28272842	cytomorphologic	C0243092
28272842	criteria	C0243161
28272842	TPS	C2979983
28272842	HGUC	C2145472
28272842	malignant cells	C0334227
28272842	specimens	C0370003
28272842	HGUC	C2145472
28272842	TPS	C2979983
28272842	fraction of	C1264633
28272842	atypical	C0205182
28272842	cells	C0007634
28272842	criteria	C0243161
28272842	malignant	C0205282
28272842	UTC	C2979983
28272842	specimens	C0370003
28272842	TPS	C2979983
28272842	criteria	C0243161
28272842	improved	C0184511
28272842	specimen	C0370003
28272842	risk	C0035647
28272842	stratification	C1514983
28272842	approximately	C0332232
28272842	indeterminate	C0205258
28272842	specimens	C0370003
28272842	risk	C0035647
28272842	categories	C0683312
28272842	significantly	C0750502
28272842	changing	C0392747
28272842	frequency	C0376249
28272842	HGUC	C2145472
28272842	diagnoses	C0011900
28272842	Cancer	C0006826
28272842	American Cancer Society	C0002455
28273336	diagnostic	C0348026
28273336	benefit	C0814225
28273336	bee venom	C0004920
28273336	components	C1705248
28273336	years	C0439234
28273336	allergen	C0002092
28273336	rApi m 1	C0002092
28273336	ImmunoCAP system	C0282574
28273336	diagnosis	C0011900
28273336	bee venom (BV) allergy	C1828283
28273336	components	C1705248
28273336	sensitivity	C1511883
28273336	specificity	C1511884
28273336	rApi m 1	C0002092
28273336	2	C0002092
28273336	3	C0002092
28273336	5	C0002092
28273336	10	C0002092
28273336	BV-allergic	C1828283
28273336	patients	C0030705
28273336	sensitivity	C1511883
28273336	rApi m 1	C0002092
28273336	2	C0002092
28273336	investigated	C1292732
28273336	sensitization	C1325847
28273336	monosensitization	C1325847
28273336	double sensitization	C1325847
28273336	Analysis	C0936012
28273336	BV	C0004920
28273336	allergens	C0002092
28273336	CAP system	C0282574
28273336	sensitivity	C1511883
28273336	analysis	C0936012
28273336	rApi m 1	C0002092
28273336	2	C0002092
28273336	Immulite	C3829562
28273336	Sensitization	C1325847
28273336	rate	C1521828
28273336	rApi m 5	C0002092
28273336	double-sensitized	C1325847
28273336	patients	C0030705
28273336	rApi m 2	C0002092
28273336	benefit	C0814225
28273336	BV	C0004920
28273336	components	C1705248
28273336	insufficient	C0231180
28273336	sensitivity	C1511883
28273336	cross-reacting	C0010357
28273336	allergens	C0002092
28273482	Orai1	C4255013
28273482	Antimicrobial	C1136254
28273482	Secretion	C0036537
28273482	Pancreatic Acini	C0227578
28273482	Gut Microbiome	C4018878
28273482	Regulates	C1155268
28273482	Gut	C0699819
28273482	Innate Immunity	C0020969
28273482	gut microbiome	C4018878
28273482	physiologic functions	C1254359
28273482	communicates	C0566001
28273482	host	C1167395
28273482	immune system	C0020962
28273482	Antimicrobial peptides	C4084937
28273482	critica	C1511545
28273482	components	C1179435
28273482	intestinal	C0021853
28273482	innate immunity	C0020969
28273482	prominent	C0205402
28273482	antimicrobials secreted	C1819788
28273482	pancreatic acini	C0227578
28273482	gut microbiome	C4018878
28273482	intestinal	C0021853
28273482	innate immunity	C0020969
28273482	barrier function	C1254358
28273482	survival	C0220921
28273482	Deletion	C1880274
28273482	Ca(2+) channel Orai1	C1823405
28273482	pancreatic acini	C0227578
28273482	mice	C0026809
28273482	mortality	C0026565
28273482	activation of the intestinal innate immune response	C1817386
28273482	mice	C0026809
28273482	acinar	C0332207
28273482	Orai1	C1823405
28273482	intestinal	C0021853
28273482	bacterial	C0521009
28273482	outgrowth	C0007613
28273482	dysbiosis	C4287543
28273482	systemic	C0205373
28273482	translocation	C0599718
28273482	inflammation	C0021368
28273482	death	C0011065
28273482	digestive enzyme	C0544420
28273482	supplementation	C0948571
28273482	ineffective	C3242229
28273482	treatments	C0087111
28273482	bacterial	C0521009
28273482	outgrowth	C0007613
28273482	purified	C1998793
28273482	liquid diet	C0301571
28273482	broad-spectrum antibiotics	C0003232
28273482	survival	C0220921
28273482	feeding	C2987508
28273482	weight gain	C0043094
28273482	Pancreatic levels	C1306845
28273482	cathelicidin	C0671062
28273482	antimicrobial peptide	C4084937
28273482	CRAMP	C4084937
28273482	reduced	C0392756
28273482	supplement	C2348609
28273482	CRAMP	C4084937
28273482	intestinal disease	C0021831
28273482	findings	C0243095
28273482	critical	C1511545
28273482	antimicrobial	C1136254
28273482	pancreatic secretion	C0232787
28273482	gut	C0699819
28273482	innate immunity	C0020969
28274077	Palliative Care	C0030231
28274077	Attachment	C1947904
28274077	Hybrid Removable Prosthesis	C3642532
28274077	Abutment	C0545406
28274077	injury	C0178314
28274077	unsatisfactory	C0439856
28274077	aesthetics	C0014901
28274077	retention	C0011397
28274077	cast partial denture	C0545391
28274077	Removable Partial Denture	C0011463
28274077	RPD	C0011463
28274077	design	C0011395
28274077	fabrication	C1254366
28274077	economics	C0013557
28274077	patient comfort	C4277744
28274077	clinical report	C1299495
28274077	RPD	C0011463
28274077	technique	C0449851
28274077	coronal	C0205123
28274077	attachment	C1947904
28274077	reduces	C0392756
28274077	comfort	C1331418
28274077	patient	C0030705
28277189	CXCL5	C1955899
28277189	Osteosarcoma	C0029463
28277189	Cell Migration and Invasion	C0027627
28277189	Autocrine	C0596138
28277189	Paracrine	C0597170
28277189	CXCL5	C1955899
28277189	CXC-type chemokine	C0282553
28277189	granulocytic immune cells	C0018183
28277189	binding to its receptor CXCR2	C1149468
28277189	CXCL5	C1955899
28277189	CXCR2	C0527994
28277189	oncogenic	C0029005
28277189	human	C0086418
28277189	cancers	C0006826
28277189	CXCL5	C1955899
28277189	osteosarcoma	C0029463
28277189	cell migration and invasion	C0027627
28277189	protein expression	C1171362
28277189	CXCL5	C1955899
28277189	increased	C0205217
28277189	osteosarcoma	C0029463
28277189	tissues	C0040300
28277189	matched adjacent nontumor tissues	C0040300
28277189	expression	C1171362
28277189	CXCL5	C1435946
28277189	advanced clinical stage	C0205563
28277189	metastasis	C4255448
28277189	CXCL5	C1955899
28277189	expression levels	C3244092
28277189	increased	C0205217
28277189	osteosarcoma	C0029463
28277189	cell lines	C0085983
28277189	Saos-2	C0085983
28277189	MG63	C0085983
28277189	U2OS	C0085983
28277189	SW1353	C0085983
28277189	normal osteoblast	C0029418
28277189	hFoB1.19 cells	C0029418
28277189	U2OS cells	C0085983
28277189	transfected	C0314641
28277189	CXCL5	C1332819
28277189	specific siRNA	C1099354
28277189	overexpression	C1514559
28277189	plasmid	C0032136
28277189	Knockdown	C2350567
28277189	CXCL5	C1332819
28277189	suppressed	C1260953
28277189	U2OS	C0085983
28277189	cell migration and invasion	C0027627
28277189	overexpression	C1514559
28277189	CXLC5	C1955899
28277189	migration and invasion	C0027627
28277189	U2OS cells	C0085983
28277189	exogenous	C0205228
28277189	CXCL5	C1955899
28277189	treatment	C0039798
28277189	CXCL5	C1955899
28277189	overexpressing	C1514559
28277189	hFoB1.19 cells	C0029418
28277189	migration and invasion	C0027627
28277189	U2OS cells	C0085983
28277189	CXCL5	C1955899
28277189	U2OS	C0085983
28277189	cell migration and invasion	C0027627
28277189	paracrine	C0597170
28277189	CXCL5	C1955899
28277189	osteosarcoma	C0029463
28277189	oncogenic	C0029005
28277189	osteosarcoma	C0029463
28277189	metastasis	C4255448
28277189	CXCL5	C1955899
28277189	potential	C3245505
28277189	therapeutic target	C0205245
28277189	osteosarcoma	C0029463
28277189	treatment	C0039798
28278150	Integrating	C1881786
28278150	molecular	C1521991
28278150	QTL	C0597336
28278150	data	C1511726
28278150	genome-wide genetic association analysis	C2350277
28278150	Probabilistic	C0033204
28278150	assessment	C1292732
28278150	enrichment	C2986411
28278150	colocalization	C0475264
28278150	statistical framework	C0026348
28278150	integrating	C1881786
28278150	result	C1274040
28278150	molecular	C1521991
28278150	quantitative trait loci	C0597336
28278150	QTL	C0597336
28278150	mapping	C1283195
28278150	genome-wide genetic association analysis	C2350277
28278150	complex	C0439855
28278150	traits	C0599883
28278150	quantitatively	C0392762
28278150	assessing	C1292732
28278150	enrichment	C2986411
28278150	molecular	C1521991
28278150	QTLs	C0597336
28278150	complex	C0439855
28278150	trait	C0599883
28278150	associated	C0332281
28278150	genetic variants	C0678941
28278150	colocalizations	C0475264
28278150	types	C0332307
28278150	association	C0439849
28278150	signals	C1710082
28278150	natural Bayesian hierarchical model	C0242198
28278150	association	C0439849
28278150	molecular	C1521991
28278150	QTLs	C0597336
28278150	SNP	C0752046
28278150	level	C0441889
28278150	SNPs	C0752046
28278150	complex	C0439855
28278150	traits	C0599883
28278150	computational	C1880157
28278150	procedure	C2700391
28278150	enrichment	C2986411
28278150	fine-mapping	C1283195
28278150	colocalization	C0475264
28278150	analyses	C0936012
28278150	distinct feature	C2348519
28278150	compared	C1707455
28278150	colocalization	C0475264
28278150	analysis	C0936012
28278150	procedures	C2700391
28278150	literature	C0023866
28278150	approach	C0449445
28278150	computationally	C1880157
28278150	efficient	C0442799
28278150	summary	C1706244
28278150	level	C0441889
28278150	statistics	C2828391
28278150	evaluate	C1292732
28278150	computational	C1880157
28278150	approach	C0449445
28278150	extensive	C0205231
28278150	simulation	C0009609
28278150	studies	C2603343
28278150	analyses	C0936012
28278150	blood lipid	C0596192
28278150	data	C1511726
28278150	whole blood	C0370231
28278150	eQTL	C0597336
28278150	data	C1511726
28278150	GTEx project	C4289040
28278150	utility	C0025663
28278150	method	C0025663
28278150	computation	C1880157
28278150	colocalization	C0475264
28278150	signals	C1710082
28278150	characteristics	C1521970
28278150	association	C0439849
28278150	data	C1511726
28278150	utility	C0025663
28278150	enrichment	C2986411
28278150	analysis	C0936012
28278150	colocalized	C0475264
28278150	signals	C1710082
28278150	potential	C3245505
28278150	limitations	C0449295
28278150	molecular	C1521991
28278150	QTL	C0597336
28278150	data	C1511726
28278150	software	C0037585
28278150	computation	C1880157
28278150	procedures	C2700391
28278150	enloc	C0242356
28278150	https://github.com/xqwen/integrative	C2349146
28280149	Engineering	C0017387
28280149	ribosomal DNA	C0012933
28280149	megabase synthetic chromosome	C0872017
28280149	976,067-base pair linear chromosome	C0872017
28280149	synXII	C0872017
28280149	chromosome XII	C0008642
28280149	Saccharomyces cerevisiae	C0036025
28280149	SynXII	C0872017
28280149	two-step method	C0449851
28280149	megachunk integration	C0017387
28280149	meiotic recombination-mediated assembly	C0017387
28280149	functional	C0205245
28280149	chromosome	C0008642
28280149	S. cerevisiae	C0036025
28280149	Minor growth defect	C1457869
28280149	bugs	C1457869
28280149	detected	C0442726
28280149	synXII	C0872017
28280149	deletion	C0017260
28280149	tRNA	C0035711
28280149	genes	C0017337
28280149	ectopic copy	C0017337
28280149	single tRNA	C0035711
28280149	gene	C0017337
28280149	ribosomal gene cluster	C0017258
28280149	rDNA	C0017258
28280149	synXII	C0872017
28280149	assembly process	C0017387
28280149	modified	C0392747
28280149	rDNA	C0017258
28280149	regenerate	C0334213
28280149	rDNA	C0017258
28280149	chromosomal locations	C0008633
28280149	sequences	C0004793
28280149	rDNA	C0017258
28280149	species	C1705920
28280149	identity	C0243095
28280149	Saccharomyces	C0036024
28280149	synXII	C0872017
28280149	strain	C1518614
28280149	identified	C0205396
28280149	Saccharomyces bayanus	C1504647
28280149	standard	C1442989
28281646	Humidity	C0020167
28281646	Sensitive	C0332324
28281646	Clothing	C0009072
28281646	Personal Thermoregulation	C0262758
28281646	humidity	C0020167
28281646	induced	C0205263
28281646	smart clothing	C0009072
28281646	designed to reversibly adapt	C3274373
28281646	thermal insulation functionality	C1708520
28281646	pores	C0221956
28281646	human skin	C1123023
28281646	pores	C0221956
28281646	Nafion	C0068361
28281646	sheets	C0039717
28281646	humidity	C0020167
28281646	human sweating	C0038990
28281646	air flow	C0042491
28281646	humidity	C0020167
28281646	apparent temperature	C0039476
28281646	human sweating pores	C0221956
28281646	perspiration	C0038990
28281646	wearer warm	C0009072
28281646	thickness	C1280412
28281646	adjustable clothes	C0009072
28281646	bent polymer sheets	C0039717
28281646	fabrics	C0039717
28281646	humidity	C0020167
28281646	sheets	C0039717
28281646	fabrics	C0039717
28281646	thermal insulation	C0205245
28281646	insulation layer	C1708520
28281646	thickness	C1280412
28281646	humidity	C0020167
28281646	warmth-preservation	C0392197
28281646	humidity	C0020167
28281646	sensitive	C0332324
28281646	polymer materials	C0039717
28281646	personal comfort	C1331418
28281646	reducing energy consumption	C0243095
28281646	heating or cooling	C0205245
28281646	smart design	C1707689
28282592	Development	C0243107
28282592	automaton model	C0026336
28282592	rotational activity	C0441655
28282592	atrial fibrillation	C0004238
28282592	Atrial fibrillation	C0004238
28282592	AF	C0004238
28282592	treat	C0087111
28282592	effectively	C1704419
28282592	uncertainty	C0087130
28282592	ablate	C0162563
28282592	eliminate	C0441655
28282592	arrhythmogenic	C0085611
28282592	substrate	C3891814
28282592	model	C0026336
28282592	electrical	C0442828
28282592	activation	C1879547
28282592	events	C0441471
28282592	catheter ablation strategy	C0162559
28282592	two-dimensional	C1705052
28282592	576×576 node automaton	C0336537
28282592	simulate	C0441655
28282592	atrial	C0018792
28282592	atrial electrical activity	C0596673
28282592	substrate	C3891814
28282592	differing	C1705242
28282592	refractory period	C0678839
28282592	locations	C0450429
28282592	Fibrosis	C0016059
28282592	conduction	C0232217
28282592	block	C0018794
28282592	Larger	C0549177
28282592	areas	C0205146
28282592	block	C0028778
28282592	simulate	C0441655
28282592	ablation lesions	C0221198
28282592	Anisotropy	C0085406
28282592	ratio	C0456603
28282592	premature	C1254367
28282592	electrical impulse	C1720744
28282592	initiate	C1548602
28282592	activation	C1879547
28282592	Rotational activity	C0441655
28282592	refractory patch dimensions	C0439534
28282592	larger	C0549177
28282592	refractory regions	C1254362
28282592	premature	C1254367
28282592	stimulus	C0234402
28282592	inducing	C0205263
28282592	average	C1510992
28282592	rotors	C0025080
28282592	patch edges	C1254362
28282592	maximum	C0806909
28282592	rotors	C0025080
28282592	refractory patch dimensions	C0439534
28282592	size	C0456389
28282592	left atrial	C0225860
28282592	virtual field	C1254362
28282592	Rotors	C0025080
28282592	refractory patch edge	C1254362
28282592	wavefront arrival was delayed	C0243095
28282592	fiber	C1304649
28282592	cluster	C1704332
28282592	size	C0456389
28282592	rotational activity	C0441655
28282592	large	C0549177
28282592	fiber	C1304649
28282592	cluster	C1704332
28282592	spatially variable refractoriness	C0205556
28282592	obstacles	C4045969
28282592	conduction	C0232217
28282592	lacking	C0332268
28282592	size	C0456389
28282592	nascent rotors	C0025080
28282592	stabilized	C0184512
28282592	anchoring	C1624581
28282592	large	C0549177
28282592	fiber	C1304649
28282592	cluster	C1704332
28282592	Transient	C0205374
28282592	rotors	C0025080
28282592	traversing	C0441655
28282592	region	C0205147
28282592	refractory periods	C0678839
28282592	obstacle	C4045969
28282592	conduction	C0232217
28282592	delay wavefront arrival	C0243095
28282592	longest	C1522425
28282592	refractory period	C0678839
28282592	rotors	C0025080
28282592	rotor	C0025080
28282592	spin rate	C0392762
28282592	activation pathway	C1148560
28282592	Elimination	C0441655
28282592	anchors	C1293132
28282592	removal	C0015252
28282592	ablation	C0162563
28282592	region	C0205147
28282592	rotor	C0025080
28282592	onset	C0332162
28282592	location	C1515974
28282592	obstacles	C4045969
28282592	conduction	C0232217
28282592	spatial differences	C0243095
28282592	refractory period	C0678839
28282592	parameters	C0237767
28282592	maintaining	C1314677
28282592	rotational activity	C0441655
28282592	simulation	C0679083
28282592	atrial	C0018792
28282592	substrate	C3891814
28282963	Multimodal brain imaging	C1513743
28282963	magnetoencephalography	C0024489
28282963	method	C0430022
28282963	measuring	C0242485
28282963	blood pressure	C0005823
28282963	cardiorespiratory oscillations	C0871665
28282963	Studies	C2603343
28282963	magnetoencephalography	C0024489
28282963	MEG	C0024489
28282963	methods	C0430022
28282963	metabolic dimension	C0025520
28282963	MEG	C0024489
28282963	investigation	C0220825
28282963	blood pressure measurements	C3826646
28282963	MEG	C0024489
28282963	methods	C0430022
28282963	neurovascular status	C1828265
28282963	low frequency	C0205213
28282963	fluctuations	C0231239
28282963	functional connectivity	C1707489
28282963	brain networks	C2951780
28282963	multimodal brain imaging	C1513743
28282963	non-invasively	C0205303
28282963	cerebral	C0006104
28282963	hemodynamic	C0019010
28282963	cardiorespiratory	C0846599
28282963	blood pressure	C0005823
28282963	oscillations	C0871665
28282963	MEG	C0024489
28282963	methods	C0430022
28282963	MEG	C0024489
28282963	fibre optics	C0015979
28282963	method	C0430022
28282963	measuring	C0242485
28282963	blood pressure	C0005823
28282963	cardiorespiratory oscillations	C0871665
28282963	MEG	C0024489
28282963	potential	C3245505
28282963	multimodal	C1513743
28282963	brain research	C0035168
28282963	human	C0086418
28282963	effects of	C1704420
28282963	mild hypercapnia	C0020440
28282963	modalities	C1275506
28283668	Effect of	C1704420
28283668	peritoneal lavage	C0031148
28283668	solution	C0037633
28283668	temperature	C0039476
28283668	body temperature	C0005903
28283668	anaesthetised	C1720436
28283668	cats	C0007450
28283668	dogs	C0012984
28283668	prospective	C0033522
28283668	randomised	C0206034
28283668	non-blinded	C0242481
28283668	clinical study	C0008972
28283668	effect of	C1704420
28283668	peritoneal lavage	C0031148
28283668	warmed	C0687712
28283668	fluid	C0302908
28283668	body temperature	C0005903
28283668	anesthetised	C1720436
28283668	cats	C0007450
28283668	dogs	C0012984
28283668	body mass	C0518010
28283668	coeliotomy	C0023038
28283668	standardised anaesthetic protocol	C0442711
28283668	Oesophageal	C3161742
28283668	rectal temperatures	C0489749
28283668	measured	C0444706
28283668	various time points	C1552717
28283668	surgery	C0543467
28283668	group 1 patients	C0030705
28283668	lavaged	C0022100
28283668	sterile	C0232920
28283668	isotonic saline	C0445115
28283668	group	C1642385
28283668	Groups	C1642385
28283668	age	C0596090
28283668	mass	C1306372
28283668	body condition	C3687361
28283668	surgical incision	C0184898
28283668	Duration	C0449238
28283668	anaesthesia	C0002921
28283668	surgical procedures	C0543467
28283668	peritoneal lavage	C0031148
28283668	groups	C1642385
28283668	Linear regression	C0023733
28283668	no significant change	C0243095
28283668	oesophageal temperature	C3161742
28283668	lavage	C0022100
28283668	period	C1948053
28283668	group	C1642385
28283668	group 2 patients	C0030705
28283668	mean	C0444504
28283668	temperature changes	C0450031
28283668	results	C0459422
28283668	rectal temperature	C0489749
28283668	mean	C0444504
28283668	isotonic	C0022260
28283668	crystalloid solution	C0056562
28283668	peritoneal lavage	C0031148
28283668	temperature	C0039476
28283668	warms	C0687712
28283668	small animal patients	C0030705
28283668	clinical setting	C3176918
28283668	lavage	C0022100
28284875	Bioengineered	C2717958
28284875	3D	C0450363
28284875	Models	C0026339
28284875	Studying	C2603343
28284875	Human	C0086418
28284875	Cell	C0007634
28284875	Tuberculosis	C0026926
28284875	Interactions	C1704675
28284875	In vivo	C1515655
28284875	animal models	C0599779
28284875	studying	C2603343
28284875	relationships	C0439849
28284875	tuberculosis	C0026926
28284875	host	C1167395
28284875	in vitro	C1533691
28284875	cellular models	C0026339
28284875	microsphere	C0026032
28284875	3D	C0450363
28284875	in vitro	C1533691
28284875	culture system	C1516329
28284875	Mycobacterium tuberculosis	C0026926
28284875	human	C0086418
28284875	blood	C0005767
28284875	mononuclear cells	C0806987
28284875	host	C1167395
28284875	pathogen	C0450254
28284875	interactions	C1704675
28285800	Perspectives	C1254370
28285800	cardiovascular	C0007226
28285800	effects of	C1704420
28285800	incretin	C1562292
28285800	drugs	C1254351
28285800	cardiovascular	C0007226
28285800	outcome	C1274040
28285800	trials	C0008976
28285800	glucose	C0017725
28285800	drugs	C1254351
28285800	type 2 diabetes mellitus	C0011860
28285800	glucagon-like peptide-1 receptor	C0378073
28285800	agonists	C0243192
28285800	GLP-1RA	C0243192
28285800	liraglutide	C1456408
28285800	semaglutide	C3885068
28285800	reduction	C0547047
28285800	cardiovascular events	C1320716
28285800	trials	C0008976
28285800	incretin	C1562292
28285800	drugs	C1254351
28285800	lixisenatide	C2973895
28285800	dipeptidyl peptidase-4 inhibitors	C1827106
28285800	DPP4i	C1827106
28285800	Mechanisms	C0441712
28285800	cardiovascular	C0007226
28285800	differences	C1705242
28285800	DPP4i	C1827106
28285800	GLP1-RA	C0243192
28285800	GLP1-RA	C0243192
28285800	review	C0282443
28285800	evidence	C3887511
28285800	experimental	C0681814
28285800	mechanistic studies	C0681814
28285800	action	C3266814
28285800	GLP1-RA	C0243192
28285800	DPP4i	C1827106
28285800	cardiovascular system	C0007226
28285800	clinical	C0011001
28285800	pre-clinical sources	C0011001
28285800	results	C1274040
28285800	cardiovascular	C0007226
28285800	outcome	C1274040
28285800	trials	C0008976
28285800	experimental	C0681814
28285800	preclinical data	C1516606
28285800	heart failure	C0018801
28285800	results	C1274040
28285800	hypotheses	C1512571
28285800	findings	C2607943
28285800	cardioprotection	C0205245
28285800	incretin	C1562292
28285800	drugs	C1254351
28285800	incretin	C1562292
28285800	cardiovascular	C0007226
28285800	effects of	C1704420
28285800	cardiac	C0018787
28285800	action	C3266814
28285800	GLP-1	C0061355
28285800	metabolites	C0870883
28285800	GLP-1 receptor	C0378073
28285800	pathways	C1704259
28285800	DPP4	C0081937
28285800	substrates	C3891814
28285800	GLP-1	C0061355
28286021	breast magnetic resonance imaging	C0344104
28286021	predicting	C0681842
28286021	residual	C1609982
28286021	lobular carcinoma in situ	C0279563
28286021	initial	C0205265
28286021	excision	C0728940
28286021	Breast magnetic resonance (MR) imaging	C0344104
28286021	screening	C0199230
28286021	modality	C0695347
28286021	detecting	C1511790
28286021	suspicious	C4050405
28286021	lesions	C0221198
28286021	patients	C0030705
28286021	history	C0262926
28286021	lobular carcinoma in situ	C0279563
28286021	LCIS	C0279563
28286021	study	C2603343
28286021	aimed	C1947946
28286021	evaluate	C0220825
28286021	effectiveness	C1280519
28286021	breast MR imaging	C0344104
28286021	detecting	C1511790
28286021	remnant	C3272697
28286021	LCIS	C0279563
28286021	lesions	C0221198
28286021	after	C0687676
28286021	initial	C0205265
28286021	excision	C0728940
28286021	patients	C0030705
28286021	LCIS	C0279563
28286021	underwent	C2586066
28286021	initial	C0205265
28286021	excision	C0728940
28286021	Breast ultrasonography	C0080264
28286021	breast MR imaging	C0344104
28286021	after	C0687676
28286021	initial	C0205265
28286021	excision	C0728940
28286021	Imaging findings	C1287399
28286021	compared	C1707455
28286021	pathologic	C0030660
28286021	results	C1274040
28286021	cases	C1706256
28286021	positive margins	C1709603
28286021	after	C0687676
28286021	initial	C0205265
28286021	excision	C0728940
28286021	LCIS	C0279563
28286021	atypical lobular hyperplasia	C1368920
28286021	Residual	C1609982
28286021	lesions	C0221198
28286021	identified	C0205396
28286021	cases	C1706256
28286021	invasive lobular carcinoma	C0279565
28286021	LCIS	C0279563
28286021	atypical lobular hyperplasia	C1368920
28286021	papillary carcinoma in situ	C0334242
28286021	Prior	C0332152
28286021	second	C0205436
28286021	operation	C0543467
28286021	lesions	C0221198
28286021	cases	C1706256
28286021	ultrasonography	C0080264
28286021	sensitivity	C1511883
28286021	specificity	C1511884
28286021	cases	C1706256
28286021	breast MR imaging	C0344104
28286021	sensitivity	C1511883
28286021	specificity	C1511884
28286021	Breast MR imaging	C0344104
28286021	higher	C0205250
28286021	sensitivity	C1511883
28286021	breast ultrasonography	C0080264
28286021	detecting	C1511790
28286021	remnant	C3272697
28286021	LCIS	C0279563
28286021	lesions	C0221198
28286021	suspicious	C4050405
28286021	lesion	C0221198
28286021	breast MR imaging	C0344104
28286021	second	C0205436
28286021	operation	C0543467
28286021	considered	C0750591
28286021	possibility	C0332149
28286021	multifocality	C2986663
28286021	LCIS	C0279563
28286021	confirmed	C0750484
28286021	initial	C0205265
28286021	operation	C0543467
28286958	Construction	C0007987
28286958	Fused Polyheterocycles	C1254350
28286958	Sequential	C1705294
28286958	[4 + 2] and [3 + 2] Cycloadditions	C0598128
28286958	Pd	C0030230
28286958	catalyzed	C0007382
28286958	aerobic	C1510824
28286958	oxidative reaction	C0030011
28286958	quinazolinones	C1720912
28286958	alkynes	C0002078
28286958	sequential	C1705294
28286958	[4 + 2] and [3 + 2] cycloadditions	C0598128
28286958	assemble	C1706853
28286958	novel	C0205314
28286958	fused-polycyclic system	C1254350
28286958	tetrahydropyridine	C0044607
28286958	dihydrofuran rings	C0029224
28286958	reaction process	C0596319
28286958	C-H and N-H bond	C0813982
28286958	formation	C1522492
28286958	tetrahydropyridine	C0044607
28286958	oxygen radical	C0030054
28286958	cyclization	C0010546
28286958	dihydrofuran ring	C0029224
28286958	atom	C0567415
28286958	economical synthesis	C0013556
28286958	substrate	C3891814
28286958	tolerance	C1704410
28286958	construction	C0007987
28286958	polycyclic molecules	C1254350
28286958	pharmaceutical interest.	C0008003
28287035	Biological	C0205460
28287035	basis	C1874451
28287035	radiation protection	C0034533
28287035	rejuvenation	C0035016
28287035	Human beings	C0086418
28287035	radiation	C0851346
28287035	proximity	C1514583
28287035	radioactive waste	C0034552
28287035	sites	C0205145
28287035	participation	C0679823
28287035	medical procedures	C0199171
28287035	X-rays	C0043309
28287035	radiation exposures	C0015333
28287035	legally regulated	C0851285
28287035	radiation protection	C0034533
28287035	policy	C0242456
28287035	biological	C0205460
28287035	cellular	C0178539
28287035	molecular	C1521991
28287035	effects of	C1704420
28287035	low doses	C0445550
28287035	dose rates	C1512044
28287035	radiation	C0851346
28287035	high dose	C0444956
28287035	radiation exposures	C0015333
28287035	technical developments	C1527148
28287035	biology	C0005532
28287035	medicine	C0025118
28287035	single cell techniques	C0597452
28287035	big data computational research	C4297010
28287035	approaches	C1292724
28287035	study	C2603343
28287035	biology	C0005532
28287035	low doses	C0445550
28287035	radiation	C0851346
28287035	support	C1521721
28287035	idea	C1947946
28287035	low doses	C0445550
28287035	radiation	C0851346
28287035	associated with	C0332281
28287035	high dose	C0444956
28287035	exposures	C0014412
28287035	sufficient	C0205410
28287035	development	C1527148
28287035	theoretical framework	C0282574
28287035	low dose	C0445550
28287035	radiation exposures	C0015333
28287035	radiation effects	C4281532
28287035	low doses	C0445550
28287035	radiation protection	C0034533
28287035	policy	C0242456
28289065	Gleason grade grouping	C0332326
28289065	prostate cancer	C0600139
28289065	prognostic value	C1514474
28289065	Asian	C0078988
28289065	men	C0025266
28289065	International Society of Urological Pathology	C1708333
28289065	Grade Groups	C0332326
28289065	GG	C0332326
28289065	Epstein	C1547383
28289065	colleagues	C0681088
28289065	Gleason score	C3203027
28289065	GS	C3203027
28289065	adopted	C0425382
28289065	WHO classification	C4267671
28289065	studies	C2603343
28289065	revision	C0439617
28289065	Caucasian populations	C0043157
28289065	GG system	C0332326
28289065	biochemical disease-free survival	C0242793
28289065	mixed-ethnicity	C0015031
28289065	cohort	C0599755
28289065	Asian	C0078988
28289065	men	C0025266
28289065	radical prostatectomies	C0194810
28289065	RPs	C0194810
28289065	GS	C3203027
28289065	biopsy	C0005558
28289065	RP	C0194810
28289065	cases	C0868928
28289065	GG	C0332326
28289065	GS	C3203027
28289065	GS	C3203027
28289065	GS	C3203027
28289065	GS	C3203027
28289065	GS	C3203027
28289065	Biochemical recurrence	C2985506
28289065	RP	C0194810
28289065	prostate-specific antigen	C0138741
28289065	PSA	C0138741
28289065	RP	C0194810
28289065	PSA	C0138741
28289065	nadir	C1708760
28289065	data	C1511726
28289065	Kaplan-Meier analysis	C1720943
28289065	biochemical recurrence	C2985506
28289065	Gleason GG	C0332326
28289065	biopsy	C0005558
28289065	prostatectomy	C0033573
28289065	scoring	C0449820
28289065	Multivariate analysis	C0026777
28289065	GG	C0332326
28289065	risk	C0035647
28289065	biochemical recurrence	C2985506
28289065	GG system	C0332326
28289065	prognostic	C0449821
28289065	discrimination	C2945687
28289065	biopsy	C0005558
28289065	RP	C0194810
28289065	GS	C3203027
28289065	study	C2603343
28289065	validates	C1519941
28289065	revised	C0439617
28289065	updated	C1519814
28289065	GG system	C0332326
28289065	mixed-ethnicity population	C0015031
28289065	Asian	C0078988
28289065	men	C0025266
28289065	GG	C0332326
28289065	risk	C0035647
28289065	biochemical recurrence	C2985506
28289065	clinical management	C1516615
28289065	patients	C0030705
28289065	prostate cancer	C0600139
28289091	Membrane	C3161472
28289091	nanoclusters	C1704332
28289091	FcγRI	C0123263
28289091	inhibitory	C3463820
28289091	SIRPα	C0671702
28289091	activation of human macrophages	C2248379
28289091	Signal integration	C0037083
28289091	activating	C1879547
28289091	Fc receptors	C0034805
28289091	inhibitory	C3463820
28289091	signal regulatory protein α	C0671702
28289091	SIRPα	C0671702
28289091	macrophage	C0024432
28289091	phagocytosis	C0031308
28289091	dual-color direct stochastic optical reconstruction microscopy	C0430389
28289091	Fcγ receptor I	C0123263
28289091	FcγRI	C0123263
28289091	FcγRII	C0796385
28289091	SIRPα	C0671702
28289091	homogeneously	C1881065
28289091	macrophage	C0024432
28289091	surfaces	C0699040
28289091	discrete	C0443299
28289091	nanoclusters	C1704332
28289091	Nanoclusters	C1704332
28289091	FcγRI	C0123263
28289091	FcγRII	C0796385
28289091	associated with	C0332281
28289091	nanoclusters	C1704332
28289091	SIRPα	C0671702
28289091	actin cytoskeleton	C0025979
28289091	Fc receptor	C0034805
28289091	activation	C1514758
28289091	Src-family kinase	C0282625
28289091	signaling	C1154413
28289091	FcγRI	C0123263
28289091	SIRPα	C0671702
28289091	nanoclusters	C1704332
28289091	Co-ligation	C0314675
28289091	SIRPα	C0671702
28289091	CD47	C1506697
28289091	nanocluster	C1704332
28289091	signals	C0037083
28289091	activation	C1879547
28289091	FcγRI	C0123263
28289091	nanoclusters	C1704332
28289091	reorganize	C0680829
28289091	periodically	C0332182
28289091	concentric rings	C1254362
28289091	nanometer	C0439202
28289091	micron-scale	C0439201
28289091	reorganization	C0680829
28289091	activating	C1879547
28289091	inhibitory	C3463820
28289091	receptors	C0597357
28289091	human macrophages	C0024432
28289091	concurrent	C0205420
28289091	signal integration	C0037083
28289914	Firecracker	C0336696
28289914	eye exposure	C3544170
28289914	experimental study	C0681814
28289914	simulation	C0679083
28289914	mechanisms	C0441712
28289914	traumatic	C0332663
28289914	ocular injury	C0015408
28289914	accurate	C0443131
28289914	diagnoses	C0011900
28289914	symptoms	C1457887
28289914	eye protection	C3826373
28289914	comprehension	C0162340
28289914	dynamics	C3826426
28289914	primary	C0205225
28289914	blast injury	C0005700
28289914	mechanisms	C0441712
28289914	issue	C0033213
28289914	pressure	C0033095
28289914	wave	C0678544
28289914	propagation	C1254366
28289914	reflection	C4054089
28289914	cause	C0085978
28289914	ocular damage	C4061128
28289914	dissenting	C0012742
28289914	opinions	C0871010
28289914	conclusive	C2828146
28289914	evidence	C3887511
28289914	numerical investigation	C0220825
28289914	blast	C0337026
28289914	trauma	C3714660
28289914	dynamic	C0729333
28289914	effect	C1280500
28289914	pressure	C0033095
28289914	propagation	C1254366
28289914	amplification	C1521871
28289914	geometry	C0449829
28289914	bony orbit	C1266926
28289914	inducing	C0205263
28289914	resonance	C0459800
28289914	cavity	C0029180
28289914	effect	C1280500
28289914	standing wave	C0678544
28289914	hazardous	C0337044
28289914	eye	C0015392
28289914	tissues	C0040300
28289914	experimental	C1517586
28289914	evidence	C3887511
28289914	numerically	C0243174
28289914	identified	C0205396
28289914	phenomenon	C1882365
28289914	tests	C0392366
28289914	evaluating	C0220825
28289914	response	C0871261
28289914	porcine	C3665571
28289914	eyes	C0015392
28289914	blast	C0337026
28289914	overpressure	C0033095
28289914	firecrackers	C0336696
28289914	explosion	C0015329
28289914	performed	C0884358
28289914	orbital cavity	C0029180
28289914	effect	C1280500
28289914	enucleated eyes	C1396718
28289914	orbit	C0029180
28289914	experimental	C1517586
28289914	measurements	C0242485
28289914	obtained	C1301820
28289914	explosion	C0015329
28289914	tests	C0392366
28289914	paper	C0282420
28289914	corroborate	C1456348
28289914	numerical evidence	C3887511
28289914	high-frequency	C0205212
28289914	pressure	C0033095
28289914	amplification	C1521871
28289914	enhancing	C2349975
28289914	ocular	C0015392
28289914	tissues	C0040300
28289914	attributable	C0596130
28289914	orbital bony walls	C4243627
28289914	eye	C0015392
28294559	platelet-activating receptor	C0071234
28294559	C-type lectin receptor-2	C2354438
28294559	role	C1705810
28294559	liver regeneration	C0023907
28294559	partial hepatectomy	C0193398
28294559	mice	C0025929
28294559	Regeneration	C0023907
28294559	role	C1705810
28294559	C-type lectin receptor-2	C2354438
28294559	CLEC-2	C2354438
28294559	70% hepatectomy	C0193398
28294559	HPx	C0193398
28294559	Wild-type	C1883559
28294559	CLEC-2	C0017337
28294559	deleted	C0017260
28294559	platelets	C0005821
28294559	chimeric mice	C0025929
28294559	flKO	C0025929
28294559	HPx	C0193398
28294559	liver/body weight ratio	C2983636
28294559	flKO	C0025929
28294559	wild-type	C1520150
28294559	CLEC-2	C2354438
28294559	role	C1705810
28294559	liver regeneration	C0023907
28294559	HPx	C0193398
28294559	role	C1705810
28294559	C-type lectin receptor (CLEC)-2	C2354438
28294559	liver regeneration	C0023907
28294559	partial liver resection	C0193398
28294559	mice	C0025929
28294559	chimeric mice	C0025929
28294559	transplanted	C0700106
28294559	fetal	C0521457
28294559	liver cells	C0227525
28294559	wild-type (WT) mice	C1520150
28294559	CLEC-2	C0017337
28294559	deleted	C0017260
28294559	mice	C0025929
28294559	mice	C0025929
28294559	CLEC-2	C0017337
28294559	deleted	C0017260
28294559	platelets	C0005821
28294559	generated	C3146294
28294559	Mice	C0025929
28294559	70% partial hepatectomy	C0193398
28294559	PH	C0193398
28294559	Immunohistochemical staining	C0487602
28294559	expression	C1171362
28294559	endogenous	C0205227
28294559	ligand	C0023688
28294559	CLEC-2	C2354438
28294559	podoplanin	C3537357
28294559	accumulation	C0007613
28294559	platelets	C0005821
28294559	liver	C0023884
28294559	quantified	C1709793
28294559	hepatic	C0205054
28294559	expression	C1171362
28294559	IL-6	C0021760
28294559	gp130	C0017968
28294559	STAT3	C0253050
28294559	Akt	C0164786
28294559	ERK1/2	C0600388
28294559	liver/body weight ratio	C2983636
28294559	expression	C1171362
28294559	cell proliferation	C0596290
28294559	markers	C1611701
28294559	flKO group	C0025929
28294559	WT group	C1520150
28294559	expression	C1171362
28294559	phosphorylated (p) Akt	C0164786
28294559	pERK1	C0600388
28294559	WT	C1520150
28294559	flKO groups	C0025929
28294559	expression	C1171362
28294559	pSTAT3	C0253050
28294559	IL-6	C0021760
28294559	WT group	C1520150
28294559	flKO group	C0025929
28294559	expression	C1171362
28294559	podoplanin	C3537357
28294559	hepatic sinusoids	C0227523
28294559	groups	C0441833
28294559	platelets	C0005821
28294559	hepatic sinusoids	C0227523
28294559	flKO group	C0025929
28294559	WT group	C1520150
28294559	CLEC-2	C2354438
28294559	hepatic regeneration	C0023907
28294559	liver resection	C0019144
28294559	CLEC-2	C2354438
28294559	liver regeneration	C0023907
28294559	platelets	C0005821
28294559	sinusoidal	C0682624
28294559	endothelial cells	C0225336
28295414	Temporal	C1254367
28295414	Stability	C0205360
28295414	Heavy Drinking	C0556345
28295414	Drinking	C0001948
28295414	Reductions	C0441610
28295414	Heavy Drinkers	C0337678
28295414	COMBINE Study	C2603343
28295414	Food and Drug Administration	C0041714
28295414	FDA	C0041714
28295414	expand	C0205229
28295414	primary	C0205225
28295414	end points	C2349179
28295414	development	C1527148
28295414	medications	C2081612
28295414	alcohol use disorder	C0001956
28295414	abstinence	C3843422
28295414	alcohol	C0001967
28295414	nonabstinent	C0243095
28295414	outcome	C1274040
28295414	heavy drinking	C0556345
28295414	heavy drinking	C0556345
28295414	defined	C1704788
28295414	drinks	C0001967
28295414	women	C0043210
28295414	drinks	C0001967
28295414	men	C0025266
28295414	cutoff	C1442160
28295414	FDA	C0041714
28295414	suggested	C1705535
28295414	months	C0439231
28295414	appropriate	C1548787
28295414	length for a clinical trial	C1706316
28295414	stability	C0205360
28295414	nonabstinent	C0243095
28295414	drinking	C0001948
28295414	outcome	C1274040
28295414	clinical trials	C0008976
28295414	examined	C0332128
28295414	stability	C0205360
28295414	nonheavy drinking	C0556344
28295414	during	C0347984
28295414	after treatment	C0001758
28295414	secondary analysis	C0683944
28295414	COMBINE study	C2603343
28295414	data	C1511726
28295414	examined	C0332128
28295414	transitions	C2700061
28295414	heavy drinking	C0556345
28295414	during the course of treatment	C0454268
28295414	months	C0439231
28295414	during	C0347984
28295414	transition	C2700061
28295414	treatment	C0087111
28295414	months	C0439231
28295414	months	C0439231
28295414	months	C0439231
28295414	latent variable mixture models	C0681946
28295414	Heavy drinking	C0556345
28295414	nonheavy drinking	C0556344
28295414	stable	C0205360
28295414	consecutive	C1707491
28295414	months	C0439231
28295414	minimum	C1524031
28295414	months	C0439231
28295414	individuals	C0237401
28295414	stable	C0205360
28295414	low-risk	C3538919
28295414	drinkers	C0556338
28295414	abstainers	C0682156
28295414	heavy drinkers	C0337678
28295414	treatment	C0087111
28295414	characterized	C1880022
28295414	probability	C0033204
28295414	transitioning	C2700061
28295414	heavy drinking	C0556345
28295414	state	C1442792
28295414	heavy drinking	C0556345
28295414	state	C1442792
28295414	heavy drinkers	C0337678
28295414	heavy drinking	C0556345
28295414	threshold	C0449864
28295414	during treatment	C2709058
28295414	reported	C0700287
28295414	average	C1510992
28295414	reduction	C0441610
28295414	drinking frequency	C0556327
28295414	reduction	C0441610
28295414	drinking	C0001948
28295414	pretreatment	C3539076
28295414	drinking	C0001948
28295414	levels	C0441889
28295414	results	C0456984
28295414	stability	C0205360
28295414	heavy drinking	C0556345
28295414	outcome	C1274040
28295414	months	C0439231
28295414	treatment	C0087111
28295414	drink	C0001967
28295414	cutoff	C1442160
28295414	reductions	C0441610
28295414	alcohol consumption	C0001948
28295414	patients	C0030705
28295414	studies	C2603343
28295414	clinical	C0205210
28295414	reduction	C0441610
28295414	end points	C2349179
28296885	Oral health	C0029162
28296885	transition	C2700061
28296885	Hadza foragers	C1257890
28296885	Tanzania	C0039298
28296885	Conventional	C0439858
28296885	decline	C0547047
28296885	oral health	C0029162
28296885	transition	C2700061
28296885	hunting	C4255216
28296885	gathering	C2371489
28296885	agriculture	C0001829
28296885	increased	C0205217
28296885	consumption	C1947907
28296885	carbohydrates	C0012170
28296885	example	C1707959
28296885	mismatch	C1881865
28296885	biology	C0005532
28296885	modern lifestyle	C0023676
28296885	bioarchaeological record	C0034869
28296885	Neolithic Revolution	C2948499
28296885	New World	C2700280
28296885	studies	C2603343
28296885	populations	C0032659
28296885	assertion	C1301625
28296885	comprehensive	C1880156
28296885	study	C2603343
28296885	oral health	C0029162
28296885	living population	C1257890
28296885	transition	C2700061
28296885	bush	C0330099
28296885	village life	C0023676
28296885	Hadza	C1257890
28296885	hunter	C0239971
28296885	gatherers	C1257890
28296885	Tanzania	C0039298
28296885	hypothesis	C1512571
28296885	shift	C2700061
28296885	foraging	C2752984
28296885	farming	C0001829
28296885	agricultural intensification	C0001827
28296885	increased	C0205217
28296885	periodontal disease	C0031090
28296885	caries	C0011334
28296885	orthodontic	C0332276
28296885	disorders	C0012634
28296885	results	C1274040
28296885	women	C0043210
28296885	living	C0337645
28296885	villages	C0562518
28296885	consuming	C1947907
28296885	agricultural	C0242775
28296885	diet	C0012155
28296885	caries	C0011334
28296885	periodontal disease	C0031090
28296885	living	C0337645
28296885	bush	C0330099
28296885	consuming	C1947907
28296885	wild-food diet	C0012155
28296885	men	C0025266
28296885	living	C0337645
28296885	bush	C0330099
28296885	consuming	C1947907
28296885	wild-food diet	C0012155
28296885	living	C0337645
28296885	village	C0562518
28296885	consuming	C1947907
28296885	agricultural	C0242775
28296885	diet	C0012155
28296885	findings	C0243095
28296885	high	C0205250
28296885	incidence	C0021149
28296885	maize	C1138842
28296885	consumption	C1947907
28296885	village	C0562518
28296885	variation	C0205419
28296885	rate	C1521828
28296885	caries	C0011334
28296885	men	C0025266
28296885	women	C0043210
28296885	high	C0205250
28296885	caries	C0011334
28296885	incidences	C0021149
28296885	men	C0025266
28296885	bush	C0330099
28296885	honey	C0019906
28296885	tobacco	C0008038
28296885	marijuana.	C0024808
28296885	data	C1511726
28296885	mechanisms	C0441712
28296885	cariogenesis	C0011334
28296885	multifactorial	C1837655
28296885	relationships	C0439849
28296885	oral health	C0029162
28296885	shift	C2700061
28296885	wild-food diet	C0012155
28296885	cultigens	C0242775
28299441	R2R3MYB	C0040648
28299441	VvMYBPA1	C0040648
28299441	grape	C0682492
28299441	phenylpropanoid pathway	C1156966
28299441	tobacco	C0740009
28299441	flowers	C0330090
28299441	tobacco	C0740009
28299441	ectopic expression	C1512167
28299441	VvMYBPA1	C0040648
28299441	grape	C0682492
28299441	regulator	C1704735
28299441	proanthocyanidin	C0072018
28299441	up- or down-regulates	C1157519
28299441	phenylproanoid pathway	C1156966
28299441	Proanthocyanidins	C0072018
28299441	flavonoids	C0596577
28299441	animal	C3668949
28299441	human diet	C0012155
28299441	Research	C0035168
28299441	crops	C0242775
28299441	health	C0018684
28299441	compounds	C0205198
28299441	Flavonoids	C0596577
28299441	synthesis	C1883254
28299441	MBW	C1167128
28299441	transcriptional complex	C1167128
28299441	R2R3MYB	C0040648
28299441	bHLH	C0288972
28299441	WD40 proteins	C0040648
28299441	MYB	C0040648
28299441	channeling	C0439799
28299441	complex	C1704241
28299441	pathway	C1704259
28299441	tobacco	C0740009
28299441	model	C0026336
28299441	tested	C0039593
28299441	ectopic expression	C1512167
28299441	proanthocyanidin	C0072018
28299441	regulator	C1704735
28299441	VvMYBPA1	C0040648
28299441	grape	C0682492
28299441	induces	C0205263
28299441	biosynthesis	C0005572
28299441	compounds	C0205198
28299441	committed cells	C0301868
28299441	transcriptomic	C0040649
28299441	metabolic	C0311400
28299441	analyses	C0936012
28299441	transgenic lines	C0085245
28299441	progeny	C0680063
28299441	VvMYBPA1	C0040648
28299441	phenylpropanoid pathway	C1156966
28299441	tobacco	C0740009
28299441	floral organs	C0330090
28299441	VvMYBPA1	C0040648
28299441	expression	C1171362
28299441	expression	C1171362
28299441	proanthocyanidin	C0072018
28299441	early genes	C0017337
28299441	phenylpropanoid pathway	C1156966
28299441	proanthocyanidins	C0072018
28299441	chlorogenic acids	C0008240
28299441	de novo	C1515568
28299441	floral limbs, tubes	C0330090
28299441	stamens	C1136236
28299441	phenylpropanoid branches	C1156966
28299441	depleted	C0333668
28299441	floral structure	C0330090
28299441	novel	C0205314
28299441	VvMYBPA1	C0040648
28299441	MYBs	C0040648
28299441	proanthocyanidins	C0072018
28299441	findings	C2607943
28299441	designing strategies	C0679199
28299441	crops	C0242775
28299441	health	C0018684
28299441	compounds	C0205198
28301509	Genome-wide association mapping	C2350277
28301509	winter barley	C0004755
28301509	grain	C0086369
28301509	yield	C0392762
28301509	culm	C0242767
28301509	cell wall	C0007623
28301509	polymer	C0683005
28301509	content	C1264655
28301509	CoMPP technique	C0022885
28301509	collection	C1516698
28301509	winter barley varieties	C0004755
28301509	Hordeum vulgare L.	C0331554
28301509	grown	C0597252
28301509	field	C1254362
28301509	years	C0439234
28301509	northern	C1709269
28301509	Italy	C0022277
28301509	grain	C0086369
28301509	straw	C4047917
28301509	yields	C0392762
28301509	year	C0439234
28301509	barley yellow mosaic virus	C1000417
28301509	BaYMV	C1000417
28301509	influenced	C4054723
28301509	performances	C1882330
28301509	average	C1510992
28301509	reduction	C0392756
28301509	grain	C0086369
28301509	straw	C4047917
28301509	harvested	C0205245
28301509	comparison	C1707455
28301509	second	C0205436
28301509	year	C0439234
28301509	genetic determination	C1285573
28301509	GD	C1285573
28301509	grain	C0086369
28301509	yield	C0392762
28301509	years	C0439234
28301509	straw	C4047917
28301509	yield	C0392762
28301509	GD	C1285573
28301509	Cell wall	C0007623
28301509	polymers	C0683005
28301509	culms	C0242767
28301509	culms	C0242767
28301509	quantified	C1709793
28301509	monoclonal antibodies	C0003250
28301509	LM6	C1449622
28301509	LM11	C1449622
28301509	JIM13	C1449622
28301509	BS-400-3	C1449622
28301509	carbohydrate-binding module CBM3a	C1449622
28301509	CoMPP technique	C0022885
28301509	LM6	C1449622
28301509	detects	C0442726
28301509	arabinan	C0052274
28301509	components	C1705248
28301509	GD	C1285573
28301509	years	C0439234
28301509	significantly	C0750502
28301509	negative	C0205160
28301509	correlation	C1707520
28301509	grain	C0086369
28301509	yield	C0392762
28301509	GYLD	C0392762
28301509	heritability	C0392762
28301509	H2	C0392762
28301509	calculated	C1441506
28301509	GYLD	C0392762
28301509	LM6	C1449622
28301509	JIM	C1449622
28301509	total	C0439810
28301509	SNPs	C0752046
28301509	study	C2603343
28301509	population structure	C0597254
28301509	linkage disequilibrium	C0023746
28301509	LD	C0023746
28301509	genome-wide association study	C2350277
28301509	GWAS	C2350277
28301509	Marker-trait associations	C1328885
28301509	MTA	C1328885
28301509	grain	C0086369
28301509	yield	C0392762
28301509	cell wall	C0007623
28301509	LM6	C1449622
28301509	JIM13	C1449622
28301509	significant	C0750502
28301509	correlations	C1707520
28301509	years	C0439234
28301509	single QTL	C0597336
28301509	GYLD	C0392762
28301509	MTAs	C1328885
28301509	chromosome 3H	C0008633
28301509	Hv-eIF4E gene	C1414351
28301509	resistance	C4281815
28301509	BaYMV	C1000417
28301509	QTL	C0597336
28301509	rym4	C0017337
28301509	locus	C1708726
28301509	resistance	C4281815
28301509	virus	C0042776
28301509	GWAs	C2350277
28301509	arabinans	C0052274
28301509	quantified	C1709793
28301509	LM6	C1449622
28301509	identification	C0205396
28301509	major	C0205164
28301509	QTLs	C0597336
28301509	3H	C0008633
28301509	putative candidate genes	C0017337
28301509	study	C2603343
28301509	gene expression	C0017262
28301509	levels	C3244092
28301509	bioinformatics	C1140694
28301911	Prevalence	C0220900
28301911	Clinical	C0205210
28301911	Relevance	C2347946
28301911	ASA	C0004057
28301911	Nonresponse	C4282382
28301911	Cardiac Surgery	C0018821
28301911	prevalence	C0220900
28301911	acetylsalicylic acid	C0004057
28301911	ASA	C0004057
28301911	nonresponse	C4282382
28301911	patients	C0030705
28301911	coronary artery bypass graft (CABG) surgery	C0010055
28301911	consequences	C0686907
28301911	cardiovascular events	C1320716
28301911	prospective	C0033522
28301911	observational	C1518527
28301911	bicentric cohort study	C0009247
28301911	German University hospitals	C0019994
28301911	patients	C0030705
28301911	elective	C0206058
28301911	CABG surgery	C0010055
28301911	Platelet function	C1254881
28301911	postoperatively	C0032790
28301911	arachidonic acid	C0003695
28301911	ASPItest	C0032184
28301911	thrombin receptor-activating peptide 6	C0219419
28301911	TRAPtest	C0032184
28301911	multiple electrode aggregometry	C0032184
28301911	Multiplate	C0032184
28301911	ASPItest	C0032184
28301911	ASA	C0004057
28301911	nonresponders	C0919875
28301911	follow-up	C1522577
28301911	cardiovascular events	C1320716
28301911	hospital admissions	C0184666
28301911	deaths	C1306577
28301911	cardiovascular disease	C0007222
28301911	prevalence	C0220900
28301911	ASA	C0004057
28301911	nonresponse	C4282382
28301911	significantly	C0750502
28301911	increased	C0205217
28301911	aggregation curve	C3828533
28301911	TRAPtest	C0032184
28301911	platelet count	C0032181
28301911	cardiopulmonary bypass time	C0429123
28301911	ASA	C0004057
28301911	nonresponse	C4282382
28301911	follow-up	C1522577
28301911	end point	C2349179
28301911	ASA	C0004057
28301911	responders	C0919876
28301911	nonresponders	C0919875
28301911	study	C0008972
28301911	perioperative	C1518988
28301911	ASA	C0004057
28301911	nonresponse	C4282382
28301911	patients	C0030705
28301911	CABG	C0010055
28301911	cardiovascular events	C1320716
28301911	follow-up	C1522577
28301911	randomized dosage adjustment trial	C0206034
28301911	ASA	C0004057
28301911	treatment	C1533734
28301911	CABG surgery	C0010055
28302782	Genome Sequences	C2348746
28302782	Mycobacteriophages Jane and Sneeze	C0026911
28302782	isolated	C0205409
28302782	phages	C0004651
28302782	Mycobacterium smegmatis mc(2)155	C0317761
28302782	Hillsborough	C3812217
28302782	NJ	C0027971
28302782	Palo Verde	C0017446
28302782	Costa Rica	C0010182
28302782	mycobacteriophages	C0026911
28302782	nucleotide	C0028630
28302782	differences	C1705242
28302782	genomes	C0017428
28302782	mycobacteriophage	C0026911
28302782	mobile element 1	C1257903
28316382	Effect	C1280500
28316382	Punica granatum	C1001173
28316382	fruit peel	C0016767
28316382	glucose-6-phosphate dehydrogenase	C0017757
28316382	malate dehydrogenase	C0024544
28316382	amphistome	C0684063
28316382	Gastrothylax indicus	C3006520
28316382	Increasing	C0442808
28316382	anthelmintic	C0003158
28316382	resistance	C0013203
28316382	impact	C4049986
28316382	anthelmintics	C0003158
28316382	environment	C0014406
28316382	helminth parasite	C0018893
28316382	sheep	C0036945
28316382	lipogenic enzymes	C0014442
28316382	glucose-6-phosphate dehydrogenase	C0017757
28316382	G-6-PDH	C0017757
28316382	malate dehydrogenase	C0024544
28316382	MDH	C0024544
28316382	subcellular	C3893246
28316382	distribution pattern	C0449775
28316382	Activity	C0243102
28316382	G-6-PDH	C0017757
28316382	cytosolic fraction	C1511625
28316382	MDH	C0024544
28316382	cytosolic	C1511625
28316382	mitochondrial fraction	C0026237
28316382	Gastrothylax indicus	C3006520
28316382	in vitro	C1533691
28316382	treatment	C1522326
28316382	ethanolic	C0001962
28316382	aqueous extracts	C2828366
28316382	Punica granatum	C1001173
28316382	fruit peel	C0016767
28316382	anthelmintic	C0003158
28316382	albendazole	C0001911
28316382	G-6-PDH	C0017757
28316382	activity	C0243102
28316382	decreased	C0392756
28316382	MDH	C0024544
28316382	suppressed	C1260953
28316382	control	C1550141
28316382	Albendazole	C0001911
28316382	effective	C1704419
28316382	negative control	C1947986
28316382	extracts	C2828366
28316382	results	C1274040
28316382	phytochemicals	C0577749
28316382	plant	C0032098
28316382	potential	C3245505
28316382	vermifuge	C0003158
28316382	vermicide	C1254354
28319502	Remitting Seronegative Symmetrical Synovitis With Pitting Edema	C2919482
28319502	FDG PET/CT	C4271885
28319502	Remitting seronegative symmetrical synovitis with pitting edema	C2919482
28319502	RS3PE	C2919482
28319502	rare condition	C0678236
28319502	elderly	C0001792
28319502	types	C0332307
28319502	rheumatic	C0035435
28319502	malignant diseases	C0442867
28319502	year	C0439234
28319502	man	C0025266
28319502	diagnosis	C0011900
28319502	RS3PE	C2919482
28319502	clinical sign	C0037088
28319502	laboratory data	C1705214
28319502	malignancies	C0006826
28319502	RS3PE	C2919482
28319502	FDG PET/CT	C4271885
28319502	occult tumors	C0027667
28319502	images	C1704254
28319502	multiple	C0439064
28319502	symmetrically	C0332516
28319502	diffusely	C0205219
28319502	increased	C0205217
28319502	F-FDG	C0046056
28319502	uptake	C0243144
28319502	soft tissue	C0225317
28319502	joints	C0022417
28319502	bones	C0262950
28319502	shoulders	C0037004
28319502	hips	C0019552
28319502	knees	C0022742
28319502	ankles	C0003086
28322666	Parks	C0562547
28322666	Social	C0728831
28322666	Cultural	C0220814
28322666	Spaces	C1883067
28322666	U.S	C0041703
28322666	Foreign	C1517294
28322666	Born	C0005615
28322666	Latinas	C0949335
28322666	Parks	C0562547
28322666	opportunities	C0814559
28322666	people	C0027361
28322666	activities	C0441655
28322666	promote	C0033414
28322666	physical	C0205485
28322666	emotional	C0849912
28322666	well-being	C0018684
28322666	focus groups	C0016400
28322666	personal	C1519021
28322666	interviews	C0021822
28322666	Northeastern	C1709272
28322666	city	C0008848
28322666	high	C0205250
28322666	rate	C1521828
28322666	obesity	C0028754
28322666	examined	C0332128
28322666	perceptions	C0030971
28322666	barriers	C1254370
28322666	facilitators	C0205556
28322666	use of	C1524063
28322666	parks	C0562547
28322666	park	C0562547
28322666	features	C2348519
28322666	promote	C0033414
28322666	physical activity	C0026606
28322666	Latina	C0949335
28322666	women	C0043210
28322666	Foreign	C1517294
28322666	born	C0005615
28322666	Latinas	C0949335
28322666	environmental	C0014406
28322666	characteristics	C1521970
28322666	parks	C0562547
28322666	types	C0332307
28322666	amenities	C1547538
28322666	cultural	C0441655
28322666	social activities	C2371613
28322666	U.S.	C0041703
28322666	born	C0005615
28322666	Latinas	C0949335
28322666	parks	C0562547
28322666	physical activity	C0026606
28322666	weight	C0005910
28322666	management	C0441655
28322666	foreign	C1517294
28322666	born	C0005615
28322666	participants	C0679646
28322666	conceptualized	C0589138
28322666	parks	C0562547
28322666	sociocultural family centers	C1254362
28322666	common	C0205214
28322666	conceptualizations	C0589138
28322666	exercise	C0015259
28322666	individual	C0027361
28322666	health	C0018684
28322666	gain	C1517378
28322666	findings	C2607943
28322666	new	C0205314
28322666	policies	C0242456
28322666	culturally	C0220814
28322666	specific	C0205369
28322666	park	C0562547
28322666	programming	C1704769
28322666	promote	C0033414
28322666	goals	C0018017
28322666	increasing	C0442808
28322666	levels	C0441889
28322666	physical activity	C0026606
28322666	health	C0018684
28326653	impact	C4049986
28326653	childhood maltreatment	C0008060
28326653	differential	C0443199
28326653	efficacy	C1280519
28326653	CBASP	C0033968
28326653	escitalopram	C1099456
28326653	patients	C0030705
28326653	chronic depression	C0581391
28326653	secondary analysis	C0683944
28326653	Childhood maltreatment	C0008060
28326653	CM	C0008060
28326653	indicated	C1444656
28326653	predictor	C2698872
28326653	differential	C0443199
28326653	response	C0871261
28326653	antidepressant treatment	C1096649
28326653	psychotherapy	C0033968
28326653	compared	C1707455
28326653	medication	C0013227
28326653	secondary analysis	C0683944
28326653	investigated	C1292732
28326653	presence	C3854307
28326653	CM	C0008060
28326653	results	C1274040
28326653	differential	C0443199
28326653	indication	C3146298
28326653	Cognitive Behavioral Analysis System of Psychotherapy	C0033968
28326653	CBASP	C0033968
28326653	escitalopram	C1099456
28326653	clinical management	C1516615
28326653	ESC	C1099456
28326653	patients	C0030705
28326653	chronic depression	C0581391
28326653	randomized	C0034656
28326653	sessions	C1883017
28326653	CBASP	C0033968
28326653	ESC	C1099456
28326653	course	C0750729
28326653	8 weeks	C0439230
28326653	acute	C0205178
28326653	20 weeks	C0439230
28326653	extended	C0231448
28326653	treatment	C0087111
28326653	German	C0017480
28326653	treatment sites	C0337950
28326653	CM	C0008060
28326653	assessed	C1516048
28326653	Childhood	C0231335
28326653	Trauma	C1510467
28326653	Questionnaire	C0034394
28326653	clinician	C0871685
28326653	rated	C0871208
28326653	Early Trauma Inventory	C0282574
28326653	Intention-to-treat analyses	C2718028
28326653	impact	C4049986
28326653	CM	C0008060
28326653	depression	C0011570
28326653	global functioning	C0017644
28326653	quality of life	C0034380
28326653	presence	C3854307
28326653	CM	C0008060
28326653	result	C1274040
28326653	significant	C0750502
28326653	differences	C1705242
28326653	treatment response	C0521982
28326653	CBASP	C0033968
28326653	ESC	C1099456
28326653	outcome measure	C0086749
28326653	28 weeks	C0439230
28326653	treatment	C0087111
28326653	independent of	C0332291
28326653	CM	C0008060
28326653	assessment	C0220825
28326653	8 weeks	C0439230
28326653	significant	C0750502
28326653	CM	C0008060
28326653	treatment	C0087111
28326653	interaction	C1704675
28326653	found	C0150312
28326653	scores	C0449820
28326653	Montgomery-Asberg Depression Rating Scale	C4054475
28326653	Patients	C0030705
28326653	history	C0262926
28326653	CM	C0008060
28326653	receiving	C1514756
28326653	CBASP	C0033968
28326653	significantly lower	C4055638
28326653	response rate	C0237629
28326653	compared	C1707455
28326653	patients	C0030705
28326653	CM	C0008060
28326653	receiving	C1514756
28326653	ESC	C1099456
28326653	8 weeks	C0439230
28326653	Conclusively	C2828146
28326653	CBASP	C0033968
28326653	ESC	C1099456
28326653	effective	C1704419
28326653	treatment	C0087111
28326653	difficult	C0332218
28326653	treat	C1522326
28326653	subgroup	C1515021
28326653	patients	C0030705
28326653	chronic depression	C0581391
28326653	history	C0262926
28326653	CM	C0008060
28326653	CM	C0008060
28326653	predictor	C2698872
28326653	longer	C0205166
28326653	latency	C0023103
28326653	treatment response	C0521982
28326653	case	C0868928
28326653	psychotherapy	C0033968
28326653	CBASP	C0033968
28326653	escitalopram	C1099456
28326653	effective	C1704419
28326653	treatment	C0087111
28326653	chronic depression	C0581391
28326653	treatments	C0087111
28326653	effective	C1704419
28326653	difficult	C0332218
28326653	treat	C1522326
28326653	subgroup	C1515021
28326653	patients	C0030705
28326653	chronic depression	C0581391
28326653	history	C0262926
28326653	childhood maltreatment	C0008060
28326653	Childhood maltreatment	C0008060
28326653	result	C1274040
28326653	longer	C0205166
28326653	latency	C0023103
28326653	treatment response	C0521982
28326653	case	C0868928
28326653	psychotherapy	C0033968
28326936	locus coeruleus	C0023951
28326936	analgesic efficacy	C0948482
28326936	N-acetylaspartylglutamate peptidase	C0067685
28326936	GCPII	C0067685
28326936	inhibitors	C0014432
28326936	ZJ43	C1451894
28326936	2-PMPA	C0910831
28326936	N-acetylaspartylglutamate	C0130693
28326936	NAAG	C0130693
28326936	neurotransmitter	C0027908
28326936	mammalian	C0024660
28326936	nervous system	C0027763
28326936	NAAG	C0130693
28326936	activates	C1879547
28326936	group II metabotropic glutamate receptor	C0532371
28326936	mGluR3	C0532371
28326936	extracellular enzyme, glutamate carboxypeptidase II	C0067685
28326936	GCPII	C0067685
28326936	in vivo	C1515655
28326936	Inhibitors of this enzyme	C0014432
28326936	analgesic	C0002771
28326936	animal models	C0599779
28326936	inflammatory	C0234251
28326936	neuropathic	C3714625
28326936	bone cancer	C0279530
28326936	pain	C0030193
28326936	NAAG	C0130693
28326936	GCPII	C0067685
28326936	locus coeruleus	C0023951
28326936	noradrenergic	C0599861
28326936	inhibitory	C3463820
28326936	formalin	C0949307
28326936	footpad	C2985236
28326936	model	C0012644
28326936	systemic	C0205373
28326936	treatment	C0039798
28326936	GCPII inhibitors	C0014432
28326936	inflammatory pain	C0234251
28326936	response	C0871261
28326936	spinal	C0521329
28326936	noradrenaline	C0028351
28326936	analgesic efficacy	C0948482
28326936	blocked	C0332206
28326936	systemic	C0205373
28326936	injection	C0021485
28326936	group II mGluR	C0532371
28326936	antagonist	C1254351
28326936	intrathecal (spinal) injection	C0021896
28326936	alpha 2 adrenergic receptor antagonist	C0304513
28326936	microinjection	C0025991
28326936	α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor antagonist	C1254351
28326936	contralateral	C0441988
28326936	locus coeruleus	C0023951
28326936	Footpad	C2985236
28326936	inflammation	C0021368
28326936	glutamate	C0017789
28326936	contralateral	C0441988
28326936	locus coeruleu	C0023951
28326936	systemic	C0205373
28326936	treatment	C0039798
28326936	GCPII inhibitor	C0014432
28326936	blocks	C0332206
28326936	Direct	C1947931
28326936	injection	C0021485
28326936	GCPII inhibitors	C0014432
28326936	contralateral	C0441988
28326936	ipsilatera	C0441989
28326936	locus coeruleus	C0023951
28326936	inflammatory pain	C0234251
28326936	response	C0871261
28326936	dose-dependent	C1512045
28326936	contralateral	C0441988
28326936	effect	C1280500
28326936	blocked	C0332206
28326936	intrathecal injection	C0021896
28326936	alpha 2 adrenergic receptor antagonist	C0304513
28326936	hypothesis	C1512571
28326936	analgesic efficacy	C0948482
28326936	GCPII inhibitors	C0014432
28326936	contralatera	C0441988
28326936	locus coeruleus	C0023951
28326936	group II mGluR	C0532371
28326936	AMPA	C1528634
28326936	alpha 2 adrenergic receptors	C0001639
28327105	Association	C0439849
28327105	physical activity	C0026606
28327105	body composition	C0005885
28327105	cardiometabolic risk factors	C0035648
28327105	prevalence	C0220900
28327105	cardiovascular disease	C0007222
28327105	Korean population	C1556095
28327105	Korea	C0022771
28327105	national health and nutrition examination survey	C0376344
28327105	Data	C1511726
28327105	associations	C0439849
28327105	physical activity	C0026606
28327105	PA	C0026606
28327105	level	C0441889
28327105	body composition	C0005885
28327105	prevalence	C0220900
28327105	cardiovascular diseases	C0007222
28327105	Asian populations	C0032659
28327105	rare	C0522498
28327105	International Physical Activity Questionnaire	C0034394
28327105	IPAQ	C0034394
28327105	estimate	C0750572
28327105	PA	C0026606
28327105	levels	C0441889
28327105	analyze	C0936012
28327105	association	C0439849
28327105	PA	C0026606
28327105	level	C0441889
28327105	body composition	C0005885
28327105	parameters	C0549193
28327105	prevalence	C0220900
28327105	cardiovascular diseases	C0007222
28327105	data	C1511726
28327105	Korean	C0022771
28327105	National Health and Nutrition Examination Survey	C0376344
28327105	Moderate	C0205081
28327105	high	C0205250
28327105	PA	C0026606
28327105	levels	C0441889
28327105	associated	C0439849
28327105	lower prevalence	C1518029
28327105	hypertension	C0020538
28327105	diabetes mellitus	C0011849
28327105	lower	C0205251
28327105	concentrations	C1446561
28327105	serum ferritin	C4076066
28327105	parathyroid hormone	C4314193
28327105	alkaline phosphatase	C1860130
28327105	Sarcopenia	C0872084
28327105	low	C0205251
28327105	moderate	C0205081
28327105	high	C0205250
28327105	PA	C0026606
28327105	group	C0441833
28327105	p	C1709380
28327105	underweight	C0041667
28327105	central obesity	C0311277
28327105	observed	C1441672
28327105	low	C0205251
28327105	PA	C0026606
28327105	group	C0441833
28327105	prevalence	C0220900
28327105	rates	C1521828
28327105	cardiovascular diseases	C0007222
28327105	lower	C0205251
28327105	moderate	C0205081
28327105	odds ratio	C0028873
28327105	OR	C0028873
28327105	confidence interval	C0009667
28327105	CI	C0009667
28327105	p	C1709380
28327105	high	C0205250
28327105	activity	C0026606
28327105	groups	C0441833
28327105	OR	C0028873
28327105	CI	C0009667
28327105	p	C1709380
28327105	low	C0205251
28327105	activity	C0026606
28327105	group	C0441833
28327105	age	C0001779
28327105	sex	C0079399
28327105	smoking	C0037369
28327105	underlying disease	C0012634
28327105	general	C0028754
28327105	abdominal obesity	C0311277
28327105	muscle mass	C0240417
28327105	Regular physical activity	C0815170
28327105	associated	C0439849
28327105	low prevalence	C1518029
28327105	cardiovascular diseases	C0007222
28327105	stroke	C0018843
28327105	myocardial infarction	C0027051
28327105	stable angina	C0340288
28327105	chronic renal disease	C1561643
28327105	independent of	C0332291
28327105	body composition	C0005885
28327105	risk factors	C0035648
28327105	Korean population	C1556095
28327105	positive	C1446409
28327105	dose-response relationship	C0678790
28328236	Treated	C0087111
28328236	Prevalence	C0033105
28328236	Attention-Deficit/Hyperactivity Disorder	C1263846
28328236	Increased	C0205217
28328236	School-Aged Children	C2827631
28328236	Adolescents	C0205653
28328236	United States	C0041703
28328236	purpose	C1285529
28328236	describe	C1552738
28328236	changes	C0392747
28328236	treated	C0087111
28328236	prevalence	C0033105
28328236	medically	C0205476
28328236	managed	C0184516
28328236	attention-deficit/hyperactivity disorder	C1263846
28328236	ADHD	C1263846
28328236	insured	C1548605
28328236	school-aged children	C2827631
28328236	adolescents	C0205653
28328236	United States	C0041703
28328236	examine	C0332128
28328236	differences	C1705241
28328236	employer-sponsored insurance	C3824871
28328236	ESI	C3824871
28328236	Medicaid insurance	C0021682
28328236	longitudinal	C0205127
28328236	administrative datasets	C0150098
28328236	medical	C0205476
28328236	drug	C0013227
28328236	claims	C3824919
28328236	data	C1511726
28328236	individuals	C0237401
28328236	ESI	C3824871
28328236	Medicaid insurance	C0021682
28328236	Truven Health MarketScan(®) Administrative Claims Databases	C0242356
28328236	Treated	C0087111
28328236	prevalence	C0033105
28328236	measured	C0444706
28328236	percentage	C0439165
28328236	school-aged children	C2827631
28328236	adolescents	C0205653
28328236	calendar year	C0456586
28328236	criteria	C0243161
28328236	medically	C0205476
28328236	managed	C0184516
28328236	ADHD	C1263846
28328236	calendar year	C0456586
28328236	Subjects	C0080105
28328236	eligible	C1548635
28328236	inclusion	C1512693
28328236	aged	C0001779
28328236	years	C0439234
28328236	continuously	C0549178
28328236	calendar year	C0456586
28328236	annual	C0332181
28328236	prevalence	C0033105
28328236	treated	C0087111
28328236	ADHD	C1263846
28328236	school-aged children	C2827631
28328236	adolescents	C0205653
28328236	ESI	C3824871
28328236	increased	C0205217
28328236	Medicaid	C0021682
28328236	increased	C0205217
28328236	steady	C0205361
28328236	Treated	C0087111
28328236	prevalence	C0033105
28328236	ADHD	C1263846
28328236	increased	C0205217
28328236	continuously	C0549178
28328236	time	C0040223
28328236	school-aged children	C2827631
28328236	adolescents	C0205653
28328236	ESI	C3824871
28328236	declined	C0205216
28328236	Medicaid sample	C0021682
28330678	Acute	C0205178
28330678	macular edema	C0271051
28330678	peripapillary	C0442163
28330678	soft	C0205358
28330678	exudate	C0015388
28330678	pancreas transplantation	C0030275
28330678	accelerated	C0521110
28330678	progression	C0242656
28330678	diabetic retinopathy	C0011884
28330678	pancreas transplantation	C0030275
28330678	diabetic retinopathy	C0011884
28330678	inconclusive	C1629507
28330678	patients	C0030705
28330678	type 1 diabetes mellitus	C0011854
28330678	DM	C0011854
28330678	pancreas transplantation	C0030275
28330678	acute	C0205178
28330678	macular edema	C0271051
28330678	peripapillary	C0442163
28330678	soft	C0205358
28330678	exudate	C0015388
28330678	rapid	C0456962
28330678	progression	C0242656
28330678	proliferative diabetic retinopathy	C0154830
28330678	retrospective observational study	C0035363
28330678	diabetic	C0011847
28330678	patients	C0030705
28330678	pancreas transplantation	C0030275
28330678	single	C0205171
28330678	medical center	C0565990
28330678	symptomatic	C0231220
28330678	acute	C0205178
28330678	macular edema	C0271051
28330678	peripapillary	C0442163
28330678	soft	C0205358
28330678	exudate	C0015388
28330678	within	C0332285
28330678	3 months	C1442461
28330678	after	C0687676
28330678	operation	C0543467
28330678	complete	C0205197
28330678	ophthalmic course	C0449259
28330678	medical records	C0025102
28330678	patients	C0030705
28330678	retrospectively	C1514923
28330678	reviewed	C1709940
28330678	Diabetic retinopathy	C0011884
28330678	progression	C0242656
28330678	following	C0332282
28330678	treatment	C0087111
28330678	pancreas transplantation	C0030275
28330678	measured	C0444706
28330678	Chinese	C0152035
28330678	women	C0043210
28330678	type 1 DM	C0011854
28330678	study	C2603343
28330678	hemoglobin (Hb) A1c	C0019018
28330678	transplantation	C0030275
28330678	decreased	C0205216
28330678	rapidly	C0456962
28330678	within	C0332285
28330678	2 months	C1442456
28330678	postsurgery	C0032790
28330678	patients	C0030705
28330678	no	C1518422
28330678	mild	C2945599
28330678	pretransplant	C0040733
28330678	diabetic retinopathy	C0011884
28330678	acute	C0205178
28330678	symptomatic	C0231220
28330678	macular edema	C0271051
28330678	peripapillary	C0442163
28330678	soft	C0205358
28330678	exudate	C0015388
28330678	both eyes	C0229118
28330678	pancreas transplantation	C0030275
28330678	macular edema	C0271051
28330678	resolved	C3714811
28330678	without	C0332288
28330678	treatment	C0087111
28330678	cases	C0868928
28330678	progressed	C0242656
28330678	proliferative diabetic retinopathy	C0154830
28330678	received	C1709850
28330678	panretinal photocoagulation	C0730064
28330678	Diabetic retinopathy	C0011884
28330678	stable	C0205360
28330678	all	C0444868
28330678	eyes	C0015392
28330678	after	C0687676
28330678	treatment	C0087111
28330678	visual	C0234621
28330678	prognosis was good	C0278250
28330678	except	C0332300
28330678	one	C0205447
28330678	eye	C0015392
28330678	macular	C0332574
28330678	branch retinal artery occlusion	C0006123
28330678	foveal	C0016622
28330678	involvement	C1314939
28330678	Acute	C0205178
28330678	macular edema	C0271051
28330678	pancreas transplantation	C0030275
28330678	favorable	C3640814
28330678	treatment outcome	C0085415
28330678	progression	C0242656
28330678	proliferative diabetic retinopathy	C0154830
28330678	High	C0205250
28330678	pretransplant	C0040733
28330678	HbA1c	C0019018
28330678	abrupt	C1276802
28330678	blood sugar	C0005802
28330678	normalization	C0205245
28330678	disease course	C0242656
28331620	Anger	C0002957
28331620	aggression	C0001807
28331620	borderline personality disorder	C0006012
28331620	attention deficit hyperactivity disorder	C1263846
28331620	stress	C0038435
28331620	impact	C4049986
28331620	stress	C0038435
28331620	anger	C0002957
28331620	aggression	C0001807
28331620	Borderline Personality Disorder	C0006012
28331620	BPD	C0006012
28331620	Attention Deficit Hyperactivity Disorder	C1263846
28331620	ADHD	C1263846
28331620	investigated	C1292732
28331620	study	C2603343
28331620	investigate	C1292732
28331620	anger	C0002957
28331620	aggression	C0001807
28331620	patients	C0030705
28331620	disorders	C0012634
28331620	unmedicated	C0243095
28331620	female	C0086287
28331620	BPD	C0006012
28331620	patients	C0030705
28331620	ADHD	C1263846
28331620	patients	C0030705
28331620	healthy controls	C2986479
28331620	HC	C2986479
28331620	self-reports	C2700446
28331620	measuring	C0444706
28331620	trait	C0599883
28331620	anger	C0002957
28331620	aggression	C0001807
28331620	emotion regulation	C2370884
28331620	Point Subtraction Aggression Paradigm	C0681797
28331620	state anger measurement	C0242481
28331620	resting	C0348080
28331620	stress conditions	C0348080
28331620	Stress	C0038435
28331620	induced	C0205263
28331620	Mannheim Multicomponent Stress Test	C3494508
28331620	MMST	C3494508
28331620	patient	C0030705
28331620	scored	C0449820
28331620	self-report	C2700446
28331620	measures	C0444706
28331620	compared	C1707455
28331620	HCs	C2986479
28331620	Compared	C1707455
28331620	ADHD	C1263846
28331620	patients	C0030705
28331620	BPD	C0006012
28331620	patients	C0030705
28331620	trait	C0599883
28331620	aggression	C0001807
28331620	hostility	C0020039
28331620	anger	C0002957
28331620	anger	C0002957
28331620	BPD	C0006012
28331620	patients	C0030705
28331620	anger	C0002957
28331620	HCs	C2986479
28331620	ADHD	C1263846
28331620	patients	C0030705
28331620	stress-dependent	C0205245
28331620	anger	C0002957
28331620	behavioral level	C0004927
28331620	BPD	C0006012
28331620	patients	C0030705
28331620	aggression	C0001807
28331620	anger	C0002957
28331620	emotion regulation	C2370884
28331620	deficits	C2987487
28331620	findings	C0243095
28331620	impact	C4049986
28331620	stress	C0038435
28331620	anger	C0002957
28331620	BPD	C0006012
28331620	patients	C0030705
28331620	aggressive behavior	C0001807
28331620	females	C0086287
28331620	BPD	C0006012
28331620	ADHD	C1263846
28331620	anger	C0002957
28331620	clinical	C0205210
28331620	importance	C3898777
28331620	BPD	C0006012
28331620	patients	C0030705
28332776	Interferon gamma	C1334085
28332776	interleukin 10	C1334098
28332776	polymorphisms	C0678951
28332776	Chinese	C0152035
28332776	children	C0008059
28332776	hemophagocytic lymphohistiocytosis	C0024291
28332776	study	C2603343
28332776	investigate	C1292732
28332776	interferon gamma	C1334085
28332776	IFN-γ	C1334085
28332776	interleukin-10	C1334098
28332776	IL-10	C1334098
28332776	gene	C0017337
28332776	single nucleotide polymorphisms	C0752046
28332776	susceptibility	C0012655
28332776	hemophagocytic lymphohistiocytosis	C0024291
28332776	HLH	C0024291
28332776	Chinese	C0152035
28332776	children	C0008059
28332776	without known family history of	C0332123
28332776	HLH	C0024291
28332776	children	C0008059
28332776	HLH	C0024291
28332776	age	C0001779
28332776	gender	C0079399
28332776	healthy controls	C2986479
28332776	Xuzhou Children's Hospital	C0019994
28332776	study	C2603343
28332776	Serum	C0229671
28332776	IFN-γ	C3539881
28332776	IL-10	C0085295
28332776	measured	C0444706
28332776	enzyme linked-immunosorbent assay	C0014441
28332776	Polymorphisms	C0678951
28332776	IFN-γ gene	C1334085
28332776	IL-10	C1334098
28332776	analyzed	C2963401
28332776	allele	C0002085
28332776	specific	C0205369
28332776	PCR	C0032520
28332776	Median serum	C0229671
28332776	concentrations	C1446561
28332776	IFN -γ	C3539881
28332776	IL-10	C0085295
28332776	significantly higher	C4055637
28332776	children	C0008059
28332776	HLH	C0024291
28332776	compared	C1707455
28332776	healthy controls	C2986479
28332776	frequencies	C0439603
28332776	IFN-γ	C1334085
28332776	T/A and T/T genotypes	C0017431
28332776	T allele	C0002085
28332776	significantly higher	C4055637
28332776	HLH	C0024291
28332776	compared	C1707455
28332776	control group	C0009932
28332776	frequencies	C0439603
28332776	IL-10	C1334098
28332776	G/A genotype	C0017431
28332776	G allele	C0002085
28332776	significantly increased	C4055637
28332776	HLH	C0024291
28332776	patients	C0030705
28332776	compared	C1707455
28332776	healthy controls	C2986479
28332776	No significant	C1273937
28332776	difference	C3842396
28332776	distribution	C1704711
28332776	IFN-γ	C1334085
28332776	G/A genotypes	C0017431
28332776	children	C0008059
28332776	HLH	C0024291
28332776	controls	C0243148
28332776	study	C2603343
28332776	presents	C0150312
28332776	preliminary	C0439611
28332776	evidence	C3887511
28332776	IFN	C1334085
28332776	T/A, T/T	C0017431
28332776	IL-10	C1334098
28332776	A/G genotypes	C0017431
28332776	HLH	C0024291
28332776	susceptibility	C0012655
28332776	Chinese	C0152035
28332776	children	C0008059
28332776	HLH	C0024291
28334564	Data	C1511726
28334564	Implementation	C1708476
28334564	Alarm	C0336648
28334564	Reduction	C0392756
28334564	Interventions	C0184661
28334564	Cardiovascular Surgical ICU	C0587446
28334564	Alarm fatigue	C4035921
28334564	ICU	C0021708
28334564	setting	C3176918
28334564	documented	C1301725
28334564	literature	C0023866
28334564	ICU's	C0021708
28334564	high-intensity	C4081854
28334564	environment	C0014406
28334564	staff's	C0851286
28334564	vigilant	C0043012
28334564	attention	C0004268
28334564	distraction	C4060717
28334564	false	C0205237
28334564	alarms	C0336648
28334564	staff	C0851286
28334564	tasks	C3540678
28334564	dissatisfaction	C0870433
28334564	patient safety	C1113679
28334564	risk	C0035647
28334564	alarms	C0336648
28334564	missed	C1705492
28334564	ignored	C1554079
28334564	patient safety	C1113679
28334564	alarm	C0336648
28334564	systems	C0449913
28334564	cardiovascular surgical intensive care unit	C0587446
28334564	CVSICU	C0587446
28334564	examine	C0332128
28334564	nurses	C0028661
28334564	attitudes	C0004271
28334564	clinical	C0205210
28334564	alarm	C0336648
28334564	signals	C1710082
28334564	nurses	C0028661
28334564	audible alarm	C1706857
28334564	signals	C1710082
28334564	implement	C1708476
28334564	best practices	C3179154
28334564	monitor alarm	C2091666
28334564	reduction	C0392756
28334564	patient safety	C1113679
28334564	CVSICU	C0587446
28334564	nurses	C0028661
28334564	alarm	C0336648
28334564	perception survey	C0038951
28334564	alarm	C0336648
28334564	discriminability testing	C0039593
28334564	Nurse survey data	C2361339
28334564	baseline	C1442488
28334564	alarm	C0336648
28334564	data	C1511726
28334564	targeted	C1521840
28334564	alarm	C0336648
28334564	reduction	C0392756
28334564	interventions	C0184661
28334564	alarm	C0336648
28334564	data	C1511726
28334564	cardiorespiratory event	C1320716
28334564	data	C1511726
28334564	year	C0439234
28334564	CVSICU	C0587446
28334564	monitor alarm	C2091666
28334564	pulse oximetry	C0034108
28334564	heart rate	C0018810
28334564	systolic	C0277882
28334564	diastolic blood pressure	C0235222
28334564	pulse oximetry	C0034108
28334564	sensor	C0183210
28334564	ventricular tachycardia	C0042514
28334564	targeted	C1521840
28334564	implementation	C1708476
28334564	reduction	C0392756
28334564	alarms	C0336648
28334564	bed	C0004916
28334564	cardiorespiratory events	C1320716
28334564	reduce	C0392756
28334564	alarm fatigue	C4035921
28334564	decrease	C0547047
28334564	alarm	C0336648
28334564	burden	C2828008
28334564	targeted	C1521840
28334564	interventions	C0184661
28334564	alarms	C0336648
28334564	delays	C0205421
28334564	alarm	C0336648
28334564	self-correction	C1947976
28334564	alarm	C0336648
28334564	threshold	C0449864
28334564	limits	C0439801
28334564	alarm	C0336648
28334564	notification	C0422202
28334564	secondary device	C0025080
28334564	teaching	C0220924
28334564	staff	C0851286
28334564	alarm	C0336648
28334564	individual	C0237401
28334564	patients	C0030705
28334615	NCAM1 gene set	C1334863
28334615	depressive symptoms	C0086132
28334615	brain structural	C0006104
28334615	correlates	C0871083
28334615	healthy individuals	C0237401
28334615	Depressive symptoms	C0086132
28334615	depressive disorders	C0011581
28334615	continuous spectrum	C0037812
28334615	depressive symptoms	C0086132
28334615	biological underpinnings	C0243095
28334615	depression	C0011570
28334615	Gene set enrichment analysis	C0796344
28334615	GSEA	C0796344
28334615	gene groups	C0017337
28334615	complex traits	C0678922
28334615	genome-wide association study	C2350277
28334615	GWAS	C2350277
28334615	data of depression scores	C3483981
28334615	brain-level structural	C0006104
28334615	correlates	C0871083
28334615	healthy young individuals	C0237401
28334615	symptom level	C1319166
28334615	depression scores	C3483981
28334615	robust	C2986815
28334615	gene sets	C0017337
28334615	NCAM1	C1334863
28334615	Interactions	C0596610
28334615	Collagen Formation	C2246343
28334615	Depression scores	C3483981
28334615	associated with	C0332281
28334615	decreased	C0205216
28334615	fractional anisotropy	C0085406
28334615	FA	C0085406
28334615	brain white matter property	C0152381
28334615	within the forceps minor	C0152325
28334615	left superior temporal longitudinal fasciculus	C2337627
28334615	mean FA	C0085406
28334615	depression score	C3483981
28334615	associated voxels	C2700259
28334615	phenotype	C0031437
28334615	GSEA	C0796344
28334615	NCAM1	C1334863
28334615	Interactions	C0596610
28334615	gene set	C0017337
28334615	NCAM1	C1334863
28334615	Interactions	C0596610
28334615	gene set	C0017337
28334615	depression scores	C3483981
28334615	structural brain	C0006104
28334615	correlates	C0871083
28334615	healthy participants	C1708335
28334615	molecular underpinnings	C0243095
28334615	depressive symptomatology	C0086132
28334854	HPV	C0021344
28334854	diseases	C0012634
28334854	Italy	C0022277
28334854	Human papillomavirus (HPV) infection	C0343641
28334854	cervical cancer	C0007847
28334854	development	C1527148
28334854	genital warts	C1398518
28334854	cancer	C0006826
28334854	penis	C0030851
28334854	anus	C0003461
28334854	head	C0018670
28334854	neck	C0027530
28334854	oropharynx	C0521367
28334854	genitourinary system	C0042066
28334854	study	C2603343
28334854	evaluation	C1292732
28334854	hospitalizations	C0019993
28334854	HPV-related pathologies	C0343641
28334854	Italy	C0022277
28334854	national hospital discharge	C0586003
28334854	forms	C0376315
28334854	Ministry of Health	C1274109
28334854	HPV	C0021344
28334854	hospitalizations	C0019993
28334854	diagnostic	C0348026
28334854	codes	C0805701
28334854	ICD-9-CM	C1137112
28334854	coding system	C2347818
28334854	hospitalizations	C0019993
28334854	HPV-related pathologies	C0343641
28334854	literature	C0023866
28334854	evaluated	C1292732
28334854	hospitalization rates	C1521828
28334854	hr	C1521828
28334854	trend	C1521798
28334854	time	C0040223
28334854	Uterine cervical cancer	C0007847
28334854	CIN III	C0851140
28334854	hospitalizations	C0019993
28334854	hr	C1521828
28334854	Head	C0018670
28334854	neck	C0027530
28334854	oropharynx	C0521367
28334854	pathologies	C1521733
28334854	cases	C0868928
28334854	hr	C1521828
28334854	males	C0086582
28334854	females	C0086287
28334854	genital warts	C1398518
28334854	hospitalizations	C0019993
28334854	hr	C1521828
28334854	males	C0086582
28334854	females	C0086287
28334854	anal	C0153446
28334854	hospitalizations	C0019993
28334854	genitourinary	C0751569
28334854	penis cancers	C0153601
28334854	study	C2603343
28334854	evaluation	C1292732
28334854	hospitalizations	C0019993
28334854	HPV-related pathologies	C0343641
28334854	public health	C0018684
28334854	issue	C0033213
28334854	Italy	C0022277
28334854	impact	C4049986
28334854	population	C1257890
28336141	discovery	C1880355
28336141	potent	C0205556
28336141	selective	C0205556
28336141	kynurenine 3-monooxygenase	C0064449
28336141	inhibitors	C0014432
28336141	treatment	C0087111
28336141	acute pancreatitis	C0001339
28336141	series	C0205549
28336141	potent	C0205556
28336141	competitive	C0205556
28336141	highly	C0205250
28336141	selective	C0205556
28336141	kynurenine monooxygenase	C0064449
28336141	inhibitors	C0014432
28336141	discovered	C1880355
28336141	substrate	C3891814
28336141	approach	C0449445
28336141	treatment	C0087111
28336141	acute pancreatitis	C0001339
28336141	lead	C1522538
28336141	compound	C1706082
28336141	good	C0205170
28336141	cellular	C0007634
28336141	potency	C0205556
28336141	pharmacodynamic	C0851347
28336141	activity	C0441655
28336141	in vivo	C1515655
28336597	Draft Genome	C0017428
28336597	Sequence	C0314659
28336597	Providencia stuartii PS71	C0315286
28336597	Multidrug-Resistant	C0242640
28336597	Strain	C1518614
28336597	Associated with	C0332281
28336597	Nosocomial Infections	C0205721
28336597	Greece	C0018226
28336597	Providencia stuartii	C0315286
28336597	frequently	C0332183
28336597	associated with	C0332281
28336597	nosocomial outbreaks	C0205721
28336597	intrinsic	C0205102
28336597	resistance	C4281815
28336597	commonly	C0205214
28336597	antimicrobials	C1136254
28336597	draft genome	C0017428
28336597	sequence	C0314659
28336597	P. stuartii strain	C0315286
28336597	acquired	C0439661
28336597	resistance genes	C2945710
28336597	panresistance	C4281815
28336597	cephalosporins	C3536856
28336597	blaSHV-5	C0017337
28336597	blaVEB-1	C0017337
28336597	carbapenems	C0006968
28336597	blaVIM-1	C0017337
28336597	aminoglycosides	C0002556
28336597	rmtB	C0017337
28336597	outbreak	C0012652
28336597	Greek	C0018226
28336597	hospitals	C0019994
28338247	Impact	C4049986
28338247	diabetic ketoacidosis	C0011880
28338247	management	C0376636
28338247	medical intensive care unit	C2711734
28338247	order set	C0282574
28338247	implementation	C1708476
28338247	rate	C1521828
28338247	compliance	C0525058
28338247	ADA DKA guidelines	C0162791
28338247	medical intensive care unit	C2711734
28338247	MICU	C2711734
28338247	academic medical centre	C0000872
28338247	implementation	C1708476
28338247	computerised DKA order set	C0282574
28338247	protocol	C0008971
28338247	Retrospective	C1514923
28338247	chart review	C0282443
28338247	adult patients	C0030705
28338247	DKA	C0011880
28338247	admitted	C0809949
28338247	MICU	C2711734
28338247	pre-order set	C0282574
28338247	PRE	C0282574
28338247	post-order set	C0282574
28338247	POST	C0282574
28338247	primary outcome	C1274040
28338247	administration	C1533734
28338247	intravenous fluid resuscitation	C2317423
28338247	insulin	C0021641
28338247	bolus	C1511237
28338247	initial	C0205265
28338247	insulin	C0021641
28338247	infusion rate	C2964135
28338247	patients	C0030705
28338247	PRE group	C0681860
28338247	treatment	C0087111
28338247	compliant	C0566588
28338247	guidelines	C0162791
28338247	patients	C0030705
28338247	POST group	C0681860
28338247	OR	C0028873
28338247	CI	C0009667
28338247	Compliance	C0525058
28338247	guidelines	C0162791
28338247	significantly higher	C4055637
28338247	POST group	C0681860
28338247	OR	C0028873
28338247	CI	C0009667
28338247	Compliance	C0525058
28338247	fluid resuscitation	C0150238
28338247	insulin	C0021641
28338247	bolus	C1511237
28338247	initial	C0205265
28338247	insulin	C0021641
28338247	infusion rate	C2964135
28338247	Time	C0040223
28338247	DKA	C0011880
28338247	resolution	C2699488
28338247	decreased	C0205216
28338247	hypoglycaemia	C0020615
28338247	increased	C0205217
28338247	Implementation	C1708476
28338247	computerised DKA order set	C0282574
28338247	protocol	C0008971
28338247	associated with	C0332281
28338247	improved	C0184511
28338247	compliance	C0525058
28338247	ADA DKA guidelines	C0162791
28338247	fluid resuscitation	C0150238
28338247	initial	C0205265
28338247	insulin	C0021641
28338247	infusion rate	C2964135
28338247	time	C0040223
28338247	DKA	C0011880
28338247	resolution	C2699488
28338247	transition	C2700061
28338247	subcutaneous	C0443315
28338247	insulin	C0021641
28338247	patients	C0030705
28338247	POST implementation group	C0681860
28338247	hypoglycaemia	C0020615
28338634	Acetylcholinesterase	C0001044
28338634	Sensor	C0600364
28338634	Synthesized Paramagnetic Nanoparticles	C2713587
28338634	Neurotoxic Compounds	C0260049
28338634	Assay	C1510438
28338634	Magnetic particles	C2713587
28338634	MPs	C2713587
28338634	biological applications	C0205245
28338634	molecules	C0567416
28338634	immobilized	C1254366
28338634	molecules	C0567416
28338634	enzymes	C0014442
28338634	Acetylcholinesterase	C0001044
28338634	AChE	C0001044
28338634	enzyme	C0014442
28338634	neurotransmission	C0027793
28338634	enzyme	C0014442
28338634	targeted	C1521840
28338634	molecules	C0567416
28338634	Alzheimer's	C0002395
28338634	drugs	C1254351
28338634	pesticides	C0031253
28338634	warfare agents	C1113670
28338634	electrochemical biosensor	C0600364
28338634	AChE	C0001044
28338634	immobilized	C0014444
28338634	MPs	C2713587
28338634	stabilized	C0184512
28338634	glutaraldehyde (GA) molecule	C0017814
28338634	assay	C1510438
28338634	neurotoxic compounds	C0260049
28338634	prepared nanoparticles	C1450054
28338634	modified by	C0205349
28338634	pure AChE	C0001044
28338634	measurement	C0242485
28338634	anti-Alzheimer's	C0243095
28338634	drug	C1254351
28338634	galantamine	C0016967
28338634	carbamate pesticide	C0360422
28338634	carbofuran	C0006995
28338634	limit	C1549649
28338634	detection	C0442726
28338634	measurements	C0242485
28338634	screen-printed sensor	C0600364
28338634	carbon	C0007009
28338634	working	C0013812
28338634	silver	C0037125
28338634	reference	C4067887
28338634	carbon	C0007009
28338634	auxiliary electrode	C0013812
28338634	Standard Ellman's assay	C1510438
28338634	validation	C1519941
28338634	measurement	C0242485
28338634	inhibitors	C0243077
28338634	elimination	C1883720
28338634	reversible	C0205343
28338634	inhibitors	C0243077
28338634	galantamine	C0016967
28338634	active site	C0205681
28338634	AChE	C0001044
28338634	lower	C2003888
28338634	pH	C0020283
28338634	original	C0205313
28338634	activity	C0441655
28338634	AChE	C0001044
28338634	inhibition	C3463820
28338634	galantamine	C0016967
28338634	observed	C1441672
28338634	decarbamylation	C1254366
28338634	AChE	C0001044
28338634	carbofuran	C0006995
28338634	adduct	C0596040
28338634	organic solvents	C0360100
28338634	AChE	C0001044
28338634	measurement	C0242485
28338634	MPs	C2713587
28338634	AChE	C0001044
28339345	Alanine Aminotransferase	C0001899
28339345	Marker	C0005516
28339345	Lipotoxicity	C0039082
28339345	Consequences	C0686907
28339345	Hyperandrogenemia	C1299574
28339345	Women	C0043210
28339345	Polycystic Ovary Syndrome	C0032460
28339345	studies	C2603343
28339345	Alanine aminotransferase	C0001899
28339345	ALT	C0001899
28339345	women	C0043210
28339345	polycystic ovary syndrome	C0032460
28339345	PCOS	C0032460
28339345	control subjects	C0009932
28339345	Plasma ALT levels	C1272112
28339345	marker	C0005516
28339345	hepatic	C0205054
28339345	lipotoxicity	C0039082
28339345	hepatic	C0205054
28339345	hepatic steatosis	C0015695
28339345	hepatic	C0205054
28339345	insulin resistance	C0021655
28339345	Retrospective chart	C0282574
28339345	PCOS	C0032460
28339345	women	C0043210
28339345	ALT levels	C1272112
28339345	lipotoxicity	C0039082
28339345	consequences	C0686907
28339345	fasting	C0428568
28339345	oral glucose tolerance test	C0029161
28339345	Women	C0043210
28339345	PCOS	C0032460
28339345	years	C0439234
28339345	age	C0001779
28339345	body mass index	C1305855
28339345	metabolic syndrome	C0039082
28339345	MetS	C0039082
28339345	ALT levels	C1272112
28339345	homeostatic model assessment for insulin resistance	C3639411
28339345	HDL-C	C0023822
28339345	Matsuda index	C0918012
28339345	insulin secretion-sensitivity index-2	C0430022
28339345	free testosterone	C0443483
28339345	fasting glucose	C1261430
28339345	triglyceride levels	C0428475
28339345	ALT	C0001899
28339345	fasting glucose	C1261430
28339345	triglyceride levels	C0428475
28339345	women	C0043210
28339345	MetS	C0039082
28339345	whole-body insulin resistance	C0021655
28339345	Matsuda index	C0918012
28339345	Plasma ALT levels	C1272112
28339345	predictor	C2698872
28339345	liver	C0023884
28339345	lipotoxicity	C0039082
28339345	systemic lipotoxic	C0039082
28339345	consequences	C0686907
28339345	hyperandrogenemia	C1299574
28339345	women	C0043210
28339345	PCOS	C0032460
28339345	validation	C1519941
28339345	study	C2603343
28339345	ALT	C0001899
28339345	clinicians	C0871685
28339345	women	C0043210
28339345	metabolic risks	C2321263
28339928	Opioid	C0242402
28339928	Chronic Pain	C0150055
28339928	Patients	C0030705
28339928	Chronic Kidney Disease	C1561643
28339928	Systematic Review	C1955832
28339928	prevalence	C0220900
28339928	chronic pain	C0150055
28339928	opioid	C0242402
28339928	management	C1611232
28339928	patients	C0030705
28339928	chronic kidney disease	C1561643
28339928	CKD	C1561643
28339928	Systematic review	C1955832
28339928	methodological quality assessment	C0815254
28339928	studies	C0085973
28339928	prevalence	C0220900
28339928	pain	C0030193
28339928	type	C0332307
28339928	dose	C0678766
28339928	opioid	C0242402
28339928	effectiveness	C1280519
28339928	pain control	C1304888
28339928	adverse effects	C0879626
28339928	opioids	C0242402
28339928	CKD	C1561643
28339928	patients	C0030705
28339928	inclusion criteria	C1512693
28339928	randomized controlled trials	C0282440
28339928	RCT	C0282440
28339928	observational studies	C3658316
28339928	studies	C0085973
28339928	high	C0205250
28339928	quality	C0332306
28339928	moderate	C0439536
28339928	quality	C0332306
28339928	low	C0205251
28339928	quality	C0332306
28339928	studies	C0085973
28339928	studies	C0085973
28339928	countries	C0454664
28339928	sample size	C0242618
28339928	studies	C0085973
28339928	prevalence	C0220900
28339928	chronic	C0205191
28339928	uncontrolled pain	C0747149
28339928	opioids	C0242402
28339928	dose	C0678766
28339928	duration	C0920470
28339928	prescribed	C0278329
28339928	opioids	C0242402
28339928	studies	C0085973
28339928	systematic review	C1955832
28339928	prevalence	C0220900
28339928	chronic pain	C0150055
28339928	patients	C0030705
28339928	CKD	C1561643
28339928	underprescription	C0679863
28339928	analgesics	C0002771
28339928	opioids	C0242402
28339928	CKD	C1561643
28339928	population	C2361270
28339928	Clinicians	C0871685
28339928	randomized control trials	C0282440
28339928	opioid	C0242402
28339928	therapy	C0087111
28339928	opioid	C0242402
28339928	doses	C0678766
28339928	dosing	C0678766
28339928	intervals	C0031084
28339928	adequacy	C0814633
28339928	symptom control	C1274136
28339928	adverse side effects	C0879626
28342945	Cognitive impairment	C0338656
28342945	first-episode	C0439615
28342945	drug-naïve patients	C0030705
28342945	schizophrenia	C0036341
28342945	Relationships	C0439849
28342945	serum concentrations	C0683149
28342945	brain-derived neurotrophic factor	C0107103
28342945	glial cell line-derived neurotrophic factor	C0207072
28342945	brain-derived neurotrophic factor	C0107103
28342945	BDNF	C0107103
28342945	glial cell line -derived neurotrophic factor	C0207072
28342945	GDNF	C0207072
28342945	regulation of synaptic plasticity	C1326639
28342945	cognitive processes	C0871689
28342945	psychiatric disorders	C0004936
28342945	associations	C0439849
28342945	serum	C0229671
28342945	BDNF	C0107103
28342945	GDNF	C0207072
28342945	cognitive functions	C0392335
28342945	first-episode drug-naïve (FEDN) patients	C0030705
28342945	schizophrenia	C0036341
28342945	BDNF	C0107103
28342945	GDNF	C0207072
28342945	FEDN patients	C0030705
28342945	age	C0001779
28342945	sex	C1522384
28342945	healthy controls	C2986479
28342945	test subjects	C0681850
28342945	neurocognitive tests	C0872227
28342945	verbal fluency test	C0033905
28342945	VFT	C0033905
28342945	trail making test	C0040604
28342945	TMT	C0040604
28342945	digit span test	C0451577
28342945	DST	C0451577
28342945	Stroop test	C2718024
28342945	Patients	C0030705
28342945	controls	C0009932
28342945	neurocognitive performances	C0872227
28342945	DST	C0451577
28342945	BDNF	C0107103
28342945	levels	C0441889
28342945	TMT-part B scores	C0237855
28342945	VFT-action	C0033905
28342945	GDNF	C0207072
28342945	levels	C0441889
28342945	VFT-action scores	C0237855
28342945	TMT-part B scores	C0237855
28342945	patients	C0030705
28342945	cognitive dysfunction	C0338656
28342945	early stages	C2363430
28342945	schizophrenia	C0036341
28342945	BDNF	C0107103
28342945	GDNF	C0207072
28342945	pathological	C1521733
28342945	mechanisms	C0441712
28342945	cognitive impairment	C0338656
28342945	FEDN patients	C0030705
28342945	schizophrenia	C0036341
28343001	Comprehensive	C1880156
28343001	functional analysis	C0936012
28343001	genes	C0017337
28343001	proteins	C0033684
28343001	interpretation	C0459471
28343001	high dimensional datasets	C0150098
28343001	genomic	C0681814
28343001	proteomic experiments	C0681814
28343001	ClueGO software	C0037585
28343001	Cytoscape App	C3658280
28343001	biological	C0205460
28343001	information	C1533716
28343001	genes	C0017337
28343001	proteins	C0033684
28343001	functional enrichment analysis	C0936012
28343001	data	C1511726
28343001	annotation	C1706814
28343001	ontology	C1518584
28343001	resources	C0035201
28343001	automatically	C0205554
28343001	accessed	C0444454
28343001	ClueGO	C0037585
28343001	Predefined settings	C4281677
28343001	selection	C1707391
28343001	terms	C1705313
28343001	analysis	C0936012
28343001	Results	C1274040
28343001	networks	C1882071
28343001	Gene Ontology	C1138831
28343001	GO	C1138831
28343001	pathways	C1705987
28343001	species	C1705920
28343001	ClueGO	C0037585
28343001	organisms	C0029235
28343001	ClueGO	C0037585
28343001	CluePedia App	C3658280
28343001	protein-protein interactions	C0872079
28343001	pathways	C1705987
28343423	Management	C1536570
28343423	precipitated opiate withdrawal syndrome	C3274502
28343423	induced	C0205263
28343423	nalmefene	C0068377
28343423	prescribed	C0278329
28343423	opiate	C0376196
28343423	dependent patients	C0581116
28343423	review	C0282443
28343423	clinicians	C0871685
28343423	Nalmefene	C0068377
28343423	long-acting µ-opioid antagonist	C3536879
28343423	approved	C0205540
28343423	treat	C1522326
28343423	alcohol use disorder	C0001956
28343423	occasionally	C1998882
28343423	prescribed	C0278329
28343423	opiate	C0376196
28343423	dependent	C0581116
28343423	opioid	C0242402
28343423	treated	C1522326
28343423	patients	C0030705
28343423	review	C1552617
28343423	literature	C0023866
28343423	drug-drug interactions	C0687133
28343423	nalmefene	C0068377
28343423	opioids	C0242402
28343423	precipitated opioid withdrawal	C0029104
28343423	management	C1536570
28343423	planning	C1301732
28343423	care	C0017313
28343423	discharge	C0030685
28343423	comprehensive review	C3494708
28343423	precipitated opioid withdrawal syndrome	C3274502
28343423	nalmefene	C0068377
28343423	associated with	C0332281
28343423	opioid	C0242402
28343423	misused	C1997897
28343423	legally	C1301860
28343423	prescribed	C0278329
28343423	Expert opinion	C0600219
28343423	treating	C1522326
28343423	opiate	C0376196
28343423	dependent patient	C0581116
28343423	alcohol use disorder	C0001956
28343423	conditions	C0348080
28343423	clinical attention	C0205210
28343423	New	C0205314
28343423	drugs	C0013227
28343423	alcohol use disorder	C0001956
28343423	approved	C0205540
28343423	potential	C3245505
28343423	drug-drug interactions	C0687133
28343423	opioid	C0242402
28343423	medications	C4284232
28343423	Opiate	C0376196
28343423	dependent patients	C0581116
28343423	risk factors	C0035648
28343423	alcohol use disorder	C0001956
28343423	treatment maintenance	C0814469
28343423	nalmefene	C0068377
28343423	administered	C0806914
28343423	opiate	C0376196
28343423	dependent patients	C0581116
28343423	acute	C0205178
28343423	opioid withdrawal syndrome	C3274502
28343423	occur	C1709305
28343423	Management	C1536570
28343423	acute	C0205178
28343423	opioid withdrawal	C0029104
28343423	include	C2700399
28343423	long-acting µ-opioid agonists	C1373059
28343423	hospitalization	C0019993
28343423	supportive treatment	C0344211
28343423	management	C1610129
28343423	polydrug abusers	C0556390
28343423	multidisciplinary approach	C0729737
28343423	improved	C0184511
28343423	through	C0332273
28343423	continuing medical education	C1553904
28343993	residues	C1709915
28343993	dengue virus	C0011315
28343993	NS2b-NS3-protease	C1612175
28343993	binding sites	C0005456
28343993	antiviral inhibitors	C0042771
28343993	NS2B-NS3 protease	C1612175
28343993	Dengue Virus	C0011315
28343993	DENV	C0011315
28343993	replication process	C1514849
28343993	complex	C1167179
28343993	target	C1521840
28343993	antiviral	C0003451
28343993	discovery	C1880355
28343993	drug	C1254351
28343993	viral polyprotein processing	C1159314
28343993	protease	C1947941
28343993	conserved	C0009802
28343993	Dengue virus	C0011315
28343993	serotypes	C0449943
28343993	drug	C1254351
28343993	influential	C0021399
28343993	residues	C1709915
28343993	Dengue	C0011315
28343993	NS2b-NS3 Protease	C1612175
28343993	protein	C0033684
28343993	influential	C0021399
28343993	residues	C1709915
28343993	non-competitive inhibitor	C0815027
28343993	development	C1527148
28343993	computational	C0376528
28343993	alanine	C0001898
28343993	scanning mutagenesis	C1517890
28343993	sequence	C0314659
28343993	structure conservation	C0009802
28343993	structure	C0678594
28343993	characteristics	C1521970
28343993	multilayer perceptron model	C0870951
28343993	groups	C0441833
28343993	residues	C1709915
28343993	binding sites	C0005456
28343993	DENV	C0011315
28343993	protease	C1947941
28343993	residues	C1709915
28343993	amino acids	C0002520
28343993	beta sheet	C0162806
28343993	beta sheet	C0162806
28343993	closed conformation	C0033625
28343993	NS2b	C1612175
28343993	residues	C1709915
28343993	active site	C0205681
28343993	residues	C1709915
28343993	NS2b-NS3	C1612175
28343993	residues	C1709915
28343993	stability	C0205360
28343993	protease	C1947941
28343993	residues	C1709915
28343993	amino acids	C0002520
28343993	peptide	C0030956
28343993	vaccine development	C0597634
28344199	Association	C0439849
28344199	Toll-Like Receptor 4	C1411976
28344199	Human	C0086418
28344199	Monocyte	C0026473
28344199	Subsets	C1515021
28344199	Vulnerability	C1821973
28344199	Characteristics	C1521970
28344199	Coronary	C0018787
28344199	Plaque	C0332461
28344199	Assessed	C1516048
28344199	64-Slice Multidetector Computed Tomography	C3179130
28344199	Toll-like receptor 4	C1411976
28344199	TLR-4	C1411976
28344199	monocyte activation	C1155075
28344199	patients	C0030705
28344199	accelerated	C0521110
28344199	atherosclerosis	C0004153
28344199	relationship	C0439849
28344199	expression	C0597360
28344199	TLR-4	C1411976
28344199	circulating	C0175630
28344199	monocyte	C0026473
28344199	coronary	C0018787
28344199	plaque	C0332461
28344199	vulnerability	C1821973
28344199	evaluated	C0220825
28344199	relationship	C0439849
28344199	64-slice multidetector computed tomography	C3179130
28344199	MDCT	C3179130
28344199	patients	C0030705
28344199	stable angina pectoris	C0340288
28344199	SAP	C0340288
28344199	patients	C0030705
28344199	SAP	C0340288
28344199	MDCT	C3179130
28344199	monocyte	C0026473
28344199	subsets	C1515021
28344199	CD14(++)CD16(-)	C0026473
28344199	CD14(++)CD16(+)	C0026473
28344199	CD14(+)CD16(+)	C0026473
28344199	expression	C0597360
28344199	TLR-4	C1411976
28344199	flow cytometry	C0016263
28344199	Intracoronary	C0018787
28344199	plaques	C0332461
28344199	assessed	C1516048
28344199	64-slice MDCT	C3179130
28344199	vulnerability	C1821973
28344199	intracoronary	C0018787
28344199	plaques	C0332461
28344199	positive remodeling	C3854505
28344199	remodeling index	C0243095
28344199	CT	C0040405
28344199	attenuation	C2986722
28344199	circulating	C0175630
28344199	CD14(++)CD16(+)monocytes	C0026473
28344199	expressed	C0597360
28344199	TLR-4	C1411976
28344199	CD14(++)CD16(-)	C0026473
28344199	CD14(+)CD16(+)monocytes	C0026473
28344199	expression	C0597360
28344199	TLR-4	C1411976
28344199	CD14(++)CD16(+)monocytes	C0026473
28344199	patients	C0030705
28344199	vulnerable plaque	C0332461
28344199	TLR-4	C1411976
28344199	expression	C0597360
28344199	CD14(++)CD16(+)monocytes	C0026473
28344199	correlated	C1707520
28344199	remodeling index	C0243095
28344199	correlated	C1707520
28344199	CT	C0040405
28344199	attenuation value	C2986722
28344199	Upregulation	C0949479
28344199	TLR-4	C1411976
28344199	CD14(++)CD16(+)monocytes	C0026473
28344199	associated with	C0332281
28344199	coronary	C0018787
28344199	plaque	C0332461
28344199	vulnerability	C1821973
28344199	patients	C0030705
28344199	SAP	C0340288
28348382	Delta-frequency	C0429299
28348382	stimulation	C1948023
28348382	cerebellar	C0007765
28348382	projections	C0348018
28348382	compensate	C0205432
28348382	schizophrenia	C0036341
28348382	medial frontal dysfunction	C4062322
28348382	Schizophrenia	C0036341
28348382	abnormalities	C1704258
28348382	medial frontal cortex	C0016733
28348382	cognitive deficits	C0009241
28348382	investigate	C1292732
28348382	novel	C0205314
28348382	strategy	C0679199
28348382	normalize	C1882115
28348382	medial frontal brain	C2951740
28348382	activity	C0443158
28348382	stimulating	C1948023
28348382	cerebellar	C0007765
28348382	projections	C0348018
28348382	interval timing	C0872291
28348382	study	C2603343
28348382	cognitive processing	C0025361
28348382	frontal	C0016733
28348382	cerebellar networks	C2953133
28348382	disrupted	C0332454
28348382	patients	C0030705
28348382	schizophrenia	C0036341
28348382	novel	C0205314
28348382	findings	C0243095
28348382	patients	C0030705
28348382	schizophrenia	C0036341
28348382	delta rhythms	C0011227
28348382	medial frontal cortex	C0016733
28348382	cerebellar	C0007765
28348382	frontal	C0016733
28348382	interactions	C1704675
28348382	animal models	C0599779
28348382	frontal	C0016733
28348382	cerebellar neurons	C0682702
28348382	modulated	C0443264
28348382	interval timing	C0872291
28348382	delta-frequency	C0429299
28348382	interactions	C1704675
28348382	delta-frequency	C0429299
28348382	optogenetic	C3494301
28348382	stimulation	C1948023
28348382	thalamic	C0039729
28348382	synaptic terminals	C0206181
28348382	lateral	C0205093
28348382	cerebellar	C0007765
28348382	projection	C0348018
28348382	neurons	C0027882
28348382	medial frontal	C2951740
28348382	activity	C0443158
28348382	rodent model	C1519106
28348382	schizophrenia-related	C0036341
28348382	frontal dysfunction	C4062322
28348382	data	C1511726
28348382	cerebellum	C0007765
28348382	influences	C4054723
28348382	medial frontal networks	C4248854
28348382	cerebellum	C0007765
28348382	cognitive processing	C0025361
28351424	Variables	C0439828
28351424	associated with	C0332281
28351424	unplanned	C0205556
28351424	general adult	C0001675
28351424	ICU admission	C0583239
28351424	hospitalised patients	C0870668
28351424	protocol	C0442711
28351424	systematic	C0220922
28351424	review	C1552617
28351424	Failure	C0231175
28351424	identify	C0205396
28351424	deterioration	C0868945
28351424	hospitalised patients	C0870668
28351424	associated with	C0332281
28351424	delayed	C0205421
28351424	admission to intensive care units	C0583239
28351424	ICUs	C0021708
28351424	poor	C2700379
28351424	outcomes	C0085415
28351424	Existing	C2987476
28351424	vital sign	C0518766
28351424	Early Warning Score	C0449820
28351424	(EWS)	C0449820
28351424	algorithms	C0002045
28351424	sufficiently	C0205410
28351424	high	C0205250
28351424	positive	C3812269
28351424	predictive value	C1514307
28351424	automated	C0205554
28351424	activation	C1879547
28351424	ICU	C0021708
28351424	outreach team	C0586969
28351424	Incorporating	C0332257
28351424	patient data	C2707520
28351424	improve	C0184511
28351424	predictive	C0681890
28351424	power	C3854080
28351424	EWS	C0449820
28351424	algorithms	C0002045
28351424	currently	C0521116
28351424	patient data	C2707520
28351424	variables	C0439828
28351424	predictive	C0681890
28351424	ICU admission	C0583239
28351424	protocol	C0442711
28351424	systematic	C0220922
28351424	review	C1552617
28351424	variables	C0439828
28351424	associated with	C0332281
28351424	ICU admission	C0583239
28351424	MEDLINE	C0242356
28351424	EMBASE	C0242356
28351424	CINAHL	C0242356
28351424	Cochrane Library	C0242356
28351424	including	C0332257
28351424	Cochrane Database of Systematic Reviews	C0242356
28351424	Cochrane Central Register of Controlled Trials	C0282574
28351424	(CENTRAL)	C0282574
28351424	searched	C1706202
28351424	studies	C2603343
28351424	assess	C0184514
28351424	association	C0439849
28351424	routinely	C0205547
28351424	recorded	C0034869
28351424	variables	C0439828
28351424	associated with	C0332281
28351424	subsequent	C0332282
28351424	unplanned	C0205556
28351424	ICU admission	C0583239
28351424	studies	C2603343
28351424	involving	C1314939
28351424	adult	C0001675
28351424	patients	C0030705
28351424	admitted to	C0184666
28351424	general	C0205246
28351424	ICUs	C0021708
28351424	included	C0332257
28351424	extract	C0849355
28351424	data	C1511726
28351424	relating to	C0332281
28351424	statistical association	C0010101
28351424	ICU admission	C0583239
28351424	predictor	C0681842
28351424	variables	C0439828
28351424	quality	C0332306
28351424	studies	C2603343
28351424	generalisability	C0205246
28351424	findings	C0243095
28351424	results	C1274040
28351424	review	C1552617
28351424	aid	C1269765
28351424	development	C1527148
28351424	models	C3161035
28351424	predict	C0681842
28351424	risk	C0035647
28351424	unplanned	C0205556
28351424	ICU admission	C0583239
28351716	Diagnosis	C0011900
28351716	retinal	C0035298
28351716	health	C0018684
28351716	digital fundus images	C0200189
28351716	continuous wavelet transform	C2936326
28351716	CWT	C2936326
28351716	entropies	C0376522
28351716	Vision	C0042789
28351716	humans	C0086418
28351716	personal	C1519021
28351716	professional life	C2698884
28351716	prevalence	C0220900
28351716	ocular diseases	C0015397
28351716	diseases	C0012634
28351716	glaucoma	C0017601
28351716	Diabetic Retinopathy	C0011884
28351716	DR	C0011884
28351716	Age-related Macular Degeneration	C0242383
28351716	AMD	C0242383
28351716	leading	C1522538
28351716	causes	C0015127
28351716	blindness	C0456909
28351716	developed countries	C0282613
28351716	diseases	C0012634
28351716	mass screening programmes	C0024870
28351716	time-consuming	C3827829
28351716	labor	C0043227
28351716	diagnosis	C0011900
28351716	subjective	C0439655
28351716	automated computer aided diagnosis system	C0011905
28351716	analysis	C0936012
28351716	inter-observer subjective variabilities	C0021713
28351716	image interpretation	C0020910
28351716	automatic	C0205554
28351716	classification	C0008902
28351716	normal	C0205307
28351716	abnormal	C0205161
28351716	DR	C0011884
28351716	AMD	C0242383
28351716	glaucoma	C0017601
28351716	images	C0237660
28351716	normal	C0205307
28351716	abnormal	C0205161
28351716	fundus images	C0200189
28351716	database	C0242356
28351716	2D-Continuous Wavelet Transform	C2936326
28351716	CWT	C2936326
28351716	fundus images	C0200189
28351716	energy	C1442080
28351716	entropies	C0376522
28351716	images	C0237660
28351716	sampling approach	C0449370
28351716	normal	C0205307
28351716	abnormal	C0205161
28351716	datasets	C0150098
28351716	Particle Swarm Optimization	C0282574
28351716	PSO	C0282574
28351716	stratified	C0205363
28351716	cross validation	C0681935
28351716	performance rate	C3533080
28351716	sensitivity	C0036667
28351716	specificity	C0037791
28351716	abnormal	C0205161
28351716	fundus images	C0200189
28351716	eye	C0015392
28351716	health	C0018684
28351716	screening tool	C0220908
28351716	polyclinics	C0442592
28351716	workload	C0085122
28351716	specialists	C1611835
28351716	hospitals	C0019994
28352958	epigenetic landscape	C1516924
28352958	age	C0001779
28352958	related	C1552599
28352958	diseases	C0012634
28352958	geroscience	C1518533
28352958	perspective	C1254370
28352958	review	C0282443
28352958	epigenetics	C1516924
28352958	age	C0001779
28352958	related	C1552599
28352958	diseases	C0012634
28352958	studies	C0008972
28352958	DNA methylation landscape	C0376452
28352958	cardio-vascular diseases	C0007222
28352958	musculoskeletal function	C0026861
28352958	frailty	C0424594
28352958	conceptual framework	C1254372
28352958	geroscience	C1518533
28352958	advanced	C0001792
28352958	age	C0001779
28352958	risk factor	C0035648
28352958	pathologies	C0205469
28352958	aims	C1947946
28352958	mechanistic links	C0439849
28352958	aging	C0001811
28352958	age	C0001779
28352958	related	C1552599
28352958	diseases	C0012634
28352958	DNA methylation	C0376452
28352958	remodeling	C0678692
28352958	aging	C0001811
28352958	global hypomethylation	C2613367
28352958	genome	C0017428
28352958	hypermethylation	C1512554
28352958	specific	C0205369
28352958	loci	C0678933
28352958	increase	C0442805
28352958	inter-individual variation	C0042333
28352958	stochastic	C0038347
28352958	changes	C0392747
28352958	DNA methylation	C0376452
28352958	values	C0042295
28352958	epigenetic	C1516924
28352958	modifications	C3840684
28352958	development	C1527148
28352958	age	C0001779
28352958	related	C1552599
28352958	diseases	C0012634
28352958	complex	C0439855
28352958	relationship	C0439849
28352958	epigenetic signatures	C1516924
28352958	aging	C0001811
28352958	age	C0001779
28352958	related	C1552599
28352958	disease	C0012634
28352958	relevant	C2347946
28352958	results	C2825142
28352958	epigenetics clocks	C1516924
28352958	cohorts	C0599755
28352958	subjects	C0080105
28352958	affected	C0392760
28352958	age	C0001779
28352958	related	C1552599
28352958	diseases	C0012634
28352958	studies	C0008972
28352958	review	C0282443
28353042	Beneficial Effects	C1280500
28353042	Phyllanthus amarus	C0950041
28353042	High Fructose Diet	C0012155
28353042	Insulin Resistance	C0021655
28353042	Hepatic Oxidative Stress	C0242606
28353042	Male	C0086582
28353042	Wistar Rats	C0034716
28353042	Insulin resistance	C0021655
28353042	IR	C0021655
28353042	obesity	C0028754
28353042	type 2 diabetes mellitus	C0011860
28353042	cardiovascular diseases	C0007222
28353042	high-fructose	C0016745
28353042	consumption	C1947907
28353042	potential	C3245505
28353042	factor	C1521761
28353042	rising incidence	C0220888
28353042	IR	C0021655
28353042	study	C2603343
28353042	investigates	C1292732
28353042	beneficial effects	C1280500
28353042	aqueous extract	C2828366
28353042	Phyllanthus amaru	C0950041
28353042	PAAE	C2828366
28353042	IR	C0021655
28353042	oxidative stress	C0242606
28353042	high-fructose	C0016745
28353042	HF	C0016745
28353042	male	C0086582
28353042	Wistar rats	C0034716
28353042	HF diet	C0012155
28353042	PAAE	C2828366
28353042	concurrently	C0205420
28353042	rats	C0034716
28353042	Fructose-fed	C0205556
28353042	rats	C0034716
28353042	weight gain	C0043094
28353042	hyperglycemia	C0020456
28353042	hyperinsulinemia	C0020459
28353042	impaired glucose tolerance	C0271650
28353042	impaired insulin sensitivity	C0920563
28353042	dyslipidemia	C0242339
28353042	hyperleptinemia	C0012634
28353042	hypoadiponectinemia	C2675519
28353042	Co-administration	C1533734
28353042	PAAE	C2828366
28353042	HF diet	C0012155
28353042	alterations	C1515926
28353042	hepatic	C0205054
28353042	antioxidant status	C1148564
28353042	lipid peroxidation	C0023775
28353042	protein oxidation	C1159301
28353042	reduced glutathione	C0034917
28353042	lower activities	C3890174
28353042	enzymatic antioxidants	C0003402
28353042	histopathological changes	C0243140
28353042	distortion	C2919017
28353042	liver sinusoids	C0227523
28353042	HF diet	C0012155
28353042	rats	C0034716
28353042	PAAE	C2828366
28353042	treatment	C0087111
28353042	PAAE	C2828366
28353042	insulin sensitivity	C0920563
28353042	metabolic syndrome	C0025517
28353042	hepatic oxidative stress	C0242606
28353042	fructose-fed	C0205556
28353042	rats	C0034716
28356035	Environmental factors	C1516998
28356035	hypertension	C0020538
28356035	Environmental factors	C1516998
28356035	poor health	C0683321
28356035	worldwide	C2700280
28356035	evidence	C3887511
28356035	air pollution	C0001873
28356035	disability-adjusted life years	C4300518
28356035	Outdoor	C0680182
28356035	temperature	C0039476
28356035	seasonal	C0036497
28356035	climate changes	C2718051
28356035	cardiovascular	C3887460
28356035	health	C0018684
28356035	air pollution	C0001873
28356035	evidence	C3887511
28356035	environmental exposure	C0014412
28356035	noise	C0028263
28356035	poor cardiovascular outcome	C0243095
28356035	hypertension	C0020538
28356035	evidence	C3887511
28356035	environmental factors	C1516998
28356035	cardiovascular disease	C0007222
28356035	hypertension	C0020538
28356035	impact	C4049986
28356035	air pollution	C0001873
28356035	short-term	C0443303
28356035	long-term effects	C0023983
28356035	outdoor	C0680182
28356035	temperature	C0039476
28356035	noise pollution	C0686918
28356035	People	C0027361
28356035	low	C0205251
28356035	social classes	C0037402
28356035	children	C0008059
28356035	women	C0043210
28356035	older people	C3826770
28356035	cardiovascular diseases	C0007222
28356035	susceptibility	C1264642
28356035	effects	C1280500
28356035	environmental stressors	C0596519
28356035	concept	C0178566
28356035	environmental justice	C1254370
28356035	evidence	C3887511
28356035	public health policies	C0680811
28356035	social inequalities	C0680381
28356035	cardiovascular	C3887460
28356035	health	C0018684
28356129	effects of	C1704420
28356129	probiotic	C0525033
28356129	synbiotic	C2936470
28356129	supplementation	C0242296
28356129	metabolic syndrome	C0524620
28356129	indices	C0010439
28356129	adults	C0001675
28356129	risk	C0035647
28356129	type 2 diabetes	C0011860
28356129	study protocol	C1507394
28356129	randomized controlled trial	C0206035
28356129	incidence	C0021149
28356129	type 2 diabetes	C0011860
28356129	cardiovascular diseases	C0007222
28356129	obesity	C0028754
28356129	rising	C0442805
28356129	pathogenesis	C0699748
28356129	intriguing	C0543488
28356129	dysbiosis	C3658208
28356129	intestinal microbiota	C2985398
28356129	new	C0205314
28356129	candidate	C0392360
28356129	metabolic diseases	C0025517
28356129	intestinal microbiota	C2985398
28356129	probiotic	C0525033
28356129	synbiotic	C2936470
28356129	supplementation	C0242296
28356129	may improve	C1272747
28356129	metabolic dysfunction	C0025517
28356129	prevent	C0392756
28356129	diabetes	C0011847
28356129	prediabetics	C0362046
28356129	study	C2603343
28356129	synthesis	C1883254
28356129	study	C2603343
28356129	synbiotics	C2936470
28356129	carried	C0206243
28356129	Iran	C0022065
28356129	randomized triple-blind controlled clinical trial	C0206035
28356129	adults	C0001675
28356129	impaired glucose tolerance	C0271650
28356129	inclusion criteria	C1512693
28356129	selected	C1707391
28356129	random	C0439605
28356129	sampling method	C0449370
28356129	randomly	C0439605
28356129	allocated	C1706778
28356129	months	C0439231
28356129	probiotic	C0525033
28356129	synbiotic	C2936470
28356129	placebo	C1696465
28356129	fecal	C0015733
28356129	abundance	C2346714
28356129	bacteria	C0004611
28356129	blood pressure	C0005823
28356129	height	C0489786
28356129	weight	C0005910
28356129	waist	C0455829
28356129	hip circumferences	C0562350
28356129	measured	C0444706
28356129	baseline	C1442488
28356129	following	C0332282
28356129	treatment	C0087111
28356129	plasma lipid profiles	C0850354
28356129	HbA1C	C0019018
28356129	fasting plasma glucose	C0583513
28356129	insulin	C0021641
28356129	levels	C0441889
28356129	measured	C0444706
28356129	insulin resistance	C4049994
28356129	HOMA-IR	C4049994
28356129	beta-cell function	C4055385
28356129	HOMA-B	C4055385
28356129	calculated	C1441506
28356129	baseline	C1442488
28356129	repeated	C0205341
28356129	months	C0439231
28356129	data	C1511726
28356129	compared	C1707455
28356129	groups	C0681860
28356129	using	C1524063
28356129	statistical methods	C1710191
28356129	results	C1274040
28356129	trial	C0206035
28356129	contribute	C1880177
28356129	evidence-based clinical guidelines	C0282451
28356129	gut microbiota	C2985398
28356129	manipulation	C0087111
28356129	maximize	C0442805
28356129	health benefits	C0086387
28356129	prevention	C0199176
28356129	management	C0376636
28356129	metabolic syndrome	C0524620
28356129	prediabetes	C0362046
28356129	Iranian Registry	C0034975
28356129	Clinical Trials	C0008976
28356129	IRCT201511032321N2	C0282574
28356622	Evaluation	C1516048
28356622	relationship	C0439849
28356622	static	C0441463
28356622	measurement	C0242485
28356622	transverse arch	C0230467
28356622	flexibility	C0242808
28356622	forefoot	C1510667
28356622	gait	C0016928
28356622	parameters	C0549193
28356622	healthy subjects	C1708335
28356622	Purpose	C0681832
28356622	investigate	C1292732
28356622	relationship	C0439849
28356622	static	C0441463
28356622	measurement	C0242485
28356622	transverse arch	C0230467
28356622	forefoot	C1510667
28356622	3-dimensional	C0450363
28356622	3D	C0450363
28356622	foot scanner	C4052629
28356622	kinetics	C0022702
28356622	kinematics	C0600169
28356622	gait	C0016928
28356622	parameters	C0549193
28356622	sagittal plane	C0935598
28356622	Subjects	C0080105
28356622	Methods	C0025663
28356622	healthy subjects	C1708335
28356622	study	C0681814
28356622	transverse arch	C0230467
28356622	forefoot	C1510667
28356622	measured	C0444706
28356622	conditions	C0348080
28356622	condition	C0348080
28356622	sitting	C0277814
28356622	condition	C0348080
28356622	standing	C0231472
28356622	condition	C0348080
28356622	foot	C0016504
28356622	forward	C0439780
28356622	lower leg	C1140621
28356622	tilting	C1711426
28356622	anteriorly	C0205094
28356622	maximum	C0806909
28356622	position	C0733755
28356622	heel	C0018870
28356622	contact	C0332158
28356622	Gait	C0016928
28356622	parameters	C0549193
28356622	recorded	C3853788
28356622	3D motion analysis system	C1704459
28356622	force plate	C0492768
28356622	Correlation	C1707520
28356622	coefficients	C1707429
28356622	TAF	C0242808
28356622	comparison	C1707455
28356622	conditions	C0348080
28356622	gait	C0016928
28356622	parameters	C0549193
28356622	calculated	C1441506
28356622	Spearman correlation analysis	C0010101
28356622	Results	C1274040
28356622	Rates	C1521828
28356622	transverse arch	C0230467
28356622	forefoot	C1510667
28356622	width	C0487742
28356622	height	C0489786
28356622	condition	C0348080
28356622	condition	C0348080
28356622	significantly correlated	C1707520
28356622	anterior	C0205094
28356622	posterior	C0205095
28356622	component	C1705248
28356622	ground reaction forces	C0441722
28356622	hip joint	C0019558
28356622	extension	C0231448
28356622	angle	C0205143
28356622	ankle	C0003086
28356622	plantar flexion moment	C0231784
28356622	Conclusion	C1707478
28356622	study's	C0681814
28356622	findings	C0243095
28356622	indicated	C1444656
28356622	increased	C0205217
28356622	stiffness	C0427008
28356622	transverse arch	C0230467
28356622	forefoot	C1510667
28356622	related	C0439849
28356622	increase	C0442805
28356622	ankle	C0003086
28356622	plantar moment	C0231784
28356622	decreased	C0205216
28356622	stiffness	C0427008
28356622	transverse arch	C0230467
28356622	forefoot	C1510667
28356622	related	C0439849
28356622	increase	C0442805
28356622	hip joint	C0019558
28356622	extension	C0231448
28356622	angle	C0205143
28356622	gait	C0016928
28358612	Management	C0376636
28358612	Case Outcome	C0543472
28358612	Gastric Impaction	C0267223
28358612	Raptors	C0600536
28358612	Case Series	C0150093
28358612	raptors	C0600536
28358612	American kestrel	C0325583
28358612	Falco sparverius	C0325583
28358612	peregrine falcon	C0325581
28358612	Falco peregrinus	C0325581
28358612	golden eagle	C0325569
28358612	Aquila chrysaetos	C0325569
28358612	barn owl	C0326063
28358612	Tyto alba	C0326063
28358612	diagnosed	C0011900
28358612	ventricular	C2355627
28358612	proventricular	C0033745
28358612	foreign material	C0232481
28358612	impactions	C0333124
28358612	artificial turf substrate	C3891814
28358612	paper	C0030351
28358612	plastic substrate	C0032162
28358612	grass	C0018210
28358612	newspaper	C0027989
28358612	Partial or total anorexia	C0003123
28358612	birds	C0600536
28358612	decreased	C0205216
28358612	casting	C3519992
28358612	birds	C0600536
28358612	Survey	C0038951
28358612	radiographs	C1306645
28358612	gastric	C0038351
28358612	enlargement	C1293134
28358612	birds	C0600536
28358612	kestrel	C0325582
28358612	eagle	C0325569
28358612	treated	C1522326
28358612	gastroscopy	C0017195
28358612	gastric lavage	C0017134
28358612	surgical intervention	C0549433
28358612	ventricular	C2355627
28358612	impactions	C0333124
28358612	birds	C0600536
28358612	died of undetermined causes	C2826209
28358612	after surgery	C0032790
28358612	peregrine falcon	C0325581
28358612	died	C1306577
28358612	before medical	C3179131
28358612	surgical intervention	C0549433
28358612	owl	C0326063
28358612	oral mineral oil	C1250025
28358612	liquid diet	C0301571
28358612	facilitate egestion of the foreign material	C0232481
28358612	pellet	C1706128
28358612	Lead poisoning	C0023176
28358612	predisposing cause	C0032946
28358612	foreign body ingestion	C0232481
28358612	eagle	C0325569
28358612	underlying causes	C0015127
28358612	pica	C0031873
28358612	birds	C0600536
28358612	not determined	C0521096
28358612	Radiographs	C1306645
28358612	diagnostic information	C0811871
28358612	sick	C0221423
28358612	raptors	C0600536
28358612	exhibit vomiting	C0042963
28358612	changes in appetite	C0426587
28358612	casting frequency	C3519992
28358612	treatment decisions	C0087111
28358612	impacted	C0333125
28358612	birds	C0600536
28358612	consideration	C0518609
28358612	substrate	C3891814
28358612	enrichment items	C3273359
28358612	potential	C3245505
28358612	foreign material that could be ingested	C0232481
28358612	management strategy	C0376636
28358612	raptors	C0600536
28358712	Anti-inflammatory	C0243095
28358712	activity	C0441655
28358712	Elaeagnus angustifolia	C1006436
28358712	fruit extract	C0772257
28358712	rat	C0034693
28358712	paw	C0687080
28358712	edema	C0013604
28358712	Elaeagnus angustifolia	C1006436
28358712	fruit	C0016767
28358712	Iranian	C0022065
28358712	herbal medicine	C2240391
28358712	treat	C1522326
28358712	diarrhea	C0011991
28358712	rheumatoid arthritis	C0003873
28358712	effects	C1280500
28358712	E. angustifolia	C1006436
28358712	fruit extract	C0772257
28358712	acute	C0205178
28358712	chronic phases	C0457343
28358712	formalin	C0949307
28358712	induced	C0205263
28358712	rat	C0034693
28358712	paw	C0687080
28358712	edema	C0013604
28358712	examined	C0332128
28358712	acute	C0205178
28358712	chronic	C0457343
28358712	anti-inflammatory effects	C0243095
28358712	E. angustifolia	C1006436
28358712	fruit extract	C0772257
28358712	investigated	C1292732
28358712	subcutaneous injection	C0021499
28358712	formalin	C0949307
28358712	rat's	C0034693
28358712	paw	C0687080
28358712	Thirty minutes	C1442458
28358712	procedure	C2700391
28358712	experimental	C1517586
28358712	groups	C0441833
28358712	treated	C1522326
28358712	intraperitoneally	C0442120
28358712	hydroalcoholic fruit extracts	C0772257
28358712	E. angustifolia	C1006436
28358712	concentrations	C1264643
28358712	sodium salicylate	C0037549
28358712	SS	C0037549
28358712	distilled water	C0790233
28358712	positive	C1446409
28358712	negative	C0205160
28358712	control groups	C0009932
28358712	Treatment	C1522326
28358712	SS	C0037549
28358712	fruit extracts	C0772257
28358712	performed	C0884358
28358712	daily	C0332173
28358712	days	C0439228
28358712	degree	C0449286
28358712	edema	C0013604
28358712	measured	C0444706
28358712	mercury plethysmometer	C0025080
28358712	digital caliper	C0175720
28358712	acute	C0205178
28358712	anti-inflammatory	C0243095
28358712	study	C2603343
28358712	extract	C2828366
28358712	anti-inflammatory effect	C1515999
28358712	dose-dependent	C1512045
28358712	results	C1274040
28358712	extract	C2828366
28358712	different	C1705242
28358712	compared with	C1707455
28358712	negative	C0205160
28358712	control group	C0009932
28358712	sodium salicylate	C0037549
28358712	Results	C1274040
28358712	chronic	C0457343
28358712	study	C2603343
28358712	suggested	C1705535
28358712	E. angustifolia	C1006436
28358712	extract	C2828366
28358712	reduced	C0392756
28358712	paw	C0687080
28358712	edema	C0013604
28358712	inflammation	C0021368
28358712	dose-dependent	C1512045
28358712	results	C1274040
28358712	measurement	C0242485
28358712	digital caliper	C0175720
28358712	mercury plethysmometer	C0025080
28358712	Phytochemical tests	C0022885
28358712	hydroalcoholic fruit extract	C0772257
28358712	E. angustifolia	C1006436
28358712	positive	C1446409
28358712	cardiac glycosides	C0007158
28358712	flavonoids	C0596577
28358712	terpenoids	C0039561
28358712	saponins	C0036189
28358712	findings	C0243095
28358712	E. angustifolia	C1006436
28358712	fruit extract	C0772257
28358712	acute	C0205178
28358712	chronic	C0457343
28358712	anti-inflammatory	C0243095
28358712	activities	C0441655
28358712	folk medicine	C0016419
28360122	Increased	C0205217
28360122	cerebral blood volume	C4277714
28360122	pulsatility	C0577317
28360122	head-down tilt	C0242683
28360122	elevated carbon dioxide	C0020440
28360122	elevated carbon dioxide	C0020440
28360122	SPACECOT Study	C2603343
28360122	Astronauts	C0242688
28360122	hyperopic shifts	C0020490
28360122	posterior	C0205095
28360122	eye globe	C0015392
28360122	flattening	C0016203
28360122	dilated	C0700124
28360122	optic nerve sheaths	C0228673
28360122	optic disc swelling	C0030353
28360122	spaceflight	C0037741
28360122	Elevated intracranial pressure	C0151740
28360122	ICP	C0151740
28360122	cephalad	C0205096
28360122	fluid shifts	C0242705
28360122	hypothesized	C1512571
28360122	ocular changes	C0429568
28360122	Head-down tilt	C0242683
28360122	HDT	C0242683
28360122	Earth	C0242744
28360122	similar	C2348205
28360122	fluid shifts	C0242705
28360122	Sealed environments	C0014406
28360122	elevated	C3163633
28360122	carbon dioxide	C0007012
28360122	CO2	C0007012
28360122	potent	C3245505
28360122	arteriolar vasodilator	C2267010
28360122	cerebral blood volume	C4277714
28360122	flow	C0428714
28360122	intracranial	C0524466
28360122	compliance	C3714738
28360122	ICP	C0151740
28360122	collaborative pilot study	C0031928
28360122	National Space Biomedical Research Institute	C1708333
28360122	German Aerospace Center	C1561598
28360122	hypotheses	C1512571
28360122	HDT	C0242683
28360122	elevated	C3163633
28360122	CO2	C0007012
28360122	physiologically	C0205463
28360122	interact	C1704675
28360122	cerebrovascular	C1880018
28360122	pulsatility	C0577317
28360122	HDT	C0242683
28360122	elevated	C3163633
28360122	CO2	C0007012
28360122	double-blind	C0013072
28360122	crossover study	C0150097
28360122	cerebral blood volume	C4277714
28360122	CBV	C4277714
28360122	pulsatility	C0577317
28360122	near-infrared spectroscopy	C0376519
28360122	non-invasive	C0205303
28360122	ICP	C0151740
28360122	intraocular pressure	C0021888
28360122	IOP	C0021888
28360122	HDT	C0242683
28360122	nominal	C1264625
28360122	elevated	C3163633
28360122	ambient	C1879688
28360122	CO2	C0007012
28360122	cohort	C0599755
28360122	CBV	C4277714
28360122	pulsatility	C0577317
28360122	increased significantly	C0205217
28360122	cardiac	C1522601
28360122	frequencies	C0439603
28360122	increase	C0442805
28360122	pulsatility	C0577317
28360122	amplitude	C2346753
28360122	Mayer wave frequencies	C0439603
28360122	increase	C0442805
28360122	HDT	C0242683
28360122	CO2	C0007012
28360122	interaction	C1704675
28360122	pulsatility	C0577317
28360122	individual	C0027361
28360122	differences	C1705242
28360122	atmospheres	C0004178
28360122	not detected	C0442737
28360122	ICP	C0151740
28360122	IOP	C0021888
28360122	cohort	C0599755
28360122	"water hammer" effect	C0232123
28360122	cerebral	C0006104
28360122	pulsatility	C0577317
28360122	spaceflight	C0037741
28360122	associated with	C0332281
28360122	ocular changes	C0429568
28360122	astronauts	C0242688
28360979	Shift Work	C1658633
28360979	Associated with	C0332281
28360979	Metabolic Syndrome	C0524620
28360979	Young	C0332239
28360979	Female	C0086287
28360979	Korean	C1556095
28360979	Workers	C1306056
28360979	Shift work	C1658633
28360979	associated with	C0332281
28360979	health problems	C0021788
28360979	metabolic syndrome	C0524620
28360979	study	C2603343
28360979	association	C0439849
28360979	shift work	C1658633
28360979	metabolic syndrome	C0524620
28360979	young	C0332239
28360979	workers	C1306056
28360979	subjects	C0080105
28360979	Korean	C1556095
28360979	National Health and Nutrition Examination Survey	C0376344
28360979	shift	C0425104
28360979	day workers	C4316562
28360979	cross-sectional study	C0010362
28360979	calculated	C0444686
28360979	odds ratios	C0028873
28360979	multivariate	C0026777
28360979	logistic regression analysis	C0681925
28360979	examine	C0332128
28360979	association	C0439849
28360979	shift work	C1658633
28360979	metabolic syndrome	C0524620
28360979	prevalence	C0033105
28360979	metabolic syndrome	C0524620
28360979	male	C0086582
28360979	female	C0086287
28360979	shift workers	C0425104
28360979	confounding factors	C0009673
28360979	shift work	C1658633
28360979	associated with	C0332281
28360979	metabolic syndrome	C0524620
28360979	female	C0086287
28360979	workers	C1306056
28360979	odds ratio	C0028873
28360979	confidence interval	C0009667
28360979	Shift work	C1658633
28360979	associated with	C0332281
28360979	metabolic syndrome	C0524620
28360979	young	C0332239
28360979	women	C0043210
28360979	manage	C0184516
28360979	metabolic syndrome	C0524620
28360979	workplace	C0162579
28362386	In Vitro	C1533691
28362386	Differentiation	C0007589
28362386	Human	C0086418
28362386	Pluripotent Stem Cells	C0872076
28362386	Trophoblastic Cells	C1519658
28362386	placenta	C0032043
28362386	organ	C0178784
28362386	embryogenesis	C0013936
28362386	survival	C0038952
28362386	embryo	C0013935
28362386	placenta	C0032043
28362386	trophoblastic cells	C1519658
28362386	differentiate	C0007589
28362386	extra-embryonic trophectoderm cells	C1326118
28362386	preimplantation	C1446949
28362386	blastocyst	C1281743
28362386	differentiation events	C0007589
28362386	human	C0086418
28362386	placenta	C0032043
28362386	isolation	C0204727
28362386	manipulation	C0947647
28362386	human	C0086418
28362386	embryogenesis	C0013936
28362386	Human pluripotent stem cells	C0872076
28362386	hPSCs	C0872076
28362386	model system	C3161035
28362386	human development	C0020119
28362386	differentiated	C0007589
28362386	in vitro	C1533691
28362386	trophoblastic cells	C1519658
28362386	trophoblast	C1519658
28362386	cell types	C0007634
28362386	differentiating	C0007589
28362386	hPSCs	C0872076
28362386	trophoblastic cells	C1519658
28362386	bone morphogenic protein 4	C0033684
28362386	inhibitors	C1999216
28362386	Activin	C0050668
28362386	Nodal signaling pathways	C3271798
28362386	trophoblast	C1519658
28362386	cell types	C0007634
28362386	transfected	C0040669
28362386	siRNAs	C1099354
28362386	phenotypes	C0031437
28362386	infected	C0439663
28362386	pathogens	C0450254
28362386	hPSCs	C0872076
28362386	differentiated	C0007589
28362386	trophoblast	C0041178
28362386	progenitors	C0038250
28362386	in vitro	C1533691
28362386	differentiation method	C0007589
28362386	human	C0086418
28362386	trophoblasts	C0041178
28362386	hPSCs	C0872076
28362386	restrictions	C0443288
28362386	human	C0086418
28362386	embryos	C0013935
28362386	drug discovery	C0920472
28362386	stem cell research	C1514966
28364409	Metabolomics	C0870883
28364409	analysis	C0936012
28364409	anaphylactoid reaction	C0340865
28364409	reveals	C0443289
28364409	mechanism	C0441712
28364409	rat	C0034721
28364409	model	C0599779
28364409	Anaphylactoid reactions	C0340865
28364409	immune-mediated immediate hypersensitivity reactions	C0301918
28364409	serious	C0205404
28364409	threat	C0749385
28364409	public health	C0699943
28364409	effect	C1280500
28364409	mechanism	C0441712
28364409	not clear	C3845108
28364409	diagnostic tests	C0086143
28364409	limited	C0439801
28364409	Comprehensive	C1880156
28364409	metabolite	C0870883
28364409	analysis	C0936012
28364409	reveal	C0443289
28364409	anaphylactoid	C1706805
28364409	effect	C1280500
28364409	mechanism	C0441712
28364409	systematically	C0220922
28364409	provide	C1999230
28364409	reference	C0034925
28364409	future	C0016884
28364409	diagnostic	C0348026
28364409	purposes	C1285529
28364409	Plasma	C0032105
28364409	Brown Norway rats	C0034700
28364409	intravenous injection	C0021494
28364409	saline	C0036082
28364409	compound 48/80	C0009574
28364409	ovalbumin	C0029923
28364409	used	C1524063
28364409	study	C2603343
28364409	effect	C1280500
28364409	mechanism	C0441712
28364409	anaphylactoid reactions	C0340865
28364409	metabolomics	C0870883
28364409	UPLC-qTOF-MS/MS	C0599748
28364409	Metabolomics	C0870883
28364409	proteomics data	C0242356
28364409	used	C1524063
28364409	analyze	C0936012
28364409	anaphylactoid	C1706805
28364409	pathways	C1704259
28364409	MetaboAnalyst	C0037589
28364409	followed by	C0332283
28364409	pathway analysis	C0868995
28364409	metabolites	C0870883
28364409	identified	C0205396
28364409	METLIN database	C0242356
28364409	MS/MS	C0599748
28364409	confirmed by	C0521093
28364409	authentic standards	C0034925
28364409	results	C1274040
28364409	adenosine	C0001443
28364409	histamine	C0019588
28364409	N-acetylhistamine	C0067730
28364409	N(α)-γ-glutamylhistamine	C0061063
28364409	malate	C0220873
28364409	xanthine	C0043314
28364409	important	C3898777
28364409	anaphylactoid reactions	C0340865
28364409	effect	C1280500
28364409	mechanism	C0441712
28364409	histidine metabolism	C1156823
28364409	arachidonic acid metabolism	C1158360
28364409	energy metabolism	C0014272
28364409	purine metabolism	C0920640
28364409	other	C0205394
28364409	small	C0700321
28364409	molecules	C0567416
28364409	through	C0332273
28364409	metabolites	C0870883
28364409	Multiple linear regression analysis	C0681925
28364409	indicated	C1444656
28364409	not	C1518422
28364409	only	C0205171
28364409	histamine	C0019588
28364409	N(α)-γ-glutamylhistamine	C0061063
28364409	arachidonic acid	C0003695
28364409	used	C1524063
28364409	anaphylactoid	C1706805
28364409	symptoms	C1457887
28364409	animals	C0003062
28364409	citrate cycle	C1516586
28364409	histidine metabolism	C1156823
28364409	arachidonic acid metabolism	C1158360
28364409	main	C1542147
28364409	pathways	C1704259
28364409	anaphylactoid reactions	C0340865
28364409	determined by	C0521095
28364409	MetaboAnalyst	C0037589
28364409	results	C1274040
28364409	provide	C1999230
28364409	reference	C1514811
28364409	improve	C0184511
28364409	diagnostic accuracy	C0598285
28364409	predict	C0681842
28364409	treatment efficacy	C0087113
28364409	anaphylactoid reactions	C0340865
28364409	clinical setting	C3176918
28364434	Prevalence	C0683921
28364434	Sleep Apnea	C0037315
28364434	Type B Aortic Dissection	C0340647
28364434	False	C0205237
28364434	Lumen	C0524461
28364434	Thrombosis	C0040053
28364434	Obstructive sleep apnea	C0520679
28364434	OSA	C0520679
28364434	aortic dissection	C0340643
28364434	Thrombosis	C0040053
28364434	false	C0205237
28364434	lumen	C0524461
28364434	associated with	C0332281
28364434	prognosis	C0033325
28364434	type B aortic dissection	C0340647
28364434	AoD	C0340647
28364434	partial thrombosis	C0333204
28364434	predictor	C0683956
28364434	mortality	C0178686
28364434	study	C2603343
28364434	severity	C0392364
28364434	OSA	C0520679
28364434	associated with	C0332281
28364434	false	C0205237
28364434	lumen	C0524461
28364434	thrombosis	C0040053
28364434	observational study	C1518527
28364434	type B AoD	C0340647
28364434	patients	C0030705
28364434	false	C0205237
28364434	lumen	C0524461
28364434	partially	C0728938
28364434	thrombosed	C0040053
28364434	thrombosed	C0040053
28364434	computer tomography angiography	C1536105
28364434	image	C1551337
28364434	Patients	C0030705
28364434	non-OSA group	C0681860
28364434	apnea-hypopnea index	C4083070
28364434	AHI	C4083070
28364434	mild	C0681860
28364434	AHI	C4083070
28364434	moderate	C0681860
28364434	AHI	C4083070
28364434	severe OSA groups	C0681860
28364434	AHI	C4083070
28364434	AHI	C4083070
28364434	prevalence	C0683921
28364434	OSA	C0520679
28364434	type B dissection	C0340647
28364434	cases	C1706256
28364434	patients	C0030705
28364434	non-OSA group	C0681860
28364434	mild group	C0681860
28364434	moderate group	C0681860
28364434	severe group	C0681860
28364434	partially	C0728938
28364434	thrombosed	C0040053
28364434	false	C0205237
28364434	lumen	C0524461
28364434	patients	C0030705
28364434	Multivariable analysis	C0026777
28364434	OSA	C0520679
28364434	severity	C0392364
28364434	positively	C1446409
28364434	associated with	C0332281
28364434	partial	C0728938
28364434	thrombosis	C0040053
28364434	odds ratio	C0028873
28364434	confidence interval	C0009667
28364434	confounding factors	C0009673
28364434	OSA	C0520679
28364434	patients	C0030705
28364434	type B AoD	C0340647
28364434	severity	C0392364
28364434	OSA	C0520679
28364434	associated with	C0332281
28364434	increased	C0205217
28364434	risk	C0035647
28364434	partial	C0728938
28364434	false	C0205237
28364434	lumen	C0524461
28364434	thrombosis	C0040053
28364434	OSA	C0520679
28364434	etiology	C1314792
28364434	prognosis	C0033325
28364434	AoD	C0340647
28368267	Contextual Factors	C0542559
28368267	Stunting	C0018273
28368267	Children	C0008059
28368267	Age	C0001779
28368267	Months	C0439231
28368267	Under-Privileged Community	C0009462
28368267	Dhaka	C0004732
28368267	Bangladesh	C0004732
28368267	factors	C1521761
28368267	associated with	C0332281
28368267	stunting	C0018273
28368267	children	C0008059
28368267	aged	C0001779
28368267	months	C0439231
28368267	slum	C0037345
28368267	Dhaka	C0004732
28368267	Bangladesh	C0004732
28368267	case control study	C0007328
28368267	Children	C0008059
28368267	length-for-age Z-score	C0871421
28368267	LAZ	C0871421
28368267	control	C0009932
28368267	LAZ	C0871421
28368267	logistic regression model	C0681925
28368267	factors	C1521761
28368267	associated with	C0332281
28368267	stunting	C0018273
28368267	risk factors	C0035648
28368267	stunting	C0018273
28368267	child's	C0008059
28368267	age	C0001779
28368267	months	C0439231
28368267	maternal	C0026591
28368267	undernutrition	C0162429
28368267	mother's education	C2924476
28368267	years	C0439234
28368267	consumption	C0684271
28368267	untreated drinking water	C0599638
28368267	monthly	C0332177
28368267	family	C0015576
28368267	income	C0021162
28368267	USD	C1555442
28368267	findings	C0243095
28368267	study	C0007328
28368267	maternal	C0026591
28368267	undernutrition	C0162429
28368267	less education	C0013658
28368267	consumption	C0684271
28368267	untreated drinking water	C0599638
28368267	family	C0015576
28368267	income	C0021162
28368267	associated	C0332281
28368267	factors	C1521761
28368267	childhood	C0231335
28368267	stunting	C0018273
28373341	Americans	C0596070
28373341	Good Health	C3898900
28373341	Unmet Need	C4061640
28373341	Health Care Expenses	C3242647
28373341	health care expenditures	C3242647
28373341	concentrated	C0392762
28373341	Americans	C0596070
28373341	health care resources	C0018741
28373341	out-of-pocket spending	C0680969
28373341	low spenders	C1257890
28373341	population	C1257890
28373341	received	C1514756
28373341	care	C0086388
28373341	timely	C3827828
28373341	spending	C0680969
28373341	population	C1257890
28373341	year	C0439234
28373341	period	C1948053
28373341	examined	C0332128
28373959	Penile Erosion	C1536126
28373959	Paraplegic	C0030486
28373959	Man	C0025266
28373959	Indwelling Urinary Catheter	C0521197
28373959	Scrotal Edema	C0151609
28373959	chronic	C0205191
28373959	use of	C1524063
28373959	urinary indwelling catheters	C0521197
28373959	long-term	C0443252
28373959	patient care	C0017313
28373959	complications	C0009566
28373959	awareness	C0004448
28373959	urogenital	C0042066
28373959	trauma	C3714660
28373959	urinary catheterization	C0042019
28373959	symptomatic	C0231220
28373959	urinary tract infections	C0042029
28373959	preventable measures	C2700409
28373959	decrease	C0547047
28373959	risk	C0035647
28373959	mechanical trauma	C3714660
28373959	urethra	C0041967
28373959	glans penis	C0227948
28373959	chronic	C0205191
28373959	catheterization	C0007430
28373959	year	C0439234
28373959	old	C0580836
28373959	paraplegic	C0030486
28373959	male	C0086582
28373959	chronic	C0205191
28373959	indwelling catheter	C0007439
28373959	acquired	C0439661
28373959	ventral	C1704448
28373959	penile erosion	C1536126
28373959	cared	C1947933
28373959	ICU setting	C0021708
28375449	Modified	C0392747
28375449	anastomotic technique	C0677554
28375449	thoracolaparoscopic Ivor-Lewis esophagectomy	C0472889
28375449	early	C1279919
28375449	outcomes	C0085415
28375449	technical details	C1522508
28375449	Thoracoscopic intrathoracic esophagogastrostomy	C0192353
28375449	technical requirements	C0681521
28375449	application of	C1524063
28375449	minimally	C0547040
28375449	invasive	C0205281
28375449	Ivor-Lewis esophagectomy	C0472889
28375449	reduce	C0547047
28375449	surgical procedure	C0543467
28375449	modified	C0392747
28375449	anastomotic technique	C0677554
28375449	thoracolaparoscopic Ivor-Lewis esophagectomy	C0472889
28375449	modified	C0392747
28375449	approach	C1292724
28375449	operations	C0543467
28375449	intrathoracic suturing	C0009068
28375449	knotting	C0087111
28375449	instruments	C0348000
28375449	OrVil system	C0025080
28375449	reverse-puncture head	C0025080
28375449	consecutive	C1707491
28375449	patients	C0030705
28375449	cancer	C0006826
28375449	distal third of the esophagus	C0227191
28375449	gastric cardia	C0007144
28375449	modified	C0392747
28375449	surgical procedure	C0543467
28375449	short-term	C0443303
28375449	outcomes	C0085415
28375449	modified	C0392747
28375449	anastomotic technique	C0677554
28375449	thoracolaparoscopic Ivor-Lewis esophagectomy	C0472889
28375566	Quantitative analysis	C0681919
28375566	cell proliferation	C0596290
28375566	dye dilution assay	C0013341
28375566	Application	C4048755
28375566	cell lines	C0682523
28375566	cocultures	C0282547
28375566	Cell proliferation	C0596290
28375566	processes in biological systems	C3714634
28375566	quantitative analysis	C0681919
28375566	cell proliferation	C0596290
28375566	biological	C0005532
28375566	applications	C4048755
28375566	drug screening	C0373483
28375566	biologics	C0005522
28375566	assessment	C0220825
28375566	cytotoxicity	C0596402
28375566	Conventional	C0439858
28375566	proliferation assays	C3899698
28375566	cell number	C0007584
28375566	calibration curve	C0006751
28375566	homogeneous	C1881065
28375566	cell population	C0007634
28375566	analysis	C0936012
28375566	cocultured cells	C0007635
28375566	assays	C0005507
28375566	measure	C0242485
28375566	cell proliferation	C0596290
28375566	cellular metabolic activity	C1524026
28375566	DNA content	C0032246
28375566	overcome	C2983310
28375566	dye dilution assay	C0013341
28375566	fluorescent cell tracking dyes	C0016320
28375566	retained	C0333118
28375566	cells	C0007634
28375566	diluted	C1948037
28375566	proportionally	C0205351
28375566	cell divisions	C0007590
28375566	assay	C1510438
28375566	quantitatively analyze	C0681919
28375566	cell proliferation	C0596290
28375566	cell lines	C0682523
28375566	concurrently	C0205420
28375566	analyze	C0936012
28375566	proliferation	C1514485
28375566	cell lines	C0682523
28375566	coculture	C0282547
28375566	cell tracking	C2936595
28375566	dyes	C0016320
28375566	spectral	C1883073
28375566	characteristics	C1521970
28375566	mean division time	C0392762
28375566	estimated	C0750572
28375566	dye dilution assay	C0013341
28375566	population doubling time	C2986483
28375566	conventional	C0439858
28375566	methods	C0025663
28375566	values	C0456580
28375566	literature	C0023866
28375566	dye	C0016320
28375566	cocultured cells	C0007635
28375566	investigated	C1292732
28375566	characteristic	C1521970
28375566	cells	C0007634
28375566	characteristic	C1521970
28375566	dye	C0016320
28375566	flow cytometric analyses	C0016263
28375566	cellular	C0007634
28375566	properties	C0871161
28375566	valuable	C0205556
28375566	information	C1533716
28375566	cell status	C0449438
28375566	diverse	C1880371
28375566	conditions	C0348080
28375743	Engineering	C0017387
28375743	In Vivo	C1515655
28375743	Applications	C4048755
28375743	Riboswitches	C2936590
28375743	Riboswitches	C2936590
28375743	common	C0205214
28375743	gene regulatory units	C0017362
28375743	bacteria	C0004611
28375743	capable	C2698977
28375743	altering	C1515926
28375743	gene expression	C0017262
28375743	response	C0871261
28375743	small molecule	C1328819
28375743	structured RNA elements	C0035668
28375743	modular	C1709061
28375743	subunits	C1711351
28375743	aptamer domain	C0599013
28375743	binds	C1167622
28375743	high	C0205250
28375743	specificity	C0037791
28375743	affinity	C1510827
28375743	target	C1521840
28375743	ligand	C0023688
28375743	expression	C0017262
28375743	transduces	C0037083
28375743	ligand binding	C1517880
28375743	gene expression	C0017262
28375743	Significant	C0750502
28375743	progress	C1280477
28375743	engineering	C0017387
28375743	novel	C0205314
28375743	aptamer domains	C0599013
28375743	new	C0205314
28375743	small molecule	C1328819
28375743	inducers	C3898767
28375743	gene expression	C0017262
28375743	Modified	C0392747
28375743	expression	C0017262
28375743	optimized	C2698650
28375743	function	C0542341
28375743	fused	C0699952
28375743	natural	C0205296
28375743	synthetic	C2004457
28375743	aptamer domains	C0599013
28375743	field	C2346620
28375743	privileged	C1547898
28375743	scaffolds	C0337143
28375743	development	C1527148
28375743	tools	C2827396
28375743	RNA	C0035668
28375743	fluorescent	C0016315
28375743	biosensors	C0600364
28375743	review	C0282443
28375743	summarize	C1552616
28375743	methods	C0025663
28375743	engineer	C0578393
28375743	riboswitches	C2936590
28375743	applications	C4048755
28375743	natural	C0205296
28375743	synthetic	C2004457
28375743	riboswitches	C2936590
28375743	enzyme	C0033629
28375743	strain engineering	C1879848
28375743	gene expression	C0017262
28375743	cellular physiology	C0007613
28375743	real-time imaging	C0079595
28375743	cellular metabolites	C0870883
28375743	signals	C0037080
28376393	novel	C0205314
28376393	assay	C1510438
28376393	measure	C0079809
28376393	tertiary	C0597565
28376393	quaternary amines	C0578399
28376393	wastewater	C3494254
28376393	indicator	C1522602
28376393	NDMA	C0012431
28376393	wastewater	C3494254
28376393	precursors	C1709634
28376393	study	C0947630
28376393	examined	C0332128
28376393	potential	C3245505
28376393	novel	C0205314
28376393	bulk amine assay	C1510438
28376393	approximation	C0332232
28376393	tertiary	C0597565
28376393	quaternary amine	C0578399
28376393	wastewaters	C3494254
28376393	surface	C0205148
28376393	water samples	C1550678
28376393	approximation	C0332232
28376393	compared	C1707455
28376393	N-nitrosodimethylamine	C0012431
28376393	NDMA	C0012431
28376393	formation	C1522492
28376393	potential	C3245505
28376393	chloramines	C0008164
28376393	colorimetric method	C0009407
28376393	examined	C0332128
28376393	detection	C0442726
28376393	amines	C0002508
28376393	environmental	C0014406
28376393	water samples	C1550678
28376393	method	C0871511
28376393	liquid-liquid extraction	C3178840
28376393	catalyzed	C0205245
28376393	reaction	C0596319
28376393	undefined	C0750600
28376393	product	C1514468
28376393	strong	C0442821
28376393	chromophore	C0596335
28376393	fluorophore	C0598447
28376393	reaction	C0596319
28376393	catalyzed	C0205245
28376393	number	C0237753
28376393	compounds	C0205198
28376393	tertiary	C0597565
28376393	quaternary amine	C0578399
28376393	moieties	C3641152
28376393	tertiary	C0597565
28376393	quaternary compounds	C0578399
28376393	efficient	C0442799
28376393	producers	C0205245
28376393	NDMA	C0012431
28376393	chloramination	C0002505
28376393	conditions	C0348080
28376393	linear correlation	C1707520
28376393	consequently	C3845876
28376393	bulk amine signals	C1710082
28376393	NDMA	C0012431
28376393	formation	C1522492
28376393	potential	C3245505
28376393	wastewater	C3494254
28376393	samples	C0370003
28376393	evidence	C3887511
28376393	approximately	C0332232
28376393	tertiary	C0597565
28376393	measured	C0444706
28376393	NDMA	C0012431
28376393	estimated	C0750572
28376393	nitrogen	C0028158
28376393	dissolved organic nitrogen originates	C0002508
28376393	bulk amines	C0002508
28376393	normalization	C1882115
28376393	NDMA	C0012431
28376393	concentration	C1446561
28376393	amine	C0002508
28376393	measurement	C0242485
28376393	ozone	C0030106
28376393	effectively	C1704419
28376393	destroyed	C1948029
28376393	tertiary	C0597565
28376393	quaternary amine	C0578399
28376393	structures	C0678594
28376393	NDMA	C0012431
28376393	treated	C1522326
28376393	wastewater	C3494254
28376393	samples	C0370003
28376393	bulk amine assay	C1510438
28376393	measurements	C0242485
28376393	tertiary	C0597565
28376393	quaternary amines	C0578399
28376393	NDMA	C0012431
28376393	formation	C1522492
28376393	potential	C3245505
28376393	sample	C0370003
28376393	useful	C3827682
28376393	characterizing	C1880022
28376393	tool	C0449851
28376393	NDMA	C0012431
28376393	precursors	C1709634
28376393	wastewater	C3494254
28377051	Chlamydia pneumoniae	C0085504
28377051	infection	C3714514
28377051	promotes	C0033414
28377051	vascular endothelial cell	C1257792
28377051	angiogenesis	C0302600
28377051	IQGAP1	C0529338
28377051	signaling pathway	C0037080
28377051	Chlamydia pneumoniae	C0085504
28377051	C. pneumoniae	C0085504
28377051	infection	C3714514
28377051	potential role	C1705810
28377051	angiogenesis	C0302600
28377051	C. pneumoniae	C0085504
28377051	involved	C1314939
28377051	process	C1522240
28377051	investigated	C1292732
28377051	effect	C1280500
28377051	C. pneumoniae	C0085504
28377051	infection	C3714514
28377051	angiogenesis	C0302600
28377051	roles	C1705810
28377051	IQGAP1	C0529338
28377051	signaling	C0037080
28377051	C. pneumoniae	C0085504
28377051	infection	C3714514
28377051	induced	C0205263
28377051	angiogenesis	C0302600
28377051	C. pneumoniae	C0085504
28377051	infection	C3714514
28377051	significantly enhanced	C2349975
28377051	angiogenesis	C0302600
28377051	assessed	C1516048
28377051	tube formation assay	C1510438
28377051	possibly	C0332149
28377051	inducing	C0205263
28377051	vascular endothelial cell	C1257792
28377051	VEC	C1257792
28377051	migration	C0013975
28377051	wound healing	C0043240
28377051	Transwell migration assays	C1510438
28377051	Subsequently	C0332282
28377051	immunoprecipitation	C0021069
28377051	Western blot	C0949466
28377051	tube formation assay	C1510438
28377051	results	C1254595
28377051	phosphorylation	C1158886
28377051	IQGAP1	C0529338
28377051	N-WASP	C0531254
28377051	required	C1514873
28377051	angiogenesis	C0302600
28377051	induced	C0205263
28377051	C. pneumoniae	C0085504
28377051	infection	C3714514
28377051	co-immunoprecipitation	C1449705
28377051	study	C0681827
28377051	revealed	C0443289
28377051	IQGAP1	C0529338
28377051	associated with	C0332281
28377051	N-WASP	C0531254
28377051	C. pneumoniae	C0085504
28377051	infection	C3714514
28377051	VECs	C1257792
28377051	Actin polymerization	C1155982
28377051	assay	C1510438
28377051	C. pneumoniae	C0085504
28377051	infected	C0439663
28377051	VECs	C1257792
28377051	IQGAP1	C0529338
28377051	N-WASP	C0531254
28377051	filamentous actin	C1180307
28377051	common	C0205214
28377051	localized	C0392752
28377051	leading edge	C1621433
28377051	lamellipodia	C0230628
28377051	impaired	C0221099
28377051	depletion	C0333668
28377051	IQGAP1	C0529338
28377051	small interference RNA	C1099354
28377051	knockdown	C2350567
28377051	IQGAP1	C1416471
28377051	significantly decreased	C0205216
28377051	N-WASP	C0531254
28377051	phosphorylation	C1158886
28377051	Tyr256	C0041485
28377051	induced	C0205263
28377051	C. pneumoniae	C0085504
28377051	infection	C3714514
28377051	conclude	C1707478
28377051	C. pneumoniae	C0085504
28377051	infection	C3714514
28377051	promotes	C0033414
28377051	VEC	C1257792
28377051	migration	C0013975
28377051	angiogenesis	C0302600
28377051	IQGAP1	C0529338
28377051	signaling pathway	C0037080
28377738	Four-Dimensional	C2347299
28377738	Graded	C0441800
28377738	Consciousness	C0234421
28377738	multidimensional	C2347299
28377738	phenomenon	C1882365
28377738	polysemous notion	C0205556
28377738	consciousness	C0234421
28377738	resistant	C0332325
28377738	consistent	C0332290
28377738	measurement	C0242485
28377738	unambiguous definition	C1704788
28377738	no agreement	C0243095
28377738	issues	C0033213
28377738	disagreements	C0012742
28377738	debate	C0870392
28377738	consciousness	C0234421
28377738	gradational	C0441800
28377738	nature	C0349590
28377738	article	C1706852
28377738	consciousness	C0234421
28377738	graded	C0441800
28377738	multidimensional	C2347299
28377738	time	C0040223
28377738	question	C1522634
28377738	graded	C0441800
28377738	cases	C0868928
28377738	consciousness	C0234421
28377738	measure	C0079809
28377738	gradable	C0441800
28377738	aspects	C1879746
28377738	consciousness	C0234421
28377738	quality	C0332306
28377738	abstractness	C0679195
28377738	complexity	C0237521
28377738	usefulness	C3827682
28377738	dimensions	C0439534
28377738	phenomenal	C3898065
28377738	semantic	C0036612
28377738	physiological	C0205463
28377738	functional	C0542341
28377738	consciousness	C0234421
28377738	phenomenal	C3898065
28377738	quality	C0332306
28377738	semantic	C0036612
28377738	abstraction	C0679195
28377738	physiological	C0205463
28377738	complexity	C0237521
28377738	functional	C0542341
28377738	usefulness	C3827682
28377738	four-dimensional	C2347299
28377738	hierarchical nature	C0349590
28377738	consciousness	C0234421
28377738	approach	C0449445
28377738	advantageous	C3898777
28377738	attention	C0004268
28377738	important	C3898777
28377738	differences	C1705242
28377738	subjective	C0205556
28377738	measures	C0079809
28377738	awareness	C0004448
28377738	creature	C0003062
28377738	ranked	C0699794
28377738	higher	C0205250
28377738	consciousness	C0234421
28377738	innovative explanations	C0681841
28377738	phenomena	C1882365
28377738	interpretations	C0459471
28377738	blindsight	C0205556
28377738	locked-in syndrome	C0023944
28377738	4D	C2347299
28377738	predictions	C0681842
28377738	hypotheses	C1512571
28377738	experimentally	C0681814
28377738	tested	C0039593
28377738	interdimensional dependencies	C3244310
28380217	Synthesis	C1883254
28380217	Carbamate	C0006948
28380217	Derivatives	C0002776
28380217	2-Furoyl-1-piperazine	C0566267
28380217	Therapeutic Agents	C1611640
28380217	aim	C1947946
28380217	research work	C0242481
28380217	biologically active	C0566267
28380217	carbamate	C0006948
28380217	derivatives	C0002776
28380217	2-furoyl-1-piperazine	C0566267
28380217	toxicity	C0600688
28380217	synthesis	C1883254
28380217	multiple sequence	C1519249
28380217	structural	C0678594
28380217	confirmation	C0750484
28380217	EI-MS	C4054904
28380217	IR	C0037807
28380217	1H-NMR	C3850001
28380217	enzyme inhibition	C1524081
28380217	antibacterial potential	C0243095
28380217	synthesized compounds	C0566267
28380217	evaluated	C0220825
28380217	compounds	C0566267
28380217	therapeutic agents	C1611640
28380217	cytotoxicity	C0596402
28380217	compounds	C0566267
28380217	active	C0205177
28380217	acetylcholinesterase enzyme	C0001044
28380217	12	C0566267
28380217	14	C0566267
28380217	good	C0205170
28380217	inhibitory potential	C0234122
28380217	Eserine	C1314787
28380217	reference standard	C0034925
28380217	compounds	C0566267
28380217	Gram-positive	C0018154
28380217	Gram-negative bacterial strains	C0018150
28385178	Epidemiology	C0014507
28385178	outcomes	C0085565
28385178	injuries	C0178314
28385178	Kenya	C0022558
28385178	multisite surveillance study	C0681625
28385178	Injury	C0178314
28385178	disability	C0231170
28385178	death	C1306577
28385178	deaths	C1306577
28385178	year	C0439234
28385178	injury	C0178314
28385178	burden	C2828008
28385178	low- and middle-income countries	C0454664
28385178	injury	C0178314
28385178	injury -related deaths	C1306577
28385178	burden	C2828008
28385178	trauma	C3714660
28385178	registries	C0920465
28385178	injury	C0178314
28385178	epidemiology	C0014507
28385178	outcomes	C0085565
28385178	low- and middle-income countries	C0454664
28385178	Kenya	C0022558
28385178	data	C1511726
28385178	injury	C0178314
28385178	epidemiology	C0014507
28385178	care	C1947933
28385178	objective	C0018017
28385178	study	C0002783
28385178	investigate	C1292732
28385178	epidemiology	C0014507
28385178	outcomes	C0085565
28385178	injuries	C0178314
28385178	referral hospitals	C0019994
28385178	Kenya	C0022558
28385178	hospital	C0019994
28385178	trauma	C3714660
28385178	registries	C0920465
28385178	January	C3829466
28385178	May	C3812381
28385178	injured patients	C0030705
28385178	casualty departments	C0562508
28385178	Kenyatta National	C0019994
28385178	Thika Level 5	C0019994
28385178	Machakos Level 5	C0019994
28385178	Meru Level 5 Hospitals	C0019994
28385178	Data collected	C0010995
28385178	demographic characteristics	C0683970
28385178	type	C0332307
28385178	prehospital care	C2735050
28385178	received	C1514756
28385178	prehospital time	C0040223
28385178	injury pattern	C0178314
28385178	outcomes	C0085565
28385178	patients	C0030705
28385178	Patients	C0030705
28385178	male	C0086582
28385178	young	C0332239
28385178	mean age	C0001779
28385178	years	C0439234
28385178	mechanisms of injury	C0449413
28385178	road	C0442650
28385178	traffic injuries	C0178314
28385178	falls	C0000921
28385178	struck/hit by	C0332159
28385178	person	C0027361
28385178	object	C0347997
28385178	Burn	C0006434
28385178	mechanism of injury	C0449413
28385178	age	C0001779
28385178	category	C0683312
28385178	years	C0439234
28385178	Body regions	C0005898
28385178	injured	C0332664
28385178	lower extremity	C0023216
28385178	upper extremity	C1140618
28385178	head	C0018670
28385178	mortality rate	C0205848
28385178	Significant predictors	C2698872
28385178	mortality	C0205848
28385178	multivariate analysis	C0026777
28385178	Glasgow Coma Scale ≤12	C0278173
28385178	injury severity score	C0021504
28385178	burns	C0006434
28385178	gunshot injuries	C0043252
28385178	Hospital	C0019994
28385178	trauma	C3714660
28385178	registries	C0920465
28385178	sources of data	C0011001
28385178	study the epidemiology	C0002783
28385178	injuries	C0178314
28385178	low- and middle-income countries	C0454664
28385178	Data	C1511726
28385178	trauma	C3714660
28385178	registries	C0920465
28385178	public	C0678367
28385178	health	C0018684
28385178	interventions	C0184661
28385178	quality-of-care improvement programs	C1254363
28386663	child	C0008059
28386663	phenylketonuria	C0031485
28386663	focal segmental glomerulosclerosis	C0333497
28386663	proteinuria	C0033687
28386663	Phenylketonuria	C0031485
28386663	PKU	C0031485
28386663	common	C0205214
28386663	inborn error of amino acid metabolism	C0002514
28386663	Phenylalanine hydroxylase	C0031456
28386663	deficient	C0011155
28386663	enzyme	C0014442
28386663	untreated	C0332155
28386663	growth failure	C0878787
28386663	microcephaly	C0025958
28386663	global developmental delay	C0557874
28386663	seizures	C0036572
28386663	severe intellectual impairment	C4294877
28386663	characterize	C1880022
28386663	clinical picture	C0683325
28386663	PKU	C0031485
28386663	protein	C0033684
28386663	homeostasis	C0019868
28386663	nephrotic syndrome	C0027726
28386663	quantitative	C0392762
28386663	defect	C1457869
28386663	significant	C0750502
28386663	proteinuria	C0033687
28386663	Focal segmental glomerulosclerosis	C0333497
28386663	FSGS	C0333497
28386663	special	C0205555
28386663	congenital	C1744681
28386663	variant	C0205419
28386663	affecting	C0392760
28386663	children	C0008059
28386663	adults	C0001675
28386663	male	C0086582
28386663	child	C0008059
28386663	presented	C0150312
28386663	generalized edema	C1850534
28386663	global developmental delay	C0557874
28386663	Investigations	C1261322
28386663	revealed	C0443289
28386663	PKU	C0031485
28386663	FSGS	C0333497
28386663	congenital nephrosis	C3501848
28386663	ameliorated	C0184511
28386663	PKU	C0031485
28386663	salutary effect	C0205556
28386663	growth and development	C0018271
28386663	PKU	C0031485
28386663	FSGS	C0333497
28386950	Gastrointestinal disorders	C0017178
28386950	Curry-Jones syndrome	C0795915
28386950	Clinical	C0205210
28386950	molecular	C1521991
28386950	insights	C0233820
28386950	affected	C0392760
28386950	newborn	C0021289
28386950	Curry-Jones syndrome	C0795915
28386950	CJS	C0795915
28386950	pattern	C0449774
28386950	malformation	C0302142
28386950	craniosynostosis	C0010278
28386950	pre-axial polysyndactyly	C2751914
28386950	agenesis of the corpus callosum	C0175754
28386950	cutaneous	C1704258
28386950	gastrointestinal	C0521362
28386950	gastrointestinal abnormalities	C3824760
28386950	recurrent	C2945760
28386950	mosaic mutation	C0026882
28386950	SMO (c.1234 C>T; p.Leu412Phe)	C4086836
28386950	causes	C0015127
28386950	CJS	C0795915
28386950	report	C0684224
28386950	gastrointestinal	C0521362
28386950	surgical findings	C0243095
28386950	baby	C0021270
28386950	CJS	C0795915
28386950	abdominal obstruction	C0848160
28386950	reviews	C0699752
28386950	spectrum of gastrointestinal malformations	C0243095
28386950	gastrointestinal	C0521362
28386950	rare disorder	C0678236
28386950	week	C0439230
28386950	female	C0086287
28386950	craniosynostosis	C0010278
28386950	pre-axial polysyndactyly	C2751914
28386950	cutaneous findings	C0243095
28386950	clinical diagnosis	C0332140
28386950	CJS	C0795915
28386950	infant	C0021270
28386950	abdominal distension	C0000731
28386950	beginning	C0439659
28386950	second	C0205436
28386950	day	C0439228
28386950	life	C0376558
28386950	Surgical exploration	C0184899
28386950	revealed	C0443289
28386950	intestinal malrotation	C0221210
28386950	Ladd procedure	C3665975
28386950	Multiple small nodules	C0243095
28386950	found	C0243095
28386950	surface of the small and large bowel	C0735973
28386950	in addition to	C0332287
28386950	apparent	C0750489
28386950	intestinal duplication	C0221210
28386950	posterior	C0205095
28386950	pancreas	C0030274
28386950	Histopathology	C0243140
28386950	serosal	C0521344
28386950	nodules	C0028259
28386950	revealed	C0443289
28386950	bundles of smooth muscle	C1267092
28386950	with associated	C0332281
28386950	ganglion cells	C0228071
28386950	Molecular analysis	C1513380
28386950	SMO c.1234 C>T mutation	C4086836
28386950	affected	C0392760
28386950	skin	C1123023
28386950	intestinal hamartoma	C0345896
28386950	Gastrointestinal	C0521362
28386950	features	C0243095
28386950	structural malformations	C1704258
28386950	malformations	C0302142
28386950	motility disorders	C0679316
28386950	upper GI bleeding	C0041909
28386950	causes	C0015127
28386950	morbidity	C0026538
28386950	CJS	C0795915
28386950	Smooth muscle	C1267092
28386950	Smooth muscle hamartomas	C0018552
28386950	recognized feature	C0243095
28386950	children	C0008059
28386950	CJS	C0795915
28386950	abdominal obstruction	C0848160
28386950	requiring surgical intervention	C0549433
28386950	somatic mutation	C0544886
28386950	SMO	C1364142
28386950	structural malformations	C1704258
28386950	malformations	C0302142
28386950	predisposition	C0220898
28386950	bowel hamartomas	C0345896
28386950	myofibromas	C1266121
28386950	mutation	C0026882
28386950	burden	C2828008
28386950	involved	C1314939
28386950	tissues	C0040300
28386950	variable manifestations	C3150238
28387468	Sella turcica bridging	C1866959
28387468	dental anomalies	C0262444
28387468	association	C0439849
28387468	Sella turcica bridging	C1866959
28387468	STB	C1866959
28387468	calcification	C0006660
28387468	interclinoid ligament	C0023685
28387468	sella turcica	C0036609
28387468	associated with	C0332281
28387468	dental anomalies	C0262444
28387468	palatal canine	C2749981
28387468	impaction	C0040456
28387468	transposition	C1319068
28387468	study	C2603343
28387468	association	C0439849
28387468	canine	C2749981
28387468	impaction	C0040456
28387468	hyperdontia	C0040457
28387468	hypodontia	C0020608
28387468	sellar	C0036609
28387468	dimensions	C0439534
28387468	bridging	C1866959
28387468	Lateral	C0205093
28387468	cephalometric	C0007723
28387468	radiographs	C1306645
28387468	patients	C0030705
28387468	impacted	C0040456
28387468	canines	C2749981
28387468	dental agenesis	C0399352
28387468	hyperdontia	C0040457
28387468	Linear	C0205132
28387468	dimensions	C0439534
28387468	sella turcica	C0036609
28387468	control group	C0009932
28387468	individuals	C0237401
28387468	standardize scoring scale	C0349674
28387468	STB	C1866959
28387468	radiographs	C1306645
28387468	frequency	C0439603
28387468	partial	C0728938
28387468	complete	C0205197
28387468	calcifications	C0006660
28387468	sella	C0036609
28387468	patients	C0030705
28387468	dental anomalies	C0262444
28387468	increased	C0205217
28387468	controls	C0009932
28387468	STB	C1866959
28387468	interclinoid distance	C0012751
28387468	linear	C0205132
28387468	dimensions	C0439534
28387468	sella	C0036609
28387468	statistically significant	C0237881
28387468	sellar	C0036609
28387468	dimensions	C0439534
28387468	STB	C1866959
28387468	radiographs	C1306645
28387468	ages	C0001779
28387468	STB	C1866959
28387468	patients	C0030705
28387468	dental abnormalities	C0262444
28387835	Coxiella burnetii	C0010240
28387835	isolates	C1764827
28387835	infected cattle	C0007452
28387835	induce	C0205263
28387835	proinflammatory cytokine response	C2247677
28387835	isolates	C1764827
28387835	infected goats	C1510458
28387835	sheep	C0036945
28387835	Coxiella burnetii	C0010240
28387835	causative agent	C0449411
28387835	Q fever	C0034362
28387835	prevalence	C0220900
28387835	C. burnetii	C0010240
28387835	cattle	C0007452
28387835	goats	C1510458
28387835	sheep	C0036945
28387835	infected cattle	C0007452
28387835	associated with	C0332281
28387835	human	C0086418
28387835	outbreaks	C0012652
28387835	investigated	C1292732
28387835	immune response	C0301872
28387835	humans	C0086418
28387835	C. burnetii	C0010240
28387835	isolates	C1764827
28387835	host origins	C1167395
28387835	multilocus variable number of tandem repeat analysis	C1443925
28387835	MLVA	C1443925
28387835	genotypes	C0017431
28387835	Cytokine responses	C2247677
28387835	human	C0086418
28387835	peripheral blood mononuclear cells	C1321301
28387835	PBMCs	C1321301
28387835	stimulated	C1948023
28387835	C. burnetii	C0010240
28387835	isolates	C1764827
28387835	MLVA	C1443925
28387835	genotype	C0017431
28387835	goats	C1510458
28387835	sheep	C0036945
28387835	cattle	C0007452
28387835	acute	C0519066
28387835	chronic Q fever	C1443892
28387835	patients	C0030705
28387835	Coxiella burnetii	C0010240
28387835	isolates	C1764827
28387835	cattle	C0007452
28387835	induce	C0205263
28387835	IL-1β	C0021753
28387835	TNF-α	C0041368
28387835	IL-22	C0961814
28387835	isolates	C1764827
28387835	goats	C1510458
28387835	sheep	C0036945
28387835	chronic Q fever	C1443892
28387835	patients	C0030705
28387835	cytokine	C0079189
28387835	induction	C0205263
28387835	isolates	C1764827
28387835	MVLA	C1443925
28387835	genotype	C0017431
28387835	response	C2247677
28387835	MLVA	C1443925
28387835	genotypes	C0017431
28387835	proinflammatory cytokine response	C2247677
28387835	induced	C0205263
28387835	human	C0086418
28387835	PBMCs	C1321301
28387835	C. burnetii	C0010240
28387835	isolates	C1764827
28387835	cattle	C0007452
28387835	incidence	C0021149
28387835	human	C0086418
28387835	Q fever	C0034362
28387835	outbreaks	C0012652
28387835	cattle	C0007452
28387835	cytokine	C0079189
28387835	cytokine profile	C0392762
28387835	PBMCs	C1321301
28387835	stimulated	C1948023
28387835	C. burnetii	C0010240
28387835	isolates	C1764827
28387835	chronic Q fever	C1443892
28387835	patients	C0030705
28387835	isolates	C1764827
28387835	goats	C1510458
28387835	cytokine responses	C2247677
28387835	host origin	C1167395
28387835	MLVA	C1443925
28387835	genotype	C0017431
28389374	BRCA1-Associated Protein-1	C1368335
28389374	Isoform	C0597298
28389374	Affects	C4054723
28389374	Response	C0871261
28389374	Mesothelioma Cells	C0025500
28389374	Drugs	C0013227
28389374	Impairing	C0221099
28389374	BRCA1	C1528558
28389374	DNA Repair	C0012899
28389374	BRCA1 associated protein1	C1368335
28389374	BAP1	C1368335
28389374	tumor suppressor	C0597611
28389374	multiple	C0439064
28389374	cellular processes	C0007613
28389374	transcriptional regulation	C1158770
28389374	chromatin modification	C1156197
28389374	deubiquitinating	C1157996
28389374	histone 2A	C0147579
28389374	DNA repair	C0012899
28389374	BAP1	C1368335
28389374	mutations	C0026882
28389374	frequent	C0332183
28389374	malignant pleural mesothelioma	C0812413
28389374	MPM	C0812413
28389374	aim	C1947946
28389374	functionally	C0205245
28389374	characterize	C1521970
28389374	identified	C0205396
28389374	isoform	C0597298
28389374	of BAP1	C1368335
28389374	investigate	C1292732
28389374	effects	C1280500
28389374	expression	C0017262
28389374	drug sensitivity	C0237865
28389374	MPM	C0812413
28389374	Expression	C0017262
28389374	BAP1	C1368335
28389374	detected	C0442726
28389374	quantitative polymerase chain reaction	C2733022
28389374	MPM	C0812413
28389374	normal	C0205307
28389374	mesothelium	C0086610
28389374	cell lines	C0007600
28389374	tumor	C0475358
28389374	nontumor samples	C1292533
28389374	Histone H2A	C0019646
28389374	ubiquitination	C1156207
28389374	levels	C0441889
28389374	analyzed	C0936012
28389374	Western blot	C0949466
28389374	acidic extraction	C0684295
28389374	core histones	C2987130
28389374	Subcellular	C3893246
28389374	localization	C0475264
28389374	BAP1	C1368335
28389374	isoforms	C0597298
28389374	examined	C0332128
28389374	immunofluorescence	C0079603
28389374	MPM	C0812413
28389374	cell survival	C0007620
28389374	response	C0871261
28389374	poly(adenosine diphosphate-ribose) polymerase	C0032405
28389374	PARP	C0032405
28389374	phosphoinositide 3-kinase	C0044602
28389374	PI3K	C0044602
28389374	mammalian target of rapamycin	C1307407
28389374	mTOR	C1307407
28389374	inhibitors	C0014432
28389374	analyzed	C0936012
28389374	in vitro assays	C1515653
28389374	identified	C0205396
28389374	alternative splice isoform	C1720834
28389374	BAP1	C1368335
28389374	BAP1Δ	C1332380
28389374	catalytic domain	C0600499
28389374	Cells	C0007634
28389374	transfected	C0040669
28389374	BAP1Δ	C1332380
28389374	reduced	C0392756
28389374	deubiquitinating activity	C1157996
28389374	compared	C1707455
28389374	BAP1	C1368335
28389374	expression	C0017262
28389374	BAP1Δ	C1332380
28389374	transcript	C1519595
28389374	abundant	C2346714
28389374	nontumor	C1292533
28389374	MPM	C0812413
28389374	cell lines	C0085983
28389374	expressing	C0017262
28389374	BAP1Δ	C1332380
28389374	sensitive	C0332324
28389374	olaparib	C2316164
28389374	PARP1	C1567710
28389374	inhibitor	C0014432
28389374	cytotoxicity	C0596402
28389374	sensitivity	C0332324
28389374	enhanced	C2349975
28389374	olaparib	C2316164
28389374	treatment	C3887704
28389374	combined	C0205195
28389374	GDC0980	C2984520
28389374	PI3K	C0044602
28389374	mTOR	C1307407
28389374	inhibitor	C0014432
28389374	induces	C0205263
28389374	downregulation	C0013081
28389374	BRCA1	C1528558
28389374	observations	C0302523
28389374	BAP1Δ	C1332380
28389374	regulate DNA damage response	C3270705
28389374	influences	C4054723
28389374	drug sensitivity	C0237865
28389374	relevant	C2347946
28389374	investigate	C1292732
28389374	patients	C0030705
28389374	high	C0205250
28389374	expression	C0017262
28389374	BAP1Δ	C1332380
28389374	responsive	C0521982
28389374	PARP	C0032405
28389374	PI3K	C0044602
28389374	mTOR	C1307407
28389374	inhibitors	C0014432
28390176	Cucurbitacin B	C0056580
28390176	Pressure	C0497233
28390176	Overload	C0684338
28390176	Cardiac Hypertrophy	C1383860
28390176	anti-cardiac hypertrophy drugs	C1254351
28390176	cause	C0015127
28390176	prevalence	C0033105
28390176	heart failure	C0018801
28390176	anti-hypertrophy	C0243095
28390176	anti-fibrosis	C0243095
28390176	potential	C3245505
28390176	natural plant	C0032098
28390176	triterpenoid	C1519655
28390176	Cucurbitacin B	C0056580
28390176	in vitro	C0681828
28390176	in vivo	C0681829
28390176	Aortic banding	C0185014
28390176	AB	C0185014
28390176	cardiac hypertrophy	C1383860
28390176	surgery	C0543467
28390176	mice	C0025929
28390176	cucurbitacin B	C0056580
28390176	treatment	C0087111
28390176	Gavage	C2698653
28390176	body weight	C0005910
28390176	AB	C0185014
28390176	cucurbitacin B	C0056580
28390176	anti-hypertrophy	C0243095
28390176	-fibrosis	C0243095
28390176	heart	C0018787
28390176	weight	C0043100
28390176	myocardial cell	C0225828
28390176	cross-sectional area	C2923394
28390176	interstitial fibrosis	C0240035
28390176	systolic	C0039155
28390176	diastolic	C0012000
28390176	abnormalities	C0205161
28390176	gene expression	C0017262
28390176	hypertrophic	C0020564
28390176	fibrotic	C0334129
28390176	markers	C0005516
28390176	microvascular density	C3272839
28390176	pressure	C0497233
28390176	overload	C0684338
28390176	hypertrophic	C0020564
28390176	mice	C0025929
28390176	Cucurbitacin B	C0056580
28390176	hypertrophy	C0020564
28390176	inhibitory effect	C0243095
28390176	phenylephrine	C0031469
28390176	stimulated	C1948023
28390176	cardiomyocytes	C0225828
28390176	Cucurbitacin B	C0056580
28390176	mitigated	C1553901
28390176	cardiac hypertrophy	C1383860
28390176	autophagy	C0004391
28390176	associated with	C0332281
28390176	blockade	C0332206
28390176	Akt	C0164786
28390176	mTOR	C1453984
28390176	FoxO3a	C1506134
28390176	signal pathway	C0037080
28390176	SC79	C4307495
28390176	MK2206	C2933427
28390176	3-MA	C0047569
28390176	Akt	C0164786
28390176	agonist	C2987634
28390176	inhibitor	C0243077
28390176	autophagy	C0004391
28390176	inhibitor	C0243077
28390176	in vitro	C0681828
28390176	overexpression	C1514559
28390176	Akt	C0164786
28390176	Cucurbitacin B	C0056580
28390176	cardiac hypertrophy	C1383860
28390176	human	C0086418
28390176	cardiomyocytes AC16	C0225828
28390176	cucurbitacin B	C0056580
28390176	cardiac hypertrophy	C1383860
28390176	autophagy	C0004391
28390176	cardiomyocytes	C0225828
28390176	associated with	C0332281
28390176	inhibition	C1519312
28390176	Akt	C0164786
28390176	mTOR	C1453984
28390176	FoxO3a	C1506134
28390176	signal axis	C0037080
28391514	Inflammatory	C0333348
28391514	Oxidative Stress	C0242606
28391514	Markers	C0005516
28391514	Experimental	C1517586
28391514	Allergic Asthma	C0155877
28391514	Ovalbumin	C0029923
28391514	induced	C0205263
28391514	allergic lung inflammation	C0002390
28391514	ALI	C0002390
28391514	condition	C0348080
28391514	cytokines	C0079189
28391514	extracellular matrix	C0015350
28391514	remodeling	C1820201
28391514	redox	C0030012
28391514	imbalance	C1397014
28391514	study	C2603343
28391514	evaluated	C0220825
28391514	pulmonary function	C0231921
28391514	inflammatory	C0333348
28391514	markers	C0005516
28391514	interleukin-4	C0021758
28391514	IL-4	C0021758
28391514	myeloperoxidase	C0027021
28391514	MPO	C0027021
28391514	eosinophil cells	C0014467
28391514	redox	C0030012
28391514	markers	C0005516
28391514	lungs	C0024109
28391514	BALB/c mice	C0025919
28391514	ovalbumin	C0029923
28391514	OVA	C0029923
28391514	sensitization	C1325847
28391514	challenge	C0022885
28391514	results	C1274040
28391514	increase	C0442805
28391514	bronchial hyperresponsiveness	C0085129
28391514	stimulated	C1948023
28391514	methacholine	C0600370
28391514	Mch	C0600370
28391514	inflammatory	C0333348
28391514	cell influx	C0007613
28391514	eosinophils	C0014467
28391514	increase	C0442805
28391514	high mobility group box 1	C0019796
28391514	HMGB1	C0019796
28391514	lipid peroxidation	C0023775
28391514	LP	C0023775
28391514	antioxidant	C0003402
28391514	defenses	C1880266
28391514	OVA	C0029923
28391514	group	C0681860
28391514	control group	C0009932
28391514	OVA	C0029923
28391514	induced	C0205263
28391514	ALI	C0002390
28391514	redox	C0030012
28391514	concomitantly	C0521115
28391514	impaired	C0221099
28391514	lung function	C0035245
28391514	associated with	C0332281
28391514	HMGB1	C0019796
28391514	expression	C1171362
28391514	proteolytic	C0597304
28391514	remodeling	C1820201
28391514	results	C1274040
28391514	HMGB1	C0019796
28391514	important	C3898777
28391514	therapeutic	C0302350
28391514	target	C1521840
28391514	asthma	C0004096
28391514	orchestrates	C0205556
28391514	redox	C0030012
28391514	signaling	C3537152
28391514	inflammation	C0021368
28391514	remodeling	C3714634
28391514	disease	C0012634
28391514	development	C1527148
28391546	Association	C0439849
28391546	prematurity	C0021294
28391546	<30 weeks' gestational age	C0017504
28391546	blood pressure	C0005823
28391546	urinary	C1524119
28391546	albumin	C2362049
28391546	calcium	C0006675
28391546	phosphate	C0031603
28391546	early childhood	C0599196
28391546	data	C1511726
28391546	blood pressures	C0005823
28391546	BP	C0005823
28391546	urinary	C1524119
28391546	albumin	C2362049
28391546	mineral	C0026162
28391546	excretion	C0221102
28391546	early childhood	C0599196
28391546	contemporary	C1254367
28391546	cohorts	C0599755
28391546	extremely	C0205403
28391546	low	C0205251
28391546	gestational age	C0017504
28391546	GA	C0017504
28391546	neonates	C0021289
28391546	compare	C1707455
28391546	BPs	C0005823
28391546	urinary	C1524119
28391546	excretion	C0221102
28391546	albumin	C2362049
28391546	calcium	C0006675
28391546	phosphate	C0031603
28391546	preterm	C2964377
28391546	term-born	C0233324
28391546	cohorts	C0599755
28391546	early childhood	C0599196
28391546	prospective observational study	C0033522
28391546	single	C0205171
28391546	center	C0475309
28391546	involving	C1314939
28391546	children	C0008059
28391546	<5 years age	C0001779
28391546	born preterm	C0151526
28391546	GA <30 weeks	C0460089
28391546	at term	C0233324
28391546	≥37 weeks' GA	C3536634
28391546	Urinary albumin	C0587185
28391546	calcium	C0428302
28391546	phosphate levels	C0428304
28391546	indexed	C0918012
28391546	creatinine	C0010294
28391546	BP	C0005823
28391546	measured	C0444706
28391546	median	C2939193
28391546	IQR	C1711350
28391546	follow-up	C1522577
28391546	age	C0001779
28391546	cohort	C0599755
28391546	months	C0439231
28391546	Preterm-born children	C4048294
28391546	significantly lower	C4055638
28391546	mean	C0444504
28391546	GA	C0017504
28391546	birth weight	C0005612
28391546	higher	C0205250
28391546	mean	C0444504
28391546	systolic	C0871470
28391546	diastolic	C0428883
28391546	mean BPs	C0428886
28391546	compared	C1707455
28391546	term	C0233324
28391546	controls	C0009932
28391546	significantly higher	C4055637
28391546	proportion	C1709707
28391546	preterm-born children	C4048294
28391546	weighed	C0005910
28391546	<10th centile	C3276033
28391546	systolic BP	C0871470
28391546	>95th centile	C0243095
28391546	follow-up	C1522577
28391546	Albumin	C2362049
28391546	calcium	C0006675
28391546	excretion	C0221102
28391546	not differ	C3842396
28391546	groups	C0681860
28391546	median	C0876920
28391546	urine-phosphate creatinine ratios	C2735243
28391546	higher	C0205250
28391546	preterm group	C4048294
28391546	logistic regression	C0206031
28391546	lower	C0205251
28391546	GA	C0017504
28391546	younger	C0332239
28391546	age	C0001779
28391546	follow-up	C1522577
28391546	significantly	C0750502
28391546	associated with	C0332281
28391546	increased	C0205217
28391546	risk	C0035647
28391546	systolic	C0871470
28391546	diastolic BP	C0428883
28391546	95th centile	C0243095
28391546	male gender	C0086582
28391546	associated with	C0332281
28391546	decreased	C0205216
28391546	risk	C0035647
28391546	diastolic hypertension	C0235222
28391546	early childhood	C0599196
28391546	children born preterm	C4048294
28391546	significantly	C0750502
28391546	elevated	C3163633
28391546	BP	C0005823
28391546	compared	C1707455
28391546	term-born	C0233324
28391546	counterparts	C0009932
28391546	monitoring	C1283169
28391546	BPs	C0005823
28391546	population	C1257890
28391978	Recombinant	C0034861
28391978	protein transduction domain	C1514562
28391978	Cu/Zn superoxide dismutase	C0010461
28391978	alleviates	C0392756
28391978	bone cancer	C0279530
28391978	pain	C0596240
28391978	peroxiredoxin 4	C0914290
28391978	modulation	C1148560
28391978	antioxidation	C1148560
28391978	Bone cancer	C0279530
28391978	pain	C0596240
28391978	BCP	C0596240
28391978	serious	C0205404
28391978	chronic	C0205191
28391978	clinical condition	C0348080
28391978	reactive oxygen species	C0162772
28391978	ROS	C0162772
28391978	considered	C0750591
28391978	involved	C1314939
28391978	development	C1527148
28391978	persistency	C0205322
28391978	Normally	C0205307
28391978	superoxide dismutase	C0038838
28391978	SOD	C0038838
28391978	superoxide anions	C0038836
28391978	hydrogen peroxide	C0020281
28391978	H2O2	C0020281
28391978	H2O2	C0020281
28391978	water	C0043047
28391978	peroxiredoxin 4	C0914290
28391978	reported	C0684224
28391978	recombinant	C0034861
28391978	protein transduction domain	C1514562
28391978	PTD	C1514562
28391978	Cu/Zn SOD	C0010461
28391978	effectively	C1704419
28391978	scavenged	C1148560
28391978	excessive	C0442802
28391978	ROS	C0162772
28391978	prevented	C1292733
28391978	cardiomyocytes	C0225828
28391978	hypoxia-reoxygenation	C0542341
28391978	damage	C1883709
28391978	PTD	C1514562
28391978	Cu/Zn SOD	C0010461
28391978	prevent	C1292733
28391978	BCP	C0596240
28391978	development	C1527148
28391978	unknown	C0439673
28391978	current	C0521116
28391978	study	C0681814
28391978	found	C0150312
28391978	implanted	C0021102
28391978	carcinoma	C0007097
28391978	rat	C0034721
28391978	tibia	C0040184
28391978	induced	C0205263
28391978	hyperalgesia	C0020429
28391978	increased	C0205217
28391978	H2O2	C0020281
28391978	levels	C0441889
28391978	decreased	C0205216
28391978	SOD	C0038838
28391978	peroxiredoxin 4	C0914290
28391978	levels	C0441889
28391978	administration	C1521801
28391978	recombinant	C0034861
28391978	PTD	C1514562
28391978	Cu/Zn SOD	C0010461
28391978	tumor-burden	C1516167
28391978	rats	C0034721
28391978	hyperalgesia	C0020429
28391978	significantly	C0750502
28391978	attenuated	C0599946
28391978	peroxiredoxin 4	C0914290
28391978	expression	C1171362
28391978	significantly increased	C4055637
28391978	In addition	C0332287
28391978	increased	C0205217
28391978	expression	C0597360
28391978	N-methyl-d-aspartic acid (NMDA) receptors	C0080093
28391978	decreased	C0205216
28391978	expression	C0597360
28391978	γ-aminobutyric acid (GABA) receptors	C0206518
28391978	cancer pain	C0596240
28391978	prevented	C1292733
28391978	PTD	C1514562
28391978	Cu/Zn SOD	C0010461
28391978	administration	C1521801
28391978	peroxiredoxin 4	C0914290
28391978	overexpression	C1514559
28391978	data	C1511726
28391978	suggested	C1705535
28391978	reactive oxygen species	C0162772
28391978	role	C1705810
28391978	cancer metastatic	C0027627
28391978	pain	C0596240
28391978	development	C1527148
28391978	persistency	C0205322
28391978	attenuated by	C0332161
28391978	adminstration	C1521801
28391978	recombinant PTD	C0034861
28391978	Cu/Zn SOD	C0010461
28391978	peroxiredoxin 4	C0914290
28391978	modulation	C1148560
28391978	oxidative stress	C0242606
28392427	Immune dysregulation	C1844666
28392427	offspring	C0680063
28392427	bipolar	C0005586
28392427	parent	C0030551
28392427	serum	C0229671
28392427	levels	C0441889
28392427	immune	C0439662
28392427	growth factors	C0018284
28392427	adolescent age	C0205653
28392427	Immune dysregulation	C1844666
28392427	vulnerability	C1821973
28392427	mood disorders	C0525045
28392427	Immune	C0439662
28392427	growth factors	C0018284
28392427	Stem Cell Factor	C0143630
28392427	SCF	C0143630
28392427	Insulin-like Growth Factor-Binding Protein-2	C0123257
28392427	IGF-BP2	C0123257
28392427	Epidermal Growth Factor	C0242275
28392427	EGF	C0242275
28392427	IL-7	C0021761
28392427	sCD25	C0487019
28392427	altered	C0392747
28392427	patients	C0030705
28392427	mood disorders	C0525045
28392427	study	C2603343
28392427	investigate	C1292732
28392427	levels	C0441889
28392427	factors	C0018284
28392427	serum	C0229671
28392427	adolescent	C0205653
28392427	bipolar	C0005586
28392427	offspring	C0680063
28392427	heightened	C0442803
28392427	risk	C0035647
28392427	mood disorder	C0525045
28392427	development	C1527148
28392427	analyze	C0936012
28392427	data	C1511726
28392427	published data	C1704324
28392427	Growth factors	C0018284
28392427	assessed	C1516048
28392427	CBA	C0005507
28392427	ELISA	C0014441
28392427	adolescent	C0205653
28392427	bipolar	C0005586
28392427	offspring	C0680063
28392427	mean	C0444504
28392427	age	C0001779
28392427	years	C0439234
28392427	age	C0001779
28392427	gender	C0079399
28392427	matched	C1708943
28392427	healthy	C3898900
28392427	controls	C0009932
28392427	EGF	C0242275
28392427	correlating	C1707520
28392427	cluster	C1704332
28392427	neurotrophic compounds	C0132298
28392427	S100B	C3711149
28392427	BDNF	C3486709
28392427	decreased	C0205216
28392427	serum	C0229671
28392427	IL-7	C0021761
28392427	SCF	C0143630
28392427	IGF-BP2	C0123257
28392427	sCD25	C0487019
28392427	correlating	C1707520
28392427	cluster	C1704332
28392427	immune	C0439662
28392427	growth factors	C0018284
28392427	increased	C0205217
28392427	IGF-BP2	C0123257
28392427	significantly	C0750502
28392427	serum	C0229671
28392427	offspring	C0680063
28392427	mood disorder	C0525045
28392427	IL-7	C0021761
28392427	SCF	C0143630
28392427	serum	C0229671
28392427	offspring	C0680063
28392427	expirienced	C0596545
28392427	mood episode	C0525045
28392427	pattern	C0449774
28392427	de	C0547047
28392427	increases	C0442805
28392427	bipolar	C0005586
28392427	offspring	C0680063
28392427	mood disorder	C0525045
28392427	time	C0040223
28392427	IGF-BP2	C0123257
28392427	level	C0441889
28392427	significantly	C0750502
28392427	offspring	C0680063
28392427	mood disorder	C0525045
28392427	Correlations	C1707520
28392427	published	C1704324
28392427	immune-cellular abnormalities	C4023612
28392427	conclusion	C1707478
28392427	adolescents	C0205653
28392427	familial	C0241888
28392427	mood disorder	C0525045
28392427	development	C1527148
28392427	risk	C0035647
28392427	characterized	C1880022
28392427	pattern	C0449774
28392427	compounds	C0018284
28392427	network	C1882071
28392427	hematopoiesis	C0018951
28392427	neurogenesis	C0814002
28392427	inflammation	C0021368
28394935	eNOS	C0132555
28394935	S-nitrosylates	C1159123
28394935	β-actin	C0005186
28394935	Cys374	C0010654
28394935	regulates	C1327623
28394935	PKC-θ	C0171420
28394935	immune synapse	C1171348
28394935	impairing	C0221099
28394935	actin binding	C1149245
28394935	profilin-1	C0525216
28394935	actin cytoskeleton coordinates the organization	C1155966
28394935	signaling microclusters	C0021054
28394935	immune synapse	C1171348
28394935	IS	C1171348
28394935	mechanisms	C3537153
28394935	nitric oxide	C0028128
28394935	NO	C0028128
28394935	endothelial nitric oxide synthase	C0132555
28394935	eNOS	C0132555
28394935	protein kinase C-θ	C0171420
28394935	PKC-θ	C0171420
28394935	central supramolecular activation cluster	C1171348
28394935	c-SMAC	C1171348
28394935	IS	C1171348
28394935	eNOS	C0132555
28394935	translocated	C0599893
28394935	Golgi	C0018042
28394935	IS	C1171348
28394935	colocalized	C0392752
28394935	F-actin	C1180307
28394935	c-SMAC	C1171348
28394935	actin polymerization	C1155982
28394935	retrograde flow	C1709934
28394935	β-actin	C0005186
28394935	PKC-θ	C0171420
28394935	lamellipodium-like	C0230628
28394935	distal	C0205108
28394935	(d)-SMAC	C1171348
28394935	promoting	C0033414
28394935	PKC-θ	C0171420
28394935	activation	C0014429
28394935	eNOS	C0132555
28394935	NO	C0028128
28394935	S-nitrosylated	C1159123
28394935	β-actin	C0005186
28394935	Cys374	C0010654
28394935	impaired	C0221099
28394935	actin binding	C1149245
28394935	profilin-1	C0525216
28394935	PFN1	C0525216
28394935	transnitrosylating	C3158785
28394935	S-nitroso-L-cysteine	C0073896
28394935	Cys-NO	C0073896
28394935	NO	C0028128
28394935	PFN1-actin complexes	C1180347
28394935	regulation	C1327623
28394935	PKC-θ	C0171420
28394935	overexpression	C1514559
28394935	PFN1	C1456390
28394935	actin-binding	C1149245
28394935	mutants	C0596988
28394935	β-actin (C374S)	C1384510
28394935	PFN1 (H119E)	C1456390
28394935	PKC-θ	C0171420
28394935	c-SMAC	C1171348
28394935	NO	C0028128
28394935	mechanism	C3537153
28394935	actin cytoskeleton controls the organization	C1155966
28394935	activation	C1879547
28394935	signaling microclusters	C0021054
28394935	IS	C1171348
28395912	Dobutamine Stress Echocardiography	C0949700
28395912	Impact	C4049986
28395912	Abnormal	C0205161
28395912	Blood Potassium Levels	C1261540
28395912	Cardiac Arrhythmias	C0003811
28395912	Guidelines	C0162791
28395912	abnormal	C0205161
28395912	blood potassium level	C1261540
28395912	contraindication	C0522473
28395912	performing	C0884358
28395912	dobutamine stress echocardiography	C0949700
28395912	DSE	C0949700
28395912	reviewed	C1709940
28395912	consecutive series of patients	C2985408
28395912	potassium	C0032821
28395912	testing	C0039593
28395912	hours	C0439227
28395912	DSE	C0949700
28395912	evaluation	C0220825
28395912	myocardial ischemia	C0151744
28395912	year	C0439234
28395912	period	C1948053
28395912	potassium	C0032821
28395912	range	C1514721
28395912	laboratory	C0022877
28395912	Hemolyzed samples	C0475880
28395912	association	C0439849
28395912	potassium levels	C0428289
28395912	development	C1527148
28395912	supraventricular	C0428974
28395912	ventricular arrhythmias	C0085612
28395912	assessed	C1516048
28395912	arrhythmias	C0003811
28395912	low	C0205251
28395912	supraventricular tachycardia	C0039240
28395912	atrial fibrillation	C0004238
28395912	nonsustained ventricular tachycardia	C2919575
28395912	sustained ventricular tachycardia	C0750197
28395912	ventricular fibrillation	C0042510
28395912	overall safety	C0036043
28395912	DSE	C0949700
28395912	arrhythmias	C0003811
28395912	patients	C0030705
28395912	potassium levels	C0428289
28395912	arrhythmia	C0003811
28395912	rates	C1521828
28395912	low	C0205251
28395912	patients	C0030705
28395912	potassium	C0032821
28395912	abnormalities	C1704258
28395912	Patients	C0030705
28395912	hyperkalemia	C0020461
28395912	risk	C0035647
28395912	mild	C2945599
28395912	odds ratio	C0028873
28395912	OR	C0028873
28395912	CI	C0009667
28395912	severe	C0205082
28395912	OR	C0028873
28395912	CI	C0009667
28395912	supraventricular arrhythmias	C0428974
28395912	mild	C2945599
28395912	ventricular arrhythmias	C0085612
28395912	OR	C0028873
28395912	CI	C0009667
28395912	rare	C0522498
28395912	patients	C0030705
28395912	severe	C0205082
28395912	hypokalemia	C0020621
28395912	potassium levels	C0428289
28395912	increased	C0205217
28395912	risk	C0035647
28395912	supraventricular arrhythmia	C0428974
28395912	ventricular ectopy	C0012634
28395912	DSE	C0949700
28395912	abnormalities	C1704258
28395912	blood potassium concentrations	C1261540
28395912	DSE	C0949700
28395912	patients	C0030705
28395912	potassium	C0032821
28395912	abnormalities	C1704258
28395912	Elevated	C3163633
28395912	potassium levels	C0428289
28395912	associated with	C0332281
28395912	supraventricular	C0428974
28395912	ventricular arrhythmias	C0085612
28395912	low	C0205251
28395912	risk	C0035647
28395912	patients	C0030705
28395912	low	C0205251
28395912	potassium levels	C0428289
28395912	DSE	C0949700
28395912	increased	C0205217
28395912	risk	C0035647
28395912	arrhythmia	C0003811
28395912	severe	C0205082
28395912	hypokalemia	C0020621
28395912	prior	C0332152
28395912	DSE	C0949700
28397323	Anatomical	C0220784
28397323	subgroup	C1515021
28397323	analysis	C0936012
28397323	MERIDIAN	C0681784
28397323	cohort	C0599755
28397323	Posterior fossa abnormalities	C3280768
28397323	assess	C0184514
28397323	diagnostic	C0348026
28397323	clinical	C0205210
28397323	contribution	C1880177
28397323	in utero magnetic resonance (iuMR) imaging	C0024485
28397323	fetuses	C0015965
28397323	diagnosed	C0011900
28397323	abnormalities of the posterior fossa	C3280768
28397323	intracranial abnormality	C3809358
28397323	antenatal ultrasonography	C0080265
28397323	USS	C0080265
28397323	report	C0684224
28397323	sub-group	C1515021
28397323	analysis	C0936012
28397323	fetuses	C0015965
28397323	abnormalities of the posterior fossa	C3280768
28397323	diagnosed	C0011900
28397323	antenatal USS	C0080265
28397323	ventriculomegaly	C0743968
28397323	MERIDIAN	C0681784
28397323	cohort	C0599755
28397323	iuMR imaging	C0024485
28397323	USS	C0080265
28397323	outcome	C0085415
28397323	reference data	C1554143
28397323	available	C0470187
28397323	diagnostic accuracy	C0598285
28397323	USS	C0080265
28397323	iuMR	C0024485
28397323	reported	C0684224
28397323	indicators	C0021212
28397323	diagnostic confidence	C0598285
28397323	effects	C1280500
28397323	prognosis	C0033325
28397323	clinical management	C1516615
28397323	Abnormalities confined to the posterior fossa	C3280768
28397323	USS	C0080265
28397323	fetuses	C0015965
28397323	parenchymal	C0682552
28397323	CSF	C0007806
28397323	lesions	C0221198
28397323	diagnostic accuracy	C0598285
28397323	detecting	C0442726
28397323	isolated	C0205409
28397323	posterior fossa abnormality	C3280768
28397323	USS	C0080265
28397323	iuMR	C0024485
28397323	difference	C1705241
28397323	improvement	C2986411
28397323	appropriate	C1548787
28397323	diagnostic confidence	C0598285
28397323	assessed	C0184514
28397323	score	C0449820
28397323	based	C1527178
28397323	weighted	C0043100
28397323	average	C1510992
28397323	method	C0025663
28397323	reduction	C0441610
28397323	'high	C0205250
28397323	incorrect	C3827420
28397323	diagnoses	C0011900
28397323	iuMR imaging	C0024485
28397323	prognostic information	C0033325
28397323	women	C0043210
28397323	iuMR imaging	C0024485
28397323	cases	C1706256
28397323	overall	C1561607
28397323	effect	C1280500
28397323	iuMR	C0024485
28397323	clinical management	C1516615
28397323	significant	C0750502
28397323	major	C0205164
28397323	decisive	C0564585
28397323	cases	C1706256
28397323	data	C1511726
28397323	woman	C0043210
28397323	fetus	C0015965
28397323	posterior fossa abnormality	C3280768
28397323	intracranial finding	C3809358
28397323	USS	C0080265
28397323	iuMR imaging	C0024485
28397323	evaluation	C0220825
28397323	basis	C1527178
28397323	improved	C0184511
28397323	diagnostic accuracy	C0598285
28397323	confidence	C0598285
28397323	substantial	C0205082
28397323	effects	C1280500
28397323	prognostic information	C0033325
28397323	women	C0043210
28397323	clinical management	C1516615
28399452	Design	C1707689
28399452	synthesis	C1883254
28399452	evaluation	C0220825
28399452	curcumin	C0010467
28399452	derivatives	C0243072
28399452	Nrf2	C0289507
28399452	activators	C0599177
28399452	cytoprotectors	C0524828
28399452	oxidative death	C3893307
28399452	Activation	C0599177
28399452	nuclear factor erythroid-2-related factor 2	C0289507
28399452	Nrf2	C0289507
28399452	cancer	C0006826
28399452	curcumin	C0010467
28399452	Nrf2	C0289507
28399452	activator	C0599177
28399452	cancer	C0006826
28399452	chemopreventive agent	C1516463
28399452	study	C2603343
28399452	curcumin	C0010467
28399452	analogs	C0243071
28399452	geminal dimethyl substituents on the active methylene group	C1254350
28399452	Nrf2	C0289507
28399452	activators	C0599177
28399452	cytoprotectors	C0524828
28399452	oxidative death	C3893307
28399452	geminally dimethylated	C1254350
28399452	catechol	C0054858
28399452	curcumin	C0010467
28399452	analog	C0243071
28399452	compound 3	C1254351
28399452	lead molecule	C1254351
28399452	stability	C0314668
28399452	cytoprotective	C0524828
28399452	activity	C0441655
28399452	tert-butyl hydroperoxide	C0076150
28399452	t-BHP	C0076150
28399452	death	C0007587
28399452	HepG2 cells	C2717940
28399452	Mechanism	C0441712
28399452	studies	C2603343
28399452	cytoprotective	C0524828
28399452	effects	C1280500
28399452	activating	C1879547
28399452	Nrf2	C0289507
28399452	signaling pathway	C0037080
28399452	Michael acceptor	C1254351
28399452	catechol	C0054858
28399452	copper	C0009968
28399452	iron	C0302583
28399452	ion	C0022023
28399452	chelators	C0007974
28399452	metal	C0025552
28399452	ion	C0022023
28399452	oxidations	C0030011
28399452	compound 3	C1254351
28399452	o-quinone	C0034435
28399452	Nrf2	C0289507
28399452	cytoprotection	C0524828
28399452	designing	C1707689
28399452	natural	C0205296
28399452	curcumin	C0010467
28399452	Nrf2	C0289507
28399452	activators	C0599177
28399452	stability	C0314668
28399452	proelectrophilic	C1254365
28399751	Safe	C0036043
28399751	Self-Injury	C0424366
28399751	Practical Guide	C0681464
28399751	Understanding	C0162340
28399751	Responding	C0004927
28399751	Harm-reduction	C0679771
28399751	Inckle Kay	C0805191
28399751	Safe	C0036043
28399751	Self-Injury	C0424366
28399751	Practical Guide	C0681464
28399751	Understanding	C0162340
28399751	Responding	C0004927
28399751	Harm-reduction	C0679771
28399751	author	C3812881
28399751	book	C0006002
28399751	concise	C1806781
28399751	exploration	C1292732
28399751	stereotypes	C0038272
28399751	truths	C0205238
28399751	self-harm	C0424366
28399751	chapters	C0005990
28399751	grounded	C1510611
28399751	challenging view	C0449911
28399751	self-harm	C0424366
28399751	understood	C0162340
28399751	perspectives	C0030971
28400033	Pre-hospital	C1254367
28400033	policies	C0242456
28400033	care of patients	C0017313
28400033	acute coronary syndromes	C0948089
28400033	India	C0021201
28400033	policy	C0242456
28400033	document	C1301746
28400033	analysis	C0936012
28400033	Ischemic heart disease	C0002962
28400033	leading	C1522538
28400033	cause of death	C0007465
28400033	India	C0021201
28400033	high-income	C0948433
28400033	countries	C0454664
28400033	pre-hospital systems of care	C1444165
28400033	manage	C0184516
28400033	acute	C0205178
28400033	manifestations of	C1280464
28400033	ischemic heart disease	C0002962
28400033	acute coronary syndrome	C0948089
28400033	ACS	C0948089
28400033	unknown	C0439673
28400033	guidelines	C0162791
28400033	policies	C0242456
28400033	regulations	C0851285
28400033	laws	C0023150
28400033	exist	C2987476
28400033	pre-hospital	C1254367
28400033	ACS	C0948089
28400033	care	C0086388
28400033	India	C0021201
28400033	nation-wide	C1254362
28400033	document	C1301746
28400033	analysis	C0936012
28400033	knowledge	C0376554
28400033	November	C3828767
28400033	May	C3812381
28400033	searched	C1706202
28400033	publicly	C0205556
28400033	available	C0470187
28400033	emergency care	C1527398
28400033	guidelines	C0162791
28400033	legislation	C0600657
28400033	pre-hospital	C1254367
28400033	ACS	C0948089
28400033	care	C0086388
28400033	Indian	C0021201
28400033	states	C1301808
28400033	Union Territories	C0017446
28400033	Internet	C0282111
28400033	search	C1706202
28400033	direct	C1947931
28400033	correspondence	C0282413
28400033	found	C0150312
28400033	documents	C1301746
28400033	pre-hospital	C1254367
28400033	ACS	C0948089
28400033	care	C0086388
28400033	India	C0021201
28400033	legislation mandating	C0814715
28400033	acute care	C0679878
28400033	emergencies	C0013956
28400033	trauma	C3714660
28400033	regulations	C0851285
28400033	laws	C0023150
28400033	pre-hospital	C1254367
28400033	ACS	C0948089
28400033	care	C0086388
28400033	absent	C0332197
28400033	Policy makers	C0242170
28400033	urgently	C0439609
28400033	need	C0027552
28400033	comprehensive	C1880156
28400033	multi-stakeholder	C0205556
28400033	policies	C0242456
28400033	pre-hospital	C1254367
28400033	emergency	C0013956
28400033	cardiovascular care	C4273565
28400033	India	C0021201
28400056	Lack	C0332268
28400056	antimicrobial	C1271650
28400056	efficacy	C1280519
28400056	mecetronium etilsulfate	C0771499
28400056	propanol	C0175804
28400056	hand rubs	C1330330
28400056	surgical	C0543467
28400056	hand disinfection	C0018570
28400056	aim	C1947946
28400056	study	C2603343
28400056	mecetronium etilsulfate	C0771499
28400056	MES	C0771499
28400056	efficacy	C1280519
28400056	surgical	C0543467
28400056	hand disinfection	C0018570
28400056	hand rubs	C1330330
28400056	iso-propanol	C0022237
28400056	n-propanol	C0001964
28400056	applied	C4048755
28400056	compared	C1707455
28400056	EN 12791	C1254351
28400056	procedure	C2700391
28400056	crossover design	C0242817
28400056	commercial	C0680536
28400056	hand rub	C1330330
28400056	MES	C0771499
28400056	hand rubs	C1330330
28400056	identical	C0205280
28400056	MES	C0771499
28400056	formulations	C1705957
28400056	log10	C1690986
28400056	reduction	C0392756
28400056	better	C0332272
28400056	compared	C1707455
28400056	procedure	C2700391
28400056	mean	C0444504
28400056	standard deviation	C0871420
28400056	antimicrobial	C1271650
28400056	contribution	C1880177
28400056	MES	C0771499
28400056	hand rubs	C1330330
28403387	Skin Conductance	C0814024
28403387	Responses	C0871261
28403387	Neural	C3714606
28403387	Activations	C1879547
28403387	Fear	C0015726
28403387	Conditioning	C0009647
28403387	Extinction	C0015347
28403387	Recall	C0034770
28403387	Anxiety Disorders	C0003469
28403387	fear	C0015726
28403387	conditioning	C0009647
28403387	extinction	C0015347
28403387	neurocircuitry	C0596723
28403387	extensively	C0205231
28403387	studied	C2603343
28403387	healthy	C3898900
28403387	clinical	C0205210
28403387	populations	C1257890
28403387	particular focus	C0205234
28403387	posttraumatic stress disorder	C0038436
28403387	significant	C0750502
28403387	overlap	C1948020
28403387	symptoms	C1457887
28403387	posttraumatic stress disorder	C0038436
28403387	anxiety disorders	C0003469
28403387	received	C1514756
28403387	less	C0439092
28403387	attention	C0004268
28403387	fear	C0015726
28403387	levels	C0441889
28403387	characterize	C1880022
28403387	anxiety disorders	C0003469
28403387	examining	C0582103
28403387	neural	C3714606
28403387	correlates	C1707520
28403387	fear	C0015726
28403387	extinction	C0015347
28403387	learning	C0023185
28403387	pathogenesis	C0699748
28403387	anxiety disorders	C0003469
28403387	investigate	C1292732
28403387	psychophysiological	C0018467
28403387	neural	C3714606
28403387	correlates	C1707520
28403387	fear	C0015726
28403387	conditioning	C0009647
28403387	extinction	C0015347
28403387	recall	C0034770
28403387	anxiety disorders	C0003469
28403387	document	C1301746
28403387	features	C2348519
28403387	function	C0542341
28403387	multiple	C0439064
28403387	diagnoses	C0011900
28403387	anxiety	C0003467
28403387	severity	C0439793
28403387	investigation	C0220825
28403387	cross-sectional	C0010362
28403387	case-control	C0872128
28403387	functional magnetic resonance imaging	C0376335
28403387	study	C2603343
28403387	academic medical center	C0000872
28403387	Participants	C0679646
28403387	healthy	C3898900
28403387	controls	C0009932
28403387	individuals	C0237401
28403387	following	C0332282
28403387	anxiety disorders	C0003469
28403387	generalized anxiety disorder	C0270549
28403387	social anxiety disorder	C4237417
28403387	specific phobia	C0236801
28403387	panic disorder	C0030319
28403387	study	C2603343
28403387	dates	C0011008
28403387	fear	C0015726
28403387	conditioning	C0009647
28403387	extinction	C0015347
28403387	paradigm	C0681797
28403387	Skin conductance	C0814024
28403387	responses	C0871261
28403387	blood oxygenation level-dependent	C1655730
28403387	responses	C0871261
28403387	trait	C0599883
28403387	anxiety scores	C3483978
28403387	State Trait Anxiety Inventory	C0683457
28403387	Trait	C0599883
28403387	Form	C0348078
28403387	functiona	C0542341
28403387	connectivity	C1707489
28403387	study	C2603343
28403387	included	C2700399
28403387	healthy	C3898900
28403387	controls	C0009932
28403387	women	C0043210
28403387	individuals	C0237401
28403387	anxiety disorders	C0003469
28403387	women	C0043210
28403387	P values	C1709380
28403387	reported	C0700287
28403387	neuroimaging	C0679575
28403387	results	C0456984
28403387	familywise	C0015576
28403387	error	C0743559
28403387	corrected	C0205202
28403387	Skin conductance	C0814024
28403387	responses	C0871261
28403387	extinction	C0015347
28403387	recall	C0034770
28403387	individuals	C0237401
28403387	anxiety disorders	C0003469
28403387	healthy	C3898900
28403387	controls	C0009932
28403387	ηp2	C0392762
28403387	ηp2	C0392762
28403387	partial eta squared	C0392762
28403387	anxiety	C0003467
28403387	group	C1257890
28403387	lower	C0205251
28403387	activation	C1879547
28403387	ventromedial prefrontal cortex	C3850122
28403387	vmPFC	C3850122
28403387	extinction	C0015347
28403387	recall	C0034770
28403387	ηp2	C0392762
28403387	hypoactive	C0086439
28403387	pattern	C0449774
28403387	early	C1279919
28403387	conditioning	C0009647
28403387	ηp2	C0392762
28403387	vmPFC	C3850122
28403387	hypoactivation	C1879547
28403387	associated with	C0332281
28403387	anxiety symptom	C0860603
28403387	severity	C0439793
28403387	conditioning	C0009647
28403387	extinction	C0015347
28403387	recall	C0034770
28403387	number	C0237753
28403387	co-occuring	C1709305
28403387	anxiety disorders	C0003469
28403387	diagnosed	C0011900
28403387	ηp2	C0392762
28403387	conditioning	C0009647
28403387	ηp2	C0392762
28403387	extinction	C0015347
28403387	recall	C0034770
28403387	Psychophysiological	C0018467
28403387	interaction analyses	C0237688
28403387	revealed	C0443289
28403387	fear	C0015726
28403387	network connectivity	C0598941
28403387	healthy	C3898900
28403387	controls	C0009932
28403387	anxiety	C0003467
28403387	group	C1257890
28403387	fear	C0015726
28403387	learning	C0023185
28403387	ηp2	C0392762
28403387	range	C1514721
28403387	P	C1709380
28403387	range	C1514721
28403387	extinction	C0015347
28403387	recall	C0034770
28403387	ηp2	C0392762
28403387	range	C1514721
28403387	P	C1709380
28403387	range	C1514721
28403387	skin conductance	C0814024
28403387	response	C0871261
28403387	group	C1257890
28403387	differences	C1705241
28403387	extinction	C0015347
28403387	recall	C0034770
28403387	brain	C0006104
28403387	activation	C1879547
28403387	patterns	C0449774
28403387	anxious	C0849801
28403387	healthy	C3898900
28403387	individuals	C0237401
28403387	findings	C0243095
28403387	future	C0016884
28403387	studies	C2603343
28403387	examine	C0582103
28403387	conditions	C0348080
28403387	longitudinally	C0023981
28403387	context	C0449255
28403387	treatment trials	C0008976
28403387	improve	C0184511
28403387	guide therapeutics	C1562629
28403387	advanced	C0205179
28403387	neurobiological	C0027817
28403387	understanding	C0162340
28403387	disorder	C0012634
28407355	Extracellular vesicles	C3894683
28407355	bone marrow	C0005953
28407355	mesenchymal stem cells	C1257975
28407355	protect	C1545588
28407355	murine	C0026809
28407355	hepatic ischemia	C0920569
28407355	hepatic ischemia - reperfusion injury	C4303160
28407355	reperfusion injury	C0035126
28407355	Hepatic ischemia-reperfusion injury	C4303160
28407355	IRI	C4303160
28407355	associated inflammation	C0021368
28407355	liver dysfunction	C0086565
28407355	complications	C0009566
28407355	liver surgery	C0193373
28407355	transplantation	C0040732
28407355	Mesenchymal stem cells	C1257975
28407355	MSC	C1257975
28407355	reduce	C0392756
28407355	hepatic IRI	C4303160
28407355	reparative	C1254363
28407355	immunomodulatory	C1527392
28407355	immunomodulatory effects	C1280500
28407355	injured	C0332664
28407355	tissues	C0040300
28407355	beneficial effects	C1280500
28407355	extracellular vesicles	C3894683
28407355	MSCs	C1257975
28407355	MSC	C1257975
28407355	EV	C3894683
28407355	tissue injury	C2136639
28407355	systemically administered	C0678812
28407355	mouse bone marrow	C1511243
28407355	MSC	C1257975
28407355	EV	C3894683
28407355	evaluated	C0178628
28407355	experimental murine model	C0887965
28407355	hepatic IRI	C4303160
28407355	induced	C0205263
28407355	cross clamping	C1883710
28407355	hepatic artery	C0019145
28407355	portal vein	C0032718
28407355	minutes	C0439232
28407355	reperfusion	C0035124
28407355	periods	C1948053
28407355	hours	C0439227
28407355	controls, intravenous administration	C0013125
28407355	MSC	C1257975
28407355	EV	C3894683
28407355	minutes	C0439232
28407355	IRI	C4303160
28407355	dramatically reduced	C0392756
28407355	tissue necrosis	C0027540
28407355	decreased	C0205216
28407355	caspase-3 positive	C0291573
28407355	apoptotic cells	C3269134
28407355	reduced	C0392756
28407355	aminotransferase	C0002594
28407355	MSC	C1257975
28407355	EV	C3894683
28407355	increased	C0205217
28407355	hepatic	C0205054
28407355	mRNA expression	C1515670
28407355	NACHT, LRR and PYD domains-containing protein 12	C1864814
28407355	Nlrp12	C1864814
28407355	chemokine (C-X-C motif) ligand 1	C0812445
28407355	CXCL1	C0812445
28407355	reduced	C0392756
28407355	mRNA expression	C1515670
28407355	inflammatory	C0333348
28407355	cytokines	C0079189
28407355	IL-6	C0021760
28407355	IRI	C4303160
28407355	MSC	C1257975
28407355	EV	C3894683
28407355	increased	C0205217
28407355	cell viability	C0007620
28407355	suppressed	C1260953
28407355	oxidative	C0311404
28407355	injury	C1510467
28407355	NF-κB	C0961340
28407355	activity	C0441655
28407355	AML12 murine hepatocytes	C0227525
28407355	in vitro	C1533691
28407355	administration	C1533734
28407355	EV	C3894683
28407355	bone marrow	C0005953
28407355	MSCs	C1257975
28407355	ameliorate	C0243095
28407355	hepatic IRI	C4303160
28407355	reducing	C0392756
28407355	hepatic injury	C0160390
28407355	modulation	C0443264
28407355	inflammatory response	C1155266
28408723	Nucleic acid detection	C0872232
28408723	CRISPR	C3658200
28408723	Cas13a	C0599560
28408723	C2c2	C0599560
28408723	Rapid	C0456962
28408723	sensitive	C0332324
28408723	nucleic acid detection	C0872232
28408723	aid	C1269765
28408723	point-of-care	C1547702
28408723	pathogen	C0450254
28408723	detection	C1511790
28408723	genotyping	C1285573
28408723	disease	C0012634
28408723	monitoring	C1283169
28408723	RNA	C0035668
28408723	RNA	C0035668
28408723	targeting	C1521840
28408723	clustered regularly interspaced short palindromic repeats	C3658200
28408723	CRISPR	C3658200
28408723	effector	C0599560
28408723	Cas13a	C0599560
28408723	C2c2	C0599560
28408723	collateral	C1948058
28408723	effect	C1280500
28408723	ribonuclease activity	C1148840
28408723	target	C1521840
28408723	recognition	C0599844
28408723	combine	C0205195
28408723	collateral	C1948058
28408723	effect	C1280500
28408723	Cas13a	C0599560
28408723	isothermal amplification	C3539922
28408723	establish	C0443211
28408723	CRISPR	C3658200
28408723	diagnostic	C0348026
28408723	CRISPR	C3658200
28408723	Dx	C0348026
28408723	rapid	C0456962
28408723	DNA	C0012854
28408723	RNA	C0035668
28408723	detection	C1511790
28408723	attomolar sensitivity	C1511883
28408723	single-base	C1704464
28408723	mismatch	C1881865
28408723	specificity	C0037791
28408723	Cas13a	C0599560
28408723	molecular	C1521991
28408723	detection	C1511790
28408723	platform	C1710360
28408723	Specific High-Sensitivity Enzymatic Reporter UnLOCKing	C1710360
28408723	SHERLOCK	C1710360
28408723	detect	C0442726
28408723	specific	C0205369
28408723	strains	C1518614
28408723	Zika	C0318793
28408723	Dengue virus	C0011315
28408723	pathogenic	C0450254
28408723	bacteria	C0004611
28408723	genotype	C0017431
28408723	human	C0086418
28408723	DNA	C0012854
28408723	identify	C0205396
28408723	mutations	C0026882
28408723	cell-free	C0007625
28408723	tumor DNA	C0012930
28408723	SHERLOCK	C1710360
28408723	reaction	C0443286
28408723	reagents	C0034760
28408723	lyophilized	C0016698
28408723	cold-chain	C0282332
28408723	long-term	C0443252
28408723	storage	C1698986
28408723	field applications	C0869019
28409370	thoracoscopic	C0039989
28409370	resection	C0015252
28409370	solitary pulmonary nodule	C2350019
28409370	cancer	C0006826
28409370	patients	C0030705
28409370	Solitary pulmonary nodules	C2350019
28409370	SPN	C2350019
28409370	detected	C0442726
28409370	cancer	C0006826
28409370	patients	C0030705
28409370	lesions	C0577916
28409370	pulmonary metastases	C0153676
28409370	increasingly	C0442808
28409370	treated	C1522326
28409370	non-surgical techniques	C0087111
28409370	histological	C0205462
28409370	confirmation	C0750484
28409370	histological	C0205462
28409370	nature	C1262865
28409370	SPN	C2350019
28409370	resected	C1521996
28409370	thoracoscopy	C0039989
28409370	risk factors	C0035648
28409370	malignancy	C4282132
28409370	Single-institution retrospective analysis	C0035363
28409370	consecutive	C1707491
28409370	patients	C0030705
28409370	malignancies	C4282132
28409370	thoracoscopic	C0039989
28409370	resection	C0015252
28409370	SPN	C2350019
28409370	unknown	C0439673
28409370	diagnosis	C0011900
28409370	cancer	C0006826
28409370	patients	C0030705
28409370	thoracoscopic	C0039989
28409370	resection	C0015252
28409370	SPN	C2350019
28409370	resected	C1521996
28409370	SPN	C2350019
28409370	benign	C0205183
28409370	patients	C0030705
28409370	malignant	C0205282
28409370	patients	C0030705
28409370	metastasis	C0027627
28409370	patients	C0030705
28409370	primary	C0205225
28409370	lung cancer	C0242379
28409370	patients	C0030705
28409370	univariate analysis	C0683962
28409370	malignancy	C4282132
28409370	associated with	C0332281
28409370	age	C0001779
28409370	years	C1510829
28409370	disease	C0012634
28409370	interval	C1272706
28409370	months	C0439231
28409370	SPN	C2350019
28409370	size	C0475440
28409370	upper lobe	C0225756
28409370	localization	C0475264
28409370	SUVmax	C2986846
28409370	PET-CT	C1699633
28409370	multivariate analysis	C0026777
28409370	upper lobe	C0225756
28409370	localization	C0475264
28409370	SUVmax	C2986846
28409370	associated with	C0332281
28409370	malignancy	C4282132
28409370	Smoking	C0037369
28409370	associated with	C0332281
28409370	SPN	C2350019
28409370	primary	C0205225
28409370	lung cancer	C0242379
28409370	series	C0205549
28409370	SPN	C2350019
28409370	patients	C0030705
28409370	malignant disease	C0442867
28409370	pulmonary metastases	C0153676
28409370	newly diagnosed	C1518321
28409370	NSCLC	C0007131
28409370	Smoking	C0037369
28409370	associated with	C0332281
28409370	primary	C0205225
28409370	lung cancer	C0242379
28409370	no	C1513916
28409370	predictor	C2698872
28409370	pulmonary metastasis	C0153676
28409370	lung cancer	C0242379
28409370	histological	C0205462
28409370	confirmation	C0750484
28409370	SPN	C2350019
28409370	patients	C0030705
28409370	previous	C0205156
28409370	malignancies	C4282132
28409370	diagnostic	C0348026
28409370	uncertainty	C0087130
28409370	suboptimal	C2984009
28409370	treatments	C0087111
28409651	Reliability	C0205556
28409651	Fear Assessment	C4040543
28409651	Growing	C3687568
28409651	Pigs	C0039005
28409651	Exposed to	C0332157
28409651	Novel	C0205314
28409651	Object	C0347997
28409651	Test	C0039593
28409651	Commercial	C0680536
28409651	Conditions	C0348080
28409651	objective	C0018017
28409651	assess	C1516048
28409651	reliability	C0205556
28409651	feasibility	C0015730
28409651	novel	C0205314
28409651	object	C0347997
28409651	test	C0039593
28409651	assessing fear	C2364227
28409651	pigs	C0039005
28409651	commercial	C0680536
28409651	conditions	C0348080
28409651	commercial	C0680536
28409651	farms	C0557759
28409651	pens housing	C0020057
28409651	growing	C3687568
28409651	pigs	C0039005
28409651	assessed	C1516048
28409651	balloons	C3273359
28409651	novel	C0039005
28409651	stimulus	C0234402
28409651	Measures	C0079809
28409651	time	C0040223
28409651	pig	C0039005
28409651	contact	C0392367
28409651	balloons	C3273359
28409651	nonhuman	C0237798
28409651	animals	C0003062
28409651	watching	C2371283
28409651	balloons	C3273359
28409651	animals	C0003062
28409651	touching	C2584295
28409651	balloons	C3273359
28409651	periods	C1948053
28409651	time	C0040223
28409651	pig	C0039005
28409651	contact	C0392367
28409651	balloons	C3273359
28409651	ranged	C1514721
28409651	effect	C1280500
28409651	farm	C0557759
28409651	contact	C0392367
28409651	latency	C0242465
28409651	ranging	C1514721
28409651	difference	C1705242
28409651	intrafarm	C0557759
28409651	variability	C2827666
28409651	Interobserver repeatability	C0870736
28409651	high	C0205250
28409651	measure	C0079809
28409651	ranging	C1514721
28409651	contact	C0392367
28409651	latency	C0242465
28409651	measure	C0079809
28409651	assess	C1516048
28409651	fear	C0015726
28409651	stimulus	C0234402
28409651	commercial	C0680536
28409651	farms	C0557759
28412023	prediction	C0681842
28412023	activators	C0751968
28412023	human	C0086418
28412023	constitutive androstane receptor	C0914906
28412023	structure	C0026383
28412023	three-dimensional quantitative structure-activity relationship	C0887820
28412023	methods	C0025663
28412023	constitutive androstane receptor	C0914906
28412023	CAR	C0914906
28412023	NR1I3)	C0663285
28412023	regulates the expression	C2755857
28412023	numerous	C0439064
28412023	drug-metabolizing	C0683140
28412023	enzymes	C0014442
28412023	transporters	C0007292
28412023	upregulation	C0041904
28412023	enzymes	C0014442
28412023	CYP2B6	C0534137
28412023	CAR	C0914906
28412023	activators	C0751968
28412023	severe	C0205082
28412023	drug-drug interactions	C0687133
28412023	DDIs	C0687133
28412023	effective	C1704419
28412023	computational approaches	C1516769
28412023	CAR	C0914906
28412023	three-dimensional quantitative structure-activity relationship	C0887820
28412023	3D-QSAR	C0887820
28412023	models	C3161035
28412023	CAR	C0914906
28412023	activating	C1514758
28412023	potency	C3245505
28412023	compounds	C1254351
28412023	drug-discovery	C0920472
28412023	process	C1522240
28412023	Models	C3161035
28412023	comparative molecular field analysis	C1513380
28412023	CoMFA	C1513380
28412023	molecular	C0567416
28412023	alignments	C1706765
28412023	ligands binding	C1517880
28412023	CAR	C0914906
28412023	ligand-docking	C1522290
28412023	28 compounds	C1254351
28412023	CoMFA	C1513380
28412023	model	C3161035
28412023	modified by	C0205349
28412023	lipophilic	C0598631
28412023	parameter	C0598631
28412023	predictive ability	C1514307
28412023	predictability	C0237793
28412023	3D-QSAR	C0887820
28412023	model	C3161035
28412023	CAR	C0914906
28412023	activation	C1514758
28412023	compounds	C1254351
28412023	external validation	C1519941
28412023	results	C1274040
28412023	3D-QSAR	C0887820
28412023	model	C3161035
28412023	precise	C2828393
28412023	prediction	C0681842
28412023	CAR	C0914906
28412023	activating	C1514758
28412023	potency	C3245505
28412023	drug candidates	C1254351
28412023	minimized	C1524031
28412023	DDI	C0687133
28412023	risk	C0035647
28412023	enzyme-induction	C0014431
28412023	early	C1279919
28412023	drug-discovery	C0920472
28412023	stage	C1306673
28413509	Effects of	C1704420
28413509	siRNA	C1099354
28413509	suppression	C0038855
28413509	HPV-11 L1	C0017376
28413509	expression	C0017262
28413509	proliferation	C0596290
28413509	apoptosis	C0162638
28413509	vaginal epithelial cells	C1987256
28413509	aim	C1947946
28413509	study	C2603343
28413509	investigate	C1292732
28413509	effects of	C1704420
28413509	human papillomavirus (HPV) infection	C0343641
28413509	gynecological disease	C1384956
28413509	vaginitis	C0042267
28413509	small interfering RNA	C1099354
28413509	siRNA	C1099354
28413509	HPV	C0021344
28413509	prevention	C0199176
28413509	clinic	C0442592
28413509	Human	C0086418
28413509	vaginal epithelial cells	C1987256
28413509	transfected	C0040669
28413509	HPV-11 L1	C0017376
28413509	expression vector	C0599566
28413509	siRNA	C1099354
28413509	HPV-11 L1	C0017376
28413509	vectors	C0017397
28413509	control group	C0009932
28413509	transfected	C0040669
28413509	siRNA	C1099354
28413509	Cell proliferation	C0596290
28413509	MTT assay	C1510438
28413509	expression	C1171362
28413509	apoptosis	C0162638
28413509	proteins	C0033684
28413509	measured	C0444706
28413509	western blot analysis	C2121086
28413509	Compared	C1707455
28413509	control group	C0009932
28413509	HPV-11 L1	C0017376
28413509	mRNA	C0035696
28413509	protein levels	C0428479
28413509	increased	C0205217
28413509	transfection	C0040669
28413509	HPV-11 L1	C0017376
28413509	expression vector	C0599566
28413509	cells	C0007634
28413509	silencing	C0598496
28413509	HPV-11 L1	C0017376
28413509	cell proliferation	C0596290
28413509	HPV-11 group	C0441833
28413509	lower	C0205251
28413509	control group	C0009932
28413509	cell proliferation	C0596290
28413509	increased	C0205217
28413509	cells	C0007634
28413509	transfected	C0040669
28413509	silenced	C0598496
28413509	L1	C0017376
28413509	control group	C0009932
28413509	silencing	C0598496
28413509	HPV-11 L1	C0017376
28413509	decreased	C0205216
28413509	caspase-3	C1413132
28413509	caspase-9	C1332668
28413509	expressions	C0017262
28413509	cells	C0007634
28413509	expression	C0017262
28413509	increased	C0205217
28413509	HPV-11 L1	C0017376
28413509	study	C2603343
28413509	siRNA	C1099354
28413509	silencing	C0598496
28413509	HPV-11 L1	C0017376
28413509	therapeutic applications	C0278296
28413509	gynecological diseases	C1384956
28413509	associated with	C0332281
28413509	HPV-11	C1093046
28413509	infection	C3714514
28413529	evaluation	C0220825
28413529	neuroendocrine	C0027912
28413529	dysfunction	C3887504
28413529	acute	C0205178
28413529	aneurysmal subarachnoid hemorrhage	C0751530
28413529	prospective study	C0033522
28413529	aim	C1947946
28413529	investigate	C1292732
28413529	pattern	C0449774
28413529	neuroendocrine	C0027912
28413529	cases	C0030705
28413529	acute	C0205178
28413529	aneurysmal subarachnoid hemorrhage	C0751530
28413529	SAH	C0751530
28413529	Endocrine	C0014136
28413529	assessment	C0220825
28413529	cases	C0030705
28413529	acute	C0205178
28413529	aneurysmal SAH	C0751530
28413529	days	C0439228
28413529	ictus	C0038454
28413529	gonadotropic	C0018061
28413529	somatotrophic	C0037663
28413529	thyrotropic	C0040160
28413529	corticotrophic	C0001655
28413529	evaluated	C0220825
28413529	dysfunction	C3887504
28413529	cases	C0030705
28413529	males	C0086582
28413529	females	C0086287
28413529	age	C0001779
28413529	range	C1514721
28413529	years	C1510829
28413529	mean	C0444504
28413529	age	C0001779
28413529	years	C1510829
28413529	acute	C0205178
28413529	SAH	C0751530
28413529	studied	C0008972
28413529	aneurysms	C0002940
28413529	anterior circulation	C0007818
28413529	posterior circulation	C0007818
28413529	hormone deficiency	C0599750
28413529	growth hormone	C0037663
28413529	gonadotrophin	C0018061
28413529	corticotrophin	C0001655
28413529	thyrotrophin	C0040160
28413529	Hyperprolactinemia	C0020514
28413529	cases	C0030705
28413529	One-pituitary hormone axis deficiency	C0857439
28413529	cases	C0030705
28413529	cases	C0030705
28413529	pituitary hormone	C0032015
28413529	dysfunction	C3887504
28413529	cases	C0030705
28413529	hormonal	C0019932
28413529	dysfunction	C3887504
28413529	pituitary hormone axes	C0032015
28413529	cases	C0030705
28413529	hormonal	C0019932
28413529	dysfunction	C3887504
28413529	Endocrine dysfunction	C1397856
28413529	cases	C0030705
28413529	acute	C0205178
28413529	SAH	C0751530
28413529	pituitary hormone axes	C0032015
28413529	dysfunction	C3887504
28413529	cases	C0030705
28413529	hormonal	C0019932
28413529	evaluation	C0220825
28413529	acute	C0205178
28413529	SAH	C0751530
28415987	Validity	C2349101
28415987	reliability	C2347947
28415987	fluoroscopy	C0016356
28415987	digital radiography	C0012249
28415987	evaluate	C0220825
28415987	diaphragmatic	C0011980
28415987	mobility	C0026597
28415987	Fluoroscopy	C0016356
28415987	method	C2911685
28415987	evaluate	C0220825
28415987	diaphragm	C0011980
28415987	methods	C2911685
28415987	diaphragmatic	C0011980
28415987	mobility	C0026597
28415987	fluoroscopy	C0016356
28415987	validity	C2349101
28415987	reliability	C2347947
28415987	evaluation method	C2911685
28415987	diaphragmatic	C0011980
28415987	motion	C0026597
28415987	fluoroscopy	C0016356
28415987	digital radiography	C0012249
28415987	healthy	C3898900
28415987	adults	C0001675
28415987	adults	C0001675
28415987	evaluated	C0220825
28415987	anthropometry	C0003188
28415987	pulmonary function test	C0024119
28415987	evaluation	C0220825
28415987	diaphragm	C0011980
28415987	mobility	C0026597
28415987	fluoroscopy	C0016356
28415987	digital radiography	C0012249
28415987	method	C2911685
28415987	Pearson correlation coefficient	C0871052
28415987	intraclass correlation coefficient	C0392762
28415987	ICC	C0392762
28415987	validity	C2349101
28415987	reliability	C2347947
28415987	measurement	C0242485
28415987	diaphragmatic	C0011980
28415987	motion	C0026597
28415987	ICC	C0392762
28415987	relationship	C0439849
28415987	assessment	C0220825
28415987	validity	C2349101
28415987	reliability	C2347947
28415987	hemidiaphragm	C1269845
28415987	mobility	C0026597
28415987	reliability	C2347947
28415987	left hemidiaphragm	C0929194
28415987	assessment	C0220825
28415987	assessment	C0220825
28415987	reliability	C2347947
28415987	mobility	C0026597
28415987	hemidiaphragms	C1269845
28415987	reliability	C2347947
28415987	mobility	C0026597
28415987	hemidiaphragms	C1269845
28415987	evaluation	C0220825
28415987	diaphragmatic	C0011980
28415987	motion	C0026597
28415987	fluoroscopy	C0016356
28415987	digital radiography	C0012249
28415987	valid	C2349099
28415987	reliable	C0205556
28415987	method	C2911685
28415987	healthy	C3898900
28415987	adults	C0001675
28418943	Loss of control	C0243148
28418943	alcohol seeking	C0813934
28418943	rats	C0086893
28418943	individual	C0237401
28418943	vulnerability	C1821973
28418943	alcohol consumption	C0001948
28418943	Alcohol use disorder	C0001956
28418943	AUD	C0001956
28418943	excessive alcohol use	C0560219
28418943	persistent	C0205322
28418943	alcohol seeking	C0813934
28418943	AUD	C0001956
28418943	chronic	C0205191
28418943	excessive alcohol use	C0560219
28418943	subgroup	C1515021
28418943	individuals	C0237401
28418943	drink alcohol	C3842894
28418943	AUD	C0001956
28418943	interaction	C1704675
28418943	individual	C0237401
28418943	vulnerability	C1821973
28418943	prolonged alcohol exposure	C4038778
28418943	study	C2603343
28418943	assessed	C1516048
28418943	prolonged exposure to alcohol	C4038778
28418943	individual levels of alcohol intake	C0001948
28418943	development	C1527148
28418943	loss of control	C0243148
28418943	alcohol seeking	C0813934
28418943	conditioned suppression model	C3161035
28418943	investigate	C1292732
28418943	prolonged alcohol exposure	C4038778
28418943	conditioned suppression	C1260953
28418943	alcohol seeking	C0813934
28418943	assessed	C1516048
28418943	intermittent alcohol access	C1254367
28418943	IAA	C1254367
28418943	subgroup	C1515021
28418943	rats	C0086893
28418943	suppression	C1260953
28418943	alcohol seeking	C0813934
28418943	IAA	C1254367
28418943	influence	C4054723
28418943	alcohol intake	C0001948
28418943	loss of control	C0243148
28418943	alcohol seeking	C0813934
28418943	determined by	C0521095
28418943	assessing	C1516048
28418943	conditioned suppression	C1260953
28418943	subgroups	C1515021
28418943	low and high alcohol drinking	C0205556
28418943	rats	C0086893
28418943	low alcohol drinking	C0205556
28418943	rats	C0086893
28418943	high alcohol drinking	C0205556
28418943	rats	C0086893
28418943	aversion-resistant	C0332325
28418943	alcohol seeking	C0813934
28418943	IAA	C1254367
28418943	groups	C0441833
28418943	loss of control	C0243148
28418943	alcohol seeking	C0813934
28418943	AUD	C0001956
28418943	humans	C0086418
28418943	alcohol exposure	C4038778
28418943	individual's	C0237401
28419641	Neural	C3714606
28419641	correlates	C0871178
28419641	experimental	C1517586
28419641	trauma	C3714660
28419641	memory retrieval	C0679061
28419641	Traumatic	C0332663
28419641	memories	C0025260
28419641	intrusions	C4049623
28419641	flashbacks	C1821940
28419641	development	C1527148
28419641	maintenance	C0024501
28419641	post-traumatic stress disorder	C0038436
28419641	PTSD	C0038436
28419641	neural	C3714606
28419641	mechanisms	C0441712
28419641	traumatic	C0332663
28419641	memories	C0025260
28419641	diagnosis	C0011900
28419641	personalized	C1709510
28419641	treatment	C0087111
28419641	prevention	C0199176
28419641	identification	C0205396
28419641	neural	C3714606
28419641	predictor variables	C0683956
28419641	intrusion	C4049623
28419641	development	C1527148
28419641	trauma	C3714660
28419641	exposure	C0332157
28419641	investigation	C0220825
28419641	examined	C0332128
28419641	neural correlates	C0871178
28419641	experimental	C1517586
28419641	trauma	C3714660
28419641	memory retrieval	C0679061
28419641	traumatic film paradigm	C0681797
28419641	healthy	C3898900
28419641	females	C0086287
28419641	implicit	C0561768
28419641	explicit	C0561766
28419641	retrieval tasks	C0679061
28419641	implicit	C0561768
28419641	experimental	C1517586
28419641	trauma	C3714660
28419641	retrieval	C0679061
28419641	retrosplenial cortex	C4085586
28419641	anterior cingulate cortex	C0175190
28419641	ACC	C0175190
28419641	retrieval tasks	C0679061
28419641	trauma-related	C1144879
28419641	activity	C0441655
28419641	posterior cingulate cortex	C0175191
28419641	PCC	C0175191
28419641	precuneus	C1281018
28419641	neural	C3714606
28419641	activity	C0441655
28419641	experimental	C1517586
28419641	trauma	C3714660
28419641	exposure	C0332157
28419641	predicted	C0681842
28419641	intrusion	C4049623
28419641	development	C1527148
28419641	independent	C0085862
28419641	contributions	C1880177
28419641	activity	C0441655
28419641	retrosplenial cortex	C4085586
28419641	implicit	C0561768
28419641	retrieval	C0679061
28419641	PCC	C0175191
28419641	explicit	C0561766
28419641	retrieval	C0679061
28419641	Additional	C1524062
28419641	analyses	C0936012
28419641	revealed	C0443289
28419641	connectivity	C1707489
28419641	bilateral amygdala	C0002708
28419641	supplementary motor area	C3496173
28419641	precentral	C0921005
28419641	paracentral lobule	C0228203
28419641	control group	C0009932
28419641	experimental	C1517586
28419641	trauma	C3714660
28419641	group	C0441833
28419641	study	C0008972
28419641	neural	C3714606
28419641	correlates	C0871178
28419641	experimental	C1517586
28419641	trauma	C3714660
28419641	memory retrieval	C0679061
28419641	predictive value	C1514307
28419641	subsequent	C0332282
28419641	symptom	C1457887
28419641	development	C1527148
28419641	results	C1274040
28419641	personalized	C1709510
28419641	early treatment	C0814494
28419641	prevention	C2700409
28419641	PTSD	C0038436
28421738	Targeting	C1159372
28421738	Nrf2	C0289507
28421738	Amyloid-Beta Liaison	C1149161
28421738	Alzheimer's Disease	C0002395
28421738	Rational Approach	C0010998
28421738	Amyloid	C0002716
28421738	prominent	C0205402
28421738	feature	C2348519
28421738	Alzheimer's disease	C0002395
28421738	AD	C0002395
28421738	linear	C0205132
28421738	linkage	C0439849
28421738	amyloid-β peptide	C0078939
28421738	Aβ	C0078939
28421738	disease onset	C0277793
28421738	progression	C0242656
28421738	context	C0449255
28421738	partnership	C0439849
28421738	Aβ	C1510880
28421738	Nrf2 pathways	C1518762
28421738	acquiring	C0439661
28421738	paramount	C0205250
28421738	importance	C3898777
28421738	deciphering	C1285553
28421738	Aβ	C0078939
28421738	disease	C0012634
28421738	network	C1882071
28421738	new	C0205314
28421738	antiaggregating agents	C0085826
28421738	simultaneously	C0521115
28421738	activate transcription	C0162493
28421738	antioxidant	C0003402
28421738	responses	C0683154
28421738	lead 1	C1254351
28421738	properties	C0871161
28421738	preliminary	C0439611
28421738	requirements	C0556043
28421738	Aβ	C0078939
28421738	recognition	C0599844
28421738	identified	C0205396
28421738	catechol derivative 12	C1254351
28421738	SH-SY5Y neuroblastoma cells	C0815000
28421738	12	C1254351
28421738	combined	C0205195
28421738	free radical scavenger	C0079381
28421738	properties	C0871161
28421738	trigger	C1444748
28421738	Nrf2 pathway	C1518762
28421738	induce	C0017391
28421738	Nrf2	C0289507
28421738	dependent	C3244310
28421738	defensive	C2164680
28421738	gene NQO1	C0919428
28421738	electrophilic activation	C1254365
28421738	transcriptional response	C0040649
28421738	formation	C1522492
28421738	cytotoxic	C1511636
28421738	stable	C0205360
28421738	oligomeric intermediates	C1254351
28421738	significantly	C0750502
28421738	more	C0205172
28421738	effective	C1704419
28421738	less toxic	C0013221
28421738	prototype 1	C1254351
28421738	different	C1705242
28421738	chemical features	C0243178
28421738	regulate Nrf2	C1523114
28421738	Aβ	C0078939
28421738	activities	C1148560
28421738	pathways	C1704259
28421738	compound 12	C1254351
28421738	derivatives	C1254351
28421738	therapeutic	C0302350
28421738	potential	C3245505
28421738	Nrf2	C0289507
28421738	Aβ	C0078939
28421738	cellular	C0007634
28421738	network	C1882071
28421738	generating	C3146294
28421738	drug leads	C1254351
28421738	AD	C0002395
28424061	Young	C0332239
28424061	people	C0027361
28424061	mental health	C0025353
28424061	practitioners	C1306754
28424061	researchers	C0035173
28424061	Transition Preparation Programme	C0282574
28424061	outcomes	C1274040
28424061	experience	C0596545
28424061	young	C0332239
28424061	people	C0027361
28424061	Child and Adolescent Mental Health Services	C0025355
28424061	CAMHS	C0025355
28424061	UK	C0041700
28424061	young	C0332239
28424061	people	C0027361
28424061	child and adolescent mental health services	C0025355
28424061	CAMHS	C0025355
28424061	discharge	C1548175
28424061	referral to	C2585021
28424061	adult service	C0025355
28424061	age	C0001779
28424061	period	C1948053
28424061	increased	C0205217
28424061	risk	C0035647
28424061	onset of	C0332162
28424061	mental health problems	C1446377
28424061	complex	C0439855
28424061	psychosocial	C0542298
28424061	physical	C0205485
28424061	changes	C0392747
28424061	CAMHS	C0025355
28424061	transitions	C2700061
28424061	negative	C0205160
28424061	outcomes	C1274040
28424061	young	C0332239
28424061	people	C0027361
28424061	preparation	C1521827
28424061	outcomes	C1274040
28424061	experience	C0596545
28424061	study	C0008972
28424061	young	C0332239
28424061	people	C0027361
28424061	transitioned	C2700061
28424061	transition	C2700061
28424061	CAMHS	C0025355
28424061	CAMHS	C0025355
28424061	Transition Preparation Programme	C0282574
28424061	TPP	C0282574
28424061	routine	C0205547
28424061	NHS	C0027462
28424061	young	C0332239
28424061	people	C0027361
28424061	UK	C0041700
28424061	National Health Service	C0027462
28424061	NHS	C0027462
28424061	participatory research workshops	C0242262
28424061	parents	C0030551
28424061	questionnaires	C0034394
28424061	clinical staff	C0025106
28424061	workshops	C0242262
28424061	young	C0332239
28424061	people's	C0027361
28424061	ideas	C1254370
28424061	Young	C0332239
28424061	people	C0027361
28424061	co-research opportunities	C0683937
28424061	young	C0332239
28424061	people	C0027361
28424061	anxious	C0003467
28424061	fearful	C0015726
28424061	CAMHS	C0025355
28424061	perceived	C0030971
28424061	mental health services	C0025355
28424061	Participants	C0679646
28424061	transition	C2700061
28424061	procedures	C2700391
28424061	preparation activities	C0441655
28424061	Transition	C2700061
28424061	Peer Support	C0679740
28424061	transition	C2700061
28424061	booklet	C0030258
28424061	CAMHS	C0025355
28424061	leavers	C1257890
28424061	discharge	C1548175
28424061	transfer	C3244299
28424061	adult service	C0025355
28424061	Preparation	C1521827
28424061	confidence	C1704726
28424061	young	C0332239
28424061	people	C0027361
28424061	responsibility	C0678341
28424061	adult	C0001675
28424061	world	C2700280
28424061	clinicians	C0871685
28424061	anxious	C0003467
28424061	transition	C2700061
28424061	impact	C4049986
28424061	young	C0332239
28424061	people	C0027361
28424061	communication	C0009452
28424061	lack	C0332268
28424061	services	C0025355
28424061	Parents	C0030551
28424061	support	C0037438
28424061	offspring	C0680063
28424061	transition	C2700061
28424061	period	C1948053
28424061	Clinicians	C0871685
28424061	lack	C0332268
28424061	NHS	C0027462
28424061	procedures	C2700391
28424061	policies	C0242456
28424061	barriers	C0205556
28424061	implementation	C1708476
28424061	young	C0332239
28424061	people's	C0027361
28424061	ideas	C1254370
28424061	young	C0332239
28424061	people	C0027361
28424061	co-research opportunities	C0683937
28424061	Mental health services	C0025355
28424061	anxiety	C0003467
28424061	CAMHS	C0025355
28424061	leavers	C1257890
28424061	Young	C0332239
28424061	people	C0027361
28424061	ideas	C1254370
28424061	preparation	C1521827
28424061	CAMHS	C0025355
28424061	confidence	C1704726
28424061	responsibility	C0678341
28424061	health care	C0086388
28424061	collaboration	C0282116
28424061	NHS	C0027462
28424061	staff	C0851286
28424061	researchers	C0035173
28424061	implementation	C1708476
28424061	research	C0035168
28424061	findings	C2607943
28424240	Histone Acetyltransferase Gcn5	C1571486
28424240	Positively Regulates T Cell Activation	C1326165
28424240	Histone acetyltransferases	C0062773
28424240	HATs	C0062773
28424240	regulate inducible transcription	C1158770
28424240	multiple	C0439064
28424240	cellular processes	C1325880
28424240	inflammatory	C1155266
28424240	immune response	C0301872
28424240	functions	C1527118
28424240	general control nonrepressed-protein 5	C1571486
28424240	Gcn5	C1571486
28424240	HAT	C0062773
28424240	yeast	C0043393
28424240	human	C0086418
28424240	immune regulation	C1327458
28424240	study	C0008972
28424240	deleted	C0017260
28424240	Gcn5	C1571486
28424240	encoded	C2700640
28424240	Kat2a gene	C1415020
28424240	T lymphocytes	C0039194
28424240	crossing	C0010366
28424240	floxed Gcn5	C1415020
28424240	Lck-Cre	C0919477
28424240	mice	C0025929
28424240	Gcn5	C1571486
28424240	important roles	C1705810
28424240	stages	C1306673
28424240	T cell functions	C0007613
28424240	development	C0815089
28424240	clonal expansion	C1516670
28424240	differentiation	C0007589
28424240	Loss of	C0243095
28424240	Gcn5	C1571486
28424240	impaired T cell proliferation	C4022557
28424240	IL-2 production	C1819447
28424240	Th1	C0242632
28424240	Th17	C2936411
28424240	Th2	C0242633
28424240	regulatory T cell differentiation	C1155041
28424240	Gcn5	C1571486
28424240	il-2	C0879590
28424240	promoter	C0086860
28424240	interacting	C1704675
28424240	NFAT	C0288011
28424240	T cells	C0039194
28424240	TCR	C0034790
28424240	TCR stimulation	C2259054
28424240	acetylating	C0001038
28424240	NFAT	C0288011
28424240	Gcn5	C1571486
28424240	catalyzes	C0007382
28424240	histone H3 lysine H9 acetylation	C2613321
28424240	promote	C0033414
28424240	IL-2 production	C1819447
28424240	T cell	C0039194
28424240	suppression	C1260953
28424240	Gcn5	C1571486
28424240	mice	C0025929
28424240	myelin oligodendrocyte glycoprotein	C0069428
28424240	induced	C0205263
28424240	experimental autoimmune encephalomyelitis	C0014072
28424240	experimental model	C0086272
28424240	human	C0086418
28424240	multiple sclerosis	C0026769
28424240	reveals	C0443289
28424240	physiological functions	C1254359
28424240	Gcn5	C1571486
28424240	molecular mechanism	C3537153
28424240	functions	C1527118
28424240	regulating T cell immunity	C1818823
28424240	Gcn5	C1571486
28424240	autoimmune disease	C0004364
28424240	therapy	C0087111
28424384	Minor physical anomalies	C0000768
28424384	dermatoglyphic	C0221916
28424384	affective disorders	C0525045
28424384	systematic review	C1955832
28424384	increased	C0205217
28424384	prevalence	C0220900
28424384	minor physical anomalies	C0000768
28424384	MPAs	C0000768
28424384	abnormalities of dermatoglyphic patterns	C0432333
28424384	physical	C0205485
28424384	manifestations	C0205319
28424384	neurodevelopmental disruption	C0679378
28424384	affective disorders	C0525045
28424384	review	C1955832
28424384	frequency	C0439603
28424384	MPAs	C0000768
28424384	dermatoglyphic abnormalities	C0432333
28424384	mood disorders	C0525045
28424384	MEDLINE	C0025141
28424384	PsychInfo	C0242356
28424384	Web of Science search	C0242356
28424384	publications	C0034036
28424384	frequency	C0439603
28424384	MPAs	C0000768
28424384	dermatoglyphic traits	C4025116
28424384	bipolar disorder	C0005586
28424384	unipolar depression	C0041696
28424384	studies	C2603343
28424384	MPAs	C0000768
28424384	dermatoglyphics	C0011624
28424384	discrepant	C1290905
28424384	findings	C2607943
28424384	relative	C0205345
28424384	contribution	C1880177
28424384	neurodevelopmental retardation	C0679378
28424384	aetiology	C1314792
28424384	affective disorders	C0525045
28424384	research	C0035168
28424384	Increased	C0442805
28424384	recognition	C0524637
28424384	neurodevelopmental	C0599855
28424384	processes	C1522240
28424384	origin	C0439659
28424384	affective disorders	C0525045
28424384	effective	C1704419
28424384	intervention	C0184661
28424384	prevention	C0199176
28424683	Novel Strategy	C0035171
28424683	Super-Charged NK Cells	C0022688
28424683	Significant Potential	C3245505
28424683	Lyse	C0024348
28424683	Differentiate	C0205615
28424683	Cancer Stem Cells	C1956422
28424683	Differences	C1705241
28424683	NK Expansion	C0007595
28424683	Function	C0542341
28424683	Healthy	C1708335
28424683	Cancer Patients	C1516213
28424683	Natural killer (NK) cells	C0022688
28424683	cancer stem cells	C1956422
28424683	undifferentiated tumors	C0205698
28424683	novel strategy	C0035171
28424683	super-charged NK cells	C0022688
28424683	significant potential	C3245505
28424683	lyse	C0024348
28424683	differentiate	C0205615
28424683	cancer stem cells	C1956422
28424683	differences	C1705241
28424683	dynamics	C3826426
28424683	NK cell	C0022688
28424683	expansion	C0007595
28424683	healthy donors	C0013018
28424683	cancer patients	C1516213
28424683	Decline in cytotoxicity	C1849420
28424683	lower	C0441994
28424683	interferon (IFN)-γ secretion	C3156720
28424683	osteoclast	C0029431
28424683	OC	C0029431
28424683	NK cells	C0022688
28424683	cancer patients	C1516213
28424683	faster	C0456962
28424683	expansion	C0007595
28424683	contaminating	C0205279
28424683	T cells	C0039194
28424683	purified	C1998793
28424683	NK cells	C0022688
28424683	healthy donors	C0013018
28424683	OCs	C0029431
28424683	super-charged NK cells	C0022688
28424683	T cell	C0039194
28424683	expansion	C0007595
28424683	days	C0439228
28424683	patient	C0030705
28424683	NK cells	C0022688
28424683	NK cells	C0022688
28424683	tumor	C0027651
28424683	BLT-humanized mice	C2986594
28424683	faster	C0456962
28424683	expansion	C0007595
28424683	T cells resulting in decreased numbers	C2673541
28424683	function	C0542341
28424683	NK cells	C0022688
28424683	NK cells	C0022688
28424683	mice	C0025929
28424683	no	C1513916
28424683	tumor	C0027651
28424683	expanding	C0007595
28424683	NK cells	C0022688
28424683	cytotoxicity	C0596402
28424683	dendritic cells	C0011306
28424683	DCs	C0011306
28424683	OCs	C0029431
28424683	faster	C0456962
28424683	expansion	C0007595
28424683	T cells	C0039194
28424683	purified	C1998793
28424683	NK cells	C0022688
28424683	decline in NK cell numbers	C2363838
28424683	healthy individuals	C1708335
28424683	anti-CD3 mAb	C3831520
28424683	T cell proliferation	C1155046
28424683	enhancing	C2349975
28424683	NK cell	C0022688
28424683	expansion	C0007595
28424683	expanding	C0007595
28424683	NK cells	C0022688
28424683	lower	C0441994
28424683	cytotoxicity	C0596402
28424683	higher	C0205250
28424683	secretion of IFN-γ	C3156720
28424683	Expansion	C0007595
28424683	functional	C0205245
28424683	activation	C1879547
28424683	super-charged NK cells	C0022688
28424683	OCs	C0029431
28424683	dependent	C0851827
28424683	interleukin (IL)-12	C0123759
28424683	IL-15	C0254610
28424683	novel strategy	C0035171
28424683	expand	C0007595
28424683	super-charged NK cells	C0022688
28424683	rapid and sustained expansion	C0007595
28424683	T cells	C0039194
28424683	purified	C1998793
28424683	NK cells	C0022688
28424683	expansion	C0007595
28424683	DCs	C0011306
28424683	OCs	C0029431
28424683	potential	C3245505
28424683	mechanism	C0441712
28424683	numbers	C0237753
28424683	function	C0542341
28424683	NK cells decline	C2363838
28424683	cancer patients	C1516213
28424683	BLT-humanized mice	C2986594
28424986	Extremely	C0205403
28424986	Giant Liver Hemangioma	C0238246
28424986	Kasabach-Merritt Syndrome	C0221025
28424986	year	C0439234
28424986	old	C0580836
28424986	male	C0086582
28424986	found	C0150312
28424986	giant liver hemangioma	C0238246
28424986	initial	C0205265
28424986	size	C0475440
28424986	years	C0439234
28424986	received	C1514756
28424986	arterial embolization	C3163695
28424986	twice	C1948050
28424986	shrink	C0205230
28424986	tumor	C0027651
28424986	no effect	C1301751
28424986	obtained	C1301820
28424986	tumor	C0027651
28424986	rapidly	C0456962
28424986	grown	C2911660
28424986	abnormalities	C1704258
28424986	hematological	C0279810
28424986	coagulative	C0005778
28424986	systems	C0449913
28424986	Preoperative	C0445204
28424986	computed tomography	C0040405
28424986	revealed	C0443289
28424986	right	C0205090
28424986	hepatic vein	C0019155
28424986	right	C0205090
28424986	hepatic artery	C0019145
28424986	right	C0205090
28424986	portal vein	C0032718
28424986	not involved	C4296884
28424986	hemangioma	C0018916
28424986	Resection	C0728940
28424986	giant liver hemangioma	C0238246
28424986	successfully	C1272703
28424986	performed	C0884358
28424986	intraoperative	C0456904
28424986	intentional	C1283828
28424986	bloodletting	C0005857
28424986	concurrent	C0205420
28424986	blood salvage	C0200591
28424986	hematological	C0279810
28424986	coagulative	C0005778
28424986	abnormalities	C1704258
28424986	returned	C0332156
28424986	normal	C0205307
28424986	procedure	C0087111
28425861	Role	C1705810
28425861	cysteine	C0010654
28425861	residues	C1709915
28425861	regulation	C0518894
28425861	peptidyl-prolyl cis-trans isomerase activity	C1150301
28425861	wheat	C0043137
28425861	cyclophilin	C0917877
28425861	TaCYPA-1	C1418793
28425861	Oxidative	C0311404
28425861	conditions	C0348080
28425861	inhibition	C3463820
28425861	peptidyl-prolyl cis-trans isomerase (PPIase) activity	C1150301
28425861	cyclophilins	C0917877
28425861	Thiol	C0038734
28425861	redox	C0030012
28425861	regulation	C0518894
28425861	proteins	C0033684
28425861	activity	C0243102
28425861	wheat	C0043137
28425861	cyclophilin	C0917877
28425861	TaCYPA-1	C1418793
28425861	modulated	C0443264
28425861	mechanism	C0441712
28425861	redox	C0030012
28425861	regulation	C0518894
28425861	regulation	C0518894
28425861	PPIase activity	C1150301
28425861	TaCYPA-1	C1418793
28425861	mutants	C0596988
28425861	TaCYPA-1	C1418793
28425861	substituting	C1706204
28425861	cysteine	C0010654
28425861	residues	C1709915
28425861	positions	C0733755
28425861	serine	C0036720
28425861	proline	C0033382
28425861	Comparative analysis	C0683941
28425861	PPIase activity	C1150301
28425861	catalytic	C0007382
28425861	efficiencies	C0013682
28425861	TaCYPA-1C40S	C0136073
28425861	TaCYPA-1C122S	C0136073
28425861	significantly lower	C4055638
28425861	TaCYPA-1	C0136073
28425861	mutant	C0596988
28425861	TaCYPA-1C40S/C122S	C0136073
28425861	significantly higher	C4055637
28425861	wild-type	C1883559
28425861	TaCYPA-1	C1418793
28425861	mutants	C0596988
28425861	differential	C0443199
28425861	sensitivity	C0332324
28425861	Cu2+	C1177210
28425861	results	C1274040
28425861	study	C2603343
28425861	revealed	C0443289
28425861	lacking	C0332268
28425861	PPIase activity	C1150301
28425861	mutant	C0596988
28425861	TaCYPA-1C126P	C1418793
28425861	partial	C0728938
28425861	protection	C1545588
28425861	heat stress	C0282498
28425861	observations	C0302523
28425861	mechanism	C0441712
28425861	TaCYPA-1	C1418793
28425861	thermotolerance	C3544386
28425861	activities	C0441655
28425861	cis to trans isomerisation	C0596342
28425861	identified	C0205396
28427273	Association	C0439849
28427273	Exclusive Breastfeeding	C0242205
28427273	Duration	C0449238
28427273	Systemic Inflammation	C3646020
28427273	Markers	C0005516
28427273	Adolescents	C0205653
28427273	Cross-Sectional Study	C0010362
28427273	Breastfeeding duration	C2136514
28427273	associated with	C0332281
28427273	less	C0439092
28427273	low-grade	C1282907
28427273	inflammation	C0021368
28427273	healthy	C3898900
28427273	adolescents	C0205653
28427273	scarce	C0231180
28427273	information	C1533716
28427273	obese	C0028754
28427273	exclusive breastfeeding	C0242205
28427273	serum concentrations	C0683149
28427273	inflammatory	C0333348
28427273	markers	C0005516
28427273	population	C1257890
28427273	Spanish	C0086409
28427273	adolescents	C0205653
28427273	cross-sectional study	C0010362
28427273	performed	C0884358
28427273	adolescents	C0205653
28427273	schools	C0036375
28427273	southeast	C1711190
28427273	Spain	C0037747
28427273	Data	C1511726
28427273	breastfeeding duration	C2136514
28427273	collected	C1516698
28427273	parental questionnaire	C0034394
28427273	Interleukin-6	C0021760
28427273	IL-6	C0021760
28427273	tumor necrosis factor-alpha	C1456820
28427273	TNF-α	C1456820
28427273	determined by	C0521095
28427273	enzyme-linked immunosorbent assay	C0014441
28427273	C-reactive protein	C0006560
28427273	CRP	C0006560
28427273	determined by	C0521095
28427273	solid-phase chemiluminescent immunometric assay	C0020980
28427273	multivariate	C0026777
28427273	correlation analyses	C0010101
28427273	confirmed	C1456348
28427273	strong	C0442821
28427273	association	C0439849
28427273	confidence interval	C0009667
28427273	markers	C0005516
28427273	inflammation	C0021368
28427273	exclusive breastfeeding	C0242205
28427273	duration	C0449238
28427273	No significant	C1273937
28427273	differences	C1705242
28427273	observed	C1441672
28427273	IL-6	C0021760
28427273	TNF-α	C1456820
28427273	CRP	C0006560
28427273	serum concentrations	C0683149
28427273	normal weight	C1285592
28427273	overweight	C0497406
28427273	obese	C0028754
28427273	adolescents	C0205653
28427273	except for	C0332300
28427273	IL-6	C0021760
28427273	normal weight	C1285592
28427273	obese	C0028754
28427273	subjects	C0205653
28427273	no significant	C1273937
28427273	association	C0439849
28427273	found	C0150312
28427273	markers	C0005516
28427273	inflammation	C0021368
28427273	body mass index	C1305855
28427273	BMI	C1305855
28427273	z-score	C0871421
28427273	found	C0150312
28427273	possible	C0332149
28427273	association	C0439849
28427273	inflammatory	C0333348
28427273	markers	C0005516
28427273	exclusive breastfeeding	C0242205
28427273	duration	C0449238
28427273	adolescents	C0205653
28427273	regardless	C3641650
28427273	BMI	C1305855
28427273	finding	C0243095
28427273	suggests	C1705535
28427273	increased	C0205217
28427273	body weight	C0005910
28427273	obesity	C0028754
28427273	association	C0439849
28427273	breastfeeding	C0006147
28427273	inflammation	C0021368
28427273	results	C1274040
28427273	understanding	C0162340
28427273	relationship	C0439849
28427273	breastfeeding	C0006147
28427273	inflammatory	C0333348
28427273	markers	C0005516
28427273	adolescents	C0205653
28427655	Effect	C1280500
28427655	ultrasound	C1456803
28427655	enzymatic	C0014442
28427655	pre-treatment	C3539076
28427655	yield	C0392762
28427655	properties	C0871161
28427655	banana	C0004722
28427655	juice	C1268568
28427655	Effect	C1280500
28427655	ultrasound	C1456803
28427655	enzymatic	C0014442
28427655	pre-treatments	C3539076
28427655	cellulase	C0007641
28427655	pectinase	C0032491
28427655	yield	C0392762
28427655	properties	C0871161
28427655	banana	C0004722
28427655	juice	C1268568
28427655	investigated	C1292732
28427655	two-level full factorial design	C0681865
28427655	ultrasonication time	C0040223
28427655	min	C0439232
28427655	cellulase	C0007641
28427655	concentration	C0392762
28427655	pectinase	C0032491
28427655	concentration	C0392762
28427655	yield	C0392762
28427655	viscosity	C0042784
28427655	clarity	C3272888
28427655	total soluble solids	C0392762
28427655	TSS	C0392762
28427655	pH	C0020283
28427655	pectinase	C0032491
28427655	effective	C1704419
28427655	increasing	C0442808
28427655	yield	C0392762
28427655	juice	C1268568
28427655	cellulase	C0007641
28427655	Ultrasonic pre-treatment	C3539076
28427655	not	C1513916
28427655	significantly increase	C0442805
28427655	yield	C0392762
28427655	juice	C1268568
28427655	ultrasound	C1456803
28427655	pre-treatment	C3539076
28427655	enzymes	C0014442
28427655	maximum yield	C0392762
28427655	control	C0009932
28427655	viscosity	C0042784
28427655	juice	C1268568
28427655	decreased	C0205216
28427655	enzymes	C0014442
28427655	ultrasound	C1456803
28427655	clarity	C2963144
28427655	juice	C1268568
28427655	cellulase	C0007641
28427655	treatment	C1522326
28427655	improved	C0184511
28427655	pectinase	C0032491
28427655	treatment	C1522326
28427655	Ultrasonication	C1456803
28427655	effective	C1704419
28427655	pectinase	C0032491
28427655	cellulase	C0007641
28427655	treatment	C1522326
28427655	improving	C1272745
28427655	clarity	C0486588
28427655	juice	C1268568
28427655	TSS	C0392762
28427655	increased	C0205217
28427655	enzymatic	C0014442
28427655	treatment	C1522326
28427655	ultrasonication	C1456803
28427655	pH	C0020283
28427655	treatment	C1522326
28427655	treated	C1522326
28427655	juices	C1268568
28427655	Significant correlations	C1707520
28429500	Electrocardiographic appearance	C0428946
28429500	aortic stenosis	C0003507
28429500	aortic valve replacement	C0003506
28429500	QRS complex	C0429097
28429500	ST-segment	C0429029
28429500	T wave	C0239242
28429500	observed	C1441672
28429500	aortic stenosis	C0003507
28429500	AS	C0003507
28429500	S-wave	C0429094
28429500	dynamic	C0729333
28429500	change	C0392747
28429500	leads V1	C0441907
28429500	V3	C0449218
28429500	AS	C0003507
28429500	prospective study	C0033522
28429500	patients	C0030705
28429500	surgical	C0543467
28429500	aortic valve replacement	C0003506
28429500	AVR	C0003506
28429500	patients	C0030705
28429500	symptomatic	C0231220
28429500	asymptomatic	C0231221
28429500	AS	C0003507
28429500	hemodynamic stability	C0489528
28429500	EFLV	C0428772
28429500	AVA	C0428817
28429500	PG	C0232117
28429500	mm Hg	C0439475
28429500	mm Hg	C0439475
28429500	end-diastolic LV dimension	C2059470
28429500	evaluated	C0220825
28429500	impact	C4049986
28429500	S-wave	C0429094
28429500	magnitude	C1704240
28429500	right precordial	C2729494
28429500	AVR	C0003506
28429500	patients	C0030705
28429500	S-wave	C0429094
28429500	changes	C0392747
28429500	electrocardiogram	C0013798
28429500	hemodynamic measurements	C0204901
28429500	echocardiography	C0013516
28429500	Analysis	C0936012
28429500	echocardiographic	C0013516
28429500	parameters	C0449381
28429500	measured	C0444706
28429500	patients	C0030705
28429500	surgery	C0543467
28429500	statistical significance	C0237881
28429500	asymptomatic	C0231221
28429500	symptomatic	C0231220
28429500	statistical significance	C0237881
28429500	observed	C1441672
28429500	change	C0392747
28429500	S-wave	C0429094
28429500	magnitude	C1704240
28429500	right precordial	C2729494
28429500	patients	C0030705
28429500	AVR	C0003506
28429500	statistically significant	C0237881
28429500	predictive value	C1514307
28429500	S-wave	C0429094
28429500	magnitude	C1704240
28429500	leads V2	C0441908
28429500	V3	C0449218
28429500	dependent variables	C0871711
28429500	PG	C0232117
28429500	end-diastolic LV dimension	C2059470
28429500	S-wave	C0429094
28429500	right precordial	C2729494
28429500	increase	C0442805
28429500	PG	C0232117
28429500	AVA	C0428817
28429500	suggestive of	C0332299
28429500	referral for	C2585524
28429500	AVR	C0003506
28433448	Anemia	C0002871
28433448	complicating	C1522701
28433448	type 2 diabetes	C0011860
28433448	Prevalence	C0220900
28433448	risk factors	C0035648
28433448	prognosis	C0033325
28433448	prevalence	C0220900
28433448	risk factors	C0035648
28433448	prognosis	C0033325
28433448	anemia	C0002871
28433448	representative	C0030701
28433448	patients	C0030705
28433448	type 2 diabetes	C0011860
28433448	Fremantle Diabetes Study Phase II	C2603343
28433448	FDS2	C2603343
28433448	males	C0086582
28433448	Busselton Diabetes Study	C2603343
28433448	BDS	C2603343
28433448	males	C0086582
28433448	cohorts	C0599755
28433448	BDS	C2603343
28433448	participants	C0679646
28433448	diabetes	C0011847
28433448	analyzed	C0936012
28433448	prevalence	C0220900
28433448	anemia	C0002871
28433448	hemoglobin	C0019046
28433448	males	C0086582
28433448	females	C0086287
28433448	determined	C0521095
28433448	sample	C0178913
28433448	FDS2	C2603343
28433448	anemia	C0002871
28433448	assessed	C1516048
28433448	logistic regression	C0206031
28433448	Cox proportional hazards modeling	C0010235
28433448	predictors	C0035648
28433448	death	C0011065
28433448	prevalence	C0220900
28433448	anemia	C0002871
28433448	FDS2	C2603343
28433448	participants	C0679646
28433448	BDS	C2603343
28433448	patients	C0030705
28433448	BDS	C2603343
28433448	participants	C0679646
28433448	diabetes	C0011847
28433448	FDS2	C2603343
28433448	patients	C0030705
28433448	anemia	C0002871
28433448	risk factor	C0035648
28433448	serum vitamin B12	C0427408
28433448	serum ferritin	C0241012
28433448	transferrin saturation	C1277709
28433448	serum testosterone	C0428413
28433448	males	C0086582
28433448	glitazone	C1257987
28433448	therapy	C0087111
28433448	estimated glomerular filtration rate	C3811844
28433448	eGFR	C3811844
28433448	malignancy	C4282132
28433448	hemoglobinopathy	C0019045
28433448	anemic	C0857322
28433448	non-anemic	C0857322
28433448	FDS2	C2603343
28433448	patients	C0030705
28433448	predictors	C0035648
28433448	Aboriginality	C1704258
28433448	marital status	C0024819
28433448	smoking	C0037369
28433448	eGFR	C3811844
28433448	anemia	C0002871
28433448	associated with	C0332281
28433448	increase	C0442805
28433448	Type 2 diabetes	C0011860
28433448	anemia	C0002871
28433448	risk factors	C0035648
28433448	present	C0150312
28433448	Anemia	C0002871
28433448	associated with	C0332281
28433448	increased risk of death	C2749787
28433448	predictors	C0035648
28433910	Succinic acid	C0075429
28433910	production	C1883254
28433910	immobilized	C0282542
28433910	cultures	C0007585
28433910	spent sulphite liquor	C0302908
28433910	fermentation	C0015852
28433910	medium	C1705217
28433910	Spent sulphite liquor	C0010454
28433910	SSL	C0010454
28433910	carbon	C0007009
28433910	source	C0449416
28433910	production	C1883254
28433910	succinic acid	C0075429
28433910	immobilized	C0282542
28433910	cultures	C0007585
28433910	Actinobacillus succinogenes	C1026661
28433910	Basfia succiniciproducens	C3716734
28433910	supports	C0439861
28433910	delignified cellulosic material	C3256315
28433910	DCM	C3256315
28433910	alginate	C0102137
28433910	beads	C0439861
28433910	Fed-batch immobilized cultures	C3179109
28433910	A. succinogenes	C1026661
28433910	alginates	C0102137
28433910	higher	C0205250
28433910	sugar	C0242209
28433910	succinic acid	C0075429
28433910	conversion yield	C0392762
28433910	yield	C0392762
28433910	DCM	C3256315
28433910	immobilized	C0282542
28433910	cultures	C0007585
28433910	succinic acid	C0075429
28433910	concentration	C1446561
28433910	yield	C0392762
28433910	fed-batch	C3179109
28433910	immobilized	C0282542
28433910	cultures	C0007585
28433910	B. succiniciproducens	C3716734
28433910	alginates	C0102137
28433910	higher	C0205250
28433910	A. succinogenes	C1026661
28433910	immobilized	C0282542
28433910	cultures	C0007585
28433910	nano	C1553036
28433910	filtrated SSL	C0302908
28433910	fermentation	C0015852
28433910	medium	C1705217
28433910	Immobilized	C0282542
28433910	cultures	C0007585
28433910	B. succiniciproducens	C3716734
28433910	alginate	C0102137
28433910	beads	C0439861
28433910	sequential fed-batch	C3179109
28433910	fermentations	C0015852
28433910	nano	C1553036
28433910	filtrated SSL	C0010454
28433910	production	C1883254
28433910	succinic acid	C0075429
28433910	yield	C0392762
28433910	productivity	C0033269
28433910	immobilized	C0282542
28433910	cultures	C0007585
28433910	efficiency	C0013682
28433910	succinic acid	C0075429
28433910	production	C1883254
28433910	compared	C1707455
28433910	free cell cultures	C0007585
28436264	Interventions	C1273869
28436264	Improve	C0184511
28436264	Grandparent	C0337471
28436264	Caregivers'	C0086279
28436264	Mental	C0025353
28436264	Physical Health	C0517226
28436264	Integrative Review	C0282443
28436264	aim	C1947946
28436264	integrative review	C0282443
28436264	grandparent	C0337471
28436264	caregiver	C0086279
28436264	interventions	C1273869
28436264	improve	C0184511
28436264	physical	C0517226
28436264	mental health	C0025353
28436264	database	C0242356
28436264	search	C1706202
28436264	relevant	C2347946
28436264	studies	C2603343
28436264	published	C0034037
28436264	publications	C0034036
28436264	studies	C2603343
28436264	inclusion	C1512693
28436264	exclusion criteria	C0680251
28436264	studies	C2603343
28436264	grandparent	C0337471
28436264	mental health	C0025353
28436264	outcomes	C1274040
28436264	physical health	C0517226
28436264	social relations	C0337609
28436264	Improvements	C2986411
28436264	areas	C0205146
28436264	improvements	C2986411
28436264	physical health	C0517226
28436264	small effect sizes	C0814843
28436264	measures	C1879489
28436264	outcomes	C1274040
28436264	interventions	C1273869
28436264	grandparent	C0337471
28436264	caregiver	C0086279
28436264	studies	C2603343
28436264	limited	C0439801
28436264	design	C1707689
28436264	randomized controlled trial	C0206035
28436264	interventions	C1273869
28436264	variations	C0205419
28436264	grandchild's	C0337548
28436264	parent's	C0030551
28436264	ages	C0001779
28436264	grandparent	C0337471
28436264	primary	C0205225
28436264	shared	C0237876
28436264	care	C1947933
28436264	future	C0016884
28436264	research	C0035168
28436493	attenuated	C0599946
28436493	Mycobacterium tuberculosis	C0026926
28436493	clinical	C0205210
28436493	strain	C1518614
28436493	defect	C1457869
28436493	ESX-1	C1744314
28436493	secretion	C0036536
28436493	minimal	C0547040
28436493	host	C1167395
28436493	immune responses	C0301872
28436493	pathology	C0030664
28436493	Mycobacterium tuberculosis (M.tb) DK9897	C0026926
28436493	attenuated	C0599946
28436493	strain	C1518614
28436493	isolated	C0205409
28436493	patient	C0030705
28436493	extrapulmonary tuberculosis	C0679362
28436493	vaccination	C0042196
28436493	subunit vaccine	C0887892
28436493	H56	C0887892
28436493	induced	C0205263
28436493	poor	C0542537
28436493	protection	C1545588
28436493	attenuation	C0599946
28436493	lack	C0332268
28436493	protection	C1545588
28436493	M.tb DK9897	C0026926
28436493	secrete	C0036536
28436493	EsxA	C1744314
28436493	virulence factor	C1136170
28436493	host response	C0301872
28436493	Genome sequencing	C1328887
28436493	frameshift mutation	C0079380
28436493	eccCa1 gene	C0017337
28436493	encoded	C2700640
28436493	EccCa1 protein	C1254349
28436493	energy	C1442080
28436493	ESX-1	C1744314
28436493	secretion	C0036536
28436493	defect	C1457869
28436493	ESX-1	C1744314
28436493	type VII secretion system	C3159197
28436493	Genetic complementation	C0178654
28436493	plasmid	C0032136
28436493	M.tb H37Rv	C0026926
28436493	eccCa1-eccCb1-pe35	C0012931
28436493	EsxA	C1744314
28436493	secretion	C0036536
28436493	host	C1167395
28436493	EsxA	C1744314
28436493	T-cell	C0039194
28436493	responses	C0301872
28436493	increased	C0205217
28436493	strain	C1518614
28436493	virulence	C0042765
28436493	ESX-1	C1744314
28436493	secretion	C0036536
28436493	defect	C1457869
28436493	prevents	C1292733
28436493	virulence factors	C1136170
28436493	infection	C3714514
28436493	attenuates	C0599946
28436493	M.tb	C0026926
28436493	T-cell	C0039194
28436493	responses	C0301872
28436493	antigens	C0003320
28436493	in vivo	C1515655
28436493	cytokine production	C1327413
28436493	gross pathology	C0428094
28436493	granuloma formation	C1817882
28436493	lungs	C0024109
28436493	M.tb DK9897	C0026926
28436493	infected animals	C0237158
28436493	M.tb DK9897	C0026926
28436493	phagosome membrane	C1166752
28436493	cytosol	C1383501
28436593	Results	C0683954
28436593	patients	C0030705
28436593	sarcoma	C1261473
28436593	not otherwise specified	C1518425
28436593	diagnoses	C0011900
28436593	Ewing sarcoma	C0553580
28436593	treated	C0332154
28436593	Euro-EWING 99 trial	C0008976
28436593	Euro-EWING 99 trial	C0008976
28436593	European	C1535514
28436593	Ewing tumor	C0553580
28436593	Working	C0043227
28436593	Initiative	C1287154
28436593	National	C0015737
28436593	Groups	C0441833
28436593	EE99	C1507394
28436593	international	C1512888
28436593	phase III study	C0282461
28436593	patients	C0030705
28436593	Ewing sarcoma	C0553580
28436593	German Society of Pediatric Oncology and Hematology (GPOH) data center	C1708333
28436593	registered	C1514821
28436593	patients	C0030705
28436593	diagnoses	C0011900
28436593	Ewing sarcoma	C0553580
28436593	treated	C0332154
28436593	EE99 protocol	C1507394
28436593	non-Ewing database	C0242356
28436593	Data	C1511726
28436593	patients	C0030705
28436593	diagnoses	C0011900
28436593	Ewing sarcoma	C0553580
28436593	treated	C0332154
28436593	EE99 protocol	C1507394
28436593	analyzed	C0936012
28436593	Patients	C0030705
28436593	miscellaneous	C0205395
28436593	histologic	C0205462
28436593	diagnoses	C0011900
28436593	majority	C0205393
28436593	diagnosed	C0011900
28436593	sarcoma	C1261473
28436593	not otherwise specified	C1518425
28436593	NOS	C1518425
28436593	bone	C0391978
28436593	soft tissue	C0225317
28436593	median	C0876920
28436593	age	C0001779
28436593	diagnosis	C0011900
28436593	Localized disease	C0277565
28436593	diagnosed	C0011900
28436593	patients	C0030705
28436593	distant metastases	C0027627
28436593	primary	C0205225
28436593	diagnosis	C0011900
28436593	median	C0876920
28436593	follow-up	C1522577
28436593	time	C0040223
28436593	Patients	C0030705
28436593	localized disease	C0277565
28436593	event-free survival	C0242793
28436593	EFS	C0242793
28436593	EFS	C0242793
28436593	patients	C0030705
28436593	metastases	C0027627
28436593	EFS	C0242793
28436593	patients	C0030705
28436593	sarcoma	C1261473
28436593	NOS	C1518425
28436593	patients	C0030705
28436593	localized	C0277565
28436593	metastatic disease	C0027627
28436593	EFS	C0242793
28436593	EFS	C0242793
28436593	patients	C0030705
28436593	diagnoses	C0011900
28436593	Ewing sarcoma	C0553580
28436593	treated	C0332154
28436593	EE99	C1507394
28436593	significantly	C0750502
28436593	patients	C0030705
28436593	localized	C0277565
28436593	metastatic disease	C0027627
28436593	Sarcomas	C1261473
28436593	soft tissue	C0225317
28436593	bone	C0391978
28436593	classified	C0008902
28436593	current	C0521116
28436593	diagnostic categories	C1550395
28436593	therapeutic	C0302350
28436593	challenge	C0805586
28437231	Capsular Polysaccharide	C0032595
28437231	Types	C0332307
28437231	Virulence-Related	C0042765
28437231	Traits	C0599883
28437231	Epidemic	C0014499
28437231	KPC	C1855645
28437231	Producing	C0678227
28437231	Klebsiella pneumoniae	C0001699
28437231	Isolates	C1764827
28437231	Chinese	C0008115
28437231	University Hospital	C0020028
28437231	Klebsiella pneumoniae	C0001699
28437231	important	C3898777
28437231	human	C0086418
28437231	pathogen	C0450254
28437231	associated with	C0332281
28437231	variety	C2346866
28437231	diseases	C0012634
28437231	prevalence	C0220900
28437231	blaKPC	C0017337
28437231	K. pneumoniae	C0001699
28437231	KPC-Kp	C0001699
28437231	rapidly increasing	C0442808
28437231	Capsule	C0085229
28437231	important	C3898777
28437231	virulence factor	C1136170
28437231	K. pneumoniae	C0001699
28437231	study	C2603343
28437231	systematically	C0220922
28437231	characterize	C1880022
28437231	capsular polysaccharide	C0032595
28437231	CPS	C0032595
28437231	virulence	C0042765
28437231	traits	C0599883
28437231	KPC-Kp	C0001699
28437231	strains	C1518614
28437231	KPC-Kp	C0001699
28437231	isolates	C1764827
28437231	recovered	C0521108
28437231	clinical samples	C0370003
28437231	Chinese hospital	C0020028
28437231	assigned	C1516050
28437231	clonal lineages	C0282637
28437231	multilocus sequence typing	C2936544
28437231	MLST	C2936544
28437231	Capsule	C0085229
28437231	typing	C0441704
28437231	wzi sequencing	C1294197
28437231	wzc polymerase chain reaction	C0032520
28437231	PCR	C0032520
28437231	virulence	C0042765
28437231	genes	C0017337
28437231	characterized	C1880022
28437231	molecular approaches	C0200924
28437231	virulence	C0042765
28437231	strains	C1518614
28437231	biofilm formation	C1325881
28437231	serum	C0229671
28437231	killing	C0599733
28437231	resistance	C4281815
28437231	phagocytosis	C0031308
28437231	infection	C3714514
28437231	models	C3161035
28437231	STs	C2359784
28437231	found	C0150312
28437231	KPC-Kp	C0001699
28437231	isolates	C1764827
28437231	isolates	C1764827
28437231	ST11	C2359784
28437231	6	C2359784
28437231	isolates	C1764827
28437231	ST147	C2359784
28437231	isolates	C1764827
28437231	ST15	C2359784
28437231	ST1456	C2359784
28437231	ST65	C2359784
28437231	ST23	C2359784
28437231	wzi gene DNA sequences	C3708993
28437231	wzc PCR	C0032520
28437231	strains	C1518614
28437231	capsular	C0085229
28437231	type	C0332307
28437231	wzi47-K47	C0085229
28437231	wzi64-K64	C0085229
28437231	wzi8-K8	C0085229
28437231	wzi37-K37	C0085229
28437231	wzi53-K53	C0085229
28437231	wzi125-K2	C0085229
28437231	wzi1-K1	C0085229
28437231	Heterogeneity	C0242960
28437231	detected	C0442726
28437231	biofilm formation	C1325881
28437231	phagocytosis	C0031308
28437231	CPS	C0032595
28437231	types	C0332307
28437231	ST11	C2359784
28437231	strains	C1518614
28437231	virulent	C1520022
28437231	ST	C2359784
28437231	strains	C1518614
28437231	KPC-Kp	C0001699
28437231	strains	C1518614
28437231	variability	C2827666
28437231	virulence-associated	C0042765
28437231	traits	C0599883
28437231	ST	C2359784
28437231	types	C0332307
28437231	CPS	C0032595
28437254	Interaction-driven	C1704675
28437254	electronic states	C0449830
28437254	artificial atoms	C0567415
28437254	ZnO	C0043491
28437254	interface	C0205556
28437254	investigated	C1292732
28437254	electronic states	C0449830
28437254	planar quantum dots	C1258084
28437254	ZnO	C0043491
28437254	interface	C0205556
28437254	interacting	C1704675
28437254	electrons	C0013852
28437254	externally applied	C4048755
28437254	magnetic field	C0563533
28437254	electron-electron	C0013852
28437254	interaction	C1704675
28437254	effects	C1280500
28437254	much stronger	C0442821
28437254	case	C0868928
28437254	traditional semiconductor quantum systems	C0449913
28437254	GaAs	C0061005
28437254	InAs	C0172463
28437254	quantum dots	C1258084
28437254	stronger	C0442821
28437254	Coulomb effects	C1280500
28437254	ZnO	C0043491
28437254	quantum dots	C1258084
28437254	compared	C1707455
28437254	energy spectra	C1254366
28437254	magnetization	C0563532
28437254	system	C0449913
28437254	InAs	C0172463
28437254	quantum dots	C1258084
28437254	ZnO	C0043491
28437254	quantum dots	C1258084
28437254	stronger	C0442821
28437254	Coulomb interaction	C1704675
28437254	manifests	C0205319
28437254	unique	C1710548
28437254	ground state	C0449830
28437254	different	C1705242
28437254	properties	C1882134
28437254	InAs	C0172463
28437254	dot	C1258084
28437254	results	C1274040
28437254	magnetization	C0563532
28437254	exhibits behaviors	C0205556
28437254	never	C2003901
28437254	before	C0332152
28437254	observed	C1441672
28437254	quantum dot	C1258084
28437254	realistic set of parameters	C0392762
28437254	stronger	C0442821
28437254	temperature	C0039476
28437254	dependence	C0851827
28437254	unexpected features	C2348519
28437254	paramagnetic-like behavior	C1254365
28437254	high temperatures	C0039476
28437254	quantum-dot	C1258084
28437254	helium	C0018880
28438037	Evaluation	C0220825
28438037	Tobacco Control Policies	C0680803
28438037	San Francisco	C0036152
28438037	Homeless	C0019863
28438037	Housing Programs	C0687761
28438037	Surgeon General's Report	C0684224
28438037	noted	C4288581
28438037	high	C0205250
28438037	smoking rates	C1822491
28438037	vulnerable populations	C0949366
28438037	homeless	C0019863
28438037	persistent	C0205322
28438037	public	C0678367
28438037	health problem	C1398682
28438037	smoking	C0037369
28438037	prevalence	C0683919
28438037	individuals	C0237401
28438037	experiencing	C0683573
28438037	homelessness	C0237154
28438037	service providers	C0679886
28438037	homeless	C0019863
28438037	comprehensive	C1880156
28438037	tobacco control policies	C0680803
28438037	conducted	C1300196
28438037	qualitative study	C0949415
28438037	homeless	C0019863
28438037	housing programs	C0687761
28438037	San Francisco	C0036152
28438037	Administrators	C0085751
28438037	representing	C1882932
28438037	homeless service agencies	C0586395
28438037	interviewed	C0021822
28438037	assess	C0184514
28438037	institutional	C0015003
28438037	smoking	C0037369
28438037	policies	C0242456
28438037	cessation	C0085134
28438037	programs	C3484370
28438037	perceived	C0030971
28438037	barriers	C0679881
28438037	receptivity	C0205342
28438037	instituting	C1272753
28438037	tobacco	C0040329
28438037	control	C2587213
28438037	interventions	C0184661
28438037	Respondents	C0282122
28438037	indicated	C1444656
28438037	programs	C3484370
28438037	adopted	C1272684
28438037	smoke	C0037366
28438037	free	C0332296
28438037	grounds	C1254362
28438037	eliminated	C0849355
28438037	evidence	C3887511
28438037	staff	C0851286
28438037	smoking	C0037369
28438037	smoking	C0037369
28438037	status	C0449438
28438037	clients	C0008942
28438037	assessed	C1516048
28438037	required	C1514873
28438037	programs	C3484370
28438037	offered	C1444648
28438037	smoking cessation	C0085134
28438037	interventions	C0184661
28438037	administrators	C0085751
28438037	receptive	C0205342
28438037	adopting	C1272684
28438037	policies	C0242456
28438037	promote	C0033414
28438037	tobacco	C0040329
28438037	free	C0332296
28438037	culture	C0037455
28438037	noted	C4288581
28438037	clients	C0008942
28438037	unique	C1710548
28438037	challenges	C0805586
28438037	traditional	C0443324
28438037	smoking cessation	C0085134
28438037	programs	C3484370
28438037	Homeless	C0019863
28438037	housing programs	C0687761
28438037	San Francisco	C0036152
28438037	adopted	C1272684
28438037	tobacco	C0040329
28438037	free	C0332296
28438037	culture	C0037455
28438037	Existing	C2987476
28438037	policies	C0242456
28438037	created	C1706214
28438037	response	C0871261
28438037	external	C0205101
28438037	mandates	C1442085
28438037	smoking cessation	C0085134
28438037	programs	C3484370
28438037	modified	C0392747
28438037	effectively	C1704419
28438037	clients	C0008942
28438542	micromolar	C0439300
28438542	inhibitors	C0014432
28438542	aldose reductase	C0002003
28438542	ALR2	C0002003
28438542	poly (ADP-ribose) polymerase	C0032405
28438542	PARP-1	C0032405
28438542	structure	C0678594
28438542	design	C1707689
28438542	Clinical studies	C0008972
28438542	diabetic retinopathy	C0011884
28438542	disorder	C0012634
28438542	ALR2	C0002003
28438542	PARP-1	C0032405
28438542	retinal	C0035298
28438542	cells	C0007634
28438542	targets	C1521840
28438542	treatment	C0087111
28438542	diabetic retinopathy	C0011884
28438542	inhibitors	C0014432
28438542	ALR2	C0002003
28438542	PARP-1	C0032405
28438542	structure	C0678594
28438542	design	C1707689
28438542	target	C1521840
28438542	proteins	C0033684
28438542	thiazolidine-2,4-dione	C1568506
28438542	TZD	C1568506
28438542	derivatives	C1527240
28438542	designed	C1707689
28438542	synthesized	C1883254
28438542	in vitro	C1533691
28438542	inhibitory activities	C1152555
28438542	ALR2	C0002003
28438542	PARP-1	C0032405
28438542	experimental results	C2825142
28438542	compounds 5b	C1254351
28438542	5f	C1254351
28438542	biochemical	C0205474
28438542	activities	C0441655
28438542	micromolar	C0439300
28438542	submicromolar	C0439300
28438542	range	C1514721
28438542	IC50	C0600495
28438542	targeted	C1521840
28438542	enzymes	C0014442
28438542	structure-activity relationship	C0038477
28438542	inhibitors	C0014432
28438542	enzymes	C0014442
28438542	binding	C1167622
28438542	mode	C1513371
28438542	inhibitors	C0014432
28438542	active sites	C0205681
28438542	enzymes	C0014442
28438542	positive	C1446409
28438542	results	C0683954
28438542	biochemical	C0205474
28438542	assay	C0005507
28438542	compounds	C1254351
28438542	optimized	C2698650
28438542	utilized	C0042153
28438542	treatment	C0087111
28438542	diabetic retinopathy	C0011884
28440108	Microbiology	C0085672
28440108	Upper	C0225377
28440108	Lower Airways	C0231989
28440108	Pediatric	C1521725
28440108	Cystic Fibrosis	C0010674
28440108	Patients	C0030705
28440108	pediatric	C1521725
28440108	cystic fibrosis	C0010674
28440108	CF	C0010674
28440108	patients	C0030705
28440108	sinus surgery	C0748725
28440108	Retrospective	C0035363
28440108	Tertiary care	C0337954
28440108	children's hospital	C0020017
28440108	sinus	C2237356
28440108	pulmonary cultures	C2020984
28440108	CF	C0010674
28440108	patients	C0030705
28440108	Demographics	C0011289
28440108	culture	C0430400
28440108	results	C1274040
28440108	analyzed	C0681874
28440108	Results	C1274040
28440108	patients	C0030705
28440108	female	C0043210
28440108	Methicillin	C0025643
28440108	sensitive	C0332324
28440108	Staphylococcus aureus	C0038172
28440108	pathogen	C4267729
28440108	prevalence	C0683921
28440108	Pseudomonas aeruginosa	C0033809
28440108	pulmonary	C2020984
28440108	sinus cultures	C2237356
28440108	older	C1999167
28440108	patients	C0030705
28440108	younger	C0238598
28440108	patients	C0030705
28440108	P	C0033105
28440108	moderate	C1881878
28440108	agreement	C1707520
28440108	sinus	C2237356
28440108	pulmonary cultures	C2020984
28440108	Kappa	C0439099
28440108	statistic range	C0220900
28440108	prevalence	C0220900
28440108	methicillin-resistant S aureus	C1265292
28440108	MRSA	C1265292
28440108	significantly	C0237881
28440108	lower respiratory tract culture	C2199769
28440108	sinus culture	C2237356
28440108	P	C0033105
28440108	P	C0033105
28440108	prevalence	C0220900
28440108	positive	C1514241
28440108	sinus cultures	C2237356
28440108	P	C0033105
28440108	Patients	C0030705
28440108	pulmonary	C2709248
28440108	MRSA	C1265292
28440108	coinfected	C0275524
28440108	pulmonary	C2709248
28440108	P aeruginosa	C0033809
28440108	risk ratio	C0242492
28440108	CI	C0009667
28440108	Aspergillus fumigatus	C0004037
28440108	risk ratio	C0242492
28440108	CI	C0009667
28440108	moderate	C1881878
28440108	correlation	C1707520
28440108	pulmonary	C2709248
28440108	sinus	C0030471
28440108	pathogens	C4267729
28440108	CF	C0010674
28440108	patients	C0030705
28440108	treating	C0087111
28440108	infections	C3714514
28440108	prevalence	C0220900
28440108	MRSA	C1265292
28440108	sinus cultures	C2237356
28440108	investigation	C0220825
28440461	miR-451	C2603907
28440461	proliferation	C1514485
28440461	migration	C1533574
28440461	malignant glioma	C0555198
28440461	cells	C0007634
28440461	AMPK	C0252214
28440461	signaling	C3537152
28440461	mTOR	C1307407
28440461	modulation	C0443264
28440461	Rac1	C0139880
28440461	activation	C0599177
28440461	Glioblastoma multiforme	C1621958
28440461	GBM	C1621958
28440461	WHO grade IV astrocytoma	C0017636
28440461	primary neoplasm	C0677930
28440461	central nervous system	C3714787
28440461	CNS	C3714787
28440461	malignancy	C4282132
28440461	mortality rates	C0205848
28440461	invasive nature	C0205281
28440461	GBM	C1621958
28440461	surgical resection	C0728940
28440461	chemotherapeutic access	C0870057
28440461	patient	C0030705
28440461	prognosis	C0033325
28440461	migration	C1533574
28440461	tumor cells	C0597032
28440461	tumor cell	C0597032
28440461	proliferation	C1514485
28440461	acquisition	C1706701
28440461	migratory	C0232901
28440461	capability	C2698977
28440461	intracellular	C0178719
28440461	factors	C1521761
28440461	crucial mechanism	C0441712
28440461	progression	C0449258
28440461	invasion	C1269955
28440461	qRT-PCR	C1514628
28440461	analysis	C0936012
28440461	expression	C0017262
28440461	miR-451	C1826031
28440461	glioma	C0017638
28440461	tissue	C0040300
28440461	control brain tissue	C0459385
28440461	central	C0205099
28440461	portions	C0449719
28440461	tumor	C0027651
28440461	glioma	C0017638
28440461	cell lines	C0085983
28440461	decreased	C0205216
28440461	miR-451	C1826031
28440461	expression	C0017262
28440461	suppressed	C1260953
28440461	tumor cell	C0597032
28440461	proliferation	C1514485
28440461	migration	C1533574
28440461	concomitant	C0521115
28440461	CAB39	C2715759
28440461	AMPK	C0252214
28440461	mTOR	C1307407
28440461	pathway activation	C1514528
28440461	Rac1	C0139880
28440461	cofilin	C0056080
28440461	pathway activation	C1514528
28440461	miR-451	C2603907
28440461	cytological behavior	C0205471
28440461	activation	C0599177
28440461	mTOR	C1307407
28440461	Rac1	C0139880
28440461	AMPKα1	C1739697
28440461	expression	C1171362
28440461	synthetic	C1883254
28440461	shRNA	C2930586
28440461	glioma	C0017638
28440461	microenvironment	C2936626
28440461	heterogeneity	C0019409
28440461	miR-451	C1826031
28440461	expression	C0017262
28440461	miR-451	C2603907
28440461	upregulating	C0041904
28440461	AMPK	C0252214
28440461	signaling	C3537152
28440461	modulating	C0443264
28440461	activation	C0599177
28440461	mTOR	C1307407
28440461	Rac1	C0139880
28440461	cofilin	C0056080
28440461	glioma	C0017638
28440461	proliferation	C1514485
28440461	migration	C1533574
28440461	therapeutic	C0302350
28440461	suppressing	C1260953
28440461	tumor cell	C0597032
28440461	proliferation	C1514485
28440461	cell	C0007634
28440461	infiltration	C0332448
28441489	Comparison	C1707455
28441489	Gasoline Direct-Injection	C3273359
28441489	GDI	C3273359
28441489	Port Fuel Injection	C3273359
28441489	PFI	C3273359
28441489	Vehicle Emissions	C0004380
28441489	Emission	C0004380
28441489	Certification	C0007836
28441489	Standards	C0038137
28441489	Cold-Start	C0243095
28441489	Organic	C0747055
28441489	Aerosol	C0001712
28441489	Formation	C1522492
28441489	Potential	C3245505
28441489	Potential	C3245505
28441489	Climate	C0008946
28441489	Impacts	C4049986
28441489	increases	C0205217
28441489	Corporate	C0205556
28441489	Average Fuel Economy	C0870462
28441489	standards	C0038137
28441489	widespread	C0205391
28441489	vehicles	C0175845
28441489	gasoline direct-injection	C3273359
28441489	GDI	C3273359
28441489	engines	C3273359
28441489	engine	C3273359
28441489	technologies	C0039421
28441489	emissions	C0004380
28441489	quantify	C1709793
28441489	effects	C1280500
28441489	measured	C0444706
28441489	gas-	C0017110
28441489	particle-phase	C1254350
28441489	emissions	C0004380
28441489	light-duty	C0205556
28441489	gasoline	C0017113
28441489	vehicles	C0175845
28441489	California	C0006754
28441489	tested	C0392366
28441489	chassis	C1707356
28441489	dynamometer	C3273359
28441489	cold-start	C0243095
28441489	GDI	C3273359
28441489	vehicles	C0175845
28441489	GDIs	C3273359
28441489	certified	C0007836
28441489	emissions	C0004380
28441489	standard	C0038137
28441489	superultra-low-emission vehicles	C0008902
28441489	SULEV	C0008902
28441489	quantified	C1709793
28441489	effects of	C1704420
28441489	engine	C3273359
28441489	technology	C0039421
28441489	emission	C0004380
28441489	certification	C0007836
28441489	standards	C0038137
28441489	cold-start	C0243095
28441489	emissions	C0004380
28441489	vehicles	C0175845
28441489	certified	C0007836
28441489	emissions	C0004380
28441489	standard	C0038137
28441489	statistical	C0038215
28441489	difference	C1705241
28441489	gas-phase	C1254350
28441489	pollutant	C0599786
28441489	emissions	C0004380
28441489	PFIs	C3273359
28441489	GDIs	C3273359
28441489	GDIs	C3273359
28441489	average	C1510992
28441489	factor	C1521761
28441489	particulate matter	C1720884
28441489	PM	C1720884
28441489	emissions	C0004380
28441489	PFIs	C3273359
28441489	elemental carbon	C0007009
28441489	EC	C0007009
28441489	emissions	C0004380
28441489	SULEV	C0008902
28441489	certified	C0007836
28441489	GDIs	C3273359
28441489	factor	C1521761
28441489	PM	C1720884
28441489	emissions	C0004380
28441489	GDIs	C3273359
28441489	certified	C0007836
28441489	ultralow-emission vehicles	C0008902
28441489	improvements	C2986411
28441489	engine	C3273359
28441489	design	C1707689
28441489	calibration	C0006751
28441489	Comprehensive	C1880156
28441489	organic	C0747055
28441489	revealed	C0443289
28441489	statistically significant	C0237881
28441489	differences	C1705241
28441489	composition	C0243176
28441489	volatile	C1963547
28441489	organic compounds	C0029224
28441489	emissions	C0004380
28441489	PFI	C3273359
28441489	GDIs	C3273359
28441489	benzene	C0005036
28441489	toluene	C0040383
28441489	ethylbenzene	C0059792
28441489	xylenes	C0043368
28441489	BTEX	C0029224
28441489	organic	C0747055
28441489	aerosol	C0001712
28441489	ozone	C0030106
28441489	formation	C1522492
28441489	potential	C3245505
28441489	exhaust	C0178629
28441489	engine	C3273359
28441489	technology	C0039421
28441489	Cold-start	C0243095
28441489	contributes	C1880177
28441489	larger	C0549177
28441489	fraction of	C1264633
28441489	emissions	C0004380
28441489	vehicles	C0175845
28441489	emission	C0004380
28441489	standards	C0038137
28441489	Organic	C0747055
28441489	gas	C0017110
28441489	emissions	C0004380
28441489	sensitive	C0332324
28441489	cold-start	C0243095
28441489	compared	C1707455
28441489	pollutants	C0599786
28441489	tested	C0392366
28441489	statistically significant	C0237881
28441489	differences	C1705241
28441489	effects of	C1704420
28441489	cold-start	C0243095
28441489	GDIs	C3273359
28441489	PFIs	C3273359
28441489	measured	C0444706
28441489	decrease	C0205216
28441489	CO2	C0007012
28441489	emissions	C0004380
28441489	GDIs	C3273359
28441489	greater	C1704243
28441489	potential	C3245505
28441489	climate	C0008946
28441489	associated with	C0332281
28441489	black carbon	C0007010
28441489	emissions	C0004380
28441489	PFI	C3273359
28441489	GDI	C3273359
28441489	vehicles	C0175845
28441489	reduction	C0392756
28441489	global warming	C0206217
28442401	TRIB3	C1259051
28442401	downregulation	C0013081
28442401	enhances	C2349975
28442401	doxorubicin	C0013089
28442401	induced	C0458082
28442401	cytotoxicity	C0596402
28442401	gastric cancer	C0024623
28442401	cells	C0334227
28442401	TRIB3	C1259051
28442401	pseudokinase	C0033684
28442401	regulate multiple pro-survival pathways	C1327622
28442401	therapeutic	C0087111
28442401	target	C1521840
28442401	treatment	C0920425
28442401	human	C0086418
28442401	tumors	C0027651
28442401	cancer	C0006826
28442401	TRIB3	C1259051
28442401	protein levels	C0428479
28442401	good	C0278250
28442401	poor prognosis	C0278252
28442401	cancer patients	C1516213
28442401	TRIB3	C1259051
28442401	expression	C1171362
28442401	survival	C0007620
28442401	gastric cancer	C0024623
28442401	cells	C0334227
28442401	anticancer drugs	C0003392
28442401	tested	C0039593
28442401	anticancer drug	C0003392
28442401	doxorubicin	C0013089
28442401	induced	C0458082
28442401	cytotoxicity	C0596402
28442401	TRIB3	C1540055
28442401	transcription	C0040649
28442401	apoptotic cell death	C0162638
28442401	TRIB3 siRNA	C1099354
28442401	knockdown	C2350567
28442401	enhance	C2349975
28442401	doxorubicin	C0013089
28442401	induced	C0458082
28442401	apoptosis	C0162638
28442401	gastric cancer	C0024623
28442401	cells	C0334227
28442401	expression	C1171362
28442401	downstream	C0522506
28442401	apoptotic factors	C0763396
28442401	overexpression	C1514559
28442401	TRIB3	C1259051
28442401	protected cells	C0007634
28442401	doxorubicin	C0013089
28442401	induced	C0458082
28442401	apoptosis	C0162638
28442401	downregulation	C0013081
28442401	TRIB3	C1259051
28442401	promote	C0033414
28442401	cell death	C0007587
28442401	enhance	C2349975
28442401	doxorubicin	C0013089
28442401	induced	C0458082
28442401	apoptosis	C0162638
28442401	anti-apoptotic	C2986514
28442401	TRIB3	C1259051
28442401	inductions	C0017391
28442401	MAPKs	C0752312
28442401	doxorubicin	C0013089
28442401	TRIB3	C1259051
28442401	downregulation	C0013081
28442401	TRIB3	C1259051
28442401	overexpression	C1514559
28442401	doxorubicin	C0013089
28442401	induced	C0458082
28442401	MAPK activation	C1155551
28442401	findings	C2825141
28442401	TRIB3	C1259051
28442401	anti-apoptotic	C2986514
28442401	doxorubicin	C0013089
28442401	gastric cancer	C0024623
28442401	cell lines	C0334227
28442401	TRIB3	C1259051
28442401	expression	C1171362
28442401	anticancer drugs	C0003392
28442401	doxorubicin	C0013089
28442401	irinotecan	C0123931
28442401	oxaliplatin	C0069717
28442401	cancer therapy	C0920425
28442859	Digital	C0016129
28442859	Myopericytoma	C1302808
28442859	Case Report	C0007320
28442859	Systematic Literature Review	C1955832
28442859	myopericytoma	C1302808
28442859	MP	C1302808
28442859	perivascular tumor	C1335392
28442859	unknown etiology	C0743626
28442859	potential	C3245505
28442859	mimicry	C0242943
28442859	malignancy	C4282132
28442859	MP tumors	C1302808
28442859	surgeons	C0582175
28442859	differential diagnosis	C0011906
28442859	case report	C0007320
28442859	healthy	C3898900
28442859	right-hand dominant	C0344333
28442859	male	C0025266
28442859	outpatient clinic	C0029916
28442859	painless	C0234226
28442859	swelling	C0038999
28442859	erythema of the pulp of his left index finger	C2071552
28442859	plain film X-ray	C1306645
28442859	near-complete	C0205197
28442859	bony destruction	C3810196
28442859	distal phalanx	C0223821
28442859	Pathological	C0030660
28442859	evaluation	C0220825
28442859	incisional biopsy	C0184922
28442859	benign variant	C0086692
28442859	MP	C1302808
28442859	lesion	C0221198
28442859	excision	C0728940
28442859	tumor	C0027651
28442859	shelling	C1283248
28442859	no evidence of	C0332125
28442859	recurrence	C0034897
28442859	postoperatively	C0032790
28442859	management	C0376636
28442859	outcome	C0085415
28442859	cases	C0085973
28442859	hand and wrist	C0869996
28442859	MP	C1302808
28444830	Gene expression	C0017262
28444830	evidence	C3887511
28444830	EGFR	C0034802
28444830	proximal-distal limb	C0015385
28444830	patterning	C0376678
28444830	myriapod	C0597910
28444830	Evolution	C0015219
28444830	segmented limbs	C0015385
28444830	Arthropoda	C0003903
28444830	head	C0018670
28444830	trunk	C0460005
28444830	appendages	C0598782
28444830	Proximodistal limb	C0015385
28444830	patterning	C0376678
28444830	regulatory networks	C1720950
28444830	vinegar fly	C0598324
28444830	Drosophila melanogaster	C0013139
28444830	insects	C0021585
28444830	morphogens	C0566267
28444830	Wingless	C0168282
28444830	Wg	C0168282
28444830	Decapentaplegic	C0082344
28444830	Dpp	C0082344
28444830	EGFR-signaling cascade	C1155379
28444830	Wg	C0168282
28444830	Dpp	C0082344
28444830	studied	C2603343
28444830	arthropods	C0003903
28444830	Pancrustacea	C1218615
28444830	Hexapoda	C1095852
28444830	Crustacea	C0010395
28444830	Myriapoda	C0597910
28444830	Chelicerata	C0998333
28444830	investigation	C1292732
28444830	EGFR-signaling	C1155379
28444830	insects	C0021585
28444830	Hexapoda	C1095852
28444830	Gene expression analysis	C1880945
28444830	Egfr	C0034802
28444830	potential	C3245505
28444830	ligands	C0023688
28444830	putative downstream factors	C0033684
28444830	pill millipede	C0323823
28444830	Glomeris marginata	C1023180
28444830	Myriapoda	C0597910
28444830	Diplopoda	C0323823
28444830	mandibulate	C1218616
28444830	arthropods	C0003903
28444830	EGFR-signaling	C1155379
28444830	regulatory mechanism	C0243095
28444830	proximodistal limb	C0015385
28444830	patterning	C0376678
28445938	Pirfenidone	C0298067
28445938	normalizes	C0599112
28445938	tumor microenvironment	C2936626
28445938	chemotherapy	C3665472
28445938	Normalization	C0556530
28445938	tumor microenvironment	C2936626
28445938	targeting	C1521840
28445938	components	C0932050
28445938	tumor	C0027651
28445938	extracellular matrix	C0015350
28445938	potential	C3245505
28445938	decompress	C1965697
28445938	tumor	C0027651
28445938	blood vessels	C0005847
28445938	increase	C0442805
28445938	vessel	C0005847
28445938	perfusion	C0599705
28445938	drug delivery	C0087111
28445938	efficacy	C0598333
28445938	cancer therapy	C0920425
28445938	identify	C0205396
28445938	tolerated	C0243095
28445938	pharmaceutical agents	C1254351
28445938	microenvironment	C2936626
28445938	solid tumors	C0280100
28445938	enhance	C2349975
28445938	chemotherapy	C3665472
28445938	study	C2603343
28445938	Pirfenidone	C0298067
28445938	clinically	C0205210
28445938	approved	C0205540
28445938	anti-fibrotic drug	C4031950
28445938	treatment	C0087111
28445938	idiopathic pulmonary fibrosis	C1800706
28445938	investigate	C1292732
28445938	tumor microenvironment	C2936626
28445938	normalization	C0556530
28445938	orthotopic	C0574893
28445938	mammary	C0006141
28445938	tumor models	C1710493
28445938	Pirfenidone	C0298067
28445938	reduces	C0547047
28445938	collagen	C0009325
28445938	hyaluronan	C0813622
28445938	levels	C0441889
28445938	result	C1274040
28445938	significantly	C0750502
28445938	increases	C0442805
28445938	blood vessel	C0005847
28445938	functionality	C0542341
28445938	perfusion	C0599705
28445938	anti-tumor efficacy	C0598333
28445938	doxorubicin	C0013089
28445938	Reduction	C0392756
28445938	extracellular matrix components	C0932050
28445938	TGFβ signaling pathway	C2984328
28445938	inhibition	C3463820
28445938	downregulation	C0013081
28445938	TGFβ1	C1366557
28445938	COL1A1	C1332772
28445938	COL3A1	C1413581
28445938	HAS2	C1415475
28445938	HAS3	C1415476
28445938	expression	C0017262
28445938	levels	C0441889
28445938	findings	C0243095
28445938	evidence	C3887511
28445938	Pirfenidone	C0298067
28445938	strategy	C0035171
28445938	enhance	C2349975
28445938	drug delivery	C0087111
28445938	solid tumors	C0280100
28445938	normalizing	C0556530
28445938	tumor microenvironment	C2936626
28447586	Serum	C0229671
28447586	vascular endothelial growth factor receptor-3	C0169539
28447586	levels	C1446561
28447586	patients	C0030705
28447586	esophageal squamous cell cancer	C0279626
28447586	Esophageal cancer	C0014859
28447586	tumors of the gastrointestinal tract	C0017185
28447586	serum	C0229671
28447586	vascular endothelial growth factor-3	C0169539
28447586	VEGFR-3	C0169539
28447586	expression	C1171362
28447586	patients	C0030705
28447586	esophageal squamous cell carcinoma	C0279626
28447586	ESCC	C0279626
28447586	VEGFR-3	C0169539
28447586	ESCC	C0279626
28447586	patients	C0030705
28447586	ESCC	C0279626
28447586	Pre-therapy	C1882440
28447586	preoperative	C0445204
28447586	samples	C1550100
28447586	ELISA	C0014441
28447586	VEGFR-3	C0169539
28447586	serum values	C0683149
28447586	VEGFR-3	C0169539
28447586	patients	C0030705
28447586	ESCC	C0279626
28447586	healthy	C3898900
28447586	donors	C0013018
28447586	sensitivity	C1511883
28447586	VEGFR-3	C0169539
28447586	ESCC	C0279626
28447586	VEGFR-3	C0169539
28447586	diagnostic	C0348026
28447586	biomarker	C0005516
28447586	ESCC	C0279626
28447586	Biomarker	C0005516
28447586	ESCC	C0279626
28447586	VEGFR-3	C0169539
28448263	Zinc	C0043481
28448263	Wound Healing	C0043240
28448263	Review of	C0699752
28448263	Zinc	C0043481
28448263	Physiology	C0031843
28448263	Clinical Applications	C4048755
28448263	understanding	C0233820
28448263	zinc	C0043481
28448263	human	C0086418
28448263	physiology	C0031843
28448263	constantly	C1948059
28448263	gaps	C3887622
28448263	function	C0542341
28448263	zinc	C0043481
28448263	wound healing	C0043240
28448263	review	C0282443
28448263	aims	C1947946
28448263	clinician	C0871685
28448263	sufficient	C0205410
28448263	zinc	C0043481
28448263	biology	C0005532
28448263	zinc	C0043481
28448263	wound healing	C0043240
28448263	Zinc	C0043481
28448263	ion	C0022023
28448263	physiology	C0031843
28448263	zinc deficiency	C0235950
28448263	manifestations	C0205319
28448263	delayed	C0205421
28448263	wound healing	C0043240
28448263	immune dysfunction	C0021053
28448263	impairment	C0221099
28448263	multiple	C0439064
28448263	sensory systems	C0682647
28448263	consensus	C0376298
28448263	detrimental effects	C1280500
28448263	zinc deficiency	C0235950
28448263	wound healing	C0043240
28448263	discord	C0680238
28448263	literature	C0023866
28448263	optimal methods	C0025663
28448263	true benefits	C0814225
28448263	zinc	C0043481
28450196	thyroid hormone deficiency	C0020676
28450196	treatment	C0087111
28450196	risk	C0035647
28450196	herpes zoster	C0019360
28450196	Thyroid hormone	C0040135
28450196	TH	C0040135
28450196	herpes virus	C0019369
28450196	gene expression	C0017262
28450196	replication	C0598312
28450196	neurons	C0027882
28450196	epigenetics	C1516924
28450196	nuclear receptors	C0206588
28450196	patients	C0030705
28450196	hypothyroidism	C0020676
28450196	herpes zoster	C0019360
28450196	HZ	C0019360
28450196	TH deficiency	C0020676
28450196	risk factor	C0035648
28450196	varicella zoster virus	C0042338
28450196	VZV	C0042338
28450196	reactivation	C4086768
28450196	aim	C1947946
28450196	study	C2603343
28450196	hypothesis	C1512571
28450196	TH treatment	C2986608
28450196	complication	C0009566
28450196	HZ	C0019360
28450196	study	C2603343
28450196	investigated	C1292732
28450196	hypothesis	C1512571
28450196	comprehensive medical database	C0242356
28450196	Kaiser Permanente Southern California	C1708333
28450196	KPSC	C1708333
28450196	patients	C0030705
28450196	TH	C0040135
28450196	medication	C2081612
28450196	HZ	C0019360
28450196	Kaplan-Meier analysis	C1720943
28450196	hypothyroidism	C0020676
28450196	patients	C0030705
28450196	TH	C0040135
28450196	medicines	C0013227
28450196	risk	C0035647
28450196	HZ	C0019360
28450196	analysis	C0936012
28450196	patients	C0030705
28450196	medication	C2081612
28450196	treatment	C0087111
28450196	TH deficiency	C0020676
28450196	risk	C0035647
28450196	HZ	C0019360
28450196	hazard ratio	C2985465
28450196	confidence interval	C0009667
28450196	risk	C0035647
28450196	HZ	C0019360
28450196	age groups	C0027362
28450196	years	C0439234
28450196	cohort	C0599755
28450196	female	C0086287
28450196	patients	C0030705
28450196	TH treatment	C2986608
28450196	risk	C0035647
28450196	male	C0086582
28450196	findings	C0243095
28450196	hypothesis	C1512571
28450196	TH	C0040135
28450196	HZ	C0019360
28450196	studies	C2603343
28450196	evaluate the laboratory data	C0262707
28450196	analysis	C0936012
28450196	hormonal	C0458083
28450196	effects	C1280500
28450196	individuals	C0027361
28451941	Peer	C0679739
28451941	Exclusion	C2828389
28451941	Pubertal	C1627769
28451941	Transition	C2700061
28451941	Social Competence	C0683256
28451941	youth	C0087178
28451941	early puberty	C0034013
28451941	peer	C0679739
28451941	exclusion	C2828389
28451941	early	C1279919
28451941	developers	C1257890
28451941	experience	C0596545
28451941	peer	C0679739
28451941	exclusion	C2828389
28451941	social competence	C0683256
28451941	bolster	C1511253
28451941	develop	C1527148
28451941	maintain	C0024501
28451941	positive	C1446409
28451941	relationships	C0439849
28451941	peers	C0679739
28451941	present	C0150312
28451941	study	C2603343
28451941	pubertal	C1627769
28451941	timing	C0449243
28451941	tempo	C0876945
28451941	predicts	C0681842
28451941	decrements	C0392756
28451941	children's	C0008059
28451941	social competence	C0683256
28451941	decrements	C0392756
28451941	social competence	C0683256
28451941	associations	C0332281
28451941	puberty	C0034011
28451941	timing	C0449243
28451941	tempo	C0876945
28451941	peer	C0679739
28451941	exclusion	C2828389
28451941	time	C0040223
28451941	Longitudinal	C0023981
28451941	data	C1511726
28451941	families	C0015576
28451941	female	C0043210
28451941	White	C0007457
28451941	years	C0439234
28451941	participated	C0679823
28451941	Phase III	C0282461
28451941	NICHD	C1513896
28451941	SECCYD	C0023981
28451941	results	C1274040
28451941	latent growth curve models	C0814921
28451941	earlier	C1279919
28451941	pubertal	C1627769
28451941	timing	C0449243
28451941	rapid	C0456962
28451941	pubertal	C1627769
28451941	tempo	C0876945
28451941	girls	C0870604
28451941	associated with	C0332281
28451941	high	C0205250
28451941	initial	C0205265
28451941	levels	C0441889
28451941	peer	C0679739
28451941	exclusion	C2828389
28451941	mediation analyses	C0814912
28451941	early	C1279919
28451941	developers'	C1257890
28451941	susceptibility	C1264642
28451941	peer	C0679739
28451941	exclusion	C2828389
28451941	associated with	C0332281
28451941	initial	C0205265
28451941	level	C0441889
28451941	social competence	C0683256
28451941	boys	C0870221
28451941	pubertal	C1627769
28451941	timing	C0449243
28451941	tempo	C0876945
28451941	associated with	C0332281
28451941	peer	C0679739
28451941	exclusion	C2828389
28451941	effects of	C1704420
28451941	pubertal	C1627769
28451941	timing	C0449243
28451941	peer	C0679739
28451941	exclusion	C2828389
28451941	intercept	C3146232
28451941	slope	C0807955
28451941	initial	C0205265
28451941	levels	C0441889
28451941	social competence	C0683256
28451941	average	C1510992
28451941	early	C1279919
28451941	developers'	C1257890
28451941	low	C0205251
28451941	levels	C0441889
28451941	social competence	C0683256
28451941	high	C0205250
28451941	initial	C0205265
28451941	levels	C0441889
28451941	peer	C0679739
28451941	exclusion	C2828389
28451941	experienced	C0596545
28451941	decrements	C0392756
28451941	peer	C0679739
28451941	exclusion	C2828389
28451941	association	C0332281
28451941	intercepts	C3146232
28451941	puberty	C0034011
28451941	peer	C0679739
28451941	exclusion	C2828389
28451941	slopes	C0807955
28451941	social competence	C0683256
28451941	peer	C0679739
28451941	exclusion	C2828389
28451941	stronger	C0442821
28451941	boys	C0870221
28451941	girls	C0870604
28451941	findings	C0243095
28451941	early	C1279919
28451941	developers'	C1257890
28451941	susceptibility	C1264642
28451941	experiences	C0596545
28451941	peer	C0679739
28451941	exclusion	C2828389
28451941	associated with	C0332281
28451941	development	C1527148
28451941	social competence	C0683256
28454015	Air pollution	C0001873
28454015	characteristics	C1521970
28454015	health risks	C0679809
28454015	Henan Province	C1514578
28454015	China	C0008115
28454015	severe	C0205082
28454015	air pollution	C0001873
28454015	China	C0008115
28454015	air pollution	C0001873
28454015	characteristics	C1521970
28454015	health	C0018684
28454015	risks	C0035647
28454015	dataset	C0150098
28454015	daily	C0332173
28454015	concentrations	C1446561
28454015	pollutants	C0001869
28454015	PM2.5	C1720884
28454015	PM10	C1720884
28454015	CO	C0007018
28454015	SO2	C0038777
28454015	NO2	C0028160
28454015	O3	C0030106
28454015	Henan province	C1514578
28454015	air pollution	C0001873
28454015	status	C0449438
28454015	Henan province	C1514578
28454015	northern part	C1709269
28454015	Zhengzhou	C0008848
28454015	city	C0008848
28454015	worst	C1522166
28454015	air quality	C2371710
28454015	PM2.5	C1720884
28454015	concentrations	C1446561
28454015	Chinese Ambient Air Quality Standard	C0034925
28454015	PM2.5	C1720884
28454015	pollutant	C0599786
28454015	ozone	C0030106
28454015	pollution	C0001873
28454015	summer	C0241301
28454015	air quality index	C0918012
28454015	AQI	C0918012
28454015	health	C0018684
28454015	pollutants	C0599786
28454015	aggregate air quality index	C0918012
28454015	AAQI	C0918012
28454015	health-risk based air quality index	C0918012
28454015	HAQI	C0918012
28454015	evaluate the health risks	C0679809
28454015	HAQI	C0918012
28454015	AQI	C0918012
28454015	health	C0018684
28454015	risks	C0035647
28454015	air pollution	C0001873
28454015	general public	C0683971
28454015	health protection measures	C1254363
28454015	population	C0032659
28454015	HAQI	C0918012
28454015	population	C0032659
28454015	cities	C0008848
28454015	Henan province	C1514578
28454015	polluted air	C0001873
28454015	population	C0032659
28454015	exposed to	C0332157
28454015	air	C0001861
28454015	unhealthy	C0243095
28454015	sensitive	C0332324
28454015	people	C0027361
28454015	people	C0027361
28454015	exposed to	C0332157
28454015	air	C0001861
28454015	healthy	C3898900
28454015	people	C0027361
28454015	health	C0018684
28454015	risks	C0035647
28454015	winter	C0241737
28454015	seasons	C0036497
28454015	HAQI	C0918012
28454015	algorithm	C0002045
28454015	clinical	C1516606
28454015	epidemiologic	C0014508
28454015	data	C0150098
28454015	HAQI	C0918012
28456611	Increased	C0205217
28456611	risk	C0035647
28456611	PTLD	C0432487
28456611	lung transplant recipients	C2063401
28456611	cystic fibrosis	C0010674
28456611	Post-transplant lymphoproliferative disease	C0432487
28456611	PTLD	C0432487
28456611	morbidity	C0026538
28456611	mortality	C0026566
28456611	lung transplantation	C0024128
28456611	Recipients	C0376387
28456611	cystic fibrosis	C0010674
28456611	CF	C0010674
28456611	increased	C0205217
28456611	risk	C0035647
28456611	PTLD	C0432487
28456611	literature	C0023866
28456611	single center cohorts	C0599755
28456611	PTLD	C0432487
28456611	adult	C0001675
28456611	lung transplant	C0024128
28456611	population	C1257890
28456611	International Society for Heart and Lung Transplantation Registry	C0282574
28456611	studied	C2603343
28456611	adult	C0001675
28456611	recipients	C1709854
28456611	lung transplants	C0024128
28456611	outcome	C1274040
28456611	development	C1527148
28456611	time	C0040223
28456611	PTLD	C0432487
28456611	transplant	C0040732
28456611	predictors	C2698872
28456611	Epstein-Barr virus	C0014644
28456611	EBV	C0014644
28456611	cytomegalovirus	C0010825
28456611	CMV	C0010825
28456611	serostatus	C1300950
28456611	gender	C0079399
28456611	age	C0001779
28456611	Outcomes	C1274040
28456611	assessed	C1516048
28456611	univariable	C0683962
28456611	multivariable Cox proportional hazard models	C0010235
28456611	hazard ratios	C2985465
28456611	HR	C2985465
28456611	cohort	C0599755
28456611	diagnosis	C0011900
28456611	CF	C0010674
28456611	PTLD	C0432487
28456611	CF	C0010674
28456611	recipients	C0376387
28456611	non-CF recipients	C2063401
28456611	non-CF recipients	C2063401
28456611	CF	C0010674
28456611	recipients	C0376387
28456611	higher prevalence	C0220900
28456611	EBV	C0014644
28456611	CMV seronegativity	C2919629
28456611	higher prevalences	C0220900
28456611	high risk	C0035647
28456611	EBV	C0014644
28456611	CMV	C0010825
28456611	CF	C0010674
28456611	development	C1527148
28456611	PTLD	C0432487
28456611	HR	C2985465
28456611	Stratified multivariable analysis	C0026777
28456611	age	C0001779
28456611	EBV	C0014644
28456611	negative	C1513916
28456611	non-CF recipients	C2063401
28456611	increased	C0205217
28456611	risk	C0035647
28456611	PTLD	C0432487
28456611	EBV	C0014644
28456611	CF	C0010674
28456611	recipients	C0376387
28456611	increased	C0205217
28456611	risk	C0035647
28456611	CF	C0010674
28456611	recipients	C0376387
28456611	risk	C0035647
28456611	PTLD	C0432487
28456611	non-CF recipients	C2063401
28456611	studies	C2603343
28456611	risk factors	C0035648
28456611	management	C0035649
28456611	population post-transplant	C2063401
28456751	Methods	C0025663
28456751	tools	C0541506
28456751	current	C0521116
28456751	perspectives	C1254370
28456751	proteogenomics	C3897816
28456751	technological advancements	C0681519
28456751	high-throughput next-generation sequencing	C2936625
28456751	deep mass spectrometry	C0037813
28456751	proteomics	C0872252
28456751	proteogenomics	C3897816
28456751	integrative analysis	C0936012
28456751	proteomic and genomic data	C1511726
28456751	research field	C0683945
28456751	field	C0683945
28456751	protein	C0033684
28456751	identification	C0205396
28456751	sample-specific genomic	C0282574
28456751	transcriptomic sequencing data	C0026382
28456751	integrative analysis	C0936012
28456751	quantitative	C0392762
28456751	measurements	C0242485
28456751	genomic and proteomic studies	C0681814
28456751	identified	C0205396
28456751	gene expression regulation	C0017263
28456751	cell signaling	C0037083
28456751	disease	C0012634
28456751	methods	C0025663
28456751	tools	C0541506
28456751	array	C1510941
28456751	integrative proteogenomic approaches	C1292724
28456751	article	C1706852
28456751	systematically	C0220922
28456751	classify	C0008902
28456751	published	C0034037
28456751	methods	C0025663
28456751	tools	C0541506
28456751	major categories	C1550395
28456751	Sequence	C0004793
28456751	Sequence -centric proteogenomics	C3897816
28456751	Analysis	C0936012
28456751	proteogenomic relationships	C0439849
28456751	Integrative modeling	C0870071
28456751	proteogenomic data	C1511726
28456751	Data sharing	C2713450
28456751	visualization	C0175631
28456751	comprehensive	C1880156
28456751	review of	C0699752
28456751	methods	C0025663
28456751	available	C0470187
28456751	tools	C0541506
28456751	category	C0683312
28456751	typical	C3538928
28456751	applications	C0205245
28457334	Plasma	C0032105
28457334	DNA	C0012854
28457334	RNA	C0035668
28457334	differentially	C1705242
28457334	impact	C4049986
28457334	coagulation	C0005778
28457334	abdominal sepsis	C1141926
28457334	explorative study	C2603343
28457334	Cell-free DNA	C4289789
28457334	cfDNA	C4289789
28457334	extracellular	C0521119
28457334	RNA	C0035668
28457334	exRNA	C0035668
28457334	suspected	C0750491
28457334	activate	C1515877
28457334	coagulation cascades	C0005779
28457334	sepsis	C0243026
28457334	study	C2603343
28457334	investigated	C1292732
28457334	influence	C4054723
28457334	plasmatic	C0032105
28457334	nucleic acids	C0028606
28457334	coagulation	C0005778
28457334	septic	C0333534
28457334	patients	C0030705
28457334	comparison	C1707455
28457334	patients	C0030705
28457334	abdominal surgery	C0198482
28457334	patients	C0030705
28457334	sepsis	C0243026
28457334	postoperative	C0032790
28457334	patients	C0030705
28457334	healthy volunteers	C1708335
28457334	included	C0332257
28457334	longitudinal study	C0023981
28457334	Blood	C0005767
28457334	collected	C1516695
28457334	sepsis	C0243026
28457334	onset	C0277793
28457334	surgery	C0543467
28457334	Levels	C0441889
28457334	cfDNA	C4289789
28457334	exRNA	C0035668
28457334	measured	C0444706
28457334	quantitative	C0392762
28457334	probe-based	C0182400
28457334	polymerase chain reaction	C0032520
28457334	thromboelastography	C0040017
28457334	coagulation	C0005778
28457334	thromboaggregometry	C0022885
28457334	platelet function	C1254881
28457334	cfDNA	C4289789
28457334	exRNA	C0035668
28457334	elevated	C3163633
28457334	patients	C0030705
28457334	sepsis	C0243026
28457334	compared	C1707455
28457334	postoperative	C0032790
28457334	patients	C0030705
28457334	healthy volunteers	C1708335
28457334	higher	C0205250
28457334	exRNA	C0035668
28457334	levels	C0441889
28457334	correlated	C1707520
28457334	faster clotting time	C2266672
28457334	stable clots	C0302148
28457334	cfDNA	C4289789
28457334	correlated	C1707520
28457334	shorter clotting time	C2266672
28457334	fibrinolysis	C0016017
28457334	higher	C0205250
28457334	cfDNA	C4289789
28457334	associated with	C0332281
28457334	kidney dysfunction	C0151746
28457334	markers	C0005516
28457334	cell damage	C0599732
28457334	lactate dehydrogenase	C0022917
28457334	lactate	C0376261
28457334	nucleic acid	C0028606
28457334	associated with	C0332281
28457334	different	C1705242
28457334	effects	C1280500
28457334	coagulation	C0005778
28457334	sepsis	C0243026
28457334	overall	C1561607
28457334	procoagulatory	C2917275
28457334	influence	C4054723
28457334	individualized	C1881197
28457334	therapeutic approaches	C0087111
28457334	patients	C0030705
28457334	suffering	C0751408
28457334	coagulation	C0005778
28457334	associated	C0449380
28457334	organ dysfunction	C0342953
28459029	Association	C0439849
28459029	Fat Mass	C3656665
28459029	Obesity	C0028754
28459029	associated	C0332281
28459029	Gene Variant	C0678941
28459029	Lifestyle	C0023676
28459029	Factors	C1521761
28459029	Body Fat	C0344335
28459029	Indian	C1524069
28459029	Children	C0008059
28459029	intronic variants	C0678941
28459029	fat mass	C3656665
28459029	obesity	C0028754
28459029	associated	C0332281
28459029	(FTO) gene	C1970415
28459029	associated with	C0332281
28459029	obesity	C0028754
28459029	traits	C0599883
28459029	humans	C0086418
28459029	study	C2603343
28459029	study	C2603343
28459029	FTO gene	C1970415
28459029	variants	C0678941
28459029	body mass index	C1305855
28459029	BMI	C1305855
28459029	association	C0439849
28459029	FTO gene	C1970415
28459029	variants	C0678941
28459029	lifestyle	C0023676
28459029	factors	C1521761
28459029	obese	C0028754
28459029	normal weight	C2712185
28459029	Indian	C1524069
28459029	children	C0008059
28459029	children	C0008059
28459029	boys	C0870221
28459029	age	C0001779
28459029	years	C0439234
28459029	studied	C2603343
28459029	Height	C0005890
28459029	weight	C0005910
28459029	waist	C0455829
28459029	hip circumference	C0562350
28459029	measured	C0444706
28459029	Physical activity	C0026606
28459029	questionnaire	C4264334
28459029	food	C0016452
28459029	intake	C1512806
28459029	food frequency questionnaire	C2986698
28459029	assessed	C1516048
28459029	Body fat percentage	C1632383
28459029	%BF	C1632383
28459029	dual-energy X-ray absorptiometry	C1510486
28459029	FTO allelic variants	C0678941
28459029	rs9939609 site	C1517493
28459029	SYBR Green Amplification Refractory Mutation System real-time polymerase chain reaction	C1709846
28459029	allele	C0002085
28459029	specific	C0205369
28459029	primers	C0206415
28459029	Generalized linear model	C0023732
28459029	investigate	C1292732
28459029	simultaneous	C0521115
28459029	influence	C4054723
28459029	genetic	C0314603
28459029	lifestyle	C0023676
28459029	factors	C1521761
28459029	%BF	C1632383
28459029	height	C0005890
28459029	weight	C0005910
28459029	BMI	C1305855
28459029	normal	C0205307
28459029	obese	C0028754
28459029	children	C0008059
28459029	AA allele	C0002085
28459029	obese	C0028754
28459029	children	C0008059
28459029	normal weight	C2712185
28459029	children	C0008059
28459029	Children	C0008059
28459029	AA allele	C0002085
28459029	obese	C0028754
28459029	physical activity	C0026606
28459029	children	C0008059
28459029	AT allele	C0002085
28459029	obesity	C0028754
28459029	highest	C1522410
28459029	intake of calories	C4281687
28459029	compared	C1707455
28459029	children	C0008059
28459029	AT allele	C0002085
28459029	normal	C0205307
28459029	%BF	C1632383
28459029	associated with	C0332281
28459029	AA alleles	C0002085
28459029	junk food	C0681578
28459029	intake	C1512806
28459029	healthy	C3898900
28459029	food	C0016452
28459029	intake	C1512806
28459029	physical activity	C0026606
28459029	Healthy lifestyle	C4277664
28459029	physical activity	C0026606
28459029	diet	C0012155
28459029	low	C0205251
28459029	calories	C1556156
28459029	fat	C0012171
28459029	modifying	C0392747
28459029	risk	C0035647
28459029	FTO variants	C0678941
28459029	children	C0008059
28459124	Museum	C0026863
28459124	specimen	C0370003
28459124	data	C1511726
28459124	plant disease	C0032080
28459124	increases	C0442805
28459124	insect vector	C0021573
28459124	insect vector population	C1257890
28459124	emergence rate	C1521828
28459124	plant diseases	C0032080
28459124	increasing	C0442808
28459124	climate change	C2718051
28459124	changes	C0392747
28459124	vector populations	C1257890
28459124	risks	C0035647
28459124	agricultural	C0001829
28459124	agricultural sustainability	C0205245
28459124	Assessing and managing	C0441655
28459124	disease	C0012634
28459124	risks	C0035647
28459124	contemporary and historical emergence events	C0441471
28459124	potato growers	C0027363
28459124	western United States	C0041703
28459124	Mexico	C0025885
28459124	Central America	C0007674
28459124	yield loss	C0392762
28459124	Zebra Chip disease	C0012634
28459124	insecticide	C0021576
28459124	populations	C1257890
28459124	insect vector	C0021573
28459124	potato psyllid	C1502411
28459124	Bactericera cockerelli	C1502411
28459124	Hemiptera	C0018992
28459124	Triozidae	C1007295
28459124	Zebra Chip	C0012634
28459124	outbreaks	C0012652
28459124	hypotheses	C1512571
28459124	B. cockerelli	C1502411
28459124	occupancy	C2827063
28459124	increased	C0205217
28459124	century	C0719214
28459124	California	C0006754
28459124	climate change	C2718051
28459124	warmer winters	C0241737
28459124	dataset	C0150098
28459124	museum	C0026863
28459124	specimen	C0370003
28459124	records	C0034869
28459124	Hemiptera	C0018992
28459124	analyzed	C0936012
28459124	B. cockerelli	C1502411
28459124	hierarchical occupancy model	C3161035
28459124	species	C1705920
28459124	species lists	C0745732
28459124	evidence	C3887511
28459124	B. cockerelli	C1502411
28459124	occupancy	C2827063
28459124	increased	C0205217
28459124	century	C0719214
28459124	climate changes	C2718051
28459124	analysis	C0936012
28459124	species	C1705920
28459124	occupancy	C2827063
28459124	analysis	C0936012
28459124	hypothesis	C1512571
28459124	B. cockerelli	C1502411
28459124	population	C1257890
28459124	increased	C0205217
28459124	B. cockerelli	C1502411
28459124	population	C1257890
28459124	dynamics	C3826426
28459124	Zebra Chip	C0012634
28459124	Zebra Chip epidemics	C0277548
28459124	historical macro-ecological approach	C0449445
28459124	comparative risk assessment	C0086930
28459124	pest	C0684063
28459124	insect vector	C0021573
28459124	outbreaks	C0012652
28460054	Effect	C1280500
28460054	halotolerant rhizobacteria	C0004611
28460054	isolated	C0205409
28460054	halophytes	C2350261
28460054	growth	C0018270
28460054	sugar beet	C0330391
28460054	Beta vulgaris L	C0330391
28460054	salt stress	C1154956
28460054	Utilization	C0042153
28460054	rhizobacteria	C0004611
28460054	associated with	C0332281
28460054	plant roots	C0242726
28460054	harsh	C4068826
28460054	environments	C0014406
28460054	feasible strategy	C0035171
28460054	agricultural production	C0001827
28460054	soil	C0037592
28460054	salinity	C1956027
28460054	Halophytes	C2350261
28460054	high	C0205250
28460054	salt environments	C0178838
28460054	roots	C0242726
28460054	associated with	C0332281
28460054	microbial candidates	C0599840
28460054	promoting	C0033414
28460054	growth	C0018270
28460054	salt tolerance	C1752460
28460054	crops	C0242775
28460054	study	C2603343
28460054	isolate	C0205409
28460054	halotolerant plant	C2350260
28460054	growth	C0597252
28460054	promoting	C0033414
28460054	rhizobacterial	C0521009
28460054	strains	C1518614
28460054	halophytes	C2350261
28460054	evaluate	C1516048
28460054	activity	C0441655
28460054	effects	C1280500
28460054	sugar beet	C0330391
28460054	Beta vulgaris L	C0330391
28460054	growth	C0018270
28460054	salinity stress	C1154956
28460054	isolates	C1764827
28460054	ability	C0085732
28460054	1-aminocyclopropane-1-carboxylate deaminase	C0044278
28460054	ACD	C0044278
28460054	plant-growth	C0597252
28460054	promoting	C0033414
28460054	characteristics	C1521970
28460054	identified	C0205396
28460054	sequencing	C1561491
28460054	16S rRNA	C3537372
28460054	gene	C0017337
28460054	isolates	C1764827
28460054	Micrococcus yunnanensis	C2766719
28460054	Planococcus rifietoensis	C1483193
28460054	Variovorax paradoxus	C0314842
28460054	enhanced	C2349975
28460054	salt stress	C1154956
28460054	tolerance	C1704410
28460054	sugar beet	C0330391
28460054	resulting in	C0332294
28460054	greater	C1704243
28460054	seed germination	C1160189
28460054	plant	C0032098
28460054	biomass	C0005535
28460054	higher	C0205250
28460054	photosynthetic	C0031764
28460054	capacity	C1516240
28460054	lower	C0205251
28460054	stress	C0038435
28460054	induced	C0205263
28460054	ethylene	C0015075
28460054	production	C0005572
28460054	different	C1705242
28460054	NaCl	C0037494
28460054	concentrations	C1446561
28460054	results	C1274040
28460054	salinity	C1956027
28460054	adapted	C0392673
28460054	ACD	C0044278
28460054	bacteria	C0004611
28460054	isolated	C0205409
28460054	halophytes	C2350261
28460054	promote	C0033414
28460054	sugar beet	C0330391
28460054	growth	C0018270
28460054	saline stress conditions	C1154956
28461000	Potential	C3245505
28461000	Sunitinib	C1176020
28461000	Induced	C0205263
28461000	Coronary Artery	C0205042
28461000	Aortic Dissections	C0340643
28461000	Small-molecule multitargeted tyrosine kinase inhibitor (TKI) therapy	C0879484
28461000	cancer	C0006826
28461000	drugs	C0013227
28461000	associated with	C0332281
28461000	cardiovascular toxicity	C0876994
28461000	aortic dissection	C0340643
28461000	knowledge	C0376554
28461000	first time	C0040223
28461000	coronary dissection	C0340643
28461000	potentially	C3245505
28461000	associated with	C0332281
28461000	TKI treatment	C0879484
28463704	Recovery of	C0237820
28463704	orthographic	C0871846
28463704	processing	C0025361
28463704	stroke	C0038454
28463704	longitudinal	C0023981
28463704	fMRI	C0376335
28463704	orthographic	C0871846
28463704	processing	C0025361
28463704	normal reading and spelling	C1404290
28463704	neural changes	C3714606
28463704	impairment	C0221099
28463704	recovery	C0237820
28463704	orthographic	C0871846
28463704	lexical processing	C0871801
28463704	ischemic	C0022116
28463704	left posterior cerebral artery (PCA) stroke	C2062605
28463704	longitudinal case study	C0023981
28463704	MMY	C0086418
28463704	impairments	C0221099
28463704	orthographic	C0871846
28463704	lexical processing	C0871801
28463704	reading and spelling	C1404290
28463704	stroke	C0038454
28463704	onset	C0277793
28463704	stroke	C0038454
28463704	hypothesis	C1512571
28463704	acute	C0205178
28463704	impairment	C0221099
28463704	reading and spelling	C1404290
28463704	loss of	C1517945
28463704	neural activation	C3714606
28463704	left fusiform gyrus	C2337131
28463704	FG	C2337131
28463704	gain of	C1517378
28463704	neural activation	C3714606
28463704	MMY's	C0086418
28463704	neural changes	C3714606
28463704	behavioral	C0004927
28463704	recovery of naming as well	C2004454
28463704	neural recovery	C3714606
28463704	reading and spelling	C1404290
28463704	neural changes	C3714606
28463704	orthographic	C0871846
28463704	processing	C0025361
28463704	longitudinal behavioral	C0004939
28463704	functional magnetic resonance imaging	C0376335
28463704	fMRI	C0376335
28463704	reading	C0586739
28463704	spelling	C0869025
28463704	visual object naming	C0451342
28463704	stroke	C0038454
28463704	hypothesis	C1512571
28463704	orthographic	C0871846
28463704	lexical processing	C0871801
28463704	up-regulation	C0041904
28463704	neural activation	C3714606
28463704	orthographic	C0871846
28463704	lexical processing	C0871801
28463704	left mid-FG	C2953769
28463704	inferior frontal junction	C0152298
28463704	IFJ	C0152298
28463704	neural changes	C3714606
28463704	orthographic	C0871846
28463704	processing	C0025361
28463704	reading	C0586739
28463704	spelling	C0869025
28463704	visual object naming	C0451342
28463704	left mid-FG	C2953769
28463704	left PCA stroke	C2062605
28463704	orthographic	C0871846
28463704	lexical processing	C0871801
28463704	posterior region	C1254362
28463704	adjacent	C0205117
28463704	stroke	C0038454
28463704	distant frontal	C1254362
28463704	orthographic	C0871846
28463704	processing	C0025361
28464907	Nodal	C0443268
28464907	skip	C0560435
28464907	metastasis	C0596869
28464907	thoracic esophageal squamous cell carcinoma	C0861674
28464907	cohort study	C0009247
28464907	Nodal	C0443268
28464907	skip	C0560435
28464907	metastasis	C0596869
28464907	prognostic factor	C1514474
28464907	malignancies	C4282132
28464907	esophageal cancer	C0014859
28464907	unclear	C3845108
28464907	investigate	C1292732
28464907	effect	C1280500
28464907	nodal	C0443268
28464907	skip	C0560435
28464907	thoracic esophageal squamous cell carcinoma	C0861674
28464907	patients	C0030705
28464907	esophagectomy	C0085198
28464907	thoracic esophageal squamous cell carcinoma	C0861674
28464907	Center for Esophageal Diseases	C1708333
28464907	Padova	C0681784
28464907	January	C3829466
28464907	December	C3830550
28464907	retrospectively evaluated	C0035363
28464907	Selection criteria	C0242801
28464907	R0 resection	C0677874
28464907	pathological	C1521733
28464907	M0 stage	C0445034
28464907	pathological	C1521733
28464907	lymph node involvement	C0806692
28464907	Patients	C1516213
28464907	neoadjuvant therapy	C0600558
28464907	patients	C0030705
28464907	lymph node involvement	C0806692
28464907	pathological	C1521733
28464907	evaluation	C0220825
28464907	patients	C1516213
28464907	nodal	C0443268
28464907	skip	C0560435
28464907	metastasis	C0596869
28464907	lymph node metastases	C0596869
28464907	patient	C1516213
28464907	nodal	C0443268
28464907	skip	C0560435
28464907	metastasis	C0596869
28464907	overall survival	C4086681
28464907	disease free survival	C0242793
28464907	patients	C0030705
28464907	peritumoral	C3897941
28464907	distant	C0443203
28464907	lymph node metastases	C0596869
28464907	nodal	C0443268
28464907	skip	C0560435
28464907	metastasis	C0596869
28464907	C.I	C0009667
28464907	patients	C0030705
28464907	lymph node metastasis	C0596869
28464907	lymph node metastasis	C0596869
28464907	C.I	C0009667
28464907	middle	C0444598
28464907	thoracic esophagus	C0227188
28464907	C.I	C0009667
28464907	lower	C0441994
28464907	thoracic esophagus	C0227188
28464907	upper	C1282910
28464907	thoracic esophagus	C0227188
28464907	C.I.	C0009667
28464907	clinical	C0205210
28464907	N0 stage	C0441959
28464907	clinical	C0205210
28464907	N+ stage	C1272457
28464907	Nodal	C0443268
28464907	skip	C0560435
28464907	metastasis	C0596869
28464907	metastatic lymph involvement	C0806692
28464907	thoracic esophageal squamous cell carcinoma	C0861674
28464907	neither	C4284892
28464907	overall survival	C4086681
28464907	disease free survival	C0242793
28464907	associated with	C0332281
28464907	nodal	C0443268
28464907	skip	C0560435
28464907	metastasis	C0596869
28466814	Association	C0439849
28466814	leukemia inhibitory factor gene	C1366463
28466814	polymorphism	C0678951
28466814	in vitro	C1533691
28466814	fertilization	C0015914
28466814	outcome	C1274040
28466814	population	C1257890
28466814	northern Iran	C0022065
28466814	studies	C2603343
28466814	endometrial	C0227843
28466814	leukemia inhibitory factor	C0125606
28466814	LIF	C0125606
28466814	embryo implantation	C0029976
28466814	LIF	C0125606
28466814	glycoprotein	C0017968
28466814	biological functions	C3714634
28466814	stimulation	C1948023
28466814	cell proliferation	C0596290
28466814	differentiation	C0007589
28466814	survival	C0007620
28466814	essential	C0205224
28466814	blastocyete	C0005705
28466814	development	C1527148
28466814	implantation	C0029976
28466814	LIF receptor	C0125607
28466814	activates	C1879547
28466814	signaling pathways	C0037080
28466814	diverse cell types	C0449475
28466814	Jak/STAT	C2984327
28466814	MAPK	C0752312
28466814	PI3-kinase	C0044602
28466814	pathways	C0037080
28466814	endometrium	C0014180
28466814	fertile	C0015895
28466814	woman	C0043210
28466814	expression	C1171362
28466814	LIF	C0125606
28466814	proliferative	C0334094
28466814	phase	C0205390
28466814	failure	C0231174
28466814	implantation	C0021107
28466814	study	C2603343
28466814	association	C0439849
28466814	maternal	C1858460
28466814	genotype	C0017431
28466814	SNP 3951C/T	C0752046
28466814	LIF	C0125606
28466814	in vitro fertilization	C0015915
28466814	embryo transfer	C0013938
28466814	IVF	C0015915
28466814	ET	C0013938
28466814	outcome	C0085415
28466814	infertile	C0021359
28466814	women	C0043210
28466814	case-control study	C0007328
28466814	infertile	C0021359
28466814	patients	C0030705
28466814	women	C0043210
28466814	healthy child	C0686744
28466814	controls	C0009932
28466814	Genotyping	C1285573
28466814	SNP-3951C/T	C0752046
28466814	PCR/RFLP	C3714764
28466814	Allele	C0002085
28466814	genotype	C0017431
28466814	distribution	C1704711
28466814	patients	C0030705
28466814	controls	C0009932
28466814	LIF	C0125606
28466814	genotype	C0017431
28466814	frequencies	C0017270
28466814	cases	C0868928
28466814	C/C	C0004793
28466814	C/T	C0004793
28466814	T/T	C0004793
28466814	allele	C0002085
28466814	frequencies	C0017270
28466814	LIF	C0125606
28466814	genotype	C0017431
28466814	frequencies	C0017270
28466814	controls	C0009932
28466814	C/C	C0004793
28466814	C/T	C0004793
28466814	T/T	C0004793
28466814	allele	C0002085
28466814	frequencies	C0017270
28466814	results	C1274040
28466814	SNP 3951C/T	C0752046
28466814	LIF	C0125606
28466814	associated with	C0332281
28466814	IVF	C0015915
28466814	ET	C0013938
28466814	outcome	C0085415
28466814	population	C1257890
28466814	studies	C2603343
28466814	patients	C0030705
28466814	control subjects	C0009932
28466814	confirm	C1456348
28466814	results	C1274040
28467858	ANTI ANGIOGENIC EFFECT	C0243095
28467858	CHEBULAGIC ACID	C0653267
28467858	INHIBITION	C3463820
28467858	VEGFR2	C3549205
28467858	GSK3β DEPENDENT SIGNALING PATHWAYS	C0037080
28467858	Inhibition	C3463820
28467858	angiogenesis	C0302600
28467858	strategy	C0679716
28467858	prevent	C2700409
28467858	cancer growth	C1516170
28467858	targets	C1521840
28467858	vessels	C0005847
28467858	proliferating	C1514485
28467858	tumor cells	C0597032
28467858	Endothelial cells	C0225336
28467858	pathways	C0037080
28467858	angiogenesis	C0302600
28467858	pathways	C0037080
28467858	targeted	C1521840
28467858	multi targeted drugs	C1254351
28467858	anti angiogenic effect	C0243095
28467858	Chebulagic acid	C0653267
28467858	benzopyran	C0005078
28467858	tannin	C1456509
28467858	fruits	C0016767
28467858	Terminalia chebula	C1193061
28467858	molecular mechanism	C3537153
28467858	anti angiogenic effect	C0243095
28467858	chebulagic acid	C0653267
28467858	molecular docking studies	C3494274
28467858	HUVECs	C3179121
28467858	culture	C0007585
28467858	Chebulagic acid	C0653267
28467858	inhibited	C3463820
28467858	GSK-3β	C0244988
28467858	dependent	C3244310
28467858	β-catenin	C0105770
28467858	phosphorylation	C1158886
28467858	VE-cadherin	C0300423
28467858	β-catenin	C0105770
28467858	signaling	C0037080
28467858	VEGFR2	C3849882
28467858	phosphorylation	C1158886
28467858	VEGF signaling	C3271788
28467858	Chebulagic acid	C0653267
28467858	inhibits	C3463820
28467858	angiogenesis	C0302600
28467858	blocking	C0332206
28467858	VEGF	C1256770
28467858	VEGFR2	C3849882
28467858	cell-cell contact dependent downstream signaling pathway	C0037080
28468980	B-cell epitopes	C0282581
28468980	malaria vaccine	C0206255
28468980	P. falciparum Schizont Egress Antigen-1	C3849939
28468980	Naturally	C0205296
28468980	antibodies	C0003241
28468980	PfSEA-1A	C3849939
28468980	malaria	C0024530
28468980	children	C0008059
28468980	Vaccination	C0042196
28468980	mice	C0025929
28468980	PbSEA-1A	C4040232
28468980	parasitemia	C0242723
28468980	Plasmodium berghei ANKA	C0032149
28468980	immunogenicity	C4277607
28468980	PfSEA-1A	C3849939
28468980	B-cell epitopes	C0282581
28468980	peptide	C0030956
28468980	microarrays	C1136348
28468980	anti-sera	C0020960
28468980	rPfSEA-1A	C3849939
28468980	vaccinated	C1519885
28468980	primates	C0033147
28468980	evaluated	C0220825
28468980	epitope	C0003316
28468980	antibody	C0003241
28468980	parasitemia	C0242723
28468980	treatment	C0087111
28468980	reinfection	C0205339
28468980	cohort	C0599755
28468980	Western Kenya	C0022558
28468980	Antibodies	C0003241
28468980	epitopes	C0003316
28468980	parasitemia	C0242723
28468980	week	C0439230
28468980	transmission	C1521797
28468980	immunogens	C0042213
28468980	antibody responses	C0003261
28468980	epitopes	C0003316
28469263	Estrogen	C0014939
28469263	deficiency	C0011155
28469263	accelerates	C0521110
28469263	lumbar facet joints	C0507372
28469263	arthritis	C0003864
28469263	increase	C0442805
28469263	prevalence	C0220900
28469263	lumbar facet joint	C0507372
28469263	LFJ	C0507372
28469263	arthritis	C0003864
28469263	women	C0043210
28469263	age	C0001779
28469263	menopause	C0025320
28469263	protective role	C0086939
28469263	estrogen	C0014939
28469263	LFJ	C0507372
28469263	arthritis	C0003864
28469263	no evidence	C0332125
28469263	indication	C3146298
28469263	mechanism	C0441712
28469263	effect	C1280500
28469263	study	C2603343
28469263	ovariectomized (OVX) mice	C0025929
28469263	estrogen	C0014939
28469263	deficient	C0011155
28469263	status	C0449438
28469263	post-menopausal	C0206159
28469263	women	C0043210
28469263	Micro-CT	C2350281
28469263	immunohistochemistry	C0021044
28469263	assess	C0184514
28469263	morphological	C0543482
28469263	molecular	C1521991
28469263	changes	C0392747
28469263	ovariectomy	C0029936
28469263	induced	C0205263
28469263	LFJ	C0507372
28469263	arthritis	C0003864
28469263	results	C1274040
28469263	LFJ	C0507372
28469263	subchondral bone mass	C0005938
28469263	decreased	C0205216
28469263	OVX mice	C0025929
28469263	increased	C0205217
28469263	cavities	C0229984
28469263	interface	C1254362
28469263	subchondral bone	C0262950
28469263	Severe	C0205082
28469263	cartilage	C0007301
28469263	degradation	C0243125
28469263	ovariectomy	C0029936
28469263	induced	C0205263
28469263	LFJ	C0507372
28469263	arthritis	C0003864
28469263	Increased	C0205217
28469263	blood vessels	C0005847
28469263	innervations	C1619351
28469263	degenerated	C0011164
28469263	LFJ	C0507372
28469263	subchondral bone	C0262950
28469263	area	C0005898
28469263	17β-Estradiol	C0014912
28469263	treatment	C0087111
28469263	suppressed	C1260953
28469263	LFJ	C0507372
28469263	subchondral bone turnover	C0231544
28469263	inhibited	C0311403
28469263	cartilage	C0007301
28469263	degradation	C0243125
28469263	increased	C0205217
28469263	blood vessel	C0005847
28469263	nerve ending	C0027747
28469263	growth	C0018270
28469263	degenerated	C0011164
28469263	LFJ	C0507372
28469263	OVX mice	C0025929
28469263	study	C2603343
28469263	estrogen	C0014939
28469263	factor	C1521761
28469263	regulating LFJ metabolism	C0518894
28469263	Severe	C0205082
28469263	LFJ	C0507372
28469263	degeneration	C0011164
28469263	estrogen	C0014939
28469263	absent	C0332197
28469263	in vivo	C1515655
28469263	Collapsed	C0392748
28469263	subchondral bone	C0262950
28469263	initiation	C1704686
28469263	process	C1522240
28469263	estrogen replacement therapy	C0014935
28469263	degeneration	C0011164
28469263	LFJ	C0507372
28469263	estrogen	C0014939
28469263	deficient	C0011155
28469263	conditions	C0348080
28470100	Dexmedetomidine	C0113293
28470100	Effect	C1280500
28470100	Emergence Agitation	C0920253
28470100	Delirium	C0011206
28470100	Children	C0008059
28470100	Laparoscopic Hernia Repair	C2111384
28470100	Preliminary	C0439611
28470100	Study	C2603343
28470100	safety	C0678800
28470100	efficacy	C1280519
28470100	dexmedetomidine	C0113293
28470100	Dex	C0113293
28470100	emergence agitation	C0920253
28470100	EA	C0920253
28470100	delirium	C0011206
28470100	ED	C0011206
28470100	children	C0008059
28470100	laparoscopic hernia repair	C2111384
28470100	general anesthesia	C0002915
28470100	children	C0008059
28470100	years	C0439234
28470100	randomized	C0034656
28470100	groups	C0441833
28470100	controls	C0009932
28470100	saline	C0036082
28470100	intravenous	C0348016
28470100	Dex	C0113293
28470100	D1	C0178602
28470100	D2	C0178602
28470100	D3	C0178602
28470100	Dex	C0113293
28470100	saline	C0036082
28470100	infusion	C0574032
28470100	anesthesia	C4049933
28470100	EA	C0920253
28470100	ED	C0011206
28470100	5-point scale	C0282574
28470100	C	C0009932
28470100	D1	C0178602
28470100	D2	C0178602
28470100	D3	C0178602
28470100	groups	C0441833
28470100	EA	C0920253
28470100	frequencies	C0439603
28470100	ED	C0011206
28470100	frequencies	C0439603
28470100	CHIPPS	C1504479
28470100	scores	C0449820
28470100	sevoflurane	C0074414
28470100	doses	C0178602
28470100	controls	C0009932
28470100	D3	C0178602
28470100	Intervals	C1272706
28470100	mask	C0024861
28470100	removal	C1883720
28470100	spontaneous eye opening	C1882151
28470100	longer	C0205166
28470100	D2	C0178602
28470100	D3	C0178602
28470100	controls	C0009932
28470100	PACU	C0034871
28470100	stay	C3489408
28470100	longer	C0205166
28470100	D3	C0178602
28470100	postoperative	C0032790
28470100	EA	C0920253
28470100	pain	C0030201
28470100	sevoflurane	C0074414
28470100	Dex	C0113293
28471040	Farnesylthiosalicylic acid	C0297002
28471040	lipid-polyethylene glycol-polymer hybrid nanoparticles	C1254351
28471040	treatment	C0087111
28471040	glioblastoma	C0017636
28471040	lipid-polyethylene glycol (PEG)-polymer hybrid nanoparticles	C1254351
28471040	tumour tissue	C0475358
28471040	active ingredient	C1372955
28471040	generation	C0079411
28471040	antineoplastic drug	C0003392
28471040	farnesylthiosalicylic acid	C0297002
28471040	FTA	C0297002
28471040	treatment	C0087111
28471040	glioblastoma	C0017636
28471040	Farnesylthiosalicylic acid	C0297002
28471040	poly(lactic-co-glycolic acid)-1,2 distearoyl-glycerol-3-phospho-ethanolamine-N [methoxy (PEG)-2000] ammonium salt	C1254351
28471040	PLGA-DSPE-PEG	C1254351
28471040	1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) hybrid nanoparticles	C1254351
28471040	prepared	C4082130
28471040	evaluated	C0220825
28471040	in-vitro characterization	C0681828
28471040	Cytotoxicity	C0596402
28471040	FTA-loaded nanoparticles	C0297002
28471040	efficacy	C0013682
28471040	rat glioma-2 (RG2) cells	C0007634
28471040	evaluated	C0220825
28471040	in vitro	C0681828
28471040	non-malignant cell line, L929	C0007600
28471040	in vivo	C0681829
28471040	Scanning electron microscopy studies	C0523160
28471040	formulations prepared	C1705957
28471040	smooth surface	C1182795
28471040	spherical in shape	C0332501
28471040	FTA	C0297002
28471040	FTA-loaded nanoparticles	C0297002
28471040	cytotoxic activity	C0596402
28471040	RG2 glioma cell lines	C0007600
28471040	cell culture studies	C0681854
28471040	DOTAP	C1254351
28471040	Magnetic resonance imaging	C0024485
28471040	histopathologic	C0677043
28471040	evaluation	C0220825
28471040	RG2 tumour cells	C0431085
28471040	rat glioma model	C0012644
28471040	Wistar rats	C0034716
28471040	intravenous	C0021494
28471040	intratumoral injections	C1517565
28471040	drug	C1254351
28471040	FTA-loaded nanoparticles	C0297002
28471040	tumour size	C0475440
28471040	in-vivo studies	C0681829
28471040	efficiency	C0013682
28471040	intratumoral administration	C1517565
28471040	intravenous route	C1522726
28471040	Farnesylthiosalicylic acid	C0297002
28471040	PLGA-DSPE-PEG-DOTAP hybrid nanoparticles	C1254351
28471040	effective	C1704419
28471040	glioblastoma	C0017636
28471040	in-vitro	C0681828
28471040	in-vivo experiments	C0681829
28471296	Map learning	C0582587
28471296	working memory	C0025265
28471296	learning strategies	C0237896
28471296	research	C0035168
28471296	learning spatial	C0582587
28471296	information	C1533716
28471296	map	C0024779
28471296	different modalities	C1275506
28471296	working memory	C0025265
28471296	participants	C0679646
28471296	simultaneous	C0521115
28471296	interference task	C0025361
28471296	cognitive load	C0870301
28471296	without interference	C0025361
28471296	cognitive load	C0870301
28471296	modality	C0695347
28471296	interference	C0679066
28471296	tapping task	C0025361
28471296	visuospatial	C0814069
28471296	backwards counting task	C0025361
28471296	verbal	C0439824
28471296	articulatory	C0003910
28471296	suppression task	C0201782
28471296	verbal	C0439824
28471296	n-back task	C0025361
28471296	central executive	C0025361
28471296	Spatial recall	C0243095
28471296	assessed	C1516048
28471296	directional judgements	C0022423
28471296	map drawing	C0699866
28471296	Cognitive load	C0870301
28471296	spatial recall	C0243095
28471296	regardless	C3641650
28471296	interference	C0679066
28471296	modality	C0695347
28471296	learning maps	C0582587
28471296	learning strategy	C0237896
28471296	resources	C0035201
28471296	working memory	C0025265
28471656	4-Anilino-2-pyridylquinazolines	C0034407
28471656	pyrimidines	C0034289
28471656	Potent	C0442821
28471656	Nontoxic	C1518413
28471656	Inhibitors	C0243077
28471656	Breast Cancer Resistance Protein	C0761993
28471656	ABCG2	C0761993
28471656	Multidrug resistance	C0242640
28471656	MDR	C0242640
28471656	ATP-binding cassette (ABC) transport proteins	C0242738
28471656	chemotherapeutic treatment	C3665472
28471656	cancer	C0027651
28471656	overcome	C2983310
28471656	inhibition	C3463820
28471656	transporter	C0596902
28471656	mechanisms	C0441712
28471656	transport process	C1519628
28471656	breast cancer resistance protein	C0761993
28471656	BCRP	C0761993
28471656	ABCG2	C0761993
28471656	inhibitors	C0243077
28471656	ABCG2	C0761993
28471656	investigated	C1292732
28471656	4-substituted-2-pyridylquinazolines	C0034407
28471656	inhibitory	C3463820
28471656	potency	C3245505
28471656	selectivity	C0037791
28471656	ABCG2	C0761993
28471656	quinazoline scaffold	C0034407
28471656	4-methylpyrimidine	C0034289
28471656	cytotoxicity	C0596402
28471656	reverse	C1555029
28471656	MDR	C0242640
28471656	chemotherapeutic agents	C0729502
28471656	SN-38	C0142710
28471656	mitoxantrone	C0026259
28471656	MX	C0026259
28471656	Interaction	C1704675
28471656	compounds	C1706082
28471656	ABCG2	C0761993
28471656	investigated	C1292732
28471656	colorimetric	C1531834
28471656	ATPase	C0001473
28471656	assay	C2717977
28471656	Enzyme kinetic studies	C1516893
28471656	Hoechst 33342	C0062907
28471656	fluorescent dye	C0016320
28471656	substrate	C3891814
28471656	ABCG2	C0761993
28471656	compounds	C1706082
28471656	binding modes	C1145667
28472521	Biosamples	C1706958
28472521	Smoking Cessation	C0085134
28472521	Trials	C0008976
28472521	Genetic	C0730319
28472521	Metabolomic	C1328813
28472521	Epigenetic	C1516924
28472521	Findings	C0243095
28472521	genotypes	C0017431
28472521	biomarkers	C0005516
28472521	smoking cessation	C0085134
28472521	smoking cessation treatments	C1095963
28472521	smoking cessation treatment	C1095963
28472521	individual's	C0237401
28472521	genetic	C2986505
28472521	metabolic profile	C3853758
28472521	incentive	C0021147
28472521	smoking cessation	C0085134
28472521	researchers	C0687734
28472521	biosamples	C1706958
28472521	genotyping	C1285573
28472521	research studies	C0681814
28472521	clinical trials	C0008976
28473083	ACR	C1515941
28473083	Appropriateness Criteria	C0243161
28473083	Radiologic	C0205483
28473083	Management	C0376636
28473083	Mesenteric Ischemia	C1412000
28473083	Mesenteric vascular insufficiency	C1412000
28473083	medical condition	C3843040
28473083	bowel infarction	C0241950
28473083	morbidity	C0026538
28473083	mortality	C0178686
28473083	approach	C0449445
28473083	therapy	C0087111
28473083	acute mesenteric ischemia	C0001363
28473083	aspiration	C0349707
28473083	embolectomy	C0162575
28473083	transcatheter	C0203005
28473083	thrombolysis	C0040044
28473083	angioplasty	C0162577
28473083	stenting	C2348535
28473083	treatment	C0087111
28473083	arterial stenosis	C0238397
28473083	Nonocclusive mesenteric ischemia	C3852986
28473083	transarterial infusion	C0021439
28473083	vasodilators	C0042402
28473083	nitroglycerin	C0017887
28473083	papaverine	C0030350
28473083	glucagon	C0017687
28473083	prostaglandin E1	C0002335
28473083	therapy	C0087111
28473083	chronic mesenteric ischemia	C0311262
28473083	angioplasty	C0162577
28473083	stent placement	C0522776
28473083	endovascular approach	C1997114
28473083	surgical bypass	C1536078
28473083	endarterectomy	C0014098
28473083	diagnosis	C0011900
28473083	median arcuate ligament syndrome	C1861783
28473083	surgical	C0543467
28473083	clinical situation	C0018759
28473083	Venous	C0348013
28473083	mesenteric ischemia	C1412000
28473083	systemic	C0205373
28473083	anticoagulation	C0003281
28473083	Transhepatic	C0589464
28473083	transjugular	C1254362
28473083	superior mesenteric vein	C0226742
28473083	catheterization and thrombolytic infusion	C2025545
28473083	symptoms	C1457887
28473083	condition of the patient	C0683521
28473083	response	C0871261
28473083	systemic	C0205373
28473083	anticoagulation	C0003281
28473083	Adjunct	C1719882
28473083	transjugular intrahepatic portosystemic shunt creation	C0339897
28473083	improvement	C2986411
28473083	American College of Radiology	C1515941
28473083	Appropriateness Criteria	C0243161
28473083	evidence-based	C1510541
28473083	guidelines	C0162791
28473083	clinical conditions	C0683521
28473083	reviewed	C1709940
28473083	annually	C0332181
28473083	multidisciplinary expert panel	C1319406
28473083	guideline	C0162791
28473083	development	C1527148
28473083	revision	C0439617
28473083	extensive analysis	C0936012
28473083	medical literature	C0025120
28473083	peer-reviewed journals	C2985503
28473083	methodologies	C0086912
28473083	RAND	C3826892
28473083	UCLA	C4285296
28473083	Appropriateness	C0814634
28473083	Grading of Recommendations Assessment, Development, and Evaluation	C0282574
28473083	GRADE	C0282574
28473083	appropriateness	C0814634
28473083	imaging	C0079595
28473083	treatment procedures	C0087111
28473083	clinical	C0205210
28473083	scenarios	C0683579
28473083	instances	C1550608
28473083	evidence	C3887511
28473083	lacking	C0332268
28473083	equivocal	C0332241
28473083	expert opinion	C0600219
28473083	supplement	C2348609
28473083	evidence	C3887511
28473083	imaging	C0079595
28473083	treatment	C0087111
28476060	Blur	C1511231
28476060	perception	C0030971
28476060	visual field	C0042826
28476060	myopia	C0027092
28476060	emmetropia	C0234622
28476060	evaluated	C0220825
28476060	ability	C0085732
28476060	emmetropic	C0234622
28476060	myopic	C0027092
28476060	observers	C0870992
28476060	detect	C0442726
28476060	discriminate	C0205235
28476060	blur	C1511231
28476060	retina	C0035298
28476060	monocular	C0042797
28476060	binocular viewing	C0042794
28476060	conditions	C0348080
28476060	recruited	C2949735
28476060	young	C0332239
28476060	healthy adults	C0686750
28476060	myopes	C0027092
28476060	best-corrected	C4072794
28476060	visual acuity	C0042812
28476060	LogMAR (20/20)	C0007963
28476060	better	C0332272
28476060	eye	C0015392
28476060	no binocular	C0243095
28476060	accommodative dysfunction	C0042790
28476060	Monocular	C0042797
28476060	binocular	C0042794
28476060	blur	C1511231
28476060	discrimination	C0205235
28476060	thresholds	C0449864
28476060	measured	C0444706
28476060	function	C1705273
28476060	pedestal blur	C1511231
28476060	naturalistic	C0205296
28476060	stimuli	C0234402
28476060	adaptive 4AFC procedure	C0430872
28476060	Stimuli	C0234402
28476060	presented	C0449450
28476060	diameter	C1301886
28476060	Gaussian blur pedestals	C1511231
28476060	confined	C0443288
28476060	annulus	C3273359
28476060	eccentricity	C0871265
28476060	blur	C1511231
28476060	increment	C1705117
28476060	applied	C4048755
28476060	one quadrant	C1631280
28476060	image	C1704922
28476060	adaptive procedure	C0430872
28476060	efficiently	C0442799
28476060	estimated	C0750572
28476060	dipper shaped	C0243095
28476060	blur	C1511231
28476060	discrimination	C0205235
28476060	threshold	C0449864
28476060	function	C1705273
28476060	two	C0205448
28476060	parameters	C0549193
28476060	intrinsic	C0205102
28476060	blur	C1511231
28476060	blur	C1511231
28476060	sensitivity	C0332324
28476060	amount	C1265611
28476060	intrinsic	C0205102
28476060	blur	C1511231
28476060	increased	C0205217
28476060	retinal eccentricities	C0871265
28476060	lower	C2003888
28476060	binocular	C0042794
28476060	monocular	C0042797
28476060	conditions	C0348080
28476060	similar	C2348205
28476060	refractive	C0870812
28476060	groups	C0441833
28476060	Blur	C1511231
28476060	sensitivity	C0332324
28476060	decreased	C0205216
28476060	retinal eccentricity	C0871265
28476060	highest	C1522410
28476060	binocular	C0042794
28476060	central vision	C0678899
28476060	Myopes	C0027092
28476060	worse	C1457868
28476060	blur	C1511231
28476060	sensitivity	C0332324
28476060	emmetropes	C0234622
28476060	monocularly	C0042797
28476060	binocularly	C0042794
28476060	blur	C1511231
28476060	perception	C0030971
28476060	worsens	C1457868
28476060	visual periphery	C0234628
28476060	binocular	C0042794
28476060	summation	C0234108
28476060	evident	C0750489
28476060	central vision	C0678899
28476060	myopes	C0027092
28476060	monocular	C0042797
28476060	impairment	C0221099
28476060	blur	C1511231
28476060	sensitivity	C0332324
28476060	improves	C0184511
28476060	binocular	C0042794
28476060	conditions	C0348080
28476060	Implications	C0679201
28476060	development	C1527148
28476060	myopia	C0027092
28476508	Risk Factors	C0035648
28476508	Neurological Deterioration	C1536136
28476508	Patients	C0030705
28476508	Cerebral Infarction	C0007785
28476508	Large-Artery Atherosclerosis	C2711237
28476508	patients	C0030705
28476508	acute	C0205178
28476508	ischemic stroke	C0948008
28476508	neurological deterioration	C1536136
28476508	ND	C1536136
28476508	observed	C1441672
28476508	difficult	C0332218
28476508	predict	C0681842
28476508	time of admission	C3854259
28476508	patients	C0030705
28476508	large-artery atherosclerosis	C2711237
28476508	LAA	C2711237
28476508	aggressive	C0580822
28476508	medical treatments	C0237726
28476508	surgical interventions	C4035998
28476508	helpful	C3898897
28476508	ND	C1536136
28476508	investigated	C1292732
28476508	factors	C0014501
28476508	associated with	C0332281
28476508	ND	C1536136
28476508	patients	C0030705
28476508	LAA	C2711237
28476508	studied	C2603343
28476508	patients	C0030705
28476508	LAA	C2711237
28476508	admitted to our hospital	C0184666
28476508	divided	C0332849
28476508	groups	C0441833
28476508	group	C0441833
28476508	deterioration	C0234985
28476508	group	C0441833
28476508	evaluated	C0220825
28476508	medical records	C0025102
28476508	risk factors	C0035648
28476508	radiological	C0929225
28476508	findings	C0243095
28476508	diffusion	C0012222
28476508	positive	C1514241
28476508	lesion	C0221198
28476508	degree of stenosis	C4034225
28476508	study population	C2348561
28476508	patients	C0030705
28476508	suffer	C0683278
28476508	deterioration	C0234985
28476508	univariate analysis	C0683962
28476508	blood pressure	C0005823
28476508	BP	C0005823
28476508	heart rate	C0018810
28476508	National Institutes of Health Stroke Scale (NIHSS) score	C4269147
28476508	diffusion	C0012222
28476508	positive	C1514241
28476508	lesion	C0221198
28476508	count of red blood cell	C0014772
28476508	high-density lipoprotein	C0023821
28476508	degree of stenosis	C4034225
28476508	significantly	C0750502
28476508	groups	C0441833
28476508	multivariate analysis	C0026777
28476508	systolic BP	C0871470
28476508	odds ratio	C0028873
28476508	associated with	C0332281
28476508	ND	C1536136
28476508	diffusion-weighted image	C0598801
28476508	DWI	C0598801
28476508	positive	C1514241
28476508	lesion	C0221198
28476508	degree of stenosis	C4034225
28476508	NIHSS score	C4269147
28476508	independent	C0085862
28476508	factors	C0014501
28476508	associated with	C0332281
28476508	ND	C1536136
28476508	High BP	C0020538
28476508	severity	C0439793
28476508	neurological deficit	C0521654
28476508	time of admission	C3854259
28476508	radiological	C0929225
28476508	findings	C0243095
28476508	degree of stenosis	C4034225
28476508	DWI	C0598801
28476508	positive	C1514241
28476508	lesion	C0221198
28476508	independently	C0243095
28476508	associated with	C0332281
28476508	ND	C1536136
28476508	patients	C0030705
28476508	LAA	C2711237
28477843	Development	C1527148
28477843	validation	C1519941
28477843	risk assessment tool	C0086930
28477843	low back	C0230102
28477843	loading	C1318107
28477843	Lifting Fatigue Failure Tool	C0005479
28477843	LiFFT	C0005479
28477843	musculoskeletal disorders	C0026857
28477843	MSDs	C0026857
28477843	fatigue	C0015672
28477843	failure process	C0231174
28477843	affected	C0392760
28477843	tissues	C0040300
28477843	low back exposure	C1318107
28477843	assessment tool	C0005479
28477843	Lifting Fatigue Failure Tool	C0005479
28477843	LiFFT	C0005479
28477843	daily dose	C2348070
28477843	cumulative	C1511559
28477843	loading	C1318107
28477843	low back	C0230102
28477843	fatigue	C0015672
28477843	failure	C0231174
28477843	principles	C0178566
28477843	variables	C0439828
28477843	cumulative	C1511559
28477843	load	C1318107
28477843	associated with	C0332281
28477843	lifting	C0206244
28477843	task	C3540678
28477843	weight of the load	C0043100
28477843	horizontal distance	C0012751
28477843	spine	C0037949
28477843	to the load	C1318107
28477843	repetitions	C0205341
28477843	tasks performed	C0039333
28477843	workday	C0680192
28477843	new tool	C0005479
28477843	validated	C1519941
28477843	epidemiological	C1516907
28477843	databases	C0242356
28477843	Lumbar Motion	C0575375
28477843	Lumbar Motion Monitor	C0575375
28477843	LMM	C0575375
28477843	database	C0242356
28477843	database	C0242356
28477843	U.S	C0041703
28477843	automotive manufacturer	C3641679
28477843	LiFFT	C0005479
28477843	cumulative damage metric	C0558029
28477843	low back disorders	C0024031
28477843	LBDs	C0024031
28477843	LMM database	C0677336
28477843	low back outcomes	C0085415
28477843	automotive database	C0589476
28477843	outcome measure	C0086749
28477843	LiFFT	C0005479
28477843	practitioner friendly	C0205556
28477843	cumulative	C1511559
28477843	damage metric	C0558029
28477843	low back outcomes	C0085415
28478603	Genetic Diversity	C0042333
28478603	Accessions	C1510755
28478603	Pineapple	C0946573
28478603	Ananas comosus (L.) Merr.	C0946573
28478603	ISSR	C0039290
28478603	SSR	C1519302
28478603	Markers	C0012872
28478603	Inter simple sequence repeat	C0039290
28478603	ISSR	C0039290
28478603	simple sequence repeat	C1519302
28478603	SSR	C1519302
28478603	markers	C0012872
28478603	genetic diversity	C0042333
28478603	pineapple	C0946573
28478603	accessions	C1510755
28478603	countries	C0454664
28478603	regions	C0017446
28478603	ISSR	C0039290
28478603	primers	C0206415
28478603	amplified	C1441475
28478603	polymorphic	C1882417
28478603	SSR	C1519302
28478603	primers	C0206415
28478603	amplified	C1441475
28478603	polymorphic	C1882417
28478603	Nei's gene diversity	C0282574
28478603	h	C0282574
28478603	Shannon's information index	C0918012
28478603	I	C0918012
28478603	polymorphism information content	C0282574
28478603	PIC	C0282574
28478603	SSR	C1519302
28478603	primers	C0206415
28478603	ISSR	C0039290
28478603	primers	C0206415
28478603	h	C0282574
28478603	I	C0918012
28478603	PIC	C0282574
28478603	SSR system	C1519302
28478603	ISSR system	C0039290
28478603	genetic diversity	C0042333
28478603	pineapple	C0946573
28478603	accessions	C1510755
28478603	genetic	C0314603
28478603	similarities	C2348205
28478603	ISSR	C0039290
28478603	SSR	C1519302
28478603	ISSR	C0039290
28478603	SSR	C1519302
28478603	genetic diversity	C0042333
28478603	pineapple	C0946573
28478603	accessions	C1510755
28478603	clustered	C1881045
28478603	pineapple	C0946573
28478603	accessions	C1510755
28478603	phylogenetic trees	C1519069
28478603	ISSR	C0039290
28478603	SSR	C1519302
28478603	ISSR	C0039290
28478603	SSR	C1519302
28478603	analyses	C0936012
28478603	unweighted pair-group with arithmetic averaging (UPGMA) method	C0025663
28478603	principal components analysis	C0429865
28478603	PCA	C0429865
28478603	UPGMA	C0025663
28478603	clustering	C1881045
28478603	pineapple	C0946573
28478603	germplasm	C4046074
28478603	pineapple	C0946573
28478603	breeding strategies	C4042898
28478636	Advanced age	C1999167
28478636	barrier	C0443288
28478636	functional	C0205245
28478636	arteriovenous fistula	C1541850
28478636	retrospective study	C0035363
28478636	Arteriovenous fistulas	C1541850
28478636	AVFs	C1541850
28478636	vascular access	C0750138
28478636	hemodialysis	C0019004
28478636	controversy	C0680243
28478636	AVFs	C1541850
28478636	elderly	C0001792
28478636	patients	C0030705
28478636	Single-center retrospective review	C0035363
28478636	investigate	C1292732
28478636	impact	C4049986
28478636	age	C0001779
28478636	AVF	C1541850
28478636	outcomes	C1274040
28478636	patients	C0030705
28478636	AVF	C1541850
28478636	creation	C1706214
28478636	stratified	C0205363
28478636	age	C0001779
28478636	<65	C0027362
28478636	65-75	C0027362
28478636	>75	C0027362
28478636	years	C0439234
28478636	AVF	C1541850
28478636	outcomes	C1274040
28478636	primary	C0205225
28478636	failure	C0231174
28478636	AVF	C1541850
28478636	patency	C0042377
28478636	primary	C0205225
28478636	secondary	C0175668
28478636	functional	C0205245
28478636	AVF	C1541850
28478636	complications	C0009566
28478636	years	C0439234
28478636	AVF	C1541850
28478636	creation	C1706214
28478636	cohort	C0599755
28478636	male	C0025266
28478636	Caucasian	C0043157
28478636	diabetes	C0011847
28478636	cardiovascular disease	C0007222
28478636	aged	C0001779
28478636	<65	C0027362
28478636	years	C0439234
28478636	65-75	C0027362
28478636	years	C0439234
28478636	aged	C0001779
28478636	>75	C0027362
28478636	years	C0439234
28478636	primary	C0205225
28478636	failure	C0231174
28478636	primary	C0205225
28478636	patency	C0042377
28478636	complications	C0009566
28478636	intervention	C0184661
28478636	age groups	C0027362
28478636	association	C0439849
28478636	age	C0001779
28478636	secondary	C0175668
28478636	patency	C0042377
28478636	functional	C0205245
28478636	patency	C0042377
28478636	age	C0001779
28478636	>75	C0027362
28478636	risk factor	C0035648
28478636	shortened	C1282927
28478636	lifespan	C1254367
28478636	patients	C0030705
28478636	aged	C0001779
28478636	>75	C0027362
28478636	years	C0439234
28478636	secondary	C0175668
28478636	patency	C0042377
28478636	years	C0439234
28478636	younger	C0332239
28478636	patients	C0030705
28478636	Functional	C0205245
28478636	patency	C0042377
28478636	years	C0439234
28478636	aged	C0001779
28478636	>75	C0027362
28478636	years	C0439234
28478636	younger	C0332239
28478636	patients	C0030705
28478636	AVF	C1541850
28478636	maturation	C1254042
28478636	primary	C0205225
28478636	patency	C0042377
28478636	complications	C0009566
28478636	interventions	C0184661
28478636	age	C0001779
28478636	75	C0027362
28478636	younger	C0332239
28478636	secondary	C0175668
28478636	functional	C0205245
28478636	patency	C0042377
28478636	rates	C1521828
28478636	aged	C0001779
28478636	>75	C0027362
28478636	years	C0439234
28478636	advanced age	C1999167
28478636	patients	C0030705
28478636	AVF	C1541850
28478636	creation	C1706214
28479312	modified	C0392747
28479312	ESBL	C0486433
28479312	ESBL Nordmann/Dortet/Poirel-based protocol	C0022885
28479312	optimize	C2698650
28479312	early	C1279919
28479312	sepsis	C0243026
28479312	management	C0376636
28479312	evaluated	C1292732
28479312	modification	C0392747
28479312	colorimetric test	C1531834
28479312	detection	C1511790
28479312	ESBL	C0486433
28479312	Enterobacteriaceae	C0014346
28479312	positive	C1446409
28479312	blood cultures	C0200949
28479312	manipulation	C0022885
28479312	materials	C0520510
28479312	time	C0040223
28479312	protocol	C0022885
28479312	sensitivity	C0332324
28479312	specificity	C0037791
28480148	development	C1527148
28480148	robust viromics	C0042720
28480148	examinations	C0242481
28480148	Metagenomics	C2717799
28480148	microbial communities	C0599840
28480148	maintaining life on this planet	C0184640
28480148	Sequencing	C0487717
28480148	genetic content	C0017272
28480148	phage communities	C0004651
28480148	sequences	C0162801
28480148	sequence	C0162801
28480148	data repositories	C3847505
28480148	small fraction	C1264633
28480148	BLAST	C2698333
28480148	representative	C1882932
28480148	viral taxon	C0597651
28480148	Homology	C2697616
28480148	classification	C0008902
28480148	sequence repositories	C0026382
28480148	small fraction	C1264633
28480148	phage diversity	C0004651
28480148	lateral	C0205093
28480148	gene transfer	C1517499
28480148	pervasive	C0205391
28480148	phage communities	C0004651
28480148	particular gene	C0017337
28480148	particular viral species	C0042776
28480148	indication	C3146298
28480148	specific gene	C0017337
28480148	limitation	C0449295
28480148	analysis of viral metagenomic datasets	C3854164
28480148	BLAST	C2698333
28480148	integrating the sequence identity	C2359783
28480148	length of alignments	C0080143
28480148	taxonomic signal	C0008903
28480148	each gene	C0017337
28480148	information content	C1533716
28480148	quantifiable metric	C0025867
28480148	predictions	C0681842
28480148	viral community	C1956108
28480148	proof-of-concept	C1254370
28480148	implemented	C1708476
28480148	freshwater viral metagenomes	C2717745
28480148	robust method	C2986815
28480148	viral metagenomic data	C2717799
28480148	tool	C0037589
28480148	versatile	C0205556
28480148	customized	C1880202
28480148	investigations	C1261322
28480148	environment	C0014406
28480148	biome	C1956108
28480413	PRESENCE OF	C0150312
28480413	CITRININ	C0008861
28480413	GRAINS	C0007757
28480413	POSSIBLE	C0332149
28480413	HEALTH	C0018684
28480413	EFFECTS	C1280500
28480413	Citrinin	C0008861
28480413	mycotoxin	C0026955
28480413	produced	C0205245
28480413	species	C1705920
28480413	genera Aspergillus	C0004034
28480413	Penicillium	C0030843
28480413	Monascus	C0997448
28480413	occurs	C1709305
28480413	stored grain	C0007757
28480413	Citrinin	C0008861
28480413	formed	C0205431
28480413	harvest	C0205245
28480413	occurs	C1709305
28480413	stored grains	C0007757
28480413	occurs	C1709305
28480413	other plant products	C0541488
28480413	co-occurrence	C2745955
28480413	mycotoxins	C0026955
28480413	observed	C1441672
28480413	ochratoxin A	C0069299
28480413	associated with	C0332281
28480413	endemic nephropathy	C0004698
28480413	European Union	C0015179
28480413	level	C0441889
28480413	systematic	C0220922
28480413	monitoring	C1283169
28480413	Citrinin	C0008861
28480413	grains	C0007757
28480413	aim	C1947946
28480413	determining	C0205556
28480413	permissible amount	C1265611
28480413	food	C0016452
28480413	systematic	C0220922
28480413	monitoring	C1283169
28480413	above mentioned mycotoxin	C0008861
28480413	Croatia	C0010343
28480413	begin	C0439659
28480413	main goal	C0018017
28480413	study	C2603343
28480413	determine	C0205556
28480413	presence of	C0150312
28480413	Citrinin	C0008861
28480413	grains	C0007757
28480413	sampled	C0870078
28480413	area	C0205146
28480413	Međimurje	C0079170
28480413	Osijek-Baranja	C0079170
28480413	Vukovar-Srijem	C0079170
28480413	Brod-Posavina County	C0079170
28480413	purpose	C1285529
28480413	identification	C0205396
28480413	quantification	C1709793
28480413	citrinin	C0008861
28480413	high performance liquid chromatograph (HPLC) with fluorescence	C4054775
28480413	used	C1273517
28480413	Calibration curve	C0006751
28480413	Intra assay CV	C3176771
28480413	Inter assay CV	C3176771
28480413	LOQ	C1709793
28480413	area	C0205146
28480413	Međimurje County	C0079170
28480413	samples	C0370003
28480413	corn	C1138842
28480413	samples	C0370003
28480413	wheat	C0043137
28480413	analyzed	C0936012
28480413	samples	C0370003
28480413	contained	C2700400
28480413	Citrinin	C0008861
28480413	area	C0205146
28480413	Osijek-Baranja	C0079170
28480413	Vukovar-Srijem County	C0079170
28480413	samples	C0370003
28480413	County	C0079170
28480413	analyzed	C0936012
28480413	mean value	C0444504
28480413	samples	C0370003
28480413	Osijek-Baranja County	C0079170
28480413	median	C2348144
28480413	Vukovar-Srijem County	C0079170
28480413	mean value	C0444504
28480413	citrinin	C0008861
28480413	median	C2348144
28480413	analyzed	C0936012
28480413	samples	C0370003
28480413	Brod-Posavina County	C0079170
28480413	samples	C0370003
28480413	contained	C2700400
28480413	citrinin	C0008861
28480413	amount	C1265611
28480413	registered	C1514821
28480413	amount	C1265611
28480413	samples	C0370003
28480413	results	C1274040
28480413	grains	C0007757
28480413	several	C0439064
28480413	Counties	C0079170
28480413	contain	C2700400
28480413	amounts	C1265611
28480413	Citrinin	C0008861
28480413	indicating	C1444656
28480413	significant	C0750502
28480413	intake	C1512806
28480413	citrinin	C0008861
28480413	humans	C0086418
28480413	grains	C0007757
28480413	grain-based products	C0016452
28480413	everyday	C0332173
28480413	diet	C0012155
28480413	age groups	C0027362
28480413	small children	C0008059
28480413	higher	C0205250
28480413	intake	C1512806
28480413	citrinin	C0008861
28480413	occur	C1709305
28480413	emphasize	C0205556
28480413	systematic	C0220922
28480413	analysis	C0936012
28480413	larger amount	C1265611
28480413	samples	C0370003
28480413	large grains	C0007757
28480413	small grains	C0007757
28480413	area	C0205146
28480413	Brod-Posavina County	C0079170
28480413	citrinin	C0008861
28480413	contamination	C2349974
28480413	grains	C0007757
28480413	asses	C1516048
28480413	health	C0018684
28480413	risk	C0035647
28480413	humans	C0086418
28481342	Recurrent noncoding regulatory mutations	C0026882
28481342	pancreatic ductal adenocarcinoma	C1335302
28481342	contributions	C1880177
28481342	coding mutations	C0026882
28481342	tumorigenesis	C0007621
28481342	somatic alterations	C0544886
28481342	noncoding DNA	C0021920
28481342	somatic noncoding alterations	C0544886
28481342	pancreatic ductal adenocarcinomas	C1335302
28481342	PDAs	C1335302
28481342	mutated regulatory regions	C0004793
28481342	recurrent noncoding mutations	C0026882
28481342	PDA	C1335302
28481342	pathways	C1704259
28481342	axon guidance	C2984268
28481342	cell adhesion	C0007577
28481342	identified	C0205396
28481342	processes	C1522240
28481342	transcription	C0040649
28481342	homeobox genes	C0017347
28481342	identified	C0205396
28481342	mutations	C0026882
28481342	protein binding sites	C1514535
28481342	differential	C0443199
28481342	expression	C0017262
28481342	proximal	C0205107
28481342	genes	C0017337
28481342	effects of	C1704420
28481342	mutations	C0026882
28481342	expression	C0017262
28481342	expression modulation score	C0392762
28481342	quantifies	C1709793
28481342	strength	C0808080
28481342	gene regulation	C0017263
28481342	regulatory elements	C0017362
28481342	elements	C0017362
28481342	single-cancer analysis	C0022885
28481342	noncoding alterations	C0026882
28481342	regulatory mutations	C0026882
28481342	candidates	C0205556
28481342	diagnostic	C1511876
28481342	prognostic markers	C1514475
28481342	mechanisms	C0441712
28481342	tumor evolution	C0007621
28484550	Distal	C0205108
28484550	posterior cerebral artery	C0149576
28484550	revascularization	C0007794
28484550	fusiform	C0332493
28484550	PCA	C0149576
28484550	aneurysm	C0002940
28484550	revascularization	C0007794
28484550	proximal	C0205107
28484550	posterior cerebral artery	C0149576
28484550	occlusion	C0028790
28484550	treatment	C1522326
28484550	giant	C0751004
28484550	fusiform aneurysms	C0333099
28484550	infarction	C0021308
28484550	posterior cerebral artery	C0149576
28484550	occlusion	C0028790
28484550	authors	C3812881
28484550	bypass	C0741847
28484550	vessel	C0005847
28484550	fusiform aneurysm	C0333099
28484550	posterior cerebral artery	C0149576
28484550	P2-P3 junction	C0682580
28484550	clinically failed	C3640841
28484550	balloon test occlusion	C3697458
28484550	preoperatively	C0445204
28484550	occipital artery	C0226117
28484550	distal	C0205108
28484550	posterior cerebral artery	C0149576
28484550	bypass	C0741847
28484550	endovascular occlusion of the parent vessel	C2223520
28484550	aneurysm	C0002940
28484550	follow up	C1522577
28484550	cerebral angiography	C0007767
28484550	bypass	C0741847
28484550	patient	C0030705
28484550	posterior cerebral artery	C0149576
28484550	territory stroke	C0038454
28484550	distal	C0205108
28484550	revascularization	C0007794
28484550	proximal	C0205107
28484550	posterior cerebral artery	C0149576
28484550	occlusion	C0028790
28484550	cerebral ischemia	C0917798
28484550	infarction	C0021308
28484550	patients	C0030705
28484550	test occlusion	C3697458
28487667	Test Score	C0237855
28487667	Fair	C2911689
28487667	Individual	C0237401
28487667	Tested	C0392366
28487667	Effects of	C1704420
28487667	Scoring Procedures	C0036449
28487667	Multiple	C0439064
28487667	Attempts	C1516084
28487667	Testing	C0039593
28487667	Motor Skill	C0026612
28487667	Task	C3540678
28487667	Tests	C0392366
28487667	test batteries	C0392366
28487667	assessing	C1516048
28487667	motor skills	C0026612
28487667	research studies	C0681814
28487667	clinical settings	C0008976
28487667	procedures	C0025664
28487667	scoring	C0036449
28487667	performances	C0597198
28487667	attempts	C1516084
28487667	scored	C0449820
28487667	average	C1510992
28487667	computed	C1441526
28487667	scoring	C0036449
28487667	procedures	C0025664
28487667	attempts	C1516084
28487667	research	C0035168
28487667	procedures	C0025664
28487667	individual's	C0237401
28487667	skill	C0026612
28487667	level	C0441889
28487667	tests	C0392366
28487667	study	C2603343
28487667	tested	C0392366
28487667	female	C0043210
28487667	soccer	C0037393
28487667	players	C0335104
28487667	juggling	C0034872
28487667	soccer ball	C0336986
28487667	attempts	C1516084
28487667	trials	C0681815
28487667	scored	C0449820
28487667	procedures	C0025664
28487667	best of	C1522427
28487667	mean of	C0444504
28487667	attempts	C1516084
28487667	Individual	C0237401
28487667	raw scores	C0449820
28487667	trials	C0681815
28487667	no general effect	C1301751
28487667	trials	C0681815
28487667	mean (SD) percentage difference	C0392762
28487667	lowest	C1708760
28487667	highest	C1522410
28487667	scores	C0449820
28487667	players	C0335104
28487667	significant	C0750502
28487667	lowest	C1708760
28487667	highest	C1522410
28487667	score	C0449820
28487667	Correlations	C1707520
28487667	raw scores	C0449820
28487667	low	C0205251
28487667	trials	C0681815
28487667	higher	C0205250
28487667	scoring	C0036449
28487667	procedures	C0025664
28487667	trial	C0681815
28487667	significantly	C0750502
28487667	different	C1705242
28487667	raw score	C0449820
28487667	scoring	C0036449
28487667	procedure	C0025664
28487667	mean percentage difference	C0392762
28487667	best-of-two	C0449820
28487667	best-of-ten scores	C0449820
28487667	players	C0335104
28487667	significant	C0750502
28487667	difference	C1705242
28487667	scoring	C0036449
28487667	procedures	C0025664
28487667	No significant differences	C3842396
28487667	mean-of-rule scorings	C0449820
28487667	Best-of-rule	C0449820
28487667	mean-of-rule scorings	C0449820
28487667	significantly	C0750502
28487667	different	C1705242
28487667	best-of-two	C0449820
28487667	mean-of-two	C0449820
28487667	mean difference	C0392762
28487667	highest	C1522410
28487667	lowest	C1708760
28487667	rank	C0699794
28487667	players	C0335104
28487667	individual	C0237401
28487667	rankings	C0699794
28487667	group	C1257890
28487667	procedures	C0025664
28487667	procedural	C0025664
28487667	differences	C1705242
28487667	scoring	C0036449
28487667	procedures	C0025664
28487667	results	C0456984
28487667	test outcomes	C0456984
28487667	test results	C0456984
28487667	diagnosing	C0011900
28487667	intervention	C0184661
28487667	groups	C0441833
28487667	research	C0035168
28487667	scoring	C0036449
28487667	procedures	C0025664
28487667	tests	C0392366
28493435	Fast Peak-Searching Algorithm	C0002045
28493435	Ultrasonic Elastography	C3163956
28493435	Tissue axial strain estimation with ultrasound elastography	C2316047
28493435	tracking-based elastography algorithms	C0002045
28493435	locating	C0243095
28493435	extrema	C0205556
28493435	ultrasonic	C0220934
28493435	radiofrequency	C2347883
28493435	signals	C1710082
28493435	problem	C0033213
28493435	proposed	C1553874
28493435	locate	C0243095
28493435	maxima	C0806909
28493435	minima	C1524031
28493435	RF	C2347883
28493435	signals	C1710082
28493435	derivation	C1441547
28493435	operation	C3241922
28493435	algorithm	C0002045
28493435	locate	C0243095
28493435	extrema	C0205556
28493435	peaks	C0444505
28493435	noise	C0028263
28493435	algorithm	C0002045
28493435	implementation	C1708476
28493435	compared	C1707455
28493435	standard cross-correlation method	C0242481
28493435	computing	C1880157
28493435	signal-to-noise ratio	C2986823
28493435	contrast-to-noise ratio	C0392762
28494223	Audiovisual	C1254359
28494223	integration	C0679019
28494223	face	C0015450
28494223	name	C1547383
28494223	associative	C0679045
28494223	memory formation	C0025260
28494223	multisensory	C0445254
28494223	experience	C0596545
28494223	environment	C0014406
28494223	memories	C0025260
28494223	retrieval	C0679061
28494223	study	C2603343
28494223	audiovisual	C1254359
28494223	AV	C1254359
28494223	integration	C0679019
28494223	associative	C0679045
28494223	memory formation	C0025260
28494223	magnetic resonance imaging	C0024485
28494223	neural	C0027882
28494223	mechanisms	C0441712
28494223	AV	C1254359
28494223	integration	C0679019
28494223	associative	C0679045
28494223	memory	C0025260
28494223	overlap	C1948020
28494223	activity	C0441655
28494223	anterior superior temporal sulcus	C3499005
28494223	STS	C1281074
28494223	AV	C1254359
28494223	integration	C0679019
28494223	AV	C1254359
28494223	face	C0015450
28494223	name	C1547383
28494223	Dynamic causal modeling	C0681944
28494223	anterior STS	C3499005
28494223	associative	C0679045
28494223	memory system	C0025260
28494223	memory formation	C0025260
28494223	AV	C1254359
28494223	face	C0015450
28494223	name	C1547383
28494223	associations	C0679045
28494223	fusiform gyrus	C0228243
28494223	anterior STS	C3499005
28494223	participants	C0679646
28494223	remembered	C0034770
28494223	face	C0015450
28494223	name	C1547383
28494223	multisensory	C0445254
28494223	associative	C0679045
28494223	memories	C0025260
28494223	retrieval	C0679061
28494350	Liquid chromatography-tandem mass spectrometry	C4049918
28494350	quantification	C1709793
28494350	acetamiprid	C1142891
28494350	thiacloprid	C0962702
28494350	residues	C1254354
28494350	butterbur	C1019150
28494350	regulated conditions	C0014406
28494350	analytical method	C0178476
28494350	quantify	C1709793
28494350	residual	C1254354
28494350	levels	C0441889
28494350	neonicotinoid insecticides	C1997222
28494350	acetamiprid	C1142891
28494350	thiacloprid	C0962702
28494350	field-incurred	C0443318
28494350	butterbur	C1019150
28494350	samples	C0370003
28494350	liquid chromatography-tandem mass spectrometry	C4049918
28494350	LC-MS/MS	C4049918
28494350	Samples	C0370003
28494350	extracted	C0684295
28494350	acetonitrile	C0050456
28494350	dichloromethane	C0025748
28494350	purification	C1998793
28494350	Florisil(®) cartridge	C1504285
28494350	Linearity	C0205132
28494350	matrix-matched calibration curve	C0006751
28494350	compounds	C1254354
28494350	concentration	C1446561
28494350	range	C1514721
28494350	determination coefficients	C2827748
28494350	R(2)	C2827748
28494350	limits of detection	C2718050
28494350	LOD	C2718050
28494350	quantitation	C1709793
28494350	LOQ	C1709793
28494350	acetamiprid	C1142891
28494350	thiacloprid	C0962702
28494350	acetamiprid	C1142891
28494350	thiacloprid	C0962702
28494350	spiking levels	C0441889
28494350	LOQ	C1709793
28494350	LOQ	C1709793
28494350	relative standard deviations	C0871420
28494350	RSDs	C0871420
28494350	method	C0178476
28494350	field-incurred	C0443318
28494350	samples	C0370003
28494350	treated	C1522326
28494350	commercial	C0680536
28494350	pesticide product	C0031253
28494350	days	C0439228
28494350	harvest	C0205245
28494350	days	C0439228
28494350	harvest	C0205245
28494350	residues	C1254354
28494350	days	C0439228
28494350	treatment	C1522326
28494350	days	C0439228
28494350	treatment	C1522326
28494350	method	C0178476
28494350	accurate	C0443131
28494350	leafy vegetables	C0042440
28495651	Percentile	C1264641
28495651	categorization	C0008902
28495651	QT interval	C1287082
28495651	approach	C0449445
28495651	identifying	C0557971
28495651	adult	C0001675
28495651	patients	C0030705
28495651	risk	C0035647
28495651	cardiovascular death	C2926098
28495651	QT prolongation	C0151878
28495651	cardiovascular death	C2926098
28495651	CVD	C2926098
28495651	inconsistent	C0442809
28495651	purpose of this study	C0681832
28495651	compare	C1707455
28495651	correction formulas	C0392762
28495651	percentile values	C1532337
28495651	QT	C0860814
28495651	heart rate	C0018810
28495651	ranges	C1514721
28495651	ability	C0085732
28495651	remove	C1883720
28495651	relationship	C0439849
28495651	QT	C0860814
28495651	heart rate	C0018810
28495651	CVD	C2926098
28495651	Participants	C0679646
28495651	veterans	C0042610
28495651	ECG	C0013798
28495651	Veterans Affairs Medical Center	C0282574
28495651	Palo Alto	C3827373
28495651	March	C3829202
28495651	December	C3830550
28495651	CVD	C2926098
28495651	correction formulas	C0392762
28495651	Bazett	C1882512
28495651	Fridericia	C1882513
28495651	Framingham	C0392762
28495651	Hodges	C0392762
28495651	QT interval	C1287082
28495651	percentiles	C1264641
28495651	heart rate	C0018810
28495651	ranges	C1514721
28495651	Schwartz	C0086418
28495651	median	C2939193
28495651	years	C1510829
28495651	CVD	C2926098
28495651	equations	C0552449
28495651	heart rate	C0018810
28495651	hazard ratio	C2985465
28495651	confidence interval	C0009667
28495651	CVD	C2926098
28495651	percentile	C1264641
28495651	QT interval	C1287082
28495651	heart rate	C0018810
28495651	ranges	C1514721
28495651	QTc Bazett	C1882512
28495651	QTc Hodges	C0392762
28495651	QTc Framingham	C0392762
28495651	QTc Bazett	C1882512
28495651	significantly higher	C4055637
28495651	formulas	C0489829
28495651	percentile	C1264641
28495651	Framingham	C0392762
28495651	Hodges	C0392762
28495651	Fridericia equations	C0392762
28495651	remove	C1883720
28495651	effect	C1280500
28495651	heart rate	C0018810
28495651	QT interval	C1287082
28495651	Bazett equation	C0392762
28495651	QT-interval	C1287082
28495651	percentiles	C1264641
28495651	heart rate	C0018810
28495651	approach	C0449445
28495651	QT intervals	C1287082
28495651	drugs	C3687832
28495651	stressors	C0597530
28495651	CVD	C2926098
28495651	risk	C0035647
28495934	Exam	C0681376
28495934	Self-Regulated Learning	C1510634
28495934	Strategies	C0237896
28495934	Achievement	C0237912
28495934	Introductory Biology	C0005532
28495934	college	C0557806
28495934	introductory science	C0036397
28495934	courses	C0013652
28495934	students	C0038492
28495934	disciplinary content	C0205556
28495934	autonomous	C0815096
28495934	effective	C1704419
28495934	learners	C0038492
28495934	Self-regulated learning	C1510634
28495934	SRL	C1510634
28495934	learning goals	C2010704
28495934	progress	C1280477
28495934	study strategies	C0237896
28495934	SRL	C1510634
28495934	learners	C0038492
28495934	undergraduate	C0683865
28495934	introductory biology	C0005532
28495934	course	C0013652
28495934	SRL	C1510634
28495934	strategies	C0237896
28495934	students	C0038492
28495934	exams	C0681376
28495934	strategies	C0237896
28495934	achievement	C0001072
28495934	grade	C0441800
28495934	improvement	C0184511
28495934	exams	C0681376
28495934	students	C0038492
28495934	exams	C0681376
28495934	Higher	C0205250
28495934	achieving	C0001072
28495934	students	C0038492
28495934	students	C0038492
28495934	exam	C0681376
28495934	grades	C0441800
28495934	improved	C0184511
28495934	first half	C3843058
28495934	semester	C2348178
28495934	cognitive	C0009240
28495934	metacognitive strategies	C0870885
28495934	frequently	C0332183
28495934	lower	C2003888
28495934	achieving	C0001072
28495934	peers	C0679739
28495934	Lower	C2003888
28495934	achieving	C0001072
28495934	students	C0038492
28495934	frequently	C0332183
28495934	strategies	C0237896
28495934	outcomes	C1274040
28495934	students	C0038492
28495934	introductory biology	C0005532
28495934	limited	C0439801
28495934	knowledge	C0013621
28495934	SRL	C1510634
28495934	strategies	C0237896
28495934	limited	C0439801
28495934	impact	C4049986
28495934	achievement	C0237912
28495934	Course	C0013652
28495934	interventions	C0242687
28495934	SRL	C1510634
28495934	pedagogical tools	C1510624
28495934	fostering	C0242298
28495934	students	C0038492
28495934	lifelong	C4274169
28495934	learning skills	C0871370
28499120	Characterising	C1880022
28499120	bias	C0242568
28499120	regulatory risk	C0035647
28499120	decision analysis	C0011108
28499120	analysis	C0936012
28499120	heuristics	C0597916
28499120	health technology	C0752189
28499120	appraisal	C1254363
28499120	chemicals	C0220806
28499120	regulation	C0851285
28499120	climate change	C2718051
28499120	governance	C0441655
28499120	environmental	C0237095
28499120	public health domains	C3244304
28499120	heuristic methods	C0597916
28499120	risk	C0035647
28499120	decision analysis	C0011108
28499120	problem structures	C0033213
28499120	data	C1511726
28499120	lacking	C0332268
28499120	decisions	C0679006
28499120	source	C0449416
28499120	uncertainty	C0087130
28499120	model	C3161035
28499120	measurement error	C0681899
28499120	uncertainty	C0087130
28499120	inference rules	C0870077
28499120	identify	C0205245
28499120	analyse	C1524024
28499120	heuristics	C0597916
28499120	risk	C0035647
28499120	objects	C1518526
28499120	discriminate	C0205235
28499120	signal	C1710082
28499120	noise	C0028263
28499120	weight	C0043100
28499120	evidence	C3887511
28499120	models	C3161035
28499120	datasets	C0150098
28499120	policy	C0242456
28499120	heuristics	C0597916
28499120	generalisations	C0205556
28499120	relationships	C0439849
28499120	surrogates	C4053457
28499120	clinical trials	C0008976
28499120	conventions	C0205556
28499120	stability	C0205360
28499120	decision analysis	C0011108
28499120	error	C0743559
28499120	significance testing	C0039593
28499120	heuristics	C0597916
28499120	justifications	C0392360
28499120	assumptions	C1254370
28499120	practical applications	C0205245
28499120	Heuristic	C0597916
28499120	decision rules	C0870077
28499120	feasibility rules	C0870077
28499120	surrogates	C4053457
28499120	utility maximisation	C0205556
28499120	distributional	C1704711
28499120	concerns	C2699424
28499120	practice	C1254372
28499120	costs and benefits	C0010187
28499120	arbitrary	C1264693
28499120	thresholds	C0449864
28499120	problem	C0033213
28499120	rule-entrenchment	C1254366
28499120	analytical choices	C1707391
28499120	practice	C1254372
28499120	uncertainty	C0087130
28499120	bias	C0242568
28499120	Strategies	C0679199
28499120	risk	C0035647
28499120	decision analysis	C0011108
28499120	assumptions	C1254370
28499120	scope	C1710028
28499120	conditions	C1254370
28499120	heuristics	C0597916
28499120	testing	C0039593
28499120	empirical	C0392360
28499120	theoretical justifications	C0392360
28499120	sensitivity	C0036667
28499120	analysis	C0936012
28499120	simulations	C0679083
28499120	multiple bias analysis	C0242481
28499120	deductive systems of inference	C0282574
28499120	directed acyclic graphs	C1706232
28499120	rule	C0870077
28499120	uncertainty	C0087130
28499120	heuristics	C0597916
28499120	recovery schemes	C1519193
28499120	biases;	C0242568
28499120	decision rules	C0870077
28499120	values	C0042295
28499120	evidence	C3887511
28499120	convention	C0205556
28501028	Multicentric Castleman disease	C1334815
28501028	hyaline	C0020191
28501028	vascular	C0005847
28501028	variant	C0205419
28501028	unusual	C2700116
28501028	systemic	C0205373
28501028	manifestations	C1280464
28501028	case report	C0007320
28501028	Castleman disease	C1334815
28501028	rare	C0522498
28501028	lymphoproliferative disorder	C0024314
28501028	localized	C0392752
28501028	disseminated	C0205221
28501028	lymphadenopathy	C0497156
28501028	systemic	C0205373
28501028	manifestations	C1280464
28501028	categorized	C0008902
28501028	numerous	C0439064
28501028	unicentric	C0017531
28501028	multicentric	C1334815
28501028	histopathological	C0243140
28501028	variants	C0205419
28501028	hyaline	C0020191
28501028	vascular	C0005847
28501028	plasma cell	C0032112
28501028	mixed	C0205419
28501028	subtypes	C0872379
28501028	causative	C0449411
28501028	viral infections	C0042769
28501028	human immunodeficiency virus	C0019682
28501028	human herpesvirus-8	C0376526
28501028	Kaposi sarcoma herpesvirus	C0376526
28501028	asymptomatic	C0231221
28501028	symptoms	C1457887
28501028	multiple	C0439064
28501028	organs	C0178784
28501028	mechanism	C0441712
28501028	pathogenesis	C0699748
28501028	treatment	C1522326
28501028	directed	C1879741
28501028	etiologies	C0015127
28501028	interleukin-6	C0021760
28501028	cluster of differentiation 20	C0054946
28501028	viral agents	C0521026
28501028	year	C0439234
28501028	Sri Lankan	C1553327
28501028	woman	C0043210
28501028	body swelling	C0577596
28501028	foamy urine	C2188715
28501028	weeks	C0439230
28501028	duration	C0449238
28501028	Examination	C0582103
28501028	pallor	C0030232
28501028	generalized edema	C1850534
28501028	axillary	C0004454
28501028	cervical	C0205064
28501028	inguinal lymphadenopathy	C0578736
28501028	hypertension	C0020538
28501028	hepatomegaly	C0019209
28501028	Investigations	C1261322
28501028	bicytopenia	C1142446
28501028	nephrotic range proteinuria	C0445118
28501028	hypoalbuminemia	C0239981
28501028	hypogammaglobulinemia	C0086438
28501028	features	C2348519
28501028	hyaline	C0020191
28501028	vascular	C0005847
28501028	type	C0332307
28501028	Castleman disease	C1334815
28501028	lymph node biopsy	C0193842
28501028	managed	C0086583
28501028	rituximab	C0393022
28501028	clinical	C0205210
28501028	improvement	C2986411
28501028	Castleman disease	C1334815
28501028	broad	C0332464
28501028	spectrum	C2827424
28501028	clinical	C0205210
28501028	manifestations	C1280464
28501028	disease	C0012634
28501028	pathogeneses	C0699748
28501028	associations	C0205556
28501028	complications	C0009566
28501028	Medical	C0205476
28501028	professionals	C1704312
28501028	spectrum	C2827424
28501028	diagnosis	C0011900
28501028	aggressive targeted therapy	C2985566
28501028	patients	C0030705
28501699	AGES-Reykjavik study atlases	C0004171
28501699	Non-linear	C0206165
28501699	multi-spectral template	C1705542
28501699	atlases	C0004171
28501699	studies	C2603343
28501699	ageing	C0001811
28501699	brain	C0006104
28501699	Quantitative analyses	C0034384
28501699	brain	C0006104
28501699	structures	C0678594
28501699	Magnetic Resonance	C0024485
28501699	MR	C0024485
28501699	image	C0024485
28501699	data	C1511726
28501699	automatic	C0205554
28501699	segmentation	C2697664
28501699	algorithms	C0002045
28501699	algorithms	C0002045
28501699	templates	C1705542
28501699	atlases	C0004171
28501699	coordinate space	C1183514
28501699	freely	C1996904
28501699	available	C0470187
28501699	brain	C0006104
28501699	atlases	C0004171
28501699	young	C0332239
28501699	individuals	C0027361
28501699	cohort studies	C0009247
28501699	publicly	C0678367
28501699	available	C0470187
28501699	multi-spectral template	C1705542
28501699	tissue	C0040300
28501699	probability	C0033204
28501699	atlases	C0004171
28501699	regional	C0205147
28501699	atlases	C0004171
28501699	optimised	C2698650
28501699	studies	C2603343
28501699	ageing	C0001811
28501699	cohorts	C0599755
28501699	validation	C1519941
28501699	data	C1511726
28501699	regional	C0205147
28501699	segmentation	C2697664
28501699	integrity	C1947912
28501699	dataset	C0150098
28502652	Comparative	C0683941
28502652	evolutionary analysis	C0936012
28502652	adapter molecule MyD88	C1417530
28502652	invertebrate	C0021948
28502652	metazoans	C2713498
28502652	myeloid differentiation factor 88	C1417530
28502652	MyD88	C1417530
28502652	Toll-like receptor	C0670896
28502652	TLR	C0670896
28502652	signalling pathways	C0037083
28502652	TLR	C0670896
28502652	pattern-recognition receptor	C1564907
28502652	PRR	C1564907
28502652	Drosophila	C0013138
28502652	study	C2603343
28502652	MyD88 gene	C1417530
28502652	identified	C0205396
28502652	characterized	C1880022
28502652	shellfish	C1304606
28502652	Scapharca subcrenata	C3346701
28502652	DEATH domain	C1511738
28502652	TIR domain	C1956034
28502652	molluscs	C0026391
28502652	comparative genomic evidence	C0796358
28502652	MyD88	C1417530
28502652	different	C1705242
28502652	lengths	C1444754
28502652	quantitative	C0392762
28502652	exon	C0015295
28502652	intron regions	C0021920
28502652	specific mechanisms	C0441712
28502652	phylogenetic relationships	C1519068
28502652	invertebrate	C0021948
28502652	metazoan	C2713498
28502652	MyD88	C1417530
28502652	MrBayes and PhyML software	C0037589
28502652	construct	C2827421
28502652	phylogenetic trees	C1519069
28502652	Bayesian	C0242196
28502652	maximum likelihood approaches	C0024970
28502652	MyD88	C1417530
28502652	Arthropoda	C0003903
28502652	lower	C0205251
28502652	invertebrates	C0021948
28502652	contrast	C1979874
28502652	morphological	C0543482
28502652	taxonomy	C0087066
28502652	investigated	C1292732
28502652	evolutionary patterns	C0015219
28502652	positive selection sites	C0678933
28502652	PSSs	C0678933
28502652	MyD88 gene	C1417530
28502652	Arthropoda	C0003903
28502652	Mollusca	C0026391
28502652	Insecta	C0021585
28502652	PAML software	C0037589
28502652	maximum likelihood method	C0025663
28502652	data	C1511726
28502652	positive selection sites	C0678933
28502652	detected	C0442726
28502652	groups	C1257890
28502652	partial sites	C0002518
28502652	TIR domain	C1956034
28502652	not found	C0442737
28502652	DEATH domain	C1511738
28502652	study	C2603343
28502652	diversification	C0680948
28502652	MyD88	C1417530
28502652	invertebrate	C0021948
28502652	metazoans	C2713498
28502652	specific	C0205369
28502652	evolutionary position	C0015219
28502652	Arthropoda	C0003903
28502652	MyD88	C1417530
28502652	positive	C1446409
28502652	selection pressures	C0036576
28502652	MyD88	C1417530
28502652	Arthropoda	C0003903
28502652	Mollusca	C0026391
28502652	Insecta	C0021585
28502652	results	C1274040
28502652	valuable contribution	C1880177
28502652	clarify	C2986669
28502652	evolutionary pattern	C0015219
28502652	TLR	C0670896
28502652	MyD88	C1417530
28502652	signalling pathways	C0037083
28502652	invertebrate	C0021948
28502652	vertebrate taxa	C0042567
28503387	Rubinstein-Taybi Syndrome	C0035934
28503387	Associated with	C0332281
28503387	Pituitary Macroadenoma	C0346308
28503387	Case Report	C0085973
28503387	Rubinstein-Taybi Syndrome	C0035934
28503387	RSTS	C0035934
28503387	autosomal dominant disorder	C3899989
28503387	characterized	C1880022
28503387	prenatal	C2828394
28503387	postnatal	C0443281
28503387	growth restriction	C0151686
28503387	microcephaly	C0025958
28503387	dysmorphic craniofacial features	C0432072
28503387	broad thumbs	C0426891
28503387	toes	C1865038
28503387	intellectual disability	C3714756
28503387	pituitary macroadenoma	C0346308
28503387	associated with	C0332281
28503387	RSTS	C0035934
28503387	Caucasian	C0043157
28503387	female	C0043210
28503387	past medical history	C0455458
28503387	RSTS	C0035934
28503387	diagnosed	C0011900
28503387	age	C0001779
28503387	gadolinium	C0016911
28503387	pituitary mass	C0342419
28503387	magnetic resonance imaging	C0024485
28503387	MRI	C0024485
28503387	brain	C0006104
28503387	years	C0439234
28503387	migraine-like headaches	C0018681
28503387	imaging	C0011923
28503387	radiographic evidence	C3887511
28503387	growth	C0018270
28503387	size	C0456389
28503387	pituitary	C0032005
28503387	sellar lesion	C0221198
28503387	resected	C0015252
28503387	endoscopic	C0442418
28503387	transnasal	C3897344
28503387	transsphenoidal approach	C0205508
28503387	thyrotroph adenoma	C0346303
28503387	RSTS	C0035934
28503387	rare	C0522498
28503387	neurodevelopmental	C1535926
28503387	genetic disease	C0019247
28503387	patients with disabilities	C0018576
28503387	survive	C0038952
28503387	adulthood	C0700597
28503387	disorder	C0012634
28503387	associated with	C0332281
28503387	increased	C0205217
28503387	predisposition	C0220898
28503387	development	C1527148
28503387	nervous system tumors	C0027766
28503387	pituitary adenomas	C0032000
28505177	radiological	C0039431
28505177	paradox	C0221733
28505177	cognitive function	C0392335
28505177	MRI	C0024485
28505177	burden	C2828008
28505177	white matter	C0682708
28505177	lesions	C0221198
28505177	people	C0027361
28505177	multiple sclerosis	C0026769
28505177	systematic review	C1955832
28505177	meta-analysis	C0282458
28505177	Moderate	C0205081
28505177	correlation	C1707520
28505177	imaging quantification	C2984008
28505177	brain	C0006104
28505177	white matter	C0682708
28505177	lesions	C0221198
28505177	cognitive	C1516691
28505177	performance	C0597198
28505177	people	C0027361
28505177	multiple sclerosis	C0026769
28505177	MS	C0026769
28505177	features	C2348519
28505177	pathology	C0030664
28505177	methodological	C3266812
28505177	limitations	C0449295
28505177	primary	C0205225
28505177	literature	C0023866
28505177	cognitive	C1516691
28505177	radiological	C0039431
28505177	paradox	C0221733
28505177	potential	C3245505
28505177	methodological	C3266812
28505177	factors	C1521761
28505177	assessment	C1516048
28505177	relationship	C0439849
28505177	Systematic review	C1955832
28505177	meta-analysis	C0282458
28505177	primary	C0205225
28505177	research	C0035168
28505177	cognitive function	C0392335
28505177	white matter	C0682708
28505177	lesion	C0221198
28505177	burden	C2828008
28505177	papers	C0030351
28505177	eligibility criteria	C1512693
28505177	review	C0282443
28505177	meta-analysis	C0282458
28505177	results	C1274040
28505177	participants	C0679646
28505177	Aggregate	C0205418
28505177	correlation	C1707520
28505177	cognition	C0009240
28505177	T2	C0475373
28505177	lesion	C0221198
28505177	burden	C2828008
28505177	confidence interval	C0009667
28505177	methodological	C3266812
28505177	variability	C2827666
28505177	factors	C1521761
28505177	cognitive	C1516691
28505177	data	C1511726
28505177	image analysis techniques	C0200765
28505177	radiological	C0039431
28505177	paradox	C0221733
28505177	evaluation	C0220825
28505177	multiple	C0439064
28505177	components	C1705248
28505177	complex	C0439855
28505177	pathology	C0030664
28505177	optimum	C2698651
28505177	measurement	C0242485
28505177	techniques	C0449851
28505177	cognitive	C1516691
28505177	MRI	C0024485
28505177	feature	C2348519
28505177	quantification	C1709793
28505177	consensus	C0376298
28505177	standards	C1442989
28505177	image analysis	C0200765
28505177	MS	C0026769
28505177	benchmarking	C0525063
28505177	innovation	C0683888
28508329	Long Non-Coding RNA	C3494264
28508329	SNHG6	C1822801
28508329	Biomarker	C0041365
28508329	Hepatocellular Carcinoma	C2239176
28508329	Long Non-coding RNAs	C3494264
28508329	lncRNAs	C3494264
28508329	non-protein coding	C0887909
28508329	transcripts	C1519595
28508329	nucleotides	C0028630
28508329	biological	C0205460
28508329	pathways	C1705987
28508329	expression	C0017262
28508329	lncRNAs	C3494264
28508329	cancer initiation	C0598935
28508329	progression	C0178874
28508329	patients	C0030705
28508329	hepatocellular carcinoma	C2239176
28508329	HCC	C2239176
28508329	diagnosed	C0011900
28508329	late stages	C1279941
28508329	diagnostic methods	C0920688
28508329	study	C2603343
28508329	expression	C0017262
28508329	lncRNAs	C3494264
28508329	analysed	C0936012
28508329	genomic	C0150098
28508329	transcriptome datasets	C0150098
28508329	analyses	C0936012
28508329	SNHG6	C1822801
28508329	lncRNAs	C3494264
28508329	dysregulation	C0017263
28508329	expression	C0017262
28508329	HCC tumors	C2239176
28508329	normal tissues	C0040300
28508329	dysregulation	C0017263
28508329	SNHG6	C1822801
28508329	cancer	C0006826
28508329	analyses	C0936012
28508329	SNHG6	C1822801
28508329	co-expressed	C0017262
28508329	genes	C0017337
28508329	8q	C1515445
28508329	structural	C0678594
28508329	integrity	C1947912
28508329	ribosome	C0035553
28508329	translation	C1519614
28508329	comprehensive	C1880156
28508329	in silico	C3489666
28508329	analysis	C0936012
28508329	investigating	C1292732
28508329	SNHG6	C1822801
28508329	hepatocellular carcinoma	C2239176
28508329	researches	C0035168
28512014	Expressional	C0017262
28512014	divergence	C0443204
28512014	insect	C0021585
28512014	GOX genes	C1415468
28512014	glucose oxidase	C0017735
28512014	Insect herbivores	C0021585
28512014	secrete	C1327616
28512014	glucose oxidase	C0017735
28512014	GOX	C0017735
28512014	plants	C0032098
28512014	counteract	C1947978
28512014	plant	C0032098
28512014	defenses	C1880266
28512014	potential	C3245505
28512014	pathogens	C0450254
28512014	herbivores	C0021585
28512014	significantly higher	C4055637
28512014	GOX	C0017735
28512014	activities	C0441655
28512014	counterparts	C1947978
28512014	larvae	C0023047
28512014	species	C1705920
28512014	Helicoverpa armigera	C1002429
28512014	counterpart	C1947978
28512014	Helicoverpa assulta	C1093556
28512014	protein	C0033684
28512014	digestible	C0012238
28512014	carbohydrate	C0453802
28512014	allelochemical	C1135843
28512014	host plant	C0868970
28512014	treatments	C1522326
28512014	GOX	C1415468
28512014	transcripts	C1519595
28512014	activities	C0441655
28512014	labial glands	C0226928
28512014	GOX	C1415468
28512014	activity	C0441655
28512014	transcripts	C1519595
28512014	upregulated	C0041904
28512014	food	C0016452
28512014	ingestion	C0232478
28512014	body growth	C0231256
28512014	downregulated	C0013081
28512014	ingestion	C0232478
28512014	wandering	C0233569
28512014	pupation	C1326578
28512014	species	C1705920
28512014	host plants	C0868970
28512014	upregulated	C0041904
28512014	GOX	C1415468
28512014	transcripts	C1519595
28512014	GOX	C1415468
28512014	activity	C0441655
28512014	species	C1705920
28512014	GOX	C1415468
28512014	transcripts	C1519595
28512014	activity	C0441655
28512014	allelochemicals	C1135843
28512014	GOX	C1415468
28512014	transcripts	C1519595
28512014	species	C1705920
28512014	GOX	C0017735
28512014	activities	C0441655
28512014	H. armigera	C1002429
28512014	H. assulta	C1093556
28512014	GOX	C1415468
28512014	transcripts	C1519595
28512014	significantly higher	C4055637
28512014	developmental stages	C0870411
28512014	host plants	C0868970
28512014	allelochemicals	C1135843
28512014	encounter	C1947978
28512014	data	C1511726
28512014	greater	C1704243
28512014	GOX	C0017735
28512014	activity	C0441655
28512014	herbivores	C0021585
28512014	greater	C1704243
28512014	transcription	C0040649
28512014	transcript	C1519595
28512014	translation	C1519614
28512014	better enzyme stability	C0014439
28518001	Propranolol	C0033497
28518001	Decompression Sickness	C0011119
28518001	DISSUB	C0221094
28518001	Rescue	C0242857
28518001	Swine	C1135183
28518001	Disabled submarine	C0221094
28518001	DISSUB	C0221094
28518001	survivors	C1171334
28518001	elevated CO2 levels	C0020440
28518001	inert gas saturation	C0545273
28518001	CO2	C0007012
28518001	toxicity	C0040539
28518001	decompression sickness	C0011119
28518001	DCS	C0011119
28518001	Propranolol	C0033497
28518001	reduce CO2 production	C0201930
28518001	DISSUB	C0221094
28518001	model	C0026336
28518001	humans	C0086418
28518001	DCS	C0011119
28518001	DISSUB	C0221094
28518001	rescue scenario	C0242857
28518001	oxygen prebreathe	C0035203
28518001	OPB	C0035203
28518001	DCS	C0011119
28518001	DISSUB	C0221094
28518001	rescue protocols	C0242857
28518001	swine model	C1135183
28518001	DISSUB	C0221094
28518001	rescue	C0242857
28518001	propranolol	C0033497
28518001	DCS	C0011119
28518001	mortality	C0205848
28518001	OPB	C0035203
28518001	male	C0086582
28518001	Yorkshire Swine	C0324292
28518001	pressurized	C0033095
28518001	Propranolol	C0033497
28518001	administered at	C1521801
28518001	animal	C0003062
28518001	rapidly decompressed	C1965697
28518001	DCS	C0011119
28518001	onset time	C0449244
28518001	mortality	C0205848
28518001	animals	C0003062
28518001	PROP1.0	C0033497
28518001	PROP1.0	C0033497
28518001	OPB45	C0035203
28518001	dive	C0178599
28518001	OPB	C0035203
28518001	decompression	C1965697
28518001	methodology	C3266812
28518001	swine	C1135183
28518001	pressurized	C0033095
28518001	PROP0.5	C0033497
28518001	propranolol	C0033497
28518001	administered at	C1521801
28518001	Control animals	C1511501
28518001	normal saline	C0445115
28518001	OPB	C0035203
28518001	reduced mortality	C0205848
28518001	PROP1.0	C0033497
28518001	OBP45	C0035203
28518001	PROP1.0	C0033497
28518001	PROP0.5	C0033497
28518001	increased mortality	C0205848
28518001	beta blockers	C0001645
28518001	saturation decompression	C1965697
28518001	DCS	C0011119
28518001	worsen mortality	C0205848
28518001	swine	C1135183
28518001	model	C0026336
28518001	bounce diving	C0178599
28520994	Gut microbiota	C4018878
28520994	protection	C1545588
28520994	diarrheal	C0011991
28520994	infections	C3714514
28520994	mammalian	C0024660
28520994	gut microbiota	C4018878
28520994	microbial	C0445623
28520994	community	C0009462
28520994	resides	C2982691
28520994	gastrointestinal tract	C0017189
28520994	gut microbiota	C4018878
28520994	host	C1167395
28520994	colonization	C4289767
28520994	resistance	C4281815
28520994	prevent	C0205245
28520994	colonization	C4289767
28520994	foreign microbes	C0445623
28520994	diarrheal	C0011991
28520994	pathogens	C0450254
28520994	Clostridium difficile	C0079134
28520994	Salmonella enterica serovar Typhimurium	C0036126
28520994	diarrheagenic Escherichia coli	C1264842
28520994	literature review	C0282441
28520994	effects of	C1704420
28520994	gut microbiota	C4018878
28520994	infection	C3714514
28520994	diarrheal	C0011991
28520994	pathogens	C0450254
28520994	PubMed	C1138432
28520994	articles	C1706852
28520994	data	C1511726
28520994	laboratory	C0022877
28520994	gut microbiota	C4018878
28520994	protection	C1545588
28520994	diarrheal	C0011991
28520994	infections	C3714514
28520994	direct	C1947931
28520994	inhibition	C3463820
28520994	pathogens	C0450254
28520994	indirect	C0439852
28520994	effects	C1280500
28520994	host	C1167395
28520994	functions	C0542341
28520994	Direct	C1947931
28520994	effects of	C1704420
28520994	microbiota	C4018878
28520994	diarrheal	C0011991
28520994	pathogens	C0450254
28520994	nutrients	C0678695
28520994	metabolites	C0870883
28520994	inhibit	C0205245
28520994	pathogen	C0450254
28520994	growth	C0018270
28520994	virulence	C0042765
28520994	Indirect	C0439852
28520994	effects of	C1704420
28520994	gut microbiota	C4018878
28520994	maintenance	C0024501
28520994	gut mucosal barrier	C0232577
28520994	innate	C0020969
28520994	adaptive immunity	C0678209
28520994	Human	C0086418
28520994	epidemiological studies	C0002783
28520994	experimental	C1517586
28520994	infections	C3714514
28520994	laboratory animals	C0003064
28520994	antibiotic treatment	C0338237
28520994	gut microbial	C4018878
28520994	community	C0009462
28520994	colonization	C4289767
28520994	resistance	C4281815
28520994	diarrheal	C0011991
28520994	pathogens	C0450254
28520994	research	C0035168
28520994	development	C1527148
28520994	next-generation probiotics	C0525033
28520994	colonization	C4289767
28520994	resistance	C4281815
28520994	prevent	C0205245
28520994	travellers' diarrheal	C0277528
28521168	Ecotoxicity	C0600688
28521168	testing	C0039593
28521168	environmental risk assessment	C4076706
28521168	iron	C0302583
28521168	nanomaterials	C1450053
28521168	remediation	C3853059
28521168	Recommendations	C0034866
28521168	FP7 project NanoRem	C0700032
28521168	Nanoremediation	C3853059
28521168	iron	C0302583
28521168	Fe	C0302583
28521168	nanomaterials	C1450053
28521168	treating	C1522326
28521168	contaminated	C0205279
28521168	soil	C0037592
28521168	groundwater	C0043047
28521168	potential risks	C0035647
28521168	engineered nanomaterials	C1450053
28521168	environment	C0014406
28521168	study	C2603343
28521168	assessed	C1516048
28521168	ecotoxicity	C0600688
28521168	Fe	C0302583
28521168	nanomaterials	C1450053
28521168	Nano-Goethite	C0300269
28521168	Trap-Ox Fe-zeolites	C0302583
28521168	Carbo-Iron	C0302583
28521168	FerMEG12	C0302583
28521168	European FP7 project NanoRem	C0700032
28521168	remediation	C3853059
28521168	test battery	C0022885
28521168	ecotoxicity	C0600688
28521168	tests	C0022885
28521168	bacteria	C0004611
28521168	V. fisheri	C0318276
28521168	E. coli	C0014834
28521168	algae	C0002028
28521168	P. subcapitata	C1089415
28521168	Chlamydomonas sp.	C0008155
28521168	crustaceans	C0010395
28521168	D. magna	C1081963
28521168	worms	C0018893
28521168	E. fetida	C0524676
28521168	L. variegatus	C0998692
28521168	plants	C0032098
28521168	R. sativus	C0996771
28521168	L. multiflorum	C0331557
28521168	Fe oxide	C0060240
28521168	nanoscale zero valent iron	C0302583
28521168	nZVI	C0302583
28521168	Fe	C0302583
28521168	matrix	C1704640
28521168	material	C0520510
28521168	ball milled nZVI	C0302583
28521168	FerMEG12	C0302583
28521168	no toxicity	C1513916
28521168	test battery	C0022885
28521168	concentrations	C1446561
28521168	cutoff	C1442160
28521168	hazard	C0598697
28521168	labeling	C2827499
28521168	chemicals regulation	C0851285
28521168	Europe	C0015176
28521168	Fe	C0302583
28521168	nanomaterials	C1450053
28521168	turbidity	C0301633
28521168	aggregation	C0332621
28521168	sedimentation behavior	C1384604
28521168	aqueous	C0599956
28521168	media	C1705217
28521168	recommendations	C0034866
28521168	future testing	C0039593
28521168	Fe	C0302583
28521168	nanomaterials	C1450053
28521168	environmental risk assessment	C4076706
28522288	Grade Group	C0008902
28522288	Underestimation	C0243095
28522288	Prostate Biopsy	C0194804
28522288	Predictive Factors	C0683956
28522288	Outcomes	C1518681
28522288	Candidates	C1257890
28522288	Active Surveillance	C1827061
28522288	outcomes	C1518681
28522288	predictive factors	C0683956
28522288	prostate cancer	C0376358
28522288	PCa	C0376358
28522288	grade group	C0008902
28522288	GG	C0008902
28522288	prostate biopsies	C0194804
28522288	monocentric cohort	C0599755
28522288	patients	C0030705
28522288	treated	C1522326
28522288	minimally invasive radical prostatectomy	C0194810
28522288	RP	C0194810
28522288	monocentric prospectively maintained database	C0242356
28522288	patients	C0030705
28522288	minimally invasive RP	C0194810
28522288	outcomes	C1518681
28522288	associated with	C0332281
28522288	GG	C0008902
28522288	biopsy	C0005558
28522288	RP	C0194810
28522288	Multivariate logistic regression	C0206031
28522288	nomogram	C1450294
28522288	GG1	C0008902
28522288	Biopsy	C0005558
28522288	GG	C0008902
28522288	RP	C0194810
28522288	Patients	C0030705
28522288	GG1	C0008902
28522288	GG2	C0008902
28522288	GG3	C0008902
28522288	RP	C0194810
28522288	longer time	C0040223
28522288	biochemical recurrence	C2985506
28522288	GG2	C0008902
28522288	GG3	C0008902
28522288	biopsy	C0005558
28522288	RP	C0194810
28522288	shorter time	C0040223
28522288	biochemical recurrence	C2985506
28522288	GG1	C0008902
28522288	multivariate analyses	C0026777
28522288	variables	C1705098
28522288	GG1	C0008902
28522288	PCa	C0376358
28522288	age	C0001779
28522288	abnormal digital rectal examination	C1384593
28522288	prostate	C0033572
28522288	prostate -specific antigen density	C0243095
28522288	percentage of positive cores	C0243095
28522288	body mass index	C4055400
28522288	nomogram	C1450294
28522288	Biopsy	C0005558
28522288	grading system	C1273712
28522288	GG	C0008902
28522288	biopsy	C0005558
28522288	RP	C0194810
28522288	clinical outcomes	C1518681
28522288	nomogram	C1450294
28522288	probability	C0033204
28522288	GG1	C0008902
28522288	patients	C0030705
28522288	evaluation	C0220825
28523425	Characterization	C1880022
28523425	electrocorticogram	C0430797
28523425	high	C0205250
28523425	gamma	C0017011
28523425	signal	C1710082
28523425	response	C0871261
28523425	varying	C1705242
28523425	upper extremity	C1140618
28523425	movement	C0026649
28523425	velocity	C0439830
28523425	mechanism	C0441712
28523425	human	C0086418
28523425	primary motor cortex	C3495441
28523425	M1	C3495441
28523425	encodes	C2700640
28523425	upper extremity	C1140618
28523425	movement	C0026649
28523425	kinematics	C0600169
28523425	human	C0086418
28523425	electrocorticogram	C0430797
28523425	ECoG	C0430797
28523425	signals	C1710082
28523425	modulate	C0443264
28523425	upper extremity	C1140618
28523425	movement	C0026649
28523425	relationship	C0439849
28523425	explicitly	C2963144
28523425	characterized	C1880022
28523425	issue	C0033213
28523425	recorded	C3853788
28523425	high	C0205250
28523425	density	C0178587
28523425	ECoG	C0430797
28523425	signals	C1710082
28523425	patients	C0030705
28523425	epilepsy	C0014544
28523425	surgery	C0543467
28523425	evaluation	C0220825
28523425	performed	C0884358
28523425	elementary	C0013878
28523425	upper extremity	C1140618
28523425	movements	C0026649
28523425	systematically	C0220922
28523425	varying	C1705242
28523425	movement	C0026649
28523425	speed	C0678536
28523425	duration	C0449238
28523425	Specifically	C0205369
28523425	subjects	C0681850
28523425	performed	C0884358
28523425	intermittent	C0205267
28523425	pincer grasp	C0429273
28523425	release	C0391871
28523425	elbow flexion	C2215879
28523425	extension	C0231448
28523425	shoulder flexion	C0575546
28523425	extension	C0231448
28523425	slow	C0439834
28523425	moderate	C0205081
28523425	fast	C0456962
28523425	speeds	C0678536
28523425	movements	C0026649
28523425	bursts	C4296482
28523425	power	C3854080
28523425	high	C0205250
28523425	observed	C1441672
28523425	M1	C3495441
28523425	addition	C0332287
28523425	amplitude	C2346753
28523425	power	C3854080
28523425	bursts	C4296482
28523425	area	C0205146
28523425	M1	C3495441
28523425	elevated	C3163633
28523425	high	C0205250
28523425	activity	C0441655
28523425	directly	C1947931
28523425	proportional	C0205351
28523425	movement	C0026649
28523425	speed	C0678536
28523425	duration	C0449238
28523425	elevated	C3163633
28523425	high	C0205250
28523425	activity	C0441655
28523425	increased	C0205217
28523425	movement	C0026649
28523425	duration	C0449238
28523425	Based	C1527178
28523425	linear regression	C0023733
28523425	M1	C3495441
28523425	high	C0205250
28523425	power	C3854080
28523425	amplitude	C2346753
28523425	duration	C0449238
28523425	covaried	C0205419
28523425	movement	C0026649
28523425	speed	C0678536
28523425	duration	C0449238
28523425	average	C1510992
28523425	findings	C0243095
28523425	indicate	C3146298
28523425	encoding	C2700640
28523425	upper extremity	C1140618
28523425	movement	C0026649
28523425	speed	C0678536
28523425	M1	C3495441
28523425	high	C0205250
28523425	activity	C0441655
28523425	primarily	C0205225
28523425	linear	C0205132
28523425	activity	C0441655
28523425	elevated	C3163633
28523425	movement	C0026649
28523425	M1	C3495441
28523425	transient	C0205374
28523425	instructions	C1442085
28523425	specific	C0205369
28523425	movement	C0026649
28523425	duration	C0449238
28523425	entirety	C0444667
28523425	movement	C0026649
28523425	spatial distribution	C0037775
28523425	high	C0205250
28523425	activity	C0441655
28523425	presence	C0150312
28523425	recruitment	C2949735
28523425	phenomenon	C1882365
28523425	higher	C0205250
28523425	speeds	C0678536
28523425	increased	C0205217
28523425	muscle	C0026845
28523425	activity	C0441655
28523425	activation	C1879547
28523425	M1	C3495441
28523425	area	C0205146
28523479	Fatty Acids	C0015684
28523479	Different	C1705242
28523479	Adipogenic Differentiation	C0596843
28523479	Potentials	C3245505
28523479	Stromal Vascular Cells	C0162597
28523479	Isolated	C0205409
28523479	Abdominal Fat	C1563742
28523479	Laying	C1622979
28523479	Hens	C0008051
28523479	study	C2603343
28523479	effects of	C1704420
28523479	fatty acids	C0015684
28523479	FA	C0015684
28523479	chicken serum	C1440440
28523479	CS	C1440440
28523479	expression	C0017262
28523479	adipogenic	C0596843
28523479	transcripts	C1519595
28523479	adipogenesis	C0596843
28523479	chicken	C0008051
28523479	stromal vascular cells	C0162597
28523479	SVC	C0162597
28523479	SVC	C0162597
28523479	DMEM	C1665363
28523479	FBS	C3812213
28523479	Control	C0009932
28523479	treated	C1522326
28523479	oleic acid	C0028928
28523479	OLA	C0028928
28523479	FBS	C3812213
28523479	linoleic acid	C0023749
28523479	LNA	C0023749
28523479	FBS	C3812213
28523479	palmitic acid	C0030234
28523479	PAM	C0030234
28523479	FBS	C3812213
28523479	stearic acid	C0038229
28523479	STA	C0038229
28523479	FBS	C3812213
28523479	cells	C0007634
28523479	DMEM	C1665363
28523479	CS	C1440440
28523479	treated	C1522326
28523479	OLA	C0028928
28523479	CS	C1440440
28523479	OLA	C0028928
28523479	PAM	C0030234
28523479	CS	C1440440
28523479	PAM	C0030234
28523479	STA	C0038229
28523479	CS	C1440440
28523479	STA	C0038229
28523479	LNA	C0023749
28523479	CS	C1440440
28523479	LNA	C0023749
28523479	Adipogenesis	C0596843
28523479	Oil Red O staining	C1294000
28523479	glycerol-3-phosphate dehydrogenase (GPDH) activity	C1151278
28523479	OLA	C0028928
28523479	PAM	C0030234
28523479	STA	C0038229
28523479	increased	C0205217
28523479	SVC	C0162597
28523479	FBS	C3812213
28523479	CS	C1440440
28523479	OLA	C0028928
28523479	PAM	C0030234
28523479	STA	C0038229
28523479	Adipogenesis	C0596843
28523479	induced	C0205263
28523479	FBS	C3812213
28523479	OLA	C0028928
28523479	FBS	C3812213
28523479	LNA	C0023749
28523479	FBS	C3812213
28523479	PAM	C0030234
28523479	FBS	C3812213
28523479	STA	C0038229
28523479	CS	C1440440
28523479	OLA	C0028928
28523479	CS	C1440440
28523479	LNA	C0023749
28523479	CS	C1440440
28523479	PAM	C0030234
28523479	CS	C1440440
28523479	STA	C0038229
28523479	FBS	C3812213
28523479	GPDH activity	C1151278
28523479	significantly higher	C4055637
28523479	FBS	C3812213
28523479	OLA	C0028928
28523479	FBS	C3812213
28523479	LNA	C0023749
28523479	FBS	C3812213
28523479	FBS	C3812213
28523479	expression	C0017262
28523479	FABP4	C1333527
28523479	mRNA	C0035696
28523479	increased	C0205217
28523479	FBS	C3812213
28523479	OLA	C0028928
28523479	FBS	C3812213
28523479	LNA	C0023749
28523479	FBS	C3812213
28523479	PAM	C0030234
28523479	C/EBPα	C1413322
28523479	C/EBPβ	C1413323
28523479	ATGL	C1538686
28523479	increased	C0205217
28523479	FBS	C3812213
28523479	OLA	C0028928
28523479	FBS	C3812213
28523479	LNA	C0023749
28523479	cells	C0007634
28523479	Expression	C0017262
28523479	FABP4	C1333527
28523479	C/EBPβ	C1413323
28523479	mRNA	C0035696
28523479	higher	C0205250
28523479	CS	C1440440
28523479	CS	C1440440
28523479	OLA	C0028928
28523479	CS	C1440440
28523479	LNA	C0023749
28523479	CS	C1440440
28523479	PAM	C0030234
28523479	CS	C1440440
28523479	STA	C0038229
28523479	compared	C1707455
28523479	FBS	C3812213
28523479	expression	C0017262
28523479	ATGL	C1538686
28523479	C/EBPα	C1413322
28523479	higher	C0205250
28523479	CS	C1440440
28523479	CS	C1440440
28523479	OLA	C0028928
28523479	CS	C1440440
28523479	LNA	C0023749
28523479	FBS	C3812213
28523479	cells	C0007634
28523479	results	C2825142
28523479	FA	C0015684
28523479	different	C1705242
28523479	potentials	C3245505
28523479	induce	C0205263
28523479	adipogenesis	C0596843
28523479	LNA	C0023749
28523479	potent	C3245505
28523479	FA	C0015684
28523479	potentials	C3245505
28523479	presence	C0150312
28523479	CS	C1440440
28523846	novel	C0205314
28523846	rapid	C0456962
28523846	analysis	C0936012
28523846	mass spectrometry	C0037813
28523846	downstream	C0522506
28523846	refolding	C0162847
28523846	recombinant human insulin-like growth factor-1	C0904505
28523846	mecasermin	C0904505
28523846	Mecasermin	C0904505
28523846	elevated blood sugar	C0020456
28523846	growth hormone	C0037663
28523846	resistant	C0332325
28523846	Laron-type dwarfism	C0271568
28523846	Mecasermin	C0904505
28523846	inclusion bodies	C0007637
28523846	E.coli	C0014834
28523846	rapid	C0456962
28523846	analytical method	C0178476
28523846	refolding	C0162847
28523846	purification	C0597301
28523846	mecasermin	C0904505
28523846	drug product	C0013227
28523846	samples	C0370003
28523846	oxidation	C0030011
28523846	mecasermin	C0904505
28523846	mecasermin	C0904505
28523846	mecasermin	C0904505
28523846	reduction	C0301630
28523846	mecasermin	C0904505
28523846	samples	C0370003
28523846	MALDI-ISD	C0282597
28523846	peak intensity ratio	C0392762
28523846	charge state distribution	C0205556
28523846	CSD	C0205556
28523846	mecasermin	C0904505
28523846	ESI-MS	C0596495
28523846	HPLC	C0008562
28523846	drift time	C0392762
28523846	collision cross-sectional areas	C0392762
28523846	CCS	C0392762
28523846	mecasermin	C0904505
28523846	ESI-IMS-MS	C0022885
28523846	coupled	C1948027
28523846	HPLC	C0008562
28523846	MALDI-ISD	C0282597
28523846	CSD values	C0392762
28523846	ESI-MS	C0596495
28523846	CCS	C0392762
28523846	ESI-IMS-MS	C0022885
28523846	relationship	C0439849
28523846	folded	C0332462
28523846	unfolded	C1254362
28523846	proteoforms	C1510464
28523846	mecasermin	C0904505
28523846	mecasermin	C0904505
28523846	free-SH: protein ratio	C0392762
28523846	mecasermin	C0904505
28523846	drug product	C0013227
28523846	collision cross-sectional area	C0392762
28523846	ESI-IMS-MS	C0022885
28523846	proteoform	C1510464
28523846	rapid	C0456962
28523846	samples	C0370003
28523846	mecasermin	C0904505
28523846	ESI-IMS-MS	C0022885
28523846	HPLC	C0008562
28523846	rapid	C0456962
28523846	robust	C2986815
28523846	free-SH: protein ratio	C0392762
28523846	mecasermin	C0904505
28523846	proteoform	C1510464
28523846	oxidation	C0030011
28523846	mecasermin	C0904505
28523846	ESI-IMS-MS	C0022885
28523846	critical	C1511545
28523846	quality	C0332306
28523846	attributes	C1882133
28523846	quality	C0332306
28523846	design	C1707689
28523846	mecasermin	C0904505
28525754	Regulated	C0017263
28525754	Intron	C0021920
28525754	Removal	C1883720
28525754	Motivational State	C3825945
28525754	Experience	C0596545
28525754	experiences	C0596545
28525754	transient memory	C0025265
28525754	internal state	C0025361
28525754	organism	C0029235
28525754	experience	C0596545
28525754	memories	C0025260
28525754	time	C0040223
28525754	experience	C0596545
28525754	internal state	C0025361
28525754	influence	C4054723
28525754	duration	C0449238
28525754	memory	C0025260
28525754	self-assembled aggregated	C0205418
28525754	Drosophila Orb2A protein	C0949989
28525754	long-lasting memory	C0423909
28525754	adult fly	C1440070
28525754	brain	C0006104
28525754	mRNA	C0035696
28525754	encoding	C2700640
28525754	Orb2A protein	C0949989
28525754	unspliced non-protein-coding form	C0026661
28525754	convergence	C2700387
28525754	experience	C0596545
28525754	internal drive	C0013126
28525754	increases	C0442805
28525754	spliced protein-coding Orb2A mRNA	C0035696
28525754	pasilla	C1100909
28525754	fly	C1440070
28525754	mammalian	C0024660
28525754	Nova-1	C0033684
28525754	2	C0033684
28525754	mediator	C1363844
28525754	Orb2A mRNA	C0035696
28525754	processing	C0314627
28525754	single-nucleotide	C0028630
28525754	substitution	C0596324
28525754	intronic	C0021920
28525754	reduces	C0392756
28525754	Pasilla	C1100909
28525754	binding	C0033618
28525754	intron	C0021920
28525754	removal	C1883720
28525754	impairs	C0221099
28525754	long-term memory	C0423909
28525754	pasilla	C1100909
28525754	processing	C0314627
28525754	unspliced Orb2A mRNA	C0035696
28525754	experience	C0596545
28525754	internal state	C0025361
28525754	Orb2A protein	C0949989
28525754	abundance	C2346714
28525754	long-term memory	C0423909
28525754	formation	C1522492
28526360	FLASHE Study	C0038951
28526360	Survey	C0038951
28526360	Development	C1527148
28526360	Dyadic	C0870454
28526360	Participant	C0679646
28526360	Characteristics	C1521970
28526360	National Cancer Institute	C1513882
28526360	Family Life	C0015608
28526360	Activity	C0441655
28526360	Sun	C0038817
28526360	Health	C0018684
28526360	Eating	C0013470
28526360	FLASHE	C0038951
28526360	Study	C0038951
28526360	cancer preventive	C0281206
28526360	behaviors	C0018687
28526360	parent	C0030551
28526360	adolescent	C0205653
28526360	dyads	C0870454
28526360	FLASHE	C0038951
28526360	physical activity	C0026606
28526360	diet	C0012155
28526360	cancer preventive behaviors	C0281206
28526360	parent	C0030551
28526360	adolescent	C0205653
28526360	dyads	C0870454
28526360	FLASHE surveys	C0038951
28526360	literature reviews	C0282441
28526360	scientific	C0036397
28526360	input	C1708517
28526360	experts	C0009817
28526360	cognitive testing	C0204471
28526360	cross-sectional	C0010362
28526360	web-based study	C2603343
28526360	parents	C0030551
28526360	adolescent	C0205653
28526360	children	C0680063
28526360	administered	C1621583
28526360	April	C3715024
28526360	October	C3828732
28526360	parent	C0030551
28526360	adolescent	C0205653
28526360	dyads	C0870454
28526360	parents	C0030551
28526360	adolescents	C0205653
28526360	FLASHE surveys	C0038951
28526360	FLASHE	C0038951
28526360	parent	C0030551
28526360	adolescent	C0205653
28526360	interpersonal	C3476070
28526360	psychosocial variables	C0033963
28526360	parenting	C0085092
28526360	community	C0563116
28526360	home environments	C0442519
28526360	FLASHE	C0038951
28526360	responses	C1547656
28526360	parents	C0030551
28526360	adolescents	C0205653
28526360	dyads	C0870454
28526360	correlated	C0010100
28526360	FLASHE	C0038951
28526360	research questions	C0681799
28526360	individuals	C0027361
28526360	dyads	C0870454
28526360	ability	C0085732
28526360	similarity	C2348205
28526360	parents	C0030551
28526360	adolescents	C0205653
28526360	cancer preventive behaviors	C0281206
28526360	FLASHE	C0038951
28526360	researchers	C0035173
28526360	practitioners	C0017319
28526360	research	C0035168
28526360	cancer preventive	C0281206
28526360	health behaviors	C0018687
28527954	Sex differences	C0036866
28527954	effect of	C1704420
28527954	chronic mild stress	C1510527
28527954	mouse	C0025929
28527954	prefrontal cortical	C0162783
28527954	BDNF	C0107103
28527954	ovarian hormones	C0729511
28527954	Depression	C0011570
28527954	induced	C0205263
28527954	stress	C0038435
28527954	sex	C1522384
28527954	age	C0001779
28527954	hormonal	C0458083
28527954	animal	C0003062
28527954	duration	C0449238
28527954	stressors	C0597530
28527954	depression	C0011570
28527954	comorbidities	C0009488
28527954	women	C0043210
28527954	men	C0025266
28527954	sex	C1522384
28527954	animal models	C0599779
28527954	depression	C0011570
28527954	effect of	C1704420
28527954	sex	C1522384
28527954	ovarian hormones	C0729511
28527954	depression	C0011570
28527954	phenotypes	C0031437
28527954	mice	C0025929
28527954	Chronic Variable Mild Stress	C1510527
28527954	CVMS	C1510527
28527954	paradigm	C0242481
28527954	Adult	C0001675
28527954	male	C0086582
28527954	intact female	C3687560
28527954	ovariectomized (OVX) female	C3687559
28527954	mice	C0025929
28527954	CVMS	C1510527
28527954	behavior	C0004927
28527954	depression	C0011570
28527954	phenotype	C0031437
28527954	intact females	C3687560
28527954	males	C0086582
28527954	OVX females	C3687559
28527954	anhedonia	C0178417
28527954	depression	C0011570
28527954	phenotype	C0031437
28527954	molecular level	C0596958
28527954	expression	C1171362
28527954	Brain-Derived Neurotrophic Factor	C0107103
28527954	BDNF	C0107103
28527954	neuropeptide	C0027895
28527954	associated with	C0332281
28527954	depression	C0011570
28527954	stress	C0038435
28527954	genes	C0017337
28527954	CRH	C1366488
28527954	NR3C1	C1334899
28527954	CART	C1824528
28527954	NPY	C1417815
28527954	Prefrontal Cortex	C0162783
28527954	PFC	C0162783
28527954	BDNF	C0107103
28527954	protein expression	C1171362
28527954	mRNA expression	C1515670
28527954	CRH	C1366488
28527954	NR3C1	C1334899
28527954	CART	C1824528
28527954	NPY	C1417815
28527954	intact females	C3687560
28527954	mice	C0025929
28527954	OVX females	C3687559
28527954	males	C0086582
28527954	behavioral	C0243095
28527954	molecular responses	C4054479
28527954	CVMS	C1510527
28527954	17β-Estradiol	C0014912
28527954	E2	C0014912
28527954	administration	C1533734
28527954	Progesterone	C0033308
28527954	P4	C0033308
28527954	OVX female	C3687559
28527954	stress	C0038435
28527954	mice	C0025929
28527954	expression	C1171362
28527954	BDNF	C0107103
28527954	PFC	C0162783
28527954	effects of	C1704420
28527954	E2	C0014912
28527954	administration	C1533734
28527954	stress	C0038435
28528555	Development	C1527148
28528555	Evaluation	C0015194
28528555	ADHD	C1263846
28528555	ADHD Cognitions Scale	C0451081
28528555	Adults	C0001675
28528555	clinical literature	C0023866
28528555	ADHD	C1263846
28528555	adults	C0001675
28528555	overly positive	C0009240
28528555	optimistic cognitions	C0563183
28528555	impairment	C0221099
28528555	failure	C0680095
28528555	self-regulation skills	C0678856
28528555	population	C1257890
28528555	research	C0035168
28528555	literature	C0023866
28528555	ADHD	C1263846
28528555	ADHD Cognitions Scale	C0451081
28528555	ACS	C0451081
28528555	self-report	C2700446
28528555	measure	C0079809
28528555	ADHD	C1263846
28528555	thoughts	C0039869
28528555	psychometric properties	C0871161
28528555	self-report	C2700446
28528555	measures	C0079809
28528555	ACS	C0451081
28528555	community samples	C0009462
28528555	one-factor solution	C0392762
28528555	replicated	C0205173
28528555	sample	C0009462
28528555	internal consistency	C0870731
28528555	convergent	C1510594
28528555	divergent validity	C1510603
28528555	samples	C0009462
28528555	Scores	C0449820
28528555	ACS	C0451081
28528555	functional impairment	C4062321
28528555	time management problems	C0033213
28528555	avoidant coping	C0231426
28528555	strategies	C0679199
28528555	study	C2603343
28528555	ACS	C0451081
28528555	maladaptive	C0562443
28528555	ADHD	C1263846
28528555	cognitions	C0009240
28528555	cognitive-behavioral treatment	C0009244
28528555	study	C2603343
28528555	thoughts	C0039869
28528555	ADHD	C1263846
28528555	ADHD -related impairment	C4062321
28532359	Visual	C0234621
28532359	Confidence	C1704726
28532359	Visual	C0234621
28532359	confidence	C1704726
28532359	observer's	C0870992
28532359	ability	C0085732
28532359	judge	C0022423
28532359	accuracy	C0443131
28532359	perceptual decisions	C0679006
28532359	confidence	C1704726
28532359	judgments	C0022423
28532359	psychophysics	C0033930
28532359	visual perception	C0042830
28532359	visual	C0234621
28532359	confidence	C1704726
28532359	experimental evidence	C3887511
28532359	metacognitive abilities	C0589513
28532359	perceptual sensitivity	C0312418
28532359	experimental paradigms	C0681797
28532359	study	C2603343
28532359	visual	C0234621
28532359	confidence	C1704726
28532359	humans	C0086418
28532359	nonhuman animals	C0003062
28532359	origins	C0439659
28532359	confidence	C1704726
28532359	judgments	C0022423
28532359	investigators	C0035173
28532359	signal decision theory	C0011114
28532359	fails	C0231175
28532359	response times	C0034746
28532359	evidence	C3887511
28532359	models	C3161035
28532359	dynamics	C3826426
28532359	perceptual decisions	C0679006
28532359	models	C3161035
28532359	results	C1274040
28532359	paradoxical	C0205310
28532359	dissociation	C0086168
28532359	performance	C0597198
28532359	confidence	C1704726
28533788	Grapevine	C0682492
28533788	Subtilase Family	C0767764
28533788	Sequences	C0004793
28533788	Nomenclature Proposal	C0600281
28533788	grapevine	C0682492
28533788	serine peptidases	C2717971
28533788	subtilase family	C0767764
28533788	Plasmopara viticola	C1091290
28533788	resistance	C4281815
28533788	grapevine	C0682492
28533788	re-analyzed	C0936012
28533788	subtilase	C0767764
28533788	genes	C0017337
28533788	National Center for Biotechnology Information	C1705803
28533788	database	C0242356
28533788	NCBI	C1705803
28533788	grapevine	C0682492
28533788	genome annotation	C2936606
28533788	sequencing data	C0026382
28533788	prediction	C0681842
28533788	algorithms	C0002045
28533788	consequence	C0686907
28533788	gene annotations	C2936606
28533788	grapevine	C0682492
28533788	subtilase	C0767764
28533788	gene family	C1517488
28533788	sequences	C0004793
28533788	SBT	C0767764
28533788	sequence identifiers	C0600091
28533788	bioinformatic	C1140694
28533788	predictions	C0681842
28533788	nomenclature	C0600281
28533788	grapevine	C0682492
28533788	SBT	C0767764
28533788	genes	C0017337
28533788	results	C0456984
28533788	grapevine	C0682492
28533788	subtilase	C0767764
28533788	gene family	C1517488
28533788	subtilase	C0767764
28533788	genes	C0017337
28533788	encoding	C2700640
28533788	subtilase proteins	C0767764
28533788	alterations	C0596611
28533788	expression	C0017262
28533788	data	C1511726
28533788	subtilases	C0767764
28533788	grapevine	C0682492
28533788	resistance	C4281815
28533788	P. viticola	C1091290
28533788	pathosystem	C0450254
28533788	alteration	C0596611
28539192	Shared Decision Making	C3179495
28539192	promise	C1555307
28539192	healthcare system	C0018696
28539192	Peru	C0031238
28539192	Peru	C0031238
28539192	sustained development	C0282113
28539192	decades	C2981279
28539192	improvements	C2936612
28539192	quality of education	C0870471
28539192	health	C0034379
28539192	sectors	C0009433
28539192	region	C0017446
28539192	gaps	C4277599
28539192	infrastructure	C1254363
28539192	poor literacy level	C1401894
28539192	population	C1257890
28539192	health	C0018684
28539192	model	C3161035
28539192	patient care	C0017313
28539192	systems	C0018696
28539192	cooperate	C0392337
28539192	communicate	C0009452
28539192	communication	C0009452
28539192	system	C0018696
28539192	referral of patients	C0034927
28539192	basic level	C1547668
28539192	complex level	C1547668
28539192	care	C0017313
28539192	development	C1527148
28539192	person-centered clinical practice	C1254363
28539192	economic	C0013557
28539192	social	C0728831
28539192	educational	C0013652
28539192	clinical practice	C1254363
28539192	medical training	C0220931
28539192	development	C1527148
28539192	humanism	C0020156
28539192	patient	C0030705
28539192	medical act	C0079816
28539192	doctors'	C0031831
28539192	humanistic care approach	C1947933
28539192	person	C0027361
28539192	health care	C0086388
28539192	caring	C0150499
28539192	respectful	C0679133
28539192	model	C3161035
28539192	clinical practice	C1254363
28540429	markers	C0005516
28540429	quiescent	C3686820
28540429	pancreatic stellate cells	C2936598
28540429	normal	C0205307
28540429	human	C0086418
28540429	pancreas	C0030274
28540429	Pancreatic stellate cells	C2936598
28540429	PSCs	C2936598
28540429	fibrogenic cells	C0007634
28540429	pancreatic cancer	C0235974
28540429	chronic pancreatitis	C0149521
28540429	quiescent	C3686820
28540429	hepatic stellate cells	C2340138
28540429	qHSCs	C2340138
28540429	marker	C0005516
28540429	quiescent	C3686820
28540429	PSCs	C2936598
28540429	qPSCs	C2936598
28540429	formalin-fixed and paraffin embedded (FFPE) normal human pancreatic tissue	C2711483
28540429	qPSCs	C2936598
28540429	normal	C0205307
28540429	human	C0086418
28540429	FFPE pancreatic tissue	C2711483
28540429	Immunohistochemical	C1441616
28540429	IHC	C1441616
28540429	double-IHC	C1441616
28540429	immunofluorescence	C0079603
28540429	IF	C0079603
28540429	double-IF analyses	C0079603
28540429	tissue microarray	C1519522
28540429	normal	C0205307
28540429	human	C0086418
28540429	pancreatic tissue	C0587009
28540429	normal	C0205307
28540429	human	C0086418
28540429	liver	C0023884
28540429	control	C0009932
28540429	Antibodies	C0003241
28540429	adipophilin	C1505480
28540429	α-SMA	C2716282
28540429	CD146	C0386212
28540429	CRBP-1	C1872428
28540429	cytoglobin	C1450216
28540429	desmin	C0011696
28540429	GFAP	C0017626
28540429	nestin	C3711758
28540429	S100A4	C0287850
28540429	vinculin	C1454484
28540429	periacinar	C0442156
28540429	cells	C0007634
28540429	normal	C0205307
28540429	human	C0086418
28540429	pancreas	C0030274
28540429	perisinusoidal cells	C0227531
28540429	normal	C0205307
28540429	human	C0086418
28540429	liver	C0023884
28540429	immunolabelling	C0079609
28540429	capacity	C1516240
28540429	semiquantitative scoring system	C2986822
28540429	Double-IF	C0079603
28540429	markers	C0005516
28540429	markers	C0005516
28540429	periacinar	C0442156
28540429	cells	C0007634
28540429	histochemical stains	C1508788
28540429	human	C0086418
28540429	qPSCs	C2936598
28540429	ultrastructure	C0041623
28540429	electron microscopy	C0013842
28540429	Adipophilin	C1505480
28540429	CRBP-1	C1872428
28540429	cytoglobin	C1450216
28540429	vinculin	C1454484
28540429	qHSCs	C2340138
28540429	liver	C0023884
28540429	cytoglobin	C1450216
28540429	adipophilin	C1505480
28540429	qPSCs	C2936598
28540429	pancreas	C0030274
28540429	Adipophilin	C1505480
28540429	immunohistochemistry	C0021044
28540429	preanalytical time interval	C0872291
28540429	PATI	C0872291
28540429	tissue	C0040300
28540429	formalin fixation	C3536615
28540429	Cytoglobin	C1450216
28540429	S100A4	C0287850
28540429	vinculin	C1454484
28540429	periacinar	C0442156
28540429	fibroblasts	C0016030
28540429	FBs	C0016030
28540429	markers	C0005516
28540429	human	C0086418
28540429	qPSCs	C2936598
28540429	cytoglobin	C1450216
28540429	adipophilin	C1505480
28540429	markers	C0005516
28540429	qPSCs	C2936598
28540429	normal	C0205307
28540429	human	C0086418
28540429	pancreas	C0030274
28540429	adipophilin	C1505480
28540429	qPSC	C2936598
28540429	PATI	C0872291
28540429	Cytoglobin	C1450216
28540429	marker	C0005516
28540429	qPSCs	C2936598
28540429	FBs	C0016030
28541679	Biomagnetic monitoring	C0596176
28541679	atmospheric pollution	C0683932
28541679	review of	C0699752
28541679	magnetic	C0563532
28541679	biological sensors	C0600364
28541679	Biomagnetic monitoring	C0596176
28541679	atmospheric pollution	C0683932
28541679	environmental	C0014406
28541679	magnetism	C0563532
28541679	Particulate matter	C1720884
28541679	PM	C1720884
28541679	atmospheric pollution	C0683932
28541679	measurable	C1513040
28541679	magnetic minerals	C0439876
28541679	Biological	C0205460
28541679	surfaces	C0205148
28541679	atmospheric pollution	C0683932
28541679	magnetic	C0563532
28541679	particles	C0597177
28541679	location	C0450429
28541679	specific	C0205369
28541679	time-integrated	C1961029
28541679	air quality	C2371710
28541679	information	C1533716
28541679	review	C0282443
28541679	biological material	C0600364
28541679	sensors	C0600364
28541679	biomagnetic monitoring	C0596176
28541679	magnetic properties	C0563532
28541679	lichens	C0023657
28541679	mosses	C0282635
28541679	leaves	C0242724
28541679	bark	C0949119
28541679	trunk wood	C2700369
28541679	insects	C0021585
28541679	crustaceans	C1704306
28541679	mammal	C0024660
28541679	human tissues	C0440744
28541679	atmospheric pollutant species	C0001869
28541679	PM	C1720884
28541679	NOx	C0028167
28541679	trace elements	C0040577
28541679	PAHs	C0032458
28541679	pros and cons	C0243095
28541679	biomagnetic monitoring	C0596176
28541679	atmospheric pollution	C0683932
28541679	large-scale implementation	C0814860
28541679	biomagnetic monitoring	C0596176
28541679	future	C0016884
28541679	researchers	C0035173
28541679	policy makers	C0242170
28541679	biological sensor	C0600364
28541679	biomagnetic monitoring	C0596176
28545365	infrared spectroscopy	C0260249
28545365	imaging	C0079595
28545365	cancer	C0006826
28545365	diagnosis	C0011900
28545365	FTIR	C0206055
28545365	imaging	C0079595
28545365	diagnose	C0011900
28545365	differentiate	C0205615
28545365	molecular	C1521991
28545365	differences	C1705242
28545365	normal	C0040300
28545365	diseased	C0012634
28545365	tissues	C0040300
28545365	differences	C1705242
28545365	distribution	C1704711
28545365	structure	C0678594
28545365	lipids	C0023779
28545365	proteins	C0033684
28545365	nucleic acids	C0028606
28545365	metabolites	C0870883
28545365	differences	C1705242
28545365	type	C0872066
28545365	cancer	C0006826
28545365	sensitivity	C0332324
28545365	chemotherapy	C3665472
28545365	drugs	C1254351
28545365	individual	C0237401
28545365	FTIR spectroscopy	C0206055
28545365	imaging	C0079595
28545365	technique	C0449851
28545365	detection	C1511790
28545365	dreadful disease	C0012634
28545365	high sensitivity	C1441604
28545365	accuracy	C4035952
28545365	technique	C0449851
28545365	medical community	C1562642
28545365	technique	C0449851
28545365	early stage	C2363430
28545365	cancer	C0006826
28545365	detection	C1511790
28545365	technique	C0449851
28545365	challenges	C0805586
28545365	diagnosis	C0011900
28545365	cancer	C0006826
28545365	sample preparations	C3824791
28545365	data interpretation	C0262707
28545365	data analysis	C0010992
28545365	research	C0035168
28545365	morphology	C0332437
28545365	biology	C0005532
28545365	spectroscopy	C0206055
28545365	imaging	C0079595
28545365	invaluable	C1511545
28545365	information	C1533716
28550165	CLASP2	C1566863
28550165	Protein Interaction Network	C3178902
28550165	Adipocytes	C0206131
28550165	CLIP2	C2350719
28550165	AGAP3	C0061928
28550165	CLASP2	C1566863
28550165	G2L1	C0033684
28550165	MARK2	C0299851
28550165	SOGA1	C0026045
28550165	SOGA1	C0026045
28550165	Microtubule-Associated Protein	C0026045
28550165	CLASP2	C1566863
28550165	microtubule-associated protein	C0026045
28550165	insulin	C0021641
28550165	stimulated	C0599177
28550165	phosphorylation	C1158886
28550165	co-localization	C0475264
28550165	reorganized	C0680829
28550165	actin	C0001271
28550165	GLUT4	C0166441
28550165	plasma membrane	C0007603
28550165	gain	C1517378
28550165	insight	C0233820
28550165	role	C1705810
28550165	CLASP2	C1566863
28550165	system	C0597714
28550165	developed	C1527148
28550165	successfully	C1272703
28550165	executed	C1705848
28550165	streamlined	C0205357
28550165	interactome	C0872079
28550165	approach	C0444454
28550165	CLASP2	C1566863
28550165	protein network	C3178902
28550165	3T3-L1 adipocytes	C1257743
28550165	different	C1705242
28550165	commercially	C0680536
28550165	available	C0470187
28550165	antibodies	C0003241
28550165	CLASP2	C1566863
28550165	antibody	C0003241
28550165	epitope	C0003316
28550165	overexpressed	C1171362
28550165	CLASP2	C1566863
28550165	performed	C0884358
28550165	multiple	C0439064
28550165	affinity purification	C0008551
28550165	coupled	C1948027
28550165	mass spectrometry	C0037813
28550165	AP	C0008551
28550165	MS	C0037813
28550165	experiments	C0681814
28550165	combination	C0205195
28550165	label-free	C0475878
28550165	quantitative	C0392762
28550165	proteomics	C0872252
28550165	analyzed	C0936012
28550165	data	C1511726
28550165	bioinformatics	C1140694
28550165	tool	C0037589
28550165	Significance Analysis of Interactome	C3203917
28550165	SAINT	C3203917
28550165	discovered	C1880355
28550165	CLASP2	C1566863
28550165	co-immunoprecipitates	C0301871
28550165	co-IPs	C0301871
28550165	protein	C0033684
28550165	SOGA1	C0026045
28550165	microtubule-associated protein kinase	C3542416
28550165	MARK2	C0299851
28550165	microtubule	C0026046
28550165	actin	C0001271
28550165	regulating	C1327622
28550165	protein	C0033684
28550165	G2L1	C0033684
28550165	GTPase-activating proteins	C0061928
28550165	AGAP1	C1173678
28550165	AGAP3	C0061928
28550165	CLASP2	C1566863
28550165	interactome	C0872079
28550165	subsequent	C0332282
28550165	AGAP3	C0061928
28550165	CLIP2	C2350719
28550165	interactome	C0872079
28550165	analysis	C0936012
28550165	preference	C0558295
28550165	AGAP3	C0061928
28550165	CLIP2	C2350719
28550165	MARK2	C0299851
28550165	interactome	C0872079
28550165	analysis	C0936012
28550165	confirmed	C0750484
28550165	reciprocal	C1882911
28550165	co-IP	C0301871
28550165	CLASP2	C1566863
28550165	MARK2	C0299851
28550165	co-IP	C0301871
28550165	SOGA1	C0026045
28550165	glycogen synthase	C0017932
28550165	glycogenin	C1612135
28550165	Investigating	C1292732
28550165	SOGA1	C0026045
28550165	interactome	C0872079
28550165	confirmed	C0750484
28550165	SOGA1	C0026045
28550165	reciprocal	C1882911
28550165	co-IP	C0301871
28550165	CLASP2	C1566863
28550165	MARK2	C0299851
28550165	glycogen synthase	C0017932
28550165	glycogenin	C1612135
28550165	SOGA1	C0026045
28550165	confirmed	C0750484
28550165	colocalize	C0392752
28550165	CLASP2	C1566863
28550165	tubulin	C0041348
28550165	SOGA1	C0026045
28550165	microtubule-associated protein	C0026045
28550165	results	C0683954
28550165	metabolic function	C0597299
28550165	proposed	C1553874
28550165	protein networks	C3178902
28550165	relationship	C0439849
28550165	microtubules	C0026046
28550165	cytoskeleton	C0010853
28550165	associated	C0332281
28550165	protein biology	C0026376
